Psyllid ID: psy14556
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1181 | 2.2.26 [Sep-21-2011] | |||||||
| Q99683 | 1374 | Mitogen-activated protein | yes | N/A | 0.176 | 0.152 | 0.668 | 4e-79 | |
| A2AQW0 | 1331 | Mitogen-activated protein | yes | N/A | 0.150 | 0.133 | 0.777 | 9e-79 | |
| O35099 | 1380 | Mitogen-activated protein | no | N/A | 0.126 | 0.107 | 0.758 | 2e-78 | |
| Q6ZN16 | 1313 | Mitogen-activated protein | no | N/A | 0.150 | 0.135 | 0.772 | 7e-78 | |
| Q9WTR2 | 1291 | Mitogen-activated protein | no | N/A | 0.169 | 0.154 | 0.653 | 1e-74 | |
| O95382 | 1288 | Mitogen-activated protein | no | N/A | 0.169 | 0.155 | 0.663 | 2e-74 | |
| P54985 | 164 | Peptidyl-prolyl cis-trans | N/A | N/A | 0.117 | 0.847 | 0.884 | 8e-72 | |
| P25007 | 227 | Peptidyl-prolyl cis-trans | no | N/A | 0.120 | 0.625 | 0.887 | 4e-71 | |
| P29117 | 206 | Peptidyl-prolyl cis-trans | no | N/A | 0.117 | 0.674 | 0.805 | 2e-64 | |
| P30405 | 207 | Peptidyl-prolyl cis-trans | no | N/A | 0.117 | 0.671 | 0.798 | 3e-64 |
| >sp|Q99683|M3K5_HUMAN Mitogen-activated protein kinase kinase kinase 5 OS=Homo sapiens GN=MAP3K5 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 297 bits (760), Expect = 4e-79, Method: Compositional matrix adjust.
Identities = 141/211 (66%), Positives = 169/211 (80%), Gaps = 2/211 (0%)
Query: 778 MVQLVEDLRTIPTKKKYMQTPMLRFLYLFALN--RIELGKGSYGVVYAARELDRQVKLAI 835
MV + + + T++ ++ +L + Y + N R+ LGKG+YG+VYA R+L QV++AI
Sbjct: 649 MVNTITEEKGRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAI 708
Query: 836 KEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRV 895
KEIPE++ QPLHEEI LH L+H+NIVQYLGS SE G+ KIFMEQVPGGSLS LLR
Sbjct: 709 KEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRS 768
Query: 896 KWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 955
KWGPLK+NE T+ FYTKQILEGLKYLH +IVHRDIKGDNVL+NTYSGV+KISDFGTSKR
Sbjct: 769 KWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR 828
Query: 956 LAGLCPSAETFTGTLQYMAPEVIDKGQRGYG 986
LAG+ P ETFTGTLQYMAPE+IDKG RGYG
Sbjct: 829 LAGINPCTETFTGTLQYMAPEIIDKGPRGYG 859
|
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Mediates signaling for determination of cell fate such as differentiation and survival. Plays a crucial role in the apoptosis signal transduction pathway through mitochondria-dependent caspase activation. MAP3K5/ASK1 is required for the innate immune response, which is essential for host defense against a wide range of pathogens. Mediates signal transduction of various stressors like oxidative stress as well as by receptor-mediated inflammatory signals, such as the tumor necrosis factor (TNF) or lipopolysaccharide (LPS). Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K4/SEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7. These MAP2Ks in turn activate p38 MAPKs and c-jun N-terminal kinases (JNKs). Both p38 MAPK and JNKs control the transcription factors activator protein-1 (AP-1). Homo sapiens (taxid: 9606) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5 |
| >sp|A2AQW0|M3K15_MOUSE Mitogen-activated protein kinase kinase kinase 15 OS=Mus musculus GN=Map3k15 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 296 bits (757), Expect = 9e-79, Method: Compositional matrix adjust.
Identities = 140/180 (77%), Positives = 155/180 (86%), Gaps = 2/180 (1%)
Query: 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLG 869
R+ LGKGSYG+VYA R+L QV++AIKEIPE+++ QPLHEEI LH L+HRNIVQYLG
Sbjct: 659 RVVLGKGSYGIVYAGRDLSNQVRIAIKEIPERDIRYSQPLHEEIALHKYLKHRNIVQYLG 718
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
SVSE GY KIFMEQVPGGSLS LLR KWGP+KE T+ FYTKQILEGLKYLH +IVHR
Sbjct: 719 SVSENGYIKIFMEQVPGGSLSALLRSKWGPMKE--PTIKFYTKQILEGLKYLHENQIVHR 776
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPV 989
DIKGDNVLVNTYSGVVKISDFGTSKRLAG+ P ETFTGTLQYMAPE+ID+G RGYGAP
Sbjct: 777 DIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDQGPRGYGAPA 836
|
May function in a signal transduction pathway that is activated by various cell stresses and leads to apoptosis. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|O35099|M3K5_MOUSE Mitogen-activated protein kinase kinase kinase 5 OS=Mus musculus GN=Map3k5 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 295 bits (754), Expect = 2e-78, Method: Compositional matrix adjust.
Identities = 135/178 (75%), Positives = 154/178 (86%)
Query: 809 NRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYL 868
+R+ LGKG+YG+VYA R+L QV++AIKEIPE++ QPLHEEI LH L+H+NIVQYL
Sbjct: 689 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 748
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
GS SE G+ KIFMEQVPGGSLS LLR KWGPLK+NE T+ FYTKQILEGLKYLH +IVH
Sbjct: 749 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVH 808
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYG 986
RDIKGDNVL+NTYSGV+KISDFGTSKRLAG+ P ETFTGTLQYMAPE+IDKG RGYG
Sbjct: 809 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYG 866
|
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Mediates signaling for determination of cell fate such as differentiation and survival. Plays a crucial role in the apoptosis signal transduction pathway through mitochondria-dependent caspase activation. MAP3K5/ASK1 is required for the innate immune response, which is essential for host defense against a wide range of pathogens. Mediates signal transduction of various stressors like oxidative stress as well as by receptor-mediated inflammatory signals, such as the tumor necrosis factor (TNF) or lipopolysaccharide (LPS). Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K4/SEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7. These MAP2Ks in turn activate p38 MAPKs and c-jun N-terminal kinases (JNKs). Both p38 MAPK and JNKs control the transcription factors activator protein-1 (AP-1). Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q6ZN16|M3K15_HUMAN Mitogen-activated protein kinase kinase kinase 15 OS=Homo sapiens GN=MAP3K15 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 293 bits (749), Expect = 7e-78, Method: Compositional matrix adjust.
Identities = 139/180 (77%), Positives = 154/180 (85%), Gaps = 2/180 (1%)
Query: 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLG 869
R+ LGKG+YG+VYA R+L QV++AIKEIPE++ QPLHEEI LH L+HRNIVQYLG
Sbjct: 655 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKYLKHRNIVQYLG 714
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
SVSE GY KIFMEQVPGGSLS LLR KWGP+KE T+ FYTKQILEGLKYLH +IVHR
Sbjct: 715 SVSENGYIKIFMEQVPGGSLSALLRSKWGPMKE--PTIKFYTKQILEGLKYLHENQIVHR 772
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPV 989
DIKGDNVLVNTYSGVVKISDFGTSKRLAG+ P ETFTGTLQYMAPE+ID+G RGYGAP
Sbjct: 773 DIKGDNVLVNTYSGVVKISDFGTSKRLAGVNPCTETFTGTLQYMAPEIIDQGPRGYGAPA 832
|
May function in a signal transduction pathway that is activated by various cell stresses and leads to apoptosis. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q9WTR2|M3K6_MOUSE Mitogen-activated protein kinase kinase kinase 6 OS=Mus musculus GN=Map3k6 PE=1 SV=4 | Back alignment and function description |
|---|
Score = 282 bits (721), Expect = 1e-74, Method: Compositional matrix adjust.
Identities = 132/202 (65%), Positives = 165/202 (81%), Gaps = 2/202 (0%)
Query: 787 TIPTKKKYMQTPMLRFLYLFALN--RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG 844
+ PT++ +L F Y ++ R+ LG+G+YGVVYA R+ +V++AIKEIPE++
Sbjct: 627 SAPTEEAEGAREVLEFDYEYSETGERLVLGRGTYGVVYAGRDRHTRVRIAIKEIPERDSR 686
Query: 845 DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENE 904
QPLHEEI LH +LRH+NIV+YLGS S+ GY KIFME+VPGGSLS+LLR WGPLK+NE
Sbjct: 687 FSQPLHEEIALHKRLRHKNIVRYLGSASQGGYLKIFMEEVPGGSLSSLLRSVWGPLKDNE 746
Query: 905 STMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAE 964
ST+SFYT+QIL+GL YLH +IVHRDIKGDNVL+NT+SG++KISDFGTSKRLAG+ P E
Sbjct: 747 STISFYTRQILQGLSYLHENRIVHRDIKGDNVLINTFSGLLKISDFGTSKRLAGITPCTE 806
Query: 965 TFTGTLQYMAPEVIDKGQRGYG 986
TFTGTLQYMAPE+ID+G RGYG
Sbjct: 807 TFTGTLQYMAPEIIDQGPRGYG 828
|
Component of a protein kinase signal transduction cascade. Activates the JNK, but not ERK or p38 kinase pathways. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|O95382|M3K6_HUMAN Mitogen-activated protein kinase kinase kinase 6 OS=Homo sapiens GN=MAP3K6 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 281 bits (720), Expect = 2e-74, Method: Compositional matrix adjust.
Identities = 134/202 (66%), Positives = 162/202 (80%), Gaps = 2/202 (0%)
Query: 787 TIPTKKKYMQTPMLRFLYLFALN--RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG 844
T P ++ ML F Y + R+ LGKG+YGVVYA R+ +V++AIKEIPE++
Sbjct: 626 TAPAEEAEGAGEMLEFDYEYTETGERLVLGKGTYGVVYAGRDRHTRVRIAIKEIPERDSR 685
Query: 845 DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENE 904
QPLHEEI LH +LRH+NIV+YLGS S+ GY KIFME+VPGGSLS+LLR WGPLK+NE
Sbjct: 686 FSQPLHEEIALHRRLRHKNIVRYLGSASQGGYLKIFMEEVPGGSLSSLLRSVWGPLKDNE 745
Query: 905 STMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAE 964
ST+SFYT+QIL+GL YLH IVHRDIKGDNVL+NT+SG++KISDFGTSKRLAG+ P E
Sbjct: 746 STISFYTRQILQGLGYLHDNHIVHRDIKGDNVLINTFSGLLKISDFGTSKRLAGITPCTE 805
Query: 965 TFTGTLQYMAPEVIDKGQRGYG 986
TFTGTLQYMAPE+ID+G RGYG
Sbjct: 806 TFTGTLQYMAPEIIDQGPRGYG 827
|
Component of a protein kinase signal transduction cascade. Activates the JNK, but not ERK or p38 kinase pathways. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|P54985|PPIA_BLAGE Peptidyl-prolyl cis-trans isomerase OS=Blattella germanica GN=CYPA PE=2 SV=1 | Back alignment and function description |
|---|
Score = 273 bits (697), Expect = 8e-72, Method: Composition-based stats.
Identities = 123/139 (88%), Positives = 131/139 (94%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGN 187
++LRSDVVPKTAENFRALCTGEKGFG+K S FHRVIPNFMCQGGDFTNHNGTGGKSIYG
Sbjct: 22 MELRSDVVPKTAENFRALCTGEKGFGYKGSRFHRVIPNFMCQGGDFTNHNGTGGKSIYGT 81
Query: 188 KFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKK 247
KFEDENF LKHTGPGIL MANAGPNTNGSQFFITT KT+WLDNRHVVFGSVVEG+DVVKK
Sbjct: 82 KFEDENFQLKHTGPGILWMANAGPNTNGSQFFITTAKTSWLDNRHVVFGSVVEGMDVVKK 141
Query: 248 LESMGSQSGKTSKKIVVAN 266
LES+GSQSGKT+KKI V +
Sbjct: 142 LESLGSQSGKTNKKIAVVD 160
|
PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides. Blattella germanica (taxid: 6973) EC: 5 EC: . EC: 2 EC: . EC: 1 EC: . EC: 8 |
| >sp|P25007|PPIA_DROME Peptidyl-prolyl cis-trans isomerase OS=Drosophila melanogaster GN=Cyp1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 270 bits (691), Expect = 4e-71, Method: Compositional matrix adjust.
Identities = 126/142 (88%), Positives = 132/142 (92%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGN 187
++LRSDVVPKTAENFRALCTGEKGFG+K S FHRVIPNFMCQGGDFTNHNGTGGKSIYGN
Sbjct: 85 MELRSDVVPKTAENFRALCTGEKGFGYKGSIFHRVIPNFMCQGGDFTNHNGTGGKSIYGN 144
Query: 188 KFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKK 247
KF DENF LKHTG GILSMANAG NTNGSQFFI TVKTAWLDN+HVVFG VVEGLDVVKK
Sbjct: 145 KFPDENFELKHTGSGILSMANAGANTNGSQFFICTVKTAWLDNKHVVFGEVVEGLDVVKK 204
Query: 248 LESMGSQSGKTSKKIVVANSDS 269
+ES GSQSGKTSKKI+VANS S
Sbjct: 205 IESYGSQSGKTSKKIIVANSGS 226
|
PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides. Drosophila melanogaster (taxid: 7227) EC: 5 EC: . EC: 2 EC: . EC: 1 EC: . EC: 8 |
| >sp|P29117|PPIF_RAT Peptidyl-prolyl cis-trans isomerase F, mitochondrial OS=Rattus norvegicus GN=Ppif PE=1 SV=2 | Back alignment and function description |
|---|
Score = 248 bits (633), Expect = 2e-64, Method: Compositional matrix adjust.
Identities = 112/139 (80%), Positives = 127/139 (91%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGN 187
++L++DVVPKTAENFRALCTGEKGFG+K STFHRVIP FMCQ GDFTNHNGTGGKSIYG+
Sbjct: 63 LELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPAFMCQAGDFTNHNGTGGKSIYGS 122
Query: 188 KFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKK 247
+F DENFTLKH GPG+LSMANAGPNTNGSQFFI T+KT WLD +HVVFG V EG+DVVKK
Sbjct: 123 RFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVKEGMDVVKK 182
Query: 248 LESMGSQSGKTSKKIVVAN 266
+ES GS+SGKTSKKIV+ +
Sbjct: 183 IESFGSKSGKTSKKIVITD 201
|
PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides. Rattus norvegicus (taxid: 10116) EC: 5 EC: . EC: 2 EC: . EC: 1 EC: . EC: 8 |
| >sp|P30405|PPIF_HUMAN Peptidyl-prolyl cis-trans isomerase F, mitochondrial OS=Homo sapiens GN=PPIF PE=1 SV=1 | Back alignment and function description |
|---|
Score = 247 bits (631), Expect = 3e-64, Method: Compositional matrix adjust.
Identities = 111/139 (79%), Positives = 128/139 (92%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGN 187
++L++DVVPKTAENFRALCTGEKGFG+K STFHRVIP+FMCQ GDFTNHNGTGGKSIYG+
Sbjct: 64 LELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGS 123
Query: 188 KFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKK 247
+F DENFTLKH GPG+LSMANAGPNTNGSQFFI T+KT WLD +HVVFG V EG+DVVKK
Sbjct: 124 RFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVKEGMDVVKK 183
Query: 248 LESMGSQSGKTSKKIVVAN 266
+ES GS+SG+TSKKIV+ +
Sbjct: 184 IESFGSKSGRTSKKIVITD 202
|
PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides. Homo sapiens (taxid: 9606) EC: 5 EC: . EC: 2 EC: . EC: 1 EC: . EC: 8 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1181 | ||||||
| 328783588 | 1501 | PREDICTED: mitogen-activated protein kin | 0.231 | 0.181 | 0.606 | 1e-94 | |
| 307168035 | 1419 | Mitogen-activated protein kinase kinase | 0.237 | 0.198 | 0.595 | 2e-94 | |
| 332027798 | 1307 | Mitogen-activated protein kinase kinase | 0.232 | 0.209 | 0.602 | 6e-94 | |
| 383866289 | 1543 | PREDICTED: LOW QUALITY PROTEIN: mitogen- | 0.231 | 0.176 | 0.603 | 8e-94 | |
| 380024140 | 1525 | PREDICTED: mitogen-activated protein kin | 0.231 | 0.179 | 0.603 | 9e-94 | |
| 307208771 | 761 | Mitogen-activated protein kinase kinase | 0.253 | 0.392 | 0.556 | 2e-93 | |
| 350397243 | 1514 | PREDICTED: LOW QUALITY PROTEIN: mitogen- | 0.231 | 0.180 | 0.603 | 3e-93 | |
| 340726457 | 1549 | PREDICTED: mitogen-activated protein kin | 0.231 | 0.176 | 0.603 | 3e-93 | |
| 328719231 | 1346 | PREDICTED: mitogen-activated protein kin | 0.235 | 0.206 | 0.596 | 1e-92 | |
| 328719229 | 1376 | PREDICTED: mitogen-activated protein kin | 0.235 | 0.202 | 0.596 | 1e-92 |
| >gi|328783588|ref|XP_003250315.1| PREDICTED: mitogen-activated protein kinase kinase kinase 15-like [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 354 bits (909), Expect = 1e-94, Method: Compositional matrix adjust.
Identities = 193/318 (60%), Positives = 217/318 (68%), Gaps = 45/318 (14%)
Query: 775 YDAMVQLVEDLRTIPTK-KKYMQTPMLRFLYLF--ALNRIELGKGSYGVVYAARELDRQV 831
YD ++++ D + T YM ++F Y RI LGKG+YG+VYAAR+L+ QV
Sbjct: 734 YDLILEMTRDQEGMVTDLDAYMTDDRMKFEYELDDQNKRIMLGKGTYGIVYAARDLNTQV 793
Query: 832 KLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLST 891
++A+KEI E+NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS
Sbjct: 794 RIAVKEIRERNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSA 853
Query: 892 LLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFG 951
LLR KWGPLKENEST+++YTKQILEGLKYLH QKIVHRDIKGDNVLVNTYSGVVKISDFG
Sbjct: 854 LLRSKWGPLKENESTIAYYTKQILEGLKYLHDQKIVHRDIKGDNVLVNTYSGVVKISDFG 913
Query: 952 TSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRD------------------ 993
SKRLAGLCPS ETFTGTLQYMAPEVIDKGQRGYGAP
Sbjct: 914 MSKRLAGLCPSTETFTGTLQYMAPEVIDKGQRGYGAPADIWSLGCTIVEMATGKPPFIEL 973
Query: 994 -------------KINPCCRIEYKKMKINVFL-CVIISQLLVLTAA---------LKKKT 1030
KI+P E + N L C + + TAA KKKT
Sbjct: 974 GSPQAAVFKVGYYKIHPEIPSELSERAKNFILRCFEPNPDIRATAAELLEDPFLNEKKKT 1033
Query: 1031 SRALVAPPQISRSVSVPG 1048
+R L APP SRS+SVP
Sbjct: 1034 NR-LAAPPDFSRSISVPA 1050
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307168035|gb|EFN61359.1| Mitogen-activated protein kinase kinase kinase 15 [Camponotus floridanus] | Back alignment and taxonomy information |
|---|
Score = 354 bits (908), Expect = 2e-94, Method: Compositional matrix adjust.
Identities = 194/326 (59%), Positives = 222/326 (68%), Gaps = 45/326 (13%)
Query: 767 LQDYDAMDYDAMVQLVEDLRTIPTK-KKYMQTPMLRFLYLF--ALNRIELGKGSYGVVYA 823
++ Y YD ++++ D + T YM ++F Y RI LGKG+YGVVYA
Sbjct: 651 IRSYRQRFYDLILEMTRDQEGMVTDLDTYMTDDCMKFEYELDDQNKRIILGKGTYGVVYA 710
Query: 824 ARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQ 883
AR+L+ QV++A+KEI E+NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSE+GYFKIFMEQ
Sbjct: 711 ARDLNTQVRIAVKEIRERNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEDGYFKIFMEQ 770
Query: 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSG 943
VPGGSLS LLR+KWGPLKENEST+S+YTKQ+LEGLKYLH QKIVHRDIKGDNVLVNTYSG
Sbjct: 771 VPGGSLSALLRLKWGPLKENESTISYYTKQMLEGLKYLHDQKIVHRDIKGDNVLVNTYSG 830
Query: 944 VVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRD---------- 993
VVKISDFG SKRLAGLCPS ETFTGTLQYMAPEVIDKGQRGYGAP
Sbjct: 831 VVKISDFGMSKRLAGLCPSTETFTGTLQYMAPEVIDKGQRGYGAPADIWSLGCTIVEMAT 890
Query: 994 ---------------------KINPCCRIEY-KKMKINVFLCVIISQLLVLTAA------ 1025
KI+P E ++ K + C + + TAA
Sbjct: 891 GKPPFIELGSPQAAVFKVGYYKIHPEIPSELSERAKSFILRCFEPNPDIRATAAELLEDP 950
Query: 1026 ---LKKKTSRALVAPPQISRSVSVPG 1048
KKKTSR L APP SRS+SVP
Sbjct: 951 FLNEKKKTSR-LAAPPDFSRSISVPA 975
|
Source: Camponotus floridanus Species: Camponotus floridanus Genus: Camponotus Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|332027798|gb|EGI67863.1| Mitogen-activated protein kinase kinase kinase 15 [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 352 bits (904), Expect = 6e-94, Method: Compositional matrix adjust.
Identities = 191/317 (60%), Positives = 217/317 (68%), Gaps = 43/317 (13%)
Query: 775 YDAMVQLVEDLRTIPTK-KKYMQTPMLRFLYLF--ALNRIELGKGSYGVVYAARELDRQV 831
YD ++++ D + T YM ++F Y RI LGKG+YGVVYAAR+L+ QV
Sbjct: 575 YDLILEMTRDQEGMVTDLDAYMTDDRMKFEYELDDQNKRIILGKGTYGVVYAARDLNTQV 634
Query: 832 KLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLST 891
++A+KEI E+NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSE+GYFKIFMEQVPGGSLS
Sbjct: 635 RIAVKEIRERNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEDGYFKIFMEQVPGGSLSA 694
Query: 892 LLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFG 951
LLR KWGPLKENEST+S+YTKQ+LEGLKYLH QKIVHRDIKGDNVLVNTYSGVVKISDFG
Sbjct: 695 LLRSKWGPLKENESTISYYTKQMLEGLKYLHDQKIVHRDIKGDNVLVNTYSGVVKISDFG 754
Query: 952 TSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRD------------------ 993
SKRLAGLCPS ETFTGTLQYMAPEVIDKGQRGYGAP
Sbjct: 755 MSKRLAGLCPSTETFTGTLQYMAPEVIDKGQRGYGAPADIWSLGCTIVEMATGKPPFIEL 814
Query: 994 -------------KINPCCRIEY-KKMKINVFLCVIISQLLVLTAAL--------KKKTS 1031
KI+P E ++ K + C + + TAA +KK S
Sbjct: 815 GSPQAAVFKVGYYKIHPEIPSELSERAKSFILRCFEPNPDIRATAAELLEDPFLNEKKKS 874
Query: 1032 RALVAPPQISRSVSVPG 1048
LVAPP SRS+SVP
Sbjct: 875 NRLVAPPDFSRSISVPA 891
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383866289|ref|XP_003708603.1| PREDICTED: LOW QUALITY PROTEIN: mitogen-activated protein kinase kinase kinase 15-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 352 bits (903), Expect = 8e-94, Method: Compositional matrix adjust.
Identities = 192/318 (60%), Positives = 218/318 (68%), Gaps = 45/318 (14%)
Query: 775 YDAMVQLVEDLRTIPTK-KKYMQTPMLRFLYLF--ALNRIELGKGSYGVVYAARELDRQV 831
YD ++++ D + T YM ++F Y RI LGKG+YGVVYAAR+L+ QV
Sbjct: 778 YDLILEMTRDQEGMVTDLDAYMTDDRMKFEYELDDQNKRIMLGKGTYGVVYAARDLNTQV 837
Query: 832 KLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLST 891
++A+KEI E+NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSE+GYFKIFMEQVPGGSLS
Sbjct: 838 RIAVKEIRERNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEDGYFKIFMEQVPGGSLSA 897
Query: 892 LLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFG 951
LLR KWGPLKENEST+++YTKQILEGLKYLH QKIVHRDIKGDNVLVNTYSGVVKISDFG
Sbjct: 898 LLRSKWGPLKENESTIAYYTKQILEGLKYLHDQKIVHRDIKGDNVLVNTYSGVVKISDFG 957
Query: 952 TSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRD------------------ 993
SKRLAGLCPS ETFTGTLQYMAPEVIDKGQRGYGAP
Sbjct: 958 MSKRLAGLCPSTETFTGTLQYMAPEVIDKGQRGYGAPADIWSLGCTIVEMATGKPPFIEL 1017
Query: 994 -------------KINPCCRIEY-KKMKINVFLCVIISQLLVLTAA---------LKKKT 1030
KI+P E ++ K + C + + TAA KKKT
Sbjct: 1018 GSPQAAVFKVGYYKIHPEIPSELSERAKSFILRCFEPNPDIRATAAELLEDPFLNEKKKT 1077
Query: 1031 SRALVAPPQISRSVSVPG 1048
+R LVAPP RS+SVP
Sbjct: 1078 NR-LVAPPDFGRSISVPA 1094
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380024140|ref|XP_003695864.1| PREDICTED: mitogen-activated protein kinase kinase kinase 15-like [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 352 bits (902), Expect = 9e-94, Method: Compositional matrix adjust.
Identities = 192/318 (60%), Positives = 216/318 (67%), Gaps = 45/318 (14%)
Query: 775 YDAMVQLVEDLRTIPTK-KKYMQTPMLRFLYLF--ALNRIELGKGSYGVVYAARELDRQV 831
YD ++++ D + T YM ++F Y RI LGKG+YG+VYAAR+L+ QV
Sbjct: 759 YDLILEMTRDQEGMVTDLDAYMTDDRMKFEYELDDQNKRIMLGKGTYGIVYAARDLNTQV 818
Query: 832 KLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLST 891
++A+KEI E+NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS
Sbjct: 819 RIAVKEIRERNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSA 878
Query: 892 LLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFG 951
LLR KWGPLKENEST+++YTKQILEGLKYLH QKIVHRDIKGDNVLVNTYSGVVKISDFG
Sbjct: 879 LLRSKWGPLKENESTIAYYTKQILEGLKYLHDQKIVHRDIKGDNVLVNTYSGVVKISDFG 938
Query: 952 TSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRD------------------ 993
SKRLAGLCPS ETFTGTLQYMAPEVIDKGQRGYGAP
Sbjct: 939 MSKRLAGLCPSTETFTGTLQYMAPEVIDKGQRGYGAPADIWSLGCTIVEMATGKPPFIEL 998
Query: 994 -------------KINPCCRIEYKKMKINVFL-CVIISQLLVLTAA---------LKKKT 1030
KI+P E + N L C + + TAA KKKT
Sbjct: 999 GSPQAAVFKVGYYKIHPEIPSELSERAKNFILRCFEPNPDIRATAAELLEDPFLNEKKKT 1058
Query: 1031 SRALVAPPQISRSVSVPG 1048
+R L A P SRS+SVP
Sbjct: 1059 NR-LAAAPDFSRSISVPA 1075
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307208771|gb|EFN86048.1| Mitogen-activated protein kinase kinase kinase 15 [Harpegnathos saltator] | Back alignment and taxonomy information |
|---|
Score = 351 bits (900), Expect = 2e-93, Method: Compositional matrix adjust.
Identities = 173/311 (55%), Positives = 230/311 (73%), Gaps = 12/311 (3%)
Query: 326 ESETDSQSSLSSKALMDVVCVIDVSVPSDLSHRRRALDEIIQACSLVNAKLNLIEIKRLI 385
+S+ ++++ + MDV CV+D+ P L+ R+RALDE+ QAC+LVNA ++ I
Sbjct: 13 QSDISGHTTVTGRPRMDVACVLDLQQPEHLAQRKRALDEVRQACNLVNANIHHI------ 66
Query: 386 FCLFWFQFERLDWQKTEVVELFYNADVAIVDISIQEQRSSLLYHLGVRESFGMKQNILLY 445
QFE+LD+ +T V++ FYNADVA+VD+SI+ Q+S+L YHLGVRESFGMK+NILLY
Sbjct: 67 ------QFEKLDFGETNVLDTFYNADVAVVDLSIKLQQSALFYHLGVRESFGMKENILLY 120
Query: 446 NDCDTETAVRVKMSCQGYTFVTYRLEDCGSCLTTHTLSVTSEQRPSLEPRVPLTVRLKKI 505
ND DTE +R+K+SC YTFV+YR+ +CGSC+ T+ + +++P+ LT++LKK+
Sbjct: 121 NDVDTEATIRLKLSCGSYTFVSYRVVECGSCVATNPAASRITGEEAIDPKQHLTLKLKKL 180
Query: 506 LQDVEIQSKVHIKEKFLADLRKAREMYSGEELKTALYNLRQRLDDPKVLSGEVVLNVLMS 565
QDVEIQSK H+KEKFLADLRKARE YSGEEL AL N+R+RLDDP VLSGEVVLNVL+S
Sbjct: 181 FQDVEIQSKAHMKEKFLADLRKARETYSGEELSRALNNMRKRLDDPNVLSGEVVLNVLIS 240
Query: 566 FRDIQDYDAMVQLVEDLRTIPTKKKYMQTPMLRFLYLFALNSLYKRDERSLFLYVHENSD 625
FR+IQ YDAMVQLV+DLRTIPT K Y+ TP +R+LY FALN K +R L V E +
Sbjct: 241 FREIQGYDAMVQLVDDLRTIPTHKNYINTPAIRYLYAFALNRRNKEGDRERALKVIEKAL 300
Query: 626 DFESSEVGSLL 636
+ + + V +L
Sbjct: 301 EKKENHVPDML 311
|
Source: Harpegnathos saltator Species: Harpegnathos saltator Genus: Harpegnathos Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350397243|ref|XP_003484818.1| PREDICTED: LOW QUALITY PROTEIN: mitogen-activated protein kinase kinase kinase 15-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 350 bits (898), Expect = 3e-93, Method: Compositional matrix adjust.
Identities = 192/318 (60%), Positives = 216/318 (67%), Gaps = 45/318 (14%)
Query: 775 YDAMVQLVEDLRTIPTK-KKYMQTPMLRFLYLF--ALNRIELGKGSYGVVYAARELDRQV 831
YD ++++ D + T YM ++F Y RI LGKG+YG+VYAAR+L+ QV
Sbjct: 743 YDLILEMTRDQEGMVTDLDAYMTDDRMKFEYELDDQNKRIMLGKGTYGIVYAARDLNTQV 802
Query: 832 KLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLST 891
++A+KEI E+NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS
Sbjct: 803 RIAVKEIRERNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSA 862
Query: 892 LLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFG 951
LLR KWGPLKENEST+++YTKQILEGLKYLH QKIVHRDIKGDNVLVNTYSGVVKISDFG
Sbjct: 863 LLRSKWGPLKENESTIAYYTKQILEGLKYLHDQKIVHRDIKGDNVLVNTYSGVVKISDFG 922
Query: 952 TSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRD------------------ 993
SKRLAGLCPS ETFTGTLQYMAPEVIDKGQRGYGAP
Sbjct: 923 MSKRLAGLCPSTETFTGTLQYMAPEVIDKGQRGYGAPADIWSLGCTIVEMATGKPPFIEL 982
Query: 994 -------------KINPCCRIEYKKMKINVFL-CVIISQLLVLTAA---------LKKKT 1030
KI+P E + N L C + + TAA KKKT
Sbjct: 983 GSPQAAVFKVGYYKIHPEIPSELSERAKNFILRCFEPNPDIRATAAELLEDPFLNEKKKT 1042
Query: 1031 SRALVAPPQISRSVSVPG 1048
+R L A P SRS+SVP
Sbjct: 1043 NR-LAAVPDFSRSISVPA 1059
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340726457|ref|XP_003401574.1| PREDICTED: mitogen-activated protein kinase kinase kinase 15-like [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 350 bits (897), Expect = 3e-93, Method: Compositional matrix adjust.
Identities = 192/318 (60%), Positives = 216/318 (67%), Gaps = 45/318 (14%)
Query: 775 YDAMVQLVEDLRTIPTK-KKYMQTPMLRFLYLF--ALNRIELGKGSYGVVYAARELDRQV 831
YD ++++ D + T YM ++F Y RI LGKG+YG+VYAAR+L+ QV
Sbjct: 778 YDLILEMTRDQEGMVTDLDAYMTDDRMKFEYELDDQNKRIMLGKGTYGIVYAARDLNTQV 837
Query: 832 KLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLST 891
++A+KEI E+NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS
Sbjct: 838 RIAVKEIRERNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSA 897
Query: 892 LLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFG 951
LLR KWGPLKENEST+++YTKQILEGLKYLH QKIVHRDIKGDNVLVNTYSGVVKISDFG
Sbjct: 898 LLRSKWGPLKENESTIAYYTKQILEGLKYLHDQKIVHRDIKGDNVLVNTYSGVVKISDFG 957
Query: 952 TSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRD------------------ 993
SKRLAGLCPS ETFTGTLQYMAPEVIDKGQRGYGAP
Sbjct: 958 MSKRLAGLCPSTETFTGTLQYMAPEVIDKGQRGYGAPADIWSLGCTIVEMATGKPPFIEL 1017
Query: 994 -------------KINPCCRIEYKKMKINVFL-CVIISQLLVLTAA---------LKKKT 1030
KI+P E + N L C + + TAA KKKT
Sbjct: 1018 GSPQAAVFKVGYYKIHPEIPSELSERAKNFILRCFEPNPDIRATAAELLEDPFLNEKKKT 1077
Query: 1031 SRALVAPPQISRSVSVPG 1048
+R L A P SRS+SVP
Sbjct: 1078 NR-LAAVPDFSRSISVPA 1094
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328719231|ref|XP_001945657.2| PREDICTED: mitogen-activated protein kinase kinase kinase 15-like isoform 1 [Acyrthosiphon pisum] | Back alignment and taxonomy information |
|---|
Score = 348 bits (892), Expect = 1e-92, Method: Compositional matrix adjust.
Identities = 173/290 (59%), Positives = 221/290 (76%), Gaps = 12/290 (4%)
Query: 333 SSLSSKALMDVVCVIDVSVPSDLSHRRRALDEIIQACSLVNAKLNLIEIKRLIFCLFWFQ 392
S +S++ MD+VC+IDV S+L+HR+RAL+E+ QA LVNA L F
Sbjct: 35 SDISNRTKMDIVCIIDVVQSSNLAHRKRALEEVKQASILVNANL------------FIVS 82
Query: 393 FERLDWQKTEVVELFYNADVAIVDISIQEQRSSLLYHLGVRESFGMKQNILLYNDCDTET 452
FE+LD+ +T ++ FYNADVAIVD+SIQ Q+SSL YHLG+RESFGMKQNI+LYND DTE
Sbjct: 83 FEKLDFGETAELDTFYNADVAIVDLSIQFQQSSLFYHLGLRESFGMKQNIMLYNDLDTEV 142
Query: 453 AVRVKMSCQGYTFVTYRLEDCGSCLTTHTLSVTSEQRPSLEPRVPLTVRLKKILQDVEIQ 512
+R+K+SC YTF++Y+L DCG+CLTT+T + EPRVP+TV+L+K+L+DVEIQ
Sbjct: 143 TLRLKLSCGSYTFLSYKLADCGTCLTTNTSFQDESGGSTFEPRVPVTVKLRKLLKDVEIQ 202
Query: 513 SKVHIKEKFLADLRKAREMYSGEELKTALYNLRQRLDDPKVLSGEVVLNVLMSFRDIQDY 572
+KVHIKEKFL+DLRKAR+ YSGEEL+ L +R+RLDDP VLSG+VV +L+SFRD+QDY
Sbjct: 203 TKVHIKEKFLSDLRKARDNYSGEELRKKLLIMRKRLDDPHVLSGDVVHTMLISFRDVQDY 262
Query: 573 DAMVQLVEDLRTIPTKKKYMQTPMLRFLYLFALNSLYKRDERSLFLYVHE 622
DAMVQLVED++TIP KK Y+QTP LR+LY FALN K +R L V E
Sbjct: 263 DAMVQLVEDIQTIPNKKNYVQTPALRYLYPFALNRRNKPGDRKKALQVIE 312
|
Source: Acyrthosiphon pisum Species: Acyrthosiphon pisum Genus: Acyrthosiphon Family: Aphididae Order: Hemiptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328719229|ref|XP_003246702.1| PREDICTED: mitogen-activated protein kinase kinase kinase 15-like isoform 2 [Acyrthosiphon pisum] | Back alignment and taxonomy information |
|---|
Score = 348 bits (892), Expect = 1e-92, Method: Compositional matrix adjust.
Identities = 173/290 (59%), Positives = 221/290 (76%), Gaps = 12/290 (4%)
Query: 333 SSLSSKALMDVVCVIDVSVPSDLSHRRRALDEIIQACSLVNAKLNLIEIKRLIFCLFWFQ 392
S +S++ MD+VC+IDV S+L+HR+RAL+E+ QA LVNA L F
Sbjct: 35 SDISNRTKMDIVCIIDVVQSSNLAHRKRALEEVKQASILVNANL------------FIVS 82
Query: 393 FERLDWQKTEVVELFYNADVAIVDISIQEQRSSLLYHLGVRESFGMKQNILLYNDCDTET 452
FE+LD+ +T ++ FYNADVAIVD+SIQ Q+SSL YHLG+RESFGMKQNI+LYND DTE
Sbjct: 83 FEKLDFGETAELDTFYNADVAIVDLSIQFQQSSLFYHLGLRESFGMKQNIMLYNDLDTEV 142
Query: 453 AVRVKMSCQGYTFVTYRLEDCGSCLTTHTLSVTSEQRPSLEPRVPLTVRLKKILQDVEIQ 512
+R+K+SC YTF++Y+L DCG+CLTT+T + EPRVP+TV+L+K+L+DVEIQ
Sbjct: 143 TLRLKLSCGSYTFLSYKLADCGTCLTTNTSFQDESGGSTFEPRVPVTVKLRKLLKDVEIQ 202
Query: 513 SKVHIKEKFLADLRKAREMYSGEELKTALYNLRQRLDDPKVLSGEVVLNVLMSFRDIQDY 572
+KVHIKEKFL+DLRKAR+ YSGEEL+ L +R+RLDDP VLSG+VV +L+SFRD+QDY
Sbjct: 203 TKVHIKEKFLSDLRKARDNYSGEELRKKLLIMRKRLDDPHVLSGDVVHTMLISFRDVQDY 262
Query: 573 DAMVQLVEDLRTIPTKKKYMQTPMLRFLYLFALNSLYKRDERSLFLYVHE 622
DAMVQLVED++TIP KK Y+QTP LR+LY FALN K +R L V E
Sbjct: 263 DAMVQLVEDIQTIPNKKNYVQTPALRYLYPFALNRRNKPGDRKKALQVIE 312
|
Source: Acyrthosiphon pisum Species: Acyrthosiphon pisum Genus: Acyrthosiphon Family: Aphididae Order: Hemiptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1181 | ||||||
| FB|FBgn0014006 | 1367 | Pk92B "Protein kinase at 92B" | 0.149 | 0.129 | 0.813 | 9.6e-141 | |
| UNIPROTKB|K7GLD9 | 924 | MAP3K15 "Uncharacterized prote | 0.149 | 0.191 | 0.770 | 2.4e-117 | |
| MGI|MGI:2448588 | 1331 | Map3k15 "mitogen-activated pro | 0.149 | 0.132 | 0.782 | 6.9e-112 | |
| UNIPROTKB|Q6ZN16 | 1313 | MAP3K15 "Mitogen-activated pro | 0.149 | 0.134 | 0.776 | 1.3e-111 | |
| UNIPROTKB|F1N3W6 | 1314 | MAP3K15 "Uncharacterized prote | 0.149 | 0.134 | 0.776 | 1.3e-110 | |
| UNIPROTKB|F1PAG1 | 1305 | MAP3K15 "Uncharacterized prote | 0.150 | 0.136 | 0.761 | 4.1e-110 | |
| ZFIN|ZDB-GENE-091204-246 | 1331 | si:dkey-108d10.2 "si:dkey-108d | 0.150 | 0.133 | 0.761 | 7.6e-110 | |
| UNIPROTKB|I3LST3 | 1302 | MAP3K15 "Uncharacterized prote | 0.149 | 0.135 | 0.770 | 7.8e-110 | |
| UNIPROTKB|Q99683 | 1374 | MAP3K5 "Mitogen-activated prot | 0.176 | 0.152 | 0.668 | 4.4e-108 | |
| UNIPROTKB|F1PA02 | 1366 | MAP3K5 "Uncharacterized protei | 0.176 | 0.153 | 0.672 | 4.6e-108 |
| FB|FBgn0014006 Pk92B "Protein kinase at 92B" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 753 (270.1 bits), Expect = 9.6e-141, Sum P(4) = 9.6e-141
Identities = 144/177 (81%), Positives = 158/177 (89%)
Query: 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLG 869
++ LGKG+YG VYAAR+ QV++AIKE+PEKN DVQPLHEEIKLHSQLRHRNIV+YLG
Sbjct: 592 KMVLGKGTYGTVYAARDKQTQVRIAIKEVPEKNSQDVQPLHEEIKLHSQLRHRNIVRYLG 651
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
S SE G+FKIFMEQVPGGSLS LL KWGPLK+NESTM+FY+KQILEGLKYLH Q IVHR
Sbjct: 652 SCSENGFFKIFMEQVPGGSLSDLLETKWGPLKDNESTMAFYSKQILEGLKYLHEQDIVHR 711
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYG 986
DIKGDNVLVNTYSGVVKISDFGTSKRLA + P ETFTGTLQYMAPEVID+G RGYG
Sbjct: 712 DIKGDNVLVNTYSGVVKISDFGTSKRLARINPMTETFTGTLQYMAPEVIDQGVRGYG 768
|
|
| UNIPROTKB|K7GLD9 MAP3K15 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 714 (256.4 bits), Expect = 2.4e-117, Sum P(3) = 2.4e-117
Identities = 138/179 (77%), Positives = 153/179 (85%)
Query: 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLG 869
R+ LGKG+YGVVYA R+L QV++AIKEIPE++ QPLHEEI LH L+HRNIVQYLG
Sbjct: 655 RVVLGKGTYGVVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKYLKHRNIVQYLG 714
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
SVSE GY KIFMEQVPGGSLS LLR KWGP+KE T+ FYT+QILEGLKYLH +IVHR
Sbjct: 715 SVSENGYIKIFMEQVPGGSLSALLRSKWGPMKE--PTIRFYTRQILEGLKYLHENQIVHR 772
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAP 988
DIKGDNVLVNTYSGVVKISDFGTSKRLAG+ P ETF GTLQYMAPE+ID+G RGYGAP
Sbjct: 773 DIKGDNVLVNTYSGVVKISDFGTSKRLAGVNPCTETFAGTLQYMAPEIIDQGPRGYGAP 831
|
|
| MGI|MGI:2448588 Map3k15 "mitogen-activated protein kinase kinase kinase 15" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 730 (262.0 bits), Expect = 6.9e-112, Sum P(3) = 6.9e-112
Identities = 140/179 (78%), Positives = 155/179 (86%)
Query: 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLG 869
R+ LGKGSYG+VYA R+L QV++AIKEIPE+++ QPLHEEI LH L+HRNIVQYLG
Sbjct: 659 RVVLGKGSYGIVYAGRDLSNQVRIAIKEIPERDIRYSQPLHEEIALHKYLKHRNIVQYLG 718
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
SVSE GY KIFMEQVPGGSLS LLR KWGP+KE T+ FYTKQILEGLKYLH +IVHR
Sbjct: 719 SVSENGYIKIFMEQVPGGSLSALLRSKWGPMKE--PTIKFYTKQILEGLKYLHENQIVHR 776
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAP 988
DIKGDNVLVNTYSGVVKISDFGTSKRLAG+ P ETFTGTLQYMAPE+ID+G RGYGAP
Sbjct: 777 DIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDQGPRGYGAP 835
|
|
| UNIPROTKB|Q6ZN16 MAP3K15 "Mitogen-activated protein kinase kinase kinase 15" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 722 (259.2 bits), Expect = 1.3e-111, Sum P(3) = 1.3e-111
Identities = 139/179 (77%), Positives = 154/179 (86%)
Query: 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLG 869
R+ LGKG+YG+VYA R+L QV++AIKEIPE++ QPLHEEI LH L+HRNIVQYLG
Sbjct: 655 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKYLKHRNIVQYLG 714
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
SVSE GY KIFMEQVPGGSLS LLR KWGP+KE T+ FYTKQILEGLKYLH +IVHR
Sbjct: 715 SVSENGYIKIFMEQVPGGSLSALLRSKWGPMKE--PTIKFYTKQILEGLKYLHENQIVHR 772
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAP 988
DIKGDNVLVNTYSGVVKISDFGTSKRLAG+ P ETFTGTLQYMAPE+ID+G RGYGAP
Sbjct: 773 DIKGDNVLVNTYSGVVKISDFGTSKRLAGVNPCTETFTGTLQYMAPEIIDQGPRGYGAP 831
|
|
| UNIPROTKB|F1N3W6 MAP3K15 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 719 (258.2 bits), Expect = 1.3e-110, Sum P(3) = 1.3e-110
Identities = 139/179 (77%), Positives = 154/179 (86%)
Query: 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLG 869
R+ LGKG+YGVVYA R+L QV++AIKEIPE++ QPLHEEI LH L+HRNIVQYLG
Sbjct: 653 RVVLGKGTYGVVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKYLKHRNIVQYLG 712
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
SVSE+GY KIFMEQVPGGSLS LLR KWGP+KE T+ FYTKQILEGLKYLH +IVHR
Sbjct: 713 SVSEDGYIKIFMEQVPGGSLSALLRSKWGPMKE--PTIRFYTKQILEGLKYLHENQIVHR 770
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAP 988
DIKGDNVLVNTYSGVVKISDFGTSKRLAG+ P ETF GTLQYMAPE+ID+G RGYGAP
Sbjct: 771 DIKGDNVLVNTYSGVVKISDFGTSKRLAGVNPCTETFAGTLQYMAPEIIDQGPRGYGAP 829
|
|
| UNIPROTKB|F1PAG1 MAP3K15 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 719 (258.2 bits), Expect = 4.1e-110, Sum P(3) = 4.1e-110
Identities = 137/180 (76%), Positives = 156/180 (86%)
Query: 809 NRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYL 868
+R+ LGKG+YG+VYA R+L QV++AIKEIPE++ QPLHEEI LH L+HRNIVQYL
Sbjct: 647 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKYLKHRNIVQYL 706
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
GSVSE+GY KIFMEQVPGGSLS LLR KWGP+KE T+ FYT+QILEGLKYLH +IVH
Sbjct: 707 GSVSEDGYIKIFMEQVPGGSLSALLRSKWGPIKE--PTIKFYTRQILEGLKYLHENQIVH 764
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAP 988
RDIKGDNVLVNTYSG+VKISDFGTSKRLAG+ P ETFTGTLQYMAPE+ID+G RGYGAP
Sbjct: 765 RDIKGDNVLVNTYSGMVKISDFGTSKRLAGVNPCTETFTGTLQYMAPEIIDQGPRGYGAP 824
|
|
| ZFIN|ZDB-GENE-091204-246 si:dkey-108d10.2 "si:dkey-108d10.2" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 718 (257.8 bits), Expect = 7.6e-110, Sum P(4) = 7.6e-110
Identities = 137/180 (76%), Positives = 157/180 (87%)
Query: 809 NRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYL 868
+R+ LG+G+YGVVYA R+L QV++AIKEIPE++ QPLHEEI LH L+HRNIVQYL
Sbjct: 636 DRVVLGRGTYGVVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKYLKHRNIVQYL 695
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
GSVSE+GY KIFMEQVPGGSLS LLR KWGPLKE +T+ FYT+QILEG++YLH +IVH
Sbjct: 696 GSVSEDGYIKIFMEQVPGGSLSALLRSKWGPLKE--ATIIFYTRQILEGIRYLHENQIVH 753
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAP 988
RDIKGDNVLVNTYSGV+KISDFGTSKRLAG+ P ETFTGTLQYMAPE+IDKG RGYGAP
Sbjct: 754 RDIKGDNVLVNTYSGVLKISDFGTSKRLAGVNPCTETFTGTLQYMAPEIIDKGPRGYGAP 813
|
|
| UNIPROTKB|I3LST3 MAP3K15 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 714 (256.4 bits), Expect = 7.8e-110, Sum P(3) = 7.8e-110
Identities = 138/179 (77%), Positives = 153/179 (85%)
Query: 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLG 869
R+ LGKG+YGVVYA R+L QV++AIKEIPE++ QPLHEEI LH L+HRNIVQYLG
Sbjct: 655 RVVLGKGTYGVVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKYLKHRNIVQYLG 714
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
SVSE GY KIFMEQVPGGSLS LLR KWGP+KE T+ FYT+QILEGLKYLH +IVHR
Sbjct: 715 SVSENGYIKIFMEQVPGGSLSALLRSKWGPMKE--PTIRFYTRQILEGLKYLHENQIVHR 772
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAP 988
DIKGDNVLVNTYSGVVKISDFGTSKRLAG+ P ETF GTLQYMAPE+ID+G RGYGAP
Sbjct: 773 DIKGDNVLVNTYSGVVKISDFGTSKRLAGVNPCTETFAGTLQYMAPEIIDQGPRGYGAP 831
|
|
| UNIPROTKB|Q99683 MAP3K5 "Mitogen-activated protein kinase kinase kinase 5" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 734 (263.4 bits), Expect = 4.4e-108, Sum P(5) = 4.4e-108
Identities = 141/211 (66%), Positives = 169/211 (80%)
Query: 778 MVQLVEDLRTIPTKKKYMQTPMLRFLYLFALN--RIELGKGSYGVVYAARELDRQVKLAI 835
MV + + + T++ ++ +L + Y + N R+ LGKG+YG+VYA R+L QV++AI
Sbjct: 649 MVNTITEEKGRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAI 708
Query: 836 KEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRV 895
KEIPE++ QPLHEEI LH L+H+NIVQYLGS SE G+ KIFMEQVPGGSLS LLR
Sbjct: 709 KEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRS 768
Query: 896 KWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 955
KWGPLK+NE T+ FYTKQILEGLKYLH +IVHRDIKGDNVL+NTYSGV+KISDFGTSKR
Sbjct: 769 KWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR 828
Query: 956 LAGLCPSAETFTGTLQYMAPEVIDKGQRGYG 986
LAG+ P ETFTGTLQYMAPE+IDKG RGYG
Sbjct: 829 LAGINPCTETFTGTLQYMAPEIIDKGPRGYG 859
|
|
| UNIPROTKB|F1PA02 MAP3K5 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 735 (263.8 bits), Expect = 4.6e-108, Sum P(5) = 4.6e-108
Identities = 142/211 (67%), Positives = 168/211 (79%)
Query: 778 MVQLVEDLRTIPTKKKYMQTPMLRFLYLFALN--RIELGKGSYGVVYAARELDRQVKLAI 835
MV + + + T++ +T L + Y + N R+ LGKG+YG+VYA R+L QV++AI
Sbjct: 641 MVNTITEEKGRSTEEGDCETDSLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAI 700
Query: 836 KEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRV 895
KEIPE++ QPLHEEI LH L+H+NIVQYLGS SE G+ KIFMEQVPGGSLS LLR
Sbjct: 701 KEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRS 760
Query: 896 KWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 955
KWGPLK+NE T+ FYTKQILEGLKYLH +IVHRDIKGDNVL+NTYSGV+KISDFGTSKR
Sbjct: 761 KWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR 820
Query: 956 LAGLCPSAETFTGTLQYMAPEVIDKGQRGYG 986
LAG+ P ETFTGTLQYMAPE+IDKG RGYG
Sbjct: 821 LAGINPCTETFTGTLQYMAPEIIDKGPRGYG 851
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P18253 | CYPH_SCHPO | 5, ., 2, ., 1, ., 8 | 0.7647 | 0.1151 | 0.8395 | yes | N/A |
| P14832 | CYPH_YEAST | 5, ., 2, ., 1, ., 8 | 0.7410 | 0.1176 | 0.8580 | yes | N/A |
| Q9SKQ0 | CP19B_ARATH | 5, ., 2, ., 1, ., 8 | 0.7328 | 0.1176 | 0.7988 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 5.2.1 | 0.691 |
| 4th Layer | 5.2.1.8 | 0.737 |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1181 | |||
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-115 | |
| cd01926 | 164 | cd01926, cyclophilin_ABH_like, cyclophilin_ABH_lik | 4e-98 | |
| PTZ00060 | 183 | PTZ00060, PTZ00060, cyclophilin; Provisional | 3e-76 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-64 | |
| PLN03149 | 186 | PLN03149, PLN03149, peptidyl-prolyl isomerase H (c | 2e-59 | |
| pfam13281 | 365 | pfam13281, DUF4071, Domain of unknown function (DU | 1e-58 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-58 | |
| cd00317 | 146 | cd00317, cyclophilin, cyclophilin: cyclophilin-typ | 3e-56 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-55 | |
| COG0652 | 158 | COG0652, PpiB, Peptidyl-prolyl cis-trans isomerase | 3e-54 | |
| pfam00160 | 144 | pfam00160, Pro_isomerase, Cyclophilin type peptidy | 7e-52 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-49 | |
| cd01927 | 148 | cd01927, cyclophilin_WD40, cyclophilin_WD40: cyclo | 8e-49 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-48 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-44 | |
| cd01923 | 159 | cd01923, cyclophilin_RING, cyclophilin_RING: cyclo | 8e-44 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-43 | |
| cd01922 | 146 | cd01922, cyclophilin_SpCYP2_like, cyclophilin_SpCY | 7e-43 | |
| cd01928 | 153 | cd01928, Cyclophilin_PPIL3_like, Cyclophilin_PPIL3 | 4e-41 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-40 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-39 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-38 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-38 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-38 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-37 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-36 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-35 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-35 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-35 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-34 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-34 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-34 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-33 | |
| cd01925 | 171 | cd01925, cyclophilin_CeCYP16-like, cyclophilin_CeC | 1e-31 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-31 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-30 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-30 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-29 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-29 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-29 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-28 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-28 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-28 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-27 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-27 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-27 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-26 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-26 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-25 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-25 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-25 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-24 | |
| pfam13281 | 365 | pfam13281, DUF4071, Domain of unknown function (DU | 3e-24 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-24 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-24 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-24 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-23 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-23 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-23 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-23 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-23 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-22 | |
| cd01921 | 166 | cd01921, cyclophilin_RRM, cyclophilin_RRM: cycloph | 1e-22 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-22 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-22 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-22 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-22 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-22 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-21 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-21 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-21 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-21 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-21 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-21 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-20 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-20 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-20 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-20 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-19 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-19 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-18 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-18 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-18 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-18 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-18 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-18 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-18 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-17 | |
| cd01920 | 155 | cd01920, cyclophilin_EcCYP_like, cyclophilin_EcCYP | 5e-17 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-17 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-17 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-16 | |
| PTZ00221 | 249 | PTZ00221, PTZ00221, cyclophilin; Provisional | 1e-16 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-16 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-16 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-16 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-15 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-15 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-15 | |
| PRK10791 | 164 | PRK10791, PRK10791, peptidyl-prolyl cis-trans isom | 9e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-14 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-14 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-14 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-14 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-13 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-13 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-13 | |
| pfam13281 | 365 | pfam13281, DUF4071, Domain of unknown function (DU | 4e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-12 | |
| PRK10903 | 190 | PRK10903, PRK10903, peptidyl-prolyl cis-trans isom | 3e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-12 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-11 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-11 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-11 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-10 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-09 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-09 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-09 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-09 | |
| cd01924 | 176 | cd01924, cyclophilin_TLP40_like, cyclophilin_TLP40 | 7e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-07 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-07 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-06 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 3e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 5e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.001 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 0.001 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.002 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.002 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.003 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.003 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 357 bits (919), Expect = e-115
Identities = 148/191 (77%), Positives = 164/191 (85%), Gaps = 2/191 (1%)
Query: 800 LRFLYLFALN--RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHS 857
L + Y + N R+ LGKG+YG+VYAAR+L QV++AIKEIPE++ VQPLHEEI LHS
Sbjct: 1 LEYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHS 60
Query: 858 QLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEG 917
L+HRNIVQYLGS SE G+FKIFMEQVPGGSLS LLR KWGPLK+NE T+ FYTKQILEG
Sbjct: 61 YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEG 120
Query: 918 LKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEV 977
LKYLH +IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG+ P ETFTGTLQYMAPEV
Sbjct: 121 LKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEV 180
Query: 978 IDKGQRGYGAP 988
IDKG RGYGAP
Sbjct: 181 IDKGPRGYGAP 191
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|238907 cd01926, cyclophilin_ABH_like, cyclophilin_ABH_like: Cyclophilin A, B and H-like cyclophilin-type peptidylprolyl cis- trans isomerase (PPIase) domain | Back alignment and domain information |
|---|
Score = 308 bits (790), Expect = 4e-98
Identities = 110/145 (75%), Positives = 125/145 (86%), Gaps = 5/145 (3%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKG-----FGFKDSTFHRVIPNFMCQGGDFTNHNGTGGK 182
++L +DVVPKTAENFRALCTGEKG FG+K STFHRVIP+FM QGGDFT NGTGGK
Sbjct: 19 MELFADVVPKTAENFRALCTGEKGKGGKPFGYKGSTFHRVIPDFMIQGGDFTRGNGTGGK 78
Query: 183 SIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGL 242
SIYG KF DENF LKHTGPG+LSMANAGPNTNGSQFFITTVKT WLD +HVVFG VVEG+
Sbjct: 79 SIYGEKFPDENFKLKHTGPGLLSMANAGPNTNGSQFFITTVKTPWLDGKHVVFGKVVEGM 138
Query: 243 DVVKKLESMGSQSGKTSKKIVVANS 267
DVVKK+E++GS +GK KK+V+A+
Sbjct: 139 DVVKKIENVGSGNGKPKKKVVIADC 163
|
This family represents the archetypal cystolic cyclophilin similar to human cyclophilins A, B and H. PPIase is an enzyme which accelerates protein folding by catalyzing the cis-trans isomerization of the peptide bonds preceding proline residues. These enzymes have been implicated in protein folding processes which depend on catalytic /chaperone-like activities. As cyclophilins, Human hCyP-A, human cyclophilin-B (hCyP-19), S. cerevisiae Cpr1 and C. elegans Cyp-3, are inhibited by the immunosuppressive drug cyclopsporin A (CsA). CsA binds to the PPIase active site. Cyp-3. S. cerevisiae Cpr1 interacts with the Rpd3 - Sin3 complex and in addition is a component of the Set3 complex. S. cerevisiae Cpr1 has also been shown to have a role in Zpr1p nuclear transport. Human cyclophilin H associates with the [U4/U6.U5] tri-snRNP particles of the splicesome. Length = 164 |
| >gnl|CDD|240249 PTZ00060, PTZ00060, cyclophilin; Provisional | Back alignment and domain information |
|---|
Score = 248 bits (636), Expect = 3e-76
Identities = 104/188 (55%), Positives = 124/188 (65%), Gaps = 23/188 (12%)
Query: 88 FQMFFPSSQMRQR-FYDLVLEMTRDQEGMVTNLDDNLESEHI--KLRSDVVPKTAENFRA 144
F FP R + F+D+ + DN + I +L SDV PKTAENFRA
Sbjct: 5 FSQSFPEMSKRPKVFFDISI--------------DNAPAGRIVFELFSDVTPKTAENFRA 50
Query: 145 LCTGE------KGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFEDENFTLKH 198
LC G+ K +K S FHR+IP FMCQGGD TNHNGTGG+SIYG KF DENF LKH
Sbjct: 51 LCIGDKVGSSGKNLHYKGSIFHRIIPQFMCQGGDITNHNGTGGESIYGRKFTDENFKLKH 110
Query: 199 TGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGSQSGKT 258
PG+LSMANAGPNTNGSQFFITTV WLD +HVVFG V+EG++VV+ +E G+QSG
Sbjct: 111 DQPGLLSMANAGPNTNGSQFFITTVPCPWLDGKHVVFGKVIEGMEVVRAMEKEGTQSGYP 170
Query: 259 SKKIVVAN 266
K +VV +
Sbjct: 171 KKPVVVTD 178
|
Length = 183 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 218 bits (558), Expect = 3e-64
Identities = 82/181 (45%), Positives = 112/181 (61%), Gaps = 10/181 (5%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEI--PEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
LG+GS+G VY A + D +A+K + + +++ L EI++ S L+H NIV+Y GS
Sbjct: 8 LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGS 67
Query: 871 -VSEEG-YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
EE IF+E V GGSLS+LL+ K+G L E + YT+QILEGL YLH IVH
Sbjct: 68 ERDEEKNTLNIFLEYVSGGSLSSLLK-KFGKL--PEPVIRKYTRQILEGLAYLHSNGIVH 124
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA--ETFTGTLQYMAPEVIDKGQRGYG 986
RDIKG N+LV++ GVVK++DFG +KRL + + GT +MAPEVI + G
Sbjct: 125 RDIKGANILVDS-DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRA 183
Query: 987 A 987
A
Sbjct: 184 A 184
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|178694 PLN03149, PLN03149, peptidyl-prolyl isomerase H (cyclophilin H); Provisional | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 2e-59
Identities = 83/139 (59%), Positives = 101/139 (72%), Gaps = 6/139 (4%)
Query: 128 IKLRSDVVPKTAENFRALCTGE---KGF--GFKDSTFHRVIPNFMCQGGDFTNHNGTGGK 182
++L +D+ PKTAENFR CTGE G G+K FHRVI +FM QGGDF +GTG
Sbjct: 37 MELFADIAPKTAENFRQFCTGEFRKAGLPQGYKGCQFHRVIKDFMIQGGDFLKGDGTGCV 96
Query: 183 SIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVV-EG 241
SIYG+KFEDENF KHTGPG+LSMAN+GPNTNG QFFIT K WLDN+HVVFG V+ +G
Sbjct: 97 SIYGSKFEDENFIAKHTGPGLLSMANSGPNTNGCQFFITCAKCDWLDNKHVVFGRVLGDG 156
Query: 242 LDVVKKLESMGSQSGKTSK 260
L VV+K+E++ + K
Sbjct: 157 LLVVRKIENVATGPNNRPK 175
|
Length = 186 |
| >gnl|CDD|222023 pfam13281, DUF4071, Domain of unknown function (DUF4071) | Back alignment and domain information |
|---|
Score = 206 bits (526), Expect = 1e-58
Identities = 90/182 (49%), Positives = 119/182 (65%), Gaps = 2/182 (1%)
Query: 426 LLYHLGVRESFGMKQNILLYNDCDTETAVRVKMSCQGYTFVTYRLEDCGSCLTTHTLSVT 485
L YHLGVRESF MK NILLY D + +K+SC TF+ YR+ G +
Sbjct: 1 LFYHLGVRESFKMKNNILLYADGQDDVLQSLKISCANLTFIPYRVNPNGRPMNLADSRAN 60
Query: 486 SEQRPSLEPR-VPLTVRLKKILQDVEIQSKVHIKEKFLADLRKAREMYSGEELKTALYNL 544
+R L PL RL ++L+ V IQS H +EKFL+DLRKARE SG+EL+ L L
Sbjct: 61 LAERLQLARLLTPLDSRLYQLLKGVPIQSSAHKREKFLSDLRKAREKLSGKELRKELREL 120
Query: 545 RQRLDDPKVLSGEVVLNVLMSFRDIQDYDAMVQLVEDLRTIPTKKKYMQTPMLRFLYLFA 604
R RLDDP +LS ++V+N+L+S+RD+QDYDAM++LVEDL+ IPT + T +++F Y FA
Sbjct: 121 RARLDDPDLLSPDIVINLLLSYRDVQDYDAMIKLVEDLKAIPT-QDLADTVLIQFQYAFA 179
Query: 605 LN 606
LN
Sbjct: 180 LN 181
|
This domain is found at the N-terminus of many serine-threonine kinase-like proteins. Length = 365 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 3e-58
Identities = 66/181 (36%), Positives = 99/181 (54%), Gaps = 6/181 (3%)
Query: 809 NRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYL 868
++GKG +G VY AR ++AIK I ++ + + EI++ + +H NIV+Y
Sbjct: 4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYY 63
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
GS ++ I ME GGSL LL+ L ES +++ K++L+GL+YLH I+H
Sbjct: 64 GSYLKKDELWIVMEFCSGGSLKDLLKSTNQTL--TESQIAYVCKELLKGLEYLHSNGIIH 121
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAP 988
RDIK N+L+ + G VK+ DFG S +L+ T GT +MAPEVI+ Y
Sbjct: 122 RDIKAANILLTS-DGEVKLIDFGLSAQLSDTKAR-NTMVGTPYWMAPEVINGKP--YDYK 177
Query: 989 V 989
Sbjct: 178 A 178
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|238194 cd00317, cyclophilin, cyclophilin: cyclophilin-type peptidylprolyl cis- trans isomerases | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 3e-56
Identities = 76/141 (53%), Positives = 90/141 (63%), Gaps = 7/141 (4%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGN 187
I+L D PKT ENF +L G + +TFHRVIP FM QGGD T G G S G
Sbjct: 11 IELYGDEAPKTVENFLSLARGG---FYDGTTFHRVIPGFMIQGGDPTGTGG--GGSGPGY 65
Query: 188 KFEDENFTLK-HTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVK 246
KF DENF LK H G LSMANAGPNTNGSQFFITT T LD +H VFG VVEG+DVV
Sbjct: 66 KFPDENFPLKYHHRRGTLSMANAGPNTNGSQFFITTAPTPHLDGKHTVFGKVVEGMDVVD 125
Query: 247 KLESMG-SQSGKTSKKIVVAN 266
K+E ++G+ K + +++
Sbjct: 126 KIERGDTDENGRPIKPVTISD 146
|
This family contains eukaryotic, bacterial and archeal proteins which exhibit a peptidylprolyl cis- trans isomerases activity (PPIase, Rotamase) and in addition bind the immunosuppressive drug cyclosporin (CsA). Immunosuppression in vertebrates is believed to be the result of the cyclophilin A-cyclosporin protein drug complex binding to and inhibiting the protein-phosphatase calcineurin. PPIase is an enzyme which accelerates protein folding by catalyzing the cis-trans isomerization of the peptide bonds preceding proline residues. Cyclophilins are a diverse family in terms of function and have been implicated in protein folding processes which depend on catalytic /chaperone-like activities. This group contains human cyclophilin 40, a co-chaperone of the hsp90 chaperone system; human cyclophilin A, a chaperone in the HIV-1 infectious process and; human cyclophilin H, a component of the U4/U6 snRNP, whose isomerization or chaperoning activities may play a role in RNA splicing. . Length = 146 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 192 bits (490), Expect = 4e-55
Identities = 73/179 (40%), Positives = 105/179 (58%), Gaps = 8/179 (4%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIP-EKNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
+LG+GS+G VY AR+ +AIK I +K D + + EIK+ +L+H NIV+
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 871 VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRD 930
+E + ME GG L LL+ K G L +E FY +QIL L+YLH + IVHRD
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLK-KRGRL--SEDEARFYLRQILSALEYLHSKGIVHRD 122
Query: 931 IKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPV 989
+K +N+L++ G VK++DFG +++L TF GT +YMAPEV+ +GYG V
Sbjct: 123 LKPENILLDE-DGHVKLADFGLARQLDP-GEKLTTFVGTPEYMAPEVLL--GKGYGKAV 177
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|223725 COG0652, PpiB, Peptidyl-prolyl cis-trans isomerase (rotamase) - cyclophilin family [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 3e-54
Identities = 65/126 (51%), Positives = 79/126 (62%), Gaps = 9/126 (7%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGN 187
I+L D PKT NF L +GF + + FHRVIP FM QGGD T +GTGG
Sbjct: 13 IELYPDKAPKTVANFLQLVK--EGF-YDGTIFHRVIPGFMIQGGDPTGGDGTGGPGP--- 66
Query: 188 KFEDENFTLKH--TGPGILSMANAG-PNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDV 244
F+DENF L G LSMA AG PN+NGSQFFIT V +LD ++ VFG VVEG+DV
Sbjct: 67 PFKDENFALNGDRHKRGTLSMARAGDPNSNGSQFFITVVDNPFLDGKYTVFGQVVEGMDV 126
Query: 245 VKKLES 250
V K+++
Sbjct: 127 VDKIKN 132
|
Length = 158 |
| >gnl|CDD|215759 pfam00160, Pro_isomerase, Cyclophilin type peptidyl-prolyl cis-trans isomerase/CLD | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 7e-52
Identities = 62/140 (44%), Positives = 81/140 (57%), Gaps = 8/140 (5%)
Query: 127 HIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYG 186
I+L D PKT ENF +LC +KGF + + FHRVIP FM QGGD T G +SI
Sbjct: 12 VIELFGDEAPKTVENFLSLC--KKGF-YDGTIFHRVIPGFMIQGGDPTGPGTGGKRSI-- 66
Query: 187 NKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVK 246
DE + G LSMA +GPN+ GSQFFIT LD + VFG VVEG+DVV+
Sbjct: 67 ---PDEFVSKLKHKRGTLSMARSGPNSAGSQFFITLGDAPHLDGGYTVFGRVVEGMDVVE 123
Query: 247 KLESMGSQSGKTSKKIVVAN 266
K+E + + + K + + +
Sbjct: 124 KIEKVETDGDRPLKDVKITS 143
|
The peptidyl-prolyl cis-trans isomerases, also known as cyclophilins, share this domain of about 109 amino acids. Cyclophilins have been found in all organisms studied so far and catalyze peptidyl-prolyl isomerisation during which the peptide bond preceding proline (the peptidyl-prolyl bond) is stabilised in the cis conformation. Mammalian cyclophilin A (CypA) is a major cellular target for the immunosuppressive drug cyclosporin A (CsA). Other roles for cyclophilins may include chaperone and cell signalling function. Length = 144 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 2e-51
Identities = 86/182 (47%), Positives = 116/182 (63%), Gaps = 11/182 (6%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD-----VQPLHEEIKLHSQLRHRNIVQY 867
LG GS+G VY LD A+KE+ + G V+ L +EI L S+L+H NIVQY
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
LG+ EE IF+E VPGGSL+ LL+ K+G E + YT+QIL GL+YLH + V
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLK-KYGSFP--EPVIRLYTRQILLGLEYLHDRNTV 124
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGA 987
HRDIKG N+LV+T +GVVK++DFG +K++ A++F G+ +MAPEVI + Q GYG
Sbjct: 125 HRDIKGANILVDT-NGVVKLADFGMAKQVVEF-SFAKSFKGSPYWMAPEVIAQ-QGGYGL 181
Query: 988 PV 989
Sbjct: 182 AA 183
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 7e-49
Identities = 71/178 (39%), Positives = 104/178 (58%), Gaps = 4/178 (2%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD-VQPLHEEIKLHSQLRHRNIVQYLGSV 871
LG+G +G VY AR+ K+AIK I +++ ++ L EI++ +L H NIV+ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
+E + + ME GGSL LL+ G L E+E + QILEGL+YLH I+HRD+
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDE--ILRILLQILEGLEYLHSNGIIHRDL 118
Query: 932 KGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPV 989
K +N+L+++ +G VK++DFG SK L +T GT YMAPEV+ G+ Y
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVL-LGKGYYSEKS 175
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|238908 cd01927, cyclophilin_WD40, cyclophilin_WD40: cyclophilin-type peptidylprolyl cis- trans isomerases (cyclophilins) having a WD40 domain | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 8e-49
Identities = 73/137 (53%), Positives = 95/137 (69%), Gaps = 7/137 (5%)
Query: 127 HIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYG 186
HI+L + PKT ENF T + + ++ FHRVI FM Q GD T +GTGG+SI+G
Sbjct: 10 HIRLFPEEAPKTVENF---TTHARNGYYNNTIFHRVIKGFMIQTGDPTG-DGTGGESIWG 65
Query: 187 NKFEDE-NFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVV 245
+FEDE + +LKH P LSMANAGPNTNGSQFFITTV T WLDN+H VFG VV+G+DVV
Sbjct: 66 KEFEDEFSPSLKHDRPYTLSMANAGPNTNGSQFFITTVATPWLDNKHTVFGRVVKGMDVV 125
Query: 246 KKLESMGSQSGKTSKKI 262
+++E+ ++ K +
Sbjct: 126 QRIEN--VKTDKNDRPY 140
|
This group consists of several hypothetical and putative eukaryotic and bacterial proteins which have a cyclophilin domain and a WD40 domain. Function of the protein is not known. Length = 148 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 2e-48
Identities = 67/172 (38%), Positives = 100/172 (58%), Gaps = 12/172 (6%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEI-----PEKNLGDVQPLHEEIKLHSQLRHRNIVQ 866
+G+G++GVVY L+ +AIK+I E+ L + +EI L L+H NIV+
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIM---QEIDLLKNLKHPNIVK 63
Query: 867 YLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
Y+GS+ I +E GSL +++ K+GP ES ++ Y Q+L+GL YLH Q +
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIK-KFGPF--PESLVAVYVYQVLQGLAYLHEQGV 120
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
+HRDIK N+L T GVVK++DFG + +L + + GT +MAPEVI
Sbjct: 121 IHRDIKAANILT-TKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVI 171
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 3e-48
Identities = 69/179 (38%), Positives = 101/179 (56%), Gaps = 7/179 (3%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQP--LHEEIKLHSQLRHRNIVQYLGS 870
LG GS+G VY A+ +A+K + +++ + EI++ +L H NIV+ + +
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 871 VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRD 930
++ + + ME GG L L GPL E+E QIL GL+YLH I+HRD
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRG-GPLSEDE--AKKIALQILRGLEYLHSNGIIHRD 123
Query: 931 IKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPV 989
+K +N+L++ +GVVKI+DFG +K+L S TF GT YMAPEV+ G GYG V
Sbjct: 124 LKPENILLDE-NGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVL-LGGNGYGPKV 180
|
Length = 260 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 5e-44
Identities = 78/189 (41%), Positives = 112/189 (59%), Gaps = 16/189 (8%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIK--EIP--------EKNLGDVQPLHEEIKLHSQLRHR 862
+GKG+YG VY A + +A+K E+P + V+ L EI+ L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 863 NIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLH 922
NIVQYLG + E Y IF+E VPGGS+ + LR +G +E + F+T+Q+LEGL YLH
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR-TYGRFEE--QLVRFFTEQVLEGLAYLH 125
Query: 923 GQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT--GTLQYMAPEVIDK 980
+ I+HRD+K DN+LV+ G+ KISDFG SK+ + + + + G++ +MAPEVI
Sbjct: 126 SKGILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHS 184
Query: 981 GQRGYGAPV 989
+GY A V
Sbjct: 185 YSQGYSAKV 193
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|238904 cd01923, cyclophilin_RING, cyclophilin_RING: cyclophilin-type peptidylprolyl cis- trans isomerases (cyclophilins) having a modified RING finger domain | Back alignment and domain information |
|---|
Score = 156 bits (395), Expect = 8e-44
Identities = 71/153 (46%), Positives = 93/153 (60%), Gaps = 12/153 (7%)
Query: 115 MVTNLDD-NLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDF 173
+ TN D NLE L D PK ENF LC +KG+ + + FHR I NFM QGGD
Sbjct: 4 LHTNKGDLNLE-----LHCDKAPKACENFIKLC--KKGY-YDGTIFHRSIRNFMIQGGDP 55
Query: 174 TNHNGTGGKSIYGNKFEDE-NFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRH 232
T G GG+SI+G F+DE L H G G+LSMAN+GPNTNGSQFFIT LD +H
Sbjct: 56 TG-TGRGGESIWGKPFKDEFKPNLSHDGRGVLSMANSGPNTNGSQFFITYRSCKHLDGKH 114
Query: 233 VVFGSVVEGLDVVKKLESMGSQ-SGKTSKKIVV 264
VFG VV GL+ ++ +E++ + + ++I +
Sbjct: 115 TVFGRVVGGLETLEAMENVPDPGTDRPKEEIKI 147
|
This group includes the nuclear proteins, Human hCyP-60 and Caenorhabditis elegans MOG-6 which, compared to the archetypal cyclophilin Human cyclophilin A exhibit reduced peptidylprolyl cis- trans isomerase activity and lack a residue important for cyclophilin binding. Human hCyP-60 has been shown to physically interact with the proteinase inhibitor peptide eglin c and; C. elegans MOG-6 to physically interact with MEP-1, a nuclear zinc finger protein. MOG-6 has been shown to function in germline sex determination. Length = 159 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (400), Expect = 4e-43
Identities = 78/182 (42%), Positives = 110/182 (60%), Gaps = 14/182 (7%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLG-----DVQPLHEEIKLHSQLRHRNIVQY 867
LG+G++G VY ++D +LA+K++P +V L EI+L L+H IVQY
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
G + ++ IFME +PGGS+ L+ +G L E+ YT+QILEG++YLH IV
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKA-YGAL--TETVTRKYTRQILEGVEYLHSNMIV 126
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS---AETFTGTLQYMAPEVIDKGQRG 984
HRDIKG N+L ++ G VK+ DFG SKRL +C S ++ TGT +M+PEVI G
Sbjct: 127 HRDIKGANILRDSA-GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG--EG 183
Query: 985 YG 986
YG
Sbjct: 184 YG 185
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|238903 cd01922, cyclophilin_SpCYP2_like, cyclophilin_SpCYP2_like: cyclophilin 2-like peptidylprolyl cis- trans isomerase (PPIase) domain similar to Schizosaccharomyces pombe cyp-2 | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 7e-43
Identities = 67/124 (54%), Positives = 84/124 (67%), Gaps = 7/124 (5%)
Query: 136 PKTAENFRALCTGEKGFGFKDST-FHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFEDE-N 193
PKT +NF L G+ + T FHR+I +FM QGGD T G GG SIYG KFEDE +
Sbjct: 19 PKTCKNFYELAK----RGYYNGTIFHRLIKDFMIQGGDPTG-TGRGGASIYGKKFEDEIH 73
Query: 194 FTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGS 253
LKHTG GILSMANAGPNTNGSQFFIT T WLD +H +FG V +G+ V++ + + +
Sbjct: 74 PELKHTGAGILSMANAGPNTNGSQFFITLAPTPWLDGKHTIFGRVSKGMKVIENMVEVQT 133
Query: 254 QSGK 257
Q+ +
Sbjct: 134 QTDR 137
|
These proteins bind their respective SNW chromatin binding protein in autologous systems, in a CsA independent manner indicating interaction with a surface outside the PPIase active site. SNW proteins play a basic and broad range role in signaling. Length = 146 |
| >gnl|CDD|238909 cd01928, Cyclophilin_PPIL3_like, Cyclophilin_PPIL3_like | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 4e-41
Identities = 69/150 (46%), Positives = 85/150 (56%), Gaps = 7/150 (4%)
Query: 115 MVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFT 174
M L NL I+L D PK ENF ALC G+ + FHR I FM Q GD T
Sbjct: 1 MSVTLHTNLGDIKIELFCDDCPKACENFLALCAS--GY-YNGCIFHRNIKGFMVQTGDPT 57
Query: 175 NHNGTGGKSIYGNKFEDENF-TLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHV 233
G GG+SI+G KFEDE TLKH G++SMAN GPNTNGSQFFIT K LD ++
Sbjct: 58 G-TGKGGESIWGKKFEDEFRETLKHDSRGVVSMANNGPNTNGSQFFITYAKQPHLDGKYT 116
Query: 234 VFGSVVEGLDVVKKLESMGSQSGKTSKKIV 263
VFG V++G + + LE + K + +
Sbjct: 117 VFGKVIDGFETLDTLEKL--PVDKKYRPLE 144
|
Proteins similar to Human cyclophilin-like peptidylprolyl cis- trans isomerase (PPIL3). Members of this family lack a key residue important for cyclosporin binding: the tryptophan residue corresponding to W121 in human hCyP-18a; most members have a histidine at this position. The exact function of the protein is not known. Length = 153 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 62/172 (36%), Positives = 95/172 (55%), Gaps = 8/172 (4%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLG 869
++GKGS+G VY R +KEI N+ + + E+K+ +L H NI++Y
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLL---RVKWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
S E+G I ME GG LS + + + P E + + ++ Q+ LKYLH +KI
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQ-ILDWFV-QLCLALKYLHSRKI 124
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
+HRDIK N+ + T +G+VK+ DFG SK L+ A+T GT Y++PE+
Sbjct: 125 LHRDIKPQNIFL-TSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 5e-39
Identities = 66/167 (39%), Positives = 95/167 (56%), Gaps = 3/167 (1%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
+G G+YG VY AR++ +AIK I + D + + +EI + + RH NIV Y GS
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY 69
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
I ME GGSL + +V GPL E + +++ ++ L+GL YLH +HRDI
Sbjct: 70 LRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQ--IAYVCRETLKGLAYLHETGKIHRDI 127
Query: 932 KGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
KG N+L+ T G VK++DFG S +L ++F GT +MAPEV
Sbjct: 128 KGANILL-TEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVA 173
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 64/168 (38%), Positives = 92/168 (54%), Gaps = 5/168 (2%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVS 872
LG+GSYG VY A + +AIK +P + D+Q + +EI + Q IV+Y GS
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVE--EDLQEIIKEISILKQCDSPYIVKYYGSYF 68
Query: 873 EEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIK 932
+ I ME GS+S ++++ L E E ++ Q L+GL+YLH K +HRDIK
Sbjct: 69 KNTDLWIVMEYCGAGSVSDIMKITNKTLTEEE--IAAILYQTLKGLEYLHSNKKIHRDIK 126
Query: 933 GDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDK 980
N+L+N G K++DFG S +L T GT +MAPEVI +
Sbjct: 127 AGNILLNE-EGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE 173
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 5e-38
Identities = 67/181 (37%), Positives = 100/181 (55%), Gaps = 11/181 (6%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIP--EKNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
+G G++G VY A LD +A+KEI + + ++ + +E+K+ L+H N+V+Y G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 871 VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRD 930
IFME GG+L LL +E + YT Q+LEGL YLH IVHRD
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSHGIVHRD 124
Query: 931 IKGDNVLVNTYSGVVKISDFGTSKRLAG----LCPSAETFTGTLQYMAPEVIDKGQR-GY 985
IK N+ + ++GV+K+ DFG + +L + ++ GT YMAPEVI G+ G+
Sbjct: 125 IKPANIFL-DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGH 183
Query: 986 G 986
G
Sbjct: 184 G 184
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 7e-38
Identities = 68/184 (36%), Positives = 112/184 (60%), Gaps = 15/184 (8%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIP--EKNLGD----VQPLHEEIKLHSQLRHRNIVQ 866
LG G++ Y AR++ +A+K++ + V+ L +EI+L ++L H +I++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 867 YLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
LG+ E+ +F +F+E + GGS+S LL K+G KE YT+Q+L GL YLH +I
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLS-KYGAFKEAVIIN--YTEQLLRGLSYLHENQI 124
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT----GTLQYMAPEVIDKGQ 982
+HRD+KG N+L+++ ++I+DFG + RLA A F GT+ +MAPEV+ +G+
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL-RGE 183
Query: 983 RGYG 986
+ YG
Sbjct: 184 Q-YG 186
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 9e-37
Identities = 67/177 (37%), Positives = 98/177 (55%), Gaps = 6/177 (3%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIP-EKNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
+GKGS+G VY A + +AIK I E+ +++ + +EI+ SQ R I +Y GS
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 871 VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRD 930
+ I ME GGS LL K G L +E+ ++F +++L GL+YLH + +HRD
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLL--KPGKL--DETYIAFILREVLLGLEYLHEEGKIHRD 123
Query: 931 IKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGA 987
IK N+L++ G VK++DFG S +L TF GT +MAPEVI + A
Sbjct: 124 IKAANILLSE-EGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKA 179
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 80/187 (42%), Positives = 115/187 (61%), Gaps = 21/187 (11%)
Query: 813 LGKGSYGVVYAARELDRQVKL-AIKEI---PEKNLG---DVQPLHEEIKLHSQLRHRNIV 865
LGKG+YG VY L Q +L A+K++ L + + L EE+ L L+H NIV
Sbjct: 8 LGKGAYGTVYCG--LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
QYLG+ ++ IFME VPGGS+S++L ++GPL E YTKQIL+G+ YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILN-RFGPLP--EPVFCKYTKQILDGVAYLHNNC 122
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA------ETFTGTLQYMAPEVID 979
+VHRDIKG+NV++ +G++K+ DFG ++RLA + ++ GT +MAPEVI+
Sbjct: 123 VVHRDIKGNNVMLMP-NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181
Query: 980 KGQRGYG 986
+ GYG
Sbjct: 182 --ESGYG 186
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 68/182 (37%), Positives = 94/182 (51%), Gaps = 14/182 (7%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHE-----EIKLHSQLRHRNIVQ 866
LG+GS GVVY R A+K+I D E+K +V+
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIH----VDGDEEFRKQLLRELKTLRSCESPYVVK 63
Query: 867 YLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ-K 925
G+ +EG I +E + GGSL+ LL+ K G + E +++ +QIL+GL YLH +
Sbjct: 64 CYGAFYKEGEISIVLEYMDGGSLADLLK-KVGKIPEP--VLAYIARQILKGLDYLHTKRH 120
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGY 985
I+HRDIK N+L+N+ G VKI+DFG SK L TF GT+ YM+PE I Y
Sbjct: 121 IIHRDIKPSNLLINSK-GEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSY 179
Query: 986 GA 987
A
Sbjct: 180 AA 181
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 3e-35
Identities = 60/186 (32%), Positives = 102/186 (54%), Gaps = 16/186 (8%)
Query: 809 NRIELGKGSYGVVYAARELDRQVKLAIKEIP-----EKNLGDVQPLHEEIKLHSQLRHRN 863
N ++G+G+ G VY A + ++AIK++ ++ + + EI + +H N
Sbjct: 23 NLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN------EILIMKDCKHPN 76
Query: 864 IVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHG 923
IV Y S + ME + GGSL+ ++ ++ NE +++ +++L+GL+YLH
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIIT--QNFVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 924 QKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQR 983
Q ++HRDIK DN+L++ G VK++DFG + +L + GT +MAPEVI K +
Sbjct: 135 QNVIHRDIKSDNILLSK-DGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVI-KRKD 192
Query: 984 GYGAPV 989
YG V
Sbjct: 193 -YGPKV 197
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 4e-35
Identities = 82/199 (41%), Positives = 118/199 (59%), Gaps = 19/199 (9%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIP-----EKNLGDVQPLHEEIKLHSQLRHRNIVQY 867
LG+G++G VY + D +LA+K++P ++ +V L EI+L LRH IVQY
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 868 LGSVS--EEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
G + EE IF+E +PGGS+ L+ +G L EN + YT+QIL+G+ YLH
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKA-YGALTENVTRR--YTRQILQGVSYLHSNM 126
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA---ETFTGTLQYMAPEVIDKGQ 982
IVHRDIKG N+L ++ +G VK+ DFG SKR+ +C S ++ TGT +M+PEVI
Sbjct: 127 IVHRDIKGANILRDS-AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG-- 183
Query: 983 RGYGAPVRQRDKINPCCRI 1001
GYG R+ D + C +
Sbjct: 184 EGYG---RKADVWSVACTV 199
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 69/182 (37%), Positives = 101/182 (55%), Gaps = 21/182 (11%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQP----------LHEEIKLHSQLRHR 862
+G GS+G VY +A+K++ E L EI L +L+H
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQV-ELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 863 NIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLH 922
NIVQYLGS + + IF+E VPGGS++ LL +G + E+ + + +QIL+GL YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLN-NYGAFE--ETLVRNFVRQILKGLNYLH 123
Query: 923 GQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL------AGLCPSAETFTGTLQYMAPE 976
+ I+HRDIKG N+LV+ G +KISDFG SK+L + + G++ +MAPE
Sbjct: 124 NRGIIHRDIKGANILVDN-KGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182
Query: 977 VI 978
V+
Sbjct: 183 VV 184
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 61/180 (33%), Positives = 96/180 (53%), Gaps = 9/180 (5%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLG 869
LGKGS+G V R+ D A+K + +K + +V+ E + S++ H IV+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
+ E + +E PGG L + L K G +E FY +I+ L+YLH I++R
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLS-KEGRF--SEERARFYAAEIVLALEYLHSLGIIYR 117
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPV 989
D+K +N+L++ G +K++DFG +K L+ TF GT +Y+APEV+ GYG V
Sbjct: 118 DLKPENILLDA-DGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK--GYGKAV 174
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 4e-34
Identities = 80/185 (43%), Positives = 109/185 (58%), Gaps = 18/185 (9%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEI------PEKNLGDVQPLHEEIKLHSQLRHRNIVQ 866
LG+G++G VY ++D +LA K++ PE + +V L EI+L L+H IVQ
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETS-KEVSALECEIQLLKNLQHERIVQ 68
Query: 867 YLGSVSEEG--YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ 924
Y G + + IFME +PGGS+ L+ +G L ES YT+QILEG+ YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA-YGAL--TESVTRKYTRQILEGMSYLHSN 125
Query: 925 KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA---ETFTGTLQYMAPEVIDKG 981
IVHRDIKG N+L ++ +G VK+ DFG SKRL +C S + TGT +M+PEVI
Sbjct: 126 MIVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG- 183
Query: 982 QRGYG 986
GYG
Sbjct: 184 -EGYG 187
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 81/185 (43%), Positives = 110/185 (59%), Gaps = 18/185 (9%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEI------PEKNLGDVQPLHEEIKLHSQLRHRNIVQ 866
LG+G++G VY + D +LA+K++ PE + +V L EI+L L H IVQ
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETS-KEVNALECEIQLLKNLLHERIVQ 68
Query: 867 YLGSVSE--EGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ 924
Y G + + E IFME +PGGS+ L+ +G L EN + YT+QILEG+ YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLK-SYGALTENVTRK--YTRQILEGVSYLHSN 125
Query: 925 KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA---ETFTGTLQYMAPEVIDKG 981
IVHRDIKG N+L ++ G VK+ DFG SKRL +C S ++ TGT +M+PEVI
Sbjct: 126 MIVHRDIKGANILRDS-VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG- 183
Query: 982 QRGYG 986
GYG
Sbjct: 184 -EGYG 187
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|238906 cd01925, cyclophilin_CeCYP16-like, cyclophilin_CeCYP16-like: cyclophilin-type peptidylprolyl cis- trans isomerase) (PPIase) domain similar to Caenorhabditis elegans cyclophilin 16 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 55/115 (47%), Positives = 71/115 (61%), Gaps = 7/115 (6%)
Query: 127 HIKLRSDVVPKTAENFRALCTGEKGFGFKDST-FHRVIPNFMCQGGDFTNHNGTGGKSIY 185
I+L S PK NF LC G+ D+T FHRV+P F+ QGGD T GTGG+SIY
Sbjct: 18 DIELWSKEAPKACRNFIQLCLE----GYYDNTIFHRVVPGFIIQGGDPTG-TGTGGESIY 72
Query: 186 GNKFEDE-NFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVV 239
G F+DE + L+ G++ MANAG ++NGSQFF T K L+N+H +FG V
Sbjct: 73 GEPFKDEFHSRLRFNRRGLVGMANAGDDSNGSQFFFTLDKADELNNKHTLFGKVT 127
|
C. elegans CeCYP-16, compared to the archetypal cyclophilin Human cyclophilin A has, a reduced peptidylprolyl cis- trans isomerase activity, is cyclosporin insensitive and shows an altered substrate preference favoring, hydrophobic, acidic or amide amino acids. Most members of this subfamily have a glutamate residue in the active site at the position equivalent to a tryptophan (W121 in Human cyclophilin A), which has been shown to be important for cyclophilin binding. Length = 171 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 67/181 (37%), Positives = 98/181 (54%), Gaps = 7/181 (3%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIP-EKNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
+G G+ VVYAA L K+AIK I EK V L +E++ SQ H N+V+Y S
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 871 VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRD 930
+ M + GGSL +++ + +E+ ++ K++L+GL+YLH +HRD
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRD 127
Query: 931 IKGDNVLVNTYSGVVKISDFGTSKRLA--GLCPSA--ETFTGTLQYMAPEVIDKGQRGYG 986
IK N+L+ G VKI+DFG S LA G +TF GT +MAPEV+++ GY
Sbjct: 128 IKAGNILLGE-DGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ-VHGYD 185
Query: 987 A 987
Sbjct: 186 F 186
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 57/185 (30%), Positives = 84/185 (45%), Gaps = 26/185 (14%)
Query: 812 ELGKGSYGVVYAAR----ELDRQVKLAIKEIPEKN-LGDVQPLHEEIKLHSQLRHRNIVQ 866
+LG+G++G VY + K+A+K + E + + EE + +L H NIV+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 867 YLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
LG ++ I E +PGG L LR L + QI +G++YL +
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKL--TLKDLLQMALQIAKGMEYLESKNF 123
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFG----------TSKRLAGLCPSAETFTGTLQYMAPE 976
VHRD+ N LV + VVKISDFG KR G P +++MAPE
Sbjct: 124 VHRDLAARNCLVTE-NLVVKISDFGLSRDIYEDDYYRKRGGGKLP--------IKWMAPE 174
Query: 977 VIDKG 981
+ G
Sbjct: 175 SLKDG 179
|
Length = 258 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 7e-30
Identities = 70/181 (38%), Positives = 102/181 (56%), Gaps = 16/181 (8%)
Query: 810 RIEL-GKGSYGVVYAARELDRQVKLAIKEI----PEKNLGDVQPLHEEIKLHSQLRH--- 861
R+EL G+G+YG VY + + +A+K I P+ ++ D+Q E+ L SQLR
Sbjct: 5 RLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQ---REVALLSQLRQSQP 61
Query: 862 RNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYL 921
NI +Y GS + I ME GGS+ TL++ GP+ E +S +++L LKY+
Sbjct: 62 PNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA--GPIAE--KYISVIIREVLVALKYI 117
Query: 922 HGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKG 981
H ++HRDIK N+LV T +G VK+ DFG + L TF GT +MAPEVI +G
Sbjct: 118 HKVGVIHRDIKAANILV-TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176
Query: 982 Q 982
+
Sbjct: 177 K 177
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 54/180 (30%), Positives = 94/180 (52%), Gaps = 17/180 (9%)
Query: 812 ELGKGSYGVVYAAR----ELDRQVKLAIKEI-PEKNLGDVQPLHEEIKLHSQLRHRNIVQ 866
+LG+G++G VY + ++V++A+K + + + ++ E ++ +L H N+V+
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 867 YLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
LG +EE I ME + GG L + LR L + S + + QI G++YL +
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKL--SLSDLLSFALQIARGMEYLESKNF 123
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT-----LQYMAPEVIDKG 981
+HRD+ N LV + VVKISDFG S+ L + + +++MAPE + +G
Sbjct: 124 IHRDLAARNCLVGE-NLVVKISDFGLSRDL----YDDDYYRKRGGKLPIRWMAPESLKEG 178
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 2e-29
Identities = 67/184 (36%), Positives = 96/184 (52%), Gaps = 13/184 (7%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIP---EKNLGDVQPLHEEIKLHSQLRH-RNIVQY 867
+LG+GS+G VY AR + +A+K + E +V+ EI++ + L H NIV+
Sbjct: 7 KLGEGSFGEVYLAR---DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
+EG + ME V GGSL LL+ +ES F QIL L+YLH + I+
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGII 123
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAE------TFTGTLQYMAPEVIDKG 981
HRDIK +N+L++ VVK+ DFG +K L ++ T GT YMAPEV+
Sbjct: 124 HRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGL 183
Query: 982 QRGY 985
Y
Sbjct: 184 SLAY 187
|
Length = 384 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 56/185 (30%), Positives = 91/185 (49%), Gaps = 19/185 (10%)
Query: 812 ELGKGSYGVVYAAR---ELDRQVKLAIKEIPE-KNLGDVQPLHEEIKLHSQLRHRNIVQY 867
+LG+G++G VY + + + ++A+K + E + + + +E ++ +L H N+V+
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENE-STMSF-----YTKQILEGLKYL 921
LG +EE + +E + GG L LR E ST+S + QI +G++YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 922 HGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQ-----YMAPE 976
+K VHRD+ N LV VVKISDFG S+ + T +MAPE
Sbjct: 122 ASKKFVHRDLAARNCLVGE-DLVVKISDFGLSRDVY---DDDYYRKKTGGKLPIRWMAPE 177
Query: 977 VIDKG 981
+ G
Sbjct: 178 SLKDG 182
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 56/180 (31%), Positives = 94/180 (52%), Gaps = 16/180 (8%)
Query: 812 ELGKGSYGVVYAAR----ELDRQVKLAIKEI-PEKNLGDVQPLHEEIKLHSQLRHRNIVQ 866
+LG+G++G VY ++V++A+K + + + ++ E ++ +L H NIV+
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 867 YLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
LG +EE I ME +PGG L LR P + + S + + QI G++YL +
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKN-RPKELSLSDLLSFALQIARGMEYLESKNF 124
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT-----LQYMAPEVIDKG 981
+HRD+ N LV + VVKISDFG S+ L + + +++MAPE + +G
Sbjct: 125 IHRDLAARNCLVGE-NLVVKISDFGLSRDL----YDDDYYKVKGGKLPIRWMAPESLKEG 179
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 67/183 (36%), Positives = 99/183 (54%), Gaps = 18/183 (9%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKN----LGDVQPLHEEIKLHSQLRHRNIVQYL 868
LG GS+G V R A+K I K L V+ + E ++ +RH +V
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALK-ILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLY 67
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
GS ++ + ME VPGG L + LR K G E + FY Q++ L+YLH IV+
Sbjct: 68 GSFQDDSNLYLVMEYVPGGELFSHLR-KSGRFPEPVAR--FYAAQVVLALEYLHSLDIVY 124
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT--GTLQYMAPEVIDKGQRGYG 986
RD+K +N+L+++ G +KI+DFG +KR+ G T+T GT +Y+APE+I +GYG
Sbjct: 125 RDLKPENLLLDSD-GYIKITDFGFAKRVKG-----RTYTLCGTPEYLAPEIILS--KGYG 176
Query: 987 APV 989
V
Sbjct: 177 KAV 179
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 61/175 (34%), Positives = 87/175 (49%), Gaps = 7/175 (4%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIP-EKNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
ELG G+ GVV +A+K I E N + + E+ + + IV + G+
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 871 VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ-KIVHR 929
G I ME + GGSL +L+ G + E + +L+GL YLH + KI+HR
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQGRI--PERILGKIAVAVLKGLTYLHEKHKIIHR 125
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRG 984
D+K N+LVN+ G +K+ DFG S +L A+TF GT YMAPE I
Sbjct: 126 DVKPSNILVNS-RGQIKLCDFGVSGQLVN--SLAKTFVGTSSYMAPERIQGNDYS 177
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 5e-28
Identities = 69/186 (37%), Positives = 101/186 (54%), Gaps = 16/186 (8%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIP---EKNLGDVQPLHEEIKLHSQLRHRNIVQYL 868
++G+G+YG VY AR +A+K+I EK + + EIKL +LRH NIV+
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAI-REIKLLQKLRHPNIVRLK 64
Query: 869 GSVSEEGYFKIFM--EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
V+ +G I+M E + L+ LL ES + Y KQ+LEGL+YLH I
Sbjct: 65 EIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKF--TESQIKCYMKQLLEGLQYLHSNGI 121
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG---TLQYMAPEVIDKGQR 983
+HRDIKG N+L+N GV+K++DFG ++ ++ +T TL Y PE++ G
Sbjct: 122 LHRDIKGSNILINN-DGVLKLADFGLARPYTK--RNSADYTNRVITLWYRPPELL-LGAT 177
Query: 984 GYGAPV 989
YG V
Sbjct: 178 RYGPEV 183
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 56/167 (33%), Positives = 92/167 (55%), Gaps = 3/167 (1%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
ELG G++G VY A+ + + A K I ++ +++ EI + S+ +H NIV +
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY 71
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
E I +E GG+L +++ L E + + + +Q+LE L +LH K++HRD+
Sbjct: 72 FYENKLWILIEFCDGGALDSIMLELERGLTEPQ--IRYVCRQMLEALNFLHSHKVIHRDL 129
Query: 932 KGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
K N+L+ T G VK++DFG S + +TF GT +MAPEV+
Sbjct: 130 KAGNILL-TLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVV 175
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 59/185 (31%), Positives = 100/185 (54%), Gaps = 10/185 (5%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGS 870
+G+G++G+V+ R Q + IK+IP + + + E ++ L H NI++Y +
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 871 VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRD 930
E+ I ME PGG+L+ ++ + L + ++ + F+ QIL L ++H + I+HRD
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV-QILLALHHVHTKLILHRD 126
Query: 931 IKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVR 990
+K N+L++ + VVKI DFG SK L A T GT Y++PE+ + G P
Sbjct: 127 LKTQNILLDKHKMVVKIGDFGISKIL-SSKSKAYTVVGTPCYISPELCE------GKPYN 179
Query: 991 QRDKI 995
Q+ I
Sbjct: 180 QKSDI 184
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 54/177 (30%), Positives = 95/177 (53%), Gaps = 10/177 (5%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQLRHRNIVQYLG 869
LG G +G V + + A+K + +++ G + + E ++ + H IV+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
+ ++ Y + ME GG L T+LR + G +E T FY ++ +YLH + I++R
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDR-GLF--DEYTARFYIACVVLAFEYLHNRGIIYR 117
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYG 986
D+K +N+L+++ +G VK+ DFG +K+L TF GT +Y+APE+I +GY
Sbjct: 118 DLKPENLLLDS-NGYVKLVDFGFAKKLKSG-QKTWTFCGTPEYVAPEIIL--NKGYD 170
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 67/187 (35%), Positives = 100/187 (53%), Gaps = 23/187 (12%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQP---LHEEIKLHSQLRHRNIVQYLG 869
LG+G+YGVVY AR+ +A+K+I N + P L EI L +L+H NIV+ L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTAL-REISLLKELKHPNIVK-LL 64
Query: 870 SV--SEEGYFKIF--MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
V +E + +F + L L + GPL + + + Q+L GL Y H +
Sbjct: 65 DVIHTERKLYLVFEYCDM----DLKKYLDKRPGPL--SPNLIKSIMYQLLRGLAYCHSHR 118
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG---TLQYMAPEVIDKGQ 982
I+HRD+K N+L+N GV+K++DFG + R G+ P T+T TL Y APE++ G
Sbjct: 119 ILHRDLKPQNILINR-DGVLKLADFGLA-RAFGI-PLR-TYTHEVVTLWYRAPEIL-LGS 173
Query: 983 RGYGAPV 989
+ Y V
Sbjct: 174 KHYSTAV 180
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 8e-27
Identities = 68/177 (38%), Positives = 100/177 (56%), Gaps = 14/177 (7%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIP---EKNLGDVQPLHEEIKLHSQLRHRNIVQYL 868
E+G GS+G VY AR++ +AIK++ +++ Q + +E++ QLRH N ++Y
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
G E + ME G S S +L V PL+E E ++ L+GL YLH + +H
Sbjct: 82 GCYLREHTAWLVMEYCLG-SASDILEVHKKPLQEVE--IAAICHGALQGLAYLHSHERIH 138
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI---DKGQ 982
RDIK N+L+ T G VK++DFG+ A L A +F GT +MAPEVI D+GQ
Sbjct: 139 RDIKAGNILL-TEPGTVKLADFGS----ASLVSPANSFVGTPYWMAPEVILAMDEGQ 190
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 1e-26
Identities = 66/172 (38%), Positives = 98/172 (56%), Gaps = 4/172 (2%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVS 872
+G G+YG VY AR ++ AIK I + D + +EI + +H NIV Y GS
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 873 EEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIK 932
I ME GGSL + V GPL +ES +++ +++ L+GL YLH + +HRDIK
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVT-GPL--SESQIAYVSRETLQGLYYLHSKGKMHRDIK 133
Query: 933 GDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRG 984
G N+L+ T +G VK++DFG S ++ ++F GT +MAPEV ++G
Sbjct: 134 GANILL-TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKG 184
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 65/185 (35%), Positives = 99/185 (53%), Gaps = 19/185 (10%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEI--PEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
+G+G+YGVVY AR+ +AIK+I ++ G + EIKL +L H NI++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 871 VSEEGYFKI---FMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
+G + FM+ L L++ + L ES + Y Q+L+GL + H I+
Sbjct: 67 FRHKGDLYLVFEFMDT----DLYKLIKDRQRGL--PESLIKSYLYQLLQGLAFCHSHGIL 120
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT---GTLQYMAPEVIDKGQRG 984
HRD+K +N+L+NT GV+K++DFG R G +T T Y APE++ G +G
Sbjct: 121 HRDLKPENLLINT-EGVLKLADFG-LARSFG--SPVRPYTHYVVTRWYRAPELL-LGDKG 175
Query: 985 YGAPV 989
Y PV
Sbjct: 176 YSTPV 180
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 63/165 (38%), Positives = 93/165 (56%), Gaps = 4/165 (2%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVS 872
+G G+YG VY AR L A+K I + D + +EI + + +H NIV Y GS
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 873 EEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIK 932
I ME GGSL + V GPL E + +++ ++ L+GL YLH + +HRDIK
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVT-GPLSELQ--IAYVCRETLQGLAYLHSKGKMHRDIK 133
Query: 933 GDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEV 977
G N+L+ T +G VK++DFG + ++ ++F GT +MAPEV
Sbjct: 134 GANILL-TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV 177
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 60/188 (31%), Positives = 96/188 (51%), Gaps = 17/188 (9%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLG 869
+ KG+YG V+ A++ AIK I + ++ V + E + SQ + +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
S + + ME +PGG L++LL G L E+ + Y +I+ L+YLH I+HR
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLE-NVGSLDEDVAR--IYIAEIVLALEYLHSNGIIHR 117
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSK----RLAGLCPSAET----FTGTLQYMAPEVIDKG 981
D+K DN+L+++ +G +K++DFG SK R E GT Y+APEVI
Sbjct: 118 DLKPDNILIDS-NGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG- 175
Query: 982 QRGYGAPV 989
+G+ V
Sbjct: 176 -QGHSKTV 182
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 68/186 (36%), Positives = 93/186 (50%), Gaps = 32/186 (17%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQ-LR----HRNIVQ 866
+G+G+YG VY AR +AIK + + D + EEIK LR H NI
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMD--IIEDEE---EEIKEEYNILRKYSNHPNIAT 67
Query: 867 YLGSVSEEGYFK-----------IFMEQVPGGSLSTL---LRVKWGPLKENESTMSFYTK 912
+ G + K + ME GGS++ L LR K LKE +++ +
Sbjct: 68 FYG-----AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW--IAYILR 120
Query: 913 QILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQY 972
+ L GL YLH K++HRDIKG N+L+ T + VK+ DFG S +L TF GT +
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILL-TKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYW 179
Query: 973 MAPEVI 978
MAPEVI
Sbjct: 180 MAPEVI 185
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 60/168 (35%), Positives = 96/168 (57%), Gaps = 5/168 (2%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
ELG G++G VY A+ + A K I K+ +++ EI++ + H IV+ LG+
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 872 SEEGYFKIFMEQVPGGSL-STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRD 930
+G I +E PGG++ + +L + G L E + + +Q+LE L+YLH KI+HRD
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQ--IQVICRQMLEALQYLHSMKIIHRD 135
Query: 931 IKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
+K NVL+ T G +K++DFG S + ++F GT +MAPEV+
Sbjct: 136 LKAGNVLL-TLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVV 182
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 61/173 (35%), Positives = 99/173 (57%), Gaps = 8/173 (4%)
Query: 809 NRIELGKGSYGVVY-AARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIV 865
++GKGS+GVV+ R+ D++V A+K+I + + + +E ++ ++L I+
Sbjct: 4 ILNKIGKGSFGVVFKVVRKADKRV-YAMKQIDLSKMNRREREEAIDEARVLAKLDSSYII 62
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWG-PLKENESTMSFYTKQILEGLKYLHGQ 924
+Y S ++G I ME G L LL+++ G PL E++ F+ QIL GL +LH +
Sbjct: 63 RYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQ-VWRFFI-QILLGLAHLHSK 120
Query: 925 KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEV 977
KI+HRDIK N+ ++ Y VKI D G +K L+ A T GT Y++PE+
Sbjct: 121 KILHRDIKSLNLFLDAYDN-VKIGDLGVAKLLSDNTNFANTIVGTPYYLSPEL 172
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|222023 pfam13281, DUF4071, Domain of unknown function (DUF4071) | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-24
Identities = 39/56 (69%), Positives = 45/56 (80%)
Query: 12 RTLAMVLNNLIGKKGSLSSVTDYWDVATFFEISVLAEDYGKAIQAAECMFKLKPPD 67
R + + LNNL+G+KGSLS + DYWDVAT E+SVLA DY KAIQAAE MFKLKPP
Sbjct: 274 RKIGVTLNNLLGRKGSLSKLEDYWDVATLLELSVLANDYAKAIQAAERMFKLKPPV 329
|
This domain is found at the N-terminus of many serine-threonine kinase-like proteins. Length = 365 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 55/180 (30%), Positives = 95/180 (52%), Gaps = 8/180 (4%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLH--EEIKLHSQLRHRNIVQYLGS 870
+G+G++G+V+ A++ + +A+K++ + L P EIK +H +V+ L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 871 VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRD 930
F + ME +P LS +LR + PL E + Y + +L+G+ Y+H I+HRD
Sbjct: 68 FPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKS--YMRMLLKGVAYMHANGIMHRD 124
Query: 931 IKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF-TGTLQYMAPEVIDKGQRGYGAPV 989
+K N+L++ GV+KI+DFG ++ + P + T Y APE++ G R Y V
Sbjct: 125 LKPANLLISA-DGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL-YGARKYDPGV 182
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 64/170 (37%), Positives = 89/170 (52%), Gaps = 10/170 (5%)
Query: 813 LGKGSYGVVYAAREL-DRQVKLAIKEIPEKNLGDVQPLH--EEIKLHSQLRHRNIVQYLG 869
LGKGSYG VY + L D Q A+KE+ ++ + EI++ + + H NI+ Y
Sbjct: 8 LGKGSYGSVYKVKRLSDNQF-YALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLL--RVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
+ + I ME P G LS + R K L + + Q+L GL+ LH QKI+
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QLLRGLQALHEQKIL 125
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEV 977
HRD+K N+L+ + +VKI D G SK L A+T GT YMAPEV
Sbjct: 126 HRDLKSANILLVA-NDLVKIGDLGISKVLKKN--MAKTQIGTPHYMAPEV 172
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 70/175 (40%), Positives = 99/175 (56%), Gaps = 10/175 (5%)
Query: 808 LNRIELGKGSYGVVYAARELDRQVKLAIKEIP-EKNLGDVQPLHEEIKLHSQLRHRNIVQ 866
L RI GKGS+G V+ + Q +AIK I E+ +++ + +EI + SQ + +
Sbjct: 9 LERI--GKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 66
Query: 867 YLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENE-STMSFYTKQILEGLKYLHGQK 925
Y GS + I ME + GGS LLR GP E + +TM K+IL+GL YLH +K
Sbjct: 67 YYGSYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIATM---LKEILKGLDYLHSEK 121
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDK 980
+HRDIK NVL++ G VK++DFG + +L TF GT +MAPEVI +
Sbjct: 122 KIHRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQ 175
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 70/184 (38%), Positives = 104/184 (56%), Gaps = 15/184 (8%)
Query: 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIP---EKNLGDVQPLHEEIKLHSQLRH 861
LF+ R E+G GS+G VY AR++ +AIK++ +++ Q + +E++ +LRH
Sbjct: 16 LFSDLR-EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 862 RNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYL 921
N +QY G E + ME G S S LL V PL+E E ++ T L+GL YL
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVE--IAAVTHGALQGLAYL 131
Query: 922 HGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI--- 978
H ++HRD+K N+L+ + G+VK+ DFG+ A + A F GT +MAPEVI
Sbjct: 132 HSHNMIHRDVKAGNILL-SEPGLVKLGDFGS----ASIMAPANXFVGTPYWMAPEVILAM 186
Query: 979 DKGQ 982
D+GQ
Sbjct: 187 DEGQ 190
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 60/182 (32%), Positives = 103/182 (56%), Gaps = 16/182 (8%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIK--EIPEK-NLGDVQPLHEEIKLHSQLRHRNIVQYLG 869
+G G++G V+ R+ + A+K IPE L Q +H E ++ ++ H I++
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
+ ++ + + ME VPGG L + LR + + ST FY +I+ L+YLH ++IV+R
Sbjct: 69 TEHDQRFLYMLMEYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKEIVYR 125
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT--GTLQYMAPEVIDKGQRGYGA 987
D+K +N+L++ G +K++DFG +K+L T+T GT +Y+APEVI +G+
Sbjct: 126 DLKPENILLDK-EGHIKLTDFGFAKKL-----RDRTWTLCGTPEYLAPEVI--QSKGHNK 177
Query: 988 PV 989
V
Sbjct: 178 AV 179
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 36/204 (17%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKE------IPEKNLGDVQPLHEEIKLHSQLRHRNIV 865
+G+GS+ V A+E + + AIK I EK + V E+ L H I+
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYV--KIEKEVLTRLNGHPGII 65
Query: 866 QYLGSVSEEG--YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHG 923
+ + +E YF +E P G L +R K+G L +E FY +IL L+YLH
Sbjct: 66 KLYYTFQDEENLYF--VLEYAPNGELLQYIR-KYGSL--DEKCTRFYAAEILLALEYLHS 120
Query: 924 QKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGLCPSAE------------------ 964
+ I+HRD+K +N+L+ +KI+DFGT+K L P +
Sbjct: 121 KGIIHRDLKPENILL-DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179
Query: 965 -TFTGTLQYMAPEVIDKGQRGYGA 987
+F GT +Y++PE++++ G +
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSS 203
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 63/170 (37%), Positives = 90/170 (52%), Gaps = 7/170 (4%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQP-LHEEIKLHSQLRHRNIVQYLGSV 871
LG+G+ G V R + + A+K I D+Q + E++++ + IV+Y G+
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 872 SEE--GYFKIFMEQVPGGSL-STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
+E I ME GGSL S +VK + E + + +L+GL YLH +KI+H
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIH 128
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
RDIK N+L+ G VK+ DFG S L + A TFTGT YMAPE I
Sbjct: 129 RDIKPSNILLTR-KGQVKLCDFGVSGEL--VNSLAGTFTGTSFYMAPERI 175
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 60/170 (35%), Positives = 89/170 (52%), Gaps = 10/170 (5%)
Query: 813 LGKGSYG--VVYAARELDRQV---KLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQY 867
LGKG++G +Y E D V ++ + + EK D EI + S L+H NI+ Y
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL---NEIVILSLLQHPNIIAY 64
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
++ I ME GG+L + + G L E E + +Y QI+ + Y+H I+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFE-EEMVLWYLFQIVSAVSYIHKAGIL 123
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEV 977
HRDIK N+ + T +G++K+ DFG SK L AET GT YM+PE+
Sbjct: 124 HRDIKTLNIFL-TKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPEL 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 5e-23
Identities = 69/183 (37%), Positives = 103/183 (56%), Gaps = 8/183 (4%)
Query: 808 LNRIELGKGSYGVVYAARELDRQVKLAIKEIP-EKNLGDVQPLHEEIKLHSQLRHRNIVQ 866
L RI GKGS+G VY + + +AIK I E+ +++ + +EI + SQ I +
Sbjct: 9 LERI--GKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITR 66
Query: 867 YLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
Y GS + I ME + GGS LL K GPL+E + ++ ++IL+GL YLH ++
Sbjct: 67 YYGSYLKGTKLWIIMEYLGGGSALDLL--KPGPLEE--TYIATILREILKGLDYLHSERK 122
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYG 986
+HRDIK NVL++ G VK++DFG + +L TF GT +MAPEVI + +
Sbjct: 123 IHRDIKAANVLLSE-QGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181
Query: 987 APV 989
A +
Sbjct: 182 ADI 184
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 6e-23
Identities = 57/182 (31%), Positives = 87/182 (47%), Gaps = 21/182 (11%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDV--QPLHEEIKLHSQLRHRNIVQYLG 869
+GKGS+G V R L KEI N+ + Q L E+ + +L+H NIV+Y
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 870 SV----SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKEN----ESTMSFYTKQILEGLKYL 921
+ ++ Y I ME GG L+ L++ KE E + Q+L L
Sbjct: 67 RIIDRSNQTLY--IVMEYCEGGDLAQLIQKCK---KERKYIEEEFIWRILTQLLLALYEC 121
Query: 922 H-----GQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPE 976
H G ++HRD+K N+ ++ + VK+ DFG +K L A+T+ GT YM+PE
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPE 180
Query: 977 VI 978
+
Sbjct: 181 QL 182
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 6e-23
Identities = 66/186 (35%), Positives = 99/186 (53%), Gaps = 24/186 (12%)
Query: 813 LGKGSYGVVYAA--RELDRQVKLAI-KEIPEKNLGDVQP-----LHEEIKLHSQLRHRNI 864
LGKGS+G VY ++ + +L + KEIP +G++ P ++E +L S+L H I
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIP---VGELNPNETVQANQEAQLLSKLDHPAI 64
Query: 865 VQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSF-----YTKQILEGLK 919
V++ S E F I E G L L LK T+S + Q+L G+
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLE----ELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 920 YLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVID 979
Y+H ++I+HRD+K N+ + + ++KI DFG S+ L G C A TFTGT YM+PE +
Sbjct: 121 YMHQRRILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALK 178
Query: 980 KGQRGY 985
+GY
Sbjct: 179 --HQGY 182
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 8e-23
Identities = 55/167 (32%), Positives = 91/167 (54%), Gaps = 3/167 (1%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEI--PEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
+G+GS+G +Y A+ IKEI + + + + +E+ L ++++H NIV + S
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 871 VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRD 930
E G I ME GG L + + G L + +S++ QI GLK++H +KI+HRD
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV-QISLGLKHIHDRKILHRD 126
Query: 931 IKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEV 977
IK N+ ++ V K+ DFG +++L A T GT Y++PE+
Sbjct: 127 IKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEI 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 62/190 (32%), Positives = 92/190 (48%), Gaps = 26/190 (13%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHE----EIKLHSQLRHRNIVQY 867
+G+G+YGVV R +AIK+ K D + + + E+K+ QLRH NIV
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKF--KESEDDEDVKKTALREVKVLRQLRHENIVNL 65
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMS-----FYTKQILEGLKYLH 922
+ +G + E V TLL + L+ + + Y Q+L+ + Y H
Sbjct: 66 KEAFRRKGRLYLVFEYVE----RTLLEL----LEASPGGLPPDAVRSYIWQLLQAIAYCH 117
Query: 923 GQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT---GTLQYMAPEVID 979
I+HRDIK +N+LV+ SGV+K+ DFG ++ L A T T Y APE++
Sbjct: 118 SHNIIHRDIKPENILVSE-SGVLKLCDFGFARALR--ARPASPLTDYVATRWYRAPELL- 173
Query: 980 KGQRGYGAPV 989
G YG PV
Sbjct: 174 VGDTNYGKPV 183
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|238902 cd01921, cyclophilin_RRM, cyclophilin_RRM: cyclophilin-type peptidylprolyl cis- trans isomerase domain occuring with a C-terminal RNA recognition motif domain (RRM) | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 1e-22
Identities = 56/130 (43%), Positives = 71/130 (54%), Gaps = 13/130 (10%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGN 187
I L +D P NF LC K + F F+ V +F+ Q GD T G GG+SIY
Sbjct: 11 IDLFTDECPLACLNFLKLCK-LKYYNF--CLFYNVQKDFIAQTGDPTG-TGAGGESIYSQ 66
Query: 188 K-------FEDE-NFTLKHTGPGILSMANAGPNTNGSQFFITTVK-TAWLDNRHVVFGSV 238
FE E LKH+ G +SM NAG N NGSQF+IT + +LD +H VFG V
Sbjct: 67 LYGRQARFFEPEILPLLKHSKKGTVSMVNAGDNLNGSQFYITLGENLDYLDGKHTVFGQV 126
Query: 239 VEGLDVVKKL 248
VEG DV++K+
Sbjct: 127 VEGFDVLEKI 136
|
This subfamily of the cyclophilin domain family contains a number of eukaryotic cyclophilins having the RRM domain including the nuclear proteins: human hCyP-57, Arabidopsis thaliana AtCYP59, Caenorhabditis elegans CeCyP-44 and Paramecium tetrurelia Kin241. The Kin241 protein has been shown to have a role in cell morphogenesis. Length = 166 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 1e-22
Identities = 56/175 (32%), Positives = 97/175 (55%), Gaps = 15/175 (8%)
Query: 809 NRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYL 868
N +++G+GS G+V A + ++A+K++ + + L E+ + +H NIV+
Sbjct: 23 NFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMY 82
Query: 869 GS--VSEEGYFKIFMEQVPGGSLS---TLLRVKWGPLKENESTMSFYTKQILEGLKYLHG 923
S V +E + + ME + GG+L+ T R+ NE ++ +L+ L +LH
Sbjct: 83 SSYLVGDELW--VVMEFLEGGALTDIVTHTRM-------NEEQIATVCLAVLKALSFLHA 133
Query: 924 QKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
Q ++HRDIK D++L+ T G VK+SDFG +++ P ++ GT +MAPEVI
Sbjct: 134 QGVIHRDIKSDSILL-TSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 2e-22
Identities = 70/216 (32%), Positives = 113/216 (52%), Gaps = 36/216 (16%)
Query: 780 QLVEDLRTIPT----KKKYMQTPMLRFLYLFALNRIE-LGKGSYGVVYAARELDRQVKLA 834
+++E LRTI + KKKY R E +G+G+ G VY A ++ ++A
Sbjct: 3 EILEKLRTIVSVGDPKKKY--------------TRFEKIGQGASGTVYTAIDVATGQEVA 48
Query: 835 IKEIPEKNLGDVQPLHE----EIKLHSQLRHRNIVQYLGS--VSEEGYFKIFMEQVPGGS 888
IK++ NL QP E EI + + +H NIV YL S V +E + + ME + GGS
Sbjct: 49 IKQM---NLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELW--VVMEYLAGGS 102
Query: 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKIS 948
L+ ++ +E ++ ++ L+ L++LH +++HRDIK DN+L+ G VK++
Sbjct: 103 LTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM-DGSVKLT 157
Query: 949 DFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRG 984
DFG ++ T GT +MAPEV+ + G
Sbjct: 158 DFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 3e-22
Identities = 59/171 (34%), Positives = 90/171 (52%), Gaps = 7/171 (4%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDV---QPLHEEIKLHSQLRHRNIVQYLG 869
+GKG + VVY A L +A+K++ + D Q +EI L QL H N+++YL
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLR--VKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
S E I +E G LS +++ K L E T+ Y Q+ L+++H ++I+
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIP-ERTIWKYFVQLCSALEHMHSKRIM 128
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
HRDIK NV + T +GVVK+ D G + + +A + GT YM+PE I
Sbjct: 129 HRDIKPANVFI-TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 4e-22
Identities = 67/177 (37%), Positives = 101/177 (57%), Gaps = 14/177 (7%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIP---EKNLGDVQPLHEEIKLHSQLRHRNIVQYL 868
E+G GS+G VY AR++ +AIK++ +++ Q + +E+K +++H N ++Y
Sbjct: 32 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
G E + ME G S S LL V PL+E E ++ T L+GL YLH ++H
Sbjct: 92 GCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVE--IAAITHGALQGLAYLHSHNMIH 148
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI---DKGQ 982
RDIK N+L+ T G VK++DFG+ A + A +F GT +MAPEVI D+GQ
Sbjct: 149 RDIKAGNILL-TEPGQVKLADFGS----ASIASPANSFVGTPYWMAPEVILAMDEGQ 200
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 8e-22
Identities = 67/177 (37%), Positives = 97/177 (54%), Gaps = 14/177 (7%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIP---EKNLGDVQPLHEEIKLHSQLRHRNIVQYL 868
E+G GS+G VY A +A+K++ ++ Q + +E+K QL+H N ++Y
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
G +E + ME G S S LL V PL+E E ++ T L+GL YLH ++H
Sbjct: 88 GCYLKEHTAWLVMEYCLG-SASDLLEVHKKPLQEVE--IAAITHGALQGLAYLHSHNMIH 144
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI---DKGQ 982
RDIK N+L+ T G VK++DFG+ A A +F GT +MAPEVI D+GQ
Sbjct: 145 RDIKAGNILL-TEPGQVKLADFGS----ASKSSPANSFVGTPYWMAPEVILAMDEGQ 196
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 8e-22
Identities = 64/170 (37%), Positives = 100/170 (58%), Gaps = 6/170 (3%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIP-EKNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
++GKGS+G V+ + Q +AIK I E+ +++ + +EI + SQ + +Y GS
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 871 VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRD 930
++ I ME + GGS LL GPL +E+ ++ ++IL+GL YLH +K +HRD
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLLEP--GPL--DETQIATILREILKGLDYLHSEKKIHRD 126
Query: 931 IKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDK 980
IK NVL++ + G VK++DFG + +L TF GT +MAPEVI +
Sbjct: 127 IKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 8e-22
Identities = 55/173 (31%), Positives = 90/173 (52%), Gaps = 10/173 (5%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQP-----LHEEIKLHSQLRHRNIVQ 866
++G+GS+G + + + IKEI N+ + P +E+ + S ++H NIVQ
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEI---NISKMSPKEREESRKEVAVLSNMKHPNIVQ 63
Query: 867 YLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
Y S E G I M+ GG L + + G L + + ++ QI LK++H +KI
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV-QICLALKHVHDRKI 122
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVID 979
+HRDIK N+ + T G +K+ DFG ++ L A T GT Y++PE+ +
Sbjct: 123 LHRDIKSQNIFL-TKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICE 174
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 49/171 (28%), Positives = 88/171 (51%), Gaps = 12/171 (7%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQP----LHEEIKLHSQLRHRNIVQY 867
+ KG++G VY A++ AIK + + ++ E + Q + +
Sbjct: 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
S + Y + ME + GG ++L++ G L E+ + Y +++ G++ LH + I+
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIK-TLGGLPEDWAKQ--YIAEVVLGVEDLHQRGII 119
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
HRDIK +N+L++ +G +K++DFG S+ GL + F GT Y+APE I
Sbjct: 120 HRDIKPENLLIDQ-TGHLKLTDFGLSR--NGLEN--KKFVGTPDYLAPETI 165
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 1e-21
Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 38/204 (18%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLH--EEIKLHSQLRHRNIVQYLGS 870
LG+G++G VY AR++ +A+K+I N D P+ EIK+ +L+H N+V +
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 871 VSEEG---------YFKIF--MEQVPGGSLSTLL---RVKWGPLKENESTMSFYTKQILE 916
E + + M+ LS LL VK ES + Y Q+LE
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYMDH----DLSGLLENPSVKL-----TESQIKCYMLQLLE 126
Query: 917 GLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP--------SAETFTG 968
G+ YLH I+HRDIK N+L++ G++KI+DFG ++ G P +T
Sbjct: 127 GINYLHENHILHRDIKAANILIDN-QGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTN 185
Query: 969 ---TLQYMAPEVIDKGQRGYGAPV 989
T Y PE++ G+R Y V
Sbjct: 186 LVVTRWYRPPELL-LGERRYTTAV 208
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 2e-21
Identities = 59/167 (35%), Positives = 88/167 (52%), Gaps = 3/167 (1%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
ELG G++G VY A+ + V A K I K+ +++ EI + + H NIV+ L +
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
E I +E GG++ ++ PL E + KQ LE L YLH KI+HRD+
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERPL--TEPQIRVVCKQTLEALNYLHENKIIHRDL 129
Query: 932 KGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
K N+L T G +K++DFG S + ++F GT +MAPEV+
Sbjct: 130 KAGNILF-TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 175
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 64/178 (35%), Positives = 92/178 (51%), Gaps = 16/178 (8%)
Query: 808 LNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLH--EEIKLHSQLRHRNIV 865
LNRI G+G+YG+VY AR+ +A+K++ N D P+ EI L LRH NIV
Sbjct: 12 LNRI--GEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIV 69
Query: 866 QYLGSVSEEGYFKIFM-----EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKY 920
+ V + IF+ EQ L++LL P +ES + Q+L GL+Y
Sbjct: 70 ELKEVVVGKHLDSIFLVMEYCEQ----DLASLLDNMPTPF--SESQVKCLMLQLLRGLQY 123
Query: 921 LHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
LH I+HRD+K N+L+ T G +KI+DFG ++ TL Y APE++
Sbjct: 124 LHENFIIHRDLKVSNLLL-TDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELL 180
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 2e-21
Identities = 58/174 (33%), Positives = 100/174 (57%), Gaps = 9/174 (5%)
Query: 809 NRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYL 868
N I++G+GS G+V ARE ++A+K + + + L E+ + +H+N+V+
Sbjct: 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 869 GS--VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
S V EE + + ME + GG+L+ ++ + NE ++ + +L+ L YLH Q +
Sbjct: 85 KSYLVGEELW--VLMEFLQGGALTDIV----SQTRLNEEQIATVCESVLQALCYLHSQGV 138
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDK 980
+HRDIK D++L+ T G VK+SDFG +++ P ++ GT +MAPEVI +
Sbjct: 139 IHRDIKSDSILL-TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR 191
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (241), Expect = 2e-21
Identities = 63/194 (32%), Positives = 93/194 (47%), Gaps = 30/194 (15%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEI--PEKNLGDVQPLHEEIKLHSQLRHRNIVQ---Y 867
+G G+YGVV +A + K+AIK+I +L D + + EIKL LRH NI+
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDI 67
Query: 868 LGSVSEEGYFKI-----FMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLH 922
L S E + + ME + L +V P + + ++ QIL GLKYLH
Sbjct: 68 LRPPSPEDFNDVYIVTELME-------TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120
Query: 923 GQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GLCPSAETFTG------TLQYMAP 975
++HRD+K N+LVN+ + +KI DFG LA G+ P + T Y AP
Sbjct: 121 SANVIHRDLKPSNILVNS-NCDLKICDFG----LARGVDPDEDEKGFLTEYVVTRWYRAP 175
Query: 976 EVIDKGQRGYGAPV 989
E++ Y +
Sbjct: 176 ELL-LSSSRYTKAI 188
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 58/187 (31%), Positives = 101/187 (54%), Gaps = 11/187 (5%)
Query: 806 FALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQLRHR 862
F L R+ +GKG++G V ++ D + A+K + ++ G V+ + E ++ +L H
Sbjct: 2 FELLRV-IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 863 NIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLH 922
+V S +E + ++ + GG L L K +K +E + F+ +I+ L+YLH
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLH 117
Query: 923 GQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQ 982
+ I+HRDIK DN+L++ G V I+DF + ++ + T +GT YMAPEV+ +
Sbjct: 118 SKGIIHRDIKPDNILLDE-QGHVHITDFNIATKVTPDTLTTST-SGTPGYMAPEVLCR-- 173
Query: 983 RGYGAPV 989
+GY V
Sbjct: 174 QGYSVAV 180
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 1e-20
Identities = 51/166 (30%), Positives = 96/166 (57%), Gaps = 3/166 (1%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIP-EKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
+G+GS+G + ++ K A+KEI K+ V+ +E L ++++H NIV + S
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
+G+ I ME GG L ++++ G L ++ + ++ Q+ G++++H ++++HRDI
Sbjct: 68 EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV-QMCLGVQHIHEKRVLHRDI 126
Query: 932 KGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEV 977
K N+ + T +G VK+ DFG+++ L A T+ GT Y+ PE+
Sbjct: 127 KSKNIFL-TQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEI 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 2e-20
Identities = 66/175 (37%), Positives = 87/175 (49%), Gaps = 11/175 (6%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDV---QPLHEEIKLHSQLRHRNIVQYL 868
ELGKG+YG VY V +A+KEI L + Q + E LH + IV +
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEI-RLELDESKFNQIIMELDILH-KAVSPYIVDFY 65
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ-KIV 927
G+ EG + ME + GSL L E + T +++GLK+L + I+
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNII 125
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGLCPSAETFTGTLQYMAPEVIDKG 981
HRD+K NVLVN +G VK+ DFG S L A L A+T G YMAPE I G
Sbjct: 126 HRDVKPTNVLVNG-NGQVKLCDFGVSGNLVASL---AKTNIGCQSYMAPERIKSG 176
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 3e-20
Identities = 66/179 (36%), Positives = 93/179 (51%), Gaps = 22/179 (12%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDV-QPLHEEIKLHSQL-----RHRNIVQ 866
+G G+YG VY R + AIK + DV + EEIKL + HRNI
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVM------DVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 867 YLGSV------SEEGYFKIFMEQVPGGSLSTLLR-VKWGPLKENESTMSFYTKQILEGLK 919
Y G+ + + ME GS++ L++ K LKE+ +++ ++IL GL
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKED--WIAYICREILRGLA 135
Query: 920 YLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
+LH K++HRDIKG NVL+ T + VK+ DFG S +L TF GT +MAPEVI
Sbjct: 136 HLHAHKVIHRDIKGQNVLL-TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 193
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 4e-20
Identities = 65/198 (32%), Positives = 96/198 (48%), Gaps = 9/198 (4%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGS 870
+GKGSYG V R + IK++ +N + + +E +L SQL+H NIV Y S
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 871 -VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
E+G I M GG L L+ + G L + ++ QI L+YLH + I+HR
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFV-QIAMALQYLHEKHILHR 126
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPV 989
D+K NV + T + ++K+ D G ++ L C A T GT YM+PE+ Y + V
Sbjct: 127 DLKTQNVFL-TRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDV 185
Query: 990 RQRDKINPCCRIEYKKMK 1007
CC E +K
Sbjct: 186 WALG----CCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 58/184 (31%), Positives = 97/184 (52%), Gaps = 8/184 (4%)
Query: 806 FALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHE---EIKLHSQLRHR 862
F + + ++G+G + VY A L V +A+K++ +L D + + EI L QL H
Sbjct: 4 FRIEK-KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 863 NIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLR-VKWGPLKENESTMSFYTKQILEGLKYL 921
N+++Y S E+ I +E G LS +++ K E T+ Y Q+ L+++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 922 HGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKG 981
H ++++HRDIK NV + T +GVVK+ D G + + +A + GT YM+PE I
Sbjct: 123 HSRRVMHRDIKPANVFI-TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH-- 179
Query: 982 QRGY 985
+ GY
Sbjct: 180 ENGY 183
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 3e-19
Identities = 60/174 (34%), Positives = 95/174 (54%), Gaps = 12/174 (6%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQYLGSV 871
+G G+YG VY R + + +LA ++ + + + + +EI + + HRNI Y G+
Sbjct: 14 VGNGTYGQVYKGRHV-KTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 872 SEEG------YFKIFMEQVPGGSLSTLLR-VKWGPLKENESTMSFYTKQILEGLKYLHGQ 924
++ + ME GS++ L++ K LKE +++ ++IL GL +LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE--EWIAYICREILRGLSHLHQH 130
Query: 925 KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
K++HRDIKG NVL+ T + VK+ DFG S +L TF GT +MAPEVI
Sbjct: 131 KVIHRDIKGQNVLL-TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 183
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 5e-19
Identities = 64/190 (33%), Positives = 98/190 (51%), Gaps = 19/190 (10%)
Query: 808 LNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLH--EEIKLHSQLRHRNIV 865
LNRIE +G+YGVVY AR+ +A+K++ + + P+ EI + +L+H NIV
Sbjct: 10 LNRIE--EGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIV 67
Query: 866 QYLGSVSEEGYFKIF--MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHG 923
V KI+ ME V L +L+ P ++E + Q+L G+ +LH
Sbjct: 68 TVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSE--VKCLMLQLLSGVAHLHD 124
Query: 924 QKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS-AETFTG---TLQYMAPEVID 979
I+HRD+K N+L+N G++KI DFG LA S + +T TL Y APE++
Sbjct: 125 NWILHRDLKTSNLLLNN-RGILKICDFG----LAREYGSPLKPYTQLVVTLWYRAPELL- 178
Query: 980 KGQRGYGAPV 989
G + Y +
Sbjct: 179 LGAKEYSTAI 188
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 6e-19
Identities = 63/194 (32%), Positives = 98/194 (50%), Gaps = 28/194 (14%)
Query: 816 GSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLGSVS 872
G+YG VY R + + + A+K+I ++NL +Q + E + + + +V S
Sbjct: 12 GAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE 71
Query: 873 EEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIK 932
+ + + ME V GG +TLL+ G L + + M Y + + L+YLH IVHRD+K
Sbjct: 72 TKRHLCMVMEYVEGGDCATLLK-NIGALPVDMARM--YFAETVLALEYLHNYGIVHRDLK 128
Query: 933 GDNVLVNTYSGVVKISDFGTSKRLAGLCPSA-----------------ETFTGTLQYMAP 975
DN+L+ T G +K++DFG SK GL + GT +Y+AP
Sbjct: 129 PDNLLI-TSMGHIKLTDFGLSK--IGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAP 185
Query: 976 EVIDKGQRGYGAPV 989
EVI + +GYG PV
Sbjct: 186 EVILR--QGYGKPV 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 6e-19
Identities = 63/214 (29%), Positives = 112/214 (52%), Gaps = 24/214 (11%)
Query: 780 QLVEDLRTIPT----KKKYMQTPMLRFLYLFALNRIELGKGSYGVVYAARELDRQVKLAI 835
+++E LRTI + KKKY + ++G+G+ G V+ A ++ ++AI
Sbjct: 3 EIMEKLRTIVSIGDPKKKYTRYE-------------KIGQGASGTVFTAIDVATGQEVAI 49
Query: 836 KEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRV 895
K+I + + + EI + +L++ NIV +L S + ME + GGSL+ ++
Sbjct: 50 KQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVT- 108
Query: 896 KWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 955
+E+ ++ ++ L+ L++LH +++HRDIK DNVL+ G VK++DFG +
Sbjct: 109 ---ETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGM-DGSVKLTDFGFCAQ 164
Query: 956 LAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPV 989
+ T GT +MAPEV+ + + YG V
Sbjct: 165 ITPEQSKRSTMVGTPYWMAPEVVTR--KAYGPKV 196
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 51/178 (28%), Positives = 81/178 (45%), Gaps = 18/178 (10%)
Query: 811 IELGKGSYGVV---YAARELDRQVKLAIKEI-PEKNLGDVQPLHEEIKLHSQLRHRNIVQ 866
ELG G++G V + ++V++A+K + E + E + +QL H IV+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 867 YLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
+G V + + ME P G L L+ K + S + Q+ G+ YL +
Sbjct: 61 LIG-VCKGEPLMLVMELAPLGPLLKYLK-KRREI--PVSDLKELAHQVAMGMAYLESKHF 116
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT------LQYMAPEVI 978
VHRD+ NVL+ KISDFG S+ L ++ + T L++ APE I
Sbjct: 117 VHRDLAARNVLLVN-RHQAKISDFGMSRALG---AGSDYYRATTAGRWPLKWYAPECI 170
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 49/153 (32%), Positives = 77/153 (50%), Gaps = 16/153 (10%)
Query: 812 ELGKGSYGVVYAAR---ELDRQVKL-AIK----EIPEKNLGDVQPLHEEIKLHSQLRHRN 863
+LG+G +G V R D + A+K E++ D EI++ L H N
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD---FEREIEILRTLDHEN 67
Query: 864 IVQYLGSVSEEGY--FKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYL 921
IV+Y G + G ++ ME +P GSL L+ + N + ++ QI +G+ YL
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQI--NLKRLLLFSSQICKGMDYL 125
Query: 922 HGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954
Q+ +HRD+ N+LV + +VKISDFG +K
Sbjct: 126 GSQRYIHRDLAARNILVES-EDLVKISDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 49/204 (24%)
Query: 810 RIE-LGKGSYGVVYAARELDRQVKLAIKEI---------PEKNLGDVQPLHEEIKLHSQL 859
++E +G+G+YGVVY AR+ +A+K+I P + EI L +L
Sbjct: 3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI-------REISLLKEL 55
Query: 860 RHRNIVQYLGSVSEEG--Y---------FKIFMEQVPGGSLSTLLRVKWGPLKENESTMS 908
H NIV+ L V E Y K +M+ P L + +
Sbjct: 56 NHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGL-------------DPPLIK 102
Query: 909 FYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968
Y Q+L+G+ Y H +++HRD+K N+L++ G +K++DFG + R G+ T+T
Sbjct: 103 SYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDR-EGALKLADFGLA-RAFGV--PVRTYTH 158
Query: 969 ---TLQYMAPEVIDKGQRGYGAPV 989
TL Y APE++ G R Y PV
Sbjct: 159 EVVTLWYRAPEIL-LGSRQYSTPV 181
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 2e-18
Identities = 58/181 (32%), Positives = 98/181 (54%), Gaps = 12/181 (6%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEK---NLGDVQPLHEEIKLHSQLRHRNIVQYL 868
++G+G YG V+ A++ D +A+K + + L +V+ + E + + + +V+ L
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
+ ++ Y + ME VPGG TLL G L E+ + FY ++ E + LH +H
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNL-GVLSEDHA--RFYMAEMFEAVDALHELGYIH 124
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAP 988
RD+K +N L++ SG +K++DFG SK G+ A + G+ YMAPEV+ +GY
Sbjct: 125 RDLKPENFLIDA-SGHIKLTDFGLSK---GIVTYANSVVGSPDYMAPEVLRG--KGYDFT 178
Query: 989 V 989
V
Sbjct: 179 V 179
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 65/195 (33%), Positives = 95/195 (48%), Gaps = 30/195 (15%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLH--EEIKLHSQLR---HRNIVQ 866
E+G+G+YG VY AR+L+ +A+K++ + PL EI L QL H NIV+
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65
Query: 867 YLGSVSE----EGYFKIFM-----EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEG 917
L V + K+ + +Q L+T L K T+ +Q+L G
Sbjct: 66 LL-DVCHGPRTDRELKLTLVFEHVDQ----DLATYLS-KCPKPGLPPETIKDLMRQLLRG 119
Query: 918 LKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA---GLCPSAETFTGTLQYMA 974
+ +LH +IVHRD+K N+LV + G VKI+DFG ++ + L TL Y A
Sbjct: 120 VDFLHSHRIVHRDLKPQNILVTS-DGQVKIADFGLARIYSFEMALTS----VVVTLWYRA 174
Query: 975 PEVIDKGQRGYGAPV 989
PEV+ Q Y PV
Sbjct: 175 PEVLL--QSSYATPV 187
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 58/179 (32%), Positives = 96/179 (53%), Gaps = 9/179 (5%)
Query: 812 ELGKGSYGVVYAAR-ELDRQVKLAIKEIPEKNLGDV---QPLHEEIKLHSQLRHRNIVQY 867
++G+G + VY A LDR+ +A+K++ + D Q +EI L QL H N+++Y
Sbjct: 9 KIGRGQFSEVYRATCLLDRK-PVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKY 67
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLR-VKWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
L S E+ I +E G LS +++ K E T+ Y Q+ ++++H +++
Sbjct: 68 LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRV 127
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGY 985
+HRDIK NV + T +GVVK+ D G + + +A + GT YM+PE I + GY
Sbjct: 128 MHRDIKPANVFI-TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH--ENGY 183
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 52/172 (30%), Positives = 91/172 (52%), Gaps = 5/172 (2%)
Query: 809 NRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYL 868
+ I++G+GS G+V A E ++A+K++ + + L E+ + H N+V
Sbjct: 26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMY 85
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
S + ME + GG+L+ ++ + NE ++ +L L YLH Q ++H
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQGVIH 141
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDK 980
RDIK D++L+ T G +K+SDFG +++ P ++ GT +MAPEVI +
Sbjct: 142 RDIKSDSILL-TSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISR 192
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 3e-18
Identities = 61/186 (32%), Positives = 93/186 (50%), Gaps = 24/186 (12%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHE--------EIKLHSQLRHRNI 864
LG+G+Y VVY AR+ + +AIK+I LG+ + + EIKL +L+H NI
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKI---KLGERKEAKDGINFTALREIKLLQELKHPNI 64
Query: 865 VQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ 924
+ L + + E + L +++ K L + + Y L GL+YLH
Sbjct: 65 IGLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTP--ADIKSYMLMTLRGLEYLHSN 121
Query: 925 KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAET-FTG---TLQYMAPEVIDK 980
I+HRD+K +N+L+ + GV+K++DFG LA S T T Y APE++
Sbjct: 122 WILHRDLKPNNLLIAS-DGVLKLADFG----LARSFGSPNRKMTHQVVTRWYRAPELL-F 175
Query: 981 GQRGYG 986
G R YG
Sbjct: 176 GARHYG 181
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 60/179 (33%), Positives = 91/179 (50%), Gaps = 7/179 (3%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD-VQPLH-EEIKLHSQLRHRNIVQYLGS 870
+G+GSYG+V + + +AIK+ E V+ + EI++ QLRH N+V +
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 871 VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRD 930
+ + E V L L + P +ES + Y QIL G+++ H I+HRD
Sbjct: 69 FRRKKRLYLVFEFVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHNIIHRD 125
Query: 931 IKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPV 989
IK +N+LV + SGVVK+ DFG ++ LA + T Y APE++ G YG V
Sbjct: 126 IKPENILV-SQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELL-VGDTKYGRAV 182
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 4e-18
Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 38/206 (18%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLG 869
+G+G++G V+ R+ D A+K + + ++ + + E + + IV+
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYY 68
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
S +E + + ME +PGG L LL ++ E + FY +++ L +H +HR
Sbjct: 69 SFQDEEHLYLVMEYMPGGDLMNLL-IRKDVFPEETA--RFYIAELVLALDSVHKLGFIHR 125
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRLA--------------GLCPS------------- 962
DIK DN+L+ G +K++DFG K++ L
Sbjct: 126 DIKPDNILI-DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRR 184
Query: 963 --AETFTGTLQYMAPEVIDKGQRGYG 986
A + GT Y+APEV+ +G YG
Sbjct: 185 VRANSTVGTPDYIAPEVL-RGT-PYG 208
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 5e-18
Identities = 58/173 (33%), Positives = 88/173 (50%), Gaps = 11/173 (6%)
Query: 808 LNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQ-PLHEEIKLHSQLRHRNIVQ 866
+NRI G G+ G VY A+K I + V+ + EI++ + H N+V+
Sbjct: 79 VNRI--GSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 867 YLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
G ++ +E + GGSL G +E ++ +QIL G+ YLH + I
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLE-------GTHIADEQFLADVARQILSGIAYLHRRHI 189
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVID 979
VHRDIK N+L+N+ VKI+DFG S+ LA + GT+ YM+PE I+
Sbjct: 190 VHRDIKPSNLLINSAKN-VKIADFGVSRILAQTMDPCNSSVGTIAYMSPERIN 241
|
Length = 353 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 7e-18
Identities = 63/177 (35%), Positives = 92/177 (51%), Gaps = 28/177 (15%)
Query: 812 ELGKGSYGVVYA----------ARELDRQVKLAIK-EIPEKNLGDVQPLHEEIKLHSQLR 860
ELG G+ GVV AR+L + L IK I + + +++ LHE
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKL---IHLEIKPAIRNQIIRELKVLHE-------CN 57
Query: 861 HRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKY 920
IV + G+ +G I ME + GGSL +L+ K G + EN + + +L GL Y
Sbjct: 58 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEN--ILGKISIAVLRGLTY 114
Query: 921 LHGQ-KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPE 976
L + KI+HRD+K N+LVN+ G +K+ DFG S +L + A +F GT YM+PE
Sbjct: 115 LREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPE 168
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 8e-18
Identities = 60/195 (30%), Positives = 95/195 (48%), Gaps = 30/195 (15%)
Query: 810 RIE-LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLH--EEIKLHSQLRHRNIVQ 866
+IE +G+G+YGVVY R +A+K+I ++ + P EI L +L+H NIV
Sbjct: 4 KIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVC 63
Query: 867 YLGSVSEEGY-----------FKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQIL 915
+ +E K +++ +P G VK Y QIL
Sbjct: 64 LQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVK------------SYLYQIL 111
Query: 916 EGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF-TGTLQYMA 974
+G+ + H ++++HRD+K N+L++ GV+K++DFG + R G+ T TL Y A
Sbjct: 112 QGILFCHSRRVLHRDLKPQNLLIDN-KGVIKLADFGLA-RAFGIPVRVYTHEVVTLWYRA 169
Query: 975 PEVIDKGQRGYGAPV 989
PEV+ R Y PV
Sbjct: 170 PEVLLGSPR-YSTPV 183
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 8e-18
Identities = 59/189 (31%), Positives = 91/189 (48%), Gaps = 25/189 (13%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEK--------NLGDVQPLHEEIKLHSQLRHRN 863
+LG G++G VY AR + +AIK++ +K NL +V+ L KL+ H N
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSL---RKLNE---HPN 59
Query: 864 IVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHG 923
IV+ E E + G + K P +ES + QIL+GL ++H
Sbjct: 60 IVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPF--SESVIRSIIYQILQGLAHIHK 117
Query: 924 QKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT---GTLQYMAPEVIDK 980
HRD+K +N+LV+ VVKI+DFG ++ + S +T T Y APE++ +
Sbjct: 118 HGFFHRDLKPENLLVSG-PEVVKIADFGLAREIR----SRPPYTDYVSTRWYRAPEILLR 172
Query: 981 GQRGYGAPV 989
Y +PV
Sbjct: 173 -STSYSSPV 180
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 9e-18
Identities = 57/184 (30%), Positives = 91/184 (49%), Gaps = 13/184 (7%)
Query: 813 LGKGSYGVVYAARELDRQ-------VKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIV 865
LGKG YG V+ R++ +K+ K +N D E + ++H IV
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
+ + G + +E + GG L L + G E+ T FY +I L++LH Q
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLE-REGIFMED--TACFYLSEISLALEHLHQQG 120
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGY 985
I++RD+K +N+L++ G VK++DFG K TF GT++YMAPE++ + G+
Sbjct: 121 IIYRDLKPENILLDAQ-GHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRS--GH 177
Query: 986 GAPV 989
G V
Sbjct: 178 GKAV 181
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 50/176 (28%), Positives = 82/176 (46%), Gaps = 4/176 (2%)
Query: 806 FALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIV 865
F L R +LG G +G V+ +R V++AIK + +L Q +E++ +LRH++++
Sbjct: 8 FTLER-KLGSGYFGEVWEGLWKNR-VRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
S I E + GSL LR G + S + Q+ EG+ YL Q
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMAC-QVAEGMAYLEEQN 124
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKG 981
+HRD+ N+LV V K++DFG ++ + + ++ APE G
Sbjct: 125 SIHRDLAARNILVGE-DLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHG 179
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 1e-17
Identities = 63/214 (29%), Positives = 110/214 (51%), Gaps = 24/214 (11%)
Query: 780 QLVEDLRTIPT----KKKYMQTPMLRFLYLFALNRIELGKGSYGVVYAARELDRQVKLAI 835
+++E LR+I + KKKY RF ++G+G+ G VY A ++ ++AI
Sbjct: 3 EILEKLRSIVSVGDPKKKYT-----RFE--------KIGQGASGTVYTAIDIATGQEVAI 49
Query: 836 KEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRV 895
K++ + + + EI + + ++ NIV YL S + ME + GGSL+ ++
Sbjct: 50 KQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT- 108
Query: 896 KWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 955
+E ++ ++ L+ L +LH +++HRDIK DN+L+ G VK++DFG +
Sbjct: 109 ---ETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQ 164
Query: 956 LAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPV 989
+ T GT +MAPEV+ + + YG V
Sbjct: 165 ITPEQSKRSTMVGTPYWMAPEVVTR--KAYGPKV 196
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 4e-17
Identities = 61/178 (34%), Positives = 89/178 (50%), Gaps = 11/178 (6%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQ-PLHEEIKLHSQLRHRNIVQYLGSV 871
LG G+ G VY A L + LA+K IP ++Q + E+++ + I+ + G+
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
E I E + GGSL ++ E + +++GL YL KI+HRD+
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIP-------EHVLGRIAVAVVKGLTYLWSLKILHRDV 121
Query: 932 KGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPV 989
K N+LVNT G VK+ DFG S +L A+T+ GT YMAPE I Q G + V
Sbjct: 122 KPSNMLVNT-RGQVKLCDFGVSTQLVN--SIAKTYVGTNAYMAPERISGEQYGIHSDV 176
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|238901 cd01920, cyclophilin_EcCYP_like, cyclophilin_EcCYP_like: cyclophilin-type A-like peptidylprolyl cis- trans isomerase (PPIase) domain similar to the cytosolic E | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 5e-17
Identities = 48/140 (34%), Positives = 65/140 (46%), Gaps = 16/140 (11%)
Query: 119 LDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNG 178
+L ++L D P T ENF A KGF + ++ FHRVI F+ QGG FT
Sbjct: 2 FQTSLGDIVVELYDDKAPITVENFLAYV--RKGF-YDNTIFHRVISGFVIQGGGFT---- 54
Query: 179 TGGKSIYGNK--FEDENFTLKHTGPGILSMA-NAGPNTNGSQFFITTVKTAWLDNR---- 231
K + L +T G ++MA P++ SQFFI A LD +
Sbjct: 55 PDLAQKETLKPIKNEAGNGLSNTR-GTIAMARTNAPDSATSQFFINLKDNASLDYQNEQW 113
Query: 232 -HVVFGSVVEGLDVVKKLES 250
+ VFG V EG+DVV K+
Sbjct: 114 GYTVFGEVTEGMDVVDKIAG 133
|
coli cyclophilin A and Streptomyces antibioticus SanCyp18. Compared to the archetypal cyclophilin Human cyclophilin A, these have reduced affinity for cyclosporin A. E. coli cyclophilin A has a similar peptidylprolyl cis- trans isomerase activity to the human cyclophilin A. Most members of this subfamily contain a phenylalanine residue at the position equivalent to Human cyclophilin W121, where a tyrptophan has been shown to be important for cyclophilin binding. Length = 155 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 7e-17
Identities = 49/170 (28%), Positives = 81/170 (47%), Gaps = 8/170 (4%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVS 872
+GKG +G V ++V A+K + + + Q E + + LRH N+VQ LG V
Sbjct: 14 IGKGEFGDVMLGDYRGQKV--AVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 873 EEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIK 932
+ I E + GSL LR + + + F + EG++YL + VHRD+
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGF-ALDVCEGMEYLEEKNFVHRDLA 129
Query: 933 GDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQ 982
NVLV+ V K+SDFG +K ++ +++ APE + + +
Sbjct: 130 ARNVLVSE-DLVAKVSDFGLAKE---ASQGQDSGKLPVKWTAPEALREKK 175
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 7e-17
Identities = 60/185 (32%), Positives = 92/185 (49%), Gaps = 33/185 (17%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIK-----LHSQLRHRNIVQY 867
+GKG+YG V+ K A+K L + + EEI+ L + H N+V++
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKI-----LDPIHDIDEEIEAEYNILKALSDHPNVVKF 80
Query: 868 LGSVSEEGYFK----------IFMEQVPGGSLSTLLRVKWGPLKE----NESTMSFYTKQ 913
G Y+K + +E GGS++ L++ G LK E +++ +
Sbjct: 81 YGM-----YYKKDVKNGDQLWLVLELCNGGSVTDLVK---GFLKRGERMEEPIIAYILHE 132
Query: 914 ILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYM 973
L GL++LH K +HRD+KG+N+L+ T G VK+ DFG S +L T GT +M
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEGG-VKLVDFGVSAQLTSTRLRRNTSVGTPFWM 191
Query: 974 APEVI 978
APEVI
Sbjct: 192 APEVI 196
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 8e-17
Identities = 51/172 (29%), Positives = 92/172 (53%), Gaps = 5/172 (2%)
Query: 809 NRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYL 868
N I++G+GS G+V A +A+K++ + + L E+ + +H N+V+
Sbjct: 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMY 83
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
S + ME + GG+L+ ++ + NE ++ +L+ L LH Q ++H
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTDIVT----HTRMNEEQIAAVCLAVLKALSVLHAQGVIH 139
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDK 980
RDIK D++L+ T+ G VK+SDFG +++ P ++ GT +MAPE+I +
Sbjct: 140 RDIKSDSILL-THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR 190
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 8e-17
Identities = 52/174 (29%), Positives = 83/174 (47%), Gaps = 10/174 (5%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
ELG G +GVV+ + ++ +AIK I E + + EE K+ +L H N+VQ G
Sbjct: 11 ELGSGQFGVVHLGKWRG-KIDVAIKMIREGAMSE-DDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
+++ I E + G L LR + G K + + E ++YL +HRD+
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNGFIHRDL 126
Query: 932 KGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT---LQYMAPEVIDKGQ 982
N LV VVK+SDFG ++ + L + GT +++ PEV D +
Sbjct: 127 AARNCLVGE-DNVVKVSDFGLARYV--LDDQYTSSQGTKFPVKWAPPEVFDYSR 177
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 9e-17
Identities = 61/182 (33%), Positives = 97/182 (53%), Gaps = 16/182 (8%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQLRHRNIVQYLG 869
LG GS+G V A+ AIK + ++ + VQ + +E + +L H IV +
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
S +E +E V GG L T LR K G + + FY +++ +YLH + I++R
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLR-KAGRFPNDVA--KFYHAELVLAFEYLHSKDIIYR 142
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT--GTLQYMAPEVIDKGQRGYGA 987
D+K +N+L++ G VK++DFG +K++ TFT GT +Y+APEVI +G+G
Sbjct: 143 DLKPENLLLDN-KGHVKVTDFGFAKKV-----PDRTFTLCGTPEYLAPEVIQ--SKGHGK 194
Query: 988 PV 989
V
Sbjct: 195 AV 196
|
Length = 329 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 9e-17
Identities = 60/194 (30%), Positives = 92/194 (47%), Gaps = 34/194 (17%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEI--PEKNLGDVQPLHEEIKLHSQLRHRNIVQYLG 869
++G+G+YGVVY AR +A+K+I + G EI L +L H NIV+ L
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66
Query: 870 SVSEEGYF-----------KIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGL 918
+ E K FM+ P + L + Y Q+L+GL
Sbjct: 67 VIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPL-------------IKSYLFQLLQGL 113
Query: 919 KYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG---TLQYMAP 975
+ H +++HRD+K N+L+NT G +K++DFG + R G+ T+T TL Y AP
Sbjct: 114 AFCHSHRVLHRDLKPQNLLINT-EGAIKLADFGLA-RAFGV--PVRTYTHEVVTLWYRAP 169
Query: 976 EVIDKGQRGYGAPV 989
E++ G + Y V
Sbjct: 170 EIL-LGCKYYSTAV 182
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 9e-17
Identities = 56/175 (32%), Positives = 88/175 (50%), Gaps = 9/175 (5%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIK-LHSQLRHRNIVQYL 868
LGKGS+G V A AIK + + + DV+ E + L H +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
+ + + ME + GG L ++ + +E+ FY +I+ GL++LH + I++
Sbjct: 63 CTFQTKEHLFFVMEYLNGGDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKKGIIY 119
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQR 983
RD+K DNVL++ G +KI+DFG K A TF GT Y+APE++ KGQ+
Sbjct: 120 RDLKLDNVLLD-KDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEIL-KGQK 172
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 9e-17
Identities = 62/214 (28%), Positives = 111/214 (51%), Gaps = 24/214 (11%)
Query: 780 QLVEDLRTIPT----KKKYMQTPMLRFLYLFALNRIELGKGSYGVVYAARELDRQVKLAI 835
+++E LR+I + KKKY RF ++G+G+ G VY A ++ ++AI
Sbjct: 4 EILEKLRSIVSVGDPKKKYT-----RFE--------KIGQGASGTVYTAMDVATGQEVAI 50
Query: 836 KEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRV 895
+++ + + + EI + + ++ NIV YL S + ME + GGSL+ ++
Sbjct: 51 RQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT- 109
Query: 896 KWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 955
+E ++ ++ L+ L++LH +++HRDIK DN+L+ G VK++DFG +
Sbjct: 110 ---ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQ 165
Query: 956 LAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPV 989
+ T GT +MAPEV+ + + YG V
Sbjct: 166 ITPEQSKRSTMVGTPYWMAPEVVTR--KAYGPKV 197
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 56/173 (32%), Positives = 89/173 (51%), Gaps = 14/173 (8%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL----GDVQ-PLHEEIKLHSQLRHRNIVQY 867
LGKGS+G V A A+K + +K++ DV+ + E+ L +H + Q
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVL-KKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
+ ME V GG L ++ + G E + FY +I+ GL++LH + I+
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQ-RSGRFDEPRAR--FYAAEIVLGLQFLHERGII 118
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAET--FTGTLQYMAPEVI 978
+RD+K DNVL+++ G +KI+DFG K G+ T F GT Y+APE++
Sbjct: 119 YRDLKLDNVLLDS-EGHIKIADFGMCKE--GILGGVTTSTFCGTPDYIAPEIL 168
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|140248 PTZ00221, PTZ00221, cyclophilin; Provisional | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 51/133 (38%), Positives = 71/133 (53%), Gaps = 13/133 (9%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGF----GFK----DSTFHRVIPNF-MCQGGDFTNHNG 178
+L DVVP+T ENFRAL TG G G K + H V N + G+ + N
Sbjct: 71 FELFEDVVPETVENFRALITGSCGIDTNTGVKLDYLYTPVHHVDRNNNIIVLGELDSFN- 129
Query: 179 TGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSV 238
S G DE + +HT G+L+M + GP+T+GS F IT + LD + VVFG
Sbjct: 130 ---VSSTGTPIADEGYRHRHTERGLLTMISEGPHTSGSVFGITLGPSPSLDFKQVVFGKA 186
Query: 239 VEGLDVVKKLESM 251
V+ L +++KLES+
Sbjct: 187 VDDLSLLEKLESL 199
|
Length = 249 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 1e-16
Identities = 59/182 (32%), Positives = 93/182 (51%), Gaps = 17/182 (9%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEI--PEKNLGDVQPLHEEIKLHSQLRHRNIVQYLG- 869
+G G++G+V +AR+ +AIK+I P + + E+KL LRH NI+
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77
Query: 870 --SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
S E+ YF + ++ G L LL + PL++ + ++ QIL GLKY+H +V
Sbjct: 78 FISPLEDIYF---VTELLGTDLHRLLTSR--PLEKQ--FIQYFLYQILRGLKYVHSAGVV 130
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGA 987
HRD+K N+L+N +KI DFG ++ P + T Y APE++ Q+ Y
Sbjct: 131 HRDLKPSNILINENCD-LKICDFGLARIQD---PQMTGYVSTRYYRAPEIMLTWQK-YDV 185
Query: 988 PV 989
V
Sbjct: 186 EV 187
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 62/195 (31%), Positives = 97/195 (49%), Gaps = 18/195 (9%)
Query: 806 FALNRIELGKGSYGVVYAARELDR--QVKL-AIKEIPEKNLGDVQPLHEEIKLHSQL--- 859
F L R+ LG G+YG V+ R++ KL A+K + + + E + Q+
Sbjct: 2 FELLRV-LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 860 --RHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLL--RVKWGPLKENESTMSFYTKQIL 915
R +V + + + ++ V GG L T L R + ES + Y +I+
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHF-----TESEVRVYIAEIV 115
Query: 916 EGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKR-LAGLCPSAETFTGTLQYMA 974
L +LH I++RDIK +N+L+++ G V ++DFG SK LA A +F GT++YMA
Sbjct: 116 LALDHLHQLGIIYRDIKLENILLDS-EGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174
Query: 975 PEVIDKGQRGYGAPV 989
PEVI G G+ V
Sbjct: 175 PEVIRGGSGGHDKAV 189
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-16
Identities = 59/178 (33%), Positives = 92/178 (51%), Gaps = 19/178 (10%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIK-----LHSQLRHRNIVQY 867
+GKG+YG VY A+K L + + EEI+ L S H N+V++
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKI-----LDPISDVDEEIEAEYNILQSLPNHPNVVKF 84
Query: 868 LGSVSEE-----GYFKIFMEQVPGGSLSTLLR--VKWGPLKENESTMSFYTKQILEGLKY 920
G + G + +E GGS++ L++ + G + +E+ +S+ L GL++
Sbjct: 85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ-RLDEAMISYILYGALLGLQH 143
Query: 921 LHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
LH +I+HRD+KG+N+L+ T G VK+ DFG S +L T GT +MAPEVI
Sbjct: 144 LHNNRIIHRDVKGNNILLTTEGG-VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 200
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 61/180 (33%), Positives = 89/180 (49%), Gaps = 16/180 (8%)
Query: 806 FALNRIEL------GKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL 859
+ALN EL GKG +G V R K+A+K I KN Q E + +QL
Sbjct: 1 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCI--KNDATAQAFLAEASVMTQL 56
Query: 860 RHRNIVQYLGSVSEE-GYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGL 918
RH N+VQ LG + EE G I E + GSL LR + + + + F + + E +
Sbjct: 57 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF-SLDVCEAM 115
Query: 919 KYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
+YL VHRD+ NVLV+ V K+SDFG +K + + +T +++ APE +
Sbjct: 116 EYLEANNFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASS---TQDTGKLPVKWTAPEAL 171
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 58/194 (29%), Positives = 99/194 (51%), Gaps = 25/194 (12%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLH--EEIKLHSQLRHRNIVQYL-- 868
+G+G++G V+ AR + +A+K++ +N + P+ EIK+ L+H N+V +
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 869 -------GSVSEEGYFKI--FMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLK 919
+ + ++ + F E G LS VK+ L E + M K +L GL
Sbjct: 80 CRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNK-NVKFT-LSEIKKVM----KMLLNGLY 133
Query: 920 YLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGLCPSAETFTG---TLQYMAP 975
Y+H KI+HRD+K N+L+ T G++K++DFG ++ +T TL Y P
Sbjct: 134 YIHRNKILHRDMKAANILI-TKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPP 192
Query: 976 EVIDKGQRGYGAPV 989
E++ G+R YG P+
Sbjct: 193 ELL-LGERDYGPPI 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 55/180 (30%), Positives = 88/180 (48%), Gaps = 21/180 (11%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDV-QPLHEEIKLHSQLRHRNIVQYLGSV 871
+GKG++G VY L ++A+K D+ + +E ++ Q H NIV+ +G
Sbjct: 3 IGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILE-------GLKYLHGQ 924
++ I ME VPGGSL T LR K L K++L+ G++YL +
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLT---------VKKLLQMSLDAAAGMEYLESK 112
Query: 925 KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL--QYMAPEVIDKGQ 982
+HRD+ N LV + V+KISDFG S+ G + + ++ APE ++ G+
Sbjct: 113 NCIHRDLAARNCLV-GENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 4e-16
Identities = 60/194 (30%), Positives = 97/194 (50%), Gaps = 33/194 (17%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEI--PEKNLGDVQPLHEEIKLHSQLRHRNIVQYLG 869
++G+G+YGVVY AR+ +A+K+I +++ G EI L +++H NIV+
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 870 SV-SEEGYFKIF----------MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGL 918
V SE+ + +F M+ P +N + Y QIL G+
Sbjct: 69 VVHSEKRLYLVFEYLDLDLKKHMDSSPD-------------FAKNPRLIKTYLYQILRGI 115
Query: 919 KYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG---TLQYMAP 975
Y H +++HRD+K N+L++ + +K++DFG + R G+ TFT TL Y AP
Sbjct: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA-RAFGI--PVRTFTHEVVTLWYRAP 172
Query: 976 EVIDKGQRGYGAPV 989
E++ G R Y PV
Sbjct: 173 EIL-LGSRHYSTPV 185
|
Length = 294 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 6e-16
Identities = 60/156 (38%), Positives = 82/156 (52%), Gaps = 13/156 (8%)
Query: 808 LNRI-ELGKGSYGVVYAAR---ELDRQVKL-AIKEI-PEKNLGDVQPLHEEIKLHSQLRH 861
L RI +LG+G +G V R E D + A+K + PE + L +EI++ L H
Sbjct: 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH 65
Query: 862 RNIVQYLGSVSEEG--YFKIFMEQVPGGSLSTLL-RVKWGPLKENESTMSFYTKQILEGL 918
NIV+Y G +E+G K+ ME +P GSL L R K K N Y QI +G+
Sbjct: 66 ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGM 122
Query: 919 KYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954
YL ++ VHRD+ NVLV + VKI DFG +K
Sbjct: 123 DYLGSRQYVHRDLAARNVLVES-EHQVKIGDFGLTK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 6e-16
Identities = 52/182 (28%), Positives = 85/182 (46%), Gaps = 13/182 (7%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPL-----HEEIKLHSQLRHRNIVQY 867
+G+GSYGVV+ R + +AIK+ E + P+ EI++ QL+H N+V
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVES---EDDPVIKKIALREIRMLKQLKHPNLVNL 65
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
+ + + E L+ L + P E + Q L+ + + H +
Sbjct: 66 IEVFRRKRKLHLVFEYCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHNCI 122
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGA 987
HRD+K +N+L+ T G +K+ DFG ++ L G + T Y APE++ G YG
Sbjct: 123 HRDVKPENILI-TKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELL-VGDTQYGP 180
Query: 988 PV 989
PV
Sbjct: 181 PV 182
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 8e-16
Identities = 60/197 (30%), Positives = 86/197 (43%), Gaps = 35/197 (17%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHR--------- 862
ELG+G+YGVV R + +A+K I ++SQ + R
Sbjct: 8 ELGRGAYGVVDKMRHVPTGTIMAVKRIRA-------------TVNSQEQKRLLMDLDISM 54
Query: 863 ------NIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLR-VKWGPLKENESTMSFYTKQIL 915
V + G++ EG I ME V SL + V L E + I+
Sbjct: 55 RSVDCPYTVTFYGALFREGDVWICME-VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIV 113
Query: 916 EGLKYLHGQ-KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF-TGTLQYM 973
+ L+YLH + ++HRD+K NVL+N +G VK+ DFG S L A+T G YM
Sbjct: 114 KALEYLHSKLSVIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVD--SVAKTIDAGCKPYM 170
Query: 974 APEVIDKGQRGYGAPVR 990
APE I+ G V+
Sbjct: 171 APERINPELNQKGYDVK 187
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-15
Identities = 53/158 (33%), Positives = 82/158 (51%), Gaps = 23/158 (14%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQ------ 866
LG GS G+V++A + D ++A+K+I + V+ EIK+ +L H NIV+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 867 --------YLGSVSEEGYFKIFMEQVPGGSLSTLLRV--KWGPLKENESTMSFYTKQILE 916
+GS++E I E + T L + GPL E + + Y Q+L
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLSEEHARLFMY--QLLR 125
Query: 917 GLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954
GLKY+H ++HRD+K NV +NT V+KI DFG ++
Sbjct: 126 GLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLAR 163
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-15
Identities = 67/196 (34%), Positives = 102/196 (52%), Gaps = 26/196 (13%)
Query: 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLH--EEIKLHSQLRHRNIVQYL 868
++G+G+YG VY AR+ D +A+K++ N + P+ EIK+ QL HRNIV
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 869 GSVS----------EEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGL 918
V+ ++G F + E + L LL G + +E + + KQ+LEGL
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLES--GLVHFSEDHIKSFMKQLLEGL 129
Query: 919 KYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAET--FTG---TLQYM 973
Y H + +HRDIK N+L+N G +K++DFG LA L S E+ +T TL Y
Sbjct: 130 NYCHKKNFLHRDIKCSNILLNN-KGQIKLADFG----LARLYNSEESRPYTNKVITLWYR 184
Query: 974 APEVIDKGQRGYGAPV 989
PE++ G+ YG +
Sbjct: 185 PPELL-LGEERYGPAI 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-15
Identities = 59/192 (30%), Positives = 97/192 (50%), Gaps = 29/192 (15%)
Query: 813 LGKGSYGVVYAAREL--DRQ---------VKLAIKEIPEKNLGDVQPLHEEIKLHSQLRH 861
LG+G +G V A L D+ VK+ + EK+L D+ E +K+ +H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG--KH 80
Query: 862 RNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKE--------NESTMSFY--- 910
+NI+ LG+ +++G + +E G+L LR + P E + M+F
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 911 --TKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968
T Q+ G++YL QK +HRD+ NVLV T + V+KI+DFG ++ + + +T G
Sbjct: 141 SCTYQVARGMEYLASQKCIHRDLAARNVLV-TENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 969 TL--QYMAPEVI 978
L ++MAPE +
Sbjct: 200 RLPVKWMAPEAL 211
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 2e-15
Identities = 58/208 (27%), Positives = 83/208 (39%), Gaps = 59/208 (28%)
Query: 814 GKGSYGVVYAARELDRQVK--LAIKEI---PEKNLGDVQPLHEEIKLHSQLRHRNIVQYL 868
G+G+YG VY A+ + + AIK+ E+ G Q EI L +L+H N+V +
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 869 GSVSEEGYFKIFM---------------------EQVPGGSLSTLLRVKWGPLKENESTM 907
E +++ +P + +LL W
Sbjct: 69 EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLL---W---------- 115
Query: 908 SFYTKQILEGLKYLHGQKIVHRDIKGDNVLV---NTYSGVVKISDFGTSKRLAGLC--PS 962
QIL G+ YLH ++HRD+K N+LV GVVKI D G LA L P
Sbjct: 116 -----QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG----LARLFNAPL 166
Query: 963 AETFTG-----TLQYMAPEVIDKGQRGY 985
T+ Y APE++ G R Y
Sbjct: 167 KPLADLDPVVVTIWYRAPELL-LGARHY 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 39/212 (18%)
Query: 808 LNRIE-LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHE---EIKLHSQLRHRN 863
+I+ LGKG G V+ R A+K + +K + + E ++ + L H
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62
Query: 864 IVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHG 923
+ S E Y + M+ PGG L LL+ + G E FY ++L L+YLH
Sbjct: 63 LPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLS-EEVARFYAAEVLLALEYLHL 121
Query: 924 QKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG------------------------- 958
IV+RD+K +N+L++ SG + +SDF SK+
Sbjct: 122 LGIVYRDLKPENILLHE-SGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180
Query: 959 -LCPSAE---TFTGTLQYMAPEVIDKGQRGYG 986
+ +F GT +Y+APEVI G G
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVI----SGDG 208
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 2e-15
Identities = 51/154 (33%), Positives = 74/154 (48%), Gaps = 20/154 (12%)
Query: 812 ELGKGSYGVV----YAARELDRQVKLAIKEIPEKNLGDVQPLHE-----EIKLHSQLRHR 862
LG+G +G V Y +A+K + + + EI + L H
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC----GQQNTSGWKKEINILKTLYHE 66
Query: 863 NIVQYLGSVSEEG--YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKY 920
NIV+Y G SE+G ++ ME VP GSL L K N + + + +QI EG+ Y
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAY 122
Query: 921 LHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954
LH Q +HRD+ NVL++ +VKI DFG +K
Sbjct: 123 LHSQHYIHRDLAARNVLLDN-DRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 2e-15
Identities = 56/184 (30%), Positives = 87/184 (47%), Gaps = 31/184 (16%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPL----HEEIKLHSQLRHRNIVQYL 868
+G G+YGVV +A + K+AIK+IP + DV L E+K+ +H NI+
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIP--HAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70
Query: 869 GSV-SEEGYFK-IF-----MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYL 921
+ FK ++ ME L ++ PL E + ++ Q+L GLKY+
Sbjct: 71 DILRPPGADFKDVYVVMDLME----SDLHHIIHSD-QPLTEEH--IRYFLYQLLRGLKYI 123
Query: 922 HGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG-------TLQYMA 974
H ++HRD+K N+LVN ++I DFG ++ GL S T Y A
Sbjct: 124 HSANVIHRDLKPSNLLVNE-DCELRIGDFGMAR---GLSSSPTEHKYFMTEYVATRWYRA 179
Query: 975 PEVI 978
PE++
Sbjct: 180 PELL 183
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 57/180 (31%), Positives = 89/180 (49%), Gaps = 22/180 (12%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIK--------EIPEKNLGDVQPLHEEIKLHSQLRHRN 863
+LG G+ G V + + +A K + ++ L ++Q +HE R
Sbjct: 12 DLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHE-------CRSPY 64
Query: 864 IVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHG 923
IV + G+ E + ME + GSL + + K GP+ + ++EGL YL+
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSLDRIYK-KGGPIPVE--ILGKIAVAVVEGLTYLYN 121
Query: 924 -QKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQ 982
+I+HRDIK N+LVN+ G +K+ DFG S L + A+TF GT YM+PE I G+
Sbjct: 122 VHRIMHRDIKPSNILVNS-RGQIKLCDFGVSGEL--INSIADTFVGTSTYMSPERIQGGK 178
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 4e-15
Identities = 51/174 (29%), Positives = 89/174 (51%), Gaps = 17/174 (9%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEI--PEKNLGDVQPLHEEIKLHSQLRHRNIVQYLG- 869
+G G+YG V +A + K+AIK++ P ++ + + E++L + H N++ L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 870 ---SVSEEGYFKIFM-EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
+ S E + +++ + G L+ +++ + K ++ + F QIL GLKY+H
Sbjct: 83 FTPASSLEDFQDVYLVTHLMGADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSAG 138
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAET-FTGTLQYMAPEVI 978
I+HRD+K N+ VN +KI DFG LA T + T Y APE++
Sbjct: 139 IIHRDLKPSNIAVNEDCE-LKILDFG----LARHTDDEMTGYVATRWYRAPEIM 187
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 48/162 (29%), Positives = 71/162 (43%), Gaps = 22/162 (13%)
Query: 812 ELGKGSYGVVYAAR-----ELDRQVKLAIKEIPEKNLGDVQP-LHEEIKLHSQLRHRNIV 865
ELG+G++G V+ + + +A+K + E D + E +L + +H NIV
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLRV-------------KWGPLKENESTMSFYTK 912
++ G +E + E + G L+ LR G L S +
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL--TLSQLLQIAV 129
Query: 913 QILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954
QI G+ YL Q VHRD+ N LV Y VVKI DFG S+
Sbjct: 130 QIASGMVYLASQHFVHRDLATRNCLVG-YDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 6e-15
Identities = 57/174 (32%), Positives = 86/174 (49%), Gaps = 15/174 (8%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIK-----EIPEKNLGDVQPLHEEIKLH---SQLRHRNI 864
LG+G +G V A AIK +I ++ +V+ L E ++ + RH +
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARD--EVESLMCEKRIFETANSERHPFL 64
Query: 865 VQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ 924
V E + ME GG L ++ + E + FY ++ GL+YLH
Sbjct: 65 VNLFACFQTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAV--FYAACVVLGLQYLHEN 120
Query: 925 KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
KIV+RD+K DN+L++T G VKI+DFG K G TF GT +++APEV+
Sbjct: 121 KIVYRDLKLDNLLLDT-EGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVL 173
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 55/179 (30%), Positives = 90/179 (50%), Gaps = 20/179 (11%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQ-PLHEEIKLHSQLRHRNIVQYLGSV 871
LGKG++G V+ L + +A+K E +++ E ++ Q H NIV+ +G
Sbjct: 3 LGKGNFGEVFKG-TLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILE-------GLKYLHGQ 924
++ I ME VPGG + LR K LK TKQ+++ G+ YL +
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELK---------TKQLVKFALDAAAGMAYLESK 112
Query: 925 KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGLCPSAETFTGTLQYMAPEVIDKGQ 982
+HRD+ N LV + V+KISDFG S++ G+ S+ +++ APE ++ G+
Sbjct: 113 NCIHRDLAARNCLVGE-NNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGR 170
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|182734 PRK10791, PRK10791, peptidyl-prolyl cis-trans isomerase B (rotamase B); Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 9e-15
Identities = 51/140 (36%), Positives = 71/140 (50%), Gaps = 18/140 (12%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFGFKDST-FHRVIPNFMCQGGDFTNHNGTGGKSIYG 186
IK D P+T +NF C GF ++T FHRVI FM QGG F G K+
Sbjct: 13 IKTFDDKAPETVKNFLDYCRE----GFYNNTIFHRVINGFMIQGGGF--EPGMKQKATKE 66
Query: 187 NKFEDENFTLKHTGPGILSMANAG-PNTNGSQFFITTVKTAWLDNR--------HVVFGS 237
+ N LK+T G L+MA P++ +QFFI V +L+ + VF
Sbjct: 67 PIKNEANNGLKNT-RGTLAMARTQAPHSATAQFFINVVDNDFLNFSGESLQGWGYCVFAE 125
Query: 238 VVEGLDVVKKLESMGS-QSG 256
VVEG+DVV K++ + + +SG
Sbjct: 126 VVEGMDVVDKIKGVATGRSG 145
|
Length = 164 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-15
Identities = 51/171 (29%), Positives = 88/171 (51%), Gaps = 12/171 (7%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVS 872
+G+G +G V ++V A+K I K Q EE + ++L H+N+V+ LG +
Sbjct: 14 IGEGEFGAVLQGEYTGQKV--AVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 873 EEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIK 932
G + I ME + G+L LR + G + + ++ + EG++YL +K+VHRD+
Sbjct: 70 HNGLY-IVMELMSKGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLA 127
Query: 933 GDNVLVNTYSGVVKISDFGTSKRLAGLCP-SAETFTGTLQYMAPEVIDKGQ 982
N+LV+ GV K+SDFG LA + + +++ APE + +
Sbjct: 128 ARNILVSE-DGVAKVSDFG----LARVGSMGVDNSKLPVKWTAPEALKHKK 173
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 1e-14
Identities = 50/144 (34%), Positives = 80/144 (55%), Gaps = 7/144 (4%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
ELG G +GVV+ + Q+K+AIK I E + + + EE K+ +L H +VQ G
Sbjct: 11 ELGSGQFGVVHLG-KWRAQIKVAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPL-KENESTMSFYTKQILEGLKYLHGQKIVHRD 930
+++ I E + G L LR + G L K+ +M + + EG++YL +HRD
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSM---CQDVCEGMEYLERNSFIHRD 125
Query: 931 IKGDNVLVNTYSGVVKISDFGTSK 954
+ N LV++ +GVVK+SDFG ++
Sbjct: 126 LAARNCLVSS-TGVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-14
Identities = 54/179 (30%), Positives = 83/179 (46%), Gaps = 15/179 (8%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL----GDVQPLHEEIKLHSQLRHRNIVQYL 868
LGKG++G V RE A+K I +K + +V E ++ RH +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMK-ILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKE---NESTMSFYTKQILEGLKYLHGQK 925
S ME GG L L +E +E FY +I+ L YLH
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLS------RERVFSEDRARFYGAEIVSALGYLHSCD 115
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRG 984
+V+RD+K +N++++ G +KI+DFG K + +TF GT +Y+APEV++ G
Sbjct: 116 VVYRDLKLENLMLDK-DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 173
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 56/182 (30%), Positives = 85/182 (46%), Gaps = 20/182 (10%)
Query: 813 LGKGSYGVVYAARELDR-QVKLAIKEIPEKNLGDVQPLHE----------EIK-LHSQLR 860
LG G++G VY R+ + Q LA+KEI N + E E+ + QLR
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 861 HRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTL---LRVKWGPLKENESTMSFYTKQILEG 917
H NIV+Y + E I M+ + G L L+ K E F Q++
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV--QMVLA 125
Query: 918 LKYLHGQK-IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPE 976
L+YLH +K IVHRD+ +N+++ V I+DFG +K+ + GT+ Y PE
Sbjct: 126 LRYLHKEKRIVHRDLTPNNIMLGEDDKVT-ITDFGLAKQ-KQPESKLTSVVGTILYSCPE 183
Query: 977 VI 978
++
Sbjct: 184 IV 185
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 58/182 (31%), Positives = 88/182 (48%), Gaps = 31/182 (17%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIP--EKNLGDVQPLHEEIKLHSQLRHRNIVQYL-- 868
+G+G+YG+V +A VK+AIK+I E + L EIK+ + +H NI+ L
Sbjct: 13 IGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL-REIKILRRFKHENIIGILDI 71
Query: 869 ---GSVSE--EGYF-KIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLH 922
S + Y + ME L L++ + L + + ++ QIL GLKY+H
Sbjct: 72 IRPPSFESFNDVYIVQELMET----DLYKLIKTQ--HLSNDH--IQYFLYQILRGLKYIH 123
Query: 923 GQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQ-------YMAP 975
++HRD+K N+L+NT +KI DFG LA + TG L Y AP
Sbjct: 124 SANVLHRDLKPSNLLLNTNCD-LKICDFG----LARIADPEHDHTGFLTEYVATRWYRAP 178
Query: 976 EV 977
E+
Sbjct: 179 EI 180
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-14
Identities = 69/259 (26%), Positives = 109/259 (42%), Gaps = 52/259 (20%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHE----EIKLHSQLRHRNIVQYL 868
+GKG G VY A + ++A+K+I E +L + L + E K+ + L H IV
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIRE-DLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKW------GPLKENESTMSFYT--KQILEGLKY 920
S+ M + G +L +LL+ W L E S +F + +I ++Y
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128
Query: 921 LHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK--------------RLAGLCPSAET- 965
+H + ++HRD+K DN+L+ + VV I D+G + +C S+ T
Sbjct: 129 VHSKGVLHRDLKPDNILLGLFGEVV-ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTI 187
Query: 966 ---FTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVL 1022
GT YMAPE R G P + I Y L VI+ Q+L L
Sbjct: 188 PGKIVGTPDYMAPE------RLLGVPASESTDI-------YA-------LGVILYQMLTL 227
Query: 1023 TAALKKKTSRALVAPPQIS 1041
+ ++K R + I
Sbjct: 228 SFPYRRKKGRKISYRDVIL 246
|
Length = 932 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 56/181 (30%), Positives = 95/181 (52%), Gaps = 17/181 (9%)
Query: 813 LGKGSYGVVYAAREL---DRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQY 867
LG+GS+G V+ R++ D A+K + + L D E + +++ H IV+
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKE---NESTMSFYTKQILEGLKYLHGQ 924
+ EG + ++ + GG L T L KE E + FY ++ L +LH
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDLFTRLS------KEVMFTEEDVKFYLAELALALDHLHSL 117
Query: 925 KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRG 984
I++RD+K +N+L++ G +K++DFG SK A +F GT++YMAPEV+++ RG
Sbjct: 118 GIIYRDLKPENILLDE-EGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR--RG 174
Query: 985 Y 985
+
Sbjct: 175 H 175
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-14
Identities = 55/186 (29%), Positives = 92/186 (49%), Gaps = 12/186 (6%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLG 869
+G+G++G V R + A+K + + + D EE + + IVQ
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHY 110
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
+ ++ Y + ME +PGG L L+ E FYT +++ L +H +HR
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLM----SNYDIPEKWARFYTAEVVLALDAIHSMGFIHR 166
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRL--AGLCPSAETFTGTLQYMAPEVIDKGQRGYGA 987
D+K DN+L++ SG +K++DFGT ++ G+ +T GT Y++PEV+ K Q G G
Sbjct: 167 DVKPDNMLLDK-SGHLKLADFGTCMKMDANGMVRC-DTAVGTPDYISPEVL-KSQGGDGY 223
Query: 988 PVRQRD 993
R+ D
Sbjct: 224 YGRECD 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 55/185 (29%), Positives = 90/185 (48%), Gaps = 20/185 (10%)
Query: 805 LFALNRIELGKGSYGVVYAA---RELDRQVKLAIKEIPEKNLGDV-QPLHEEIKLHSQLR 860
L R +G+G +G VY + ++ +A+K V + +E + Q
Sbjct: 7 DITLGRC-IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 861 HRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKY 920
H +IV+ +G ++E + I ME P G L + L+V L +++ Y+ Q+ L Y
Sbjct: 66 HPHIVKLIGVITENPVW-IVMELAPLGELRSYLQVNKYSLDL--ASLILYSYQLSTALAY 122
Query: 921 LHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF----TGTL--QYMA 974
L ++ VHRDI NVLV++ VK+ DFG S+ L E++ G L ++MA
Sbjct: 123 LESKRFVHRDIAARNVLVSS-PDCVKLGDFGLSRYL-----EDESYYKASKGKLPIKWMA 176
Query: 975 PEVID 979
PE I+
Sbjct: 177 PESIN 181
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 57/192 (29%), Positives = 98/192 (51%), Gaps = 29/192 (15%)
Query: 813 LGKGSYGVVYAAREL-------DRQVKLAIK----EIPEKNLGDVQPLHEEIKLHSQLRH 861
LG+G +G V A + +R K+A+K + EK+L D+ E +K+ +H
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG--KH 83
Query: 862 RNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVK--------WGPLKENESTMSFY--- 910
+NI+ LG+ +++G + +E G+L LR + + P + E +SF
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 911 --TKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968
Q+ G++YL +K +HRD+ NVLV T V+KI+DFG ++ + + +T G
Sbjct: 144 SCAYQVARGMEYLASKKCIHRDLAARNVLV-TEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 969 TL--QYMAPEVI 978
L ++MAPE +
Sbjct: 203 RLPVKWMAPEAL 214
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-14
Identities = 55/186 (29%), Positives = 94/186 (50%), Gaps = 12/186 (6%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLG 869
+G+G++G V R Q A+K + + + D EE + + +VQ
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
+ ++ Y + ME +PGG L L+ P E FYT +++ L +H ++HR
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYDVP----EKWAKFYTAEVVLALDAIHSMGLIHR 166
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRL--AGLCPSAETFTGTLQYMAPEVIDKGQRGYGA 987
D+K DN+L++ + G +K++DFGT ++ G+ +T GT Y++PEV+ K Q G G
Sbjct: 167 DVKPDNMLLDKH-GHLKLADFGTCMKMDETGMV-RCDTAVGTPDYISPEVL-KSQGGDGY 223
Query: 988 PVRQRD 993
R+ D
Sbjct: 224 YGRECD 229
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-14
Identities = 46/177 (25%), Positives = 78/177 (44%), Gaps = 21/177 (11%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIK-----EIPEKNLGDVQPLHE---------EIKLHSQ 858
LG+G+YG V A + +AIK EI D Q + E+K+ ++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 859 LRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGL 918
++H NI+ + E + + M+ + L ++ K ++ ES + QIL GL
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMD-IMASDLKKVVDRK---IRLTESQVKCILLQILNGL 132
Query: 919 KYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAP 975
LH +HRD+ N+ +N+ G+ KI+DFG ++R P + M
Sbjct: 133 NVLHKWYFMHRDLSPANIFINSK-GICKIADFGLARRYG--YPPYSDTLSKDETMQR 186
|
Length = 335 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 56/175 (32%), Positives = 88/175 (50%), Gaps = 14/175 (8%)
Query: 813 LGKGSYGVVYAAR-ELDRQ---VKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIV--Q 866
+GKGS+G V A+ + D + VK+ K+ K + E L ++H +V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 867 YLGSVSEEGYFKIFMEQVPGGSL-STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
Y +++ YF ++ V GG L L R + P E FY +I L YLH
Sbjct: 63 YSFQTADKLYF--VLDYVNGGELFFHLQRERSFP----EPRARFYAAEIASALGYLHSLN 116
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDK 980
I++RD+K +N+L+++ G V ++DFG K + TF GT +Y+APEV+ K
Sbjct: 117 IIYRDLKPENILLDS-QGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK 170
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 4e-14
Identities = 52/184 (28%), Positives = 87/184 (47%), Gaps = 23/184 (12%)
Query: 811 IELGKGSYGVVYAARELDRQVKLAIKEIPE--KNLGDVQPLHEEIKLHSQLRHRNIVQY- 867
+G+G+YG+V +A+ + K+AIK+I N D + EIKL L H N++
Sbjct: 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70
Query: 868 --LGSVSEEGYFKIF-MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ 924
+ E + ++ + ++ L ++R L ++ Y Q+L GLKY+H
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDTDLHQIIRSS-QTLSDDHCQYFLY--QLLRGLKYIHSA 127
Query: 925 KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRG 984
++HRD+K N+L+N + +KI DFG A T + +M V+ R
Sbjct: 128 NVLHRDLKPSNLLLNA-NCDLKICDFGL----------ARTTSEKGDFMTEYVV---TRW 173
Query: 985 YGAP 988
Y AP
Sbjct: 174 YRAP 177
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 4e-14
Identities = 62/177 (35%), Positives = 93/177 (52%), Gaps = 28/177 (15%)
Query: 812 ELGKGSYGVVYA----------ARELDRQVKLAIK-EIPEKNLGDVQPLHEEIKLHSQLR 860
ELG G+ GVV+ AR+L + L IK I + + ++Q LHE
Sbjct: 12 ELGAGNGGVVFKVSHKPSGLIMARKL---IHLEIKPAIRNQIIRELQVLHE-------CN 61
Query: 861 HRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKY 920
IV + G+ +G I ME + GGSL +L+ K G + E + + +++GL Y
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQ--ILGKVSIAVIKGLTY 118
Query: 921 LHGQ-KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPE 976
L + KI+HRD+K N+LVN+ G +K+ DFG S +L + A +F GT YM+PE
Sbjct: 119 LREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPE 172
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 52/175 (29%), Positives = 90/175 (51%), Gaps = 10/175 (5%)
Query: 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
E+G G +G+V+ L+++ K+AIK I E + + + EE ++ +L H +VQ G
Sbjct: 10 QEIGSGQFGLVWLGYWLEKR-KVAIKTIREGAMSE-EDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 871 VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRD 930
+E + E + G LS LR + G ++ T+ + EG+ YL ++HRD
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRGKF--SQETLLGMCLDVCEGMAYLESSNVIHRD 125
Query: 931 IKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT---LQYMAPEVIDKGQ 982
+ N LV + VVK+SDFG ++ + L + TGT +++ +PEV +
Sbjct: 126 LAARNCLVGE-NQVVKVSDFGMTRFV--LDDQYTSSTGTKFPVKWSSPEVFSFSK 177
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 50/174 (28%), Positives = 83/174 (47%), Gaps = 20/174 (11%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHE---EIKLHSQLRHRNIVQYL 868
+LG G YG VY + +A+K + E D + E E + +++H N+VQ L
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHPNLVQLL 68
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
G + E F I E + G+L LR + + N + + QI ++YL + +H
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 127
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG------TLQYMAPE 976
RD+ N LV +VK++DFG S+ + G +T+T +++ APE
Sbjct: 128 RDLAARNCLVGENH-LVKVADFGLSRLMTG-----DTYTAHAGAKFPIKWTAPE 175
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 5e-14
Identities = 57/171 (33%), Positives = 84/171 (49%), Gaps = 10/171 (5%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL----GDVQ-PLHEEIKLHSQLRHRNIVQY 867
LGKGS+G V A AIK I +K++ DV+ + E+ L + + Q
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIK-ILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
ME V GG L ++ + G KE + FY +I GL +LH + I+
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGKFKEPHAV--FYAAEIAIGLFFLHSKGII 123
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
+RD+K DNV+++ G +KI+DFG K + TF GT Y+APE+I
Sbjct: 124 YRDLKLDNVMLDA-EGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII 173
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 6e-14
Identities = 62/200 (31%), Positives = 93/200 (46%), Gaps = 40/200 (20%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLH--EEIKLHSQLR---HRNIVQ 866
E+G G+YG VY AR+ +A+K + + D PL E+ L +L H NIV+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 867 YLGSVSE----------------EGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFY 910
+ + + + ++++VP L P + + M
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGL---------PAETIKDLM--- 114
Query: 911 TKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAET-FTGT 969
+Q L GL +LH IVHRD+K +N+LV T G VK++DFG ++ + C A T T
Sbjct: 115 -RQFLRGLDFLHANCIVHRDLKPENILV-TSGGQVKLADFGLARIYS--CQMALTPVVVT 170
Query: 970 LQYMAPEVIDKGQRGYGAPV 989
L Y APEV+ Q Y PV
Sbjct: 171 LWYRAPEVLL--QSTYATPV 188
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 9e-14
Identities = 58/192 (30%), Positives = 95/192 (49%), Gaps = 29/192 (15%)
Query: 813 LGKGSYGVVYAAREL-------DRQVKLAIKEI----PEKNLGDVQPLHEEIKLHSQLRH 861
LG+G +G V A D+ V +A+K + +K+L D+ E +KL +H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG--KH 77
Query: 862 RNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGP--------LKENESTMSFY--- 910
+NI+ LG ++EG + +E G+L LR + P K E +SF
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 911 --TKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968
Q+ G++YL ++ +HRD+ NVLV T V+KI+DFG ++ + + +T G
Sbjct: 138 SCAYQVARGMEYLESRRCIHRDLAARNVLV-TEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 969 TL--QYMAPEVI 978
L ++MAPE +
Sbjct: 197 RLPVKWMAPEAL 208
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 48/151 (31%), Positives = 72/151 (47%), Gaps = 11/151 (7%)
Query: 812 ELGKGSYGVVYAA---RELDRQVKLAIKEIPEKNLGDVQP--LHEEIKLHSQLRHRNIVQ 866
+LG GS+GVV + + +A+K + L D+ L E +HS L H N+++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHS-LDHENLIR 60
Query: 867 YLGSVSEEGYFKIFMEQVPGGSLSTLLR-VKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
G V + E P GSL LR G ST+ Y QI G++YL ++
Sbjct: 61 LYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLI--STLCDYAVQIANGMRYLESKR 117
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956
+HRD+ N+L+ + VKI DFG + L
Sbjct: 118 FIHRDLAARNILLAS-DDKVKIGDFGLMRAL 147
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 1e-13
Identities = 58/172 (33%), Positives = 89/172 (51%), Gaps = 18/172 (10%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQP-LHEEIKLHSQLRHR----NIVQ 866
ELG G+ GVV + + +A K I +++P + +I Q+ H IV
Sbjct: 12 ELGAGNGGVVTKVQHKPSGLIMARKLIHL----EIKPAIRNQIIRELQVLHECNSPYIVG 67
Query: 867 YLGSVSEEGYFKIFMEQVPGGSLSTLLR-VKWGPLKENESTMSFYTKQILEGLKYLHGQ- 924
+ G+ +G I ME + GGSL +L+ K P E + + +L GL YL +
Sbjct: 68 FYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIP----EEILGKVSIAVLRGLAYLREKH 123
Query: 925 KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPE 976
+I+HRD+K N+LVN+ G +K+ DFG S +L + A +F GT YM+PE
Sbjct: 124 QIMHRDVKPSNILVNS-RGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPE 172
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 1e-13
Identities = 57/183 (31%), Positives = 92/183 (50%), Gaps = 24/183 (13%)
Query: 812 ELGKGSYGVVYAAR--ELDRQVKLAIKEIP---EKNLGDVQPLHEEIKLHSQLR-HRNIV 865
ELG+G+YG+V +AR E + +AIK+I K + + L E+KL R H+NI
Sbjct: 7 ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL-RELKLLRHFRGHKNIT 65
Query: 866 QY--LGSVSEEGYFKIFM-EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLH 922
+ V + ++++ E++ L ++R PL ++ + QIL GLKY+H
Sbjct: 66 CLYDMDIVFPGNFNELYLYEELMEADLHQIIRSG-QPL--TDAHFQSFIYQILCGLKYIH 122
Query: 923 GQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG-------TLQYMAP 975
++HRD+K N+LVN +KI DFG ++ G + G T Y AP
Sbjct: 123 SANVLHRDLKPGNLLVNA-DCELKICDFGLAR---GFSENPGENAGFMTEYVATRWYRAP 178
Query: 976 EVI 978
E++
Sbjct: 179 EIM 181
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 52/163 (31%), Positives = 71/163 (43%), Gaps = 22/163 (13%)
Query: 812 ELGKGSYGVVYAAR-----ELDRQVKLAIKEIPEKNLGDVQ-PLHEEIKLHSQLRHRNIV 865
ELG+G++G VY E +AIK + E VQ +E +L S L+H NIV
Sbjct: 12 ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIV 71
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTK------------- 912
LG ++E + E + G L L V+ P + + T
Sbjct: 72 CLLGVCTKEQPTCMLFEYLAHGDLHEFL-VRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 913 -QILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954
QI G++YL VHRD+ N LV VKISDFG S+
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGL-TVKISDFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 60/182 (32%), Positives = 90/182 (49%), Gaps = 29/182 (15%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPE--KNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
+GKGSYGVV +A + K+AIK+I + +++ D + EIKL LRH +IV+
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 871 V---SEEGYFKIF-----MEQVPGGSLSTLLRVKWGPLKENESTM----SFYTKQILEGL 918
+ S + I+ ME S L +V +K N+ F+ Q+L L
Sbjct: 68 MLPPSRREFKDIYVVFELME-------SDLHQV----IKANDDLTPEHHQFFLYQLLRAL 116
Query: 919 KYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT---GTLQYMAP 975
KY+H + HRD+K N+L N +KI DFG ++ P+A +T T Y AP
Sbjct: 117 KYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175
Query: 976 EV 977
E+
Sbjct: 176 EL 177
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-13
Identities = 61/175 (34%), Positives = 90/175 (51%), Gaps = 14/175 (8%)
Query: 813 LGKGSYG-VVYAARELDRQ---VKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIV--Q 866
+GKGS+G V+ A R+LD + VK+ K+I + E L ++H +V
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 867 YLGSVSEEGYFKIFMEQVPGGSLS-TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
Y +E+ YF ++ V GG L L R + P E FY +I L YLH
Sbjct: 63 YSFQTTEKLYF--VLDFVNGGELFFHLQRERSFP----EPRARFYAAEIASALGYLHSIN 116
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDK 980
IV+RD+K +N+L+++ VV ++DFG K + TF GT +Y+APEVI K
Sbjct: 117 IVYRDLKPENILLDSQGHVV-LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK 170
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-13
Identities = 51/170 (30%), Positives = 83/170 (48%), Gaps = 7/170 (4%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD---VQPLHEEIKLHSQLRHRNIVQYLG 869
+G+G +G V RE A+K + + L V EE + S I Q
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
+ ++ + ME PGG L +LL +E FY +++ + +H VHR
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQF--DEDMAQFYLAELVLAIHSVHQMGYVHR 126
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRL-AGLCPSAETFTGTLQYMAPEVI 978
DIK +NVL++ +G +K++DFG++ RL A +++ GT Y+APEV+
Sbjct: 127 DIKPENVLIDR-TGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVL 175
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 53/167 (31%), Positives = 82/167 (49%), Gaps = 24/167 (14%)
Query: 800 LRFLYLFALNRIELGKGSYGVVYAARELDRQVKL--------AIKEIPEKNLGDVQPLHE 851
L+F+ LGKG++G V EL R L A+K++ ++
Sbjct: 6 LKFIQQ-------LGKGNFGSV----ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFER 54
Query: 852 EIKLHSQLRHRNIVQYLGSVSEEGY--FKIFMEQVPGGSLSTLLRVKWGPLKENESTMSF 909
EI++ L+H NIV+Y G G ++ ME +P GSL L+ L + +
Sbjct: 55 EIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL--DHRKLLL 112
Query: 910 YTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956
Y QI +G++YL ++ VHRD+ N+LV + + VKI DFG +K L
Sbjct: 113 YASQICKGMEYLGSKRYVHRDLATRNILVESEN-RVKIGDFGLTKVL 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-13
Identities = 56/192 (29%), Positives = 97/192 (50%), Gaps = 29/192 (15%)
Query: 813 LGKGSYGVVYAAREL-------DRQVKLAIKEIPE----KNLGDVQPLHEEIKLHSQLRH 861
LG+G +G V A + ++ V +A+K + + K+L D+ E +K+ +H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG--KH 77
Query: 862 RNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGP--------LKENESTMSFY--- 910
+NI+ LG+ +++G + +E G+L LR + P K E ++F
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 911 --TKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968
Q+ G++YL QK +HRD+ NVLV T V+KI+DFG ++ + + +T G
Sbjct: 138 SCAYQVARGMEYLASQKCIHRDLAARNVLV-TEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 969 TL--QYMAPEVI 978
L ++MAPE +
Sbjct: 197 RLPVKWMAPEAL 208
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|222023 pfam13281, DUF4071, Domain of unknown function (DUF4071) | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 4e-13
Identities = 37/112 (33%), Positives = 52/112 (46%), Gaps = 47/112 (41%)
Query: 699 YNLRQRLDDPKVLSGEVVLNVLMSFRDIQDYDAMVQLVEFLPYLGTIRTQQLQFPLANLL 758
LR RLDDP +LS ++V+N+L+S+RD+Q
Sbjct: 118 RELRARLDDPDLLSPDIVINLLLSYRDVQ------------------------------- 146
Query: 759 EKLLLLIDLQDYDAMDYDAMVQLVEDLRTIPTKKKYMQTPMLRFLYLFALNR 810
DYDAM++LVEDL+ IPT + T +++F Y FALNR
Sbjct: 147 ---------------DYDAMIKLVEDLKAIPT-QDLADTVLIQFQYAFALNR 182
|
This domain is found at the N-terminus of many serine-threonine kinase-like proteins. Length = 365 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-13
Identities = 49/180 (27%), Positives = 91/180 (50%), Gaps = 21/180 (11%)
Query: 809 NRIELGKGSYGVVYAARELDRQVKLAIKEI--PEKNLGDVQPLHEEIKLHSQLRHRNIVQ 866
N +G G+YG V AA + +++A+K++ P +++ + + E++L ++H N++
Sbjct: 21 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 80
Query: 867 YLGSVSEEGYFKIF-----MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYL 921
L + + F + + G L+ +++ + K + + F QIL GLKY+
Sbjct: 81 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYI 136
Query: 922 HGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG---TLQYMAPEVI 978
H I+HRD+K N+ VN +KI DFG ++ + + TG T Y APE++
Sbjct: 137 HSADIIHRDLKPSNLAVNE-DCELKILDFGLARH------TDDEMTGYVATRWYRAPEIM 189
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 58/177 (32%), Positives = 88/177 (49%), Gaps = 16/177 (9%)
Query: 811 IELGKGSYGVV----YAARELDRQVKLAIKEIPEKNLGDVQ-PLHEEIKLHSQLRHRNIV 865
+ELG G++G V Y R+ +Q+ +AIK + +N V+ + E ++ QL + IV
Sbjct: 1 VELGSGNFGCVKKGVYKMRK--KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIV 58
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
+ +G V E + ME GG L+ L K + + + Q+ G+KYL G+
Sbjct: 59 RMIG-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMH--QVSMGMKYLEGKN 115
Query: 926 IVHRDIKGDNVL-VNTYSGVVKISDFGTSKRLAGLCPSAETFTG---TLQYMAPEVI 978
VHRD+ NVL VN + KISDFG SK L + + L++ APE I
Sbjct: 116 FVHRDLAARNVLLVNQH--YAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI 170
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 4e-13
Identities = 57/183 (31%), Positives = 94/183 (51%), Gaps = 10/183 (5%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPE--KNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
+G G++GVV++ + ++A+K++P +NL + + E+K+ +H N++ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL-D 66
Query: 871 VSEEGYFKIFMEQVPGGSL--STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
+ + + F E L S L ++ P + + + QIL GLKYLH I+H
Sbjct: 67 ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILH 126
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG--TLQYMAPEVIDKGQRGYG 986
RDIK N+LVN+ + V+KI DFG + R+ S T Y APE++ G R Y
Sbjct: 127 RDIKPGNLLVNS-NCVLKICDFGLA-RVEEPDESKHMTQEVVTQYYRAPEIL-MGSRHYT 183
Query: 987 APV 989
+ V
Sbjct: 184 SAV 186
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 57/181 (31%), Positives = 92/181 (50%), Gaps = 16/181 (8%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIP-EKNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
+LG+G+Y VY R +A+KEI + G EI L +L+H NIV+
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66
Query: 871 VSEEGYFKI---FMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
+ E + +M++ + T G L N T+ +T Q+L+G+ + H +++
Sbjct: 67 IHTENKLMLVFEYMDKDLKKYMDT--HGVRGALDPN--TVKSFTYQLLKGIAFCHENRVL 122
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG---TLQYMAPEVIDKGQRG 984
HRD+K N+L+N G +K++DFG + R G+ TF+ TL Y AP+V+ G R
Sbjct: 123 HRDLKPQNLLINK-RGELKLADFGLA-RAFGI--PVNTFSNEVVTLWYRAPDVL-LGSRT 177
Query: 985 Y 985
Y
Sbjct: 178 Y 178
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 56/179 (31%), Positives = 88/179 (49%), Gaps = 8/179 (4%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL----GDVQPLHEEIKLHSQLRHRNIVQYL 868
LGKG +G V A + A K++ +K L G+ L+E+ L ++ R IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKIL-EKVSSRFIVSLA 59
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
+ + + M + GG L + G E+ FY QI+ GL++LH ++IV+
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHI-YNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGA 987
RD+K +NVL++ + G V+ISD G + L G + GT YMAPEV+ +
Sbjct: 119 RDLKPENVLLDDH-GNVRISDLGLAVELKGGKKI-KGRAGTPGYMAPEVLQGEVYDFSV 175
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 7e-13
Identities = 60/189 (31%), Positives = 93/189 (49%), Gaps = 17/189 (8%)
Query: 812 ELGKGSYGVVYAARELDRQVK-LAIKEIPEKNLGDVQPLH--EEIKLHSQLR---HRNIV 865
E+G+G+YG V+ AR+L + +A+K + + + PL E+ + L H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 866 QY-----LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKY 920
+ + E + E V L+T L P E T+ Q+L GL +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTE-TIKDMMFQLLRGLDF 125
Query: 921 LHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDK 980
LH ++VHRD+K N+LV T SG +K++DFG + R+ + + TL Y APEV+
Sbjct: 126 LHSHRVVHRDLKPQNILV-TSSGQIKLADFGLA-RIYSFQMALTSVVVTLWYRAPEVLL- 182
Query: 981 GQRGYGAPV 989
Q Y PV
Sbjct: 183 -QSSYATPV 190
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 1e-12
Identities = 55/178 (30%), Positives = 86/178 (48%), Gaps = 13/178 (7%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLG 869
LGKG++G V RE A+K + ++ + +V E ++ RH +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKE---NESTMSFYTKQILEGLKYLHGQKI 926
S + ME V GG L L +E +E FY +I+ L YLH KI
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLS------RERVFSEDRTRFYGAEIVSALDYLHSGKI 116
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRG 984
V+RD+K +N++++ G +KI+DFG K + +TF GT +Y+APEV++ G
Sbjct: 117 VYRDLKLENLMLDK-DGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYG 173
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 1e-12
Identities = 60/182 (32%), Positives = 94/182 (51%), Gaps = 28/182 (15%)
Query: 813 LGKGSYGVVYAARELDRQVK--LAIKEIPE--KNLGDVQPLHEEIKLHSQLR-HRNIVQY 867
LGKG+YG+V+ A +DR+ K +A+K+I + +N D Q EI +L H NIV+
Sbjct: 15 LGKGAYGIVWKA--IDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKL 72
Query: 868 LGSVSEEGYFKI-----FMEQVPGGSLSTLLRV-KWGPLKENESTMSFYTKQILEGLKYL 921
L + E I +ME + L V + L++ Y Q+L+ LKY+
Sbjct: 73 LNVIKAENDKDIYLVFEYME-------TDLHAVIRANILEDVHKRYIMY--QLLKALKYI 123
Query: 922 HGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGL--CPSAETFT---GTLQYMAPE 976
H ++HRD+K N+L+N+ VK++DFG ++ L+ L P T T Y APE
Sbjct: 124 HSGNVIHRDLKPSNILLNSDC-RVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPE 182
Query: 977 VI 978
++
Sbjct: 183 IL 184
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 54/188 (28%), Positives = 96/188 (51%), Gaps = 17/188 (9%)
Query: 813 LGKGSYGVVYAAREL---DRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQ-LRHRNIVQYL 868
LG G+YG V+ R++ D A+K + + + E + Q L H +L
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 869 GSV----SEEGYFKIFMEQVPGGSLSTLL--RVKWGPLKENESTMSFYTKQILEGLKYLH 922
++ + + ++ + GG L T L R ++ KE E + Y+ +I+ L++LH
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHLSQRERF---KEQEVQI--YSGEIVLALEHLH 122
Query: 923 GQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKR-LAGLCPSAETFTGTLQYMAPEVIDKG 981
I++RDIK +N+L+++ +G V ++DFG SK A +F GT++YMAP+++ G
Sbjct: 123 KLGIIYRDIKLENILLDS-NGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGG 181
Query: 982 QRGYGAPV 989
G+ V
Sbjct: 182 DGGHDKAV 189
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 49/150 (32%), Positives = 71/150 (47%), Gaps = 19/150 (12%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
ELG G +GVV + Q +AIK I E ++ + EE K+ +L H +VQ G
Sbjct: 11 ELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILE-------GLKYLHGQ 924
+++ I E + G L LR E F Q+LE G+ YL +
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLR---------EHGKRFQPSQLLEMCKDVCEGMAYLESK 119
Query: 925 KIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954
+ +HRD+ N LV+ G VK+SDFG S+
Sbjct: 120 QFIHRDLAARNCLVDD-QGCVKVSDFGLSR 148
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 52/177 (29%), Positives = 88/177 (49%), Gaps = 12/177 (6%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQ-PLHEEIKLHSQLRHRNIVQYLGS 870
+G+G++G V++ R +A+K E D++ +E ++ Q H NIV+ +G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 871 VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRD 930
+++ I ME V GG T LR + LK E + + G++YL + +HRD
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKE--LIQMVENAAAGMEYLESKHCIHRD 119
Query: 931 IKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL-----QYMAPEVIDKGQ 982
+ N LV T V+KISDFG S+ ++ TG + ++ APE ++ G+
Sbjct: 120 LAARNCLV-TEKNVLKISDFGMSREEEDGVYAS---TGGMKQIPVKWTAPEALNYGR 172
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 57/188 (30%), Positives = 92/188 (48%), Gaps = 19/188 (10%)
Query: 806 FALNRIELGK----GSYGVV-----YAARELDRQVKLAIKEI-PEKNLGDVQPLHEEIKL 855
F N + GK G++G V Y + D +K+A+K + P + + + L E+K+
Sbjct: 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKI 91
Query: 856 HSQL-RHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQI 914
S L H NIV LG+ + G + E G L LR K E +SF + Q+
Sbjct: 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSF-SYQV 150
Query: 915 LEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT----L 970
+G+ +L + +HRD+ NVL+ T+ +VKI DFG ++ + + S G +
Sbjct: 151 AKGMAFLASKNCIHRDLAARNVLL-THGKIVKICDFGLARDI--MNDSNYVVKGNARLPV 207
Query: 971 QYMAPEVI 978
++MAPE I
Sbjct: 208 KWMAPESI 215
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 48/172 (27%), Positives = 87/172 (50%), Gaps = 12/172 (6%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEI--PEKNLGDVQPLHEEIKLHSQLRHRNIVQYLG 869
++G+G+YG V+ A+ + +A+K + + + G EI L +L+H+NIV+
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
+ + + E L G + + + + Q+L+GL + H ++HR
Sbjct: 67 VLHSDKKLTLVFEYC-DQDLKKYFDSCNGDI--DPEIVKSFMFQLLKGLAFCHSHNVLHR 123
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRLAGL---CPSAETFTGTLQYMAPEVI 978
D+K N+L+N +G +K++DFG + R G+ C SAE TL Y P+V+
Sbjct: 124 DLKPQNLLINK-NGELKLADFGLA-RAFGIPVRCYSAEVV--TLWYRPPDVL 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 2e-12
Identities = 57/183 (31%), Positives = 92/183 (50%), Gaps = 30/183 (16%)
Query: 813 LGKGSYGVV-----------YAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRH 861
+GKGS+G V YA + L ++ L KE + ++ + E L L+H
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKE--QNHI-----MAERNVLLKNLKH 55
Query: 862 RNIV--QYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLK 919
+V Y +E+ YF ++ V GG L L+ + L E FY ++ +
Sbjct: 56 PFLVGLHYSFQTAEKLYF--VLDYVNGGELFFHLQRERCFL---EPRARFYAAEVASAIG 110
Query: 920 YLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP--SAETFTGTLQYMAPEV 977
YLH I++RD+K +N+L+++ VV ++DFG K G+ P + TF GT +Y+APEV
Sbjct: 111 YLHSLNIIYRDLKPENILLDSQGHVV-LTDFGLCKE--GVEPEETTSTFCGTPEYLAPEV 167
Query: 978 IDK 980
+ K
Sbjct: 168 LRK 170
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|182824 PRK10903, PRK10903, peptidyl-prolyl cis-trans isomerase A (rotamase A); Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 55/175 (31%), Positives = 74/175 (42%), Gaps = 48/175 (27%)
Query: 115 MVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFT 174
++T N+E E L S P + +NF GF + ++TFHRVIP FM QGG FT
Sbjct: 32 LLTTSAGNIELE---LNSQKAPVSVKNFVDYV--NSGF-YNNTTFHRVIPGFMIQGGGFT 85
Query: 175 NHNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAG-PNTNG--------------SQFF 219
E K P I + A+ G NT G SQFF
Sbjct: 86 -----------------EQMQQKKPNPPIKNEADNGLRNTRGTIAMARTADKDSATSQFF 128
Query: 220 ITTVKTAWLDN-----RHVVFGSVVEGLDVVKKL-----ESMGSQSGKTSKKIVV 264
I A+LD+ + VFG VV+G+DV K+ +G SK +V+
Sbjct: 129 INVADNAFLDHGQRDFGYAVFGKVVKGMDVADKISQVPTHDVGPYQNVPSKPVVI 183
|
Length = 190 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 3e-12
Identities = 61/195 (31%), Positives = 101/195 (51%), Gaps = 19/195 (9%)
Query: 806 FALNRIELGKGSYGVVYAAREL---DRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQ-LRH 861
F L ++ LG G+YG V+ R++ D A+K + + L E + L H
Sbjct: 2 FELLKV-LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 862 RNIVQYLGSV----SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEG 917
+L ++ E + ++ V GG + T L + E+E + FY+ +I+
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR-DNFSEDE--VRFYSGEIILA 117
Query: 918 LKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAE---TFTGTLQYMA 974
L++LH IV+RDIK +N+L+++ G V ++DFG SK L E +F GT++YMA
Sbjct: 118 LEHLHKLGIVYRDIKLENILLDS-EGHVVLTDFGLSKEF--LSEEKERTYSFCGTIEYMA 174
Query: 975 PEVIDKGQRGYGAPV 989
PE+I +G+ G+G V
Sbjct: 175 PEII-RGKGGHGKAV 188
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-12
Identities = 55/186 (29%), Positives = 93/186 (50%), Gaps = 12/186 (6%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLG 869
+G+G++G V R + A+K + + + D EE + + +VQ
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
+ ++ Y + ME +PGG L L+ P E FYT +++ L +H +HR
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVP----EKWARFYTAEVVLALDAIHSMGFIHR 166
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRL--AGLCPSAETFTGTLQYMAPEVIDKGQRGYGA 987
D+K DN+L++ SG +K++DFGT ++ G+ +T GT Y++PEV+ K Q G G
Sbjct: 167 DVKPDNMLLDK-SGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVL-KSQGGDGY 223
Query: 988 PVRQRD 993
R+ D
Sbjct: 224 YGRECD 229
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 57/191 (29%), Positives = 95/191 (49%), Gaps = 27/191 (14%)
Query: 813 LGKGSYG-VVYA-ARELDRQ---VKLAIKEIP----EKNLGDVQPLHEEIKLHSQLRHRN 863
LG+G++G VV A A LD +A+K + EK+L D+ E +K+ + H+N
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--HKN 77
Query: 864 IVQYLGSVSEEGYFKIFMEQVPGGSLSTLLR--------VKWGPLKENESTMSFY----- 910
I+ LG ++EG + +E G+L LR + E T++
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 911 TKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL 970
Q+ G+++L +K +HRD+ NVLV T V+KI+DFG ++ + + +T G L
Sbjct: 138 AYQVARGMEFLASKKCIHRDLAARNVLV-TEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196
Query: 971 --QYMAPEVID 979
++MAPE +
Sbjct: 197 PVKWMAPEALF 207
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 5e-12
Identities = 49/176 (27%), Positives = 96/176 (54%), Gaps = 21/176 (11%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEI--PEKNLGDVQPLHEEIKLHSQLRHRNIVQYLG- 869
+G G+YG V +A + + K+A+K++ P ++L + + E++L ++H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 870 ---SVSEEGYFKIFM-EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
+ S E + ++++ + G L+ +++ + K ++ + F Q+L GLKY+H
Sbjct: 83 FTPATSIENFNEVYLVTNLMGADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSAG 138
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG---TLQYMAPEVI 978
I+HRD+K NV VN ++I DFG +++ + + TG T Y APE++
Sbjct: 139 IIHRDLKPSNVAVNE-DCELRILDFGLARQ------ADDEMTGYVATRWYRAPEIM 187
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-12
Identities = 60/175 (34%), Positives = 91/175 (52%), Gaps = 18/175 (10%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL----GDVQPLHEEIKLHSQLRHRNIVQYL 868
LGKGS+G V A AIK I +K++ DV+ E ++ + + L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIK-ILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 869 GS---VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
S + YF ME V GG L ++ + G KE ++ FY +I GL +LH +
Sbjct: 67 HSCFQTVDRLYF--VMEYVNGGDLMYHIQ-QVGKFKEPQAV--FYAAEISVGLFFLHRRG 121
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFGTSKR--LAGLCPSAETFTGTLQYMAPEVI 978
I++RD+K DNV++++ G +KI+DFG K + G+ TF GT Y+APE+I
Sbjct: 122 IIYRDLKLDNVMLDS-EGHIKIADFGMCKEHMVDGVT--TRTFCGTPDYIAPEII 173
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 5e-12
Identities = 49/173 (28%), Positives = 88/173 (50%), Gaps = 14/173 (8%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEI--PEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
+G G+ G+V AA + +AIK++ P +N+ + + E+ L + H+NI+ L
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV 83
Query: 871 VSEEGYFKIFME-----QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
+ + + F + ++ +L +++ + + MS+ Q+L G+K+LH
Sbjct: 84 FTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MDLDHERMSYLLYQMLCGIKHLHSAG 138
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
I+HRD+K N++V + +KI DFG + R AG + T Y APEVI
Sbjct: 139 IIHRDLKPSNIVVKS-DCTLKILDFGLA-RTAGTSFMMTPYVVTRYYRAPEVI 189
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 6e-12
Identities = 54/171 (31%), Positives = 83/171 (48%), Gaps = 13/171 (7%)
Query: 813 LGKGSYGVVYAARELDRQVK-LAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYL 868
LG GS+G V A + +AIK + + V + E K+ + + H V
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRV-KWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
GS +E Y + +E V GG T LR K P FY QI+ +YL IV
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFP----NDVGCFYAAQIVLIFEYLQSLNIV 153
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
+RD+K +N+L++ G +K++DFG +K + T GT +Y+APE++
Sbjct: 154 YRDLKPENLLLDK-DGFIKMTDFGFAKVVD---TRTYTLCGTPEYIAPEIL 200
|
Length = 340 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-12
Identities = 50/178 (28%), Positives = 87/178 (48%), Gaps = 21/178 (11%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIV-----QY 867
+G GS+GVVY A +D K+AIK++ L D Q + E+ + L H NI+ Y
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYKNRELLIMKNLNHINIIFLKDYYY 129
Query: 868 LGSVSEEG---YFKIFMEQVPGGSLSTLLRVKWGPLKENEST----MSFYTKQILEGLKY 920
+ + + ME +P T+ + + N + + Y+ Q+ L Y
Sbjct: 130 TECFKKNEKNIFLNVVMEFIP----QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAY 185
Query: 921 LHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
+H + I HRD+K N+L++ + +K+ DFG++K L S ++ + Y APE++
Sbjct: 186 IHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV-SYICSRFYRAPELM 242
|
Length = 440 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 7e-12
Identities = 51/172 (29%), Positives = 83/172 (48%), Gaps = 8/172 (4%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL----GDVQPLHEEIKLHSQLRHRNIVQYL 868
+GKGS+G V AR + A+K + +K + + + E L ++H +V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
S ++ + GG L L+ + L E FY +I L YLH IV+
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFL---EPRARFYAAEIASALGYLHSLNIVY 119
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDK 980
RD+K +N+L+++ G + ++DFG K + TF GT +Y+APEV+ K
Sbjct: 120 RDLKPENILLDS-QGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHK 170
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 8e-12
Identities = 58/179 (32%), Positives = 90/179 (50%), Gaps = 14/179 (7%)
Query: 813 LGKGSYGVVYAAR--ELDR--QVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR-HRNIVQY 867
LGKGS+G V AR E R VK+ K++ ++ DV+ E ++ S R H + Q
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQD-DDVECTMTEKRILSLARNHPFLTQL 61
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
ME V GG L ++ + +E+ FY +I L +LH + I+
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQ---KSRRFDEARARFYAAEITSALMFLHDKGII 118
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP--SAETFTGTLQYMAPEVIDKGQRG 984
+RD+K DNVL++ + G K++DFG K G+ + TF GT Y+APE++ + G
Sbjct: 119 YRDLKLDNVLLD-HEGHCKLADFGMCKE--GIFNGKTTSTFCGTPDYIAPEILQEMLYG 174
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 8e-12
Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 31/203 (15%)
Query: 807 ALNRIE-LGKGSYGVVYAARELDRQVKLAIKE---------IPEKNLGDV---QPLHEEI 853
A ++E +G+G+YG VY AR+ + +A+K+ IP L ++ Q L E I
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESI 61
Query: 854 KLHSQLRHRNIVQYLGSVSEEGYF-------KIFMEQVPGGSLSTLLRVKWGPLKENEST 906
+ L ++ + G S F K FM+ G T
Sbjct: 62 YIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGP----------GRPLPAKT 111
Query: 907 MSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF 966
+ + Q+L+G+ + H ++HRD+K N+LV+ G++KI+D G + + S
Sbjct: 112 IKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHE 171
Query: 967 TGTLQYMAPEVIDKGQRGYGAPV 989
TL Y APEV+ G Y PV
Sbjct: 172 IVTLWYRAPEVL-LGSTHYSTPV 193
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-12
Identities = 56/175 (32%), Positives = 88/175 (50%), Gaps = 12/175 (6%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL----GDVQPLHEEIKLH--SQLRHRNIVQ 866
+G+G +G VY R+ D A+K + +K + G+ L+E I L S IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 867 YLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
+ ++ + GG L L + G E E M FY +I+ GL+++H + +
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLS-QHGVFSEKE--MRFYATEIILGLEHMHNRFV 118
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKG 981
V+RD+K N+L++ + G V+ISD G + + P A GT YMAPEV+ KG
Sbjct: 119 VYRDLKPANILLDEH-GHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKG 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 9e-12
Identities = 49/140 (35%), Positives = 65/140 (46%), Gaps = 17/140 (12%)
Query: 849 LHEEIKLHSQLRHRNIVQYLGS-VSEEGY-FKIFMEQVPGGSLSTLLRVKWGPLKENEST 906
E L ++L H NIV L S + G F +F E VPG +L +L G L E T
Sbjct: 25 FRRETALCARLYHPNIVALLDSGEAPPGLLFAVF-EYVPGRTLREVLAAD-GALPAGE-T 81
Query: 907 MSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGV---VKISDFGTSKRLAGLCPSA 963
Q+L+ L H Q IVHRD+K N++V+ +GV K+ DFG L G+ +
Sbjct: 82 GRLML-QVLDALACAHNQGIVHRDLKPQNIMVSQ-TGVRPHAKVLDFGIGTLLPGVRDAD 139
Query: 964 ET-------FTGTLQYMAPE 976
GT Y APE
Sbjct: 140 VATLTRTTEVLGTPTYCAPE 159
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-11
Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 7/169 (4%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLG 869
+GKGS+G V R+ D Q A+K I + ++ +V E + +Q+ IV
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
S + + + GG L L+ + G + + S FYT ++L L+ LH +++R
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQ-REG--RFDLSRARFYTAELLCALENLHKFNVIYR 117
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
D+K +N+L++ Y G + + DFG K TF GT +Y+APE++
Sbjct: 118 DLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELL 165
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 45/146 (30%), Positives = 69/146 (47%), Gaps = 5/146 (3%)
Query: 806 FALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIV 865
L R +LG G +G V+ + K+A+K + + + +E ++ +LRH +V
Sbjct: 8 LKLER-KLGAGQFGEVWMGT-WNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLV 64
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
Q SEE I E + GSL L+ G K + QI EG+ YL +
Sbjct: 65 QLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGK-KLRLPQLVDMAAQIAEGMAYLESRN 123
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFG 951
+HRD+ N+LV + V KI+DFG
Sbjct: 124 YIHRDLAARNILVGE-NLVCKIADFG 148
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 2e-11
Identities = 46/187 (24%), Positives = 86/187 (45%), Gaps = 13/187 (6%)
Query: 812 ELGKGSYG--VVYAARELDRQVKLAIKEI--PEKNLGDVQPLHEEIKLHSQLRHRNIVQY 867
+GK +V+ A+ +A+K+I + D++ L +EI QL+H NI+ Y
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
+ S + + + GS LL+ + P E ++F K +L L Y+H + +
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKGFI 123
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTS-------KRLAGLCPSAETFTGTLQYMAPEVIDK 980
HR +K ++L+ + G V +S S KR + ++ L +++PEV+ +
Sbjct: 124 HRSVKASHILL-SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ 182
Query: 981 GQRGYGA 987
+GY
Sbjct: 183 NLQGYNE 189
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 54/191 (28%), Positives = 84/191 (43%), Gaps = 31/191 (16%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG-DVQPL---HEEIKLHSQLRHRNIVQY 867
E+G+G++G V +A+K I + + L + + S IV++
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP--YIVKF 68
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKEN--ESTMSFYTKQILEGLKYLHGQ- 924
G++ EG I ME + SL + + LK E + ++ L YL +
Sbjct: 69 YGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL 127
Query: 925 KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL---------AGLCPSAETFTGTLQYMAP 975
KI+HRD+K N+L++ +G +K+ DFG S +L AG P YMAP
Sbjct: 128 KIIHRDVKPSNILLDR-NGNIKLCDFGISGQLVDSIAKTRDAGCRP----------YMAP 176
Query: 976 EVIDKGQR-GY 985
E ID R GY
Sbjct: 177 ERIDPSARDGY 187
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 56/175 (32%), Positives = 87/175 (49%), Gaps = 12/175 (6%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL----GDVQPLHEEIKLH--SQLRHRNIVQ 866
+G+G +G VY R+ D A+K + +K + G+ L+E I L S IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 867 YLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
+ ++ + GG L L + G E E M FY +I+ GL+++H + +
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEAE--MRFYAAEIILGLEHMHNRFV 118
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKG 981
V+RD+K N+L++ G V+ISD G + + P A GT YMAPEV+ KG
Sbjct: 119 VYRDLKPANILLDE-HGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKG 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 51/174 (29%), Positives = 85/174 (48%), Gaps = 13/174 (7%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHE---EIKLHSQLRHRNIVQYLG 869
LGKG +G V A + A K++ +K L + E ++ +++ R IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKEN-----ESTMSFYTKQILEGLKYLHGQ 924
+ + + M + GG L R + E E FYT QI+ GL++LH +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDL----RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116
Query: 925 KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
+I++RD+K +NVL++ G V+ISD G + L + + GT +MAPE++
Sbjct: 117 RIIYRDLKPENVLLDN-DGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELL 169
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 51/162 (31%), Positives = 75/162 (46%), Gaps = 22/162 (13%)
Query: 812 ELGKGSYGVVYAAR------ELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIV 865
ELG+G++G V+ A E D+ + +A+K + E + Q E +L + L+H++IV
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKML-VAVKALKEASESARQDFQREAELLTVLQHQHIV 70
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGP----LKENE---------STMSFYTK 912
++ G +E + E + G L+ LR GP L E M
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSH-GPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 913 QILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954
QI G+ YL VHRD+ N LV VVKI DFG S+
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGL-VVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 2e-11
Identities = 50/173 (28%), Positives = 87/173 (50%), Gaps = 14/173 (8%)
Query: 813 LGKGSYGVVYAARE--LDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
+G G+ G+V AA + LDR V + P +N + + E+ L + H+NI+ L
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 871 VSEEGYFKIFME-----QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
+ + + F + ++ +L +++ ++ + MS+ Q+L G+K+LH
Sbjct: 85 FTPQKSLEEFQDVYLVMELMDANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG 139
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
I+HRD+K N++V + +KI DFG + R AG + T Y APEVI
Sbjct: 140 IIHRDLKPSNIVVKS-DCTLKILDFGLA-RTAGTSFMMTPYVVTRYYRAPEVI 190
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 19/177 (10%)
Query: 813 LGKGSYGVVYAA--RELDRQVKL--AIKEIPEKN-LGDVQPLHEEIKLHSQLRHRNIVQY 867
LG G++G VY +VK+ AIK + E+ + + +E + + + H ++V+
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
LG + ++ + +P G L +R + + + QI +G+ YL +++V
Sbjct: 75 LG-ICLSSQVQLITQLMPLGCLLDYVRNHKDNI--GSQYLLNWCVQIAKGMSYLEEKRLV 131
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAET---FTG---TLQYMAPEVI 978
HRD+ NVLV T VKI+DFG LA L E G +++MA E I
Sbjct: 132 HRDLAARNVLVKTPQ-HVKITDFG----LAKLLDVDEKEYHAEGGKVPIKWMALESI 183
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 3e-11
Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 18/159 (11%)
Query: 812 ELGKGSYGVVYAAR------ELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIV 865
ELG+G++G V+ A E D+ + +A+K + + + + H E +L + L+H +IV
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDK-ILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWG----------PLKENESTMSFYTKQIL 915
++ G E + E + G L+ LR P + +S M +QI
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 916 EGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954
G+ YL Q VHRD+ N LV + +VKI DFG S+
Sbjct: 131 AGMVYLASQHFVHRDLATRNCLVGE-NLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 60/188 (31%), Positives = 86/188 (45%), Gaps = 42/188 (22%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIP-----EKN---LGDVQPLHEEIKLHSQLRHR- 862
E+G G+ G VY R +A+K++ E+N L D+ ++ L S H
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDL-----DVVLKS---HDC 73
Query: 863 -NIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKEN-ESTMSFYTKQILEGLKY 920
IV+ G + I ME + L LL+ GP+ E+ M+ + L LK
Sbjct: 74 PYIVKCYGYFITDSDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE 132
Query: 921 LHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL---------AGLCPSAETFTGTLQ 971
HG ++HRD+K N+L++ SG VK+ DFG S RL AG C +
Sbjct: 133 KHG--VIHRDVKPSNILLDA-SGNVKLCDFGISGRLVDSKAKTRSAG-CAA--------- 179
Query: 972 YMAPEVID 979
YMAPE ID
Sbjct: 180 YMAPERID 187
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-11
Identities = 61/186 (32%), Positives = 93/186 (50%), Gaps = 20/186 (10%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKL------HSQLRHRN 863
LGKGS+G V+ A AIK + + + DV+ E ++ H L H
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH-- 60
Query: 864 IVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHG 923
Y ++E F + ME + GG L ++ K + +FY +I+ GL++LH
Sbjct: 61 --LYCTFQTKENLFFV-MEYLNGGDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLHS 114
Query: 924 QKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQR 983
+ IV+RD+K DN+L++T G +KI+DFG K TF GT Y+APE++ GQ+
Sbjct: 115 KGIVYRDLKLDNILLDT-DGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEIL-LGQK 172
Query: 984 GYGAPV 989
Y V
Sbjct: 173 -YNTSV 177
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 3e-11
Identities = 49/172 (28%), Positives = 80/172 (46%), Gaps = 13/172 (7%)
Query: 808 LNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR-HRNIVQ 866
+ +++L G +G V + Q K I KN + E +H ++ + N ++
Sbjct: 19 VKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKN---FNAI--EPMVHQLMKDNPNFIK 73
Query: 867 YLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
SV+ + M+ + G L LL+ + G L E E + +Q++E L LH I
Sbjct: 74 LYYSVTTLKGHVLIMDYIKDGDLFDLLKKE-GKLSEAE--VKKIIRQLVEALNDLHKHNI 130
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
+H DIK +NVL + + + D+G K G PS + GTL Y +PE I
Sbjct: 131 IHNDIKLENVLYDRAKDRIYLCDYGLCKI-IGT-PS--CYDGTLDYFSPEKI 178
|
Length = 267 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-11
Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 13/178 (7%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLG 869
LGKG++G V RE A+K + ++ + +V E ++ RH +
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLL---RVKWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
+ ME GG L L RV E FY +I+ L+YLH + +
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRERVF------TEERARFYGAEIVSALEYLHSRDV 116
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRG 984
V+RDIK +N++++ G +KI+DFG K + +TF GT +Y+APEV++ G
Sbjct: 117 VYRDIKLENLMLDK-DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 173
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 55/188 (29%), Positives = 93/188 (49%), Gaps = 15/188 (7%)
Query: 806 FALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL----GDVQPLHEEIKLHSQLRH 861
F R+ LGKG +G V A + A K++ +K + G+ L+E+ ++ ++
Sbjct: 2 FRHYRV-LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK-QILEKVNS 59
Query: 862 RNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYL 921
R +V + + + + + GG L + G +E FY +I GL+ L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-NMGNPGFDEERAVFYAAEITCGLEDL 118
Query: 922 HGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF---TGTLQYMAPEVI 978
H ++IV+RD+K +N+L++ Y G ++ISD G LA P ET GT+ YMAPEV+
Sbjct: 119 HRERIVYRDLKPENILLDDY-GHIRISDLG----LAVEIPEGETIRGRVGTVGYMAPEVV 173
Query: 979 DKGQRGYG 986
+ +
Sbjct: 174 KNERYTFS 181
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 3e-11
Identities = 58/195 (29%), Positives = 96/195 (49%), Gaps = 35/195 (17%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRH----RNIVQYL 868
+GKG++G VY R+ D + A+K + +K EI ++ H RNI+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKK----------EIVAKKEVAHTIGERNILVR- 49
Query: 869 GSVSEEGYFKI---FMEQVP-----------GGSLSTLLRVKWGPLKENESTMSFYTKQI 914
++ +E F + F Q GG L L+ K G E+ + FY ++
Sbjct: 50 -TLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQ-KEGRFSEDRA--KFYIAEL 105
Query: 915 LEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMA 974
+ L++LH IV+RD+K +N+L++ +G + + DFG SK + TF GT +Y+A
Sbjct: 106 VLALEHLHKYDIVYRDLKPENILLDA-TGHIALCDFGLSKANLTDNKTTNTFCGTTEYLA 164
Query: 975 PEVIDKGQRGYGAPV 989
PEV+ ++GY V
Sbjct: 165 PEVLLD-EKGYTKHV 178
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 54/183 (29%), Positives = 82/183 (44%), Gaps = 29/183 (15%)
Query: 812 ELGKGSYGVVYAA--RELDRQ-VKLAIKEI----PEKNLGDVQPLHEEIKLHSQLRHRNI 864
+G G +G V + ++ + +AIK + +K D L E + Q H NI
Sbjct: 11 VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDF--LTEA-SIMGQFDHPNI 67
Query: 865 VQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILE-------G 917
++ G V++ I E + GSL LR G F Q++ G
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDG---------KFTVGQLVGMLRGIASG 118
Query: 918 LKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG--TLQYMAP 975
+KYL VHRD+ N+LVN+ + V K+SDFG S+RL + T G +++ AP
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNS-NLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAP 177
Query: 976 EVI 978
E I
Sbjct: 178 EAI 180
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-11
Identities = 51/179 (28%), Positives = 89/179 (49%), Gaps = 13/179 (7%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEI--PEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
+G+G+YGVV R + + +AIK+ E+N + E+K+ L+ NIV+ +
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 871 VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRD 930
G + E V L L + G E + Y Q+++ + + H IVHRD
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRS---YIYQLIKAIHWCHKNDIVHRD 125
Query: 931 IKGDNVLVNTYSGVVKISDFGTSKRLA-GLCPSAETFTGTLQYMAPEVIDKGQRGYGAP 988
IK +N+L+ +++ V+K+ DFG ++ L+ G + + T Y +PE++ GAP
Sbjct: 126 IKPENLLI-SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL------LGAP 177
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 51/171 (29%), Positives = 85/171 (49%), Gaps = 5/171 (2%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
+LG G +G V+ + K+A+K + + VQ EE L L+H +V+ V
Sbjct: 13 KLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
++E I E + GSL L+ G + F + QI EG+ Y+ + +HRD+
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDF-SAQIAEGMAYIERKNYIHRDL 129
Query: 932 KGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA-ETFTGTLQYMAPEVIDKG 981
+ NVLV+ S + KI+DFG ++ + +A E +++ APE I+ G
Sbjct: 130 RAANVLVSE-SLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 179
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 5e-11
Identities = 37/115 (32%), Positives = 57/115 (49%), Gaps = 11/115 (9%)
Query: 851 EEIKLHSQLRHRNIVQYLG-SVSEEGYFKIFMEQVPGGSLSTLLR---VKWGPLKENEST 906
+E+K+ S+L NI + LG + + ME + G L+ L+ + L N +
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLC-MIMEYMENGDLNQFLQKHVAETSGLACNSKS 126
Query: 907 MSFYT-----KQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956
+SF T QI G++YL VHRD+ N LV + +KI+DFG S+ L
Sbjct: 127 LSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK-NYTIKIADFGMSRNL 180
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 5e-11
Identities = 49/173 (28%), Positives = 89/173 (51%), Gaps = 14/173 (8%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEI--PEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
+G G+ G+V AA + + +AIK++ P +N + + E+ L + H+NI+ L
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91
Query: 871 VSEEGYFKIFME-----QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
+ + + F + ++ +L +++ ++ + MS+ Q+L G+K+LH
Sbjct: 92 FTPQKSLEEFQDVYIVMELMDANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG 146
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
I+HRD+K N++V + +KI DFG + R AG + T Y APEVI
Sbjct: 147 IIHRDLKPSNIVVKS-DCTLKILDFGLA-RTAGTSFMMTPYVVTRYYRAPEVI 197
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 52/180 (28%), Positives = 89/180 (49%), Gaps = 14/180 (7%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL----GDVQPLHEEIKLHSQLRHRNIVQYL 868
LGKG +G V A + A K + +K + G+ L+E+ ++ ++ + +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEK-QILEKVNSQFVVNLA 66
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
+ + + + + GG L + P E E + FY +IL GL+ LH + V+
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERAL-FYAAEILCGLEDLHRENTVY 125
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF---TGTLQYMAPEVIDKGQRGY 985
RD+K +N+L++ Y G ++ISD G LA P E+ GT+ YMAPEV++ +
Sbjct: 126 RDLKPENILLDDY-GHIRISDLG----LAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTL 180
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-11
Identities = 54/177 (30%), Positives = 91/177 (51%), Gaps = 21/177 (11%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEI--PEKNLGDVQPLHEEIKLHSQLRHRNIVQYLG 869
++G G+YG V +A + K+AIK++ P ++ + + E++L ++H N++ L
Sbjct: 22 QVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLD 81
Query: 870 SVSEE---GYFKIFMEQVP--GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ 924
+ + F F +P G L L++ + K +E + F Q+L+GLKY+H
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAA 137
Query: 925 KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG---TLQYMAPEVI 978
I+HRD+K N+ VN +KI DFG +++ + TG T Y APEVI
Sbjct: 138 GIIHRDLKPGNLAVNE-DCELKILDFGLARQ------TDSEMTGYVVTRWYRAPEVI 187
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 7e-11
Identities = 59/173 (34%), Positives = 89/173 (51%), Gaps = 14/173 (8%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL----GDVQPLHEEIKLHSQLRHRNIVQYL 868
LGKGS+G V A AIK I +K++ DV+ E ++ + + L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIK-ILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 869 GS---VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
S + YF ME V GG L ++ + G KE + FY +I GL +LH +
Sbjct: 67 HSCFQTMDRLYF--VMEYVNGGDLMYQIQ-QVGRFKEPHAV--FYAAEIAIGLFFLHSKG 121
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
I++RD+K DNV++++ G +KI+DFG K + +TF GT Y+APE+I
Sbjct: 122 IIYRDLKLDNVMLDS-EGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII 173
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 8e-11
Identities = 53/194 (27%), Positives = 87/194 (44%), Gaps = 28/194 (14%)
Query: 812 ELGKGSYGVVYAAREL-----DRQVKLAIKEIPEKNLGDVQP-LHEEIKLHSQLRHRNIV 865
++G+G++G V+ AR + +A+K + E+ D+Q E L ++ H NIV
Sbjct: 12 DIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIV 71
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLR---VKW----------------GPLKENEST 906
+ LG + + E + G L+ LR + PL + +
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 907 MSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL--AGLCPSAE 964
KQ+ G+ YL +K VHRD+ N LV VVKI+DFG S+ + A ++E
Sbjct: 132 QLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENM-VVKIADFGLSRNIYSADYYKASE 190
Query: 965 TFTGTLQYMAPEVI 978
+++M PE I
Sbjct: 191 NDAIPIRWMPPESI 204
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 8e-11
Identities = 30/73 (41%), Positives = 41/73 (56%), Gaps = 10/73 (13%)
Query: 912 KQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAET----FT 967
KQILEGL+YLH Q+I+HRD+K +N+ +N V I D G A P
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFINDVDQVC-IGDLG-----AAQFPVVAPAFLGLA 217
Query: 968 GTLQYMAPEVIDK 980
GT++ APEV+ +
Sbjct: 218 GTVETNAPEVLAR 230
|
Length = 357 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-11
Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 32/225 (14%)
Query: 845 DVQPLHEEIKLH--SQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWG---P 899
+ Q + +LH + H IV++ + + ME GG L+ ++ + P
Sbjct: 106 ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLP 165
Query: 900 LKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGL 959
+E E + FY QI+ L +H +K++HRD+K N+ + +G++K+ DFG SK+ +
Sbjct: 166 FQEYEVGLLFY--QIVLALDEVHSRKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDS 222
Query: 960 CP--SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIIS 1017
A +F GT Y+APE+ + R Y K L VI+
Sbjct: 223 VSLDVASSFCGTPYYLAPELWE--------------------RKRYSKKADMWSLGVILY 262
Query: 1018 QLLVLTAALKKKTSRALVAPPQISRSVSVPGPGGINSSSSAPVTP 1062
+LL L K + R ++ Q+ P P ++S A + P
Sbjct: 263 ELLTLHRPFKGPSQREIMQ--QVLYGKYDPFPCPVSSGMKALLDP 305
|
Length = 478 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 49/173 (28%), Positives = 90/173 (52%), Gaps = 10/173 (5%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
+LG G +G V+ A ++ K+A+K + ++ V+ E + L+H +V+ V
Sbjct: 13 KLGAGQFGEVWMA-TYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVV 70
Query: 872 SEEGYFKI--FMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
++E + I FM + GSL L+ G + + F + QI EG+ ++ + +HR
Sbjct: 71 TKEPIYIITEFMAK---GSLLDFLKSDEGSKQPLPKLIDF-SAQIAEGMAFIEQRNYIHR 126
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA-ETFTGTLQYMAPEVIDKG 981
D++ N+LV+ S V KI+DFG ++ + +A E +++ APE I+ G
Sbjct: 127 DLRAANILVSA-SLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG 178
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 46/161 (28%), Positives = 73/161 (45%), Gaps = 19/161 (11%)
Query: 812 ELGKGSYGVVYAAR-----ELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQ 866
ELG+G++G V+ A ++ +A+K + + L + E +L + L+H +IV+
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 867 YLGSVSEEGYFKIFMEQVPGGSLSTLLR---------VKWGPLKENE----STMSFYTKQ 913
+ G + + E + G L+ LR V P + S M Q
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 914 ILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954
I G+ YL Q VHRD+ N LV + +VKI DFG S+
Sbjct: 132 IASGMVYLASQHFVHRDLATRNCLVGA-NLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 54/171 (31%), Positives = 89/171 (52%), Gaps = 10/171 (5%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLG 869
LGKGS+G V A + A+K + + + DV+ E ++ + + +L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 870 SV--SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
++E F + ME + GG L ++ K G +T FY +I+ GL++LH + I+
Sbjct: 63 CTFQTKEHLFFV-MEFLNGGDLMFHIQDK-GRFDLYRAT--FYAAEIVCGLQFLHSKGII 118
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
+RD+K DNV+++ G +KI+DFG K A TF GT Y+APE++
Sbjct: 119 YRDLKLDNVMLDR-DGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEIL 168
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 54/184 (29%), Positives = 83/184 (45%), Gaps = 16/184 (8%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQ-PLHEEIKLHSQLRHRNIVQYL 868
LGKGS+G V A AIK + + + DV + E+ L +H +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 869 GSVSEEGYFKIFMEQVPGGSLS-TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
+ ME V GG L + R + K +E FY ++ L +LH ++
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSR----KFDEPRSRFYAAEVTLALMFLHRHGVI 118
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA--ETFTGTLQYMAPEVIDKGQRGY 985
+RD+K DN+L++ G K++DFG K G+ TF GT Y+APE++ + Y
Sbjct: 119 YRDLKLDNILLDA-EGHCKLADFGMCKE--GILNGVTTTTFCGTPDYIAPEILQ--ELEY 173
Query: 986 GAPV 989
G V
Sbjct: 174 GPSV 177
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-10
Identities = 80/342 (23%), Positives = 137/342 (40%), Gaps = 69/342 (20%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQP--LHEEIKLHSQLRHRNIVQYLG 869
++G G +G V+ + Q K I + L + + L E+ + +L+H+NIV+Y+
Sbjct: 20 KIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYID 79
Query: 870 SVSEEGYFK--IFMEQVPGGSLSTLLRVKWGPL-KENESTMSFYTKQILEGLKYLH---- 922
+ K I ME G LS ++ + K E + T+Q+L L Y H
Sbjct: 80 RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKD 139
Query: 923 ---GQKIVHRDIKGDNVLV--------------NTYSG--VVKISDFGTSKRLAGLCPSA 963
G++++HRD+K N+ + N +G + KI DFG SK + G+ A
Sbjct: 140 GPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI-GIESMA 198
Query: 964 ETFTGTLQYMAPEVIDKGQRGYG-------------------APVRQRD---------KI 995
+ GT Y +PE++ + Y P + + K
Sbjct: 199 HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKR 258
Query: 996 NPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQISRSVSVP-----GPG 1050
P I+ K ++N ++I LL L+A K++ S QI ++V P G
Sbjct: 259 GPDLPIKGKSKELN----ILIKNLLNLSA--KERPSALQCLGYQIIKNVGPPVGAAGGGA 312
Query: 1051 GINSSSSAPVT-PTPHSRHISVNTNLVCTGNNGGDKNMPLSP 1091
G+ ++ A V P H + + + N +SP
Sbjct: 313 GVAAAPGAVVARRNPSKEHPGLQLAAMEKAKHAEAANYGISP 354
|
Length = 1021 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 57/181 (31%), Positives = 84/181 (46%), Gaps = 18/181 (9%)
Query: 810 RIE--LGKGSYGVVYAAR---ELDRQVKLAIKEIP----EKNLGDVQPLHEEIKLHSQLR 860
+IE +G G +G V + R R++ +AIK + EK D E + Q
Sbjct: 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD---FLSEASIMGQFD 63
Query: 861 HRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKY 920
H NI+ G V++ I E + GSL LR G + + + I G+KY
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQ--LVGMLRGIASGMKY 121
Query: 921 LHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG---TLQYMAPEV 977
L VHRD+ N+LVN+ + V K+SDFG S+ L +A T G +++ APE
Sbjct: 122 LSDMGYVHRDLAARNILVNS-NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEA 180
Query: 978 I 978
I
Sbjct: 181 I 181
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 3e-10
Identities = 55/180 (30%), Positives = 88/180 (48%), Gaps = 14/180 (7%)
Query: 813 LGKGSYGVVYAAR--ELDR--QVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQY 867
+G+GSY V R + +R +K+ KE+ + D+ + E + Q H +V
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD-EDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
E +E V GG L ++ + K E FY+ +I L YLH + I+
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERGII 118
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAET--FTGTLQYMAPEVIDKGQRGY 985
+RD+K DNVL+++ G +K++D+G K GL P T F GT Y+APE++ G+
Sbjct: 119 YRDLKLDNVLLDS-EGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYIAPEILRGEDYGF 175
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 56/191 (29%), Positives = 90/191 (47%), Gaps = 30/191 (15%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIP-EKNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
+LG+G+Y V+ R + +A+KEI E G E+ L L+H NIV
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 871 VSEEGYFKIFMEQVPG---------GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYL 921
+ E + E + G+L ++ VK + Q+L GL Y
Sbjct: 72 IHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVK------------IFMFQLLRGLSYC 119
Query: 922 HGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG---TLQYMAPEVI 978
H +KI+HRD+K N+L+N G +K++DFG ++ A P+ +T++ TL Y P+V+
Sbjct: 120 HKRKILHRDLKPQNLLINE-KGELKLADFGLAR--AKSVPT-KTYSNEVVTLWYRPPDVL 175
Query: 979 DKGQRGYGAPV 989
G Y P+
Sbjct: 176 -LGSTEYSTPI 185
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 51/178 (28%), Positives = 80/178 (44%), Gaps = 20/178 (11%)
Query: 813 LGKGSYGVVYAA---RELDRQVKLAIKEI-PEKNLGDVQPLHEEIKLHSQLRHRNIVQYL 868
+G G +G V+ ++V +AIK + P Q E + Q H NI++
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYT-----KQILEGLKYLHG 923
G V++ I E + G+L LR +++ S Y + I G+KYL
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLR-------DHDGEFSSYQLVGMLRGIAAGMKYLSD 125
Query: 924 QKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG---TLQYMAPEVI 978
VHRD+ N+LVN+ + K+SDFG S+ L T +G +++ APE I
Sbjct: 126 MNYVHRDLAARNILVNS-NLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI 182
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 56/182 (30%), Positives = 88/182 (48%), Gaps = 35/182 (19%)
Query: 813 LGKGSYGVVYAAR-ELDRQVKLAIKEIP-EKNLGDVQPLHEEIKLHSQLRHRNIV----- 865
LG+GSY VY R +L Q+ +A+KEI E G E L L+H NIV
Sbjct: 13 LGEGSYATVYKGRSKLTGQL-VALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 866 ----QYLGSVSE--EGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLK 919
+ L V E + K +M+ GG + + + Q+L GL
Sbjct: 72 IHTKKTLTLVFEYLDTDLKQYMDDCGGGL--------------SMHNVRLFLFQLLRGLA 117
Query: 920 YLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG---TLQYMAPE 976
Y H ++++HRD+K N+L++ G +K++DFG ++ A PS +T++ TL Y P+
Sbjct: 118 YCHQRRVLHRDLKPQNLLISE-RGELKLADFGLAR--AKSVPS-KTYSNEVVTLWYRPPD 173
Query: 977 VI 978
V+
Sbjct: 174 VL 175
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 5e-10
Identities = 61/220 (27%), Positives = 94/220 (42%), Gaps = 55/220 (25%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIK-----EIPEKNLGDVQPLH--EEIKLHSQLRHRNIV 865
+G+G++G V ++ D A+K E+ EK Q H E + ++ + +V
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKE----QVAHVRAERDILAEADNPWVV 64
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
+ S +E Y + ME +PGG + TLL +K E E+ FY + + + +H
Sbjct: 65 KLYYSFQDENYLYLIMEYLPGGDMMTLL-MKKDTFTEEET--RFYIAETILAIDSIHKLG 121
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFGTSK------------RLAGLCPS----------- 962
+HRDIK DN+L++ G +K+SDFG L+ PS
Sbjct: 122 YIHRDIKPDNLLLDA-KGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180
Query: 963 ----AETF-----------TGTLQYMAPEVIDKGQRGYGA 987
AET+ GT Y+APEV Q GY
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVF--LQTGYNK 218
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 54/183 (29%), Positives = 92/183 (50%), Gaps = 15/183 (8%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL----GDVQPLHEEIKLHSQLRHRNIVQYL 868
LGKG +G V A + A K++ +K + G+ L+E+ ++ ++ R +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEK-QILEKVNSRFVVSLA 66
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
+ + + + + GG L + G E FY +I GL+ LH ++IV+
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHI-YHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF---TGTLQYMAPEVIDKGQRGY 985
RD+K +N+L++ + G ++ISD G LA P +T GT+ YMAPEV+ K +R
Sbjct: 126 RDLKPENILLDDH-GHIRISDLG----LAVHVPEGQTIKGRVGTVGYMAPEVV-KNERYT 179
Query: 986 GAP 988
+P
Sbjct: 180 FSP 182
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 5e-10
Identities = 42/157 (26%), Positives = 68/157 (43%), Gaps = 22/157 (14%)
Query: 812 ELGKGSYGVVY---AARELDRQVKL--AIKEIPEK-NLGDVQPLHEEIKLHSQLRHRNIV 865
ELG+GS+G+VY A + + + AIK + E ++ + E + + ++V
Sbjct: 13 ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFY-----------TKQI 914
+ LG VS + ME + G L + LR + + +I
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSR----RPEAENNPGLGPPTLQKFIQMAAEI 128
Query: 915 LEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFG 951
+G+ YL +K VHRD+ N +V VKI DFG
Sbjct: 129 ADGMAYLAAKKFVHRDLAARNCMVAE-DLTVKIGDFG 164
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 6e-10
Identities = 54/175 (30%), Positives = 90/175 (51%), Gaps = 20/175 (11%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEI--PEKNLGDVQPLHEEIKLHSQLRHRNIVQYL-- 868
+G G+YG V +A + K+AIK++ P ++ + + E+ L ++H N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 869 --GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
+VS + + ++ V + L ++ PL E++ + + Q+L GLKY+H I
Sbjct: 83 FTSAVSGDEFQDFYL--VMPYMQTDLQKIMGHPLSEDK--VQYLVYQMLCGLKYIHSAGI 138
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG---TLQYMAPEVI 978
+HRD+K N+ VN +KI DFG ++ AE TG T Y APEVI
Sbjct: 139 IHRDLKPGNLAVNE-DCELKILDFGLARH-----ADAE-MTGYVVTRWYRAPEVI 186
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 7e-10
Identities = 57/187 (30%), Positives = 86/187 (45%), Gaps = 30/187 (16%)
Query: 813 LGKGSYGVV-----------YAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRH 861
LGKG++G V YA + L ++V +A E+ L E L + RH
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEV-------AHTLTENRVLQNS-RH 54
Query: 862 RNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLL---RVKWGPLKENESTMSFYTKQILEGL 918
+ S ME GG L L RV +E FY +I+ L
Sbjct: 55 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVF------SEDRARFYGAEIVSAL 108
Query: 919 KYLHGQK-IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEV 977
YLH +K +V+RD+K +N++++ G +KI+DFG K + +TF GT +Y+APEV
Sbjct: 109 DYLHSEKNVVYRDLKLENLMLDK-DGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV 167
Query: 978 IDKGQRG 984
++ G
Sbjct: 168 LEDNDYG 174
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 7e-10
Identities = 50/178 (28%), Positives = 86/178 (48%), Gaps = 10/178 (5%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL----GDVQPLHEEIKLHSQLRHRNIVQYL 868
+G+GSY V R L + ++ ++ +K L D+ + E + Q + L
Sbjct: 3 IGRGSYAKVLLVR-LKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 869 GSVSE-EGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
S + + +E V GG L ++ + K E FY +I L +LH + I+
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERGII 118
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGY 985
+RD+K DNVL++ G +K++D+G K G + TF GT Y+APE++ + G+
Sbjct: 119 YRDLKLDNVLLDA-DGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGF 175
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 9e-10
Identities = 57/184 (30%), Positives = 86/184 (46%), Gaps = 29/184 (15%)
Query: 808 LNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLH--EEIKLHSQLRHRNIV 865
LN +LG+GSY VY +A+K I K V P E L L+H NIV
Sbjct: 8 LNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIV 66
Query: 866 ---------QYLGSVSEEGYFKI--FMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQI 914
+ L V E + + +M Q PGG +R+ + Q+
Sbjct: 67 LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL--------------FMFQL 112
Query: 915 LEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMA 974
L GL Y+HGQ I+HRD+K N+L+ +Y G +K++DFG ++ + + + TL Y
Sbjct: 113 LRGLAYIHGQHILHRDLKPQNLLI-SYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRP 171
Query: 975 PEVI 978
P+V+
Sbjct: 172 PDVL 175
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-09
Identities = 42/145 (28%), Positives = 72/145 (49%), Gaps = 11/145 (7%)
Query: 815 KGSYGVVYAARELDRQVKLAIK-----EIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLG 869
+G++G VY R+ + A+K ++ KN+ V + E + + IV
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNM--VHQVQAERDALALSKSPFIVHLYY 71
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
S+ + ME + GG + +LL + +G +E Y ++ L YLH I+HR
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHI-YGYF--DEEMAVKYISEVALALDYLHRHGIIHR 128
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSK 954
D+K DN+L++ G +K++DFG SK
Sbjct: 129 DLKPDNMLISN-EGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 49/177 (27%), Positives = 81/177 (45%), Gaps = 23/177 (12%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIP-EKNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
+LG+G+Y V+ R + +A+KEI E G E+ L L+H NIV
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 871 VSEEGYFKIFMEQVPG---------GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYL 921
V + + E + G++ ++ VK + QIL GL Y
Sbjct: 73 VHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVK------------IFLYQILRGLAYC 120
Query: 922 HGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
H +K++HRD+K N+L+N G +K++DFG ++ + + TL Y P+V+
Sbjct: 121 HRRKVLHRDLKPQNLLINE-RGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 176
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-09
Identities = 45/154 (29%), Positives = 73/154 (47%), Gaps = 27/154 (17%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRH----RNI---- 864
+GKG++G V ++ D A+K + L E+ QL H R++
Sbjct: 9 IGKGAFGEVRLVQKKDTGKIYAMKTL----------LKSEMFKKDQLAHVKAERDVLAES 58
Query: 865 -----VQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLK 919
V S + Y + ME +PGG L T+L +K+ E+ FY + + ++
Sbjct: 59 DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML-IKYDTFSED--VTRFYMAECVLAIE 115
Query: 920 YLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTS 953
+H +HRDIK DN+L++ G +K+SDFG S
Sbjct: 116 AVHKLGFIHRDIKPDNILIDR-GGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 57/184 (30%), Positives = 85/184 (46%), Gaps = 22/184 (11%)
Query: 810 RIE--LGKGSYGVVYAAR---ELDRQVKLAIKEIP----EKNLGDVQPLHEEIKLHSQLR 860
+IE +G G +G V R R++ +AIK + EK D E + Q
Sbjct: 7 KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRD---FLSEASIMGQFD 63
Query: 861 HRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKY 920
H NI+ G V++ I E + G+L + LR G + + + I G+KY
Sbjct: 64 HPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQ--LVGMLRGIAAGMKY 121
Query: 921 LHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL------QYMA 974
L VHRD+ N+LVN+ + V K+SDFG S+ L S T+T +L ++ A
Sbjct: 122 LSEMNYVHRDLAARNILVNS-NLVCKVSDFGLSRFLED-DTSDPTYTSSLGGKIPIRWTA 179
Query: 975 PEVI 978
PE I
Sbjct: 180 PEAI 183
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-09
Identities = 39/142 (27%), Positives = 76/142 (53%), Gaps = 7/142 (4%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLG 869
LG G++G V AR++D + A+K + +K++ V + E + ++ + +V+
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
S ++ M+ +PGG + +LL ++ G E FY ++ ++ +H +HR
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLL-IRMGIFPE--DLARFYIAELTCAVESVHKMGFIHR 125
Query: 930 DIKGDNVLVNTYSGVVKISDFG 951
DIK DN+L++ G +K++DFG
Sbjct: 126 DIKPDNILIDR-DGHIKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 34/98 (34%), Positives = 55/98 (56%), Gaps = 4/98 (4%)
Query: 881 MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNT 940
+E V GG L ++ + K E FY+ +I L +LH + I++RD+K DNVL++
Sbjct: 75 IEFVSGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDA 131
Query: 941 YSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
G +K++D+G K + TF GT Y+APE++
Sbjct: 132 -EGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEIL 168
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 47/171 (27%), Positives = 86/171 (50%), Gaps = 6/171 (3%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
+LG G +G V+ K+AIK + + ++ + E L QL+H +V+ V
Sbjct: 13 KLGAGQFGEVWMGYYNGHT-KVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
++E + I E + GSL L+ G +K + + QI EG+ ++ + +HRD+
Sbjct: 71 TQEPIY-IITEYMENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERKNYIHRDL 128
Query: 932 KGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA-ETFTGTLQYMAPEVIDKG 981
+ N+LV + + KI+DFG ++ + +A E +++ APE I+ G
Sbjct: 129 RAANILV-SETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 178
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 53/194 (27%), Positives = 79/194 (40%), Gaps = 33/194 (17%)
Query: 813 LGKGSYGVVYAARELD------RQVKLAIKEIPEKNLGDVQ-PLHEEIKLHSQLRHRNIV 865
LG G++G VY D +++A+K + + + +E L S H NIV
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLR----VKWGPLKENESTMSFYTKQILEGLKYL 921
+ LG I ME + GG L + LR ++GP + + +G YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 922 HGQKIVHRDIKGDNVLVNTYSG----VVKISDFGTS----------KRLAGLCPSAETFT 967
+HRD+ N LV+ VVKI DFG + K GL P
Sbjct: 123 EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP------ 176
Query: 968 GTLQYMAPEVIDKG 981
+++MAPE + G
Sbjct: 177 --VRWMAPESLLDG 188
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 49/159 (30%), Positives = 74/159 (46%), Gaps = 22/159 (13%)
Query: 813 LGKGSYGVVYAARELDR-----QVKLAIKEIPEKNLGDVQPLHE-----EIKLHSQLRHR 862
LG G++G VY R ++++A+K +PE E E + S+ H+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPE----SCSEQDESDFLMEALIMSKFNHQ 69
Query: 863 NIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENES--TMS---FYTKQILEG 917
NIV+ +G E I +E + GG L + LR + P E S TM F + + +G
Sbjct: 70 NIVRLIGVSFERLPRFILLELMAGGDLKSFLR-ENRPRPERPSSLTMKDLLFCARDVAKG 128
Query: 918 LKYLHGQKIVHRDIKGDNVLVNTY--SGVVKISDFGTSK 954
KYL +HRDI N L+ V KI+DFG ++
Sbjct: 129 CKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-09
Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 30/202 (14%)
Query: 805 LFALNRIELGKGSYGVVYAARELD--RQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHR 862
LF ++G+G+YG VY A+ D + + A+K+I + G EI L +L+H
Sbjct: 1 LFEYEGCKVGRGTYGHVYKAKRKDGKDEKEYALKQI--EGTGISMSACREIALLRELKHP 58
Query: 863 NIV---QYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWG------PLKENESTMSFYTKQ 913
N++ + S S+ + +F L +++ P++ S + Q
Sbjct: 59 NVIALQKVFLSHSDRKVWLLF--DYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQ 116
Query: 914 ILEGLKYLHGQKIVHRDIKGDNVLV---NTYSGVVKISDFGTS-------KRLAGLCPSA 963
IL+G+ YLH ++HRD+K N+LV G VKI+D G + K LA L P
Sbjct: 117 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 964 ETFTGTLQYMAPEVIDKGQRGY 985
TF Y APE++ G R Y
Sbjct: 177 VTF----WYRAPELL-LGARHY 193
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-09
Identities = 47/173 (27%), Positives = 87/173 (50%), Gaps = 14/173 (8%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEI--PEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
+G G+ G+V AA + + +A+K++ P +N + + E+ L + H+NI+ L
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88
Query: 871 VSEEGYFKIFME-----QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
+ + + F + ++ +L ++ ++ + MS+ Q+L G+K+LH
Sbjct: 89 FTPQKSLEEFQDVYLVMELMDANLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG 143
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
I+HRD+K N++V + +KI DFG + R A + T Y APEVI
Sbjct: 144 IIHRDLKPSNIVVKS-DCTLKILDFGLA-RTACTNFMMTPYVVTRYYRAPEVI 194
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-09
Identities = 48/177 (27%), Positives = 78/177 (44%), Gaps = 23/177 (12%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIP-EKNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
+LG+G+Y VY R +A+KEI E G E+ L L+H NIV
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 871 VSEEGYFKIFMEQVPG---------GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYL 921
+ E + E + G+ + VK + Q+L GL Y
Sbjct: 73 IHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVK------------LFLFQLLRGLNYC 120
Query: 922 HGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
H +K++HRD+K N+L+N G +K++DFG ++ + + TL Y P+++
Sbjct: 121 HRRKVLHRDLKPQNLLINE-RGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDIL 176
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 41/144 (28%), Positives = 72/144 (50%), Gaps = 5/144 (3%)
Query: 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
++LG+G +G V+ + ++AIK + + + +E ++ +LRH +VQ
Sbjct: 12 VKLGQGCFGEVWMG-TWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAV 69
Query: 871 VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRD 930
VSEE + I E + GSL L+ + G + QI G+ Y+ VHRD
Sbjct: 70 VSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM-AAQIASGMAYVERMNYVHRD 127
Query: 931 IKGDNVLVNTYSGVVKISDFGTSK 954
++ N+LV + V K++DFG ++
Sbjct: 128 LRAANILVGE-NLVCKVADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-09
Identities = 46/162 (28%), Positives = 77/162 (47%), Gaps = 24/162 (14%)
Query: 813 LGKGSYGVVYAAR------ELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIV 865
+G+G++G V AR +D +K +KE K+ D + E+++ +L H NI+
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIK-RMKEYASKD--DHRDFAGELEVLCKLGHHPNII 71
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLRVK--------WGPLKENESTMS-----FYTK 912
LG+ GY + +E P G+L LR + ST+S +
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 913 QILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954
+ G+ YL ++ +HRD+ N+LV + V KI+DFG S+
Sbjct: 132 DVARGMDYLSQKQFIHRDLAARNILVGE-NYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 55/194 (28%), Positives = 91/194 (46%), Gaps = 34/194 (17%)
Query: 812 ELGKGSYGVVYA--AREL---DRQVKLAIKEIPEK-NLGDVQPLHEEIKLHSQLRHRNIV 865
ELG+GS+G+VY AR++ + + ++A+K + E +L + E + ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENES--------TMSFYTKQILEG 917
+ LG VS+ + ME + G L + LR P EN M +I +G
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLR-SLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 918 LKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL----------AGLCPSAETFT 967
+ YL+ +K VHRD+ N +V + VKI DFG ++ + GL P
Sbjct: 132 MAYLNAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP------ 184
Query: 968 GTLQYMAPEVIDKG 981
+++MAPE + G
Sbjct: 185 --VRWMAPESLKDG 196
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 47/159 (29%), Positives = 84/159 (52%), Gaps = 18/159 (11%)
Query: 813 LGKGSYGVVYAA--RELDRQVKLAIKEIPE-KNLGDVQPLHEEIKLHSQL-RHRNIVQYL 868
+G+G++G V A ++ ++ AIK + E + D + E+++ +L H NI+ L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLR----VKWGP--LKENESTMSFYTKQILE------ 916
G+ GY I +E P G+L LR ++ P KE+ + + ++Q+L+
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 917 -GLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954
G++YL ++ +HRD+ NVLV + KI+DFG S+
Sbjct: 130 TGMQYLSEKQFIHRDLAARNVLVGE-NLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|238905 cd01924, cyclophilin_TLP40_like, cyclophilin_TLP40_like: cyclophilin-type peptidylprolyl cis- trans isomerases (cyclophilins) similar ot the Spinach thylakoid lumen protein TLP40 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 7e-09
Identities = 49/156 (31%), Positives = 65/156 (41%), Gaps = 37/156 (23%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHN------GTG- 180
I L P TA NF L E+GF + FHRV F+ Q GD N TG
Sbjct: 11 IVLDGYNAPVTAGNFVDLV--ERGF-YDGMEFHRVEGGFVVQTGDPQGKNPGFPDPETGK 67
Query: 181 -------------GKSIYGNKFE-----DENFTLKHTGPGILSMANA--GPNTNGSQFFI 220
+ +YG E DE L G ++MA PN+ SQFF
Sbjct: 68 SRTIPLEIKPEGQKQPVYGKTLEEAGRYDEQPVLPFNAFGAIAMARTEFDPNSASSQFFF 127
Query: 221 -------TTVKTAWLDNRHVVFGSVVEGLDVVKKLE 249
T + LD R+ VFG V +GLD++++L+
Sbjct: 128 LLKDNELTPSRNNVLDGRYAVFGYVTDGLDILRELK 163
|
Compared to the archetypal cyclophilin Human cyclophilin A, these proteins have similar peptidylprolyl cis- trans isomerase activity and reduced affinity for cyclosporin A. Spinach TLP40 has been shown to have a dual function as a folding catalyst and regulator of dephosphorylation. Length = 176 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 8e-09
Identities = 40/143 (27%), Positives = 74/143 (51%), Gaps = 9/143 (6%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEK---NLGDVQPLHEEIKLHSQLRHRNIVQYLG 869
LG G++G V A ++D A+K + +K N V + E + ++ + +V+
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 870 SVSEEGYFKIFMEQVPGGSL-STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
S ++ M+ +PGG + S L+R++ P E FY ++ ++ +H +H
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFP----EVLARFYIAELTLAIESVHKMGFIH 124
Query: 929 RDIKGDNVLVNTYSGVVKISDFG 951
RDIK DN+L++ G +K++DFG
Sbjct: 125 RDIKPDNILID-LDGHIKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 9e-09
Identities = 37/116 (31%), Positives = 63/116 (54%), Gaps = 6/116 (5%)
Query: 873 EEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIK 932
+E Y + M+ GG L TLL L E+ + FY +++ + +H VHRDIK
Sbjct: 72 DENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMA--RFYIAEMVLAIHSIHQLHYVHRDIK 129
Query: 933 GDNVLVNTYSGVVKISDFGTSKRLA--GLCPSAETFTGTLQYMAPEVIDKGQRGYG 986
DNVL++ +G ++++DFG+ ++ G S+ GT Y++PE++ + G G
Sbjct: 130 PDNVLLDM-NGHIRLADFGSCLKMNQDGTVQSS-VAVGTPDYISPEILQAMEDGMG 183
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 51/174 (29%), Positives = 87/174 (50%), Gaps = 14/174 (8%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL----GDVQPLHEEIKLHSQLRHRNIVQYL 868
LGKG +G V A + A K++ +K + G+ L+E+ ++ ++ R +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK-RILEKVNSRFVVSLA 66
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
+ + + + + GG L + G +E FY ++ GL+ L ++IV+
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHI-YNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF---TGTLQYMAPEVID 979
RD+K +N+L++ G ++ISD G LA P ET GT+ YMAPEVI+
Sbjct: 126 RDLKPENILLDD-RGHIRISDLG----LAVQIPEGETVRGRVGTVGYMAPEVIN 174
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 36/114 (31%), Positives = 55/114 (48%), Gaps = 9/114 (7%)
Query: 851 EEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLL---RVKWGPLKENESTM 907
+EIK+ S+L+ NI++ L + E + G L+ L + K + T+
Sbjct: 68 KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127
Query: 908 SFYT-----KQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956
S+ T QI G+KYL VHRD+ N LV + +KI+DFG S+ L
Sbjct: 128 SYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGK-NYTIKIADFGMSRNL 180
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 51/194 (26%), Positives = 88/194 (45%), Gaps = 34/194 (17%)
Query: 812 ELGKGSYGVVY-----AARELDRQVKLAIKEIPEK-NLGDVQPLHEEIKLHSQLRHRNIV 865
ELG+GS+G+VY + + + ++AIK + E ++ + E + + ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYT--------KQILEG 917
+ LG VS+ + ME + G L + LR P EN + + +I +G
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLR-SLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 918 LKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL----------AGLCPSAETFT 967
+ YL+ K VHRD+ N +V VKI DFG ++ + GL P
Sbjct: 132 MAYLNANKFVHRDLAARNCMV-AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP------ 184
Query: 968 GTLQYMAPEVIDKG 981
+++M+PE + G
Sbjct: 185 --VRWMSPESLKDG 196
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 50/181 (27%), Positives = 84/181 (46%), Gaps = 10/181 (5%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL----GDVQPLHEEIKLHSQLRHRNIVQYL 868
LGKG +G V A + + A K++ +K L G+ L E+ ++ ++ IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEK-EILEKVNSPFIVNLA 59
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
+ + + + M + GG L + G + Y+ QI G+ +LH IV+
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHI-YNVGERGLEMERVIHYSAQITCGILHLHSMDIVY 118
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAP 988
RD+K +NVL++ G ++SD G + L + GT YMAPE++ + Y P
Sbjct: 119 RDMKPENVLLDD-QGNCRLSDLGLAVELKDGKTITQR-AGTNGYMAPEILK--EEPYSYP 174
Query: 989 V 989
V
Sbjct: 175 V 175
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 24/162 (14%)
Query: 813 LGKGSYGVVYAAR------ELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIV 865
+G+G++G V AR +D +K +KE K+ D + E+++ +L H NI+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKR-MKEYASKD--DHRDFAGELEVLCKLGHHPNII 59
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLR----VKWGP--LKENESTMSFYTKQILE--- 916
LG+ GY + +E P G+L LR ++ P N + + ++Q+L
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 917 ----GLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954
G+ YL ++ +HRD+ N+LV + V KI+DFG S+
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGE-NYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-08
Identities = 30/81 (37%), Positives = 49/81 (60%), Gaps = 5/81 (6%)
Query: 899 PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 958
+E+E+ + F Q+L + ++H + ++HRDIK N+L+ + +G+VK+ DFG SK A
Sbjct: 139 TFREHEAGLLFI--QVLLAVHHVHSKHMIHRDIKSANILLCS-NGLVKLGDFGFSKMYAA 195
Query: 959 LCPS--AETFTGTLQYMAPEV 977
TF GT Y+APE+
Sbjct: 196 TVSDDVGRTFCGTPYYVAPEI 216
|
Length = 496 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 48/177 (27%), Positives = 78/177 (44%), Gaps = 37/177 (20%)
Query: 810 RIELGKGSYGVVY--------------AARELDRQVKLAIKEI-PEKNLGDVQPLHEEIK 854
+ +LG+G +G V+ A + V +A+K + + +EIK
Sbjct: 10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK 69
Query: 855 LHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMS------ 908
+ S+L++ NI++ LG + + E + G L+ L +E EST +
Sbjct: 70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLS-----QREIESTFTHANNIP 124
Query: 909 --------FYTKQILEGLKYLHGQKIVHRDIKGDNVLV-NTYSGVVKISDFGTSKRL 956
+ QI G+KYL VHRD+ N LV N Y+ +KI+DFG S+ L
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYT--IKIADFGMSRNL 179
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 57/201 (28%), Positives = 88/201 (43%), Gaps = 46/201 (22%)
Query: 813 LGKGSYGVVYAARELDRQ-----VKLAIKEIPE-KNLGDVQPLHEEIKLHSQLRHRNIVQ 866
LG+G +G V A + +A+K + E + +++ L E L Q+ H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 867 YLGSVSEEGYFKIFMEQVPGGSLSTLLRV--KWGP--LKENESTMSFYTK---------- 912
G+ S++G + +E GSL + LR K GP L + + S Y
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 913 -------QILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTS----------KR 955
QI G++YL K+VHRD+ NVLV +KISDFG S KR
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLV-AEGRKMKISDFGLSRDVYEEDSYVKR 186
Query: 956 LAGLCPSAETFTGTLQYMAPE 976
G P +++MA E
Sbjct: 187 SKGRIP--------VKWMAIE 199
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 6e-08
Identities = 38/142 (26%), Positives = 74/142 (52%), Gaps = 7/142 (4%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKN-LGDVQPLH--EEIKLHSQLRHRNIVQYLG 869
+G G++G V R++D A+K + + + L Q H E + ++ + +V+
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
S ++ M+ +PGG + +LL ++ G +E FY ++ ++ +H +HR
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLL-IRLGIFEE--DLARFYIAELTCAIESVHKMGFIHR 125
Query: 930 DIKGDNVLVNTYSGVVKISDFG 951
DIK DN+L++ G +K++DFG
Sbjct: 126 DIKPDNILIDR-DGHIKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 7e-08
Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 10/168 (5%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPE--KNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
+G+G++ V A+ AIK + + K+L V L E L H NI++ +
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 871 VSEE--GYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
+ + G + E + +L L++ + PL E + Y Q+L+ L ++H I H
Sbjct: 67 LFDRKTGRLALVFELMDM-NLYELIKGRKRPL--PEKRVKSYMYQLLKSLDHMHRNGIFH 123
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPE 976
RDIK +N+L+ ++K++DFG+ + + P E + T Y APE
Sbjct: 124 RDIKPENILIKDD--ILKLADFGSCRGIYSKPPYTE-YISTRWYRAPE 168
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 8e-08
Identities = 46/180 (25%), Positives = 79/180 (43%), Gaps = 18/180 (10%)
Query: 812 ELGKGSYGVVY--AARELDRQVKLAIKEIPEKNLGDVQPLH-EEIKLHSQLRHRNIVQYL 868
E+G G +G V A + ++ +KE+ D Q L +E++ + +L H N++Q L
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSF--YTKQILEGLKYLHGQKI 926
G E + + +E P G L LR G + + ++ GL +LH
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADF 121
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT-------LQYMAPEVID 979
+H D+ N + T VKI D+G L E + T L+++APE+++
Sbjct: 122 IHSDLALRNCQL-TADLSVKIGDYGL-----ALEQYPEDYYITKDCHAVPLRWLAPELVE 175
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 1e-07
Identities = 57/200 (28%), Positives = 88/200 (44%), Gaps = 26/200 (13%)
Query: 805 LFALNRIELGKGSYGVVYAARELDRQ--VKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHR 862
LF ++G+G+YG VY A+ D + A+K+I + G EI L +L+H
Sbjct: 1 LFEYEGCKVGRGTYGHVYKAKRKDGKDDRDYALKQI--EGTGISMSACREIALLRELKHP 58
Query: 863 NIVQ----YLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWG---PLKENESTMSFYTKQIL 915
N++ +L + + + + R P++ + QIL
Sbjct: 59 NVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 118
Query: 916 EGLKYLHGQKIVHRDIKGDNVLV---NTYSGVVKISDFGTS-------KRLAGLCPSAET 965
+G+ YLH ++HRD+K N+LV G VKI+D G + K LA L P T
Sbjct: 119 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178
Query: 966 FTGTLQYMAPEVIDKGQRGY 985
F Y APE++ G R Y
Sbjct: 179 F----WYRAPELL-LGARHY 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 51/171 (29%), Positives = 82/171 (47%), Gaps = 11/171 (6%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIP-EKNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
+LG+GSY VY + +A+K I ++ G E L L+H NIV
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71
Query: 871 VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRD 930
+ + + E V + + G EN F Q+L GL Y+H + I+HRD
Sbjct: 72 IHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLF---QLLRGLSYIHQRYILHRD 128
Query: 931 IKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG---TLQYMAPEVI 978
+K N+L++ +G +K++DFG ++ A PS T++ TL Y P+V+
Sbjct: 129 LKPQNLLISD-TGELKLADFGLAR--AKSVPS-HTYSNEVVTLWYRPPDVL 175
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 45/149 (30%), Positives = 70/149 (46%), Gaps = 9/149 (6%)
Query: 812 ELGKGSYGVV----YAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQY 867
ELG G++G V Y ++ ++ V + I + + L E + QL + IV+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
+G E + + ME G L+ L+ ++N + + Q+ G+KYL V
Sbjct: 62 IGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITEL---VHQVSMGMKYLEETNFV 117
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRL 956
HRD+ NVL+ T KISDFG SK L
Sbjct: 118 HRDLAARNVLLVT-QHYAKISDFGLSKAL 145
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 43/146 (29%), Positives = 73/146 (50%), Gaps = 9/146 (6%)
Query: 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQP--LHEEIKLHSQLRHRNIVQYL 868
++LG+G +G V+ + K+AIK + G + P +E ++ +LRH +V
Sbjct: 12 VKLGQGCFGEVWMG-TWNGTTKVAIKTLKP---GTMMPEAFLQEAQIMKKLRHDKLVPLY 67
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
VSEE + I E + GSL L+ G + + QI +G+ Y+ +H
Sbjct: 68 AVVSEEPIY-IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM-AAQIADGMAYIERMNYIH 125
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSK 954
RD++ N+LV + V KI+DFG ++
Sbjct: 126 RDLRAANILVGD-NLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 38/116 (32%), Positives = 61/116 (52%), Gaps = 6/116 (5%)
Query: 873 EEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIK 932
+E + M+ GG L TLL K+ + E FY +++ + +H VHRDIK
Sbjct: 72 DENNLYLVMDYYVGGDLLTLLS-KFED-RLPEDMARFYLAEMVLAIDSVHQLGYVHRDIK 129
Query: 933 GDNVLVNTYSGVVKISDFGTSKRLA--GLCPSAETFTGTLQYMAPEVIDKGQRGYG 986
DNVL++ +G ++++DFG+ RL G S GT Y++PE++ + G G
Sbjct: 130 PDNVLLDK-NGHIRLADFGSCLRLLADGTVQSN-VAVGTPDYISPEILQAMEDGKG 183
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 40/142 (28%), Positives = 73/142 (51%), Gaps = 7/142 (4%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD---VQPLHEEIKLHSQLRHRNIVQYLG 869
+G+G++G V ++ D A+K + + ++ + V + E + + +V+
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFY 68
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
S ++ + ME +PGG + TLL +K L E + FY + + + +H +HR
Sbjct: 69 SFQDKRNLYLIMEFLPGGDMMTLL-MKKDTLSEEAT--QFYIAETVLAIDAIHQLGFIHR 125
Query: 930 DIKGDNVLVNTYSGVVKISDFG 951
DIK DN+L++ G VK+SDFG
Sbjct: 126 DIKPDNLLLDA-KGHVKLSDFG 146
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 41/143 (28%), Positives = 70/143 (48%), Gaps = 5/143 (3%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
+LG G +G V+ + K+A+K + + + EE ++ +LRH +VQ V
Sbjct: 13 KLGNGQFGEVWMG-TWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDKLVQLYAVV 70
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
SEE + I E + GSL L+ G + + + Q+ G+ Y+ +HRD+
Sbjct: 71 SEEPIY-IVTEYMSKGSLLDFLKDGEGRALKLPNLVDM-AAQVAAGMAYIERMNYIHRDL 128
Query: 932 KGDNVLVNTYSGVVKISDFGTSK 954
+ N+LV V KI+DFG ++
Sbjct: 129 RSANILVGD-GLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 6e-07
Identities = 41/142 (28%), Positives = 75/142 (52%), Gaps = 7/142 (4%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD---VQPLHEEIKLHSQLRHRNIVQYLG 869
+G+G++G V ++ D A+K + + ++ + V + E + + +V+
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY 68
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
S ++ + ME +PGG + TLL +K L E E+ FY + + + +H +HR
Sbjct: 69 SFQDKLNLYLIMEFLPGGDMMTLL-MKKDTLTEEET--QFYIAETVLAIDSIHQLGFIHR 125
Query: 930 DIKGDNVLVNTYSGVVKISDFG 951
DIK DN+L+++ G VK+SDFG
Sbjct: 126 DIKPDNLLLDS-KGHVKLSDFG 146
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 6e-07
Identities = 37/142 (26%), Positives = 64/142 (45%), Gaps = 4/142 (2%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVS 872
LG G +G V+ + +A+K + + D + E ++ +LRH ++Q +
Sbjct: 14 LGAGQFGEVWEGL-WNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 873 EEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIK 932
E I E + GSL L+ G + Q+ G+ YL Q +HRD+
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGR-ALKLPQLIDMAAQVASGMAYLEAQNYIHRDLA 130
Query: 933 GDNVLVNTYSGVVKISDFGTSK 954
NVLV + + K++DFG ++
Sbjct: 131 ARNVLVGE-NNICKVADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 7e-07
Identities = 33/92 (35%), Positives = 48/92 (52%), Gaps = 5/92 (5%)
Query: 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKIS 948
L T L + PL + T +Q+L + Y+HG+ I+HRDIK +NVLVN + +
Sbjct: 246 LYTYLGARLRPLGLAQVTA--VARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDIC-LG 302
Query: 949 DFGTS--KRLAGLCPSAETFTGTLQYMAPEVI 978
DFG + R + P GT+ APEV+
Sbjct: 303 DFGAACFARGSWSTPFHYGIAGTVDTNAPEVL 334
|
Length = 461 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 38/149 (25%), Positives = 74/149 (49%), Gaps = 12/149 (8%)
Query: 813 LGKGSYGVVYAARELD---RQVKLAIKEIPE-KNLGDVQPLHEEIKLHSQLRHRNIVQYL 868
+GKG +G VY +D +++ A+K + +L +V+ +E + H N++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 869 G-SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSF--YTKQILEGLKYLHGQK 925
G + EG + + + G L +R + N + + Q+ +G++YL +K
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSE----THNPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFGTSK 954
VHRD+ N +++ S VK++DFG ++
Sbjct: 119 FVHRDLAARNCMLDE-SFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 46/204 (22%)
Query: 812 ELGKGSYGVVYAAREL-----DRQVKLAIKEIPEKNLGDVQPLHEEIK----LHSQLRHR 862
ELG+ +G VY ++ +AIK + +K G PL EE K + S+L+H
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG---PLREEFKHEAMMRSRLQHP 68
Query: 863 NIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKW-----GPLKENESTMS--------F 909
NIV LG V++E + L L ++ G ++++ S
Sbjct: 69 NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH 128
Query: 910 YTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGV-VKISDFGTSK--------RLAG-- 958
QI G+++L +VH+D+ NVLV + + VKISD G + +L G
Sbjct: 129 IVTQIAAGMEFLSSHHVVHKDLATRNVLV--FDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 959 LCPSAETFTGTLQYMAPEVIDKGQ 982
L P +++M+PE I G+
Sbjct: 187 LLP--------IRWMSPEAIMYGK 202
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 35/110 (31%), Positives = 60/110 (54%), Gaps = 6/110 (5%)
Query: 879 IFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLV 938
+ M+ GG L TLL L E+ + FY +++ + +H VHRDIK DN+L+
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMA--RFYLAEMVIAIDSVHQLHYVHRDIKPDNILM 135
Query: 939 NTYSGVVKISDFGTSKRLA--GLCPSAETFTGTLQYMAPEVIDKGQRGYG 986
+ +G ++++DFG+ +L G S+ GT Y++PE++ + G G
Sbjct: 136 DM-NGHIRLADFGSCLKLMEDGTVQSS-VAVGTPDYISPEILQAMEDGKG 183
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 3e-06
Identities = 49/168 (29%), Positives = 85/168 (50%), Gaps = 16/168 (9%)
Query: 800 LRFLYLFALNRIE-LGKGSYGVVYAARELDR----QVKLAIKEIPEKN--LGDVQPLHEE 852
LR L L R++ LG G++G VY + ++ +AIK + E +V+ + E
Sbjct: 1 LRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEA 60
Query: 853 IKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSF--Y 910
+ + S + H ++V+ LG V ++ + +P G L + K+N + +
Sbjct: 61 LIMAS-MDHPHLVRLLG-VCLSPTIQLVTQLMPHGCLLDYVHEH----KDNIGSQLLLNW 114
Query: 911 TKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 958
QI +G+ YL +++VHRD+ NVLV + VKI+DFG ++ L G
Sbjct: 115 CVQIAKGMMYLEERRLVHRDLAARNVLVKS-PNHVKITDFGLARLLEG 161
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 55/199 (27%), Positives = 89/199 (44%), Gaps = 36/199 (18%)
Query: 812 ELGKGSYGVVYAAR----ELDRQVKLAIKEIPEKN----LGDVQPLHEEIKLHSQLRHRN 863
ELG+ ++G +Y +D +AIK + + N G+ Q +E L ++L H N
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQ---QEASLMAELHHPN 68
Query: 864 IVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKW------------GPLKENESTMSFY- 910
IV LG V++E + E + G L L ++ G +K + F
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 911 -TKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF--- 966
QI G++YL VH+D+ N+L+ VKISD G S+ + SA+ +
Sbjct: 129 IAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH-VKISDLGLSREIY----SADYYRVQ 183
Query: 967 TGTL---QYMAPEVIDKGQ 982
+L ++M PE I G+
Sbjct: 184 PKSLLPIRWMPPEAIMYGK 202
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 6e-06
Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 14/165 (8%)
Query: 800 LRFLYLFALNRIE-LGKGSYGVVYAARELDR----QVKLAIKEIPEKNLGDV-QPLHEEI 853
LR L +I+ LG G++G VY + ++ +AIKE+ E + + +E
Sbjct: 1 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 60
Query: 854 KLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSF--YT 911
+ + + + ++ + LG + ++ + +P G L +R K+N + +
Sbjct: 61 YVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREH----KDNIGSQYLLNWC 115
Query: 912 KQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956
QI +G+ YL +++VHRD+ NVLV T VKI+DFG +K L
Sbjct: 116 VQIAKGMNYLEERRLVHRDLAARNVLVKTPQH-VKITDFGLAKLL 159
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-06
Identities = 49/183 (26%), Positives = 85/183 (46%), Gaps = 22/183 (12%)
Query: 812 ELGKGSYGVVYAARELDRQV---KLAIKEIPEKNLGDVQPLH--EEIKLHSQLRHRNIVQ 866
E+G G +G V E++ ++ +KE+ + + + EE + + L+H N++Q
Sbjct: 2 EIGNGWFGKVILG-EVNSGYTPAQVVVKEL-RVSASVQEQMKFLEEAQPYRSLQHSNLLQ 59
Query: 867 YLGSVSEEGYFKIFMEQVPGGSLSTLLRV--KWGPLKENESTMSFYTKQILEGLKYLHGQ 924
LG +E + + ME P G L LR K + + +T+ +I GL +LH
Sbjct: 60 CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119
Query: 925 KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT-------LQYMAPEV 977
+H D+ N L+ T VKI D+G S E + T L+++APE+
Sbjct: 120 NFIHSDLALRNCLL-TADLTVKIGDYGLSH-----NKYKEDYYVTPDQLWVPLRWIAPEL 173
Query: 978 IDK 980
+D+
Sbjct: 174 VDE 176
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 8e-06
Identities = 42/158 (26%), Positives = 67/158 (42%), Gaps = 17/158 (10%)
Query: 811 IELGKGSYGVVYAAR------ELDRQVKL--AIKEIPEKNLGDVQPLHEEIKLHSQLRHR 862
LG+G +G V+ A+ E + L A+++ ++NL E+ + +L H+
Sbjct: 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENL--QSEFRRELDMFRKLSHK 68
Query: 863 NIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRV------KWGPLKENESTMSFYTKQILE 916
N+V+ LG E + +E G L LR K P + QI
Sbjct: 69 NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128
Query: 917 GLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954
G+ +L + VHRD+ N LV + VK+S SK
Sbjct: 129 GMDHLSNARFVHRDLAARNCLV-SSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 9e-06
Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 18/166 (10%)
Query: 806 FALNRIELGKGSYGVVYAAR---ELDRQVKLAIKEIPEK--NLGDVQPLHEEIKLHSQLR 860
F L R+ LGKG +G V A+ E K+A+K + + D++ E +
Sbjct: 1 FTLGRM-LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD 59
Query: 861 HRNIVQYLGSVS----EEGYFKIFMEQVP---GGSLSTLL---RVKWGPLKENESTMSFY 910
H N+++ +G VS +G I M +P G L T L R+ P T+ +
Sbjct: 60 HPNVIKLIG-VSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118
Query: 911 TKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956
I G++YL + +HRD+ N ++N + V ++DFG SK++
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLNE-NMTVCVADFGLSKKI 163
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 16/165 (9%)
Query: 806 FALNRIELGKGSYGVVYAAR---ELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLR 860
L +I LG+G +G V + + Q+K+A+K + +++ E
Sbjct: 1 LKLGKI-LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD 59
Query: 861 HRNIVQYLG---SVSEEGYFKIFMEQVP---GGSLSTLL---RVKWGPLKENESTMSFYT 911
H N+++ +G S M +P G L + L R+ P K T+ +
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 912 KQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956
I G++YL + +HRD+ N ++ V ++DFG SK++
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVC-VADFGLSKKI 163
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-05
Identities = 33/130 (25%), Positives = 63/130 (48%), Gaps = 9/130 (6%)
Query: 852 EIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYT 911
EI + + HR I+ + + + + M + + + R PL+
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLE----QAITIQ 191
Query: 912 KQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC---PSAETFTG 968
+++LE L YLHG+ I+HRD+K +N+ ++ V + DFG + +L P ++G
Sbjct: 192 RRLLEALAYLHGRGIIHRDVKTENIFLDEPENAV-LGDFGAACKL-DAHPDTPQCYGWSG 249
Query: 969 TLQYMAPEVI 978
TL+ +PE++
Sbjct: 250 TLETNSPELL 259
|
Length = 392 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 3e-05
Identities = 24/42 (57%), Positives = 30/42 (71%), Gaps = 1/42 (2%)
Query: 912 KQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTS 953
+Q+L GL+ LH IVHRDIK +N+LV T G VKI DFG +
Sbjct: 316 RQVLTGLRKLHRIGIVHRDIKPENLLV-TVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 5e-05
Identities = 30/83 (36%), Positives = 42/83 (50%), Gaps = 8/83 (9%)
Query: 898 GPLKEN---ESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954
G +EN ++ M +QIL L LH IVHRD+K N++ + SG KI D G +
Sbjct: 249 GLERENKIIQTIM----RQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAA 304
Query: 955 RL-AGLCPSAETFTGTLQYMAPE 976
L G+ + F +Y APE
Sbjct: 305 DLRVGINYIPKEFLLDPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 24/81 (29%), Positives = 42/81 (51%), Gaps = 16/81 (19%)
Query: 912 KQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFG--------TSKRLAGLCPSA 963
+ +L ++YLH +I+HRDIK +N+ +N + G V + DFG + + G
Sbjct: 189 RSVLRAIQYLHENRIIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDINANKYYG----- 242
Query: 964 ETFTGTLQYMAPEVIDKGQRG 984
+ GT+ APE++ + G
Sbjct: 243 --WAGTIATNAPELLARDPYG 261
|
Length = 391 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 36/122 (29%), Positives = 55/122 (45%), Gaps = 17/122 (13%)
Query: 851 EEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENES----- 905
+E+K+ S+L+ NI++ LG +E + E + G L+ L KE
Sbjct: 68 KEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127
Query: 906 ------TMSF-----YTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954
+S+ QI G+KYL VHRD+ N LV + +KI+DFG S+
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGE-NLTIKIADFGMSR 186
Query: 955 RL 956
L
Sbjct: 187 NL 188
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 32/123 (26%), Positives = 53/123 (43%), Gaps = 15/123 (12%)
Query: 838 IPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKW 897
+ + D E L SQL H+++V+ G + + E V G L L
Sbjct: 37 VLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLH--- 92
Query: 898 GPLKENESTMSFY---TKQILEGLKYLHGQKIVHRDIKGDNVLV------NTYSGVVKIS 948
++N ++ + KQ+ L YL +K+VH ++ G N+LV Y +K+S
Sbjct: 93 --REKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLS 150
Query: 949 DFG 951
D G
Sbjct: 151 DPG 153
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 43/152 (28%), Positives = 75/152 (49%), Gaps = 15/152 (9%)
Query: 813 LGKGSYGVVYAA---RELDR-QVKLAIKEIPEKNLGDVQPLHEEIKLH----SQLRHRNI 864
LG G +G V+ E D ++ +AIK I +++ + +EI H L H I
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS---GRQTFQEITDHMLAMGSLDHAYI 71
Query: 865 VQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ 924
V+ LG + ++ + P GSL +R L + + + QI +G+ YL
Sbjct: 72 VRLLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDSL--DPQRLLNWCVQIAKGMYYLEEH 128
Query: 925 KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956
++VHR++ N+L+ + S +V+I+DFG + L
Sbjct: 129 RMVHRNLAARNILLKSDS-IVQIADFGVADLL 159
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 36/131 (27%), Positives = 52/131 (39%), Gaps = 14/131 (10%)
Query: 858 QLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEG 917
Q H NIV+ G ++ I E + G+L + LR G L + M + G
Sbjct: 62 QFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQ-LMGMLPG-LASG 119
Query: 918 LKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQ------ 971
+KYL VH+ + VLVN+ V KIS F + +E T+
Sbjct: 120 MKYLSEMGYVHKGLAAHKVLVNS-DLVCKISGFRRLQE-----DKSEAIYTTMSGKSPVL 173
Query: 972 YMAPEVIDKGQ 982
+ APE I
Sbjct: 174 WAAPEAIQYHH 184
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 5e-04
Identities = 27/83 (32%), Positives = 44/83 (53%), Gaps = 22/83 (26%)
Query: 910 YTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-----------AG 958
Y+ Q+ G+++L +K +HRD+ N+L++ + VVKI DFG ++ + A
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDAR 236
Query: 959 LCPSAETFTGTLQYMAPEVI-DK 980
L L++MAPE I DK
Sbjct: 237 L---------PLKWMAPESIFDK 250
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 5e-04
Identities = 43/189 (22%), Positives = 84/189 (44%), Gaps = 17/189 (8%)
Query: 810 RIELGKG--SYGVVYAARELDRQVKLAIKEIPEKNLGD--VQPLHEEIKLHSQLRHRNIV 865
++E+G+G + VY AR + ++ +N + ++ L E+ L RH NI+
Sbjct: 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIM 62
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
+ + + + GS ++LL+ + P +E+ + L GL YLH
Sbjct: 63 TSWTVFTTGSWLWVISPFMAYGSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG 121
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDF---------GTSKRLAGLCPSAETFTGTLQYMAPE 976
+HR+IK ++L++ G+V +S G ++ P T L +++PE
Sbjct: 122 YIHRNIKASHILISG-DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFS--TSVLPWLSPE 178
Query: 977 VIDKGQRGY 985
++ + GY
Sbjct: 179 LLRQDLYGY 187
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 8e-04
Identities = 21/53 (39%), Positives = 35/53 (66%), Gaps = 5/53 (9%)
Query: 900 LKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGT 952
LK+ + M KQ+L ++Y+H +K++HRDIK +N+ +N G + + DFGT
Sbjct: 266 LKQTRAIM----KQLLCAVEYIHDKKLIHRDIKLENIFLNC-DGKIVLGDFGT 313
|
Length = 501 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 0.001
Identities = 24/72 (33%), Positives = 40/72 (55%), Gaps = 5/72 (6%)
Query: 910 YTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL---AGLCPSAETF 966
+T Q+ G+++L + VHRD+ NVL+ +VKI DFG ++ + + TF
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLL-AQGKIVKICDFGLARDIMHDSNYVSKGSTF 300
Query: 967 TGTLQYMAPEVI 978
+++MAPE I
Sbjct: 301 L-PVKWMAPESI 311
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 40/157 (25%), Positives = 74/157 (47%), Gaps = 14/157 (8%)
Query: 813 LGKGSYGVVYAAR--ELDRQVKLAIK--EIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYL 868
LG+G +G V + + D +K+A+K +I +++ E + H N+++ +
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 869 G----SVSEEGYFK--IFMEQVPGGSL-STLLRVKWG--PLKENESTMSFYTKQILEGLK 919
G +V EGY + + + G L S LL + G P + + I G++
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 920 YLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956
YL + +HRD+ N ++N V ++DFG SK++
Sbjct: 127 YLSSKSFIHRDLAARNCMLNENMNVC-VADFGLSKKI 162
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.002
Identities = 25/74 (33%), Positives = 43/74 (58%), Gaps = 4/74 (5%)
Query: 910 YTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG- 968
Y+ Q+ G+++L +K +HRD+ N+L++ + VVKI DFG ++ + +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGSAR 237
Query: 969 -TLQYMAPEVI-DK 980
L++MAPE I DK
Sbjct: 238 LPLKWMAPESIFDK 251
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.002
Identities = 25/72 (34%), Positives = 40/72 (55%), Gaps = 5/72 (6%)
Query: 910 YTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK---RLAGLCPSAETF 966
++ Q+ G+++L + VHRD+ NVL+ +VKI DFG ++ R + TF
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLI-CEGKLVKICDFGLARDIMRDSNYISKGSTF 302
Query: 967 TGTLQYMAPEVI 978
L++MAPE I
Sbjct: 303 L-PLKWMAPESI 313
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 20/44 (45%), Positives = 30/44 (68%), Gaps = 1/44 (2%)
Query: 913 QILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956
QI +G+ YL ++VHRD+ NVLV + + VKI+DFG ++ L
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNH-VKITDFGLARLL 159
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.003
Identities = 23/73 (31%), Positives = 40/73 (54%), Gaps = 7/73 (9%)
Query: 910 YTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT 969
++ Q+ +G+ +L + +HRD+ NVL+ T V KI DFG ++ + + S G
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLL-TDGRVAKICDFGLARDI--MNDSNYVVKGN 273
Query: 970 ----LQYMAPEVI 978
+++MAPE I
Sbjct: 274 ARLPVKWMAPESI 286
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.003
Identities = 23/71 (32%), Positives = 41/71 (57%), Gaps = 3/71 (4%)
Query: 910 YTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG- 968
Y+ Q+ +G+++L +K +HRD+ N+L++ + VVKI DFG ++ +
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGDAR 242
Query: 969 -TLQYMAPEVI 978
L++MAPE I
Sbjct: 243 LPLKWMAPETI 253
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1181 | |||
| KOG4279|consensus | 1226 | 100.0 | ||
| PF13281 | 374 | DUF4071: Domain of unknown function (DUF4071) | 100.0 | |
| KOG0546|consensus | 372 | 100.0 | ||
| KOG0880|consensus | 217 | 100.0 | ||
| KOG0879|consensus | 177 | 100.0 | ||
| KOG0111|consensus | 298 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0881|consensus | 164 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| PTZ00060 | 183 | cyclophilin; Provisional | 100.0 | |
| PTZ00221 | 249 | cyclophilin; Provisional | 100.0 | |
| KOG0598|consensus | 357 | 100.0 | ||
| cd01926 | 164 | cyclophilin_ABH_like cyclophilin_ABH_like: Cycloph | 100.0 | |
| KOG0615|consensus | 475 | 100.0 | ||
| PLN03149 | 186 | peptidyl-prolyl isomerase H (cyclophilin H); Provi | 100.0 | |
| COG0652 | 158 | PpiB Peptidyl-prolyl cis-trans isomerase (rotamase | 100.0 | |
| cd01923 | 159 | cyclophilin_RING cyclophilin_RING: cyclophilin-typ | 100.0 | |
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| cd01928 | 153 | Cyclophilin_PPIL3_like Cyclophilin_PPIL3_like. Pro | 100.0 | |
| KOG0882|consensus | 558 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| cd01921 | 166 | cyclophilin_RRM cyclophilin_RRM: cyclophilin-type | 100.0 | |
| cd01927 | 148 | cyclophilin_WD40 cyclophilin_WD40: cyclophilin-typ | 100.0 | |
| KOG0192|consensus | 362 | 100.0 | ||
| KOG0883|consensus | 518 | 100.0 | ||
| cd01922 | 146 | cyclophilin_SpCYP2_like cyclophilin_SpCYP2_like: c | 100.0 | |
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0884|consensus | 161 | 100.0 | ||
| cd01925 | 171 | cyclophilin_CeCYP16-like cyclophilin_CeCYP16-like: | 100.0 | |
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0865|consensus | 167 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PRK10903 | 190 | peptidyl-prolyl cis-trans isomerase A (rotamase A) | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0611|consensus | 668 | 100.0 | ||
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK10791 | 164 | peptidyl-prolyl cis-trans isomerase B (rotamase B) | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0582|consensus | 516 | 100.0 | ||
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0588|consensus | 786 | 100.0 | ||
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0610|consensus | 459 | 100.0 | ||
| KOG1989|consensus | 738 | 100.0 | ||
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd01920 | 155 | cyclophilin_EcCYP_like cyclophilin_EcCYP_like: cyc | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.98 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.98 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.98 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.98 | |
| KOG0663|consensus | 419 | 99.98 | ||
| KOG0885|consensus | 439 | 99.98 | ||
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG1187|consensus | 361 | 99.98 | ||
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.98 | |
| KOG0580|consensus | 281 | 99.98 | ||
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.98 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0660|consensus | 359 | 99.97 | ||
| KOG4721|consensus | 904 | 99.97 | ||
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| KOG0032|consensus | 382 | 99.97 | ||
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.97 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0415|consensus | 479 | 99.97 | ||
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.97 | |
| KOG0033|consensus | 355 | 99.97 | ||
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| KOG0594|consensus | 323 | 99.97 | ||
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0599|consensus | 411 | 99.97 | ||
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0193|consensus | 678 | 99.97 | ||
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.97 | |
| KOG0579|consensus | 1187 | 99.97 | ||
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0658|consensus | 364 | 99.97 | ||
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0667|consensus | 586 | 99.97 | ||
| cd00317 | 146 | cyclophilin cyclophilin: cyclophilin-type peptidyl | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| KOG1095|consensus | 1025 | 99.97 | ||
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| PF00160 | 155 | Pro_isomerase: Cyclophilin type peptidyl-prolyl ci | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| KOG0194|consensus | 474 | 99.97 | ||
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd01924 | 176 | cyclophilin_TLP40_like cyclophilin_TLP40_like: cyc | 99.97 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| KOG4250|consensus | 732 | 99.97 | ||
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.97 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.97 | |
| KOG1026|consensus | 774 | 99.97 | ||
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.96 | |
| KOG4717|consensus | 864 | 99.96 | ||
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| KOG0574|consensus | 502 | 99.96 | ||
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0577|consensus | 948 | 99.96 | ||
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.96 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0690|consensus | 516 | 99.96 | ||
| KOG0986|consensus | 591 | 99.96 | ||
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.96 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG2345|consensus | 302 | 99.96 | ||
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.96 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0612|consensus | 1317 | 99.96 | ||
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| KOG4645|consensus | 1509 | 99.96 | ||
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.96 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.96 | |
| KOG0586|consensus | 596 | 99.96 | ||
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.96 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.96 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.96 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG4257|consensus | 974 | 99.96 | ||
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.96 | |
| KOG0696|consensus | 683 | 99.96 | ||
| KOG0607|consensus | 463 | 99.96 | ||
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.96 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.96 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.96 | |
| KOG0199|consensus | 1039 | 99.96 | ||
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.96 | |
| KOG0584|consensus | 632 | 99.96 | ||
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.95 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.95 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG4236|consensus | 888 | 99.95 | ||
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG0196|consensus | 996 | 99.95 | ||
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG0604|consensus | 400 | 99.95 | ||
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.95 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.95 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.95 | |
| KOG0614|consensus | 732 | 99.95 | ||
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.95 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.95 | |
| KOG0695|consensus | 593 | 99.95 | ||
| KOG1094|consensus | 807 | 99.95 | ||
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.95 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.94 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.94 | |
| KOG0983|consensus | 391 | 99.94 | ||
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.94 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.94 | |
| KOG0596|consensus | 677 | 99.94 | ||
| KOG1035|consensus | 1351 | 99.94 | ||
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG4278|consensus | 1157 | 99.94 | ||
| KOG0587|consensus | 953 | 99.94 | ||
| KOG1025|consensus | 1177 | 99.94 | ||
| KOG0662|consensus | 292 | 99.94 | ||
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.94 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.94 | |
| KOG0608|consensus | 1034 | 99.94 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.93 | |
| KOG0666|consensus | 438 | 99.93 | ||
| KOG1152|consensus | 772 | 99.93 | ||
| KOG1151|consensus | 775 | 99.93 | ||
| KOG0603|consensus | 612 | 99.93 | ||
| KOG2052|consensus | 513 | 99.93 | ||
| KOG1006|consensus | 361 | 99.92 | ||
| KOG3653|consensus | 534 | 99.92 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.92 | |
| KOG0669|consensus | 376 | 99.92 | ||
| KOG0984|consensus | 282 | 99.91 | ||
| KOG0200|consensus | 609 | 99.91 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.91 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.91 | |
| KOG1027|consensus | 903 | 99.91 | ||
| KOG0671|consensus | 415 | 99.91 | ||
| KOG0664|consensus | 449 | 99.9 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.9 | |
| KOG1345|consensus | 378 | 99.89 | ||
| KOG0670|consensus | 752 | 99.89 | ||
| KOG0576|consensus | 829 | 99.89 | ||
| KOG0668|consensus | 338 | 99.87 | ||
| KOG0665|consensus | 369 | 99.86 | ||
| KOG1290|consensus | 590 | 99.84 | ||
| KOG1024|consensus | 563 | 99.84 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG1167|consensus | 418 | 99.82 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.81 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.81 | |
| KOG1164|consensus | 322 | 99.8 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.76 | |
| KOG1165|consensus | 449 | 99.75 | ||
| KOG1163|consensus | 341 | 99.75 | ||
| KOG0603|consensus | 612 | 99.74 | ||
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.73 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.69 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.69 | |
| KOG0590|consensus | 601 | 99.68 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.65 | |
| KOG4279|consensus | 1226 | 99.65 | ||
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.64 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.61 | |
| KOG1166|consensus | 974 | 99.61 | ||
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.61 | |
| KOG0195|consensus | 448 | 99.59 | ||
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.57 | |
| KOG0606|consensus | 1205 | 99.55 | ||
| KOG4158|consensus | 598 | 99.54 | ||
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.54 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.53 | |
| KOG1240|consensus | 1431 | 99.49 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.47 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.45 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.45 | |
| KOG1033|consensus | 516 | 99.45 | ||
| KOG1023|consensus | 484 | 99.41 | ||
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.3 | |
| KOG0590|consensus | 601 | 99.25 | ||
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.23 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.1 | |
| KOG1243|consensus | 690 | 99.02 | ||
| KOG0601|consensus | 524 | 99.01 | ||
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.0 | |
| PF13281 | 374 | DUF4071: Domain of unknown function (DUF4071) | 98.96 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.86 | |
| KOG3087|consensus | 229 | 98.83 | ||
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.82 | |
| KOG0606|consensus | 1205 | 98.65 | ||
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.59 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.56 | |
| KOG0601|consensus | 524 | 98.53 | ||
| KOG1266|consensus | 458 | 98.44 | ||
| KOG3741|consensus | 655 | 98.44 | ||
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.35 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.26 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.21 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.21 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.11 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.89 | |
| KOG2137|consensus | 700 | 97.77 | ||
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.74 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.72 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.71 | |
| KOG0576|consensus | 829 | 97.7 | ||
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.65 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.56 | |
| KOG1235|consensus | 538 | 97.56 | ||
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.29 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.16 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.07 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.93 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.84 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.83 |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-123 Score=1070.06 Aligned_cols=665 Identities=43% Similarity=0.678 Sum_probs=503.9
Q ss_pred EEeCCCCchhHhHHHHHHHHHHHhhhhcccchhhhhhhhhcccccccccccccchhhhhhhhccceEEEEcchhcccccc
Q psy14556 347 IDVSVPSDLSHRRRALDEIIQACSLVNAKLNLIEIKRLIFCLFWFQFERLDWQKTEVVELFYNADVAIVDISIQEQRSSL 426 (1181)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (1181)
||.+||++|..|+|||++|+|||+.+||+|+. ++|+|||||||+|||.||||||||||||+..|||||
T Consensus 1 ~d~~vg~~l~~r~~AL~~~~~a~~t~ganl~r------------i~F~kLDFGET~vLd~FYNADvA~vd~s~~~qQpsL 68 (1226)
T KOG4279|consen 1 IDQKVGKNLRVREMALKDVQKAADTLGANLTR------------IDFDKLDFGETEVLDLFYNADVALVDVSVTHQQPSL 68 (1226)
T ss_pred CchhhhhHHHHHHHHHHHHHHHHHHhcCCeEE------------eeccccCCcchhHHHHHhccceEEEEeeecccCCcc
Confidence 68899999999999999999999999999996 779999999999999999999999999999999999
Q ss_pred eeeecccccccccccEEEeecCCchhhHHHHhhcCCeeEEEEEEecCCC-ce-eccCcccccccCCCCCCCCc-hHHHHH
Q psy14556 427 LYHLGVRESFGMKQNILLYNDCDTETAVRVKMSCQGYTFVTYRLEDCGS-CL-TTHTLSVTSEQRPSLEPRVP-LTVRLK 503 (1181)
Q Consensus 427 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~-~~~~~~ 503 (1181)
|||+||||||||++|||+|||+++...+|+|+||+||+|++|+.++... || .+.+++....|+|++|..|| |++|+|
T Consensus 69 ~YH~GVRESfgm~~NIltY~D~~s~~~~sLK~~~any~fi~Y~~~~~~n~c~~~s~~n~~~~sk~Pnae~~vptlq~R~k 148 (1226)
T KOG4279|consen 69 CYHIGVRESFGMSYNILTYWDPESHIMDSLKKTHANYPFIVYIHHQDSNQCQSYSKNNNDDDSKPPNAETNVPTLQHRMK 148 (1226)
T ss_pred eeeechhhhhccccceeeecCCchHHHHHHHHhcCCcceEEEEecCCcchhhhcccCCCCcccCCCcccccCccHHHHHH
Confidence 9999999999999999999999999999999999999999999966555 77 77788888889999999997 999999
Q ss_pred HHhhhhhhchhHHHHHHHHHHHHHHHhhcchHHHHHHHHHHHhhcCCCCccchhhhHHhhhccccchhhHHHHHHHHHhc
Q psy14556 504 KILQDVEIQSKVHIKEKFLADLRKAREMYSGEELKTALYNLRQRLDDPKVLSGEVVLNVLMSFRDIQDYDAMVQLVEDLR 583 (1181)
Q Consensus 504 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 583 (1181)
++|++|+++|++||||+|++|||||||.|+|.+|+.+|.++|+||||++||++|+|+||||||||+|||||||+|||||+
T Consensus 149 q~Lk~vq~~ssah~REkflsD~RkAR~~y~G~~l~~~L~~mR~RlDnp~VL~~d~V~nlmlSyRDvQdY~amirLVe~Lk 228 (1226)
T KOG4279|consen 149 QVLKSVQVESSAHSREKFLSDLRKAREIYDGDQLNDYLDKMRTRLDNPDVLHPDTVSNLMLSYRDVQDYDAMIRLVEDLK 228 (1226)
T ss_pred HHHHHHHHhhHHHHHHHHHHHHHHHhhccccHHHHHHHHHHHhhcCCccccCHHHHHHHHhhhccccchHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCc-chhhhccCCceeeeehhhhccCCCCCCceEEE----------------------------EEeccCCcccchhhhh
Q psy14556 584 TIP-TKKKYMQTPMLRFLYLFALNSLYKRDERSLFL----------------------------YVHENSDDFESSEVGS 634 (1181)
Q Consensus 584 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~ 634 (1181)
+|| || +++.|||++||||||||||||+|||..-| ++..|-.|-||- .+
T Consensus 229 ~iP~t~-~vve~~nv~f~YaFALNRRNr~GDRakAL~~~l~lve~eg~vapDm~Cl~GRIYKDmF~~S~ytDa~s~--~~ 305 (1226)
T KOG4279|consen 229 RIPDTL-KVVETHNVRFHYAFALNRRNRPGDRAKALNTVLPLVEKEGPVAPDMYCLCGRIYKDMFIASNYTDAESL--NH 305 (1226)
T ss_pred hCcchh-hhhccCceEEEeeehhcccCCCccHHHHHHHHHHHHHhcCCCCCceeeeechhhhhhhhccCCcchhhH--HH
Confidence 999 66 66999999999999999999999996432 122222233322 34
Q ss_pred HHHHHHHhhccCCCCCCchh--hHHHhhccceEEeeccCcccceeeeccccccccCCCCeeEeccccccccccCCcccch
Q psy14556 635 LLEFLLQCYSNCSSLGYGSN--TLLEALEGCYLFSLQNTNLSTALISLRSVPTCRSGKNRVVCSGKYNLRQRLDDPKVLS 712 (1181)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 712 (1181)
-.+|..+.+.--.++--|-| |||-|----+- | ++-.-.|.. +-.|--| |--+.++
T Consensus 306 a~~WyrkaFeveP~~~sGIN~atLL~aaG~~Fe----n-s~Elq~Igm--kLn~Llg--------------rKG~lek-- 362 (1226)
T KOG4279|consen 306 AIEWYRKAFEVEPLEYSGINLATLLRAAGEHFE----N-SLELQQIGM--KLNSLLG--------------RKGALEK-- 362 (1226)
T ss_pred HHHHHHHHhccCchhhccccHHHHHHHhhhhcc----c-hHHHHHHHH--HHHHHhh--------------ccchHHH--
Confidence 46677776655444433333 45544211111 0 111011110 0011112 1122222
Q ss_pred HHHHHHHHHHhhhhhh----------h----HHHHHHHhhcccccchhhh-----------hcccchhh-HHHHHhhhcc
Q psy14556 713 GEVVLNVLMSFRDIQD----------Y----DAMVQLVEFLPYLGTIRTQ-----------QLQFPLAN-LLEKLLLLID 766 (1181)
Q Consensus 713 ~~~~~~~~~~~~diq~----------~----d~~~klv~Flp~L~~irsq-----------~~q~~l~~-~~ek~~~L~D 766 (1181)
|+++-|++- | .+-++|.+..|-.+=+.+. ....++.. ...-.+|+.-
T Consensus 363 -------lq~YWdV~~y~~asVLAnd~~kaiqAae~mfKLk~P~WYLkS~meni~l~~~fr~t~e~p~~e~q~~~FWmdF 435 (1226)
T KOG4279|consen 363 -------LQEYWDVATYFEASVLANDYQKAIQAAEMMFKLKPPVWYLKSTMENILLINRFRPTIEPPEKEKQQFLFWMDF 435 (1226)
T ss_pred -------HHHHHhHHHhhhhhhhccCHHHHHHHHHHHhccCCceehHHHHHHHHHHHHhcCCCCCCCCcchHHHHHHHHH
Confidence 233333331 1 1224444442222211100 00011110 0000111100
Q ss_pred cc---------------------------cccccChH--------------HH---------------------------
Q psy14556 767 LQ---------------------------DYDAMDYD--------------AM--------------------------- 778 (1181)
Q Consensus 767 lq---------------------------e~~~md~d--------------~~--------------------------- 778 (1181)
.. .|-+...+ ..
T Consensus 436 ~leat~td~t~~~~rfpVLILE~nKiy~Psyltin~~~eektv~l~~vl~~~q~~~k~ih~w~F~assIk~Vs~sKrddR 515 (1226)
T KOG4279|consen 436 FLEATETDTTISCPRFPVLILEPNKIYTPSYLTINNTDEEKTVILSHVLPNSQQKLKGIHRWHFAASSIKGVSESKRDDR 515 (1226)
T ss_pred HHHhcCcccccccccccEEEecccccccceEEEecCCCCcceEEEEEEcccchhhhcCceeeeeehhceecccccccccc
Confidence 00 00000000 00
Q ss_pred ----------------------HH----HHHhhc-----cCCCCcccccchHHHHhhhcccC--ceeecccCceEEEEEE
Q psy14556 779 ----------------------VQ----LVEDLR-----TIPTKKKYMQTPMLRFLYLFALN--RIELGKGSYGVVYAAR 825 (1181)
Q Consensus 779 ----------------------~q----lle~lr-----~~p~~~k~~~~p~~~~~~~~~l~--~~kIG~G~fG~VYka~ 825 (1181)
.+ ++...- ..+....-......++.++|... +-+||+|.||+||.|+
T Consensus 516 c~fLYv~~nsdDfql~Fps~~hcqkf~dmi~~~~t~~d~~~~~~e~d~ane~iefeYeyde~~ervVLGKGTYG~VYA~R 595 (1226)
T KOG4279|consen 516 CCFLYVHHNSDDFQLYFPSKAHCQKFYDMIKSMATVADGNYQREESDPANEKIEFEYEYDESNERVVLGKGTYGTVYAAR 595 (1226)
T ss_pred eEEEEEccCccceeEecCcHHHHHHHHHHHHHhhccccccccccccCCcccceEEEeeecCCCceEEeecCceeEEEeec
Confidence 00 000000 00000111111233344444333 3369999999999999
Q ss_pred EcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcccchhcccCCCCCChH
Q psy14556 826 ELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENES 905 (1181)
Q Consensus 826 d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~ 905 (1181)
+..++...|||.++.......+.+..|+.+.++|+|.|||+++|.+.+++++-|.||-++||+|.++++.++++..-++.
T Consensus 596 D~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEs 675 (1226)
T KOG4279|consen 596 DMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNES 675 (1226)
T ss_pred cccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchh
Confidence 99999999999999888888899999999999999999999999999999999999999999999999999999988999
Q ss_pred HHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCccccCchhhccCCCCC
Q psy14556 906 TMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGY 985 (1181)
Q Consensus 906 ~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ 985 (1181)
.+..+.+||++||+|||++.|||||||-+|+|++...|.+||+|||.++.+....+-+.++.||..|||||++..|..+|
T Consensus 676 tm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGY 755 (1226)
T KOG4279|consen 676 TMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGY 755 (1226)
T ss_pred HHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCC
Confidence 99999999999999999999999999999999999899999999999999998888889999999999999999999999
Q ss_pred CCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC-CCC---CCCCCCCCCCcchHHhhccCCC
Q psy14556 986 GAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA-PPQ---ISRSVSVPGPGGINSSSSAPVT 1061 (1181)
Q Consensus 986 ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~-~~~---ip~~l~~~~p~~L~~li~r~la 1061 (1181)
+...|+ |||||++.||.||++||.......-.. +.. .-..++......-...+.+|.+
T Consensus 756 G~aADI------------------WS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFe 817 (1226)
T KOG4279|consen 756 GKAADI------------------WSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFE 817 (1226)
T ss_pred Cchhhh------------------hhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcC
Confidence 999888 999999999999999998765433211 111 1111222233334448889999
Q ss_pred CCCCCCchhHHHH
Q psy14556 1062 PTPHSRHISVNTN 1074 (1181)
Q Consensus 1062 ~dPs~Rp~s~~~~ 1074 (1181)
++|-.||..-+++
T Consensus 818 pd~~~R~sA~~LL 830 (1226)
T KOG4279|consen 818 PDPCDRPSAKDLL 830 (1226)
T ss_pred CCcccCccHHHhc
Confidence 9999999744443
|
|
| >PF13281 DUF4071: Domain of unknown function (DUF4071) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-60 Score=542.77 Aligned_cols=189 Identities=50% Similarity=0.838 Sum_probs=182.4
Q ss_pred ceeeecccccccccccEEEeecCCchhhHHHHhhcCCeeEEEEEEecCCC--ceeccCcccccc-cCCCC----CC-CCc
Q psy14556 426 LLYHLGVRESFGMKQNILLYNDCDTETAVRVKMSCQGYTFVTYRLEDCGS--CLTTHTLSVTSE-QRPSL----EP-RVP 497 (1181)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-~~~~~----~~-~~~ 497 (1181)
|||||||||||+|++|||||||+++..++|+|.+||||+||||+|+|+|+ ||++.++.+.++ ++|+. +| +.|
T Consensus 1 lfYhLGVReSf~m~~niily~~~~~~~~~~lk~~~~~y~fipY~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (374)
T PF13281_consen 1 LFYHLGVRESFSMKNNIILYCDTDDESTQSLKFDVGNYTFIPYIVTPQGKVFCCESSPMKGLTELMQPSFELALAPQCTP 80 (374)
T ss_pred CceeeccccccCccccEEEeeCCCchHHHHHHHhhcCCCccCeeecCCCceeeecchhhhhhhhhcCcchhhcccccccc
Confidence 79999999999999999999999999999999999999999999999997 778888888888 88883 46 789
Q ss_pred hHHHHHHHhhhhhhchhHHHHHHHHHHHHHHHhhcch--HHHHHHHHHHHhhcCCCCccchhhhHHhhhccccchhhHHH
Q psy14556 498 LTVRLKKILQDVEIQSKVHIKEKFLADLRKAREMYSG--EELKTALYNLRQRLDDPKVLSGEVVLNVLMSFRDIQDYDAM 575 (1181)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 575 (1181)
|++||+++|+++++||+.|+||+||+|||||||+|+| +||++||.|||+|||+++++|+|||+|||||||||||||||
T Consensus 81 l~~rl~~lL~~~~~~s~~~~~e~fl~dirkare~~~g~~~~l~~~L~~i~~rLd~~~~ls~div~~lllSyRdiqdydam 160 (374)
T PF13281_consen 81 LVSRLKQLLKDVEIQSSAHKREKFLNDIRKARERYSGARKELAKELRRIRQRLDDPELLSPDIVINLLLSYRDIQDYDAM 160 (374)
T ss_pred hHHHHHHHHhhccCchHHHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHhhCCHhhcChhHHHHHHHHhhhhhhHHHH
Confidence 9999999999999999999999999999999999999 99999999999999999999999999999999999999999
Q ss_pred HHHHHHhccCcchhhhccCCceeeeehhhhccCCCCCCce
Q psy14556 576 VQLVEDLRTIPTKKKYMQTPMLRFLYLFALNSLYKRDERS 615 (1181)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 615 (1181)
|+|||||+++|||+ ++.||+|||||||||||||++|+|.
T Consensus 161 I~Lve~l~~~p~~~-~~~~~~i~~~yafALnRrn~~gdre 199 (374)
T PF13281_consen 161 IKLVETLEALPTCD-VANQHNIKFQYAFALNRRNKPGDRE 199 (374)
T ss_pred HHHHHHhhccCccc-hhcchHHHHHHHHHHhhcccCCCHH
Confidence 99999999999997 6999999999999999999999985
|
|
| >KOG0546|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=438.56 Aligned_cols=168 Identities=54% Similarity=0.857 Sum_probs=161.4
Q ss_pred ccccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCc--------cccCCEEEEecCCce
Q psy14556 96 QMRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGF--------GFKDSTFHRVIPNFM 167 (1181)
Q Consensus 96 ~~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~--------~Y~g~~FhRVip~f~ 167 (1181)
..|++||||+ +.+.+.||||||||.|+||+||+||+.||||++|. +|+|+.|||||++||
T Consensus 7 ~~pr~ffDIS------------I~ge~~GRIvfeLf~dv~PKTaENFraLCtGE~G~~~~~gk~L~YKG~~FHRViK~FM 74 (372)
T KOG0546|consen 7 TNPRVFFDIS------------IGGEPAGRIVFELFNDVVPKTAENFRALCTGEKGGGLTTGKPLHYKGSRFHRVIKNFM 74 (372)
T ss_pred CCceEEEEEE------------eCCcccceEEEEeecccCchhHHHHHHHhccccCCCCCCCCeeeecCchhheeeecce
Confidence 4789999997 77999999999999999999999999999999874 499999999999999
Q ss_pred EeeCCCCCCCCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHH
Q psy14556 168 CQGGDFTNHNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKK 247 (1181)
Q Consensus 168 iQgGd~~~~~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~k 247 (1181)
|||||++.++|+||+||||..|+||++.++|+++|+|||||.||||||||||||+.++|||||+|+|||+||+|++||+.
T Consensus 75 iQgGDfs~gnGtGGeSIYG~~FdDEnF~lKHdrpflLSMAN~GpNTNgSQFFITT~p~PHLdGkHVVFGqVI~G~~VVr~ 154 (372)
T KOG0546|consen 75 IQGGDFSEGNGTGGESIYGEKFDDENFELKHDRPFLLSMANRGPNTNGSQFFITTVPTPHLDGKHVVFGQVIKGKEVVRE 154 (372)
T ss_pred eeccccccCCCCCcccccccccccccceeccCcchhhhhhcCCCCCCCcceEEeCCCCCCcCCceeEEeeEeechhHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHhCCCC-CCCcccceEEeeeccccCCCC
Q psy14556 248 LESMGSQ-SGKTSKKIVVANSDSHSETDS 275 (1181)
Q Consensus 248 I~~~~t~-~g~P~~~V~I~~cGvl~~~~~ 275 (1181)
|+++.++ .++|..+|+|.+||+|.....
T Consensus 155 IEn~~~d~~skP~~dV~I~dCGel~~~~~ 183 (372)
T KOG0546|consen 155 IENLETDEESKPLADVVISDCGELVKKSK 183 (372)
T ss_pred HhccccccCCCCccceEeccccccccccc
Confidence 9999994 458999999999999988865
|
|
| >KOG0880|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-47 Score=387.53 Aligned_cols=169 Identities=58% Similarity=0.938 Sum_probs=161.7
Q ss_pred ccccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHc-cCCCccccCCEEEEecCCceEeeCCCC
Q psy14556 96 QMRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCT-GEKGFGFKDSTFHRVIPNFMCQGGDFT 174 (1181)
Q Consensus 96 ~~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~Lct-G~~G~~Y~g~~FhRVip~f~iQgGd~~ 174 (1181)
...++|||+. +.+...|||+|+||++.+|+||+||.+||+ |.+|++|.|++||||||+|||||||++
T Consensus 38 vT~kV~fdi~------------~g~~~~grIvigLfG~~vPKTV~NF~~l~~~~~~~~gY~gS~FhRVi~nfmIQGGd~t 105 (217)
T KOG0880|consen 38 VTHKVYFDIE------------IGGEPVGRIVIGLFGKVVPKTVENFRALATSGEKGYGYKGSKFHRVIPNFMIQGGDFT 105 (217)
T ss_pred ceeEEEEEEE------------ECCEeccEEEEEeccccchHHHHHHHHHHccCCCCcccCCceeeeeecCceeecCccc
Confidence 3459999997 568899999999999999999999999999 899999999999999999999999999
Q ss_pred CCCCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCC-
Q psy14556 175 NHNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGS- 253 (1181)
Q Consensus 175 ~~~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t- 253 (1181)
.++|+||.|+||.+|+||++.++|+++|.|||||.||++||||||||+..+|||||+|+|||+|++|||||.+|+.+.+
T Consensus 106 ~g~gtGg~SIyG~~F~DENf~LkH~rpG~lSMAn~GpDtNGsQFfItT~~t~wLDGkhVVFGqVl~Gmdvv~~Ie~~~TD 185 (217)
T KOG0880|consen 106 KGDGTGGKSIYGEKFPDENFKLKHDRPGRLSMANAGPDTNGSQFFITTVKTPWLDGKHVVFGQVLEGMDVVRKIENVKTD 185 (217)
T ss_pred cCCCCCCeEeecCCCCCccceeecCCCceEeeeccCCCCCCceEEEEecCCccccCceeEEeeehhhHHHHHHHHhcccC
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCcccceEEeeeccccCCCCC
Q psy14556 254 QSGKTSKKIVVANSDSHSETDSQ 276 (1181)
Q Consensus 254 ~~g~P~~~V~I~~cGvl~~~~~~ 276 (1181)
.+++|.++++|.+||+|+.....
T Consensus 186 ~~dkP~e~v~I~~~g~l~~~~~~ 208 (217)
T KOG0880|consen 186 ERDKPLEDVVIANCGELPVEYLE 208 (217)
T ss_pred CCCCccccEEEeecCcccccchh
Confidence 78999999999999999877544
|
|
| >KOG0879|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=343.22 Aligned_cols=165 Identities=51% Similarity=0.855 Sum_probs=157.9
Q ss_pred CcccccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCC-----CccccCCEEEEecCCceE
Q psy14556 94 SSQMRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEK-----GFGFKDSTFHRVIPNFMC 168 (1181)
Q Consensus 94 ss~~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~-----G~~Y~g~~FhRVip~f~i 168 (1181)
++.+|.||||++ +.+++.|||+||||.|.+|+|+|||++.|||+- ..||++++|||||++|||
T Consensus 7 ~~~nPvVF~dv~------------igg~~~GrikieLFadivPkTAENFRQFCTGE~r~~g~PiGYK~~tFHRvIkdFMi 74 (177)
T KOG0879|consen 7 SPNNPVVFFDVA------------IGGRPIGRIKIELFADIVPKTAENFRQFCTGEYRKDGVPIGYKNSTFHRVIKDFMI 74 (177)
T ss_pred CCCCCeEEEEEe------------eCCEEcceEEEEEeeccChhhHHHHHhhcccccccCCccccccccchHHHhhhhee
Confidence 346899999997 679999999999999999999999999999963 257999999999999999
Q ss_pred eeCCCCCCCCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHH
Q psy14556 169 QGGDFTNHNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKL 248 (1181)
Q Consensus 169 QgGd~~~~~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI 248 (1181)
||||+.+++|+|..+|||.+|+||++.++|+++|+|||||+|+++||.|||||..+..||||+|+|||||++|+.++++|
T Consensus 75 QgGDFv~gDGtG~~sIy~~~F~DENFtlkH~~PGlLSMANsG~~tNGCQFFITcakcdfLD~KHVVFGrvldGlli~rkI 154 (177)
T KOG0879|consen 75 QGGDFVNGDGTGVASIYGSTFPDENFTLKHDGPGLLSMANSGKDTNGCQFFITCAKCDFLDGKHVVFGRVLDGLLIMRKI 154 (177)
T ss_pred ccCceecCCCceEEEEcCCCCCCcceeeecCCCceeeccccCCCCCCceEEEEecccccccCceEEEeeeehhhhhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhCCC-CCCCcccceEEeeeccc
Q psy14556 249 ESMGS-QSGKTSKKIVVANSDSH 270 (1181)
Q Consensus 249 ~~~~t-~~g~P~~~V~I~~cGvl 270 (1181)
+++++ .+++|+-+|+|+.||++
T Consensus 155 Envp~G~NnkPKl~v~i~qCGem 177 (177)
T KOG0879|consen 155 ENVPTGPNNKPKLPVVIVQCGEM 177 (177)
T ss_pred hcCCCCCCCCCCCcEEEeecccC
Confidence 99999 89999999999999975
|
|
| >KOG0111|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=359.60 Aligned_cols=164 Identities=62% Similarity=1.025 Sum_probs=159.8
Q ss_pred ccccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCC
Q psy14556 96 QMRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTN 175 (1181)
Q Consensus 96 ~~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~ 175 (1181)
.+|.+|+|+. +.....|||+++|..|+.|+|++||+.||||++||||+|+.||||||.||+||||+++
T Consensus 135 ~~pqv~~~ik------------ig~~~~Gri~~~lrtdv~Pmtaenfr~Lctge~gfgykgssfhriip~fmcqggdftn 202 (298)
T KOG0111|consen 135 ENPQVYHDIK------------IGEDRAGRIVMLLRTDVVPMTAENFRCLCTGEAGFGYKGSSFHRIIPKFMCQGGDFTN 202 (298)
T ss_pred hChHhhhhee------------ecccccceEEEeecccCChhhhhhhhhhccccCccCccccchhhhhhhhhccCCcccc
Confidence 5799999998 4578889999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCCCC
Q psy14556 176 HNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGSQS 255 (1181)
Q Consensus 176 ~~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t~~ 255 (1181)
++|+||.||||.+|.||++.++|..+|+|||||+|+|+|||||||++..+.||||+|+|||.|++||+||++++++++.+
T Consensus 203 ~ngtggksiygkkfddenf~lkht~pgtlsmansgantngsqffict~ktdwldgkhvvfghv~eg~~vvrq~e~qgsks 282 (298)
T KOG0111|consen 203 GNGTGGKSIYGKKFDDENFTLKHTMPGTLSMANSGANTNGSQFFICTEKTDWLDGKHVVFGHVVEGMNVVRQVEQQGSKS 282 (298)
T ss_pred CCCCCCcccccccccccceeeecCCCceeeccccCCCCCCceEEEEecccccccCceeEEeeecchHHHHHHHHhccCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcccceEEeeecccc
Q psy14556 256 GKTSKKIVVANSDSHS 271 (1181)
Q Consensus 256 g~P~~~V~I~~cGvl~ 271 (1181)
|+|.+.|+|.+||++.
T Consensus 283 gkp~qkv~i~~cge~~ 298 (298)
T KOG0111|consen 283 GKPQQKVKIVECGEIE 298 (298)
T ss_pred CCcceEEEEEeccccC
Confidence 9999999999999873
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=367.65 Aligned_cols=252 Identities=30% Similarity=0.401 Sum_probs=204.4
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCC--CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEE
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKN--LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFM 881 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~--~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVm 881 (1181)
.+|...+ +||.|+||+||+|+++.++..||||.+.+.. ....+.+..|+.+|+.++|||||++++++...+.+|+||
T Consensus 10 ~~y~~~~-~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 10 GDYELSR-EIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred ccceehh-hccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 4455555 4999999999999999999999999997774 344677899999999999999999999999999999999
Q ss_pred eecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccC--C---CeeeeecCCccccc
Q psy14556 882 EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTY--S---GVVKISDFGTSKRL 956 (1181)
Q Consensus 882 Ey~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~--~---g~vKLiDFGlAk~l 956 (1181)
|||.||+|.++++.+ ..+++..++.++.||+.||++||+++||||||||.||||+.. + -.+||+|||+|+.+
T Consensus 89 EyC~gGDLs~yi~~~---~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR---GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999999999999965 368899999999999999999999999999999999999762 1 46899999999988
Q ss_pred ccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC
Q psy14556 957 AGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA 1036 (1181)
Q Consensus 957 ~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~ 1036 (1181)
... ....+.+|++.|||||++..++ |.++.|+ ||+|+|||+|++|+.||...+..++..
T Consensus 166 ~~~-~~a~tlcGSplYMAPEV~~~~~--YdAKADL------------------WSiG~Ilyq~l~g~~Pf~a~t~~eL~~ 224 (429)
T KOG0595|consen 166 QPG-SMAETLCGSPLYMAPEVIMSQQ--YDAKADL------------------WSIGTILYQCLTGKPPFDAETPKELLL 224 (429)
T ss_pred Cch-hHHHHhhCCccccCHHHHHhcc--ccchhhH------------------HHHHHHHHHHHhCCCCccccCHHHHHH
Confidence 743 4456788999999999997554 4444444 999999999999999999999888654
Q ss_pred CCCCCCCCCC----CCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1037 PPQISRSVSV----PGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1037 ~~~ip~~l~~----~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
.........+ ...+.+..++.+.+..+|..|-.+.+-.....-.
T Consensus 225 ~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~ 272 (429)
T KOG0595|consen 225 YIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLA 272 (429)
T ss_pred HHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcc
Confidence 4443333222 2233334566667777777777766664444333
|
|
| >KOG0881|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=316.85 Aligned_cols=152 Identities=45% Similarity=0.803 Sum_probs=144.4
Q ss_pred CCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCCCCC
Q psy14556 113 EGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFEDE 192 (1181)
Q Consensus 113 ~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~~dE 192 (1181)
+...|.++|+.|.|++|||-+.||+||.||.+|+ ++|| |+|..|||||++||||||||+ ++|.||.||||.+|+||
T Consensus 8 q~~~V~LeTsmG~i~~ElY~kHaP~TC~NF~eLa--rrgY-Yn~v~FHRii~DFmiQGGDPT-GTGRGGaSIYG~kF~DE 83 (164)
T KOG0881|consen 8 QPPNVTLETSMGKITLELYWKHAPRTCQNFAELA--RRGY-YNGVIFHRIIKDFMIQGGDPT-GTGRGGASIYGDKFEDE 83 (164)
T ss_pred CCCeEEEeecccceehhhhhhcCcHHHHHHHHHH--hccc-ccceeeeehhhhheeecCCCC-CCCCCccccccchhhhh
Confidence 3456889999999999999999999999999999 9999 999999999999999999999 69999999999999999
Q ss_pred cC-ccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCC-CCCCcccceEEeeec
Q psy14556 193 NF-TLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGS-QSGKTSKKIVVANSD 268 (1181)
Q Consensus 193 ~~-~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t-~~g~P~~~V~I~~cG 268 (1181)
.. .++|.++|.|||||+|||+|||||||||.|++||||+|++||||..||+|++++..+.+ +++||..+++|.+.-
T Consensus 84 i~~dLkhTGAGILsMANaGPnTNgSQFFiTLAPt~~LDGKHTIFGRV~~Gm~vikr~G~v~Td~~DRPi~~~kIika~ 161 (164)
T KOG0881|consen 84 IHSDLKHTGAGILSMANAGPNTNGSQFFITLAPTQWLDGKHTIFGRVCSGMEVIKRMGMVETDNSDRPIDEVKIIKAY 161 (164)
T ss_pred hhhhhcccchhhhhhhccCCCCCCceEEEEecCccccCCcceeehhhhhhHHHHHhhcceecCCCCCCccceeeEeee
Confidence 54 79999999999999999999999999999999999999999999999999999999988 678999999998754
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=374.95 Aligned_cols=250 Identities=29% Similarity=0.379 Sum_probs=212.9
Q ss_pred cccCceeecccCceEEEEEEEcCCCeEEEEEEecCC---CCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEe
Q psy14556 806 FALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEK---NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 806 ~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~---~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmE 882 (1181)
.+..+..||+|||+.||++++..+|+.||+|++.+. .....+.+.+|++|.++|+|||||+++++|++.+++|||+|
T Consensus 19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE 98 (592)
T KOG0575|consen 19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE 98 (592)
T ss_pred eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence 344456899999999999999999999999999875 33457889999999999999999999999999999999999
Q ss_pred ecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC
Q psy14556 883 QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS 962 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~ 962 (1181)
+|+.++|..+++. ...++|..++.+++||+.||.|||+++|+|||||..|+||+. +.++||+|||+|..+....+.
T Consensus 99 LC~~~sL~el~Kr---rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~-~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 99 LCHRGSLMELLKR---RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNE-NMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred ecCCccHHHHHHh---cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecC-cCcEEecccceeeeecCcccc
Confidence 9999999999983 457889999999999999999999999999999999999998 889999999999999887788
Q ss_pred CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCCCCC
Q psy14556 963 AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQISR 1042 (1181)
Q Consensus 963 ~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~ip~ 1042 (1181)
..+.+|||.|+|||++... +++-.+|+ ||+||+||.||+|++||+..+..+....+....
T Consensus 175 k~TlCGTPNYIAPEVl~k~--gHsfEvDi------------------WSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~ 234 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKS--GHSFEVDI------------------WSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE 234 (592)
T ss_pred cceecCCCcccChhHhccC--CCCCchhh------------------hhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC
Confidence 8899999999999999854 55556665 999999999999999999998877655444222
Q ss_pred C-CCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcc
Q psy14556 1043 S-VSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTG 1079 (1181)
Q Consensus 1043 ~-l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~ 1079 (1181)
- ++..+...-..+|.+.++++|..||+.-+.+.....
T Consensus 235 Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 235 YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 1 222445555668888889999999975554444444
|
|
| >PTZ00060 cyclophilin; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=338.63 Aligned_cols=170 Identities=58% Similarity=0.954 Sum_probs=158.6
Q ss_pred ccccCCcccccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccC-------CCccccCCEEEE
Q psy14556 89 QMFFPSSQMRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGE-------KGFGFKDSTFHR 161 (1181)
Q Consensus 89 ~~~~~ss~~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~-------~G~~Y~g~~FhR 161 (1181)
|.|+.++..|++|||++ +.+++.|+|+||||.+.||+||+||++||+|. .++ |+|+.|||
T Consensus 7 ~~~~~~~~~~~v~~di~------------i~~~~~G~ivIeL~~d~aP~t~~nF~~L~~g~~~~~~g~~~~-Y~~~~fhR 73 (183)
T PTZ00060 7 QSFPEMSKRPKVFFDIS------------IDNAPAGRIVFELFSDVTPKTAENFRALCIGDKVGSSGKNLH-YKGSIFHR 73 (183)
T ss_pred cCCcccCCCCEEEEEEE------------ECCEeCceEEEEEcCCCCcHHHHHHHHHhcCCcccccCcccc-cCCeEEEE
Confidence 56777778899999996 56889999999999999999999999999753 456 99999999
Q ss_pred ecCCceEeeCCCCCCCCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcC
Q psy14556 162 VIPNFMCQGGDFTNHNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEG 241 (1181)
Q Consensus 162 Vip~f~iQgGd~~~~~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG 241 (1181)
|+|+|+|||||+..++|+++.++||..+++|...++|+.+|+|||++.++++++||||||++++|+||++|+|||||++|
T Consensus 74 vi~~~~iqgGd~~~~~g~~g~~~~g~~~~~e~~~~~h~~~G~lsma~~g~~~~~sqFfIt~~~~~~Ldg~~tvFG~Vi~G 153 (183)
T PTZ00060 74 IIPQFMCQGGDITNHNGTGGESIYGRKFTDENFKLKHDQPGLLSMANAGPNTNGSQFFITTVPCPWLDGKHVVFGKVIEG 153 (183)
T ss_pred EcCCCeEEeCCccCCCCCCCCcccccccCCccccccCCCCCEEEeccCCCCCCcceEEEEeCCCcccCCCccEEEEEEcc
Confidence 99999999999987788999999999999998899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCcccceEEeeecccc
Q psy14556 242 LDVVKKLESMGSQSGKTSKKIVVANSDSHS 271 (1181)
Q Consensus 242 ~dVL~kI~~~~t~~g~P~~~V~I~~cGvl~ 271 (1181)
||||++|++.++.+++|.++|+|.+||++.
T Consensus 154 ~dvl~~I~~~~~~~~~P~~~v~I~~cg~~~ 183 (183)
T PTZ00060 154 MEVVRAMEKEGTQSGYPKKPVVVTDCGELQ 183 (183)
T ss_pred HHHHHHHHccCCCCCCCcCCeEEEEeEEcC
Confidence 999999999999889999999999999974
|
|
| >PTZ00221 cyclophilin; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.98 Aligned_cols=192 Identities=30% Similarity=0.385 Sum_probs=165.5
Q ss_pred ccccCCcceEEeec-cCcccccccCCcccccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHcc
Q psy14556 70 YKRDERSLFLYVHE-NSDDFQMFFPSSQMRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTG 148 (1181)
Q Consensus 70 ~~~~~~~~~l~~~~-~~~~~~~~~~ss~~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG 148 (1181)
-+-+++.|..|.+- +|+.+++ .+..+++|||+. +.+++.|+|+||||.|.||+||+||++||+|
T Consensus 27 ~~~~~~~~~~w~~~~~~~~~~~---~~~~~rVfldis------------ig~~~~GrIvIELf~d~aP~T~eNF~~Lc~g 91 (249)
T PTZ00221 27 NDIEERRLKEWENYQKSHRMKE---EQNSCRAFLDIS------------IGDVLAGRLVFELFEDVVPETVENFRALITG 91 (249)
T ss_pred hHHHhccceeccchhhcccccc---CCCCCEEEEEEe------------eCCeecceEEEEEeCCCCcHHHHHHHHHhhc
Confidence 34455667777553 3444442 245678999986 5578899999999999999999999999988
Q ss_pred CCCc--------cccCCEEEEecCC-ceEeeCCCCCCCCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEE
Q psy14556 149 EKGF--------GFKDSTFHRVIPN-FMCQGGDFTNHNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFF 219 (1181)
Q Consensus 149 ~~G~--------~Y~g~~FhRVip~-f~iQgGd~~~~~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFf 219 (1181)
+.++ +|+|+.||||+++ |+|||||+.. ++.++||..|.+|++.++|+++|+||||+.|++++|||||
T Consensus 92 ~~g~~~~~g~k~~Y~gt~FhRVi~~~f~iqgGD~~~----~g~s~~G~~f~dE~~~~~h~~~G~LsMan~GpntngSQFf 167 (249)
T PTZ00221 92 SCGIDTNTGVKLDYLYTPVHHVDRNNNIIVLGELDS----FNVSSTGTPIADEGYRHRHTERGLLTMISEGPHTSGSVFG 167 (249)
T ss_pred ccccccccCcccccCCCEEEEEeCCCCEEEeCCCCC----CCccCCCCcccCccccccCCCCCEEEeCcCCCCCccceEE
Confidence 7643 3999999999986 8999999863 3456789999999999999999999999999999999999
Q ss_pred EEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCC-CCCCcccceEEeeeccccCCCCCCccc
Q psy14556 220 ITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGS-QSGKTSKKIVVANSDSHSETDSQSSLS 280 (1181)
Q Consensus 220 Itl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t-~~g~P~~~V~I~~cGvl~~~~~~p~~~ 280 (1181)
||++++|+|||+|+|||+|++|||||++|+++++ .+++|.++|+|.+||+++.+.+.+..+
T Consensus 168 ITl~~~p~LDgk~vVFGrVveGmdVv~kIe~v~~d~~grP~~~V~I~~Cgvl~~~~p~~~~~ 229 (249)
T PTZ00221 168 ITLGPSPSLDFKQVVFGKAVDDLSLLEKLESLPLDDVGRPLLPVTVSFCGALTGEKPPGRQQ 229 (249)
T ss_pred EECCCCCccCCCceEEEEEEeCHHHHHHHHcCCcCCCCCCCCCeEEEECeEecCCCCCcccc
Confidence 9999999999999999999999999999999987 679999999999999999999888655
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=360.16 Aligned_cols=233 Identities=25% Similarity=0.394 Sum_probs=203.1
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
+||+|+||+||.++.+.+++.+|+|++++... .+.+...+|..||.+++||+||+++..|++.+++|+|+||+.||.
T Consensus 32 viGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGe 111 (357)
T KOG0598|consen 32 VIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGE 111 (357)
T ss_pred eeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCcc
Confidence 79999999999999999999999999987644 346778999999999999999999999999999999999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|...|++. ..+++..++.++.+|+.||.|||++|||||||||+|||||. +|+++|+|||+|+..........+++|
T Consensus 112 Lf~hL~~e---g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~-~GHi~LtDFgL~k~~~~~~~~t~tfcG 187 (357)
T KOG0598|consen 112 LFYHLQRE---GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDE-QGHIKLTDFGLCKEDLKDGDATRTFCG 187 (357)
T ss_pred HHHHHHhc---CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecC-CCcEEEeccccchhcccCCCccccccC
Confidence 99999844 46789999999999999999999999999999999999998 999999999999977666667778999
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCCCCC-CCCCC
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQISR-SVSVP 1047 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~ip~-~l~~~ 1047 (1181)
|+.|||||++.+. +|+..||+ ||||+++|+|++|.+||.+.+...+...+...+ ...+.
T Consensus 188 T~eYmAPEil~~~--gy~~~vDW------------------WsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~ 247 (357)
T KOG0598|consen 188 TPEYMAPEILLGK--GYDKAVDW------------------WSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPG 247 (357)
T ss_pred CccccChHHHhcC--CCCcccch------------------HhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCc
Confidence 9999999999865 56666665 999999999999999999999877655544333 22333
Q ss_pred -CCcchHHhhccCCCCCCCCCc
Q psy14556 1048 -GPGGINSSSSAPVTPTPHSRH 1068 (1181)
Q Consensus 1048 -~p~~L~~li~r~la~dPs~Rp 1068 (1181)
+......++.+.+.++|.+|-
T Consensus 248 ~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 248 YLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred cCCHHHHHHHHHHhccCHHHhc
Confidence 566667788888888888884
|
|
| >cd01926 cyclophilin_ABH_like cyclophilin_ABH_like: Cyclophilin A, B and H-like cyclophilin-type peptidylprolyl cis- trans isomerase (PPIase) domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=327.65 Aligned_cols=159 Identities=70% Similarity=1.139 Sum_probs=149.8
Q ss_pred ccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCC-----ccccCCEEEEecCCceEeeCC
Q psy14556 98 RQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKG-----FGFKDSTFHRVIPNFMCQGGD 172 (1181)
Q Consensus 98 ~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G-----~~Y~g~~FhRVip~f~iQgGd 172 (1181)
|++|||+. +.+++.|+|+||||.+.||+||+||++||+|.+| ++|+++.||||+|+|+|||||
T Consensus 1 p~v~~di~------------i~~~~~G~i~ieL~~~~aP~~~~nF~~L~~~~~g~~~~~~~Y~~~~f~Rv~~~~~iq~Gd 68 (164)
T cd01926 1 PKVFFDIT------------IGGEPAGRIVMELFADVVPKTAENFRALCTGEKGKGGKPFGYKGSTFHRVIPDFMIQGGD 68 (164)
T ss_pred CEEEEEEe------------ECCeeceeEEEEEeCCCCCHHHHHHHHHhcccCCCcccccccCCCEEEEEeCCcEEEcCC
Confidence 57899986 5588999999999999999999999999987666 339999999999999999999
Q ss_pred CCCCCCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCC
Q psy14556 173 FTNHNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMG 252 (1181)
Q Consensus 173 ~~~~~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~ 252 (1181)
+..++++++.++||.++++|...++|+.+|+||||+.++++++||||||++++|+||++|+|||||++|||||++|++++
T Consensus 69 ~~~~~g~~~~~~~g~~~~~e~~~~~h~~~G~lsma~~~~~~~~sqFfIt~~~~~~Ld~~~tvFG~V~~G~dvl~~i~~~~ 148 (164)
T cd01926 69 FTRGNGTGGKSIYGEKFPDENFKLKHTGPGLLSMANAGPNTNGSQFFITTVKTPWLDGKHVVFGKVVEGMDVVKKIENVG 148 (164)
T ss_pred ccCCCCCCCCcccCCccCCCCccccCCCccEEEeeECCCCCcccEEEEEeCCCCccCCcccEEEEEEEcHHHHHHHHcCC
Confidence 98778899999999999999889999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCcccceEEeeec
Q psy14556 253 SQSGKTSKKIVVANSD 268 (1181)
Q Consensus 253 t~~g~P~~~V~I~~cG 268 (1181)
+++++|..+|+|.+||
T Consensus 149 ~~~~~P~~~i~I~~cG 164 (164)
T cd01926 149 SGNGKPKKKVVIADCG 164 (164)
T ss_pred CCCCCCcCCeEEEECC
Confidence 9888999999999998
|
This family represents the archetypal cystolic cyclophilin similar to human cyclophilins A, B and H. PPIase is an enzyme which accelerates protein folding by catalyzing the cis-trans isomerization of the peptide bonds preceding proline residues. These enzymes have been implicated in protein folding processes which depend on catalytic /chaperone-like activities. As cyclophilins, Human hCyP-A, human cyclophilin-B (hCyP-19), S. cerevisiae Cpr1 and C. elegans Cyp-3, are inhibited by the immunosuppressive drug cyclopsporin A (CsA). CsA binds to the PPIase active site. Cyp-3. S. cerevisiae Cpr1 interacts with the Rpd3 - Sin3 complex and in addition is a component of the Set3 complex. S. cerevisiae Cpr1 has also been shown to have a role in Zpr1p nuclear transport. Human cyclophilin H associates with the [U4/U6.U5] tri-snRNP particles of the spl |
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=361.17 Aligned_cols=249 Identities=24% Similarity=0.276 Sum_probs=204.2
Q ss_pred hhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC-------ChhHHHHHHHHHHhcCCCCeeeEccccccCC
Q psy14556 803 LYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG-------DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEG 875 (1181)
Q Consensus 803 ~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~-------~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~ 875 (1181)
.+.+++..+.||+|+||.|-+|..+.+++.||||++++.... ......+|+++|++|+|||||+++++|+..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 344555566899999999999999999999999999766332 1234679999999999999999999999999
Q ss_pred cEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccC--CCeeeeecCCcc
Q psy14556 876 YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTY--SGVVKISDFGTS 953 (1181)
Q Consensus 876 ~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~--~g~vKLiDFGlA 953 (1181)
..|+||||++||.|.+.+-.+ ..+.+...+.+++|++.|+.|||++||+||||||+|||+..+ +..+||+|||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n---k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN---KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc---cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 999999999999999988743 456677778899999999999999999999999999999762 358999999999
Q ss_pred cccccCCCCCccccCCccccCchhhccCCCCCC-CccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc
Q psy14556 954 KRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYG-APVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR 1032 (1181)
Q Consensus 954 k~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~s-sDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~ 1032 (1181)
+... ......+.+|||.|.|||++.++...+. ..||+ ||+||+||-+++|.+||.+....
T Consensus 327 K~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDi------------------WSlGcvLfvcLsG~pPFS~~~~~ 387 (475)
T KOG0615|consen 327 KVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDI------------------WSLGCVLFVCLSGYPPFSEEYTD 387 (475)
T ss_pred hccc-cceehhhhcCCccccChhheecCCeecccchhee------------------eeccceEEEEeccCCCcccccCC
Confidence 9876 4467788999999999999987665543 46777 99999999999999999987654
Q ss_pred c-ccCC-----CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1033 A-LVAP-----PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1033 ~-l~~~-----~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
. +... -.+..............++..++..||..||+..+.
T Consensus 388 ~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~ea 434 (475)
T KOG0615|consen 388 PSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEA 434 (475)
T ss_pred ccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHH
Confidence 4 3222 222223333455556669999999999999985555
|
|
| >PLN03149 peptidyl-prolyl isomerase H (cyclophilin H); Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=331.10 Aligned_cols=166 Identities=52% Similarity=0.877 Sum_probs=152.6
Q ss_pred CCcccccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCC---C--ccccCCEEEEecCCce
Q psy14556 93 PSSQMRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEK---G--FGFKDSTFHRVIPNFM 167 (1181)
Q Consensus 93 ~ss~~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~---G--~~Y~g~~FhRVip~f~ 167 (1181)
.+..++.+|||+. +.+++.|||+||||.+.+|+||+||++||+|+. | .+|+++.||||+|+|+
T Consensus 14 ~~~~~~~v~~di~------------~~~~~~G~i~ieL~~~~aP~t~~NF~~Lc~g~~~~~g~~~~Y~~~~fhrVi~~f~ 81 (186)
T PLN03149 14 PNPKNPVVFFDVT------------IGGIPAGRIKMELFADIAPKTAENFRQFCTGEFRKAGLPQGYKGCQFHRVIKDFM 81 (186)
T ss_pred CCCCCCEEEEEEe------------eCCcccccEEEEEcCCCCcHHHHHHHHHHhhhccccCcccccCCcEEEEEcCCcE
Confidence 3345688999987 346789999999999999999999999998643 3 2599999999999999
Q ss_pred EeeCCCCCCCCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEE-cCHHHHH
Q psy14556 168 CQGGDFTNHNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVV-EGLDVVK 246 (1181)
Q Consensus 168 iQgGd~~~~~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVi-eG~dVL~ 246 (1181)
|||||+..++|+|+.++||..|++|.+..+|+++|+|||+++++++++||||||++++|+||++|+|||+|+ +|||||+
T Consensus 82 iqgGd~~~~~g~g~~~~~g~~f~~e~~~~~h~~~G~lsma~~g~~s~~sqFfIt~~~~p~Ldg~~tVFG~Vi~eG~dvl~ 161 (186)
T PLN03149 82 IQGGDFLKGDGTGCVSIYGSKFEDENFIAKHTGPGLLSMANSGPNTNGCQFFITCAKCDWLDNKHVVFGRVLGDGLLVVR 161 (186)
T ss_pred EEcCCcccCCCCCcccccCCccCCcccccccCCCCEEEEeeCCCCCcccEEEEECCCCCccCCCceEEEEEEECcHHHHH
Confidence 999999878899999999999999988999999999999999999999999999999999999999999999 8999999
Q ss_pred HHHhCCC-CCCCcccceEEeeeccc
Q psy14556 247 KLESMGS-QSGKTSKKIVVANSDSH 270 (1181)
Q Consensus 247 kI~~~~t-~~g~P~~~V~I~~cGvl 270 (1181)
+|+++++ .+++|..+|+|.+||++
T Consensus 162 ~I~~~~~~~~~~P~~~i~I~~cG~~ 186 (186)
T PLN03149 162 KIENVATGPNNRPKLACVISECGEM 186 (186)
T ss_pred HHHcCCCCCCCCCcCCeEEEeCEeC
Confidence 9999999 78899999999999985
|
|
| >COG0652 PpiB Peptidyl-prolyl cis-trans isomerase (rotamase) - cyclophilin family [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=320.84 Aligned_cols=147 Identities=47% Similarity=0.762 Sum_probs=133.5
Q ss_pred EEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCCCCCcCcc
Q psy14556 117 TNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFEDENFTL 196 (1181)
Q Consensus 117 vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~~dE~~~l 196 (1181)
++++|+.|+|+||||++.||+||+||++|| +.|| |+|+.||||||+||||||||+.++|.||+ +.+|++|....
T Consensus 2 v~~~t~~G~I~ieL~~~~aP~Tv~NF~~l~--~~g~-Ydg~~FHRVi~~FmiQgGd~~~~~g~gg~---~~~f~~E~~~~ 75 (158)
T COG0652 2 VILETNKGDITIELYPDKAPKTVANFLQLV--KEGF-YDGTIFHRVIPGFMIQGGDPTGGDGTGGP---GPPFKDENFAL 75 (158)
T ss_pred ceeeccCCCEEEEECCCcCcHHHHHHHHHH--HcCC-CCCceEEEeecCceeecCCCCCCCCCCCC---CCCCccccccc
Confidence 568999999999999999999999999999 7889 99999999999999999999987789888 48899999988
Q ss_pred ccCC--CceEEeecCC-CCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCCC-C----CCcccceEEeeec
Q psy14556 197 KHTG--PGILSMANAG-PNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGSQ-S----GKTSKKIVVANSD 268 (1181)
Q Consensus 197 ~h~~--~G~Lsma~~g-~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t~-~----g~P~~~V~I~~cG 268 (1181)
.|++ +|+|||||++ ||++|||||||+.++||||++|+|||+|++|||||++|++..+. . +.|..+++|...+
T Consensus 76 ~~~~~~~G~lsMA~~g~P~t~~SQFFI~~~~~~~Ld~~ytVFG~Vv~GmdvvdkI~~~~~~~~~~~~~~~~~~~~i~~~~ 155 (158)
T COG0652 76 NGDRHKRGTLSMARAGDPNSNGSQFFITVVDNPFLDGKYTVFGQVVEGMDVVDKIKNGDTDDSGYVQDVPADPVKILSVK 155 (158)
T ss_pred ccccCCcceEeEcccCCcCCccCeEEEEecCCcccCCCCcEEEEEehhHHHHHHHHcCCccCCCcccCCCCCCeEEeeee
Confidence 8887 9999999999 99999999999999999999999999999999999999997773 2 3454667776655
Q ss_pred c
Q psy14556 269 S 269 (1181)
Q Consensus 269 v 269 (1181)
+
T Consensus 156 ~ 156 (158)
T COG0652 156 I 156 (158)
T ss_pred e
Confidence 4
|
|
| >cd01923 cyclophilin_RING cyclophilin_RING: cyclophilin-type peptidylprolyl cis- trans isomerases (cyclophilins) having a modified RING finger domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=318.46 Aligned_cols=155 Identities=43% Similarity=0.751 Sum_probs=146.4
Q ss_pred EEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCCCCCcC-c
Q psy14556 117 TNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFEDENF-T 195 (1181)
Q Consensus 117 vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~~dE~~-~ 195 (1181)
|.+.|+.|+|+||||++.||+||+||++|| +.|+ |+|+.||||+|+|++||||+. ++|.++.++||.++++|.. .
T Consensus 2 v~~~T~~G~i~ieL~~~~aP~t~~nF~~L~--~~g~-Y~~~~f~rv~~~~~iq~Gd~~-~~g~~~~~~~g~~~~~E~~~~ 77 (159)
T cd01923 2 VRLHTNKGDLNLELHCDKAPKACENFIKLC--KKGY-YDGTIFHRSIRNFMIQGGDPT-GTGRGGESIWGKPFKDEFKPN 77 (159)
T ss_pred EEEEEccccEEEEEeCCCChHHHHHHHHHH--hcCc-cCCcEEEEEeCCcEEEecccC-CCCCCCccccCCccCcccccC
Confidence 578999999999999999999999999999 7888 999999999999999999987 5788999999999999854 6
Q ss_pred cccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCC-CCCCcccceEEeeeccccCCC
Q psy14556 196 LKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGS-QSGKTSKKIVVANSDSHSETD 274 (1181)
Q Consensus 196 l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t-~~g~P~~~V~I~~cGvl~~~~ 274 (1181)
++|+++|+|||++++++++|||||||++++|+||++|+|||||++|||||++|+++++ .+++|..+|+|.+|+++.+|.
T Consensus 78 ~~h~~~G~v~ma~~~~~s~~sqFfIt~~~~~~Ld~~~~vFG~V~~G~~vl~~I~~~~~~~~~~P~~~i~I~~~~i~~dpf 157 (159)
T cd01923 78 LSHDGRGVLSMANSGPNTNGSQFFITYRSCKHLDGKHTVFGRVVGGLETLEAMENVPDPGTDRPKEEIKIEDTSVFVDPF 157 (159)
T ss_pred cCcCCCcEEEEeeCCCCCcccEEEEECCCCcccCCCccEEEEEEcCHHHHHHHHcCCCCCCCCCCCCeEEEEeEEEeCCC
Confidence 7899999999999999999999999999999999999999999999999999999988 678999999999999999876
Q ss_pred C
Q psy14556 275 S 275 (1181)
Q Consensus 275 ~ 275 (1181)
+
T Consensus 158 ~ 158 (159)
T cd01923 158 E 158 (159)
T ss_pred C
Confidence 4
|
This group includes the nuclear proteins, Human hCyP-60 and Caenorhabditis elegans MOG-6 which, compared to the archetypal cyclophilin Human cyclophilin A exhibit reduced peptidylprolyl cis- trans isomerase activity and lack a residue important for cyclophilin binding. Human hCyP-60 has been shown to physically interact with the proteinase inhibitor peptide eglin c and; C. elegans MOG-6 to physically interact with MEP-1, a nuclear zinc finger protein. MOG-6 has been shown to function in germline sex determination. |
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=346.23 Aligned_cols=239 Identities=27% Similarity=0.363 Sum_probs=206.7
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEcc-ccccCCc-EEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLG-SVSEEGY-FKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g-~~~d~~~-l~LVmEy~~gG 887 (1181)
+||+|.||+||++.+..++..+|.|.+...... ..+....|+.+|++|+|||||++++ .|.+++. ++||||+|.+|
T Consensus 26 ~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~G 105 (375)
T KOG0591|consen 26 KIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAG 105 (375)
T ss_pred HHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhccc
Confidence 699999999999999999999999999755433 3677999999999999999999999 4555555 89999999999
Q ss_pred Ccccchhc-ccCCCCCChHHHHHHHHHHHhhhhhccc--cc--eecccCCCCCcccccCCCeeeeecCCcccccccCCCC
Q psy14556 888 SLSTLLRV-KWGPLKENESTMSFYTKQILEGLKYLHG--QK--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS 962 (1181)
Q Consensus 888 SL~dlL~~-~~~~~~l~e~~i~~Ia~QIa~AL~yLHs--~g--IVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~ 962 (1181)
+|..+++. +.....+++..+|.++.|++.||.++|+ .. |+||||||.||+++. +|.+||+|||+++.+......
T Consensus 106 DLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~-~gvvKLGDfGL~r~l~s~~tf 184 (375)
T KOG0591|consen 106 DLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTA-NGVVKLGDFGLGRFLSSKTTF 184 (375)
T ss_pred CHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcC-CCceeeccchhHhHhcchhHH
Confidence 99999974 3356688999999999999999999999 44 999999999999998 999999999999999887777
Q ss_pred CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCCCCC
Q psy14556 963 AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQISR 1042 (1181)
Q Consensus 963 ~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~ip~ 1042 (1181)
..+.+|||+||+||.+.+.++++++|| ||+||++|||+.-++||.+.+..++..++....
T Consensus 185 A~S~VGTPyYMSPE~i~~~~Y~~kSDi--------------------WslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd 244 (375)
T KOG0591|consen 185 AHSLVGTPYYMSPERIHESGYNFKSDI--------------------WSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGD 244 (375)
T ss_pred HHhhcCCCcccCHHHHhcCCCCcchhH--------------------HHHHHHHHHHHhcCCCcccccHHHHHHHHHcCC
Confidence 778899999999999998877777766 999999999999999999998877766555443
Q ss_pred CCC---CCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1043 SVS---VPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1043 ~l~---~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
..+ .-.+..+..++..|++.||..||.++
T Consensus 245 ~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~ 276 (375)
T KOG0591|consen 245 YPPLPDEHYSTDLRELINMCIAVDPEQRPDTV 276 (375)
T ss_pred CCCCcHHHhhhHHHHHHHHHccCCcccCCCcc
Confidence 221 23467788899999999999999753
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=348.80 Aligned_cols=233 Identities=30% Similarity=0.397 Sum_probs=200.5
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCc-EEEEEeecCCCCc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGY-FKIFMEQVPGGSL 889 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~-l~LVmEy~~gGSL 889 (1181)
.||+|..|+||+++++.+++.+|+|.+...... ..+++.+|+++++.++|||||++||.|..++. ++|+||||.+|+|
T Consensus 86 ~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSL 165 (364)
T KOG0581|consen 86 VLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSL 165 (364)
T ss_pred hcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCH
Confidence 599999999999999999999999999554333 36789999999999999999999999999985 9999999999999
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccc-cceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHG-QKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs-~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
++++... ..+++.....++.++++||.|||+ ++||||||||+|||++. .|.+||||||.++.+... ...+++|
T Consensus 166 d~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNs-kGeVKicDFGVS~~lvnS--~a~tfvG 239 (364)
T KOG0581|consen 166 DDILKRV---GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNS-KGEVKICDFGVSGILVNS--IANTFVG 239 (364)
T ss_pred HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeecc-CCCEEeccccccHHhhhh--hcccccc
Confidence 9999854 457899999999999999999995 99999999999999998 999999999999988753 5567889
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCc-----ccc----c--CC
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTS-----RAL----V--AP 1037 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~-----~~l----~--~~ 1037 (1181)
|..|||||.+.+..++.++|| ||||+.++|+.+|+.||..... .++ . .+
T Consensus 240 T~~YMsPERi~g~~Ys~~sDI--------------------WSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp 299 (364)
T KOG0581|consen 240 TSAYMSPERISGESYSVKSDI--------------------WSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP 299 (364)
T ss_pred cccccChhhhcCCcCCcccce--------------------ecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC
Confidence 999999999998887777666 9999999999999999988522 111 1 22
Q ss_pred CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1038 PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1038 ~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
+.+|.. .++..+...+..|+.+||..|+..-++
T Consensus 300 P~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qL 332 (364)
T KOG0581|consen 300 PRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQL 332 (364)
T ss_pred CCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHH
Confidence 333332 467778889999999999999985555
|
|
| >cd01928 Cyclophilin_PPIL3_like Cyclophilin_PPIL3_like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=314.07 Aligned_cols=150 Identities=46% Similarity=0.749 Sum_probs=141.7
Q ss_pred cEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCCCCCcC
Q psy14556 115 MVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFEDENF 194 (1181)
Q Consensus 115 ~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~~dE~~ 194 (1181)
|+|+++|+.|+|+||||++.||+||+||++|| +.|| |+|+.||||+|+|++||||+. ++|+++.++||..+++|..
T Consensus 1 m~v~l~T~~G~i~ieL~~~~aP~t~~nF~~L~--~~g~-Y~~~~f~rv~~~f~iq~Gd~~-~~g~g~~~~~~~~~~~e~~ 76 (153)
T cd01928 1 MSVTLHTNLGDIKIELFCDDCPKACENFLALC--ASGY-YNGCIFHRNIKGFMVQTGDPT-GTGKGGESIWGKKFEDEFR 76 (153)
T ss_pred CEEEEEEccccEEEEEcCCCCcHHHHHHHHHH--hcCc-cCCcEEEEeCCCCEEEccccC-CCCCCCCccCCCccccccc
Confidence 67889999999999999999999999999999 6788 999999999999999999987 5788899999999999976
Q ss_pred -ccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCC-CCCCcccceEEeeec
Q psy14556 195 -TLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGS-QSGKTSKKIVVANSD 268 (1181)
Q Consensus 195 -~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t-~~g~P~~~V~I~~cG 268 (1181)
.++|+.+|+|+||+++++++||||||+++++|+||++|+|||||++|||||++|+++++ .+++|..+|+|.+|.
T Consensus 77 ~~~~~~~~G~v~ma~~~~~~~~SqFfI~~~~~~~Ld~~~tvFG~V~~G~dvl~~I~~~~~~~~~~P~~~i~I~~~~ 152 (153)
T cd01928 77 ETLKHDSRGVVSMANNGPNTNGSQFFITYAKQPHLDGKYTVFGKVIDGFETLDTLEKLPVDKKYRPLEEIRIKDVT 152 (153)
T ss_pred cCCCcCCCcEEEEeeCCCCCcccEEEEEeCCCcccCCCceEEEEEEeCHHHHHHHHcCCCCCCCCCcCCeEEEEeE
Confidence 57899999999999999999999999999999999999999999999999999999988 678999999999884
|
Proteins similar to Human cyclophilin-like peptidylprolyl cis- trans isomerase (PPIL3). Members of this family lack a key residue important for cyclosporin binding: the tryptophan residue corresponding to W121 in human hCyP-18a; most members have a histidine at this position. The exact function of the protein is not known. |
| >KOG0882|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=350.58 Aligned_cols=152 Identities=46% Similarity=0.784 Sum_probs=145.7
Q ss_pred CcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCCCCCc
Q psy14556 114 GMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFEDEN 193 (1181)
Q Consensus 114 ~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~~dE~ 193 (1181)
+..++++|+.|+|.|.||++.||+||+||...| ++|| |+|..|||||+|||||+|||. |+|+||+||||..|+||.
T Consensus 404 ~~~aiihtt~gdi~~kl~p~ecpktvenf~th~--rngy-y~~~~fhriik~fmiqtgdp~-g~gtggesiwg~dfedef 479 (558)
T KOG0882|consen 404 GKAAIIHTTQGDIHIKLYPEECPKTVENFTTHS--RNGY-YDNHTFHRIIKGFMIQTGDPL-GDGTGGESIWGKDFEDEF 479 (558)
T ss_pred ccceEEEecccceEEEecccccchhhhhhhccc--cCcc-ccCcchHHhhhhheeecCCCC-CCCCCCcccccccchhhc
Confidence 457889999999999999999999999999999 9999 999999999999999999998 699999999999999996
Q ss_pred C-ccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCC-CCCCcccceEEeeecc
Q psy14556 194 F-TLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGS-QSGKTSKKIVVANSDS 269 (1181)
Q Consensus 194 ~-~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t-~~g~P~~~V~I~~cGv 269 (1181)
. .++|+++-+|||||+|||+||||||||+.++|||||+|+|||||..|||||++|+++.+ ..+||.++|.|.+.-+
T Consensus 480 h~~lrhdrpft~smanag~ntngsqffit~~~tpwld~khtvfgrv~~gm~vvqri~~v~t~k~drp~e~v~iinisv 557 (558)
T KOG0882|consen 480 HPNLRHDRPFTVSMANAGPNTNGSQFFITTVPTPWLDGKHTVFGRVTAGMDVVQRIEQVKTDKYDRPYEDVKIINISV 557 (558)
T ss_pred CcccccCCCceEEecccCCCCCCceEEEEecCccccCCcceeEEEEecchhHHhHhhhcccCcCCCCCCceeEEEEec
Confidence 5 79999999999999999999999999999999999999999999999999999999999 7899999999998653
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=354.38 Aligned_cols=243 Identities=27% Similarity=0.402 Sum_probs=208.1
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.||.|+|++|++|+.+.+++.||||++.+.. ....+.+.+|-.+|.+| .||.|++++..|+++..+|+|+||+++|
T Consensus 80 ~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nG 159 (604)
T KOG0592|consen 80 ILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNG 159 (604)
T ss_pred eeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCC
Confidence 5999999999999999999999999997663 33456788999999999 8999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC-----
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS----- 962 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~----- 962 (1181)
+|.+++++. ..+++...+.++.||+.||+|||++|||||||||+|||||. ++++||+|||.|+.+......
T Consensus 160 dll~~i~K~---Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~-dmhikITDFGsAK~l~~~~~~~~~~~ 235 (604)
T KOG0592|consen 160 DLLDLIKKY---GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDK-DGHIKITDFGSAKILSPSQKSQENPV 235 (604)
T ss_pred cHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcC-CCcEEEeeccccccCChhhccccCcc
Confidence 999999865 46889999999999999999999999999999999999998 999999999999877532111
Q ss_pred ------C--ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc
Q psy14556 963 ------A--ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL 1034 (1181)
Q Consensus 963 ------~--~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l 1034 (1181)
. .+++||..|.+||++..+..++++|+ |+||||||+|+.|.+||.+.++-.+
T Consensus 236 ~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDi--------------------WAlGCilyQmlaG~PPFra~Neyli 295 (604)
T KOG0592|consen 236 DPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDL--------------------WALGCILYQMLAGQPPFRAANEYLI 295 (604)
T ss_pred CcccccCcccceeeeecccCHHHhcCCCCCcccch--------------------HHHHHHHHHHhcCCCCCccccHHHH
Confidence 1 45889999999999998877777776 9999999999999999999998665
Q ss_pred cCCCC-CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1035 VAPPQ-ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1035 ~~~~~-ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
..++. +.-..+...|+....++.+.+..||..|....+....-.
T Consensus 296 FqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpF 340 (604)
T KOG0592|consen 296 FQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPF 340 (604)
T ss_pred HHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcc
Confidence 44333 333445566788888999999999999998655544333
|
|
| >cd01921 cyclophilin_RRM cyclophilin_RRM: cyclophilin-type peptidylprolyl cis- trans isomerase domain occuring with a C-terminal RNA recognition motif domain (RRM) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.26 Aligned_cols=155 Identities=38% Similarity=0.599 Sum_probs=141.5
Q ss_pred ecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCC-------CCCCC
Q psy14556 119 LDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYG-------NKFED 191 (1181)
Q Consensus 119 ~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g-------~~~~d 191 (1181)
+.|+.|+|+||||.+.||+||+||++|| +.++ |+|++||||+|+|+|||||+. +++.++.++|+ ..+.+
T Consensus 2 l~Ts~G~i~ieL~~~~aP~t~~nF~~L~--~~~~-Y~g~~fhrvi~~f~iQgGd~~-~~g~~~~~~~~~~~~~~~~~~~~ 77 (166)
T cd01921 2 LETTLGDLVIDLFTDECPLACLNFLKLC--KLKY-YNFCLFYNVQKDFIAQTGDPT-GTGAGGESIYSQLYGRQARFFEP 77 (166)
T ss_pred cEeccCCEEEEEcCCCCCHHHHHHHHHH--hcCC-cCCCEEEEEeCCceEEECCcC-CCCCCCcccccccccccCcccCc
Confidence 5799999999999999999999999999 7788 999999999999999999997 57788887765 24666
Q ss_pred CcC-ccccCCCceEEeecCCCCCCcceEEEEcCC-CCCCCCCCeEEEEEEcCHHHHHHHHhCCC-CCCCcccceEEeeec
Q psy14556 192 ENF-TLKHTGPGILSMANAGPNTNGSQFFITTVK-TAWLDNRHVVFGSVVEGLDVVKKLESMGS-QSGKTSKKIVVANSD 268 (1181)
Q Consensus 192 E~~-~l~h~~~G~Lsma~~g~nt~gSQFfItl~~-~p~LDg~~vVFGrVieG~dVL~kI~~~~t-~~g~P~~~V~I~~cG 268 (1181)
|.. .++|+.+|+||||+.++++++||||||+++ .|+||++|+|||||++|||||++|+++.+ .+++|..+|+|.+|+
T Consensus 78 e~~~~~~h~~~G~l~ma~~~~~~~~SQFfIt~~~~~~~Ldg~~tvFG~Vi~G~dvv~~I~~~~~~~~~~P~~~i~I~~~~ 157 (166)
T cd01921 78 EILPLLKHSKKGTVSMVNAGDNLNGSQFYITLGENLDYLDGKHTVFGQVVEGFDVLEKINDAIVDDDGRPLKDIRIKHTH 157 (166)
T ss_pred ccCCccccCCceEEEEeECCCCCccceEEEEcCCCCcccCCCccEEEEEEcCHHHHHHHHcCCCCCCCCCCCCeEEEEEE
Confidence 654 689999999999999999999999999975 79999999999999999999999999988 678999999999999
Q ss_pred cccCCCCCC
Q psy14556 269 SHSETDSQS 277 (1181)
Q Consensus 269 vl~~~~~~p 277 (1181)
++.+|.+.|
T Consensus 158 i~~~pf~~~ 166 (166)
T cd01921 158 ILDDPFPDP 166 (166)
T ss_pred EECCCCCCC
Confidence 999888765
|
This subfamily of the cyclophilin domain family contains a number of eukaryotic cyclophilins having the RRM domain including the nuclear proteins: human hCyP-57, Arabidopsis thaliana AtCYP59, Caenorhabditis elegans CeCyP-44 and Paramecium tetrurelia Kin241. The Kin241 protein has been shown to have a role in cell morphogenesis. |
| >cd01927 cyclophilin_WD40 cyclophilin_WD40: cyclophilin-type peptidylprolyl cis- trans isomerases (cyclophilins) having a WD40 domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=308.66 Aligned_cols=144 Identities=51% Similarity=0.864 Sum_probs=136.7
Q ss_pred ecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCCCCCcC-ccc
Q psy14556 119 LDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFEDENF-TLK 197 (1181)
Q Consensus 119 ~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~~dE~~-~l~ 197 (1181)
+.|+.|+|+||||.+.||+||+||++|| +.|| |+|+.||||+|+|++||||+. ++|.|+.++|+..+++|.. .++
T Consensus 2 i~T~~G~i~ieL~~~~aP~t~~nF~~L~--~~g~-Y~~~~f~Rvi~~f~iq~Gd~~-~~g~g~~~~~~~~~~~e~~~~~~ 77 (148)
T cd01927 2 IHTTKGDIHIRLFPEEAPKTVENFTTHA--RNGY-YNNTIFHRVIKGFMIQTGDPT-GDGTGGESIWGKEFEDEFSPSLK 77 (148)
T ss_pred eEeccccEEEEEeCCCCcHHHHHHHHHh--hcCC-cCCcEEEEEcCCcEEEecccC-CCCCCCCcccCCccccccccccC
Confidence 5799999999999999999999999999 7788 999999999999999999987 5888999999999999976 788
Q ss_pred cCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCC-CCCCcccceEEee
Q psy14556 198 HTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGS-QSGKTSKKIVVAN 266 (1181)
Q Consensus 198 h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t-~~g~P~~~V~I~~ 266 (1181)
|+++|+||||+.++++++||||||++++|+||++|+|||+|++|||||++|+++++ .+++|..+|+|.+
T Consensus 78 h~~~G~l~ma~~~~~s~~SqFfIt~~~~p~Ldg~~tvFG~V~~G~dvl~~I~~~~~~~~~~P~~~i~I~~ 147 (148)
T cd01927 78 HDRPYTLSMANAGPNTNGSQFFITTVATPWLDNKHTVFGRVVKGMDVVQRIENVKTDKNDRPYEDIKIIN 147 (148)
T ss_pred cCCCeEEEEeeCCCCCCCceEEEEcCCCcccCCCceEEEEEEcCHHHHHHHHcCCCCCCCCCcCCeEEEe
Confidence 99999999999999999999999999999999999999999999999999999998 6789999999985
|
This group consists of several hypothetical and putative eukaryotic and bacterial proteins which have a cyclophilin domain and a WD40 domain. Function of the protein is not known. |
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=344.90 Aligned_cols=241 Identities=29% Similarity=0.425 Sum_probs=197.1
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCC--hhHHHHHHHHHHhcCCCCeeeEccccccCC-cEEEEEeecCCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD--VQPLHEEIKLHSQLRHRNIVQYLGSVSEEG-YFKIFMEQVPGGS 888 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~--~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~-~l~LVmEy~~gGS 888 (1181)
+||.|+||+||+|.+..+. .||+|++....... .+.|.+|+.+|.+++|||||+++|++.+.. ..++||||+++|+
T Consensus 48 ~iG~G~~g~V~~~~~~g~~-~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~Gs 126 (362)
T KOG0192|consen 48 VLGSGSFGTVYKGKWRGTD-VVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGS 126 (362)
T ss_pred hcccCCceeEEEEEeCCce-eEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCc
Confidence 4999999999999985442 29999997654332 558999999999999999999999999887 7999999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccc-eecccCCCCCcccccCCC-eeeeecCCcccccccCCCCCccc
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK-IVHRDIKGDNVLVNTYSG-VVKISDFGTSKRLAGLCPSAETF 966 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~g-IVHrDLKP~NILLd~~~g-~vKLiDFGlAk~l~~~~~~~~t~ 966 (1181)
|.+++... ....++...+..|+.||+.||.|||+++ ||||||||+|||++. ++ ++||+|||+++............
T Consensus 127 L~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~-~~~~~KI~DFGlsr~~~~~~~~~~~~ 204 (362)
T KOG0192|consen 127 LSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDL-KGKTLKIADFGLSREKVISKTSMTSV 204 (362)
T ss_pred HHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcC-CCCEEEECCCccceeeccccccccCC
Confidence 99999864 4567889999999999999999999999 999999999999998 66 99999999998765432333336
Q ss_pred cCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCC---CCCCCC
Q psy14556 967 TGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAP---PQISRS 1043 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~---~~ip~~ 1043 (1181)
.||+.|||||++.+....++..+|+ ||||++||||+||+.||.+.....+... ......
T Consensus 205 ~GT~~wMAPEv~~~~~~~~~~K~Dv------------------ySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~ 266 (362)
T KOG0192|consen 205 AGTYRWMAPEVLRGEKSPYTEKSDV------------------YSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP 266 (362)
T ss_pred CCCccccChhhhcCCCCcCCccchh------------------hhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 7999999999998432223333333 9999999999999999999887443211 112222
Q ss_pred CCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1044 VSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1044 l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
++..+++.+..++.+||..+|..||.+.+-
T Consensus 267 ~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei 296 (362)
T KOG0192|consen 267 IPKECPPHLSSLMERCWLVDPSRRPSFLEI 296 (362)
T ss_pred CCccCCHHHHHHHHHhCCCCCCcCCCHHHH
Confidence 333488899999999999999999987665
|
|
| >KOG0883|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=337.37 Aligned_cols=165 Identities=41% Similarity=0.710 Sum_probs=156.0
Q ss_pred cccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCC
Q psy14556 107 EMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYG 186 (1181)
Q Consensus 107 ~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g 186 (1181)
.+.+..+.-.|.+.|+.|++-+||+.|.+|++|+||+.|| ++|| |+|+.|||.|.+||||||||+ |+|.||+||||
T Consensus 270 ry~rvKkkgyvrl~Tn~G~lNlELhcd~~P~aceNFI~lc--~~gY-Ynnt~FHRsIrnFmiQGGDPT-GTG~GGeSiWg 345 (518)
T KOG0883|consen 270 RYTRVKKKGYVRLVTNHGPLNLELHCDYAPRACENFITLC--KNGY-YNNTIFHRSIRNFMIQGGDPT-GTGRGGESIWG 345 (518)
T ss_pred hhccccccceEEEeccCCceeeEeecCcchHHHHHHHHHH--hccc-ccchHHHHHHHHHeeeCCCCC-CCCCCCccccC
Confidence 4556666678899999999999999999999999999999 9999 999999999999999999999 69999999999
Q ss_pred CCCCCCc-CccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCC-CCCCcccceEE
Q psy14556 187 NKFEDEN-FTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGS-QSGKTSKKIVV 264 (1181)
Q Consensus 187 ~~~~dE~-~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t-~~g~P~~~V~I 264 (1181)
.+|.||. ..+.|+.||+|||||+|||+|||||||+..++.|||++|++||+|+.|+++|.+|+++++ ++++|..+|+|
T Consensus 346 KpFkDEf~~~l~H~gRGvlSMANsGpnTNgSQFFItyrsckhLd~KHTIFGrvVGGldtL~amEnve~d~~DrP~e~I~i 425 (518)
T KOG0883|consen 346 KPFKDEFCSNLSHDGRGVLSMANSGPNTNGSQFFITYRSCKHLDNKHTIFGRVVGGLDTLTAMENVETDEKDRPKEEIKI 425 (518)
T ss_pred CccccccCCCCCcCCcceEeeccCCCCCCCceEEEEecchhhccccceeeeeeeccHHHHHHHhcCCCCCCCCcccceEE
Confidence 9999995 479999999999999999999999999999999999999999999999999999999999 67899999999
Q ss_pred eeeccccCCCC
Q psy14556 265 ANSDSHSETDS 275 (1181)
Q Consensus 265 ~~cGvl~~~~~ 275 (1181)
.+.-+..+|.+
T Consensus 426 ~~~~VFVdPfe 436 (518)
T KOG0883|consen 426 EDAIVFVDPFE 436 (518)
T ss_pred eeeEEeeCcHH
Confidence 99999888764
|
|
| >cd01922 cyclophilin_SpCYP2_like cyclophilin_SpCYP2_like: cyclophilin 2-like peptidylprolyl cis- trans isomerase (PPIase) domain similar to Schizosaccharomyces pombe cyp-2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=305.21 Aligned_cols=144 Identities=47% Similarity=0.844 Sum_probs=135.9
Q ss_pred ecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCCCCCc-Cccc
Q psy14556 119 LDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFEDEN-FTLK 197 (1181)
Q Consensus 119 ~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~~dE~-~~l~ 197 (1181)
+.|+.|+|+||||.+.||+||+||++|| +.|| |+|+.||||+|+|++||||+. ++|.++.++||.+|++|. ..++
T Consensus 2 i~T~~G~i~ieL~~~~aP~t~~nF~~L~--~~g~-Y~~~~f~Rvi~~f~iq~Gd~~-~~g~~~~~~~~~~~~~e~~~~~~ 77 (146)
T cd01922 2 LETTMGEITLELYWNHAPKTCKNFYELA--KRGY-YNGTIFHRLIKDFMIQGGDPT-GTGRGGASIYGKKFEDEIHPELK 77 (146)
T ss_pred eEeccccEEEEEcCCCCcHHHHHHHHHH--hcCC-cCCcEEEEEcCCcEEEecccC-CCCCCcccccCCCcccccccCcC
Confidence 5799999999999999999999999999 7888 999999999999999999987 578888999999999985 4789
Q ss_pred cCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCCCCCCcccceEEee
Q psy14556 198 HTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGSQSGKTSKKIVVAN 266 (1181)
Q Consensus 198 h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t~~g~P~~~V~I~~ 266 (1181)
|+++|+|||+++++++++||||||++++|+||++|+|||+|++|||||++|+++++++++|..+|+|..
T Consensus 78 h~~~G~l~ma~~~~~s~~sqFfIt~~~~p~Ld~~~tvFG~V~~G~dvl~~I~~~~~~~~~P~~~I~I~~ 146 (146)
T cd01922 78 HTGAGILSMANAGPNTNGSQFFITLAPTPWLDGKHTIFGRVSKGMKVIENMVEVQTQTDRPIDEVKILK 146 (146)
T ss_pred CCCCeEEEEeeCCCCCCccEEEEEcCCCcccCCCCCEEEEEEcCHHHHHHHHhCCCCCCCcCCCeEEeC
Confidence 999999999999999999999999999999999999999999999999999999998889999999963
|
These proteins bind their respective SNW chromatin binding protein in autologous systems, in a CsA independent manner indicating interaction with a surface outside the PPIase active site. SNW proteins play a basic and broad range role in signaling. |
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=327.14 Aligned_cols=239 Identities=24% Similarity=0.348 Sum_probs=197.4
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
++|+|+||+||+|+++.||+.||||++...... -.+-.++|+++|++++|||+|.++++|.....+++|+|||+..-|
T Consensus 9 kvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL 88 (396)
T KOG0593|consen 9 KVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVL 88 (396)
T ss_pred ccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHH
Confidence 699999999999999999999999999655332 245578999999999999999999999999999999999965555
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT 969 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT 969 (1181)
.++-+ .+..++...+..++.|++.|+.|+|++++|||||||+|||++. +|.+||||||+|+.+..+....+.++.|
T Consensus 89 ~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~-~gvvKLCDFGFAR~L~~pgd~YTDYVAT 164 (396)
T KOG0593|consen 89 HELER---YPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQ-NGVVKLCDFGFARTLSAPGDNYTDYVAT 164 (396)
T ss_pred HHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEec-CCcEEeccchhhHhhcCCcchhhhhhhh
Confidence 44433 3556789999999999999999999999999999999999998 9999999999999998766666678899
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc---------------
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL--------------- 1034 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l--------------- 1034 (1181)
.+|+|||.+.| ...|+..||+ |++||++.||++|.+.|.+.+.-+.
T Consensus 165 RWYRaPELLvG-DtqYG~pVDi------------------WAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prh 225 (396)
T KOG0593|consen 165 RWYRAPELLVG-DTQYGKPVDI------------------WAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRH 225 (396)
T ss_pred hhccChhhhcc-cCcCCCcccc------------------hhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHH
Confidence 99999999975 3578899988 9999999999999999999887431
Q ss_pred ---cCC------CCCCCC-----CCC---CCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1035 ---VAP------PQISRS-----VSV---PGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1035 ---~~~------~~ip~~-----l~~---~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
... ..+|.. +.. .....+-.++..|+..||..|+...+.
T Consensus 226 q~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~ql 281 (396)
T KOG0593|consen 226 QSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQL 281 (396)
T ss_pred HHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHH
Confidence 000 112211 111 122234458899999999999986666
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=327.39 Aligned_cols=224 Identities=29% Similarity=0.465 Sum_probs=193.8
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.||.|+||.|.+++.+.++..+|+|++++... .+.+...+|..+|+.+.||+++++++.+.+.+.+|+||||++||.
T Consensus 51 tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGE 130 (355)
T KOG0616|consen 51 TLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGE 130 (355)
T ss_pred eeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCcc
Confidence 59999999999999999999999999977643 346678899999999999999999999999999999999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|..++++. ..+++..++.++.||+.||+|||+++|++|||||+|||+|. +|.+||+|||+|+...+ ...+.+|
T Consensus 131 lFS~Lrk~---~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~-~G~iKitDFGFAK~v~~---rT~TlCG 203 (355)
T KOG0616|consen 131 LFSYLRKS---GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQ-NGHIKITDFGFAKRVSG---RTWTLCG 203 (355)
T ss_pred HHHHHHhc---CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeecc-CCcEEEEeccceEEecC---cEEEecC
Confidence 99999854 46789999999999999999999999999999999999998 99999999999998764 4678899
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc-----CCCCCCCC
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV-----APPQISRS 1043 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~-----~~~~ip~~ 1043 (1181)
||.|+|||++... +++..+|. |+||+++|||+.|.+||...+...+. .+..+|+.
T Consensus 204 TPeYLAPEii~sk--~ynkavDW------------------WalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~ 263 (355)
T KOG0616|consen 204 TPEYLAPEIIQSK--GYNKAVDW------------------WALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSY 263 (355)
T ss_pred CccccChHHhhcC--CCCcchhH------------------HHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcc
Confidence 9999999999855 45666665 88999999999999999999986643 34556666
Q ss_pred CCCCCCcchHHhhccCCCC
Q psy14556 1044 VSVPGPGGINSSSSAPVTP 1062 (1181)
Q Consensus 1044 l~~~~p~~L~~li~r~la~ 1062 (1181)
.++.....+..+++..+++
T Consensus 264 fs~~~kdLl~~LL~vD~t~ 282 (355)
T KOG0616|consen 264 FSSDAKDLLKKLLQVDLTK 282 (355)
T ss_pred cCHHHHHHHHHHHhhhhHh
Confidence 6666555555555544433
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=344.86 Aligned_cols=239 Identities=24% Similarity=0.351 Sum_probs=204.5
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
+.||+|+||.||+|+.+.+.+.||+|.+.+... .+.+.+.+|++|++.++||||+.++++|+...++|+|+||+.| +
T Consensus 8 e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~ 86 (808)
T KOG0597|consen 8 EMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-D 86 (808)
T ss_pred HHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-h
Confidence 369999999999999999999999999976643 3467799999999999999999999999999999999999966 9
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|..++... ..++++.+..++.|++.||.|||+.+|+|||+||.|||++. ++.+|+||||+|+.............|
T Consensus 87 L~~il~~d---~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~-~~~~KlcdFg~Ar~m~~~t~vltsikG 162 (808)
T KOG0597|consen 87 LFTILEQD---GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEK-GGTLKLCDFGLARAMSTNTSVLTSIKG 162 (808)
T ss_pred HHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecC-CCceeechhhhhhhcccCceeeeeccC
Confidence 99999843 46889999999999999999999999999999999999998 899999999999988766555666789
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCCCCC-CCCCC
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQISR-SVSVP 1047 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~ip~-~l~~~ 1047 (1181)
||.|||||++.++.+...+|. ||+|||+||+++|++||.......++..+.-.. ..+..
T Consensus 163 tPlYmAPElv~e~pyd~~sDl--------------------WslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~ 222 (808)
T KOG0597|consen 163 TPLYMAPELVEEQPYDHTSDL--------------------WSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPST 222 (808)
T ss_pred cccccCHHHHcCCCccchhhH--------------------HHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCccc
Confidence 999999999987665444444 999999999999999999988766544333211 11224
Q ss_pred CCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1048 GPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1048 ~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
....+...++..+.+||..|-+|.++.
T Consensus 223 ~S~~f~nfl~gLL~kdP~~RltW~~Ll 249 (808)
T KOG0597|consen 223 ASSSFVNFLQGLLIKDPAQRLTWTDLL 249 (808)
T ss_pred ccHHHHHHHHHHhhcChhhcccHHHHh
Confidence 556677788899999999999988873
|
|
| >KOG0884|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=284.24 Aligned_cols=155 Identities=43% Similarity=0.705 Sum_probs=144.8
Q ss_pred cEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCCCCCcC
Q psy14556 115 MVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFEDENF 194 (1181)
Q Consensus 115 ~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~~dE~~ 194 (1181)
|+|.++|..|+|.||+|.+.+|+||+||+.+| ...| |+|+.|||-+||||+|+||++ .+|.||.||||.+|+||..
T Consensus 1 msvtlht~~gdikiev~~e~tpktce~~l~~~--~~~~-~n~~~~~~~~~~f~v~~~~~~-~tgrgg~siwg~~fede~~ 76 (161)
T KOG0884|consen 1 MSVTLHTDVGDIKIEVFCERTPKTCENFLALC--ASDY-YNGCIFHRNIKGFMVQTGDPT-HTGRGGNSIWGKKFEDEYS 76 (161)
T ss_pred CeEEEeeccCcEEEEEEecCChhHHHHHHHHh--hhhh-ccceeecCCCCCcEEEeCCCC-CCCCCCccccCCcchHHHH
Confidence 67899999999999999999999999999999 6677 999999999999999999998 5899999999999999965
Q ss_pred -ccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCCC--CCCcccceEEeeecccc
Q psy14556 195 -TLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGSQ--SGKTSKKIVVANSDSHS 271 (1181)
Q Consensus 195 -~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t~--~g~P~~~V~I~~cGvl~ 271 (1181)
.++|+.||.|||||.|||+||||||||.+..||||-+|+|||+||+|+|+|++|++++++ ..||..++.|.+..+--
T Consensus 77 ~~lkh~~rg~vsmanngp~tn~sqffity~kq~hldmkytvfgkvidg~etldele~l~v~~ktyrpl~~~~ik~itiha 156 (161)
T KOG0884|consen 77 EYLKHNVRGVVSMANNGPNTNGSQFFITYGKQPHLDMKYTVFGKVIDGLETLDELEKLPVNEKTYRPLNDVHIKDITIHA 156 (161)
T ss_pred HHHhhccceeEEcccCCCCCCCceEEEEecCCCccceeEeeeeeeccchhhHHHHhhcccCccccccchheeeeeeEEec
Confidence 699999999999999999999999999999999999999999999999999999999994 36899999999877654
Q ss_pred CC
Q psy14556 272 ET 273 (1181)
Q Consensus 272 ~~ 273 (1181)
.+
T Consensus 157 np 158 (161)
T KOG0884|consen 157 NP 158 (161)
T ss_pred Cc
Confidence 44
|
|
| >cd01925 cyclophilin_CeCYP16-like cyclophilin_CeCYP16-like: cyclophilin-type peptidylprolyl cis- trans isomerase) (PPIase) domain similar to Caenorhabditis elegans cyclophilin 16 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=305.84 Aligned_cols=161 Identities=35% Similarity=0.582 Sum_probs=148.5
Q ss_pred cCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCCC
Q psy14556 111 DQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFE 190 (1181)
Q Consensus 111 ~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~~ 190 (1181)
+++.-.|.+.|+.|+|+||||.+.+|+||+||++|| ++|+ |+|+.||||+|+|++||||+. ++|+|+.++||.++.
T Consensus 2 ~~~~~~v~i~Ts~G~i~ieL~~~~~P~t~~nF~~L~--~~~~-Y~~~~f~Rvi~~f~iQgGd~~-~~g~g~~s~~g~~~~ 77 (171)
T cd01925 2 PPTTGKVILKTTAGDIDIELWSKEAPKACRNFIQLC--LEGY-YDNTIFHRVVPGFIIQGGDPT-GTGTGGESIYGEPFK 77 (171)
T ss_pred CCcccEEEEEEccccEEEEEeCCCChHHHHHHHHHH--hcCC-CCCCEEEEEcCCcEEEccccC-CCCccCcccCCCccC
Confidence 455667889999999999999999999999999999 7888 999999999999999999987 578999999999999
Q ss_pred CCcC-ccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEE-cCHHHHHHHHhCCC-CCCCcccceEEeee
Q psy14556 191 DENF-TLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVV-EGLDVVKKLESMGS-QSGKTSKKIVVANS 267 (1181)
Q Consensus 191 dE~~-~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVi-eG~dVL~kI~~~~t-~~g~P~~~V~I~~c 267 (1181)
+|.. .++|+++|+||||++++++++||||||++++|+||++|+|||+|+ +|+++|++|+++.+ .+++|..+|+|.+|
T Consensus 78 ~E~~~~~~~~~~G~l~ma~~g~~s~~sqFfIt~~~~~~ldg~~tvFG~V~g~~~~~v~~i~~~~~~~~~~P~~~i~I~~~ 157 (171)
T cd01925 78 DEFHSRLRFNRRGLVGMANAGDDSNGSQFFFTLDKADELNNKHTLFGKVTGDTIYNLLKLAEVETDKDERPVYPPKITSV 157 (171)
T ss_pred cccccCcCCCCCcEEEECcCCCCCcccEEEEEcCCCcccCCCceEEEEEEECcHHHHHHHhcCCcCCCCCcCCCeEEEEE
Confidence 9966 578999999999999999999999999999999999999999999 46889999999988 67899999999999
Q ss_pred ccccCCCC
Q psy14556 268 DSHSETDS 275 (1181)
Q Consensus 268 Gvl~~~~~ 275 (1181)
+++.++.+
T Consensus 158 ~i~~~pf~ 165 (171)
T cd01925 158 EVLENPFD 165 (171)
T ss_pred EEEcCCch
Confidence 99987654
|
C. elegans CeCYP-16, compared to the archetypal cyclophilin Human cyclophilin A has, a reduced peptidylprolyl cis- trans isomerase activity, is cyclosporin insensitive and shows an altered substrate preference favoring, hydrophobic, acidic or amide amino acids. Most members of this subfamily have a glutamate residue in the active site at the position equivalent to a tryptophan (W121 in Human cyclophilin A), which has been shown to be important for cyclophilin binding. |
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=340.15 Aligned_cols=243 Identities=28% Similarity=0.321 Sum_probs=201.4
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCC----CC-CChhHHHHHHHHHHhcC-CCCeeeEccccccCCcEEEEEeec
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEK----NL-GDVQPLHEEIKLHSQLR-HRNIVQYLGSVSEEGYFKIFMEQV 884 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~----~~-~~~e~f~rEi~IL~~L~-HPNIVkl~g~~~d~~~l~LVmEy~ 884 (1181)
..||+|+||+|+.|.+..+++.||+|++.+. .. ...+.+.+|+.++++++ ||||+++++++.....+|+||||+
T Consensus 23 ~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~ 102 (370)
T KOG0583|consen 23 RTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYC 102 (370)
T ss_pred eeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEec
Confidence 3699999999999999999999999987664 12 23456779999999998 999999999999999999999999
Q ss_pred CCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCc
Q psy14556 885 PGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAE 964 (1181)
Q Consensus 885 ~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~ 964 (1181)
.||+|.+++... ..+.+..+..+++|++.|++|||++||+||||||+|||++...+.+||+|||++...........
T Consensus 103 ~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~ 179 (370)
T KOG0583|consen 103 SGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLK 179 (370)
T ss_pred CCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCccc
Confidence 999999999863 35667999999999999999999999999999999999998339999999999987743445677
Q ss_pred cccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCCCCCCC
Q psy14556 965 TFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQISRSV 1044 (1181)
Q Consensus 965 t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~ip~~l 1044 (1181)
+.+||+.|+|||++.+.....+..+|+ ||+|++||.|++|..||...+...+..++......
T Consensus 180 t~cGsp~Y~aPEvl~~~~~Y~g~~aDv------------------WS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~ 241 (370)
T KOG0583|consen 180 TFCGSPAYAAPEVLSGKGTYSGKAADV------------------WSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFK 241 (370)
T ss_pred CCCCCcccCCHHHhCCCCCcCCchhhh------------------hhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCcc
Confidence 889999999999998755233566666 99999999999999999997766654443222211
Q ss_pred CC-CC-CcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1045 SV-PG-PGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1045 ~~-~~-p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
.+ -. ......++.+++..+|.+|+...+..
T Consensus 242 ~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 242 IPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 11 12 66778899999999999998744443
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=347.74 Aligned_cols=233 Identities=26% Similarity=0.357 Sum_probs=198.4
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhcC-CCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLR-HRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L~-HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
+||+|+||+|+++..+.+++.+|||.+++... .+.+..+.|..|+.... ||.+++++..|+..+++|+||||+.||
T Consensus 375 vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Gg 454 (694)
T KOG0694|consen 375 VLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGG 454 (694)
T ss_pred EeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCC
Confidence 69999999999999999999999999988743 45788999999999885 999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
++..+.+. ..+++..+..|+..|+.||+|||++||||||||.+|||||. +|++||+|||+++..-.....+.+++
T Consensus 455 dm~~~~~~----~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~-eGh~kiADFGlcKe~m~~g~~TsTfC 529 (694)
T KOG0694|consen 455 DLMHHIHT----DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDT-EGHVKIADFGLCKEGMGQGDRTSTFC 529 (694)
T ss_pred cEEEEEec----ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcc-cCcEEecccccccccCCCCCcccccc
Confidence 96655543 36889999999999999999999999999999999999998 99999999999987665556788999
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCCCCC-CCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQISR-SVSV 1046 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~ip~-~l~~ 1046 (1181)
|||.|||||++.+. .|+..||+ |+|||+|||||+|..||.+++.+++...+...+ ..+.
T Consensus 530 GTpey~aPEil~e~--~Yt~aVDW------------------W~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~ 589 (694)
T KOG0694|consen 530 GTPEFLAPEVLTEQ--SYTRAVDW------------------WGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR 589 (694)
T ss_pred CChhhcChhhhccC--cccchhhH------------------HHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence 99999999999865 56777776 999999999999999999999988654433222 1222
Q ss_pred CCCcchHHhhccCCCCCCCCCch
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
-++.....++.+.++++|.+|=-
T Consensus 590 ~ls~ea~~il~~ll~k~p~kRLG 612 (694)
T KOG0694|consen 590 FLSKEAIAIMRRLLRKNPEKRLG 612 (694)
T ss_pred cccHHHHHHHHHHhccCcccccC
Confidence 33444555777777777777764
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=333.40 Aligned_cols=234 Identities=24% Similarity=0.308 Sum_probs=192.7
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.||+|+||.||+|++..+++.||+|++.+... .....+.+|+.++++++||||+++++++...+.+|+||||+++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 59999999999999999999999999975422 234567889999999999999999999999999999999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.............|
T Consensus 82 L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~-~~~~kl~DfG~a~~~~~~~~~~~~~~g 157 (323)
T cd05571 82 LFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDK-DGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred HHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECC-CCCEEEeeCCCCcccccCCCcccceec
Confidence 99888743 35788999999999999999999999999999999999988 889999999998764433333445679
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-CCCCCCCC
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-ISRSVSVP 1047 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-ip~~l~~~ 1047 (1181)
|+.|+|||++.+..++..+|+ ||+||++|+|++|+.||.+.+...+..... -....+..
T Consensus 158 t~~y~aPE~~~~~~~~~~~Di--------------------wSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~ 217 (323)
T cd05571 158 TPEYLAPEVLEDNDYGRAVDW--------------------WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT 217 (323)
T ss_pred CccccChhhhcCCCCCccccC--------------------cccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 999999999976654444333 999999999999999998876544321111 01122335
Q ss_pred CCcchHHhhccCCCCCCCCCch
Q psy14556 1048 GPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1048 ~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
.+..+..++.+|+..||.+|+.
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05571 218 LSPEAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred CCHHHHHHHHHHccCCHHHcCC
Confidence 6777888999999999999995
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=338.60 Aligned_cols=233 Identities=27% Similarity=0.380 Sum_probs=194.8
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
+||+|+||.||+|+.+.||..+|+|++++... .+.+.++.|-.+|...++|+||+++..|++.+++||||||++||+
T Consensus 148 ~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD 227 (550)
T KOG0605|consen 148 VIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGD 227 (550)
T ss_pred eeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCcc
Confidence 69999999999999999999999999987744 456778899999999999999999999999999999999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccccccc----------
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG---------- 958 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~---------- 958 (1181)
+..+|... ..+++..++.++.+++.|+..||+.|+|||||||+|+|||. .|++||+|||+|..+..
T Consensus 228 ~mTLL~~~---~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~-~GHiKLSDFGLs~gl~~~~~~~~~~~~ 303 (550)
T KOG0605|consen 228 MMTLLMRK---DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDA-KGHIKLSDFGLSTGLDKKHRIESYRLD 303 (550)
T ss_pred HHHHHHhc---CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecC-CCCEeeccccccchhhhhhhhhhhcch
Confidence 99999844 57889999999999999999999999999999999999998 99999999999853321
Q ss_pred -------------CCC-----C-------------------CccccCCccccCchhhccCCCCCCCccccccCCCccccc
Q psy14556 959 -------------LCP-----S-------------------AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRI 1001 (1181)
Q Consensus 959 -------------~~~-----~-------------------~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i 1001 (1181)
... . ....+|||.|||||++.+.. |+..+|+
T Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg--Y~~~cDw---------- 371 (550)
T KOG0605|consen 304 EQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG--YGKECDW---------- 371 (550)
T ss_pred hhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC--CCccccH----------
Confidence 000 0 01246999999999998764 5666665
Q ss_pred cccccchhHHHHHHHHHHHhCCCCCCCCCcccccC-----CCCCCCCCCCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1002 EYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA-----PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1002 ~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~-----~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
||||||+||||.|.+||.+.++.+... +..+..+........-..+|.+++. +|..|-.
T Consensus 372 --------WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 372 --------WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred --------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 999999999999999999999977433 2223333334444556668888888 8988876
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=340.29 Aligned_cols=239 Identities=27% Similarity=0.401 Sum_probs=207.6
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
..+||+|+.|.||.|....+++.||||.+........+-+.+|+.+|+..+|+|||++++.|...+.+|+|||||+||+|
T Consensus 278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL 357 (550)
T ss_pred hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence 34799999999999999999999999999988888888999999999999999999999999988999999999999999
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT 969 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT 969 (1181)
.+++... .+++.++..|+++++.||+|||.+||+|||||.+|||++. +|.+||+|||+|..+........+.+||
T Consensus 358 TDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~-~g~vKltDFGFcaqi~~~~~KR~TmVGT 432 (550)
T KOG0578|consen 358 TDVVTKT----RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTM-DGSVKLTDFGFCAQISEEQSKRSTMVGT 432 (550)
T ss_pred hhhhhcc----cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEecc-CCcEEEeeeeeeeccccccCccccccCC
Confidence 9999754 5889999999999999999999999999999999999998 8999999999999998877778889999
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc-c--cCCCCCC-CCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA-L--VAPPQIS-RSVS 1045 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~-l--~~~~~ip-~~l~ 1045 (1181)
|+|||||++.... |+..+|+ ||||++++||+-|++||-.+++-. + .+....| -..+
T Consensus 433 PYWMAPEVvtrk~--YG~KVDI------------------WSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~ 492 (550)
T KOG0578|consen 433 PYWMAPEVVTRKP--YGPKVDI------------------WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNP 492 (550)
T ss_pred CCccchhhhhhcc--cCccccc------------------hhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCc
Confidence 9999999998665 4555555 999999999999999999766532 2 2221112 1223
Q ss_pred CCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1046 VPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1046 ~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
..+...+...+.+|+..||.+|++.-++
T Consensus 493 ~klS~~~kdFL~~cL~~dv~~RasA~eL 520 (550)
T KOG0578|consen 493 EKLSPELKDFLDRCLVVDVEQRASAKEL 520 (550)
T ss_pred cccCHHHHHHHHHHhhcchhcCCCHHHH
Confidence 4567788888999999999999974444
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=328.62 Aligned_cols=242 Identities=33% Similarity=0.446 Sum_probs=194.8
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCC--cEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEG--YFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~--~l~LVmEy~~gGS 888 (1181)
..||+|+||.||++.+..++...|+|.+........+.+.+|+.+|++++|||||+++|...... .+++.|||+++|+
T Consensus 23 ~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~Gs 102 (313)
T KOG0198|consen 23 KLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGS 102 (313)
T ss_pred ccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCc
Confidence 36999999999999999999999999997664444677999999999999999999999754444 6999999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccccccc---CCCCCcc
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG---LCPSAET 965 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~---~~~~~~t 965 (1181)
|.+++.... . .+++..+..+.+||++||+|||++|||||||||+|||++..++.+||+|||+++.... .......
T Consensus 103 L~~~~~~~g-~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~ 180 (313)
T KOG0198|consen 103 LSDLIKRYG-G-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELS 180 (313)
T ss_pred HHHHHHHcC-C-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccccccccc
Confidence 999998763 3 6899999999999999999999999999999999999987458999999999987763 1122345
Q ss_pred ccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCC-Cccc----ccCCCCC
Q psy14556 966 FTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKK-TSRA----LVAPPQI 1040 (1181)
Q Consensus 966 ~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~-~~~~----l~~~~~i 1040 (1181)
..||+.|||||++..+. .....+|+ ||+||++.||+||++||... .... +......
T Consensus 181 ~~Gtp~~maPEvi~~g~-~~~~~sDi------------------WSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~ 241 (313)
T KOG0198|consen 181 VQGTPNYMAPEVIRNGE-VARRESDI------------------WSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSL 241 (313)
T ss_pred ccCCccccCchhhcCCC-cCCccchh------------------hhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCC
Confidence 67999999999998521 12123444 99999999999999999983 2222 1111112
Q ss_pred CCCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1041 SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1041 p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
| .++..++......+.+|+..+|..||+...++
T Consensus 242 P-~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL 274 (313)
T KOG0198|consen 242 P-EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELL 274 (313)
T ss_pred C-CCCcccCHHHHHHHHHHhhcCcccCcCHHHHh
Confidence 2 44555777788899999999999999744443
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=327.05 Aligned_cols=235 Identities=28% Similarity=0.346 Sum_probs=189.2
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHH---HhcCCCCeeeEccccccCCcEEEEEeec
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLH---SQLRHRNIVQYLGSVSEEGYFKIFMEQV 884 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL---~~L~HPNIVkl~g~~~d~~~l~LVmEy~ 884 (1181)
.+||+|+||.||+|.+..+++.||+|++++.. ....+.+.+|+.++ +.++||||+++++++.+.+..|+||||+
T Consensus 5 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~ 84 (324)
T cd05589 5 AVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYA 84 (324)
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCC
Confidence 36999999999999999999999999997542 22345677777665 4568999999999999999999999999
Q ss_pred CCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCc
Q psy14556 885 PGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAE 964 (1181)
Q Consensus 885 ~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~ 964 (1181)
++++|..++... .+++..++.++.||+.||+|||++||+||||||+||+++. ++.+||+|||+++..........
T Consensus 85 ~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~-~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05589 85 AGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDT-EGFVKIADFGLCKEGMGFGDRTS 159 (324)
T ss_pred CCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC-CCcEEeCcccCCccCCCCCCccc
Confidence 999998887632 5788999999999999999999999999999999999998 89999999999875443333344
Q ss_pred cccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-CCCC
Q psy14556 965 TFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-ISRS 1043 (1181)
Q Consensus 965 t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-ip~~ 1043 (1181)
...|++.|+|||++.+..++..+| + ||+||++|+|++|+.||.+.+...+..... ....
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~D--i------------------wslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~ 219 (324)
T cd05589 160 TFCGTPEFLAPEVLTETSYTRAVD--W------------------WGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR 219 (324)
T ss_pred ccccCccccCHhHhcCCCCCcccc--h------------------hhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence 567999999999997655443333 3 999999999999999999877544321111 1111
Q ss_pred CCCCCCcchHHhhccCCCCCCCCCchh
Q psy14556 1044 VSVPGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1044 l~~~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
.+...+..+..++.+|+..+|.+||.+
T Consensus 220 ~p~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 220 YPRFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 233456778889999999999999963
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=324.46 Aligned_cols=241 Identities=22% Similarity=0.273 Sum_probs=190.7
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHH-HHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIK-LHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~-IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
+||+|+||.||+|++..+++.||+|++.+... .....+..|.. +++.++||||+++++++.+.+..|+||||++++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 59999999999999999999999999965422 22344555554 678899999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|...+... ..+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++.............
T Consensus 82 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05603 82 ELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDS-QGHVVLTDFGLCKEGVEPEETTSTFC 157 (321)
T ss_pred CHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC-CCCEEEccCCCCccCCCCCCcccccc
Confidence 998887643 35678888899999999999999999999999999999988 89999999999875433323334456
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-CCCCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-ISRSVSV 1046 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-ip~~l~~ 1046 (1181)
||+.|+|||++.+..++...| + ||+||++|+|++|..||.+.+...+..... .+...+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~D--i------------------wslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 217 (321)
T cd05603 158 GTPEYLAPEVLRKEPYDRTVD--W------------------WCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPG 217 (321)
T ss_pred CCcccCCHHHhcCCCCCCcCc--c------------------cccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence 899999999997655444333 3 999999999999999999876544322111 1222334
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHHHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNTNLV 1076 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~~~~ 1076 (1181)
..+..+..++.+|++.+|..|+.....+..
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (321)
T cd05603 218 GKTVAACDLLVGLLHKDQRRRLGAKADFLE 247 (321)
T ss_pred CCCHHHHHHHHHHccCCHhhcCCCCCCHHH
Confidence 456678889999999999999976544333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0865|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=303.19 Aligned_cols=162 Identities=67% Similarity=1.109 Sum_probs=155.7
Q ss_pred cccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEE---ecCCceEeeCCC
Q psy14556 97 MRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHR---VIPNFMCQGGDF 173 (1181)
Q Consensus 97 ~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhR---Vip~f~iQgGd~ 173 (1181)
+|.+|||++ +.+++.|+++++||.|..|+|++||..||||++|++|+++.||| .+++||+||||+
T Consensus 3 ~~~vf~d~~------------~~~~p~gr~~~~l~ad~~Pktaenf~al~tgekg~~yk~s~fhr~~~~~~~fm~qggDf 70 (167)
T KOG0865|consen 3 NPTVFFDIA------------IDGEPLGRIVFELFADKIPKTAENFRALCTGEKGFGYKGSCFHRLIPIIPGFMCQGGDF 70 (167)
T ss_pred CCeeeeeee------------ecCccccccceecccccCcchHhhhhhcccCCCccccccchhhhccccccceeeccCcc
Confidence 689999997 44899999999999999999999999999999999999999999 345799999999
Q ss_pred CCCCCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCC
Q psy14556 174 TNHNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGS 253 (1181)
Q Consensus 174 ~~~~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t 253 (1181)
+.++|+||.++|+++|+||++.++|..+|+|||||.|||+|||||||++.++.||||+|+|||+|.+||+++++++..++
T Consensus 71 t~hngtggkSiy~ekF~DenFilkhtgpGiLSmaNagpntngsqffictaktewLdgkhVVfGkv~eGm~iv~a~e~~gs 150 (167)
T KOG0865|consen 71 TCHNGTGGKSIYGEKFDDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMDIVEAMERFGS 150 (167)
T ss_pred cccCCccceEecccccCCcCcEEecCCCCeeehhhcCCCccccEEEEEccccccccCceeEcCceEcccchhhhhhccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCcccceEEeeeccc
Q psy14556 254 QSGKTSKKIVVANSDSH 270 (1181)
Q Consensus 254 ~~g~P~~~V~I~~cGvl 270 (1181)
.+|++.++|.|.+||.+
T Consensus 151 ~~gk~~~~i~i~dcg~l 167 (167)
T KOG0865|consen 151 RNGKTSKKITIADCGQL 167 (167)
T ss_pred cCCcccccEEEecCCcC
Confidence 99999999999999975
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=329.08 Aligned_cols=245 Identities=23% Similarity=0.333 Sum_probs=201.4
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChh-HHHHHHHHHHhcC-CCCeeeEccccccCC-cEEEE
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQ-PLHEEIKLHSQLR-HRNIVQYLGSVSEEG-YFKIF 880 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e-~f~rEi~IL~~L~-HPNIVkl~g~~~d~~-~l~LV 880 (1181)
++|...+ +||.|.||.||+|+.+.++..||||.++++.....+ .-.||++.|++|+ ||||+++.+++.+.+ .+|+|
T Consensus 10 ~RY~~i~-klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 10 DRYTVIR-KLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHH-HhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 3444444 699999999999999999999999999776544322 2468999999998 999999999999887 99999
Q ss_pred EeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC
Q psy14556 881 MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC 960 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~ 960 (1181)
|||| ..+|+++++.+ +..+++..++.|+.||++||+|+|.+|+.|||+||+|||+.. +..+||+|||+|+.+.+.
T Consensus 89 fE~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~-~~~iKiaDFGLARev~Sk- 163 (538)
T KOG0661|consen 89 FEFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISG-NDVIKIADFGLAREVRSK- 163 (538)
T ss_pred HHhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecc-cceeEecccccccccccC-
Confidence 9999 78999999876 567889999999999999999999999999999999999987 789999999999988764
Q ss_pred CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc------
Q psy14556 961 PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL------ 1034 (1181)
Q Consensus 961 ~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l------ 1034 (1181)
+..+.++.|.+|+|||++... ..|+..||+ |++|||++|+.+-++.|.|.+..+-
T Consensus 164 pPYTeYVSTRWYRAPEvLLrs-~~Ys~pvD~------------------wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~ 224 (538)
T KOG0661|consen 164 PPYTEYVSTRWYRAPEVLLRS-GYYSSPVDM------------------WAVGCIMAELYSLRPLFPGASEIDQIYKICE 224 (538)
T ss_pred CCcchhhhcccccchHHhhhc-cccCCchHH------------------HHHHHHHHHHHHhcccCCCCcHHHHHHHHHH
Confidence 344557789999999999754 468888988 9999999999999999999887431
Q ss_pred ------------------cCCCCCCCCC-------CCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1035 ------------------VAPPQISRSV-------SVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1035 ------------------~~~~~ip~~l-------~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.....+|... -+.++.....++.++++=||..||+..+.
T Consensus 225 VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~a 288 (538)
T KOG0661|consen 225 VLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQA 288 (538)
T ss_pred HhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHH
Confidence 0011122211 11244555668899999999999974443
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=326.60 Aligned_cols=240 Identities=28% Similarity=0.423 Sum_probs=195.5
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccC--CcEEEEEeecCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEE--GYFKIFMEQVPG 886 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~--~~l~LVmEy~~g 886 (1181)
++||+|.||.||+|++..+|+.||+|++..... ....-..+||.||++|+||||+++.+...+. +.+|||+||| .
T Consensus 123 ~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYM-d 201 (560)
T KOG0600|consen 123 EKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYM-D 201 (560)
T ss_pred HHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecc-c
Confidence 379999999999999999999999999977653 3456678999999999999999999988766 7899999999 5
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC-Ccc
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS-AET 965 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~-~~t 965 (1181)
-+|.-++.. ....+++.+++.++.||+.||+|||++||+|||||.+|||||. +|.+||+|||+|+.+...... .+.
T Consensus 202 hDL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn-~G~LKiaDFGLAr~y~~~~~~~~T~ 278 (560)
T KOG0600|consen 202 HDLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDN-NGVLKIADFGLARFYTPSGSAPYTS 278 (560)
T ss_pred chhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcC-CCCEEeccccceeeccCCCCccccc
Confidence 677777763 3567889999999999999999999999999999999999998 999999999999977654433 445
Q ss_pred ccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc-------c---
Q psy14556 966 FTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL-------V--- 1035 (1181)
Q Consensus 966 ~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l-------~--- 1035 (1181)
.+-|.+|+|||++.|. ..|+..||+ ||.||||.||++|++.|.+.+..+- .
T Consensus 279 rVvTLWYRpPELLLG~-t~Yg~aVDl------------------WS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP 339 (560)
T KOG0600|consen 279 RVVTLWYRPPELLLGA-TSYGTAVDL------------------WSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSP 339 (560)
T ss_pred ceEEeeccChHHhcCC-cccccceee------------------hhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCC
Confidence 6689999999999865 578999988 9999999999999999999887431 0
Q ss_pred ----C-CCCCCCCCC---------------CCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1036 ----A-PPQISRSVS---------------VPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1036 ----~-~~~ip~~l~---------------~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
. ...+|.... ...+...-.++...|+.||.+|.+..+.
T Consensus 340 ~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~a 397 (560)
T KOG0600|consen 340 TEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSA 397 (560)
T ss_pred ChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHH
Confidence 0 111221110 1122233347888999999999874444
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=323.68 Aligned_cols=240 Identities=25% Similarity=0.319 Sum_probs=195.0
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.||+|+||.||++++..+++.||+|++.+.. ......+.+|+.+++.++||||+++++++...+.+++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 5999999999999999999999999997542 2234678889999999999999999999999999999999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.............|
T Consensus 82 L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~-~~~~kL~DfG~~~~~~~~~~~~~~~~g 157 (328)
T cd05593 82 LFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDK-DGHIKITDFGLCKEGITDAATMKTFCG 157 (328)
T ss_pred HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECC-CCcEEEecCcCCccCCCcccccccccC
Confidence 98888643 35788999999999999999999999999999999999987 899999999998764333233344579
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-CCCCCCCC
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-ISRSVSVP 1047 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-ip~~l~~~ 1047 (1181)
|+.|+|||++.+..++..+|+ ||+||++|+|++|+.||.+.+...+..... .....+..
T Consensus 158 t~~y~aPE~~~~~~~~~~~Di--------------------wslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~ 217 (328)
T cd05593 158 TPEYLAPEVLEDNDYGRAVDW--------------------WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRT 217 (328)
T ss_pred CcCccChhhhcCCCCCccCCc--------------------cccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCC
Confidence 999999999976654444333 999999999999999998876544322211 11122345
Q ss_pred CCcchHHhhccCCCCCCCCCch----hHHHHH
Q psy14556 1048 GPGGINSSSSAPVTPTPHSRHI----SVNTNL 1075 (1181)
Q Consensus 1048 ~p~~L~~li~r~la~dPs~Rp~----s~~~~~ 1075 (1181)
.+..+..++.+|+.++|..|+. ++.+.+
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il 249 (328)
T cd05593 218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIM 249 (328)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHh
Confidence 6677888999999999999973 555543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=324.50 Aligned_cols=233 Identities=23% Similarity=0.258 Sum_probs=192.7
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 813 IG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
||+|+||.||+|++..+++.||+|++.+.. ......+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999999999999999996532 23356688999999999999999999999999999999999999999
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT 969 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT 969 (1181)
.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.............||
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 156 (312)
T cd05585 81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDY-QGHIALCDFGLCKLNMKDDDKTNTFCGT 156 (312)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECC-CCcEEEEECcccccCccCCCccccccCC
Confidence 9998743 35778899999999999999999999999999999999987 8999999999997654333334456799
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-CCCCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-ISRSVSVPG 1048 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-ip~~l~~~~ 1048 (1181)
+.|+|||++.+..++...| + ||+||++|+|++|+.||.+.+...+..... -+...+...
T Consensus 157 ~~y~aPE~~~~~~~~~~~D--v------------------wslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 216 (312)
T cd05585 157 PEYLAPELLLGHGYTKAVD--W------------------WTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGF 216 (312)
T ss_pred cccCCHHHHcCCCCCCccc--e------------------echhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcC
Confidence 9999999997665444433 3 999999999999999998876654322111 112233456
Q ss_pred CcchHHhhccCCCCCCCCCch
Q psy14556 1049 PGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1049 p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
+..+..++.+|+..+|..|+.
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCC
Confidence 677888999999999999985
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=326.72 Aligned_cols=233 Identities=25% Similarity=0.344 Sum_probs=192.3
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..|+||||++++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 103 (329)
T PTZ00263 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGG 103 (329)
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCC
Confidence 36999999999999999999999999996542 233567889999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++..... .....
T Consensus 104 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~~~~~~~~---~~~~~ 176 (329)
T PTZ00263 104 ELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDN-KGHVKVTDFGFAKKVPDR---TFTLC 176 (329)
T ss_pred hHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECC-CCCEEEeeccCceEcCCC---cceec
Confidence 999998743 35678888999999999999999999999999999999998 899999999999866432 23457
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCCC-CCCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQI-SRSVSV 1046 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~i-p~~l~~ 1046 (1181)
||+.|+|||++.+...+..+| + ||+||++|+|++|..||.+.+...+.....- ....+.
T Consensus 177 gt~~y~aPE~~~~~~~~~~~D--i------------------wslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~ 236 (329)
T PTZ00263 177 GTPEYLAPEVIQSKGHGKAVD--W------------------WTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN 236 (329)
T ss_pred CChhhcCHHHHcCCCCCCcce--e------------------echHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCC
Confidence 999999999998665444333 3 9999999999999999988765443211110 011122
Q ss_pred CCCcchHHhhccCCCCCCCCCchh
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
..+..+..++.+|+..||.+|+..
T Consensus 237 ~~~~~~~~li~~~L~~dP~~R~~~ 260 (329)
T PTZ00263 237 WFDGRARDLVKGLLQTDHTKRLGT 260 (329)
T ss_pred CCCHHHHHHHHHHhhcCHHHcCCC
Confidence 355678889999999999999975
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=323.89 Aligned_cols=234 Identities=26% Similarity=0.353 Sum_probs=188.5
Q ss_pred eecccCceEEEEEEEc---CCCeEEEEEEecCCC----CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeec
Q psy14556 812 ELGKGSYGVVYAAREL---DRQVKLAIKEIPEKN----LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQV 884 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~---~tg~~VAIKii~~~~----~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~ 884 (1181)
+||+|+||.||++++. .+++.||+|++.... ......+.+|+.+++.++||||+++++++..++.+|+||||+
T Consensus 3 ~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 82 (323)
T cd05584 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYL 82 (323)
T ss_pred eeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCC
Confidence 6999999999999864 468899999996532 223456788999999999999999999999999999999999
Q ss_pred CCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCc
Q psy14556 885 PGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAE 964 (1181)
Q Consensus 885 ~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~ 964 (1181)
++++|.+++... ..+.+..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++..........
T Consensus 83 ~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~ 158 (323)
T cd05584 83 SGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDA-QGHVKLTDFGLCKESIHEGTVTH 158 (323)
T ss_pred CCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC-CCCEEEeeCcCCeecccCCCccc
Confidence 999999998743 35678888889999999999999999999999999999988 89999999999875443333334
Q ss_pred cccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-CCCC
Q psy14556 965 TFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-ISRS 1043 (1181)
Q Consensus 965 t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-ip~~ 1043 (1181)
...||+.|+|||++.+...+.. .|+ ||+|+++|+|++|+.||.+.+......... ....
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~--~Di------------------wslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~ 218 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHGKA--VDW------------------WSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN 218 (323)
T ss_pred ccCCCccccChhhccCCCCCCc--cee------------------cccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 4569999999999976554433 333 999999999999999998876543221111 1112
Q ss_pred CCCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1044 VSVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1044 l~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
.+...+..+..++.+|+..+|.+|+.
T Consensus 219 ~~~~~~~~~~~li~~~l~~~p~~R~~ 244 (323)
T cd05584 219 LPPYLTPEARDLLKKLLKRNPSSRLG 244 (323)
T ss_pred CCCCCCHHHHHHHHHHcccCHhHcCC
Confidence 23445667888999999999999985
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=321.57 Aligned_cols=234 Identities=24% Similarity=0.308 Sum_probs=191.4
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.||+|+||.||++++..++..||+|++.... ......+.+|+.+++.++||||+++++++...+.+|+||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 5999999999999999999999999997542 2234567789999999999999999999999999999999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.............|
T Consensus 82 L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~g 157 (323)
T cd05595 82 LFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDGATMKTFCG 157 (323)
T ss_pred HHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcC-CCCEEecccHHhccccCCCCccccccC
Confidence 98888643 35788999999999999999999999999999999999988 899999999998754333233344569
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-CCCCCCCC
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-ISRSVSVP 1047 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-ip~~l~~~ 1047 (1181)
|+.|+|||++.++.++..+|+ ||+||++|+|++|+.||...+...+..... .....+..
T Consensus 158 t~~y~aPE~~~~~~~~~~~Di--------------------wSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~ 217 (323)
T cd05595 158 TPEYLAPEVLEDNDYGRAVDW--------------------WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT 217 (323)
T ss_pred CcCcCCcccccCCCCCchhch--------------------hhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence 999999999976654444433 999999999999999998876544321111 11122335
Q ss_pred CCcchHHhhccCCCCCCCCCch
Q psy14556 1048 GPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1048 ~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
.+..+..++.+|+..+|..|+.
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05595 218 LSPEAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred CCHHHHHHHHHHccCCHHHhCC
Confidence 6777888999999999999973
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PRK10903 peptidyl-prolyl cis-trans isomerase A (rotamase A); Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=300.04 Aligned_cols=153 Identities=30% Similarity=0.497 Sum_probs=134.1
Q ss_pred CCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCCCCC
Q psy14556 113 EGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFEDE 192 (1181)
Q Consensus 113 ~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~~dE 192 (1181)
....|+++|+.|+|+||||++.||+||+||++|| +.|| |+|+.||||+|+|++||||+....+ ...++.++.+|
T Consensus 27 ~~~~v~l~T~~G~i~ieL~~~~aP~t~~NF~~L~--~~g~-Ydg~~FhRvi~~f~iQgG~~~~~~~---~~~~~~~~~~e 100 (190)
T PRK10903 27 GDPHVLLTTSAGNIELELNSQKAPVSVKNFVDYV--NSGF-YNNTTFHRVIPGFMIQGGGFTEQMQ---QKKPNPPIKNE 100 (190)
T ss_pred CCcEEEEEeccccEEEEEeCCCCcHHHHHHHHHH--hcCC-cCCcEEEEEeCCceEEeCCcCCCCC---CCCCCCcccCc
Confidence 3445788999999999999999999999999999 7899 9999999999999999999874322 22346678888
Q ss_pred cCccccCCCceEEeecCC-CCCCcceEEEEcCCCCCCCC-----CCeEEEEEEcCHHHHHHHHhCCCC-----CCCcccc
Q psy14556 193 NFTLKHTGPGILSMANAG-PNTNGSQFFITTVKTAWLDN-----RHVVFGSVVEGLDVVKKLESMGSQ-----SGKTSKK 261 (1181)
Q Consensus 193 ~~~l~h~~~G~Lsma~~g-~nt~gSQFfItl~~~p~LDg-----~~vVFGrVieG~dVL~kI~~~~t~-----~g~P~~~ 261 (1181)
.....|+.+|+||||+.+ ++++||||||+++++++||+ +|+|||+|++|||||++|++++++ +++|..+
T Consensus 101 ~~~~l~~~~G~lama~~~~~~sn~SQFfIt~~~~~~ld~~~~dg~ytvFG~V~eG~dvl~~I~~~~~~~~~~~~~~P~~~ 180 (190)
T PRK10903 101 ADNGLRNTRGTIAMARTADKDSATSQFFINVADNAFLDHGQRDFGYAVFGKVVKGMDVADKISQVPTHDVGPYQNVPSKP 180 (190)
T ss_pred ccccCcCCCcEEEeCCCCCCCCcccEEEEECcCcccccCCccCCCccEEEEEecCHHHHHHHHcCCCCCCCCCCCcccCC
Confidence 666667789999999865 89999999999999999984 899999999999999999999884 3689999
Q ss_pred eEEeeecccc
Q psy14556 262 IVVANSDSHS 271 (1181)
Q Consensus 262 V~I~~cGvl~ 271 (1181)
|+|.+|++++
T Consensus 181 v~I~~~~v~~ 190 (190)
T PRK10903 181 VVILSAKVLP 190 (190)
T ss_pred eEEEEEEEeC
Confidence 9999998763
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=322.08 Aligned_cols=236 Identities=22% Similarity=0.296 Sum_probs=188.9
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHH-HHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIK-LHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~-IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.||+|+||+||+|++..+++.||+|++.+... ...+.+..|.. +++.++||||+++++.+.+.+..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 59999999999999999999999999965422 22344555554 567899999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.............
T Consensus 82 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (323)
T cd05575 82 ELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDS-QGHVVLTDFGLCKEGIEHSKTTSTFC 157 (323)
T ss_pred CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECC-CCcEEEeccCCCcccccCCCcccccc
Confidence 999888743 35778889999999999999999999999999999999988 89999999999875433333344556
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCC-CCCCCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPP-QISRSVSV 1046 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~-~ip~~l~~ 1046 (1181)
||+.|+|||++.+..++..+|+ ||+||++|+|++|..||.+.+..++.... ..+...+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~Dv--------------------wslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 217 (323)
T cd05575 158 GTPEYLAPEVLRKQPYDRTVDW--------------------WCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKP 217 (323)
T ss_pred CChhhcChhhhcCCCCCccccc--------------------cccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 9999999999976654444333 99999999999999999987654432111 11122334
Q ss_pred CCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
..+..+..++.+++..+|..|+...
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 5577788888999999999998754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=335.13 Aligned_cols=238 Identities=24% Similarity=0.336 Sum_probs=201.7
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCccc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLST 891 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~d 891 (1181)
+||+|-||.||.|++..+ ..||+|.++..... .+.|.+|+++|++|+|+|||++++++..++.+|||||||+.|+|.+
T Consensus 213 ~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~-~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~ 290 (468)
T KOG0197|consen 213 ELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMS-PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLD 290 (468)
T ss_pred HhcCCccceEEEEEEcCC-CcccceEEeccccC-hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHH
Confidence 599999999999998543 37999999776433 3678899999999999999999999999889999999999999999
Q ss_pred chhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC-CccccCCc
Q psy14556 892 LLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS-AETFTGTL 970 (1181)
Q Consensus 892 lL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~-~~t~~GT~ 970 (1181)
+|+.. ....+...+...++.|||+|++||+++++|||||.++|||++. +..+||+|||+|+.+.+.... .....-..
T Consensus 291 yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~-~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPI 368 (468)
T KOG0197|consen 291 YLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDE-DLVVKISDFGLARLIGDDEYTASEGGKFPI 368 (468)
T ss_pred Hhhhc-CCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeecc-CceEEEcccccccccCCCceeecCCCCCCc
Confidence 99974 4556778889999999999999999999999999999999998 899999999999965543221 22223467
Q ss_pred cccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCCCCCC--CCCC
Q psy14556 971 QYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQISRS--VSVP 1047 (1181)
Q Consensus 971 ~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~ip~~--l~~~ 1047 (1181)
.|.|||.+..+.++.++|| ||||++||||+| |+.||.+.+..++......... .+..
T Consensus 369 kWtAPEa~~~~~FS~kSDV--------------------WSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~ 428 (468)
T KOG0197|consen 369 KWTAPEALNYGKFSSKSDV--------------------WSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEG 428 (468)
T ss_pred eecCHHHHhhCCcccccce--------------------eehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCC
Confidence 8999999998888777777 999999999999 8899999988775443332222 2346
Q ss_pred CCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1048 GPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1048 ~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
+|+.+-.++..|+..+|..||++..+
T Consensus 429 CP~~vY~lM~~CW~~~P~~RPtF~~L 454 (468)
T KOG0197|consen 429 CPDEVYELMKSCWHEDPEDRPTFETL 454 (468)
T ss_pred CCHHHHHHHHHHhhCCcccCCCHHHH
Confidence 89999999999999999999998866
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.39 Aligned_cols=200 Identities=29% Similarity=0.451 Sum_probs=180.6
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC--hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD--VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~--~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.++||+|.||.||+|++..+|+.||||+++.....+ .....+|++.|+.++|+||+.++++|...+.+.||+||| ..
T Consensus 7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm-~t 85 (318)
T KOG0659|consen 7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM-PT 85 (318)
T ss_pred hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec-cc
Confidence 347999999999999999999999999997664432 346889999999999999999999999999999999999 57
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|+..++.+ ...+...+++.|+.++++||+|||++.|+||||||.|+|++. +|.+||+|||+++.+..........+
T Consensus 86 dLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~-~g~lKiADFGLAr~f~~p~~~~~~~V 162 (318)
T KOG0659|consen 86 DLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISS-DGQLKIADFGLARFFGSPNRIQTHQV 162 (318)
T ss_pred cHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcC-CCcEEeecccchhccCCCCcccccce
Confidence 899999864 567889999999999999999999999999999999999998 99999999999999987766666667
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR 1032 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~ 1032 (1181)
-|.+|+|||.+.| ...|+..||+ ||.|||+.||+.|.+-|.|.++-
T Consensus 163 ~TRWYRAPELLfG-sr~Yg~~VDm------------------WavGCI~AELllr~P~fpG~sDi 208 (318)
T KOG0659|consen 163 VTRWYRAPELLFG-SRQYGTGVDM------------------WAVGCIFAELLLRVPFFPGDSDI 208 (318)
T ss_pred eeeeccChHHhcc-chhcCCcchh------------------hhHHHHHHHHHccCCCCCCCchH
Confidence 8999999999975 4689999998 99999999999999999998873
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=325.81 Aligned_cols=256 Identities=25% Similarity=0.305 Sum_probs=202.4
Q ss_pred HhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCC--------------CChhHHHHHHHHHHhcCCCCeeeE
Q psy14556 802 FLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--------------GDVQPLHEEIKLHSQLRHRNIVQY 867 (1181)
Q Consensus 802 ~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--------------~~~e~f~rEi~IL~~L~HPNIVkl 867 (1181)
..+.|.+.. +||+|.||.|-+|++..+++.||||++.+... ...+...+|+.||++|.|||||++
T Consensus 95 ~lNqy~l~~-eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 95 QLNQYELIK-EIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred ehhheehhh-hhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 345566655 59999999999999999999999999976522 124689999999999999999999
Q ss_pred ccccccC--CcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCee
Q psy14556 868 LGSVSEE--GYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVV 945 (1181)
Q Consensus 868 ~g~~~d~--~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~v 945 (1181)
+++..+. +.+|||+|||..|.+...=.. ...+.+.+++.|+++++.||+|||.+|||||||||+|+||+. +|++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d---~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~-~g~V 249 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPD---KPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSS-DGTV 249 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCC---cccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcC-CCcE
Confidence 9999775 689999999998877654332 222789999999999999999999999999999999999998 8999
Q ss_pred eeecCCcccccccCC-----CCCccccCCccccCchhhccCC--CCCCCccccccCCCccccccccccchhHHHHHHHHH
Q psy14556 946 KISDFGTSKRLAGLC-----PSAETFTGTLQYMAPEVIDKGQ--RGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQ 1018 (1181)
Q Consensus 946 KLiDFGlAk~l~~~~-----~~~~t~~GT~~Y~APEvl~gg~--~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyE 1018 (1181)
||+|||.+....... .......|||.|+|||...++. ...+..+|+ ||+|++||.
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~Di------------------WalGVTLYC 311 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDI------------------WALGVTLYC 311 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhh------------------hhhhhhHHH
Confidence 999999997663221 1223367999999999997643 223445555 999999999
Q ss_pred HHhCCCCCCCCCcccccCCCCCCCCC---CCCCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1019 LLVLTAALKKKTSRALVAPPQISRSV---SVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1019 LLTGk~PF~~~~~~~l~~~~~ip~~l---~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
|+.|+.||.+....++..++.-.... .+.....++.++.+.+.+||..|-...+....-+..
T Consensus 312 llfG~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 312 LLFGQLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT 376 (576)
T ss_pred hhhccCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence 99999999999887765544321111 224567788899999999999998755554444433
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=319.26 Aligned_cols=234 Identities=25% Similarity=0.352 Sum_probs=192.2
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.+||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+.+++||||++++
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 86 (291)
T cd05612 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGG 86 (291)
T ss_pred eeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCC
Confidence 369999999999999999999999999965422 23456889999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+++..... .....
T Consensus 87 ~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~-~~~~kl~Dfg~~~~~~~~---~~~~~ 159 (291)
T cd05612 87 ELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDK-EGHIKLTDFGFAKKLRDR---TWTLC 159 (291)
T ss_pred CHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC-CCCEEEEecCcchhccCC---ccccc
Confidence 999998743 35778888999999999999999999999999999999987 899999999999766432 23456
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCCC-CCCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQI-SRSVSV 1046 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~i-p~~l~~ 1046 (1181)
|++.|+|||++.+...+.+ .|+ ||+||++|+|++|+.||.+.+...+...... ....+.
T Consensus 160 gt~~y~aPE~~~~~~~~~~--~Di------------------wSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 219 (291)
T cd05612 160 GTPEYLAPEVIQSKGHNKA--VDW------------------WALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPR 219 (291)
T ss_pred CChhhcCHHHHcCCCCCch--hhH------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCc
Confidence 8999999999976544333 333 9999999999999999998776443221111 111222
Q ss_pred CCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
..+..+..++.+|+..+|.+|+..+
T Consensus 220 ~~~~~~~~li~~~l~~dp~~R~~~~ 244 (291)
T cd05612 220 HLDLYAKDLIKKLLVVDRTRRLGNM 244 (291)
T ss_pred cCCHHHHHHHHHHcCCCHHHccCCc
Confidence 3466788899999999999999743
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=321.04 Aligned_cols=239 Identities=24% Similarity=0.296 Sum_probs=192.6
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
+||+|+||.||+|++..+++.||+|.++... ....+.+..|..++..+ +||||+++++++...+.+++||||++||
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5999999999999999999999999997542 22345566777777654 8999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.............
T Consensus 82 ~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 82 DLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK-DGHIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECC-CCCEEEccCcCCeECCCCCCcccccc
Confidence 999888743 35788889999999999999999999999999999999987 89999999999976543333344567
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-CCCCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-ISRSVSV 1046 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-ip~~l~~ 1046 (1181)
||+.|+|||++.+..++..+|+ ||+||++|+|++|+.||.+.+...+..... .....+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~Dv--------------------wslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 217 (316)
T cd05592 158 GTPDYIAPEILKGQKYNESVDW--------------------WSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR 217 (316)
T ss_pred CCccccCHHHHcCCCCCCcccc--------------------hhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 9999999999976654444333 999999999999999999877654322111 1112233
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
..+..+..++.+|+..+|..|++..++.
T Consensus 218 ~~~~~~~~ll~~~l~~~P~~R~~~~~~l 245 (316)
T cd05592 218 WISKEAKDCLSKLFERDPTKRLGVDGDI 245 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHH
Confidence 4566778899999999999999865443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=321.09 Aligned_cols=240 Identities=24% Similarity=0.304 Sum_probs=193.3
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.||+|+||.||++++..+++.||+|++.+... .....+.+|+.+++.++||||+++++++...+.+|+||||+++|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 59999999999999999999999999975422 234567889999999999999999999999999999999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccc-cceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHG-QKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs-~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
|..++... ..+++..++.++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++.............
T Consensus 82 L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (325)
T cd05594 82 LFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK-DGHIKITDFGLCKEGIKDGATMKTFC 157 (325)
T ss_pred HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECC-CCCEEEecCCCCeecCCCCccccccc
Confidence 99888643 357889999999999999999997 79999999999999987 89999999999875433333334456
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-CCCCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-ISRSVSV 1046 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-ip~~l~~ 1046 (1181)
||+.|+|||++.++.++..+|+ ||+||++|+|++|+.||.+.+...+..... .....+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~Di--------------------wslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~ 217 (325)
T cd05594 158 GTPEYLAPEVLEDNDYGRAVDW--------------------WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR 217 (325)
T ss_pred CCcccCCHHHHccCCCCCcccc--------------------ccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence 9999999999976654444433 999999999999999998876544322111 1111223
Q ss_pred CCCcchHHhhccCCCCCCCCCch----hHHHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHI----SVNTNL 1075 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~----s~~~~~ 1075 (1181)
..+..+..++.+|+..+|..|+. ++.+.+
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il 250 (325)
T cd05594 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIM 250 (325)
T ss_pred CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHh
Confidence 45667888999999999999973 455543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=320.88 Aligned_cols=238 Identities=26% Similarity=0.384 Sum_probs=209.1
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCC---hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD---VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~---~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.||+|.||+|-+|.....|+.||||.+++....+ .-.+.+|++||+.|+||||+.+|++|+..+.+.|||||..+|.
T Consensus 60 tLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~Ge 139 (668)
T KOG0611|consen 60 TLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGE 139 (668)
T ss_pred HhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCcc
Confidence 6999999999999999999999999998776544 4458899999999999999999999999999999999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|++++... ..+++..+..+++||..|+.|+|.++++|||||.+|||+|. ++++||+|||++..+... ....+++|
T Consensus 140 LYDYiSer---~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~-N~NiKIADFGLSNly~~~-kfLqTFCG 214 (668)
T KOG0611|consen 140 LYDYISER---GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQ-NNNIKIADFGLSNLYADK-KFLQTFCG 214 (668)
T ss_pred HHHHHHHh---ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecC-CCCeeeeccchhhhhccc-cHHHHhcC
Confidence 99999854 46889999999999999999999999999999999999998 899999999999877643 45678999
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCCCCCCCCCCC
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQISRSVSVPG 1048 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~ip~~l~~~~ 1048 (1181)
++.|.+||++.| ....+..||. ||||++||.|+.|..||+|.+...++..+.-..-..++-
T Consensus 215 SPLYASPEIvNG-~PY~GPEVDs------------------WsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~ 275 (668)
T KOG0611|consen 215 SPLYASPEIVNG-TPYKGPEVDS------------------WSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET 275 (668)
T ss_pred CcccCCccccCC-CCCCCCccch------------------hhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC
Confidence 999999999965 4567788887 999999999999999999999988877766555555666
Q ss_pred CcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1049 PGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1049 p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
|..-.-++.-++..+|.+|-+.-+.
T Consensus 276 PSdA~gLIRwmLmVNP~RRATieDi 300 (668)
T KOG0611|consen 276 PSDASGLIRWMLMVNPERRATIEDI 300 (668)
T ss_pred CchHHHHHHHHHhcCcccchhHHHH
Confidence 6667777788888899988764443
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=321.75 Aligned_cols=238 Identities=22% Similarity=0.297 Sum_probs=190.3
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHH-HHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEI-KLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi-~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.||+|+||+||+|++..+++.||+|++.+... .....+..|. .+++.++||||+++++++.+.+..|+||||++++
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 59999999999999999999999999965421 2223444444 4567889999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|.+++... ..+.+..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.............
T Consensus 82 ~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~-~~~~kl~DfG~a~~~~~~~~~~~~~~ 157 (325)
T cd05602 82 ELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS-QGHIVLTDFGLCKENIEHNGTTSTFC 157 (325)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC-CCCEEEccCCCCcccccCCCCccccc
Confidence 999988743 35668888889999999999999999999999999999987 88999999999976543333344567
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCC-CCCCCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPP-QISRSVSV 1046 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~-~ip~~l~~ 1046 (1181)
||+.|+|||++.+..++..+|+ ||+||++|+|++|+.||.+.+...+.... ..+....+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~Di--------------------wslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 217 (325)
T cd05602 158 GTPEYLAPEVLHKQPYDRTVDW--------------------WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP 217 (325)
T ss_pred CCccccCHHHHcCCCCCCcccc--------------------ccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCC
Confidence 9999999999986654444333 99999999999999999987764432111 11222334
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
..+..+..++.+++.++|.+|+...+.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 218 NITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 567788889999999999999975543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PRK10791 peptidyl-prolyl cis-trans isomerase B (rotamase B); Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=291.35 Aligned_cols=148 Identities=30% Similarity=0.520 Sum_probs=127.8
Q ss_pred EEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCCCCCcCcc
Q psy14556 117 TNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFEDENFTL 196 (1181)
Q Consensus 117 vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~~dE~~~l 196 (1181)
|++.|+.|+|+|+||.+.||+||+||++|| +.|| |+|+.||||+|+|+|||||+..+.+. ..++.++.+|....
T Consensus 2 v~~~T~~G~i~ieL~~~~aP~t~~nF~~L~--~~g~-Yd~~~fhRvi~~f~iQgGd~~~~~~~---~~~~~~~~~e~~~~ 75 (164)
T PRK10791 2 VTFHTNHGDIVIKTFDDKAPETVKNFLDYC--REGF-YNNTIFHRVINGFMIQGGGFEPGMKQ---KATKEPIKNEANNG 75 (164)
T ss_pred EEEEEccccEEEEEeCCCCcHHHHHHHHHH--hcCC-cCCcEEEEEecCcEEEeCCcCCCCCc---CCCCCCcCCccccc
Confidence 568999999999999999999999999999 7888 99999999999999999997644332 22466777775544
Q ss_pred ccCCCceEEeecCC-CCCCcceEEEEcCCCCCCC-------C-CCeEEEEEEcCHHHHHHHHhCCCC-----CCCcccce
Q psy14556 197 KHTGPGILSMANAG-PNTNGSQFFITTVKTAWLD-------N-RHVVFGSVVEGLDVVKKLESMGSQ-----SGKTSKKI 262 (1181)
Q Consensus 197 ~h~~~G~Lsma~~g-~nt~gSQFfItl~~~p~LD-------g-~~vVFGrVieG~dVL~kI~~~~t~-----~g~P~~~V 262 (1181)
.|+.+|+||||+.+ ++++||||||+++++++|| + +|+|||+|++|||||++|+++.+. +++|..+|
T Consensus 76 ~~~~~G~lsma~~~~p~s~~SQFfI~~~~~~~ld~~~~~~d~~~~tvFG~V~eG~dvl~~I~~~~~~~~~~~~~~P~~~v 155 (164)
T PRK10791 76 LKNTRGTLAMARTQAPHSATAQFFINVVDNDFLNFSGESLQGWGYCVFAEVVEGMDVVDKIKGVATGRSGMHQDVPKEDV 155 (164)
T ss_pred ccCCCcEEEECCCCCcCCccceEEEEecCchhhcccccccCCCCccEEEEEecCHHHHHHHHcCcCCCCCccCCCcCCCe
Confidence 45579999999875 9999999999999998886 3 799999999999999999999884 36899999
Q ss_pred EEeeeccc
Q psy14556 263 VVANSDSH 270 (1181)
Q Consensus 263 ~I~~cGvl 270 (1181)
+|.+|.+.
T Consensus 156 ~I~~~~i~ 163 (164)
T PRK10791 156 IIESVTVS 163 (164)
T ss_pred EEEEEEEe
Confidence 99999654
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=323.93 Aligned_cols=237 Identities=25% Similarity=0.345 Sum_probs=192.7
Q ss_pred eecccCceEEEEEEEc---CCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCC
Q psy14556 812 ELGKGSYGVVYAAREL---DRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~---~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
+||+|+||.||++++. .+++.||+|++..... .....+.+|+.++++++||||+++++++.+++.+|+||||+++
T Consensus 3 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 82 (318)
T cd05582 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRG 82 (318)
T ss_pred eeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCC
Confidence 6999999999999863 5788999999975432 2345678899999999999999999999999999999999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccc
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF 966 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~ 966 (1181)
++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++............
T Consensus 83 ~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~-~~~~kL~Dfg~~~~~~~~~~~~~~~ 158 (318)
T cd05582 83 GDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDE-EGHIKLTDFGLSKESIDHEKKAYSF 158 (318)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECC-CCcEEEeeccCCcccCCCCCceecc
Confidence 9999988643 35789999999999999999999999999999999999987 8899999999987655433334456
Q ss_pred cCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-CCCCCC
Q psy14556 967 TGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-ISRSVS 1045 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-ip~~l~ 1045 (1181)
.|++.|+|||++.+...+.+. |+ ||+||++|+|++|+.||.+.+......... .....+
T Consensus 159 ~g~~~y~aPE~~~~~~~~~~~--Di------------------wslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p 218 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHTQSA--DW------------------WSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP 218 (318)
T ss_pred cCChhhcCHHHHcCCCCCCcc--ce------------------eccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 799999999999765544433 33 999999999999999998876544321111 111223
Q ss_pred CCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1046 VPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1046 ~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
...+..+..++.+|+..+|..||+..+
T Consensus 219 ~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 219 QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 345677888999999999999998644
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=311.18 Aligned_cols=236 Identities=22% Similarity=0.304 Sum_probs=191.8
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
..||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.++++++|+||+++++++.+.+..++||||+++|
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g 85 (285)
T cd05631 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGG 85 (285)
T ss_pred EEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCC
Confidence 469999999999999999999999999865432 22345788999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|.+++... ....+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||++...... .......
T Consensus 86 ~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~-~~~~kl~Dfg~~~~~~~~-~~~~~~~ 162 (285)
T cd05631 86 DLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDD-RGHIRISDLGLAVQIPEG-ETVRGRV 162 (285)
T ss_pred cHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECC-CCCEEEeeCCCcEEcCCC-CeecCCC
Confidence 998887643 3345788999999999999999999999999999999999987 889999999999765432 2223456
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc----ccCC-CCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA----LVAP-PQISR 1042 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~----l~~~-~~ip~ 1042 (1181)
||..|+|||++.+..++...|+ ||+||++|+|++|+.||.+..... +... .....
T Consensus 163 g~~~y~aPE~~~~~~~~~~~Dv--------------------wslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 222 (285)
T cd05631 163 GTVGYMAPEVINNEKYTFSPDW--------------------WGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE 222 (285)
T ss_pred CCCCccCHhhhcCCCCCcccCc--------------------hhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccc
Confidence 8999999999987655444433 999999999999999998765422 1111 11112
Q ss_pred CCCCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1043 SVSVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1043 ~l~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
..+...+..+..++.+|+..+|..|+.
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~ 249 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLG 249 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcC
Confidence 233456778888999999999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=318.00 Aligned_cols=236 Identities=25% Similarity=0.346 Sum_probs=186.4
Q ss_pred eeecccCceEEEEEEEc---CCCeEEEEEEecCCC----CCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEe
Q psy14556 811 IELGKGSYGVVYAAREL---DRQVKLAIKEIPEKN----LGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~---~tg~~VAIKii~~~~----~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmE 882 (1181)
++||+|+||.||++++. .+++.||+|++.+.. ....+.+.+|+.+++.+ +||||+++++++...+.+++|||
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (332)
T cd05614 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILD 85 (332)
T ss_pred EEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEe
Confidence 47999999999999864 478899999996532 22345688899999999 59999999999999999999999
Q ss_pred ecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC-C
Q psy14556 883 QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC-P 961 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~-~ 961 (1181)
|+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++...... .
T Consensus 86 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~-~~~~kl~DfG~~~~~~~~~~~ 161 (332)
T cd05614 86 YVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDS-EGHVVLTDFGLSKEFLSEEKE 161 (332)
T ss_pred CCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECC-CCCEEEeeCcCCccccccCCC
Confidence 99999999988743 35778899999999999999999999999999999999988 8899999999997654322 2
Q ss_pred CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc----ccC-
Q psy14556 962 SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA----LVA- 1036 (1181)
Q Consensus 962 ~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~----l~~- 1036 (1181)
......||+.|+|||++.+.. .++...|+ ||+||++|+|++|+.||....... +..
T Consensus 162 ~~~~~~gt~~y~aPE~~~~~~-~~~~~~Di------------------wslG~il~elltg~~pf~~~~~~~~~~~~~~~ 222 (332)
T cd05614 162 RTYSFCGTIEYMAPEIIRGKG-GHGKAVDW------------------WSLGILIFELLTGASPFTLEGERNTQSEVSRR 222 (332)
T ss_pred ccccccCCccccCHHHhcCCC-CCCCcccc------------------ccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH
Confidence 233456999999999996432 22333343 999999999999999997543321 110
Q ss_pred CCCCCCCCCCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1037 PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1037 ~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
........+...+..+..++.+|+..+|.+|+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~ 255 (332)
T cd05614 223 ILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLG 255 (332)
T ss_pred HhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCC
Confidence 011112233346677888999999999999995
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=309.15 Aligned_cols=237 Identities=24% Similarity=0.312 Sum_probs=192.0
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEecCCCCC---ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLG---DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 813 IG~G~fG~VYka~d~~tg~~VAIKii~~~~~~---~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
||+|+||+||++.+..+++.||+|.+...... ..+.+..|+.+++.++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999999999999999999654322 235678899999999999999999999999999999999999999
Q ss_pred ccchhcc-cCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 890 STLLRVK-WGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 890 ~dlL~~~-~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
..++... .....+++..++.++.||+.||+|||++||+||||||+||+++. ++.+||+|||++..+...........|
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~g 159 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDN-DGNVRISDLGLAVELKDGQSKTKGYAG 159 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC-CCCEEEeeCccceecCCCCccccccCC
Confidence 8877432 13346789999999999999999999999999999999999987 889999999999776544333444578
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc----ccCC-CCCCCC
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA----LVAP-PQISRS 1043 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~----l~~~-~~ip~~ 1043 (1181)
|+.|+|||++.+..++..+|+ ||+|+++|+|++|+.||....... +... ...+..
T Consensus 160 ~~~y~aPE~~~~~~~~~~~Dv--------------------wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 219 (280)
T cd05608 160 TPGFMAPELLQGEEYDFSVDY--------------------FALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVT 219 (280)
T ss_pred CcCccCHHHhcCCCCCccccH--------------------HHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCC
Confidence 999999999987655444433 999999999999999998754321 1111 111122
Q ss_pred CCCCCCcchHHhhccCCCCCCCCCchh
Q psy14556 1044 VSVPGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1044 l~~~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
.+...+..+..++.+|+..+|..|+.+
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (280)
T cd05608 220 YPDKFSPASKSFCEALLAKDPEKRLGF 246 (280)
T ss_pred CcccCCHHHHHHHHHHhcCCHHHhcCC
Confidence 234567788899999999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=318.16 Aligned_cols=239 Identities=23% Similarity=0.290 Sum_probs=192.8
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
+||+|+||.||+|++..+++.||+|.+++.. ....+.+..|..++..+ +||||+++++++.+.+.+|+||||++++
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 81 (316)
T cd05620 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence 5999999999999999999999999997542 23345677788888764 8999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|..++... ..+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+++.............
T Consensus 82 ~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 82 DLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDR-DGHIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC-CCCEEeCccCCCeecccCCCceeccC
Confidence 999888743 35678889999999999999999999999999999999988 88999999999875433223344567
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCCCC-CCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQIS-RSVSV 1046 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~ip-~~l~~ 1046 (1181)
||+.|+|||++.+..++..+|+ ||+||++|+|++|+.||.+.+...+....... ...+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~Di--------------------wslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 217 (316)
T cd05620 158 GTPDYIAPEILQGLKYTFSVDW--------------------WSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR 217 (316)
T ss_pred CCcCccCHHHHcCCCCCcccch--------------------hhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 9999999999986654444333 99999999999999999987765433221111 11222
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
..+..+..++.+|+..+|.+|+...++.
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~~~~~~~ 245 (316)
T cd05620 218 WITKESKDILEKLFERDPTRRLGVVGNI 245 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHH
Confidence 3566788899999999999999865543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=320.05 Aligned_cols=240 Identities=25% Similarity=0.317 Sum_probs=191.0
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
++||+|+||+||+|++..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+.+|+||||+++|
T Consensus 7 ~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g 86 (364)
T cd05599 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGG 86 (364)
T ss_pred EEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCc
Confidence 46999999999999999999999999996542 223456788999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC------
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP------ 961 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~------ 961 (1181)
+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..+.....
T Consensus 87 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~ 162 (364)
T cd05599 87 DMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDA-KGHIKLSDFGLCTGLKKSHRTEFYRI 162 (364)
T ss_pred HHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC-CCCEEEeecccceecccccccccccc
Confidence 999998743 35789999999999999999999999999999999999988 89999999999875432110
Q ss_pred --------------------------------CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchh
Q psy14556 962 --------------------------------SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKIN 1009 (1181)
Q Consensus 962 --------------------------------~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~D 1009 (1181)
......||+.|+|||++.+..++ ..+|+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~Di------------------ 222 (364)
T cd05599 163 LSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN--KECDW------------------ 222 (364)
T ss_pred ccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC--Ceeee------------------
Confidence 01124589999999999765443 33444
Q ss_pred HHHHHHHHHHHhCCCCCCCCCcccccC-----CCCCCCCCCCCCCcchHHhhccCCCCCCCCCch--hHHHHH
Q psy14556 1010 VFLCVIISQLLVLTAALKKKTSRALVA-----PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHI--SVNTNL 1075 (1181)
Q Consensus 1010 wSLGvILyELLTGk~PF~~~~~~~l~~-----~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~--s~~~~~ 1075 (1181)
||+||++|+|++|..||.+.+...... ...+........+..+..++.+++. +|..|+. ++.+++
T Consensus 223 wSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll 294 (364)
T cd05599 223 WSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIK 294 (364)
T ss_pred ecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHh
Confidence 999999999999999999877543211 1111111122456677778888885 8999997 455543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=318.82 Aligned_cols=237 Identities=26% Similarity=0.301 Sum_probs=192.7
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
+||+|+||.||+|++..+++.||+|++.+.. ....+.+..|..++..+ +||||+++++++.+.+.+|+||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 5999999999999999999999999996542 23356677888888876 7999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||+++.............
T Consensus 82 ~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~-~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 82 DLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDH-EGHCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred hHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECC-CCcEEEeeCCCCeecCcCCCcccccc
Confidence 999888743 35778999999999999999999999999999999999988 89999999999876433333344567
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCCC-CCCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQI-SRSVSV 1046 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~i-p~~l~~ 1046 (1181)
||+.|+|||++.+..++..+|+ ||+||++|+|++|+.||.+.+...+.....- ....+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~Di--------------------wslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 217 (320)
T cd05590 158 GTPDYIAPEILQEMLYGPSVDW--------------------WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT 217 (320)
T ss_pred cCccccCHHHHcCCCCCCccch--------------------hhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence 9999999999976544443333 9999999999999999998876553221111 111223
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
..+..+..++.+|+..+|..|+..++
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 218 WLSQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 45677888999999999999998643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=320.57 Aligned_cols=234 Identities=24% Similarity=0.318 Sum_probs=185.7
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhc---CCCCeeeEccccccCCcEEEEEeecCC
Q psy14556 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQL---RHRNIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 813 IG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L---~HPNIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
||+|+||+||+|++..+++.||+|++.+... ........|..++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999999999999999965422 1233455677777665 699999999999999999999999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccc
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF 966 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~ 966 (1181)
|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++............
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~-~~~~kl~Dfg~a~~~~~~~~~~~~~ 156 (330)
T cd05586 81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDA-TGHIALCDFGLSKANLTDNKTTNTF 156 (330)
T ss_pred ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC-CCCEEEecCCcCcCCCCCCCCccCc
Confidence 9999888743 35788999999999999999999999999999999999988 8899999999987644333334456
Q ss_pred cCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCCCCC--CC
Q psy14556 967 TGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQISR--SV 1044 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~ip~--~l 1044 (1181)
.||+.|+|||++.+.. .+....|+ ||+||++|+|++|+.||.+.+...+........ ..
T Consensus 157 ~gt~~y~aPE~~~~~~-~~~~~~Dv------------------wslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~ 217 (330)
T cd05586 157 CGTTEYLAPEVLLDEK-GYTKHVDF------------------WSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFP 217 (330)
T ss_pred cCCccccCHHHHcCCC-CCCCccce------------------eccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 7999999999996432 23333444 999999999999999999877655322211111 11
Q ss_pred CCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1045 SVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1045 ~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
....+..+..++.+|+..+|..|+.
T Consensus 218 ~~~~~~~~~~li~~~L~~~P~~R~~ 242 (330)
T cd05586 218 KNVLSDEGRQFVKGLLNRNPQHRLG 242 (330)
T ss_pred CccCCHHHHHHHHHHcCCCHHHCCC
Confidence 1235667788999999999999985
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=317.81 Aligned_cols=245 Identities=26% Similarity=0.370 Sum_probs=205.7
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC-hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD-VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~-~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.++||.|.-++||+|+...+++.||||++..+.... .+.+.+|+..|+.++||||++++..|..+..+|+||.||.+|+
T Consensus 31 ~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS 110 (516)
T KOG0582|consen 31 QEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGS 110 (516)
T ss_pred EEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCc
Confidence 347999999999999999999999999997665443 5889999999999999999999999999999999999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCC----c
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA----E 964 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~----~ 964 (1181)
+.++++.. -+..++|..+..|++++++||.|||.+|.||||||+.||||+. +|.+||+|||.+..+-...... .
T Consensus 111 ~ldIik~~-~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~-dG~VkLadFgvsa~l~~~G~R~~~rf~ 188 (516)
T KOG0582|consen 111 LLDIIKTY-YPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDS-DGTVKLADFGVSASLFDSGDRQVTRFN 188 (516)
T ss_pred HHHHHHHH-ccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcC-CCcEEEcCceeeeeecccCceeeEeec
Confidence 99999876 4556899999999999999999999999999999999999998 9999999999876554332221 4
Q ss_pred cccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc-----cCCC-
Q psy14556 965 TFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL-----VAPP- 1038 (1181)
Q Consensus 965 t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l-----~~~~- 1038 (1181)
++.||+.|||||++.....+|..+.|+ ||||++..||.+|..||....+..+ ...+
T Consensus 189 tfvgtp~wmAPEvl~q~~~GYdfKaDI------------------wSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp 250 (516)
T KOG0582|consen 189 TFVGTPCWMAPEVLMQQLHGYDFKADI------------------WSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPP 250 (516)
T ss_pred cccCcccccChHHhhhcccCccchhhh------------------hhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCC
Confidence 568999999999987776777777766 9999999999999999998886552 1111
Q ss_pred -----CCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1039 -----QISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1039 -----~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
.++..........+..++..|+.+||.+||+..+++
T Consensus 251 ~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLl 291 (516)
T KOG0582|consen 251 TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLL 291 (516)
T ss_pred CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 111222223344677899999999999999876663
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=320.88 Aligned_cols=231 Identities=23% Similarity=0.301 Sum_probs=182.4
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
++||+|+||.||++.+..+++.||+|++.+.. ....+.+.+|+.++++++||||+++++++.+.+.+|+||||+++|
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg 86 (377)
T cd05629 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGG 86 (377)
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCC
Confidence 47999999999999999999999999986532 223466889999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC------
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP------ 961 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~------ 961 (1181)
+|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++. ++.+||+|||+++.+.....
T Consensus 87 ~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~ 162 (377)
T cd05629 87 DLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDR-GGHIKLSDFGLSTGFHKQHDSAYYQK 162 (377)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC-CCCEEEeecccccccccccccccccc
Confidence 999998743 35778889999999999999999999999999999999987 89999999999863321000
Q ss_pred -----------------------------------------CCccccCCccccCchhhccCCCCCCCccccccCCCcccc
Q psy14556 962 -----------------------------------------SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCR 1000 (1181)
Q Consensus 962 -----------------------------------------~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~ 1000 (1181)
......||+.|+|||++.+..++. .+|+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~Di--------- 231 (377)
T cd05629 163 LLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ--ECDW--------- 231 (377)
T ss_pred cccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCC--ceee---------
Confidence 001246899999999997665443 3444
Q ss_pred ccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC-------CCCCCCCCCCCCCcchHHhhccCCCCCCCCCc
Q psy14556 1001 IEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA-------PPQISRSVSVPGPGGINSSSSAPVTPTPHSRH 1068 (1181)
Q Consensus 1001 i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~-------~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp 1068 (1181)
||+||++|||++|..||.+.+...... ...++. ....+..+..++.+++. +|..|.
T Consensus 232 ---------wSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~dli~~lL~-~~~~r~ 294 (377)
T cd05629 232 ---------WSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPD--DIHLSVEAEDLIRRLIT-NAENRL 294 (377)
T ss_pred ---------EecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCC--CCCCCHHHHHHHHHHhc-CHhhcC
Confidence 999999999999999998876543211 111111 11244566778888886 666663
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=316.71 Aligned_cols=235 Identities=26% Similarity=0.310 Sum_probs=192.3
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.||+|+||+||+|++..+++.||+|++++.. ....+.+.+|..++..+ +||||+++++++.+.+.+|+||||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5999999999999999999999999997542 23356678899999888 7999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|..++... ..+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++.............
T Consensus 82 ~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 82 DLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDS-EGHIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECC-CCcEEecccCCCeecCcCCCccccee
Confidence 999888743 35789999999999999999999999999999999999988 89999999999875333223334456
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-CCCCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-ISRSVSV 1046 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-ip~~l~~ 1046 (1181)
|++.|+|||++.+..++.++|+ ||+||++|+|++|+.||.+.+...+..... .....+.
T Consensus 158 g~~~y~aPE~~~~~~~~~~~Di--------------------wslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~ 217 (318)
T cd05570 158 GTPDYIAPEILSYQPYGPAVDW--------------------WALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR 217 (318)
T ss_pred cCccccCHHHhcCCCCCcchhh--------------------hhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 8999999999976654444333 999999999999999998876544322111 1111233
Q ss_pred CCCcchHHhhccCCCCCCCCCchh
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
..+..+..++.+|+..+|..|++.
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~s~ 241 (318)
T cd05570 218 WLSKEAKSILKSFLTKNPEKRLGC 241 (318)
T ss_pred cCCHHHHHHHHHHccCCHHHcCCC
Confidence 467778899999999999999986
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=318.15 Aligned_cols=234 Identities=25% Similarity=0.290 Sum_probs=190.8
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
+||+|+||.||+|++..+++.||+|++.+.. ....+.+..|..++..+ +||||+++++++.+.+.+|+||||++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 5999999999999999999999999997542 23345677889988866 8999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..............
T Consensus 82 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 82 DLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDA-EGHCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC-CCCEEEeecccceecccCCccccccc
Confidence 999888743 35778889999999999999999999999999999999988 89999999999876443333344566
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCCCC-CCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQIS-RSVSV 1046 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~ip-~~l~~ 1046 (1181)
||+.|+|||++.+..++..+|+ ||+||++|+|++|+.||.+.+...+....... ...+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~Dv--------------------wslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~ 217 (321)
T cd05591 158 GTPDYIAPEILQELEYGPSVDW--------------------WALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV 217 (321)
T ss_pred cCccccCHHHHcCCCCCCccce--------------------echhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 9999999999976554444333 99999999999999999988765543221111 11223
Q ss_pred CCCcchHHhhccCCCCCCCCCch
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
..+..+..++.+|+.++|..|+.
T Consensus 218 ~~~~~~~~ll~~~L~~dp~~R~~ 240 (321)
T cd05591 218 WLSKEAVSILKAFMTKNPNKRLG 240 (321)
T ss_pred CCCHHHHHHHHHHhccCHHHcCC
Confidence 35677888999999999999994
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=323.77 Aligned_cols=239 Identities=28% Similarity=0.383 Sum_probs=203.6
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
++||+|+||.||+|.+..+++.||+|++...... ..+.+++|+.+|.+++++||.++|+.+..+..+|++||||.||++
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv 98 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV 98 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence 4699999999999999999999999999766543 478899999999999999999999999999999999999999999
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT 969 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT 969 (1181)
.++++.. ..+.+..+..++++++.||.|||.++.+|||||+.|||+.. +|.+||+|||.+..+........+++||
T Consensus 99 ~~lL~~~---~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~-~g~vkl~DfgVa~ql~~~~~rr~tfvGT 174 (467)
T KOG0201|consen 99 LDLLKSG---NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSE-SGDVKLADFGVAGQLTNTVKRRKTFVGT 174 (467)
T ss_pred hhhhccC---CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEec-cCcEEEEecceeeeeechhhcccccccc
Confidence 9999854 23467777789999999999999999999999999999998 6999999999999888766666889999
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC--CCCCCCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA--PPQISRSVSVP 1047 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~--~~~ip~~l~~~ 1047 (1181)
+.|||||++.+..+ ....|+ ||||++.+||++|.+||....+..... +...|..+.-.
T Consensus 175 PfwMAPEVI~~~~Y--~~KADI------------------WSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~ 234 (467)
T KOG0201|consen 175 PFWMAPEVIKQSGY--DTKADI------------------WSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGD 234 (467)
T ss_pred ccccchhhhccccc--cchhhh------------------hhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccc
Confidence 99999999985444 333333 999999999999999999988755322 11133333336
Q ss_pred CCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1048 GPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1048 ~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
....+...+..|+.++|..||+...+
T Consensus 235 ~S~~~kEFV~~CL~k~P~~RpsA~~L 260 (467)
T KOG0201|consen 235 FSPPFKEFVEACLDKNPEFRPSAKEL 260 (467)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHH
Confidence 67778889999999999999985555
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=316.98 Aligned_cols=235 Identities=24% Similarity=0.281 Sum_probs=186.0
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHH-HHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIK-LHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~-IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
+||+|+||+||+|++..+++.||+|++.+... .....+..|.. +++.++||||+++++++...+..|+||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 59999999999999999999999999965422 22344555554 567799999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.............
T Consensus 82 ~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~-~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (325)
T cd05604 82 ELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDS-QGHVVLTDFGLCKEGIAQSDTTTTFC 157 (325)
T ss_pred CHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC-CCCEEEeecCCcccCCCCCCCccccc
Confidence 998888643 36788999999999999999999999999999999999988 89999999999875433333344567
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-CCCCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-ISRSVSV 1046 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-ip~~l~~ 1046 (1181)
||+.|+|||++.+..++..+|+ ||+||++|+|++|..||...+...+..... ......+
T Consensus 158 gt~~y~aPE~~~~~~~~~~~Dv--------------------wslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~ 217 (325)
T cd05604 158 GTPEYLAPEVIRKQPYDNTVDW--------------------WCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRP 217 (325)
T ss_pred CChhhCCHHHHcCCCCCCcCcc--------------------ccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCC
Confidence 9999999999987655444433 999999999999999999876544322111 1112223
Q ss_pred CCCcchHHhhccCCCCCCCCCchh
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
..+..+..++.+++.++|.+||..
T Consensus 218 ~~~~~~~~ll~~ll~~~p~~R~~~ 241 (325)
T cd05604 218 GASLTAWSILEELLEKDRQRRLGA 241 (325)
T ss_pred CCCHHHHHHHHHHhccCHHhcCCC
Confidence 455666677888888888888764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=322.33 Aligned_cols=237 Identities=25% Similarity=0.325 Sum_probs=191.3
Q ss_pred cccCceeecccCceEEEEEEEcCCC-eEEEEEEecCCC---CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEE
Q psy14556 806 FALNRIELGKGSYGVVYAARELDRQ-VKLAIKEIPEKN---LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFM 881 (1181)
Q Consensus 806 ~~l~~~kIG~G~fG~VYka~d~~tg-~~VAIKii~~~~---~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVm 881 (1181)
|... .+||+|+||.||+|.+..++ ..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 32 y~~~-~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 110 (340)
T PTZ00426 32 FNFI-RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL 110 (340)
T ss_pred cEEE-EEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence 4443 47999999999999876654 689999986432 233567889999999999999999999999999999999
Q ss_pred eecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC
Q psy14556 882 EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP 961 (1181)
Q Consensus 882 Ey~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~ 961 (1181)
||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 111 Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~-~~~ikL~DFG~a~~~~~--- 183 (340)
T PTZ00426 111 EFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDK-DGFIKMTDFGFAKVVDT--- 183 (340)
T ss_pred eCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECC-CCCEEEecCCCCeecCC---
Confidence 999999999999743 35788899999999999999999999999999999999987 89999999999976543
Q ss_pred CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-C
Q psy14556 962 SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-I 1040 (1181)
Q Consensus 962 ~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-i 1040 (1181)
......||+.|+|||++.+..++..+| + ||+||++|+|++|..||.+.+...+..... .
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~D--i------------------wSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~ 243 (340)
T PTZ00426 184 RTYTLCGTPEYIAPEILLNVGHGKAAD--W------------------WTLGIFIYEILVGCPPFYANEPLLIYQKILEG 243 (340)
T ss_pred CcceecCChhhcCHHHHhCCCCCcccc--c------------------cchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC
Confidence 233457999999999997655443333 3 999999999999999999877643221111 1
Q ss_pred CCCCCCCCCcchHHhhccCCCCCCCCCchh
Q psy14556 1041 SRSVSVPGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1041 p~~l~~~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
....+...+..+..++.+|+..+|..|+..
T Consensus 244 ~~~~p~~~~~~~~~li~~~l~~dp~~R~~~ 273 (340)
T PTZ00426 244 IIYFPKFLDNNCKHLMKKLLSHDLTKRYGN 273 (340)
T ss_pred CCCCCCCCCHHHHHHHHHHcccCHHHcCCC
Confidence 111233456677889999999999999853
|
|
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=321.80 Aligned_cols=241 Identities=25% Similarity=0.370 Sum_probs=214.0
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEccccccCCc-EEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGY-FKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~-l~LVmEy~~gG 887 (1181)
+++|+|+||.+++++++..+..+++|.+...... ..+...+|+.++++++|||||.+.+.|.+++. .+|||+||+||
T Consensus 10 ~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg 89 (426)
T KOG0589|consen 10 RQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGG 89 (426)
T ss_pred hhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCC
Confidence 3699999999999999999999999999766443 35568899999999999999999999999888 99999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|.+.+...+ ...++++.++.|+.|++.|+.|||++.|+|||||+.|||++. ++.+||+|||+|+.+........+..
T Consensus 90 ~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk-~~~VkLgDfGlaK~l~~~~~~a~tvv 167 (426)
T KOG0589|consen 90 DLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTK-DKKVKLGDFGLAKILNPEDSLASTVV 167 (426)
T ss_pred CHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccc-cCceeecchhhhhhcCCchhhhheec
Confidence 9999998763 567889999999999999999999999999999999999998 78889999999999988766777889
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC--CCCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ--ISRSVS 1045 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~--ip~~l~ 1045 (1181)
||+.||.||++.+.++++++|+ |||||++|||++-+++|.+.+...++.++. .-.+++
T Consensus 168 GTp~YmcPEil~d~pYn~KSDi--------------------WsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp 227 (426)
T KOG0589|consen 168 GTPYYMCPEILSDIPYNEKSDI--------------------WSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP 227 (426)
T ss_pred CCCcccCHHHhCCCCCCccCcc--------------------hhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC
Confidence 9999999999998777766666 999999999999999999999988765444 334556
Q ss_pred CCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1046 VPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1046 ~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
......+..++..++.++|..||...+.
T Consensus 228 ~~ys~el~~lv~~~l~~~P~~RPsa~~L 255 (426)
T KOG0589|consen 228 SMYSSELRSLVKSMLRKNPEHRPSALEL 255 (426)
T ss_pred ccccHHHHHHHHHHhhcCCccCCCHHHH
Confidence 6778889999999999999999975555
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=316.86 Aligned_cols=241 Identities=25% Similarity=0.336 Sum_probs=196.5
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.+||+|+||+||+|++..+++.||+|++.... ....+.+.+|+.++..++||||+++++++.+.+..++||||++++
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (350)
T cd05573 7 KVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGG 86 (350)
T ss_pred EEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCC
Confidence 47999999999999999999999999997542 234567889999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC-------
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC------- 960 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~------- 960 (1181)
+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.......
T Consensus 87 ~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~ 162 (350)
T cd05573 87 DLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDA-DGHIKLADFGLCKKMNKAKDREYYLN 162 (350)
T ss_pred CHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC-CCCEEeecCCCCccCcccCccccccc
Confidence 999999754 45778899999999999999999999999999999999988 8999999999997665432
Q ss_pred ----------------------CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHH
Q psy14556 961 ----------------------PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQ 1018 (1181)
Q Consensus 961 ----------------------~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyE 1018 (1181)
.......||+.|+|||++.+..++... |+ ||+||++|+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~--Di------------------wSlG~il~e 222 (350)
T cd05573 163 DSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLEC--DW------------------WSLGVILYE 222 (350)
T ss_pred ccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCce--ee------------------Eecchhhhh
Confidence 122335689999999999876444443 33 999999999
Q ss_pred HHhCCCCCCCCCcccccCC-----CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHH
Q psy14556 1019 LLVLTAALKKKTSRALVAP-----PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLV 1076 (1181)
Q Consensus 1019 LLTGk~PF~~~~~~~l~~~-----~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~ 1076 (1181)
|++|+.||...+....... ..+........+..+..++.+|+. +|..|+.++.+.+.
T Consensus 223 ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 223 MLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred hccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 9999999998775432110 111111222357788889999997 99999997666554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=328.52 Aligned_cols=238 Identities=26% Similarity=0.343 Sum_probs=203.7
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
-||.|+-|.|-+|++..||+.+|||++.+.. ......+.+|+.||+.+.||||+++|+++++..++|+|.||++||.
T Consensus 19 TLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGE 98 (786)
T KOG0588|consen 19 TLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGE 98 (786)
T ss_pred cccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCch
Confidence 4999999999999999999999999997662 2234568999999999999999999999999999999999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|.+++-.+ .++++..+.+++.||+.|+.|+|..+|+||||||+|+|||. .+++||+|||+|..-. +.....+.+|
T Consensus 99 LFdylv~k---G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~-~~nIKIADFGMAsLe~-~gklLeTSCG 173 (786)
T KOG0588|consen 99 LFDYLVRK---GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDV-KNNIKIADFGMASLEV-PGKLLETSCG 173 (786)
T ss_pred hHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhc-ccCEeeeccceeeccc-CCccccccCC
Confidence 99999855 36778889999999999999999999999999999999998 6669999999997543 3456678899
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCCCCC-CCCCC
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQISR-SVSVP 1047 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~ip~-~l~~~ 1047 (1181)
+|.|.|||++.|.. ..+...|+ ||.|+|||.||||+.||++.+...+..+.+... .++..
T Consensus 174 SPHYA~PEIV~G~p-YdG~~sDV------------------WSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~ 234 (786)
T KOG0588|consen 174 SPHYAAPEIVSGRP-YDGRPSDV------------------WSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSN 234 (786)
T ss_pred CcccCCchhhcCCC-CCCCcccc------------------chhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCc
Confidence 99999999998654 44555555 999999999999999999998877755444332 23346
Q ss_pred CCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1048 GPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1048 ~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
++.....++.++++.||.+|.++.+-
T Consensus 235 Is~eaQdLLr~ml~VDp~~RiT~~eI 260 (786)
T KOG0588|consen 235 ISSEAQDLLRRMLDVDPSTRITTEEI 260 (786)
T ss_pred CCHHHHHHHHHHhccCccccccHHHH
Confidence 67778889999999999999875554
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=316.16 Aligned_cols=237 Identities=26% Similarity=0.289 Sum_probs=190.7
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhcCCC-CeeeEccccccCCcEEEEEeecCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQLRHR-NIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L~HP-NIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
..||+|+||.||+|++..+++.||+|++.+.. ....+.+..|..++..++|+ +|+++++++.+.+.+|+||||+++
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 85 (324)
T cd05587 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG 85 (324)
T ss_pred EEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCC
Confidence 36999999999999999999999999997542 23456788899999999765 688899999999999999999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccc
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF 966 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~ 966 (1181)
|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++.............
T Consensus 86 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~-~~~~kL~Dfg~~~~~~~~~~~~~~~ 161 (324)
T cd05587 86 GDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDA-EGHIKIADFGMCKENIFGGKTTRTF 161 (324)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcC-CCCEEEeecCcceecCCCCCceeee
Confidence 9999888743 35678899999999999999999999999999999999988 8999999999987543222333445
Q ss_pred cCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-CCCCCC
Q psy14556 967 TGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-ISRSVS 1045 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-ip~~l~ 1045 (1181)
.||+.|+|||++.+..++..+ |+ ||+||++|+|+||+.||.+.+...+..... .....+
T Consensus 162 ~gt~~y~aPE~~~~~~~~~~~--Di------------------wslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~ 221 (324)
T cd05587 162 CGTPDYIAPEIIAYQPYGKSV--DW------------------WAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP 221 (324)
T ss_pred cCCccccChhhhcCCCCCccc--ch------------------hhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 699999999999866544333 33 999999999999999999877654322111 111223
Q ss_pred CCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1046 VPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1046 ~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
...+..+..++.+|+.++|..|+...
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~ 247 (324)
T cd05587 222 KSLSKEAVSICKGLLTKHPAKRLGCG 247 (324)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCCC
Confidence 34566777899999999999999753
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=312.84 Aligned_cols=236 Identities=25% Similarity=0.310 Sum_probs=190.8
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEeecCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
.+||+|+||.||+|++..+++.||+|++.+... ...+.+..|..++..+ +||+|+++++++.+.+.+++||||+++
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 85 (323)
T cd05616 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNG 85 (323)
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCC
Confidence 369999999999999999999999999975432 2344567788888777 589999999999999999999999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccc
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF 966 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~ 966 (1181)
|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++............
T Consensus 86 g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~-~~~~kL~DfG~~~~~~~~~~~~~~~ 161 (323)
T cd05616 86 GDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS-EGHIKIADFGMCKENMWDGVTTKTF 161 (323)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECC-CCcEEEccCCCceecCCCCCccccC
Confidence 9999888643 35778899999999999999999999999999999999998 8999999999987544332333456
Q ss_pred cCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-CCCCCC
Q psy14556 967 TGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-ISRSVS 1045 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-ip~~l~ 1045 (1181)
.||+.|+|||++.+..++.++|+ ||+||++|+|++|+.||.+.+...+...+. .....+
T Consensus 162 ~gt~~y~aPE~~~~~~~~~~~Di--------------------wSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p 221 (323)
T cd05616 162 CGTPDYIAPEIIAYQPYGKSVDW--------------------WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP 221 (323)
T ss_pred CCChhhcCHHHhcCCCCCCccch--------------------hchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 79999999999986654444333 999999999999999999877654322111 111223
Q ss_pred CCCCcchHHhhccCCCCCCCCCchh
Q psy14556 1046 VPGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1046 ~~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
...+..+..++.+|+..+|.+|+..
T Consensus 222 ~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 222 KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 3456777889999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=315.82 Aligned_cols=234 Identities=23% Similarity=0.315 Sum_probs=188.3
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
+||+|+||.||+|++..+++.||+|++++... ...+.+.+|..++..+ +||||+++++++.+.+.+|+||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 59999999999999999999999999976432 2345688899999998 7999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|..++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++.............
T Consensus 82 ~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 82 DLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDA-EGHIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC-CCCEEECcCccccccccCCCcccccc
Confidence 998888643 35789999999999999999999999999999999999988 89999999999875433333344567
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc---------ccC-C
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA---------LVA-P 1037 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~---------l~~-~ 1037 (1181)
||+.|+|||++.+..++..+|+ ||+||++|+|++|+.||....... +.. .
T Consensus 158 gt~~y~aPE~~~~~~~~~~~Di--------------------wslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 217 (329)
T cd05588 158 GTPNYIAPEILRGEDYGFSVDW--------------------WALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI 217 (329)
T ss_pred CCccccCHHHHcCCCCCCccce--------------------echHHHHHHHHHCCCCcccccccccccccchHHHHHHH
Confidence 9999999999986654444333 999999999999999997432211 000 0
Q ss_pred CCCCCCCCCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1038 PQISRSVSVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1038 ~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
.......+...+..+..++.+|+..+|.+|+.
T Consensus 218 ~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~ 249 (329)
T cd05588 218 LEKQIRIPRSLSVKASSVLKGFLNKDPKERLG 249 (329)
T ss_pred HcCCCCCCCCCCHHHHHHHHHHhccCHHHcCC
Confidence 00111122345566788999999999999986
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=314.11 Aligned_cols=238 Identities=24% Similarity=0.300 Sum_probs=191.2
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHh-cCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQ-LRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~-L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.||+|+||+||+|++..+++.||+|+++... ....+....|..++.. ++||||+++++++.+.+.+++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 5999999999999999999999999997542 2334556778888876 49999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+++.............
T Consensus 82 ~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 82 DLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDT-DGHIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECC-CCCEEEccCCcceECCCCCCceeeec
Confidence 999998743 35678888999999999999999999999999999999988 88999999999875433223334456
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCCCC-CCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQIS-RSVSV 1046 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~ip-~~l~~ 1046 (1181)
||+.|+|||++.+..++..+ |+ ||+||++|+|++|+.||.+.+...+....... ...+.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~--Dv------------------wslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~ 217 (316)
T cd05619 158 GTPDYIAPEILLGQKYNTSV--DW------------------WSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR 217 (316)
T ss_pred CCccccCHHHHcCCCCCchh--hh------------------hhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence 89999999999765544333 33 99999999999999999987765543222111 11222
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
..+..+..++.+|+..+|..|+....+
T Consensus 218 ~~~~~~~~li~~~l~~~P~~R~~~~~~ 244 (316)
T cd05619 218 WLTREAKDILVKLFVREPERRLGVKGD 244 (316)
T ss_pred cCCHHHHHHHHHHhccCHhhcCCChHH
Confidence 356667889999999999999976433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=317.56 Aligned_cols=234 Identities=21% Similarity=0.277 Sum_probs=184.5
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.+||+|+||.||+|++..+++.||+|++.+.. ....+.+.+|+.++++++||||+++++.+.+++.+|+||||+++|
T Consensus 7 ~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g 86 (376)
T cd05598 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGG 86 (376)
T ss_pred EEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999999999999999996532 223566889999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC-------
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC------- 960 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~------- 960 (1181)
+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..+....
T Consensus 87 ~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~-~~~ikL~DFG~a~~~~~~~~~~~~~~ 162 (376)
T cd05598 87 DMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR-DGHIKLTDFGLCTGFRWTHDSKYYQK 162 (376)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECC-CCCEEEEeCCCCcccccccccccccc
Confidence 999999743 35678888999999999999999999999999999999987 8999999999975331000
Q ss_pred ------------------------------------CCCccccCCccccCchhhccCCCCCCCccccccCCCcccccccc
Q psy14556 961 ------------------------------------PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYK 1004 (1181)
Q Consensus 961 ------------------------------------~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~ 1004 (1181)
.......||+.|+|||++.+..++..+| +
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D--i------------- 227 (376)
T cd05598 163 GDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD--W------------- 227 (376)
T ss_pred ccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCccee--e-------------
Confidence 0011346999999999997665444433 3
Q ss_pred ccchhHHHHHHHHHHHhCCCCCCCCCcccccC-----CCCCCCCCCCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1005 KMKINVFLCVIISQLLVLTAALKKKTSRALVA-----PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1005 ~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~-----~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
||+||++|+|++|+.||.+....+... ............+..+..++.+++ .+|..|+.
T Consensus 228 -----wSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~ 291 (376)
T cd05598 228 -----WSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLG 291 (376)
T ss_pred -----eeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCC
Confidence 999999999999999999877543211 111111112234556666777654 59999984
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=315.75 Aligned_cols=240 Identities=22% Similarity=0.282 Sum_probs=185.9
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.+||+|+||+||+|++..+++.||+|++.+... ...+.+.+|+.++++++||||+++++++.+.+.+|+||||+++|
T Consensus 7 ~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg 86 (381)
T cd05626 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGG 86 (381)
T ss_pred EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCC
Confidence 369999999999999999999999999975432 23456889999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC-------
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC------- 960 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~------- 960 (1181)
+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.+....
T Consensus 87 ~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~-~~~~kL~DFGl~~~~~~~~~~~~~~~ 162 (381)
T cd05626 87 DMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDL-DGHIKLTDFGLCTGFRWTHNSKYYQK 162 (381)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECC-CCCEEEeeCcCCcccccccccccccc
Confidence 999998743 35778889999999999999999999999999999999987 8999999999975431100
Q ss_pred ----------------------------------------CCCccccCCccccCchhhccCCCCCCCccccccCCCcccc
Q psy14556 961 ----------------------------------------PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCR 1000 (1181)
Q Consensus 961 ----------------------------------------~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~ 1000 (1181)
.......||+.|+|||++.+..++.. +|+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~--~Di--------- 231 (381)
T cd05626 163 GSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL--CDW--------- 231 (381)
T ss_pred cccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc--cce---------
Confidence 00123469999999999976554433 444
Q ss_pred ccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC-----CCCCCCCCCCCCCcchHHhhcc--CCCCCCCCCchhHHH
Q psy14556 1001 IEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA-----PPQISRSVSVPGPGGINSSSSA--PVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1001 i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~-----~~~ip~~l~~~~p~~L~~li~r--~la~dPs~Rp~s~~~ 1073 (1181)
||+||++|||++|+.||...+...... ...+........+.....++.+ |...+|..|+...+.
T Consensus 232 ---------wSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 232 ---------WSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred ---------eehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 999999999999999998876543211 1111111112344555666666 556667778764444
Q ss_pred H
Q psy14556 1074 N 1074 (1181)
Q Consensus 1074 ~ 1074 (1181)
.
T Consensus 303 l 303 (381)
T cd05626 303 K 303 (381)
T ss_pred h
Confidence 3
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=314.06 Aligned_cols=236 Identities=25% Similarity=0.338 Sum_probs=186.2
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
+||+|+||.||+|++..+++.||+|++...... ..+.+.+|+.+++.++|+||+++++++.+.+.+++||||+++++|.
T Consensus 81 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 160 (353)
T PLN00034 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE 160 (353)
T ss_pred hccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccc
Confidence 699999999999999999999999999654332 2467889999999999999999999999999999999999999986
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCc
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL 970 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~ 970 (1181)
... ...+..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.+...........||.
T Consensus 161 ~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 232 (353)
T PLN00034 161 GTH-------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINS-AKNVKIADFGVSRILAQTMDPCNSSVGTI 232 (353)
T ss_pred ccc-------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC-CCCEEEcccccceecccccccccccccCc
Confidence 543 2356778889999999999999999999999999999988 89999999999987654333334457999
Q ss_pred cccCchhhccCC---CCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc---cCC--CCCCC
Q psy14556 971 QYMAPEVIDKGQ---RGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL---VAP--PQISR 1042 (1181)
Q Consensus 971 ~Y~APEvl~gg~---~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l---~~~--~~ip~ 1042 (1181)
.|+|||++.... ...+...|+ |||||++|||++|+.||......+. ... .....
T Consensus 233 ~y~aPE~~~~~~~~~~~~~~~~Dv------------------wslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 294 (353)
T PLN00034 233 AYMSPERINTDLNHGAYDGYAGDI------------------WSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPP 294 (353)
T ss_pred cccCccccccccccCcCCCcchhH------------------HHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCC
Confidence 999999885321 111122333 9999999999999999985433221 100 11122
Q ss_pred CCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1043 SVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1043 ~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
......+..+..++.+|+..+|..||+..+.
T Consensus 295 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~el 325 (353)
T PLN00034 295 EAPATASREFRHFISCCLQREPAKRWSAMQL 325 (353)
T ss_pred CCCCccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 2234566788999999999999999974443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=312.67 Aligned_cols=247 Identities=22% Similarity=0.291 Sum_probs=187.4
Q ss_pred eeecccCceEEEEEEEc-----CCCeEEEEEEecCCCC-CChhHHHHHHHHHHhc-CCCCeeeEccccccC-CcEEEEEe
Q psy14556 811 IELGKGSYGVVYAAREL-----DRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEE-GYFKIFME 882 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~-----~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~-~~l~LVmE 882 (1181)
++||+|+||.||+|.+. .+++.||+|++..... ...+.+.+|+.++..+ +||||+++++++... +.++++||
T Consensus 13 ~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~e 92 (338)
T cd05102 13 KVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVE 92 (338)
T ss_pred eEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEe
Confidence 47999999999999752 3456899999865432 2345789999999999 899999999987654 56899999
Q ss_pred ecCCCCcccchhcccC-----------------------------------------------------------CCCCC
Q psy14556 883 QVPGGSLSTLLRVKWG-----------------------------------------------------------PLKEN 903 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~-----------------------------------------------------------~~~l~ 903 (1181)
|+++|+|.+++..... ...++
T Consensus 93 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 172 (338)
T cd05102 93 FCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLT 172 (338)
T ss_pred cCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCC
Confidence 9999999998874311 12466
Q ss_pred hHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC--CCccccCCccccCchhhccC
Q psy14556 904 ESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP--SAETFTGTLQYMAPEVIDKG 981 (1181)
Q Consensus 904 e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~--~~~t~~GT~~Y~APEvl~gg 981 (1181)
+..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++....... ......++..|+|||++.+.
T Consensus 173 ~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 251 (338)
T cd05102 173 MEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDK 251 (338)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcC-CCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcC
Confidence 7788889999999999999999999999999999987 88999999999976543211 11223456789999999766
Q ss_pred CCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccc-cCC--CCCCCCCCCCCCcchHHhhc
Q psy14556 982 QRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRAL-VAP--PQISRSVSVPGPGGINSSSS 1057 (1181)
Q Consensus 982 ~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l-~~~--~~ip~~l~~~~p~~L~~li~ 1057 (1181)
.++.++|+ ||+|+++|||++ |..||.+...... ... .......+...+..+..++.
T Consensus 252 ~~~~~sDi--------------------wslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 311 (338)
T cd05102 252 VYTTQSDV--------------------WSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIML 311 (338)
T ss_pred CCCcccCH--------------------HHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 55444443 999999999997 9999987654321 100 00111123345677889999
Q ss_pred cCCCCCCCCCchhHHHHHHhcc
Q psy14556 1058 APVTPTPHSRHISVNTNLVCTG 1079 (1181)
Q Consensus 1058 r~la~dPs~Rp~s~~~~~~al~ 1079 (1181)
+|+..+|..||+ +.+.+..+.
T Consensus 312 ~cl~~dp~~RPs-~~el~~~l~ 332 (338)
T cd05102 312 ACWQGDPKERPT-FSALVEILG 332 (338)
T ss_pred HHccCChhhCcC-HHHHHHHHH
Confidence 999999999995 555444443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=312.09 Aligned_cols=234 Identities=27% Similarity=0.394 Sum_probs=197.7
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCC---hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD---VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~---~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.||+|.-|+||+++...++..+|+|++.+..... ..+.+.|.+||+.++||.++.+|..|+.++..|++||||+||+
T Consensus 84 ~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGd 163 (459)
T KOG0610|consen 84 RLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGD 163 (459)
T ss_pred HcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCcc
Confidence 5999999999999999999999999998775443 4567789999999999999999999999999999999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccccccc----------
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG---------- 958 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~---------- 958 (1181)
|..+.+++ ....+++..++.++.+++.||+|||-.|||+|||||+|||+.+ +|++.|+||.++.....
T Consensus 164 L~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvre-dGHIMLsDFDLS~~~~~~Pt~~~s~~~ 241 (459)
T KOG0610|consen 164 LHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVRE-DGHIMLSDFDLSLRCPVSPTLVKSSSP 241 (459)
T ss_pred HHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEec-CCcEEeeeccccccCCCCCeeeccCCC
Confidence 99998876 5667899999999999999999999999999999999999987 99999999998732210
Q ss_pred -----------------------C-C----------------------CCCccccCCccccCchhhccCCCCCCCccccc
Q psy14556 959 -----------------------L-C----------------------PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQR 992 (1181)
Q Consensus 959 -----------------------~-~----------------------~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~ 992 (1181)
. . .....++||-.|.|||++.|. +.++.||+
T Consensus 242 ~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~--GHgsAVDW- 318 (459)
T KOG0610|consen 242 RSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE--GHGSAVDW- 318 (459)
T ss_pred CCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC--CCCchhhH-
Confidence 0 0 011235699999999999865 57778876
Q ss_pred cCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC-----CCCCCCCCCCCCCcchHHhhccCCCCCCCCC
Q psy14556 993 DKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA-----PPQISRSVSVPGPGGINSSSSAPVTPTPHSR 1067 (1181)
Q Consensus 993 ~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~-----~~~ip~~l~~~~p~~L~~li~r~la~dPs~R 1067 (1181)
|.||++||||+.|+.||.|.+..+... +..+|... ........+|.+.+.+||.+|
T Consensus 319 -----------------WtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kR 379 (459)
T KOG0610|consen 319 -----------------WTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKR 379 (459)
T ss_pred -----------------HHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhh
Confidence 889999999999999999999877433 33333332 445678889999999999998
Q ss_pred ch
Q psy14556 1068 HI 1069 (1181)
Q Consensus 1068 p~ 1069 (1181)
-.
T Consensus 380 lg 381 (459)
T KOG0610|consen 380 LG 381 (459)
T ss_pred hc
Confidence 76
|
|
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=329.42 Aligned_cols=244 Identities=24% Similarity=0.324 Sum_probs=198.4
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcC-CCCeeeEccc-ccc------CCcEEEEE
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR-HRNIVQYLGS-VSE------EGYFKIFM 881 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~-HPNIVkl~g~-~~d------~~~l~LVm 881 (1181)
++.|.+|||+.||+|.+...+..||+|++-.......+.+.+|+.+|++|+ |+|||.+++. ... .-.++|+|
T Consensus 42 ~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLm 121 (738)
T KOG1989|consen 42 EKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLM 121 (738)
T ss_pred EEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeeh
Confidence 347999999999999999888999999997777777888999999999996 9999999993 211 12578999
Q ss_pred eecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccc--eecccCCCCCcccccCCCeeeeecCCcccccccC
Q psy14556 882 EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGL 959 (1181)
Q Consensus 882 Ey~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~g--IVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~ 959 (1181)
|||.||.|-+++..+... .+++..+++|+.|+++|+.+||... |||||||-+||||+. +|..||||||.+...-..
T Consensus 122 EyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~-~g~~KLCDFGSatt~~~~ 199 (738)
T KOG1989|consen 122 EYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSA-DGNYKLCDFGSATTKILS 199 (738)
T ss_pred hhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcC-CCCEEeCcccccccccCC
Confidence 999999999999866333 4899999999999999999999987 999999999999998 899999999998643321
Q ss_pred CCCCc---------cccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCC
Q psy14556 960 CPSAE---------TFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKT 1030 (1181)
Q Consensus 960 ~~~~~---------t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~ 1030 (1181)
..... ....|+.|+|||++. ...+..||-..|| |+|||+||.|+..+.||++..
T Consensus 200 ~~~~~e~~~ve~eI~k~TTp~YRsPEMID---lysg~pI~eKsDI--------------WALGclLYkLCy~t~PFe~sg 262 (738)
T KOG1989|consen 200 PTSAQEVNYVEEEIEKYTTPQYRSPEMID---LYSGLPIGEKSDI--------------WALGCLLYKLCYFTTPFEESG 262 (738)
T ss_pred CccHHHHHHHHHHHHhhCCccccChHHHh---hhcCCCCcchhHH--------------HHHHHHHHHHHHhCCCcCcCc
Confidence 11110 123689999999995 2233344443333 999999999999999999984
Q ss_pred -cccccCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1031 -SRALVAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1031 -~~~l~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
...+...-.+|.. ++.+..+..+|..||+.+|..||...+..
T Consensus 263 ~laIlng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~ 305 (738)
T KOG1989|consen 263 KLAILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVL 305 (738)
T ss_pred ceeEEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHH
Confidence 4445556666654 67888999999999999999999877763
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=341.05 Aligned_cols=250 Identities=24% Similarity=0.271 Sum_probs=199.5
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC---ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG---DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~---~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.+||+|+||.||+|.+..+++.||+|++...... ..+++.+|+.++++++||||+++++++.+.+..+++|||++|+
T Consensus 8 ~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGG 87 (932)
T PRK13184 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGY 87 (932)
T ss_pred EEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCC
Confidence 3799999999999999999999999999754322 2457899999999999999999999999999999999999999
Q ss_pred CcccchhcccC--------CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccC
Q psy14556 888 SLSTLLRVKWG--------PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGL 959 (1181)
Q Consensus 888 SL~dlL~~~~~--------~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~ 959 (1181)
+|.+++..... ....+...+..++.||+.||+|||++||+||||||+||+++. ++.+||+|||+++.....
T Consensus 88 SL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~-dg~vKLiDFGLAk~i~~~ 166 (932)
T PRK13184 88 TLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGL-FGEVVILDWGAAIFKKLE 166 (932)
T ss_pred CHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcC-CCCEEEEecCcceecccc
Confidence 99999864211 123445677889999999999999999999999999999988 899999999999765211
Q ss_pred C------------------CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh
Q psy14556 960 C------------------PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV 1021 (1181)
Q Consensus 960 ~------------------~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT 1021 (1181)
. .......||+.|+|||++.+...+.++|+ ||+||++|+|+|
T Consensus 167 ~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDI--------------------WSLGVILyELLT 226 (932)
T PRK13184 167 EEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDI--------------------YALGVILYQMLT 226 (932)
T ss_pred cccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHH--------------------HHHHHHHHHHHH
Confidence 0 01122468999999999976654433333 999999999999
Q ss_pred CCCCCCCCCcccccCCCCCCC--C--CCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcccC
Q psy14556 1022 LTAALKKKTSRALVAPPQISR--S--VSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGNN 1081 (1181)
Q Consensus 1022 Gk~PF~~~~~~~l~~~~~ip~--~--l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~~ 1081 (1181)
|+.||.......+........ . .....|..+..++.+|++.+|..|++++++....+...
T Consensus 227 G~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 227 LSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred CCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 999998766544322211111 1 11356778999999999999999999999887777663
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=313.29 Aligned_cols=235 Identities=24% Similarity=0.375 Sum_probs=191.3
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.+||+|+||.||+|++..+++.||+|++++.. ....+.+.+|+.++..++||||+++++++.+.+..|+||||++++
T Consensus 7 ~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~ 86 (333)
T cd05600 7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGG 86 (333)
T ss_pred EEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCC
Confidence 37999999999999999999999999997542 233566889999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..... ......
T Consensus 87 ~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~-~~~~kL~Dfg~a~~~~~---~~~~~~ 159 (333)
T cd05600 87 DFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDA-SGHIKLTDFGLSKGIVT---YANSVV 159 (333)
T ss_pred CHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC-CCCEEEEeCcCCccccc---ccCCcc
Confidence 999999743 35778899999999999999999999999999999999988 89999999999976543 233456
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC-----CCCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA-----PPQISR 1042 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~-----~~~ip~ 1042 (1181)
||+.|+|||++.+..++..+|+ ||+||++|+|++|..||.+.+..+... ...+..
T Consensus 160 gt~~y~aPE~~~~~~~~~~~Dv--------------------wslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 219 (333)
T cd05600 160 GSPDYMAPEVLRGKGYDFTVDY--------------------WSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR 219 (333)
T ss_pred cCccccChhHhcCCCCCCccce--------------------ecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccC
Confidence 9999999999986654444333 999999999999999999876644211 111111
Q ss_pred CC----CCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1043 SV----SVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1043 ~l----~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
.. ....+..+..++.+|+..+|.+|++..+
T Consensus 220 ~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ 253 (333)
T cd05600 220 PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLED 253 (333)
T ss_pred CCCCccccccCHHHHHHHHHHhhChhhhcCCHHH
Confidence 11 1234667888999999988888886333
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=313.15 Aligned_cols=235 Identities=24% Similarity=0.332 Sum_probs=187.9
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.||+|+||.||+|++..+++.||+|++.+... ...+.+.+|+.++.++ +||||+++++++.+.+..++||||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 59999999999999999999999999976532 2345678899888877 8999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|..++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++.............
T Consensus 82 ~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~-~~~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 82 DLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS-EGHIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECC-CCCEEEeeCCccccccCCCCcccccc
Confidence 998887643 35788999999999999999999999999999999999988 89999999999875433333344567
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc---------ccCC-
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA---------LVAP- 1037 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~---------l~~~- 1037 (1181)
||+.|+|||++.+..++..+|+ ||+||++|+|++|+.||....... +...
T Consensus 158 gt~~y~aPE~~~~~~~~~~~Di--------------------wslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i 217 (329)
T cd05618 158 GTPNYIAPEILRGEDYGFSVDW--------------------WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 217 (329)
T ss_pred CCccccCHHHHcCCCCCCccce--------------------ecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH
Confidence 9999999999987655444443 999999999999999996322111 0000
Q ss_pred CCCCCCCCCCCCcchHHhhccCCCCCCCCCchh
Q psy14556 1038 PQISRSVSVPGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1038 ~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
.......+...+..+..++.+|+..+|..|+..
T Consensus 218 ~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 218 LEKQIRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred hcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 001111233456667789999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=311.84 Aligned_cols=199 Identities=27% Similarity=0.366 Sum_probs=168.9
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
++||+|+||+||+|.+..+++.||+|++.+... ...+.+.+|+.++.+++||||+++++.+.+.+.+|+||||++||
T Consensus 7 ~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg 86 (363)
T cd05628 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGG 86 (363)
T ss_pred EEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCC
Confidence 379999999999999999999999999965422 23456888999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC------
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP------ 961 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~------ 961 (1181)
+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+++.+.....
T Consensus 87 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~-~~~vkL~DFGla~~~~~~~~~~~~~~ 162 (363)
T cd05628 87 DMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDS-KGHVKLSDFGLCTGLKKAHRTEFYRN 162 (363)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC-CCCEEEeeccCccccccccccccccc
Confidence 999998743 35788999999999999999999999999999999999988 89999999999875432110
Q ss_pred -----------------------------CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHH
Q psy14556 962 -----------------------------SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFL 1012 (1181)
Q Consensus 962 -----------------------------~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSL 1012 (1181)
.....+||+.|+|||++.+..++.. +|+ ||+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~--~Dv------------------wSl 222 (363)
T cd05628 163 LNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL--CDW------------------WSL 222 (363)
T ss_pred ccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCc--hhh------------------hhh
Confidence 0123469999999999976554433 333 999
Q ss_pred HHHHHHHHhCCCCCCCCCccc
Q psy14556 1013 CVIISQLLVLTAALKKKTSRA 1033 (1181)
Q Consensus 1013 GvILyELLTGk~PF~~~~~~~ 1033 (1181)
||++|||++|+.||.+.+..+
T Consensus 223 Gvil~ell~G~~Pf~~~~~~~ 243 (363)
T cd05628 223 GVIMYEMLIGYPPFCSETPQE 243 (363)
T ss_pred HHHHHHHHhCCCCCCCCCHHH
Confidence 999999999999999877654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd01920 cyclophilin_EcCYP_like cyclophilin_EcCYP_like: cyclophilin-type A-like peptidylprolyl cis- trans isomerase (PPIase) domain similar to the cytosolic E | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=280.95 Aligned_cols=142 Identities=33% Similarity=0.518 Sum_probs=124.5
Q ss_pred ecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCCCCCcCcccc
Q psy14556 119 LDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFEDENFTLKH 198 (1181)
Q Consensus 119 ~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~~dE~~~l~h 198 (1181)
+.|+.|+|+||||++.||+||+||++|| +.|| |+|+.||||+|+|++||||+..+.+. ..++.++.+|.....|
T Consensus 2 l~T~~G~i~ieL~~~~aP~t~~nF~~L~--~~g~-Yd~~~fhRvi~~f~iQ~Gd~~~~~~~---~~~~~~~~~e~~~~~~ 75 (155)
T cd01920 2 FQTSLGDIVVELYDDKAPITVENFLAYV--RKGF-YDNTIFHRVISGFVIQGGGFTPDLAQ---KETLKPIKNEAGNGLS 75 (155)
T ss_pred cEecceeEEEEEeCCCCcHHHHHHHHHH--hcCC-CCCCEEEEEeCCcEEEeCCCCCCCCc---cccCCcccCccccccc
Confidence 4799999999999999999999999999 7889 99999999999999999998754322 2346677888766667
Q ss_pred CCCceEEeecCC-CCCCcceEEEEcCCCCCCCC-----CCeEEEEEEcCHHHHHHHHhCCCCC-----CCcccceEEee
Q psy14556 199 TGPGILSMANAG-PNTNGSQFFITTVKTAWLDN-----RHVVFGSVVEGLDVVKKLESMGSQS-----GKTSKKIVVAN 266 (1181)
Q Consensus 199 ~~~G~Lsma~~g-~nt~gSQFfItl~~~p~LDg-----~~vVFGrVieG~dVL~kI~~~~t~~-----g~P~~~V~I~~ 266 (1181)
+.+|+||||+++ +++++|||||+++++|+||+ +|+|||+|++|||||++|+++.++. +.|..+|+|.+
T Consensus 76 ~~~G~v~ma~~~~~~s~~SqFfI~~~~~~~ld~~~~~~~ytvFG~V~eG~dvl~~I~~~~~~~~~~~~~~p~~~v~i~~ 154 (155)
T cd01920 76 NTRGTIAMARTNAPDSATSQFFINLKDNASLDYQNEQWGYTVFGEVTEGMDVVDKIAGVETYSFGSYQDVPVQDVIIES 154 (155)
T ss_pred CCceEEEECCCCCCCCccceEEEECCCchhcCCcccCCCccEEEEEecCHHHHHHHHcCCccCCCCcCCCcCCCeEEEE
Confidence 889999999875 89999999999999999995 7999999999999999999999843 57888888865
|
coli cyclophilin A and Streptomyces antibioticus SanCyp18. Compared to the archetypal cyclophilin Human cyclophilin A, these have reduced affinity for cyclosporin A. E. coli cyclophilin A has a similar peptidylprolyl cis- trans isomerase activity to the human cyclophilin A. Most members of this subfamily contain a phenylalanine residue at the position equivalent to Human cyclophilin W121, where a tyrptophan has been shown to be important for cyclophilin binding. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=300.05 Aligned_cols=238 Identities=22% Similarity=0.313 Sum_probs=187.7
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
..||+|+||.||+|++..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..++||||++++.
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 86 (287)
T cd07848 7 GVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNM 86 (287)
T ss_pred EEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCH
Confidence 369999999999999999999999999965432 235678899999999999999999999999999999999998887
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC-CCcccc
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP-SAETFT 967 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~-~~~t~~ 967 (1181)
+..+... ...+++..++.++.|++.||.|||+.||+||||||+||+++. ++.+||+|||++........ ......
T Consensus 87 l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 162 (287)
T cd07848 87 LELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISH-NDVLKLCDFGFARNLSEGSNANYTEYV 162 (287)
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC-CCcEEEeeccCcccccccccccccccc
Confidence 7655432 235778899999999999999999999999999999999987 88999999999987643221 223356
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc-------C----
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV-------A---- 1036 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~-------~---- 1036 (1181)
|++.|+|||++.+..++.. .|+ ||+||++|+|++|+.||.+.+..+.. .
T Consensus 163 ~~~~y~aPE~~~~~~~~~~--~Di------------------wslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 222 (287)
T cd07848 163 ATRWYRSPELLLGAPYGKA--VDM------------------WSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPA 222 (287)
T ss_pred cccccCCcHHHcCCCCCCc--hhH------------------HhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCH
Confidence 8999999999976554333 333 99999999999999999876532210 0
Q ss_pred --------CC-----CCCCC---------CCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1037 --------PP-----QISRS---------VSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1037 --------~~-----~ip~~---------l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
.+ ..+.. .....+..+..++.+|+..+|.+||+..+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~ 280 (287)
T cd07848 223 EQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQ 280 (287)
T ss_pred HHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHH
Confidence 00 00000 01124556888999999999999998543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=311.41 Aligned_cols=234 Identities=23% Similarity=0.325 Sum_probs=188.8
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.||+|+||.||+|++..+++.||+|++++... ...+.+.+|+.++.++ +||||+++++++.+.+.+|+||||++++
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 59999999999999999999999999976532 2345688999999888 6999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.............
T Consensus 82 ~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 82 DLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDA-DGHIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeC-CCCEEEeccccceeccCCCCceeccc
Confidence 999888643 35789999999999999999999999999999999999988 89999999999875433323334567
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc-------ccC-CCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA-------LVA-PPQ 1039 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~-------l~~-~~~ 1039 (1181)
||+.|+|||++.+..++..+|+ ||+|+++|+|++|+.||....... +.. ...
T Consensus 158 gt~~y~aPE~~~~~~~~~~~Di--------------------wslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 217 (327)
T cd05617 158 GTPNYIAPEILRGEEYGFSVDW--------------------WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE 217 (327)
T ss_pred CCcccCCHHHHCCCCCCchhee--------------------ehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh
Confidence 9999999999986655444443 999999999999999997533211 000 001
Q ss_pred CCCCCCCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1040 ISRSVSVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1040 ip~~l~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
.+...+...+..+..++.+++..+|..|+.
T Consensus 218 ~~~~~p~~~~~~~~~li~~~L~~dP~~R~~ 247 (327)
T cd05617 218 KPIRIPRFLSVKASHVLKGFLNKDPKERLG 247 (327)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccCHHHcCC
Confidence 111223345667788999999999999986
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-33 Score=312.99 Aligned_cols=237 Identities=27% Similarity=0.294 Sum_probs=190.4
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhcC-CCCeeeEccccccCCcEEEEEeecCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQLR-HRNIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L~-HPNIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
..||+|+||.||+|++..+++.||+|++.+.. ....+.+..|..++..+. |++|+++++++.+.+.+|+||||+++
T Consensus 6 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~ 85 (323)
T cd05615 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNG 85 (323)
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCC
Confidence 36999999999999999999999999997542 233456788999998885 57788899999999999999999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccc
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF 966 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~ 966 (1181)
|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++............
T Consensus 86 g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~-~~~ikL~Dfg~~~~~~~~~~~~~~~ 161 (323)
T cd05615 86 GDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS-EGHIKIADFGMCKEHMVDGVTTRTF 161 (323)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC-CCCEEEeccccccccCCCCccccCc
Confidence 9999988743 35778999999999999999999999999999999999998 8999999999987654332333445
Q ss_pred cCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-CCCCCC
Q psy14556 967 TGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-ISRSVS 1045 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-ip~~l~ 1045 (1181)
.||+.|+|||++.+..++.. +|+ ||+||++|+|++|+.||.+.+...+..... .....+
T Consensus 162 ~gt~~y~aPE~~~~~~~~~~--~Di------------------wslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p 221 (323)
T cd05615 162 CGTPDYIAPEIIAYQPYGKS--VDW------------------WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP 221 (323)
T ss_pred cCCccccCHHHHcCCCCCCc--cch------------------hhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 69999999999976544333 333 999999999999999999877644322111 111222
Q ss_pred CCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1046 VPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1046 ~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
...+..+..++.+|+.++|..|+...
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 222 KSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred ccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 34566677899999999999999754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=328.13 Aligned_cols=243 Identities=21% Similarity=0.323 Sum_probs=196.9
Q ss_pred ceeecccCceEEEEEEEcCC-CeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 810 RIELGKGSYGVVYAARELDR-QVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~t-g~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
...||+|+||.||+|.+..+ +..||+|.+..........+.+|+.+++.++||||+++++++...+..|+||||+++|+
T Consensus 72 ~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~ 151 (478)
T PTZ00267 72 TTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGD 151 (478)
T ss_pred EEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCC
Confidence 44799999999999998877 78899998765544445668889999999999999999999999999999999999999
Q ss_pred cccchhcc-cCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC--CCcc
Q psy14556 889 LSTLLRVK-WGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP--SAET 965 (1181)
Q Consensus 889 L~dlL~~~-~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~--~~~t 965 (1181)
|.+++... ....++++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.+..... ....
T Consensus 152 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~-~~~~kL~DFgla~~~~~~~~~~~~~~ 230 (478)
T PTZ00267 152 LNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASS 230 (478)
T ss_pred HHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECC-CCcEEEEeCcCceecCCccccccccc
Confidence 99887642 13346788899999999999999999999999999999999998 89999999999987654322 2334
Q ss_pred ccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCCC--CCC
Q psy14556 966 FTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQI--SRS 1043 (1181)
Q Consensus 966 ~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~i--p~~ 1043 (1181)
..||+.|+|||++.+..++.. .|+ ||+||++|+|++|+.||.+.+..++...... ...
T Consensus 231 ~~gt~~y~aPE~~~~~~~~~~--~Dv------------------~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 290 (478)
T PTZ00267 231 FCGTPYYLAPELWERKRYSKK--ADM------------------WSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP 290 (478)
T ss_pred cCCCccccCHhHhCCCCCCcH--HhH------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 569999999999976544333 333 9999999999999999988766443221111 112
Q ss_pred CCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1044 VSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1044 l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.+...+..+..++.+|+.++|..||+..+.
T Consensus 291 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~ 320 (478)
T PTZ00267 291 FPCPVSSGMKALLDPLLSKNPALRPTTQQL 320 (478)
T ss_pred CCccCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 233466778899999999999999986655
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=301.41 Aligned_cols=240 Identities=15% Similarity=0.126 Sum_probs=191.6
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC---hhHHHHHHHHHHhcCCCCeeeEcccccc----CCcEEEEEee
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD---VQPLHEEIKLHSQLRHRNIVQYLGSVSE----EGYFKIFMEQ 883 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~---~e~f~rEi~IL~~L~HPNIVkl~g~~~d----~~~l~LVmEy 883 (1181)
..||+|++|.||+|.+ +++.||+|.++...... .+.+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 3699999999999987 78899999997654433 4678899999999999999999999866 3578999999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhcccc-ceecccCCCCCcccccCCCeeeeecCCcccccccCCCC
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ-KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS 962 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~-gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~ 962 (1181)
+++|+|.+++... ..+++.....++.|++.||.|||+. +++||||||+||+++. ++.+||+|||+++.....
T Consensus 104 ~~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~-~~~~kl~dfg~~~~~~~~--- 176 (283)
T PHA02988 104 CTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTE-NYKLKIICHGLEKILSSP--- 176 (283)
T ss_pred CCCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECC-CCcEEEcccchHhhhccc---
Confidence 9999999999753 3567888899999999999999984 9999999999999998 899999999998765432
Q ss_pred CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCC---C
Q psy14556 963 AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPP---Q 1039 (1181)
Q Consensus 963 ~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~---~ 1039 (1181)
.....|+..|+|||++.+....++...|+ |||||++|||++|+.||.+.+..++.... .
T Consensus 177 ~~~~~~~~~y~aPE~~~~~~~~~~~k~Di------------------~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~ 238 (283)
T PHA02988 177 PFKNVNFMVYFSYKMLNDIFSEYTIKDDI------------------YSLGVVLWEIFTGKIPFENLTTKEIYDLIINKN 238 (283)
T ss_pred cccccCcccccCHHHhhhccccccchhhh------------------hHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcC
Confidence 22345889999999996522233333433 99999999999999999987765432211 1
Q ss_pred CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1040 ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1040 ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
.....+...+..+..++.+|++.+|..||+ +++.+..+
T Consensus 239 ~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-~~ell~~l 276 (283)
T PHA02988 239 NSLKLPLDCPLEIKCIVEACTSHDSIKRPN-IKEILYNL 276 (283)
T ss_pred CCCCCCCcCcHHHHHHHHHHhcCCcccCcC-HHHHHHHH
Confidence 122233457888999999999999999995 55544433
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=299.23 Aligned_cols=198 Identities=28% Similarity=0.381 Sum_probs=174.1
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCC--hhHHHHHHHHHHhcCCCCeeeEcccccc--CCcEEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD--VQPLHEEIKLHSQLRHRNIVQYLGSVSE--EGYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~--~e~f~rEi~IL~~L~HPNIVkl~g~~~d--~~~l~LVmEy~~gG 887 (1181)
+|++|.||.||+|+++.+++.||+|.++...... --.-.+|+.+|.+++|||||.+-.+... -+.+|+||||| ..
T Consensus 83 rI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~-Eh 161 (419)
T KOG0663|consen 83 RIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYV-EH 161 (419)
T ss_pred hcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHH-Hh
Confidence 5999999999999999999999999997554322 2346799999999999999999887643 36799999999 57
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|..++..-. .++....++.++.|+++|++|||.+.|+||||||+|+|+.. .|.+||+|||+|+.+.+.....+..+
T Consensus 162 DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~-~G~lKiaDFGLAR~ygsp~k~~T~lV 238 (419)
T KOG0663|consen 162 DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSH-KGILKIADFGLAREYGSPLKPYTPLV 238 (419)
T ss_pred hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeecc-CCcEEecccchhhhhcCCcccCcceE
Confidence 8888888643 46778888889999999999999999999999999999988 89999999999999988766666777
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR 1032 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~ 1032 (1181)
-|.+|+|||++.+. .+|+..||+ ||+|||+.||+++++.|.|.+..
T Consensus 239 VTLWYRaPELLLG~-~tyst~iDM------------------WSvGCI~aE~l~~kPlf~G~sE~ 284 (419)
T KOG0663|consen 239 VTLWYRAPELLLGA-KTYSTAVDM------------------WSVGCIFAELLTQKPLFPGKSEI 284 (419)
T ss_pred EEeeecCHHHhcCC-cccCcchhh------------------hhHHHHHHHHHhcCCCCCCCchH
Confidence 89999999999854 589999998 99999999999999999998863
|
|
| >KOG0885|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=303.86 Aligned_cols=201 Identities=29% Similarity=0.495 Sum_probs=174.3
Q ss_pred ccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCC
Q psy14556 110 RDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKF 189 (1181)
Q Consensus 110 ~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~ 189 (1181)
++++.-.|++.|+.|+|.|||++..||++|.||++|| -.|| |+|+.|||++|||.+|||||+ ++|+||.+|||.+|
T Consensus 8 EP~ttgkvil~TT~G~I~iELW~kE~P~acrnFiqKO--Gegy-y~nt~fhrlvp~f~~Qggdp~-~~gtGgesiyg~~f 83 (439)
T KOG0885|consen 8 EPPTTGKVILKTTKGDIDIELWAKECPKACRNFIQLC--LEGY-YDNTEFHRLVPGFLVQGGDPT-GTGTGGESIYGRPF 83 (439)
T ss_pred CCCccceEEEEeccCceeeeehhhhhhHHHHHHHHHH--Hhcc-ccCceeeeeccchhcccCCCC-CCCCCccccccccc
Confidence 5677778899999999999999999999999999999 7899 999999999999999999998 59999999999999
Q ss_pred CCCcC-ccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEE-cCHHHHHHHHhCCC-CCCCcccceEEee
Q psy14556 190 EDENF-TLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVV-EGLDVVKKLESMGS-QSGKTSKKIVVAN 266 (1181)
Q Consensus 190 ~dE~~-~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVi-eG~dVL~kI~~~~t-~~g~P~~~V~I~~ 266 (1181)
.+|.. +++++++|+|+|||++.+.||||||+|++++|||+++|++||+|+ +-+-.+-+|..+.+ .+.||..+.+|.+
T Consensus 84 adE~h~Rlrf~rrGlvgmana~~~~ngsqFfftl~~~~el~nk~tiFGKVtGdtIYn~lri~e~eida~~Rp~~p~kI~s 163 (439)
T KOG0885|consen 84 ADEFHPRLRFNRRGLVGMANAGNDDNGSQFFFTLGDTPELNNKHTIFGKVTGDTIYNMLRISEVEIDADDRPVDPPKIKS 163 (439)
T ss_pred hhhcCcceeeeccceeeecccCCCCCCceEEEEecCChHhcccCceeeeecchhhhhhhhhcccccccccCCCCccceee
Confidence 99965 789999999999999999999999999999999999999999999 46788889988888 5789999999999
Q ss_pred eccccCCCCCCccccccccceeeeccCCCCCchhhccc-ccccccccccccccccceeeecccccc
Q psy14556 267 SDSHSETDSQSSLSSKALMDVVCVIDVSVPSDLSHRRR-ALDEIIQACSLVNAKLNLIEFESETDS 331 (1181)
Q Consensus 267 cGvl~~~~~~p~~~~~~~~~~~~~~d~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (1181)
|.++-.+.+... |...+..+. .++++..+.+++-.+.++.+|+-|-++
T Consensus 164 ~EV~~npFdDI~-----------------pr~~r~~~~e~~ke~k~~k~~~~k~~~lLsfgdE~E~ 212 (439)
T KOG0885|consen 164 VEVLINPFDDIK-----------------PRELRKESEEKKKERKELKKKGTKNKNLLSFGDEAEE 212 (439)
T ss_pred eEeecCchhhcc-----------------hhhhhcccchhhhhhcccccccccccceecccccccc
Confidence 999988875543 333222222 445555566666669999999877554
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=315.72 Aligned_cols=234 Identities=23% Similarity=0.311 Sum_probs=182.9
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.+||+|+||.||+|++..+++.||+|++.+... ...+.+.+|+.++++++||||+++++.+.+.+.+|+||||+++|
T Consensus 7 ~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg 86 (382)
T cd05625 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 86 (382)
T ss_pred EEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCC
Confidence 369999999999999999999999999965422 23457889999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC-------
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC------- 960 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~------- 960 (1181)
+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..+....
T Consensus 87 ~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~-~g~~kL~DFGla~~~~~~~~~~~~~~ 162 (382)
T cd05625 87 DMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDR-DGHIKLTDFGLCTGFRWTHDSKYYQS 162 (382)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC-CCCEEEeECCCCcccccccccccccc
Confidence 999998743 35678889999999999999999999999999999999987 8999999999975321000
Q ss_pred ----------------------------------------CCCccccCCccccCchhhccCCCCCCCccccccCCCcccc
Q psy14556 961 ----------------------------------------PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCR 1000 (1181)
Q Consensus 961 ----------------------------------------~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~ 1000 (1181)
.......||+.|+|||++.+..++. .+|+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~--~~Di--------- 231 (382)
T cd05625 163 GDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ--LCDW--------- 231 (382)
T ss_pred ccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC--eeeE---------
Confidence 0012346899999999997665443 3444
Q ss_pred ccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC-----CCCCCCCCCCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1001 IEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA-----PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1001 i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~-----~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
||+||++|||++|+.||.+.+..+... ............+.....++.+++ .+|..|+.
T Consensus 232 ---------wSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~ 295 (382)
T cd05625 232 ---------WSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLG 295 (382)
T ss_pred ---------EechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCC
Confidence 999999999999999999876543211 111111111234455555666644 58888875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=312.93 Aligned_cols=260 Identities=26% Similarity=0.329 Sum_probs=198.4
Q ss_pred cccchHHHHhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEcccccc
Q psy14556 794 YMQTPMLRFLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSE 873 (1181)
Q Consensus 794 ~~~~p~~~~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d 873 (1181)
+......+.++.|.... .||+|+||.||+|.... +..||||.+.........+|.+|+.++.+++|||+|+++|||.+
T Consensus 65 fs~~el~~AT~~Fs~~~-~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e 142 (361)
T KOG1187|consen 65 FSYDELRKATNNFSESN-LIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLE 142 (361)
T ss_pred eeHHHHHHHHhCCchhc-ceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEec
Confidence 33344556666776655 69999999999998654 48999998876554313459999999999999999999999999
Q ss_pred CC-cEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccc---eecccCCCCCcccccCCCeeeeec
Q psy14556 874 EG-YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK---IVHRDIKGDNVLVNTYSGVVKISD 949 (1181)
Q Consensus 874 ~~-~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~g---IVHrDLKP~NILLd~~~g~vKLiD 949 (1181)
.+ ..+||+|||++|+|.++|...... +++|....+|+.++++||+|||... ||||||||+|||||. +..+||+|
T Consensus 143 ~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~-~~~aKlsD 220 (361)
T KOG1187|consen 143 GGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDE-DFNAKLSD 220 (361)
T ss_pred CCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECC-CCCEEccC
Confidence 98 599999999999999999865443 7899999999999999999999864 999999999999997 89999999
Q ss_pred CCcccccccCCCCCccc-cCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCC
Q psy14556 950 FGTSKRLAGLCPSAETF-TGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKK 1028 (1181)
Q Consensus 950 FGlAk~l~~~~~~~~t~-~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~ 1028 (1181)
||+|+..........+. .||.+|+|||++..+..+.++|| ||||++|.|++||+.|.+.
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDV--------------------ySFGVvllElitgr~~~d~ 280 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDV--------------------YSFGVVLLELITGRKAVDQ 280 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhccCCcCccccc--------------------ccchHHHHHHHhCCcccCC
Confidence 99996654311222222 79999999999988777777777 9999999999999988886
Q ss_pred CCcc---ccc-------CCCCCCCCCC-----CCC-----CcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1029 KTSR---ALV-------APPQISRSVS-----VPG-----PGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1029 ~~~~---~l~-------~~~~ip~~l~-----~~~-----p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
.... .+. ....+.+-+. ... -..+..+..+|+..+|..||...+ .+..+
T Consensus 281 ~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~-Vv~~L 349 (361)
T KOG1187|consen 281 SRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQ-VVKEL 349 (361)
T ss_pred CCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHH-HHHHH
Confidence 4311 110 0101111111 111 122444778999999999997444 34444
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=290.48 Aligned_cols=241 Identities=26% Similarity=0.321 Sum_probs=198.0
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCC--CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKN--LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~--~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
..||+|++|.||+|.+..+++.|++|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd08529 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGD 85 (256)
T ss_pred EEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCc
Confidence 36999999999999999999999999986543 2345678899999999999999999999999999999999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|.+++... ....+++..++.++.|++.||.|||++|++|+||||+||+++. ++.++|+|||+++.+...........|
T Consensus 86 L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~-~~~~~l~df~~~~~~~~~~~~~~~~~~ 163 (256)
T cd08529 86 LHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDA-YDNVKIGDLGVAKLLSDNTNFANTIVG 163 (256)
T ss_pred HHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeC-CCCEEEcccccceeccCccchhhcccc
Confidence 99999754 2346788999999999999999999999999999999999998 889999999999876554333344568
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC--CCCCCCC
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ--ISRSVSV 1046 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~--ip~~l~~ 1046 (1181)
++.|+|||++.++..+..+|+ ||+|+++|+|++|+.||...+......... .....+.
T Consensus 164 ~~~y~aPE~~~~~~~~~~~Di--------------------~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 223 (256)
T cd08529 164 TPYYLSPELCEDKPYNEKSDV--------------------WALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQ 223 (256)
T ss_pred CccccCHHHhcCCCCCCccch--------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence 899999999986654443333 999999999999999998877544321111 1112222
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
..+..+..++.+|+..+|..||...+.
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l 250 (256)
T cd08529 224 MYSQQLAQLIDQCLTKDYRQRPDTFQL 250 (256)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHH
Confidence 567788999999999999999986554
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-33 Score=294.82 Aligned_cols=245 Identities=28% Similarity=0.411 Sum_probs=206.9
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEE
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIF 880 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LV 880 (1181)
++|..++ .||.|-||.||.|+.+.++-.||+|++.+... ...+++.+|++|.+.|+||||+++|++|.+....|++
T Consensus 22 ~dfeigr-~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 22 DDFEIGR-PLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhccccc-cccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 3455555 69999999999999999999999999976633 2356799999999999999999999999999999999
Q ss_pred EeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC
Q psy14556 881 MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC 960 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~ 960 (1181)
+||.++|+|...|+.. ....+++...+.++.|++.||.|+|.++++||||||+|+|++. .+.+||+|||.+.... .
T Consensus 101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~-~~~lkiAdfGwsV~~p--~ 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAP--S 176 (281)
T ss_pred EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCC-CCCeeccCCCceeecC--C
Confidence 9999999999999854 3456788999999999999999999999999999999999998 8999999999997654 4
Q ss_pred CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-
Q psy14556 961 PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ- 1039 (1181)
Q Consensus 961 ~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~- 1039 (1181)
....+.+||..|.+||+..+. .+...||. |++|++.||++.|.+||...+..+....+.
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~--~hd~~Vd~------------------w~lgvl~yeflvg~ppFes~~~~etYkrI~k 236 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGR--GHDKFVDL------------------WSLGVLCYEFLVGLPPFESQSHSETYKRIRK 236 (281)
T ss_pred CCceeeecccccCCHhhcCCC--CccchhhH------------------HHHHHHHHHHHhcCCchhhhhhHHHHHHHHH
Confidence 566788999999999999865 45556666 999999999999999999988766544333
Q ss_pred CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1040 ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1040 ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
..-..+...+.....++.+++.++|..|.+-.+.
T Consensus 237 ~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v 270 (281)
T KOG0580|consen 237 VDLKFPSTISGGAADLISRLLVKNPIERLALTEV 270 (281)
T ss_pred ccccCCcccChhHHHHHHHHhccCccccccHHHH
Confidence 1122234567777888899999999999875544
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.9e-32 Score=298.64 Aligned_cols=239 Identities=23% Similarity=0.292 Sum_probs=187.2
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
++||.|+||.||+|++..++..||+|.++.... .....+.+|+.++++++||||+++++++.+.+..++||||++ ++|
T Consensus 11 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l 89 (288)
T cd07871 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SDL 89 (288)
T ss_pred eEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cCH
Confidence 479999999999999999999999999965433 234567899999999999999999999999999999999996 588
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT 969 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT 969 (1181)
.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.............++
T Consensus 90 ~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~-~~~~kl~DfG~~~~~~~~~~~~~~~~~~ 166 (288)
T cd07871 90 KQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINE-KGELKLADFGLARAKSVPTKTYSNEVVT 166 (288)
T ss_pred HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC-CCCEEECcCcceeeccCCCccccCceec
Confidence 8888643 234678888999999999999999999999999999999988 8999999999997654333333445689
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC--------CC---
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA--------PP--- 1038 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~--------~~--- 1038 (1181)
+.|+|||++.+. ..++..+|+ ||+||++|+|++|+.||.+.+..+... ++
T Consensus 167 ~~y~aPE~~~~~-~~~~~~~Di------------------wslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07871 167 LWYRPPDVLLGS-TEYSTPIDM------------------WGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEET 227 (288)
T ss_pred ccccChHHhcCC-cccCcHHHH------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHH
Confidence 999999998643 223444444 999999999999999998766432100 00
Q ss_pred -------------CCCCC-------CCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1039 -------------QISRS-------VSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1039 -------------~ip~~-------l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
..+.. ...........++.+++..+|.+|++..+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~ 281 (288)
T cd07871 228 WPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEA 281 (288)
T ss_pred hhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHH
Confidence 00000 01123445667999999999999997433
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=307.54 Aligned_cols=242 Identities=24% Similarity=0.288 Sum_probs=191.3
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.+||+|+||+||+|++..+++.||+|+++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||++++
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (330)
T cd05601 7 SLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGG 86 (330)
T ss_pred EEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCC
Confidence 379999999999999999999999999975432 23456889999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC-Cccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS-AETF 966 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~-~~t~ 966 (1181)
+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..+...... ....
T Consensus 87 ~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~-~~~~kL~Dfg~a~~~~~~~~~~~~~~ 163 (330)
T cd05601 87 DLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDR-TGHIKLADFGSAARLTANKMVNSKLP 163 (330)
T ss_pred CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECC-CCCEEeccCCCCeECCCCCceeeecc
Confidence 999999754 235788999999999999999999999999999999999987 899999999999876533221 2234
Q ss_pred cCCccccCchhhccCCC----CCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCC----C
Q psy14556 967 TGTLQYMAPEVIDKGQR----GYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAP----P 1038 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~----~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~----~ 1038 (1181)
.||+.|+|||++..... .++...|+ ||+||++|+|++|+.||...+....... .
T Consensus 164 ~gt~~y~aPE~~~~~~~~~~~~~~~~~Di------------------wslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~ 225 (330)
T cd05601 164 VGTPDYIAPEVLTTMNGDGKGTYGVECDW------------------WSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ 225 (330)
T ss_pred cCCccccCHHHhccccccccCCCCCccee------------------ecccceeeeeccCCCCCCCCCHHHHHHHHHcCC
Confidence 68999999999863221 12222333 9999999999999999987765332111 1
Q ss_pred C-CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1039 Q-ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1039 ~-ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
. +.-...+..+..+..++..++. +|..|+...+..
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~ 261 (330)
T cd05601 226 RFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLC 261 (330)
T ss_pred CccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHh
Confidence 1 1111123456677888888997 999999855543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-32 Score=299.17 Aligned_cols=238 Identities=22% Similarity=0.279 Sum_probs=192.1
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC---ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG---DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~---~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.+||+|+||.||++.+..+++.||+|++...... ....+.+|+.+++.++||||+++++.+..++..++||||++++
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 85 (285)
T cd05605 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG 85 (285)
T ss_pred EEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCC
Confidence 3699999999999999999999999999654322 2345778999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|.+++... ....+++..+..++.|++.||.|||++|++||||||+||+++. ++.++|+|||++....... ......
T Consensus 86 ~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~-~~~~~l~Dfg~~~~~~~~~-~~~~~~ 162 (285)
T cd05605 86 DLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDD-YGHIRISDLGLAVEIPEGE-TIRGRV 162 (285)
T ss_pred cHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECC-CCCEEEeeCCCceecCCCC-cccccc
Confidence 999888643 3345789999999999999999999999999999999999987 7899999999987654322 223346
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc----cCC-CCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL----VAP-PQISR 1042 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l----~~~-~~ip~ 1042 (1181)
|++.|+|||++.+..++... |+ ||+|+++|+|++|+.||.+...... ... ...+.
T Consensus 163 ~~~~y~aPE~~~~~~~~~~~--Di------------------ws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 222 (285)
T cd05605 163 GTVGYMAPEVVKNERYTFSP--DW------------------WGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQE 222 (285)
T ss_pred CCCCccCcHHhcCCCCCccc--cc------------------hhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhccc
Confidence 89999999999765544333 33 9999999999999999987654321 111 11122
Q ss_pred CCCCCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1043 SVSVPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1043 ~l~~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
..+...+..+..++.+|+..+|..|+.+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCR 251 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCC
Confidence 23345677889999999999999999643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-32 Score=303.41 Aligned_cols=240 Identities=24% Similarity=0.291 Sum_probs=184.5
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCC--CCChhHHHHHHHHHHhcCCCCeeeEccccccC-----CcEEEEEee
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKN--LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEE-----GYFKIFMEQ 883 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~--~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~-----~~l~LVmEy 883 (1181)
.+||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++++... ..+|+||||
T Consensus 6 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~ 85 (338)
T cd07859 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL 85 (338)
T ss_pred EEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEec
Confidence 47999999999999999999999999986432 23345688999999999999999999987433 358999999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC--
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP-- 961 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~-- 961 (1181)
+ +++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.......
T Consensus 86 ~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~-~~~~kL~Dfg~~~~~~~~~~~~ 160 (338)
T cd07859 86 M-ESDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANA-DCKLKICDFGLARVAFNDTPTA 160 (338)
T ss_pred C-CCCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC-CCcEEEccCccccccccccCcc
Confidence 9 57888888643 35788999999999999999999999999999999999988 89999999999976532211
Q ss_pred -CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc-----
Q psy14556 962 -SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV----- 1035 (1181)
Q Consensus 962 -~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~----- 1035 (1181)
......||+.|+|||++.+....++..+|+ ||+||++|+|++|+.||.+.+.....
T Consensus 161 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~Dv------------------wSlGvvl~el~tg~~pf~~~~~~~~~~~~~~ 222 (338)
T cd07859 161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDI------------------WSIGCIFAEVLTGKPLFPGKNVVHQLDLITD 222 (338)
T ss_pred ccccCCCCCCCcCCHHHHhccccccCchhHH------------------HHHHHHHHHHHcCCCCCCCCChHHHHHHHHH
Confidence 112356899999999986532233444444 99999999999999999876532100
Q ss_pred --C----------------------CCCCCC---CCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1036 --A----------------------PPQISR---SVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1036 --~----------------------~~~ip~---~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
. ....+. ...+..+..+..++.+|+..+|..||+..+.
T Consensus 223 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~ 287 (338)
T cd07859 223 LLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEA 287 (338)
T ss_pred HhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHH
Confidence 0 000000 0112345667889999999999999974444
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-32 Score=300.33 Aligned_cols=242 Identities=23% Similarity=0.278 Sum_probs=187.6
Q ss_pred eeecccCceEEEEEEEcC----------------CCeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEcccccc
Q psy14556 811 IELGKGSYGVVYAARELD----------------RQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSE 873 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~----------------tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d 873 (1181)
.+||+|+||.||+|.+.. ++..||+|.+...... ....+.+|+.++++++||||+++++++.+
T Consensus 11 ~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 90 (304)
T cd05096 11 EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD 90 (304)
T ss_pred eEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEec
Confidence 479999999999997532 3457999998765332 24578999999999999999999999999
Q ss_pred CCcEEEEEeecCCCCcccchhccc----------------CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcc
Q psy14556 874 EGYFKIFMEQVPGGSLSTLLRVKW----------------GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVL 937 (1181)
Q Consensus 874 ~~~l~LVmEy~~gGSL~dlL~~~~----------------~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NIL 937 (1181)
.+..++||||+++++|.+++.... ....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nil 170 (304)
T cd05096 91 EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCL 170 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheE
Confidence 999999999999999999886431 1123567788899999999999999999999999999999
Q ss_pred cccCCCeeeeecCCcccccccCCC--CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHH
Q psy14556 938 VNTYSGVVKISDFGTSKRLAGLCP--SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVI 1015 (1181)
Q Consensus 938 Ld~~~g~vKLiDFGlAk~l~~~~~--~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvI 1015 (1181)
++. ++.+||+|||+++....... ......++..|+|||++.++.++..+|+ ||+|++
T Consensus 171 l~~-~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv--------------------~slG~~ 229 (304)
T cd05096 171 VGE-NLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDV--------------------WAFGVT 229 (304)
T ss_pred EcC-CccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhh--------------------HHHHHH
Confidence 997 88999999999976543221 1122345788999999976654444333 999999
Q ss_pred HHHHHh--CCCCCCCCCcccccCC---------CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1016 ISQLLV--LTAALKKKTSRALVAP---------PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1016 LyELLT--Gk~PF~~~~~~~l~~~---------~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
+|+|++ +..||.+.+...+... .......++..+..+..++.+|+..+|..||+..+.
T Consensus 230 l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i 298 (304)
T cd05096 230 LWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDI 298 (304)
T ss_pred HHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence 999987 5688887655432110 111122234677889999999999999999975443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=304.42 Aligned_cols=197 Identities=28% Similarity=0.433 Sum_probs=173.8
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEec--CCCCCChhHHHHHHHHHHhcCCCCeeeEcccccc-----CCcEEEEEee
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIP--EKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSE-----EGYFKIFMEQ 883 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~--~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d-----~~~l~LVmEy 883 (1181)
+.||.|+||.|+.+.+..+++.||||++. .......++..+|+++|+.++|+||+.+.+++.. -+.+|+|+|+
T Consensus 28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el 107 (359)
T KOG0660|consen 28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL 107 (359)
T ss_pred ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence 46999999999999999999999999997 4455567889999999999999999999998865 2579999999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccC--CC
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGL--CP 961 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~--~~ 961 (1181)
| +.+|...++.. ..+++..+..+++||+.||+|+|+.+|+||||||.|++++. +..+||+|||+|+..... ..
T Consensus 108 M-etDL~~iik~~---~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~-~c~lKI~DFGLAR~~~~~~~~~ 182 (359)
T KOG0660|consen 108 M-ETDLHQIIKSQ---QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNA-DCDLKICDFGLARYLDKFFEDG 182 (359)
T ss_pred H-hhHHHHHHHcC---ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeecc-CCCEEeccccceeeccccCccc
Confidence 9 78999999844 45889999999999999999999999999999999999998 889999999999987642 23
Q ss_pred CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCc
Q psy14556 962 SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTS 1031 (1181)
Q Consensus 962 ~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~ 1031 (1181)
..+..+.|.+|+|||++... ..|+..||+ ||.||||.||++|++.|.|.+.
T Consensus 183 ~mTeYVaTRWYRAPElll~~-~~Yt~aiDi------------------WSvGCI~AEmL~gkplFpG~d~ 233 (359)
T KOG0660|consen 183 FMTEYVATRWYRAPELLLNS-SEYTKAIDI------------------WSVGCILAEMLTGKPLFPGKDY 233 (359)
T ss_pred chhcceeeeeecCHHHHhcc-ccccchhhh------------------hhhhHHHHHHHcCCCCCCCCch
Confidence 34556789999999999644 578888888 9999999999999999999886
|
|
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=315.35 Aligned_cols=227 Identities=30% Similarity=0.449 Sum_probs=192.0
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcccc
Q psy14556 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTL 892 (1181)
Q Consensus 813 IG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~dl 892 (1181)
||.|+.|.||+|+. .++.||||+++.- -..+|+-|++|+||||+.+.|+|.....+|||||||..|-|..+
T Consensus 132 lGSGaQGAVF~Grl--~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V 202 (904)
T KOG4721|consen 132 LGSGAQGAVFLGRL--HNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV 202 (904)
T ss_pred hccCcccceeeeec--cCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence 89999999999986 5679999988432 23678999999999999999999999999999999999999999
Q ss_pred hhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCccc
Q psy14556 893 LRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQY 972 (1181)
Q Consensus 893 L~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~~Y 972 (1181)
|+.. ..+.......|..+|+.|++|||.+.|||||||.-||||.. +..+||+|||.++.+... .....++||..|
T Consensus 203 Lka~---~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~-~d~VKIsDFGTS~e~~~~-STkMSFaGTVaW 277 (904)
T KOG4721|consen 203 LKAG---RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISY-DDVVKISDFGTSKELSDK-STKMSFAGTVAW 277 (904)
T ss_pred Hhcc---CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeec-cceEEeccccchHhhhhh-hhhhhhhhhHhh
Confidence 9843 57788999999999999999999999999999999999987 889999999999887765 334567899999
Q ss_pred cCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC---CCCCCCCCCCCCC
Q psy14556 973 MAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA---PPQISRSVSVPGP 1049 (1181)
Q Consensus 973 ~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~---~~~ip~~l~~~~p 1049 (1181)
||||++.+.+. +.+||+ |||||+|||||||..||...+...|+. ...+.-.++..+|
T Consensus 278 MAPEvIrnePc--sEKVDI------------------wSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP 337 (904)
T KOG4721|consen 278 MAPEVIRNEPC--SEKVDI------------------WSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCP 337 (904)
T ss_pred hCHHHhhcCCc--ccccce------------------ehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCc
Confidence 99999987654 555665 999999999999999999998877644 2234445566788
Q ss_pred cchHHhhccCCCCCCCCCchhHHH
Q psy14556 1050 GGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1050 ~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
..+.-++..|+...|-.||++-+.
T Consensus 338 ~GfklL~Kqcw~sKpRNRPSFrqi 361 (904)
T KOG4721|consen 338 DGFKLLLKQCWNSKPRNRPSFRQI 361 (904)
T ss_pred hHHHHHHHHHHhcCCCCCccHHHH
Confidence 888777777777777777765443
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=291.30 Aligned_cols=239 Identities=28% Similarity=0.411 Sum_probs=190.3
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
.+||+|+||.||+|.+..+++.||+|++..........+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 15 ~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~ 94 (267)
T cd06646 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQ 94 (267)
T ss_pred heeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHH
Confidence 36999999999999999999999999997665555567889999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCc
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL 970 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~ 970 (1181)
+++... ..+++..+..++.|++.||+|||++||+||||||+||+++. ++.++|+|||++..............++.
T Consensus 95 ~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 170 (267)
T cd06646 95 DIYHVT---GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTD-NGDVKLADFGVAAKITATIAKRKSFIGTP 170 (267)
T ss_pred HHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC-CCCEEECcCccceeecccccccCccccCc
Confidence 988643 35678899999999999999999999999999999999987 78999999999987654333333456889
Q ss_pred cccCchhhccCC-CCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC---CCCC--CCC-
Q psy14556 971 QYMAPEVIDKGQ-RGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA---PPQI--SRS- 1043 (1181)
Q Consensus 971 ~Y~APEvl~gg~-~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~---~~~i--p~~- 1043 (1181)
.|+|||.+.+.. ..++...|+ ||+|+++|+|++|+.||.......... ...+ +..
T Consensus 171 ~y~~PE~~~~~~~~~~~~~~Dv------------------ws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 232 (267)
T cd06646 171 YWMAPEVAAVEKNGGYNQLCDI------------------WAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLK 232 (267)
T ss_pred cccCHhHcccccCCCCcchhhH------------------HHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCc
Confidence 999999885321 112222333 999999999999999997654332111 1111 110
Q ss_pred CCCCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1044 VSVPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1044 l~~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
.....+..+..++.+|+..+|.+||+..
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~ 260 (267)
T cd06646 233 DKTKWSSTFHNFVKISLTKNPKKRPTAE 260 (267)
T ss_pred cccccCHHHHHHHHHHhhCChhhCcCHH
Confidence 1123466788999999999999999643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=311.83 Aligned_cols=244 Identities=29% Similarity=0.396 Sum_probs=210.0
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC---ChhHHHHHHHHHHhcC-CCCeeeEccccccCCcEEEE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG---DVQPLHEEIKLHSQLR-HRNIVQYLGSVSEEGYFKIF 880 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~---~~e~f~rEi~IL~~L~-HPNIVkl~g~~~d~~~l~LV 880 (1181)
.|.+. .+||+|.||.||+|+.+.+|+.+|+|.+.+.... ..+.+.+|+.+|+++. ||||+.++++|++...+++|
T Consensus 36 ~Y~l~-~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 36 KYELG-RELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred cEEeh-hhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 34444 4799999999999999999999999999877554 3468999999999998 99999999999999999999
Q ss_pred EeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCC---CeeeeecCCcccccc
Q psy14556 881 MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYS---GVVKISDFGTSKRLA 957 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~---g~vKLiDFGlAk~l~ 957 (1181)
||++.||.|.+.+... .+++..+..++.|++.+++|||+.||+||||||+|+|+...+ +.+|++|||++....
T Consensus 115 mEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999999999865 388999999999999999999999999999999999997642 489999999999887
Q ss_pred cCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc---
Q psy14556 958 GLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL--- 1034 (1181)
Q Consensus 958 ~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l--- 1034 (1181)
. .......+||+.|+|||++... .++..+|+ ||+|+++|.|+.|.+||.+.+....
T Consensus 191 ~-~~~~~~~~Gtp~y~APEvl~~~--~y~~~~Di------------------WS~Gvi~yiLL~G~~PF~~~~~~~~~~~ 249 (382)
T KOG0032|consen 191 P-GERLHTIVGTPEYVAPEVLGGR--PYGDEVDV------------------WSIGVILYILLSGVPPFWGETEFEIFLA 249 (382)
T ss_pred C-CceEeeecCCccccCchhhcCC--CCCcccch------------------hHHHHHHHHHhhCCCCCcCCChhHHHHH
Confidence 6 4556678899999999999754 45555555 9999999999999999999986543
Q ss_pred --cCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1035 --VAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1035 --~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
.....+...............+.+++..||.+|.+..+.+
T Consensus 250 i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L 291 (382)
T KOG0032|consen 250 ILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQAL 291 (382)
T ss_pred HHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHh
Confidence 3344566677777788899999999999999999754443
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=290.76 Aligned_cols=244 Identities=61% Similarity=0.930 Sum_probs=196.1
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
..||+|+||.||+|.+..++..|++|.+........+.+.+|+.++++++|+||+++++++..++..++++||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 47999999999999999999999999987766556678999999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCc
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL 970 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~ 970 (1181)
+++.........++..+..++.||+.||+|||++||+||||||+||+++..++.++|+|||.+..............+++
T Consensus 94 ~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 173 (268)
T cd06624 94 ALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTL 173 (268)
T ss_pred HHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCc
Confidence 99985433333378888899999999999999999999999999999986567999999999876644333333445889
Q ss_pred cccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc-cCCC---CCCCCCCC
Q psy14556 971 QYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL-VAPP---QISRSVSV 1046 (1181)
Q Consensus 971 ~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l-~~~~---~ip~~l~~ 1046 (1181)
.|+|||.+.+....++...|+ ||+|+++|+|++|+.||........ .... ......+.
T Consensus 174 ~~~aPE~~~~~~~~~~~~~Dv------------------~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (268)
T cd06624 174 QYMAPEVIDKGPRGYGAPADI------------------WSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPE 235 (268)
T ss_pred cccChhhhccccccCCchhhh------------------HHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCc
Confidence 999999987654444444444 9999999999999999976543221 1111 11122333
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
..+..+..++.+|+..+|..||+..+
T Consensus 236 ~~~~~~~~li~~~l~~~p~~Rpt~~~ 261 (268)
T cd06624 236 SLSAEAKNFILRCFEPDPDKRASAHD 261 (268)
T ss_pred ccCHHHHHHHHHHcCCCchhCCCHHH
Confidence 45667888999999999999986443
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=304.20 Aligned_cols=195 Identities=28% Similarity=0.421 Sum_probs=166.8
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
.+||+|+||.||++++..++..+|+|.+..... ...+.+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 90 (331)
T cd06649 11 SELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 90 (331)
T ss_pred EeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcH
Confidence 369999999999999999999999999975532 2346789999999999999999999999999999999999999999
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhcccc-ceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ-KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~-gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||++..+... ......|
T Consensus 91 ~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~--~~~~~~g 164 (331)
T cd06649 91 DQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDS--MANSFVG 164 (331)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcC-CCcEEEccCccccccccc--ccccCCC
Confidence 9999753 3577889999999999999999986 6999999999999988 899999999998766432 2234568
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCc
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTS 1031 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~ 1031 (1181)
++.|+|||++.+..++..+|+ ||+||++|+|++|+.||.....
T Consensus 165 ~~~y~aPE~~~~~~~~~~~Di--------------------wslG~il~el~tg~~p~~~~~~ 207 (331)
T cd06649 165 TRSYMSPERLQGTHYSVQSDI--------------------WSMGLSLVELAIGRYPIPPPDA 207 (331)
T ss_pred CcCcCCHhHhcCCCCCchHhH--------------------HHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999976544433333 9999999999999999976544
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=310.34 Aligned_cols=239 Identities=24% Similarity=0.339 Sum_probs=189.7
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.+||+|+||.||++++..+++.||+|.+.+.. ....+.+.+|+.+++.++||||+++++++.+++.+|+||||++||
T Consensus 49 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg 128 (370)
T cd05596 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGG 128 (370)
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCC
Confidence 36999999999999999999999999996532 223455788999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC-CCccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP-SAETF 966 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~-~~~t~ 966 (1181)
+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++........ .....
T Consensus 129 ~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~-~~~~kL~DfG~~~~~~~~~~~~~~~~ 203 (370)
T cd05596 129 DLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK-SGHLKLADFGTCMKMDANGMVRCDTA 203 (370)
T ss_pred cHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcC-CCCEEEEeccceeeccCCCcccCCCC
Confidence 999998643 4678888889999999999999999999999999999988 89999999999976643221 22345
Q ss_pred cCCccccCchhhccCCC--CCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCC-----CC
Q psy14556 967 TGTLQYMAPEVIDKGQR--GYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAP-----PQ 1039 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~--~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~-----~~ 1039 (1181)
.||+.|+|||++.+... .++...|+ ||+||++|+|++|+.||.+.+....... ..
T Consensus 204 ~gt~~y~aPE~~~~~~~~~~~~~~~Di------------------wSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~ 265 (370)
T cd05596 204 VGTPDYISPEVLKSQGGDGYYGRECDW------------------WSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS 265 (370)
T ss_pred CCCcCeECHHHhccCCCCCCCCCceee------------------eehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCc
Confidence 69999999999965321 12333444 9999999999999999998776432111 11
Q ss_pred CCCCCCCCCCcchHHhhccCCCCCCCC--CchhHHH
Q psy14556 1040 ISRSVSVPGPGGINSSSSAPVTPTPHS--RHISVNT 1073 (1181)
Q Consensus 1040 ip~~l~~~~p~~L~~li~r~la~dPs~--Rp~s~~~ 1073 (1181)
+.-......+..+..++.+++..+|.+ |++ +.+
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s-~~e 300 (370)
T cd05596 266 LTFPDDIEISKQAKDLICAFLTDREVRLGRNG-VDE 300 (370)
T ss_pred CCCCCcCCCCHHHHHHHHHHccChhhccCCCC-HHH
Confidence 111112245677888999999988876 664 444
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=298.66 Aligned_cols=240 Identities=22% Similarity=0.299 Sum_probs=184.9
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
.+||+|+||.||+|++..+++.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++||||++ ++|
T Consensus 11 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l 89 (303)
T cd07869 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDL 89 (303)
T ss_pred eeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCH
Confidence 4799999999999999999999999999754332 23467889999999999999999999999999999999995 677
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT 969 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT 969 (1181)
.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..............++
T Consensus 90 ~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 166 (303)
T cd07869 90 CQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISD-TGELKLADFGLARAKSVPSHTYSNEVVT 166 (303)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC-CCCEEECCCCcceeccCCCccCCCCccc
Confidence 7777643 235678889999999999999999999999999999999987 8999999999987654332333345689
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc--c------cCCC---
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA--L------VAPP--- 1038 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~--l------~~~~--- 1038 (1181)
+.|+|||++.+.. .+...+|+ ||+||++|+|++|..||.+..... + ...+
T Consensus 167 ~~y~aPE~~~~~~-~~~~~~Di------------------wslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
T cd07869 167 LWYRPPDVLLGST-EYSTCLDM------------------WGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNED 227 (303)
T ss_pred CCCCChHHHcCCC-CCCcHHHH------------------HHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChh
Confidence 9999999986432 23333444 999999999999999998754311 0 0000
Q ss_pred ---------C-CCCCC-------------CCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1039 ---------Q-ISRSV-------------SVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1039 ---------~-ip~~l-------------~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
. .+... ....+..+..++.+|+..+|.+|++..+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~ 285 (303)
T cd07869 228 TWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAA 285 (303)
T ss_pred hccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHH
Confidence 0 00000 00123456679999999999999974433
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=295.56 Aligned_cols=237 Identities=22% Similarity=0.251 Sum_probs=188.6
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEecCCCCC---ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLG---DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 813 IG~G~fG~VYka~d~~tg~~VAIKii~~~~~~---~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
||+|+||.||++++..+++.||+|.+...... ....+..|+.++++++||||+++++++.+....++||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999653221 233456799999999999999999999999999999999999999
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT 969 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT 969 (1181)
.+++... ....+++..+..++.|++.||+|||++||+||||||+||+++. ++.++|+|||++....... ......|+
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~-~~~~~l~Dfg~~~~~~~~~-~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDD-QGNCRLSDLGLAVELKDGK-TITQRAGT 157 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcC-CCCEEEeeceeeeecCCCc-eeeccCCC
Confidence 9888644 3445788889999999999999999999999999999999987 8899999999987664322 22234689
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc----cccCCCC--CCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR----ALVAPPQ--ISRS 1043 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~----~l~~~~~--ip~~ 1043 (1181)
..|+|||++.+..++..+|+ ||+||++|+|++|+.||...... .+..... ....
T Consensus 158 ~~y~aPE~~~~~~~~~~~Dv--------------------wslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 217 (277)
T cd05607 158 NGYMAPEILKEEPYSYPVDW--------------------FAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF 217 (277)
T ss_pred CCccCHHHHccCCCCCchhH--------------------HHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc
Confidence 99999999976654444333 99999999999999999865331 1111100 0011
Q ss_pred CCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1044 VSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1044 l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
.....+..+..++.+|+.++|..||+..+
T Consensus 218 ~~~~~~~~~~~li~~~L~~~P~~R~~~~~ 246 (277)
T cd05607 218 EHQNFTEESKDICRLFLAKKPEDRLGSRE 246 (277)
T ss_pred ccccCCHHHHHHHHHHhccCHhhCCCCcc
Confidence 11245677888999999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=307.33 Aligned_cols=236 Identities=24% Similarity=0.336 Sum_probs=184.7
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.+||+|+||.||++++..+++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+++.+|+||||+++|
T Consensus 49 ~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg 128 (370)
T cd05621 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGG 128 (370)
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCC
Confidence 36999999999999999999999999996432 223456889999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC-CCccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP-SAETF 966 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~-~~~t~ 966 (1181)
+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++........ .....
T Consensus 129 ~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~-~~~~kL~DFG~a~~~~~~~~~~~~~~ 203 (370)
T cd05621 129 DLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDK-HGHLKLADFGTCMKMDETGMVRCDTA 203 (370)
T ss_pred cHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECC-CCCEEEEecccceecccCCceecccC
Confidence 999998643 4678889999999999999999999999999999999987 89999999999987643221 22355
Q ss_pred cCCccccCchhhccCCC--CCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCC-----C
Q psy14556 967 TGTLQYMAPEVIDKGQR--GYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPP-----Q 1039 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~--~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~-----~ 1039 (1181)
.||+.|+|||++.+... .++..+|+ ||+||++|+|++|+.||.+.+.......+ .
T Consensus 204 ~gt~~Y~aPE~~~~~~~~~~~~~~~Di------------------wSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 265 (370)
T cd05621 204 VGTPDYISPEVLKSQGGDGYYGRECDW------------------WSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNS 265 (370)
T ss_pred CCCcccCCHHHHhccCCCCCCCcccCE------------------EeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc
Confidence 69999999999975421 13334444 99999999999999999987753321111 1
Q ss_pred CCCCCCCCCCcchHHhhccCCCCCCCC--Cch
Q psy14556 1040 ISRSVSVPGPGGINSSSSAPVTPTPHS--RHI 1069 (1181)
Q Consensus 1040 ip~~l~~~~p~~L~~li~r~la~dPs~--Rp~ 1069 (1181)
+.-......+..+..++.+++..+|.+ |++
T Consensus 266 ~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~ 297 (370)
T cd05621 266 LNFPEDVEISKHAKNLICAFLTDREVRLGRNG 297 (370)
T ss_pred cCCCCcccCCHHHHHHHHHHccCchhccCCCC
Confidence 111111234566777777777644432 554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0415|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=296.81 Aligned_cols=160 Identities=36% Similarity=0.545 Sum_probs=148.2
Q ss_pred cEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCC------
Q psy14556 115 MVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNK------ 188 (1181)
Q Consensus 115 ~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~------ 188 (1181)
|+|++.|++|+|||+||.+.+|.||.||++|| +..| |+++.||.|..+|.+|+|||++ +|.||.++||.-
T Consensus 1 MsVlieTtlGDlvIDLf~~erP~~clNFLKLC--k~KY-YN~clfh~vq~~f~aQTGDPtG-tG~GG~si~~~lyG~q~r 76 (479)
T KOG0415|consen 1 MSVLIETTLGDLVIDLFVKERPRTCLNFLKLC--KIKY-YNFCLFHTVQRDFTAQTGDPTG-TGDGGESIYGVLYGEQAR 76 (479)
T ss_pred CcEEEEeecccEEeeeecccCcHHHHHHHHHH--hHhh-cccceeeeccccceeecCCCCC-CCCCcceeeeecccccch
Confidence 67899999999999999999999999999999 7888 9999999999999999999994 999999999754
Q ss_pred -CCCCc-CccccCCCceEEeecCCCCCCcceEEEEcCCC-CCCCCCCeEEEEEEcCHHHHHHHHhCCC-CCCCcccceEE
Q psy14556 189 -FEDEN-FTLKHTGPGILSMANAGPNTNGSQFFITTVKT-AWLDNRHVVFGSVVEGLDVVKKLESMGS-QSGKTSKKIVV 264 (1181)
Q Consensus 189 -~~dE~-~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~-p~LDg~~vVFGrVieG~dVL~kI~~~~t-~~g~P~~~V~I 264 (1181)
|+.|. ..++|.+.|+|||++.|.|-+||||||||+++ ..|||+|+|||+|.+|+|+|.+|+.+-+ .+++|+++|+|
T Consensus 77 ffeaE~~p~l~Hsk~G~vsmvs~g~n~~gSQF~iTlgenLdyLDg~htvfGqV~EG~dtl~kiNea~vD~~~rPykdIRI 156 (479)
T KOG0415|consen 77 FFEAEFLPKLKHSKMGTVSMVSAGENLNGSQFFITLGENLDYLDGKHTVFGQVAEGFDTLTKINEAIVDPKNRPYKDIRI 156 (479)
T ss_pred hhhhhhcccccccccceEEeecCCcccccceEEEEccccccccccccceeeehhhhHHHHHHHHHHhcCCCCCcccceee
Confidence 34443 37999999999999999999999999999887 5899999999999999999999998877 78999999999
Q ss_pred eeeccccCCCCCCc
Q psy14556 265 ANSDSHSETDSQSS 278 (1181)
Q Consensus 265 ~~cGvl~~~~~~p~ 278 (1181)
.+--+|++|.+.|+
T Consensus 157 ~HTiiLdDPFddpp 170 (479)
T KOG0415|consen 157 KHTIILDDPFDDPP 170 (479)
T ss_pred eeeEEecCCCCCch
Confidence 99999999988883
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=290.63 Aligned_cols=241 Identities=24% Similarity=0.358 Sum_probs=195.6
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCC-CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKN-LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~-~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
++||+|+||.||++.+..+++.+++|.++... ....+.+.+|+.+++.++||||+++++.+.+.+.++++|||+++++|
T Consensus 6 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 85 (255)
T cd08219 6 RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDL 85 (255)
T ss_pred EEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcH
Confidence 47999999999999999999999999986432 33456788999999999999999999999999999999999999999
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT 969 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT 969 (1181)
.+++... ....+++..++.++.|++.||.|||++|++|+||||+||+++. ++.++|+|||.+..............++
T Consensus 86 ~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 163 (255)
T cd08219 86 MQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQ-NGKVKLGDFGSARLLTSPGAYACTYVGT 163 (255)
T ss_pred HHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECC-CCcEEEcccCcceeecccccccccccCC
Confidence 9988653 2345678899999999999999999999999999999999987 8899999999997765443333445689
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC--CCCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ--ISRSVSVP 1047 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~--ip~~l~~~ 1047 (1181)
+.|+|||++.+...+..+|+ ||+|+++|+|++|..||...+......... .....+..
T Consensus 164 ~~~~aPE~~~~~~~~~~~Dv--------------------~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 223 (255)
T cd08219 164 PYYVPPEIWENMPYNNKSDI--------------------WSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSH 223 (255)
T ss_pred ccccCHHHHccCCcCchhhh--------------------hhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcc
Confidence 99999999976544333333 999999999999999999876544321111 11122334
Q ss_pred CCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1048 GPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1048 ~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.+..+..++.+|+..+|..||+..+.
T Consensus 224 ~~~~~~~li~~~l~~~P~~Rp~~~~i 249 (255)
T cd08219 224 YSYELRSLIKQMFKRNPRSRPSATTI 249 (255)
T ss_pred cCHHHHHHHHHHHhCCcccCCCHHHH
Confidence 56678889999999999999974443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=291.05 Aligned_cols=241 Identities=20% Similarity=0.272 Sum_probs=197.3
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCccc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLST 891 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~d 891 (1181)
+||.|+||.||+|.+.. +..+++|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+
T Consensus 13 ~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 91 (261)
T cd05148 13 KLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLA 91 (261)
T ss_pred hhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHH
Confidence 69999999999999877 88999999987766567789999999999999999999999999999999999999999999
Q ss_pred chhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCcc
Q psy14556 892 LLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQ 971 (1181)
Q Consensus 892 lL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~~ 971 (1181)
++... ....+++..++.++.||+.||.|||++|++|+||||+||+++. ++.+||+|||.+..............++..
T Consensus 92 ~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~-~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~ 169 (261)
T cd05148 92 FLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGE-DLVCKVADFGLARLIKEDVYLSSDKKIPYK 169 (261)
T ss_pred HHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcC-CceEEEccccchhhcCCccccccCCCCceE
Confidence 99864 3346788899999999999999999999999999999999988 889999999999776543222333346778
Q ss_pred ccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCC--CCCCCCCCCCC
Q psy14556 972 YMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAP--PQISRSVSVPG 1048 (1181)
Q Consensus 972 Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~--~~ip~~l~~~~ 1048 (1181)
|+|||.+.++.++..+|+ ||+|+++|+|++ |+.||.+.+..++... .......+...
T Consensus 170 ~~~PE~~~~~~~~~~~Di--------------------wslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (261)
T cd05148 170 WTAPEAASHGTFSTKSDV--------------------WSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKC 229 (261)
T ss_pred ecCHHHHccCCCCchhhH--------------------HHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCC
Confidence 999999976554433333 999999999998 8999988765443221 11222334567
Q ss_pred CcchHHhhccCCCCCCCCCchhHHHHHH
Q psy14556 1049 PGGINSSSSAPVTPTPHSRHISVNTNLV 1076 (1181)
Q Consensus 1049 p~~L~~li~r~la~dPs~Rp~s~~~~~~ 1076 (1181)
+..+..++.+|+..+|..||+ +.+...
T Consensus 230 ~~~~~~~i~~~l~~~p~~Rpt-~~~l~~ 256 (261)
T cd05148 230 PQEIYKIMLECWAAEPEDRPS-FKALRE 256 (261)
T ss_pred CHHHHHHHHHHcCCCchhCcC-HHHHHH
Confidence 788999999999999999986 444333
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=293.58 Aligned_cols=238 Identities=23% Similarity=0.296 Sum_probs=182.3
Q ss_pred eeecccCceEEEEEEEcC-CCeEEEEEEecCCCCC--ChhHHHHHHHHHHhc---CCCCeeeEccccc-----cCCcEEE
Q psy14556 811 IELGKGSYGVVYAARELD-RQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQL---RHRNIVQYLGSVS-----EEGYFKI 879 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~-tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L---~HPNIVkl~g~~~-----d~~~l~L 879 (1181)
.+||+|+||.||+|++.. +++.||+|.+...... ....+.+|+.+++.+ +||||+++++++. ....+++
T Consensus 7 ~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~l 86 (290)
T cd07862 7 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 86 (290)
T ss_pred eEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEE
Confidence 369999999999999854 4688999998654322 234567788877766 6999999999874 3457999
Q ss_pred EEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccC
Q psy14556 880 FMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGL 959 (1181)
Q Consensus 880 VmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~ 959 (1181)
||||++ ++|.+++... ....+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||+++.....
T Consensus 87 v~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~ 163 (290)
T cd07862 87 VFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQ 163 (290)
T ss_pred EEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcC-CCCEEEccccceEeccCC
Confidence 999995 6888888754 2345788999999999999999999999999999999999988 899999999999765432
Q ss_pred CCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC---
Q psy14556 960 CPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA--- 1036 (1181)
Q Consensus 960 ~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~--- 1036 (1181)
.......|++.|+|||++.+..++..+ |+ ||+||++|+|++|++||.+.+..+...
T Consensus 164 -~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di------------------wslG~il~el~~g~~~f~~~~~~~~~~~i~ 222 (290)
T cd07862 164 -MALTSVVVTLWYRAPEVLLQSSYATPV--DL------------------WSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 222 (290)
T ss_pred -cccccccccccccChHHHhCCCCCCcc--ch------------------HHHHHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence 233345689999999999765544433 33 999999999999999999876532110
Q ss_pred -------CCCCC------------------CCCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1037 -------PPQIS------------------RSVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1037 -------~~~ip------------------~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
+...+ ....+..+..+..++.+|++.+|.+||+..+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~ 283 (290)
T cd07862 223 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 283 (290)
T ss_pred HHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHH
Confidence 00000 0111234566778999999999999997433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=303.79 Aligned_cols=234 Identities=20% Similarity=0.278 Sum_probs=183.0
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.+||+|+||.||++++..+++.||+|++.+.. ....+.+.+|..++..++|+||+++++++.+.+..|+||||++||
T Consensus 7 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg 86 (331)
T cd05624 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGG 86 (331)
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999999999999999986532 223455788999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC-Cccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS-AETF 966 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~-~~t~ 966 (1181)
+|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||++......... ....
T Consensus 87 ~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~-~~~~kl~DfG~a~~~~~~~~~~~~~~ 163 (331)
T cd05624 87 DLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDM-NGHIRLADFGSCLKMNQDGTVQSSVA 163 (331)
T ss_pred cHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcC-CCCEEEEeccceeeccCCCceeeccc
Confidence 999999753 235678889999999999999999999999999999999987 889999999999766543221 2234
Q ss_pred cCCccccCchhhccCC---CCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC-------
Q psy14556 967 TGTLQYMAPEVIDKGQ---RGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA------- 1036 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~---~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~------- 1036 (1181)
.||+.|+|||++.+.. ..++...|+ ||+|+++|+|++|+.||...+..+...
T Consensus 164 ~gt~~y~aPE~~~~~~~~~~~~~~~~Di------------------wSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~ 225 (331)
T cd05624 164 VGTPDYISPEILQAMEDGMGKYGPECDW------------------WSLGVCMYEMLYGETPFYAESLVETYGKIMNHEE 225 (331)
T ss_pred cCCcccCCHHHHhccccCCCCCCCcccE------------------EeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCC
Confidence 6999999999986421 112223333 999999999999999998876543211
Q ss_pred CCCCCCCCCCCCCcchHHhhccCCCCCCCC
Q psy14556 1037 PPQISRSVSVPGPGGINSSSSAPVTPTPHS 1066 (1181)
Q Consensus 1037 ~~~ip~~l~~~~p~~L~~li~r~la~dPs~ 1066 (1181)
...++.. ....+..+..++.+++..++.+
T Consensus 226 ~~~~p~~-~~~~~~~~~~li~~ll~~~~~~ 254 (331)
T cd05624 226 RFQFPSH-ITDVSEEAKDLIQRLICSRERR 254 (331)
T ss_pred cccCCCc-cccCCHHHHHHHHHHccCchhh
Confidence 1112221 1234666777888887765543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-33 Score=298.80 Aligned_cols=242 Identities=29% Similarity=0.376 Sum_probs=202.7
Q ss_pred hhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCC--CCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEE
Q psy14556 803 LYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEK--NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIF 880 (1181)
Q Consensus 803 ~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~--~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LV 880 (1181)
.+.|.+ .++||+|.|+.|+++.+..+|+.+|+|++... .....+.+.+|+.|-+.|+||||+++.+...+.+..|+|
T Consensus 10 ~d~y~l-~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 10 SDNYDV-KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred chhhhH-HHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 334444 33699999999999999999999999999644 334578899999999999999999999999999999999
Q ss_pred EeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccC--CCeeeeecCCccccccc
Q psy14556 881 MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTY--SGVVKISDFGTSKRLAG 958 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~--~g~vKLiDFGlAk~l~~ 958 (1181)
+|+|.|++|..-+-.+ ...++..+..+++||+++|.|+|.+||||||+||.|+++.+. ..-+||+|||++..+.
T Consensus 89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 9999999986544322 467789999999999999999999999999999999999542 2379999999999887
Q ss_pred CCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC--
Q psy14556 959 LCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA-- 1036 (1181)
Q Consensus 959 ~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~-- 1036 (1181)
.......+.|||.|||||++... .++.++|+ |+.|+|||-++.|.+||.+.+...+..
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkd--py~kpvDi------------------W~cGViLfiLL~G~~PF~~~~~~rlye~I 224 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKD--PYSKPVDI------------------WACGVILYILLVGYPPFWDEDQHRLYEQI 224 (355)
T ss_pred CccccccccCCCcccCHHHhhcC--CCCCcchh------------------hhhhHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 33444567899999999999855 46667766 999999999999999999977655432
Q ss_pred ---CCCCCCCCCCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1037 ---PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1037 ---~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
....+........+.-..++.+++..+|++|-+
T Consensus 225 ~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIt 260 (355)
T KOG0033|consen 225 KAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRIT 260 (355)
T ss_pred hccccCCCCcccCcCCHHHHHHHHHHhccChhhhcc
Confidence 344666666677788888999999999999975
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=310.03 Aligned_cols=232 Identities=24% Similarity=0.302 Sum_probs=185.8
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
..||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++..++||||+++++.+.+.+.+|+||||++||
T Consensus 7 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg 86 (360)
T cd05627 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGG 86 (360)
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCc
Confidence 36999999999999999999999999996532 233567889999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC------
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP------ 961 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~------ 961 (1181)
+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||++..+.....
T Consensus 87 ~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~-~~~vkL~DfG~~~~~~~~~~~~~~~~ 162 (360)
T cd05627 87 DMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDA-KGHVKLSDFGLCTGLKKAHRTEFYRN 162 (360)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECC-CCCEEEeeccCCcccccccccccccc
Confidence 999998743 35778899999999999999999999999999999999987 89999999999875432100
Q ss_pred -----------------------------CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHH
Q psy14556 962 -----------------------------SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFL 1012 (1181)
Q Consensus 962 -----------------------------~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSL 1012 (1181)
......||+.|+|||++.+..++. .+|+ ||+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~--~~Di------------------wSl 222 (360)
T cd05627 163 LTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNK--LCDW------------------WSL 222 (360)
T ss_pred cccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCC--ccee------------------ccc
Confidence 011346999999999997665443 3444 999
Q ss_pred HHHHHHHHhCCCCCCCCCcccccC-------CCCCCCCCCCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1013 CVIISQLLVLTAALKKKTSRALVA-------PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1013 GvILyELLTGk~PF~~~~~~~l~~-------~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
||++|+|++|+.||.+.+...... ...++. ..+.+.....++.+++ .+|..|+.
T Consensus 223 Gvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~~li~~l~-~~p~~R~~ 283 (360)
T cd05627 223 GVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPP--EVPISEKAKDLILRFC-TDSENRIG 283 (360)
T ss_pred cceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCC--CCCCCHHHHHHHHHhc-cChhhcCC
Confidence 999999999999999877654321 111221 1234556666777755 48888875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=301.22 Aligned_cols=230 Identities=21% Similarity=0.280 Sum_probs=180.5
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCC---CCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEK---NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~---~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.+||+|+||.||++++..+++.||+|++.+. .....+.+.+|+.++..++||||+++++++.+.+.+|+||||+++|
T Consensus 7 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~ 86 (331)
T cd05597 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGG 86 (331)
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCC
Confidence 3699999999999999999999999999643 2223456889999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC-Cccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS-AETF 966 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~-~~t~ 966 (1181)
+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..+...... ....
T Consensus 87 ~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~ 163 (331)
T cd05597 87 DLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDK-NGHIRLADFGSCLRLLADGTVQSNVA 163 (331)
T ss_pred cHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECC-CCCEEEEECCceeecCCCCCccccce
Confidence 999999743 235778899999999999999999999999999999999987 899999999998765433222 2224
Q ss_pred cCCccccCchhhccC---CCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC-------
Q psy14556 967 TGTLQYMAPEVIDKG---QRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA------- 1036 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg---~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~------- 1036 (1181)
.||+.|+|||++.+. ...++..+|+ ||+||++|+|++|+.||.+.+..+...
T Consensus 164 ~gt~~y~aPE~~~~~~~~~~~~~~~~Di------------------wslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~ 225 (331)
T cd05597 164 VGTPDYISPEILQAMEDGKGRYGPECDW------------------WSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE 225 (331)
T ss_pred eccccccCHHHHhhccccccCCCCccee------------------ehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCC
Confidence 589999999999642 1123334444 999999999999999998876543211
Q ss_pred CCCCCCCCCCCCCcchHHhhccCCCC
Q psy14556 1037 PPQISRSVSVPGPGGINSSSSAPVTP 1062 (1181)
Q Consensus 1037 ~~~ip~~l~~~~p~~L~~li~r~la~ 1062 (1181)
...++.. ....+..+..++.+++..
T Consensus 226 ~~~~~~~-~~~~~~~~~~li~~ll~~ 250 (331)
T cd05597 226 HFQFPPD-VTDVSEEAKDLIRRLICS 250 (331)
T ss_pred cccCCCc-cCCCCHHHHHHHHHHccC
Confidence 1112211 123566677777776654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=293.24 Aligned_cols=245 Identities=23% Similarity=0.267 Sum_probs=193.9
Q ss_pred eecccCceEEEEEEEcCCC-----eEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 812 ELGKGSYGVVYAARELDRQ-----VKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg-----~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
.||+|+||.||+|.+...+ ..|++|.+...... ..+.+.+|+.++++++||||+++++++...+..+++|||++
T Consensus 12 ~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 91 (283)
T cd05048 12 ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLA 91 (283)
T ss_pred cccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCC
Confidence 6999999999999876555 78999998654332 24568899999999999999999999999999999999999
Q ss_pred CCCcccchhcccC-------------CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCc
Q psy14556 886 GGSLSTLLRVKWG-------------PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGT 952 (1181)
Q Consensus 886 gGSL~dlL~~~~~-------------~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGl 952 (1181)
+++|.+++..... ...+++..++.++.|++.||.|||++|++|+||||+||+++. ++.++|+|||+
T Consensus 92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~-~~~~~L~dfg~ 170 (283)
T cd05048 92 HGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE-GLTVKISDFGL 170 (283)
T ss_pred CCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC-CCcEEECCCcc
Confidence 9999999875311 135678889999999999999999999999999999999987 88999999999
Q ss_pred ccccccCCC--CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCC
Q psy14556 953 SKRLAGLCP--SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKK 1029 (1181)
Q Consensus 953 Ak~l~~~~~--~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~ 1029 (1181)
++....... ......+++.|+|||.+.++..+..+|+ ||+||++|||++ |..||.+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv--------------------~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05048 171 SRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDI--------------------WSFGVVLWEIFSYGLQPYYGF 230 (283)
T ss_pred eeeccccccccccCCCcccccccCHHHhccCcCchhhhH--------------------HHHHHHHHHHHcCCCCCCCCC
Confidence 876533211 1223346788999999876654444333 999999999998 99999987
Q ss_pred CcccccCCC--CCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1030 TSRALVAPP--QISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1030 ~~~~l~~~~--~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
...++.... ......+...+..+..++.+|++.+|..||. +++....+
T Consensus 231 ~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~-~~~i~~~l 280 (283)
T cd05048 231 SNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPR-FKDIHTRL 280 (283)
T ss_pred CHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcC-HHHHHHHH
Confidence 765543221 1122234567889999999999999999996 44444433
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=297.31 Aligned_cols=201 Identities=27% Similarity=0.379 Sum_probs=175.4
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCC-eeeEccccccCC------cEEEEEe
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRN-IVQYLGSVSEEG------YFKIFME 882 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPN-IVkl~g~~~d~~------~l~LVmE 882 (1181)
+||+|+||+||+|+.+.+|+.||+|++...... .-....+|+.+++.++|+| |+.+++++...+ .+++|+|
T Consensus 18 klGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe 97 (323)
T KOG0594|consen 18 KLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFE 97 (323)
T ss_pred HhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEE
Confidence 599999999999999999999999999766442 3456789999999999999 999999997776 8999999
Q ss_pred ecCCCCcccchhcccCC-CCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC
Q psy14556 883 QVPGGSLSTLLRVKWGP-LKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP 961 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~~-~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~ 961 (1181)
|+ ..+|..++...... ..++...++.++.||+.||+|||+++|+||||||.|||+++ +|.+||+|||+|+...-+..
T Consensus 98 ~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~-~G~lKlaDFGlAra~~ip~~ 175 (323)
T KOG0594|consen 98 FL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISS-SGVLKLADFGLARAFSIPMR 175 (323)
T ss_pred ee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECC-CCcEeeeccchHHHhcCCcc
Confidence 99 78899999865321 35667889999999999999999999999999999999998 99999999999997764444
Q ss_pred CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc
Q psy14556 962 SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA 1033 (1181)
Q Consensus 962 ~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~ 1033 (1181)
....-++|.+|+|||++.+.. .|+..+|+ ||+|||++||+++++.|.+.+..+
T Consensus 176 ~yt~evvTlWYRaPEvLlGs~-~Ys~~vDi------------------Ws~GcIfaEm~~~~~LFpG~se~~ 228 (323)
T KOG0594|consen 176 TYTPEVVTLWYRAPEVLLGST-SYSTSVDI------------------WSLGCIFAEMFTRRPLFPGDSEID 228 (323)
T ss_pred cccccEEEeeccCHHHhcCCC-cCCCCcch------------------HhHHHHHHHHHhCCCCCCCCcHHH
Confidence 455567899999999998654 58889988 999999999999999999988743
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=301.66 Aligned_cols=234 Identities=20% Similarity=0.280 Sum_probs=182.0
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.+||+|+||.||++++..+++.+|+|++.+.. ....+.+.+|+.++..++|+||+++++.+.+.+.+|+||||+++|
T Consensus 7 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g 86 (332)
T cd05623 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGG 86 (332)
T ss_pred EEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCC
Confidence 37999999999999999999999999986432 223445888999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC-Cccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS-AETF 966 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~-~~t~ 966 (1181)
+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..+...... ....
T Consensus 87 ~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~-~~~~kL~DfG~a~~~~~~~~~~~~~~ 163 (332)
T cd05623 87 DLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM-NGHIRLADFGSCLKLMEDGTVQSSVA 163 (332)
T ss_pred cHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECC-CCCEEEeecchheecccCCcceeccc
Confidence 999999753 235778889999999999999999999999999999999987 899999999998765432221 2235
Q ss_pred cCCccccCchhhccC---CCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCC------
Q psy14556 967 TGTLQYMAPEVIDKG---QRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAP------ 1037 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg---~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~------ 1037 (1181)
.||+.|+|||++.+. ...++...|+ ||+||++|+|++|+.||.+.+.......
T Consensus 164 ~gt~~y~aPE~~~~~~~~~~~~~~~~Dv------------------wSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~ 225 (332)
T cd05623 164 VGTPDYISPEILQAMEDGKGKYGPECDW------------------WSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE 225 (332)
T ss_pred ccCccccCHHHHhccccCCCCCCCcCCE------------------EeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc
Confidence 699999999998632 1122333343 9999999999999999998765442111
Q ss_pred -CCCCCCCCCCCCcchHHhhccCCCCCCCC
Q psy14556 1038 -PQISRSVSVPGPGGINSSSSAPVTPTPHS 1066 (1181)
Q Consensus 1038 -~~ip~~l~~~~p~~L~~li~r~la~dPs~ 1066 (1181)
..++.. ....+..+..++.+++..+|.+
T Consensus 226 ~~~~p~~-~~~~s~~~~~li~~ll~~~~~r 254 (332)
T cd05623 226 RFQFPAQ-VTDVSEDAKDLIRRLICSREHR 254 (332)
T ss_pred cccCCCc-cccCCHHHHHHHHHHccChhhh
Confidence 111111 1234666777888877654443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=294.87 Aligned_cols=239 Identities=22% Similarity=0.316 Sum_probs=195.1
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
.+||+|+||.||+|.+..+++.|++|.+........+.+.+|+.+++.++||||+++++.+......++||||+++++|.
T Consensus 26 ~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (296)
T cd06654 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105 (296)
T ss_pred EEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHH
Confidence 36999999999999999999999999998766666678999999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCc
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL 970 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~ 970 (1181)
+++... .+++..+..++.|++.||.|||++||+||||||+||+++. ++.+||+|||.+..............+++
T Consensus 106 ~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 180 (296)
T cd06654 106 DVVTET----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQITPEQSKRSTMVGTP 180 (296)
T ss_pred HHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC-CCCEEECccccchhccccccccCcccCCc
Confidence 998643 4678889999999999999999999999999999999987 88999999999876554333333456889
Q ss_pred cccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC----CCCCCCCCCC
Q psy14556 971 QYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA----PPQISRSVSV 1046 (1181)
Q Consensus 971 ~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~----~~~ip~~l~~ 1046 (1181)
.|+|||.+.+...+..+|+ ||+||++|+|++|+.||.......... ....+...+.
T Consensus 181 ~y~aPE~~~~~~~~~~~Dv--------------------~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T cd06654 181 YWMAPEVVTRKAYGPKVDI--------------------WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE 240 (296)
T ss_pred cccCHHHHcCCCCCccchH--------------------HHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCcc
Confidence 9999999976554444333 999999999999999998766532110 0111111223
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
..+..+..++.+|+.++|..||+..+..
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil 268 (296)
T cd06654 241 KLSAIFRDFLNRCLDMDVEKRGSAKELL 268 (296)
T ss_pred ccCHHHHHHHHHHCcCCcccCcCHHHHh
Confidence 4566788899999999999999744443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=293.39 Aligned_cols=242 Identities=24% Similarity=0.333 Sum_probs=205.8
Q ss_pred CceeecccCceEEEEEEEcCCCeEEEEEEecCCCC----CC----hhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEE
Q psy14556 809 NRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL----GD----VQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKI 879 (1181)
Q Consensus 809 ~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~----~~----~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~L 879 (1181)
.++.||.|..++|-++.++.++..+|+|++..... .. .+.-.+|+.||+++ .||||+++.++++.+..+++
T Consensus 21 pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~Fl 100 (411)
T KOG0599|consen 21 PKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFL 100 (411)
T ss_pred hHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhh
Confidence 34469999999999999999999999999954322 11 35567899999998 69999999999999999999
Q ss_pred EEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccC
Q psy14556 880 FMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGL 959 (1181)
Q Consensus 880 VmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~ 959 (1181)
|+|.|+.|.|.++|.. ...+++.....|++|+++|+.|||.++||||||||+|||+++ +.++||+|||+++.+...
T Consensus 101 VFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILldd-n~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 101 VFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDD-NMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecc-ccceEEeccceeeccCCc
Confidence 9999999999999984 457889999999999999999999999999999999999998 889999999999988754
Q ss_pred CCCCccccCCccccCchhhc----cCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc-
Q psy14556 960 CPSAETFTGTLQYMAPEVID----KGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL- 1034 (1181)
Q Consensus 960 ~~~~~t~~GT~~Y~APEvl~----gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l- 1034 (1181)
......+|||+|.|||.+. .+..+|+..||. |++|+|||.++.|.+||.......+
T Consensus 177 -ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~------------------Wa~GVImyTLLaGcpPFwHRkQmlML 237 (411)
T KOG0599|consen 177 -EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDE------------------WACGVIMYTLLAGCPPFWHRKQMLML 237 (411)
T ss_pred -hhHHHhcCCCcccChhheeeecccCCCCccchhhH------------------HHHHHHHHHHHcCCCchhHHHHHHHH
Confidence 4556679999999999985 334566677766 9999999999999999998766432
Q ss_pred ----cCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1035 ----VAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1035 ----~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
..+-++..+...........++.+++..||.+|.+.-+.
T Consensus 238 R~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~ 280 (411)
T KOG0599|consen 238 RMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEA 280 (411)
T ss_pred HHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHH
Confidence 334556666666778889999999999999999864443
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=288.09 Aligned_cols=242 Identities=24% Similarity=0.352 Sum_probs=192.2
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
++||+|+||.||+|++..+++.||+|.+..... .....+.+|+.+++.++||||+++++++.+.+..++++||++++
T Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 87 (267)
T cd08228 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAG 87 (267)
T ss_pred eeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCC
Confidence 369999999999999999999999998864332 22456889999999999999999999999999999999999999
Q ss_pred Ccccchhccc-CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccc
Q psy14556 888 SLSTLLRVKW-GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF 966 (1181)
Q Consensus 888 SL~dlL~~~~-~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~ 966 (1181)
+|.+++.... ....+++..++.++.|++.||.|||++|++|+||||+||+++. ++.++|+|||.+.............
T Consensus 88 ~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~-~~~~~l~d~g~~~~~~~~~~~~~~~ 166 (267)
T cd08228 88 DLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSL 166 (267)
T ss_pred cHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcC-CCCEEECccccceeccchhHHHhcC
Confidence 9998886421 2345778889999999999999999999999999999999987 8899999999988765433323345
Q ss_pred cCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc--ccc---CCCCCC
Q psy14556 967 TGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR--ALV---APPQIS 1041 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~--~l~---~~~~ip 1041 (1181)
.+++.|+|||.+.+...+..+|+ ||+|+++|+|++|+.||...... .+. .....+
T Consensus 167 ~~~~~~~aPE~~~~~~~~~~~Di--------------------~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 226 (267)
T cd08228 167 VGTPYYMSPERIHENGYNFKSDI--------------------WSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYP 226 (267)
T ss_pred CCCccccChhhhccCCCCchhhH--------------------HHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCC
Confidence 68899999999976544333333 99999999999999999765432 111 111122
Q ss_pred CCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1042 RSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1042 ~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.......+..+..++.+|+..+|..||...+.
T Consensus 227 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~v 258 (267)
T cd08228 227 PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYV 258 (267)
T ss_pred CCChhhcCHHHHHHHHHHCCCCcccCcCHHHH
Confidence 22223456778999999999999999975443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=289.05 Aligned_cols=240 Identities=22% Similarity=0.290 Sum_probs=193.6
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
.+||+|+||.||+|.+..+++.|++|.+.... ...+.+.+|+.++++++||||+++++++...+.++++|||+++++|.
T Consensus 12 ~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (263)
T cd05052 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 90 (263)
T ss_pred eecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHH
Confidence 36999999999999999999999999986542 33567899999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC-CccccCC
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS-AETFTGT 969 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~-~~t~~GT 969 (1181)
+++... ....+++..++.++.|++.||+|||++|++||||||+||+++. ++.+||+|||.+......... .....++
T Consensus 91 ~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~-~~~~kl~df~~~~~~~~~~~~~~~~~~~~ 168 (263)
T cd05052 91 DYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE-NHLVKVADFGLSRLMTGDTYTAHAGAKFP 168 (263)
T ss_pred HHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcC-CCcEEeCCCccccccccceeeccCCCCCc
Confidence 998754 3345788889999999999999999999999999999999987 899999999999766532211 1112245
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCC--CCCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPP--QISRSVSV 1046 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~--~ip~~l~~ 1046 (1181)
..|+|||.+.+...+..+|+ ||+|+++|+|++ |..||.+.+..+..... ......+.
T Consensus 169 ~~y~aPE~~~~~~~~~~~Dv--------------------~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 228 (263)
T cd05052 169 IKWTAPESLAYNKFSIKSDV--------------------WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPE 228 (263)
T ss_pred cccCCHHHhccCCCCchhHH--------------------HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Confidence 68999999976654433333 999999999998 99999886654432111 12223344
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
..+..+..++.+|+..+|..||+..+.
T Consensus 229 ~~~~~~~~li~~cl~~~p~~Rp~~~~l 255 (263)
T cd05052 229 GCPPKVYELMRACWQWNPSDRPSFAEI 255 (263)
T ss_pred CCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 567889999999999999999975444
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=283.44 Aligned_cols=243 Identities=23% Similarity=0.321 Sum_probs=196.8
Q ss_pred eecccCceEEEEEEEcCC---CeEEEEEEecCCCCCC-hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAARELDR---QVKLAIKEIPEKNLGD-VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~t---g~~VAIKii~~~~~~~-~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
+||+|+||.||+|.+... +..|++|.+....... .+.+.+|+..++.++|+||+++++++.....++++|||++++
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG 81 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence 599999999999999866 8899999997664443 678999999999999999999999999999999999999999
Q ss_pred CcccchhcccC------CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC-
Q psy14556 888 SLSTLLRVKWG------PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC- 960 (1181)
Q Consensus 888 SL~dlL~~~~~------~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~- 960 (1181)
+|.+++..... ...+++..++.++.|++.||+|||++|++|+||||+||+++. ++.+||+|||.+.......
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~-~~~~~l~dfg~~~~~~~~~~ 160 (262)
T cd00192 82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGE-DLVVKISDFGLSRDVYDDDY 160 (262)
T ss_pred cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECC-CCcEEEcccccccccccccc
Confidence 99999985421 256889999999999999999999999999999999999998 7999999999998765432
Q ss_pred -CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCC
Q psy14556 961 -PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPP 1038 (1181)
Q Consensus 961 -~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~ 1038 (1181)
.......++..|+|||.+.+...+..+|+ ||+|+++|+|++ |..||.......+....
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di--------------------~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 220 (262)
T cd00192 161 YRKKTGGKLPIRWMAPESLKDGIFTSKSDV--------------------WSFGVLLWEIFTLGATPYPGLSNEEVLEYL 220 (262)
T ss_pred cccccCCCcCccccCHHHhccCCcchhhcc--------------------HHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 12233457889999999976543333333 999999999999 69999887654432211
Q ss_pred C--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHH
Q psy14556 1039 Q--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLV 1076 (1181)
Q Consensus 1039 ~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~ 1076 (1181)
. .....+...+..+..++.+|+..+|..||+ +.+...
T Consensus 221 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~~~l~~ 259 (262)
T cd00192 221 RKGYRLPKPEYCPDELYELMLSCWQLDPEDRPT-FSELVE 259 (262)
T ss_pred HcCCCCCCCccCChHHHHHHHHHccCCcccCcC-HHHHHH
Confidence 1 111223445778899999999999999985 444443
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=308.24 Aligned_cols=233 Identities=24% Similarity=0.337 Sum_probs=184.7
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
++||+|+||.||+|++..+++.||+|++.+.. ....+.+.+|+.+++.++||||+++++.+.+.+..|+||||+++|
T Consensus 49 ~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg 128 (371)
T cd05622 49 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG 128 (371)
T ss_pred EEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCC
Confidence 46999999999999999999999999986432 223456788999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC-CCccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP-SAETF 966 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~-~~~t~ 966 (1181)
+|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++........ .....
T Consensus 129 ~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~-~~~ikL~DfG~a~~~~~~~~~~~~~~ 203 (371)
T cd05622 129 DLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK-SGHLKLADFGTCMKMNKEGMVRCDTA 203 (371)
T ss_pred cHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECC-CCCEEEEeCCceeEcCcCCcccccCc
Confidence 999998743 4678888899999999999999999999999999999987 89999999999987653221 22345
Q ss_pred cCCccccCchhhccCCC--CCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC-----CCC
Q psy14556 967 TGTLQYMAPEVIDKGQR--GYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA-----PPQ 1039 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~--~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~-----~~~ 1039 (1181)
.||+.|+|||++.+... .++...|+ ||+||++|+|++|..||.+.+...... ...
T Consensus 204 ~gt~~y~aPE~l~~~~~~~~~~~~~Di------------------wSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 265 (371)
T cd05622 204 VGTPDYISPEVLKSQGGDGYYGRECDW------------------WSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS 265 (371)
T ss_pred ccCccccCHHHHhccCCCccCCCccce------------------eehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc
Confidence 69999999999975321 13334444 999999999999999999877543211 111
Q ss_pred CCCCCCCCCCcchHHhhccCCCCCCCCC
Q psy14556 1040 ISRSVSVPGPGGINSSSSAPVTPTPHSR 1067 (1181)
Q Consensus 1040 ip~~l~~~~p~~L~~li~r~la~dPs~R 1067 (1181)
+.-......+..+..++.+++. +|..|
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~-~~~~r 292 (371)
T cd05622 266 LTFPDDNDISKEAKNLICAFLT-DREVR 292 (371)
T ss_pred ccCCCcCCCCHHHHHHHHHHcC-Chhhh
Confidence 1112223456677778888887 44444
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-32 Score=314.60 Aligned_cols=249 Identities=23% Similarity=0.280 Sum_probs=201.2
Q ss_pred hhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEE
Q psy14556 803 LYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIF 880 (1181)
Q Consensus 803 ~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LV 880 (1181)
..+.......||+|.||+||+|+|.. .||||++..... ...+.|++|+..+++-+|.||+-+.|++...+. .||
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIi 465 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AII 465 (678)
T ss_pred CHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eee
Confidence 33333444579999999999999865 699999976644 347889999999999999999999999998877 999
Q ss_pred EeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccc--c
Q psy14556 881 MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA--G 958 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~--~ 958 (1181)
+.+|+|.+|+.+++... ..++....+.|++||++|+.|||.++|||||||..||++.+ ++.|||+|||++.... .
T Consensus 466 TqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~-~~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHE-DLKVKIGDFGLATVKTRWS 542 (678)
T ss_pred ehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEcc-CCcEEEecccceeeeeeec
Confidence 99999999999998653 46778889999999999999999999999999999999988 7999999999985432 2
Q ss_pred CCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCC
Q psy14556 959 LCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPP 1038 (1181)
Q Consensus 959 ~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~ 1038 (1181)
.........|...|||||+++.+. ..+|..-++.||||+++|||+||..||...+...+....
T Consensus 543 g~~q~~qp~gsilwmAPEvIRmqd-----------------~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV 605 (678)
T KOG0193|consen 543 GEQQLEQPHGSLLWMAPEVIRMQD-----------------DNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV 605 (678)
T ss_pred cccccCCCccchhhhcHHHHhhcc-----------------cCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe
Confidence 223334456889999999997321 235556666699999999999999999976666653322
Q ss_pred CC------CCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHH
Q psy14556 1039 QI------SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNL 1075 (1181)
Q Consensus 1039 ~i------p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~ 1075 (1181)
.. .......+|..+.+++..|+..+|..||.+-+.+.
T Consensus 606 GrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 606 GRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred cccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 11 11223467889999999999999999999887754
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=319.50 Aligned_cols=247 Identities=21% Similarity=0.302 Sum_probs=196.5
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccCC-------
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEG------- 875 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~------- 875 (1181)
.|.+ .++||+|+||+||+|++..+++.||+|++..... .....+.+|+.++..++|+||+++++.+...+
T Consensus 33 rY~i-~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 33 KYWI-SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CEEE-EEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 3444 3479999999999999999999999999976533 23456889999999999999999988764332
Q ss_pred -cEEEEEeecCCCCcccchhccc-CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcc
Q psy14556 876 -YFKIFMEQVPGGSLSTLLRVKW-GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTS 953 (1181)
Q Consensus 876 -~l~LVmEy~~gGSL~dlL~~~~-~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlA 953 (1181)
.+++||||+++|+|.+++.... ....+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||++
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~-~~~vkL~DFGls 190 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCS-NGLVKLGDFGFS 190 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeC-CCCEEEEecccC
Confidence 3789999999999999987432 2346788999999999999999999999999999999999988 899999999999
Q ss_pred cccccCC--CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCc
Q psy14556 954 KRLAGLC--PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTS 1031 (1181)
Q Consensus 954 k~l~~~~--~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~ 1031 (1181)
+.+.... .......||+.|+|||++.+..++.. .|+ ||+||++|+|++|+.||.+.+.
T Consensus 191 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k--~DV------------------wSlGvilyeLltG~~Pf~~~~~ 250 (496)
T PTZ00283 191 KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK--ADM------------------FSLGVLLYELLTLKRPFDGENM 250 (496)
T ss_pred eeccccccccccccccCCcceeCHHHhCCCCCCcH--HHH------------------HHHHHHHHHHHHCCCCCCCCCH
Confidence 7654321 22334579999999999976544333 333 9999999999999999998776
Q ss_pred ccccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1032 RALVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1032 ~~l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
..+..... .....+...+..+..++.+|+..+|..||+..+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~el 294 (496)
T PTZ00283 251 EEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKL 294 (496)
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 54322111 1122345567789999999999999999986654
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=291.24 Aligned_cols=245 Identities=22% Similarity=0.246 Sum_probs=194.0
Q ss_pred eecccCceEEEEEEEcC-----CCeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 812 ELGKGSYGVVYAARELD-----RQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~-----tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
+||+|+||.||+|.+.. +++.||+|.+...... ..+.+.+|+++++.++||||+++++++...+..++||||++
T Consensus 12 ~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 91 (280)
T cd05049 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYME 91 (280)
T ss_pred hccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCC
Confidence 69999999999998743 4578999999765444 35679999999999999999999999999999999999999
Q ss_pred CCCcccchhccc-----------CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccc
Q psy14556 886 GGSLSTLLRVKW-----------GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954 (1181)
Q Consensus 886 gGSL~dlL~~~~-----------~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk 954 (1181)
+++|.+++.... ....+++..+..++.|++.||.|||++|++||||||+||+++. ++.+||+|||++.
T Consensus 92 ~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~-~~~~kl~d~g~~~ 170 (280)
T cd05049 92 HGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY-DLVVKIGDFGMSR 170 (280)
T ss_pred CCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcC-CCeEEECCcccce
Confidence 999999997532 1235678889999999999999999999999999999999988 8999999999987
Q ss_pred ccccCCC--CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCc
Q psy14556 955 RLAGLCP--SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTS 1031 (1181)
Q Consensus 955 ~l~~~~~--~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~ 1031 (1181)
....... ......+++.|+|||++.++.++..+|+ ||+|+++|+|++ |..||.+...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di--------------------~slG~il~e~~~~g~~p~~~~~~ 230 (280)
T cd05049 171 DVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV--------------------WSFGVVLWEIFTYGKQPWYGLSN 230 (280)
T ss_pred ecccCcceecCCCCcccceecChhhhccCCcchhhhH--------------------HHHHHHHHHHHhcCCCCCCCCCH
Confidence 5532211 1223345788999999986654444333 999999999998 9999987765
Q ss_pred ccccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1032 RALVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1032 ~~l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
........ .....+...+..+..++.+|+..+|..||. +.+.+..+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~-~~eil~~l 278 (280)
T cd05049 231 EEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRIN-IKDIHERL 278 (280)
T ss_pred HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCC-HHHHHHHh
Confidence 54322111 112223456788999999999999999995 45544443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=328.04 Aligned_cols=250 Identities=23% Similarity=0.317 Sum_probs=193.5
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEcccccc--CCcEEEE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSE--EGYFKIF 880 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d--~~~l~LV 880 (1181)
.|.+. .+||+|+||+||+|++..++..||+|.+...... ....+..|+.++++++||||++++++|.+ ...+|||
T Consensus 14 ~YeIl-~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIV 92 (1021)
T PTZ00266 14 EYEVI-KKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYIL 92 (1021)
T ss_pred CEEEE-EEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEE
Confidence 34443 3699999999999999999999999999755332 35678899999999999999999998854 4579999
Q ss_pred EeecCCCCcccchhccc-CCCCCChHHHHHHHHHHHhhhhhcccc-------ceecccCCCCCcccccC-----------
Q psy14556 881 MEQVPGGSLSTLLRVKW-GPLKENESTMSFYTKQILEGLKYLHGQ-------KIVHRDIKGDNVLVNTY----------- 941 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~-~~~~l~e~~i~~Ia~QIa~AL~yLHs~-------gIVHrDLKP~NILLd~~----------- 941 (1181)
|||+++++|.+++.... ....+++..++.|+.||+.||.|||+. +||||||||+||||+..
T Consensus 93 MEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~ 172 (1021)
T PTZ00266 93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172 (1021)
T ss_pred EeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence 99999999999987532 224688999999999999999999984 49999999999999641
Q ss_pred -----CCeeeeecCCcccccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHH
Q psy14556 942 -----SGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVII 1016 (1181)
Q Consensus 942 -----~g~vKLiDFGlAk~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvIL 1016 (1181)
.+.+||+|||++..+... .......||+.|+|||++.+....++...|+ |||||||
T Consensus 173 ~n~ng~~iVKLsDFGlAr~l~~~-s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDV------------------WSLG~IL 233 (1021)
T PTZ00266 173 NNLNGRPIAKIGDFGLSKNIGIE-SMAHSCVGTPYYWSPELLLHETKSYDDKSDM------------------WALGCII 233 (1021)
T ss_pred cccCCCCceEEccCCcccccccc-ccccccCCCccccCHHHHhccCCCCCchhHH------------------HHHHHHH
Confidence 235899999999766432 2223456999999999996544344444444 9999999
Q ss_pred HHHHhCCCCCCCCCccc-ccCCCC-CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1017 SQLLVLTAALKKKTSRA-LVAPPQ-ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1017 yELLTGk~PF~~~~~~~-l~~~~~-ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
|+|++|..||....... +..... .+.......+..+..++.+|+..+|..||+..+.+
T Consensus 234 YELLTGk~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL 293 (1021)
T PTZ00266 234 YELCSGKTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCL 293 (1021)
T ss_pred HHHHHCCCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHh
Confidence 99999999998655322 111111 11111223567788999999999999999977764
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=291.69 Aligned_cols=238 Identities=18% Similarity=0.193 Sum_probs=188.1
Q ss_pred eeecccCceEEEEEEEc---CCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCC
Q psy14556 811 IELGKGSYGVVYAAREL---DRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~---~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
+.||+|+||.||+|.+. ..+..||+|.++.... ...+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 11 ~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 90 (266)
T cd05064 11 RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSN 90 (266)
T ss_pred eeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCC
Confidence 36999999999999865 4567899999976533 2245688999999999999999999999999999999999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC-CCcc
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP-SAET 965 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~-~~~t 965 (1181)
|+|.+++... ...+++..++.++.|++.||+|||++|++||||||+||+++. ++.++++|||.+........ ....
T Consensus 91 ~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~ 167 (266)
T cd05064 91 GALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNS-DLVCKISGFRRLQEDKSEAIYTTMS 167 (266)
T ss_pred CcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcC-CCcEEECCCcccccccccchhcccC
Confidence 9999998754 235678899999999999999999999999999999999987 88999999998765432111 1112
Q ss_pred ccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--CCC
Q psy14556 966 FTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--ISR 1042 (1181)
Q Consensus 966 ~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--ip~ 1042 (1181)
..++..|+|||.+.++.++..+|+ ||+||++|++++ |..||...+...+..... ...
T Consensus 168 ~~~~~~y~aPE~~~~~~~~~~~Di--------------------~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~ 227 (266)
T cd05064 168 GKSPVLWAAPEAIQYHHFSSASDV--------------------WSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL 227 (266)
T ss_pred CCCceeecCHHHHhhCCccchhHH--------------------HHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC
Confidence 235678999999976654444333 999999999775 999998876544321111 111
Q ss_pred CCCCCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1043 SVSVPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1043 ~l~~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
..+...+..+..++.+|+..+|..||+..
T Consensus 228 ~~~~~~~~~~~~li~~c~~~~p~~RP~~~ 256 (266)
T cd05064 228 PAPRNCPNLLHQLMLDCWQKERGERPRFS 256 (266)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCCCHH
Confidence 23445678899999999999999999743
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=313.87 Aligned_cols=250 Identities=22% Similarity=0.306 Sum_probs=209.0
Q ss_pred cccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 806 FALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 806 ~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
|.+.+ .||-|+||.||+|.++.++...|.|++........+.+.-||.||..++||+||++++.|..++.+||+.|||.
T Consensus 34 WeIiG-ELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 34 WEIIG-ELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHh-hhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 34444 49999999999999999998899999988888888999999999999999999999999999999999999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcc
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAET 965 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t 965 (1181)
||-.+.++-.- ...+.+.++..+++|++.||.|||+++|||||||..|||++- +|.++|+|||.+...........+
T Consensus 113 GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tl-dGdirLADFGVSAKn~~t~qkRDs 189 (1187)
T KOG0579|consen 113 GGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTL-DGDIRLADFGVSAKNKSTRQKRDS 189 (1187)
T ss_pred CchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEe-cCcEeeecccccccchhHHhhhcc
Confidence 99998887643 336778999999999999999999999999999999999998 899999999998776655556667
Q ss_pred ccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC---CCC
Q psy14556 966 FTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ---ISR 1042 (1181)
Q Consensus 966 ~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~---ip~ 1042 (1181)
+.|||+|||||+..-.. ..+.+|+..++.||||++|.||..+.+|....++..+..++. .|.
T Consensus 190 FIGTPYWMAPEVvmCET---------------~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPT 254 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCET---------------FKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT 254 (1187)
T ss_pred ccCCcccccchheeecc---------------ccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCc
Confidence 89999999999985221 113356666666999999999999999999888766533332 222
Q ss_pred CC-CCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1043 SV-SVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1043 ~l-~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
.. +..+...+...+.+|+.++|..||+.++.+
T Consensus 255 LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll 287 (1187)
T KOG0579|consen 255 LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLL 287 (1187)
T ss_pred ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHh
Confidence 22 234566788899999999999999977764
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=290.66 Aligned_cols=246 Identities=24% Similarity=0.331 Sum_probs=194.4
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
.+||+|+||.||++.+..++..+++|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~ 90 (282)
T cd06643 11 GELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVD 90 (282)
T ss_pred hhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHH
Confidence 36999999999999999999999999997665555677889999999999999999999999999999999999999998
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCc
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL 970 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~ 970 (1181)
.++... ...+++..+..++.|++.||.|||+.|++||||||+||+++. ++.+||+|||++..............++.
T Consensus 91 ~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 167 (282)
T cd06643 91 AVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTL-DGDIKLADFGVSAKNTRTIQRRDSFIGTP 167 (282)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcc-CCCEEEccccccccccccccccccccccc
Confidence 887642 235788999999999999999999999999999999999987 88999999999876544333334456899
Q ss_pred cccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCC----CCCCCCCC
Q psy14556 971 QYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPP----QISRSVSV 1046 (1181)
Q Consensus 971 ~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~----~ip~~l~~ 1046 (1181)
.|+|||++...... ... ++...+.||+||++|+|++|+.||...+........ ......+.
T Consensus 168 ~y~aPE~~~~~~~~-~~~--------------~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd06643 168 YWMAPEVVMCETSK-DRP--------------YDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPS 232 (282)
T ss_pred cccCHhhccccCCC-CCC--------------CCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCcc
Confidence 99999998532110 011 111222299999999999999999877654321111 01111223
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
..+..+..++.+|+..+|..||...+..
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rp~~~~il 260 (282)
T cd06643 233 RWSSEFKDFLKKCLEKNVDARWTTTQLL 260 (282)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 4567889999999999999999865543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=287.14 Aligned_cols=239 Identities=20% Similarity=0.289 Sum_probs=188.7
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
+||+|+||.||+|.+..+++.+|+|.+...... ....+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 599999999999999999999999988654322 2456899999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCC--ccccC
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA--ETFTG 968 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~--~t~~G 968 (1181)
+++... ...+++..++.++.|++.||.|||++|++||||||+||+++. ++.+||+|||++.......... .....
T Consensus 82 ~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 82 TFLRTE--GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTE-KNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred HHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcC-CCcEEECccccCcccccccccccCCCCCC
Confidence 998743 235678899999999999999999999999999999999987 8899999999987544221111 11123
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCC--CCCCCCCC
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAP--PQISRSVS 1045 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~--~~ip~~l~ 1045 (1181)
+..|+|||.+.++..+..+| + ||+|+++|+|++ |..||........... ...+...+
T Consensus 159 ~~~y~aPE~~~~~~~~~~~D--v------------------~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 218 (252)
T cd05084 159 PVKWTAPEALNYGRYSSESD--V------------------WSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCP 218 (252)
T ss_pred ceeecCchhhcCCCCChHHH--H------------------HHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCc
Confidence 45799999997665433333 3 999999999998 8899976655332111 11122333
Q ss_pred CCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1046 VPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1046 ~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
...+..+..++.+|+..+|.+||+..+.
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~ 246 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTV 246 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 4567788899999999999999864443
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=302.04 Aligned_cols=243 Identities=24% Similarity=0.318 Sum_probs=190.9
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
.+||+|+||.||++.+..++..+|+|.+..... ...+.+.+|++++++++||||+++++++.+.+.+++||||+++++|
T Consensus 11 ~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 90 (333)
T cd06650 11 SELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 90 (333)
T ss_pred ccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcH
Confidence 369999999999999999999999999875532 2345689999999999999999999999999999999999999999
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhcccc-ceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ-KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~-gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||++...... ......|
T Consensus 91 ~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~-~~~~kL~Dfg~~~~~~~~--~~~~~~~ 164 (333)
T cd06650 91 DQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDS--MANSFVG 164 (333)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcC-CCCEEEeeCCcchhhhhh--ccccCCC
Confidence 9998743 3567888999999999999999975 7999999999999987 889999999998765432 2233468
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCC--------C--
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAP--------P-- 1038 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~--------~-- 1038 (1181)
+..|+|||++.+...+..+ |+ ||+||++|+|++|+.||.......+... .
T Consensus 165 ~~~y~aPE~~~~~~~~~~~--Dv------------------wslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (333)
T cd06650 165 TRSYMSPERLQGTHYSVQS--DI------------------WSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAE 224 (333)
T ss_pred CccccCHHHhcCCCCCcHH--HH------------------HHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccc
Confidence 9999999999765443333 33 9999999999999999986543221000 0
Q ss_pred -------------------------------------CCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcc
Q psy14556 1039 -------------------------------------QISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTG 1079 (1181)
Q Consensus 1039 -------------------------------------~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~ 1079 (1181)
..+.......+..+..++.+|+..+|..||+..+.....+-
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~ 302 (333)
T cd06650 225 SETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFI 302 (333)
T ss_pred cccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHH
Confidence 00000001134456789999999999999987666444333
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=288.37 Aligned_cols=237 Identities=29% Similarity=0.427 Sum_probs=190.0
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCccc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLST 891 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~d 891 (1181)
+||+|+||.||+|++..+++.||+|.++.........+.+|+.+++.++||||+++++.+...+..+++|||+++++|.+
T Consensus 16 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (267)
T cd06645 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQD 95 (267)
T ss_pred HhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHH
Confidence 69999999999999999999999999976655555678899999999999999999999999999999999999999999
Q ss_pred chhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCcc
Q psy14556 892 LLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQ 971 (1181)
Q Consensus 892 lL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~~ 971 (1181)
++... ..+++..++.++.|++.||+|||++|++|+||||+||+++. ++.++|+|||++..............|+..
T Consensus 96 ~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 171 (267)
T cd06645 96 IYHVT---GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTD-NGHVKLADFGVSAQITATIAKRKSFIGTPY 171 (267)
T ss_pred HHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC-CCCEEECcceeeeEccCcccccccccCccc
Confidence 98743 35789999999999999999999999999999999999987 889999999998766543333344568999
Q ss_pred ccCchhhccC-CCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC-----CCCCCCC-C
Q psy14556 972 YMAPEVIDKG-QRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA-----PPQISRS-V 1044 (1181)
Q Consensus 972 Y~APEvl~gg-~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~-----~~~ip~~-l 1044 (1181)
|+|||++... ...+....|+ ||+||++|+|++|+.||.......... ....+.. .
T Consensus 172 y~aPE~~~~~~~~~~~~~~Dv------------------wSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (267)
T cd06645 172 WMAPEVAAVERKGGYNQLCDI------------------WAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKD 233 (267)
T ss_pred ccChhhhccccCCCCCchhhh------------------HHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccc
Confidence 9999998421 1112233333 999999999999999997655422111 0111110 1
Q ss_pred CCCCCcchHHhhccCCCCCCCCCchh
Q psy14556 1045 SVPGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1045 ~~~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
....+..+..++.+|+..+|..||..
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~R~~~ 259 (267)
T cd06645 234 KMKWSNSFHHFVKMALTKNPKKRPTA 259 (267)
T ss_pred cCCCCHHHHHHHHHHccCCchhCcCH
Confidence 12356678889999999999999964
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=306.16 Aligned_cols=247 Identities=21% Similarity=0.288 Sum_probs=189.3
Q ss_pred ceeecccCceEEEEEEE-----cCCCeEEEEEEecCCC-CCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEe
Q psy14556 810 RIELGKGSYGVVYAARE-----LDRQVKLAIKEIPEKN-LGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d-----~~tg~~VAIKii~~~~-~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmE 882 (1181)
.++||+|+||.||+|.+ ..++..||+|+++... ....+.+.+|+.+++.+ +||||+++++++.+.+..++|||
T Consensus 40 ~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E 119 (375)
T cd05104 40 GKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITE 119 (375)
T ss_pred hheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeeh
Confidence 34799999999999974 3456789999986443 23356788999999999 89999999999999999999999
Q ss_pred ecCCCCcccchhcccC----------------------------------------------------------------
Q psy14556 883 QVPGGSLSTLLRVKWG---------------------------------------------------------------- 898 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~---------------------------------------------------------------- 898 (1181)
|+++|+|.++++....
T Consensus 120 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (375)
T cd05104 120 YCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDV 199 (375)
T ss_pred hccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceeccccc
Confidence 9999999998864321
Q ss_pred --------CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC--CccccC
Q psy14556 899 --------PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS--AETFTG 968 (1181)
Q Consensus 899 --------~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~--~~t~~G 968 (1181)
...+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++........ .....+
T Consensus 200 ~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 278 (375)
T cd05104 200 TSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTH-GRITKICDFGLARDIRNDSNYVVKGNARL 278 (375)
T ss_pred HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEEC-CCcEEEecCccceeccCcccccccCCCCC
Confidence 124677888999999999999999999999999999999987 789999999999766432211 112234
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCccc-ccC--CCCCCCCC
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRA-LVA--PPQISRSV 1044 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~-l~~--~~~ip~~l 1044 (1181)
+..|+|||++.+..++..+|+ ||+|+++|+|++ |..||....... +.. ........
T Consensus 279 ~~~y~aPE~~~~~~~~~~sDi--------------------~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 338 (375)
T cd05104 279 PVKWMAPESIFNCVYTFESDV--------------------WSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLS 338 (375)
T ss_pred CcceeChhHhcCCCCCCCCCH--------------------HHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCC
Confidence 667999999987655544444 999999999998 889998754322 100 00111112
Q ss_pred CCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1045 SVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1045 ~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
+...+..+..++.+|+..+|.+||+ +.+.+..+
T Consensus 339 ~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~~l 371 (375)
T cd05104 339 PECAPSEMYDIMKSCWDADPLKRPT-FKQIVQLI 371 (375)
T ss_pred CCCCCHHHHHHHHHHccCChhHCcC-HHHHHHHH
Confidence 2345677889999999999999995 44444433
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-32 Score=300.56 Aligned_cols=246 Identities=27% Similarity=0.362 Sum_probs=194.2
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccC-----CcEEEEEeec
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEE-----GYFKIFMEQV 884 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~-----~~l~LVmEy~ 884 (1181)
.+++|.|+||.||.|....+++.||||..-.+.. .-.+|+.+|+.++|||||++..+|... -+..+|||||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 3479999999999999999999999999854432 224899999999999999999887432 2567899999
Q ss_pred CCCCcccchhcc-cCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCC
Q psy14556 885 PGGSLSTLLRVK-WGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA 963 (1181)
Q Consensus 885 ~gGSL~dlL~~~-~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~ 963 (1181)
| .+|.++++.. ..+..++...++-+..||++||.|||+.||+||||||.|+|+|.+.|.+||||||.|+.+....+.
T Consensus 105 P-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn- 182 (364)
T KOG0658|consen 105 P-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN- 182 (364)
T ss_pred h-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc-
Confidence 5 6888888731 134567777888899999999999999999999999999999998899999999999998765444
Q ss_pred ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc---------
Q psy14556 964 ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL--------- 1034 (1181)
Q Consensus 964 ~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l--------- 1034 (1181)
.+...|..|+|||.+.|. ..|+..||+ ||.||++.||+-|++.|.|.+..+.
T Consensus 183 iSYicSRyYRaPELifga-~~Yt~~IDi------------------WSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG 243 (364)
T KOG0658|consen 183 ISYICSRYYRAPELIFGA-TEYTTSIDI------------------WSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLG 243 (364)
T ss_pred eeEEEeccccCHHHHcCc-cccCceeEE------------------hhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhC
Confidence 455679999999999754 578889988 9999999999999999999876331
Q ss_pred ----------cC------CCCC-----CCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1035 ----------VA------PPQI-----SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1035 ----------~~------~~~i-----p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
.. .+++ .+......++..-.++.+.+.-+|..|-...+........
T Consensus 244 ~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFd 310 (364)
T KOG0658|consen 244 TPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFD 310 (364)
T ss_pred CCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhH
Confidence 00 0111 1112334455666688999999999999766554444333
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=293.18 Aligned_cols=238 Identities=22% Similarity=0.283 Sum_probs=191.9
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC---ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG---DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~---~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.+||+|+||+||++.+..+++.||+|.+...... ..+.+.+|+.++++++|+||+++++.+..++..+++|||++++
T Consensus 6 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 85 (285)
T cd05632 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGG 85 (285)
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCc
Confidence 3699999999999999999999999999654322 2345788999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|.+++... ....+++..+..++.|++.||.|||++||+||||||+||+++. ++.++|+|||++...... .......
T Consensus 86 ~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~-~~~~kl~Dfg~~~~~~~~-~~~~~~~ 162 (285)
T cd05632 86 DLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDD-YGHIRISDLGLAVKIPEG-ESIRGRV 162 (285)
T ss_pred cHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECC-CCCEEEecCCcceecCCC-CcccCCC
Confidence 999888643 3346889999999999999999999999999999999999987 789999999998765432 2223446
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc----ccCC-CCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA----LVAP-PQISR 1042 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~----l~~~-~~ip~ 1042 (1181)
|+..|+|||++.+..++..+|+ ||+|+++|+|++|..||.+..... +... .....
T Consensus 163 g~~~~~aPE~~~~~~~~~~~Di--------------------~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~ 222 (285)
T cd05632 163 GTVGYMAPEVLNNQRYTLSPDY--------------------WGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE 222 (285)
T ss_pred CCcCccChHHhcCCCCCcccch--------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccc
Confidence 8999999999976554443333 999999999999999998765432 1111 11112
Q ss_pred CCCCCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1043 SVSVPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1043 ~l~~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
..+...+..+..++.+|+..+|..||+..
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 23345667788899999999999999843
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=306.78 Aligned_cols=245 Identities=22% Similarity=0.272 Sum_probs=187.7
Q ss_pred eeecccCceEEEEEEEcCC-----CeEEEEEEecCCCC-CChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEee
Q psy14556 811 IELGKGSYGVVYAARELDR-----QVKLAIKEIPEKNL-GDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQ 883 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~t-----g~~VAIKii~~~~~-~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy 883 (1181)
++||+|+||.||+|.+... ...||+|.+..... ...+.+.+|+.+++.+ +||||+++++++...+..++||||
T Consensus 44 ~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey 123 (374)
T cd05106 44 KTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEY 123 (374)
T ss_pred heecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhh
Confidence 4799999999999986443 35799999975433 2346688999999999 899999999999999999999999
Q ss_pred cCCCCcccchhccc------------------------------------------------------------------
Q psy14556 884 VPGGSLSTLLRVKW------------------------------------------------------------------ 897 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~------------------------------------------------------------------ 897 (1181)
+++|+|.+++....
T Consensus 124 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (374)
T cd05106 124 CCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDT 203 (374)
T ss_pred ccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhcc
Confidence 99999999885421
Q ss_pred -CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC--CccccCCccccC
Q psy14556 898 -GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS--AETFTGTLQYMA 974 (1181)
Q Consensus 898 -~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~--~~t~~GT~~Y~A 974 (1181)
....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++........ .....++..|+|
T Consensus 204 ~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~-~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~a 282 (374)
T cd05106 204 EDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTD-GRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMA 282 (374)
T ss_pred CCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeC-CCeEEEeeceeeeeccCCcceeeccCCCCccceeC
Confidence 0124677888999999999999999999999999999999987 889999999999765432211 112235568999
Q ss_pred chhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccC---CCCCCCCCCCCCCc
Q psy14556 975 PEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVA---PPQISRSVSVPGPG 1050 (1181)
Q Consensus 975 PEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~---~~~ip~~l~~~~p~ 1050 (1181)
||++.+..++...|+ ||+|+++|+|++ |+.||.......... ........+...+.
T Consensus 283 PE~~~~~~~~~~~Dv--------------------wSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 342 (374)
T cd05106 283 PESIFDCVYTVQSDV--------------------WSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPP 342 (374)
T ss_pred HHHhcCCCCCccccH--------------------HHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCH
Confidence 999976554443333 999999999997 999998765432110 11111122234567
Q ss_pred chHHhhccCCCCCCCCCchhHHHHHHh
Q psy14556 1051 GINSSSSAPVTPTPHSRHISVNTNLVC 1077 (1181)
Q Consensus 1051 ~L~~li~r~la~dPs~Rp~s~~~~~~a 1077 (1181)
.+..++.+|+..+|..||+. .+....
T Consensus 343 ~l~~li~~cl~~dp~~RPs~-~~l~~~ 368 (374)
T cd05106 343 EIYSIMKMCWNLEPTERPTF-SQISQL 368 (374)
T ss_pred HHHHHHHHHcCCChhhCcCH-HHHHHH
Confidence 88999999999999999964 443333
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=293.49 Aligned_cols=238 Identities=22% Similarity=0.324 Sum_probs=194.5
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
.+||+|+||.||++.+..+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 104 (297)
T cd06656 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 104 (297)
T ss_pred eeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHH
Confidence 36999999999999999999999999997766556677899999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCc
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL 970 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~ 970 (1181)
+++... .+++..+..++.|++.||.|||+.|++||||||+||+++. ++.++|+|||.+..............+++
T Consensus 105 ~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 179 (297)
T cd06656 105 DVVTET----CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQITPEQSKRSTMVGTP 179 (297)
T ss_pred HHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC-CCCEEECcCccceEccCCccCcCcccCCc
Confidence 998643 4678889999999999999999999999999999999987 88999999999876554333333456889
Q ss_pred cccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC---CCC-CCCC
Q psy14556 971 QYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ---ISR-SVSV 1046 (1181)
Q Consensus 971 ~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~---ip~-~l~~ 1046 (1181)
.|+|||.+.+...+..+|+ ||+|+++|+|++|..||.+.+......... .+. ..+.
T Consensus 180 ~y~aPE~~~~~~~~~~~Di--------------------~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (297)
T cd06656 180 YWMAPEVVTRKAYGPKVDI--------------------WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE 239 (297)
T ss_pred cccCHHHHcCCCCCcHHHH--------------------HHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCcc
Confidence 9999999976544433333 999999999999999998765432211111 111 1223
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
..+..+..++.+|+..+|..||+..+.
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~i 266 (297)
T cd06656 240 RLSAVFRDFLNRCLEMDVDRRGSAKEL 266 (297)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 456678889999999999999975444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=285.63 Aligned_cols=237 Identities=33% Similarity=0.516 Sum_probs=191.1
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC-----ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeec
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG-----DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQV 884 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~-----~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~ 884 (1181)
...||+|++|.||.|.+..+++.|++|.+...... ..+.+.+|+.++++++||||+++++++.+++..++++||+
T Consensus 7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 86 (263)
T cd06625 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86 (263)
T ss_pred cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEEC
Confidence 34799999999999999999999999998654321 2456889999999999999999999999999999999999
Q ss_pred CCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCC-
Q psy14556 885 PGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA- 963 (1181)
Q Consensus 885 ~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~- 963 (1181)
++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++. ++.++|+|||.++.........
T Consensus 87 ~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~-~~~~~l~dfg~~~~~~~~~~~~~ 162 (263)
T cd06625 87 PGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICSSGT 162 (263)
T ss_pred CCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC-CCCEEEeecccceeccccccccc
Confidence 999999998743 34678888999999999999999999999999999999987 8999999999987654322111
Q ss_pred --ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC---CC
Q psy14556 964 --ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA---PP 1038 (1181)
Q Consensus 964 --~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~---~~ 1038 (1181)
....++..|+|||++.+...+..+|+ ||+|+++|+|++|+.||.......... ..
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di--------------------~slG~il~el~~g~~p~~~~~~~~~~~~~~~~ 222 (263)
T cd06625 163 GMKSVTGTPYWMSPEVISGEGYGRKADV--------------------WSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ 222 (263)
T ss_pred cccCCCcCccccCcceeccCCCCchhhh--------------------HHHHHHHHHHHhCCCCccccchHHHHHHHhcc
Confidence 23457889999999976553333333 999999999999999998765433211 11
Q ss_pred CCCCCCCCCCCcchHHhhccCCCCCCCCCchh
Q psy14556 1039 QISRSVSVPGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1039 ~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
......+...+..+..++.+|+..+|..||..
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 254 (263)
T cd06625 223 PTNPQLPSHVSPDARNFLRRTFVENAKKRPSA 254 (263)
T ss_pred CCCCCCCccCCHHHHHHHHHHhhcCcccCCCH
Confidence 11222344567788899999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=292.09 Aligned_cols=236 Identities=21% Similarity=0.304 Sum_probs=190.7
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC---hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD---VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~---~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
..||+|+||.||++.+..+++.||+|.+....... .+.+.+|+.++++++|++|+++++.+.+.+..++||||++++
T Consensus 6 ~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~ 85 (285)
T cd05630 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG 85 (285)
T ss_pred EEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCC
Confidence 46999999999999999999999999986543322 345778999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|.+++... ....+++..+..++.|++.||.|||++||+||||||+||+++. ++.++|+|||++....... ......
T Consensus 86 ~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~-~~~~~l~Dfg~~~~~~~~~-~~~~~~ 162 (285)
T cd05630 86 DLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDD-HGHIRISDLGLAVHVPEGQ-TIKGRV 162 (285)
T ss_pred cHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECC-CCCEEEeeccceeecCCCc-cccCCC
Confidence 999988643 3345788999999999999999999999999999999999988 8899999999987654322 222346
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc----ccCC-CCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA----LVAP-PQISR 1042 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~----l~~~-~~ip~ 1042 (1181)
|+..|+|||++.+..++..+|+ ||+|+++|+|++|+.||....... .... ...+.
T Consensus 163 g~~~y~aPE~~~~~~~~~~~Di--------------------wslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 222 (285)
T cd05630 163 GTVGYMAPEVVKNERYTFSPDW--------------------WALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQE 222 (285)
T ss_pred CCccccChHHHcCCCCCCcccc--------------------HHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhh
Confidence 8999999999976654444433 999999999999999998754321 1000 11122
Q ss_pred CCCCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1043 SVSVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1043 ~l~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
..+...+..+..++.+|+..+|..|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s 249 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLG 249 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccC
Confidence 233456677888999999999999997
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=309.85 Aligned_cols=197 Identities=27% Similarity=0.311 Sum_probs=172.0
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcC-C-----CCeeeEccccccCCcEEEEEee
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR-H-----RNIVQYLGSVSEEGYFKIFMEQ 883 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~-H-----PNIVkl~g~~~d~~~l~LVmEy 883 (1181)
.+.||+|.||.|-+|.+..+++.||||+++.... ...+...|+.+|..|+ | -|+|+++++|...+++|||+|.
T Consensus 191 ~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfEL 269 (586)
T KOG0667|consen 191 LEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFEL 269 (586)
T ss_pred EEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehh
Confidence 4479999999999999999999999999975533 3456778999999997 4 3899999999999999999999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccC-CCeeeeecCCcccccccCCCC
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTY-SGVVKISDFGTSKRLAGLCPS 962 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~-~g~vKLiDFGlAk~l~~~~~~ 962 (1181)
+ +.+|.++++.+ .-..++...++.++.||+.||.+||+.||||+||||+||||... ...+||+|||.|+.... .
T Consensus 270 L-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q---~ 344 (586)
T KOG0667|consen 270 L-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ---R 344 (586)
T ss_pred h-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC---c
Confidence 9 88999999876 45568899999999999999999999999999999999999652 34899999999987654 2
Q ss_pred CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc
Q psy14556 963 AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR 1032 (1181)
Q Consensus 963 ~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~ 1032 (1181)
..+...+..|+|||++.|. .|...||+ ||||||+.||++|.+.|.|.+..
T Consensus 345 vytYiQSRfYRAPEVILGl--pY~~~IDm------------------WSLGCIlAEL~tG~PLfpG~ne~ 394 (586)
T KOG0667|consen 345 VYTYIQSRFYRAPEVILGL--PYDTAIDM------------------WSLGCILAELFTGEPLFPGDNEY 394 (586)
T ss_pred ceeeeeccccccchhhccC--CCCCccce------------------eehhhhHHhHhcCccccCCCCHH
Confidence 3366789999999999976 46777877 99999999999999999998873
|
|
| >cd00317 cyclophilin cyclophilin: cyclophilin-type peptidylprolyl cis- trans isomerases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=266.19 Aligned_cols=143 Identities=55% Similarity=0.845 Sum_probs=129.9
Q ss_pred ecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCCCCCcCccc-
Q psy14556 119 LDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFEDENFTLK- 197 (1181)
Q Consensus 119 ~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~~dE~~~l~- 197 (1181)
+.|+.|+|+||||.+.+|++|+||++|| +.++ |+|+.|||++|++++||||+....+.+ +.++..+++|.....
T Consensus 2 ~~T~~G~i~IeL~~~~~P~~~~nF~~l~--~~~~-Y~~~~f~rv~~~~~iq~Gd~~~~~~~~--~~~~~~~~~E~~~~~~ 76 (146)
T cd00317 2 LDTTKGRIVIELYGDEAPKTVENFLSLA--RGGF-YDGTTFHRVIPGFMIQGGDPTGTGGGG--SGPGYKFPDENFPLKY 76 (146)
T ss_pred eEeccCcEEEEEcCCCChHHHHHHHHHH--hcCC-cCCCEEEEEeCCCeEEECCCCCCCCCC--CcCCCccCCccccCcC
Confidence 5789999999999999999999999999 6667 999999999999999999987644332 456788899988766
Q ss_pred cCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCC-CCCCcccceEEee
Q psy14556 198 HTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGS-QSGKTSKKIVVAN 266 (1181)
Q Consensus 198 h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t-~~g~P~~~V~I~~ 266 (1181)
|+.+|+|+|++.++++++|||||++++.|+||++|+|||+|++|||||++|++.++ ++++|.++|+|.+
T Consensus 77 ~~~~G~v~~~~~~~~~~~sqF~Itl~~~~~ld~~~~vfG~V~~G~~vl~~I~~~~~~~~~~P~~~i~I~~ 146 (146)
T cd00317 77 HHRRGTLSMANAGPNTNGSQFFITTAPTPHLDGKHTVFGKVVEGMDVVDKIERGDTDENGRPIKPVTISD 146 (146)
T ss_pred cCCCcEEEEeeCCCCCcccEEEEECCCCcccCCCceEEEEEeCCHHHHHHHHcCCCCCCCcCcCceEEeC
Confidence 89999999999999999999999999999999999999999999999999999999 5899999999963
|
This family contains eukaryotic, bacterial and archeal proteins which exhibit a peptidylprolyl cis- trans isomerases activity (PPIase, Rotamase) and in addition bind the immunosuppressive drug cyclosporin (CsA). Immunosuppression in vertebrates is believed to be the result of the cyclophilin A-cyclosporin protein drug complex binding to and inhibiting the protein-phosphatase calcineurin. PPIase is an enzyme which accelerates protein folding by catalyzing the cis-trans isomerization of the peptide bonds preceding proline residues. Cyclophilins are a diverse family in terms of function and have been implicated in protein folding processes which depend on catalytic /chaperone-like activities. This group contains human cyclophilin 40, a co-chaperone of the hsp90 chaperone system; human cyclophilin A, a chaperone in the HIV-1 infectious process and; human cyclophilin H, a component of the U4/U6 snRNP |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=282.42 Aligned_cols=241 Identities=26% Similarity=0.359 Sum_probs=192.7
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
++||+|+||.||+|.+..+++.|++|.++.... ...+.+.+|+.++++++|+||+++++++.+.+..++||||++++
T Consensus 8 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (267)
T cd08224 8 KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAG 87 (267)
T ss_pred eeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCC
Confidence 369999999999999998999999999864322 23567899999999999999999999999999999999999999
Q ss_pred Ccccchhcc-cCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccc
Q psy14556 888 SLSTLLRVK-WGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF 966 (1181)
Q Consensus 888 SL~dlL~~~-~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~ 966 (1181)
+|..++... .....+++..++.++.|++.||.|||+.|++||||||+||+++. ++.++|+|||++.............
T Consensus 88 ~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~ 166 (267)
T cd08224 88 DLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSL 166 (267)
T ss_pred CHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECC-CCcEEEeccceeeeccCCCccccee
Confidence 999988642 12345788999999999999999999999999999999999987 8899999999987665433333445
Q ss_pred cCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc--cccCC---CCCC
Q psy14556 967 TGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR--ALVAP---PQIS 1041 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~--~l~~~---~~ip 1041 (1181)
.++..|+|||.+.+..++..+|+ ||+|+++|+|++|+.||...... .+... ...+
T Consensus 167 ~~~~~y~apE~~~~~~~~~~~Di--------------------~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 226 (267)
T cd08224 167 VGTPYYMSPERIHENGYNFKSDI--------------------WSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP 226 (267)
T ss_pred cCCccccCHHHhccCCCCchhcH--------------------HHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCC
Confidence 68899999999976544433333 99999999999999999765432 11111 1111
Q ss_pred CCCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1042 RSVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1042 ~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
.......+..+..++.+|+..+|..||+..+
T Consensus 227 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ 257 (267)
T cd08224 227 PLPADHYSEELRDLVSRCINPDPEKRPDISY 257 (267)
T ss_pred CCChhhcCHHHHHHHHHHcCCCcccCCCHHH
Confidence 1111245668888999999999999997544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=294.56 Aligned_cols=241 Identities=23% Similarity=0.357 Sum_probs=195.2
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
.+||+|+||.||++.+..++..||||.+........+.+.+|+.+++.++||||+++++.+...+..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 46999999999999999999999999987655555677899999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCc
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL 970 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~ 970 (1181)
+++... .+++..++.++.||+.||.|||++||+||||||+||+++. ++.++|+|||++..............|+.
T Consensus 108 ~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~-~~~~kL~dfg~~~~~~~~~~~~~~~~~~~ 182 (292)
T cd06658 108 DIVTHT----RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTS-DGRIKLSDFGFCAQVSKEVPKRKSLVGTP 182 (292)
T ss_pred HHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC-CCCEEEccCcchhhcccccccCceeecCc
Confidence 988532 4678889999999999999999999999999999999987 78999999999876554333334456899
Q ss_pred cccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCC--CCCCC--CCC
Q psy14556 971 QYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPP--QISRS--VSV 1046 (1181)
Q Consensus 971 ~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~--~ip~~--l~~ 1046 (1181)
.|+|||.+.+...+..+|+ ||+|+++|||++|+.||...+........ ..+.. ...
T Consensus 183 ~y~aPE~~~~~~~~~~~Dv--------------------~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (292)
T cd06658 183 YWMAPEVISRLPYGTEVDI--------------------WSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSH 242 (292)
T ss_pred cccCHHHHccCCCCchhhH--------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcccccc
Confidence 9999999976544433333 99999999999999999876653321110 11111 122
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHHHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNTNLV 1076 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~~~~ 1076 (1181)
..+..+..++.+|+..+|..||+..+....
T Consensus 243 ~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 243 KVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 456678889999999999999975544433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=287.54 Aligned_cols=238 Identities=26% Similarity=0.321 Sum_probs=182.7
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhc---CCCCeeeEcccccc-----CCcEEEE
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQL---RHRNIVQYLGSVSE-----EGYFKIF 880 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L---~HPNIVkl~g~~~d-----~~~l~LV 880 (1181)
.+||+|+||+||+|.+..+++.||+|.++..... ....+.+|+.+++.+ +||||+++++++.. ....+++
T Consensus 6 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv 85 (288)
T cd07863 6 AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLV 85 (288)
T ss_pred eEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEE
Confidence 3699999999999999999999999998754322 234566788777765 79999999998754 3468999
Q ss_pred EeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC
Q psy14556 881 MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC 960 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~ 960 (1181)
|||++ ++|.+++... ....+++..+..++.|++.||.|||++||+||||||+||+++. ++.+||+|||++......
T Consensus 86 ~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~-~~~~kl~dfg~~~~~~~~- 161 (288)
T cd07863 86 FEHVD-QDLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS-GGQVKLADFGLARIYSCQ- 161 (288)
T ss_pred Ecccc-cCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC-CCCEEECccCccccccCc-
Confidence 99996 5888887654 2345789999999999999999999999999999999999987 899999999999766432
Q ss_pred CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc-----
Q psy14556 961 PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV----- 1035 (1181)
Q Consensus 961 ~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~----- 1035 (1181)
.......++..|+|||++.+...+..+ |+ ||+||++|+|++|++||.+.......
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di------------------wslG~~l~~l~~g~~~f~~~~~~~~~~~~~~ 221 (288)
T cd07863 162 MALTPVVVTLWYRAPEVLLQSTYATPV--DM------------------WSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 221 (288)
T ss_pred ccCCCccccccccCchHhhCCCCCCcc--hh------------------hhHHHHHHHHHhCCcCcCCCCHHHHHHHHHH
Confidence 222334689999999999765443333 33 99999999999999999876543210
Q ss_pred -----CCCCCC------------------CCCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1036 -----APPQIS------------------RSVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1036 -----~~~~ip------------------~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
.....+ ....+..+..+..++.+|+..||.+||+..+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~ 281 (288)
T cd07863 222 LIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFR 281 (288)
T ss_pred HhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHH
Confidence 000000 0112244566778999999999999997443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=284.53 Aligned_cols=240 Identities=27% Similarity=0.372 Sum_probs=189.9
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhc-CCCCeeeEccccccC------CcEEEEEeec
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEE------GYFKIFMEQV 884 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~------~~l~LVmEy~ 884 (1181)
+||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++++ +||||+++++++... ..+|++|||+
T Consensus 13 ~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~ 91 (272)
T cd06637 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFC 91 (272)
T ss_pred heeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcC
Confidence 6999999999999999999999999996543 3346788999999998 799999999988643 4689999999
Q ss_pred CCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCc
Q psy14556 885 PGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAE 964 (1181)
Q Consensus 885 ~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~ 964 (1181)
++++|.+++... ....+++..+..++.|++.||+|||+++|+|+||||+||+++. ++.++|+|||++...........
T Consensus 92 ~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~-~~~~~l~Dfg~~~~~~~~~~~~~ 169 (272)
T cd06637 92 GAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLDRTVGRRN 169 (272)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECC-CCCEEEccCCCceecccccccCC
Confidence 999999998754 2345778899999999999999999999999999999999998 88999999999986654333444
Q ss_pred cccCCccccCchhhccCC---CCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC---CC
Q psy14556 965 TFTGTLQYMAPEVIDKGQ---RGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA---PP 1038 (1181)
Q Consensus 965 t~~GT~~Y~APEvl~gg~---~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~---~~ 1038 (1181)
...|+..|+|||++.+.. ..++...|+ ||+||++|+|++|+.||.......... ..
T Consensus 170 ~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv------------------~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~ 231 (272)
T cd06637 170 TFIGTPYWMAPEVIACDENPDATYDFKSDL------------------WSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 231 (272)
T ss_pred cccccccccCHhHhccccCcCCCCCchhhH------------------HHHHHHHHHHHhCCCCccccCHHHHHHHHhcC
Confidence 566899999999986332 122223333 999999999999999997654322111 11
Q ss_pred CCCCCCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1039 QISRSVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1039 ~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
..........+..+..++.+|+..+|..||+..+
T Consensus 232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 265 (272)
T cd06637 232 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQ 265 (272)
T ss_pred CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHH
Confidence 1122222345678889999999999999997543
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=284.43 Aligned_cols=239 Identities=25% Similarity=0.359 Sum_probs=192.1
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCC---ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG---DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~---~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.||+|+||.||++.+..+++.+++|.+...... ..+.+.+|+.+++.++||||+++++++.+.+..+++|||+++++
T Consensus 9 ~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 88 (267)
T cd08229 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGD 88 (267)
T ss_pred hhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCC
Confidence 699999999999999999999999988654322 24578899999999999999999999999999999999999999
Q ss_pred cccchhcc-cCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 889 LSTLLRVK-WGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 889 L~dlL~~~-~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
|.+++... .....+++..++.++.||+.||.|||++|++|+||||+||+++. ++.++|+|||++..............
T Consensus 89 L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~ 167 (267)
T cd08229 89 LSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLV 167 (267)
T ss_pred HHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC-CCCEEECcchhhhccccCCccccccc
Confidence 99988642 12346788999999999999999999999999999999999987 88999999999876654333333456
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc--ccCC---CCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA--LVAP---PQISR 1042 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~--l~~~---~~ip~ 1042 (1181)
++..|+|||.+.+...+..+|+ ||+|+++|+|++|..||.+..... .... ...+.
T Consensus 168 ~~~~~~ape~~~~~~~~~~~Dv--------------------~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 227 (267)
T cd08229 168 GTPYYMSPERIHENGYNFKSDI--------------------WSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP 227 (267)
T ss_pred CCcCccCHHHhcCCCccchhhH--------------------HHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCC
Confidence 8899999999976544433333 999999999999999997654421 1111 11111
Q ss_pred CCCCCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1043 SVSVPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1043 ~l~~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
......+..+..++.+|+..+|..||+..
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 256 (267)
T cd08229 228 LPSDHYSEELRQLVNMCINPDPEKRPDIT 256 (267)
T ss_pred CCcccccHHHHHHHHHhcCCCcccCCCHH
Confidence 11223566788999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=284.62 Aligned_cols=240 Identities=22% Similarity=0.298 Sum_probs=189.6
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
++||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.++++++||||+++++.+.+.+..+++|||+++++|.
T Consensus 12 ~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 89 (261)
T cd05072 12 KKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLL 89 (261)
T ss_pred eecCCcCCceEEEEEec-CCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHH
Confidence 37999999999999864 456799998865432 3577899999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC-CccccCC
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS-AETFTGT 969 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~-~~t~~GT 969 (1181)
+++... ....+++..+..++.|++.||+|||+++++||||||+||+++. ++.++|+|||++......... .....++
T Consensus 90 ~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 167 (261)
T cd05072 90 DFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSE-SLMCKIADFGLARVIEDNEYTAREGAKFP 167 (261)
T ss_pred HHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecC-CCcEEECCCccceecCCCceeccCCCccc
Confidence 998754 3345678888899999999999999999999999999999998 889999999999876432211 1223356
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--CCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--ISRSVSV 1046 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--ip~~l~~ 1046 (1181)
..|+|||.+.++..+...|+ ||+|+++|+|++ |..||.+........... .......
T Consensus 168 ~~y~aPE~~~~~~~~~~~Di--------------------~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 227 (261)
T cd05072 168 IKWTAPEAINFGSFTIKSDV--------------------WSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRME 227 (261)
T ss_pred eecCCHHHhccCCCChhhhh--------------------hhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 78999999976554443333 999999999998 999998766544221111 1112223
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNTNL 1075 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~~~ 1075 (1181)
..+..+..++.+|+..+|..||. +++..
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rp~-~~~i~ 255 (261)
T cd05072 228 NCPDELYDIMKTCWKEKAEERPT-FDYLQ 255 (261)
T ss_pred CCCHHHHHHHHHHccCCcccCcC-HHHHH
Confidence 46778899999999999999996 34433
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=290.61 Aligned_cols=246 Identities=23% Similarity=0.306 Sum_probs=192.2
Q ss_pred eeecccCceEEEEEEE-----cCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 811 IELGKGSYGVVYAARE-----LDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d-----~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
..||+|+||.||++.. ..++..+|+|.+........+.+.+|+.++++++||||+++++++...+.+++||||++
T Consensus 11 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 90 (288)
T cd05093 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMK 90 (288)
T ss_pred cccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCC
Confidence 3699999999999985 33556799999876554456679999999999999999999999999999999999999
Q ss_pred CCCcccchhccc----------CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccc
Q psy14556 886 GGSLSTLLRVKW----------GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 955 (1181)
Q Consensus 886 gGSL~dlL~~~~----------~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~ 955 (1181)
+++|.+++.... ....+++..++.++.|++.||+|||++|++||||||+||+++. ++.+||+|||+++.
T Consensus 91 ~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~-~~~~kl~dfg~~~~ 169 (288)
T cd05093 91 HGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE-NLLVKIGDFGMSRD 169 (288)
T ss_pred CCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc-CCcEEeccCCcccc
Confidence 999999987432 1234789999999999999999999999999999999999987 89999999999976
Q ss_pred cccCCC--CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q psy14556 956 LAGLCP--SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSR 1032 (1181)
Q Consensus 956 l~~~~~--~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~ 1032 (1181)
...... ......++..|+|||++.+...+..+|+ ||||+++|+|++ |..||.+....
T Consensus 170 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi--------------------wslG~il~~l~t~g~~p~~~~~~~ 229 (288)
T cd05093 170 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV--------------------WSLGVVLWEIFTYGKQPWYQLSNN 229 (288)
T ss_pred ccCCceeecCCCCCccccccCHHHhccCCCCchhhH--------------------HHHHHHHHHHHhCCCCCCCCCCHH
Confidence 543211 1122335778999999976544443333 999999999998 99999887654
Q ss_pred cccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1033 ALVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1033 ~l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
.+..... .....+...+..+..++.+|+..+|.+||+ +++....+
T Consensus 230 ~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-~~~v~~~l 276 (288)
T cd05093 230 EVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLN-IKEIHSLL 276 (288)
T ss_pred HHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCC-HHHHHHHH
Confidence 4321111 111122345678999999999999999995 44433333
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=288.66 Aligned_cols=241 Identities=22% Similarity=0.271 Sum_probs=188.2
Q ss_pred eeecccCceEEEEEEEc----CCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 811 IELGKGSYGVVYAAREL----DRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~----~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
++||+|+||.||+|.+. .++..+++|.+..... .....+.+|+.++++++||||+++++++...+..|++|||++
T Consensus 11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 90 (283)
T cd05090 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLN 90 (283)
T ss_pred eeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCC
Confidence 36999999999999853 4567899999965432 224578899999999999999999999999999999999999
Q ss_pred CCCcccchhccc--------------CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCC
Q psy14556 886 GGSLSTLLRVKW--------------GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFG 951 (1181)
Q Consensus 886 gGSL~dlL~~~~--------------~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFG 951 (1181)
+++|.+++.... ....+++..+..++.|++.||.|||++|++||||||+||+++. ++.+||+|||
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~-~~~~kl~dfg 169 (283)
T cd05090 91 QGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE-QLHVKISDLG 169 (283)
T ss_pred CCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC-CCcEEecccc
Confidence 999999985321 1234678888999999999999999999999999999999997 7899999999
Q ss_pred cccccccCC--CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCC
Q psy14556 952 TSKRLAGLC--PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKK 1028 (1181)
Q Consensus 952 lAk~l~~~~--~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~ 1028 (1181)
+++...... .......++..|+|||.+.++..+..+| + ||+|+++|||++ |..||.+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D--v------------------~slG~il~el~~~g~~p~~~ 229 (283)
T cd05090 170 LSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSD--I------------------WSFGVVLWEIFSFGLQPYYG 229 (283)
T ss_pred ccccccCCcceecccCCCccceecChHHhccCCCCchhh--h------------------HHHHHHHHHHHcCCCCCCCC
Confidence 997654321 1122334567899999997654433333 3 999999999998 9999987
Q ss_pred CCcccccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1029 KTSRALVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1029 ~~~~~l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
.....+..... .....+...+..+..++.+|+.++|..||...+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ 275 (283)
T cd05090 230 FSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKD 275 (283)
T ss_pred CCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHH
Confidence 66543221111 111233456778899999999999999997544
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=293.00 Aligned_cols=242 Identities=26% Similarity=0.364 Sum_probs=196.2
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
+.||+|+||.||++.+..+++.||+|.+..... ...+.+.+|++++++++||||+++++++.+.+.+++||||++++
T Consensus 7 ~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 86 (290)
T cd05580 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGG 86 (290)
T ss_pred EEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCC
Confidence 479999999999999999999999999865432 33567889999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++. ++.+||+|||++...... .....
T Consensus 87 ~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~-~~~~kl~dfg~~~~~~~~---~~~~~ 159 (290)
T cd05580 87 ELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDS-DGYIKITDFGFAKRVKGR---TYTLC 159 (290)
T ss_pred CHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECC-CCCEEEeeCCCccccCCC---CCCCC
Confidence 999998754 35778899999999999999999999999999999999988 889999999999876543 33446
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCC-CCCCCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPP-QISRSVSV 1046 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~-~ip~~l~~ 1046 (1181)
+++.|+|||.+.+...+.+ .|+ ||+|+++|+|++|+.||............ ......+.
T Consensus 160 ~~~~y~aPE~~~~~~~~~~--~Di------------------~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 219 (290)
T cd05580 160 GTPEYLAPEIILSKGYGKA--VDW------------------WALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS 219 (290)
T ss_pred CCccccChhhhcCCCCCcc--ccH------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCc
Confidence 8899999999976544333 333 99999999999999999877643322111 11112233
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHHHHHhcc
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNTNLVCTG 1079 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~ 1079 (1181)
..+..+..++.+|+..+|..|+.++...+..+.
T Consensus 220 ~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 220 FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred cCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 456788889999999999999976544444333
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=297.12 Aligned_cols=201 Identities=23% Similarity=0.318 Sum_probs=162.7
Q ss_pred HhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCC--CCChhHHHHHHHHHHhcCCCCeeeEccccccC-----
Q psy14556 802 FLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKN--LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEE----- 874 (1181)
Q Consensus 802 ~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~--~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~----- 874 (1181)
....|... ++||+|+||.||++.+..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 19 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQL-KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEE-EEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 34455544 47999999999999999999999999996542 23356788999999999999999999988644
Q ss_pred -CcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcc
Q psy14556 875 -GYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTS 953 (1181)
Q Consensus 875 -~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlA 953 (1181)
..+|+||||+.+ +|...+.. .+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~-~~~~kl~Dfg~a 170 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-DCTLKILDFGLA 170 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC-CCCEEEecCCCc
Confidence 357999999964 55555542 3678888899999999999999999999999999999988 899999999999
Q ss_pred cccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCc
Q psy14556 954 KRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTS 1031 (1181)
Q Consensus 954 k~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~ 1031 (1181)
+..... .......||+.|+|||++.+..++..+ |+ ||+||++|+|++|+.||.+.+.
T Consensus 171 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~--Di------------------wSlG~il~el~tg~~pf~~~~~ 227 (359)
T cd07876 171 RTACTN-FMMTPYVVTRYYRAPEVILGMGYKENV--DI------------------WSVGCIMGELVKGSVIFQGTDH 227 (359)
T ss_pred cccccC-ccCCCCcccCCCCCchhccCCCCCcch--hh------------------HHHHHHHHHHHhCCCCCCCCCH
Confidence 765332 222345689999999999766544433 33 9999999999999999987653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=283.57 Aligned_cols=237 Identities=31% Similarity=0.467 Sum_probs=191.0
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC---------hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEE
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD---------VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFM 881 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~---------~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVm 881 (1181)
..||.|++|.||+|.+..+++.+|+|.+....... .+.+.+|+.++++++||||+++++++.+.+..+++|
T Consensus 6 ~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (267)
T cd06628 6 ALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFL 85 (267)
T ss_pred ceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEE
Confidence 36999999999999998899999999986553322 246889999999999999999999999999999999
Q ss_pred eecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC
Q psy14556 882 EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP 961 (1181)
Q Consensus 882 Ey~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~ 961 (1181)
||+++++|.+++... ..+++..+..++.|++.||+|||++|++||||+|+||+++. ++.++|+|||.++.......
T Consensus 86 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~-~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06628 86 EYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDN-KGGIKISDFGISKKLEANSL 161 (267)
T ss_pred EecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcC-CCCEEecccCCCcccccccc
Confidence 999999999999743 35678888999999999999999999999999999999987 88999999999887653211
Q ss_pred ------CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc
Q psy14556 962 ------SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV 1035 (1181)
Q Consensus 962 ------~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~ 1035 (1181)
......|+..|+|||.+.++..+..+|+ ||+|+++|+|++|+.||...+.....
T Consensus 162 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv--------------------~slG~il~~l~~g~~p~~~~~~~~~~ 221 (267)
T cd06628 162 STKTNGARPSLQGSVFWMAPEVVKQTSYTRKADI--------------------WSLGCLVVEMLTGKHPFPDCTQLQAI 221 (267)
T ss_pred cCCccccccccCCCcCccChhHhccCCCCchhhh--------------------HHHHHHHHHHhhCCCCCCCccHHHHH
Confidence 1122457889999999976544333333 99999999999999999876543221
Q ss_pred CC--CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1036 AP--PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1036 ~~--~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
.. .......+...+..+..++.+|+..+|.+||...
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 259 (267)
T cd06628 222 FKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAA 259 (267)
T ss_pred HHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHH
Confidence 11 1112223345677888999999999999999743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=290.64 Aligned_cols=241 Identities=22% Similarity=0.314 Sum_probs=197.4
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
.+||.|++|.||+|.+..+++.|++|.+........+.+.+|+.+++.++||||+++++++...+.+++|+||+++++|.
T Consensus 25 ~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 104 (296)
T cd06655 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT 104 (296)
T ss_pred EEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHH
Confidence 36999999999999999999999999997766666678899999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCc
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL 970 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~ 970 (1181)
.++... .+++..+..++.|++.||.|||++|++||||||+||+++. ++.+||+|||++..............++.
T Consensus 105 ~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 179 (296)
T cd06655 105 DVVTET----CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGM-DGSVKLTDFGFCAQITPEQSKRSTMVGTP 179 (296)
T ss_pred HHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC-CCCEEEccCccchhcccccccCCCcCCCc
Confidence 988643 4788999999999999999999999999999999999987 89999999999876654333333456889
Q ss_pred cccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc----cCCCCCCCCCCC
Q psy14556 971 QYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL----VAPPQISRSVSV 1046 (1181)
Q Consensus 971 ~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l----~~~~~ip~~l~~ 1046 (1181)
.|+|||.+.+...+..+|+ ||+||++|+|++|+.||.+.+.... .......-..+.
T Consensus 180 ~y~aPE~~~~~~~~~~~Dv--------------------~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T cd06655 180 YWMAPEVVTRKAYGPKVDI--------------------WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE 239 (296)
T ss_pred cccCcchhcCCCCCchhhH--------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcc
Confidence 9999999976554444333 9999999999999999988765321 111111111233
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHHHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNTNLV 1076 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~~~~ 1076 (1181)
..+..+..++.+|+..+|..||+..+....
T Consensus 240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 240 KLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred cCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 456778889999999999999876555433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=291.33 Aligned_cols=241 Identities=20% Similarity=0.238 Sum_probs=188.2
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
.+||+|+||.||+|++..+++.||+|.++..... ....+.+|+.++++++||||+++++++..++..++||||++ ++|
T Consensus 12 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l 90 (309)
T cd07872 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD-KDL 90 (309)
T ss_pred EEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC-CCH
Confidence 4799999999999999999999999999755332 34467899999999999999999999999999999999996 478
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT 969 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT 969 (1181)
.+++... ...+++..+..++.||+.||+|||++||+||||||+||+++. ++.+||+|||++..............++
T Consensus 91 ~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 167 (309)
T cd07872 91 KQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINE-RGELKLADFGLARAKSVPTKTYSNEVVT 167 (309)
T ss_pred HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC-CCCEEECccccceecCCCcccccccccc
Confidence 7777643 234678888899999999999999999999999999999988 8899999999997654333333344678
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC-------------
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA------------- 1036 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~------------- 1036 (1181)
+.|+|||++.+.. .++...|+ ||+|+++|+|+||+.||.+.+..+...
T Consensus 168 ~~y~aPE~~~~~~-~~~~~~Di------------------wslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 228 (309)
T cd07872 168 LWYRPPDVLLGSS-EYSTQIDM------------------WGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEET 228 (309)
T ss_pred ccccCCHHHhCCC-CCCcHHHH------------------HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 9999999986432 23333444 999999999999999998766432100
Q ss_pred -----------CCCCCC-------CCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1037 -----------PPQISR-------SVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1037 -----------~~~ip~-------~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
....+. ......+..+..++.+|+..+|.+|++..+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 284 (309)
T cd07872 229 WPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAM 284 (309)
T ss_pred HhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHh
Confidence 000011 01123456677899999999999999754443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=310.93 Aligned_cols=239 Identities=22% Similarity=0.322 Sum_probs=182.2
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEcccccc--------CCcEEEEE
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSE--------EGYFKIFM 881 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d--------~~~l~LVm 881 (1181)
..+||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.++||||+++++++.. ...+++||
T Consensus 71 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvm 146 (440)
T PTZ00036 71 GNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVM 146 (440)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEE
Confidence 347999999999999999999999999885432 335679999999999999999887632 12577999
Q ss_pred eecCCCCcccchhcc-cCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC
Q psy14556 882 EQVPGGSLSTLLRVK-WGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC 960 (1181)
Q Consensus 882 Ey~~gGSL~dlL~~~-~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~ 960 (1181)
||++ ++|.+++... .....+++..++.++.||+.||+|||++||+||||||+|||++..++.+||+|||+++.+....
T Consensus 147 E~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~ 225 (440)
T PTZ00036 147 EFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ 225 (440)
T ss_pred ecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCC
Confidence 9996 4676666431 1344678889999999999999999999999999999999998745689999999998765432
Q ss_pred CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC----
Q psy14556 961 PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA---- 1036 (1181)
Q Consensus 961 ~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~---- 1036 (1181)
......||+.|+|||++.+.. .++..+|+ ||+||++|+|++|.+||.+.+..+...
T Consensus 226 -~~~~~~~t~~y~aPE~~~~~~-~~~~~~Di------------------wSlGvil~elltG~~pf~~~~~~~~~~~i~~ 285 (440)
T PTZ00036 226 -RSVSYICSRFYRAPELMLGAT-NYTTHIDL------------------WSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ 285 (440)
T ss_pred -CcccCCCCcCccCHHHhcCCC-CCCcHHHH------------------HHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 233456899999999986432 34444554 999999999999999998875422100
Q ss_pred ------------------CCCCCC--------CCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1037 ------------------PPQISR--------SVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1037 ------------------~~~ip~--------~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
...++. ..+...+..+..++.+|+..+|.+|++..+.
T Consensus 286 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~ 348 (440)
T PTZ00036 286 VLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEA 348 (440)
T ss_pred HhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 000111 1122345667789999999999999976555
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=282.24 Aligned_cols=238 Identities=24% Similarity=0.310 Sum_probs=187.0
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
.+||+|+||.||++.+.. +..+|+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|.
T Consensus 10 ~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 87 (256)
T cd05114 10 KELGSGQFGVVHLGKWRA-QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLL 87 (256)
T ss_pred eEecCCcCceEEEEEecc-CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHH
Confidence 369999999999998754 4579999886443 23467889999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCC-ccccCC
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA-ETFTGT 969 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~-~t~~GT 969 (1181)
+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++. ++.+||+|||.++......... ....++
T Consensus 88 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~-~~~~kl~d~g~~~~~~~~~~~~~~~~~~~ 164 (256)
T cd05114 88 NYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSS-TGVVKVSDFGMTRYVLDDEYTSSSGAKFP 164 (256)
T ss_pred HHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcC-CCeEEECCCCCccccCCCceeccCCCCCc
Confidence 9987532 24678889999999999999999999999999999999987 8899999999987654322111 122356
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--CCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--ISRSVSV 1046 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--ip~~l~~ 1046 (1181)
..|+|||++.+..++..+|+ ||+|+++|+|++ |+.||...+......... .....+.
T Consensus 165 ~~y~aPE~~~~~~~~~~~Di--------------------~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 224 (256)
T cd05114 165 VKWSPPEVFNFSKYSSKSDV--------------------WSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPK 224 (256)
T ss_pred hhhCChhhcccCccchhhhh--------------------HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCC
Confidence 68999999976554443333 999999999999 899998877544322111 1111223
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
..+..+..++.+|+..+|..||+..+.
T Consensus 225 ~~~~~~~~li~~c~~~~p~~Rps~~~l 251 (256)
T cd05114 225 LASMTVYEVMYSCWHEKPEGRPTFAEL 251 (256)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHH
Confidence 356678899999999999999964443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=284.26 Aligned_cols=236 Identities=22% Similarity=0.229 Sum_probs=185.5
Q ss_pred eecccCceEEEEEEE--cCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAARE--LDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d--~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
+||+|+||.||+|.+ ..++..+|+|+++..... ..+.+.+|+.+++.++||||+++++++.. +..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 599999999999964 456789999998654332 25678999999999999999999998754 4678999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC---Cc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS---AE 964 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~---~~ 964 (1181)
+|.+++... ..+++..+..++.|++.||+|||++|++||||||.||+++. ++.+||+|||++......... ..
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVT-QHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcC-CCeEEECCCccccccCCCCCeeeecC
Confidence 999998743 35778999999999999999999999999999999999998 889999999999776533221 11
Q ss_pred cccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--CC
Q psy14556 965 TFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--IS 1041 (1181)
Q Consensus 965 t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--ip 1041 (1181)
...++..|+|||.+.+...+..+|+ ||+|+++|||++ |..||.......+..... ..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di--------------------~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~ 216 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDV--------------------WSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER 216 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHH--------------------HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC
Confidence 2234578999999865543333333 999999999998 999998776544322111 11
Q ss_pred CCCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1042 RSVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1042 ~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
...+...+..+..++.+|+..+|..||+...
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~ 247 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAV 247 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHH
Confidence 1233456788999999999999999997433
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=293.73 Aligned_cols=239 Identities=21% Similarity=0.212 Sum_probs=185.7
Q ss_pred eeecccCceEEEEEEEcCCCe----EEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 811 IELGKGSYGVVYAARELDRQV----KLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~----~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
..||+|+||.||+|.+..++. .||+|.+..... ...+.+.+|+.+++.++||||+++++++... ..++++||++
T Consensus 13 ~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~ 91 (316)
T cd05108 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMP 91 (316)
T ss_pred eeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCC
Confidence 369999999999999866554 489999865432 3356788999999999999999999998765 5779999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCC--
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA-- 963 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~-- 963 (1181)
+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+||+++. ++.+||+|||+++.........
T Consensus 92 ~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~-~~~~kl~DfG~a~~~~~~~~~~~~ 168 (316)
T cd05108 92 FGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKT-PQHVKITDFGLAKLLGADEKEYHA 168 (316)
T ss_pred CCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecC-CCcEEEccccccccccCCCcceec
Confidence 99999998754 234678888999999999999999999999999999999987 8899999999998765432211
Q ss_pred ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--C
Q psy14556 964 ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--I 1040 (1181)
Q Consensus 964 ~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--i 1040 (1181)
....++..|+|||++.+...+..+|+ ||+|+++|||++ |+.||.+.....+..... .
T Consensus 169 ~~~~~~~~y~apE~~~~~~~~~~~Di--------------------~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~ 228 (316)
T cd05108 169 EGGKVPIKWMALESILHRIYTHQSDV--------------------WSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 228 (316)
T ss_pred cCCccceeecChHHhccCCCCchhhh--------------------HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCC
Confidence 11224678999999976554433333 999999999998 999998876544321111 1
Q ss_pred CCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1041 SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1041 p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
....+...+..+..++.+|+..+|..||...+.
T Consensus 229 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l 261 (316)
T cd05108 229 RLPQPPICTIDVYMIMVKCWMIDADSRPKFREL 261 (316)
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 111223456678889999999999999975544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=287.78 Aligned_cols=238 Identities=28% Similarity=0.369 Sum_probs=192.9
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
.||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.++++++||||+++++.+...+..++||||+++++|.
T Consensus 11 ~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (277)
T cd06642 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSAL 90 (277)
T ss_pred HhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHH
Confidence 59999999999999999999999999875432 33567899999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCc
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL 970 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~ 970 (1181)
+++.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++. ++.++|+|||++..+...........++.
T Consensus 91 ~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 165 (277)
T cd06642 91 DLLKP----GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSE-QGDVKLADFGVAGQLTDTQIKRNTFVGTP 165 (277)
T ss_pred HHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeC-CCCEEEccccccccccCcchhhhcccCcc
Confidence 98863 25678899999999999999999999999999999999987 88999999999977654332233345888
Q ss_pred cccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCC--CCCCCCCCCC
Q psy14556 971 QYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPP--QISRSVSVPG 1048 (1181)
Q Consensus 971 ~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~--~ip~~l~~~~ 1048 (1181)
.|+|||.+.+...+..+|+ ||+|+++|+|++|+.||............ ..+.......
T Consensus 166 ~y~aPE~~~~~~~~~~~Dv--------------------~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (277)
T cd06642 166 FWMAPEVIKQSAYDFKADI--------------------WSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQY 225 (277)
T ss_pred cccCHHHhCcCCCchhhhH--------------------HHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCccc
Confidence 9999999976544333333 99999999999999999866543322111 1112222345
Q ss_pred CcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1049 PGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1049 p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
+..+..++.+|+..+|..||...+..
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il 251 (277)
T cd06642 226 SKPFKEFVEACLNKDPRFRPTAKELL 251 (277)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHH
Confidence 66788899999999999999765553
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=287.53 Aligned_cols=249 Identities=20% Similarity=0.251 Sum_probs=190.2
Q ss_pred hcccCceeecccCceEEEEEEEcC-----CCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELD-----RQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFK 878 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~-----tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~ 878 (1181)
+|... .+||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 7 ~~~~~-~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~ 85 (277)
T cd05062 7 KITMS-RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 85 (277)
T ss_pred Hceee-eeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence 34443 469999999999998642 356899999864322 23456889999999999999999999999999999
Q ss_pred EEEeecCCCCcccchhcccC-------CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCC
Q psy14556 879 IFMEQVPGGSLSTLLRVKWG-------PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFG 951 (1181)
Q Consensus 879 LVmEy~~gGSL~dlL~~~~~-------~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFG 951 (1181)
+||||+++++|.+++..... ....++..+..++.|++.||.|||+.|++|+||||+||+++. ++.++|+|||
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~-~~~~~l~dfg 164 (277)
T cd05062 86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE-DFTVKIGDFG 164 (277)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcC-CCCEEECCCC
Confidence 99999999999999875321 123567788889999999999999999999999999999997 8999999999
Q ss_pred cccccccCCCC--CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCC
Q psy14556 952 TSKRLAGLCPS--AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKK 1028 (1181)
Q Consensus 952 lAk~l~~~~~~--~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~ 1028 (1181)
+++........ .....+++.|+|||.+.++..+..+|+ ||||+++|+|++ |..||.+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di--------------------~slG~~l~el~~~~~~p~~~ 224 (277)
T cd05062 165 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDV--------------------WSFGVVLWEIATLAEQPYQG 224 (277)
T ss_pred CccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHH--------------------HHHHHHHHHHHcCCCCCCCC
Confidence 98765432211 112235778999999976554444333 999999999999 7899988
Q ss_pred CCcccccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHH
Q psy14556 1029 KTSRALVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLV 1076 (1181)
Q Consensus 1029 ~~~~~l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~ 1076 (1181)
.+......... .....+...+..+..++.+|+..+|..||+ +.+.+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~~e~l~ 273 (277)
T cd05062 225 MSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPS-FLEIIS 273 (277)
T ss_pred CCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcC-HHHHHH
Confidence 76644321100 111223346778899999999999999996 444443
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=283.58 Aligned_cols=238 Identities=29% Similarity=0.393 Sum_probs=193.7
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
.+||.|+||.||+|.+..+++.+++|.+........+.+.+|+.++++++||||+++++++.+.+.+|++|||+++++|.
T Consensus 9 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~ 88 (262)
T cd06613 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQ 88 (262)
T ss_pred EEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHH
Confidence 47999999999999999899999999998766666788999999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCc
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL 970 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~ 970 (1181)
+++... ...+++..++.++.|++.||.|||++|++|+||||+||+++. ++.+||+|||.+..............++.
T Consensus 89 ~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 165 (262)
T cd06613 89 DIYQVT--RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTE-DGDVKLADFGVSAQLTATIAKRKSFIGTP 165 (262)
T ss_pred HHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECC-CCCEEECccccchhhhhhhhccccccCCc
Confidence 988753 245778999999999999999999999999999999999997 88999999999977654333334456888
Q ss_pred cccCchhhccC---CCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC---CCCCCC--
Q psy14556 971 QYMAPEVIDKG---QRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA---PPQISR-- 1042 (1181)
Q Consensus 971 ~Y~APEvl~gg---~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~---~~~ip~-- 1042 (1181)
.|+|||.+.+. ..+.. .|+ ||+|+++|+|++|+.||...+...... ...+..
T Consensus 166 ~y~~Pe~~~~~~~~~~~~~--~Di------------------~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 225 (262)
T cd06613 166 YWMAPEVAAVERKGGYDGK--CDI------------------WALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPK 225 (262)
T ss_pred cccCchhhcccccCCcCch--hhh------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCcc
Confidence 99999998654 22222 222 999999999999999998766433211 110011
Q ss_pred -CCCCCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1043 -SVSVPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1043 -~l~~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
......+..+..++.+|+..+|..||+.-
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 255 (262)
T cd06613 226 LKDKEKWSPVFHDFIKKCLTKDPKKRPTAT 255 (262)
T ss_pred ccchhhhhHHHHHHHHHHcCCChhhCCCHH
Confidence 11223456688899999999999999743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=285.24 Aligned_cols=237 Identities=30% Similarity=0.396 Sum_probs=194.9
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCC-CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKN-LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~-~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
+||.|++|.||+|.+..++..|++|.+.... ......+.+|+.+++.++||||+++++++.++...++|+||+++++|.
T Consensus 8 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 87 (274)
T cd06609 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCL 87 (274)
T ss_pred hhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHH
Confidence 5999999999999999999999999997554 334567889999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCc
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL 970 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~ 970 (1181)
+++... .+++..++.++.|++.||.|||+++++|+||+|+||+++. ++.++|+|||.++.+...........+++
T Consensus 88 ~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 162 (274)
T cd06609 88 DLLKPG----KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSE-EGDVKLADFGVSGQLTSTMSKRNTFVGTP 162 (274)
T ss_pred HHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC-CCCEEEcccccceeecccccccccccCCc
Confidence 998743 6788999999999999999999999999999999999998 89999999999987765433344456888
Q ss_pred cccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC--CCCCCCCC-
Q psy14556 971 QYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ--ISRSVSVP- 1047 (1181)
Q Consensus 971 ~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~--ip~~l~~~- 1047 (1181)
.|+|||.+.+..++..+|+ ||+|+++|+|++|..||...+......... .+......
T Consensus 163 ~y~~PE~~~~~~~~~~sDv--------------------~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (274)
T cd06609 163 FWMAPEVIKQSGYDEKADI--------------------WSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNK 222 (274)
T ss_pred cccChhhhccCCCCchhhH--------------------HHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccc
Confidence 9999999986654444443 999999999999999998766433221111 11111122
Q ss_pred CCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1048 GPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1048 ~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.+..+..++.+|+..+|..||+.-+.
T Consensus 223 ~~~~~~~~l~~~l~~~p~~Rpt~~~i 248 (274)
T cd06609 223 FSKPFKDFVSLCLNKDPKERPSAKEL 248 (274)
T ss_pred cCHHHHHHHHHHhhCChhhCcCHHHH
Confidence 56778899999999999999864333
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=325.34 Aligned_cols=244 Identities=22% Similarity=0.306 Sum_probs=199.4
Q ss_pred eeecccCceEEEEEEEcCCC-----eEEEEEEecCCC-CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeec
Q psy14556 811 IELGKGSYGVVYAARELDRQ-----VKLAIKEIPEKN-LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQV 884 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg-----~~VAIKii~~~~-~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~ 884 (1181)
+.||+|.||.||.|...... ..||+|.+.+.. .++...|.+|+.+|+.++|||||+++|++.+.+..+|++|||
T Consensus 698 ~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM 777 (1025)
T KOG1095|consen 698 RVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYM 777 (1025)
T ss_pred eeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhc
Confidence 46999999999999875433 359999997664 345678999999999999999999999999999999999999
Q ss_pred CCCCcccchhccc----CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC
Q psy14556 885 PGGSLSTLLRVKW----GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC 960 (1181)
Q Consensus 885 ~gGSL~dlL~~~~----~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~ 960 (1181)
+||+|..+|++.+ ++..+.......++.||++|++||+++++|||||..+|+||+. ...+||+|||+|+.+-...
T Consensus 778 ~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~-~r~VKIaDFGlArDiy~~~ 856 (1025)
T KOG1095|consen 778 EGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDE-RRVVKIADFGLARDIYDKD 856 (1025)
T ss_pred ccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecc-cCcEEEcccchhHhhhhch
Confidence 9999999998642 3567788999999999999999999999999999999999998 7999999999999443221
Q ss_pred -CCCc-cccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCC
Q psy14556 961 -PSAE-TFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAP 1037 (1181)
Q Consensus 961 -~~~~-t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~ 1037 (1181)
.... ...-...|||||.+..+.++.++|| |||||+|||++| |..||.+.+..++...
T Consensus 857 yyr~~~~a~lPvkWm~PEsl~d~iFtskSDv--------------------WsFGVllWEifslG~~PY~~~~n~~v~~~ 916 (1025)
T KOG1095|consen 857 YYRKHGEAMLPVKWMPPESLKDGIFTSKSDV--------------------WSFGVLLWEIFSLGATPYPSRSNFEVLLD 916 (1025)
T ss_pred heeccCccccceecCCHHHHhhcccccccch--------------------hhhHHHHHHHHhCCCCCCCCcchHHHHHH
Confidence 1111 1123578999999987776666666 999999999999 7899999887765331
Q ss_pred CCCC--CCCCCCCCcchHHhhccCCCCCCCCCchhHHHHH
Q psy14556 1038 PQIS--RSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNL 1075 (1181)
Q Consensus 1038 ~~ip--~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~ 1075 (1181)
.... =..+.-+|..+.++++.|+..+|..||.+....-
T Consensus 917 ~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 917 VLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred HHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 1111 1123457899999999999999999999777643
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=287.18 Aligned_cols=243 Identities=25% Similarity=0.370 Sum_probs=191.6
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCccc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLST 891 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~d 891 (1181)
+||.|+||.||+|++..+++.+++|.+........+.+.+|+.+++.++||||+++++.+..++.+++||||+++++|..
T Consensus 19 ~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 98 (292)
T cd06644 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDA 98 (292)
T ss_pred eecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHH
Confidence 69999999999999999999999999977665566788999999999999999999999999999999999999999988
Q ss_pred chhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCcc
Q psy14556 892 LLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQ 971 (1181)
Q Consensus 892 lL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~~ 971 (1181)
++... ...+++..+..++.|++.||.|||++|++||||||+||+++. ++.+||+|||++..............+++.
T Consensus 99 ~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 175 (292)
T cd06644 99 IMLEL--DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTL-DGDIKLADFGVSAKNVKTLQRRDSFIGTPY 175 (292)
T ss_pred HHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcC-CCCEEEccCccceeccccccccceecCCcc
Confidence 87643 235778999999999999999999999999999999999987 889999999998765433233334568899
Q ss_pred ccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCC---CC-CCCCCCC
Q psy14556 972 YMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPP---QI-SRSVSVP 1047 (1181)
Q Consensus 972 Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~---~i-p~~l~~~ 1047 (1181)
|+|||++.+.... .. .++...+.||+||++|+|++|..||...+........ .. ....+..
T Consensus 176 y~aPE~~~~~~~~-~~--------------~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T cd06644 176 WMAPEVVMCETMK-DT--------------PYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSK 240 (292)
T ss_pred ccCceeecccccc-CC--------------CCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcc
Confidence 9999998532211 00 1112223399999999999999999876543321111 01 1111234
Q ss_pred CCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1048 GPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1048 ~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
.+..+..++.+|+..+|..||...+
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rp~~~~ 265 (292)
T cd06644 241 WSMEFRDFLKTALDKHPETRPSAAQ 265 (292)
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHH
Confidence 5567888999999999999997433
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=291.35 Aligned_cols=237 Identities=24% Similarity=0.381 Sum_probs=193.5
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCccc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLST 891 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~d 891 (1181)
+||+|+||.||++.+..+++.||+|.+........+.+.+|+.+++.++||||+++++.+..++..+++|||+++++|..
T Consensus 28 ~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~ 107 (297)
T cd06659 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD 107 (297)
T ss_pred hcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHH
Confidence 69999999999999998999999999976655556778999999999999999999999999999999999999999998
Q ss_pred chhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCcc
Q psy14556 892 LLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQ 971 (1181)
Q Consensus 892 lL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~~ 971 (1181)
++... .+++..++.++.|++.||.|||++|++||||||+||+++. ++.+||+|||++..+...........++..
T Consensus 108 ~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~-~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~ 182 (297)
T cd06659 108 IVSQT----RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTL-DGRVKLSDFGFCAQISKDVPKRKSLVGTPY 182 (297)
T ss_pred HHhhc----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEcc-CCcEEEeechhHhhcccccccccceecCcc
Confidence 87542 5778999999999999999999999999999999999987 899999999998765543333344568999
Q ss_pred ccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC----CCCCCCCCCCC
Q psy14556 972 YMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA----PPQISRSVSVP 1047 (1181)
Q Consensus 972 Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~----~~~ip~~l~~~ 1047 (1181)
|+|||++.+...+..+|+ ||+|+++|+|++|+.||.......... ...........
T Consensus 183 y~aPE~~~~~~~~~~~Dv--------------------~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (297)
T cd06659 183 WMAPEVISRTPYGTEVDI--------------------WSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHK 242 (297)
T ss_pred ccCHHHHccCCCCchhhH--------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCC
Confidence 999999976544333333 999999999999999998765433211 11111112234
Q ss_pred CCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1048 GPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1048 ~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.+..+..++.+|+..+|.+||+..+.
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~l 268 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQEL 268 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 56678889999999999999974444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=280.56 Aligned_cols=237 Identities=27% Similarity=0.384 Sum_probs=191.9
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEcccccc-CCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSE-EGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d-~~~l~LVmEy~~gG 887 (1181)
++||+|++|.||++.+..+++.|++|.+..... ...+.+.+|+.++++++|||++++++.+.. ...++++|||++++
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~ 85 (257)
T cd08223 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGG 85 (257)
T ss_pred EEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCC
Confidence 369999999999999999999999999965433 234568899999999999999999998764 45689999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|.+++... ....+++..++.++.|++.||.+||++|++|+||||+||+++. ++.++|+|||++..............
T Consensus 86 ~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~ 163 (257)
T cd08223 86 DLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTR-TNIIKVGDLGIARVLENQCDMASTLI 163 (257)
T ss_pred cHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEec-CCcEEEecccceEEecccCCcccccc
Confidence 999998754 2345789999999999999999999999999999999999987 88999999999987654433344456
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCC--CCCCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPP--QISRSVS 1045 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~--~ip~~l~ 1045 (1181)
+++.|+|||++.+...+.++| + ||+|+++|+|++|+.||...+........ ......+
T Consensus 164 ~~~~y~aPE~~~~~~~~~~~D--v------------------~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (257)
T cd08223 164 GTPYYMSPELFSNKPYNYKSD--V------------------WALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMP 223 (257)
T ss_pred CCcCccChhHhcCCCCCchhh--h------------------HHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence 899999999997665443333 3 99999999999999999876654321111 0111233
Q ss_pred CCCCcchHHhhccCCCCCCCCCch
Q psy14556 1046 VPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1046 ~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
...+..+..++.+|+..+|..||.
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rp~ 247 (257)
T cd08223 224 KDYSPELGELIATMLSKRPEKRPS 247 (257)
T ss_pred cccCHHHHHHHHHHhccCcccCCC
Confidence 456778899999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=286.69 Aligned_cols=237 Identities=29% Similarity=0.367 Sum_probs=193.8
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCC-CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKN-LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~-~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
+||.|+||.||+|.+..++..||+|.+.... ....+.+.+|+.++++++||||+++++.+.+.+..++||||+++++|.
T Consensus 11 ~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (277)
T cd06640 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSAL 90 (277)
T ss_pred hcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHH
Confidence 5999999999999999999999999987543 233567889999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCc
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL 970 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~ 970 (1181)
+++... .+++..+..++.|++.||+|||+++++|+||+|+||+++. ++.++|+|||++..............++.
T Consensus 91 ~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 165 (277)
T cd06640 91 DLLRAG----PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSE-QGDVKLADFGVAGQLTDTQIKRNTFVGTP 165 (277)
T ss_pred HHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcC-CCCEEEcccccceeccCCccccccccCcc
Confidence 988643 4678888999999999999999999999999999999987 88999999999977654332333345788
Q ss_pred cccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCC--CCCCCCCCCC
Q psy14556 971 QYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPP--QISRSVSVPG 1048 (1181)
Q Consensus 971 ~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~--~ip~~l~~~~ 1048 (1181)
.|+|||++.+...+..+|+ ||+|+++|+|++|..||............ ..+.......
T Consensus 166 ~y~apE~~~~~~~~~~~Dv--------------------~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (277)
T cd06640 166 FWMAPEVIQQSAYDSKADI--------------------WSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEF 225 (277)
T ss_pred cccCHhHhccCCCccHHHH--------------------HHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhh
Confidence 9999999976544433333 99999999999999999876654432211 1122233345
Q ss_pred CcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1049 PGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1049 p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
+..+..++.+|+..+|..||...+.
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~i 250 (277)
T cd06640 226 SKPFKEFIDACLNKDPSFRPTAKEL 250 (277)
T ss_pred hHHHHHHHHHHcccCcccCcCHHHH
Confidence 6778889999999999999975444
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=290.91 Aligned_cols=241 Identities=26% Similarity=0.391 Sum_probs=187.2
Q ss_pred eeecccCceEEEEEEEc----CCCeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 811 IELGKGSYGVVYAAREL----DRQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~----~tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
+.||.|.||.||+|.+. ..+..|+||.+...... ..+.+.+|++.+++++||||+++++++...+..++||||++
T Consensus 5 ~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~ 84 (259)
T PF07714_consen 5 KQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCP 84 (259)
T ss_dssp EEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--T
T ss_pred eEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccccc
Confidence 46999999999999987 45678999999554332 36789999999999999999999999998888999999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC--CC
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP--SA 963 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~--~~ 963 (1181)
+|+|.+++... ....+++..++.|+.||+.||.|||+++++|+||+++||+++. ++.+||+|||++........ ..
T Consensus 85 ~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~-~~~~Kl~~f~~~~~~~~~~~~~~~ 162 (259)
T PF07714_consen 85 GGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDS-NGQVKLSDFGLSRPISEKSKYKND 162 (259)
T ss_dssp TEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEET-TTEEEEESTTTGEETTTSSSEEES
T ss_pred ccccccccccc-ccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccc
Confidence 99999999865 3456789999999999999999999999999999999999998 88999999999987632111 11
Q ss_pred ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--C
Q psy14556 964 ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--I 1040 (1181)
Q Consensus 964 ~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--i 1040 (1181)
........|+|||.+.+...+.++|| ||||+++||+++ |+.||...+..++..... .
T Consensus 163 ~~~~~~~~~~aPE~~~~~~~~~ksDV--------------------ysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~ 222 (259)
T PF07714_consen 163 SSQQLPLRYLAPEVLKDGEYTKKSDV--------------------YSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ 222 (259)
T ss_dssp TTSESGGGGS-HHHHHHSEESHHHHH--------------------HHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE
T ss_pred cccccccccccccccccccccccccc--------------------cccccccccccccccccccccccccccccccccc
Confidence 22346788999999986654434433 999999999999 789998876655322111 1
Q ss_pred CCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1041 SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1041 p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
....+...+..+..++.+|++.+|..||+..+.
T Consensus 223 ~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i 255 (259)
T PF07714_consen 223 RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEI 255 (259)
T ss_dssp ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHH
T ss_pred cceeccchhHHHHHHHHHHcCCChhhCcCHHHH
Confidence 112234568889999999999999999985544
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=279.98 Aligned_cols=242 Identities=26% Similarity=0.349 Sum_probs=197.4
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCC--CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKN--LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~--~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
+.||.|+||.||.+++..+++.+++|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..+++|||+++++
T Consensus 6 ~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (256)
T cd08221 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGT 85 (256)
T ss_pred eEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCc
Confidence 36999999999999999999999999986543 3345678899999999999999999999999999999999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|.+++.... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++. ++.+||+|||.+..............+
T Consensus 86 L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~-~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (256)
T cd08221 86 LYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTK-AGLIKLGDFGISKILGSEYSMAETVVG 163 (256)
T ss_pred HHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeC-CCCEEECcCcceEEcccccccccccCC
Confidence 999997542 346788999999999999999999999999999999999988 889999999999876544333344568
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC--CCCCCCC
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ--ISRSVSV 1046 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~--ip~~l~~ 1046 (1181)
++.|+|||.+.+...+..+|+ ||+|+++|+|++|..||......+...... .......
T Consensus 164 ~~~y~ape~~~~~~~~~~~Dv--------------------~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (256)
T cd08221 164 TPYYMSPELCQGVKYNFKSDI--------------------WALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVS 223 (256)
T ss_pred CccccCHhhcCCCCCCCcchh--------------------HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence 999999999976554444443 999999999999999998876544322111 1111224
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNTNL 1075 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~~~ 1075 (1181)
..+..+..++.+|+..+|..||+ +.+.+
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~s-~~~ll 251 (256)
T cd08221 224 VYSSELISLVHSLLQQDPEKRPT-ADEVL 251 (256)
T ss_pred ccCHHHHHHHHHHcccCcccCCC-HHHHh
Confidence 45677888999999999999985 44433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PF00160 Pro_isomerase: Cyclophilin type peptidyl-prolyl cis-trans isomerase/CLD; InterPro: IPR002130 Cyclophilin [] is the major high-affinity binding protein in vertebrates for the immunosuppressive drug cyclosporin A (CSA), but is also found in other organisms | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=266.29 Aligned_cols=148 Identities=42% Similarity=0.726 Sum_probs=128.6
Q ss_pred EEeccc-ceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCC-cccCCCCCCCCcC
Q psy14556 117 TNLDDN-LESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGG-KSIYGNKFEDENF 194 (1181)
Q Consensus 117 vv~~T~-~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg-~si~g~~~~dE~~ 194 (1181)
+.+.|. .|+|+||||++.||++|+||++|| +.|+ |+|+.|||++|+++||||++......+. ....+.++++|..
T Consensus 2 ~~i~t~~~G~i~ieL~~~~aP~~~~nF~~l~--~~~~-y~g~~f~ri~~~~~i~~G~~~~~~~~~~~~~~~~~~~~~E~~ 78 (155)
T PF00160_consen 2 VDIETSGLGRIVIELFGDEAPKTVENFLRLC--TSGF-YDGTKFHRIIPNFVIQGGDPTGNGGYGREDSTGGEPIPDEFN 78 (155)
T ss_dssp EEEEETTEEEEEEEEETTTSHHHHHHHHHHH--HTTS-STTEBEEEEETTTEEEESSTTTSSSSTSEEBTTBSCBSSSGB
T ss_pred EEEEeCCccCEEEEEeCCCCcHHHHhhehhh--cccc-cCCceeecccccceeeeeeccCCCCcccccccCccccccccc
Confidence 456675 999999999999999999999999 5667 9999999999999999999875443111 1233456888874
Q ss_pred --ccccCCCceEEeecCC--CCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCCCCCCcccceEEeeecc
Q psy14556 195 --TLKHTGPGILSMANAG--PNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGSQSGKTSKKIVVANSDS 269 (1181)
Q Consensus 195 --~l~h~~~G~Lsma~~g--~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t~~g~P~~~V~I~~cGv 269 (1181)
.+.| ++|+|+|++.+ +++++|||||++++.|+||++|+|||+|++||+||++|++..+++ +|.++|+|.+||+
T Consensus 79 ~~~~~~-~~G~v~~~~~~~~~~~~~sqF~I~l~~~~~ld~~~~vfG~V~~G~~vl~~i~~~~~~~-~p~~~v~I~~cgv 155 (155)
T PF00160_consen 79 PSLLKH-RRGLVSMARSGKDPNSNGSQFFITLSDAPHLDGKYTVFGRVIEGMDVLDKIEAGPTDE-RPKQDVTISSCGV 155 (155)
T ss_dssp TTSSSS-STTEEEEEBSSSSTTEBSSEEEEESSCGGGGTTTSEEEEEEEEHHHHHHHHHTSBBTT-EBSSTEEEEEEEE
T ss_pred cccccc-cceeeeecccccCCCCCCceEEeeccCCCccccceeeeeEEehhHHHHHHHHCCCCCC-ccCCCeEEEEeEC
Confidence 4555 79999999986 899999999999999999999999999999999999999988877 9999999999996
|
It exhibits a peptidyl-prolyl cis-trans isomerase activity (5.2.1.8 from EC) (PPIase or rotamase). PPIase is an enzyme that accelerates protein folding by catalysing the cis-trans isomerisation of proline imidic peptide bonds in oligopeptides []. It is probable that CSA mediates some of its effects via an forming a tight complex with cyclophilin that inhibits the phosphatase activity of calcineurin [], []. Cyclophilin A is a cytosolic and highly abundant protein. The protein belongs to a family of isozymes, including cyclophilins B and C, and natural killer cell cyclophilin-related protein [, , ]. Major isoforms have been found throughout the cell, including the ER, and some are even secreted. The sequences of the different forms of cyclophilin-type PPIases are well conserved. Note: FKBP's, a family of proteins that bind the immunosuppressive drug FK506, are also PPIases, but their sequence is not at all related to that of cyclophilin (see IPR001179 from INTERPRO).; GO: 0003755 peptidyl-prolyl cis-trans isomerase activity, 0006457 protein folding; PDB: 1Z81_A 1IHG_A 1IIP_A 3PMP_B 3O7T_A 2B71_A 1QNG_A 1QNH_A 2HQJ_A 2RMC_G .... |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=289.98 Aligned_cols=200 Identities=24% Similarity=0.380 Sum_probs=159.0
Q ss_pred CceeecccCceEEEEEEEc--CCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEcccccc--CCcEEEEEeec
Q psy14556 809 NRIELGKGSYGVVYAAREL--DRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSE--EGYFKIFMEQV 884 (1181)
Q Consensus 809 ~~~kIG~G~fG~VYka~d~--~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d--~~~l~LVmEy~ 884 (1181)
+..+||+|+||+||+|++. .+++.||+|.+.... ....+.+|+.++++++||||+++++++.. ....+++|||+
T Consensus 5 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred cccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 3457999999999999965 467899999986543 23567899999999999999999998854 45789999998
Q ss_pred CCCCcccchhccc------CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccccc---CCCeeeeecCCcccc
Q psy14556 885 PGGSLSTLLRVKW------GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNT---YSGVVKISDFGTSKR 955 (1181)
Q Consensus 885 ~gGSL~dlL~~~~------~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~---~~g~vKLiDFGlAk~ 955 (1181)
+++|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||++. .++.+||+|||+++.
T Consensus 83 -~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 83 -EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred -CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 567877765321 2235788999999999999999999999999999999999942 257899999999987
Q ss_pred cccCCC---CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCC
Q psy14556 956 LAGLCP---SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKT 1030 (1181)
Q Consensus 956 l~~~~~---~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~ 1030 (1181)
...... ......||+.|+|||++.+.. .++..+|+ ||+||++|+|++|++||.+..
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~Di------------------wslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGAR-HYTKAIDI------------------WAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCCC-CcCchhhH------------------HHHHHHHHHHHhCCCCccCCc
Confidence 653321 123456899999999997532 23444544 999999999999999997644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=278.33 Aligned_cols=242 Identities=27% Similarity=0.356 Sum_probs=196.3
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
..||+|+||.||++.+..+++.+|+|.+..... ...+.+.+|+.++++++||||+++++.+...+..++||||+++++
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd08220 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGT 85 (256)
T ss_pred EEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCC
Confidence 369999999999999999999999999975532 235678999999999999999999999999999999999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|.+++... ....+++..++.++.|++.||+|||++|++|+||||+||+++..++.+||+|||.+....... ......+
T Consensus 86 L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~ 163 (256)
T cd08220 86 LAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-KAYTVVG 163 (256)
T ss_pred HHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-ccccccc
Confidence 99999754 334578889999999999999999999999999999999998756678999999998765432 2233468
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC--CCCCCCC
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ--ISRSVSV 1046 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~--ip~~l~~ 1046 (1181)
+..|+|||.+.+...+... |+ ||+|+++|+|++|+.||.+.+......... .....+.
T Consensus 164 ~~~y~aPE~~~~~~~~~~~--Dv------------------~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (256)
T cd08220 164 TPCYISPELCEGKPYNQKS--DI------------------WALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISD 223 (256)
T ss_pred CCcccCchhccCCCCCccc--ch------------------HHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCC
Confidence 8999999999765443333 33 999999999999999998876544322111 1112233
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
..+..+..++.+|+..+|..||+..+..
T Consensus 224 ~~~~~l~~li~~~l~~~p~~Rpt~~~ll 251 (256)
T cd08220 224 RYSPDLRQLILSMLNLDPSKRPQLSQIM 251 (256)
T ss_pred CcCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 4677788999999999999999855543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=285.40 Aligned_cols=230 Identities=28% Similarity=0.326 Sum_probs=184.4
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
+||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 8 ~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~ 87 (279)
T cd06619 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLD 87 (279)
T ss_pred eeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChH
Confidence 69999999999999999999999999865532 23456889999999999999999999999999999999999999986
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCc
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL 970 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~ 970 (1181)
.+. .+++..+..++.|++.||.|||+.||+|+||||+||+++. ++.++|+|||++..+... ......|+.
T Consensus 88 ~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~-~~~~~l~dfg~~~~~~~~--~~~~~~~~~ 157 (279)
T cd06619 88 VYR-------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNT-RGQVKLCDFGVSTQLVNS--IAKTYVGTN 157 (279)
T ss_pred Hhh-------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECC-CCCEEEeeCCcceecccc--cccCCCCCh
Confidence 542 3567888899999999999999999999999999999998 899999999999765432 233456899
Q ss_pred cccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc----------CCCCC
Q psy14556 971 QYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV----------APPQI 1040 (1181)
Q Consensus 971 ~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~----------~~~~i 1040 (1181)
.|+|||++.+..++..+|+ ||+|+++|+|++|+.||......... .....
T Consensus 158 ~y~aPE~~~~~~~~~~~Dv--------------------wslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 217 (279)
T cd06619 158 AYMAPERISGEQYGIHSDV--------------------WSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP 217 (279)
T ss_pred hhcCceeecCCCCCCcchH--------------------HHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC
Confidence 9999999976654444443 99999999999999999764321100 00111
Q ss_pred CCCCCCCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1041 SRSVSVPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1041 p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
+.......+..+..++.+|+..+|..||..-
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~ 248 (279)
T cd06619 218 PVLPVGQFSEKFVHFITQCMRKQPKERPAPE 248 (279)
T ss_pred CCCCCCcCCHHHHHHHHHHhhCChhhCCCHH
Confidence 1111223456688899999999999999643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=287.36 Aligned_cols=248 Identities=20% Similarity=0.289 Sum_probs=193.0
Q ss_pred ceeecccCceEEEEEEEcCC-----CeEEEEEEecCCCC-CChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEe
Q psy14556 810 RIELGKGSYGVVYAARELDR-----QVKLAIKEIPEKNL-GDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~t-----g~~VAIKii~~~~~-~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmE 882 (1181)
...||+|+||.||++.+... ...+|+|.+..... .....+.+|+.+++++ +||||+++++++...+.++++||
T Consensus 17 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e 96 (293)
T cd05053 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVE 96 (293)
T ss_pred eeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEE
Confidence 34799999999999987643 37899999875432 2345688999999999 89999999999999999999999
Q ss_pred ecCCCCcccchhcc-------------cCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeec
Q psy14556 883 QVPGGSLSTLLRVK-------------WGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISD 949 (1181)
Q Consensus 883 y~~gGSL~dlL~~~-------------~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiD 949 (1181)
|+++++|.++++.. .....+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~-~~~~kL~D 175 (293)
T cd05053 97 YAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE-DHVMKIAD 175 (293)
T ss_pred eCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC-CCeEEeCc
Confidence 99999999998642 12346788899999999999999999999999999999999987 89999999
Q ss_pred CCcccccccCCCC--CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCC
Q psy14556 950 FGTSKRLAGLCPS--AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAAL 1026 (1181)
Q Consensus 950 FGlAk~l~~~~~~--~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF 1026 (1181)
||.++........ .....++..|+|||++.+...+..+|+ ||+||++|+|++ |..||
T Consensus 176 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di--------------------~slG~il~el~~~g~~p~ 235 (293)
T cd05053 176 FGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDV--------------------WSFGVLLWEIFTLGGSPY 235 (293)
T ss_pred cccccccccccceeccCCCCCCccccCHHHhccCCcCcccce--------------------eehhhHHHHHhcCCCCCC
Confidence 9999866532211 112234578999999876544443333 999999999997 99999
Q ss_pred CCCCcccccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcc
Q psy14556 1027 KKKTSRALVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTG 1079 (1181)
Q Consensus 1027 ~~~~~~~l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~ 1079 (1181)
.+....++..... .....+...+..+..++.+|+..+|..|| ++.+.+..+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~eil~~l~ 289 (293)
T cd05053 236 PGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRP-TFKQLVEDLD 289 (293)
T ss_pred CCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCc-CHHHHHHHHH
Confidence 8876544322111 11122345567888899999999999999 5666555543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=285.15 Aligned_cols=245 Identities=24% Similarity=0.345 Sum_probs=194.6
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCccc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLST 891 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~d 891 (1181)
+||.|+||.||++.+..++..+|+|.+........+.+.+|+.++++++||||+++++.+..++..++||||+++++|.+
T Consensus 12 ~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 91 (280)
T cd06611 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDS 91 (280)
T ss_pred HhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHH
Confidence 59999999999999988999999999976655556778999999999999999999999999999999999999999999
Q ss_pred chhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCcc
Q psy14556 892 LLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQ 971 (1181)
Q Consensus 892 lL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~~ 971 (1181)
++... ...+++..++.++.|++.||.|||++||+|+||||+||+++. ++.++|+|||.+..............+++.
T Consensus 92 ~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 168 (280)
T cd06611 92 IMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTL-DGDVKLADFGVSAKNKSTLQKRDTFIGTPY 168 (280)
T ss_pred HHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECC-CCCEEEccCccchhhcccccccceeecchh
Confidence 98753 235788999999999999999999999999999999999988 899999999998765543333344568999
Q ss_pred ccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC---CCC-CCCCC
Q psy14556 972 YMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ---ISR-SVSVP 1047 (1181)
Q Consensus 972 Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~---ip~-~l~~~ 1047 (1181)
|+|||++..+... ....+. ..+.||+|+++|+|++|+.||............. .+. ..+..
T Consensus 169 y~~PE~~~~~~~~-~~~~~~--------------~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (280)
T cd06611 169 WMAPEVVACETFK-DNPYDY--------------KADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSK 233 (280)
T ss_pred hcCHHHHhhcccC-CCCCCc--------------cccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCccc
Confidence 9999998633211 111111 2222999999999999999998766433211111 011 11234
Q ss_pred CCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1048 GPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1048 ~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
.+..+..++.+|+..+|..||+..+..
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rps~~~il 260 (280)
T cd06611 234 WSSSFNDFLKSCLVKDPDDRPTAAELL 260 (280)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHh
Confidence 567788899999999999999755543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=282.24 Aligned_cols=238 Identities=24% Similarity=0.265 Sum_probs=186.0
Q ss_pred eecccCceEEEEEEEc--CCCeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 812 ELGKGSYGVVYAAREL--DRQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~--~tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
+||+|+||.||+|.+. ..+..||+|++...... ..+.+.+|+.++++++||||+++++++.. +..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999765 45567999998655432 24668999999999999999999998864 57899999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCC---cc
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA---ET 965 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~---~t 965 (1181)
|.+++... ...+++..++.++.|++.||.|||++|++||||||+||+++. ++.+||+|||++.......... ..
T Consensus 81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVN-QHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcC-CCcEEeccCCccccccCCccceeccCC
Confidence 99998743 235788999999999999999999999999999999999987 8899999999997654322111 11
Q ss_pred ccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--CCC
Q psy14556 966 FTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--ISR 1042 (1181)
Q Consensus 966 ~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--ip~ 1042 (1181)
..++..|+|||.+.+...+..+|+ ||||+++|++++ |..||.......+..... ...
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di--------------------~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 217 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDV--------------------WSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL 217 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhH--------------------HHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC
Confidence 223578999999876554433333 999999999996 999998776544321111 112
Q ss_pred CCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1043 SVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1043 ~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
..+...+..+.+++.+|+..+|..||...+.
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i 248 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKV 248 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 2334567888999999999999999975544
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=283.23 Aligned_cols=239 Identities=24% Similarity=0.326 Sum_probs=187.3
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
++||+|++|.||+|++..++..||+|.+..... ...+.+.+|+.++++++||||+++++++.+++..++||||++ ++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~ 84 (285)
T cd07861 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MD 84 (285)
T ss_pred eEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CC
Confidence 369999999999999999999999999865432 234678899999999999999999999999999999999996 68
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|.+++........+++..++.++.||+.||+|||++|++|+||||+||+++. ++.+||+|||++..............+
T Consensus 85 l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~ 163 (285)
T cd07861 85 LKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDN-KGVIKLADFGLARAFGIPVRVYTHEVV 163 (285)
T ss_pred HHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcC-CCcEEECcccceeecCCCcccccCCcc
Confidence 8888765434456889999999999999999999999999999999999987 899999999998765433222233457
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc--------CC---
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV--------AP--- 1037 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~--------~~--- 1037 (1181)
++.|+|||++.+.. .++...|+ ||+|+++|+|+||+.||.+....... ..
T Consensus 164 ~~~y~aPE~~~~~~-~~~~~~Dv------------------~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (285)
T cd07861 164 TLWYRAPEVLLGSP-RYSTPVDI------------------WSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTED 224 (285)
T ss_pred cccccChHHhcCCC-CcCcHHHH------------------HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 88999999986432 22333333 99999999999999999876532100 00
Q ss_pred ------------CCCC-------CCCCCCCCcchHHhhccCCCCCCCCCchh
Q psy14556 1038 ------------PQIS-------RSVSVPGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1038 ------------~~ip-------~~l~~~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
...+ .......+..+..++.+|+..+|..||+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~ 276 (285)
T cd07861 225 VWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISA 276 (285)
T ss_pred hhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCH
Confidence 0000 01112356667789999999999999963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=286.22 Aligned_cols=243 Identities=21% Similarity=0.250 Sum_probs=190.4
Q ss_pred eecccCceEEEEEEEcCC-----CeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 812 ELGKGSYGVVYAARELDR-----QVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~t-----g~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
+||+|+||.||+|.+..+ +..||+|.++..... ..+.+.+|+.+++.++||||+++++++.+.+..++++||++
T Consensus 12 ~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~ 91 (283)
T cd05091 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCS 91 (283)
T ss_pred HhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCC
Confidence 699999999999987543 578999999755332 24568899999999999999999999999999999999999
Q ss_pred CCCcccchhccc-------------CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCc
Q psy14556 886 GGSLSTLLRVKW-------------GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGT 952 (1181)
Q Consensus 886 gGSL~dlL~~~~-------------~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGl 952 (1181)
+++|.+++.... ....+++..+..++.|++.||.|||++||+||||||+||+++. ++.+||+|||+
T Consensus 92 ~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~-~~~~kl~Dfg~ 170 (283)
T cd05091 92 HSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD-KLNVKISDLGL 170 (283)
T ss_pred CCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC-CCceEeccccc
Confidence 999999985321 1234678888999999999999999999999999999999987 78999999999
Q ss_pred ccccccCCC--CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCC
Q psy14556 953 SKRLAGLCP--SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKK 1029 (1181)
Q Consensus 953 Ak~l~~~~~--~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~ 1029 (1181)
++....... ......+++.|+|||.+.++..+..+|+ ||+|+++|||++ |..||.+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv--------------------~slG~~l~el~~~g~~p~~~~ 230 (283)
T cd05091 171 FREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDI--------------------WSYGVVLWEVFSYGLQPYCGY 230 (283)
T ss_pred ccccccchheeeccCccCCccccCHHHHhcCCCCcchhH--------------------HHHHHHHHHHHcCCCCCCCCC
Confidence 876543221 1122345789999999976654444333 999999999998 88899887
Q ss_pred CcccccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHH
Q psy14556 1030 TSRALVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLV 1076 (1181)
Q Consensus 1030 ~~~~l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~ 1076 (1181)
...++..... .....+...+..+..++.+|++.+|..||. +++.+.
T Consensus 231 ~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~-~~~i~~ 278 (283)
T cd05091 231 SNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPR-FKDIHS 278 (283)
T ss_pred CHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCC-HHHHHH
Confidence 6654332211 112234467888999999999999999996 444333
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=281.34 Aligned_cols=245 Identities=21% Similarity=0.259 Sum_probs=192.2
Q ss_pred ceeecccCceEEEEEEEcCC---CeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 810 RIELGKGSYGVVYAARELDR---QVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~t---g~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
.+.||+|+||.||+|.+..+ ...||+|.++..... ..+.+.+|+.++++++||||+++++++...+..+++|||++
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 88 (266)
T cd05033 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYME 88 (266)
T ss_pred eeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCC
Confidence 34799999999999988644 468999998655433 24578899999999999999999999999999999999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCC--
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA-- 963 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~-- 963 (1181)
+++|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+||+++. ++.++|+|||++..........
T Consensus 89 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~-~~~~~l~dfg~~~~~~~~~~~~~~ 165 (266)
T cd05033 89 NGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNS-NLVCKVSDFGLSRRLEDSEATYTT 165 (266)
T ss_pred CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC-CCCEEECccchhhcccccccceec
Confidence 999999987542 25778999999999999999999999999999999999988 8899999999998775222211
Q ss_pred ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--C
Q psy14556 964 ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--I 1040 (1181)
Q Consensus 964 ~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--i 1040 (1181)
....++..|+|||.+.+...+..+|+ ||+|+++|+|++ |..||.......+..... .
T Consensus 166 ~~~~~~~~y~~Pe~~~~~~~~~~~Dv--------------------~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~ 225 (266)
T cd05033 166 KGGKIPIRWTAPEAIAYRKFTSASDV--------------------WSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY 225 (266)
T ss_pred cCCCCCccccChhhhccCCCccccch--------------------HHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC
Confidence 12234678999999976554443333 999999999998 999997766544321111 1
Q ss_pred CCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1041 SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1041 p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
....+...+..+..++.+|+..+|..||+ +.+.+..+
T Consensus 226 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~-~~ei~~~l 262 (266)
T cd05033 226 RLPPPMDCPSALYQLMLDCWQKDRNERPT-FSQIVSTL 262 (266)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcC-HHHHHHHH
Confidence 11223456788999999999999999985 44444433
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=311.56 Aligned_cols=240 Identities=23% Similarity=0.326 Sum_probs=198.8
Q ss_pred eeecccCceEEEEEEEcCCC----eEEEEEEecCCC---CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEee
Q psy14556 811 IELGKGSYGVVYAARELDRQ----VKLAIKEIPEKN---LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQ 883 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg----~~VAIKii~~~~---~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy 883 (1181)
.+||+|+||.||+|.....+ ..||+|...... .....++++|+++|++++|||||++||+......+++|||+
T Consensus 163 kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl 242 (474)
T KOG0194|consen 163 KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMEL 242 (474)
T ss_pred ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEe
Confidence 37999999999999876542 238999987532 34467899999999999999999999999999999999999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCC
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA 963 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~ 963 (1181)
|.||+|.++|++... .++..+...++.+.+.||+|||+++++||||-.+|+|++. ++.+||+|||+++.-.......
T Consensus 243 ~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~-~~~vKISDFGLs~~~~~~~~~~ 319 (474)
T KOG0194|consen 243 CNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSK-KGVVKISDFGLSRAGSQYVMKK 319 (474)
T ss_pred cCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecC-CCeEEeCccccccCCcceeecc
Confidence 999999999997532 5778888899999999999999999999999999999987 7788999999987543211111
Q ss_pred ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCC---C
Q psy14556 964 ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPP---Q 1039 (1181)
Q Consensus 964 ~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~---~ 1039 (1181)
....-...|+|||.+..+.+++.+|| ||+|+++||+++ |..||.+....++...+ .
T Consensus 320 ~~~klPirWLAPEtl~~~~~s~kTDV--------------------~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~ 379 (474)
T KOG0194|consen 320 FLKKLPIRWLAPETLNTGIFSFKTDV--------------------WSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNG 379 (474)
T ss_pred ccccCcceecChhhhccCccccccch--------------------hheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcC
Confidence 11234679999999998876677766 999999999999 88999999987765544 3
Q ss_pred CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1040 ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1040 ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.+-..+...|..+..++.+|+..+|..|++....
T Consensus 380 ~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i 413 (474)
T KOG0194|consen 380 YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTI 413 (474)
T ss_pred ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHH
Confidence 4455556788899999999999999999974433
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=281.88 Aligned_cols=235 Identities=24% Similarity=0.343 Sum_probs=195.5
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.+||.|+||.||+|.+..++..||+|.+.+... ...+.+.+|+.++++++||||+++++.+.+.+..++|+||++++
T Consensus 6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 85 (258)
T cd05578 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGG 85 (258)
T ss_pred EEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCC
Confidence 479999999999999998999999999975532 23567899999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|.+++... .++++..+..++.||++||.|||++|++|+||+|+||+++. ++.++|+|||.+....... ......
T Consensus 86 ~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~-~~~~~l~d~~~~~~~~~~~-~~~~~~ 160 (258)
T cd05578 86 DLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDE-QGHVHITDFNIATKVTPDT-LTTSTS 160 (258)
T ss_pred CHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcC-CCCEEEeecccccccCCCc-cccccC
Confidence 999998743 46778999999999999999999999999999999999998 8999999999987665432 223345
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCc---ccccCCCC-CCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTS---RALVAPPQ-ISRS 1043 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~---~~l~~~~~-ip~~ 1043 (1181)
|+..|+|||.+.+...+..+|+ ||+|+++|+|++|..||...+. ..+..... ....
T Consensus 161 ~~~~y~~PE~~~~~~~~~~~Di--------------------~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 220 (258)
T cd05578 161 GTPGYMAPEVLCRQGYSVAVDW--------------------WSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVL 220 (258)
T ss_pred CChhhcCHHHHcccCCCCcccc--------------------hhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcccccc
Confidence 8889999999976554444443 9999999999999999998774 22222111 2333
Q ss_pred CCCCCCcchHHhhccCCCCCCCCCchh
Q psy14556 1044 VSVPGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1044 l~~~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
.+...+..+..++.+|+..+|..||..
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~~~ 247 (258)
T cd05578 221 YPATWSTEAIDAINKLLERDPQKRLGD 247 (258)
T ss_pred CcccCcHHHHHHHHHHccCChhHcCCc
Confidence 444567889999999999999999987
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=284.93 Aligned_cols=238 Identities=32% Similarity=0.483 Sum_probs=190.4
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCCh--hHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDV--QPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~--e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.+||+|+||+||++.+..+++.||+|.+........ ....+|+.++++++||||+++++++.+....++|||++++++
T Consensus 5 ~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~ 84 (260)
T PF00069_consen 5 KKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGS 84 (260)
T ss_dssp EEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEB
T ss_pred EEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccccc
Confidence 479999999999999999999999999977754432 234569999999999999999999999999999999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|.+++... ..+++..++.++.|++.||++||++|++|+||||+||+++. ++.++|+|||.+..............+
T Consensus 85 L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 160 (260)
T PF00069_consen 85 LQDYLQKN---KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDE-NGEVKLIDFGSSVKLSENNENFNPFVG 160 (260)
T ss_dssp HHHHHHHH---SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEEST-TSEEEESSGTTTEESTSTTSEBSSSSS
T ss_pred cccccccc---ccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccc
Confidence 99999822 35789999999999999999999999999999999999996 899999999999764333334445668
Q ss_pred CccccCchhhc-cCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCc---ccccC-----CCC
Q psy14556 969 TLQYMAPEVID-KGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTS---RALVA-----PPQ 1039 (1181)
Q Consensus 969 T~~Y~APEvl~-gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~---~~l~~-----~~~ 1039 (1181)
+..|+|||++. +...+..+|+ ||+|+++|+|++|..||..... ..... ...
T Consensus 161 ~~~y~aPE~~~~~~~~~~~~Di--------------------~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 220 (260)
T PF00069_consen 161 TPEYMAPEVLQQGKKYTRKSDI--------------------WSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLP 220 (260)
T ss_dssp SGGGSCHHHHTTTSSBSTHHHH--------------------HHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHH
T ss_pred cccccccccccccccccccccc--------------------cccccccccccccccccccccchhhhhhhhhccccccc
Confidence 99999999987 4433333333 9999999999999999998732 11110 111
Q ss_pred CCCCCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1040 ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1040 ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
.........+..+..++.+|++.+|.+||+..+
T Consensus 221 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ 253 (260)
T PF00069_consen 221 SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEE 253 (260)
T ss_dssp HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHH
T ss_pred ccccccchhHHHHHHHHHHHccCChhHCcCHHH
Confidence 111111222378899999999999999998443
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=279.84 Aligned_cols=234 Identities=21% Similarity=0.249 Sum_probs=183.2
Q ss_pred eecccCceEEEEEEEcCCC----------eEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEE
Q psy14556 812 ELGKGSYGVVYAARELDRQ----------VKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFM 881 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg----------~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVm 881 (1181)
.||+|+||.||+|.+..++ ..+++|.+...... ...+.+|+.++++++||||+++++++.. +..++||
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 5999999999999987766 45888887554433 5788999999999999999999999887 7789999
Q ss_pred eecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCC-------eeeeecCCccc
Q psy14556 882 EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSG-------VVKISDFGTSK 954 (1181)
Q Consensus 882 Ey~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g-------~vKLiDFGlAk 954 (1181)
||+++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++. ++ .+||+|||++.
T Consensus 80 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~-~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 80 EYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVAR-YGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEec-CccccCCceeEEeCCCCccc
Confidence 9999999999998542 25778889999999999999999999999999999999987 55 79999999987
Q ss_pred ccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q psy14556 955 RLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRA 1033 (1181)
Q Consensus 955 ~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~ 1033 (1181)
.... .....++..|+|||++.+....++...|+ ||+|+++|+|++ |..||...+...
T Consensus 157 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di------------------~slG~~~~~l~~~~~~p~~~~~~~~ 214 (259)
T cd05037 157 TVLS----REERVERIPWIAPECIRNGQASLTIAADK------------------WSFGTTLLEICSNGEEPLSTLSSSE 214 (259)
T ss_pred cccc----ccccccCCCccChhhhcCCCCCcchhhHH------------------HHHHHHHHHHHhCCCCCcccCCchh
Confidence 6543 22334677899999997652233333343 999999999999 578887765433
Q ss_pred ccCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1034 LVAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1034 l~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
...........+.+....+..++.+|+..+|..||+..+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 253 (259)
T cd05037 215 KERFYQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRA 253 (259)
T ss_pred HHHHHhcCCCCCCCCchHHHHHHHHHhccChhhCCCHHH
Confidence 221111122222333467888999999999999996443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=285.39 Aligned_cols=245 Identities=27% Similarity=0.333 Sum_probs=192.6
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCC-CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKN-LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~-~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
+||+|+||.||++.+..++..||+|.+.... ....+.+.+|+.++++++||||+++++.+...+..++||||+++++|.
T Consensus 8 ~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 87 (286)
T cd06622 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLD 87 (286)
T ss_pred hhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHH
Confidence 6999999999999999999999999986542 223467889999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccc-cceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCC
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHG-QKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT 969 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs-~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT 969 (1181)
.++........+++..+..++.|++.||.|||+ .|++|+||||+||+++. ++.+||+|||.+..+... ......++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~~~--~~~~~~~~ 164 (286)
T cd06622 88 KLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNG-NGQVKLCDFGVSGNLVAS--LAKTNIGC 164 (286)
T ss_pred HHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECC-CCCEEEeecCCcccccCC--ccccCCCc
Confidence 988753223467899999999999999999996 59999999999999998 889999999998765432 22334588
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC-----CCCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA-----PPQISRSV 1044 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~-----~~~ip~~l 1044 (1181)
+.|+|||.+.+........ +....+.||+||++|+|++|+.||.......... ....+...
T Consensus 165 ~~y~aPE~~~~~~~~~~~~--------------~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd06622 165 QSYMAPERIKSGGPNQNPT--------------YTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTL 230 (286)
T ss_pred cCccCcchhcCCCCCccCC--------------CCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCC
Confidence 8999999986543211111 1122233999999999999999997655433211 01122223
Q ss_pred CCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1045 SVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1045 ~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
+...+..+..++.+|+..+|..||...+.
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l 259 (286)
T cd06622 231 PSGYSDDAQDFVAKCLNKIPNRRPTYAQL 259 (286)
T ss_pred CcccCHHHHHHHHHHcccCcccCCCHHHH
Confidence 34467778889999999999999985544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=277.99 Aligned_cols=236 Identities=28% Similarity=0.359 Sum_probs=192.2
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCccc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLST 891 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~d 891 (1181)
+||+|+||.||+|.+..++..+++|.+..... .+.+.+|+.++++++||||+++++++.+....|+++||+++++|.+
T Consensus 10 ~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~ 87 (256)
T cd06612 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSD 87 (256)
T ss_pred hhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHH
Confidence 69999999999999998899999999965533 6789999999999999999999999999999999999999999999
Q ss_pred chhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCcc
Q psy14556 892 LLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQ 971 (1181)
Q Consensus 892 lL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~~ 971 (1181)
++... ...+++..++.++.|++.||.|||+.|++|+||+|+||+++. ++.++|+|||++..............++..
T Consensus 88 ~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 164 (256)
T cd06612 88 IMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNE-EGQAKLADFGVSGQLTDTMAKRNTVIGTPF 164 (256)
T ss_pred HHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECC-CCcEEEcccccchhcccCccccccccCCcc
Confidence 98743 245788999999999999999999999999999999999998 889999999999876654333334558899
Q ss_pred ccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC--CCC--CCCCC
Q psy14556 972 YMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ--ISR--SVSVP 1047 (1181)
Q Consensus 972 Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~--ip~--~l~~~ 1047 (1181)
|+|||++.+...+..+ |+ ||+|+++|+|++|+.||............. ... ..+..
T Consensus 165 y~~PE~~~~~~~~~~~--Di------------------~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (256)
T cd06612 165 WMAPEVIQEIGYNNKA--DI------------------WSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEK 224 (256)
T ss_pred ccCHHHHhcCCCCchh--hH------------------HHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhh
Confidence 9999999765433333 33 999999999999999998765433211111 111 11223
Q ss_pred CCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1048 GPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1048 ~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
.+..+..++.+|++.+|..||+.-+
T Consensus 225 ~~~~~~~~i~~~l~~~P~~Rps~~~ 249 (256)
T cd06612 225 WSPEFNDFVKKCLVKDPEERPSAIQ 249 (256)
T ss_pred cCHHHHHHHHHHHhcChhhCcCHHH
Confidence 4567888999999999999987443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=280.32 Aligned_cols=236 Identities=19% Similarity=0.244 Sum_probs=188.7
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
.+||+|++|.||+|.+. +++.||+|.++.... ..+.+.+|+.++++++||||+++++++...+..+++|||+++++|.
T Consensus 12 ~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 89 (261)
T cd05068 12 RKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLL 89 (261)
T ss_pred EEecccCCccEEEEEec-CCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHH
Confidence 47999999999999865 456899999865442 3567899999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC-CccccCC
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS-AETFTGT 969 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~-~~t~~GT 969 (1181)
+++.... ...+++..+..++.|++.||.|||++|++||||||+||+++. ++.+||+|||++......... ......+
T Consensus 90 ~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 167 (261)
T cd05068 90 EYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGE-NNICKVADFGLARVIKEDIYEAREGAKFP 167 (261)
T ss_pred HHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcC-CCCEEECCcceEEEccCCcccccCCCcCc
Confidence 9997542 345788999999999999999999999999999999999998 889999999999876532111 1111234
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCC--CCCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPP--QISRSVSV 1046 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~--~ip~~l~~ 1046 (1181)
..|+|||.+.+...+..+|+ ||+|+++|+|++ |+.||.+.....+.... ......+.
T Consensus 168 ~~y~aPE~~~~~~~~~~~Di--------------------~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 227 (261)
T cd05068 168 IKWTAPEAALYNRFSIKSDV--------------------WSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPP 227 (261)
T ss_pred eeccCccccccCCCCchhhH--------------------HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 57999999876554444433 999999999999 99999887654322111 11112334
Q ss_pred CCCcchHHhhccCCCCCCCCCchh
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
..+..+..++.+|+..+|..||..
T Consensus 228 ~~~~~~~~li~~~l~~~P~~Rp~~ 251 (261)
T cd05068 228 GCPKELYDIMLDCWKEDPDDRPTF 251 (261)
T ss_pred cCCHHHHHHHHHHhhcCcccCCCH
Confidence 567888999999999999999963
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=282.88 Aligned_cols=246 Identities=21% Similarity=0.260 Sum_probs=192.1
Q ss_pred eeecccCceEEEEEEEcCC-----CeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeec
Q psy14556 811 IELGKGSYGVVYAARELDR-----QVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQV 884 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~t-----g~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~ 884 (1181)
.+||+|+||.||+|.+... +..||+|.+..... .....+.+|+.+++.++||||+++++++......++||||+
T Consensus 12 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 91 (277)
T cd05032 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELM 91 (277)
T ss_pred eEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecC
Confidence 4699999999999987643 37899999865432 23456889999999999999999999999999999999999
Q ss_pred CCCCcccchhcccC-------CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccc
Q psy14556 885 PGGSLSTLLRVKWG-------PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 957 (1181)
Q Consensus 885 ~gGSL~dlL~~~~~-------~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~ 957 (1181)
++++|.+++..... ...+++..++.++.|++.||.|||++|++||||||+||+++. ++.+||+|||+++...
T Consensus 92 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~-~~~~kl~dfg~~~~~~ 170 (277)
T cd05032 92 AKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAE-DLTVKIGDFGMTRDIY 170 (277)
T ss_pred CCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcC-CCCEEECCcccchhhc
Confidence 99999999875321 123577889999999999999999999999999999999998 8999999999987654
Q ss_pred cCCC--CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccc
Q psy14556 958 GLCP--SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRAL 1034 (1181)
Q Consensus 958 ~~~~--~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l 1034 (1181)
.... ......++..|+|||.+.++..+..+|+ ||||+++|++++ |..||.+.+....
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di--------------------~slG~il~el~t~g~~p~~~~~~~~~ 230 (277)
T cd05032 171 ETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDV--------------------WSFGVVLWEMATLAEQPYQGLSNEEV 230 (277)
T ss_pred cCcccccCCCCCccccccCHHHHhcCCCCcccch--------------------HHHHHHHHHhhccCCCCCccCCHHHH
Confidence 3221 1223346789999999976654444433 999999999998 9999987765443
Q ss_pred cCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1035 VAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1035 ~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
..... .....+...+..+..++.+|+..+|..||+ +.+....+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt-~~~l~~~l 275 (277)
T cd05032 231 LKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPT-FLEIVSSL 275 (277)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCC-HHHHHHHh
Confidence 21111 111223446788899999999999999985 44444433
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=287.48 Aligned_cols=201 Identities=24% Similarity=0.389 Sum_probs=157.8
Q ss_pred cCceeecccCceEEEEEEEcC--CCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccc--cCCcEEEEEee
Q psy14556 808 LNRIELGKGSYGVVYAARELD--RQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVS--EEGYFKIFMEQ 883 (1181)
Q Consensus 808 l~~~kIG~G~fG~VYka~d~~--tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~--d~~~l~LVmEy 883 (1181)
.+..+||+|+||.||+|++.. ++..||+|.+.... ....+.+|+.+++.++||||+++++++. .+...++||||
T Consensus 4 ~~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 4 YEGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eeceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 345589999999999999654 56889999986543 2346789999999999999999999884 35678999999
Q ss_pred cCCCCcccchhcc------cCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccccc---CCCeeeeecCCccc
Q psy14556 884 VPGGSLSTLLRVK------WGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNT---YSGVVKISDFGTSK 954 (1181)
Q Consensus 884 ~~gGSL~dlL~~~------~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~---~~g~vKLiDFGlAk 954 (1181)
+. ++|.+++... .....+++..++.++.||+.||.|||++||+||||||+||++.. .++.+||+|||+++
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 85 5777766421 12335788899999999999999999999999999999999942 25789999999998
Q ss_pred ccccCCC---CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCC
Q psy14556 955 RLAGLCP---SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKT 1030 (1181)
Q Consensus 955 ~l~~~~~---~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~ 1030 (1181)
....... ......+|+.|+|||++.+.. .++...|+ ||+||++|+|+||++||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~Di------------------wSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGAR-HYTKAIDI------------------WAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCC-ccCcHHHH------------------HhHHHHHHHHHhCCCCccccc
Confidence 7654322 122346899999999986532 23333444 999999999999999997644
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=284.85 Aligned_cols=237 Identities=25% Similarity=0.325 Sum_probs=190.6
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 813 IG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
||+|+||+||+|.+..+++.|++|.+..... ...+.+.+|+.++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6899999999999999999999999965432 2345577899999999999999999999999999999999999999
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT 969 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT 969 (1181)
.+++... ....+++..+..++.|++.||.|||++|++||||+|+||+++. ++.++|+|||.+...... .......++
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~-~~~~~l~dfg~~~~~~~~-~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNV-GEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDD-HGNVRISDLGLAVELKGG-KKIKGRAGT 157 (277)
T ss_pred HHHHHHc-CcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC-CCCEEEccCcchhhhccC-CccccccCC
Confidence 9998754 2346789999999999999999999999999999999999988 889999999998765432 222334578
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc----cccC-CCCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR----ALVA-PPQISRSV 1044 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~----~l~~-~~~ip~~l 1044 (1181)
..|+|||.+.++.++...|+ ||+|+++|+|++|+.||...... .+.. ....+...
T Consensus 158 ~~y~~PE~~~~~~~~~~~Di--------------------~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 217 (277)
T cd05577 158 PGYMAPEVLQGEVYDFSVDW--------------------FALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEY 217 (277)
T ss_pred CCcCCHHHhcCCCCCchhhh--------------------HHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccC
Confidence 89999999976654434333 99999999999999999876541 1111 11122233
Q ss_pred CCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1045 SVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1045 ~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
+...+..+..++.+|+..+|..||.+.+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 218 PDKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred CccCCHHHHHHHHHHccCChhHccCCCc
Confidence 3445777888999999999999996433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=279.49 Aligned_cols=239 Identities=22% Similarity=0.282 Sum_probs=191.1
Q ss_pred eecccCceEEEEEEEcC-CC--eEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAARELD-RQ--VKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~-tg--~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
+||+|++|.||+|.+.. .+ ..||+|.+..... ...+.+.+|+.++++++||||+++++.+.+ ...+++|||++++
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~ 80 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG 80 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence 58999999999998765 33 3699999987765 456789999999999999999999999988 8899999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC---Cc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS---AE 964 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~---~~ 964 (1181)
+|.+++..... ..+++..++.++.|++.||+|||++|++|+||||+||+++. ++.+||+|||++..+...... ..
T Consensus 81 ~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~ 158 (257)
T cd05040 81 SLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLAS-DDKVKIGDFGLMRALPQNEDHYVMEE 158 (257)
T ss_pred cHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEec-CCEEEeccccccccccccccceeccc
Confidence 99999976422 46789999999999999999999999999999999999998 799999999999876542211 11
Q ss_pred cccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC---C
Q psy14556 965 TFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ---I 1040 (1181)
Q Consensus 965 t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~---i 1040 (1181)
...++..|+|||.+.+...+..+|+ ||+|+++|+|++ |+.||...+..++..... .
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Di--------------------~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~ 218 (257)
T cd05040 159 HLKVPFAWCAPESLRTRTFSHASDV--------------------WMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGE 218 (257)
T ss_pred CCCCCceecCHHHhcccCcCchhhh--------------------HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC
Confidence 2346788999999876544433333 999999999998 999998766544321111 1
Q ss_pred CCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1041 SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1041 p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
....+...|..+..++.+|+..+|..||+..+.
T Consensus 219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~ 251 (257)
T cd05040 219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAAL 251 (257)
T ss_pred cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHH
Confidence 111223457789999999999999999964443
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=281.46 Aligned_cols=247 Identities=17% Similarity=0.181 Sum_probs=187.7
Q ss_pred eeecccCceEEEEEEEcCCCe--EEEEEEecCCC--CCChhHHHHHHHHHHhcCCCCeeeEcccccc------CCcEEEE
Q psy14556 811 IELGKGSYGVVYAARELDRQV--KLAIKEIPEKN--LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSE------EGYFKIF 880 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~--~VAIKii~~~~--~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d------~~~l~LV 880 (1181)
++||+|+||.||+|.+..++. .+|+|.++... ....+.+.+|+.+++.++||||+++++++.. ....+++
T Consensus 5 ~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v 84 (272)
T cd05075 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVI 84 (272)
T ss_pred cccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEE
Confidence 469999999999999877664 68999886543 2335678899999999999999999987632 1357899
Q ss_pred EeecCCCCcccchhcc---cCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccc
Q psy14556 881 MEQVPGGSLSTLLRVK---WGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 957 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~---~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~ 957 (1181)
|||+++|+|.+++... .....+++..+..++.|++.||+|||++||+||||||+||+++. ++.+||+|||+++...
T Consensus 85 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~ 163 (272)
T cd05075 85 LPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNE-NMNVCVADFGLSKKIY 163 (272)
T ss_pred EEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcC-CCCEEECCCCcccccC
Confidence 9999999999887432 12345788999999999999999999999999999999999987 8899999999998764
Q ss_pred cCCC--CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccc
Q psy14556 958 GLCP--SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRAL 1034 (1181)
Q Consensus 958 ~~~~--~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l 1034 (1181)
.... ......+++.|+|||.+.+...+.. .|+ ||+|+++|+|++ |+.||.+.....+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~--~Di------------------~slG~il~el~~~g~~p~~~~~~~~~ 223 (272)
T cd05075 164 NGDYYRQGRIAKMPVKWIAIESLADRVYTTK--SDV------------------WSFGVTMWEIATRGQTPYPGVENSEI 223 (272)
T ss_pred cccceecCCcccCCcccCCHHHccCCCcChH--HHH------------------HHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 3221 1122335678999999976543333 333 999999999999 8899987655443
Q ss_pred cCCCCC--CCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcc
Q psy14556 1035 VAPPQI--SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTG 1079 (1181)
Q Consensus 1035 ~~~~~i--p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~ 1079 (1181)
.....- ....+...+..+..++.+|+..+|..|| ++++.+..+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~~l~~~l~ 269 (272)
T cd05075 224 YDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRP-SFETLRCELE 269 (272)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCc-CHHHHHHHHH
Confidence 211110 1112345677889999999999999997 4666554443
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=286.71 Aligned_cols=241 Identities=22% Similarity=0.293 Sum_probs=189.8
Q ss_pred eeecccCceEEEEEEEc-----CCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 811 IELGKGSYGVVYAAREL-----DRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~-----~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
.+||+|+||.||++... .++..+++|.+........+.+.+|+.+++.++||||+++++++.+.+..+++|||++
T Consensus 11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 90 (280)
T cd05092 11 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMR 90 (280)
T ss_pred cccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCC
Confidence 47999999999999742 3567899999876655556789999999999999999999999999999999999999
Q ss_pred CCCcccchhcccC------------CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcc
Q psy14556 886 GGSLSTLLRVKWG------------PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTS 953 (1181)
Q Consensus 886 gGSL~dlL~~~~~------------~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlA 953 (1181)
+++|.+++..... ...+++..++.++.|++.||+|||++|++||||||+||+++. ++.+||+|||++
T Consensus 91 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~-~~~~kL~dfg~~ 169 (280)
T cd05092 91 HGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ-GLVVKIGDFGMS 169 (280)
T ss_pred CCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcC-CCCEEECCCCce
Confidence 9999999875421 134678899999999999999999999999999999999987 889999999998
Q ss_pred cccccCCC--CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCC
Q psy14556 954 KRLAGLCP--SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKT 1030 (1181)
Q Consensus 954 k~l~~~~~--~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~ 1030 (1181)
........ ......+++.|+|||.+.+...+..+|+ |||||++|+|++ |..||....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di--------------------~slG~il~el~~~g~~p~~~~~ 229 (280)
T cd05092 170 RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDI--------------------WSFGVVLWEIFTYGKQPWYQLS 229 (280)
T ss_pred eEcCCCceeecCCCccccccccCHHHhccCCcCchhhH--------------------HHHHHHHHHHHcCCCCCCccCC
Confidence 75532211 1122335678999999976554433333 999999999998 899997765
Q ss_pred cccccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1031 SRALVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1031 ~~~l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
......... .+...+...+..+..++.+|+..+|..||...+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ 273 (280)
T cd05092 230 NTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKD 273 (280)
T ss_pred HHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 543221111 111223456788999999999999999997443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=289.44 Aligned_cols=246 Identities=27% Similarity=0.360 Sum_probs=195.2
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC---ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG---DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~---~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.+||+|++|.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++.+.+.+..++||||+.++
T Consensus 7 ~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (316)
T cd05574 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGG 86 (316)
T ss_pred eeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCC
Confidence 3699999999999999999999999999765433 3456889999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC------
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP------ 961 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~------ 961 (1181)
+|.+++... ....+++..++.++.|++.||+|||+.|++|+||||+||+++. ++.++|+|||++........
T Consensus 87 ~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~ 164 (316)
T cd05574 87 ELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHE-SGHIMLSDFDLSKQSDVEPPPVSKAL 164 (316)
T ss_pred CHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcC-CCCEEEeecchhhccccccccccccc
Confidence 999998744 3346788999999999999999999999999999999999998 88999999999865432111
Q ss_pred -----------------------CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHH
Q psy14556 962 -----------------------SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQ 1018 (1181)
Q Consensus 962 -----------------------~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyE 1018 (1181)
......|+..|+|||++.+...+. ..|+ ||+|+++|+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~--~~Di------------------~slG~ll~~ 224 (316)
T cd05574 165 RKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGS--AVDW------------------WTLGILLYE 224 (316)
T ss_pred ccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCc--hHHH------------------HHHHHHHHH
Confidence 011235788999999997654433 3333 999999999
Q ss_pred HHhCCCCCCCCCcccccCC---CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1019 LLVLTAALKKKTSRALVAP---PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1019 LLTGk~PF~~~~~~~l~~~---~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
|++|+.||.+.+....... ...........+..+..++.+|+..+|..||++...+...+
T Consensus 225 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll 287 (316)
T cd05574 225 MLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIK 287 (316)
T ss_pred HhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHH
Confidence 9999999987765332111 11111111226788999999999999999998554433333
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=302.47 Aligned_cols=188 Identities=21% Similarity=0.324 Sum_probs=158.5
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
++||+|+||.||+|.+..+++.||+|... .+.+.+|+.++++++||||+++++++......++|||++ +++|.
T Consensus 98 ~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~~~L~ 170 (391)
T PHA03212 98 ETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLY 170 (391)
T ss_pred EEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-CCCHH
Confidence 47999999999999999999999999753 234789999999999999999999999999999999999 57888
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC-CCCccccCC
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC-PSAETFTGT 969 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~-~~~~t~~GT 969 (1181)
.++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++...... .......||
T Consensus 171 ~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~-~~~vkL~DFG~a~~~~~~~~~~~~~~~gt 246 (391)
T PHA03212 171 CYLAAK---RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINH-PGDVCLGDFGAACFPVDINANKYYGWAGT 246 (391)
T ss_pred HHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcC-CCCEEEEeCCcccccccccccccccccCc
Confidence 777643 35678889999999999999999999999999999999987 8899999999997543221 223345799
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKK 1029 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~ 1029 (1181)
+.|+|||++.+..++ ..+|+ ||+||++|+|++|..||...
T Consensus 247 ~~y~aPE~~~~~~~~--~~~Di------------------wSlGvil~elltg~~p~~~~ 286 (391)
T PHA03212 247 IATNAPELLARDPYG--PAVDI------------------WSAGIVLFEMATCHDSLFEK 286 (391)
T ss_pred cCCCChhhhcCCCCC--cHHHH------------------HHHHHHHHHHHHCCCCcCCc
Confidence 999999999765443 33444 99999999999999887543
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=297.58 Aligned_cols=238 Identities=23% Similarity=0.339 Sum_probs=185.5
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccCC-----cEEEEEeec
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEG-----YFKIFMEQV 884 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~-----~l~LVmEy~ 884 (1181)
+||+|+||.||++.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++...+ ..|+||||+
T Consensus 7 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 86 (372)
T cd07853 7 PIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELM 86 (372)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeecc
Confidence 69999999999999999999999999865422 23467889999999999999999999998776 789999999
Q ss_pred CCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC-CC
Q psy14556 885 PGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP-SA 963 (1181)
Q Consensus 885 ~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~-~~ 963 (1181)
. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++....... ..
T Consensus 87 ~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~-~~~~kL~Dfg~a~~~~~~~~~~~ 161 (372)
T cd07853 87 Q-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNS-NCVLKICDFGLARVEEPDESKHM 161 (372)
T ss_pred c-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECC-CCCEEeccccceeecccCccccC
Confidence 5 677777653 346788999999999999999999999999999999999998 89999999999976543221 12
Q ss_pred ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC-------
Q psy14556 964 ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA------- 1036 (1181)
Q Consensus 964 ~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~------- 1036 (1181)
....+++.|+|||++.+.. .++...|+ ||+||++|+|++|+.||.+.+......
T Consensus 162 ~~~~~~~~y~aPE~~~~~~-~~~~~~Di------------------wslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g 222 (372)
T cd07853 162 TQEVVTQYYRAPEILMGSR-HYTSAVDI------------------WSVGCIFAELLGRRILFQAQSPIQQLDLITDLLG 222 (372)
T ss_pred CCCCcCCCcCCHHHHcCCC-CCCcHHHH------------------HhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcC
Confidence 2345789999999997532 23333444 999999999999999998766432100
Q ss_pred ---------------------CCCCCC-----CCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1037 ---------------------PPQISR-----SVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1037 ---------------------~~~ip~-----~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
....+. ......+..+..++.+|+..||.+||+..+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~ 285 (372)
T cd07853 223 TPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADA 285 (372)
T ss_pred CCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHH
Confidence 000000 1122345567789999999999999975444
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd01924 cyclophilin_TLP40_like cyclophilin_TLP40_like: cyclophilin-type peptidylprolyl cis- trans isomerases (cyclophilins) similar ot the Spinach thylakoid lumen protein TLP40 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=271.48 Aligned_cols=128 Identities=36% Similarity=0.568 Sum_probs=112.0
Q ss_pred cccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCC--------------------C
Q psy14556 120 DDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNG--------------------T 179 (1181)
Q Consensus 120 ~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g--------------------~ 179 (1181)
.|+.|+|+|+||++.||+||+||++|| +.|| |+|+.||||+|+|||||||+...+. .
T Consensus 3 ~T~~G~i~ieL~~~~aP~t~~NF~~L~--~~g~-Ydg~~FhRVi~~fviQgGdp~~~~~~~~~~~~~~~~~~p~e~~~~~ 79 (176)
T cd01924 3 ATDNGTITIVLDGYNAPVTAGNFVDLV--ERGF-YDGMEFHRVEGGFVVQTGDPQGKNPGFPDPETGKSRTIPLEIKPEG 79 (176)
T ss_pred ccccceEEEEEcCCCCCHHHHHHHHHH--HhCC-cCCCEEEEecCCcEEEecCCCCCCCCcccccccccccccceecccC
Confidence 589999999999999999999999999 7899 9999999999999999999874311 1
Q ss_pred CCcccCCCCCC-----CCcCccccCCCceEEeecCC--CCCCcceEEEEcC-------CCCCCCCCCeEEEEEEcCHHHH
Q psy14556 180 GGKSIYGNKFE-----DENFTLKHTGPGILSMANAG--PNTNGSQFFITTV-------KTAWLDNRHVVFGSVVEGLDVV 245 (1181)
Q Consensus 180 gg~si~g~~~~-----dE~~~l~h~~~G~Lsma~~g--~nt~gSQFfItl~-------~~p~LDg~~vVFGrVieG~dVL 245 (1181)
.+.++|+..+. ++.....|+.+|+||||+++ +|+++|||||+++ +.|+||++|+|||+|++|||||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~G~laMa~~~~~~ns~~SQFfI~~~~~~~~~~~~~~Ldg~ytVFG~VveG~dvl 159 (176)
T cd01924 80 QKQPVYGKTLEEAGRYDEQPVLPFNAFGAIAMARTEFDPNSASSQFFFLLKDNELTPSRNNVLDGRYAVFGYVTDGLDIL 159 (176)
T ss_pred CCCCccCcccccccccccccccccCCCCeEEEccCCCCCCCccceEEEEeccccccCCCCCccCCCceEEEEEecCHHHH
Confidence 23456665542 45566788889999999987 7999999999998 7899999999999999999999
Q ss_pred HHHHh
Q psy14556 246 KKLES 250 (1181)
Q Consensus 246 ~kI~~ 250 (1181)
++|+.
T Consensus 160 ~~I~~ 164 (176)
T cd01924 160 RELKV 164 (176)
T ss_pred HhhcC
Confidence 99976
|
Compared to the archetypal cyclophilin Human cyclophilin A, these proteins have similar peptidylprolyl cis- trans isomerase activity and reduced affinity for cyclosporin A. Spinach TLP40 has been shown to have a dual function as a folding catalyst and regulator of dephosphorylation. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=279.48 Aligned_cols=241 Identities=24% Similarity=0.286 Sum_probs=188.4
Q ss_pred eecccCceEEEEEEEcCCC---eEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQ---VKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg---~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
+||+|+||.||+|.+...+ ..+|+|.+...... ..+.+.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~ 80 (257)
T cd05060 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLG 80 (257)
T ss_pred ccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCC
Confidence 6999999999999876555 78999999765442 3457889999999999999999999876 45689999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCc---
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAE--- 964 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~--- 964 (1181)
+|.+++... ..+++..++.++.|++.||+|||+++++|+||||+||+++. ++.+||+|||.++..........
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~-~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 81 PLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVN-RHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred cHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcC-CCcEEeccccccceeecCCccccccc
Confidence 999999754 26789999999999999999999999999999999999988 89999999999986643322211
Q ss_pred cccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--CC
Q psy14556 965 TFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--IS 1041 (1181)
Q Consensus 965 t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--ip 1041 (1181)
...++..|+|||.+.+...+..+|+ ||+|+++|+|++ |..||...+...+..... .+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di--------------------~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~ 216 (257)
T cd05060 157 AGRWPLKWYAPECINYGKFSSKSDV--------------------WSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER 216 (257)
T ss_pred CccccccccCHHHhcCCCCCccchH--------------------HHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc
Confidence 1123467999999976554443333 999999999998 999998776544321111 11
Q ss_pred CCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1042 RSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1042 ~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
...+...+..+..++.+|+..+|..||. +.+....+
T Consensus 217 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~-~~~l~~~l 252 (257)
T cd05060 217 LPRPEECPQEIYSIMLSCWKYRPEDRPT-FSELESTF 252 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcC-HHHHHHHH
Confidence 1233456678889999999999999996 44444333
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=280.17 Aligned_cols=235 Identities=21% Similarity=0.306 Sum_probs=186.4
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
++||+|+||.||+|... +++.||+|.+..... ..+.+.+|+.++++++||||+++++++. .+..+++|||+++++|.
T Consensus 12 ~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 88 (260)
T cd05067 12 KKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLV 88 (260)
T ss_pred eeeccCccceEEeeecC-CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHH
Confidence 47999999999999864 567899999875443 3467899999999999999999999874 45689999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC-CCCccccCC
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC-PSAETFTGT 969 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~-~~~~t~~GT 969 (1181)
+++... ....+++..+..++.|++.||+|||+.|++||||||+||+++. ++.++|+|||++....... .......++
T Consensus 89 ~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 166 (260)
T cd05067 89 DFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSE-TLCCKIADFGLARLIEDNEYTAREGAKFP 166 (260)
T ss_pred HHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcC-CCCEEEccCcceeecCCCCcccccCCccc
Confidence 998754 3346788899999999999999999999999999999999988 8899999999997665221 111223456
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCC--CCCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPP--QISRSVSV 1046 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~--~ip~~l~~ 1046 (1181)
..|+|||++.++..+...|+ ||+|+++|++++ |+.||.+.+...+.... ......+.
T Consensus 167 ~~y~~pe~~~~~~~~~~~Di--------------------~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T cd05067 167 IKWTAPEAINYGTFTIKSDV--------------------WSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPD 226 (260)
T ss_pred ccccCHHHhccCCcCcccch--------------------HHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCC
Confidence 78999999976554444333 999999999999 99999877654432111 11112233
Q ss_pred CCCcchHHhhccCCCCCCCCCchh
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
..+..+..++.+|+..+|..||+.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rp~~ 250 (260)
T cd05067 227 NCPEELYELMRLCWKEKPEERPTF 250 (260)
T ss_pred CCCHHHHHHHHHHccCChhhCCCH
Confidence 456789999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=280.49 Aligned_cols=236 Identities=23% Similarity=0.291 Sum_probs=186.9
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCccc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLST 891 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~d 891 (1181)
+||+|+||.||++.+. ++..+|+|++..... ....+.+|+.++++++||||+++++++...+..++||||+++++|.+
T Consensus 11 ~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 88 (256)
T cd05059 11 ELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLN 88 (256)
T ss_pred hhccCCCceEEEeEec-CCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHH
Confidence 6999999999999875 466899999864432 34568899999999999999999999999999999999999999999
Q ss_pred chhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCC-ccccCCc
Q psy14556 892 LLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA-ETFTGTL 970 (1181)
Q Consensus 892 lL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~-~t~~GT~ 970 (1181)
++.... ..+++..++.++.|++.||+|||++|++||||||+||+++. ++.+||+|||.++......... ....++.
T Consensus 89 ~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 165 (256)
T cd05059 89 YLRERK--GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGE-DNVVKVSDFGLARYVLDDQYTSSQGTKFPV 165 (256)
T ss_pred HHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECC-CCcEEECCcccceecccccccccCCCCCCc
Confidence 987542 25788899999999999999999999999999999999998 8999999999987654321111 1112345
Q ss_pred cccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCC--CCCCCCCCC
Q psy14556 971 QYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPP--QISRSVSVP 1047 (1181)
Q Consensus 971 ~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~--~ip~~l~~~ 1047 (1181)
.|+|||.+.+..++..+|+ ||+|+++|+|++ |+.||...+..+..... ......+..
T Consensus 166 ~y~~Pe~~~~~~~~~~~Di--------------------~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (256)
T cd05059 166 KWAPPEVFDYSRFSSKSDV--------------------WSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKL 225 (256)
T ss_pred cccCHHHhccCCCCchhhH--------------------HHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCC
Confidence 7999999976654443333 999999999999 89999876654432111 111222345
Q ss_pred CCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1048 GPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1048 ~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
.+..+..++.+|+..+|..||+..+
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rpt~~~ 250 (256)
T cd05059 226 APTEVYTIMYSCWHEKPEDRPAFKK 250 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHH
Confidence 6788999999999999999986433
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=280.14 Aligned_cols=241 Identities=29% Similarity=0.386 Sum_probs=194.9
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCC-CCChhHHHHHHHHHHhcC---CCCeeeEccccccCCcEEEEEeecCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKN-LGDVQPLHEEIKLHSQLR---HRNIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~-~~~~e~f~rEi~IL~~L~---HPNIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
++||+|+||.||+|.+..+++.|++|.+.... ....+.+.+|+.++++++ |||++++++++......++||||+++
T Consensus 7 ~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06917 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEG 86 (277)
T ss_pred hheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCC
Confidence 36999999999999999999999999987553 334567889999999996 99999999999999999999999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccc
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF 966 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~ 966 (1181)
++|.++++.. .+++..++.++.|++.||.|||+.|++|+||+|+||+++. ++.++|+|||.+.............
T Consensus 87 ~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~-~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06917 87 GSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTN-TGNVKLCDFGVAALLNQNSSKRSTF 161 (277)
T ss_pred CcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcC-CCCEEEccCCceeecCCCccccccc
Confidence 9999988643 5788999999999999999999999999999999999998 8999999999998776544334445
Q ss_pred cCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC--CCCCC
Q psy14556 967 TGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ--ISRSV 1044 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~--ip~~l 1044 (1181)
.|+..|+|||.+.++. .++...|+ ||+|+++|+|++|..||............. .+...
T Consensus 162 ~~~~~y~aPE~~~~~~-~~~~~~Dv------------------~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 222 (277)
T cd06917 162 VGTPYWMAPEVITEGK-YYDTKADI------------------WSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRL 222 (277)
T ss_pred cCCcceeCHHHhccCC-ccccchhH------------------HHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCC
Confidence 6899999999986432 22333333 999999999999999998766543221111 11111
Q ss_pred CC-CCCcchHHhhccCCCCCCCCCchhHHHHH
Q psy14556 1045 SV-PGPGGINSSSSAPVTPTPHSRHISVNTNL 1075 (1181)
Q Consensus 1045 ~~-~~p~~L~~li~r~la~dPs~Rp~s~~~~~ 1075 (1181)
.. ..+..+..++.+|+..+|..||+..+...
T Consensus 223 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 223 EDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 11 25677888999999999999998655543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=286.86 Aligned_cols=246 Identities=22% Similarity=0.281 Sum_probs=192.4
Q ss_pred eeecccCceEEEEEEEc-----CCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 811 IELGKGSYGVVYAAREL-----DRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~-----~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
..||+|+||.||+|.+. .++..+++|.+........+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 90 (291)
T cd05094 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMK 90 (291)
T ss_pred eeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCC
Confidence 36999999999999854 3456799999876655555679999999999999999999999999999999999999
Q ss_pred CCCcccchhcccC-------------CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCc
Q psy14556 886 GGSLSTLLRVKWG-------------PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGT 952 (1181)
Q Consensus 886 gGSL~dlL~~~~~-------------~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGl 952 (1181)
+++|.+++..... ...+++..++.++.||+.||+|||++||+||||||+||+++. ++.++|+|||+
T Consensus 91 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~-~~~~~l~dfg~ 169 (291)
T cd05094 91 HGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA-NLLVKIGDFGM 169 (291)
T ss_pred CCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc-CCcEEECCCCc
Confidence 9999999875321 134678899999999999999999999999999999999998 88999999999
Q ss_pred ccccccCCC--CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCC
Q psy14556 953 SKRLAGLCP--SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKK 1029 (1181)
Q Consensus 953 Ak~l~~~~~--~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~ 1029 (1181)
+........ ......++..|+|||.+.+...+..+|+ ||+|+++|+|+| |..||...
T Consensus 170 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di--------------------~slG~il~el~t~g~~p~~~~ 229 (291)
T cd05094 170 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV--------------------WSFGVILWEIFTYGKQPWFQL 229 (291)
T ss_pred ccccCCCceeecCCCCCcceeecChHHhccCCCCchhhH--------------------HHHHHHHHHHHhCCCCCCCCC
Confidence 976543211 1223346788999999976554444333 999999999999 99999876
Q ss_pred CcccccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1030 TSRALVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1030 ~~~~l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
+......... .........+..+..++.+|+..+|..||+ +++....+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt-~~~v~~~l 279 (291)
T cd05094 230 SNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLN-IKEIYKIL 279 (291)
T ss_pred CHHHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcC-HHHHHHHH
Confidence 6544321111 111123345778999999999999999995 44433333
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=279.98 Aligned_cols=240 Identities=29% Similarity=0.480 Sum_probs=190.5
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC------ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeec
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG------DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQV 884 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~------~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~ 884 (1181)
..||+|++|.||++.+..+++.||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~ 85 (268)
T cd06630 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWM 85 (268)
T ss_pred ceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEecc
Confidence 4699999999999999999999999999654321 2457889999999999999999999999999999999999
Q ss_pred CCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC--
Q psy14556 885 PGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS-- 962 (1181)
Q Consensus 885 ~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~-- 962 (1181)
++++|.+++... .++++..+..++.|++.||.|||++|++|+||||+||+++..+..+||+|||.+.........
T Consensus 86 ~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~ 162 (268)
T cd06630 86 AGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAG 162 (268)
T ss_pred CCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCC
Confidence 999999998743 357788999999999999999999999999999999999873457999999998776543211
Q ss_pred --CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC----
Q psy14556 963 --AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA---- 1036 (1181)
Q Consensus 963 --~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~---- 1036 (1181)
.....++..|+|||.+.+...+..+|+ ||+|+++|+|++|..||..........
T Consensus 163 ~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv--------------------~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 222 (268)
T cd06630 163 EFQGQLLGTIAFMAPEVLRGEQYGRSCDV--------------------WSVGCVIIEMATAKPPWNAEKHSNHLALIFK 222 (268)
T ss_pred ccccccccccceeCHhHhccCCCCcccch--------------------HHHHHHHHHHHhCCCCCCCCCCcchHHHHHH
Confidence 122457889999999976544333333 999999999999999997654322110
Q ss_pred --CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1037 --PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1037 --~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
........+...+..+..++.+|+..+|..||+..+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~l 261 (268)
T cd06630 223 IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSREL 261 (268)
T ss_pred HhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 0111222333456678889999999999999975544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=288.94 Aligned_cols=237 Identities=26% Similarity=0.315 Sum_probs=187.7
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
++||+|+||.||++.+..++..+|+|.+..... ...+.+.+|++++++++||||+++++.+.+++.+++||||+++++|
T Consensus 7 ~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L 86 (308)
T cd06615 7 GELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 86 (308)
T ss_pred eeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcH
Confidence 369999999999999999999999999865432 2245688999999999999999999999999999999999999999
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccc-cceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHG-QKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs-~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++. ++.+||+|||++...... ......+
T Consensus 87 ~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~~~--~~~~~~~ 160 (308)
T cd06615 87 DQVLKKA---GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDS--MANSFVG 160 (308)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEec-CCcEEEccCCCccccccc--ccccCCC
Confidence 9999743 356788899999999999999997 59999999999999987 889999999998765432 2234568
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-----C---
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-----I--- 1040 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-----i--- 1040 (1181)
+..|+|||.+.+...+.. .|+ ||+|+++|+|++|+.||...+......... .
T Consensus 161 ~~~~~aPE~~~~~~~~~~--~Di------------------wslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 220 (308)
T cd06615 161 TRSYMSPERLQGTHYTVQ--SDI------------------WSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAK 220 (308)
T ss_pred CcCccChhHhcCCCCCcc--chH------------------HHHHHHHHHHHhCCCCCCCcchhhHHHhhcCcccccccc
Confidence 999999999875543333 333 999999999999999997654332211000 0
Q ss_pred -------------------------------CCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1041 -------------------------------SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1041 -------------------------------p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
+.......+..+..++.+|+..+|..||...+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~l 284 (308)
T cd06615 221 ESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKEL 284 (308)
T ss_pred CCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHH
Confidence 000001134467789999999999999975444
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=280.64 Aligned_cols=236 Identities=21% Similarity=0.288 Sum_probs=185.8
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
.+||+|+||.||+|.+..++ .||+|+++.... ..+.+.+|+.++++++||||+++++.+.+ +..++||||+++++|.
T Consensus 12 ~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~ 88 (262)
T cd05071 12 VKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 88 (262)
T ss_pred eecCCCCCCcEEEEEecCCc-eEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHH
Confidence 37999999999999886654 699999975433 34678999999999999999999998754 5689999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC-CCccccCC
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP-SAETFTGT 969 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~-~~~t~~GT 969 (1181)
+++... ....+++..+..++.|++.||.|||+++++|+||||+||+++. ++.++|+|||.+..+..... ......++
T Consensus 89 ~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~-~~~~~L~dfg~~~~~~~~~~~~~~~~~~~ 166 (262)
T cd05071 89 DFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE-NLVCKVADFGLARLIEDNEYTARQGAKFP 166 (262)
T ss_pred HHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcC-CCcEEeccCCceeeccccccccccCCccc
Confidence 999754 2335678889999999999999999999999999999999988 88999999999976643221 11123456
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--CCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--ISRSVSV 1046 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--ip~~l~~ 1046 (1181)
..|+|||++.++..+..+|+ ||+|+++|+|+| |..||.+.....+..... .+...+.
T Consensus 167 ~~y~~PE~~~~~~~~~~~Dv--------------------wslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 226 (262)
T cd05071 167 IKWTAPEAALYGRFTIKSDV--------------------WSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP 226 (262)
T ss_pred ceecCHhHhccCCCCchhhH--------------------HHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCcc
Confidence 78999999876554433333 999999999999 888998776544322111 1122244
Q ss_pred CCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
..+..+..++.+|++++|..||...
T Consensus 227 ~~~~~l~~li~~~l~~~p~~Rp~~~ 251 (262)
T cd05071 227 ECPESLHDLMCQCWRKEPEERPTFE 251 (262)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHH
Confidence 5778899999999999999998633
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-30 Score=293.17 Aligned_cols=200 Identities=25% Similarity=0.324 Sum_probs=162.9
Q ss_pred hhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCC--CCChhHHHHHHHHHHhcCCCCeeeEccccccC------
Q psy14556 803 LYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKN--LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEE------ 874 (1181)
Q Consensus 803 ~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~--~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~------ 874 (1181)
.+.|...+ +||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 23 LKRYQNLK-PIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hcceeEEE-EeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 34455443 6999999999999999999999999997543 23356788999999999999999999987543
Q ss_pred CcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccc
Q psy14556 875 GYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954 (1181)
Q Consensus 875 ~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk 954 (1181)
..+|+||||++ ++|.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+++
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~kL~DfG~a~ 174 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-DCTLKILDFGLAR 174 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECC-CCcEEEEeCCCcc
Confidence 35799999995 466666642 3668888999999999999999999999999999999988 8999999999997
Q ss_pred ccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCc
Q psy14556 955 RLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTS 1031 (1181)
Q Consensus 955 ~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~ 1031 (1181)
..... .......+|+.|+|||++.+..++.. +|+ ||+||++|+|++|+.||.+.+.
T Consensus 175 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~--~Di------------------wSlG~il~ell~g~~pf~~~~~ 230 (364)
T cd07875 175 TAGTS-FMMTPYVVTRYYRAPEVILGMGYKEN--VDI------------------WSVGCIMGEMIKGGVLFPGTDH 230 (364)
T ss_pred ccCCC-CcccCCcccCCcCCHHHHhCCCCCch--hhH------------------HhHHHHHHHHHhCCCCCCCCCH
Confidence 65432 22234568999999999976544333 333 9999999999999999987654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=294.24 Aligned_cols=200 Identities=24% Similarity=0.332 Sum_probs=162.5
Q ss_pred HhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccC-----
Q psy14556 802 FLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEE----- 874 (1181)
Q Consensus 802 ~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~----- 874 (1181)
....|...+ .||+|+||.||++.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLK-PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEE-EeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 344555444 69999999999999999999999999975432 2346788999999999999999999987543
Q ss_pred -CcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcc
Q psy14556 875 -GYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTS 953 (1181)
Q Consensus 875 -~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlA 953 (1181)
...++||||+++ +|.+.+.. .+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~-~~~~kl~Dfg~~ 166 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-DCTLKILDFGLA 166 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECC-CCCEEEeeCccc
Confidence 357999999954 56665542 3678888999999999999999999999999999999987 899999999999
Q ss_pred cccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCC
Q psy14556 954 KRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKT 1030 (1181)
Q Consensus 954 k~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~ 1030 (1181)
+..... .......||+.|+|||++.+..++.. +|+ ||+||++|+|++|+.||.+.+
T Consensus 167 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~--~Di------------------wslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 167 RTAGTS-FMMTPYVVTRYYRAPEVILGMGYKEN--VDI------------------WSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred ccCCCc-cccCCccccCCccCHHHHcCCCCCch--hhH------------------HHHHHHHHHHHhCCCCCCCCC
Confidence 765432 22234568999999999976544333 333 999999999999999998765
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=279.75 Aligned_cols=236 Identities=24% Similarity=0.360 Sum_probs=191.1
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 813 IG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
||.|++|.||+|++..+++.+++|.+.+... ...+.+.+|+.+++.++||||+++++.+.+++..+++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6999999999999998899999999975533 2346789999999999999999999999999999999999999999
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT 969 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT 969 (1181)
.+++... ..+++..+..++.||+.||+|||++|++|+||||+||+++. ++.++|+|||.+....... ......++
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~-~~~~~l~df~~~~~~~~~~-~~~~~~~~ 155 (262)
T cd05572 81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDS-NGYVKLVDFGFAKKLKSGQ-KTWTFCGT 155 (262)
T ss_pred HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcC-CCCEEEeeCCcccccCccc-ccccccCC
Confidence 9999743 34778889999999999999999999999999999999988 8899999999998765432 22334688
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCC--cccccCCC---CCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKT--SRALVAPP---QISRSV 1044 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~--~~~l~~~~---~ip~~l 1044 (1181)
..|+|||.+.+..++..+| + ||+|+++|+|++|..||.... ...+.... ......
T Consensus 156 ~~~~~PE~~~~~~~~~~~D--i------------------~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 215 (262)
T cd05572 156 PEYVAPEIILNKGYDFSVD--Y------------------WSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEF 215 (262)
T ss_pred cCccChhHhcCCCCCChhh--h------------------hhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCC
Confidence 9999999987554433333 3 999999999999999998776 22211100 111122
Q ss_pred CCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1045 SVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1045 ~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
+...+..+..++.+|+..+|..|++.+..
T Consensus 216 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~ 244 (262)
T cd05572 216 PNYIDKAAKDLIKQLLRRNPEERLGNLKG 244 (262)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCCccc
Confidence 23346788999999999999999985443
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=280.37 Aligned_cols=240 Identities=23% Similarity=0.316 Sum_probs=188.9
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.+||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.++++++||||+++++++......++||||+++++
T Consensus 7 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 86 (286)
T cd07847 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTV 86 (286)
T ss_pred eeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccH
Confidence 369999999999999999999999999865432 234567899999999999999999999999999999999999988
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|..++.. ...+++..+..++.|++.||.|||++|++|+||||+||+++. ++.++|+|||++..+...........+
T Consensus 87 l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~ 162 (286)
T cd07847 87 LNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITK-QGQIKLCDFGFARILTGPGDDYTDYVA 162 (286)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcC-CCcEEECccccceecCCCcccccCccc
Confidence 8877653 235789999999999999999999999999999999999987 889999999999877554333334557
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc-------------
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV------------- 1035 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~------------- 1035 (1181)
+..|+|||.+.+.. .++...|+ ||+|+++|+|++|+.||.+.+..+..
T Consensus 163 ~~~~~aPE~~~~~~-~~~~~~Di------------------~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 223 (286)
T cd07847 163 TRWYRAPELLVGDT-QYGPPVDV------------------WAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPR 223 (286)
T ss_pred ccccCCHHHHhCCC-CcCchhhh------------------HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence 88999999986532 22333333 99999999999999999876542110
Q ss_pred -----------CCCCCCCCC--------CCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1036 -----------APPQISRSV--------SVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1036 -----------~~~~ip~~l--------~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.....+... ....+..+..++.+|+..+|.+||...+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ei 280 (286)
T cd07847 224 HQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEEL 280 (286)
T ss_pred HhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHH
Confidence 000001100 11235567789999999999999975443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=288.27 Aligned_cols=241 Identities=21% Similarity=0.278 Sum_probs=186.1
Q ss_pred eeecccCceEEEEEEEcCCCe--EEEEEEecCCCC-CChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEeecCC
Q psy14556 811 IELGKGSYGVVYAARELDRQV--KLAIKEIPEKNL-GDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~--~VAIKii~~~~~-~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
+.||+|+||.||+|.+..++. .+++|.+..... ...+.+.+|+.++.++ +||||+++++++.+.+.+|+||||+++
T Consensus 13 ~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 92 (303)
T cd05088 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 92 (303)
T ss_pred eeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCC
Confidence 469999999999999877765 457777654322 2345688999999999 899999999999999999999999999
Q ss_pred CCcccchhccc-------------CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcc
Q psy14556 887 GSLSTLLRVKW-------------GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTS 953 (1181)
Q Consensus 887 GSL~dlL~~~~-------------~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlA 953 (1181)
++|.+++.... ....+++..++.++.|++.||+|||++|++||||||+|||++. ++.+||+|||++
T Consensus 93 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~-~~~~kl~dfg~~ 171 (303)
T cd05088 93 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE-NYVAKIADFGLS 171 (303)
T ss_pred CcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecC-CCcEEeCccccC
Confidence 99999987432 1235778899999999999999999999999999999999987 889999999998
Q ss_pred cccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q psy14556 954 KRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSR 1032 (1181)
Q Consensus 954 k~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~ 1032 (1181)
...... .......++..|+|||.+.+...+.. .|+ ||+|+++|+|+| |..||.+.+..
T Consensus 172 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~--~Di------------------~slG~il~ellt~g~~p~~~~~~~ 230 (303)
T cd05088 172 RGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTN--SDV------------------WSYGVLLWEIVSLGGTPYCGMTCA 230 (303)
T ss_pred cccchh-hhcccCCCcccccCHHHHhccCCccc--ccc------------------hhhhhHHHHHHhcCCCCcccCChH
Confidence 643211 11112234667999999876544333 333 999999999998 99999877654
Q ss_pred cccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1033 ALVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1033 ~l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
+...... .....+...+..+..++.+|+..+|..||+..+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 273 (303)
T cd05088 231 ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 273 (303)
T ss_pred HHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 4322111 1112223456778889999999999999864443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=282.45 Aligned_cols=236 Identities=18% Similarity=0.211 Sum_probs=182.4
Q ss_pred eecccCceEEEEEEEcC------------CCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEE
Q psy14556 812 ELGKGSYGVVYAARELD------------RQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKI 879 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~------------tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~L 879 (1181)
.||+|+||.||+|+... ....|++|.+........+.+.+|+.+++.++||||+++++++......++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 59999999999998532 234689998866555555678899999999999999999999999889999
Q ss_pred EEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCC-------eeeeecCCc
Q psy14556 880 FMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSG-------VVKISDFGT 952 (1181)
Q Consensus 880 VmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g-------~vKLiDFGl 952 (1181)
+|||+++++|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++. ++ .++++|||.
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~-~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 82 VEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAR-EGIDGECGPFIKLSDPGI 158 (262)
T ss_pred EEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEec-CCccCCCCceeEeCCCCC
Confidence 99999999998887643 235778889999999999999999999999999999999976 34 389999999
Q ss_pred ccccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHH-hCCCCCCCCCc
Q psy14556 953 SKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLL-VLTAALKKKTS 1031 (1181)
Q Consensus 953 Ak~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELL-TGk~PF~~~~~ 1031 (1181)
+...... ....++..|+|||.+.++ ..++...|+ ||+|+++|+|+ +|..||.....
T Consensus 159 ~~~~~~~----~~~~~~~~y~aPE~~~~~-~~~~~~~Di------------------wslG~~l~el~~~~~~p~~~~~~ 215 (262)
T cd05077 159 PITVLSR----QECVERIPWIAPECVEDS-KNLSIAADK------------------WSFGTTLWEICYNGEIPLKDKTL 215 (262)
T ss_pred CccccCc----ccccccccccChhhhcCC-CCCCchhHH------------------HHHHHHHHHHHhCCCCCCCCcch
Confidence 8655322 233578899999988532 223333444 99999999998 58899887654
Q ss_pred ccccCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1032 RALVAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1032 ~~l~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.+.............+.+..+..++.+|+..+|..||...+.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~i 257 (262)
T cd05077 216 AEKERFYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAI 257 (262)
T ss_pred hHHHHHHhcCccCCCCChHHHHHHHHHHcCCChhhCcCHHHH
Confidence 332111111112233445678889999999999999975443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=279.20 Aligned_cols=237 Identities=23% Similarity=0.274 Sum_probs=186.8
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCccc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLST 891 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~d 891 (1181)
+||+|+||.||++.+.. +..+|+|.+..... ..+.+.+|+.++++++||||+++++++.+.+..+++|||+++++|.+
T Consensus 11 ~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 88 (256)
T cd05113 11 ELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLN 88 (256)
T ss_pred EecCcccceEEEEEecC-CCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHH
Confidence 69999999999998754 44699999865432 34678999999999999999999999999999999999999999999
Q ss_pred chhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC-CccccCCc
Q psy14556 892 LLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS-AETFTGTL 970 (1181)
Q Consensus 892 lL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~-~~t~~GT~ 970 (1181)
++.... ..+++..++.++.||+.||+|||++|++|+||||+||+++. ++.+||+|||.++........ .....++.
T Consensus 89 ~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~-~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~ 165 (256)
T cd05113 89 YLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD-QGCVKVSDFGLSRYVLDDEYTSSVGSKFPV 165 (256)
T ss_pred HHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC-CCCEEECCCccceecCCCceeecCCCccCh
Confidence 987532 25788999999999999999999999999999999999987 889999999998765432211 11123567
Q ss_pred cccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--CCCCCCCC
Q psy14556 971 QYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--ISRSVSVP 1047 (1181)
Q Consensus 971 ~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--ip~~l~~~ 1047 (1181)
.|+|||.+.++.++..+|+ ||+|+++|+|++ |..||...+...+..... .....+..
T Consensus 166 ~y~~pe~~~~~~~~~~~Di--------------------~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (256)
T cd05113 166 RWSPPEVLLYSKFSSKSDV--------------------WAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHL 225 (256)
T ss_pred hhCCHHHHhcCcccchhHH--------------------HHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCC
Confidence 8999999976544443333 999999999998 999998776543211111 11112234
Q ss_pred CCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1048 GPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1048 ~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.+..+..++.+|+..+|.+||...+.
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rp~~~~l 251 (256)
T cd05113 226 ASEKVYAIMYSCWHEKAEERPTFQQL 251 (256)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 56788889999999999999975443
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-31 Score=311.48 Aligned_cols=201 Identities=26% Similarity=0.375 Sum_probs=175.5
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCC-CCCChhHHHHHHHHHHhcCCCCeeeEccccccCC------cEEEEEe
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEK-NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEG------YFKIFME 882 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~-~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~------~l~LVmE 882 (1181)
.+.||+|+||.||+++++.+|+.||||.+.+. ....++...+|+++|++++|||||+++++-++.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 34699999999999999999999999999765 3456788999999999999999999999865543 5789999
Q ss_pred ecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccC-CC--eeeeecCCcccccccC
Q psy14556 883 QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTY-SG--VVKISDFGTSKRLAGL 959 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~-~g--~vKLiDFGlAk~l~~~ 959 (1181)
||.||+|+..++...+...+++..++.++.++..||.|||++||+||||||.||++-.. +| ..||+|||.|+.+.+.
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~ 177 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDN 177 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCC
Confidence 99999999999987777789999999999999999999999999999999999998431 23 6799999999988765
Q ss_pred CCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCC
Q psy14556 960 CPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKT 1030 (1181)
Q Consensus 960 ~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~ 1030 (1181)
. ...+..||+.|.+||++.. ...|++.||. ||+||++|+..||..||....
T Consensus 178 s-~~~S~vGT~~YLhPel~E~-q~~y~~tVDL------------------WS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 178 S-LFTSLVGTEEYLHPELYER-QKKYTATVDL------------------WSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred C-eeeeecCchhhcChHHHhh-ccCcCceeeh------------------hhhhhHHHHHhccCCCCCcCC
Confidence 4 5667789999999999975 3467778877 999999999999999996543
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=278.63 Aligned_cols=236 Identities=21% Similarity=0.282 Sum_probs=186.1
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCccc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLST 891 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~d 891 (1181)
+||+|+||.||+|.+. .+..+|+|.+..... ..+.+.+|+.++++++||||+++++++.. +..+++|||+++++|.+
T Consensus 13 ~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~ 89 (260)
T cd05070 13 KLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLD 89 (260)
T ss_pred eeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCCCcHHH
Confidence 6999999999999865 456799999875443 34678999999999999999999998754 56889999999999999
Q ss_pred chhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC-CCccccCCc
Q psy14556 892 LLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP-SAETFTGTL 970 (1181)
Q Consensus 892 lL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~-~~~t~~GT~ 970 (1181)
++... ....+++..++.++.|++.||.|||++|++||||||+||+++. ++.++|+|||.+........ ......++.
T Consensus 90 ~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 167 (260)
T cd05070 90 FLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGD-GLVCKIADFGLARLIEDNEYTARQGAKFPI 167 (260)
T ss_pred HHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeC-CceEEeCCceeeeeccCcccccccCCCCCc
Confidence 98754 2345788899999999999999999999999999999999987 88999999999976543221 111223566
Q ss_pred cccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCC--CCCCCCCCC
Q psy14556 971 QYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPP--QISRSVSVP 1047 (1181)
Q Consensus 971 ~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~--~ip~~l~~~ 1047 (1181)
.|+|||.+.+...+..+|+ ||||+++|+|++ |..||.+.+..+..... ..+...+..
T Consensus 168 ~y~aPE~~~~~~~~~~~Di--------------------~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 227 (260)
T cd05070 168 KWTAPEAALYGRFTIKSDV--------------------WSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQD 227 (260)
T ss_pred cccChHHHhcCCCcchhhh--------------------HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCc
Confidence 8999999876554433333 999999999999 89999876654432211 112223345
Q ss_pred CCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1048 GPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1048 ~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
.+..+..++.+|+.++|.+||+...
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rpt~~~ 252 (260)
T cd05070 228 CPISLHELMLQCWKKDPEERPTFEY 252 (260)
T ss_pred CCHHHHHHHHHHcccCcccCcCHHH
Confidence 6778999999999999999997443
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=285.54 Aligned_cols=240 Identities=18% Similarity=0.184 Sum_probs=183.4
Q ss_pred eecccCceEEEEEEEcCCCe-------EEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeec
Q psy14556 812 ELGKGSYGVVYAARELDRQV-------KLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQV 884 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~-------~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~ 884 (1181)
+||+|+||.||+|.+...+. .+++|.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 59999999999998865443 48888886555445567899999999999999999999999989999999999
Q ss_pred CCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCC-------eeeeecCCcccccc
Q psy14556 885 PGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSG-------VVKISDFGTSKRLA 957 (1181)
Q Consensus 885 ~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g-------~vKLiDFGlAk~l~ 957 (1181)
++|+|..++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++. .++++|||.+....
T Consensus 82 ~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~ 159 (258)
T cd05078 82 KFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL 159 (258)
T ss_pred CCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence 9999999997542 25678888999999999999999999999999999999976322 37999999886543
Q ss_pred cCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCC-CCCCCCCcccccC
Q psy14556 958 GLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLT-AALKKKTSRALVA 1036 (1181)
Q Consensus 958 ~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk-~PF~~~~~~~l~~ 1036 (1181)
. .....++..|+|||++.+.. .++...|+ ||+|+++|+|++|. .||..........
T Consensus 160 ~----~~~~~~~~~y~aPE~~~~~~-~~~~~~Di------------------wslG~~l~~l~~g~~~~~~~~~~~~~~~ 216 (258)
T cd05078 160 P----KEILLERIPWVPPECIENPQ-NLSLAADK------------------WSFGTTLWEIFSGGDKPLSALDSQKKLQ 216 (258)
T ss_pred C----chhccccCCccCchhccCCC-CCCchhhH------------------HHHHHHHHHHHcCCCCChhhccHHHHHH
Confidence 2 22345788999999996532 22233333 99999999999994 6666655433211
Q ss_pred CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHh
Q psy14556 1037 PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVC 1077 (1181)
Q Consensus 1037 ~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~a 1077 (1181)
........+......+..++.+|++.+|..||+ +++.+..
T Consensus 217 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~~~il~~ 256 (258)
T cd05078 217 FYEDRHQLPAPKWTELANLINQCMDYEPDFRPS-FRAIIRD 256 (258)
T ss_pred HHHccccCCCCCcHHHHHHHHHHhccChhhCCC-HHHHHHh
Confidence 101111222334466888999999999999985 4444443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=276.92 Aligned_cols=238 Identities=24% Similarity=0.308 Sum_probs=187.9
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEcccc-ccCCcEEEEEeecCCCCc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV-SEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~-~d~~~l~LVmEy~~gGSL 889 (1181)
+.||+|+||.||++.. .+..+++|.+.... ..+.+.+|+.++++++|+|++++++++ ...+..+++|||+++++|
T Consensus 12 ~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L 87 (256)
T cd05082 12 QTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 87 (256)
T ss_pred eeecccCCCeEEEEEE--cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcH
Confidence 3699999999999976 46789999985432 356789999999999999999999975 455779999999999999
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT 969 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT 969 (1181)
.+++... ....+++..++.++.|++.||+|||++|++||||||+||+++. ++.+||+|||++....... ....++
T Consensus 88 ~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~-~~~~kl~dfg~~~~~~~~~---~~~~~~ 162 (256)
T cd05082 88 VDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASSTQ---DTGKLP 162 (256)
T ss_pred HHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcC-CCcEEecCCccceeccccC---CCCccc
Confidence 9998754 3345778889999999999999999999999999999999987 8999999999987654321 223356
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCC--CCCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPP--QISRSVSV 1046 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~--~ip~~l~~ 1046 (1181)
..|+|||++.+...+..+|+ ||+|+++|+|++ |+.||...+...+.... ..+.....
T Consensus 163 ~~y~aPE~~~~~~~~~~~Dv--------------------~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 222 (256)
T cd05082 163 VKWTAPEALREKKFSTKSDV--------------------WSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD 222 (256)
T ss_pred eeecCHHHHccCCCCchhhh--------------------HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence 78999999976544333333 999999999997 99999877665442211 12223334
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
..+..+..++.+|+..+|..||. +.+....+
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rpt-~~~l~~~l 253 (256)
T cd05082 223 GCPPVVYDVMKQCWHLDAATRPS-FLQLREQL 253 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcC-HHHHHHHH
Confidence 56788999999999999999985 55544443
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=285.66 Aligned_cols=240 Identities=20% Similarity=0.222 Sum_probs=181.8
Q ss_pred eecccCceEEEEEEEcC------------------------CCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeE
Q psy14556 812 ELGKGSYGVVYAARELD------------------------RQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQY 867 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~------------------------tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl 867 (1181)
.||+|+||.||+|.... ....|++|.+........+.+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 49999999999997532 224689998865544445678889999999999999999
Q ss_pred ccccccCCcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccC------
Q psy14556 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTY------ 941 (1181)
Q Consensus 868 ~g~~~d~~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~------ 941 (1181)
++++.+....++||||+++++|..++... ...+++..+..++.||+.||+|||++||+||||||+||+++..
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence 99999999999999999999999988643 2356788889999999999999999999999999999999752
Q ss_pred CCeeeeecCCcccccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHH-
Q psy14556 942 SGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLL- 1020 (1181)
Q Consensus 942 ~g~vKLiDFGlAk~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELL- 1020 (1181)
...+|++|||.+...... ....++..|+|||.+.+. ..++...|+ ||+|+++|||+
T Consensus 160 ~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~-~~~~~~~Dv------------------~slG~~l~el~~ 216 (274)
T cd05076 160 SPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGG-NSLSTAADK------------------WSFGTTLLEICF 216 (274)
T ss_pred cceeeecCCccccccccc----cccccCCcccCchhhcCC-CCCCcHHHH------------------HHHHHHHHHHHh
Confidence 225899999987654321 223477889999988643 223334444 99999999994
Q ss_pred hCCCCCCCCCcccccCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHh
Q psy14556 1021 VLTAALKKKTSRALVAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVC 1077 (1181)
Q Consensus 1021 TGk~PF~~~~~~~l~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~a 1077 (1181)
+|+.||..................+.+....+..++.+|+..+|..||+ +.+.+..
T Consensus 217 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps-~~~il~~ 272 (274)
T cd05076 217 DGEVPLKERTPSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPS-FRTILRD 272 (274)
T ss_pred CCCCCccccChHHHHHHHHhccCCCCCCChHHHHHHHHHcccChhhCcC-HHHHHHh
Confidence 7999998766543211111111222234456888999999999999985 4544443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=285.09 Aligned_cols=240 Identities=22% Similarity=0.272 Sum_probs=188.3
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
.+||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++...+..++||||++ ++|
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l 90 (301)
T cd07873 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDL 90 (301)
T ss_pred eEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCH
Confidence 469999999999999999999999999865433 234567899999999999999999999999999999999996 688
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT 969 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT 969 (1181)
.+++... ...+++..++.++.|++.||.|||++||+|+||||+||+++. ++.+||+|||++..............++
T Consensus 91 ~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 167 (301)
T cd07873 91 KQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINE-RGELKLADFGLARAKSIPTKTYSNEVVT 167 (301)
T ss_pred HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECC-CCcEEECcCcchhccCCCCCccccccee
Confidence 8887643 235678899999999999999999999999999999999988 8899999999987654332223334578
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc--------C-----
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV--------A----- 1036 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~--------~----- 1036 (1181)
+.|+|||++.+.. .++...|+ ||+|+++|+|++|+.||.+.+..+.. .
T Consensus 168 ~~y~~PE~~~~~~-~~~~~~Dv------------------~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 228 (301)
T cd07873 168 LWYRPPDILLGST-DYSTQIDM------------------WGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEET 228 (301)
T ss_pred ecccCcHHHhCCC-CCccHHHH------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhh
Confidence 9999999986432 23333333 99999999999999999876542210 0
Q ss_pred -----------CCCCCC-------CCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1037 -----------PPQISR-------SVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1037 -----------~~~ip~-------~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
....+. ......+..+..++.+|+..+|.+||+..+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~ei 283 (301)
T cd07873 229 WPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEA 283 (301)
T ss_pred chhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 000111 1112346667889999999999999975544
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=278.52 Aligned_cols=244 Identities=16% Similarity=0.188 Sum_probs=188.0
Q ss_pred eecccCceEEEEEEEcCC---CeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEccccccCC------cEEEE
Q psy14556 812 ELGKGSYGVVYAARELDR---QVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEG------YFKIF 880 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~t---g~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~------~l~LV 880 (1181)
.||+|+||.||+|....+ +..||+|.++..... ..+.+.+|+..++.++||||+++++++.... ..+++
T Consensus 6 ~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v 85 (273)
T cd05035 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVI 85 (273)
T ss_pred ccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEE
Confidence 699999999999987653 478999998754332 2457899999999999999999999875544 38999
Q ss_pred EeecCCCCcccchhccc---CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccc
Q psy14556 881 MEQVPGGSLSTLLRVKW---GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 957 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~---~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~ 957 (1181)
|||+++++|..++.... ....+++..+..++.|++.||.|||++|++||||||+||+++. ++.+||+|||+++...
T Consensus 86 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~~~~ 164 (273)
T cd05035 86 LPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRE-DMTVCVADFGLSKKIY 164 (273)
T ss_pred EeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECC-CCeEEECCccceeecc
Confidence 99999999998885431 2346788899999999999999999999999999999999987 8899999999997654
Q ss_pred cCCCC--CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccc
Q psy14556 958 GLCPS--AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRAL 1034 (1181)
Q Consensus 958 ~~~~~--~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l 1034 (1181)
..... .....++..|+|||.+.+...+..+|+ ||+|+++|||++ |..||.+.....+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv--------------------~SlG~il~el~~~g~~p~~~~~~~~~ 224 (273)
T cd05035 165 SGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDV--------------------WAFGVTMWEIATRGQTPYPGVENHEI 224 (273)
T ss_pred ccccccccccccCCccccCHhhcccCCCCcccch--------------------HHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 32211 111234678999999876554444443 999999999999 8899987665443
Q ss_pred cCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHh
Q psy14556 1035 VAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVC 1077 (1181)
Q Consensus 1035 ~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~a 1077 (1181)
..... .....+...+..+..++.+|+..+|..||+ +.+....
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~-~~e~~~~ 268 (273)
T cd05035 225 YDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPT-FTKLREV 268 (273)
T ss_pred HHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcC-HHHHHHH
Confidence 21111 111233456778889999999999999985 4444443
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-30 Score=275.56 Aligned_cols=240 Identities=29% Similarity=0.384 Sum_probs=192.6
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
..||.|+||+||+|.+..++..+++|.+..... ...+.+.+|+.+++.++|+||+++++.+...+..+++||++++++|
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l 86 (267)
T cd06610 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSL 86 (267)
T ss_pred eeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcH
Confidence 369999999999999988999999999975433 2457789999999999999999999999999999999999999999
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC----Ccc
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS----AET 965 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~----~~t 965 (1181)
.+++........+++..++.++.|++.||.|||++|++|+||||+||+++. ++.++|+|||++..+...... ...
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~ 165 (267)
T cd06610 87 LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGE-DGSVKIADFGVSASLADGGDRTRKVRKT 165 (267)
T ss_pred HHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcC-CCCEEEcccchHHHhccCcccccccccc
Confidence 999976433356789999999999999999999999999999999999998 789999999998766543222 133
Q ss_pred ccCCccccCchhhccC-CCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCC------
Q psy14556 966 FTGTLQYMAPEVIDKG-QRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPP------ 1038 (1181)
Q Consensus 966 ~~GT~~Y~APEvl~gg-~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~------ 1038 (1181)
..|+..|+|||++... ..+..+|+ ||+|+++|+|++|+.||...+........
T Consensus 166 ~~~~~~y~~Pe~~~~~~~~~~~~Dv--------------------~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 225 (267)
T cd06610 166 FVGTPCWMAPEVMEQVHGYDFKADI--------------------WSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPP 225 (267)
T ss_pred ccCChhhcChHHHccccCcCcccch--------------------HhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCC
Confidence 4588999999998755 33333333 99999999999999999876653321111
Q ss_pred CCCCCC-CCCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1039 QISRSV-SVPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1039 ~ip~~l-~~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
..+... ....+..+..++.+|+..+|..||...
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 259 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAE 259 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHH
Confidence 111111 123456778899999999999999633
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=277.63 Aligned_cols=240 Identities=20% Similarity=0.278 Sum_probs=186.3
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
++||+|++|.||+|.+..+. .+|+|.+..... ..+.+.+|+.++++++||||+++++++.. +..+++|||+++++|.
T Consensus 12 ~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~ 88 (260)
T cd05069 12 VKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLL 88 (260)
T ss_pred eeecCcCCCeEEEEEEcCCc-eEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCCCCHH
Confidence 47999999999999876554 689998865432 34678899999999999999999998754 5688999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC-CCccccCC
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP-SAETFTGT 969 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~-~~~t~~GT 969 (1181)
+++... ....+++..+..++.|++.||.|||+.|++|+||||+||+++. ++.++|+|||.+........ ......++
T Consensus 89 ~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 166 (260)
T cd05069 89 DFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGD-NLVCKIADFGLARLIEDNEYTARQGAKFP 166 (260)
T ss_pred HHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcC-CCeEEECCCccceEccCCcccccCCCccc
Confidence 999754 3345678889999999999999999999999999999999987 88999999999976543211 11223356
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCC--CCCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPP--QISRSVSV 1046 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~--~ip~~l~~ 1046 (1181)
..|+|||.+.++..+...|+ ||+|+++|+|++ |..||.+.......... ......+.
T Consensus 167 ~~y~~Pe~~~~~~~~~~~Di--------------------~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T cd05069 167 IKWTAPEAALYGRFTIKSDV--------------------WSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQ 226 (260)
T ss_pred hhhCCHHHhccCCcChHHHH--------------------HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 78999999876544333333 999999999999 89999887654421111 11112233
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHHHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNTNLV 1076 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~~~~ 1076 (1181)
..+..+..++.+|+.++|..||+ +++...
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rp~-~~~i~~ 255 (260)
T cd05069 227 GCPESLHELMKLCWKKDPDERPT-FEYIQS 255 (260)
T ss_pred ccCHHHHHHHHHHccCCcccCcC-HHHHHH
Confidence 56778999999999999999996 444333
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=276.43 Aligned_cols=242 Identities=23% Similarity=0.283 Sum_probs=191.3
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
+||+|+||.||++.+.. ++.|++|.+...... ..+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.
T Consensus 2 ~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 2 KIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred ccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 69999999999999877 899999998765443 4567899999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCC--ccccC
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA--ETFTG 968 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~--~t~~G 968 (1181)
+++... ...+++..+..++.+++.||.|||+++++||||||+||+++. ++.+||+|||.+.......... .....
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGE-NNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcC-CCcEEEeeccccccccCCcceeccccCcc
Confidence 998753 235678888999999999999999999999999999999987 8899999999987654221111 11223
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--CCCCCC
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--ISRSVS 1045 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--ip~~l~ 1045 (1181)
+..|+|||.+.++..+..+|+ ||+|+++|+|++ |..||............. .....+
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di--------------------~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~ 217 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDV--------------------WSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAP 217 (251)
T ss_pred eeccCChHhhccCCCCcchhH--------------------HHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCC
Confidence 567999999976654444433 999999999999 889998766433211111 111223
Q ss_pred CCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1046 VPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1046 ~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
...+..+..++.+|+..+|..||+ +.+.+..+
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~-~~ell~~l 249 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPS-FSEIYNEL 249 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcC-HHHHHHHh
Confidence 345678888999999999999985 55555544
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=289.02 Aligned_cols=248 Identities=21% Similarity=0.295 Sum_probs=190.6
Q ss_pred ceeecccCceEEEEEEEcC-------CCeEEEEEEecCCCC-CChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEE
Q psy14556 810 RIELGKGSYGVVYAARELD-------RQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIF 880 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~-------tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LV 880 (1181)
.++||+|+||.||++++.. +...+|+|.+..... ...+.+.+|+.+++.+ +||||+++++++...+..|+|
T Consensus 23 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 102 (307)
T cd05098 23 GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 102 (307)
T ss_pred eeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 4479999999999998643 235699999975432 2345688899999999 799999999999999999999
Q ss_pred EeecCCCCcccchhcccC-------------CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeee
Q psy14556 881 MEQVPGGSLSTLLRVKWG-------------PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKI 947 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~~-------------~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKL 947 (1181)
|||+++++|.+++..... ...+++..+..++.|++.||+|||++|++||||||+||+++. ++.+||
T Consensus 103 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~-~~~~kL 181 (307)
T cd05098 103 VEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE-DNVMKI 181 (307)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcC-CCcEEE
Confidence 999999999999975421 124678889999999999999999999999999999999987 789999
Q ss_pred ecCCcccccccCCCC--CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCC
Q psy14556 948 SDFGTSKRLAGLCPS--AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTA 1024 (1181)
Q Consensus 948 iDFGlAk~l~~~~~~--~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~ 1024 (1181)
+|||.+......... .....+++.|+|||.+.+..++..+|+ ||+|+++|+|++ |..
T Consensus 182 ~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv--------------------wslG~~l~el~~~g~~ 241 (307)
T cd05098 182 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV--------------------WSFGVLLWEIFTLGGS 241 (307)
T ss_pred CCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHH--------------------HHHHHHHHHHHcCCCC
Confidence 999998765432111 111224568999999976544333333 999999999998 889
Q ss_pred CCCCCCcccccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcc
Q psy14556 1025 ALKKKTSRALVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTG 1079 (1181)
Q Consensus 1025 PF~~~~~~~l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~ 1079 (1181)
||.+.+..++..... .....+...+..+..++.+|+..+|..||+ +.+.+..+.
T Consensus 242 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~~evl~~l~ 297 (307)
T cd05098 242 PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPT-FKQLVEDLD 297 (307)
T ss_pred CCCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcC-HHHHHHHHH
Confidence 998776654322111 111223456778888999999999999994 555544443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=277.82 Aligned_cols=241 Identities=25% Similarity=0.358 Sum_probs=194.8
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCC--CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKN--LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~--~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.+||+|+||.||++.+..+++.|++|.+.... ....+.+.+|+.++++++||||+++++++...+..++||||+++++
T Consensus 6 ~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd08218 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGD 85 (256)
T ss_pred EEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCc
Confidence 47999999999999999999999999986542 2234578999999999999999999999999999999999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|.+++... ....+++..+..++.|++.||.|||++|++|+||+|+||+++. ++.++|+|||.+..............|
T Consensus 86 l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~ 163 (256)
T cd08218 86 LYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTK-DGTIKLGDFGIARVLNSTVELARTCIG 163 (256)
T ss_pred HHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC-CCCEEEeeccceeecCcchhhhhhccC
Confidence 99988754 2335678889999999999999999999999999999999987 789999999999766543333334458
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC--CCCCCCC
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ--ISRSVSV 1046 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~--ip~~l~~ 1046 (1181)
++.|+|||++.++..+..+|+ ||+|+++|+|++|+.||......++..... .....+.
T Consensus 164 ~~~~~~pe~~~~~~~~~~~Dv--------------------~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (256)
T cd08218 164 TPYYLSPEICENRPYNNKSDI--------------------WALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSS 223 (256)
T ss_pred CccccCHHHhCCCCCCCccch--------------------hHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcc
Confidence 889999999976554433333 999999999999999998766544322111 1112233
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
..+..+..++.+|+..+|..||...+.
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~v 250 (256)
T cd08218 224 HYSYDLRNLVSQLFKRNPRDRPSVNSI 250 (256)
T ss_pred cCCHHHHHHHHHHhhCChhhCcCHHHH
Confidence 456778889999999999999975443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=280.35 Aligned_cols=238 Identities=28% Similarity=0.372 Sum_probs=192.0
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
.+||.|+||.||+|.+..++..||+|.+..... ...+.+.+|+.++++++||||+++++++..++..++||||+++++|
T Consensus 10 ~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l 89 (277)
T cd06641 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA 89 (277)
T ss_pred eeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcH
Confidence 369999999999999988999999999865432 2346788999999999999999999999999999999999999999
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT 969 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT 969 (1181)
.+++... .+++..+..++.|++.|+.+||++|++|+||||+||+++. ++.++|+|||++..+...........++
T Consensus 90 ~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 164 (277)
T cd06641 90 LDLLEPG----PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE-HGEVKLADFGVAGQLTDTQIKRNTFVGT 164 (277)
T ss_pred HHHHhcC----CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECC-CCCEEEeecccceecccchhhhccccCC
Confidence 9988632 5678899999999999999999999999999999999987 8899999999987665432223334688
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCC--CCCCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPP--QISRSVSVP 1047 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~--~ip~~l~~~ 1047 (1181)
..|+|||.+.+...+..+|+ ||+|+++|+|++|..||............ .........
T Consensus 165 ~~y~~PE~~~~~~~~~~~Dv--------------------~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 224 (277)
T cd06641 165 PFWMAPEVIKQSAYDSKADI--------------------WSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGN 224 (277)
T ss_pred ccccChhhhccCCCCchhhH--------------------HHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcc
Confidence 89999999875543333332 99999999999999999876543322111 111222334
Q ss_pred CCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1048 GPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1048 ~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.+..+..++.+|+..+|..||...+.
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~~ 250 (277)
T cd06641 225 YSKPLKEFVEACLNKEPSFRPTAKEL 250 (277)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHH
Confidence 56778889999999999999875444
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-30 Score=283.63 Aligned_cols=238 Identities=23% Similarity=0.371 Sum_probs=193.7
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
.+||+|++|.||++.+..+++.+++|.+........+.+.+|+.+++.++||||+++++++...+..++++||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~ 104 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence 37999999999999998899999999986555455667899999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCc
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL 970 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~ 970 (1181)
+++.. ..+++..++.++.|++.||+|||++|++||||+|+||+++. ++.++|+|||.+..............|++
T Consensus 105 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 179 (285)
T cd06648 105 DIVTH----TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTS-DGRVKLSDFGFCAQVSKEVPRRKSLVGTP 179 (285)
T ss_pred HHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcC-CCcEEEcccccchhhccCCcccccccCCc
Confidence 99875 25678889999999999999999999999999999999988 89999999998876554333333456899
Q ss_pred cccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC--CCCCC--CC
Q psy14556 971 QYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ--ISRSV--SV 1046 (1181)
Q Consensus 971 ~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~--ip~~l--~~ 1046 (1181)
.|+|||.+.+...+..+|+ ||+|+++|+|++|+.||...+......... .+... ..
T Consensus 180 ~y~aPE~~~~~~~~~~~Dv--------------------~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
T cd06648 180 YWMAPEVISRLPYGTEVDI--------------------WSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLH 239 (285)
T ss_pred cccCHHHhcCCCCCCcccH--------------------HHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccc
Confidence 9999999976554443333 999999999999999998766433211100 11111 12
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
..+..+..++.+|+..+|..||+..+.
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rpt~~~i 266 (285)
T cd06648 240 KVSPRLRSFLDRMLVRDPAQRATAAEL 266 (285)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 356789999999999999999964443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=292.43 Aligned_cols=241 Identities=21% Similarity=0.320 Sum_probs=184.3
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccC------C
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEE------G 875 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~------~ 875 (1181)
+.|... ..||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.++++++||||+++++++... .
T Consensus 15 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 15 ERYQNL-TPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhh-eecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 334443 369999999999999999999999999865432 2345678999999999999999999987543 4
Q ss_pred cEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccc
Q psy14556 876 YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 955 (1181)
Q Consensus 876 ~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~ 955 (1181)
..|++++++ +++|.+++... .+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++.
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~-~~~~kl~Dfg~~~~ 167 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNE-DCELRILDFGLARQ 167 (343)
T ss_pred cEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECC-CCCEEEcCCcccee
Confidence 578999988 88998887632 5788999999999999999999999999999999999988 89999999999986
Q ss_pred cccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc
Q psy14556 956 LAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV 1035 (1181)
Q Consensus 956 l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~ 1035 (1181)
... ......||+.|+|||++.+. ..++..+|+ ||+||++|+|++|+.||.+.+.....
T Consensus 168 ~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~Di------------------wslG~il~el~~g~~pf~~~~~~~~~ 225 (343)
T cd07878 168 ADD---EMTGYVATRWYRAPEIMLNW-MHYNQTVDI------------------WSVGCIMAELLKGKALFPGNDYIDQL 225 (343)
T ss_pred cCC---CcCCccccccccCchHhcCC-ccCCchhhh------------------HhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 543 22345689999999998652 223344444 99999999999999999875432110
Q ss_pred C-------C---------------------CCCCCC----CCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1036 A-------P---------------------PQISRS----VSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1036 ~-------~---------------------~~ip~~----l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
. . +..+.. ........+..++.+|+..||.+||+..+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~el 295 (343)
T cd07878 226 KRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEA 295 (343)
T ss_pred HHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 0 0 000000 001123346679999999999999974443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-30 Score=286.62 Aligned_cols=240 Identities=21% Similarity=0.263 Sum_probs=186.4
Q ss_pred eecccCceEEEEEEEcCCCe--EEEEEEecCCC-CCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQV--KLAIKEIPEKN-LGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~--~VAIKii~~~~-~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.||+|+||.||+|....++. .+++|.++... ....+.+.+|+.++.++ +||||+++++++...+.++++|||++++
T Consensus 9 ~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 88 (297)
T cd05089 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYG 88 (297)
T ss_pred eecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCC
Confidence 69999999999999877664 46888876432 22346788999999999 7999999999999999999999999999
Q ss_pred Ccccchhccc-------------CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccc
Q psy14556 888 SLSTLLRVKW-------------GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954 (1181)
Q Consensus 888 SL~dlL~~~~-------------~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk 954 (1181)
+|.+++.... ....+++..++.++.|++.||+|||++||+||||||+||+++. ++.+||+|||++.
T Consensus 89 ~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~-~~~~kl~dfg~~~ 167 (297)
T cd05089 89 NLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGE-NLASKIADFGLSR 167 (297)
T ss_pred cHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECC-CCeEEECCcCCCc
Confidence 9999986431 1124778899999999999999999999999999999999987 8899999999986
Q ss_pred ccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q psy14556 955 RLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRA 1033 (1181)
Q Consensus 955 ~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~ 1033 (1181)
...... .......+..|+|||++.+..++..+|+ ||||+++|+|++ |..||.+.....
T Consensus 168 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv--------------------wSlG~il~el~t~g~~pf~~~~~~~ 226 (297)
T cd05089 168 GEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDV--------------------WSFGVLLWEIVSLGGTPYCGMTCAE 226 (297)
T ss_pred ccccee-ccCCCCcCccccCchhhccCCCCchhhH--------------------HHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 432211 1111223557999999976554443333 999999999997 999998876654
Q ss_pred ccCCC--CCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1034 LVAPP--QISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1034 l~~~~--~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
+.... ......+...+..+..++.+|+..+|..||+..+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 268 (297)
T cd05089 227 LYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268 (297)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 32211 11122233467788899999999999999975554
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=289.19 Aligned_cols=199 Identities=20% Similarity=0.278 Sum_probs=163.2
Q ss_pred eeccc--CceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 812 ELGKG--SYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G--~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
+||+| +|++||++.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++..++..++||||++++
T Consensus 5 ~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~ 84 (327)
T cd08227 5 VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 84 (327)
T ss_pred hccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCC
Confidence 68999 7899999999999999999999755332 2456788999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC------
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP------ 961 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~------ 961 (1181)
+|.+++... ....+++..++.++.|++.||+|||++||+||||||+||+++. ++.++++||+.+........
T Consensus 85 ~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~ 162 (327)
T cd08227 85 SAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISV-DGKVYLSGLRSNLSMINHGQRLRVVH 162 (327)
T ss_pred cHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEec-CCcEEEcccchhhccccccccccccc
Confidence 999998754 2234788999999999999999999999999999999999987 78999999986544322111
Q ss_pred -CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCC
Q psy14556 962 -SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKT 1030 (1181)
Q Consensus 962 -~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~ 1030 (1181)
......++..|+|||++.+....++...|+ ||+||++|+|++|+.||....
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di------------------wslG~il~el~~g~~pf~~~~ 214 (327)
T cd08227 163 DFPKYSVKVLPWLSPEVLQQNLQGYDAKSDI------------------YSVGITACELANGHVPFKDMP 214 (327)
T ss_pred cccccccceecccChHHhhcccCCCCchhhH------------------HHHHHHHHHHHHCCCCCCCcc
Confidence 111234677899999997543334444444 999999999999999997643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=276.08 Aligned_cols=236 Identities=37% Similarity=0.520 Sum_probs=190.0
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCC-----CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeec
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-----GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQV 884 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-----~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~ 884 (1181)
.+.||+|++|.||+|.+..++..|++|.+..... ...+.+.+|+.+++.++||||+++++++.+.+.+++++||+
T Consensus 5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (258)
T cd06632 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELV 84 (258)
T ss_pred cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEec
Confidence 3479999999999999988899999999865432 23467889999999999999999999999999999999999
Q ss_pred CCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCc
Q psy14556 885 PGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAE 964 (1181)
Q Consensus 885 ~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~ 964 (1181)
++++|.+++... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++. ++.+||+|||.+....... ...
T Consensus 85 ~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~-~~~~kl~d~~~~~~~~~~~-~~~ 159 (258)
T cd06632 85 PGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDT-NGVVKLADFGMAKQVVEFS-FAK 159 (258)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC-CCCEEEccCccceeccccc-ccc
Confidence 999999998743 34678889999999999999999999999999999999987 8999999999987654432 223
Q ss_pred cccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCC---CCC
Q psy14556 965 TFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPP---QIS 1041 (1181)
Q Consensus 965 t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~---~ip 1041 (1181)
...++..|+|||.+.... .++...|+ ||+|+++|+|++|+.||............ ...
T Consensus 160 ~~~~~~~y~~pe~~~~~~-~~~~~~D~------------------~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 220 (258)
T cd06632 160 SFKGSPYWMAPEVIAQQG-GYGLAADI------------------WSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKEL 220 (258)
T ss_pred ccCCCcceeCHHHhcCCC-CCCchhhh------------------HHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccC
Confidence 455889999999986543 12333333 99999999999999999876543321111 111
Q ss_pred CCCCCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1042 RSVSVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1042 ~~l~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
...+...+..+..++.+|+..+|..||.
T Consensus 221 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 248 (258)
T cd06632 221 PPIPDHLSDEAKDFILKCLQRDPSLRPT 248 (258)
T ss_pred CCcCCCcCHHHHHHHHHHhhcCcccCcC
Confidence 1223345677888999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=300.88 Aligned_cols=241 Identities=21% Similarity=0.259 Sum_probs=186.4
Q ss_pred eeecccCceEEEEEEEcCC-----CeEEEEEEecCCCC-CChhHHHHHHHHHHhcC-CCCeeeEccccccCCcEEEEEee
Q psy14556 811 IELGKGSYGVVYAARELDR-----QVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLR-HRNIVQYLGSVSEEGYFKIFMEQ 883 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~t-----g~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~-HPNIVkl~g~~~d~~~l~LVmEy 883 (1181)
++||+|+||.||+|.+... +..||+|++..... ...+.+.+|+.+++++. ||||+++++++.+.+..|+||||
T Consensus 43 ~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey 122 (400)
T cd05105 43 RILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEY 122 (400)
T ss_pred heecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEe
Confidence 4799999999999987433 35799999965433 23567899999999996 99999999999999999999999
Q ss_pred cCCCCcccchhcccC-----------------------------------------------------------------
Q psy14556 884 VPGGSLSTLLRVKWG----------------------------------------------------------------- 898 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~----------------------------------------------------------------- 898 (1181)
|++|+|.+++.....
T Consensus 123 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (400)
T cd05105 123 CFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSD 202 (400)
T ss_pred cCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhh
Confidence 999999988764210
Q ss_pred ----------------------------CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecC
Q psy14556 899 ----------------------------PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDF 950 (1181)
Q Consensus 899 ----------------------------~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDF 950 (1181)
...+++..+..++.|++.||+|||+++|+||||||+|||++. ++.+||+||
T Consensus 203 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~-~~~~kL~Df 281 (400)
T cd05105 203 IQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ-GKIVKICDF 281 (400)
T ss_pred cccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC-CCEEEEEeC
Confidence 123667788899999999999999999999999999999988 889999999
Q ss_pred CcccccccCCC--CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCC
Q psy14556 951 GTSKRLAGLCP--SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALK 1027 (1181)
Q Consensus 951 GlAk~l~~~~~--~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~ 1027 (1181)
|+++....... ......++..|+|||++.+..++...|+ ||+|+++|+|++ |..||.
T Consensus 282 Gla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di--------------------wSlGvil~ellt~g~~P~~ 341 (400)
T cd05105 282 GLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDV--------------------WSYGILLWEIFSLGGTPYP 341 (400)
T ss_pred CcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhH--------------------HHHHHHHHHHHHCCCCCCc
Confidence 99976543221 1222346788999999976654444333 999999999997 999998
Q ss_pred CCCccccc-C--CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1028 KKTSRALV-A--PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1028 ~~~~~~l~-~--~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
........ . ........+...+..+..++.+|+..+|..||...+
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~ 389 (400)
T cd05105 342 GMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLH 389 (400)
T ss_pred ccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHH
Confidence 75432211 0 011111223456778889999999999999986444
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=275.14 Aligned_cols=239 Identities=23% Similarity=0.304 Sum_probs=188.0
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCC-hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD-VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~-~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
+||+|+||.||+|... ++..+|+|.+....... ...+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 2 ~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 2 LLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred ccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 5999999999999854 67889999986554322 346889999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC-CccccCC
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS-AETFTGT 969 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~-~~t~~GT 969 (1181)
+++... ...+++..+..++.|++.||.|||++|++||||||+||+++. ++.+||+|||++......... .....++
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGE-NNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcC-CCeEEECCCccceeccccccccCCCCCCc
Confidence 988643 234678899999999999999999999999999999999987 889999999998754332111 1122346
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCC--CCCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPP--QISRSVSV 1046 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~--~ip~~l~~ 1046 (1181)
..|+|||++.++..+...|+ ||+|+++|++++ |..||.+.......... ......+.
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di--------------------~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 217 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDV--------------------WSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQ 217 (250)
T ss_pred ccccCHHHhccCCCCchhHH--------------------HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 67999999976654443333 999999999998 99999876654321111 11112334
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNTNL 1075 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~~~ 1075 (1181)
..+..+..++.+|+..+|..||+ +.+..
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~-~~~l~ 245 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPK-FSELQ 245 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCC-HHHHH
Confidence 56788999999999999999975 44433
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=281.23 Aligned_cols=242 Identities=23% Similarity=0.316 Sum_probs=188.7
Q ss_pred eeecccCceEEEEEEEcC-----CCeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeec
Q psy14556 811 IELGKGSYGVVYAARELD-----RQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQV 884 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~-----tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~ 884 (1181)
..||+|++|.||+|.+.. ++..|++|.+...... ....+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 12 ~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 91 (277)
T cd05036 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELM 91 (277)
T ss_pred eECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecC
Confidence 369999999999999877 7789999988654332 2356889999999999999999999999888999999999
Q ss_pred CCCCcccchhcccC----CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccC--CCeeeeecCCccccccc
Q psy14556 885 PGGSLSTLLRVKWG----PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTY--SGVVKISDFGTSKRLAG 958 (1181)
Q Consensus 885 ~gGSL~dlL~~~~~----~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~--~g~vKLiDFGlAk~l~~ 958 (1181)
++++|.+++..... ...+++..+..++.||+.||+|||+++++||||||+||+++.. +..+||+|||+++.+..
T Consensus 92 ~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~ 171 (277)
T cd05036 92 AGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR 171 (277)
T ss_pred CCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCC
Confidence 99999999875421 2357888999999999999999999999999999999999762 23699999999987632
Q ss_pred CCCC--CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCccccc
Q psy14556 959 LCPS--AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALV 1035 (1181)
Q Consensus 959 ~~~~--~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~ 1035 (1181)
.... ......+..|+|||++.+..++..+|+ ||+||++|+|++ |..||.+.+...+.
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di--------------------wslG~il~el~~~g~~pf~~~~~~~~~ 231 (277)
T cd05036 172 ASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDV--------------------WSFGVLLWEIFSLGYMPYPGRTNQEVM 231 (277)
T ss_pred ccceecCCCCCccHhhCCHHHHhcCCcCchhHH--------------------HHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 2111 112223568999999976654444443 999999999997 99999887654432
Q ss_pred CCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1036 APPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1036 ~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
.... .....+...+..+..++.+|+..+|..||+..+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~ 270 (277)
T cd05036 232 EFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFAT 270 (277)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 2111 111223456778889999999999999986444
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=279.39 Aligned_cols=244 Identities=23% Similarity=0.291 Sum_probs=189.6
Q ss_pred eecccCceEEEEEEEcCCC------eEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeec
Q psy14556 812 ELGKGSYGVVYAARELDRQ------VKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQV 884 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg------~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~ 884 (1181)
.||+|+||.||+|++.... +.+++|.+..... .....+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 4899999999999876543 7899998865432 34567899999999999999999999999999999999999
Q ss_pred CCCCcccchhccc----CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCC-----eeeeecCCcccc
Q psy14556 885 PGGSLSTLLRVKW----GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSG-----VVKISDFGTSKR 955 (1181)
Q Consensus 885 ~gGSL~dlL~~~~----~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g-----~vKLiDFGlAk~ 955 (1181)
++++|.+++.... ....+++..+..++.|++.||+|||+++++|+||||+||+++. ++ .++|+|||++..
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~-~~~~~~~~~~l~dfg~~~~ 160 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSE-KGYDADRVVKIGDFGLARD 160 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEec-CCCCCCcceEECCcccccc
Confidence 9999999987532 1234678888999999999999999999999999999999987 55 899999999876
Q ss_pred cccCCC--CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q psy14556 956 LAGLCP--SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSR 1032 (1181)
Q Consensus 956 l~~~~~--~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~ 1032 (1181)
...... ......++..|+|||.+.++..+..+|+ ||||+++|+|++ |+.||...+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv--------------------~slG~il~ellt~g~~p~~~~~~~ 220 (269)
T cd05044 161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDV--------------------WSFGVLMWEILTLGQQPYPALNNQ 220 (269)
T ss_pred cccccccccCcccCCCccccCHHHHccCCcccchhH--------------------HHHHHHHHHHHHcCCCCCcccCHH
Confidence 543211 1112345678999999987655444444 999999999998 99999876654
Q ss_pred cccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHh
Q psy14556 1033 ALVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVC 1077 (1181)
Q Consensus 1033 ~l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~a 1077 (1181)
....... .....+...+..+..++.+|+..+|..||. +++....
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~-~~~i~~~ 266 (269)
T cd05044 221 EVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPT-FDRIQEI 266 (269)
T ss_pred HHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCC-HHHHHHH
Confidence 4322111 111223345778889999999999999996 4444433
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=277.17 Aligned_cols=251 Identities=26% Similarity=0.344 Sum_probs=192.0
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhc-CCCCeeeEccccccCC------cE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEG------YF 877 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~------~l 877 (1181)
.|.+. ..||+|++|.||+|.+..+++.+++|++..... ..+.+.+|+.+++++ +||||+++++++.... .+
T Consensus 7 ~y~~~-~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 7 IFELV-EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred heehe-eeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 34443 479999999999999998999999999875543 346789999999999 7999999999986544 58
Q ss_pred EEEEeecCCCCcccchhccc-CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccccc
Q psy14556 878 KIFMEQVPGGSLSTLLRVKW-GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956 (1181)
Q Consensus 878 ~LVmEy~~gGSL~dlL~~~~-~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l 956 (1181)
++||||+++++|.+++.... ....+++..++.++.|++.||.|||++|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~-~~~~~l~d~~~~~~~ 163 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTK-NAEVKLVDFGVSAQL 163 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEcc-CCeEEECCCccceec
Confidence 99999999999999987532 2346788999999999999999999999999999999999998 899999999998766
Q ss_pred ccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC
Q psy14556 957 AGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA 1036 (1181)
Q Consensus 957 ~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~ 1036 (1181)
...........++..|+|||++...... .... +...+.||+|+++|+|++|+.||..........
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~--------------~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 228 (275)
T cd06608 164 DSTLGRRNTFIGTPYWMAPEVIACDEQP-DASY--------------DARSDVWSLGITAIELADGKPPLCDMHPMRALF 228 (275)
T ss_pred ccchhhhcCccccccccCHhHhcccccc-cCCc--------------cccccHHHhHHHHHHHHhCCCCccccchHHHHH
Confidence 5433334445689999999998643211 1111 122233999999999999999998654322111
Q ss_pred C--CCCCCCC--CCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1037 P--PQISRSV--SVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1037 ~--~~ip~~l--~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
. ...+... ....+..+..++.+|+..+|..||+..+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~l 269 (275)
T cd06608 229 KIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEEL 269 (275)
T ss_pred HhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHH
Confidence 1 0011111 11256678899999999999999975443
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=286.36 Aligned_cols=247 Identities=21% Similarity=0.298 Sum_probs=191.4
Q ss_pred eeecccCceEEEEEEEc-------CCCeEEEEEEecCCC-CCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEE
Q psy14556 811 IELGKGSYGVVYAAREL-------DRQVKLAIKEIPEKN-LGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFM 881 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~-------~tg~~VAIKii~~~~-~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVm 881 (1181)
..||+|+||.||+|++. ..+..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...+..+++|
T Consensus 21 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 100 (304)
T cd05101 21 KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 100 (304)
T ss_pred ceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEE
Confidence 47999999999999753 234579999986543 23356789999999999 8999999999999999999999
Q ss_pred eecCCCCcccchhcccC-------------CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeee
Q psy14556 882 EQVPGGSLSTLLRVKWG-------------PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKIS 948 (1181)
Q Consensus 882 Ey~~gGSL~dlL~~~~~-------------~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLi 948 (1181)
||+++++|.+++..... ...+++..+..++.||+.||.|||++|++||||||+||+++. ++.+||+
T Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~-~~~~kl~ 179 (304)
T cd05101 101 EYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTE-NNVMKIA 179 (304)
T ss_pred ecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcC-CCcEEEC
Confidence 99999999999875421 134667788899999999999999999999999999999987 8899999
Q ss_pred cCCcccccccCCCC--CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCC
Q psy14556 949 DFGTSKRLAGLCPS--AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAA 1025 (1181)
Q Consensus 949 DFGlAk~l~~~~~~--~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~P 1025 (1181)
|||.++........ .....+++.|+|||++.+..++..+ |+ ||+|+++|+|++ |..|
T Consensus 180 D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~--Di------------------~slG~~l~el~~~g~~p 239 (304)
T cd05101 180 DFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS--DV------------------WSFGVLMWEIFTLGGSP 239 (304)
T ss_pred CCccceecccccccccccCCCCCceeeCchhhccCCCCchh--hH------------------HHHHHHHHHHHcCCCCC
Confidence 99999876532221 1223356789999999765443333 33 999999999998 7899
Q ss_pred CCCCCcccccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcc
Q psy14556 1026 LKKKTSRALVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTG 1079 (1181)
Q Consensus 1026 F~~~~~~~l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~ 1079 (1181)
|.+.+..++..... .....+...+..+..++.+|+..+|..||+ +.+.+..+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps-~~e~l~~l~ 294 (304)
T cd05101 240 YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPT-FKQLVEDLD 294 (304)
T ss_pred cccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCC-HHHHHHHHH
Confidence 98876655432111 111223456778889999999999999995 555444443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=276.23 Aligned_cols=241 Identities=26% Similarity=0.373 Sum_probs=194.2
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
+.||+|+||.||++.+..++..+|+|.+..... ...+.+.+|+.+++.++||||+++++.+.+.+..++++||+++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (257)
T cd08225 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGD 85 (257)
T ss_pred EEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCc
Confidence 469999999999999999999999999965422 334678899999999999999999999999999999999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|.+++... ....+++..+..++.|++.||.|||+.+++|+||||+||+++..+..+||+|||.+..............|
T Consensus 86 L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 164 (257)
T cd08225 86 LMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVG 164 (257)
T ss_pred HHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccccccCC
Confidence 99998754 23356889999999999999999999999999999999999874456899999999876544333334568
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCC--CCCCCCCC
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPP--QISRSVSV 1046 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~--~ip~~l~~ 1046 (1181)
++.|+|||++.+...+..+|+ ||+|+++|+|++|..||...+........ ........
T Consensus 165 ~~~~~ape~~~~~~~~~~~Dv--------------------~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (257)
T cd08225 165 TPYYLSPEICQNRPYNNKTDI--------------------WSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISP 224 (257)
T ss_pred CccccCHHHHcCCCCCchhhH--------------------HHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCC
Confidence 999999999875543333333 99999999999999999876654432111 11122234
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
..+..+..++.+|+..+|..||+..+
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~ 250 (257)
T cd08225 225 NFSRDLRSLISQLFKVSPRDRPSITS 250 (257)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHH
Confidence 55678899999999999999996433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-30 Score=273.85 Aligned_cols=240 Identities=26% Similarity=0.350 Sum_probs=191.8
Q ss_pred eeecccCceEEEEEEEcCCC----eEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 811 IELGKGSYGVVYAARELDRQ----VKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg----~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
+.||.|+||.||++++...+ ..||+|.+...... ..+.+.+|+.+++.++||||+++++++.+.+..+++|||++
T Consensus 5 ~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~ 84 (258)
T smart00219 5 KKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYME 84 (258)
T ss_pred ceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccC
Confidence 36999999999999998766 89999999766443 46789999999999999999999999999999999999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCc-
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAE- 964 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~- 964 (1181)
+++|.+++.... ...+++..++.++.|++.||++||+.|++|+||||+||+++. ++.++|+|||++...........
T Consensus 85 ~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~ 162 (258)
T smart00219 85 GGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGE-NLVVKISDFGLSRDLYDDDYYKKK 162 (258)
T ss_pred CCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEcc-CCeEEEcccCCceecccccccccc
Confidence 999999997542 222789999999999999999999999999999999999998 88999999999977654321111
Q ss_pred cccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--CC
Q psy14556 965 TFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--IS 1041 (1181)
Q Consensus 965 t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--ip 1041 (1181)
...+++.|+|||.+.+...+..+|+ ||+|+++|+|++ |..||...+...+..... ..
T Consensus 163 ~~~~~~~y~~Pe~~~~~~~~~~~Di--------------------~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~ 222 (258)
T smart00219 163 GGKLPIRWMAPESLKDGKFTSKSDV--------------------WSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR 222 (258)
T ss_pred cCCCcccccChHHhccCCCCcchhH--------------------HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC
Confidence 1236789999999965544444443 999999999998 789998765544321111 11
Q ss_pred CCCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1042 RSVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1042 ~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
...+...+..+..++.+|+..+|..||+..+
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 253 (258)
T smart00219 223 LPKPENCPPEIYKLMLQCWAEDPEDRPTFSE 253 (258)
T ss_pred CCCCCcCCHHHHHHHHHHCcCChhhCcCHHH
Confidence 1122346778888999999999999996433
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-30 Score=279.89 Aligned_cols=240 Identities=21% Similarity=0.284 Sum_probs=185.9
Q ss_pred eecccCceEEEEEEEcCCCe--EEEEEEecCCCC-CChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQV--KLAIKEIPEKNL-GDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~--~VAIKii~~~~~-~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.||+|+||.||+|++..++. .+++|.+..... ...+.+.+|+.++.++ +||||+++++++...+..+++|||++++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 58999999999999887765 468888864332 2346788999999999 8999999999999999999999999999
Q ss_pred Ccccchhccc-------------CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccc
Q psy14556 888 SLSTLLRVKW-------------GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954 (1181)
Q Consensus 888 SL~dlL~~~~-------------~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk 954 (1181)
+|.+++.... ....+++..++.++.|++.||+|||++|++||||||+||+++. ++.+||+|||++.
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~-~~~~kl~dfgl~~ 160 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE-NYVAKIADFGLSR 160 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcC-CCeEEECCCCCcc
Confidence 9999987432 1124678899999999999999999999999999999999988 8999999999985
Q ss_pred ccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q psy14556 955 RLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRA 1033 (1181)
Q Consensus 955 ~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~ 1033 (1181)
..... ........+..|+|||++.+...+.. .|+ ||||+++|+|++ |..||.+.+...
T Consensus 161 ~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~--~Di------------------~slG~il~el~~~g~~pf~~~~~~~ 219 (270)
T cd05047 161 GQEVY-VKKTMGRLPVRWMAIESLNYSVYTTN--SDV------------------WSYGVLLWEIVSLGGTPYCGMTCAE 219 (270)
T ss_pred ccchh-hhccCCCCccccCChHHHccCCCCch--hhH------------------HHHHHHHHHHHcCCCCCccccCHHH
Confidence 43211 11111224567999999865543333 333 999999999997 999998766544
Q ss_pred ccCCC--CCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1034 LVAPP--QISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1034 l~~~~--~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
..... ......+...+..+..++.+|+..+|..||+..+.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 261 (270)
T cd05047 220 LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 261 (270)
T ss_pred HHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 32211 11112233456778899999999999999975544
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=318.20 Aligned_cols=242 Identities=25% Similarity=0.337 Sum_probs=202.8
Q ss_pred eeecccCceEEEEEEEc-----CCCeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeec
Q psy14556 811 IELGKGSYGVVYAAREL-----DRQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQV 884 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~-----~tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~ 884 (1181)
++||+|+||+||+|+.. .....||||.++..... ..++|++|++++..++|||||+++|+|.+++.+++|+|||
T Consensus 492 ~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm 571 (774)
T KOG1026|consen 492 EELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYM 571 (774)
T ss_pred hhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEec
Confidence 36999999999999853 34467999999877665 6789999999999999999999999999999999999999
Q ss_pred CCCCcccchhccc-------C----CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcc
Q psy14556 885 PGGSLSTLLRVKW-------G----PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTS 953 (1181)
Q Consensus 885 ~gGSL~dlL~~~~-------~----~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlA 953 (1181)
..|+|.++|+... . +.+++..+.+.|+.||+.|+.||-++.+|||||..+|+|+.+ +..|||+|||++
T Consensus 572 ~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge-~l~VKIsDfGLs 650 (774)
T KOG1026|consen 572 DHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGE-NLVVKISDFGLS 650 (774)
T ss_pred ccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceecc-ceEEEecccccc
Confidence 9999999997432 1 234788999999999999999999999999999999999988 889999999999
Q ss_pred cccccC-CCC-CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCC
Q psy14556 954 KRLAGL-CPS-AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKT 1030 (1181)
Q Consensus 954 k~l~~~-~~~-~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~ 1030 (1181)
+.+-+. ... .....-..+|||||.|..++++..+|| ||+||+|||+++ |+.||.+.+
T Consensus 651 RdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDV--------------------Ws~GVvLWEIFsyG~QPy~glS 710 (774)
T KOG1026|consen 651 RDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDV--------------------WSFGVVLWEIFSYGKQPYYGLS 710 (774)
T ss_pred hhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhh--------------------hhhhhhhhhhhccccCcccccc
Confidence 865321 111 112334679999999998877766666 999999999998 899999999
Q ss_pred cccccCCCCCCC--CCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1031 SRALVAPPQISR--SVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1031 ~~~l~~~~~ip~--~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
..+.+..++-.+ +.+..+|..+.+++..|+...|.+||++-+-
T Consensus 711 n~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 711 NQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred hHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 888655444222 2345789999999999999999999975444
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=281.24 Aligned_cols=239 Identities=19% Similarity=0.190 Sum_probs=185.4
Q ss_pred eeecccCceEEEEEEEcCCCe----EEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 811 IELGKGSYGVVYAARELDRQV----KLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~----~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
++||+|+||+||+|.+..++. .||+|.+...... ..+.+.+|+.+++.++||||+++++++... ..++++||++
T Consensus 13 ~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~ 91 (279)
T cd05109 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMP 91 (279)
T ss_pred eecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCC
Confidence 369999999999999877665 4899998654332 356788999999999999999999988754 5789999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC--C
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS--A 963 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~--~ 963 (1181)
+|+|.+++... ...+++..+..++.|++.||+|||++||+||||||+||+++. ++.+||+|||+++........ .
T Consensus 92 ~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~-~~~~kL~dfG~~~~~~~~~~~~~~ 168 (279)
T cd05109 92 YGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKS-PNHVKITDFGLARLLDIDETEYHA 168 (279)
T ss_pred CCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC-CCcEEECCCCceeecccccceeec
Confidence 99999998753 235778899999999999999999999999999999999987 789999999999876532221 1
Q ss_pred ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--C
Q psy14556 964 ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--I 1040 (1181)
Q Consensus 964 ~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--i 1040 (1181)
....++..|+|||.+.+...+..+| + ||+||++|||++ |..||.......+..... .
T Consensus 169 ~~~~~~~~y~~PE~~~~~~~~~~~D--i------------------~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~ 228 (279)
T cd05109 169 DGGKVPIKWMALESILHRRFTHQSD--V------------------WSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE 228 (279)
T ss_pred CCCccchhhCCHHHhccCCCCchhH--H------------------HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC
Confidence 1223467899999997654433333 3 999999999998 899998765543211111 1
Q ss_pred CCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1041 SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1041 p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
....+...+..+..++.+|+..+|..||+..+.
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l 261 (279)
T cd05109 229 RLPQPPICTIDVYMIMVKCWMIDSECRPRFREL 261 (279)
T ss_pred cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 111233466778889999999999999875554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-30 Score=285.88 Aligned_cols=242 Identities=22% Similarity=0.293 Sum_probs=188.3
Q ss_pred ceeecccCceEEEEEEEc-----CCCeEEEEEEecCCCC-CChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEe
Q psy14556 810 RIELGKGSYGVVYAAREL-----DRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~-----~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmE 882 (1181)
..+||+|+||.||++.+. .++..||+|.++.... ...+.+.+|+.+++++ +||||+++++++...+..+++||
T Consensus 40 ~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 119 (302)
T cd05055 40 GKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITE 119 (302)
T ss_pred cceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEE
Confidence 347999999999999752 3456899999875532 2346789999999999 79999999999999999999999
Q ss_pred ecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC
Q psy14556 883 QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS 962 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~ 962 (1181)
|+++++|.++++... ...+++..+..++.|++.||+|||+++|+|+||||+||+++. ++.++|+|||+++.+......
T Consensus 120 ~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~-~~~~~l~dfg~~~~~~~~~~~ 197 (302)
T cd05055 120 YCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTH-GKIVKICDFGLARDIMNDSNY 197 (302)
T ss_pred cCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcC-CCeEEECCCcccccccCCCce
Confidence 999999999997542 233789999999999999999999999999999999999987 889999999999765432211
Q ss_pred --CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCccccc-C--
Q psy14556 963 --AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALV-A-- 1036 (1181)
Q Consensus 963 --~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~-~-- 1036 (1181)
.....++..|+|||.+.++..+..+|+ ||+|+++|+|++ |..||.+....... .
T Consensus 198 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di--------------------wslGvil~el~t~g~~p~~~~~~~~~~~~~~ 257 (302)
T cd05055 198 VVKGNARLPVKWMAPESIFNCVYTFESDV--------------------WSYGILLWEIFSLGSNPYPGMPVDSKFYKLI 257 (302)
T ss_pred eecCCCCcccccCCHhhhccCCCCcHhHH--------------------HHHHHHHHHHHhCCCCCcCCCCchHHHHHHH
Confidence 112345778999999976654443333 999999999998 99999876643211 0
Q ss_pred CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1037 PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1037 ~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
........+...+..+..++.+|+..+|..||+..+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~el 294 (302)
T cd05055 258 KEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294 (302)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 0111112223456778899999999999999864433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=277.10 Aligned_cols=234 Identities=28% Similarity=0.380 Sum_probs=190.6
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 813 IG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
||.|+||.||++.+..+++.+++|.+..... ...+.+.+|+.++++++||||+++++.+...+..|++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999998899999999976543 3456789999999999999999999999999999999999999999
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC--------
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP-------- 961 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~-------- 961 (1181)
.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++. ++.++|+|||++........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDS-NGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcC-CCCEEEEecccchhcccCcccccccccc
Confidence 9999754 26789999999999999999999999999999999999998 89999999999875443211
Q ss_pred CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCC---
Q psy14556 962 SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPP--- 1038 (1181)
Q Consensus 962 ~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~--- 1038 (1181)
......++..|+|||...+...+...|+ ||+|+++|++++|..||............
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv--------------------~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~ 216 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDW--------------------WSLGCILYEFLVGIPPFHGETPEEIFQNILNG 216 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhh--------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Confidence 2223457889999999976554333333 99999999999999999877665432111
Q ss_pred CCCCCCCCCCCcchHHhhccCCCCCCCCCchh
Q psy14556 1039 QISRSVSVPGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1039 ~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
..+.......+..+..++.+|+..+|..||+.
T Consensus 217 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~ 248 (265)
T cd05579 217 KIEWPEDVEVSDEAIDLISKLLVPDPEKRLGA 248 (265)
T ss_pred CcCCCccccCCHHHHHHHHHHhcCCHhhcCCC
Confidence 11111111237788999999999999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-30 Score=280.94 Aligned_cols=238 Identities=19% Similarity=0.204 Sum_probs=183.1
Q ss_pred eecccCceEEEEEEEcCCCe----EEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCC
Q psy14556 812 ELGKGSYGVVYAARELDRQV----KLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~----~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
.||+|+||+||+|.+..++. .+++|.+..... ...+.+..|+.++++++||||+++++++.. ...++++||+++
T Consensus 14 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~ 92 (279)
T cd05111 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPL 92 (279)
T ss_pred ccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCC
Confidence 69999999999999877765 477787754322 224567788889999999999999998764 457899999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC--CCc
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP--SAE 964 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~--~~~ 964 (1181)
|+|.+++... ...+++..+..++.||+.||.|||++|++||||||+||+++. ++.+||+|||.++....... ...
T Consensus 93 gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~-~~~~kl~Dfg~~~~~~~~~~~~~~~ 169 (279)
T cd05111 93 GSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKS-DSIVQIADFGVADLLYPDDKKYFYS 169 (279)
T ss_pred CcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcC-CCcEEEcCCccceeccCCCcccccC
Confidence 9999999754 235778899999999999999999999999999999999987 88999999999976543221 122
Q ss_pred cccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--CC
Q psy14556 965 TFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--IS 1041 (1181)
Q Consensus 965 t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--ip 1041 (1181)
...++..|+|||.+.++.++..+|+ ||+|+++||+++ |..||.+.....+..... ..
T Consensus 170 ~~~~~~~y~~pE~~~~~~~~~~~Dv--------------------~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~ 229 (279)
T cd05111 170 EHKTPIKWMALESILFGRYTHQSDV--------------------WSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGER 229 (279)
T ss_pred CCCCcccccCHHHhccCCcCchhhH--------------------HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCc
Confidence 3346778999999976654444443 999999999998 999998876543211111 00
Q ss_pred CCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1042 RSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1042 ~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
...+...+..+..++.+|+..+|..||+..+.
T Consensus 230 ~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el 261 (279)
T cd05111 230 LAQPQICTIDVYMVMVKCWMIDENVRPTFKEL 261 (279)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 11122345567778999999999999975444
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-30 Score=286.00 Aligned_cols=248 Identities=20% Similarity=0.289 Sum_probs=189.7
Q ss_pred ceeecccCceEEEEEEEcC-------CCeEEEEEEecCCCC-CChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEE
Q psy14556 810 RIELGKGSYGVVYAARELD-------RQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIF 880 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~-------tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LV 880 (1181)
..+||+|+||.||+|.+.. ....+|+|.+..... .....+.+|+.+++++ +||||+++++++.+.+..+++
T Consensus 17 ~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 96 (314)
T cd05099 17 GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVI 96 (314)
T ss_pred eeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEE
Confidence 4479999999999997632 345799999875432 2345688999999999 699999999999999999999
Q ss_pred EeecCCCCcccchhcccC-------------CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeee
Q psy14556 881 MEQVPGGSLSTLLRVKWG-------------PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKI 947 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~~-------------~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKL 947 (1181)
|||+++|+|.+++..... ...+++..+..++.|++.||.|||++|++||||||+||+++. ++.+||
T Consensus 97 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~-~~~~kL 175 (314)
T cd05099 97 VEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTE-DNVMKI 175 (314)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcC-CCcEEE
Confidence 999999999999975321 234678888999999999999999999999999999999987 889999
Q ss_pred ecCCcccccccCCCCC--ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCC
Q psy14556 948 SDFGTSKRLAGLCPSA--ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTA 1024 (1181)
Q Consensus 948 iDFGlAk~l~~~~~~~--~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~ 1024 (1181)
+|||.++......... ....++..|+|||++.++..+..+| + ||+|+++|+|++ |..
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D--i------------------wslG~~l~el~~~g~~ 235 (314)
T cd05099 176 ADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSD--V------------------WSFGILMWEIFTLGGS 235 (314)
T ss_pred ccccccccccccccccccccCCCCccccCHHHHccCCcCccch--h------------------hHHHHHHHHHHhCCCC
Confidence 9999997664322111 1122456799999997654433333 3 999999999999 899
Q ss_pred CCCCCCcccccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcc
Q psy14556 1025 ALKKKTSRALVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTG 1079 (1181)
Q Consensus 1025 PF~~~~~~~l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~ 1079 (1181)
||.+.+...+..... .....+...+..+..++.+|+..+|..||+ +++.+..+.
T Consensus 236 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-~~~ll~~l~ 291 (314)
T cd05099 236 PYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPT-FKQLVEALD 291 (314)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcC-HHHHHHHHH
Confidence 998876544322111 111223455677889999999999999995 455444443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=281.98 Aligned_cols=244 Identities=23% Similarity=0.270 Sum_probs=189.8
Q ss_pred eeecccCceEEEEEEEcCCC----------------eEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEcccccc
Q psy14556 811 IELGKGSYGVVYAARELDRQ----------------VKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSE 873 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg----------------~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d 873 (1181)
++||+|+||.||+|.+...+ ..||+|.+..... ...+.+.+|+.++++++||||+++++++..
T Consensus 11 ~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 90 (296)
T cd05051 11 EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTV 90 (296)
T ss_pred ccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEec
Confidence 36999999999999876533 5689999875533 235678899999999999999999999999
Q ss_pred CCcEEEEEeecCCCCcccchhccc--------CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCee
Q psy14556 874 EGYFKIFMEQVPGGSLSTLLRVKW--------GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVV 945 (1181)
Q Consensus 874 ~~~l~LVmEy~~gGSL~dlL~~~~--------~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~v 945 (1181)
++..+++||++++++|.+++.... ....+++..++.++.|++.||+|||++|++|+||||+||+++. ++.+
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~-~~~~ 169 (296)
T cd05051 91 DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK-NYTI 169 (296)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecC-CCce
Confidence 999999999999999999987542 1225789999999999999999999999999999999999988 7999
Q ss_pred eeecCCcccccccCCC--CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh--
Q psy14556 946 KISDFGTSKRLAGLCP--SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-- 1021 (1181)
Q Consensus 946 KLiDFGlAk~l~~~~~--~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-- 1021 (1181)
+|+|||+++....... ......++..|+|||.+.++..+..+|+ ||+|+++|+|++
T Consensus 170 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv--------------------~slG~~l~el~~~~ 229 (296)
T cd05051 170 KIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDV--------------------WAFGVTLWEILTLC 229 (296)
T ss_pred EEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchh--------------------hhhHHHHHHHHhcC
Confidence 9999999876543221 1223346778999999976554444443 999999999998
Q ss_pred CCCCCCCCCcccccCC---------CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHH
Q psy14556 1022 LTAALKKKTSRALVAP---------PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLV 1076 (1181)
Q Consensus 1022 Gk~PF~~~~~~~l~~~---------~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~ 1076 (1181)
|..||...+...+... .......+...+..+..++.+|++.+|..||+ +.+...
T Consensus 230 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt-~~el~~ 292 (296)
T cd05051 230 REQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPT-FREIHL 292 (296)
T ss_pred CCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCC-HHHHHH
Confidence 7788887654432110 01111122345678899999999999999996 444443
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=279.08 Aligned_cols=241 Identities=26% Similarity=0.341 Sum_probs=188.5
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhc-CCCCeeeEcccccc------CCcEEEEEee
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSE------EGYFKIFMEQ 883 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d------~~~l~LVmEy 883 (1181)
++||.|+||.||+|++..+++.+|+|++..... ....+..|+.+++++ +||||+++++++.. .+..+++|||
T Consensus 22 ~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~ 100 (282)
T cd06636 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEF 100 (282)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEe
Confidence 379999999999999999999999999865432 345688899999998 79999999998843 4678999999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCC
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA 963 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~ 963 (1181)
+++++|.+++... ....+++..++.++.||+.||.|||++||+|+||||+||+++. ++.++|+|||++..........
T Consensus 101 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~-~~~~~l~dfg~~~~~~~~~~~~ 178 (282)
T cd06636 101 CGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLDRTVGRR 178 (282)
T ss_pred CCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC-CCCEEEeeCcchhhhhccccCC
Confidence 9999999998754 2335678888999999999999999999999999999999987 8899999999987664333333
Q ss_pred ccccCCccccCchhhccCC---CCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC---C
Q psy14556 964 ETFTGTLQYMAPEVIDKGQ---RGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA---P 1037 (1181)
Q Consensus 964 ~t~~GT~~Y~APEvl~gg~---~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~---~ 1037 (1181)
....|+..|+|||++.... ..++...|+ ||+|+++|+|++|+.||.......... .
T Consensus 179 ~~~~~~~~y~aPE~l~~~~~~~~~~~~~~Dv------------------wslG~~l~el~~g~~p~~~~~~~~~~~~~~~ 240 (282)
T cd06636 179 NTFIGTPYWMAPEVIACDENPDATYDYRSDI------------------WSLGITAIEMAEGAPPLCDMHPMRALFLIPR 240 (282)
T ss_pred CcccccccccCHhhcCcccCcCcCCCcccch------------------hHHHHHHHHHHhCCCCccccCHHhhhhhHhh
Confidence 4456899999999985321 122222333 999999999999999997665433211 1
Q ss_pred CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1038 PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1038 ~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
...+.......+..+..++.+|+..+|..||..-+
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~e 275 (282)
T cd06636 241 NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQ 275 (282)
T ss_pred CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHH
Confidence 11111222245778889999999999999997433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=282.43 Aligned_cols=239 Identities=23% Similarity=0.323 Sum_probs=193.5
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
++||+|+||.||++.+..++..|++|.+........+.+.+|+.+++.++||||+++++.+...+..|+|+||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 104 (293)
T cd06647 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT 104 (293)
T ss_pred eEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHH
Confidence 46999999999999998899999999987655555677899999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCc
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL 970 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~ 970 (1181)
+++... .+++..+..++.|++.||.|||++|++|+||||+||+++. ++.++|+|||++..............+++
T Consensus 105 ~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~-~~~~kL~dfg~~~~~~~~~~~~~~~~~~~ 179 (293)
T cd06647 105 DVVTET----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQITPEQSKRSTMVGTP 179 (293)
T ss_pred HHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcC-CCCEEEccCcceecccccccccccccCCh
Confidence 998743 4678888999999999999999999999999999999987 88999999998876654333333456889
Q ss_pred cccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCCCCC----CCCC
Q psy14556 971 QYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQISR----SVSV 1046 (1181)
Q Consensus 971 ~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~ip~----~l~~ 1046 (1181)
.|+|||.+.++..+...|+ ||+|+++|++++|+.||...+............ ..+.
T Consensus 180 ~y~~PE~~~~~~~~~~~Dv--------------------~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd06647 180 YWMAPEVVTRKAYGPKVDI--------------------WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPE 239 (293)
T ss_pred hhcCchhhccCCCCchhhH--------------------HHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCcc
Confidence 9999999976544333333 999999999999999998766533221111111 1122
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
..+..+..++.+|+..+|..||...+..
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il 267 (293)
T cd06647 240 KLSAIFRDFLNRCLEMDVEKRGSAKELL 267 (293)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 3456788899999999999998754443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=275.68 Aligned_cols=246 Identities=22% Similarity=0.291 Sum_probs=192.3
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeec
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQV 884 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~ 884 (1181)
+|.+. .+||+|+||.||+|.+. .++.+++|.+..... ..+.+.+|+.++++++||||+++++++......+++|||+
T Consensus 7 ~~~i~-~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 7 SLKLE-RKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred heeee-eeeccCcceEEEEEEEc-CCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 34443 37999999999999875 457799999875433 3567999999999999999999999999889999999999
Q ss_pred CCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC-CC
Q psy14556 885 PGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP-SA 963 (1181)
Q Consensus 885 ~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~-~~ 963 (1181)
++++|.+++... ....+++..+..++.|++.||.|||++|++|+||||+||+++. ++.+||+|||.+........ ..
T Consensus 84 ~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~-~~~~~l~d~g~~~~~~~~~~~~~ 161 (261)
T cd05034 84 SKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGE-NLVCKIADFGLARLIEDDEYTAR 161 (261)
T ss_pred CCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcC-CCCEEECccccceeccchhhhhh
Confidence 999999999754 3345788899999999999999999999999999999999988 89999999999876643211 11
Q ss_pred ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCC--CC
Q psy14556 964 ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPP--QI 1040 (1181)
Q Consensus 964 ~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~--~i 1040 (1181)
....++..|+|||.+.+...+..+|+ ||+|+++|++++ |+.||.+.+........ ..
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~Di--------------------~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~ 221 (261)
T cd05034 162 EGAKFPIKWTAPEAANYGRFTIKSDV--------------------WSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY 221 (261)
T ss_pred hccCCCccccCHHHhccCCcCchhHH--------------------HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 12234568999999976554443333 999999999998 99999876654322111 11
Q ss_pred CCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHH
Q psy14556 1041 SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLV 1076 (1181)
Q Consensus 1041 p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~ 1076 (1181)
....+...+..+..++.+|+..+|..||. +++...
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~-~~~l~~ 256 (261)
T cd05034 222 RMPRPPNCPEELYDLMLQCWDKDPEERPT-FEYLQS 256 (261)
T ss_pred CCCCCCCCCHHHHHHHHHHcccCcccCCC-HHHHHH
Confidence 22233445778899999999999999995 444433
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=295.10 Aligned_cols=242 Identities=25% Similarity=0.345 Sum_probs=203.3
Q ss_pred HHhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC--hhHHHHHHHHHHhcCCCCeeeEccccccCCcEE
Q psy14556 801 RFLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD--VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFK 878 (1181)
Q Consensus 801 ~~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~--~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~ 878 (1181)
++...|.+++ -||+|.|+.|-+|++..+|..||||++.+..... ...+.+|+..|+.++|||||++|++...+..+|
T Consensus 15 kIAGLYDLek-TlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly 93 (864)
T KOG4717|consen 15 KIAGLYDLEK-TLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY 93 (864)
T ss_pred ceeeeehhhh-hhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEE
Confidence 3445556655 4999999999999999999999999998876654 356899999999999999999999999999999
Q ss_pred EEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccccccc
Q psy14556 879 IFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 958 (1181)
Q Consensus 879 LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~ 958 (1181)
||+|+-.+|+|.+++-++ ...+.+..+.+++.||+.|+.|+|+..+|||||||+|+.+-+.-|.+||.|||++-.+..
T Consensus 94 LiLELGD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EEEEecCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 999999999999999865 345779999999999999999999999999999999999877689999999999987765
Q ss_pred CCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc----
Q psy14556 959 LCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL---- 1034 (1181)
Q Consensus 959 ~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l---- 1034 (1181)
. ....+.+|+..|-|||++.|..+ ....||+ ||||+|||.|+.|++||+..+..+.
T Consensus 172 G-~kL~TsCGSLAYSAPEILLGDsY-DAPAVDi------------------WSLGVILyMLVCGq~PFqeANDSETLTmI 231 (864)
T KOG4717|consen 172 G-KKLTTSCGSLAYSAPEILLGDSY-DAPAVDI------------------WSLGVILYMLVCGQPPFQEANDSETLTMI 231 (864)
T ss_pred c-chhhcccchhhccCchhhhcCcc-CCcchhh------------------hHHHHHHHHHHhCCCccccccchhhhhhh
Confidence 3 55677899999999999987643 3455666 9999999999999999999887663
Q ss_pred -cCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1035 -VAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1035 -~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
..+..+|..+ ......+|++++..||.+|-+
T Consensus 232 mDCKYtvPshv----S~eCrdLI~sMLvRdPkkRAs 263 (864)
T KOG4717|consen 232 MDCKYTVPSHV----SKECRDLIQSMLVRDPKKRAS 263 (864)
T ss_pred hcccccCchhh----hHHHHHHHHHHHhcCchhhcc
Confidence 2233344443 344556777888888888875
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=288.16 Aligned_cols=249 Identities=20% Similarity=0.286 Sum_probs=191.5
Q ss_pred ceeecccCceEEEEEEEcCC-------CeEEEEEEecCCCC-CChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEE
Q psy14556 810 RIELGKGSYGVVYAARELDR-------QVKLAIKEIPEKNL-GDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIF 880 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~t-------g~~VAIKii~~~~~-~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LV 880 (1181)
..+||+|+||.||+|++... +..||+|.+..... ...+.+.+|+.+++++ +||||+++++++...+..+++
T Consensus 17 ~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 96 (334)
T cd05100 17 GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVL 96 (334)
T ss_pred cceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEE
Confidence 34799999999999986432 24789998865432 2356789999999999 899999999999999999999
Q ss_pred EeecCCCCcccchhccc-------------CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeee
Q psy14556 881 MEQVPGGSLSTLLRVKW-------------GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKI 947 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~-------------~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKL 947 (1181)
|||+++|+|.+++.... ....+++..+..++.|++.||.|||++|++||||||+||+++. ++.+||
T Consensus 97 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~-~~~~kL 175 (334)
T cd05100 97 VEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE-DNVMKI 175 (334)
T ss_pred EecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC-CCcEEE
Confidence 99999999999987532 1224667788889999999999999999999999999999987 789999
Q ss_pred ecCCcccccccCCCC--CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCC
Q psy14556 948 SDFGTSKRLAGLCPS--AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTA 1024 (1181)
Q Consensus 948 iDFGlAk~l~~~~~~--~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~ 1024 (1181)
+|||+++........ .....++..|+|||++.+..++..+| + ||+|+++|+|++ |..
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D--i------------------~slG~il~el~~~g~~ 235 (334)
T cd05100 176 ADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD--V------------------WSFGVLLWEIFTLGGS 235 (334)
T ss_pred CCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhh--h------------------HHHHHHHHHHHhcCCC
Confidence 999999765432211 11223456799999997654443333 3 999999999998 889
Q ss_pred CCCCCCcccccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1025 ALKKKTSRALVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1025 PF~~~~~~~l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
||.+.+...+..... .....+...+..+..++.+|+..+|..||. +.+.+..+..
T Consensus 236 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-~~ell~~l~~ 292 (334)
T cd05100 236 PYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPT-FKQLVEDLDR 292 (334)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcC-HHHHHHHHHH
Confidence 998877655422111 112223455678889999999999999984 5665555554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-30 Score=278.00 Aligned_cols=240 Identities=20% Similarity=0.218 Sum_probs=188.0
Q ss_pred eeecccCceEEEEEEEcCCCe---EEEEEEecCCC-CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCC
Q psy14556 811 IELGKGSYGVVYAARELDRQV---KLAIKEIPEKN-LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~---~VAIKii~~~~-~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
.+||+|+||.||+|.+..++. .+++|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (268)
T cd05063 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMEN 90 (268)
T ss_pred eEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCC
Confidence 479999999999999876554 79999986553 22356788999999999999999999999999999999999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcc-
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAET- 965 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t- 965 (1181)
++|.+++... ...+++..+..++.|++.||+|||+.|++|+||||+||+++. ++.+||+|||++............
T Consensus 91 ~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~-~~~~kl~dfg~~~~~~~~~~~~~~~ 167 (268)
T cd05063 91 GALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNS-NLECKVSDFGLSRVLEDDPEGTYTT 167 (268)
T ss_pred CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcC-CCcEEECCCccceecccccccceec
Confidence 9999998753 235678889999999999999999999999999999999987 889999999998765432221111
Q ss_pred --ccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--C
Q psy14556 966 --FTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--I 1040 (1181)
Q Consensus 966 --~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--i 1040 (1181)
...+..|+|||++.++..+.. .|+ ||+|+++|+|++ |+.||...+...+..... .
T Consensus 168 ~~~~~~~~y~~PE~~~~~~~~~~--~Dv------------------~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~ 227 (268)
T cd05063 168 SGGKIPIRWTAPEAIAYRKFTSA--SDV------------------WSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF 227 (268)
T ss_pred cCCCcCceecCHHHhhcCCcChH--hHH------------------HHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC
Confidence 123457999999975543333 333 999999999998 999998766544322111 1
Q ss_pred CCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1041 SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1041 p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
..+.....+..+..++.+|+..+|..||...+.
T Consensus 228 ~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i 260 (268)
T cd05063 228 RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDI 260 (268)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 222233567788899999999999999964443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=279.03 Aligned_cols=239 Identities=21% Similarity=0.287 Sum_probs=184.2
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
++||+|+||.||+|.+..+++.|++|.++.... .....+.+|+.++++++||||+++++++.+.+..++++||++ ++
T Consensus 6 ~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~ 84 (284)
T cd07839 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QD 84 (284)
T ss_pred EEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CC
Confidence 369999999999999999999999999965432 223567889999999999999999999999999999999996 57
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|.+++... ...+++..++.++.||++||.|||++|++||||||+||+++. ++.+||+|||+++.............+
T Consensus 85 l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~ 161 (284)
T cd07839 85 LKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINK-NGELKLADFGLARAFGIPVRCYSAEVV 161 (284)
T ss_pred HHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcC-CCcEEECccchhhccCCCCCCcCCCcc
Confidence 77776543 235789999999999999999999999999999999999998 899999999999866543333333457
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCc-ccc-------------
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTS-RAL------------- 1034 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~-~~l------------- 1034 (1181)
+..|+|||++.+.. .++...|+ ||+|+++|+|+||+.||..... ...
T Consensus 162 ~~~y~aPE~~~~~~-~~~~~~Di------------------wslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 222 (284)
T cd07839 162 TLWYRPPDVLFGAK-LYSTSIDM------------------WSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 222 (284)
T ss_pred ccCCcChHHHhCCc-ccCcHHHH------------------HHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence 89999999986532 22333333 9999999999999988643322 110
Q ss_pred ------cC------CCCCCC-----CCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1035 ------VA------PPQISR-----SVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1035 ------~~------~~~ip~-----~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
.. .+..+. ...+..+..+..++.+|+..+|.+||+..+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ 277 (284)
T cd07839 223 ESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEE 277 (284)
T ss_pred HHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHH
Confidence 00 000000 111234566778999999999999996443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=273.03 Aligned_cols=239 Identities=31% Similarity=0.411 Sum_probs=195.6
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
+.||+|++|.||+|.+..+++.|++|++..... ...+.+.+|+..+.+++||||+++++++...+..++||||+++++|
T Consensus 7 ~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 86 (264)
T cd06623 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSL 86 (264)
T ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcH
Confidence 469999999999999999999999999976644 3456799999999999999999999999999999999999999999
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccc-cceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHG-QKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs-~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
.+++... ..+++..++.++.|++.||.|||+ +|++|+||+|+||+++. ++.++|+|||.+..............+
T Consensus 87 ~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~ 162 (264)
T cd06623 87 ADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINS-KGEVKIADFGISKVLENTLDQCNTFVG 162 (264)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECC-CCCEEEccCccceecccCCCcccceee
Confidence 9999753 467899999999999999999999 99999999999999988 899999999999877654433334568
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCc---ccccCC--CCCCCC
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTS---RALVAP--PQISRS 1043 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~---~~l~~~--~~ip~~ 1043 (1181)
+..|+|||.+.+...+..+|+ |++|+++|+|++|+.||..... ..+... ......
T Consensus 163 ~~~y~~pE~~~~~~~~~~~Dv--------------------~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 222 (264)
T cd06623 163 TVTYMSPERIQGESYSYAADI--------------------WSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS 222 (264)
T ss_pred cccccCHhhhCCCCCCchhhH--------------------HHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCC
Confidence 899999999876644333333 9999999999999999988752 111110 011111
Q ss_pred CCCC-CCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1044 VSVP-GPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1044 l~~~-~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.... .+..+..++++|+..+|..||...+.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l 253 (264)
T cd06623 223 LPAEEFSPEFRDFISACLQKDPKKRPSAAEL 253 (264)
T ss_pred CCcccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 2223 67789999999999999999964443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-31 Score=290.39 Aligned_cols=238 Identities=29% Similarity=0.425 Sum_probs=201.2
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
++||+|+||.||+|.++.+|..+|||.++.. .+.+++..|+.||++++.|++|++||.+.....+|+|||||..|+..
T Consensus 39 ~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiS 116 (502)
T KOG0574|consen 39 GKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSIS 116 (502)
T ss_pred HHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHH
Confidence 4799999999999999999999999998655 46788999999999999999999999999899999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCc
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL 970 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~ 970 (1181)
++++.+ ..++.+..+..+++..++||+|||...-+|||||..|||++. +|..||+|||.+..+.+.-....+..|||
T Consensus 117 DI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT-~G~AKLADFGVAGQLTDTMAKRNTVIGTP 193 (502)
T KOG0574|consen 117 DIMRAR--RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNT-DGIAKLADFGVAGQLTDTMAKRNTVIGTP 193 (502)
T ss_pred HHHHHh--cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcc-cchhhhhhccccchhhhhHHhhCccccCc
Confidence 999865 457889999999999999999999999999999999999998 89999999999988877666667788999
Q ss_pred cccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc-ccCCCCCC-CCC--CC
Q psy14556 971 QYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA-LVAPPQIS-RSV--SV 1046 (1181)
Q Consensus 971 ~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~-l~~~~~ip-~~l--~~ 1046 (1181)
.|||||++..- +|....| .||||++..||..|++||....+.. +..-+.-| ... +.
T Consensus 194 FWMAPEVI~EI--GY~~~AD------------------IWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE 253 (502)
T KOG0574|consen 194 FWMAPEVIEEI--GYDTKAD------------------IWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPE 253 (502)
T ss_pred ccccHHHHHHh--ccchhhh------------------HhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChH
Confidence 99999999743 3333333 3999999999999999999887643 22222211 111 22
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.+...+...+..|+-+.|..|-+..++
T Consensus 254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L 280 (502)
T KOG0574|consen 254 EWSSEFNDFIRSCLIKKPEERKTALRL 280 (502)
T ss_pred hhhhHHHHHHHHHhcCCHHHHHHHHHH
Confidence 456677889999999999999875555
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=274.98 Aligned_cols=239 Identities=23% Similarity=0.274 Sum_probs=191.9
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
..||.|+||.||+|.. .++.||+|.+..... ..+++.+|+.+++.++|+||+++++++.+.+..++||||+++++|.
T Consensus 12 ~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 88 (256)
T cd05039 12 ATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLV 88 (256)
T ss_pred eeeecCCCceEEEEEe--cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHH
Confidence 3699999999999987 478899999976644 4577999999999999999999999999899999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCc
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL 970 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~ 970 (1181)
+++... ....+++..++.++.|++.||.|||++|++|+||||+||+++. ++.+||+|||.++....... ....+.
T Consensus 89 ~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~-~~~~~l~d~g~~~~~~~~~~---~~~~~~ 163 (256)
T cd05039 89 DYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSE-DLVAKVSDFGLAKEASQGQD---SGKLPV 163 (256)
T ss_pred HHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeC-CCCEEEcccccccccccccc---cCCCcc
Confidence 999754 2335789999999999999999999999999999999999987 88999999999987643211 223466
Q ss_pred cccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCC--CCCCCCCCC
Q psy14556 971 QYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPP--QISRSVSVP 1047 (1181)
Q Consensus 971 ~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~--~ip~~l~~~ 1047 (1181)
.|+|||.+.++..+.. .|+ ||+|+++|+|++ |..||...+...+.... ......+..
T Consensus 164 ~~~ape~~~~~~~~~~--~Di------------------~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 223 (256)
T cd05039 164 KWTAPEALREKKFSTK--SDV------------------WSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEG 223 (256)
T ss_pred cccCchhhcCCcCCcH--HHH------------------HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccC
Confidence 8999999876544333 333 999999999997 99999887665432111 112223345
Q ss_pred CCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1048 GPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1048 ~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
.+..+..++.+|+..+|.+||.. .+.+..+
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rp~~-~~l~~~l 253 (256)
T cd05039 224 CPPEVYKVMKDCWELDPAKRPTF-KQLREQL 253 (256)
T ss_pred CCHHHHHHHHHHhccChhhCcCH-HHHHHHH
Confidence 67889999999999999999864 4444433
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-30 Score=274.10 Aligned_cols=241 Identities=26% Similarity=0.361 Sum_probs=194.1
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEcccccc--CCcEEEEEeecCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSE--EGYFKIFMEQVPG 886 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d--~~~l~LVmEy~~g 886 (1181)
..||.|+||.||++.+..++..+++|.+..... ...+.+.+|+.++++++||||+++++++.. ....+++|||+++
T Consensus 6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~ 85 (265)
T cd08217 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEG 85 (265)
T ss_pred eeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccC
Confidence 369999999999999999999999999865433 234568899999999999999999997753 4568999999999
Q ss_pred CCcccchhccc-CCCCCChHHHHHHHHHHHhhhhhcc-----ccceecccCCCCCcccccCCCeeeeecCCcccccccCC
Q psy14556 887 GSLSTLLRVKW-GPLKENESTMSFYTKQILEGLKYLH-----GQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC 960 (1181)
Q Consensus 887 GSL~dlL~~~~-~~~~l~e~~i~~Ia~QIa~AL~yLH-----s~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~ 960 (1181)
++|.+++.... ....+++..++.++.||+.||.||| +.+++|+||||+||+++. ++.+||+|||++.......
T Consensus 86 ~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~-~~~~kl~d~g~~~~~~~~~ 164 (265)
T cd08217 86 GDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDA-NNNVKLGDFGLAKILGHDS 164 (265)
T ss_pred CCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEec-CCCEEEecccccccccCCc
Confidence 99999987531 2346788999999999999999999 999999999999999997 8999999999998776544
Q ss_pred CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-
Q psy14556 961 PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ- 1039 (1181)
Q Consensus 961 ~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~- 1039 (1181)
.......+++.|+|||.+.+...+..+|+ ||+|+++|+|++|+.||...+...+.....
T Consensus 165 ~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv--------------------~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 224 (265)
T cd08217 165 SFAKTYVGTPYYMSPEQLNHMSYDEKSDI--------------------WSLGCLIYELCALSPPFTARNQLQLASKIKE 224 (265)
T ss_pred ccccccccCCCccChhhhcCCCCCchhHH--------------------HHHHHHHHHHHHCCCcccCcCHHHHHHHHhc
Confidence 32344568999999999976554333333 999999999999999999876544322111
Q ss_pred -CCCCCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1040 -ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1040 -ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
.....+...+..+..++.+|+..+|..||...+
T Consensus 225 ~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~ 258 (265)
T cd08217 225 GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEE 258 (265)
T ss_pred CCCCCCccccCHHHHHHHHHHccCCcccCCCHHH
Confidence 112233456678889999999999999996443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-30 Score=278.13 Aligned_cols=240 Identities=21% Similarity=0.247 Sum_probs=187.9
Q ss_pred eeecccCceEEEEEEEcCCC---eEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCC
Q psy14556 811 IELGKGSYGVVYAARELDRQ---VKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg---~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
..||+|+||.||+|.+..++ ..+|+|.++.... ...+.+.+|+.++++++||||+++++++..++..++||||+++
T Consensus 10 ~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (267)
T cd05066 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMEN 89 (267)
T ss_pred eeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCC
Confidence 47999999999999876443 4799999865432 2346789999999999999999999999999999999999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCc--
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAE-- 964 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~-- 964 (1181)
++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++. ++.++|+|||++...........
T Consensus 90 ~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~ 166 (267)
T cd05066 90 GSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNS-NLVCKVSDFGLSRVLEDDPEAAYTT 166 (267)
T ss_pred CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECC-CCeEEeCCCCcccccccccceeeec
Confidence 9999999754 235678889999999999999999999999999999999987 88999999999987654322111
Q ss_pred -cccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--C
Q psy14556 965 -TFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--I 1040 (1181)
Q Consensus 965 -t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--i 1040 (1181)
...++..|+|||.+.++..+...|+ ||+|+++|++++ |..||......+...... .
T Consensus 167 ~~~~~~~~y~~pe~~~~~~~~~~~Dv--------------------~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~ 226 (267)
T cd05066 167 RGGKIPIRWTAPEAIAYRKFTSASDV--------------------WSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY 226 (267)
T ss_pred CCCccceeecCHhHhccCccCchhhh--------------------HHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCC
Confidence 1223568999999976554443333 999999999886 999998766543211111 1
Q ss_pred CCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1041 SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1041 p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
....+...+..+..++.+|+..+|..||+..+.
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 259 (267)
T cd05066 227 RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQI 259 (267)
T ss_pred cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHH
Confidence 112233457788999999999999999964433
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-30 Score=278.60 Aligned_cols=240 Identities=20% Similarity=0.243 Sum_probs=188.0
Q ss_pred ceeecccCceEEEEEEEcCCCe---EEEEEEecCCC-CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 810 RIELGKGSYGVVYAARELDRQV---KLAIKEIPEKN-LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~---~VAIKii~~~~-~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
.+.||+|+||.||+|.+..+++ .||+|.+.... ....+.+..|+.++++++||||+++++++.+++..++||||++
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T cd05065 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFME 88 (269)
T ss_pred EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCC
Confidence 3469999999999999876654 69999986542 2235679999999999999999999999999999999999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCC--
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA-- 963 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~-- 963 (1181)
+++|.+++... ...+++..++.++.|++.||.|||++|++|+||||+||+++. ++.+||+|||++..........
T Consensus 89 ~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~-~~~~kl~dfg~~~~~~~~~~~~~~ 165 (269)
T cd05065 89 NGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNS-NLVCKVSDFGLSRFLEDDTSDPTY 165 (269)
T ss_pred CCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcC-CCcEEECCCccccccccCcccccc
Confidence 99999998754 235678889999999999999999999999999999999987 8899999999987654322111
Q ss_pred -cccc--CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCC-
Q psy14556 964 -ETFT--GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPP- 1038 (1181)
Q Consensus 964 -~t~~--GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~- 1038 (1181)
.... .+..|+|||.+.++..+..+|+ ||+|+++||+++ |..||...+........
T Consensus 166 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv--------------------wslG~~l~e~l~~g~~p~~~~~~~~~~~~i~ 225 (269)
T cd05065 166 TSSLGGKIPIRWTAPEAIAYRKFTSASDV--------------------WSYGIVMWEVMSYGERPYWDMSNQDVINAIE 225 (269)
T ss_pred ccccCCCcceeecCHhHhccCcccchhhh--------------------hhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 1111 2457999999976554433333 999999999986 99999876654322111
Q ss_pred -CCCCCCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1039 -QISRSVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1039 -~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
......+...+..+..++.+|+.++|..||...+
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 260 (269)
T cd05065 226 QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQ 260 (269)
T ss_pred cCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 1111223456778899999999999999997543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-30 Score=286.29 Aligned_cols=235 Identities=27% Similarity=0.353 Sum_probs=189.4
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
+.||+|+||.||++.+..+++.|++|.+..... ...+.+.+|+.+++.++||||+++++.+..++.+++||||++|+
T Consensus 7 ~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~ 86 (305)
T cd05609 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGG 86 (305)
T ss_pred eEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCC
Confidence 369999999999999999999999999875532 23456889999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC-------
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC------- 960 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~------- 960 (1181)
+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++. ++.+||+|||+++......
T Consensus 87 ~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~-~~~~~l~dfg~~~~~~~~~~~~~~~~ 162 (305)
T cd05609 87 DCATLLKNI---GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITS-MGHIKLTDFGLSKIGLMSLTTNLYEG 162 (305)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECC-CCCEEEeeCCCccccCcCcccccccc
Confidence 999999743 35788889999999999999999999999999999999987 8999999999886321000
Q ss_pred --------CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc
Q psy14556 961 --------PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR 1032 (1181)
Q Consensus 961 --------~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~ 1032 (1181)
.......++..|+|||.+.+...+.. .|+ ||+|+++|+|++|..||.+.+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~--~Di------------------~slG~vl~el~~g~~pf~~~~~~ 222 (305)
T cd05609 163 HIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKP--VDW------------------WAMGIILYEFLVGCVPFFGDTPE 222 (305)
T ss_pred ccccchhhccccCCccCccccCchhccCCCCCch--hhH------------------HHHHHHHHHHHhCCCCCCCCCHH
Confidence 00112347889999999876544333 333 99999999999999999887655
Q ss_pred cccCCC-----CCCCCCCCCCCcchHHhhccCCCCCCCCCchh
Q psy14556 1033 ALVAPP-----QISRSVSVPGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1033 ~l~~~~-----~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
++.... ..+.. ....+..+..++.+|+..+|..||++
T Consensus 223 ~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~~~ 264 (305)
T cd05609 223 ELFGQVISDDIEWPEG-DEALPADAQDLISRLLRQNPLERLGT 264 (305)
T ss_pred HHHHHHHhcccCCCCc-cccCCHHHHHHHHHHhccChhhccCc
Confidence 432211 11111 12467778999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=298.61 Aligned_cols=236 Identities=31% Similarity=0.411 Sum_probs=192.2
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.||.|+||.||-|++..+.+.||||.+..... ..++.+..|+.+|++++|||++.+-|+|..+...|+||||| -|+
T Consensus 33 EIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lGS 111 (948)
T KOG0577|consen 33 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LGS 111 (948)
T ss_pred HhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hcc
Confidence 59999999999999999999999999975533 34678999999999999999999999999999999999999 677
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
-.+++... ..++.+..+..|..+.+.||+|||+.+.||||||..|||++. .|.|||+|||.+..... ..+++|
T Consensus 112 AsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse-~g~VKLaDFGSAsi~~P----AnsFvG 184 (948)
T KOG0577|consen 112 ASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSE-PGLVKLADFGSASIMAP----ANSFVG 184 (948)
T ss_pred HHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecC-CCeeeeccccchhhcCc----hhcccC
Confidence 78887754 346778899999999999999999999999999999999988 89999999999976543 356789
Q ss_pred CccccCchhhccCCC-CCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc---cCCCCCCCCC
Q psy14556 969 TLQYMAPEVIDKGQR-GYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL---VAPPQISRSV 1044 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~-~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l---~~~~~ip~~l 1044 (1181)
||+|||||++....- .|...||+ ||||++..|+.-.++|+...+...- ++....|...
T Consensus 185 TPywMAPEVILAMDEGqYdgkvDv------------------WSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLq 246 (948)
T KOG0577|consen 185 TPYWMAPEVILAMDEGQYDGKVDV------------------WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ 246 (948)
T ss_pred CccccchhHheeccccccCCccce------------------eeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCC
Confidence 999999999963221 23444444 9999999999999999877665331 2223333333
Q ss_pred CCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1045 SVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1045 ~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
+..+...+...+..|+.+-|..||++...
T Consensus 247 s~eWS~~F~~Fvd~CLqKipqeRptse~l 275 (948)
T KOG0577|consen 247 SNEWSDYFRNFVDSCLQKIPQERPTSEEL 275 (948)
T ss_pred CchhHHHHHHHHHHHHhhCcccCCcHHHH
Confidence 55667777777777777777777765544
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=280.18 Aligned_cols=233 Identities=23% Similarity=0.302 Sum_probs=181.4
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCC---hhHHHHHHHHHHh---cCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD---VQPLHEEIKLHSQ---LRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~---~e~f~rEi~IL~~---L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
.||+|+||.||++.+..+++.+|+|.+.+..... ...+.+|..+++. .+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 3899999999999999999999999996553321 2234445444433 479999999999999999999999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcc
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAET 965 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t 965 (1181)
+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++. ++.++|+|||++...... ....
T Consensus 81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~-~~~~~l~dfg~~~~~~~~--~~~~ 154 (279)
T cd05633 81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDE-HGHVRISDLGLACDFSKK--KPHA 154 (279)
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECC-CCCEEEccCCcceecccc--CccC
Confidence 99999888743 35789999999999999999999999999999999999987 889999999998765432 2223
Q ss_pred ccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc---c-CCCCCC
Q psy14556 966 FTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL---V-APPQIS 1041 (1181)
Q Consensus 966 ~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l---~-~~~~ip 1041 (1181)
..|+..|+|||.+.++. .++...|+ ||+||++|+|++|..||........ . .....+
T Consensus 155 ~~~~~~y~aPE~~~~~~-~~~~~~Di------------------~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 215 (279)
T cd05633 155 SVGTHGYMAPEVLQKGT-AYDSSADW------------------FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVN 215 (279)
T ss_pred cCCCcCccCHHHhcCCC-CCCchhhh------------------HHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCC
Confidence 46899999999986322 12222333 9999999999999999986543221 1 111122
Q ss_pred CCCCCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1042 RSVSVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1042 ~~l~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
...+...+..+..++.+|+..+|.+|+.
T Consensus 216 ~~~~~~~~~~~~~li~~~l~~~p~~R~~ 243 (279)
T cd05633 216 VELPDSFSPELKSLLEGLLQRDVSKRLG 243 (279)
T ss_pred cCCccccCHHHHHHHHHHhcCCHHHhcC
Confidence 3334456778888999999999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=278.00 Aligned_cols=252 Identities=24% Similarity=0.286 Sum_probs=188.9
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhc-CCCCeeeEccccc-----cCCcE
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQYLGSVS-----EEGYF 877 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~-----d~~~l 877 (1181)
..|...+ .||+|+||.||+|.+..+++.+|+|++.... ...+.+.+|+.+++.+ +||||+++++++. ..+.+
T Consensus 18 ~~~~~~~-~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 18 DTWEIIE-TIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred cceeeee-eeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 3444433 6999999999999999999999999886432 2235688899999999 7999999999873 44679
Q ss_pred EEEEeecCCCCcccchhcc-cCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccccc
Q psy14556 878 KIFMEQVPGGSLSTLLRVK-WGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956 (1181)
Q Consensus 878 ~LVmEy~~gGSL~dlL~~~-~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l 956 (1181)
++||||+++++|.+++... .....+++..++.++.|++.||.|||+++++||||||+||+++. ++.+||+|||++...
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~-~~~~kl~dfg~~~~~ 174 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTT-EGGVKLVDFGVSAQL 174 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECC-CCCEEEccCCceeec
Confidence 9999999999999887632 12345778889999999999999999999999999999999988 788999999999776
Q ss_pred ccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC
Q psy14556 957 AGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA 1036 (1181)
Q Consensus 957 ~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~ 1036 (1181)
...........|++.|+|||++..... ... .++...+.||+||++|+|++|+.||..........
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~--------------~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~ 239 (286)
T cd06638 175 TSTRLRRNTSVGTPFWMAPEVIACEQQ-LDS--------------TYDARCDVWSLGITAIELGDGDPPLADLHPMRALF 239 (286)
T ss_pred ccCCCccccccCCCcccChhhhchhhh-ccc--------------cccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh
Confidence 543333334568999999999853221 000 01122233999999999999999998765433211
Q ss_pred CCC--C-C-CCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1037 PPQ--I-S-RSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1037 ~~~--i-p-~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
... . + ...+...+..+..++.+|+..+|..||. +.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~~el 280 (286)
T cd06638 240 KIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPT-VSDL 280 (286)
T ss_pred hccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCC-HHHH
Confidence 111 0 1 1112224556888999999999999986 4443
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=275.09 Aligned_cols=247 Identities=21% Similarity=0.254 Sum_probs=181.4
Q ss_pred eecccCceEEEEEEEc--CCCeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 812 ELGKGSYGVVYAAREL--DRQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~--~tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.||+|+||.||+|... .++..+++|.+...... ....+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 5999999999999864 34568999988655432 23468889999999999999999999999999999999999999
Q ss_pred cccchhccc--CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC--CCc
Q psy14556 889 LSTLLRVKW--GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP--SAE 964 (1181)
Q Consensus 889 L~dlL~~~~--~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~--~~~ 964 (1181)
|.+++.... .....++..+..++.|++.||+|||++|++|+||||+||+++. ++.+||+|||.++....... ...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~-~~~~kL~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTA-DLTVKIGDYGLSHNKYKEDYYVTPD 160 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcC-CCcEEECCccccccccCcceeecCC
Confidence 999987532 2234566777889999999999999999999999999999988 88999999999865433211 112
Q ss_pred cccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccC------C
Q psy14556 965 TFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVA------P 1037 (1181)
Q Consensus 965 t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~------~ 1037 (1181)
...++..|+|||++.+...... ...+....+.||+|+++|+|++ |+.||......+... .
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~-------------~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 227 (269)
T cd05087 161 QLWVPLRWIAPELVDEVHGNLL-------------VVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQ 227 (269)
T ss_pred CcCCcccccCHhHhcccccccc-------------ccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhccc
Confidence 2346788999999864321100 0011222333999999999996 999998765443210 1
Q ss_pred CCCC-CCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1038 PQIS-RSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1038 ~~ip-~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
...+ .......+..+..++.+|+ .+|..||+..+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l 263 (269)
T cd05087 228 LKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEV 263 (269)
T ss_pred CCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHH
Confidence 1111 1122245566777888888 689999974443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=274.10 Aligned_cols=236 Identities=33% Similarity=0.497 Sum_probs=187.1
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC------ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeec
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG------DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQV 884 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~------~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~ 884 (1181)
..||+|+||.||+|.. .+++.+|+|.+...... ..+.+.+|+.++++++|+||+++++++.+.+..+++|||+
T Consensus 6 ~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (265)
T cd06631 6 EVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFV 84 (265)
T ss_pred ceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecC
Confidence 4699999999999986 47789999998654321 1356889999999999999999999999999999999999
Q ss_pred CCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccC-----
Q psy14556 885 PGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGL----- 959 (1181)
Q Consensus 885 ~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~----- 959 (1181)
++++|.+++... ..+++..++.++.|++.||+|||+.||+|+||+|+||+++. ++.++|+|||.+......
T Consensus 85 ~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~~~~~~~~ 160 (265)
T cd06631 85 PGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMP-NGIIKLIDFGCARRLAWVGLHGT 160 (265)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECC-CCeEEeccchhhHhhhhcccccc
Confidence 999999999753 24678889999999999999999999999999999999987 899999999998765321
Q ss_pred -CCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc---
Q psy14556 960 -CPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV--- 1035 (1181)
Q Consensus 960 -~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~--- 1035 (1181)
........++..|+|||++.+...+..+ |+ ||+|+++|+|++|..||...+.....
T Consensus 161 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~--Dv------------------~slG~~~~~l~~g~~p~~~~~~~~~~~~~ 220 (265)
T cd06631 161 HSNMLKSMHGTPYWMAPEVINESGYGRKS--DI------------------WSIGCTVFEMATGKPPLASMDRLAAMFYI 220 (265)
T ss_pred ccccccccCCCccccChhhhcCCCCcchh--hH------------------HHHHHHHHHHHhCCCccccCChHHHHHHh
Confidence 1112234588999999999765433333 33 99999999999999999875543211
Q ss_pred -CCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1036 -APPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1036 -~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
.........+...+..+..++++|+..+|..||...
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~ 257 (265)
T cd06631 221 GAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSAL 257 (265)
T ss_pred hhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHH
Confidence 110111223445677888899999999999998643
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=283.74 Aligned_cols=238 Identities=26% Similarity=0.337 Sum_probs=195.6
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCC---hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD---VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~---~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
+||+|.||+|.+++.+.+++.+|||++++...-. ...-..|-++|+..+||.+..+-..|+..+++|+||||..||.
T Consensus 175 vLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGe 254 (516)
T KOG0690|consen 175 VLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGE 254 (516)
T ss_pred HhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCce
Confidence 5999999999999999999999999998875543 3445678899999999999999999999999999999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|.-+|.. ...+++...+.+..+|+.||.|||+++||+||||.+|+|+|. +|++||+|||+++.--.......+++|
T Consensus 255 Lf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDk-DGHIKitDFGLCKE~I~~g~t~kTFCG 330 (516)
T KOG0690|consen 255 LFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDK-DGHIKITDFGLCKEEIKYGDTTKTFCG 330 (516)
T ss_pred Eeeehhh---hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheecc-CCceEeeecccchhcccccceeccccC
Confidence 9988874 346788999999999999999999999999999999999998 999999999999866555566788999
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc-----cCCCCCCCC
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL-----VAPPQISRS 1043 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l-----~~~~~ip~~ 1043 (1181)
||.|.|||++... .|+..||. |.+|+++|||+.|+.||...+...+ .....+|+.
T Consensus 331 TPEYLAPEVleDn--DYgraVDW------------------WG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ 390 (516)
T KOG0690|consen 331 TPEYLAPEVLEDN--DYGRAVDW------------------WGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRT 390 (516)
T ss_pred ChhhcCchhhccc--cccceeeh------------------hhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCcc
Confidence 9999999999744 45555654 6799999999999999998876553 345567776
Q ss_pred CCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1044 VSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1044 l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
+++.....|.-++.+.|.++-.--|..+.+
T Consensus 391 ls~eAktLLsGLL~kdP~kRLGgGpdDakE 420 (516)
T KOG0690|consen 391 LSPEAKTLLSGLLKKDPKKRLGGGPDDAKE 420 (516)
T ss_pred CCHHHHHHHHHHhhcChHhhcCCCchhHHH
Confidence 666555555544444444333333555555
|
|
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-30 Score=295.94 Aligned_cols=235 Identities=23% Similarity=0.333 Sum_probs=191.4
Q ss_pred ccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC---hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEee
Q psy14556 807 ALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD---VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQ 883 (1181)
Q Consensus 807 ~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~---~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy 883 (1181)
....++||+||||.||-+.-..||+.+|+|.+.++.... .....+|..||.+++.+.||.+-..|+..+.+|+||..
T Consensus 187 F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtl 266 (591)
T KOG0986|consen 187 FRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTL 266 (591)
T ss_pred eeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEe
Confidence 334558999999999999999999999999996654322 24467899999999999999999999999999999999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCC
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA 963 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~ 963 (1181)
|.||+|.-++... ++..+++..+..++.+|+.||++||+.+||+|||||+|||||+ .|+++|+|+|+|..+....+.
T Consensus 267 MNGGDLkfHiyn~-g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd-~GhvRISDLGLAvei~~g~~~- 343 (591)
T KOG0986|consen 267 MNGGDLKFHIYNH-GNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDD-HGHVRISDLGLAVEIPEGKPI- 343 (591)
T ss_pred ecCCceeEEeecc-CCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeecc-CCCeEeeccceEEecCCCCcc-
Confidence 9999999988866 5578899999999999999999999999999999999999998 999999999999988765443
Q ss_pred ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc----c-----
Q psy14556 964 ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA----L----- 1034 (1181)
Q Consensus 964 ~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~----l----- 1034 (1181)
...+||.+|||||++.++. |+..+|+ |++||+||||+.|+.||....... +
T Consensus 344 ~~rvGT~GYMAPEvl~ne~--Y~~s~Dw------------------f~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~ 403 (591)
T KOG0986|consen 344 RGRVGTVGYMAPEVLQNEV--YDFSPDW------------------FSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL 403 (591)
T ss_pred ccccCcccccCHHHHcCCc--ccCCccH------------------HHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh
Confidence 3448999999999998776 4444444 889999999999999998776532 1
Q ss_pred cCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCc
Q psy14556 1035 VAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRH 1068 (1181)
Q Consensus 1035 ~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp 1068 (1181)
..+...+.. .++....+....+++||.+|-
T Consensus 404 ~~~~ey~~k----FS~eakslc~~LL~Kdp~~RL 433 (591)
T KOG0986|consen 404 EDPEEYSDK----FSEEAKSLCEGLLTKDPEKRL 433 (591)
T ss_pred cchhhcccc----cCHHHHHHHHHHHccCHHHhc
Confidence 223334433 344444455555556666553
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=277.86 Aligned_cols=245 Identities=22% Similarity=0.306 Sum_probs=190.1
Q ss_pred eeecccCceEEEEEEEcCC---CeEEEEEEecCCC-CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCC
Q psy14556 811 IELGKGSYGVVYAARELDR---QVKLAIKEIPEKN-LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~t---g~~VAIKii~~~~-~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
.+||+|+||.||+|.+... ...|++|...... ....+.+.+|+.++++++||||+++++++.+ +..++||||+++
T Consensus 12 ~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~ 90 (270)
T cd05056 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPL 90 (270)
T ss_pred eeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCC
Confidence 4799999999999987544 4578999886554 2345679999999999999999999998876 457899999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCC-cc
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA-ET 965 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~-~t 965 (1181)
++|.+++... ...+++..++.++.|++.||+|||+.|++|+||||+||+++. ++.+||+|||+++......... ..
T Consensus 91 ~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~-~~~~~l~d~g~~~~~~~~~~~~~~~ 167 (270)
T cd05056 91 GELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSS-PDCVKLGDFGLSRYLEDESYYKASK 167 (270)
T ss_pred CcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEec-CCCeEEccCceeeecccccceecCC
Confidence 9999999753 235788999999999999999999999999999999999987 8899999999987665432111 12
Q ss_pred ccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--CCC
Q psy14556 966 FTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--ISR 1042 (1181)
Q Consensus 966 ~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--ip~ 1042 (1181)
..++..|+|||.+.+..++.. .|+ ||+|+++|++++ |..||.+.+..+...... ...
T Consensus 168 ~~~~~~y~aPE~~~~~~~~~~--~Di------------------~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 227 (270)
T cd05056 168 GKLPIKWMAPESINFRRFTSA--SDV------------------WMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL 227 (270)
T ss_pred CCccccccChhhhccCCCCch--hhh------------------HHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC
Confidence 234568999999875544333 333 999999999986 999998876544321111 111
Q ss_pred CCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1043 SVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1043 ~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
..+...+..+..++.+|+..+|..|| ++.++...+..
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~P~~Rp-t~~~~~~~l~~ 264 (270)
T cd05056 228 PMPPNCPPTLYSLMTKCWAYDPSKRP-RFTELKAQLSD 264 (270)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCc-CHHHHHHHHHH
Confidence 23345678899999999999999999 56555555443
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=279.31 Aligned_cols=241 Identities=25% Similarity=0.353 Sum_probs=188.6
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCC-----ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG-----DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~-----~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
+||+|+||.||+|.+..+++.|++|.+...... ....+.+|+.++++++|+||+++++++.+.+..++||||+ +
T Consensus 7 ~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 85 (298)
T cd07841 7 KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-E 85 (298)
T ss_pred eeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-C
Confidence 699999999999999999999999999765433 2345778999999999999999999999999999999999 9
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccc
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF 966 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~ 966 (1181)
++|.+++.... ..+++..++.++.||++||.|||++|++|+||||+||+++. ++.++|+|||++.............
T Consensus 86 ~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~-~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (298)
T cd07841 86 TDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIAS-DGVLKLADFGLARSFGSPNRKMTHQ 162 (298)
T ss_pred CCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcC-CCCEEEccceeeeeccCCCcccccc
Confidence 99999997542 36789999999999999999999999999999999999998 8999999999998766543333334
Q ss_pred cCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCC---------
Q psy14556 967 TGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAP--------- 1037 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~--------- 1037 (1181)
.+++.|+|||.+.+.. .+....|+ ||+||++|+|++|.+||.+.+.......
T Consensus 163 ~~~~~y~aPE~~~~~~-~~~~~~Dv------------------~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 223 (298)
T cd07841 163 VVTRWYRAPELLFGAR-HYGVGVDM------------------WSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPT 223 (298)
T ss_pred ccceeeeCHHHHhCCC-CCCcHHHH------------------HHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCc
Confidence 5688999999885422 22333333 9999999999999888876554221000
Q ss_pred -----------CCCC---------CCCCCCCCcchHHhhccCCCCCCCCCchhHHHHH
Q psy14556 1038 -----------PQIS---------RSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNL 1075 (1181)
Q Consensus 1038 -----------~~ip---------~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~ 1075 (1181)
.... .......+..+..++.+|+..+|..||+..+.+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 224 EENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred hhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0000 0011223456677999999999999996444433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=278.14 Aligned_cols=240 Identities=25% Similarity=0.325 Sum_probs=184.7
Q ss_pred CceeecccCceEEEEEE----EcCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccC--CcEEEEE
Q psy14556 809 NRIELGKGSYGVVYAAR----ELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEE--GYFKIFM 881 (1181)
Q Consensus 809 ~~~kIG~G~fG~VYka~----d~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~--~~l~LVm 881 (1181)
....||+|+||+||++. ...++..||+|.+..... ...+.+.+|+.+++.++||||+++++++... ...+++|
T Consensus 8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (283)
T cd05080 8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIM 87 (283)
T ss_pred eceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEe
Confidence 34579999999998865 335678899999975533 2356788999999999999999999987553 4689999
Q ss_pred eecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC
Q psy14556 882 EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP 961 (1181)
Q Consensus 882 Ey~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~ 961 (1181)
||+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||+++.......
T Consensus 88 e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~-~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 88 EYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDN-DRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred cCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcC-CCcEEEeecccccccCCcch
Confidence 999999999998743 4789999999999999999999999999999999999987 78999999999976643221
Q ss_pred C---CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc--ccC
Q psy14556 962 S---AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA--LVA 1036 (1181)
Q Consensus 962 ~---~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~--l~~ 1036 (1181)
. .....++..|+|||.+.+...+.++|+ ||+|+++|+|++|..||....... +..
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di--------------------~slG~~l~el~tg~~p~~~~~~~~~~~~~ 222 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKENKFSYASDV--------------------WSFGVTLYELLTHCDSKQSPPKKFEEMIG 222 (283)
T ss_pred hhccCCCCCCCceeeCHhHhcccCCCccccc--------------------HHHHHHHHHHHhCCCCCCCCcchhhhhhc
Confidence 1 112235677999999976554444433 999999999999999987543211 000
Q ss_pred -C--------------CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1037 -P--------------PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1037 -~--------------~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
. .......+...+..+..++.+|+..+|..||+..+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i 274 (283)
T cd05080 223 PKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSL 274 (283)
T ss_pred ccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHH
Confidence 0 000111233467789999999999999999974443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=277.11 Aligned_cols=245 Identities=19% Similarity=0.255 Sum_probs=192.0
Q ss_pred eecccCceEEEEEEEcC-----CCeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 812 ELGKGSYGVVYAARELD-----RQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~-----tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
.||+|+||.||+|+... +.+.+++|.+...... ..+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 12 ~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 91 (275)
T cd05046 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTD 91 (275)
T ss_pred eecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecC
Confidence 69999999999999754 3467999988655443 35679999999999999999999999999999999999999
Q ss_pred CCCcccchhcccCC------CCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccC
Q psy14556 886 GGSLSTLLRVKWGP------LKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGL 959 (1181)
Q Consensus 886 gGSL~dlL~~~~~~------~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~ 959 (1181)
+++|.+++...... ..+++..+..++.|++.||+|||++||+||||||+||+++. ++.++|+|||.+......
T Consensus 92 ~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~-~~~~~l~~~~~~~~~~~~ 170 (275)
T cd05046 92 LGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSS-QREVKVSLLSLSKDVYNS 170 (275)
T ss_pred CCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeC-CCcEEEcccccccccCcc
Confidence 99999999754321 25789999999999999999999999999999999999988 889999999998654321
Q ss_pred C-CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCC
Q psy14556 960 C-PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAP 1037 (1181)
Q Consensus 960 ~-~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~ 1037 (1181)
. .......++..|+|||.+.+......+|+ ||+|+++|+|++ |..||.......+...
T Consensus 171 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di--------------------~slG~~l~~l~~~~~~p~~~~~~~~~~~~ 230 (275)
T cd05046 171 EYYKLRNALIPLRWLAPEAVQEDDFSTKSDV--------------------WSFGVLMWEVFTQGELPFYGLSDEEVLNR 230 (275)
T ss_pred cccccCCceeEEeecChhhhccCCCCchhhH--------------------HHHHHHHHHHHhCCCCCccccchHHHHHH
Confidence 1 11222346778999999876544433333 999999999999 7889977655443221
Q ss_pred C---CCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1038 P---QISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1038 ~---~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
. ......+...+..+..++.+|+..+|..|| ++.+.+..+
T Consensus 231 ~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp-~~~~~l~~l 273 (275)
T cd05046 231 LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRP-SFSELVSAL 273 (275)
T ss_pred HHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCC-CHHHHHHHh
Confidence 1 122223446778899999999999999998 455555443
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=277.81 Aligned_cols=243 Identities=23% Similarity=0.335 Sum_probs=184.8
Q ss_pred eecccCceEEEEEEE----cCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEcccccc--CCcEEEEEeecC
Q psy14556 812 ELGKGSYGVVYAARE----LDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSE--EGYFKIFMEQVP 885 (1181)
Q Consensus 812 kIG~G~fG~VYka~d----~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d--~~~l~LVmEy~~ 885 (1181)
.||+|+||.||++.. ..+++.||+|.+........+.+.+|+.++++++||||+++++++.. ...+++||||++
T Consensus 11 ~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~ 90 (284)
T cd05081 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLP 90 (284)
T ss_pred eccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecC
Confidence 699999999999974 45788999999876655556788999999999999999999997643 457899999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC---
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS--- 962 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~--- 962 (1181)
+++|.+++... ...+++..++.++.|++.||+|||++|++||||||+||+++. ++.+||+|||++.........
T Consensus 91 ~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~-~~~~~l~dfg~~~~~~~~~~~~~~ 167 (284)
T cd05081 91 YGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVES-ENRVKIGDFGLTKVLPQDKEYYKV 167 (284)
T ss_pred CCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECC-CCeEEECCCcccccccCCCcceee
Confidence 99999998743 235778899999999999999999999999999999999987 889999999999876432211
Q ss_pred CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC--C---
Q psy14556 963 AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA--P--- 1037 (1181)
Q Consensus 963 ~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~--~--- 1037 (1181)
.....++..|+|||++.+...+..+ |+ ||+|+++|||++|..|+.......... .
T Consensus 168 ~~~~~~~~~y~aPE~~~~~~~~~~~--Di------------------~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd05081 168 REPGESPIFWYAPESLTESKFSVAS--DV------------------WSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQ 227 (284)
T ss_pred cCCCCCceEeeCHHHhccCCcChHH--HH------------------HHHHHHHHHHhhcCCcCCCcchhhhhhcccccc
Confidence 1112234569999999765443333 33 999999999999987765433211100 0
Q ss_pred -------------CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1038 -------------PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1038 -------------~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
...........+..+..++.+|+..+|..||+ +++....+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt-~~ei~~~l 280 (284)
T cd05081 228 GQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPS-FSELALQV 280 (284)
T ss_pred cccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCC-HHHHHHHH
Confidence 00011122345678999999999999999985 55554444
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=281.07 Aligned_cols=241 Identities=21% Similarity=0.258 Sum_probs=187.0
Q ss_pred eecccCceEEEEEEEcC-----CCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 812 ELGKGSYGVVYAARELD-----RQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~-----tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
.||+|+||.||+|.+.. ....+++|.+..... ...+.+.+|+.+++.++||||+++++.+...+..+++|||++
T Consensus 7 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 86 (290)
T cd05045 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAK 86 (290)
T ss_pred cccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecC
Confidence 69999999999998753 235789998865433 234678899999999999999999999999999999999999
Q ss_pred CCCcccchhccc---------------------CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCe
Q psy14556 886 GGSLSTLLRVKW---------------------GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGV 944 (1181)
Q Consensus 886 gGSL~dlL~~~~---------------------~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~ 944 (1181)
+++|.+++.... ....+++..++.++.|++.||.|||++|++||||||+||+++. ++.
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~-~~~ 165 (290)
T cd05045 87 YGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAE-GRK 165 (290)
T ss_pred CCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcC-CCc
Confidence 999999876421 1235678889999999999999999999999999999999987 889
Q ss_pred eeeecCCcccccccCCCC--CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-
Q psy14556 945 VKISDFGTSKRLAGLCPS--AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV- 1021 (1181)
Q Consensus 945 vKLiDFGlAk~l~~~~~~--~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT- 1021 (1181)
+||+|||+++........ .....++..|+|||.+.+...+..+ |+ ||+|+++|+|++
T Consensus 166 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~--Di------------------~slG~~l~el~t~ 225 (290)
T cd05045 166 MKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQS--DV------------------WSFGVLLWEIVTL 225 (290)
T ss_pred EEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHh--HH------------------HHHHHHHHHHHhc
Confidence 999999999765332211 1223356789999998655433333 32 999999999998
Q ss_pred CCCCCCCCCcccccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1022 LTAALKKKTSRALVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1022 Gk~PF~~~~~~~l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
|..||.+.....+..... .....+...+..+..++.+|++.+|..||...+.
T Consensus 226 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i 279 (290)
T cd05045 226 GGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279 (290)
T ss_pred CCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 999998876654322111 1122234466788899999999999999864433
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=274.67 Aligned_cols=251 Identities=20% Similarity=0.207 Sum_probs=200.4
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccC-----CcEE
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEE-----GYFK 878 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~-----~~l~ 878 (1181)
+..+...++||+|||+.||++++..+++.+|+|++...+.++.+..++|++..++++|||+++++++...+ ...|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 33444455799999999999999999999999999888777889999999999999999999999987544 3499
Q ss_pred EEEeecCCCCcccchhccc-CCCCCChHHHHHHHHHHHhhhhhccccc--eecccCCCCCcccccCCCeeeeecCCcccc
Q psy14556 879 IFMEQVPGGSLSTLLRVKW-GPLKENESTMSFYTKQILEGLKYLHGQK--IVHRDIKGDNVLVNTYSGVVKISDFGTSKR 955 (1181)
Q Consensus 879 LVmEy~~gGSL~dlL~~~~-~~~~l~e~~i~~Ia~QIa~AL~yLHs~g--IVHrDLKP~NILLd~~~g~vKLiDFGlAk~ 955 (1181)
|+++|...|+|.+.++... ....+++.++..|+.+|++||++||+.. ++||||||.|||+.. ++.++|.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~-~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSD-SGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecC-CCceEEEeccCccc
Confidence 9999999999999987543 3447899999999999999999999998 999999999999987 89999999999865
Q ss_pred cccCCCC---------CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCC
Q psy14556 956 LAGLCPS---------AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAAL 1026 (1181)
Q Consensus 956 l~~~~~~---------~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF 1026 (1181)
..-.-.. ...-..|..|+|||.+.- ...+.++.+.|| |||||+||+|+.|..||
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~v---k~~~ti~ertDI--------------WSLGCtLYa~mf~~sPf 241 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNV---KSHCTITERTDI--------------WSLGCTLYAMMFGESPF 241 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheec---ccCcccccccch--------------hhhhHHHHHHHHcCCcc
Confidence 4311100 011236889999999952 234445554444 99999999999999999
Q ss_pred CCCCcc-----cccCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1027 KKKTSR-----ALVAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1027 ~~~~~~-----~l~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
+..-.. --+...++.-+...+.+..+.+++..|+..||.+||..-+
T Consensus 242 e~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ 292 (302)
T KOG2345|consen 242 ERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPE 292 (302)
T ss_pred hHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHH
Confidence 754331 1222333333334558999999999999999999996433
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=274.47 Aligned_cols=238 Identities=36% Similarity=0.527 Sum_probs=190.0
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC----------ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEE
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG----------DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKI 879 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~----------~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~L 879 (1181)
.+.||.|+||.||+|.+..+++.+|+|.+...... ..+.+.+|+.+++.++||||+++++++...+..++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 85 (272)
T cd06629 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI 85 (272)
T ss_pred cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence 34799999999999999889999999988543111 12457889999999999999999999999999999
Q ss_pred EEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccC
Q psy14556 880 FMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGL 959 (1181)
Q Consensus 880 VmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~ 959 (1181)
||||+++++|.++++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++. ++.++|+|||+++.....
T Consensus 86 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~-~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 86 FLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDA-DGICKISDFGISKKSDDI 161 (272)
T ss_pred EEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcC-CCeEEEeecccccccccc
Confidence 99999999999998754 35778889999999999999999999999999999999987 899999999998765432
Q ss_pred CC--CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc---
Q psy14556 960 CP--SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL--- 1034 (1181)
Q Consensus 960 ~~--~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l--- 1034 (1181)
.. ......++..|+|||.+......++...|+ ||+|+++|++++|..||........
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv------------------~slG~~l~~l~~g~~p~~~~~~~~~~~~ 223 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDI------------------WSLGCVVLEMFAGRRPWSDEEAIAAMFK 223 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchh------------------HHHHHHHHHHHhCCCCCcCcchHHHHHH
Confidence 11 122345888999999987544223333343 9999999999999999976543221
Q ss_pred ----cCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1035 ----VAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1035 ----~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
.....++.......+..+..++.+|+..+|..||+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 262 (272)
T cd06629 224 LGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPT 262 (272)
T ss_pred hhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCC
Confidence 11122333333456778888999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=279.82 Aligned_cols=253 Identities=21% Similarity=0.252 Sum_probs=191.2
Q ss_pred hcccCceeecccCceEEEEEEEcC-----CCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELD-----RQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFK 878 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~-----tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~ 878 (1181)
+|.+. ++||+|+||.||+|.... .+..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 7 ~~~i~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (288)
T cd05061 7 KITLL-RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL 85 (288)
T ss_pred Hceee-eeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 34443 479999999999997642 356899998864432 22345788999999999999999999999999999
Q ss_pred EEEeecCCCCcccchhcccC-------CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCC
Q psy14556 879 IFMEQVPGGSLSTLLRVKWG-------PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFG 951 (1181)
Q Consensus 879 LVmEy~~gGSL~dlL~~~~~-------~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFG 951 (1181)
+||||+++|+|.+++..... ........+..++.|++.||.|||++||+||||||+||+++. ++.++|+|||
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~-~~~~~L~Dfg 164 (288)
T cd05061 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH-DFTVKIGDFG 164 (288)
T ss_pred EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcC-CCcEEECcCC
Confidence 99999999999999975321 233456778889999999999999999999999999999997 8999999999
Q ss_pred cccccccCCCC--CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCC
Q psy14556 952 TSKRLAGLCPS--AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKK 1028 (1181)
Q Consensus 952 lAk~l~~~~~~--~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~ 1028 (1181)
+++........ .....++..|+|||.+.++..+..+|+ ||+||++|||++ |..||.+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv--------------------wslG~~l~el~~~~~~p~~~ 224 (288)
T cd05061 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDM--------------------WSFGVVLWEITSLAEQPYQG 224 (288)
T ss_pred ccccccccccccccCCCcccccccCHHHhccCCCChHhHH--------------------HHHHHHHHHHHhCCCCCCCC
Confidence 98765432211 112235678999999976554443333 999999999998 7899987
Q ss_pred CCcccccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1029 KTSRALVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1029 ~~~~~l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
.....+..... .....+...+..+..++.+|+..+|..||+ +.+.+..+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~~~ll~~l~~ 277 (288)
T cd05061 225 LSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPT-FLEIVNLLKD 277 (288)
T ss_pred CCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcC-HHHHHHHHHh
Confidence 66544322110 001122345678999999999999999995 5555555444
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=271.76 Aligned_cols=241 Identities=29% Similarity=0.457 Sum_probs=191.5
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
++||+|+||.||+|.+..+++.|++|.++..... ..+.+.+|+.++++++|+||+++++.+...+..++|+||+++++
T Consensus 6 ~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (264)
T cd06626 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGT 85 (264)
T ss_pred eEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCc
Confidence 4799999999999999889999999999766543 46789999999999999999999999999999999999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCc----
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAE---- 964 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~---- 964 (1181)
|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++. ++.+||+|||.+...........
T Consensus 86 L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~-~~~~kl~d~g~~~~~~~~~~~~~~~~~ 161 (264)
T cd06626 86 LEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDH-NGVIKLGDFGCAVKLKNNTTTMGEEVQ 161 (264)
T ss_pred HHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC-CCCEEEcccccccccCCCCCccccccc
Confidence 99998743 34678888899999999999999999999999999999998 89999999999877654322211
Q ss_pred cccCCccccCchhhccCC-CCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc-ccC--CCCC
Q psy14556 965 TFTGTLQYMAPEVIDKGQ-RGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA-LVA--PPQI 1040 (1181)
Q Consensus 965 t~~GT~~Y~APEvl~gg~-~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~-l~~--~~~i 1040 (1181)
...++..|+|||++.+.. .......|+ |++|+++|++++|+.||....... ... ....
T Consensus 162 ~~~~~~~~~~PE~~~~~~~~~~~~~~Dv------------------~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 223 (264)
T cd06626 162 SLAGTPAYMAPEVITGGKGKGHGRAADI------------------WSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH 223 (264)
T ss_pred CCcCCcCccChhhccCCCCCCCCcccch------------------HHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCC
Confidence 245788999999997544 112333333 999999999999999997653221 110 0011
Q ss_pred CCCCCC--CCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1041 SRSVSV--PGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1041 p~~l~~--~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
....+. ..+..+..++.+|+..+|.+||+..+.
T Consensus 224 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i 258 (264)
T cd06626 224 KPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASEL 258 (264)
T ss_pred CCCCCcccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 111111 236678889999999999999875443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-31 Score=322.20 Aligned_cols=201 Identities=28% Similarity=0.400 Sum_probs=176.3
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCC---CCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEK---NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~---~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
+||+|+||.|..++++.+++.||+|++.+. ...+..-|..|-.+|..-+.+-|++++..|+++.++|+|||||+||+
T Consensus 82 vIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGD 161 (1317)
T KOG0612|consen 82 VIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGD 161 (1317)
T ss_pred HhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCch
Confidence 699999999999999999999999999773 23345668999999999999999999999999999999999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC-CCCcccc
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC-PSAETFT 967 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~-~~~~t~~ 967 (1181)
|-.++.+. . .+++..+++|+..|+.||.-||+.|+|||||||+|||||. .|++||+|||.|-.+...+ -.....+
T Consensus 162 lltLlSk~-~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~-~GHikLADFGsClkm~~dG~V~s~~aV 237 (1317)
T KOG0612|consen 162 LLTLLSKF-D--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDK-SGHIKLADFGSCLKMDADGTVRSSVAV 237 (1317)
T ss_pred HHHHHhhc-C--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecc-cCcEeeccchhHHhcCCCCcEEecccc
Confidence 99999854 2 6889999999999999999999999999999999999998 9999999999998776433 3345567
Q ss_pred CCccccCchhhccCC---CCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc
Q psy14556 968 GTLQYMAPEVIDKGQ---RGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL 1034 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~---~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l 1034 (1181)
|||.|+|||++.... ..|+..+|+ ||+|+++|||+.|..||+.++..+.
T Consensus 238 GTPDYISPEvLqs~~~~~g~yG~ecDw------------------WSlGV~~YEMlyG~TPFYadslveT 289 (1317)
T KOG0612|consen 238 GTPDYISPEVLQSQGDGKGEYGRECDW------------------WSLGVFMYEMLYGETPFYADSLVET 289 (1317)
T ss_pred CCCCccCHHHHHhhcCCccccCCccch------------------hhhHHHHHHHHcCCCcchHHHHHHH
Confidence 999999999996332 335666665 9999999999999999999887554
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=281.08 Aligned_cols=241 Identities=22% Similarity=0.267 Sum_probs=186.2
Q ss_pred eeecccCceEEEEEEEcC----------------CCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEcccccc
Q psy14556 811 IELGKGSYGVVYAARELD----------------RQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSE 873 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~----------------tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d 873 (1181)
++||+|+||.||++.+.. ++..+|+|.+..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 11 ~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~ 90 (296)
T cd05095 11 EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCIT 90 (296)
T ss_pred eeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 479999999999986432 345799999875432 234678999999999999999999999999
Q ss_pred CCcEEEEEeecCCCCcccchhcccC--------CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCee
Q psy14556 874 EGYFKIFMEQVPGGSLSTLLRVKWG--------PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVV 945 (1181)
Q Consensus 874 ~~~l~LVmEy~~gGSL~dlL~~~~~--------~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~v 945 (1181)
.+..+++|||+++++|.+++..... ...+++..+..++.|++.||+|||++|++|+||||+||+++. ++.+
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~-~~~~ 169 (296)
T cd05095 91 SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGK-NYTI 169 (296)
T ss_pred CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcC-CCCE
Confidence 9999999999999999999875321 123567789999999999999999999999999999999987 8899
Q ss_pred eeecCCcccccccCCC--CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh--
Q psy14556 946 KISDFGTSKRLAGLCP--SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-- 1021 (1181)
Q Consensus 946 KLiDFGlAk~l~~~~~--~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-- 1021 (1181)
+|+|||+++.+..... ......++..|+|||...++.++..+|+ ||+||++|||++
T Consensus 170 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di--------------------wSlG~~l~el~~~~ 229 (296)
T cd05095 170 KIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDV--------------------WAFGVTLWEILTLC 229 (296)
T ss_pred EeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhh--------------------hHHHHHHHHHHHhC
Confidence 9999999876543221 1112234678999998876654444443 999999999998
Q ss_pred CCCCCCCCCcccccCCC---------CCCCCCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1022 LTAALKKKTSRALVAPP---------QISRSVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1022 Gk~PF~~~~~~~l~~~~---------~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
|..||...+..++.... ......+...+..+..++.+|+..+|..||...+
T Consensus 230 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ 289 (296)
T cd05095 230 KEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQE 289 (296)
T ss_pred CCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHH
Confidence 77999876654432110 0111122345678889999999999999996443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=279.00 Aligned_cols=240 Identities=26% Similarity=0.350 Sum_probs=189.6
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
++||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++..++..++||||+++++
T Consensus 7 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 86 (286)
T cd07846 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTV 86 (286)
T ss_pred eeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccH
Confidence 4799999999999999989999999998654332 34568899999999999999999999999999999999999998
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|..+.... ..+++..++.++.|++.||+|||+.|++|+||+|+||+++. ++.++|+|||++..+...........+
T Consensus 87 l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~ 162 (286)
T cd07846 87 LDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYTDYVA 162 (286)
T ss_pred HHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC-CCcEEEEeeeeeeeccCCccccCcccc
Confidence 88776532 34789999999999999999999999999999999999988 899999999999876543333334568
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc-------------
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV------------- 1035 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~------------- 1035 (1181)
+..|+|||++.+.. .++...|+ ||+|+++|+|++|+.||......+..
T Consensus 163 ~~~y~aPE~~~~~~-~~~~~~Dv------------------~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (286)
T cd07846 163 TRWYRAPELLVGDT-KYGRAVDI------------------WAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPR 223 (286)
T ss_pred eeeccCcHHhcccc-ccCchHhH------------------HHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchh
Confidence 89999999986432 12222333 99999999999999999765531100
Q ss_pred -----------CCCCCCC--------CCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1036 -----------APPQISR--------SVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1036 -----------~~~~ip~--------~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.....+. ...+..+..+..++.+|+..+|..||...+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i 280 (286)
T cd07846 224 HQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQL 280 (286)
T ss_pred hHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHH
Confidence 0000000 1123456778889999999999999975443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-31 Score=329.66 Aligned_cols=246 Identities=32% Similarity=0.448 Sum_probs=199.7
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
+.+||.|.||.||.|.+..+|+-.|+|.+..... .....+.+|..++..++|||+|+++|+-.+.+..+|.||||++|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 3479999999999999999999999999864432 33566889999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC----CC
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP----SA 963 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~----~~ 963 (1181)
+|.++++.. .-.++.....+..|++.|+.|||+.|||||||||+||+|+. +|.+|++|||.|..+..... ..
T Consensus 1320 sLa~ll~~g---ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~-~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1320 SLASLLEHG---RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDF-NGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred cHHHHHHhc---chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeec-CCcEEeecccceeEecCchhcCCHHH
Confidence 999999843 34567777778999999999999999999999999999998 89999999999988875431 22
Q ss_pred ccccCCccccCchhhccCC-CCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc-------cc
Q psy14556 964 ETFTGTLQYMAPEVIDKGQ-RGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA-------LV 1035 (1181)
Q Consensus 964 ~t~~GT~~Y~APEvl~gg~-~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~-------l~ 1035 (1181)
....||+.|||||++.+.. .+.....|+ ||+||++.||+||+.||...+... ..
T Consensus 1396 ~~~~GT~~YMAPEvit~t~~kG~~~A~Di------------------WslGCVVlEM~tGkrPW~~~dne~aIMy~V~~g 1457 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITGTKGKGHGGAADI------------------WSLGCVVLEMATGKRPWAELDNEWAIMYHVAAG 1457 (1509)
T ss_pred HhhcCCchhcCchhhcccccCCCCcchhh------------------hcccceEEEeecCCCchhhccchhHHHhHHhcc
Confidence 3467999999999997644 333344444 999999999999999999876543 12
Q ss_pred CCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcccC
Q psy14556 1036 APPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGNN 1081 (1181)
Q Consensus 1036 ~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~~ 1081 (1181)
.+|++|..++. .=...+.+|+..||.+|....+....+....
T Consensus 1458 h~Pq~P~~ls~----~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1458 HKPQIPERLSS----EGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred CCCCCchhhhH----hHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 35556665433 3344666889999999987666666666554
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=275.06 Aligned_cols=247 Identities=18% Similarity=0.253 Sum_probs=180.2
Q ss_pred eecccCceEEEEEEEcC--CCeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 812 ELGKGSYGVVYAARELD--RQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~--tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
+||+|+||.||+|.... ....+++|.+...... ....+.+|+.+++.++||||+++++.+.+.+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 59999999999996533 4457888987644332 23567899999999999999999999999999999999999999
Q ss_pred cccchhcccC--CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC--CCc
Q psy14556 889 LSTLLRVKWG--PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP--SAE 964 (1181)
Q Consensus 889 L~dlL~~~~~--~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~--~~~ 964 (1181)
|.+++..... ....++..+..++.||+.||+|||++||+||||||+||+++. ++.+||+|||++........ ...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~-~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTA-DLSVKIGDYGLALEQYPEDYYITKD 160 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecC-CCcEEEeccccccccccchheeccC
Confidence 9999975422 123456778889999999999999999999999999999998 88999999999865432211 112
Q ss_pred cccCCccccCchhhccCCCCC-CCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCccccc------C
Q psy14556 965 TFTGTLQYMAPEVIDKGQRGY-GAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALV------A 1036 (1181)
Q Consensus 965 t~~GT~~Y~APEvl~gg~~~~-ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~------~ 1036 (1181)
...++..|+|||++....... .. .+....+.||+||++|+|++ |..||......+.. .
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~--------------~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 226 (269)
T cd05042 161 CHAVPLRWLAPELVEIRGQDLLPK--------------DQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQ 226 (269)
T ss_pred CCCCcccccCHHHHhhcccccccc--------------ccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhcc
Confidence 234567899999986432111 11 11223344999999999999 78898876543321 1
Q ss_pred CCCCC-CCCCCCCCcchHHhhccCCCCCCCCCchhHHHHH
Q psy14556 1037 PPQIS-RSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNL 1075 (1181)
Q Consensus 1037 ~~~ip-~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~ 1075 (1181)
...++ .......+..+..++..|+ .||..||+ +.+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt-~~~v~ 264 (269)
T cd05042 227 DIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPT-AEEVH 264 (269)
T ss_pred CccCCCCcccccCCHHHHHHHHHHh-cCcccccC-HHHHH
Confidence 11111 1223355666777777777 59999996 44433
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=266.55 Aligned_cols=238 Identities=30% Similarity=0.419 Sum_probs=194.7
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
..||+|++|.||++.+..+++.+++|++........+.+.+|+.+++.++||||+++++.+...+..++++||+++++|.
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~ 85 (253)
T cd05122 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLK 85 (253)
T ss_pred eeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHH
Confidence 46999999999999998899999999997766556678999999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCc
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL 970 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~ 970 (1181)
+++.... ..+++..+..++.|++.||++||++|++||||+|+||+++. ++.++|+|||.+........ .....++.
T Consensus 86 ~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~-~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 161 (253)
T cd05122 86 DLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTS-DGEVKLIDFGLSAQLSDTKA-RNTMVGTP 161 (253)
T ss_pred HHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEcc-CCeEEEeecccccccccccc-ccceecCC
Confidence 9987542 46789999999999999999999999999999999999998 89999999999977654322 33456889
Q ss_pred cccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc---cCCCCCCCCC-CC
Q psy14556 971 QYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL---VAPPQISRSV-SV 1046 (1181)
Q Consensus 971 ~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l---~~~~~ip~~l-~~ 1046 (1181)
.|+|||.+.+...+...|+ ||+|+++|+|++|+.||...+.... ......+... ..
T Consensus 162 ~~~~PE~~~~~~~~~~~Dv--------------------~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (253)
T cd05122 162 YWMAPEVINGKPYDYKADI--------------------WSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPE 221 (253)
T ss_pred cccCHHHHcCCCCCccccH--------------------HHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCccc
Confidence 9999999976553333333 9999999999999999987743221 1111111111 11
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
..+..+..++.+|+..+|..||+..+
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~t~~~ 247 (253)
T cd05122 222 KWSDEFKDFLKKCLQKNPEKRPTAEQ 247 (253)
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHH
Confidence 23677899999999999999997433
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=278.85 Aligned_cols=238 Identities=26% Similarity=0.355 Sum_probs=186.3
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
.||.|++|.||+|++..++..|++|.+..... ...+.+.+|+.++++++||||+++++++.+.+..++||||+. ++|
T Consensus 7 ~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l 85 (284)
T cd07860 7 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDL 85 (284)
T ss_pred eecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCH
Confidence 69999999999999999999999999865432 234578899999999999999999999999999999999995 688
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT 969 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT 969 (1181)
..++... ....+++..++.++.|++.||+|||++|++|+||+|+||+++. ++.+||+|||++..............++
T Consensus 86 ~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 163 (284)
T cd07860 86 KKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYTHEVVT 163 (284)
T ss_pred HHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC-CCCEEEeeccchhhcccCcccccccccc
Confidence 8887654 3346788999999999999999999999999999999999998 8899999999987664433333334578
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc--------CCC---
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV--------APP--- 1038 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~--------~~~--- 1038 (1181)
..|+|||++.+.. .++...|+ ||+|+++|+|+||+.||.+.+..... .+.
T Consensus 164 ~~y~aPE~~~~~~-~~~~~~Dv------------------~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 224 (284)
T cd07860 164 LWYRAPEILLGCK-YYSTAVDI------------------WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 224 (284)
T ss_pred ccccCCeEEecCC-CCCcHHHH------------------HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 8999999886432 12222333 99999999999999999876542210 000
Q ss_pred ------------CCC-------CCCCCCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1039 ------------QIS-------RSVSVPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1039 ------------~ip-------~~l~~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
..+ ....+..+..+..++.+|+..+|..||+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~ 276 (284)
T cd07860 225 WPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAK 276 (284)
T ss_pred hhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHH
Confidence 000 011123456677899999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=274.38 Aligned_cols=241 Identities=20% Similarity=0.277 Sum_probs=180.4
Q ss_pred eecccCceEEEEEEEcC---CCeEEEEEEecCCC-CCChhHHHHHHHHHHhcCCCCeeeEccccc-cCCcEEEEEeecCC
Q psy14556 812 ELGKGSYGVVYAARELD---RQVKLAIKEIPEKN-LGDVQPLHEEIKLHSQLRHRNIVQYLGSVS-EEGYFKIFMEQVPG 886 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~---tg~~VAIKii~~~~-~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~-d~~~l~LVmEy~~g 886 (1181)
.||+|+||.||+|.+.. .+..||+|.+.... ....+.+.+|+.+++.++||||+++++++. .++..+++|||+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 81 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence 58999999999998653 34679999985432 233567889999999999999999999764 45678999999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC----C
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP----S 962 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~----~ 962 (1181)
++|.+++... .....+..+..++.|++.||.|||+.+++||||||+||+++. ++.+||+|||+++....... .
T Consensus 82 ~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~-~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 82 GDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDE-SFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcC-CCcEEECCccccccccCCcceeecc
Confidence 9999998753 223456777889999999999999999999999999999987 88999999999875533111 1
Q ss_pred CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhC-CCCCCCCCcccccCCCC--
Q psy14556 963 AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVL-TAALKKKTSRALVAPPQ-- 1039 (1181)
Q Consensus 963 ~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTG-k~PF~~~~~~~l~~~~~-- 1039 (1181)
.....++..|+|||.+.+...+.. .|+ ||+|+++|||++| .+||...+...+.....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~--~Di------------------~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~ 218 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKFTTK--SDV------------------WSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG 218 (262)
T ss_pred cccCcCCccccChhHhccCccchH--HHH------------------HHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence 112335678999999876544333 333 9999999999995 56676655433221111
Q ss_pred CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHH
Q psy14556 1040 ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLV 1076 (1181)
Q Consensus 1040 ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~ 1076 (1181)
.....+...+..+..++.+|+..+|..||.. .+.+.
T Consensus 219 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~-~~il~ 254 (262)
T cd05058 219 RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTF-SELVS 254 (262)
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhhCCCH-HHHHH
Confidence 0111122356788899999999999999864 44333
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=275.55 Aligned_cols=236 Identities=32% Similarity=0.466 Sum_probs=181.2
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC-----CChhHHHHHHHHHHhcCCCCeeeEccccccC--CcEEEEEee
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-----GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEE--GYFKIFMEQ 883 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-----~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~--~~l~LVmEy 883 (1181)
+.||+|+||.||++.+..+++.|++|.+..... ...+.+.+|+.++++++||||+++++++.+. ..++++|||
T Consensus 8 ~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~ 87 (265)
T cd06652 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEH 87 (265)
T ss_pred eEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEe
Confidence 479999999999999999999999998854321 1245788899999999999999999988664 568899999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC---
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC--- 960 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~--- 960 (1181)
+++++|.+++... ..+++..+..++.|++.||.|||+++++|+||||+||+++. ++.++|+|||.+.......
T Consensus 88 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~-~~~~~l~Dfg~~~~~~~~~~~~ 163 (265)
T cd06652 88 MPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDS-VGNVKLGDFGASKRLQTICLSG 163 (265)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecC-CCCEEECcCccccccccccccc
Confidence 9999999998743 24678888899999999999999999999999999999987 8899999999987654311
Q ss_pred CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-
Q psy14556 961 PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ- 1039 (1181)
Q Consensus 961 ~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~- 1039 (1181)
.......++..|+|||++.+...+..+|+ ||+|+++|+|++|+.||.............
T Consensus 164 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv--------------------~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 223 (265)
T cd06652 164 TGMKSVTGTPYWMSPEVISGEGYGRKADI--------------------WSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT 223 (265)
T ss_pred cccccCCCCccccChhhhcCCCCCcchhH--------------------HHHHHHHHHHhhCCCCCCccchHHHHHHHhc
Confidence 11223458889999999975543333333 999999999999999998764332211111
Q ss_pred --CCCCCCCCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1040 --ISRSVSVPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1040 --ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
.....+...+..+..++.+++ .+|..||...
T Consensus 224 ~~~~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~ 256 (265)
T cd06652 224 QPTNPVLPPHVSDHCRDFLKRIF-VEAKLRPSAD 256 (265)
T ss_pred CCCCCCCchhhCHHHHHHHHHHh-cChhhCCCHH
Confidence 111122234455666777777 4899999743
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=275.39 Aligned_cols=237 Identities=27% Similarity=0.344 Sum_probs=190.5
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
+||.|++|.||++.+..+++.+++|.+..... ...+.+.+|+.++++++||||+++++.+...+..++++||+++++|.
T Consensus 8 ~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 87 (265)
T cd06605 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLD 87 (265)
T ss_pred HhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHH
Confidence 69999999999999999999999999976543 33467889999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccc-cceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCC
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHG-QKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT 969 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs-~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT 969 (1181)
+++.... ..+++..++.++.|++.||+|||+ .|++|+||||+||+++. ++.++|+|||.+......... ...++
T Consensus 88 ~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~-~~~~~l~d~g~~~~~~~~~~~--~~~~~ 162 (265)
T cd06605 88 KILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNS-RGQIKLCDFGVSGQLVNSLAK--TFVGT 162 (265)
T ss_pred HHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECC-CCCEEEeecccchhhHHHHhh--cccCC
Confidence 9997542 467888999999999999999999 99999999999999998 889999999998766432221 25688
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCc-----ccccC---CCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTS-----RALVA---PPQIS 1041 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~-----~~l~~---~~~ip 1041 (1181)
..|+|||.+.+...+..+|+ ||+|+++|+|++|+.||..... ..... ....+
T Consensus 163 ~~y~~PE~~~~~~~~~~~Dv--------------------~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 222 (265)
T cd06605 163 SSYMAPERIQGNDYSVKSDI--------------------WSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP 222 (265)
T ss_pred hhccCHHHHcCCCCCchhhH--------------------HHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCC
Confidence 99999999976544333333 9999999999999999976531 11110 01111
Q ss_pred CCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1042 RSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1042 ~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.......+..+..++.+|+..+|.+||...+.
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l 254 (265)
T cd06605 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKEL 254 (265)
T ss_pred CCChhhcCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 11111156678889999999999999975544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=280.87 Aligned_cols=240 Identities=22% Similarity=0.246 Sum_probs=185.4
Q ss_pred eeecccCceEEEEEEEcCC--------------CeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCC
Q psy14556 811 IELGKGSYGVVYAARELDR--------------QVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEG 875 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~t--------------g~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~ 875 (1181)
++||+|+||.||+|.+..+ ...||+|.++..... ..+.+.+|++++++++||||+++++++...+
T Consensus 11 ~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 90 (295)
T cd05097 11 EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDD 90 (295)
T ss_pred hccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC
Confidence 4699999999999987543 235899998755322 3456899999999999999999999999999
Q ss_pred cEEEEEeecCCCCcccchhccc---------CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeee
Q psy14556 876 YFKIFMEQVPGGSLSTLLRVKW---------GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVK 946 (1181)
Q Consensus 876 ~l~LVmEy~~gGSL~dlL~~~~---------~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vK 946 (1181)
..++||||+++++|.+++.... ....+++..++.++.|++.||+|||++|++||||||+||+++. ++.+|
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~-~~~~k 169 (295)
T cd05097 91 PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN-HYTIK 169 (295)
T ss_pred ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcC-CCcEE
Confidence 9999999999999999986431 1123577888999999999999999999999999999999987 78999
Q ss_pred eecCCcccccccCCC--CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh--C
Q psy14556 947 ISDFGTSKRLAGLCP--SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV--L 1022 (1181)
Q Consensus 947 LiDFGlAk~l~~~~~--~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT--G 1022 (1181)
|+|||++........ ......++..|+|||++.++..+..+|+ ||||+++|+|++ |
T Consensus 170 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv--------------------wSlG~~l~el~~~~~ 229 (295)
T cd05097 170 IADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDV--------------------WAFGVTLWEMFTLCK 229 (295)
T ss_pred ecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhH--------------------HHHHHHHHHHHHcCC
Confidence 999999876533211 1112235678999999976654433333 999999999988 6
Q ss_pred CCCCCCCCcccccCC---------CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1023 TAALKKKTSRALVAP---------PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1023 k~PF~~~~~~~l~~~---------~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
..||...+...+... .......+...+..+..++.+|++.+|..||+..
T Consensus 230 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~ 287 (295)
T cd05097 230 EQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFN 287 (295)
T ss_pred CCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHH
Confidence 788887655432110 1111122345677899999999999999999743
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-30 Score=298.21 Aligned_cols=233 Identities=27% Similarity=0.356 Sum_probs=197.1
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCC--hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD--VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~--~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
.||+|.|++|.+|++..++..||||++.+..... .+.+.+|+++|+.++|||||+++.+...+..+|+||||+.+|.+
T Consensus 63 tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~ 142 (596)
T KOG0586|consen 63 TIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGEL 142 (596)
T ss_pred eeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchh
Confidence 6999999999999999999999999998775543 46689999999999999999999999999999999999999999
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT 969 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT 969 (1181)
.+++.... .+.+..+..++.|+..|++|||+++|||||||++||||+. +..+||+|||++..+.. .....+++|+
T Consensus 143 ~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~-~mnikIaDfgfS~~~~~-~~~lqt~cgs 217 (596)
T KOG0586|consen 143 FDYLVKHG---RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDE-NMNIKIADFGFSTFFDY-GLMLQTFCGS 217 (596)
T ss_pred HHHHHhcc---cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccc-ccceeeeccccceeecc-cccccccCCC
Confidence 99998652 3445788889999999999999999999999999999998 77899999999988873 4566778999
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC-----CCCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA-----PPQISRSV 1044 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~-----~~~ip~~l 1044 (1181)
+.|.|||++.+.. ..+..+|+ |++|++||.|+.|..||++.+..++.. +..++..+
T Consensus 218 ppyAaPEl~~g~~-y~gpe~D~------------------Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~m 278 (596)
T KOG0586|consen 218 PPYAAPELFNGKK-YDGPEVDI------------------WSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYM 278 (596)
T ss_pred CCccChHhhcCcc-cCCcceeh------------------hhhhhhheeeeecccccCCcccccccchheeeeeccccee
Confidence 9999999997665 56777777 999999999999999999988877543 33344444
Q ss_pred CCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1045 SVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1045 ~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
+. ....++.+.+-.+|.+|++..+
T Consensus 279 s~----dce~lLrk~lvl~Pskr~~~dq 302 (596)
T KOG0586|consen 279 SC----DCEDLLRKFLVLNPSKRGPCDQ 302 (596)
T ss_pred ec----hhHHHHHHhhccCccccCCHHH
Confidence 44 4444555666677777765333
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=281.52 Aligned_cols=240 Identities=22% Similarity=0.333 Sum_probs=193.8
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
.+||+|+||.||++.+..++..||+|.+........+.+.+|+.+++.++||||+++++.+...+..+++|||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 36999999999999999999999999986555445667899999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCc
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL 970 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~ 970 (1181)
+++... .+++..+..++.|++.||+|||++|++|+||+|+||+++. ++.++|+|||++..............++.
T Consensus 106 ~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~ 180 (292)
T cd06657 106 DIVTHT----RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTH-DGRVKLSDFGFCAQVSKEVPRRKSLVGTP 180 (292)
T ss_pred HHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC-CCCEEEcccccceecccccccccccccCc
Confidence 887532 4678889999999999999999999999999999999997 78999999999876654333333456889
Q ss_pred cccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCC--CCCCCC--CCC
Q psy14556 971 QYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAP--PQISRS--VSV 1046 (1181)
Q Consensus 971 ~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~--~~ip~~--l~~ 1046 (1181)
.|+|||.+.+...+..+|+ ||+|+++|+|++|..||.+......... ...+.. ...
T Consensus 181 ~y~~pE~~~~~~~~~~~Dv--------------------~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T cd06657 181 YWMAPELISRLPYGPEVDI--------------------WSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLH 240 (292)
T ss_pred cccCHHHhcCCCCCchhhH--------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcc
Confidence 9999999875544433333 9999999999999999987654332110 011111 112
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNTNL 1075 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~~~ 1075 (1181)
..+..+..++.+|+..+|.+||+..+...
T Consensus 241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 241 KVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred cCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 35667888999999999999998655543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=279.21 Aligned_cols=240 Identities=23% Similarity=0.298 Sum_probs=187.8
Q ss_pred eecccCceEEEEEEEcC-----CCeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 812 ELGKGSYGVVYAARELD-----RQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~-----tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
+||+|+||.||+|.+.. ++..||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+..+++|||++
T Consensus 12 ~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 91 (288)
T cd05050 12 DIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMA 91 (288)
T ss_pred cccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCC
Confidence 69999999999998743 6789999998755332 24568899999999999999999999999999999999999
Q ss_pred CCCcccchhccc-------------------CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeee
Q psy14556 886 GGSLSTLLRVKW-------------------GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVK 946 (1181)
Q Consensus 886 gGSL~dlL~~~~-------------------~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vK 946 (1181)
+++|.+++.... ....+++..++.++.|++.||.|||++|++||||||+||+++. ++.++
T Consensus 92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~-~~~~~ 170 (288)
T cd05050 92 YGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGE-NMVVK 170 (288)
T ss_pred CCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecC-CCceE
Confidence 999999987431 1234677888999999999999999999999999999999987 89999
Q ss_pred eecCCcccccccCCC--CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CC
Q psy14556 947 ISDFGTSKRLAGLCP--SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LT 1023 (1181)
Q Consensus 947 LiDFGlAk~l~~~~~--~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk 1023 (1181)
|+|||.+........ .......+..|+|||.+.+..++..+|+ ||+||++|+|++ |.
T Consensus 171 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv--------------------~slG~il~el~~~~~ 230 (288)
T cd05050 171 IADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDV--------------------WAYGVVLWEIFSYGM 230 (288)
T ss_pred ECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHH--------------------HHHHHHHHHHHhCCC
Confidence 999999876533211 1112234667999999876654444443 999999999998 88
Q ss_pred CCCCCCCcccccCCCCCCC--CCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1024 AALKKKTSRALVAPPQISR--SVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1024 ~PF~~~~~~~l~~~~~ip~--~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
.||.+....++........ ..+...+..+..++.+|+..+|..||+..+
T Consensus 231 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~e 281 (288)
T cd05050 231 QPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFAS 281 (288)
T ss_pred CCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 8998776555322111111 112345678889999999999999997444
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=274.89 Aligned_cols=236 Identities=34% Similarity=0.487 Sum_probs=182.8
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC-----CChhHHHHHHHHHHhcCCCCeeeEcccccc--CCcEEEEEee
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-----GDVQPLHEEIKLHSQLRHRNIVQYLGSVSE--EGYFKIFMEQ 883 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-----~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d--~~~l~LVmEy 883 (1181)
..||+|+||.||+|.+..++..|++|.+..... ...+.+.+|+.++++++||||+++++++.+ .+..++++||
T Consensus 8 ~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~ 87 (266)
T cd06651 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEY 87 (266)
T ss_pred ceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeC
Confidence 479999999999999999999999999865432 123568889999999999999999998765 3678999999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC---
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC--- 960 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~--- 960 (1181)
+++++|.+++... ..+++...+.++.|++.||+|||+++|+||||||+||+++. ++.+||+|||++..+....
T Consensus 88 ~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~-~~~~~l~dfg~~~~~~~~~~~~ 163 (266)
T cd06651 88 MPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICMSG 163 (266)
T ss_pred CCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC-CCCEEEccCCCccccccccccC
Confidence 9999999998743 24678888899999999999999999999999999999987 8899999999987654321
Q ss_pred CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-
Q psy14556 961 PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ- 1039 (1181)
Q Consensus 961 ~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~- 1039 (1181)
.......++..|+|||.+.+..++..+|+ ||+|+++|+|++|+.||.............
T Consensus 164 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv--------------------~slG~i~~el~~g~~pf~~~~~~~~~~~~~~ 223 (266)
T cd06651 164 TGIRSVTGTPYWMSPEVISGEGYGRKADV--------------------WSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT 223 (266)
T ss_pred CccccCCccccccCHHHhCCCCCCchhhh--------------------HHHHHHHHHHHHCCCCccccchHHHHHHHhc
Confidence 11223458889999999976544333333 999999999999999998765433211111
Q ss_pred --CCCCCCCCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1040 --ISRSVSVPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1040 --ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
.....+...+..+..++ +|+..+|.+||+..
T Consensus 224 ~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~ 256 (266)
T cd06651 224 QPTNPQLPSHISEHARDFL-GCIFVEARHRPSAE 256 (266)
T ss_pred CCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHH
Confidence 11112223455566666 67778999999633
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=277.91 Aligned_cols=242 Identities=24% Similarity=0.340 Sum_probs=186.8
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.+||+|++|.||+|.+..+++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..++||||++ ++
T Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~ 86 (294)
T PLN00009 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LD 86 (294)
T ss_pred EEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-cc
Confidence 479999999999999999999999999865433 224568899999999999999999999999999999999995 57
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|.+++... .....++..++.++.||+.||+|||++|++|+||+|+||+++..++.+||+|||++..............+
T Consensus 87 l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 165 (294)
T PLN00009 87 LKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV 165 (294)
T ss_pred HHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccccCce
Confidence 77777543 33456788888999999999999999999999999999999864678999999999765433222233457
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC--------C---
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA--------P--- 1037 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~--------~--- 1037 (1181)
++.|+|||.+.+.. .+....|+ ||+|+++|+|+||..||...+..+... +
T Consensus 166 ~~~y~~PE~~~~~~-~~~~~~Dv------------------~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 226 (294)
T PLN00009 166 TLWYRAPEILLGSR-HYSTPVDI------------------WSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEE 226 (294)
T ss_pred eecccCHHHHhCCC-CCCcHHHH------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 88999999986432 23333333 999999999999999998664322100 0
Q ss_pred ------------CCCC-------CCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1038 ------------PQIS-------RSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1038 ------------~~ip-------~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
...+ ....+..+..+..++.+|+..+|..||+..+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~ 281 (294)
T PLN00009 227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAA 281 (294)
T ss_pred hccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHH
Confidence 0000 01123455667789999999999999975444
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=276.54 Aligned_cols=197 Identities=23% Similarity=0.319 Sum_probs=162.2
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
.+||+|++|.||+|.+..+++.||+|.+...... ....+.+|+.++++++||||+++++++.+.+..++||||++ ++|
T Consensus 11 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~L 89 (291)
T cd07844 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TDL 89 (291)
T ss_pred EEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-CCH
Confidence 4799999999999999989999999998654322 23457789999999999999999999999999999999996 589
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT 969 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT 969 (1181)
.+++... ...+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||+++.............++
T Consensus 90 ~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 166 (291)
T cd07844 90 KQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISE-RGELKLADFGLARAKSVPSKTYSNEVVT 166 (291)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcC-CCCEEECccccccccCCCCccccccccc
Confidence 8888644 235678899999999999999999999999999999999988 8899999999987543222222223468
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKT 1030 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~ 1030 (1181)
..|+|||++.+.. .++...|+ ||+|+++|+|++|+.||.+..
T Consensus 167 ~~~~aPE~~~~~~-~~~~~~Dv------------------~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 167 LWYRPPDVLLGST-EYSTSLDM------------------WGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred cccCCcHHhhcCc-ccCcHHHH------------------HHHHHHHHHHHhCCCCCCCCc
Confidence 8999999986432 23333444 999999999999999997655
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=275.75 Aligned_cols=245 Identities=25% Similarity=0.323 Sum_probs=186.4
Q ss_pred CceeecccCceEEEEEEE----cCCCeEEEEEEecCCC-CCChhHHHHHHHHHHhcCCCCeeeEccccccC--CcEEEEE
Q psy14556 809 NRIELGKGSYGVVYAARE----LDRQVKLAIKEIPEKN-LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEE--GYFKIFM 881 (1181)
Q Consensus 809 ~~~kIG~G~fG~VYka~d----~~tg~~VAIKii~~~~-~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~--~~l~LVm 881 (1181)
...+||+|+||.||+++. ..++..||+|.++... ....+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus 8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (284)
T cd05079 8 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIM 87 (284)
T ss_pred hceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEE
Confidence 344799999999999974 4567899999986553 23356789999999999999999999988765 5789999
Q ss_pred eecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC
Q psy14556 882 EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP 961 (1181)
Q Consensus 882 Ey~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~ 961 (1181)
||++|++|.+++... ...+++..+..++.|++.||+|||++|++||||||+||+++. ++.++|+|||++..+.....
T Consensus 88 e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~-~~~~~l~dfg~~~~~~~~~~ 164 (284)
T cd05079 88 EFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES-EHQVKIGDFGLTKAIETDKE 164 (284)
T ss_pred EccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcC-CCCEEECCCccccccccCcc
Confidence 999999999998643 235688889999999999999999999999999999999987 88999999999986643221
Q ss_pred ---CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc--cC
Q psy14556 962 ---SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL--VA 1036 (1181)
Q Consensus 962 ---~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l--~~ 1036 (1181)
......++..|+|||.+.+...+..+|+ ||+|+++|+|+++..|+........ ..
T Consensus 165 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di--------------------~slG~il~ellt~~~~~~~~~~~~~~~~~ 224 (284)
T cd05079 165 YYTVKDDLDSPVFWYAPECLIQSKFYIASDV--------------------WSFGVTLYELLTYCDSESSPMTLFLKMIG 224 (284)
T ss_pred ceeecCCCCCCccccCHHHhccCCCCccccc--------------------hhhhhhhhhhhcCCCCCccccchhhhhcc
Confidence 1123446778999999876654444433 9999999999998776543211000 00
Q ss_pred ---------------CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHh
Q psy14556 1037 ---------------PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVC 1077 (1181)
Q Consensus 1037 ---------------~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~a 1077 (1181)
............+..+..++.+|+..+|..||+ +++.+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt-~~~il~~ 279 (284)
T cd05079 225 PTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTT-FQNLIEG 279 (284)
T ss_pred cccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcC-HHHHHHH
Confidence 000111122345678889999999999999996 4444433
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=275.43 Aligned_cols=239 Identities=21% Similarity=0.206 Sum_probs=186.9
Q ss_pred eeecccCceEEEEEEEcCCCe----EEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 811 IELGKGSYGVVYAARELDRQV----KLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~----~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
++||+|+||.||+|.+..++. .+|+|.+...... ..+.+.+|+.++++++||||+++++++.. ...++||||++
T Consensus 13 ~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 91 (279)
T cd05057 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMP 91 (279)
T ss_pred ceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCC
Confidence 369999999999999876654 6899988655432 34678899999999999999999999877 78999999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCc-
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAE- 964 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~- 964 (1181)
+|+|.+++... ...+++..+..++.|++.||+|||++|++||||||+||+++. ++.+||+|||.++..........
T Consensus 92 ~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~-~~~~kL~dfg~~~~~~~~~~~~~~ 168 (279)
T cd05057 92 LGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKT-PQHVKITDFGLAKLLDVDEKEYHA 168 (279)
T ss_pred CCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcC-CCeEEECCCcccccccCcccceec
Confidence 99999998754 234788999999999999999999999999999999999987 88999999999987653222111
Q ss_pred -cccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCCCC-
Q psy14556 965 -TFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQIS- 1041 (1181)
Q Consensus 965 -t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~ip- 1041 (1181)
...++..|+|||.+.....+..+|+ ||+|+++||+++ |+.||.+....++.......
T Consensus 169 ~~~~~~~~y~~PE~~~~~~~~~~~Di--------------------~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 228 (279)
T cd05057 169 EGGKVPIKWMALESILHRIYTHKSDV--------------------WSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE 228 (279)
T ss_pred CCCcccccccCHHHhhcCCcCchhhH--------------------HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC
Confidence 1123568999999875544333333 999999999998 99999987765543222211
Q ss_pred -CCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1042 -RSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1042 -~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
...+...+..+..++.+|+..+|..||...+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l 261 (279)
T cd05057 229 RLPQPPICTIDVYMVLVKCWMIDAESRPTFKEL 261 (279)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 11122345567788999999999999964443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=276.96 Aligned_cols=234 Identities=26% Similarity=0.348 Sum_probs=188.3
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
+||+|+||+||++.+..+++.||+|++..... ...+.+.+|+++++.++||||+++++++...+.+++||||+++++|.
T Consensus 12 ~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (284)
T cd06620 12 DLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLD 91 (284)
T ss_pred HcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHH
Confidence 69999999999999999999999999865433 33567899999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccc-cceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCC
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHG-QKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT 969 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs-~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT 969 (1181)
+++... ..+++..+..++.+++.||.|||+ .+++||||||+||+++. ++.++|+|||++...... ......|+
T Consensus 92 ~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~-~~~~~l~d~gl~~~~~~~--~~~~~~~~ 165 (284)
T cd06620 92 RIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNS-RGQIKLCDFGVSGELINS--IADTFVGT 165 (284)
T ss_pred HHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECC-CCcEEEccCCcccchhhh--ccCccccC
Confidence 988743 357788999999999999999997 59999999999999987 889999999998655332 12234689
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc-----------cccC--
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR-----------ALVA-- 1036 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~-----------~l~~-- 1036 (1181)
..|+|||++.++..+...|+ ||+||++|+|++|..||...... ....
T Consensus 166 ~~~~aPE~~~~~~~~~~~Di--------------------~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd06620 166 STYMSPERIQGGKYTVKSDV--------------------WSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI 225 (284)
T ss_pred cccCCHHHHccCCCCccchH--------------------HHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHH
Confidence 99999999976544433333 99999999999999999875542 1000
Q ss_pred -CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1037 -PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1037 -~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
....+.......+..+..++.+|+..+|..||+..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~ 261 (284)
T cd06620 226 VQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQ 261 (284)
T ss_pred hhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHH
Confidence 00111111112566788899999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=266.19 Aligned_cols=239 Identities=35% Similarity=0.496 Sum_probs=196.3
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccC--CcEEEEEeecCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEE--GYFKIFMEQVPG 886 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~--~~l~LVmEy~~g 886 (1181)
..||+|++|.||+|.+..+++.|++|.+..... ...+.+.+|+.++++++||||+++++.+.+. ...++++||+++
T Consensus 6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 85 (260)
T cd06606 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSG 85 (260)
T ss_pred eEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCC
Confidence 469999999999999998999999999976543 3467799999999999999999999999888 889999999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC--CCc
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP--SAE 964 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~--~~~ 964 (1181)
++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++. ++.++|+|||.+........ ...
T Consensus 86 ~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~-~~~~~l~d~~~~~~~~~~~~~~~~~ 161 (260)
T cd06606 86 GSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDS-DGVVKLADFGCAKRLGDIETGEGTG 161 (260)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcC-CCCEEEcccccEEeccccccccccc
Confidence 99999987542 7789999999999999999999999999999999999998 89999999999987765432 133
Q ss_pred cccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc-cccCC---CCC
Q psy14556 965 TFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR-ALVAP---PQI 1040 (1181)
Q Consensus 965 t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~-~l~~~---~~i 1040 (1181)
...++..|+|||.+.+...+..+|+ |++|+++|+|++|..||...... ..... ...
T Consensus 162 ~~~~~~~y~~pE~~~~~~~~~~~Dv--------------------~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 221 (260)
T cd06606 162 SVRGTPYWMAPEVIRGEEYGRAADI--------------------WSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGE 221 (260)
T ss_pred CCCCCccccCHhhhcCCCCCchhhH--------------------HHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCC
Confidence 4568899999999976654444444 99999999999999999887621 11111 112
Q ss_pred CCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1041 SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1041 p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
....+...+..+..++.+|++.+|..||...+.
T Consensus 222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~l 254 (260)
T cd06606 222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADEL 254 (260)
T ss_pred CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHH
Confidence 223344557889999999999999999965444
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=275.06 Aligned_cols=242 Identities=21% Similarity=0.306 Sum_probs=189.7
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
++||.|++|.||+|++..++..||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+..++||||++ ++|
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l 84 (284)
T cd07836 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD-KDL 84 (284)
T ss_pred eeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC-ccH
Confidence 4799999999999999999999999999765432 34667889999999999999999999999999999999997 488
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT 969 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT 969 (1181)
.+++........+++..+..++.|++.||.|||++|++||||||+||+++. ++.++|+|||++..............++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 163 (284)
T cd07836 85 KKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINK-RGELKLADFGLARAFGIPVNTFSNEVVT 163 (284)
T ss_pred HHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECC-CCcEEEeecchhhhhcCCcccccccccc
Confidence 888765433456889999999999999999999999999999999999987 8899999999997654332222334578
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC-------------
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA------------- 1036 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~------------- 1036 (1181)
..|++||++.+.. .++...|+ |++|+++|+|++|+.||.+.+..+...
T Consensus 164 ~~y~~PE~~~~~~-~~~~~~Dv------------------~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (284)
T cd07836 164 LWYRAPDVLLGSR-TYSTSIDI------------------WSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTEST 224 (284)
T ss_pred ccccChHHhcCCC-CCCcHHHH------------------HHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh
Confidence 8999999986432 22233333 999999999999999998766432100
Q ss_pred ------CCCC----CC-------CCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1037 ------PPQI----SR-------SVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1037 ------~~~i----p~-------~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
...+ +. ...+..+..+..++.+|+..+|.+||...+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~ 278 (284)
T cd07836 225 WPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDA 278 (284)
T ss_pred HHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHH
Confidence 0000 00 0112346677789999999999999975443
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=272.57 Aligned_cols=236 Identities=21% Similarity=0.298 Sum_probs=185.4
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
.+||+|+||.||++.+. .+..+++|.+.... ...+.+.+|+.++++++|+||+++++.+.+ ...+++|||+++++|.
T Consensus 12 ~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~ 88 (260)
T cd05073 12 KKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLL 88 (260)
T ss_pred eEecCccceEEEEEEec-CCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHH
Confidence 47999999999999854 45579999886543 234678899999999999999999999887 7789999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC-CCccccCC
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP-SAETFTGT 969 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~-~~~t~~GT 969 (1181)
+++... ....+++..+..++.|++.||.|||+.|++|+||||+||+++. ++.+||+|||.+..+..... ......++
T Consensus 89 ~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~ 166 (260)
T cd05073 89 DFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA-SLVCKIADFGLARVIEDNEYTAREGAKFP 166 (260)
T ss_pred HHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcC-CCcEEECCCcceeeccCCCcccccCCccc
Confidence 999754 2345678888899999999999999999999999999999988 88999999999876543221 11223356
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCC--CCCCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAP--PQISRSVSV 1046 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~--~~ip~~l~~ 1046 (1181)
..|+|||++.++..+..+|+ ||+|+++|++++ |+.||.+.+...+... .........
T Consensus 167 ~~y~~PE~~~~~~~~~~~Di--------------------~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T cd05073 167 IKWTAPEAINFGSFTIKSDV--------------------WSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPE 226 (260)
T ss_pred ccccCHhHhccCCcCccccc--------------------hHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcc
Confidence 77999999976544333333 999999999999 9999988765443211 111112234
Q ss_pred CCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
..+..+..++.+|+..+|..||...
T Consensus 227 ~~~~~~~~~i~~~l~~~p~~Rp~~~ 251 (260)
T cd05073 227 NCPEELYNIMMRCWKNRPEERPTFE 251 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHH
Confidence 5677888999999999999999643
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=275.56 Aligned_cols=238 Identities=25% Similarity=0.409 Sum_probs=194.4
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCccc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLST 891 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~d 891 (1181)
.||+|++|.||++.+..++..+++|.+..... ..+.+.+|+.+++.++|+||+++++.+...+..++++||+++++|.+
T Consensus 26 ~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 104 (286)
T cd06614 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTD 104 (286)
T ss_pred hccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHH
Confidence 69999999999999988899999999976544 45678999999999999999999999999999999999999999999
Q ss_pred chhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCcc
Q psy14556 892 LLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQ 971 (1181)
Q Consensus 892 lL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~~ 971 (1181)
++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++. ++.++|+|||.+..............++..
T Consensus 105 ~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 181 (286)
T cd06614 105 IITQNF--VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSK-DGSVKLADFGFAAQLTKEKSKRNSVVGTPY 181 (286)
T ss_pred HHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcC-CCCEEECccchhhhhccchhhhccccCCcc
Confidence 998642 36788899999999999999999999999999999999997 889999999998765543333334457889
Q ss_pred ccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC---CCCCCCCC-CCC
Q psy14556 972 YMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA---PPQISRSV-SVP 1047 (1181)
Q Consensus 972 Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~---~~~ip~~l-~~~ 1047 (1181)
|+|||.+.+...+..+|+ ||+|+++|+|++|+.||...+...... ....+... ...
T Consensus 182 y~~PE~~~~~~~~~~~Dv--------------------~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (286)
T cd06614 182 WMAPEVIKRKDYGPKVDI--------------------WSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEK 241 (286)
T ss_pred cCCHhHhcCCCCCCcccc--------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhh
Confidence 999999876544333333 999999999999999998766533211 11111111 122
Q ss_pred CCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1048 GPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1048 ~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.+..+..++.+|++.+|..||+..+.
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~~i 267 (286)
T cd06614 242 WSPEFKDFLNKCLVKDPEKRPSAEEL 267 (286)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHH
Confidence 67789999999999999999976554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=275.84 Aligned_cols=238 Identities=27% Similarity=0.351 Sum_probs=187.2
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.+||+|+||.||+|.+..+++.|++|.+..... ...+.+.+|+.++++++|+||+++++++...+..+++|||++++.
T Consensus 7 ~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~ 86 (288)
T cd07833 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTL 86 (288)
T ss_pred EEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCH
Confidence 369999999999999999999999999865432 335678999999999999999999999999999999999998877
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC-CCcccc
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP-SAETFT 967 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~-~~~t~~ 967 (1181)
+..+... ...+++..++.++.|++.||.|||++|++|+||+|+||+++. ++.+||+|||.+........ ......
T Consensus 87 l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~-~~~~kl~d~g~~~~~~~~~~~~~~~~~ 162 (288)
T cd07833 87 LELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSE-SGVLKLCDFGFARALRARPASPLTDYV 162 (288)
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC-CCCEEEEeeecccccCCCccccccCcc
Confidence 7665543 234788999999999999999999999999999999999998 89999999999987665432 223456
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc------------
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV------------ 1035 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~------------ 1035 (1181)
++..|+|||++.+.. .++...|+ ||+|+++|+|++|+.||.+....+..
T Consensus 163 ~~~~~~~PE~~~~~~-~~~~~~Dv------------------~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (288)
T cd07833 163 ATRWYRAPELLVGDT-NYGKPVDV------------------WAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPP 223 (288)
T ss_pred cccCCcCCchhcCCC-CcCchhhH------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 789999999997551 22223333 99999999999999999865432100
Q ss_pred ------------CCCCCC---------CCCCCCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1036 ------------APPQIS---------RSVSVPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1036 ------------~~~~ip---------~~l~~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
.....+ ...+...+..+..++.+|+..+|..||+..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 280 (288)
T cd07833 224 SHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCD 280 (288)
T ss_pred HHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHH
Confidence 000000 011112366788899999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=270.11 Aligned_cols=240 Identities=23% Similarity=0.307 Sum_probs=187.8
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
++||+|+||.||++.+. .+..+|+|.+..... ....+.+|+.++++++||||+++++++......+++|||+++++|.
T Consensus 10 ~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 87 (256)
T cd05112 10 QEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLS 87 (256)
T ss_pred eeecCcccceEEEEEEe-CCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHH
Confidence 36999999999999875 366899998865433 3457899999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC-CccccCC
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS-AETFTGT 969 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~-~~t~~GT 969 (1181)
+++.... ..+++..++.++.|++.||+|||+++++|+||||+||+++. ++.++|+|||.+......... .....++
T Consensus 88 ~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 164 (256)
T cd05112 88 DYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGE-NQVVKVSDFGMTRFVLDDQYTSSTGTKFP 164 (256)
T ss_pred HHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcC-CCeEEECCCcceeecccCcccccCCCccc
Confidence 9987542 24678889999999999999999999999999999999987 889999999998765432111 1122346
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--CCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--ISRSVSV 1046 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--ip~~l~~ 1046 (1181)
..|+|||.+.++.++..+|+ ||+|+++|+|++ |..||.......+..... .....+.
T Consensus 165 ~~~~aPe~~~~~~~~~~~Dv--------------------~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (256)
T cd05112 165 VKWSSPEVFSFSKYSSKSDV--------------------WSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPR 224 (256)
T ss_pred hhhcCHhHhccCCcChHHHH--------------------HHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCC
Confidence 78999999976554433333 999999999998 999998766544322111 1111123
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHHHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNTNLV 1076 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~~~~ 1076 (1181)
..+..+..++.+|+..+|..||+ +.+.+.
T Consensus 225 ~~~~~~~~l~~~~l~~~p~~Rp~-~~~~l~ 253 (256)
T cd05112 225 LASQSVYELMQHCWKERPEDRPS-FSLLLH 253 (256)
T ss_pred CCCHHHHHHHHHHcccChhhCCC-HHHHHH
Confidence 35678888999999999999985 444443
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=287.22 Aligned_cols=246 Identities=22% Similarity=0.272 Sum_probs=186.1
Q ss_pred eeecccCceEEEEEEEcC-----CCeEEEEEEecCCCC-CChhHHHHHHHHHHhc-CCCCeeeEcccccc-CCcEEEEEe
Q psy14556 811 IELGKGSYGVVYAARELD-----RQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQL-RHRNIVQYLGSVSE-EGYFKIFME 882 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~-----tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d-~~~l~LVmE 882 (1181)
++||+|+||.||+|.+.. +++.||+|++..... ...+.+.+|+.++.++ +||||+++++++.. ...++++||
T Consensus 13 ~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~e 92 (337)
T cd05054 13 KPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVE 92 (337)
T ss_pred cccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEe
Confidence 479999999999997543 457899999864432 2245678899999999 89999999998754 467899999
Q ss_pred ecCCCCcccchhcccC----------------------------------------------------------CCCCCh
Q psy14556 883 QVPGGSLSTLLRVKWG----------------------------------------------------------PLKENE 904 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~----------------------------------------------------------~~~l~e 904 (1181)
|+++++|.+++..... ...+++
T Consensus 93 y~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 172 (337)
T cd05054 93 YCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTL 172 (337)
T ss_pred cCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCH
Confidence 9999999998864311 125678
Q ss_pred HHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC--CccccCCccccCchhhccCC
Q psy14556 905 STMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS--AETFTGTLQYMAPEVIDKGQ 982 (1181)
Q Consensus 905 ~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~--~~t~~GT~~Y~APEvl~gg~ 982 (1181)
..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||++..+...... .....++..|+|||++.+..
T Consensus 173 ~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~-~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 251 (337)
T cd05054 173 EDLISYSFQVARGMEFLASRKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKV 251 (337)
T ss_pred HHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeC-CCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCC
Confidence 889999999999999999999999999999999997 889999999999876432211 12234567899999998765
Q ss_pred CCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCccccc-C--CCCCCCCCCCCCCcchHHhhcc
Q psy14556 983 RGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALV-A--PPQISRSVSVPGPGGINSSSSA 1058 (1181)
Q Consensus 983 ~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~-~--~~~ip~~l~~~~p~~L~~li~r 1058 (1181)
++.++|+ ||+||++|+|++ |..||.+....+.. . ........+...+..+..++.+
T Consensus 252 ~~~~~Di--------------------~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 311 (337)
T cd05054 252 YTTQSDV--------------------WSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLD 311 (337)
T ss_pred CCccccH--------------------HHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHH
Confidence 5554444 999999999998 99999875432210 0 0111112223456678889999
Q ss_pred CCCCCCCCCchhHHHHHHhc
Q psy14556 1059 PVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1059 ~la~dPs~Rp~s~~~~~~al 1078 (1181)
|+..+|..||+ +.+.+..+
T Consensus 312 cl~~~p~~RPs-~~ell~~l 330 (337)
T cd05054 312 CWHNNPEDRPT-FSELVEIL 330 (337)
T ss_pred HccCChhhCcC-HHHHHHHH
Confidence 99999999985 44444433
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=272.14 Aligned_cols=231 Identities=23% Similarity=0.305 Sum_probs=184.9
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCC---hhHHHHHHHHH-HhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD---VQPLHEEIKLH-SQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~---~e~f~rEi~IL-~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.||+|+||.||+|.+..+++.||+|.+++..... ...+..|..++ ...+||||+++++++...+.+|+|+||++++
T Consensus 3 ~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 82 (260)
T cd05611 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGG 82 (260)
T ss_pred cCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCC
Confidence 5899999999999999999999999997543221 22344454443 4558999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|.++++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++. ++.++|+|||++..... .....
T Consensus 83 ~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~~----~~~~~ 154 (260)
T cd05611 83 DCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQ-TGHLKLTDFGLSRNGLE----NKKFV 154 (260)
T ss_pred CHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC-CCcEEEeecccceeccc----cccCC
Confidence 999999743 35778889999999999999999999999999999999988 88999999998875432 23345
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC-----CCCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA-----PPQISR 1042 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~-----~~~ip~ 1042 (1181)
++..|+|||.+.+...+. ..|+ ||+|+++|+|++|..||...+...+.. ....+.
T Consensus 155 ~~~~y~~pe~~~~~~~~~--~~Dv------------------~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 214 (260)
T cd05611 155 GTPDYLAPETILGVGDDK--MSDW------------------WSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPE 214 (260)
T ss_pred CCcCccChhhhcCCCCcc--hhhh------------------HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 888999999997654333 3333 999999999999999998776544311 122233
Q ss_pred CCCCCCCcchHHhhccCCCCCCCCCchh
Q psy14556 1043 SVSVPGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1043 ~l~~~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
......+..+..++.+|++.+|..||..
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~ 242 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGA 242 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCC
Confidence 3333567888999999999999999963
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=267.97 Aligned_cols=242 Identities=28% Similarity=0.412 Sum_probs=198.7
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
+.||.|+||.||++.+..++..+++|.+..... ...+.+.+|+++++.++|||++++++.+...+..++++||+++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~ 85 (258)
T cd08215 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGD 85 (258)
T ss_pred eeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCc
Confidence 469999999999999998999999999976544 345678999999999999999999999999999999999999999
Q ss_pred cccchhccc-CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 889 LSTLLRVKW-GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 889 L~dlL~~~~-~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
|.+++.... ....+++..++.++.|++.||.|||++|++|+||+|+||+++. ++.++|+|||.+..............
T Consensus 86 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~ 164 (258)
T cd08215 86 LSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTS-NGLVKLGDFGISKVLSSTVDLAKTVV 164 (258)
T ss_pred HHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcC-CCcEEECCccceeecccCcceeccee
Confidence 999987542 1356789999999999999999999999999999999999987 89999999999987655433334456
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCC--CCCCCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAP--PQISRSVS 1045 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~--~~ip~~l~ 1045 (1181)
|++.|+|||.+.+...+...|+ |++|+++|+|++|+.||.......+... .......+
T Consensus 165 ~~~~y~~pe~~~~~~~~~~~Dv--------------------~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 224 (258)
T cd08215 165 GTPYYLSPELCQNKPYNYKSDI--------------------WSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIP 224 (258)
T ss_pred eeecccChhHhccCCCCccccH--------------------HHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCC
Confidence 8899999999876554443333 9999999999999999987765443211 11122233
Q ss_pred CCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1046 VPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1046 ~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
...+..+..++.+|+..+|..||+..+.
T Consensus 225 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l 252 (258)
T cd08215 225 SQYSSELRNLVSSLLQKDPEERPSIAQI 252 (258)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 3567788999999999999999986554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=276.69 Aligned_cols=241 Identities=22% Similarity=0.247 Sum_probs=185.3
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcC-CCCeeeEccccccCCc-----EEEEEe
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLR-HRNIVQYLGSVSEEGY-----FKIFME 882 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~-HPNIVkl~g~~~d~~~-----l~LVmE 882 (1181)
..||+|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.+. ||||+++++++...+. .|+|||
T Consensus 7 ~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e 86 (295)
T cd07837 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFE 86 (295)
T ss_pred eEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEee
Confidence 3699999999999999999999999998654322 3456889999999995 6999999998876655 899999
Q ss_pred ecCCCCcccchhcccC--CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC
Q psy14556 883 QVPGGSLSTLLRVKWG--PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC 960 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~--~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~ 960 (1181)
|+++ +|.+++..... ...+++..++.++.||+.||.|||++||+||||||+||+++..++.+||+|||++..+....
T Consensus 87 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~ 165 (295)
T cd07837 87 YLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV 165 (295)
T ss_pred ccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCCc
Confidence 9975 78888764321 24678999999999999999999999999999999999998757899999999987654332
Q ss_pred CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc-----
Q psy14556 961 PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV----- 1035 (1181)
Q Consensus 961 ~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~----- 1035 (1181)
.......+++.|+|||.+.+.. .++...|+ ||+|+++|+|++|..||.+.+.....
T Consensus 166 ~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di------------------~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~ 226 (295)
T cd07837 166 KSYTHEIVTLWYRAPEVLLGST-HYSTPVDI------------------WSVGCIFAEMSRKQPLFPGDSELQQLLHIFK 226 (295)
T ss_pred cccCCcccccCCCChHHhhCCC-CCCchHHH------------------HHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 2223335788999999986432 23333444 99999999999999999876532210
Q ss_pred ---CC---------------------CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1036 ---AP---------------------PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1036 ---~~---------------------~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
.+ +.......+..+..+..++.+|+..+|..||+.-
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~ 286 (295)
T cd07837 227 LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAK 286 (295)
T ss_pred HhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHH
Confidence 00 0000111134567788899999999999999743
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=268.57 Aligned_cols=239 Identities=28% Similarity=0.420 Sum_probs=195.9
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.+||+|++|.||++.+..+++.|++|.+..... ...+.+.+|++++++++|||++++++++.+.+..+++|||+++++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (254)
T cd06627 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGS 85 (254)
T ss_pred eEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCc
Confidence 479999999999999998999999999976654 345679999999999999999999999999999999999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|.+++... ..+++..++.++.|++.||.+||++|++||||||+||+++. ++.++|+|||.+..............+
T Consensus 86 L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~ 161 (254)
T cd06627 86 LRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTK-DGVVKLADFGVATKLNDVSKDDASVVG 161 (254)
T ss_pred HHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECC-CCCEEEeccccceecCCCccccccccc
Confidence 99998743 46789999999999999999999999999999999999998 899999999999877654433344568
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCC--CCCCCCCCC
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAP--PQISRSVSV 1046 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~--~~ip~~l~~ 1046 (1181)
+..|+|||.+.+.. .+...|+ |++|+++|+|++|..||........... .......+.
T Consensus 162 ~~~y~~pe~~~~~~--~~~~~Dv------------------~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 221 (254)
T cd06627 162 TPYWMAPEVIEMSG--ASTASDI------------------WSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPE 221 (254)
T ss_pred chhhcCHhhhcCCC--CCcchhH------------------HHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCC
Confidence 89999999986544 2333333 9999999999999999987654221110 111122334
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
..+..+..++.+|+..+|..||+..+.
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~ 248 (254)
T cd06627 222 GISPELKDFLMQCFQKDPNLRPTAKQL 248 (254)
T ss_pred CCCHHHHHHHHHHHhCChhhCcCHHHH
Confidence 567788999999999999999975443
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=273.16 Aligned_cols=231 Identities=23% Similarity=0.286 Sum_probs=182.2
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
+||+|+||.||++.+..++..+|+|.+........ |+.....+ +||||+++++.+...+..++||||+++++|.
T Consensus 23 ~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~ 97 (267)
T PHA03390 23 KLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLF 97 (267)
T ss_pred eecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHH
Confidence 47999999999999999999999999876533221 22222222 7999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCC-eeeeecCCcccccccCCCCCccccCC
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSG-VVKISDFGTSKRLAGLCPSAETFTGT 969 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g-~vKLiDFGlAk~l~~~~~~~~t~~GT 969 (1181)
+++... ..+++..++.++.|+++||.|||+.|++||||||+||+++. ++ .++|+|||.+...... ....++
T Consensus 98 ~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~-~~~~~~l~dfg~~~~~~~~----~~~~~~ 169 (267)
T PHA03390 98 DLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDR-AKDRIYLCDYGLCKIIGTP----SCYDGT 169 (267)
T ss_pred HHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeC-CCCeEEEecCccceecCCC----ccCCCC
Confidence 999754 26789999999999999999999999999999999999988 55 9999999998765432 234588
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc-----cCCCCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL-----VAPPQISRSV 1044 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l-----~~~~~ip~~l 1044 (1181)
..|+|||++.+..++.. .|+ ||+|+++|+|++|+.||.......+ ..........
T Consensus 170 ~~y~aPE~~~~~~~~~~--~Dv------------------wslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 229 (267)
T PHA03390 170 LDYFSPEKIKGHNYDVS--FDW------------------WAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPF 229 (267)
T ss_pred CcccChhhhcCCCCCch--hhH------------------HHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCc
Confidence 99999999976554433 333 9999999999999999986544322 1111111122
Q ss_pred CCCCCcchHHhhccCCCCCCCCCchhHHHHH
Q psy14556 1045 SVPGPGGINSSSSAPVTPTPHSRHISVNTNL 1075 (1181)
Q Consensus 1045 ~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~ 1075 (1181)
....+..+..++.+++..+|..|+.++++.+
T Consensus 230 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 230 IKNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred ccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 2246677888999999999999998766654
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=293.56 Aligned_cols=247 Identities=21% Similarity=0.224 Sum_probs=188.4
Q ss_pred ceeecccCceEEEEEEEc-----CCCeEEEEEEecCCCCC-ChhHHHHHHHHHHhcC-CCCeeeEccccccCCcEEEEEe
Q psy14556 810 RIELGKGSYGVVYAAREL-----DRQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLR-HRNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~-----~tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~-HPNIVkl~g~~~d~~~l~LVmE 882 (1181)
.++||+|+||.||+|++. .+++.||+|++...... ..+.+.+|+.++.++. ||||+++++++...+..++|||
T Consensus 42 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E 121 (401)
T cd05107 42 GRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITE 121 (401)
T ss_pred hhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEe
Confidence 347999999999999864 34578999999754322 2457889999999997 9999999999999999999999
Q ss_pred ecCCCCcccchhcccC----------------------------------------------------------------
Q psy14556 883 QVPGGSLSTLLRVKWG---------------------------------------------------------------- 898 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~---------------------------------------------------------------- 898 (1181)
|+++|+|.++++....
T Consensus 122 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (401)
T cd05107 122 YCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKY 201 (401)
T ss_pred ccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhh
Confidence 9999999999864311
Q ss_pred -------------------------------CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeee
Q psy14556 899 -------------------------------PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKI 947 (1181)
Q Consensus 899 -------------------------------~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKL 947 (1181)
...+++..+..++.||+.||.|||+++++||||||+|||++. ++.+||
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~-~~~~kL 280 (401)
T cd05107 202 ADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICE-GKLVKI 280 (401)
T ss_pred hhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeC-CCEEEE
Confidence 113456677889999999999999999999999999999987 889999
Q ss_pred ecCCcccccccCCC--CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCC
Q psy14556 948 SDFGTSKRLAGLCP--SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTA 1024 (1181)
Q Consensus 948 iDFGlAk~l~~~~~--~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~ 1024 (1181)
+|||+++....... ......++..|+|||.+.+..++.. .|+ ||+|+++|||++ |+.
T Consensus 281 ~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~--~Dv------------------wslGvil~e~l~~g~~ 340 (401)
T cd05107 281 CDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTL--SDV------------------WSFGILLWEIFTLGGT 340 (401)
T ss_pred EecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcH--hHH------------------HHHHHHHHHHHHcCCC
Confidence 99999976532211 1122346788999999976544333 333 999999999998 899
Q ss_pred CCCCCCcccccCC---CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1025 ALKKKTSRALVAP---PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1025 PF~~~~~~~l~~~---~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
||......+.... .......+...+..+..++.+|+..+|..||... +.+..+
T Consensus 341 P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~-ell~~L 396 (401)
T cd05107 341 PYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFS-QLVHLV 396 (401)
T ss_pred CCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHH-HHHHHH
Confidence 9987554332100 0111122334577888999999999999999744 444333
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=275.43 Aligned_cols=246 Identities=18% Similarity=0.197 Sum_probs=190.2
Q ss_pred eeecccCceEEEEEEEcC----CCeEEEEEEecCCC-CCChhHHHHHHHHHHhcCCCCeeeEcccccc-CCcEEEEEeec
Q psy14556 811 IELGKGSYGVVYAARELD----RQVKLAIKEIPEKN-LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSE-EGYFKIFMEQV 884 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~----tg~~VAIKii~~~~-~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d-~~~l~LVmEy~ 884 (1181)
+.||+|+||.||+|.+.. ++..|++|.+.... ....+.+.+|+.++++++||||+++++++.. ....++++||+
T Consensus 12 ~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~ 91 (280)
T cd05043 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYM 91 (280)
T ss_pred eeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcC
Confidence 479999999999999876 35789999886442 2235668899999999999999999998655 57789999999
Q ss_pred CCCCcccchhcccCC-----CCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccC
Q psy14556 885 PGGSLSTLLRVKWGP-----LKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGL 959 (1181)
Q Consensus 885 ~gGSL~dlL~~~~~~-----~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~ 959 (1181)
++++|.+++...... ..+++..++.++.|++.||+|||+++++||||||+||+++. ++.+||+|||+++.+...
T Consensus 92 ~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~-~~~~kl~d~g~~~~~~~~ 170 (280)
T cd05043 92 NWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDE-ELQVKITDNALSRDLFPM 170 (280)
T ss_pred CCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcC-CCcEEECCCCCcccccCC
Confidence 999999998754222 46789999999999999999999999999999999999987 799999999999765432
Q ss_pred CCC--CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccC
Q psy14556 960 CPS--AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVA 1036 (1181)
Q Consensus 960 ~~~--~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~ 1036 (1181)
... .....++..|+|||++.+..++.. .|+ ||+|+++|++++ |+.||...+..++..
T Consensus 171 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~--~Di------------------~slG~~l~el~~~g~~p~~~~~~~~~~~ 230 (280)
T cd05043 171 DYHCLGDNENRPVKWMALESLVNKEYSSA--SDV------------------WSFGVLLWELMTLGQTPYVEIDPFEMAA 230 (280)
T ss_pred ceEEeCCCCCcchhccCHHHHhcCCCCch--hhH------------------HHhHHHHHHHhcCCCCCcCcCCHHHHHH
Confidence 111 112335678999999976544333 333 999999999999 999998876544322
Q ss_pred CC--CCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1037 PP--QISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1037 ~~--~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
.. ..........+..+..++.+|+..+|..||+ +.+.+..+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~~~~~~~l 273 (280)
T cd05043 231 YLKDGYRLAQPINCPDELFAVMACCWALDPEERPS-FSQLVQCL 273 (280)
T ss_pred HHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCC-HHHHHHHH
Confidence 11 1111123345778999999999999999985 44444443
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-29 Score=273.94 Aligned_cols=247 Identities=26% Similarity=0.317 Sum_probs=189.2
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhc-CCCCeeeEccccccC-----CcEE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEE-----GYFK 878 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~-----~~l~ 878 (1181)
.|.... .||+|+||.||++.+..+++.+|+|.+..... ..+.+.+|+.+++++ +||||+++++++... +..+
T Consensus 23 ~y~~~~-~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~ 100 (291)
T cd06639 23 TWEIIE-TIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW 100 (291)
T ss_pred CeEEEE-EeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence 344433 69999999999999999999999999865422 245678899999999 899999999988643 4689
Q ss_pred EEEeecCCCCcccchhccc-CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccc
Q psy14556 879 IFMEQVPGGSLSTLLRVKW-GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 957 (1181)
Q Consensus 879 LVmEy~~gGSL~dlL~~~~-~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~ 957 (1181)
+||||+++++|.++++... ....+++..++.++.|++.||+|||++|++|+||||+||+++. ++.+||+|||++....
T Consensus 101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~-~~~~kl~dfg~~~~~~ 179 (291)
T cd06639 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTT-EGGVKLVDFGVSAQLT 179 (291)
T ss_pred EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcC-CCCEEEeecccchhcc
Confidence 9999999999999886321 2345788999999999999999999999999999999999987 7899999999988765
Q ss_pred cCCCCCccccCCccccCchhhccCCC---CCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc
Q psy14556 958 GLCPSAETFTGTLQYMAPEVIDKGQR---GYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL 1034 (1181)
Q Consensus 958 ~~~~~~~t~~GT~~Y~APEvl~gg~~---~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l 1034 (1181)
..........|+..|+|||++..+.. .++...|+ ||+||++|+|++|+.||........
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di------------------~slGvi~~el~~g~~p~~~~~~~~~ 241 (291)
T cd06639 180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDV------------------WSLGITAIELGDGDPPLFDMHPVKT 241 (291)
T ss_pred cccccccCccCCccccChhhhcCCCCcccccCCccch------------------HHHHHHHHHHhhCCCCCCCCcHHHH
Confidence 43333334568899999999864321 12223333 9999999999999999987654321
Q ss_pred cCC---CCCCC-CCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1035 VAP---PQISR-SVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1035 ~~~---~~ip~-~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
... ...+. ..+...+..+..++.+|+..+|..||...+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 283 (291)
T cd06639 242 LFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTH 283 (291)
T ss_pred HHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHH
Confidence 111 10111 112234567888999999999999997443
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=271.48 Aligned_cols=236 Identities=23% Similarity=0.342 Sum_probs=184.4
Q ss_pred cccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 806 FALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 806 ~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
|.+. ..||+|+||.||++.. +++.||+|.++... ..+.+.+|+.++++++||||+++++++... ..+++|||++
T Consensus 8 ~~~~-~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 8 LTLG-EIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred ceee-eeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4443 3699999999999864 67789999986432 346789999999999999999999998765 4799999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcc
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAET 965 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t 965 (1181)
+++|.+++... ....+++..++.++.|++.||.|||++|++||||||+||+++. ++.+||+|||.+...... ...
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~-~~~~kl~Dfg~~~~~~~~---~~~ 156 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSE-DGVAKVSDFGLARVGSMG---VDN 156 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC-CCcEEECCCccceecccc---CCC
Confidence 99999999754 3445788889999999999999999999999999999999987 889999999998754321 112
Q ss_pred ccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCC--CCCC
Q psy14556 966 FTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPP--QISR 1042 (1181)
Q Consensus 966 ~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~--~ip~ 1042 (1181)
...+..|+|||.+.++..+...|+ ||+|+++|+|++ |..||............ ....
T Consensus 157 ~~~~~~y~~pe~~~~~~~~~~~Dv--------------------~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 216 (254)
T cd05083 157 SKLPVKWTAPEALKHKKFSSKSDV--------------------WSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM 216 (254)
T ss_pred CCCCceecCHHHhccCCcCchhhH--------------------HHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCC
Confidence 234578999999876544333333 999999999997 99999877654422111 1111
Q ss_pred CCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1043 SVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1043 ~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
......+..+..++.+|+..+|..||...+
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 246 (254)
T cd05083 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHK 246 (254)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 122345678889999999999999996433
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-29 Score=273.92 Aligned_cols=239 Identities=23% Similarity=0.306 Sum_probs=182.1
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC-hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD-VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~-~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
++||+|+||.||+|.+..++..|++|.+....... ...+.+|+.+++.++|+||+++++++...+..|+||||+. ++|
T Consensus 11 ~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l 89 (291)
T cd07870 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDL 89 (291)
T ss_pred EEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCH
Confidence 36999999999999999999999999996554332 3467899999999999999999999999999999999995 666
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT 969 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT 969 (1181)
.+++... ...+++..+..++.|++.||.|||++||+|+||||+||+++. ++.+||+|||+++.............++
T Consensus 90 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~ 166 (291)
T cd07870 90 AQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISY-LGELKLADFGLARAKSIPSQTYSSEVVT 166 (291)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcC-CCcEEEeccccccccCCCCCCCCCcccc
Confidence 6665432 234567788889999999999999999999999999999987 8899999999987654333233334578
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc--c-------------
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA--L------------- 1034 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~--l------------- 1034 (1181)
+.|+|||.+.+.. .++...|+ ||+|+++|+|++|..||.+..... +
T Consensus 167 ~~y~aPE~~~~~~-~~~~~~Dv------------------~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 227 (291)
T cd07870 167 LWYRPPDVLLGAT-DYSSALDI------------------WGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTED 227 (291)
T ss_pred ccccCCceeecCC-CCCcHHHH------------------HHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChh
Confidence 9999999986432 12223333 999999999999999998654310 0
Q ss_pred -----cCCCC---------CCCCC-----CCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1035 -----VAPPQ---------ISRSV-----SVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1035 -----~~~~~---------ip~~l-----~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
...+. .+... ....+..+.+++.+|+..+|..||+..+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~ 284 (291)
T cd07870 228 TWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQD 284 (291)
T ss_pred hhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHH
Confidence 00000 00000 0122456778999999999999996433
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=274.67 Aligned_cols=233 Identities=24% Similarity=0.310 Sum_probs=179.4
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCC---hhHHHHHHH---HHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD---VQPLHEEIK---LHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~---~e~f~rEi~---IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
.||+|+||.||+|.+..+++.||+|.+.+..... ...+..|.. .++...||+|+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3899999999999999999999999997653321 122334433 4444589999999999999999999999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcc
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAET 965 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t 965 (1181)
|++|..++... ..+++..++.++.|++.||.|||+++++||||||+||+++. ++.+||+|||++..+... ....
T Consensus 81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~-~~~~kl~dfg~~~~~~~~--~~~~ 154 (278)
T cd05606 81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE-HGHVRISDLGLACDFSKK--KPHA 154 (278)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECC-CCCEEEccCcCccccCcc--CCcC
Confidence 99999888643 35789999999999999999999999999999999999987 889999999998765432 2233
Q ss_pred ccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC----CCCCC
Q psy14556 966 FTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA----PPQIS 1041 (1181)
Q Consensus 966 ~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~----~~~ip 1041 (1181)
..|+..|+|||++.++. .++..+|+ ||+|+++|+|++|+.||.......... .....
T Consensus 155 ~~~~~~y~aPE~~~~~~-~~~~~~Di------------------~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 215 (278)
T cd05606 155 SVGTHGYMAPEVLQKGV-AYDSSADW------------------FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 215 (278)
T ss_pred cCCCcCCcCcHHhcCCC-CCCcccch------------------HhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccC
Confidence 46899999999996432 23333444 999999999999999998764322111 01111
Q ss_pred CCCCCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1042 RSVSVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1042 ~~l~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
...+...+..+..++.+++..+|..|+.
T Consensus 216 ~~~~~~~s~~~~~li~~~l~~~p~~R~~ 243 (278)
T cd05606 216 VELPDSFSPELRSLLEGLLQRDVNRRLG 243 (278)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCHHhccC
Confidence 2222334667777888888888888883
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=273.60 Aligned_cols=239 Identities=23% Similarity=0.335 Sum_probs=189.3
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.+||+|+||.||+|.+..++..|++|++..... ...+.+.+|+.++++++||||+++++++...+..++||||+ +++
T Consensus 6 ~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~ 84 (286)
T cd07832 6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSD 84 (286)
T ss_pred eecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCC
Confidence 369999999999999999999999999976543 23567899999999999999999999999999999999999 999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC-CCcccc
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP-SAETFT 967 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~-~~~t~~ 967 (1181)
|.+++.... ..+++..++.++.||+.||+|||++|++|+||||+||+++. ++.++|+|||.+........ ......
T Consensus 85 L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~ 161 (286)
T cd07832 85 LSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISA-DGVLKIADFGLARLFSEEEPRLYSHQV 161 (286)
T ss_pred HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcC-CCcEEEeeeeecccccCCCCCcccccc
Confidence 999987542 45789999999999999999999999999999999999998 89999999999987654321 123346
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc------------
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV------------ 1035 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~------------ 1035 (1181)
++..|+|||.+.+.. .+....|+ ||+|+++|+|++|.+||.+.......
T Consensus 162 ~~~~y~aPE~~~~~~-~~~~~~Di------------------~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (286)
T cd07832 162 ATRWYRAPELLYGAR-KYDPGVDL------------------WAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNE 222 (286)
T ss_pred CcccccCceeeeccc-cCCchhHH------------------HHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCCh
Confidence 889999999986432 12223333 99999999999998888765532110
Q ss_pred ------------CCCCCCC-------CCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1036 ------------APPQISR-------SVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1036 ------------~~~~ip~-------~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
.....+. ......+..+..++.+|+..+|.+||+..+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 278 (286)
T cd07832 223 ETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAE 278 (286)
T ss_pred HHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHH
Confidence 0000000 111234577788999999999999997443
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=289.90 Aligned_cols=191 Identities=21% Similarity=0.305 Sum_probs=159.2
Q ss_pred eeecccCceEEEEEEEc--CCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAAREL--DRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~--~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.+||+|+||.||+|... .+++.|++|.+... +...+|+.++++++||||+++++++...+..+++||++ +++
T Consensus 98 ~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~ 171 (392)
T PHA03207 98 SSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY-KCD 171 (392)
T ss_pred EeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc-CCC
Confidence 47999999999999754 35678999988543 23568999999999999999999999999999999999 467
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC--CCccc
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP--SAETF 966 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~--~~~t~ 966 (1181)
|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.+..... .....
T Consensus 172 l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~-~~~~~l~DfG~a~~~~~~~~~~~~~~~ 247 (392)
T PHA03207 172 LFTYVDR---SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDE-PENAVLGDFGAACKLDAHPDTPQCYGW 247 (392)
T ss_pred HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcC-CCCEEEccCccccccCccccccccccc
Confidence 8887742 346788999999999999999999999999999999999988 89999999999976654322 12345
Q ss_pred cCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCc
Q psy14556 967 TGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTS 1031 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~ 1031 (1181)
.||+.|+|||++.+..++.. .|+ ||+||++|+|++|+.||.+...
T Consensus 248 ~gt~~y~aPE~~~~~~~~~~--~Dv------------------wslGvil~el~~g~~pf~~~~~ 292 (392)
T PHA03207 248 SGTLETNSPELLALDPYCAK--TDI------------------WSAGLVLFEMSVKNVTLFGKQV 292 (392)
T ss_pred ccccCccCHhHhcCCCCCch--hhH------------------HHHHHHHHHHHHCCCCCCCCCC
Confidence 69999999999976554433 333 9999999999999999987653
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-29 Score=271.24 Aligned_cols=243 Identities=24% Similarity=0.298 Sum_probs=184.3
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC-ChhHHHHHHHH-HHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG-DVQPLHEEIKL-HSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~-~~e~f~rEi~I-L~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.+||+|+||.||++.+..+++.||+|.++..... ....+..|+.+ ++.++||||+++++++..++..|++|||++ ++
T Consensus 7 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~ 85 (283)
T cd06617 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TS 85 (283)
T ss_pred EEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-cc
Confidence 3699999999999999999999999999765332 23445566665 566799999999999999999999999995 78
Q ss_pred cccchhcc-cCCCCCChHHHHHHHHHHHhhhhhcccc-ceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccc
Q psy14556 889 LSTLLRVK-WGPLKENESTMSFYTKQILEGLKYLHGQ-KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF 966 (1181)
Q Consensus 889 L~dlL~~~-~~~~~l~e~~i~~Ia~QIa~AL~yLHs~-gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~ 966 (1181)
|.+++... .....+++..++.++.|++.||+|||++ +++||||||+||+++. ++.+||+|||++....... .....
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~-~~~~kl~dfg~~~~~~~~~-~~~~~ 163 (283)
T cd06617 86 LDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINR-NGQVKLCDFGISGYLVDSV-AKTID 163 (283)
T ss_pred HHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECC-CCCEEEeeccccccccccc-ccccc
Confidence 88777642 1335688999999999999999999997 9999999999999988 8999999999987654321 12234
Q ss_pred cCCccccCchhhccCCC--CCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCc--ccccC--CCCC
Q psy14556 967 TGTLQYMAPEVIDKGQR--GYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTS--RALVA--PPQI 1040 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~--~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~--~~l~~--~~~i 1040 (1181)
.++..|+|||.+.+... .++...|+ ||+|+++|+|++|+.||..... ..+.. ....
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~~~~Di------------------~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd06617 164 AGCKPYMAPERINPELNQKGYDVKSDV------------------WSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS 225 (283)
T ss_pred cCCccccChhhcCCcccccccCccccc------------------hhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC
Confidence 58889999999864221 12222333 9999999999999999975322 11111 0111
Q ss_pred CCCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1041 SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1041 p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
+.......+..+..++.+|+..+|..||...+..
T Consensus 226 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il 259 (283)
T cd06617 226 PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELL 259 (283)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 1111223567788999999999999999865553
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=270.82 Aligned_cols=240 Identities=24% Similarity=0.361 Sum_probs=187.8
Q ss_pred eecccCceEEEEEEEcC-CCeEEEEEEecCCCC----------CChhHHHHHHHHHHh-cCCCCeeeEccccccCCcEEE
Q psy14556 812 ELGKGSYGVVYAARELD-RQVKLAIKEIPEKNL----------GDVQPLHEEIKLHSQ-LRHRNIVQYLGSVSEEGYFKI 879 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~-tg~~VAIKii~~~~~----------~~~e~f~rEi~IL~~-L~HPNIVkl~g~~~d~~~l~L 879 (1181)
.||+|+||.||+|.+.. +++.+|+|.+..... .....+.+|+.++.+ ++||||+++++++.+.+..++
T Consensus 7 ~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~l 86 (269)
T cd08528 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYI 86 (269)
T ss_pred hhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEE
Confidence 69999999999999887 678999998854321 123457778888865 799999999999999999999
Q ss_pred EEeecCCCCcccchhcc-cCCCCCChHHHHHHHHHHHhhhhhccc-cceecccCCCCCcccccCCCeeeeecCCcccccc
Q psy14556 880 FMEQVPGGSLSTLLRVK-WGPLKENESTMSFYTKQILEGLKYLHG-QKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 957 (1181)
Q Consensus 880 VmEy~~gGSL~dlL~~~-~~~~~l~e~~i~~Ia~QIa~AL~yLHs-~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~ 957 (1181)
+|||+++++|.+++... .....+++..++.++.|++.||.|||+ .|++|+||||+||+++. ++.+||+|||.+....
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~-~~~~~l~dfg~~~~~~ 165 (269)
T cd08528 87 VMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGE-DDKVTITDFGLAKQKQ 165 (269)
T ss_pred EEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECC-CCcEEEecccceeecc
Confidence 99999999999988542 234467889999999999999999996 78999999999999988 8899999999997655
Q ss_pred cCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCC
Q psy14556 958 GLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAP 1037 (1181)
Q Consensus 958 ~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~ 1037 (1181)
... ......++..|+|||.+.++..+. ..|+ ||+|+++|+|++|+.||...........
T Consensus 166 ~~~-~~~~~~~~~~~~~Pe~~~~~~~~~--~~Dv------------------~slG~ll~~l~~g~~p~~~~~~~~~~~~ 224 (269)
T cd08528 166 PES-KLTSVVGTILYSCPEIVKNEPYGE--KADV------------------WAFGCILYQMCTLQPPFYSTNMLSLATK 224 (269)
T ss_pred ccc-ccccccCcccCcChhhhcCCCCch--HHHH------------------HHHHHHHHHHHhCCCcccccCHHHHHHH
Confidence 432 233456889999999997654333 3333 9999999999999999987655332111
Q ss_pred ---CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1038 ---PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1038 ---~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
...........+..+..++.+|+..+|..||...+.
T Consensus 225 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~ 263 (269)
T cd08528 225 IVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQV 263 (269)
T ss_pred HhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHH
Confidence 111111112456788999999999999999964443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=289.68 Aligned_cols=238 Identities=24% Similarity=0.329 Sum_probs=198.7
Q ss_pred eecccCceEEEEEEEcC----CCeEEEEEEecCC-CCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCC
Q psy14556 812 ELGKGSYGVVYAARELD----RQVKLAIKEIPEK-NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~----tg~~VAIKii~~~-~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
+||.|-||.||.|.... ....||||..+.+ .....+.|..|+.+|+.++||||++++|++.+. ..|||||.++-
T Consensus 396 ~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL~~~ 474 (974)
T KOG4257|consen 396 LIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMELAPL 474 (974)
T ss_pred hhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEecccc
Confidence 69999999999998643 2346999999774 445688999999999999999999999999875 58999999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC-Ccc
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS-AET 965 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~-~~t 965 (1181)
|.|..+|+.+ ...++......++.||+.||.|||++.+|||||..+|||+.. ...+||+|||+++.+.....- .+.
T Consensus 475 GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsS-p~CVKLaDFGLSR~~ed~~yYkaS~ 551 (974)
T KOG4257|consen 475 GELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSS-PQCVKLADFGLSRYLEDDAYYKASR 551 (974)
T ss_pred hhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecC-cceeeecccchhhhccccchhhccc
Confidence 9999999865 345667888889999999999999999999999999999988 789999999999988754322 222
Q ss_pred ccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCCCCC--
Q psy14556 966 FTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQISR-- 1042 (1181)
Q Consensus 966 ~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~ip~-- 1042 (1181)
..-...|||||.+....++..+|| |-||+.+||++. |..||.+....+++..+.-.+
T Consensus 552 ~kLPIKWmaPESINfRrFTtASDV--------------------WMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRl 611 (974)
T KOG4257|consen 552 GKLPIKWMAPESINFRRFTTASDV--------------------WMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERL 611 (974)
T ss_pred cccceeecCccccchhcccchhhH--------------------HHHHHHHHHHHHhcCCccccccccceEEEecCCCCC
Confidence 334678999999986665555555 999999999976 889999998887765554333
Q ss_pred CCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1043 SVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1043 ~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
+.++.+|+.+..+..+||+-+|++||.+-+.
T Consensus 612 P~P~nCPp~LYslmskcWayeP~kRPrftei 642 (974)
T KOG4257|consen 612 PCPPNCPPALYSLMSKCWAYEPSKRPRFTEI 642 (974)
T ss_pred CCCCCCChHHHHHHHHHhccCcccCCcHHHH
Confidence 3456789999999999999999999986555
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=283.82 Aligned_cols=247 Identities=22% Similarity=0.289 Sum_probs=183.3
Q ss_pred eeecccCceEEEEEEE-----cCCCeEEEEEEecCCCCC-ChhHHHHHHHHHHhc-CCCCeeeEccccccC-CcEEEEEe
Q psy14556 811 IELGKGSYGVVYAARE-----LDRQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQL-RHRNIVQYLGSVSEE-GYFKIFME 882 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d-----~~tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~-~~l~LVmE 882 (1181)
++||+|+||.||+|.+ ..+++.||+|+++..... ....+.+|+.++.++ +||||+++++++... ...+++||
T Consensus 13 ~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~e 92 (343)
T cd05103 13 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVE 92 (343)
T ss_pred ccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEe
Confidence 3699999999999985 346789999999754332 345688999999999 689999999987554 56899999
Q ss_pred ecCCCCcccchhcccC----------------------------------------------------------------
Q psy14556 883 QVPGGSLSTLLRVKWG---------------------------------------------------------------- 898 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~---------------------------------------------------------------- 898 (1181)
|+++|+|.+++.....
T Consensus 93 y~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (343)
T cd05103 93 FCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLY 172 (343)
T ss_pred ccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhh
Confidence 9999999998864311
Q ss_pred CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC--CCccccCCccccCch
Q psy14556 899 PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP--SAETFTGTLQYMAPE 976 (1181)
Q Consensus 899 ~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~--~~~t~~GT~~Y~APE 976 (1181)
...+++..+..++.||+.||+|||++||+||||||+||+++. ++.+||+|||++........ ......++..|+|||
T Consensus 173 ~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 251 (343)
T cd05103 173 KKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE-NNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 251 (343)
T ss_pred hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcC-CCcEEEEecccccccccCcchhhcCCCCCCcceECcH
Confidence 123567778889999999999999999999999999999987 88999999999876532211 111233567899999
Q ss_pred hhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCccc-ccC--CCCCCCCCCCCCCcch
Q psy14556 977 VIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRA-LVA--PPQISRSVSVPGPGGI 1052 (1181)
Q Consensus 977 vl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~-l~~--~~~ip~~l~~~~p~~L 1052 (1181)
.+.+..++..+|+ ||+|+++|+|++ |..||....... +.. ........+...+..+
T Consensus 252 ~~~~~~~~~~~Di--------------------~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (343)
T cd05103 252 TIFDRVYTIQSDV--------------------WSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEM 311 (343)
T ss_pred HhcCCCCCchhhH--------------------HHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHH
Confidence 9976544433333 999999999997 999997654321 110 0001111122345567
Q ss_pred HHhhccCCCCCCCCCchhHHHHHHhcc
Q psy14556 1053 NSSSSAPVTPTPHSRHISVNTNLVCTG 1079 (1181)
Q Consensus 1053 ~~li~r~la~dPs~Rp~s~~~~~~al~ 1079 (1181)
.+++.+|+..+|..||+ +.+.+..++
T Consensus 312 ~~~~~~cl~~~p~~Rps-~~eil~~l~ 337 (343)
T cd05103 312 YQTMLDCWHGEPSQRPT-FSELVEHLG 337 (343)
T ss_pred HHHHHHHccCChhhCcC-HHHHHHHHH
Confidence 88999999999999985 555544443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=267.32 Aligned_cols=235 Identities=27% Similarity=0.360 Sum_probs=192.9
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEecCCCCC---ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLG---DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 813 IG~G~fG~VYka~d~~tg~~VAIKii~~~~~~---~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
||+|+||.||++.+..+++.+++|.+...... ....+..|+.++++++||||+++++.+..++..+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999888999999999765432 345788999999999999999999999999999999999999999
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT 969 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT 969 (1181)
.+++... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++. ++.++|+|||.+..............++
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDA-DGHIKLTDFGLAKELSSEGSRTNTFCGT 156 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcC-CCcEEEeecCcceecccCCCcccCCcCC
Confidence 9998744 35788999999999999999999999999999999999988 8899999999997765432333445688
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-CCCCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-ISRSVSVPG 1048 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-ip~~l~~~~ 1048 (1181)
..|+|||.+.+...+..+|+ |++|+++|++++|..||.......+..... .....+...
T Consensus 157 ~~~~~Pe~~~~~~~~~~~D~--------------------~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 216 (250)
T cd05123 157 PEYLAPEVLLGKGYGKAVDW--------------------WSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFL 216 (250)
T ss_pred ccccChHHhCCCCCCchhhH--------------------HHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence 99999999976543333333 999999999999999998776433211111 112233445
Q ss_pred CcchHHhhccCCCCCCCCCchhH
Q psy14556 1049 PGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1049 p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
+..+..++.+|+..+|..||+..
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~ 239 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSG 239 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCcc
Confidence 77888999999999999999863
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=269.05 Aligned_cols=236 Identities=32% Similarity=0.496 Sum_probs=185.4
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCC-----CCChhHHHHHHHHHHhcCCCCeeeEccccccC--CcEEEEEee
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKN-----LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEE--GYFKIFMEQ 883 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~-----~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~--~~l~LVmEy 883 (1181)
+.||+|+||.||+|.+..+++.|++|.+.... ....+.+.+|+.++++++||||+++++++.+. +.+++++||
T Consensus 8 ~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~ 87 (264)
T cd06653 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEY 87 (264)
T ss_pred eeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEe
Confidence 37999999999999999999999999885431 12345788999999999999999999988654 568899999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC---
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC--- 960 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~--- 960 (1181)
+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++. ++.++|+|||+++......
T Consensus 88 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~-~~~~~l~dfg~~~~~~~~~~~~ 163 (264)
T cd06653 88 MPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDS-AGNVKLGDFGASKRIQTICMSG 163 (264)
T ss_pred CCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC-CCCEEECccccccccccccccC
Confidence 9999999998743 24678888999999999999999999999999999999987 8899999999997654321
Q ss_pred CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCC---
Q psy14556 961 PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAP--- 1037 (1181)
Q Consensus 961 ~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~--- 1037 (1181)
.......++..|+|||.+.+...+..+|+ ||+|+++|+|++|+.||...........
T Consensus 164 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di--------------------~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 223 (264)
T cd06653 164 TGIKSVTGTPYWMSPEVISGEGYGRKADV--------------------WSVACTVVEMLTEKPPWAEYEAMAAIFKIAT 223 (264)
T ss_pred ccccccCCcccccCHhhhcCCCCCccccH--------------------HHHHHHHHHHHhCCCCCCccCHHHHHHHHHc
Confidence 11223458899999999976544333333 9999999999999999987654332111
Q ss_pred CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1038 PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1038 ~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
.......+...+..+..++.+|+. +|.+||...
T Consensus 224 ~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~ 256 (264)
T cd06653 224 QPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAE 256 (264)
T ss_pred CCCCCCCCcccCHHHHHHHHHHhc-CcccCccHH
Confidence 112223344566778889999988 578888644
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=270.89 Aligned_cols=244 Identities=23% Similarity=0.337 Sum_probs=189.3
Q ss_pred eeecccCceEEEEEEEc----CCCeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEcccccc--CCcEEEEEee
Q psy14556 811 IELGKGSYGVVYAAREL----DRQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSE--EGYFKIFMEQ 883 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~----~tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d--~~~l~LVmEy 883 (1181)
.+||+|+||.||+|.+. .++..+|+|.+...... ..+.+.+|+.+++.++||||+++++++.. ....+++|||
T Consensus 10 ~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 89 (284)
T cd05038 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEY 89 (284)
T ss_pred eeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEec
Confidence 36999999999999864 34789999999766543 35679999999999999999999998877 5679999999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC-
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS- 962 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~- 962 (1181)
+++++|.+++... ...+++..++.++.|++.||+|||++|++|+||||+||+++. ++.++|+|||.+.........
T Consensus 90 ~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~~~~~~~ 166 (284)
T cd05038 90 LPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVES-EDLVKISDFGLAKVLPEDKDYY 166 (284)
T ss_pred CCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcC-CCCEEEcccccccccccCCcce
Confidence 9999999999754 224788899999999999999999999999999999999988 799999999999876532111
Q ss_pred --CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc-----
Q psy14556 963 --AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV----- 1035 (1181)
Q Consensus 963 --~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~----- 1035 (1181)
.....++..|+|||.+.+...+..+|+ ||+|+++|+|++|..||.......+.
T Consensus 167 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di--------------------~slG~~l~el~tg~~p~~~~~~~~~~~~~~~ 226 (284)
T cd05038 167 YVKEPGESPIFWYAPECLRTSKFSSASDV--------------------WSFGVTLYELFTYGDPSQSPPAEFLRMIGIA 226 (284)
T ss_pred eccCCCCCcccccCcHHHccCCCCcccch--------------------HHHhhhhheeeccCCCcccccchhccccccc
Confidence 111234567999999976654444444 99999999999999998764432211
Q ss_pred ----------C--CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1036 ----------A--PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1036 ----------~--~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
. ........+...+..+..++.+|+..+|..||. +.+.+..+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt-~~ei~~~l 280 (284)
T cd05038 227 QGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPS-FADLILIV 280 (284)
T ss_pred cccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCC-HHHHHHHH
Confidence 0 000111122345677889999999999999995 55544433
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=271.53 Aligned_cols=238 Identities=24% Similarity=0.320 Sum_probs=186.9
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
++||.|++|.||+|.+..++..|++|++...... ..+.+.+|+.+++.++||||+++++++.+.+..+++|||+ +++
T Consensus 5 ~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~-~~~ 83 (283)
T cd07835 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLD 83 (283)
T ss_pred eEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc-CcC
Confidence 4699999999999999999999999999755322 2356889999999999999999999999999999999999 568
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|.+++... ....+++..++.++.|++.||+|||+++++||||+|+||+++. ++.++|+|||.+..............+
T Consensus 84 l~~~~~~~-~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~ 161 (283)
T cd07835 84 LKKYMDSS-PLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDR-EGALKLADFGLARAFGVPVRTYTHEVV 161 (283)
T ss_pred HHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcC-CCcEEEeecccccccCCCccccCcccc
Confidence 98888754 2245789999999999999999999999999999999999998 899999999999765433222233356
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc-------------
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV------------- 1035 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~------------- 1035 (1181)
+..|+|||++.+.. .++...|+ ||+|+++|+|++|+.||...+.....
T Consensus 162 ~~~~~aPE~~~~~~-~~~~~~Di------------------~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 222 (283)
T cd07835 162 TLWYRAPEILLGSR-QYSTPVDI------------------WSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDED 222 (283)
T ss_pred ccCCCCCceeecCc-ccCcHHHH------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChH
Confidence 88999999886432 12223333 99999999999999999866531100
Q ss_pred ------C-----------CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchh
Q psy14556 1036 ------A-----------PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1036 ------~-----------~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
. ............+..+..++.+|++.+|..||+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 274 (283)
T cd07835 223 VWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISA 274 (283)
T ss_pred HhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCH
Confidence 0 0000111123455678889999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=285.59 Aligned_cols=185 Identities=23% Similarity=0.333 Sum_probs=154.6
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
.+||+|+||.||+|++..+++.||+|+.... ....|+.++++++||||+++++++...+..++|||++ .++|.
T Consensus 72 ~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~ 144 (357)
T PHA03209 72 KTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLY 144 (357)
T ss_pred EEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CCcHH
Confidence 4799999999999999999999999985433 2357999999999999999999999999999999999 56888
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCc
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL 970 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~ 970 (1181)
+++... ...+++..++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..... .......||+
T Consensus 145 ~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~~~~-~~~~~~~gt~ 220 (357)
T PHA03209 145 TYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIND-VDQVCIGDLGAAQFPVVA-PAFLGLAGTV 220 (357)
T ss_pred HHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC-CCCEEEecCccccccccC-cccccccccc
Confidence 877643 345788999999999999999999999999999999999987 889999999998753321 2233456899
Q ss_pred cccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCC
Q psy14556 971 QYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAAL 1026 (1181)
Q Consensus 971 ~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF 1026 (1181)
.|+|||++.+..++.. .|+ ||+||++|||+++..|+
T Consensus 221 ~y~aPE~~~~~~~~~~--~Di------------------wSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 221 ETNAPEVLARDKYNSK--ADI------------------WSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccCCeecCCCCCCch--hhH------------------HHHHHHHHHHHHcCCcc
Confidence 9999999976654433 333 99999999999866554
|
|
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-30 Score=285.67 Aligned_cols=229 Identities=29% Similarity=0.379 Sum_probs=187.6
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
+||+|+||.|.+|..+.+.+.+|||++++... .+.+--+.|-++|... +-|.+++++.+|+.-+++|+||||+.||
T Consensus 356 VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGG 435 (683)
T KOG0696|consen 356 VLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGG 435 (683)
T ss_pred EeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCc
Confidence 69999999999999999999999999987733 3455567788888776 5789999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|-..++.- + .+.+..+..++.+|+-||-+||++||++||||.+||||+. +|++||+|||+++.---......+++
T Consensus 436 DLMyhiQQ~-G--kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~-eGHiKi~DFGmcKEni~~~~TTkTFC 511 (683)
T KOG0696|consen 436 DLMYHIQQV-G--KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS-EGHIKIADFGMCKENIFDGVTTKTFC 511 (683)
T ss_pred hhhhHHHHh-c--ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEecc-CCceEeeecccccccccCCcceeeec
Confidence 998888754 3 4557788889999999999999999999999999999998 89999999999986555555677899
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC-----CCCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA-----PPQISR 1042 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~-----~~~ip~ 1042 (1181)
|||.|+|||++... .|+..+|+ ||+|++||||+.|++||++++..++.. ....|+
T Consensus 512 GTPdYiAPEIi~Yq--PYgksvDW------------------Wa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPK 571 (683)
T KOG0696|consen 512 GTPDYIAPEIIAYQ--PYGKSVDW------------------WAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPK 571 (683)
T ss_pred CCCcccccceEEec--ccccchhH------------------HHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcc
Confidence 99999999999754 45666665 889999999999999999999887643 233555
Q ss_pred CCCCCCCcchHHhhccCCCCCCCCCc
Q psy14556 1043 SVSVPGPGGINSSSSAPVTPTPHSRH 1068 (1181)
Q Consensus 1043 ~l~~~~p~~L~~li~r~la~dPs~Rp 1068 (1181)
+++........ ..+.+.|.+|-
T Consensus 572 slSkEAv~ick----g~ltK~P~kRL 593 (683)
T KOG0696|consen 572 SLSKEAVAICK----GLLTKHPGKRL 593 (683)
T ss_pred cccHHHHHHHH----HHhhcCCcccc
Confidence 55444433333 34455555543
|
|
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-30 Score=277.86 Aligned_cols=253 Identities=23% Similarity=0.257 Sum_probs=198.8
Q ss_pred HHHHhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcE
Q psy14556 799 MLRFLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYF 877 (1181)
Q Consensus 799 ~~~~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l 877 (1181)
-.+|.+.|.+..+.||+|+|+.|-.+....++.+||||++.+.....+.++.+|++++.++ .|+||++++++|+++..+
T Consensus 72 ~g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F 151 (463)
T KOG0607|consen 72 SGKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF 151 (463)
T ss_pred cchHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE
Confidence 3457788888888999999999999999999999999999888666788999999999999 599999999999999999
Q ss_pred EEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCC--eeeeecCCcccc
Q psy14556 878 KIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSG--VVKISDFGTSKR 955 (1181)
Q Consensus 878 ~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g--~vKLiDFGlAk~ 955 (1181)
|||||.|.||+|...++++ ..+++..+..+.++|+.||.|||.+||.||||||+|||....+. -+|||||.+...
T Consensus 152 YLVfEKm~GGplLshI~~~---~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg 228 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKR---KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSG 228 (463)
T ss_pred EEEEecccCchHHHHHHHh---hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccc
Confidence 9999999999999988854 46889999999999999999999999999999999999865222 589999988754
Q ss_pred ccc-------CCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCC
Q psy14556 956 LAG-------LCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKK 1028 (1181)
Q Consensus 956 l~~-------~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~ 1028 (1181)
+.- ..+...+.+|+..|||||+..- - ......|+..-+.||||+|||-||.|.+||.|
T Consensus 229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~-f--------------v~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG 293 (463)
T KOG0607|consen 229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDV-F--------------VDQATFYDKRCDLWSLGVILYIMLSGYPPFVG 293 (463)
T ss_pred cccCCCCCCCCCccccCcccchhhcchhHHhh-h--------------ccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence 321 1123345779999999999841 0 01122344555559999999999999999998
Q ss_pred CCcccc--------------------cCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1029 KTSRAL--------------------VAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1029 ~~~~~l--------------------~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
....+- .....+|......++..-..++...+..++..|-.
T Consensus 294 ~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rls 354 (463)
T KOG0607|consen 294 HCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLS 354 (463)
T ss_pred ccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhh
Confidence 766431 11223444444444555555666666666666654
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=272.68 Aligned_cols=239 Identities=25% Similarity=0.318 Sum_probs=185.8
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEccccccC--CcEEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSEE--GYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~--~~l~LVmEy~~gG 887 (1181)
.||.|+||.||+|.+..+++.+++|.++..... ....+.+|+.++++++||||+++++++... +..|+||||++ +
T Consensus 12 ~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~ 90 (293)
T cd07843 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-H 90 (293)
T ss_pred hhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-c
Confidence 699999999999999999999999999654332 234567899999999999999999998776 89999999996 5
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|.+++.... ..+++..++.++.|++.||+|||++|++|+||||+||+++. ++.+||+|||++..............
T Consensus 91 ~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~-~~~~~l~d~g~~~~~~~~~~~~~~~~ 167 (293)
T cd07843 91 DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNN-RGILKICDFGLAREYGSPLKPYTQLV 167 (293)
T ss_pred CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECC-CCcEEEeecCceeeccCCcccccccc
Confidence 8988887542 25789999999999999999999999999999999999998 89999999999987655433333345
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCC----------
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAP---------- 1037 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~---------- 1037 (1181)
+++.|+|||.+.+.. ..+...|+ ||+|+++|+|++|..||...........
T Consensus 168 ~~~~~~aPE~~~~~~-~~~~~~Di------------------~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 228 (293)
T cd07843 168 VTLWYRAPELLLGAK-EYSTAIDM------------------WSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTE 228 (293)
T ss_pred ccccccCchhhcCCc-cccchhhH------------------HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCch
Confidence 788999999986432 12333333 9999999999999999986653221000
Q ss_pred ---------C-------------CCCCCCCCC-CCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1038 ---------P-------------QISRSVSVP-GPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1038 ---------~-------------~ip~~l~~~-~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
+ .+....+.. .+..+..++.+|+..+|.+||+..+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~el 287 (293)
T cd07843 229 KIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDA 287 (293)
T ss_pred HHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHH
Confidence 0 000111111 35667889999999999999974443
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=265.91 Aligned_cols=240 Identities=28% Similarity=0.361 Sum_probs=194.4
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
++||+|+||.||++.+..+++.+++|.+..... .....+.+|+.++++++||||+++++++.+....++||||+++++
T Consensus 6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (256)
T cd08530 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGD 85 (256)
T ss_pred eeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCC
Confidence 479999999999999999999999999975432 234567899999999999999999999999999999999999999
Q ss_pred cccchhccc-CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 889 LSTLLRVKW-GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 889 L~dlL~~~~-~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
|.+++.... ....+++..++.++.|++.||.|||+.|++|+||+|+||+++. ++.+||+|||++...... ......
T Consensus 86 L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~-~~~~kl~d~g~~~~~~~~--~~~~~~ 162 (256)
T cd08530 86 LSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVA-NDLVKIGDLGISKVLKKN--MAKTQI 162 (256)
T ss_pred HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEec-CCcEEEeeccchhhhccC--Cccccc
Confidence 999986521 2346788899999999999999999999999999999999998 889999999999776543 222345
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC--CCCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ--ISRSVS 1045 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~--ip~~l~ 1045 (1181)
++..|+|||.+.+...+..+|+ ||+|+++|+|++|+.||...+...+..... .....+
T Consensus 163 ~~~~~~~Pe~~~~~~~~~~~D~--------------------~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 222 (256)
T cd08530 163 GTPHYMAPEVWKGRPYSYKSDI--------------------WSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIP 222 (256)
T ss_pred CCccccCHHHHCCCCCCchhhH--------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCc
Confidence 8899999999976544333333 999999999999999998877644321111 111222
Q ss_pred CCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1046 VPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1046 ~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
...+..+..++.+|+..+|..||+..+.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~ 250 (256)
T cd08530 223 PIYSQDLQNFIRSMLQVKPKLRPNCDKI 250 (256)
T ss_pred hhhCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 3556778899999999999999975443
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=270.73 Aligned_cols=241 Identities=27% Similarity=0.367 Sum_probs=188.0
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEcccccc--CCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSE--EGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d--~~~l~LVmEy~~gG 887 (1181)
++||.|++|.||++.+..+++.+|+|.+..... .....+.+|++++++++||||+++++++.+ .+.+++||||++++
T Consensus 7 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~ 86 (287)
T cd06621 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGG 86 (287)
T ss_pred EEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCC
Confidence 379999999999999999999999999975533 234678999999999999999999998854 35789999999999
Q ss_pred Ccccchhcc-cCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccc
Q psy14556 888 SLSTLLRVK-WGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF 966 (1181)
Q Consensus 888 SL~dlL~~~-~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~ 966 (1181)
+|.+++... .....+++..+..++.||+.||.|||+.|++|+||+|+||+++. ++.++|+|||++....... ....
T Consensus 87 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~-~~~~~l~dfg~~~~~~~~~--~~~~ 163 (287)
T cd06621 87 SLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTR-KGQVKLCDFGVSGELVNSL--AGTF 163 (287)
T ss_pred CHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEec-CCeEEEeeccccccccccc--cccc
Confidence 999887632 12345788889999999999999999999999999999999987 8899999999987554321 1234
Q ss_pred cCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc-----cc----c--
Q psy14556 967 TGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR-----AL----V-- 1035 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~-----~l----~-- 1035 (1181)
.++..|+|||.+.+..++...|+ |++|+++|+|++|..||...... ++ .
T Consensus 164 ~~~~~y~~pE~~~~~~~~~~~Dv--------------------~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 223 (287)
T cd06621 164 TGTSFYMAPERIQGKPYSITSDV--------------------WSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM 223 (287)
T ss_pred cCCccccCHHHhcCCCCCchhhH--------------------HHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC
Confidence 57889999999976544433333 99999999999999999876321 10 0
Q ss_pred CCCCCCCCCC--CCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1036 APPQISRSVS--VPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1036 ~~~~ip~~l~--~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
..+.++.... ...+..+..++.+|+..+|..||+..+..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil 264 (287)
T cd06621 224 PNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDML 264 (287)
T ss_pred CchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 0111111111 12345688899999999999999865543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=279.50 Aligned_cols=199 Identities=22% Similarity=0.335 Sum_probs=162.7
Q ss_pred eeccc--CceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 812 ELGKG--SYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G--~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
+||.| +||+||++++..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++..++..++||||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999999999999999998754322 3467889999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC-----
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS----- 962 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~----- 962 (1181)
+|.+++... ....+++..+..++.|++.||+|||++|++||||||+||+++. ++.++++||+.+.........
T Consensus 85 ~l~~~l~~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 85 SANSLLKTY-FPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISG-DGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeC-CCcEEEechHHHhhhhccCccccccc
Confidence 999998754 2345788899999999999999999999999999999999987 789999999865432211111
Q ss_pred --CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCC
Q psy14556 963 --AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKT 1030 (1181)
Q Consensus 963 --~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~ 1030 (1181)
.....++..|+|||++.++...++...|+ ||+||++|+|++|+.||.+..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di------------------wslG~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDI------------------YSVGITACELATGRVPFQDML 214 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhH------------------HHHHHHHHHHHhCCCCCCCcC
Confidence 11123466799999997654444555555 999999999999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=272.13 Aligned_cols=237 Identities=22% Similarity=0.343 Sum_probs=186.4
Q ss_pred eeecccCceEEEEEEEc---CCCeEEEEEEecCCCC----CChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEe
Q psy14556 811 IELGKGSYGVVYAAREL---DRQVKLAIKEIPEKNL----GDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~---~tg~~VAIKii~~~~~----~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmE 882 (1181)
.+||.|+||.||+|++. .++..||+|.+..... ...+.+.+|+.+++++ +|+||+++++.+..++..++|||
T Consensus 6 ~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (290)
T cd05613 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILD 85 (290)
T ss_pred eeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEe
Confidence 36999999999999874 4788999999965422 2246688899999999 69999999999999999999999
Q ss_pred ecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC-C
Q psy14556 883 QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC-P 961 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~-~ 961 (1181)
|+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++. ++.+||+|||++....... .
T Consensus 86 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~-~~~~kl~dfg~~~~~~~~~~~ 161 (290)
T cd05613 86 YINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDS-NGHVVLTDFGLSKEFHEDEVE 161 (290)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECC-CCCEEEeeCccceeccccccc
Confidence 99999999998743 35678888899999999999999999999999999999988 8999999999987654322 1
Q ss_pred CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc----ccCC
Q psy14556 962 SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA----LVAP 1037 (1181)
Q Consensus 962 ~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~----l~~~ 1037 (1181)
......|+..|+|||.+.++....+...|+ ||+|+++|+|++|..||....... +...
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv------------------~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~ 223 (290)
T cd05613 162 RAYSFCGTIEYMAPDIVRGGDGGHDKAVDW------------------WSMGVLMYELLTGASPFTVDGEKNSQAEISRR 223 (290)
T ss_pred ccccccCCcccCChhhccCCCCCCCccccH------------------HHHHHHHHHHhcCCCCCCcCCccccHHHHHHH
Confidence 222355889999999987543333444444 999999999999999997543211 1110
Q ss_pred C-CCCCCCCCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1038 P-QISRSVSVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1038 ~-~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
. ......+...+..+..++.+|+..+|..|+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~ 256 (290)
T cd05613 224 ILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLG 256 (290)
T ss_pred hhccCCCCCccCCHHHHHHHHHHhcCCHHHhcC
Confidence 0 0111223345677888999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=270.96 Aligned_cols=236 Identities=26% Similarity=0.396 Sum_probs=192.0
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhcC-CCCeeeEccccccCCcEEEEEeecCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLR-HRNIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L~-HPNIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
..||+|+||.||++.+..++..|++|++.+... ...+.+.+|+.++++++ ||||+++++++.+.+..++|||++++
T Consensus 7 ~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (280)
T cd05581 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPN 86 (280)
T ss_pred eeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCC
Confidence 369999999999999999999999999965422 22456889999999998 99999999999999999999999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC-----
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP----- 961 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~----- 961 (1181)
++|.+++... ..+++..++.++.|++.||.+||+.|++|+||||+||+++. ++.++|+|||++........
T Consensus 87 ~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~-~~~~~l~df~~~~~~~~~~~~~~~~ 162 (280)
T cd05581 87 GELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDK-DMHIKITDFGTAKVLDPNSSPESNK 162 (280)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECC-CCCEEecCCccccccCCccccccCC
Confidence 9999999754 26789999999999999999999999999999999999987 89999999999876654321
Q ss_pred ---------------CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCC
Q psy14556 962 ---------------SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAAL 1026 (1181)
Q Consensus 962 ---------------~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF 1026 (1181)
......++..|+|||.+.+...+...|+ ||+|+++|++++|+.||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di--------------------~slG~~l~~l~~g~~p~ 222 (280)
T cd05581 163 GDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDL--------------------WALGCIIYQMLTGKPPF 222 (280)
T ss_pred CCCccccccccccccccccccCCccccCHHHhCCCCCChhhhH--------------------HHHHHHHHHHHhCCCCC
Confidence 1123457889999999876543333333 99999999999999999
Q ss_pred CCCCcccccCC-CCCCCCCCCCCCcchHHhhccCCCCCCCCCchh
Q psy14556 1027 KKKTSRALVAP-PQISRSVSVPGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1027 ~~~~~~~l~~~-~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
........... .......+...+..+..++.+|+..+|..||+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 267 (280)
T cd05581 223 RGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGV 267 (280)
T ss_pred CCccHHHHHHHHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCc
Confidence 97764332111 112223334557788899999999999999986
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-29 Score=294.62 Aligned_cols=193 Identities=22% Similarity=0.248 Sum_probs=154.7
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCC------CCeeeEccccccC-CcEEEEEee
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRH------RNIVQYLGSVSEE-GYFKIFMEQ 883 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~H------PNIVkl~g~~~d~-~~l~LVmEy 883 (1181)
.+||+|+||+||+|.+..+++.||||+++... ........|+.+++.++| ++++++++++... +++|+|||+
T Consensus 135 ~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~ 213 (467)
T PTZ00284 135 SLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPK 213 (467)
T ss_pred EEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEec
Confidence 47999999999999999999999999996432 223456678888877754 4588888888654 578999998
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccc-cceecccCCCCCcccccCC---------------Ceeee
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHG-QKIVHRDIKGDNVLVNTYS---------------GVVKI 947 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs-~gIVHrDLKP~NILLd~~~---------------g~vKL 947 (1181)
+ |++|.+++... ..+++..+..++.||+.||+|||+ .|||||||||+|||++..+ ..+||
T Consensus 214 ~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl 289 (467)
T PTZ00284 214 Y-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRI 289 (467)
T ss_pred c-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEE
Confidence 8 78888887643 357788999999999999999997 5999999999999997622 15999
Q ss_pred ecCCcccccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCC
Q psy14556 948 SDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALK 1027 (1181)
Q Consensus 948 iDFGlAk~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~ 1027 (1181)
+|||.+.... .......||+.|+|||++.+..++. .+|+ ||+||++|||++|+.||.
T Consensus 290 ~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~--~~Di------------------wSlGvil~elltG~~pf~ 346 (467)
T PTZ00284 290 CDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMY--STDM------------------WSMGCIIYELYTGKLLYD 346 (467)
T ss_pred CCCCccccCc---cccccccCCccccCcHHhhcCCCCc--HHHH------------------HHHHHHHHHHHhCCCCCC
Confidence 9999876432 2233467999999999998665443 3444 999999999999999998
Q ss_pred CCCc
Q psy14556 1028 KKTS 1031 (1181)
Q Consensus 1028 ~~~~ 1031 (1181)
+.+.
T Consensus 347 ~~~~ 350 (467)
T PTZ00284 347 THDN 350 (467)
T ss_pred CCCh
Confidence 7664
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=277.99 Aligned_cols=200 Identities=24% Similarity=0.342 Sum_probs=162.9
Q ss_pred HhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCC--CCChhHHHHHHHHHHhcCCCCeeeEccccccC-----
Q psy14556 802 FLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKN--LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEE----- 874 (1181)
Q Consensus 802 ~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~--~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~----- 874 (1181)
+...|...+ .||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~-~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLK-PIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEE-EeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 344455443 6999999999999999999999999986532 23345678899999999999999999987543
Q ss_pred -CcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcc
Q psy14556 875 -GYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTS 953 (1181)
Q Consensus 875 -~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlA 953 (1181)
...|+||||+. ++|.+.+... +++..+..++.|++.||+|||++||+||||||+||+++. ++.+||+|||++
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~-~~~~kL~Dfg~~ 165 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-DCTLKILDFGLA 165 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC-CCCEEEccCccc
Confidence 35799999995 5777776532 678889999999999999999999999999999999988 889999999999
Q ss_pred cccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCC
Q psy14556 954 KRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKT 1030 (1181)
Q Consensus 954 k~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~ 1030 (1181)
+...... ......++..|+|||.+.+...+...|+ ||+||++|+|++|+.||...+
T Consensus 166 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv--------------------wslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 166 RTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDI--------------------WSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred eeCCCCC-CCCCCcccccccCHHHHhCCCCCCchhh--------------------HhHHHHHHHHHHCCCCCCCCC
Confidence 8765422 2233457899999999976554433333 999999999999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=271.03 Aligned_cols=242 Identities=24% Similarity=0.287 Sum_probs=185.4
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCC-ChhHHHHHHHHHHhcC-CCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLR-HRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~-HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
+||+|+||.||++.+..+++.||+|.+...... ....+.+|+.++.++. ||||+++++++..++..+++|||+. +++
T Consensus 11 ~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l 89 (288)
T cd06616 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-ISL 89 (288)
T ss_pred HhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCH
Confidence 699999999999999999999999998754332 3456889999999996 9999999999998999999999984 565
Q ss_pred ccchhc--ccCCCCCChHHHHHHHHHHHhhhhhcccc-ceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccc
Q psy14556 890 STLLRV--KWGPLKENESTMSFYTKQILEGLKYLHGQ-KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF 966 (1181)
Q Consensus 890 ~dlL~~--~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~-gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~ 966 (1181)
.++... ......+++..+..++.|++.||+|||+. +++||||||+||+++. ++.+||+|||++..+.... .....
T Consensus 90 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~~~~~~~-~~~~~ 167 (288)
T cd06616 90 DKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDR-NGNIKLCDFGISGQLVDSI-AKTRD 167 (288)
T ss_pred HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEcc-CCcEEEeecchhHHhccCC-ccccc
Confidence 554321 11234678899999999999999999974 9999999999999987 8899999999997654322 12233
Q ss_pred cCCccccCchhhccCC-CCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc--ccc-----CCC
Q psy14556 967 TGTLQYMAPEVIDKGQ-RGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR--ALV-----APP 1038 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~-~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~--~l~-----~~~ 1038 (1181)
.|+..|+|||++.+.. ..++...|+ ||+|+++|+|++|+.||...... .+. ..+
T Consensus 168 ~~~~~y~aPE~~~~~~~~~~~~~~Di------------------~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd06616 168 AGCRPYMAPERIDPSARDGYDVRSDV------------------WSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPP 229 (288)
T ss_pred cCccCccCHHHhccccccCCcchhhh------------------hHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCC
Confidence 5889999999996542 122222333 99999999999999999865421 111 112
Q ss_pred CCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1039 QISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1039 ~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
.++.......+..+.+++.+|+.++|..||+.-+..
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~ 265 (288)
T cd06616 230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELL 265 (288)
T ss_pred cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 222222334677788999999999999999855543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=275.77 Aligned_cols=238 Identities=21% Similarity=0.234 Sum_probs=182.8
Q ss_pred eecccCceEEEEEEEcCCCe----EEEEEEecCCCCCC-hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCC
Q psy14556 812 ELGKGSYGVVYAARELDRQV----KLAIKEIPEKNLGD-VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~----~VAIKii~~~~~~~-~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
.||+|+||.||+|.+..++. .+|+|.+....... ...+.+|+.+++.++||||+++++++... ..++++||+++
T Consensus 14 ~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~ 92 (303)
T cd05110 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPH 92 (303)
T ss_pred ccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCC
Confidence 69999999999999877765 57888886543322 34688999999999999999999988654 46799999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC--Cc
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS--AE 964 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~--~~ 964 (1181)
|+|.+++... ...+++..+..++.|++.||.|||++||+||||||+||+++. ++.+||+|||+++........ ..
T Consensus 93 g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~-~~~~kL~Dfg~~~~~~~~~~~~~~~ 169 (303)
T cd05110 93 GCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKS-PNHVKITDFGLARLLEGDEKEYNAD 169 (303)
T ss_pred CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecC-CCceEEccccccccccCcccccccC
Confidence 9999998754 234678889999999999999999999999999999999987 789999999999876533221 11
Q ss_pred cccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--CC
Q psy14556 965 TFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--IS 1041 (1181)
Q Consensus 965 t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--ip 1041 (1181)
...++..|+|||.+.+...+..+|+ ||+|+++|+|++ |+.||.+.....+..... ..
T Consensus 170 ~~~~~~~y~~PE~~~~~~~~~~~Di--------------------wslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~ 229 (303)
T cd05110 170 GGKMPIKWMALECIHYRKFTHQSDV--------------------WSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGER 229 (303)
T ss_pred CCccccccCCHHHhccCCCChHHHH--------------------HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC
Confidence 2335678999999976544333333 999999999997 999998765443211111 00
Q ss_pred CCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1042 RSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1042 ~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
...+...+..+..++.+|+..+|..||...+.
T Consensus 230 ~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l 261 (303)
T cd05110 230 LPQPPICTIDVYMVMVKCWMIDADSRPKFKEL 261 (303)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 11123345677889999999999999975553
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=295.10 Aligned_cols=188 Identities=25% Similarity=0.300 Sum_probs=157.4
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
.+||+|+||.||+|.+..+++.||+|... ...+.+|+.++++++||||+++++++...+..++|||++ .++|.
T Consensus 175 ~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L~ 247 (461)
T PHA03211 175 RALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDLY 247 (461)
T ss_pred EEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCHH
Confidence 37999999999999999999999999642 234678999999999999999999999999999999999 57888
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC--CCccccC
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP--SAETFTG 968 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~--~~~t~~G 968 (1181)
+++... ...+++..++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|||+++....... ......|
T Consensus 248 ~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~~~G 324 (461)
T PHA03211 248 TYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNG-PEDICLGDFGAACFARGSWSTPFHYGIAG 324 (461)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECC-CCCEEEcccCCceecccccccccccccCC
Confidence 877643 235789999999999999999999999999999999999987 88999999999986643221 1223569
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCC
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKK 1028 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~ 1028 (1181)
|+.|+|||++.+..++..+| + |||||+||||++|..|+..
T Consensus 325 T~~Y~APE~~~~~~~~~~sD--v------------------wSlGviL~El~~g~~~lf~ 364 (461)
T PHA03211 325 TVDTNAPEVLAGDPYTPSVD--I------------------WSAGLVIFEAAVHTASLFS 364 (461)
T ss_pred CcCCcCHHHHcCCCCCchHH--H------------------HHHHHHHHHHHHcCCCccc
Confidence 99999999997665443333 3 9999999999998866543
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=287.82 Aligned_cols=239 Identities=21% Similarity=0.252 Sum_probs=202.7
Q ss_pred eecccCceEEEEEEEcCC---CeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAARELDR---QVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~t---g~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
+||+|.||.|++|.|... ...||||.+...... ....|.+|+.+|.+|+|||++++||+..+ ....+|||+++.|
T Consensus 117 ~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplG 195 (1039)
T KOG0199|consen 117 LLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLG 195 (1039)
T ss_pred HhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccc
Confidence 699999999999998753 357999999877665 57789999999999999999999999987 6788999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCC---c
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA---E 964 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~---~ 964 (1181)
+|.+.|++. ....+.......++.||+.|+.||.++++|||||..+|+|+-. ...+||+|||+.+.+....... .
T Consensus 196 SLldrLrka-~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllas-prtVKI~DFGLmRaLg~ned~Yvm~p 273 (1039)
T KOG0199|consen 196 SLLDRLRKA-KKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLAS-PRTVKICDFGLMRALGENEDMYVMAP 273 (1039)
T ss_pred hHHHHHhhc-cccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecc-cceeeeecccceeccCCCCcceEecC
Confidence 999999873 4556778889999999999999999999999999999999987 7899999999999887543321 1
Q ss_pred cccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCCCCCC
Q psy14556 965 TFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQISRS 1043 (1181)
Q Consensus 965 t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~ip~~ 1043 (1181)
...-...|+|||.+....++..+|| |++|++||||+| |+.||.|.....+...+.-.+.
T Consensus 274 ~rkvPfAWCaPEsLrh~kFShaSDv--------------------WmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er 333 (1039)
T KOG0199|consen 274 QRKVPFAWCAPESLRHRKFSHASDV--------------------WMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER 333 (1039)
T ss_pred CCcCcccccCHhHhccccccccchh--------------------hhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc
Confidence 1223568999999998877777777 999999999998 6799999998776555442222
Q ss_pred C--CCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1044 V--SVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1044 l--~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
+ +..+++.|..++..||+..|..||.+...
T Consensus 334 LpRPk~csedIY~imk~cWah~paDRptFsai 365 (1039)
T KOG0199|consen 334 LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAI 365 (1039)
T ss_pred CCCCCCChHHHHHHHHHhccCCccccccHHHH
Confidence 2 35688899999999999999999998776
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=271.66 Aligned_cols=202 Identities=27% Similarity=0.406 Sum_probs=162.8
Q ss_pred eeecccCceEEEEEEEcC--CCeEEEEEEecCCC---CCChhHHHHHHHHHHhcCCCCeeeEccccccC--CcEEEEEee
Q psy14556 811 IELGKGSYGVVYAARELD--RQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEE--GYFKIFMEQ 883 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~--tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~--~~l~LVmEy 883 (1181)
.+||+|+||.||+|.+.. ++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+. +.+++||||
T Consensus 6 ~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 85 (316)
T cd07842 6 GCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDY 85 (316)
T ss_pred EEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeC
Confidence 369999999999999988 88999999997643 33456788999999999999999999999888 889999999
Q ss_pred cCCCCcccchhccc--CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccccc---CCCeeeeecCCccccccc
Q psy14556 884 VPGGSLSTLLRVKW--GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNT---YSGVVKISDFGTSKRLAG 958 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~--~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~---~~g~vKLiDFGlAk~l~~ 958 (1181)
++ ++|.+++.... ....+++..++.++.|++.||.|||+++|+||||||+||+++. .++.+||+|||++.....
T Consensus 86 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~ 164 (316)
T cd07842 86 AE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA 164 (316)
T ss_pred CC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCC
Confidence 96 46666664321 2236788999999999999999999999999999999999975 257899999999986643
Q ss_pred CCC---CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc
Q psy14556 959 LCP---SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR 1032 (1181)
Q Consensus 959 ~~~---~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~ 1032 (1181)
... ......++..|+|||++.+.. .++...|+ ||+|+++|+|++|+.||.+....
T Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv------------------~slG~~l~~l~~~~~~~~~~~~~ 222 (316)
T cd07842 165 PLKPLADLDPVVVTIWYRAPELLLGAR-HYTKAIDI------------------WAIGCIFAELLTLEPIFKGREAK 222 (316)
T ss_pred CcccccccCCccccccccCHHHHhCCC-CCCcHHHH------------------HHHHHHHHHHHhcCCCCcCCccc
Confidence 322 122345788999999886432 22333333 99999999999999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=276.92 Aligned_cols=250 Identities=22% Similarity=0.305 Sum_probs=189.2
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC--------------hhHHHHHHHHHHhcCCCCeeeEccc
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD--------------VQPLHEEIKLHSQLRHRNIVQYLGS 870 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~--------------~e~f~rEi~IL~~L~HPNIVkl~g~ 870 (1181)
+|......||.|+||+||+|.+..+++.||+|.+....... ...+.+|+.++++++||||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 34333446999999999999999999999999986543221 1247799999999999999999999
Q ss_pred cccCCcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecC
Q psy14556 871 VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDF 950 (1181)
Q Consensus 871 ~~d~~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDF 950 (1181)
+...+..++||||+. ++|.+++... ..+++..+..++.|++.||+|||++|++|+||+|+||+++. ++.++|+||
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~-~~~~kl~df 163 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINS-KGICKIADF 163 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECC-CCCEEECCc
Confidence 999999999999995 6888888643 35778899999999999999999999999999999999987 889999999
Q ss_pred CcccccccC--------------CCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHH
Q psy14556 951 GTSKRLAGL--------------CPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVII 1016 (1181)
Q Consensus 951 GlAk~l~~~--------------~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvIL 1016 (1181)
|.+...... ........++..|+|||.+.+.. .++...|+ ||+|+++
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv------------------~slG~~l 224 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAE-KYHFAVDM------------------WSVGCIF 224 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCC-CCCcHHHH------------------HHHHHHH
Confidence 998765411 11112234678899999986432 22333333 9999999
Q ss_pred HHHHhCCCCCCCCCcccccC--------CCC--CCC-------------------CCCCCCCcchHHhhccCCCCCCCCC
Q psy14556 1017 SQLLVLTAALKKKTSRALVA--------PPQ--ISR-------------------SVSVPGPGGINSSSSAPVTPTPHSR 1067 (1181)
Q Consensus 1017 yELLTGk~PF~~~~~~~l~~--------~~~--ip~-------------------~l~~~~p~~L~~li~r~la~dPs~R 1067 (1181)
|+|++|+.||.+.+...... +.. ++. ......+..+..++.+|+..+|..|
T Consensus 225 ~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 304 (335)
T PTZ00024 225 AELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLER 304 (335)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhc
Confidence 99999999998776432100 000 000 0012335567789999999999999
Q ss_pred chhHHHHHHhc
Q psy14556 1068 HISVNTNLVCT 1078 (1181)
Q Consensus 1068 p~s~~~~~~al 1078 (1181)
|+..+.+...+
T Consensus 305 ~s~~~~l~~~~ 315 (335)
T PTZ00024 305 ISAKEALKHEY 315 (335)
T ss_pred cCHHHHhcCcc
Confidence 97555544333
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=266.90 Aligned_cols=246 Identities=17% Similarity=0.221 Sum_probs=178.5
Q ss_pred eecccCceEEEEEEEcCC--CeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 812 ELGKGSYGVVYAARELDR--QVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~t--g~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
+||+|+||.||++..... ...+++|.+..... ...+.+.+|+.+++.++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975433 34567777755432 335679999999999999999999999999999999999999999
Q ss_pred cccchhcccC-CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC--CCCcc
Q psy14556 889 LSTLLRVKWG-PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC--PSAET 965 (1181)
Q Consensus 889 L~dlL~~~~~-~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~--~~~~t 965 (1181)
|.+++..... ....++..++.++.||+.||+|||+++++||||||+|||++. ++.+||+|||++....... .....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~ 160 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTS-DLTVKVGDYGIGPSRYKEDYIETEDD 160 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcC-CccEEecccccccccCcchhhhcccC
Confidence 9999875422 234566777889999999999999999999999999999987 8899999999886432111 11223
Q ss_pred ccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccC------CC
Q psy14556 966 FTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVA------PP 1038 (1181)
Q Consensus 966 ~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~------~~ 1038 (1181)
..++..|+|||++....... ....+....+.||+|+++|||++ |..||......+... ..
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~-------------~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (268)
T cd05086 161 KCVPLRWLAPELVGEFHGGL-------------ITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQV 227 (268)
T ss_pred CcCcccccCchhcccccCcc-------------ccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccc
Confidence 45788999999985321100 00012223344999999999997 567887665543211 11
Q ss_pred CC-CCCCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1039 QI-SRSVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1039 ~i-p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
.+ ...........+..+++.|+ .+|..||+..+
T Consensus 228 ~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~ 261 (268)
T cd05086 228 KLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEE 261 (268)
T ss_pred ccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHH
Confidence 11 12223345566777888888 67999997444
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=273.85 Aligned_cols=194 Identities=23% Similarity=0.336 Sum_probs=159.6
Q ss_pred CceEEEEEEEcCCCeEEEEEEecCC--CCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcccchh
Q psy14556 817 SYGVVYAARELDRQVKLAIKEIPEK--NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLR 894 (1181)
Q Consensus 817 ~fG~VYka~d~~tg~~VAIKii~~~--~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~dlL~ 894 (1181)
++|.||.++...+++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..+++|||+++++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 5566777777779999999999765 23345789999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC-------CCcccc
Q psy14556 895 VKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP-------SAETFT 967 (1181)
Q Consensus 895 ~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~-------~~~t~~ 967 (1181)
.. ....+++..+..++.|++.||+|||+++|+||||||+||+++. ++.+||+|||.+........ ......
T Consensus 92 ~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~-~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (314)
T cd08216 92 TH-FPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSG-DGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169 (314)
T ss_pred Hh-cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEec-CCceEEecCccceeecccccccccccccccccc
Confidence 54 2345788899999999999999999999999999999999987 89999999998865542211 122334
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKT 1030 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~ 1030 (1181)
++..|+|||++.+....++...|+ ||+|+++|+|++|+.||....
T Consensus 170 ~~~~y~aPE~~~~~~~~~~~~~Di------------------ws~G~il~el~~g~~pf~~~~ 214 (314)
T cd08216 170 KNLPWLSPEVLQQNLQGYNEKSDI------------------YSVGITACELANGHVPFKDMP 214 (314)
T ss_pred ccccccCHHHhcCCCCCCCcchhH------------------HHHHHHHHHHHhCCCCCCCCC
Confidence 678899999997543334444444 999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=295.76 Aligned_cols=244 Identities=23% Similarity=0.339 Sum_probs=197.9
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCC----CCCChhHHHHHHHHHHhcCCCCeeeEccccccCCc--EEEEEee
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEK----NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGY--FKIFMEQ 883 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~----~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~--l~LVmEy 883 (1181)
.++||+|+|-+||+|.+..+|..||--.++.. .....++|..|+.+|+.|+||||+++|++|.+... +.+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 45799999999999999999999886555322 23346889999999999999999999999987654 8899999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhcccc--ceecccCCCCCcccccCCCeeeeecCCcccccccCCC
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ--KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP 961 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~--gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~ 961 (1181)
+..|+|+.|.++. ...+...++.|++||++||.|||++ .|||||||.+||+++...|.|||+|+|+|..... .
T Consensus 125 ~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~--s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK--S 199 (632)
T ss_pred ccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc--c
Confidence 9999999999865 3567889999999999999999998 5999999999999998889999999999987764 3
Q ss_pred CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc-cccCC---
Q psy14556 962 SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR-ALVAP--- 1037 (1181)
Q Consensus 962 ~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~-~l~~~--- 1037 (1181)
......|||.|||||++.. .|...||+ ||||+++.||+|+.+||...... .+..+
T Consensus 200 ~aksvIGTPEFMAPEmYEE---~YnE~VDV------------------YaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S 258 (632)
T KOG0584|consen 200 HAKSVIGTPEFMAPEMYEE---NYNELVDV------------------YAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS 258 (632)
T ss_pred ccceeccCccccChHHHhh---hcchhhhh------------------hhhhHHHHHHHhccCChhhhCCHHHHHHHHHc
Confidence 3344689999999999973 46777777 99999999999999999987653 33221
Q ss_pred CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1038 PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1038 ~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
-..|..+..---+.+..+|.+|+.. ...|++..+++...+..
T Consensus 259 GiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~ 300 (632)
T KOG0584|consen 259 GIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFD 300 (632)
T ss_pred CCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhc
Confidence 1133333333345577788888888 88888866666555555
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=273.42 Aligned_cols=237 Identities=29% Similarity=0.385 Sum_probs=185.6
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC---ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG---DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~---~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.+||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++.+.+..++||||++ |
T Consensus 21 ~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g 99 (307)
T cd06607 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-G 99 (307)
T ss_pred eeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-C
Confidence 3699999999999999989999999998654332 23568899999999999999999999999999999999996 5
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++. ++.++|+|||++..... .....
T Consensus 100 ~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~-~~~~kL~dfg~~~~~~~----~~~~~ 172 (307)
T cd06607 100 SASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTE-PGTVKLADFGSASLVSP----ANSFV 172 (307)
T ss_pred CHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECC-CCCEEEeecCcceecCC----CCCcc
Confidence 666666533 235788999999999999999999999999999999999988 89999999999875432 22345
Q ss_pred CCccccCchhhccC-CCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCC---CCCCCC
Q psy14556 968 GTLQYMAPEVIDKG-QRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAP---PQISRS 1043 (1181)
Q Consensus 968 GT~~Y~APEvl~gg-~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~---~~ip~~ 1043 (1181)
++..|+|||++.+. ...++...|+ ||+|+++|+|++|+.||.+.+....... ...+..
T Consensus 173 ~~~~y~aPE~~~~~~~~~~~~~sDv------------------~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 234 (307)
T cd06607 173 GTPYWMAPEVILAMDEGQYDGKVDV------------------WSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL 234 (307)
T ss_pred CCccccCceeeeccCCCCCCcccch------------------HHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCC
Confidence 78899999988521 1112223333 9999999999999999987664332110 111111
Q ss_pred CCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1044 VSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1044 l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.....+..+..++.+|+..+|..||+..+.
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 264 (307)
T cd06607 235 SSNDWSDYFRNFVDSCLQKIPQDRPSSEEL 264 (307)
T ss_pred CchhhCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 122356678899999999999999975554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=265.84 Aligned_cols=241 Identities=27% Similarity=0.388 Sum_probs=188.6
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCC-----CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKN-----LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~-----~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
++||+|+||.||++.+...+..+++|.++... ......+.+|+.+++.++||||+++++++.+....++||||++
T Consensus 6 ~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (260)
T cd08222 6 QRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCE 85 (260)
T ss_pred eeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCC
Confidence 47999999999999998877767777664322 1223457789999999999999999999999999999999999
Q ss_pred CCCcccchhcc-cCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCc
Q psy14556 886 GGSLSTLLRVK-WGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAE 964 (1181)
Q Consensus 886 gGSL~dlL~~~-~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~ 964 (1181)
+++|.+++... .....+++..++.++.|++.||.|||++|++|+||||+||+++. +.++|+|||.+...........
T Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~--~~~~l~d~g~~~~~~~~~~~~~ 163 (260)
T cd08222 86 GRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN--NLLKIGDFGVSRLLMGSCDLAT 163 (260)
T ss_pred CCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec--CCEeecccCceeecCCCccccc
Confidence 99999888642 12346789999999999999999999999999999999999975 6799999999877654433344
Q ss_pred cccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCC--CCCC
Q psy14556 965 TFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPP--QISR 1042 (1181)
Q Consensus 965 t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~--~ip~ 1042 (1181)
...+++.|+|||.+.+...+.. .|+ ||+|+++|+|++|..||............ ....
T Consensus 164 ~~~~~~~~~~pe~~~~~~~~~~--~Dv------------------~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (260)
T cd08222 164 TFTGTPYYMSPEALKHQGYDSK--SDI------------------WSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTP 223 (260)
T ss_pred CCCCCcCccCHHHHccCCCCch--hhH------------------HHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCC
Confidence 4568899999999865443322 333 99999999999999999866543321111 1112
Q ss_pred CCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1043 SVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1043 ~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
..+...+..+..++.+|+..+|..||...+.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 254 (260)
T cd08222 224 SLPETYSRQLNSIMQSMLNKDPSLRPSAAEI 254 (260)
T ss_pred CCcchhcHHHHHHHHHHhcCChhhCcCHHHH
Confidence 2234566788889999999999999975544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-28 Score=270.88 Aligned_cols=237 Identities=27% Similarity=0.335 Sum_probs=182.1
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCC--hhHHHHHHHHHHhcCCCCeeeEccccccC--CcEEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD--VQPLHEEIKLHSQLRHRNIVQYLGSVSEE--GYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~--~e~f~rEi~IL~~L~HPNIVkl~g~~~d~--~~l~LVmEy~~gG 887 (1181)
+||+|+||.||+|.+..+++.||+|.++...... ...+.+|+.++++++|+||+++++++... +..++||||+. +
T Consensus 14 ~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~ 92 (309)
T cd07845 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-Q 92 (309)
T ss_pred eeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-C
Confidence 6999999999999999999999999996543222 33467899999999999999999998654 56899999995 5
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|.+++... ...+++..++.++.||+.||+|||++|++||||||+||+++. ++.+||+|||.+..............
T Consensus 93 ~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~-~~~~kL~dfg~~~~~~~~~~~~~~~~ 169 (309)
T cd07845 93 DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTD-KGCLKIADFGLARTYGLPAKPMTPKV 169 (309)
T ss_pred CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC-CCCEEECccceeeecCCccCCCCccc
Confidence 788887643 245788999999999999999999999999999999999987 88999999999987654332333334
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC-----------
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA----------- 1036 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~----------- 1036 (1181)
+++.|+|||.+.+.. .++...|+ ||+|+++|+|++|+.||.+.+......
T Consensus 170 ~~~~y~aPE~~~~~~-~~~~~~Dv------------------wslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 230 (309)
T cd07845 170 VTLWYRAPELLLGCT-TYTTAIDM------------------WAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNE 230 (309)
T ss_pred ccccccChhhhcCCC-CcCchHHH------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 678899999986432 22333333 999999999999999998766533110
Q ss_pred -------------CCCCCCCC-------CCCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1037 -------------PPQISRSV-------SVPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1037 -------------~~~ip~~l-------~~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
...++... ....+..+..++.+|+..||.+||+.-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~ 285 (309)
T cd07845 231 SIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAE 285 (309)
T ss_pred hhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHH
Confidence 00000000 011345566799999999999999633
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=277.02 Aligned_cols=244 Identities=25% Similarity=0.345 Sum_probs=183.1
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccC-----CcE
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEE-----GYF 877 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~-----~~l 877 (1181)
++|.+. .+||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.++++++||||+++++++... ...
T Consensus 5 ~~y~i~-~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 5 PRYQNL-SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred cceEEE-EEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 344443 479999999999999999999999999864322 2345688899999999999999999876543 358
Q ss_pred EEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccc
Q psy14556 878 KIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 957 (1181)
Q Consensus 878 ~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~ 957 (1181)
++++||+. ++|..++... .+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||++....
T Consensus 84 ~lv~e~~~-~~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~-~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT-NCDLKICDFGLARIAD 157 (336)
T ss_pred EEEehhcc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECC-CCCEEECcccceeecc
Confidence 99999995 5777766532 5788999999999999999999999999999999999988 8999999999987654
Q ss_pred cCCCC---CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc
Q psy14556 958 GLCPS---AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL 1034 (1181)
Q Consensus 958 ~~~~~---~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l 1034 (1181)
..... .....|+..|+|||.+.+.. .++...|+ ||+|+++|+|++|+.||.+.+....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv------------------wslGvil~el~~G~~~f~~~~~~~~ 218 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSK-GYTKAIDI------------------WSVGCILAEMLSNRPLFPGKDYLHQ 218 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCC-CCCcHHHH------------------HHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 32211 12345889999999875421 22233333 9999999999999999976542110
Q ss_pred c-------CCC------------------CCCCC-------CCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1035 V-------APP------------------QISRS-------VSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1035 ~-------~~~------------------~ip~~-------l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
. ..+ ..+.. ..+..+..+..++.+|+..+|.+||+..+.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~ 289 (336)
T cd07849 219 LNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEA 289 (336)
T ss_pred HHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHH
Confidence 0 000 00000 012235667789999999999999975444
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=265.68 Aligned_cols=239 Identities=28% Similarity=0.405 Sum_probs=188.4
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
..||+|++|.||+|.+..+++.+++|.+...... ....+.+|+.++++++||||+++++++.+++..++++||+++ +
T Consensus 5 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~ 83 (283)
T cd05118 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-D 83 (283)
T ss_pred eeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-C
Confidence 3699999999999999989999999998765433 356788999999999999999999999999999999999964 8
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|.+++... ...+++..++.++.|++.||.|||++||+|+||||+||+++. ++.++|+|||.+..............+
T Consensus 84 l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~-~~~~~l~df~~~~~~~~~~~~~~~~~~ 160 (283)
T cd05118 84 LYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINT-EGVLKLADFGLARSFGSPVRPYTHYVV 160 (283)
T ss_pred HHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECC-CCcEEEeeeeeeEecCCCcccccCccC
Confidence 88887653 246788999999999999999999999999999999999987 899999999999776543322233457
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc--------CC---
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV--------AP--- 1037 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~--------~~--- 1037 (1181)
+..|+|||.+.+. ...+...|+ ||+|+++|+|++|+.||...+..+.. ..
T Consensus 161 ~~~~~~PE~~~~~-~~~~~~~Di------------------~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (283)
T cd05118 161 TRWYRAPELLLGD-KGYSTPVDI------------------WSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPE 221 (283)
T ss_pred cccccCcHHHhcC-CCCCchhHH------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchH
Confidence 8899999998654 122333333 99999999999999999776542210 00
Q ss_pred -------------CCCCC-------CCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1038 -------------PQISR-------SVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1038 -------------~~ip~-------~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
..++. ......+..+..++.+|+..+|..||..-+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ 276 (283)
T cd05118 222 VWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQ 276 (283)
T ss_pred hcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHH
Confidence 00000 112235667888999999999999997543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=276.31 Aligned_cols=239 Identities=23% Similarity=0.317 Sum_probs=184.8
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCC--CCChhHHHHHHHHHHhcCCCCeeeEccccccC-----CcEEEEEee
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKN--LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEE-----GYFKIFMEQ 883 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~--~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~-----~~l~LVmEy 883 (1181)
..||+|+||+||+|++..+++.||+|.+.... ......+.+|+.+++.++||||+++++++... ...++++||
T Consensus 11 ~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~ 90 (337)
T cd07858 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYEL 90 (337)
T ss_pred EEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeC
Confidence 37999999999999999999999999986542 22345678899999999999999999987654 358999999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCC
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA 963 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~ 963 (1181)
+ +++|.+++... ..+++..+..++.|++.||.|||+++++||||||+||+++. ++.+||+|||+++.........
T Consensus 91 ~-~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~-~~~~kL~Dfg~~~~~~~~~~~~ 165 (337)
T cd07858 91 M-DTDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA-NCDLKICDFGLARTTSEKGDFM 165 (337)
T ss_pred C-CCCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC-CCCEEECcCccccccCCCcccc
Confidence 9 47888887643 35789999999999999999999999999999999999987 8899999999998765433333
Q ss_pred ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc-------cC
Q psy14556 964 ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL-------VA 1036 (1181)
Q Consensus 964 ~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l-------~~ 1036 (1181)
....++..|+|||.+.+.. .++...|+ ||+|+++|+|++|+.||.+.+.... ..
T Consensus 166 ~~~~~~~~y~aPE~~~~~~-~~~~~~Di------------------wslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 226 (337)
T cd07858 166 TEYVVTRWYRAPELLLNCS-EYTTAIDV------------------WSVGCIFAELLGRKPLFPGKDYVHQLKLITELLG 226 (337)
T ss_pred cccccccCccChHHHhcCC-CCCCcccH------------------HHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhC
Confidence 3456889999999986432 13333333 9999999999999999976542110 00
Q ss_pred ---------------------CCCCC----CCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1037 ---------------------PPQIS----RSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1037 ---------------------~~~ip----~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.+..+ .......+..+..++.+|+..+|..||+..+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~el 288 (337)
T cd07858 227 SPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEA 288 (337)
T ss_pred CCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHH
Confidence 00000 01123456677889999999999999975444
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=264.68 Aligned_cols=245 Identities=18% Similarity=0.213 Sum_probs=185.3
Q ss_pred eecccCceEEEEEEEc---CCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccCC------cEEEE
Q psy14556 812 ELGKGSYGVVYAAREL---DRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEG------YFKIF 880 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~---~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~------~l~LV 880 (1181)
.||+|+||.||+|.+. .+++.||+|.+..... ...+.+.+|+.++++++||||+++++++.... ..+++
T Consensus 6 ~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 85 (273)
T cd05074 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVI 85 (273)
T ss_pred cccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEE
Confidence 6999999999999864 3578999999965432 23567889999999999999999999875432 34789
Q ss_pred EeecCCCCcccchhcc---cCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccc
Q psy14556 881 MEQVPGGSLSTLLRVK---WGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 957 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~---~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~ 957 (1181)
+||+++|+|.+++... .....+++..++.++.|++.||+|||++||+||||||+||+++. ++.+||+|||+++...
T Consensus 86 ~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~-~~~~kl~dfg~~~~~~ 164 (273)
T cd05074 86 LPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNE-NMTVCVADFGLSKKIY 164 (273)
T ss_pred EecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcC-CCCEEECccccccccc
Confidence 9999999998876432 12235678889999999999999999999999999999999987 8899999999988654
Q ss_pred cCCC--CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccc
Q psy14556 958 GLCP--SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRAL 1034 (1181)
Q Consensus 958 ~~~~--~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l 1034 (1181)
.... ......+++.|++||.+.+...+..+|+ ||+|+++|+|++ |..||.+.+...+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi--------------------~slG~il~el~~~g~~p~~~~~~~~~ 224 (273)
T cd05074 165 SGDYYRQGCASKLPVKWLALESLADNVYTTHSDV--------------------WAFGVTMWEIMTRGQTPYAGVENSEI 224 (273)
T ss_pred CCcceecCCCccCchhhcCHhHHhcCccchhhhh--------------------HHHHHHHHHHhhCCCCCCCCCCHHHH
Confidence 3211 1122335678999999875544333333 999999999999 8899987765443
Q ss_pred cCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1035 VAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1035 ~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
..... .....+...+..+..++.+|+..+|..||+ +++....+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps-~~~~~~~l 269 (273)
T cd05074 225 YNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPS-FQHLRDQL 269 (273)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcC-HHHHHHHH
Confidence 21111 011122356678899999999999999985 55544433
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-28 Score=272.26 Aligned_cols=238 Identities=29% Similarity=0.380 Sum_probs=186.0
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC---ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG---DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~---~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.+||+|+||.||++++..++..+|+|.+...... ..+.+.+|+.++++++|||++++++++.+.+..++||||++ |
T Consensus 31 ~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g 109 (317)
T cd06635 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-G 109 (317)
T ss_pred heeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-C
Confidence 3699999999999999999999999998654322 24568899999999999999999999999999999999996 5
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|.+++... ...+++..+..++.|++.||.|||++|++||||+|+||+++. ++.++|+|||++..... .....
T Consensus 110 ~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~-~~~~kl~dfg~~~~~~~----~~~~~ 182 (317)
T cd06635 110 SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE-PGQVKLADFGSASIASP----ANSFV 182 (317)
T ss_pred CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECC-CCCEEEecCCCccccCC----ccccc
Confidence 777776533 335788999999999999999999999999999999999987 88999999998865432 23345
Q ss_pred CCccccCchhhccCC-CCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC---CCCCCCC
Q psy14556 968 GTLQYMAPEVIDKGQ-RGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA---PPQISRS 1043 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~-~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~---~~~ip~~ 1043 (1181)
++..|+|||.+.+.. .......|+ ||+|+++|+|++|+.||.......... ....+..
T Consensus 183 ~~~~y~aPE~~~~~~~~~~~~~~Dv------------------~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 244 (317)
T cd06635 183 GTPYWMAPEVILAMDEGQYDGKVDV------------------WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL 244 (317)
T ss_pred CCccccChhhhhcCCCCCCCccccH------------------HHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC
Confidence 888999999984211 112222333 999999999999999998765433211 1111222
Q ss_pred CCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1044 VSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1044 l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
.....+..+..++.+|+..+|..||...+..
T Consensus 245 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il 275 (317)
T cd06635 245 QSNEWSDYFRNFVDSCLQKIPQDRPTSEELL 275 (317)
T ss_pred CCccccHHHHHHHHHHccCCcccCcCHHHHH
Confidence 2334566788999999999999999754443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-28 Score=267.95 Aligned_cols=204 Identities=26% Similarity=0.407 Sum_probs=161.5
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEccccccCC------
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEG------ 875 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~------ 875 (1181)
..|... .+||+|+||.||+|.+..+++.||+|.+...... ....+.+|+.++++++||||+++++++...+
T Consensus 12 ~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 12 SKYEKL-AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hheEEE-EEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 344443 3699999999999999999999999998654322 2345678999999999999999999876543
Q ss_pred --cEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcc
Q psy14556 876 --YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTS 953 (1181)
Q Consensus 876 --~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlA 953 (1181)
..++||||+. ++|.+++... ...+++..++.++.||+.||+|||++|++|+||||+||+++. ++.+||+|||++
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~-~~~~kl~dfg~~ 166 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITK-DGILKLADFGLA 166 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECC-CCcEEECcCCCc
Confidence 4599999995 5787777643 235789999999999999999999999999999999999987 899999999999
Q ss_pred cccccCCCC----CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCC
Q psy14556 954 KRLAGLCPS----AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKK 1029 (1181)
Q Consensus 954 k~l~~~~~~----~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~ 1029 (1181)
......... .....++..|+|||.+.+.. .++...|+ ||+|+++|+|++|..||.+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di------------------~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGER-DYGPPIDM------------------WGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCc-ccCchhhh------------------HHHHHHHHHHHhCCCCCCCC
Confidence 766432211 12345788999999986432 22333343 99999999999999999876
Q ss_pred Cc
Q psy14556 1030 TS 1031 (1181)
Q Consensus 1030 ~~ 1031 (1181)
+.
T Consensus 228 ~~ 229 (310)
T cd07865 228 TE 229 (310)
T ss_pred CH
Confidence 54
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-29 Score=286.84 Aligned_cols=197 Identities=29% Similarity=0.415 Sum_probs=170.3
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
++||+|-||+||-|+++.+|+.||||++.+.... ....+++|+.||+.+.||.||.+--.|+..+.+++|||.+.|.-
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM 649 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM 649 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence 3799999999999999999999999999766432 34678999999999999999999999999999999999996666
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCC--eeeeecCCcccccccCCCCCccc
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSG--VVKISDFGTSKRLAGLCPSAETF 966 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g--~vKLiDFGlAk~l~~~~~~~~t~ 966 (1181)
|+-+|... ...+++.....++.||+.||.|||.++|+|+||||+|||+...+. ++||||||+|+.+... ....+.
T Consensus 650 LEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-sFRrsV 726 (888)
T KOG4236|consen 650 LEMILSSE--KGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-SFRRSV 726 (888)
T ss_pred HHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh-hhhhhh
Confidence 66556543 346778889999999999999999999999999999999976332 8999999999998754 455667
Q ss_pred cCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCC
Q psy14556 967 TGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKT 1030 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~ 1030 (1181)
+|||.|.|||++++. +|....|+ ||.|+|+|--+.|..||+.+.
T Consensus 727 VGTPAYLaPEVLrnk--GyNrSLDM------------------WSVGVIiYVsLSGTFPFNEdE 770 (888)
T KOG4236|consen 727 VGTPAYLAPEVLRNK--GYNRSLDM------------------WSVGVIIYVSLSGTFPFNEDE 770 (888)
T ss_pred cCCccccCHHHHhhc--cccccccc------------------eeeeEEEEEEecccccCCCcc
Confidence 899999999999865 45666666 999999999999999998754
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-28 Score=273.68 Aligned_cols=244 Identities=23% Similarity=0.335 Sum_probs=187.1
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEcccccc----CCcEE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSE----EGYFK 878 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d----~~~l~ 878 (1181)
.|... +.||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.++++++||||+++++++.. ....+
T Consensus 6 ~y~~~-~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 6 RYKPI-ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred ceeee-eeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 34443 469999999999999999999999999975432 335678889999999999999999998753 35789
Q ss_pred EEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccccccc
Q psy14556 879 IFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 958 (1181)
Q Consensus 879 LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~ 958 (1181)
+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++.....
T Consensus 85 lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~-~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 85 VVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNE-DCELRIGDFGMARGLSS 159 (334)
T ss_pred EEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC-CCcEEecccccceeecc
Confidence 9999994 6888888633 34789999999999999999999999999999999999998 89999999999876543
Q ss_pred CCCC----CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc
Q psy14556 959 LCPS----AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL 1034 (1181)
Q Consensus 959 ~~~~----~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l 1034 (1181)
.... .....++..|+|||.+.+.. .++...|+ ||+|+++|+|++|+.||.+.+....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Di------------------~slG~~l~el~~g~~pf~~~~~~~~ 220 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLP-EYTTAIDM------------------WSVGCIFAEMLGRRQLFPGKNYVHQ 220 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCc-ccccccch------------------HHHHHHHHHHHcCCCccCCCChHHH
Confidence 2211 12346889999999986432 23333333 9999999999999999977653210
Q ss_pred c--------CC-----------------CCCCCC-------CCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1035 V--------AP-----------------PQISRS-------VSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1035 ~--------~~-----------------~~ip~~-------l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
. .+ ...+.. .....+..+..++.+|+..+|..||+..+.
T Consensus 221 ~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~ 291 (334)
T cd07855 221 LKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQA 291 (334)
T ss_pred HHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 0 00 000110 112356778889999999999999975544
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-29 Score=298.23 Aligned_cols=241 Identities=22% Similarity=0.278 Sum_probs=203.5
Q ss_pred ceeecccCceEEEEEEEcCCC---eEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 810 RIELGKGSYGVVYAARELDRQ---VKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg---~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
.++||.|.||.|++|+.+..+ ..||||.++....+ ++..|..|+.||-+++||||+++.|+......++||+|||+
T Consensus 634 e~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyME 713 (996)
T KOG0196|consen 634 EKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYME 713 (996)
T ss_pred EEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhh
Confidence 447999999999999987655 57999999876543 46789999999999999999999999999999999999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcc
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAET 965 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t 965 (1181)
+|+|+.+|+.+.+. ++..++..+++.|+.|++||-+.|+|||||..+|||++. +-..|++|||+++.+.+..+...+
T Consensus 714 NGsLDsFLR~~DGq--ftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNs-nLvCKVsDFGLSRvledd~~~~yt 790 (996)
T KOG0196|consen 714 NGSLDSFLRQNDGQ--FTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNS-NLVCKVSDFGLSRVLEDDPEAAYT 790 (996)
T ss_pred CCcHHHHHhhcCCc--eEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeecc-ceEEEeccccceeecccCCCcccc
Confidence 99999999987543 677888889999999999999999999999999999998 889999999999988655433333
Q ss_pred ccC---CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--
Q psy14556 966 FTG---TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ-- 1039 (1181)
Q Consensus 966 ~~G---T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~-- 1039 (1181)
..| ...|.|||.+...+++..+|| ||+|++|||.++ |+.||..-+.++++..+.
T Consensus 791 t~GGKIPiRWTAPEAIa~RKFTsASDV--------------------WSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~g 850 (996)
T KOG0196|consen 791 TLGGKIPIRWTAPEAIAYRKFTSASDV--------------------WSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQG 850 (996)
T ss_pred ccCCccceeecChhHhhhcccCchhhc--------------------cccceEEEEecccCCCcccccchHHHHHHHHhc
Confidence 222 578999999988776666666 999999999877 999999888776544333
Q ss_pred CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1040 ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1040 ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
..-+.+..+|..|.+++.-|+++|-+.||.+.+.
T Consensus 851 yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qi 884 (996)
T KOG0196|consen 851 YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQI 884 (996)
T ss_pred cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHH
Confidence 2222245789999999999999999999998777
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=272.23 Aligned_cols=241 Identities=28% Similarity=0.367 Sum_probs=187.9
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC---ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCC
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG---DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~---~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
..+||+|+||+||+|++..+++.|++|.+...... ..+.+.+|+.+++.++|||++++++++.+....|+||||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 34699999999999999999999999998654332 23568899999999999999999999999999999999995
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccc
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF 966 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~ 966 (1181)
++|.+++... ...+++..+..++.||+.||.|||++|++|+||+|+||+++. ++.+||+|||++.... .....
T Consensus 105 ~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~-~~~~kL~dfg~~~~~~----~~~~~ 177 (313)
T cd06633 105 GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTE-PGQVKLADFGSASKSS----PANSF 177 (313)
T ss_pred CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECC-CCCEEEeecCCCcccC----CCCCc
Confidence 5777776543 235778899999999999999999999999999999999987 7899999999886432 22345
Q ss_pred cCCccccCchhhccCC-CCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC---CCCCCC
Q psy14556 967 TGTLQYMAPEVIDKGQ-RGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA---PPQISR 1042 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~-~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~---~~~ip~ 1042 (1181)
.|+..|+|||++.... ..+....| .||+|+++|+|++|..||...+...... ....+.
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~~~sD------------------v~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 239 (313)
T cd06633 178 VGTPYWMAPEVILAMDEGQYDGKVD------------------VWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPT 239 (313)
T ss_pred cccccccChhhccccCCCCCCchhh------------------HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC
Confidence 6889999999985311 11222222 2999999999999999998765433211 111222
Q ss_pred CCCCCCCcchHHhhccCCCCCCCCCchhHHHHHH
Q psy14556 1043 SVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLV 1076 (1181)
Q Consensus 1043 ~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~ 1076 (1181)
......+..+..++.+|+..+|..||...+.+..
T Consensus 240 ~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2233455678889999999999999986655433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-28 Score=273.58 Aligned_cols=240 Identities=25% Similarity=0.351 Sum_probs=189.0
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCC--CCChhHHHHHHHHHHhcCCCCeeeEccccccCC-----cEEEEEee
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKN--LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEG-----YFKIFMEQ 883 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~--~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~-----~l~LVmEy 883 (1181)
.+||+|++|.||+|++..+++.|++|.+.... ....+.+.+|+.+++.++||||+++++++...+ ..|++|||
T Consensus 6 ~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~ 85 (330)
T cd07834 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTEL 85 (330)
T ss_pred eeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecc
Confidence 46999999999999999889999999997654 334567999999999999999999999987775 78999999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC---
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC--- 960 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~--- 960 (1181)
++ ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++. ++.++|+|||.+.......
T Consensus 86 ~~-~~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~-~~~~~L~dfg~~~~~~~~~~~~ 160 (330)
T cd07834 86 ME-TDLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNS-NCDLKICDFGLARGVDPDEDEK 160 (330)
T ss_pred hh-hhHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC-CCCEEEcccCceEeeccccccc
Confidence 96 5788888643 36789999999999999999999999999999999999998 7999999999998765432
Q ss_pred CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC----
Q psy14556 961 PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA---- 1036 (1181)
Q Consensus 961 ~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~---- 1036 (1181)
.......++..|+|||.+.+.. .++...|+ ||+|+++|+|++|+.||.+.+..+...
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~sDi------------------~slG~il~~l~~g~~pf~~~~~~~~~~~i~~ 221 (330)
T cd07834 161 GFLTEYVVTRWYRAPELLLSSS-RYTKAIDI------------------WSVGCIFAELLTRKPLFPGRDYIDQLNLIVE 221 (330)
T ss_pred ccccccccccCcCCceeeeccc-CCCcchhH------------------HHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence 1223345788999999997652 22333333 999999999999999998766432100
Q ss_pred ---CCC------------------CC-------CCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1037 ---PPQ------------------IS-------RSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1037 ---~~~------------------ip-------~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
.+. .+ .......+..+..++.+|+..+|..||+..+..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll 287 (330)
T cd07834 222 VLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEAL 287 (330)
T ss_pred hcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 000 00 001123466778899999999999999755553
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=266.09 Aligned_cols=236 Identities=20% Similarity=0.281 Sum_probs=181.5
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcC-CCCeeeEccccccC--CcEEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLR-HRNIVQYLGSVSEE--GYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~-HPNIVkl~g~~~d~--~~l~LVmEy~~gG 887 (1181)
+||+|+||.||+|.+..++..||+|.++.... .......+|+.++.++. ||||+++++++.+. +.+++||||++ +
T Consensus 6 ~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~ 84 (282)
T cd07831 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-M 84 (282)
T ss_pred eccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-c
Confidence 69999999999999999999999999875432 22234557888898885 99999999999887 89999999996 5
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|.+.+... ...+++..++.++.|++.||+|||++|++||||||+||+++. +.+||+|||.+..+..... .....
T Consensus 85 ~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~--~~~kl~dfg~~~~~~~~~~-~~~~~ 159 (282)
T cd07831 85 NLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD--DILKLADFGSCRGIYSKPP-YTEYI 159 (282)
T ss_pred cHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC--CCeEEEecccccccccCCC-cCCCC
Confidence 777777643 235789999999999999999999999999999999999987 9999999999987654322 22345
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC-----------
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA----------- 1036 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~----------- 1036 (1181)
++..|+|||.+.++. ..+...|+ ||+||++|+|++|..||.+.+..+...
T Consensus 160 ~~~~y~aPE~~~~~~-~~~~~~Di------------------~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 220 (282)
T cd07831 160 STRWYRAPECLLTDG-YYGPKMDI------------------WAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDA 220 (282)
T ss_pred CCcccCChhHhhcCC-CCCcchhH------------------HHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCH
Confidence 789999999875432 12222333 999999999999999998765422100
Q ss_pred ------------CCCCCCC-------CCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1037 ------------PPQISRS-------VSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1037 ------------~~~ip~~-------l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
....+.. .....+..+..++.+|+..+|..||+..+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 275 (282)
T cd07831 221 EVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQ 275 (282)
T ss_pred HHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHH
Confidence 0001110 11234677888999999999999997543
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-29 Score=271.46 Aligned_cols=242 Identities=24% Similarity=0.269 Sum_probs=198.0
Q ss_pred HHhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhc-CCCCeeeEcccccc----CC
Q psy14556 801 RFLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSE----EG 875 (1181)
Q Consensus 801 ~~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d----~~ 875 (1181)
.++++|.+...+||-|-.|.|-.|.++.+++.+|+|++... ...++|+++.-.. .|||||.++++++. ..
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 45677888888999999999999999999999999998533 5567888876665 69999999998854 35
Q ss_pred cEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccC--CCeeeeecCCcc
Q psy14556 876 YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTY--SGVVKISDFGTS 953 (1181)
Q Consensus 876 ~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~--~g~vKLiDFGlA 953 (1181)
.+.+|||.|+||.|...++.+ +...+++..+..|++||+.|+.|||+.+|.||||||+|+|.... +..+||+|||+|
T Consensus 133 cLLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 688999999999999999877 67789999999999999999999999999999999999999652 448999999999
Q ss_pred cccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc
Q psy14556 954 KRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA 1033 (1181)
Q Consensus 954 k~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~ 1033 (1181)
+.-... ....+.+-||+|.|||++.... |....|+ ||+|+++|-||.|.+||....-..
T Consensus 212 K~t~~~-~~L~TPc~TPyYvaPevlg~eK--ydkscdm------------------wSlgVimYIlLCGyPPFYS~hg~a 270 (400)
T KOG0604|consen 212 KETQEP-GDLMTPCFTPYYVAPEVLGPEK--YDKSCDM------------------WSLGVIMYILLCGYPPFYSNHGLA 270 (400)
T ss_pred cccCCC-ccccCCcccccccCHHHhCchh--cCCCCCc------------------cchhHHHHHhhcCCCcccccCCcc
Confidence 876542 3455678899999999996443 3334444 999999999999999999877644
Q ss_pred cc----C-----CCCCCCCCCCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1034 LV----A-----PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1034 l~----~-----~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
+. . .-.+|.......+.....++...+.-+|..|-+
T Consensus 271 ispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlT 315 (400)
T KOG0604|consen 271 ISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLT 315 (400)
T ss_pred CChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhhee
Confidence 31 1 223555544455667777888999999999886
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-28 Score=266.93 Aligned_cols=243 Identities=26% Similarity=0.379 Sum_probs=180.5
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC--hhHHHHHHHHHHhcCCCCeeeEccccccC--------
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD--VQPLHEEIKLHSQLRHRNIVQYLGSVSEE-------- 874 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~--~e~f~rEi~IL~~L~HPNIVkl~g~~~d~-------- 874 (1181)
+|.+.+ +||+|+||.||+|.+..+++.+++|.+....... ...+.+|+.+++.++||||+++++++.+.
T Consensus 9 ~y~~~~-~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 87 (311)
T cd07866 9 DYEILG-KLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87 (311)
T ss_pred cEEEEE-EeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence 444433 6999999999999999999999999986543322 34678999999999999999999987443
Q ss_pred CcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccc
Q psy14556 875 GYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954 (1181)
Q Consensus 875 ~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk 954 (1181)
..+++||||+. ++|...+... ...+++..++.++.|+++||.|||++||+|+||||+||+++. ++.++|+|||++.
T Consensus 88 ~~~~lv~~~~~-~~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~-~~~~~l~dfg~~~ 163 (311)
T cd07866 88 GSVYMVTPYMD-HDLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDN-QGILKIADFGLAR 163 (311)
T ss_pred ceEEEEEecCC-cCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC-CCCEEECcCccch
Confidence 35799999995 4666665532 346889999999999999999999999999999999999988 8999999999997
Q ss_pred ccccCCCC-----------CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCC
Q psy14556 955 RLAGLCPS-----------AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLT 1023 (1181)
Q Consensus 955 ~l~~~~~~-----------~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk 1023 (1181)
........ .....+++.|+|||.+.+.. .++...|+ ||+|+++|+|++|+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv------------------~slG~il~el~~g~ 224 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGER-RYTTAVDI------------------WGIGCVFAEMFTRR 224 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCC-ccCchhHh------------------HHHHHHHHHHHhCC
Confidence 65432211 11234678899999986432 22333333 99999999999999
Q ss_pred CCCCCCCcccccC-------C---------CCCCC------------C---CCCCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1024 AALKKKTSRALVA-------P---------PQISR------------S---VSVPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1024 ~PF~~~~~~~l~~-------~---------~~ip~------------~---l~~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
+||.+.+...... . ..++. . ........+..++.+|+..+|.+||+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ 303 (311)
T cd07866 225 PILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTAS 303 (311)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHH
Confidence 9998765432100 0 00000 0 0012234566799999999999999743
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=262.11 Aligned_cols=239 Identities=26% Similarity=0.333 Sum_probs=188.5
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCC--CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKN--LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~--~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.+||+|++|.||+|.+..+++.+++|.+.... ....+.+..|+.++++++||||+++++++.+.+..++||||++ ++
T Consensus 5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~ 83 (282)
T cd07829 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MD 83 (282)
T ss_pred hcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cC
Confidence 36999999999999999999999999997653 2334678899999999999999999999999999999999996 58
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|.+++.... ..+++..++.++.|++.||+|||++||+||||+|+||+++. ++.++|+|||.+..............+
T Consensus 84 l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~ 160 (282)
T cd07829 84 LKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINR-DGVLKLADFGLARAFGIPLRTYTHEVV 160 (282)
T ss_pred HHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcC-CCCEEEecCCcccccCCCccccCcccc
Confidence 999987542 46789999999999999999999999999999999999988 899999999999876543333333446
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc-------------
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV------------- 1035 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~------------- 1035 (1181)
+..|+|||.+.+.. .++...|+ ||+|+++|+|++|+.||.+.+.....
T Consensus 161 ~~~~~aPE~~~~~~-~~~~~~Dv------------------~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (282)
T cd07829 161 TLWYRAPEILLGSK-HYSTAVDI------------------WSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEE 221 (282)
T ss_pred CcCcCChHHhcCCc-CCCccccH------------------HHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHH
Confidence 78899999986541 22233333 99999999999999999876532110
Q ss_pred ----------CCCCCCC-------CCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1036 ----------APPQISR-------SVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1036 ----------~~~~ip~-------~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
.....+. ...+..+..+..++.+|+..+|.+||...+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ 275 (282)
T cd07829 222 SWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKE 275 (282)
T ss_pred HHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHH
Confidence 0000010 111123567888999999999999997443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-28 Score=272.12 Aligned_cols=238 Identities=24% Similarity=0.375 Sum_probs=183.1
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCC--CCCChhHHHHHHHHHHhc-CCCCeeeEccccccC--CcEEEEEeecCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEK--NLGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEE--GYFKIFMEQVPG 886 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~--~~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~--~~l~LVmEy~~g 886 (1181)
+||+|+||.||+|.+..+++.+|+|.+... .......+.+|+.+++++ +||||+++++++... ...++||||++
T Consensus 14 ~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~- 92 (337)
T cd07852 14 KLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME- 92 (337)
T ss_pred hhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-
Confidence 699999999999999989999999988543 223345678899999999 999999999987643 46899999996
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC-----
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP----- 961 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~----- 961 (1181)
++|..++... .+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||.+........
T Consensus 93 ~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~-~~~~kl~d~g~~~~~~~~~~~~~~~ 167 (337)
T cd07852 93 TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNS-DCRVKLADFGLARSLSELEENPENP 167 (337)
T ss_pred cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC-CCcEEEeeccchhccccccccccCc
Confidence 5888887642 5678888889999999999999999999999999999998 89999999999976643321
Q ss_pred CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC-----
Q psy14556 962 SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA----- 1036 (1181)
Q Consensus 962 ~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~----- 1036 (1181)
......|+..|+|||.+.+.. ..+...|+ ||+|+++|+|++|+.||.+........
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~-~~~~~sDi------------------~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~ 228 (337)
T cd07852 168 VLTDYVATRWYRAPEILLGST-RYTKGVDM------------------WSVGCILGEMLLGKPLFPGTSTLNQLEKIIEV 228 (337)
T ss_pred chhcccccccccCceeeeccc-cccccchH------------------HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 222345889999999885432 22223333 999999999999999997654322100
Q ss_pred ---------------------------CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1037 ---------------------------PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1037 ---------------------------~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
............+..+..++.+|+..+|..||+..+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il 293 (337)
T cd07852 229 IGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEAL 293 (337)
T ss_pred hCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHh
Confidence 00000111123566788899999999999999855554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=262.31 Aligned_cols=239 Identities=26% Similarity=0.320 Sum_probs=183.2
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhc---CCCCeeeEccccccCCc-----EEEE
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQL---RHRNIVQYLGSVSEEGY-----FKIF 880 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L---~HPNIVkl~g~~~d~~~-----l~LV 880 (1181)
.+||+|+||.||+|++..++..||+|.+...... ....+.+|+.+++++ +||||+++++++...+. .+++
T Consensus 5 ~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~ 84 (287)
T cd07838 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLV 84 (287)
T ss_pred EEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEE
Confidence 4799999999999999888999999999754332 234566788877766 59999999999988776 9999
Q ss_pred EeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC
Q psy14556 881 MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC 960 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~ 960 (1181)
|||+. ++|.+++... ....+++..++.++.|++.||.|||+.+++|+||+|+||+++. ++.+||+|||.+.......
T Consensus 85 ~e~~~-~~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~-~~~~~l~dfg~~~~~~~~~ 161 (287)
T cd07838 85 FEHVD-QDLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTS-DGQVKIADFGLARIYSFEM 161 (287)
T ss_pred ehhcc-cCHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEcc-CCCEEEeccCcceeccCCc
Confidence 99996 5788887654 2335789999999999999999999999999999999999998 7999999999987764332
Q ss_pred CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC----
Q psy14556 961 PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA---- 1036 (1181)
Q Consensus 961 ~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~---- 1036 (1181)
......++..|+|||.+.+...+..+|+ ||+|+++|+|++|.+||.+.+..+...
T Consensus 162 -~~~~~~~~~~~~~PE~~~~~~~~~~~Di--------------------~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~ 220 (287)
T cd07838 162 -ALTSVVVTLWYRAPEVLLQSSYATPVDM--------------------WSVGCIFAELFRRRPLFRGTSEADQLDKIFD 220 (287)
T ss_pred -ccccccccccccChHHhccCCCCCcchh--------------------hhHHHHHHHHHhCCCcccCCChHHHHHHHHH
Confidence 2223347889999999976654444333 999999999999999998766432100
Q ss_pred -----------------CCCCCCCC-------CCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1037 -----------------PPQISRSV-------SVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1037 -----------------~~~ip~~l-------~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
...++... ....+..+..++.+|+..+|..||...+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~i 281 (287)
T cd07838 221 VIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEA 281 (287)
T ss_pred HcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHH
Confidence 00000000 11223456678999999999999975543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=270.35 Aligned_cols=241 Identities=16% Similarity=0.144 Sum_probs=172.2
Q ss_pred cccCceeecccCceEEEEEEEcCC---CeEEEEEEecCCCCCC-hh----------HHHHHHHHHHhcCCCCeeeEcccc
Q psy14556 806 FALNRIELGKGSYGVVYAARELDR---QVKLAIKEIPEKNLGD-VQ----------PLHEEIKLHSQLRHRNIVQYLGSV 871 (1181)
Q Consensus 806 ~~l~~~kIG~G~fG~VYka~d~~t---g~~VAIKii~~~~~~~-~e----------~f~rEi~IL~~L~HPNIVkl~g~~ 871 (1181)
|.+. ++||+|+||.||+|.+..+ +..+++|+........ .+ ....+...+..++|++|+++++++
T Consensus 14 y~i~-~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~ 92 (294)
T PHA02882 14 WKID-KLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG 92 (294)
T ss_pred eEEe-eEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence 4443 3799999999999998877 6677887654332211 01 122333445667899999999876
Q ss_pred ccCC----cEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeee
Q psy14556 872 SEEG----YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKI 947 (1181)
Q Consensus 872 ~d~~----~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKL 947 (1181)
.... ..++++|++ ..++.+.+... ...++..+..++.|++.||+|||+++|+||||||+|||++. ++.++|
T Consensus 93 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~-~~~~~l 167 (294)
T PHA02882 93 SFKRCRMYYRFILLEKL-VENTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDG-NNRGYI 167 (294)
T ss_pred eEecCCceEEEEEEehh-ccCHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC-CCcEEE
Confidence 5443 347788877 44566665532 23467788899999999999999999999999999999987 789999
Q ss_pred ecCCcccccccCC-------CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHH
Q psy14556 948 SDFGTSKRLAGLC-------PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLL 1020 (1181)
Q Consensus 948 iDFGlAk~l~~~~-------~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELL 1020 (1181)
+|||+++.+.... .......||+.|+|||++.+..++... |+ ||+||++|+|+
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~--Di------------------wSlG~~l~el~ 227 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRG--DL------------------ESLGYCMLKWA 227 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHH--HH------------------HHHHHHHHHHH
Confidence 9999997664221 111234699999999999766544333 33 99999999999
Q ss_pred hCCCCCCCCCccc---------ccCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1021 VLTAALKKKTSRA---------LVAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1021 TGk~PF~~~~~~~---------l~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
+|+.||.+..... .......+.......+..+...+..|+..+|..||....
T Consensus 228 ~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~ 288 (294)
T PHA02882 228 GIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDA 288 (294)
T ss_pred hCCCCCCccccchHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHH
Confidence 9999998874321 111111222223455788899999999999999997443
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=265.49 Aligned_cols=239 Identities=28% Similarity=0.393 Sum_probs=182.3
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccCC----------cEE
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEG----------YFK 878 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~----------~l~ 878 (1181)
.+||+|+||.||+|.+..+++.||+|.++.... .....+.+|+.++++++||||+++++++.+.. .++
T Consensus 13 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 92 (302)
T cd07864 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFY 92 (302)
T ss_pred eeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEE
Confidence 369999999999999999999999999965432 23356788999999999999999999886654 799
Q ss_pred EEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccccccc
Q psy14556 879 IFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 958 (1181)
Q Consensus 879 LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~ 958 (1181)
+|+||+++ ++..++... ...+++..++.++.||+.||+|||+.||+|+||||+||+++. ++.+||+|||.+.....
T Consensus 93 lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~-~~~~kl~dfg~~~~~~~ 168 (302)
T cd07864 93 LVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNN-KGQIKLADFGLARLYNS 168 (302)
T ss_pred EEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC-CCcEEeCcccccccccC
Confidence 99999975 666666533 335788999999999999999999999999999999999988 89999999999977654
Q ss_pred CCCCC-ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc--
Q psy14556 959 LCPSA-ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV-- 1035 (1181)
Q Consensus 959 ~~~~~-~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~-- 1035 (1181)
..... ....++..|+|||.+.+.. .++...|+ ||+|+++|+|++|++||.........
T Consensus 169 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~~Di------------------~slG~~~~el~~g~~~~~~~~~~~~~~~ 229 (302)
T cd07864 169 EESRPYTNKVITLWYRPPELLLGEE-RYGPAIDV------------------WSCGCILGELFTKKPIFQANQELAQLEL 229 (302)
T ss_pred CcccccccceeccCccChHHhcCCC-CCCchhHH------------------HHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 33211 2234678899999886432 12223333 99999999999999999865432100
Q ss_pred -----CCC---------CCC---------------CCCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1036 -----APP---------QIS---------------RSVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1036 -----~~~---------~ip---------------~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
..+ ..+ .......+..+..++.+|+..+|..||+..+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 295 (302)
T cd07864 230 ISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEE 295 (302)
T ss_pred HHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 000 000 0011235677888999999999999997433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-28 Score=273.67 Aligned_cols=239 Identities=23% Similarity=0.285 Sum_probs=183.0
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccC--------------Cc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEE--------------GY 876 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~--------------~~ 876 (1181)
+.||.|+||.||+|.+..+++.||+|.+........+.+.+|+.++++++||||+++++.+... ..
T Consensus 11 ~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (342)
T cd07854 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNS 90 (342)
T ss_pred EEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccce
Confidence 3699999999999999999999999999776666667889999999999999999999876544 35
Q ss_pred EEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccccc
Q psy14556 877 FKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956 (1181)
Q Consensus 877 l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l 956 (1181)
.++||||++ ++|.+++... .+++..++.++.||+.||.|||+.|++||||||+||+++..++.+||+|||.+..+
T Consensus 91 ~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~ 165 (342)
T cd07854 91 VYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIV 165 (342)
T ss_pred EEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceec
Confidence 799999996 5888777532 47788999999999999999999999999999999999865678999999999765
Q ss_pred ccCCCC---CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc
Q psy14556 957 AGLCPS---AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA 1033 (1181)
Q Consensus 957 ~~~~~~---~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~ 1033 (1181)
...... .....++..|+|||.+.++. .++...|+ ||+||++|+|++|+.||.+.+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di------------------wSlGvil~el~~g~~pf~~~~~~~ 226 (342)
T cd07854 166 DPHYSHKGYLSEGLVTKWYRSPRLLLSPN-NYTKAIDM------------------WAAGCIFAEMLTGKPLFAGAHELE 226 (342)
T ss_pred CCccccccccccccccccccCHHHHhCcc-ccCchhhH------------------HHHHHHHHHHHhCCCCCCCCCHHH
Confidence 432111 12234788999999875422 23333444 999999999999999997654322
Q ss_pred ccC----C-----------------------CCCC----CCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1034 LVA----P-----------------------PQIS----RSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1034 l~~----~-----------------------~~ip----~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
... . ...+ ....+..+..+..++.+|+..+|.+||+.-+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el 297 (342)
T cd07854 227 QMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEA 297 (342)
T ss_pred HHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHH
Confidence 100 0 0000 00112345566679999999999999964433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-29 Score=288.14 Aligned_cols=228 Identities=25% Similarity=0.402 Sum_probs=188.3
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
-||-||||.|-++........+|+|++++... .+.+.+..|-.||..++.|+||++|..|.++.++|++||-|-||.
T Consensus 427 TLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGE 506 (732)
T KOG0614|consen 427 TLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGE 506 (732)
T ss_pred hcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCch
Confidence 39999999999998766665689999977643 345678899999999999999999999999999999999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|+..++.+ ..+++.....++..+++|++|||++|||+|||||+|.+++. +|.+||.|||+|+.+... ..+.+++|
T Consensus 507 lWTiLrdR---g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~-~Gy~KLVDFGFAKki~~g-~KTwTFcG 581 (732)
T KOG0614|consen 507 LWTILRDR---GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDN-RGYLKLVDFGFAKKIGSG-RKTWTFCG 581 (732)
T ss_pred hhhhhhhc---CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeecc-CCceEEeehhhHHHhccC-CceeeecC
Confidence 99999854 46788899999999999999999999999999999999998 999999999999998764 56788999
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc-------cCCCCCC
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL-------VAPPQIS 1041 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l-------~~~~~ip 1041 (1181)
||.|.|||++.+.. +...+|. ||||+++|||++|.+||.+.++... ...+.+|
T Consensus 582 TpEYVAPEIILnKG--HD~avDy------------------WaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P 641 (732)
T KOG0614|consen 582 TPEYVAPEIILNKG--HDRAVDY------------------WALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP 641 (732)
T ss_pred CcccccchhhhccC--cchhhHH------------------HHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc
Confidence 99999999998653 3344444 9999999999999999999988553 2234455
Q ss_pred CCCCCCCCcchHHhhccCCCCCCCCCc
Q psy14556 1042 RSVSVPGPGGINSSSSAPVTPTPHSRH 1068 (1181)
Q Consensus 1042 ~~l~~~~p~~L~~li~r~la~dPs~Rp 1068 (1181)
+.+..... .++.+...-.|..|-
T Consensus 642 r~I~k~a~----~Lik~LCr~~P~ERL 664 (732)
T KOG0614|consen 642 RRITKTAT----DLIKKLCRDNPTERL 664 (732)
T ss_pred cccchhHH----HHHHHHHhcCcHhhh
Confidence 54433333 344444455565554
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=258.74 Aligned_cols=220 Identities=17% Similarity=0.157 Sum_probs=175.2
Q ss_pred cCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcccchhc
Q psy14556 816 GSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRV 895 (1181)
Q Consensus 816 G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~dlL~~ 895 (1181)
|.+|.||++++..+++.||+|.+..... ..+|...+....||||+++++++.+.+..+++|||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 8999999999999999999999976532 33455555666899999999999999999999999999999999875
Q ss_pred ccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCccccCc
Q psy14556 896 KWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAP 975 (1181)
Q Consensus 896 ~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~~Y~AP 975 (1181)
. ..+++..+..++.|++.||+|||++|++||||||+||+++. ++.++|+|||.+...... .....++..|+||
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~-~~~~~l~df~~~~~~~~~---~~~~~~~~~y~aP 151 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDD-RGHIQLTYFSRWSEVEDS---CDGEAVENMYCAP 151 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcC-CCCEEEecccchhccccc---cccCCcCccccCC
Confidence 3 24788999999999999999999999999999999999998 889999999987665432 2233467789999
Q ss_pred hhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCCCCCCCCCCCCcchHHh
Q psy14556 976 EVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQISRSVSVPGPGGINSS 1055 (1181)
Q Consensus 976 Evl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~ip~~l~~~~p~~L~~l 1055 (1181)
|.+.++..+...|+ ||+|+++|+|++|..||...... +.... .-..+...+..+..+
T Consensus 152 E~~~~~~~~~~~Dv--------------------wslG~il~el~~g~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~l 208 (237)
T cd05576 152 EVGGISEETEACDW--------------------WSLGAILFELLTGKTLVECHPSG-INTHT--TLNIPEWVSEEARSL 208 (237)
T ss_pred cccCCCCCCchhhH--------------------HHHHHHHHHHHHCcchhhcCchh-ccccc--ccCCcccCCHHHHHH
Confidence 99865544444433 99999999999999988654321 11101 111223356678889
Q ss_pred hccCCCCCCCCCchh
Q psy14556 1056 SSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1056 i~r~la~dPs~Rp~s 1070 (1181)
+.+|+..+|.+|+..
T Consensus 209 i~~~l~~dp~~R~~~ 223 (237)
T cd05576 209 LQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHccCCHHHhcCC
Confidence 999999999999974
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=262.21 Aligned_cols=238 Identities=31% Similarity=0.422 Sum_probs=185.2
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCC--CCChhHHHHHHHHHHhcCCCCeeeEccccccC--CcEEEEEeecCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKN--LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEE--GYFKIFMEQVPG 886 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~--~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~--~~l~LVmEy~~g 886 (1181)
.+||.|++|.||+|.+..+++.+|+|.+.... ....+.+.+|+.++++++|||++++++++.+. +..++||||++
T Consensus 5 ~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~- 83 (287)
T cd07840 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD- 83 (287)
T ss_pred EEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc-
Confidence 46999999999999999999999999997663 33346688999999999999999999999887 89999999996
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC-CCcc
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP-SAET 965 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~-~~~t 965 (1181)
++|.+++... ...+++..++.++.||+.||+|||++|++|+||||+||+++. ++.+||+|||.+........ ....
T Consensus 84 ~~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~-~~~~~l~d~g~~~~~~~~~~~~~~~ 160 (287)
T cd07840 84 HDLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINN-DGVLKLADFGLARPYTKRNSADYTN 160 (287)
T ss_pred ccHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcC-CCCEEEccccceeeccCCCcccccc
Confidence 5888887643 246789999999999999999999999999999999999998 89999999999987654321 1222
Q ss_pred ccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC-------CC
Q psy14556 966 FTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA-------PP 1038 (1181)
Q Consensus 966 ~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~-------~~ 1038 (1181)
..++..|+|||.+.+.. .++...|+ ||+|+++|+|++|+.||...+...... .+
T Consensus 161 ~~~~~~y~~PE~~~~~~-~~~~~~Dv------------------~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~ 221 (287)
T cd07840 161 RVITLWYRPPELLLGAT-RYGPEVDM------------------WSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSP 221 (287)
T ss_pred cccccccCCceeeEccc-cCChHHHH------------------HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 34678899999876432 22333333 999999999999999998766422100 00
Q ss_pred ---CCC----------------------CCCCCCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1039 ---QIS----------------------RSVSVPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1039 ---~ip----------------------~~l~~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
..+ .......+..+..++.+|+..+|.+||...
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~ 279 (287)
T cd07840 222 TDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISAD 279 (287)
T ss_pred chhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHH
Confidence 000 000011256677799999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=266.30 Aligned_cols=236 Identities=30% Similarity=0.398 Sum_probs=185.0
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
+||+|+||.||+|++..++..+++|.+..... ...+.+.+|+.+++.++|+|++++++++...+..++||||+. ++
T Consensus 22 ~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~ 100 (308)
T cd06634 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GS 100 (308)
T ss_pred heeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CC
Confidence 69999999999999999999999999864322 224567889999999999999999999999999999999996 67
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|.+++... ...+++..+..++.|++.||.|||+++++||||||+||+++. ++.++|+|||++..... .....+
T Consensus 101 l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~-~~~~kl~dfg~~~~~~~----~~~~~~ 173 (308)
T cd06634 101 ASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE-PGLVKLGDFGSASIMAP----ANXFVG 173 (308)
T ss_pred HHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECC-CCcEEECCcccceeecC----cccccC
Confidence 77776533 234678889999999999999999999999999999999987 89999999999876543 223458
Q ss_pred CccccCchhhccCC-CCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc---CCCCCCCCC
Q psy14556 969 TLQYMAPEVIDKGQ-RGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV---APPQISRSV 1044 (1181)
Q Consensus 969 T~~Y~APEvl~gg~-~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~---~~~~ip~~l 1044 (1181)
+..|+|||.+.+.. ...+...|+ ||+|+++|+|++|..||......... .....+...
T Consensus 174 ~~~y~aPE~~~~~~~~~~~~~~Di------------------~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
T cd06634 174 TPYWMAPEVILAMDEGQYDGKVDV------------------WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQ 235 (308)
T ss_pred CccccCHHHHhhcccCCCCcccch------------------HHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcC
Confidence 88999999985311 112222333 99999999999999999776543211 111122222
Q ss_pred CCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1045 SVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1045 ~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
....+..+..++.+|+..+|..||...+.
T Consensus 236 ~~~~~~~~~~li~~cl~~~P~~Rp~~~~l 264 (308)
T cd06634 236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264 (308)
T ss_pred cccccHHHHHHHHHHhhCCcccCCCHHHH
Confidence 33566778889999999999999974443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=269.62 Aligned_cols=243 Identities=23% Similarity=0.293 Sum_probs=185.9
Q ss_pred HhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCC--CCChhHHHHHHHHHHhcCCCCeeeEcccccc-CCcEE
Q psy14556 802 FLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKN--LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSE-EGYFK 878 (1181)
Q Consensus 802 ~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~--~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d-~~~l~ 878 (1181)
+.+.|... .+||.|+||.||+|.+..+++.||+|.+.+.. ....+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 8 ~~~~y~~~-~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDL-QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEE-EeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 34455444 47999999999999999999999999886532 2235678899999999999999999998865 56789
Q ss_pred EEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccccccc
Q psy14556 879 IFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 958 (1181)
Q Consensus 879 LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~ 958 (1181)
+++||+ +++|..+++.. .+++..+..++.|+++||+|||++||+||||+|+||+++. ++.++|+|||.+.....
T Consensus 87 lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~-~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 87 FVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINE-NCDLKICDFGLARIQDP 160 (328)
T ss_pred EEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECC-CCCEEeCccccccccCC
Confidence 999998 67888887632 4677888889999999999999999999999999999987 88999999999875432
Q ss_pred CCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc----
Q psy14556 959 LCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL---- 1034 (1181)
Q Consensus 959 ~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l---- 1034 (1181)
......++..|+|||.+.++. .++...|+ ||+|+++|+|++|+.||.+......
T Consensus 161 ---~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv------------------~slG~il~el~tg~~~f~~~~~~~~~~~~ 218 (328)
T cd07856 161 ---QMTGYVSTRYYRAPEIMLTWQ-KYDVEVDI------------------WSAGCIFAEMLEGKPLFPGKDHVNQFSII 218 (328)
T ss_pred ---CcCCCcccccccCceeeeccC-CcCcHHHH------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 223345788999999875422 22333333 9999999999999999976543110
Q ss_pred -----------c------------CC----CCCC-CCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1035 -----------V------------AP----PQIS-RSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1035 -----------~------------~~----~~ip-~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
. .. ...+ ....+..+..+..++.+|+..+|..||+..+.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~el 285 (328)
T cd07856 219 TDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEA 285 (328)
T ss_pred HHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 0 00 0000 01112356678889999999999999975544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=272.91 Aligned_cols=244 Identities=24% Similarity=0.316 Sum_probs=186.6
Q ss_pred HhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEccccccCC----
Q psy14556 802 FLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEG---- 875 (1181)
Q Consensus 802 ~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~---- 875 (1181)
+.+.|... ..||+|+||.||++.+..++..||+|.+...... ..+.+.+|+.++++++||||+++++++....
T Consensus 13 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRDL-KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEEE-EEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 34444443 3699999999999999999999999998654322 2456889999999999999999999886553
Q ss_pred --cEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcc
Q psy14556 876 --YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTS 953 (1181)
Q Consensus 876 --~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlA 953 (1181)
.+++||||+ +++|.+++... .+++..++.++.|++.||.|||+.||+||||||+||+++. ++.++|+|||++
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~-~~~~kl~dfg~~ 165 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNE-DCELKILDFGLA 165 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC-CCCEEEeecccc
Confidence 468999999 78898887632 5788999999999999999999999999999999999987 889999999999
Q ss_pred cccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc
Q psy14556 954 KRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA 1033 (1181)
Q Consensus 954 k~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~ 1033 (1181)
...... .....+++.|+|||.+.+.. .++...|+ ||+|+++|++++|+.||.+.+...
T Consensus 166 ~~~~~~---~~~~~~~~~y~aPE~~~~~~-~~~~~~Di------------------~slG~ll~~l~~g~~pf~~~~~~~ 223 (343)
T cd07880 166 RQTDSE---MTGYVVTRWYRAPEVILNWM-HYTQTVDI------------------WSVGCIMAEMLTGKPLFKGHDHLD 223 (343)
T ss_pred cccccC---ccccccCCcccCHHHHhCCC-CCCcHHHH------------------HHHHHHHHHHHhCCCCCCCCCHHH
Confidence 765432 22345788999999986422 12223333 999999999999999998765321
Q ss_pred ccC-----CC--------------------CCCC-------CCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1034 LVA-----PP--------------------QISR-------SVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1034 l~~-----~~--------------------~ip~-------~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
... .. .++. ......+..+..++.+|+..+|.+||+..+..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 224 QLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred HHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 100 00 0000 11123455677899999999999999866554
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-28 Score=264.88 Aligned_cols=239 Identities=26% Similarity=0.349 Sum_probs=198.1
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIF 880 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LV 880 (1181)
+|.+-+ +||+|+|++|..++.+.+.+.+|+|++++... ++....+.|..+..+. +||.+|-++.+|+.+..+++|
T Consensus 251 df~ll~-vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 251 DFDLLR-VIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred cceeee-eecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 344433 79999999999999999999999999987633 3456678888888776 799999999999999999999
Q ss_pred EeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC
Q psy14556 881 MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC 960 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~ 960 (1181)
.||++||+|--.++. ...++++.+..+..+|+.||.|||++||++||||.+|+|+|. .|++||.|+|+++.-..+.
T Consensus 330 ieyv~ggdlmfhmqr---qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvllda-eghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDA-EGHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred EEEecCcceeeehhh---hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEcc-CCceeecccchhhcCCCCC
Confidence 999999999877774 347889999999999999999999999999999999999998 8999999999998766666
Q ss_pred CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc-------
Q psy14556 961 PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA------- 1033 (1181)
Q Consensus 961 ~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~------- 1033 (1181)
...++++|||.|+|||++++..+ +-.||+ |+||++++||+.|+.||+-.....
T Consensus 406 d~tstfcgtpnyiapeilrgeey--gfsvdw------------------walgvlmfemmagrspfdivgm~n~d~nted 465 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEEY--GFSVDW------------------WALGVLMFEMMAGRSPFDIVGMDNPDMNTED 465 (593)
T ss_pred cccccccCCCcccchhhhccccc--CceehH------------------HHHHHHHHHHHcCCCCcceecCCCcccchhH
Confidence 77889999999999999987654 445555 889999999999999997443211
Q ss_pred ------ccCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCc
Q psy14556 1034 ------LVAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRH 1068 (1181)
Q Consensus 1034 ------l~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp 1068 (1181)
+...+.+|++++......+...+.+.|..+-.-+|
T Consensus 466 ylfqvilekqiriprslsvkas~vlkgflnkdp~erlgc~~ 506 (593)
T KOG0695|consen 466 YLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRP 506 (593)
T ss_pred HHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhcCCCc
Confidence 35567788888877777777665555544433444
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=280.50 Aligned_cols=241 Identities=23% Similarity=0.284 Sum_probs=199.9
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC-hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD-VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~-~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.++||+|-||.|.+|.- ..+..||+|+++.....+ +..|.+|+++|.+|+||||++++++|..++.+++++|||+.|+
T Consensus 543 ~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGD 621 (807)
T KOG1094|consen 543 KEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGD 621 (807)
T ss_pred hhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCc
Confidence 45799999999999975 347899999998776555 5789999999999999999999999999999999999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC-C-Cccc
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP-S-AETF 966 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~-~-~~t~ 966 (1181)
|.+++..+..+. ........|+.||+.|++||.+.++|||||.+.|+|++. ++++||+|||+++.+-.... . ....
T Consensus 622 LnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~-e~~iKiadfgmsR~lysg~yy~vqgr~ 699 (807)
T KOG1094|consen 622 LNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDG-EFTIKIADFGMSRNLYSGDYYRVQGRA 699 (807)
T ss_pred HHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhchhhccccccceeecC-cccEEecCcccccccccCCceeeecce
Confidence 999998763333 445556679999999999999999999999999999998 89999999999986533211 1 1223
Q ss_pred cCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh--CCCCCCCCCcccccCC-------
Q psy14556 967 TGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV--LTAALKKKTSRALVAP------- 1037 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT--Gk~PF~~~~~~~l~~~------- 1037 (1181)
+-...|||||.+..++++..+|+ |++|+++||+++ ...||...+.++++..
T Consensus 700 vlpiRwmawEsillgkFttaSDv--------------------WafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~ 759 (807)
T KOG1094|consen 700 VLPIRWMAWESILLGKFTTASDV--------------------WAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRD 759 (807)
T ss_pred eeeeeehhHHHHHhccccchhhh--------------------hhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCC
Confidence 45689999999998888777777 999999999976 6899998887665321
Q ss_pred --CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1038 --PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1038 --~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.+.--..+.-+|..+-+++.+|+..+...||++-+.
T Consensus 760 ~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~l 797 (807)
T KOG1094|consen 760 QGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQL 797 (807)
T ss_pred CCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHH
Confidence 112223355678899999999999999999997766
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=263.89 Aligned_cols=237 Identities=25% Similarity=0.340 Sum_probs=184.4
Q ss_pred eeecccCceEEEEEEEc---CCCeEEEEEEecCCCC----CChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEe
Q psy14556 811 IELGKGSYGVVYAAREL---DRQVKLAIKEIPEKNL----GDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~---~tg~~VAIKii~~~~~----~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmE 882 (1181)
+.||+|++|.||++++. .+++.||+|.+.+... ...+.+.+|+.++.++ +||||+++++.+......++|||
T Consensus 6 ~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e 85 (288)
T cd05583 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILD 85 (288)
T ss_pred EEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEe
Confidence 46999999999999864 4668899999865422 2345688999999999 69999999999999999999999
Q ss_pred ecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC-
Q psy14556 883 QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP- 961 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~- 961 (1181)
|+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++. ++.++|+|||++..+.....
T Consensus 86 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~-~~~~~l~dfg~~~~~~~~~~~ 161 (288)
T cd05583 86 YVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDS-EGHVVLTDFGLSKEFLAEEEE 161 (288)
T ss_pred cCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC-CCCEEEEECcccccccccccc
Confidence 99999999988743 35778889999999999999999999999999999999987 78999999999876543321
Q ss_pred CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc----cccCC
Q psy14556 962 SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR----ALVAP 1037 (1181)
Q Consensus 962 ~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~----~l~~~ 1037 (1181)
......|+..|+|||.+.+.....+...|+ ||+|+++|+|++|..||...... .+...
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv------------------~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 223 (288)
T cd05583 162 RAYSFCGTIEYMAPEVIRGGSGGHDKAVDW------------------WSLGVLTFELLTGASPFTVDGEQNSQSEISRR 223 (288)
T ss_pred ccccccCCccccCHHHhcCCCCCCcchhhh------------------HHHHHHHHHHHhCCCCcccCcccchHHHHHHH
Confidence 122345889999999987554223333333 99999999999999999754321 11000
Q ss_pred -CCCCCCCCCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1038 -PQISRSVSVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1038 -~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
.......+...+..+..++.+|++.+|..||+
T Consensus 224 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t 256 (288)
T cd05583 224 ILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLG 256 (288)
T ss_pred HHccCCCCCcccCHHHHHHHHHHhcCCHhhccC
Confidence 01111223345677888999999999999996
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=258.76 Aligned_cols=237 Identities=25% Similarity=0.343 Sum_probs=184.7
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC-ChhHHHHHHHHHHhcC-CCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLR-HRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~-HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.+||+|++|+||+|+...+++.|++|.+...... ......+|+..+++++ ||||+++++++.+++..++||||+ +++
T Consensus 5 ~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~ 83 (283)
T cd07830 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGN 83 (283)
T ss_pred eeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCC
Confidence 3699999999999999889999999998655332 2234567999999999 999999999999999999999999 889
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|.+++... ....+++..+..++.|++.+|.|||++|++|+||+|+||+++. ++.++|+|||.+....... ......+
T Consensus 84 l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~-~~~~~l~d~~~~~~~~~~~-~~~~~~~ 160 (283)
T cd07830 84 LYQLMKDR-KGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSG-PEVVKIADFGLAREIRSRP-PYTDYVS 160 (283)
T ss_pred HHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcC-CCCEEEeecccceeccCCC-CcCCCCC
Confidence 98888754 2346789999999999999999999999999999999999998 8999999999997665422 2223457
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC------------
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA------------ 1036 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~------------ 1036 (1181)
+..|+|||++.+.. .+....|+ ||+|+++|+|++|++||..........
T Consensus 161 ~~~~~aPE~~~~~~-~~~~~~Di------------------~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (283)
T cd07830 161 TRWYRAPEILLRST-SYSSPVDI------------------WALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQ 221 (283)
T ss_pred cccccCceeeecCc-CcCCccch------------------hhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChh
Confidence 88999999885432 12223333 999999999999999997665321100
Q ss_pred ------------CCCCCC-------CCCCCCCcchHHhhccCCCCCCCCCchh
Q psy14556 1037 ------------PPQISR-------SVSVPGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1037 ------------~~~ip~-------~l~~~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
...++. ......+..+..++.+|+..+|..||+.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~ 274 (283)
T cd07830 222 DWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTA 274 (283)
T ss_pred hhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCH
Confidence 000000 0111225667889999999999999974
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=261.93 Aligned_cols=240 Identities=23% Similarity=0.258 Sum_probs=181.2
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC-ChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.+||+|+||.||+|.+..+++.||+|.++..... ....+.+|+.++.+. .||||+++++++.+....+++|||+ +++
T Consensus 21 ~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~ 99 (296)
T cd06618 21 GEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM-STC 99 (296)
T ss_pred eEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc-CcC
Confidence 4799999999999999988999999999755332 344566777767666 4999999999999999999999998 457
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccc-cceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHG-QKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs-~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
|.+++... ...+++..+..++.|++.||+|||+ .||+||||+|+||+++. ++.+||+|||++..+..... .....
T Consensus 100 l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~-~~~~kL~dfg~~~~~~~~~~-~~~~~ 175 (296)
T cd06618 100 LDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDA-SGNVKLCDFGISGRLVDSKA-KTRSA 175 (296)
T ss_pred HHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcC-CCCEEECccccchhccCCCc-ccCCC
Confidence 77776543 2367888899999999999999997 59999999999999987 89999999999876643222 22335
Q ss_pred CCccccCchhhccCC--CCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc-c-cc--CCCCCC
Q psy14556 968 GTLQYMAPEVIDKGQ--RGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR-A-LV--APPQIS 1041 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~--~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~-~-l~--~~~~ip 1041 (1181)
++..|+|||.+.+.. ..++... +.||+|+++|+|++|+.||...... + +. .....+
T Consensus 176 ~~~~y~aPE~~~~~~~~~~~~~~~------------------Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 237 (296)
T cd06618 176 GCAAYMAPERIDPPDPNPKYDIRA------------------DVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP 237 (296)
T ss_pred CCccccCHhhcCCCCCccccccch------------------hHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCC
Confidence 788999999986443 1122222 2399999999999999999764321 1 10 011111
Q ss_pred C-CCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1042 R-SVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1042 ~-~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
. ......+..+..++.+|+..+|..||...+.
T Consensus 238 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~i 270 (296)
T cd06618 238 SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYREL 270 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 1 1111356778899999999999999975444
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-27 Score=268.94 Aligned_cols=241 Identities=23% Similarity=0.297 Sum_probs=181.1
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccC------C
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEE------G 875 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~------~ 875 (1181)
.+|.. ...||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++... .
T Consensus 15 ~~y~~-~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTS-LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEE-EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 34433 3479999999999999999999999999865422 2245688999999999999999999988654 3
Q ss_pred cEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccc
Q psy14556 876 YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 955 (1181)
Q Consensus 876 ~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~ 955 (1181)
.+++|+||+. .+|..+.. ..+++..+..++.|++.||+|||++|++||||||+||+++. ++.+||+|||+++.
T Consensus 94 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~-~~~~kL~dfg~~~~ 166 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNE-DCELKILDFGLARH 166 (342)
T ss_pred eEEEEecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC-CCCEEEeeCCCCcC
Confidence 4699999985 46655442 24678889999999999999999999999999999999998 89999999999876
Q ss_pred cccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc
Q psy14556 956 LAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV 1035 (1181)
Q Consensus 956 l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~ 1035 (1181)
... ......++..|+|||.+.+.. .++...|+ ||+|+++|+|++|+.||.+.+.....
T Consensus 167 ~~~---~~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv------------------~slGvil~el~~g~~pf~~~~~~~~~ 224 (342)
T cd07879 167 ADA---EMTGYVVTRWYRAPEVILNWM-HYNQTVDI------------------WSVGCIMAEMLTGKTLFKGKDYLDQL 224 (342)
T ss_pred CCC---CCCCceeeecccChhhhcCcc-ccCchHHH------------------HHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 532 222345788999999986422 12223333 99999999999999999876532210
Q ss_pred C----------------------------CCCCCC-C---CCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1036 A----------------------------PPQISR-S---VSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1036 ~----------------------------~~~ip~-~---l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
. .+..+. . ..+..+..+..++.+|+..+|.+||...+.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l 295 (342)
T cd07879 225 TQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEAL 295 (342)
T ss_pred HHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 0 000000 0 0123455677899999999999999754443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.8e-27 Score=266.70 Aligned_cols=241 Identities=22% Similarity=0.323 Sum_probs=182.3
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccC------C
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEE------G 875 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~------~ 875 (1181)
+.|... ..||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.++++++||||+++++++... .
T Consensus 17 ~~y~~~-~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 17 ERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred CceEEE-EEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 344433 479999999999999999999999999965432 2346688899999999999999999987533 3
Q ss_pred cEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccc
Q psy14556 876 YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 955 (1181)
Q Consensus 876 ~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~ 955 (1181)
..+++++++ +++|.+++... .+++..++.++.|++.||+|||++||+||||||+||+++. ++.+||+|||++..
T Consensus 96 ~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~-~~~~kl~dfg~~~~ 169 (345)
T cd07877 96 DVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE-DCELKILDFGLARH 169 (345)
T ss_pred cEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcC-CCCEEEeccccccc
Confidence 578888887 88998887633 4778899999999999999999999999999999999998 88999999999876
Q ss_pred cccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc
Q psy14556 956 LAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV 1035 (1181)
Q Consensus 956 l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~ 1035 (1181)
... ......++..|+|||.+.+. ..++...|+ ||+|+++|+|++|+.||...+.....
T Consensus 170 ~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv------------------wslG~il~el~~g~~pf~~~~~~~~~ 227 (345)
T cd07877 170 TDD---EMTGYVATRWYRAPEIMLNW-MHYNQTVDI------------------WSVGCIMAELLTGRTLFPGTDHIDQL 227 (345)
T ss_pred ccc---cccccccCCCccCHHHHhCc-cCCCchhhH------------------HHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 532 22334678999999998642 123333333 99999999999999999765432210
Q ss_pred C---------C-------------------CCCCCC----CCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1036 A---------P-------------------PQISRS----VSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1036 ~---------~-------------------~~ip~~----l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
. . +..+.. .....+..+..++.+|+..+|..|++..+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 297 (345)
T cd07877 228 KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 297 (345)
T ss_pred HHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHH
Confidence 0 0 000000 011235567789999999999999974433
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-28 Score=259.90 Aligned_cols=238 Identities=23% Similarity=0.274 Sum_probs=188.5
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCC-CCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKN-LGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~-~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
.||.|.-|.||+++.+.++...|||.+.+.. ..+.+++...+.++... ++|+||+.+|+|..+..+++.||.| +..+
T Consensus 99 dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ 177 (391)
T KOG0983|consen 99 DLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-STCA 177 (391)
T ss_pred hhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HHHH
Confidence 3999999999999999999999999997653 34456777777777665 4899999999999999999999998 5566
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhcccc-ceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ-KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~-gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
+.+++.- ..++++..+-++...+++||.||.++ ||+|||+||+|||+|. .|++||||||++..+.+.... +...|
T Consensus 178 ekLlkri--k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe-~GniKlCDFGIsGrlvdSkAh-trsAG 253 (391)
T KOG0983|consen 178 EKLLKRI--KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE-RGNIKLCDFGISGRLVDSKAH-TRSAG 253 (391)
T ss_pred HHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEcc-CCCEEeecccccceeeccccc-ccccC
Confidence 6666643 34578999999999999999999965 8999999999999998 899999999999877654333 33469
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc--c-----cCCCCCC
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA--L-----VAPPQIS 1041 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~--l-----~~~~~ip 1041 (1181)
.+.|||||.+.- ....+.|+++|+ ||||+.++||.||..||.+.+.+- + ..++.++
T Consensus 254 C~~YMaPERidp---~~~~kYDiRaDV--------------WSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~ 316 (391)
T KOG0983|consen 254 CAAYMAPERIDP---PDKPKYDIRADV--------------WSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLP 316 (391)
T ss_pred CccccCccccCC---CCCCccchhhhh--------------hhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCC
Confidence 999999999962 235566665555 999999999999999999965421 1 1122233
Q ss_pred CCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1042 RSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1042 ~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
... ...+.+.+.+..|+++|+.+||..-++
T Consensus 317 ~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~L 346 (391)
T KOG0983|consen 317 GHM--GFSPDFQSFVKDCLTKDHRKRPKYNKL 346 (391)
T ss_pred ccc--CcCHHHHHHHHHHhhcCcccCcchHHH
Confidence 222 256667788899999999999975444
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-27 Score=263.90 Aligned_cols=238 Identities=24% Similarity=0.300 Sum_probs=181.2
Q ss_pred eeecccCceEEEEEEEcCC--CeEEEEEEecCCCC--CChhHHHHHHHHHHhc-CCCCeeeEcccccc----CCcEEEEE
Q psy14556 811 IELGKGSYGVVYAARELDR--QVKLAIKEIPEKNL--GDVQPLHEEIKLHSQL-RHRNIVQYLGSVSE----EGYFKIFM 881 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~t--g~~VAIKii~~~~~--~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d----~~~l~LVm 881 (1181)
..||+|+||.||++.+..+ +..||+|.+..... ...+.+.+|+.+++++ +||||+++++.+.. ....++++
T Consensus 6 ~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~ 85 (332)
T cd07857 6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYE 85 (332)
T ss_pred EEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEE
Confidence 3699999999999999888 88999999865322 2245688999999999 59999999986432 25678999
Q ss_pred eecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC
Q psy14556 882 EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP 961 (1181)
Q Consensus 882 Ey~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~ 961 (1181)
||+ +++|.+++.. ...+++..++.++.||+.||+|||++|++||||||+||+++. ++.+||+|||.++.+.....
T Consensus 86 e~~-~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~-~~~~kl~Dfg~a~~~~~~~~ 160 (332)
T cd07857 86 ELM-EADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNA-DCELKICDFGLARGFSENPG 160 (332)
T ss_pred ecc-cCCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcC-CCCEEeCcCCCceecccccc
Confidence 998 4688888863 346788999999999999999999999999999999999988 88999999999976543221
Q ss_pred ----CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC-
Q psy14556 962 ----SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA- 1036 (1181)
Q Consensus 962 ----~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~- 1036 (1181)
......|+..|+|||.+.+. ..++...|+ ||+|+++|+|++|++||.+.+......
T Consensus 161 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di------------------~slGv~l~~l~~g~~pf~~~~~~~~~~~ 221 (332)
T cd07857 161 ENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDV------------------WSVGCILAELLGRKPVFKGKDYVDQLNQ 221 (332)
T ss_pred cccccccCcccCccccCcHHHhCC-CCCCcHHHH------------------HHHHHHHHHHHhCCcCCCCCCHHHHHHH
Confidence 12234689999999988543 123333443 999999999999999998755311100
Q ss_pred --------------------------------CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1037 --------------------------------PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1037 --------------------------------~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
...++ ......+..+..++.+|+..+|..||+..+.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~l 289 (332)
T cd07857 222 ILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEA 289 (332)
T ss_pred HHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 00000 1112345678889999999999999975544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=287.17 Aligned_cols=203 Identities=20% Similarity=0.240 Sum_probs=149.9
Q ss_pred HhhhcccCceeecccCceEEEEEEEcCCC-eEEEEEE--------------ecC---CCCCChhHHHHHHHHHHhcCCCC
Q psy14556 802 FLYLFALNRIELGKGSYGVVYAARELDRQ-VKLAIKE--------------IPE---KNLGDVQPLHEEIKLHSQLRHRN 863 (1181)
Q Consensus 802 ~~~~~~l~~~kIG~G~fG~VYka~d~~tg-~~VAIKi--------------i~~---~~~~~~e~f~rEi~IL~~L~HPN 863 (1181)
+...|.+.+ +||+|+||+||+|..+... ...+.|. +.+ ......+.+.+|+.++++++|||
T Consensus 146 ~~~~Y~ii~-~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVID-DLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEe-EecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 344555544 6999999999998764322 1122221 110 11112456889999999999999
Q ss_pred eeeEccccccCCcEEEEEeecCCCCcccchhcccC--CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccC
Q psy14556 864 IVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWG--PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTY 941 (1181)
Q Consensus 864 IVkl~g~~~d~~~l~LVmEy~~gGSL~dlL~~~~~--~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~ 941 (1181)
|+++++++.+.+..|+++|++ +++|.+++..... ........+..++.||+.||+|||++||+||||||+|||++.
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~- 302 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC- 302 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC-
Confidence 999999999999999999998 4566666543211 112235667789999999999999999999999999999988
Q ss_pred CCeeeeecCCcccccccCCC-CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHH
Q psy14556 942 SGVVKISDFGTSKRLAGLCP-SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLL 1020 (1181)
Q Consensus 942 ~g~vKLiDFGlAk~l~~~~~-~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELL 1020 (1181)
++.+||+|||+++.+..... ......||..|+|||++.+..++.. .|+ ||+||++|||+
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~Di------------------wSlGvil~ell 362 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEI--TDI------------------WSCGLILLDML 362 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcH--HHH------------------HHHHHHHHHHH
Confidence 89999999999987654322 2234579999999999976544333 333 99999999999
Q ss_pred hCCCCCC
Q psy14556 1021 VLTAALK 1027 (1181)
Q Consensus 1021 TGk~PF~ 1027 (1181)
+|..++.
T Consensus 363 ~~~~~p~ 369 (501)
T PHA03210 363 SHDFCPI 369 (501)
T ss_pred HCCCCCc
Confidence 9986443
|
|
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-28 Score=277.25 Aligned_cols=242 Identities=22% Similarity=0.323 Sum_probs=182.2
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCC--CCCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEeecCC
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEK--NLGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~--~~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
-.+||+||.+.||++..... ..||+|.+... ......-+.+|+..|.+| .|.+|+++++|-..++++|+||||- .
T Consensus 366 lk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d 443 (677)
T KOG0596|consen 366 LKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-D 443 (677)
T ss_pred HHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-c
Confidence 34799999999999986544 45666665433 233467799999999999 5899999999999999999999986 6
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC--Cc
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS--AE 964 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~--~~ 964 (1181)
.+|..+|+.+... .+...++.+..|++.|++++|..||||.||||.|+|+-. |.+||+|||+|..+...... ..
T Consensus 444 ~DL~kiL~k~~~~--~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk--G~LKLIDFGIA~aI~~DTTsI~kd 519 (677)
T KOG0596|consen 444 IDLNKILKKKKSI--DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK--GRLKLIDFGIANAIQPDTTSIVKD 519 (677)
T ss_pred ccHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe--eeEEeeeechhcccCccccceeec
Confidence 7999999876332 223377889999999999999999999999999999975 99999999999888765433 33
Q ss_pred cccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc-----ccCC--
Q psy14556 965 TFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA-----LVAP-- 1037 (1181)
Q Consensus 965 t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~-----l~~~-- 1037 (1181)
+.+||+.||+||.+.....+...+- -.+.-.+.++.||+|||||+|+.|+.||....... +..+
T Consensus 520 sQvGT~NYMsPEAl~~~~s~~~~~~---------~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~ 590 (677)
T KOG0596|consen 520 SQVGTVNYMSPEALTDMSSSRENGK---------SKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNH 590 (677)
T ss_pred cccCcccccCHHHHhhccccccCCC---------cceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCc
Confidence 4679999999999974433311110 01123455666999999999999999999765211 1111
Q ss_pred -CCCCCCCCCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1038 -PQISRSVSVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1038 -~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
+.+|.. +.+..+-.++..|++.||.+||+
T Consensus 591 ~Iefp~~---~~~~~li~~mK~CL~rdPkkR~s 620 (677)
T KOG0596|consen 591 EIEFPDI---PENDELIDVMKCCLARDPKKRWS 620 (677)
T ss_pred cccccCC---CCchHHHHHHHHHHhcCcccCCC
Confidence 112221 22223777899999999999996
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=293.90 Aligned_cols=239 Identities=26% Similarity=0.347 Sum_probs=180.1
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCC-CCChhHHHHHHHHHHhcCCCCeeeEccccccC----------------
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKN-LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEE---------------- 874 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~-~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~---------------- 874 (1181)
.||+||||.||+++++-+|+.||||+++... ......+.+|+..+++|+|||||+++..|.+.
T Consensus 486 lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~~ 565 (1351)
T KOG1035|consen 486 LLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSES 565 (1351)
T ss_pred HhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchhh
Confidence 5999999999999999999999999997664 23356789999999999999999997643100
Q ss_pred --------------------------------------------------------------------------------
Q psy14556 875 -------------------------------------------------------------------------------- 874 (1181)
Q Consensus 875 -------------------------------------------------------------------------------- 874 (1181)
T Consensus 566 ~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~ 645 (1351)
T KOG1035|consen 566 RSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDDT 645 (1351)
T ss_pred hcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCcc
Confidence
Q ss_pred -----------------------CcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccC
Q psy14556 875 -----------------------GYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931 (1181)
Q Consensus 875 -----------------------~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDL 931 (1181)
..+||-||||+..+|+++++.+... -.....|.+++||++||.|+|++|||||||
T Consensus 646 ~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYIH~~giIHRDL 723 (1351)
T KOG1035|consen 646 SESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYIHDQGIIHRDL 723 (1351)
T ss_pred hhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHHHhCceeeccC
Confidence 1257889999888888888754211 146778999999999999999999999999
Q ss_pred CCCCcccccCCCeeeeecCCcccccc------------------cCCCCCccccCCccccCchhhccCCC-CCCCccccc
Q psy14556 932 KGDNVLVNTYSGVVKISDFGTSKRLA------------------GLCPSAETFTGTLQYMAPEVIDKGQR-GYGAPVRQR 992 (1181)
Q Consensus 932 KP~NILLd~~~g~vKLiDFGlAk~l~------------------~~~~~~~t~~GT~~Y~APEvl~gg~~-~~ssDVDi~ 992 (1181)
||.||++++ ++.|||+|||+++... ......+..+||.-|+|||++.+... .|.+++|+
T Consensus 724 KP~NIFLd~-~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDm- 801 (1351)
T KOG1035|consen 724 KPRNIFLDS-RNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDM- 801 (1351)
T ss_pred CcceeEEcC-CCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhh-
Confidence 999999997 8999999999997621 01112344679999999999975432 57777777
Q ss_pred cCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc----cCCCCCCCCCCCCC--CcchHHhhccCCCCCCCC
Q psy14556 993 DKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL----VAPPQISRSVSVPG--PGGINSSSSAPVTPTPHS 1066 (1181)
Q Consensus 993 ~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l----~~~~~ip~~l~~~~--p~~L~~li~r~la~dPs~ 1066 (1181)
||||+||+||+ +||...-.+.- .....+|....... -..-.++++..+++||++
T Consensus 802 -----------------YSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~k 861 (1351)
T KOG1035|consen 802 -----------------YSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSK 861 (1351)
T ss_pred -----------------HHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCcc
Confidence 99999999998 45765544321 11333443311111 222344888999999999
Q ss_pred CchhHHHH
Q psy14556 1067 RHISVNTN 1074 (1181)
Q Consensus 1067 Rp~s~~~~ 1074 (1181)
||+..+++
T Consensus 862 RPtA~eLL 869 (1351)
T KOG1035|consen 862 RPTATELL 869 (1351)
T ss_pred CCCHHHHh
Confidence 99865553
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-27 Score=269.92 Aligned_cols=240 Identities=23% Similarity=0.327 Sum_probs=185.6
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCC--CCChhHHHHHHHHHHhcCCCCeeeEccccccCCc-----
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKN--LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGY----- 876 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~--~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~----- 876 (1181)
++|.. ..+||+|++|.||+|++..++..||+|.+.... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 15 ~~y~~-~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 15 DRYQN-LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred CceEE-EEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 34443 347999999999999999999999999986542 2234567889999999999999999998876554
Q ss_pred -EEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccc
Q psy14556 877 -FKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 955 (1181)
Q Consensus 877 -l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~ 955 (1181)
.++|+||+ +++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++. ++.++|+|||++..
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~-~~~~kL~dfg~~~~ 167 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE-DCELKILDFGLARH 167 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC-CCCEEEcccccccc
Confidence 89999998 7799888864 25788999999999999999999999999999999999988 89999999999976
Q ss_pred cccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc
Q psy14556 956 LAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV 1035 (1181)
Q Consensus 956 l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~ 1035 (1181)
.... .....++..|+|||.+.+.. .++...|+ ||+|+++|+|++|+.||.+.......
T Consensus 168 ~~~~---~~~~~~~~~y~aPE~~~~~~-~~~~~~Dv------------------wslGv~l~elltg~~pf~~~~~~~~~ 225 (343)
T cd07851 168 TDDE---MTGYVATRWYRAPEIMLNWM-HYNQTVDI------------------WSVGCIMAELLTGKTLFPGSDHIDQL 225 (343)
T ss_pred cccc---ccCCcccccccCHHHHhCCC-CCCchHhH------------------HHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 5432 23346788999999986432 23333333 99999999999999999866542210
Q ss_pred C--------CC-C----------------CCC-------CCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1036 A--------PP-Q----------------ISR-------SVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1036 ~--------~~-~----------------ip~-------~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
. ++ . .+. ......+..+..++.+|+.++|.+||+..+
T Consensus 226 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~e 294 (343)
T cd07851 226 KRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAE 294 (343)
T ss_pred HHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHH
Confidence 0 00 0 000 001234667788999999999999996443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=276.31 Aligned_cols=240 Identities=22% Similarity=0.283 Sum_probs=201.8
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
.+||-|-||.||.|.|+.-...||||.++.+. -..++|..|+.+|+.++|||+|+++|+|..+..+|||+|||..|+|.
T Consensus 273 hKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLL 351 (1157)
T KOG4278|consen 273 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLL 351 (1157)
T ss_pred eccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHH
Confidence 47999999999999999999999999997554 35688999999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC-CccccCC
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS-AETFTGT 969 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~-~~t~~GT 969 (1181)
++|+.. ....++.....+++.||..|+.||..+++|||||..+|.|+.+ +..+|++|||+++........ .....-.
T Consensus 352 dYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgE-nhiVKvADFGLsRlMtgDTYTAHAGAKFP 429 (1157)
T KOG4278|consen 352 DYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE-NHIVKVADFGLSRLMTGDTYTAHAGAKFP 429 (1157)
T ss_pred HHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccc-cceEEeeccchhhhhcCCceecccCccCc
Confidence 999876 4556777888899999999999999999999999999999988 889999999999987653221 1122246
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--CCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--ISRSVSV 1046 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--ip~~l~~ 1046 (1181)
..|.|||.+....++.++|| |+||++|||+.| |-.||.+.+...+..... ..-.-+.
T Consensus 430 IKWTAPEsLAyNtFSiKSDV--------------------WAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~Pe 489 (1157)
T KOG4278|consen 430 IKWTAPESLAYNTFSIKSDV--------------------WAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPE 489 (1157)
T ss_pred ccccCcccccccccccchhh--------------------HHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCC
Confidence 78999999986665555555 999999999988 789999988766432111 2222345
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.+|+.+.+++.+||.-.|+.||.+++.
T Consensus 490 GCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 490 GCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred CCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 688999999999999999999987765
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-27 Score=281.55 Aligned_cols=243 Identities=26% Similarity=0.354 Sum_probs=203.4
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhc-CCCCeeeEccccc-----cCCcEEEEEeec
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQYLGSVS-----EEGYFKIFMEQV 884 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~-----d~~~l~LVmEy~ 884 (1181)
++||.|.+|.||+++++.+++..|+|+.......+ +++..|.++++.+ +|||++.++++|. .++.+|||||||
T Consensus 25 evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC 103 (953)
T KOG0587|consen 25 EVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFC 103 (953)
T ss_pred EEEeeccceeEEEEeeeecCceeeeEeecCCcccc-HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeecc
Confidence 47999999999999999999999999997665444 6788899999988 6999999999874 246899999999
Q ss_pred CCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCc
Q psy14556 885 PGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAE 964 (1181)
Q Consensus 885 ~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~ 964 (1181)
.|||..++++... ...+.|..+..|++.++.||.+||...++|||||-.|||++. ++.+||+|||.+..+........
T Consensus 104 ~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~-e~~VKLvDFGvSaQldsT~grRn 181 (953)
T KOG0587|consen 104 GGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLDSTVGRRN 181 (953)
T ss_pred CCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEec-cCcEEEeeeeeeeeeeccccccc
Confidence 9999999998764 667889999999999999999999999999999999999998 89999999999999887767777
Q ss_pred cccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCCCCCCC
Q psy14556 965 TFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQISRSV 1044 (1181)
Q Consensus 965 t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~ip~~l 1044 (1181)
+..|||.|||||++.- ...+.+++|.++|+ ||||++..||.-|.+|+.+..+.-.. ..+|+..
T Consensus 182 T~iGtP~WMAPEViac-~e~~d~tyd~R~D~--------------WsLGITaIEladG~PPl~DmHPmraL--F~IpRNP 244 (953)
T KOG0587|consen 182 TFIGTPYWMAPEVIAC-DESPDATYDYRSDL--------------WSLGITAIEMAEGAPPLCDMHPMRAL--FLIPRNP 244 (953)
T ss_pred CcCCCcccccceeeec-ccCCCCCcccccch--------------hhccceeehhcCCCCCccCcchhhhh--ccCCCCC
Confidence 8899999999999963 34566666665555 99999999999999999876653321 2222222
Q ss_pred C------CCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1045 S------VPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1045 ~------~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
+ ..+...+...+..|+.+|-.+||.....
T Consensus 245 PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~l 279 (953)
T KOG0587|consen 245 PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEEL 279 (953)
T ss_pred CccccchhhHHHHHHHHHHHHHhhccccCcchhhh
Confidence 2 2345567778899999999999986665
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=274.63 Aligned_cols=239 Identities=24% Similarity=0.263 Sum_probs=199.1
Q ss_pred eeecccCceEEEEEEEcCCC----eEEEEEEecCCC-CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 811 IELGKGSYGVVYAARELDRQ----VKLAIKEIPEKN-LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg----~~VAIKii~~~~-~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
.+||+|+||+||+|.+...+ .+||||++.... ....+++..|+-+|.+++|||++++++++.... +.||++||+
T Consensus 702 kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP 780 (1177)
T KOG1025|consen 702 KVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMP 780 (1177)
T ss_pred ceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcc
Confidence 37999999999999987655 468999886543 344678999999999999999999999998766 889999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcc
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAET 965 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t 965 (1181)
+|+|.++++.++. .+..+..+.|..||++||.|||++++|||||-.+|||+.. ...+||.|||+++.+.........
T Consensus 781 ~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVks-P~hvkitdfgla~ll~~d~~ey~~ 857 (1177)
T KOG1025|consen 781 LGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKS-PNHVKITDFGLAKLLAPDEKEYSA 857 (1177)
T ss_pred cchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecC-CCeEEEEecchhhccCcccccccc
Confidence 9999999997644 4567888899999999999999999999999999999988 889999999999988765444333
Q ss_pred c--cCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCCCCC
Q psy14556 966 F--TGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQISR 1042 (1181)
Q Consensus 966 ~--~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~ip~ 1042 (1181)
. .-.+.|||=|.+....++..+|| ||+||++||++| |..||.+...+++......+.
T Consensus 858 ~~gK~pikwmale~i~~~~~thqSDV--------------------WsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge 917 (1177)
T KOG1025|consen 858 PGGKVPIKWMALESIRIRKYTHQSDV--------------------WSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE 917 (1177)
T ss_pred cccccCcHHHHHHHhhccCCCchhhh--------------------hhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc
Confidence 2 23678999999998887777777 999999999999 889999999988766555555
Q ss_pred CCCCC--CCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1043 SVSVP--GPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1043 ~l~~~--~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.++.| ++-.+-..+.+||..|+..||.+-.+
T Consensus 918 RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel 950 (1177)
T KOG1025|consen 918 RLSQPPICTIDVYMVMVKCWMIDADSRPTFKEL 950 (1177)
T ss_pred cCCCCCCccHHHHHHHHHHhccCcccCccHHHH
Confidence 54443 44455568899999999999975444
|
|
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-27 Score=241.37 Aligned_cols=200 Identities=22% Similarity=0.350 Sum_probs=170.6
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC--hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD--VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~--~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.++||+|.||+||+|++..+++.||+|.++.....+ -....+|+.+++.++|.|||+++++...++.+.+|+||| ..
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-dq 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQ 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hH
Confidence 357999999999999999999999999997654332 456889999999999999999999999999999999999 67
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|..+...- +..++.+.+..++.|+++||.++|++++.||||||.|.|++. +|.+||+|||+++.+.-+..-.+.-+
T Consensus 86 dlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~-ngelkladfglarafgipvrcysaev 162 (292)
T KOG0662|consen 86 DLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINR-NGELKLADFGLARAFGIPVRCYSAEV 162 (292)
T ss_pred HHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEecc-CCcEEecccchhhhcCCceEeeecee
Confidence 788887754 335778899999999999999999999999999999999988 99999999999988765432233345
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSR 1032 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~ 1032 (1181)
-|.+|++|.++.+.. -|+..+|+ ||.|||+.|+.. |++.|.+.+..
T Consensus 163 vtlwyrppdvlfgak-ly~tsidm------------------wsagcifaelanagrplfpg~dvd 209 (292)
T KOG0662|consen 163 VTLWYRPPDVLFGAK-LYSTSIDM------------------WSAGCIFAELANAGRPLFPGNDVD 209 (292)
T ss_pred eeeeccCcceeeeee-hhccchHh------------------hhcchHHHHHhhcCCCCCCCCcHH
Confidence 789999999997654 57778887 999999999976 66778877653
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=286.69 Aligned_cols=140 Identities=28% Similarity=0.461 Sum_probs=126.2
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC---hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD---VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~---~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.+||+|+||+||+|.+..+++.||||++....... .+.+.+|+.+++.++||||+++++++...+.+|+||||+.++
T Consensus 10 ~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~ 89 (669)
T cd05610 10 KPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGG 89 (669)
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCC
Confidence 47999999999999999999999999997543322 467889999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk 954 (1181)
+|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+++
T Consensus 90 ~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~-~g~vkL~DFGls~ 152 (669)
T cd05610 90 DVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISN-EGHIKLTDFGLSK 152 (669)
T ss_pred CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcC-CCCEEEEeCCCCc
Confidence 999998743 24678889999999999999999999999999999999987 8999999999885
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=241.27 Aligned_cols=232 Identities=30% Similarity=0.415 Sum_probs=187.5
Q ss_pred CceEEEEEEEcCCCeEEEEEEecCCCCCC-hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcccchhc
Q psy14556 817 SYGVVYAARELDRQVKLAIKEIPEKNLGD-VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRV 895 (1181)
Q Consensus 817 ~fG~VYka~d~~tg~~VAIKii~~~~~~~-~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~dlL~~ 895 (1181)
+||.||+|.+..+++.+++|++....... .+.+.+|+..+++++|+||+++++.+......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999999889999999997765555 67899999999999999999999999998999999999999999999875
Q ss_pred ccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCccccCc
Q psy14556 896 KWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAP 975 (1181)
Q Consensus 896 ~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~~Y~AP 975 (1181)
.. .+++..++.++.+++.++.+||+.+++|+||+|+||+++. ++.++|+|||.+....... ......++..|+||
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~-~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~p 155 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDE-DGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAP 155 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECC-CCcEEEccccceeeecccc-ccccccCCcCCCCH
Confidence 42 2778899999999999999999999999999999999998 7899999999998765432 23344588899999
Q ss_pred hhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCC-CCcccccCCC---CCCCCCCCC-CCc
Q psy14556 976 EVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKK-KTSRALVAPP---QISRSVSVP-GPG 1050 (1181)
Q Consensus 976 Evl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~-~~~~~l~~~~---~ip~~l~~~-~p~ 1050 (1181)
|.+.+...+..+|+ |++|+++|++++|..||.. .....+.... ......... .+.
T Consensus 156 E~~~~~~~~~~~Di--------------------~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (244)
T smart00220 156 EVLLGKGYGKAVDV--------------------WSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISP 215 (244)
T ss_pred HHHccCCCCchhhH--------------------HHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCH
Confidence 99975544443333 9999999999999999987 3332221111 111111111 677
Q ss_pred chHHhhccCCCCCCCCCchhHHH
Q psy14556 1051 GINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1051 ~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.+..++.+|+..+|..||...+.
T Consensus 216 ~~~~~i~~~l~~~p~~Rp~~~~~ 238 (244)
T smart00220 216 EAKDLIRKLLVKDPEKRLTAEEA 238 (244)
T ss_pred HHHHHHHHHccCCchhccCHHHH
Confidence 88899999999999999965443
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.8e-27 Score=270.95 Aligned_cols=199 Identities=25% Similarity=0.425 Sum_probs=168.8
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
-||-|+||+|.+++...+...||+|.+.+... ......+.|..||...+.+-||++|..|++.+.+|+||+|++||+
T Consensus 636 ~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGD 715 (1034)
T KOG0608|consen 636 TIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGD 715 (1034)
T ss_pred eecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCcc
Confidence 49999999999999999999999999977643 334567889999999999999999999999999999999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccccccc--------CC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--------LC 960 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~--------~~ 960 (1181)
+-.+|-+. .-+.+..++.++.++..|+++.|..|+|||||||+|||||. +|++||.|||+|.-+.- ..
T Consensus 716 mMSLLIrm---gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDr-dGHIKLTDFGLCTGfRWTHdskYYq~g 791 (1034)
T KOG0608|consen 716 MMSLLIRM---GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR-DGHIKLTDFGLCTGFRWTHDSKYYQEG 791 (1034)
T ss_pred HHHHHHHh---ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEcc-CCceeeeeccccccceeccccccccCC
Confidence 98888643 35778999999999999999999999999999999999998 99999999999853320 00
Q ss_pred CC----------------------------------CccccCCccccCchhhccCCCCCCCccccccCCCcccccccccc
Q psy14556 961 PS----------------------------------AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKM 1006 (1181)
Q Consensus 961 ~~----------------------------------~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~ 1006 (1181)
.+ ....+||+.|+|||++... ++..-+|+
T Consensus 792 dH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~--g~~q~cdw--------------- 854 (1034)
T KOG0608|consen 792 DHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART--GYTQLCDW--------------- 854 (1034)
T ss_pred CccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc--Cccccchh---------------
Confidence 00 0113599999999999754 45555555
Q ss_pred chhHHHHHHHHHHHhCCCCCCCCCcccc
Q psy14556 1007 KINVFLCVIISQLLVLTAALKKKTSRAL 1034 (1181)
Q Consensus 1007 k~DwSLGvILyELLTGk~PF~~~~~~~l 1034 (1181)
||.|+|||||+.|+.||...++-+.
T Consensus 855 ---ws~gvil~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 855 ---WSVGVILYEMLVGQPPFLADTPGET 879 (1034)
T ss_pred ---hHhhHHHHHHhhCCCCccCCCCCcc
Confidence 9999999999999999998887554
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-26 Score=292.73 Aligned_cols=233 Identities=19% Similarity=0.248 Sum_probs=175.1
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
.+||+|+||.||+|++..++..||+|.+...... ...|+.++++++||||+++++++.+.+..++||||+++|+|.
T Consensus 696 ~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~ 771 (968)
T PLN00113 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLS 771 (968)
T ss_pred cEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHH
Confidence 4799999999999999899999999998644322 235688999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhcc---ccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLH---GQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLH---s~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
++++ .+++..+..++.|++.||+||| +.+|+||||||+||+++. ++..++. ||....... .....
T Consensus 772 ~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~-~~~~~~~-~~~~~~~~~----~~~~~ 839 (968)
T PLN00113 772 EVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG-KDEPHLR-LSLPGLLCT----DTKCF 839 (968)
T ss_pred HHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECC-CCceEEE-ecccccccc----CCCcc
Confidence 9996 2678889999999999999999 679999999999999987 6666665 555433221 12235
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc--cc-------C--
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA--LV-------A-- 1036 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~--l~-------~-- 1036 (1181)
+++.|+|||++.+..++.++|| ||+||++|||+||+.||....... +. .
T Consensus 840 ~t~~y~aPE~~~~~~~~~~sDv--------------------~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 899 (968)
T PLN00113 840 ISSAYVAPETRETKDITEKSDI--------------------YGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC 899 (968)
T ss_pred ccccccCcccccCCCCCcccch--------------------hhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc
Confidence 7899999999976655444444 999999999999999996432110 00 0
Q ss_pred ------CCCCCCCCCC--CCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1037 ------PPQISRSVSV--PGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1037 ------~~~ip~~l~~--~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
.+.+...... .....+..++.+|+..+|..||+ +.+.+..+..
T Consensus 900 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt-~~evl~~L~~ 950 (968)
T PLN00113 900 HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPC-ANDVLKTLES 950 (968)
T ss_pred chhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcC-HHHHHHHHHH
Confidence 0011111000 11113445778999999999995 5555555554
|
|
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.6e-27 Score=254.41 Aligned_cols=205 Identities=25% Similarity=0.381 Sum_probs=169.3
Q ss_pred hcccCceeecccCceEEEEEEEcCCC----eEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEcccccc-CCcE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQ----VKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSE-EGYF 877 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg----~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d-~~~l 877 (1181)
.|...+ +||+|.||.||+|....++ +.+|||.++.... .-.....+|+.+++.++||||+.+..+|.. +..+
T Consensus 25 ~ye~ig-~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 25 EYEGIG-KIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred Hhhccc-eecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 344433 5999999999999765543 3789999965533 335678899999999999999999999877 7889
Q ss_pred EEEEeecCCCCcccchhccc--CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCC----CeeeeecCC
Q psy14556 878 KIFMEQVPGGSLSTLLRVKW--GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYS----GVVKISDFG 951 (1181)
Q Consensus 878 ~LVmEy~~gGSL~dlL~~~~--~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~----g~vKLiDFG 951 (1181)
++++||. .-+|.++++.+. ....++...++.|+.||+.|+.|||++-|+||||||.|||+.. + |++||+|||
T Consensus 104 ~l~fdYA-EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmg-dgperG~VKIaDlG 181 (438)
T KOG0666|consen 104 WLLFDYA-EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMG-DGPERGRVKIADLG 181 (438)
T ss_pred EEEehhh-hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEec-cCCccCeeEeeccc
Confidence 9999999 567888886432 2357788999999999999999999999999999999999976 5 899999999
Q ss_pred cccccccCCCC---CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCC
Q psy14556 952 TSKRLAGLCPS---AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKK 1028 (1181)
Q Consensus 952 lAk~l~~~~~~---~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~ 1028 (1181)
+++.+...-.. ....+-|.+|+|||++.|. ..|+..||+ |+.|||+.||+|-++.|.+
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDv------------------WAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDV------------------WAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhh------------------HHHHHHHHHHHccCccccc
Confidence 99988764332 2235579999999999865 578888988 9999999999999999887
Q ss_pred CCc
Q psy14556 1029 KTS 1031 (1181)
Q Consensus 1029 ~~~ 1031 (1181)
...
T Consensus 243 ~E~ 245 (438)
T KOG0666|consen 243 REE 245 (438)
T ss_pred hhh
Confidence 654
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=267.98 Aligned_cols=192 Identities=30% Similarity=0.494 Sum_probs=166.3
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCC--------CChhHHHHHHHHHHhcC---CCCeeeEccccccCCcEEEE
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--------GDVQPLHEEIKLHSQLR---HRNIVQYLGSVSEEGYFKIF 880 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--------~~~e~f~rEi~IL~~L~---HPNIVkl~g~~~d~~~l~LV 880 (1181)
+||.|+||.|++|.++.+...|+||.+.++.. ...-.+-.|+.||..++ |+||++++++|++++++||+
T Consensus 568 ~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~ 647 (772)
T KOG1152|consen 568 PLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLE 647 (772)
T ss_pred eccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEE
Confidence 69999999999999999999999999977643 11223567999999997 99999999999999999999
Q ss_pred Eeec-CCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccC
Q psy14556 881 MEQV-PGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGL 959 (1181)
Q Consensus 881 mEy~-~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~ 959 (1181)
||.. +|.+|.+++..+ ..+++..+..|++|++.|+++||++||||||||-+|++++. +|.+||+|||.+....+
T Consensus 648 te~hg~gIDLFd~IE~k---p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~-~g~~klidfgsaa~~ks- 722 (772)
T KOG1152|consen 648 TEVHGEGIDLFDFIEFK---PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDS-NGFVKLIDFGSAAYTKS- 722 (772)
T ss_pred ecCCCCCcchhhhhhcc---CccchHHHHHHHHHHHhccccccccCceecccccccEEEec-CCeEEEeeccchhhhcC-
Confidence 9986 455889999844 57889999999999999999999999999999999999998 99999999999976654
Q ss_pred CCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCC
Q psy14556 960 CPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKK 1028 (1181)
Q Consensus 960 ~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~ 1028 (1181)
.....+.||..|.|||++.|. ...+..-|+ |++|++||.++....||..
T Consensus 723 -gpfd~f~gtv~~aapevl~g~-~y~gk~qdi------------------walgillytivykenpyyn 771 (772)
T KOG1152|consen 723 -GPFDVFVGTVDYAAPEVLGGE-KYLGKPQDI------------------WALGILLYTIVYKENPYYN 771 (772)
T ss_pred -CCcceeeeeccccchhhhCCC-ccCCCcchh------------------hhhhheeeEEEeccCCCcC
Confidence 345567899999999999654 445666655 9999999999999999874
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=260.03 Aligned_cols=238 Identities=24% Similarity=0.260 Sum_probs=186.4
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC-------CChhHHHHHHHHHHhcCCCCeeeEccccc-cCCcEEEEEe
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-------GDVQPLHEEIKLHSQLRHRNIVQYLGSVS-EEGYFKIFME 882 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-------~~~e~f~rEi~IL~~L~HPNIVkl~g~~~-d~~~l~LVmE 882 (1181)
..||+|||+.||+|.+...++.||+|+-..+.. ...+...+|..|.+.|+||.||++|++|. +.+.+|-|+|
T Consensus 469 hLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLE 548 (775)
T KOG1151|consen 469 HLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLE 548 (775)
T ss_pred HHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeee
Confidence 369999999999999999999999999754422 11455788999999999999999999996 4578999999
Q ss_pred ecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhcccc--ceecccCCCCCccccc--CCCeeeeecCCccccccc
Q psy14556 883 QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ--KIVHRDIKGDNVLVNT--YSGVVKISDFGTSKRLAG 958 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~--gIVHrDLKP~NILLd~--~~g~vKLiDFGlAk~l~~ 958 (1181)
||+|.+|+-+|+.+ ..+++..+..|+.||+.||.||.+. .|||-||||.||||.. ..|.+||.|||+++...+
T Consensus 549 YceGNDLDFYLKQh---klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdd 625 (775)
T KOG1151|consen 549 YCEGNDLDFYLKQH---KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDD 625 (775)
T ss_pred ecCCCchhHHHHhh---hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccC
Confidence 99999999999844 5788999999999999999999976 6999999999999954 246899999999998765
Q ss_pred CCC-------CCccccCCccccCchhhccC--CCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCC
Q psy14556 959 LCP-------SAETFTGTLQYMAPEVIDKG--QRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKK 1029 (1181)
Q Consensus 959 ~~~-------~~~t~~GT~~Y~APEvl~gg--~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~ 1029 (1181)
... ......||.+|++||.+.-+ ++..+..||+ ||.|+|+|..+.|+.||...
T Consensus 626 dSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDV------------------WSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 626 DSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDV------------------WSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred CccCcccceeeecccCceeeecCcceeecCCCCCccccceee------------------EeeehhhhhhhccCCCCCCc
Confidence 432 23446799999999998755 3444566766 99999999999999999877
Q ss_pred Cccc-ccCC--CCCCCCC----CCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1030 TSRA-LVAP--PQISRSV----SVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1030 ~~~~-l~~~--~~ip~~l----~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
.... +... +--.... .+-....-...|.+|++-+-..|.-
T Consensus 688 qsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~D 734 (775)
T KOG1151|consen 688 QSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRID 734 (775)
T ss_pred hhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhh
Confidence 5433 2111 1111111 1233445566788888887777764
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=271.55 Aligned_cols=237 Identities=24% Similarity=0.308 Sum_probs=187.7
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEe
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmE 882 (1181)
..+.... .+|.|+|+.|-.+.+..+++..++|++.+... ...+|+.++... +||||+++.+.+.+..+.|+|||
T Consensus 322 ~~y~~~~-~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 322 ESYEFRE-ELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred hhhcccc-ccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 3344433 49999999999999999999999999976622 234677666555 79999999999999999999999
Q ss_pred ecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC
Q psy14556 883 QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS 962 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~ 962 (1181)
.+.|+-|.+.+... +.....+..|+.+|+.|+.|||++|+|||||||+|||++...++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~----~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSK----PEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--- 469 (612)
T ss_pred hccccHHHHHHHhc----chhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence 99999777766543 22336677899999999999999999999999999999533889999999999877643
Q ss_pred CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc-cccCCCCCC
Q psy14556 963 AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR-ALVAPPQIS 1041 (1181)
Q Consensus 963 ~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~-~l~~~~~ip 1041 (1181)
..+.+-|..|.|||++.. ..++..+|+ ||||++||+||+|..||...... ++...+..+
T Consensus 470 ~~tp~~t~~y~APEvl~~--~~yt~acD~------------------WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~ 529 (612)
T KOG0603|consen 470 CDTPALTLQYVAPEVLAI--QEYTEACDW------------------WSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMP 529 (612)
T ss_pred hcccchhhcccChhhhcc--CCCCcchhh------------------HHHHHHHHHHHhCCCccccCCchHHHHHhhcCC
Confidence 334467889999999973 455555555 99999999999999999988765 444444433
Q ss_pred CCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1042 RSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1042 ~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
+. +...+..-+.+++.++..+|..|+...+.
T Consensus 530 ~~-s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i 560 (612)
T KOG0603|consen 530 KF-SECVSDEAKDLLQQLLQVDPALRLGADEI 560 (612)
T ss_pred cc-ccccCHHHHHHHHHhccCChhhCcChhhh
Confidence 22 24566667778889999999999974443
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=8e-26 Score=256.65 Aligned_cols=246 Identities=24% Similarity=0.308 Sum_probs=185.0
Q ss_pred hhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHh--cCCCCeeeEccccccC----Cc
Q psy14556 803 LYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQ--LRHRNIVQYLGSVSEE----GY 876 (1181)
Q Consensus 803 ~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~--L~HPNIVkl~g~~~d~----~~ 876 (1181)
.....+.+ .||+|.||.||+|.+ .|+.||||++... +.+.+.+|.+|.+. |+|+||+.+++.=..+ ..
T Consensus 210 arqI~L~e-~IGkGRyGEVwrG~w--rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 210 ARQIVLQE-IIGKGRFGEVWRGRW--RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hheeEEEE-EecCccccceeeccc--cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 33444443 599999999999999 5778999999544 33567888888876 4999999999864332 26
Q ss_pred EEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhcccc--------ceecccCCCCCcccccCCCeeeee
Q psy14556 877 FKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ--------KIVHRDIKGDNVLVNTYSGVVKIS 948 (1181)
Q Consensus 877 l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~--------gIVHrDLKP~NILLd~~~g~vKLi 948 (1181)
+|||++|.+.|||.|+|... .++.....+++..++.||+|||-. .|.|||||+.|||+.. ++..-|+
T Consensus 284 LwLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKk-n~~C~IA 358 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIA 358 (513)
T ss_pred EEEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEcc-CCcEEEe
Confidence 89999999999999999854 788899999999999999999943 5999999999999988 9999999
Q ss_pred cCCcccccccCCC----CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhC--
Q psy14556 949 DFGTSKRLAGLCP----SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVL-- 1022 (1181)
Q Consensus 949 DFGlAk~l~~~~~----~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTG-- 1022 (1181)
|+|+|........ .....+||..|||||++.... +..+. .-..+.+.||||.++||+...
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdeti-------------n~~~F-esyk~ADIYafgLVlWEiarRc~ 424 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETI-------------NMKHF-ESYKRADIYAFGLVLWEIARRCE 424 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhc-------------Chhhh-hhhhHHHHHHHHHHHHHHHHHhh
Confidence 9999977654321 234467999999999996431 11122 223456679999999999863
Q ss_pred --------CCCCCCCCccc-----c---cC----CCCCCCC-CCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1023 --------TAALKKKTSRA-----L---VA----PPQISRS-VSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1023 --------k~PF~~~~~~~-----l---~~----~~~ip~~-l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
+.||.+-.+.+ + +. .+.+|.. .+.+....+.+++..|+..+|+.|.+...-
T Consensus 425 ~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 425 SGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred cCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 57887665433 1 11 1111111 122334467779999999999999986665
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-27 Score=252.26 Aligned_cols=242 Identities=25% Similarity=0.301 Sum_probs=187.7
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCC-CChhHHHHHHHHHHh-cCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQ-LRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~-L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
.||.|+||+|++..++.+|+..|||.++.... .+.+++..|.+...+ -+.||||++||..-.++..|+.||.| ..+|
T Consensus 71 ~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~Sl 149 (361)
T KOG1006|consen 71 EIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DISL 149 (361)
T ss_pred HhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhhH
Confidence 59999999999999999999999999976655 345678888776554 47999999999999999999999999 6677
Q ss_pred ccchhcc--cCCCCCChHHHHHHHHHHHhhhhhcccc-ceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccc
Q psy14556 890 STLLRVK--WGPLKENESTMSFYTKQILEGLKYLHGQ-KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF 966 (1181)
Q Consensus 890 ~dlL~~~--~~~~~l~e~~i~~Ia~QIa~AL~yLHs~-gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~ 966 (1181)
..+.+.- .....+++..+-.|..-.+.||.||... .|||||+||+|||++. .|.+||||||++..+.+... .+.-
T Consensus 150 DklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr-~G~vKLCDFGIcGqLv~SiA-kT~d 227 (361)
T KOG1006|consen 150 DKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDR-HGDVKLCDFGICGQLVDSIA-KTVD 227 (361)
T ss_pred HHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEec-CCCEeeecccchHhHHHHHH-hhhc
Confidence 6665421 1344678888888889999999999864 8999999999999998 89999999999987764322 2334
Q ss_pred cCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc--cc-----cCCCC
Q psy14556 967 TGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR--AL-----VAPPQ 1039 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~--~l-----~~~~~ 1039 (1181)
.|...|||||.+..... ..|+++| .||||++|||+.||..||.+-+.. ++ -.++.
T Consensus 228 aGCrpYmAPERi~p~~~----gyDiRSD--------------vWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~ 289 (361)
T KOG1006|consen 228 AGCRPYMAPERIDPSDK----GYDIRSD--------------VWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPI 289 (361)
T ss_pred cCCccccChhccCCccC----Ccchhhh--------------hhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCe
Confidence 68999999999964322 2344333 399999999999999999876641 11 11222
Q ss_pred -CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1040 -ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1040 -ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
............+...+.-|+.+|-+.||...++.
T Consensus 290 l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk 325 (361)
T KOG1006|consen 290 LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLK 325 (361)
T ss_pred ecCcccccccCHHHHHHHHHHhhcccccCcchhhhh
Confidence 22222234566788889999999999999877664
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-25 Score=252.16 Aligned_cols=235 Identities=24% Similarity=0.348 Sum_probs=178.6
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHh--cCCCCeeeEccccccCC----cEEEEEeecC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQ--LRHRNIVQYLGSVSEEG----YFKIFMEQVP 885 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~--L~HPNIVkl~g~~~d~~----~l~LVmEy~~ 885 (1181)
.||+|+||.||+|.. +++.||||+++.. +.+.+..|..|.+. ++|+||++++++-.... .++||++|.+
T Consensus 217 li~~Grfg~V~KaqL--~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~ 291 (534)
T KOG3653|consen 217 LIGRGRFGCVWKAQL--DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP 291 (534)
T ss_pred HhhcCccceeehhhc--cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence 599999999999987 5589999999644 45678888888776 48999999999865544 7999999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhcccc---------ceecccCCCCCcccccCCCeeeeecCCccccc
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ---------KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~---------gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l 956 (1181)
.|+|.++|..+ .+++....+++..+++||+|||+- .|+|||||+.|||+.+ ++...|+|||+|..+
T Consensus 292 kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~-DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 292 KGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKN-DLTCCIADFGLALRL 366 (534)
T ss_pred CCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEcc-CCcEEeeccceeEEe
Confidence 99999999865 788999999999999999999963 6999999999999988 899999999999887
Q ss_pred ccCCCC--CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCC-CCCc--
Q psy14556 957 AGLCPS--AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALK-KKTS-- 1031 (1181)
Q Consensus 957 ~~~~~~--~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~-~~~~-- 1031 (1181)
....+. ....+||.+|||||++.+.. ... . ..-...-+.||+|.+||||++.-.-+. +..+
T Consensus 367 ~p~~~~~d~~~qVGT~RYMAPEvLEgai-nl~------------d-~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Y 432 (534)
T KOG3653|consen 367 EPGKPQGDTHGQVGTRRYMAPEVLEGAI-NLQ------------D-RDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEY 432 (534)
T ss_pred cCCCCCcchhhhhhhhhhcCHHHHhhhc-ccc------------c-HHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcc
Confidence 643332 22357999999999997542 222 0 011122244999999999998643322 1111
Q ss_pred --------------cc---c----cCCCCCCCCCC-CCCCcchHHhhccCCCCCCCCCchh
Q psy14556 1032 --------------RA---L----VAPPQISRSVS-VPGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1032 --------------~~---l----~~~~~ip~~l~-~~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
.+ + ..++.++.... ......+...+..|+++||.+|-+.
T Consensus 433 qlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA 493 (534)
T KOG3653|consen 433 QLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTA 493 (534)
T ss_pred cCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhh
Confidence 00 0 12333443321 2456678889999999999999864
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.3e-25 Score=268.57 Aligned_cols=258 Identities=20% Similarity=0.176 Sum_probs=161.7
Q ss_pred eeecccCceEEEEEEEcCC----CeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccc------cccCCcEEEE
Q psy14556 811 IELGKGSYGVVYAARELDR----QVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGS------VSEEGYFKIF 880 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~t----g~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~------~~d~~~l~LV 880 (1181)
.+||+|+||.||+|.+..+ +..||+|.+..... .+....| .++...+.++..++.. .......++|
T Consensus 138 ~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV 213 (566)
T PLN03225 138 KKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWLV 213 (566)
T ss_pred EEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEEE
Confidence 4799999999999999888 89999998854322 1212221 1222223333333222 2455679999
Q ss_pred EeecCCCCcccchhcccCCC-----------------CCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCC
Q psy14556 881 MEQVPGGSLSTLLRVKWGPL-----------------KENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSG 943 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~~~~-----------------~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g 943 (1181)
|||+++++|.+++....... ......+..++.||+.||+|||++||+||||||+|||++..++
T Consensus 214 ~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~ 293 (566)
T PLN03225 214 WRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSG 293 (566)
T ss_pred EEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCCC
Confidence 99999999999887432110 1123446679999999999999999999999999999986568
Q ss_pred eeeeecCCcccccccCC-CCCccccCCccccCchhhccCCCCCCCcccc----ccCCCccccccccccchhHHHHHHHHH
Q psy14556 944 VVKISDFGTSKRLAGLC-PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQ----RDKINPCCRIEYKKMKINVFLCVIISQ 1018 (1181)
Q Consensus 944 ~vKLiDFGlAk~l~~~~-~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi----~~dI~~~~~i~~~~~k~DwSLGvILyE 1018 (1181)
.+||+|||+++.+.... .......+++.|+|||.+.....+....... ..-+.| ...+....|.||+||+|||
T Consensus 294 ~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~--~~~~~~k~DVwSlGviL~e 371 (566)
T PLN03225 294 SFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLW--QLNLPDRFDIYSAGLIFLQ 371 (566)
T ss_pred cEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhc--cccCCCCcccHHHHHHHHH
Confidence 99999999998654322 2234567899999999875433222211100 000000 1112333455999999999
Q ss_pred HHhCCCCCCCCCccc---ccC--------CCCCCCCCCCCC----------CcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1019 LLVLTAALKKKTSRA---LVA--------PPQISRSVSVPG----------PGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1019 LLTGk~PF~~~~~~~---l~~--------~~~ip~~l~~~~----------p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
|+++..|+....... +.. ........+... ......++.+++..||.+||+..+.+
T Consensus 372 l~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L 448 (566)
T PLN03225 372 MAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAAL 448 (566)
T ss_pred HHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHh
Confidence 999877765421100 000 000000011110 11122689999999999999744443
|
|
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-26 Score=244.89 Aligned_cols=199 Identities=26% Similarity=0.441 Sum_probs=166.8
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCC--CCCChhHHHHHHHHHHhcCCCCeeeEcccccc--------CCcEEEE
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEK--NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSE--------EGYFKIF 880 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~--~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d--------~~~l~LV 880 (1181)
.+||+|.||.||+|+...+++.||+|++--+ ....-....+|+++|..++|+|++.+++.|.. ...+|+|
T Consensus 23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV 102 (376)
T KOG0669|consen 23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV 102 (376)
T ss_pred HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence 3799999999999999999999999887433 23334567899999999999999999998743 2358999
Q ss_pred EeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC
Q psy14556 881 MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC 960 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~ 960 (1181)
|.+| ..+|.-++... ...++...+..++.++..||.|+|...|+|||+||+|+|++. +|.+||+|||+++.+....
T Consensus 103 f~~c-ehDLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~-dgilklADFGlar~fs~~~ 178 (376)
T KOG0669|consen 103 FDFC-EHDLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITK-DGILKLADFGLARAFSTSK 178 (376)
T ss_pred HHHh-hhhHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcC-CceEEeeccccccceeccc
Confidence 9999 56777777643 356778899999999999999999999999999999999998 8999999999998765432
Q ss_pred C----CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc
Q psy14556 961 P----SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR 1032 (1181)
Q Consensus 961 ~----~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~ 1032 (1181)
. .....+-|.+|++||.+.|. ..++..+|+ |..|||+.||.|+.+.|.+.+..
T Consensus 179 n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDi------------------WgAgCimaeMwtrspimqgnteq 235 (376)
T KOG0669|consen 179 NVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDI------------------WGAGCIMAEMWTRSPIMQGNTEQ 235 (376)
T ss_pred ccCCCCcccceeeeecCCHHHhhcc-cccCCcchh------------------HhHHHHHHHHHccCccccCChHH
Confidence 2 22234569999999999754 578888888 99999999999999999998764
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.8e-25 Score=229.59 Aligned_cols=200 Identities=26% Similarity=0.358 Sum_probs=162.3
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
.||+|++|.|-+.++..+|...|+|.+...-. +..+++.+|+.+..+. .+|++|++||...+++..|+.||.| ..||
T Consensus 53 elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tSl 131 (282)
T KOG0984|consen 53 ELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTSL 131 (282)
T ss_pred hhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhhH
Confidence 59999999999999999999999999965533 3355678888877665 7999999999999999999999999 6778
Q ss_pred ccchhcc-cCCCCCChHHHHHHHHHHHhhhhhcccc-ceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 890 STLLRVK-WGPLKENESTMSFYTKQILEGLKYLHGQ-KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 890 ~dlL~~~-~~~~~l~e~~i~~Ia~QIa~AL~yLHs~-gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
..+.++. .....+++..+-+|+..+.+||.|||++ .++|||+||+|||++. +|++|+||||++..+.+.-. .+...
T Consensus 132 dkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~-~GqVKiCDFGIsG~L~dSiA-kt~da 209 (282)
T KOG0984|consen 132 DKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINY-DGQVKICDFGISGYLVDSIA-KTMDA 209 (282)
T ss_pred HHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEcc-CCcEEEcccccceeehhhhH-HHHhc
Confidence 7766532 2455788999999999999999999987 8999999999999998 99999999999987764321 12245
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKT 1030 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~ 1030 (1181)
|...|||||.+..+... +..+++ ++.||||+++.||.+++.||..-.
T Consensus 210 GCkpYmaPEri~~e~n~--~gY~vk--------------sDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 210 GCKPYMAPERINPELNQ--KGYSVK--------------SDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred CCCccCChhhcCcccCc--ccceee--------------hhhhhhhhhhhhhhhccccccccC
Confidence 88999999999744221 133333 333999999999999999998643
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-24 Score=264.32 Aligned_cols=241 Identities=23% Similarity=0.315 Sum_probs=191.0
Q ss_pred eecccCceEEEEEEEc----C---CCeEEEEEEecCCCC-CChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEe
Q psy14556 812 ELGKGSYGVVYAAREL----D---RQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~----~---tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmE 882 (1181)
.||+|.||.|++|.-. . ....||+|.++.... .+.+.+..|+++|+.+ +||||+.++|++...+.+++|+|
T Consensus 303 ~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~E 382 (609)
T KOG0200|consen 303 YLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVE 382 (609)
T ss_pred eeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEE
Confidence 7999999999999743 1 256899999975533 4567899999999999 69999999999999999999999
Q ss_pred ecCCCCcccchhccc------CC-------CCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeec
Q psy14556 883 QVPGGSLSTLLRVKW------GP-------LKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISD 949 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~------~~-------~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiD 949 (1181)
|+..|+|.++++..+ .. ..+.....+.++.||+.|++||+++++|||||-.+|||+.. +..+||+|
T Consensus 383 y~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~-~~~~kIaD 461 (609)
T KOG0200|consen 383 YAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITK-NKVIKIAD 461 (609)
T ss_pred eccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecC-CCEEEEcc
Confidence 999999999998764 00 13778899999999999999999999999999999999988 78999999
Q ss_pred CCcccccccCCCCC-ccccC--CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCC
Q psy14556 950 FGTSKRLAGLCPSA-ETFTG--TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAA 1025 (1181)
Q Consensus 950 FGlAk~l~~~~~~~-~t~~G--T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~P 1025 (1181)
||+++.......-. ....+ ...|||||.+....++.++|| ||+|++|||++| |..|
T Consensus 462 FGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDV--------------------WSfGI~L~EifsLG~~P 521 (609)
T KOG0200|consen 462 FGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDV--------------------WSFGILLWEIFTLGGTP 521 (609)
T ss_pred ccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchh--------------------hHHHHHHHHHhhCCCCC
Confidence 99998654322211 11222 345999999987666666655 999999999999 7799
Q ss_pred CCCCC-cccccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1026 LKKKT-SRALVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1026 F~~~~-~~~l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
|.+.. ..++..... ..-..+..++..+..++..|+..+|..||.+.+.
T Consensus 522 Yp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~ 572 (609)
T KOG0200|consen 522 YPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSEC 572 (609)
T ss_pred CCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHH
Confidence 98854 333321111 1112234557788889999999999999998776
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.3e-24 Score=222.47 Aligned_cols=196 Identities=36% Similarity=0.568 Sum_probs=165.7
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
..||.|++|.||++.+..+++.+++|.+...... ..+.+.+|+..++.++|+|++++++++......++++|++++++|
T Consensus 5 ~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L 84 (225)
T smart00221 5 KKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDL 84 (225)
T ss_pred eEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCH
Confidence 4699999999999999888999999999876655 567899999999999999999999999988999999999999999
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC-CCCccccC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC-PSAETFTG 968 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~-~~~~t~~G 968 (1181)
.+++..... .+++..+..++.+++.+|.+||+++++|+||+|.||+++. ++.++|+|||.+....... .......+
T Consensus 85 ~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~-~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 161 (225)
T smart00221 85 FDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGM-DGLVKLADFGLARFIHRDLAALLKTVKG 161 (225)
T ss_pred HHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC-CCCEEEeeCceeeEecCcccccccceec
Confidence 999875421 1678899999999999999999999999999999999998 7999999999998765432 12233457
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCC
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKK 1028 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~ 1028 (1181)
+..|++||.+. ....+....|+ |++|+++|+|++|+.||..
T Consensus 162 ~~~~~~pe~~~-~~~~~~~~~Dv------------------~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 162 TPFYLAPEVLL-GGKGYGEAVDI------------------WSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cCCcCCHhHhc-CCCCCCchhhH------------------HHHHHHHHHHHHCCCCccc
Confidence 88999999984 22222223333 9999999999999999977
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=214.09 Aligned_cols=209 Identities=35% Similarity=0.493 Sum_probs=174.6
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCccc
Q psy14556 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLST 891 (1181)
Q Consensus 813 IG~G~fG~VYka~d~~tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~d 891 (1181)
||+|++|.||++....+++.+++|++...... ..+.+.+|+..++.++|++|+++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999888999999999766443 34679999999999999999999999999899999999999999999
Q ss_pred chhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCcc
Q psy14556 892 LLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQ 971 (1181)
Q Consensus 892 lL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~~ 971 (1181)
++.... ..++...++.++.+++.+|++||++|++|+||+|.||+++..++.++|+|||.+..............+...
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA 158 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCC
Confidence 987431 357788999999999999999999999999999999999864579999999999766543212333457889
Q ss_pred ccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCCCCCCCCCCCCcc
Q psy14556 972 YMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQISRSVSVPGPGG 1051 (1181)
Q Consensus 972 Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~ip~~l~~~~p~~ 1051 (1181)
|++||.+... .......|+ |++|++++++ ..
T Consensus 159 ~~~pe~~~~~-~~~~~~~D~------------------~~lg~~~~~l------------------------------~~ 189 (215)
T cd00180 159 YMAPEVLLGK-GYYSEKSDI------------------WSLGVILYEL------------------------------PE 189 (215)
T ss_pred ccChhHhccc-CCCCchhhh------------------HHHHHHHHHH------------------------------HH
Confidence 9999999654 122223333 9999999999 56
Q ss_pred hHHhhccCCCCCCCCCchhHH
Q psy14556 1052 INSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1052 L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
+..++..|+..+|..||...+
T Consensus 190 ~~~~l~~~l~~~p~~R~~~~~ 210 (215)
T cd00180 190 LKDLIRKMLQKDPEKRPSAKE 210 (215)
T ss_pred HHHHHHHHhhCCcccCcCHHH
Confidence 888999999999999997543
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-25 Score=264.81 Aligned_cols=242 Identities=26% Similarity=0.300 Sum_probs=182.2
Q ss_pred cccCceeecccCce-EEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEee
Q psy14556 806 FALNRIELGKGSYG-VVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQ 883 (1181)
Q Consensus 806 ~~l~~~kIG~G~fG-~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy 883 (1181)
+...++.+|.|+.| .||+|.. .++.||||.+-... .....+|+..|+.- +|||||++++.-.+....||..|.
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee--CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 44445578999987 5799987 67899999885442 34567999999888 699999999999999999999999
Q ss_pred cCCCCcccchhccc-CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccC----CCeeeeecCCccccccc
Q psy14556 884 VPGGSLSTLLRVKW-GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTY----SGVVKISDFGTSKRLAG 958 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~-~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~----~g~vKLiDFGlAk~l~~ 958 (1181)
| ..+|.+++.... ..........+.++.|+++||++||+.+||||||||.||||+.. ..+++|+|||+++++..
T Consensus 585 C-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 585 C-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred h-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 9 789999998631 11111114456788999999999999999999999999999762 24899999999999876
Q ss_pred CCCC---CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhC-CCCCCCCCcccc
Q psy14556 959 LCPS---AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVL-TAALKKKTSRAL 1034 (1181)
Q Consensus 959 ~~~~---~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTG-k~PF~~~~~~~l 1034 (1181)
.... ..+..||-+|+|||++..... ...+|+ +|+||++|+.++| .+||...-..+.
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~--~~avDi------------------FslGCvfyYvltgG~HpFGd~~~R~~ 723 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRK--TQAVDI------------------FSLGCVFYYVLTGGSHPFGDSLERQA 723 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhcccc--Ccccch------------------hhcCceEEEEecCCccCCCchHHhhh
Confidence 5433 334669999999999986654 346666 9999999999997 899998765542
Q ss_pred cCCCCCCCCCCCCCCc--chHHhhccCCCCCCCCCchhHHH
Q psy14556 1035 VAPPQISRSVSVPGPG--GINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1035 ~~~~~ip~~l~~~~p~--~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.-............-. .-..+|.+++.++|..||+.-+.
T Consensus 724 NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~V 764 (903)
T KOG1027|consen 724 NILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDV 764 (903)
T ss_pred hhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHH
Confidence 1111111111111111 45669999999999999985544
|
|
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-25 Score=248.58 Aligned_cols=196 Identities=23% Similarity=0.277 Sum_probs=167.2
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCC--C----CeeeEccccccCCcEEEEEeecC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRH--R----NIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~H--P----NIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
.+|+|.||.|-.+.+..++..||+|+++.-. ...+..+-|+++|.++.+ | -++++.+||.-.++.|||+|.+
T Consensus 96 ~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell- 173 (415)
T KOG0671|consen 96 LLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL- 173 (415)
T ss_pred hhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-
Confidence 6999999999999999999999999995332 234667789999999942 3 3788999999999999999998
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccC-------------------CCeee
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTY-------------------SGVVK 946 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~-------------------~g~vK 946 (1181)
|.|+.+++..+ +-.+++...+..++.|+++++++||+.+++|-||||+|||+.+. +..++
T Consensus 174 G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~ 252 (415)
T KOG0671|consen 174 GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIK 252 (415)
T ss_pred ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceE
Confidence 88999999865 56788899999999999999999999999999999999998431 23689
Q ss_pred eecCCcccccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCC
Q psy14556 947 ISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAAL 1026 (1181)
Q Consensus 947 LiDFGlAk~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF 1026 (1181)
|+|||.|..... ...+.+.|..|+|||++.+-++++..|| ||+||||+|++||...|
T Consensus 253 vIDFGsAtf~~e---~hs~iVsTRHYRAPEViLgLGwS~pCDv--------------------WSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 253 VIDFGSATFDHE---HHSTIVSTRHYRAPEVILGLGWSQPCDV--------------------WSIGCILVELYTGETLF 309 (415)
T ss_pred EEecCCcceecc---CcceeeeccccCCchheeccCcCCccCc--------------------eeeeeEEEEeeccceec
Confidence 999999976543 3356678999999999998877777666 99999999999999999
Q ss_pred CCCCccc
Q psy14556 1027 KKKTSRA 1033 (1181)
Q Consensus 1027 ~~~~~~~ 1033 (1181)
++....+
T Consensus 310 qtHen~E 316 (415)
T KOG0671|consen 310 QTHENLE 316 (415)
T ss_pred ccCCcHH
Confidence 9877533
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-25 Score=242.03 Aligned_cols=196 Identities=28% Similarity=0.448 Sum_probs=166.4
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCC--CCChhHHHHHHHHHHhcCCCCeeeEccccccCC-----cEEEEEeec
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKN--LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEG-----YFKIFMEQV 884 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~--~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~-----~l~LVmEy~ 884 (1181)
.||.|+||.||.+.+..+++.|++|++..-. ....+++.+|+++|..++|.|++..+++.+..+ .+|+++|.|
T Consensus 60 PIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELm 139 (449)
T KOG0664|consen 60 PIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELM 139 (449)
T ss_pred cccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHH
Confidence 6999999999999999999999999986443 234678999999999999999999998876543 478899998
Q ss_pred CCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC-C
Q psy14556 885 PGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS-A 963 (1181)
Q Consensus 885 ~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~-~ 963 (1181)
..+|..++- .+..++...++-+++||+.||+|||+.+|.||||||.|+|+++ +..+||||||+++........ .
T Consensus 140 -QSDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNS-NCvLKICDFGLARvee~d~~~hM 214 (449)
T KOG0664|consen 140 -QSDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNS-NCILKICDFGLARTWDQRDRLNM 214 (449)
T ss_pred -Hhhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEecc-CceEEecccccccccchhhhhhh
Confidence 677877776 4567788888889999999999999999999999999999988 889999999999876543322 2
Q ss_pred ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCc
Q psy14556 964 ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTS 1031 (1181)
Q Consensus 964 ~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~ 1031 (1181)
+.-+-|.+|+|||++.|. ..|+..||+ ||.|||+.|++..+..|...++
T Consensus 215 TqEVVTQYYRAPEiLMGa-RhYs~AvDi------------------WSVGCIFaELLgRrILFQAq~P 263 (449)
T KOG0664|consen 215 THEVVTQYYRAPELLMGA-RRYTGAVDI------------------WSVGCIFAELLQRKILFQAAGP 263 (449)
T ss_pred HHHHHHHHhccHHHhhcc-hhhcCccce------------------ehhhHHHHHHHhhhhhhhccCh
Confidence 233468899999999764 578888988 9999999999999999987766
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=249.31 Aligned_cols=222 Identities=25% Similarity=0.309 Sum_probs=151.0
Q ss_pred hcccCceeecccCceEEEEEEEc----------------CCCeEEEEEEecCCCCCChh--------------HHHHHHH
Q psy14556 805 LFALNRIELGKGSYGVVYAAREL----------------DRQVKLAIKEIPEKNLGDVQ--------------PLHEEIK 854 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~----------------~tg~~VAIKii~~~~~~~~e--------------~f~rEi~ 854 (1181)
+|.+ .++||+|+||+||+|... ..++.||||.+........+ ....|+.
T Consensus 146 ~F~i-~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~ 224 (507)
T PLN03224 146 DFQL-RDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY 224 (507)
T ss_pred CceE-eeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence 3444 457999999999999752 24467999998654332222 2345777
Q ss_pred HHHhcCCCCe-----eeEcccccc--------CCcEEEEEeecCCCCcccchhcccCC---------------------C
Q psy14556 855 LHSQLRHRNI-----VQYLGSVSE--------EGYFKIFMEQVPGGSLSTLLRVKWGP---------------------L 900 (1181)
Q Consensus 855 IL~~L~HPNI-----Vkl~g~~~d--------~~~l~LVmEy~~gGSL~dlL~~~~~~---------------------~ 900 (1181)
++.+++|.++ ++++++|.. .+..++||||+++++|.++++...+. .
T Consensus 225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~ 304 (507)
T PLN03224 225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD 304 (507)
T ss_pred HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence 7777776654 667777643 35689999999999999988643111 1
Q ss_pred CCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC-CccccCCccccCchhhc
Q psy14556 901 KENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS-AETFTGTLQYMAPEVID 979 (1181)
Q Consensus 901 ~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~-~~t~~GT~~Y~APEvl~ 979 (1181)
..++..++.++.|++.+|.|||+++|+||||||+|||++. ++.+||+|||++......... .....+++.|+|||.+.
T Consensus 305 ~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV-DGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV 383 (507)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECC-CCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence 2356678889999999999999999999999999999988 789999999999765432111 11223578999999986
Q ss_pred cCCCCCCCccccccCCCccc--cccccccchhHHHHHHHHHHHhCCC-CCCC
Q psy14556 980 KGQRGYGAPVRQRDKINPCC--RIEYKKMKINVFLCVIISQLLVLTA-ALKK 1028 (1181)
Q Consensus 980 gg~~~~ssDVDi~~dI~~~~--~i~~~~~k~DwSLGvILyELLTGk~-PF~~ 1028 (1181)
........+........... ........+.||+||++|+|++|.. ||.+
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 54332222211000000000 0111123466999999999999985 7754
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-23 Score=226.77 Aligned_cols=245 Identities=18% Similarity=0.283 Sum_probs=185.2
Q ss_pred hHHHHhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhc-CCCCeeeEccc-cccCC
Q psy14556 798 PMLRFLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQYLGS-VSEEG 875 (1181)
Q Consensus 798 p~~~~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L-~HPNIVkl~g~-~~d~~ 875 (1181)
+...+.+.|.+++ .||+|.||.+-+++++.++..+++|.++.... ....|.+|...--.| .|.||+.-|++ |+..+
T Consensus 18 ~kv~l~d~y~I~k-~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d 95 (378)
T KOG1345|consen 18 KKVDLEDVYTINK-QLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD 95 (378)
T ss_pred cccchhhhhhHHH-HhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence 3445566676666 49999999999999999999999999976543 356788988766666 58999998875 67788
Q ss_pred cEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccccc-CCCeeeeecCCccc
Q psy14556 876 YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNT-YSGVVKISDFGTSK 954 (1181)
Q Consensus 876 ~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~-~~g~vKLiDFGlAk 954 (1181)
.+++++||++-|+|..-+.. ..+.+.....++.|+++||.|+|++++||||||.+|||+-. +..++||||||..+
T Consensus 96 ~YvF~qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred eEEEeeccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccc
Confidence 99999999999999887754 35778888999999999999999999999999999999843 34499999999987
Q ss_pred ccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc
Q psy14556 955 RLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL 1034 (1181)
Q Consensus 955 ~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l 1034 (1181)
..+... .....+..|.+||+.... ... ....++..+.|.||+++|.++||.+||+.....+-
T Consensus 172 k~g~tV---~~~~~~~~y~~pe~~~~~-~ne--------------~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~ 233 (378)
T KOG1345|consen 172 KVGTTV---KYLEYVNNYHAPELCDTV-VNE--------------KLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK 233 (378)
T ss_pred ccCcee---hhhhhhcccCCcHHHhhc-ccc--------------ceEecccccchheeeeeeeeecCCCcchhhhccCc
Confidence 655322 122346689999988632 122 22234445559999999999999999995543221
Q ss_pred ---------c-CCCCCCCCCCCCCCcchHHhhccCCCCCCCCC
Q psy14556 1035 ---------V-APPQISRSVSVPGPGGINSSSSAPVTPTPHSR 1067 (1181)
Q Consensus 1035 ---------~-~~~~ip~~l~~~~p~~L~~li~r~la~dPs~R 1067 (1181)
. ..+..|+.. .+..+..-+|..+-++++|..|
T Consensus 234 ~Y~~~~~w~~rk~~~~P~~F-~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 234 PYWEWEQWLKRKNPALPKKF-NPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred hHHHHHHHhcccCccCchhh-cccCHHHHHHHHHhcCCccccc
Confidence 1 112233322 2445556678999999999988
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-24 Score=248.09 Aligned_cols=200 Identities=21% Similarity=0.275 Sum_probs=170.8
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcC------CCCeeeEccccccCCcEEEEEee
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR------HRNIVQYLGSVSEEGYFKIFMEQ 883 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~------HPNIVkl~g~~~d~~~l~LVmEy 883 (1181)
..-.|+|-|++|.+|.+...+..||||++..+..- .+.=+.|++||++|+ --|+++++..|...+++|||+|.
T Consensus 437 ~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~ 515 (752)
T KOG0670|consen 437 QGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEP 515 (752)
T ss_pred EeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehh
Confidence 33579999999999999999999999999765332 244568999999995 35899999999999999999999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCC
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA 963 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~ 963 (1181)
+ ..+|.++|++......+....+..++.|+..||..|...||+|.||||+|||+++....+||||||.|...... ..
T Consensus 516 L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~en--ei 592 (752)
T KOG0670|consen 516 L-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASEN--EI 592 (752)
T ss_pred h-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccccccc--cc
Confidence 8 78999999987777788888999999999999999999999999999999999987789999999999876542 33
Q ss_pred ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc
Q psy14556 964 ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA 1033 (1181)
Q Consensus 964 ~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~ 1033 (1181)
+.+.-+..|.|||++.|-.+ ...+|+ ||.||+|||+.||+..|.|.+...
T Consensus 593 tPYLVSRFYRaPEIiLG~~y--d~~iD~------------------WSvgctLYElYtGkIlFpG~TNN~ 642 (752)
T KOG0670|consen 593 TPYLVSRFYRAPEIILGLPY--DYPIDT------------------WSVGCTLYELYTGKILFPGRTNNQ 642 (752)
T ss_pred cHHHHHHhccCcceeecCcc--cCCccc------------------eeeceeeEEeeccceecCCCCcHH
Confidence 34456778999999997654 445555 999999999999999999987643
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.3e-24 Score=250.20 Aligned_cols=237 Identities=30% Similarity=0.446 Sum_probs=200.1
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCccc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLST 891 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~d 891 (1181)
++|.|.||.||+++++.+++..|+|+++.....+..-+++|+-+++.++||||+.+++.+...+..|++||||.||+|++
T Consensus 22 rvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQd 101 (829)
T KOG0576|consen 22 RVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQD 101 (829)
T ss_pred eecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccc
Confidence 69999999999999999999999999988877778889999999999999999999999999999999999999999999
Q ss_pred chhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCcc
Q psy14556 892 LLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQ 971 (1181)
Q Consensus 892 lL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~~ 971 (1181)
..+ ...++.+.++....+..++||+|||++|-+|||||-.||+++. .|.+|++|||.+..+...-.....+.||++
T Consensus 102 iy~---~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd-~gDvklaDfgvsaqitati~KrksfiGtpy 177 (829)
T KOG0576|consen 102 IYH---VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTD-EGDVKLADFGVSAQITATIAKRKSFIGTPY 177 (829)
T ss_pred eee---ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecc-cCceeecccCchhhhhhhhhhhhcccCCcc
Confidence 987 4567889999999999999999999999999999999999988 899999999999888766566677889999
Q ss_pred ccCchhhcc-CCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc-c-------cCCCCCCC
Q psy14556 972 YMAPEVIDK-GQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA-L-------VAPPQISR 1042 (1181)
Q Consensus 972 Y~APEvl~g-g~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~-l-------~~~~~ip~ 1042 (1181)
|||||+-.- ..-+|..-.|+ |++|+...|+---++|.....+.. + ..++.+..
T Consensus 178 wmapEvaaverkggynqlcdi------------------wa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkD 239 (829)
T KOG0576|consen 178 WMAPEVAAVERKGGYNQLCDI------------------WALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKD 239 (829)
T ss_pred ccchhHHHHHhcccccccccc------------------cccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccC
Confidence 999998742 22234444544 999999999988888876655433 1 11122111
Q ss_pred CCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1043 SVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1043 ~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
.-.+.+.+...+..++.+.|.+||..-.
T Consensus 240 --k~kws~~fh~fvK~altknpKkRptaek 267 (829)
T KOG0576|consen 240 --KTKWSEFFHNFVKGALTKNPKKRPTAEK 267 (829)
T ss_pred --CccchHHHHHHHHHHhcCCCccCCChhh
Confidence 2356778888999999999999997443
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.8e-23 Score=218.49 Aligned_cols=190 Identities=20% Similarity=0.322 Sum_probs=158.1
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcC-CCCeeeEccccccC--CcEEEEEeecCCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR-HRNIVQYLGSVSEE--GYFKIFMEQVPGGS 888 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~-HPNIVkl~g~~~d~--~~l~LVmEy~~gGS 888 (1181)
++|+|.++.||.|.+..+++.++||++++-. .+.+.+|++||..|. ||||++++++..+. ..+.+++||+.+.+
T Consensus 45 k~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~D 121 (338)
T KOG0668|consen 45 KVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTD 121 (338)
T ss_pred HHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhcccc
Confidence 6999999999999999999999999996543 366899999999996 99999999998775 56789999998888
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
...+.. .++...+..++.++++||.|+|++||+|||+||.|+++|.....++|+|+|+|...... ......+.
T Consensus 122 fk~ly~------tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~-~eYnVRVA 194 (338)
T KOG0668|consen 122 FKQLYP------TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-KEYNVRVA 194 (338)
T ss_pred HHHHhh------hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC-ceeeeeee
Confidence 777665 46677899999999999999999999999999999999987789999999999876543 22333457
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCC
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKT 1030 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~ 1030 (1181)
+..|.-||++..-+ .|+..-+.||+||+|..|+..+.||-...
T Consensus 195 SRyfKGPELLVdy~-------------------~YDYSLD~WS~GcmlA~miFrkepFFhG~ 237 (338)
T KOG0668|consen 195 SRYFKGPELLVDYQ-------------------MYDYSLDMWSLGCMLASMIFRKEPFFHGH 237 (338)
T ss_pred hhhcCCchheeech-------------------hccccHHHHHHHHHHHHHHhccCcccCCC
Confidence 88999999985321 12233333999999999999998876443
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-22 Score=223.99 Aligned_cols=191 Identities=28% Similarity=0.369 Sum_probs=163.8
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCC--CCCChhHHHHHHHHHHhcCCCCeeeEccccccC------CcEEEEEee
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEK--NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEE------GYFKIFMEQ 883 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~--~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~------~~l~LVmEy 883 (1181)
.+|.|.- .|..+.+.-.++.||+|.+... .....++..+|...+..++|+||++++.+|.-. ...|+|||+
T Consensus 24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~ 102 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL 102 (369)
T ss_pred ccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence 5788888 7888888899999999998544 334467789999999999999999999998544 368999999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCC
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA 963 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~ 963 (1181)
| ..+|...+.. .++...+..++.|++.|++|||+.||+||||||+||++.. +..+||.|||+++.-... -..
T Consensus 103 m-~~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~-~~~lKi~dfg~ar~e~~~-~~m 174 (369)
T KOG0665|consen 103 M-DANLCQVILM-----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNS-DCTLKILDFGLARTEDTD-FMM 174 (369)
T ss_pred h-hhHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecc-hhheeeccchhhcccCcc-ccc
Confidence 9 6788888763 4677889999999999999999999999999999999987 899999999999865433 244
Q ss_pred ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCc
Q psy14556 964 ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTS 1031 (1181)
Q Consensus 964 ~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~ 1031 (1181)
+..+.|..|+|||++.+.. ++..+|+ ||+||++.||++|+..|.|.+.
T Consensus 175 tpyVvtRyyrapevil~~~--~ke~vdi------------------wSvGci~gEli~~~Vlf~g~d~ 222 (369)
T KOG0665|consen 175 TPYVVTRYYRAPEVILGMG--YKENVDI------------------WSVGCIMGELILGTVLFPGKDH 222 (369)
T ss_pred CchhheeeccCchheeccC--Ccccchh------------------hhhhhHHHHHhhceEEecCchH
Confidence 5567899999999998765 7788877 9999999999999999998765
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.5e-21 Score=220.80 Aligned_cols=131 Identities=27% Similarity=0.367 Sum_probs=110.6
Q ss_pred cccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcC-----C---CCeeeEccccccC---
Q psy14556 806 FALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR-----H---RNIVQYLGSVSEE--- 874 (1181)
Q Consensus 806 ~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~-----H---PNIVkl~g~~~d~--- 874 (1181)
.+...+|||.|-|++||+|.+..+.+.||+|+.+.. ....+....||++|++++ | .+||++++.|...
T Consensus 79 RY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 79 RYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred eEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 344456899999999999999999999999998543 223567889999999983 3 4799999999654
Q ss_pred -CcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhcccc-ceecccCCCCCcccc
Q psy14556 875 -GYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ-KIVHRDIKGDNVLVN 939 (1181)
Q Consensus 875 -~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~-gIVHrDLKP~NILLd 939 (1181)
.++|+|+|++ |.+|..++... .-..++...++.|++||+.||.|||.+ ||||-||||+|||+.
T Consensus 158 G~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 158 GQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred CcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 5899999999 88898888765 455678889999999999999999965 999999999999984
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-21 Score=218.00 Aligned_cols=241 Identities=15% Similarity=0.163 Sum_probs=191.4
Q ss_pred eecccCceEEEEEEEcCC-----CeEEEEEEecCC-CCCChhHHHHHHHHHHhcCCCCeeeEcccccc-CCcEEEEEeec
Q psy14556 812 ELGKGSYGVVYAARELDR-----QVKLAIKEIPEK-NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSE-EGYFKIFMEQV 884 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~t-----g~~VAIKii~~~-~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d-~~~l~LVmEy~ 884 (1181)
.+-+|.||.||+|.+++. .+.|.+|.++.. +.-+...+..|...+..+.|||+..+.+++.+ ...+++++.++
T Consensus 291 llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~ 370 (563)
T KOG1024|consen 291 LLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPAT 370 (563)
T ss_pred hhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEecc
Confidence 367899999999977643 245667776543 33346678899999999999999999998754 46789999999
Q ss_pred CCCCcccchh-----cccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccC
Q psy14556 885 PGGSLSTLLR-----VKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGL 959 (1181)
Q Consensus 885 ~gGSL~dlL~-----~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~ 959 (1181)
.-|+|..++. +......++..+...++.|++.|++|||++|+||.||..+|.++++ .-++||+|=.+++.+-..
T Consensus 371 ~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd-~LqVkltDsaLSRDLFP~ 449 (563)
T KOG1024|consen 371 GVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDD-QLQVKLTDSALSRDLFPG 449 (563)
T ss_pred CcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehh-heeEEeccchhccccCcc
Confidence 9999999998 4445567778888889999999999999999999999999999998 789999999999865432
Q ss_pred CCCC--ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccC
Q psy14556 960 CPSA--ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVA 1036 (1181)
Q Consensus 960 ~~~~--~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~ 1036 (1181)
.... ..-.....||+||.+.+..++..+|+ ||||++||||+| |+.||...++.++..
T Consensus 450 DYhcLGDnEnRPvkWMslEal~n~~yssasDv--------------------WsfGVllWELmtlg~~PyaeIDPfEm~~ 509 (563)
T KOG1024|consen 450 DYHCLGDNENRPVKWMSLEALQNSHYSSASDV--------------------WSFGVLLWELMTLGKLPYAEIDPFEMEH 509 (563)
T ss_pred cccccCCCCCCcccccCHHHHhhhhhcchhhh--------------------HHHHHHHHHHHhcCCCCccccCHHHHHH
Confidence 2211 11124678999999987765555555 999999999998 899999999877532
Q ss_pred C--CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1037 P--PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1037 ~--~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
- ....-..+..+|+.+-.+++-||+..|..||.+.+.
T Consensus 510 ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Ql 548 (563)
T KOG1024|consen 510 YLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQL 548 (563)
T ss_pred HHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHH
Confidence 1 112222356899999999999999999999998776
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-20 Score=218.18 Aligned_cols=164 Identities=16% Similarity=0.149 Sum_probs=125.7
Q ss_pred hhhcccCceeecccCceEEEEEEEcC-CCeEEEEEEecCCC-----CCChhHHHHHHHHHHhcCCCCeee-EccccccCC
Q psy14556 803 LYLFALNRIELGKGSYGVVYAARELD-RQVKLAIKEIPEKN-----LGDVQPLHEEIKLHSQLRHRNIVQ-YLGSVSEEG 875 (1181)
Q Consensus 803 ~~~~~l~~~kIG~G~fG~VYka~d~~-tg~~VAIKii~~~~-----~~~~e~f~rEi~IL~~L~HPNIVk-l~g~~~d~~ 875 (1181)
...|.+.. +||+|+||+||+|++.. +++.||||++.... ....+.+.+|+.+|++++|+||+. ++++ +
T Consensus 17 ~~~Y~~~~-~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 17 SARFVETA-VLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred cCCceEcc-EEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 33454544 69999999999998876 67788999875331 112456899999999999999985 5442 4
Q ss_pred cEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccC-CCCCcccccCCCeeeeecCCccc
Q psy14556 876 YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI-KGDNVLVNTYSGVVKISDFGTSK 954 (1181)
Q Consensus 876 ~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDL-KP~NILLd~~~g~vKLiDFGlAk 954 (1181)
..|+||||++|++|... .. .. ...++.|++++|.|||++||+|||| ||+|||++. ++.+||+|||+|+
T Consensus 92 ~~~LVmE~~~G~~L~~~-~~------~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~-~~~ikLiDFGlA~ 160 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-RP------HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGP-DGEAAVIDFQLAS 160 (365)
T ss_pred CcEEEEEccCCCCHHHh-Cc------cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcC-CCCEEEEECccce
Confidence 57999999999999632 11 01 1357889999999999999999999 999999987 7899999999998
Q ss_pred ccccCCCC--------CccccCCccccCchhhccCC
Q psy14556 955 RLAGLCPS--------AETFTGTLQYMAPEVIDKGQ 982 (1181)
Q Consensus 955 ~l~~~~~~--------~~t~~GT~~Y~APEvl~gg~ 982 (1181)
.+...... ..+..+++.|+|||.+....
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 66543211 12455788899999996544
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.1e-21 Score=216.76 Aligned_cols=195 Identities=25% Similarity=0.376 Sum_probs=163.5
Q ss_pred ceeecccCceEEEEEEEcC---CCeEEEEEEecCCCCCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEeecC
Q psy14556 810 RIELGKGSYGVVYAARELD---RQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~---tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
..+||+|.|++||++.+.. ..+.||+|.+...+ ...++.+|+++|..+ .+.||+++.+++..++...+|+||++
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~ 118 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFE 118 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccC
Confidence 4479999999999999877 78899999986554 345699999999999 58999999999999999999999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccC------
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGL------ 959 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~------ 959 (1181)
.....++.. .++...+..+++.++.||+++|.+|||||||||.|+|.+...+.-.|+|||+|......
T Consensus 119 H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s 192 (418)
T KOG1167|consen 119 HDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHS 192 (418)
T ss_pred ccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhh
Confidence 999888887 34577888899999999999999999999999999999988889999999998611100
Q ss_pred --------CC------------------------------CCccccCCccccCchhhccCCCCCCCccccccCCCccccc
Q psy14556 960 --------CP------------------------------SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRI 1001 (1181)
Q Consensus 960 --------~~------------------------------~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i 1001 (1181)
.+ ......||++|+|||++..- ...+..||+
T Consensus 193 ~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~QttaiDi---------- 261 (418)
T KOG1167|consen 193 RSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAIDI---------- 261 (418)
T ss_pred hhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCcCCccce----------
Confidence 00 00123599999999999754 355677877
Q ss_pred cccccchhHHHHHHHHHHHhCCCCCCCCCc
Q psy14556 1002 EYKKMKINVFLCVIISQLLVLTAALKKKTS 1031 (1181)
Q Consensus 1002 ~~~~~k~DwSLGvILyELLTGk~PF~~~~~ 1031 (1181)
||.|+|+..++++.+||-....
T Consensus 262 --------ws~GVI~Lslls~~~PFf~a~d 283 (418)
T KOG1167|consen 262 --------WSAGVILLSLLSRRYPFFKAKD 283 (418)
T ss_pred --------eeccceeehhhccccccccCcc
Confidence 9999999999999999876544
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.8e-21 Score=240.35 Aligned_cols=191 Identities=18% Similarity=0.154 Sum_probs=131.0
Q ss_pred hcCC-CCeeeEcccc-------ccCCcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecc
Q psy14556 858 QLRH-RNIVQYLGSV-------SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929 (1181)
Q Consensus 858 ~L~H-PNIVkl~g~~-------~d~~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHr 929 (1181)
.++| +||.+++++| .....++.++|++ +++|.+++... ...+++..++.++.||+.||.|||++||+||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~gIvHr 104 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQGIVVH 104 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 3455 5788888877 2334677888987 77999999743 3457899999999999999999999999999
Q ss_pred cCCCCCccccc------------------CCCeeeeecCCcccccccCCC----------------CCccccCCccccCc
Q psy14556 930 DIKGDNVLVNT------------------YSGVVKISDFGTSKRLAGLCP----------------SAETFTGTLQYMAP 975 (1181)
Q Consensus 930 DLKP~NILLd~------------------~~g~vKLiDFGlAk~l~~~~~----------------~~~t~~GT~~Y~AP 975 (1181)
||||+||||+. .++.+||+|||+++....... ......||+.||||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 99999999953 144667777777754321000 00113578999999
Q ss_pred hhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc--cccCCCCCCCCCCCCCCcchH
Q psy14556 976 EVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR--ALVAPPQISRSVSVPGPGGIN 1053 (1181)
Q Consensus 976 Evl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~--~l~~~~~ip~~l~~~~p~~L~ 1053 (1181)
|++.+..++. .+|+ ||+||+||||++|..|+...... .+... .++.......+ ...
T Consensus 185 E~~~~~~~~~--~sDV------------------wSlGviL~ELl~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~ 242 (793)
T PLN00181 185 EEDNGSSSNC--ASDV------------------YRLGVLLFELFCPVSSREEKSRTMSSLRHR-VLPPQILLNWP-KEA 242 (793)
T ss_pred hhhccCCCCc--hhhh------------------hhHHHHHHHHhhCCCchhhHHHHHHHHHHh-hcChhhhhcCH-HHH
Confidence 9998765444 4444 99999999999999988753321 11111 11111111222 234
Q ss_pred HhhccCCCCCCCCCchhHHH
Q psy14556 1054 SSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1054 ~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.++.+|+.++|..||+..+.
T Consensus 243 ~~~~~~L~~~P~~Rps~~ei 262 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSEL 262 (793)
T ss_pred HHHHHhCCCChhhCcChHHH
Confidence 56678899999999875543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.4e-19 Score=188.36 Aligned_cols=244 Identities=30% Similarity=0.392 Sum_probs=187.0
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC---ChhHHHHHHHHHHhcCCC-CeeeEccccccCCcEEEEEeecCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG---DVQPLHEEIKLHSQLRHR-NIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~---~~e~f~rEi~IL~~L~HP-NIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
..||.|+||.||++.+. ..+++|.+...... ..+.+.+|+.++..+.|+ +|+++.+.+......+++++++.+
T Consensus 6 ~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 82 (384)
T COG0515 6 RKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG 82 (384)
T ss_pred EeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCC
Confidence 36999999999999986 68899999766443 367799999999999988 799999999777778999999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCC-eeeeecCCcccccccCCC----
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSG-VVKISDFGTSKRLAGLCP---- 961 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g-~vKLiDFGlAk~l~~~~~---- 961 (1181)
+++.+++........+.......++.|++.++.|+|+.+++||||||+||+++. .+ .++++|||.++.......
T Consensus 83 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~-~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (384)
T COG0515 83 GSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDR-DGRVVKLIDFGLAKLLPDPGSTSSI 161 (384)
T ss_pred CcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecC-CCCeEEEeccCcceecCCCCccccc
Confidence 999976664311126778899999999999999999999999999999999998 55 799999999986554332
Q ss_pred --CCccccCCccccCchhhccCC-CCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCc----ccc
Q psy14556 962 --SAETFTGTLQYMAPEVIDKGQ-RGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTS----RAL 1034 (1181)
Q Consensus 962 --~~~t~~GT~~Y~APEvl~gg~-~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~----~~l 1034 (1181)
......|+..|+|||.+.+.. ......+|+ |++|++++++++|..||..... ...
T Consensus 162 ~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~------------------~s~g~~~~~~~~~~~p~~~~~~~~~~~~~ 223 (384)
T COG0515 162 PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDI------------------WSLGITLYELLTGLPPFEGEKNSSATSQT 223 (384)
T ss_pred cccccccccccccCCHHHhcCCCCCCCCchHhH------------------HHHHHHHHHHHhCCCCCCCCCccccHHHH
Confidence 234567999999999997532 234444444 9999999999999999887764 111
Q ss_pred cC---CCC---CCCCCCCCC----CcchHHhhccCCCCCCCCCchhHHHHHH
Q psy14556 1035 VA---PPQ---ISRSVSVPG----PGGINSSSSAPVTPTPHSRHISVNTNLV 1076 (1181)
Q Consensus 1035 ~~---~~~---ip~~l~~~~----p~~L~~li~r~la~dPs~Rp~s~~~~~~ 1076 (1181)
.. ... ......... ...+..++.+++..+|..|.........
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 224 LKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11 011 111111111 1467778888999999999987766443
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.2e-19 Score=203.52 Aligned_cols=245 Identities=21% Similarity=0.248 Sum_probs=180.3
Q ss_pred cccCceeecccCceEEEEEEEcCCC-eEEEEEEecCCCCCChhHHHHHHHHHHhcCC----CCeeeEcccc-ccCCcEEE
Q psy14556 806 FALNRIELGKGSYGVVYAARELDRQ-VKLAIKEIPEKNLGDVQPLHEEIKLHSQLRH----RNIVQYLGSV-SEEGYFKI 879 (1181)
Q Consensus 806 ~~l~~~kIG~G~fG~VYka~d~~tg-~~VAIKii~~~~~~~~e~f~rEi~IL~~L~H----PNIVkl~g~~-~d~~~l~L 879 (1181)
|.+.+ +||+|+||.||.|.+..++ ..+|+|............+..|..++..+.. +++.++++.+ ..+...|+
T Consensus 20 ~~i~~-~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 20 YKLGK-KIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred eEEee-eccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 44443 7999999999999987774 6789998876544433368899999999873 6899999998 57788999
Q ss_pred EEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCC----CeeeeecCCccc-
Q psy14556 880 FMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYS----GVVKISDFGTSK- 954 (1181)
Q Consensus 880 VmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~----g~vKLiDFGlAk- 954 (1181)
||+.+ |.+|.++..... ...++..++..++.|++.+|++||+.|++||||||+|+++.... ..+.|.|||+++
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 99998 999999886553 56788999999999999999999999999999999999997632 469999999998
Q ss_pred -ccccCCC-------C-CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCC
Q psy14556 955 -RLAGLCP-------S-AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAA 1025 (1181)
Q Consensus 955 -~l~~~~~-------~-~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~P 1025 (1181)
....... . ...+.||..|+++....+...+...|+ ||++.++.+++.|..|
T Consensus 177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDl--------------------es~~Y~l~el~~g~LP 236 (322)
T KOG1164|consen 177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDL--------------------ESLFYMLLELLKGSLP 236 (322)
T ss_pred ccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhh--------------------hhHHHHHHHHhcCCCC
Confidence 3321111 1 223559999999999987665555554 9999999999999999
Q ss_pred CCCCCcccccCC-CC-----CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1026 LKKKTSRALVAP-PQ-----ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1026 F~~~~~~~l~~~-~~-----ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
|.+......... .. .........|..+.......-+.+...+|.....
T Consensus 237 W~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~ 290 (322)
T KOG1164|consen 237 WEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKL 290 (322)
T ss_pred CccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHH
Confidence 977664221110 00 0000222334455555544444566666654444
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.4e-18 Score=184.54 Aligned_cols=138 Identities=20% Similarity=0.122 Sum_probs=106.4
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCC--C-------hh-----------------HHHHHHHHHHhcCCCCee
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--D-------VQ-----------------PLHEEIKLHSQLRHRNIV 865 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~-------~e-----------------~f~rEi~IL~~L~HPNIV 865 (1181)
.||+|+||.||+|.+. +|+.||+|+++..... . .. ...+|+.++.++.++++.
T Consensus 4 ~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 4 CISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred ccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 6999999999999986 8999999999754221 1 11 223599999999877764
Q ss_pred eEccccccCCcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhc-cccceecccCCCCCcccccCCCe
Q psy14556 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYL-HGQKIVHRDIKGDNVLVNTYSGV 944 (1181)
Q Consensus 866 kl~g~~~d~~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yL-Hs~gIVHrDLKP~NILLd~~~g~ 944 (1181)
....+.. ...++||||++|+++...... ...+++..+..++.|++.+|.++ |+.||+||||||+|||++. +.
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~--~~ 155 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD--GK 155 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC--Cc
Confidence 3332221 223899999988877654321 23567888999999999999999 7999999999999999974 78
Q ss_pred eeeecCCcccccc
Q psy14556 945 VKISDFGTSKRLA 957 (1181)
Q Consensus 945 vKLiDFGlAk~l~ 957 (1181)
++|+|||+|....
T Consensus 156 v~LiDFG~a~~~~ 168 (190)
T cd05147 156 LYIIDVSQSVEHD 168 (190)
T ss_pred EEEEEccccccCC
Confidence 9999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.1e-18 Score=190.77 Aligned_cols=199 Identities=23% Similarity=0.325 Sum_probs=164.6
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
..+||+|+||.++.|.+.-+++.||||.-+..+. .-++..|....+.| ..+.|..+|.+..++.+-.||+|++ |.+
T Consensus 33 GkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPS 109 (449)
T KOG1165|consen 33 GKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPS 109 (449)
T ss_pred ccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcC
Confidence 3489999999999999999999999998755533 34578899988888 4689999999999998899999998 999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccccc----CCCeeeeecCCcccccccCCCC--
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNT----YSGVVKISDFGTSKRLAGLCPS-- 962 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~----~~g~vKLiDFGlAk~l~~~~~~-- 962 (1181)
|++++.-. ...++..++..++.|++.-++|+|++.+|+|||||+|+||.. ....+.|+|||+|+...++...
T Consensus 110 LEDLFD~C--gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqH 187 (449)
T KOG1165|consen 110 LEDLFDLC--GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQH 187 (449)
T ss_pred HHHHHHHh--cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcccccc
Confidence 99998754 335778999999999999999999999999999999999964 2347899999999887654332
Q ss_pred -----CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc
Q psy14556 963 -----AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA 1033 (1181)
Q Consensus 963 -----~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~ 1033 (1181)
.....||..||+-....|... ++.++.-|||-+++++|.|..||.+.....
T Consensus 188 IPYrE~KSLsGTARYMSINTHlGrEQ--------------------SRRDDLEaLGHvFmYFLRGsLPWQGLKA~t 243 (449)
T KOG1165|consen 188 IPYREHKSLSGTARYMSINTHLGREQ--------------------SRRDDLEALGHVFMYFLRGSLPWQGLKADT 243 (449)
T ss_pred CccccccccccceeeeEeeccccchh--------------------hhhhhHHHhhhhhhhhccCCCccccccCcc
Confidence 234569999999877766543 344444889999999999999999977644
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.2e-18 Score=183.95 Aligned_cols=202 Identities=23% Similarity=0.292 Sum_probs=160.5
Q ss_pred cccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCC-CCeeeEccccccCCcEEEEEeec
Q psy14556 806 FALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRH-RNIVQYLGSVSEEGYFKIFMEQV 884 (1181)
Q Consensus 806 ~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~H-PNIVkl~g~~~d~~~l~LVmEy~ 884 (1181)
|.+.+ +||+|+||.+|.|....+|+.||||+-+.... .-.+..|..+.+.|++ ..|..+..++.+..+-.+||+.+
T Consensus 17 y~lvr-kiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL 93 (341)
T KOG1163|consen 17 YKLVR-KIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL 93 (341)
T ss_pred eEEEE-eecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc
Confidence 33433 79999999999999999999999998754422 2347789999999975 66777777888888999999998
Q ss_pred CCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccccc--CCCeeeeecCCcccccccCCCC
Q psy14556 885 PGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNT--YSGVVKISDFGTSKRLAGLCPS 962 (1181)
Q Consensus 885 ~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~--~~g~vKLiDFGlAk~l~~~~~~ 962 (1181)
|.+|++++.-. ...++..+++.++-|++.-++|+|.++++||||||+|+|+.- ...++.|+|||+|+...+..+.
T Consensus 94 -GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 94 -GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred -CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 99999998753 235678889999999999999999999999999999999853 2458999999999877643221
Q ss_pred -------CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc
Q psy14556 963 -------AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA 1033 (1181)
Q Consensus 963 -------~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~ 1033 (1181)
.....||..|.+-.... .+..++.++.-|+|.+|..+..|..||++.....
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~--------------------g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHL--------------------GIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred ccCccccCCccceeeeehhhhhhh--------------------hhhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence 22345777777655443 3455666667999999999999999999987643
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.74 E-value=8.8e-19 Score=207.58 Aligned_cols=231 Identities=25% Similarity=0.302 Sum_probs=181.8
Q ss_pred ecccCceEEEEEEE---cCCCeEEEEEEecCCCCCC--hhHHHHHHHHHHhcC-CCCeeeEccccccCCcEEEEEeecCC
Q psy14556 813 LGKGSYGVVYAARE---LDRQVKLAIKEIPEKNLGD--VQPLHEEIKLHSQLR-HRNIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 813 IG~G~fG~VYka~d---~~tg~~VAIKii~~~~~~~--~e~f~rEi~IL~~L~-HPNIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
+|+|.||.|++++. ...+.-+|+|+..+..... ......|..++..++ ||.++++...++.+...++++++..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 79999999998753 3456778999887664322 224567888888886 99999999999999999999999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccc
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF 966 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~ 966 (1181)
|.|...+... ..+++.....+...++-+++++|+.+|+|||+|++||+++. +|++++.|||.++........
T Consensus 82 g~lft~l~~~---~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~-~Ghi~~tdfglske~v~~~~~---- 153 (612)
T KOG0603|consen 82 GDLFTRLSKE---VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLL-EGHIKLTDFGLSKEAVKEKIA---- 153 (612)
T ss_pred chhhhccccC---CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecc-cCccccCCchhhhHhHhhhhc----
Confidence 9998877633 45667777888999999999999999999999999999998 899999999999876543222
Q ss_pred cCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc-CCCCCCCCCC
Q psy14556 967 TGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV-APPQISRSVS 1045 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~-~~~~ip~~l~ 1045 (1181)
+||..|||||++. +....+|. ||+|+++++|+||..||.+.....|. .....|+...
T Consensus 154 cgt~eymApEI~~----gh~~a~D~------------------ws~gvl~felltg~~pf~~~~~~~Il~~~~~~p~~l~ 211 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN----GHLSAADW------------------WSFGVLAFELLTGTLPFGGDTMKRILKAELEMPRELS 211 (612)
T ss_pred ccchhhhhhHhhh----ccCCcccc------------------hhhhhhHHHHhhCCCCCchHHHHHHhhhccCCchhhh
Confidence 8999999999997 23344444 88999999999999999994443333 3566777777
Q ss_pred CCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1046 VPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1046 ~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
...+..+..+..+++..+=..-|.-+.+
T Consensus 212 ~~a~~~~~~l~~r~p~nrLg~~~~~~~e 239 (612)
T KOG0603|consen 212 AEARSLFRQLFKRNPENRLGAGPDGVDE 239 (612)
T ss_pred HHHHHHHHHHHhhCHHHHhccCcchhHH
Confidence 7777777777777666655554444444
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.3e-17 Score=176.30 Aligned_cols=138 Identities=20% Similarity=0.166 Sum_probs=108.3
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCC--------------------------hhHHHHHHHHHHhcCCCCee
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD--------------------------VQPLHEEIKLHSQLRHRNIV 865 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~--------------------------~e~f~rEi~IL~~L~HPNIV 865 (1181)
.||+|++|.||+|.+. +|+.||||+++...... ...+.+|...+.++.|++|.
T Consensus 4 ~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 4 CISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred eeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 6999999999999987 89999999997653210 12246789999999998874
Q ss_pred eEccccccCCcEEEEEeecCCCCcccc-hhcccCCCCCChHHHHHHHHHHHhhhhhccc-cceecccCCCCCcccccCCC
Q psy14556 866 QYLGSVSEEGYFKIFMEQVPGGSLSTL-LRVKWGPLKENESTMSFYTKQILEGLKYLHG-QKIVHRDIKGDNVLVNTYSG 943 (1181)
Q Consensus 866 kl~g~~~d~~~l~LVmEy~~gGSL~dl-L~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs-~gIVHrDLKP~NILLd~~~g 943 (1181)
....+... ..++||||++|+++... +.. ..++......++.|++.++.+||+ +||+||||||+||+++ ++
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~--~~ 154 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH--DG 154 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE--CC
Confidence 43333222 24899999988855433 322 245677888999999999999999 9999999999999997 58
Q ss_pred eeeeecCCccccccc
Q psy14556 944 VVKISDFGTSKRLAG 958 (1181)
Q Consensus 944 ~vKLiDFGlAk~l~~ 958 (1181)
.++|+|||++.....
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 899999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.6e-18 Score=173.64 Aligned_cols=152 Identities=21% Similarity=0.181 Sum_probs=112.6
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccc
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF 966 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~ 966 (1181)
|+|.++++.. ...+++..++.++.|++.||+|||+++ ||+|||++. ++.+|+ ||+++..... ..
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~-~~~~~~--fG~~~~~~~~-----~~ 64 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTW-DGLLKL--DGSVAFKTPE-----QS 64 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcC-ccceee--ccceEeeccc-----cC
Confidence 6888888753 335889999999999999999999998 999999987 888998 9998765432 12
Q ss_pred cCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc-----ccC--CCC
Q psy14556 967 TGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA-----LVA--PPQ 1039 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~-----l~~--~~~ 1039 (1181)
.||+.|+|||++.+..++.+ +|+ ||+||++|||+||+.||....... +.. ...
T Consensus 65 ~g~~~y~aPE~~~~~~~~~~--~Di------------------wSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 124 (176)
T smart00750 65 RVDPYFMAPEVIQGQSYTEK--ADI------------------YSLGITLYEALDYELPYNEERELSAILEILLNGMPAD 124 (176)
T ss_pred CCcccccChHHhcCCCCcch--hhH------------------HHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC
Confidence 58899999999987655444 333 999999999999999997654321 100 000
Q ss_pred CCC--CCCCCCCc--chHHhhccCCCCCCCCCchhHHHH
Q psy14556 1040 ISR--SVSVPGPG--GINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1040 ip~--~l~~~~p~--~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
.+. ........ .+..++.+|+..+|..||+..+..
T Consensus 125 ~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll 163 (176)
T smart00750 125 DPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYL 163 (176)
T ss_pred CccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHH
Confidence 000 01111222 478899999999999999866553
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=6.3e-17 Score=174.74 Aligned_cols=134 Identities=22% Similarity=0.362 Sum_probs=106.6
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhc-----CCCCeeeEccccccCC---c-EEEEE
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-----RHRNIVQYLGSVSEEG---Y-FKIFM 881 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L-----~HPNIVkl~g~~~d~~---~-l~LVm 881 (1181)
..||+|+||.||. +..++.. +||++........+.+.+|+.+++.+ +||||++++++++++. . +.+|+
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred ceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 4799999999995 6666655 69998765555567899999999999 6799999999998863 4 33789
Q ss_pred ee--cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhh-hhccccceecccCCCCCcccccC---CCeeeeecCCcc
Q psy14556 882 EQ--VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGL-KYLHGQKIVHRDIKGDNVLVNTY---SGVVKISDFGTS 953 (1181)
Q Consensus 882 Ey--~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL-~yLHs~gIVHrDLKP~NILLd~~---~g~vKLiDFGlA 953 (1181)
|| +++++|.++++.. .+++. ..++.|++.++ +|||+++|+||||||+|||++.. +..++|+||+-+
T Consensus 85 e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 85 DFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred cCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 99 5579999999743 24444 34678888888 89999999999999999999742 348999995433
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=8.3e-17 Score=173.01 Aligned_cols=186 Identities=13% Similarity=0.029 Sum_probs=135.6
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC----ChhHHHHHHHHHHhcC-CCCeeeEccccccCCcEEEEEeecC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG----DVQPLHEEIKLHSQLR-HRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~----~~e~f~rEi~IL~~L~-HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
..|++|+||+||.+.. .+.+++.+.+.....- ....+.+|+++|++|+ |++|++++++ +..+++|||+.
T Consensus 8 ~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 8 EPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred eeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 4699999999998765 6677887776544321 1235889999999995 5889999886 44799999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccC-CCCCcccccCCCeeeeecCCcccccccCCCC--
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI-KGDNVLVNTYSGVVKISDFGTSKRLAGLCPS-- 962 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDL-KP~NILLd~~~g~vKLiDFGlAk~l~~~~~~-- 962 (1181)
|.+|...... . ...++.|++.+|.++|++||+|||| ||+|||++. ++.++|+|||++.........
T Consensus 82 G~~L~~~~~~---------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~-~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 82 GAAMYQRPPR---------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQE-DGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred CccHHhhhhh---------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcC-CCCEEEEECCCceecCCcchHHH
Confidence 9988654321 1 1346789999999999999999999 799999987 789999999999855432210
Q ss_pred --C---------ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCc
Q psy14556 963 --A---------ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTS 1031 (1181)
Q Consensus 963 --~---------~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~ 1031 (1181)
. .-...++.|++|+...--. ..+ -..++.++.|.-+|.++|+..|+.++..
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~--~~~----------------~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLK--RTS----------------WIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhc--cch----------------hHHHHHHHhcchHHHHHhccCCccccCC
Confidence 0 0112577888888664210 001 0233445699999999999999887654
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.68 E-value=1e-17 Score=205.39 Aligned_cols=241 Identities=24% Similarity=0.250 Sum_probs=180.0
Q ss_pred cCceeecccCceEEEEEEEcCCCeEEEEEEecCC-----CCCC-hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEE
Q psy14556 808 LNRIELGKGSYGVVYAARELDRQVKLAIKEIPEK-----NLGD-VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFM 881 (1181)
Q Consensus 808 l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~-----~~~~-~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVm 881 (1181)
.....+|.|++|.|+.+......+..+.|.+... .... ...+..|+.+-..+.|||++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3455799999998888887666665666654311 1111 122667888888999999999888887776666669
Q ss_pred eecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC
Q psy14556 882 EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP 961 (1181)
Q Consensus 882 Ey~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~ 961 (1181)
|||++ +|..++... ..+....+..++.|++.|++|||+.||.|||||++|+++.. +|.+||+|||.+........
T Consensus 401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~-~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTE-NGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEec-CCceEEeecCcceeeccCcc
Confidence 99999 999998743 34667778889999999999999999999999999999998 88999999999876654333
Q ss_pred C----CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc---
Q psy14556 962 S----AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL--- 1034 (1181)
Q Consensus 962 ~----~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l--- 1034 (1181)
. ....+|+..|+|||++.+..+. ...+|+ ||.|+++..|.+|+.||......+-
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~yd-pr~vDi------------------wS~~ii~~~m~~~~~~Wk~a~~~~~~~~ 536 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYD-PRAVDV------------------WSCGIIYICMILGRFPWKVAKKSDNSFK 536 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccC-cchhhh------------------hhccceEEEEecCCCccccccccccchh
Confidence 2 3456799999999999866543 334444 9999999999999999987655421
Q ss_pred --cCCCC-----CCCCCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1035 --VAPPQ-----ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1035 --~~~~~-----ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
....+ -+..+...+|..-..++.+.++.+|.+|-+.-+
T Consensus 537 ~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~ 581 (601)
T KOG0590|consen 537 TNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQ 581 (601)
T ss_pred hhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHH
Confidence 11111 122223345666777899999999999986433
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.6e-16 Score=173.39 Aligned_cols=132 Identities=15% Similarity=0.135 Sum_probs=107.0
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChh---H------HHHHHHHHHhcCCCCeeeEccccccC------
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQ---P------LHEEIKLHSQLRHRNIVQYLGSVSEE------ 874 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e---~------f~rEi~IL~~L~HPNIVkl~g~~~d~------ 874 (1181)
...||.|+||.||++.. ++..+|+|.+......... . +.+|+..+.++.||+|..+.+++...
T Consensus 36 ~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~ 113 (232)
T PRK10359 36 IKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLR 113 (232)
T ss_pred EEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccccc
Confidence 44799999999999755 4668999999765443322 2 67999999999999999998886533
Q ss_pred --CcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCc
Q psy14556 875 --GYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGT 952 (1181)
Q Consensus 875 --~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGl 952 (1181)
+..+++|||++|.+|.++.. .++ ....+++.+|..||+.|++|||+||+||+++. ++ ++|+|||.
T Consensus 114 ~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~-~g-i~liDfg~ 180 (232)
T PRK10359 114 YAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSK-NG-LRIIDLSG 180 (232)
T ss_pred ccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeC-CC-EEEEECCC
Confidence 35899999999999987742 222 24569999999999999999999999999987 67 99999998
Q ss_pred cccc
Q psy14556 953 SKRL 956 (1181)
Q Consensus 953 Ak~l 956 (1181)
....
T Consensus 181 ~~~~ 184 (232)
T PRK10359 181 KRCT 184 (232)
T ss_pred cccc
Confidence 7654
|
|
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.1e-17 Score=196.68 Aligned_cols=73 Identities=52% Similarity=0.830 Sum_probs=70.6
Q ss_pred chhhHHHHHhhhcccCCCccccccceeeEEEEEEEeecccchhhhhhhhccccCCCcccccccCCcceEEeec
Q psy14556 11 SRTLAMVLNNLIGKKGSLSSVTDYWDVATFFEISVLAEDYGKAIQAAECMFKLKPPDCLYKRDERSLFLYVHE 83 (1181)
Q Consensus 11 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~va~~~~~~~~~~~~~~l~~~~ 83 (1181)
-|+|||.||+|||+||+||||++|||||||||++|+|+|+.||+||||++||++||.||+++-++++.||.+.
T Consensus 343 lq~IgmkLn~LlgrKG~leklq~YWdV~~y~~asVLAnd~~kaiqAae~mfKLk~P~WYLkS~meni~l~~~f 415 (1226)
T KOG4279|consen 343 LQQIGMKLNSLLGRKGALEKLQEYWDVATYFEASVLANDYQKAIQAAEMMFKLKPPVWYLKSTMENILLINRF 415 (1226)
T ss_pred HHHHHHHHHHHhhccchHHHHHHHHhHHHhhhhhhhccCHHHHHHHHHHHhccCCceehHHHHHHHHHHHHhc
Confidence 3899999999999999999999999999999999999999999999999999999999999999999999663
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.2e-16 Score=179.11 Aligned_cols=238 Identities=18% Similarity=0.194 Sum_probs=147.8
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhcCC----------CCeeeEccccc----
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRH----------RNIVQYLGSVS---- 872 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L~H----------PNIVkl~g~~~---- 872 (1181)
...||.|+++.||.+.+..+++.+|+|+...... ...+.+++|.-....+.+ -.++-.++...
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 4479999999999999999999999999854332 235667776655544322 12222222111
Q ss_pred -----c---CC-----cEEEEEeecCCCCcccchhc---ccCC-CCCChHHHHHHHHHHHhhhhhccccceecccCCCCC
Q psy14556 873 -----E---EG-----YFKIFMEQVPGGSLSTLLRV---KWGP-LKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDN 935 (1181)
Q Consensus 873 -----d---~~-----~l~LVmEy~~gGSL~dlL~~---~~~~-~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~N 935 (1181)
. .. ..+++|+-+ .++|.+++.. .... ..........+..|+++.+++||+.|++|+||||+|
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~n 175 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPEN 175 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGG
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceee
Confidence 1 11 246778877 6788877652 1111 112223334566899999999999999999999999
Q ss_pred cccccCCCeeeeecCCcccccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHH
Q psy14556 936 VLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVI 1015 (1181)
Q Consensus 936 ILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvI 1015 (1181)
++++. +|.++|+||+.....+..... ...+..|.+||....... +.. ....+...-+-|.||++
T Consensus 176 fll~~-~G~v~Lg~F~~~~r~g~~~~~---~~~~~~~~PPe~~~~~~~-~~~-----------~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 176 FLLDQ-DGGVFLGDFSSLVRAGTRYRC---SEFPVAFTPPELESCAGQ-FGQ-----------NNAPYTFATDAWQLGIT 239 (288)
T ss_dssp EEE-T-TS-EEE--GGGEEETTEEEEG---GGS-TTTS-HHHHHHHTS-CHH-----------SEEEE-HHHHHHHHHHH
T ss_pred EEEcC-CCCEEEcChHHHeecCceeec---cCCCcccCChhhhhhhcc-cCc-----------ccceeeeccCHHHHHHH
Confidence 99998 899999999987665542221 234578999998753210 110 01233444455999999
Q ss_pred HHHHHhCCCCCCCCCcccccCCCCCCCCCCCCCCcchHHhhccCCCCCCCCC
Q psy14556 1016 ISQLLVLTAALKKKTSRALVAPPQISRSVSVPGPGGINSSSSAPVTPTPHSR 1067 (1181)
Q Consensus 1016 LyELLTGk~PF~~~~~~~l~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~R 1067 (1181)
+|.|..|..||........... .+.... ..|+.+..++...+..+|.+|
T Consensus 240 ly~lWC~~lPf~~~~~~~~~~~-~f~~C~--~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 240 LYSLWCGRLPFGLSSPEADPEW-DFSRCR--DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHSS-STCCCGGGSTSGG-GGTTSS-----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHccCCCCCCCccccccc-cchhcC--CcCHHHHHHHHHHccCCcccC
Confidence 9999999999998765443221 333332 889999999999999999877
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.61 E-value=2e-15 Score=165.94 Aligned_cols=138 Identities=22% Similarity=0.177 Sum_probs=107.7
Q ss_pred eeecccCceEEEEEE-EcCCCeEEEEEEecCCCCC-------------------C-----hhHHHHHHHHHHhcCCC--C
Q psy14556 811 IELGKGSYGVVYAAR-ELDRQVKLAIKEIPEKNLG-------------------D-----VQPLHEEIKLHSQLRHR--N 863 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~-d~~tg~~VAIKii~~~~~~-------------------~-----~e~f~rEi~IL~~L~HP--N 863 (1181)
..||+|++|.||+|. +..+++.||+|+++..... . ...+.+|+.++.++.+. .
T Consensus 34 ~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~ 113 (237)
T smart00090 34 GCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVP 113 (237)
T ss_pred CeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 379999999999998 6778999999999754311 0 12356899999999753 3
Q ss_pred eeeEccccccCCcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccc-eecccCCCCCcccccCC
Q psy14556 864 IVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK-IVHRDIKGDNVLVNTYS 942 (1181)
Q Consensus 864 IVkl~g~~~d~~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~g-IVHrDLKP~NILLd~~~ 942 (1181)
+.+++++ ...++||||++|.+|....... .......+..++.|++.+|++||++| ++||||||+||+++ +
T Consensus 114 ~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~--~ 184 (237)
T smart00090 114 VPKPIAW----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH--D 184 (237)
T ss_pred CCeeeEe----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE--C
Confidence 4455543 2358999999998887665322 23455667789999999999999999 99999999999998 5
Q ss_pred CeeeeecCCcccccc
Q psy14556 943 GVVKISDFGTSKRLA 957 (1181)
Q Consensus 943 g~vKLiDFGlAk~l~ 957 (1181)
+.++|+|||.+....
T Consensus 185 ~~i~LiDFg~a~~~~ 199 (237)
T smart00090 185 GKVVIIDVSQSVELD 199 (237)
T ss_pred CCEEEEEChhhhccC
Confidence 789999999987544
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.61 E-value=8.5e-16 Score=192.92 Aligned_cols=190 Identities=23% Similarity=0.223 Sum_probs=149.6
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcC---CCCeeeEccccccCCcEEEEEeecCC
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR---HRNIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~---HPNIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
...||+|+||+||+|.... ++.||+|+-+.....+ |.--.+++.+|+ -+.|.++.....-.+.-++|+||.+.
T Consensus 703 ~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~ 778 (974)
T KOG1166|consen 703 SKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPY 778 (974)
T ss_pred EeeeccccceEEEEeecCC-CcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecccc
Confidence 4469999999999999877 9999999987665533 112223444444 24455666666666778899999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccccc------CCCeeeeecCCccccccc--
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNT------YSGVVKISDFGTSKRLAG-- 958 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~------~~g~vKLiDFGlAk~l~~-- 958 (1181)
|+|.+++. ....+++..++.+..|++..+++||..+|||+||||+|+||.. ...-++|+|||.+..+.-
T Consensus 779 Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp 855 (974)
T KOG1166|consen 779 GTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFP 855 (974)
T ss_pred ccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcC
Confidence 99999998 4567899999999999999999999999999999999999943 234799999998854331
Q ss_pred CCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCC
Q psy14556 959 LCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAAL 1026 (1181)
Q Consensus 959 ~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF 1026 (1181)
........++|-.+-.+|+..|..++|..|. |-+..++|-||.|++.=
T Consensus 856 ~~~~F~~~~~td~f~C~EM~~grpWtYq~Dy--------------------fGlAa~~h~mLFG~y~q 903 (974)
T KOG1166|consen 856 DGTKFKAVWHTDLFDCIEMREGRPWTYQIDY--------------------FGLAATVHVMLFGKYME 903 (974)
T ss_pred CCcEEeeeeccccchhHHHhcCCCCchhhhh--------------------HHHHHHHHHHHHHHHHH
Confidence 1223344568899999999999998887776 77999999999998553
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.7e-15 Score=160.89 Aligned_cols=133 Identities=20% Similarity=0.261 Sum_probs=111.3
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCC--------hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEee
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD--------VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQ 883 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~--------~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy 883 (1181)
.||+|++|.||+|.+ .+..+++|+........ ...+.+|+.++..+.|++|.....++.+.+..+++|||
T Consensus 3 ~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 3 LIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred ccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 599999999999987 66789999875433221 24577899999999999887776666667788999999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccc
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 955 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~ 955 (1181)
++|++|.+++... .. ....++.+++.+|.+||+.|++|+|++|.||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~--~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS--GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE--CCCEEEEECCcccC
Confidence 9999999988643 11 6778999999999999999999999999999998 57899999998865
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.9e-16 Score=167.33 Aligned_cols=232 Identities=15% Similarity=0.171 Sum_probs=178.7
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCC--CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKN--LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~--~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
||.+...|..|+|++..+ .++.|++.... ....+.|..|.-.|+-+.||||+.+++.|....++.++..||+.|+|
T Consensus 197 kl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 197 KLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 588889999999999554 56677775442 23346788999999999999999999999999999999999999999
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccc--eecccCCCCCcccccCCCeeee--ecCCcccccccCCCCCcc
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK--IVHRDIKGDNVLVNTYSGVVKI--SDFGTSKRLAGLCPSAET 965 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~g--IVHrDLKP~NILLd~~~g~vKL--iDFGlAk~l~~~~~~~~t 965 (1181)
+.+++.. .....+..++.+++.+++.|++|||+.. |.---|.+..+++|+ +-..+| +|--++..- ..
T Consensus 275 ynvlhe~-t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmide-dltarismad~kfsfqe-------~g 345 (448)
T KOG0195|consen 275 YNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDE-DLTARISMADTKFSFQE-------VG 345 (448)
T ss_pred HHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecc-hhhhheecccceeeeec-------cc
Confidence 9999865 4556678889999999999999999874 334468889999987 555554 343332211 11
Q ss_pred ccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC---CCC
Q psy14556 966 FTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ---ISR 1042 (1181)
Q Consensus 966 ~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~---ip~ 1042 (1181)
..-.|.||+||.+...+. |..+ ...+.|||.+++||+.|.+.||..-++.+.-.++. +..
T Consensus 346 r~y~pawmspealqrkpe----d~n~-------------raadmwsfaillwel~trevpfadlspmecgmkialeglrv 408 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPE----DLNI-------------RAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRV 408 (448)
T ss_pred cccCcccCCHHHHhcCch----hcch-------------hhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccc
Confidence 235789999999975432 2211 23445999999999999999999999888655544 444
Q ss_pred CCCCCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1043 SVSVPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1043 ~l~~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
.+++....-+.+++.-|+..||.+||.+-
T Consensus 409 ~ippgis~hm~klm~icmnedpgkrpkfd 437 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNICMNEDPGKRPKFD 437 (448)
T ss_pred cCCCCccHHHHHHHHHHhcCCCCcCCCcc
Confidence 55666677788899999999999999753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.57 E-value=4e-15 Score=156.91 Aligned_cols=130 Identities=23% Similarity=0.273 Sum_probs=104.6
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEecCCCCCC--------hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeec
Q psy14556 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD--------VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQV 884 (1181)
Q Consensus 813 IG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~--------~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~ 884 (1181)
||+|+||.||+|.+ ++..+++|......... .+++.+|+.++..+.|+++.....++...+..+++|||+
T Consensus 2 ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 2 IAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 89999999999985 56789999865432211 255778999999998876554444444566678999999
Q ss_pred CCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccccc
Q psy14556 885 PGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956 (1181)
Q Consensus 885 ~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l 956 (1181)
+|++|.+++.... . .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~-------~---~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~--~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN-------D---ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR--DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH-------H---HHHHHHHHHHHHHHHCCeecCCCCcceEEEE--CCcEEEEECCCCcCC
Confidence 9999998876320 0 6889999999999999999999999999998 588999999988653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.4e-15 Score=185.61 Aligned_cols=197 Identities=29% Similarity=0.443 Sum_probs=139.0
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCccc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLST 891 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~d 891 (1181)
.|..|++|.||.++++.+.+.+|+|+ .+.+.- .+- ++.....|.+| |+-..
T Consensus 90 lisngAygavylvrh~~trqrfa~ki-Nkq~li-----lRn--ilt~a~npfvv---------------------gDc~t 140 (1205)
T KOG0606|consen 90 LISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI-----LRN--ILTFAGNPFVV---------------------GDCAT 140 (1205)
T ss_pred eeccCCCCceeeeeccccccchhhcc-cccchh-----hhc--cccccCCccee---------------------chhhh
Confidence 48999999999999999999999954 333211 111 33333444443 33333
Q ss_pred chhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC-----------
Q psy14556 892 LLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC----------- 960 (1181)
Q Consensus 892 lL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~----------- 960 (1181)
+++.. +..+ . +++.+++|||+.||+|||+||+|.+++. -|++|+.|||+++......
T Consensus 141 llk~~-g~lP--v--------dmvla~Eylh~ygivhrdlkpdnllIT~-mGhiKlTDfgLsk~GLms~atnl~eg~I~k 208 (1205)
T KOG0606|consen 141 LLKNI-GPLP--V--------DMVLAVEYLHSYGIVHRDLKPDNLLITS-MGHIKLTDFGLSKKGLMSLATNLKEGHIEK 208 (1205)
T ss_pred hcccC-CCCc--c--------hhhHHhHhhccCCeecCCCCCCcceeee-cccccccchhhhhhhhhhccchhhhcchHH
Confidence 44321 2222 2 2378899999999999999999999998 8999999999986532110
Q ss_pred ----CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC
Q psy14556 961 ----PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA 1036 (1181)
Q Consensus 961 ----~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~ 1036 (1181)
-.....+||+.|+|||++.. .+|+..||+ |++|+|+|+++.|..||.+++++++..
T Consensus 209 ~t~Ef~dKqvcgTPeyiaPeVilr--qgygkpvdw------------------wamGiIlyeFLVgcvpffGdtpeelfg 268 (1205)
T KOG0606|consen 209 DTHEFQDKQVCGTPEYIAPEVILR--QGYGKPVDW------------------WAMGIILYEFLVGCVPFFGDTPEELFG 268 (1205)
T ss_pred HHHHhhhccccCCccccChhhhhh--hccCCCccH------------------HHHHHHHHHHheeeeeccCCCHHHHHh
Confidence 01223579999999999974 478899987 999999999999999999998877533
Q ss_pred -----CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchh
Q psy14556 1037 -----PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1037 -----~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
.+..++. ..+.+.....++.+.+...|..|--+
T Consensus 269 ~visd~i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 269 QVISDDIEWPEE-DEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred hhhhhhcccccc-CcCCCHHHHHHHHHHHHhChHhhccc
Confidence 3335555 44555566666666666676666543
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.5e-14 Score=163.29 Aligned_cols=190 Identities=19% Similarity=0.230 Sum_probs=134.1
Q ss_pred CCCCeeeEcccccc---------------------------CCcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHH
Q psy14556 860 RHRNIVQYLGSVSE---------------------------EGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTK 912 (1181)
Q Consensus 860 ~HPNIVkl~g~~~d---------------------------~~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~ 912 (1181)
+|||||+++++|.+ ...+|+||..+ ..+|..++..+ ..+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC----CCchHHHHHHHH
Confidence 69999999887643 23578999887 57888888754 345566677899
Q ss_pred HHHhhhhhccccceecccCCCCCcccccC-CC--eeeeecCCcccccccCC-----C-CCccccCCccccCchhhccCCC
Q psy14556 913 QILEGLKYLHGQKIVHRDIKGDNVLVNTY-SG--VVKISDFGTSKRLAGLC-----P-SAETFTGTLQYMAPEVIDKGQR 983 (1181)
Q Consensus 913 QIa~AL~yLHs~gIVHrDLKP~NILLd~~-~g--~vKLiDFGlAk~l~~~~-----~-~~~t~~GT~~Y~APEvl~gg~~ 983 (1181)
|+++|+.|||.+||.|||+|++|||+.-+ ++ .+.|+|||++---.... . ..-..-|...-||||+... .+
T Consensus 349 QlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta-~P 427 (598)
T KOG4158|consen 349 QLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA-VP 427 (598)
T ss_pred HHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc-CC
Confidence 99999999999999999999999999432 22 78899999874322110 0 1112337888999999853 34
Q ss_pred CCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC----CCCCCCCCCCCCCcchHHhhccC
Q psy14556 984 GYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA----PPQISRSVSVPGPGGINSSSSAP 1059 (1181)
Q Consensus 984 ~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~----~~~ip~~l~~~~p~~L~~li~r~ 1059 (1181)
++...++. .+.+.|+.|.+.||+++...||.+.....+.. ..++ ..++..+|..+.+++-..
T Consensus 428 Gp~avvny-------------~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qL-Palp~~vpp~~rqlV~~l 493 (598)
T KOG4158|consen 428 GPNAVVNY-------------EKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQL-PALPSRVPPVARQLVFDL 493 (598)
T ss_pred CCceeecc-------------chhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhC-CCCcccCChHHHHHHHHH
Confidence 55555533 45677999999999999999999855443322 1112 223445666677777777
Q ss_pred CCCCCCCCch
Q psy14556 1060 VTPTPHSRHI 1069 (1181)
Q Consensus 1060 la~dPs~Rp~ 1069 (1181)
+..+|++|++
T Consensus 494 L~r~pskRvs 503 (598)
T KOG4158|consen 494 LKRDPSKRVS 503 (598)
T ss_pred hcCCccccCC
Confidence 7777777774
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.7e-14 Score=153.05 Aligned_cols=132 Identities=18% Similarity=0.159 Sum_probs=103.8
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC----------------------ChhHHHHHHHHHHhcCCC--Ceee
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG----------------------DVQPLHEEIKLHSQLRHR--NIVQ 866 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~----------------------~~e~f~rEi~IL~~L~HP--NIVk 866 (1181)
+.||+|+||.||++.+. +++.||||++...... ......+|+.++..+.|+ .+.+
T Consensus 21 ~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~ 99 (198)
T cd05144 21 NQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPK 99 (198)
T ss_pred CccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCc
Confidence 46999999999999874 7899999987643210 012356789999999777 4444
Q ss_pred EccccccCCcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeee
Q psy14556 867 YLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVK 946 (1181)
Q Consensus 867 l~g~~~d~~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vK 946 (1181)
.++. ...++||||++|++|..+... .....++.+++.++.++|+.||+||||||+||+++. ++.++
T Consensus 100 ~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~-~~~~~ 165 (198)
T cd05144 100 PIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDD-DEKIY 165 (198)
T ss_pred eeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcC-CCcEE
Confidence 4432 446899999999998766431 234568899999999999999999999999999987 89999
Q ss_pred eecCCcccccc
Q psy14556 947 ISDFGTSKRLA 957 (1181)
Q Consensus 947 LiDFGlAk~l~ 957 (1181)
|+|||.+....
T Consensus 166 liDfg~~~~~~ 176 (198)
T cd05144 166 IIDWPQMVSTD 176 (198)
T ss_pred EEECCccccCC
Confidence 99999986554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.8e-14 Score=175.60 Aligned_cols=133 Identities=24% Similarity=0.249 Sum_probs=106.9
Q ss_pred CceeecccCceEEEEEEEcCCCeEEEEEEecCC--CCC------ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEE
Q psy14556 809 NRIELGKGSYGVVYAARELDRQVKLAIKEIPEK--NLG------DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIF 880 (1181)
Q Consensus 809 ~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~--~~~------~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LV 880 (1181)
..++||+|+||+||++.+... .+++|+.... ... ..+++.+|+.+++.++|++|+....++.+....++|
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred ccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 345799999999999987544 3444433211 111 135688999999999999998877777777778999
Q ss_pred EeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccccc
Q psy14556 881 MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l 956 (1181)
|||++|++|.+++. ....++.|++.+|.+||+.|++||||||+|||++ ++.++|+|||+++..
T Consensus 415 ~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~--~~~~~liDFGla~~~ 477 (535)
T PRK09605 415 MEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR--DDRLYLIDFGLGKYS 477 (535)
T ss_pred EEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE--CCcEEEEeCcccccC
Confidence 99999999988875 2356889999999999999999999999999993 689999999999764
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.49 E-value=5e-15 Score=182.71 Aligned_cols=247 Identities=16% Similarity=0.146 Sum_probs=164.4
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCC-CCChhHH---HHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKN-LGDVQPL---HEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~-~~~~e~f---~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.||.+.|-+|.+|++.+. .|++|++-+.. .-..+.+ ..|++ ...++|||.+.+.-+...+...|+|-+|. ..
T Consensus 30 ~LGstRFlKv~r~k~~eG--~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyv-kh 105 (1431)
T KOG1240|consen 30 NLGSTRFLKVARAKDREG--LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYV-KH 105 (1431)
T ss_pred ccCchhhhhhhhccCCCc--eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHH-hh
Confidence 599999999999987543 48999985554 2233333 34444 45569999999999988888899999998 67
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccccc--ccCCCCCcc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL--AGLCPSAET 965 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l--~~~~~~~~t 965 (1181)
+|.|.+..+ .-+...+.+.|+.|++.||..+|..||+|||||.+|||++. -+-+.|+||..-+.. ....+...+
T Consensus 106 nLyDRlSTR---PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTS-WNW~~LtDFAsFKPtYLPeDNPadf~ 181 (1431)
T KOG1240|consen 106 NLYDRLSTR---PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITS-WNWLYLTDFASFKPTYLPEDNPADFT 181 (1431)
T ss_pred hhhhhhccc---hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEee-echhhhhcccccCCccCCCCCcccce
Confidence 898888743 34556677779999999999999999999999999999998 677999999876532 222222111
Q ss_pred -----ccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC
Q psy14556 966 -----FTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ 1039 (1181)
Q Consensus 966 -----~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~ 1039 (1181)
......|+|||.+..+. ++....+-. -...+.=+.+|+||++.|+++ |++||.-...-....-..
T Consensus 182 fFFDTSrRRtCYiAPERFv~~~-~~~~~~q~~--------~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~ 252 (1431)
T KOG1240|consen 182 FFFDTSRRRTCYIAPERFVSAL-GKTSVGQDA--------PLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNA 252 (1431)
T ss_pred EEEecCCceeeecChHhhhccc-cccccCCcc--------cccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCc
Confidence 12345799999986432 112211110 003334445999999999988 578876432211111000
Q ss_pred -CCCC-CCCCCCcchHHhhccCCCCCCCCCchhHHHHHH
Q psy14556 1040 -ISRS-VSVPGPGGINSSSSAPVTPTPHSRHISVNTNLV 1076 (1181)
Q Consensus 1040 -ip~~-l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~ 1076 (1181)
.++. +..-.-..++.++..++..||++|-+ +++.+.
T Consensus 253 ~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlS-AedyL~ 290 (1431)
T KOG1240|consen 253 DDPEQLLEKIEDVSLRNLILSMIQRDPSKRLS-AEDYLQ 290 (1431)
T ss_pred cCHHHHHHhCcCccHHHHHHHHHccCchhccC-HHHHHH
Confidence 0000 00011125777888888889999875 444333
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.9e-13 Score=132.79 Aligned_cols=130 Identities=22% Similarity=0.280 Sum_probs=109.7
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCC--CCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRH--RNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~H--PNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.+||.|.++.||++.... ..+++|....... ...+.+|+.+++.+.| +++++++.+....+..+++|||++++.
T Consensus 4 ~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred eecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 369999999999999744 6899999865533 4578999999999976 589999998888889999999998887
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhcccc---ceecccCCCCCcccccCCCeeeeecCCcccc
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ---KIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 955 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~---gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~ 955 (1181)
+..+ +......++.+++.+|++||.. +++|+|++|+||+++. .+.++++|||.+..
T Consensus 80 ~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~-~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD-GKILGIIDWEYAGY 138 (155)
T ss_pred cccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC-CcEEEEEecccccC
Confidence 7654 2445566788999999999985 7999999999999987 78999999998854
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.9e-13 Score=142.63 Aligned_cols=134 Identities=21% Similarity=0.215 Sum_probs=96.4
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCC--hhH----------------------HHHHHHHHHhcCCC--Cee
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD--VQP----------------------LHEEIKLHSQLRHR--NIV 865 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~--~e~----------------------f~rEi~IL~~L~HP--NIV 865 (1181)
.||+|+||+||+|.+. +++.||||++....... ... ...|...+.++.+. .+.
T Consensus 4 ~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 4 PIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred ccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 5999999999999876 78899999986542211 111 13556666665433 244
Q ss_pred eEccccccCCcEEEEEeecCCCCccc-chhcccCCCCCChHHHHHHHHHHHhhhhhccc-cceecccCCCCCcccccCCC
Q psy14556 866 QYLGSVSEEGYFKIFMEQVPGGSLST-LLRVKWGPLKENESTMSFYTKQILEGLKYLHG-QKIVHRDIKGDNVLVNTYSG 943 (1181)
Q Consensus 866 kl~g~~~d~~~l~LVmEy~~gGSL~d-lL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs-~gIVHrDLKP~NILLd~~~g 943 (1181)
+.++. ...++||||++++++.. .+... .. ...+..++.+++.++.++|. .||+|+||||+||+++ ++
T Consensus 83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~----~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~--~~ 151 (187)
T cd05119 83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDV----RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD--DG 151 (187)
T ss_pred ceEec----CCCEEEEEEeCCCCccChhhhhh----hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE--CC
Confidence 44433 23689999999865432 22211 11 15567789999999999999 9999999999999998 68
Q ss_pred eeeeecCCcccccc
Q psy14556 944 VVKISDFGTSKRLA 957 (1181)
Q Consensus 944 ~vKLiDFGlAk~l~ 957 (1181)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.4e-13 Score=149.64 Aligned_cols=137 Identities=18% Similarity=0.273 Sum_probs=105.1
Q ss_pred cCceeec-ccCceEEEEEEEcCCCeEEEEEEecCCCC-------------CChhHHHHHHHHHHhcCCCCe--eeEcccc
Q psy14556 808 LNRIELG-KGSYGVVYAARELDRQVKLAIKEIPEKNL-------------GDVQPLHEEIKLHSQLRHRNI--VQYLGSV 871 (1181)
Q Consensus 808 l~~~kIG-~G~fG~VYka~d~~tg~~VAIKii~~~~~-------------~~~e~f~rEi~IL~~L~HPNI--Vkl~g~~ 871 (1181)
.....|| .||.|+||.+.. .+..+++|.+..... ....++.+|+.++.++.|++| ++.+++.
T Consensus 34 ~~~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~ 111 (239)
T PRK01723 34 QQARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAAR 111 (239)
T ss_pred hcCceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeee
Confidence 3445788 899999999976 367889998853211 123568899999999998775 6666654
Q ss_pred ccC-C---cEEEEEeecCC-CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeee
Q psy14556 872 SEE-G---YFKIFMEQVPG-GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVK 946 (1181)
Q Consensus 872 ~d~-~---~l~LVmEy~~g-GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vK 946 (1181)
... . ..++|||+++| .+|.+++... .+++. .+.||+.+|.+||++||+||||||.|||++. ++.++
T Consensus 112 ~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~-~~~v~ 182 (239)
T PRK01723 112 VVRHGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDP-DGKFW 182 (239)
T ss_pred eeecCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcC-CCCEE
Confidence 332 2 23599999997 6888887632 23333 3578999999999999999999999999987 67899
Q ss_pred eecCCcccc
Q psy14556 947 ISDFGTSKR 955 (1181)
Q Consensus 947 LiDFGlAk~ 955 (1181)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998865
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.1e-14 Score=168.04 Aligned_cols=170 Identities=24% Similarity=0.307 Sum_probs=131.0
Q ss_pred CcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccc
Q psy14556 875 GYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954 (1181)
Q Consensus 875 ~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk 954 (1181)
.++||.|++|...+|.+++..+......+......++.|++.|++| +|.+|+|+||.||+... +.++||.|||+..
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~-d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSD-DDQLKIGDFGLVT 404 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhcccccccccc-chhhhhhhhhhee
Confidence 3689999999999999999865555566788899999999999999 99999999999999987 7799999999987
Q ss_pred ccccCC------CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCC
Q psy14556 955 RLAGLC------PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALK 1027 (1181)
Q Consensus 955 ~l~~~~------~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~ 1027 (1181)
...... .......||..||+||.+.+..++.+.|+ |+||+||+|++. -..+|.
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdI--------------------yaLGlil~EL~~~f~T~~e 464 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDI--------------------YALGLILAELLIQFSTQFE 464 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcch--------------------hhHHHHHHHHHHHhccHHH
Confidence 655432 12344569999999999998765555444 999999999998 566666
Q ss_pred CCCcccccCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1028 KKTSRALVAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1028 ~~~~~~l~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
............+|+......|.... +++..+.+.|..||.
T Consensus 465 r~~t~~d~r~g~ip~~~~~d~p~e~~-ll~~lls~~p~~RP~ 505 (516)
T KOG1033|consen 465 RIATLTDIRDGIIPPEFLQDYPEEYT-LLQQLLSPSPEERPS 505 (516)
T ss_pred HHHhhhhhhcCCCChHHhhcCcHHHH-HHHHhcCCCcccCch
Confidence 55444444444455444444444333 677788899999994
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.41 E-value=3e-13 Score=160.63 Aligned_cols=202 Identities=19% Similarity=0.231 Sum_probs=149.5
Q ss_pred HHhcCCCCeeeEccccccCCcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccce-ecccCCCC
Q psy14556 856 HSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKI-VHRDIKGD 934 (1181)
Q Consensus 856 L~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gI-VHrDLKP~ 934 (1181)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.. ....+++.....++++|+.||.|||+..| .|+.+++.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 4578999999999999999999999999999999999985 45678888888999999999999998866 99999999
Q ss_pred CcccccCCCeeeeecCCcccccccC--CCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHH
Q psy14556 935 NVLVNTYSGVVKISDFGTSKRLAGL--CPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFL 1012 (1181)
Q Consensus 935 NILLd~~~g~vKLiDFGlAk~l~~~--~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSL 1012 (1181)
|.+++. ...+||.|||+....... ...........-|.|||.+.+....... .......+.||+
T Consensus 79 nClvd~-~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~-------------~~~~~~gdiYs~ 144 (484)
T KOG1023|consen 79 NCLVDS-RWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLE-------------SALTQKGDIYSF 144 (484)
T ss_pred cceeee-eEEEEechhhhcccccccccccccchhHHHHhccCHHHhccccccccc-------------ccccccCCeehH
Confidence 999998 899999999998766421 0111112245679999999754211110 001122233999
Q ss_pred HHHHHHHHhCCCCCCCCCccc----ccCC-----C--CCCCCCCC-CCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1013 CVIISQLLVLTAALKKKTSRA----LVAP-----P--QISRSVSV-PGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1013 GvILyELLTGk~PF~~~~~~~----l~~~-----~--~ip~~l~~-~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
|+++||+++.+.||....... +... . ..|..... ..++.+..+++.|++.+|..||...+.
T Consensus 145 ~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i 217 (484)
T KOG1023|consen 145 GIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQI 217 (484)
T ss_pred HHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHH
Confidence 999999999999999855432 2111 0 11111111 344567779999999999999986555
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.30 E-value=8.5e-12 Score=148.75 Aligned_cols=197 Identities=19% Similarity=0.187 Sum_probs=127.9
Q ss_pred cccchhhhhcccchhhHHHHHhhhcccccccccChHHHHHHHHhhccCCCCcccccchHHHHhhhcccCceeecccCceE
Q psy14556 741 YLGTIRTQQLQFPLANLLEKLLLLIDLQDYDAMDYDAMVQLVEDLRTIPTKKKYMQTPMLRFLYLFALNRIELGKGSYGV 820 (1181)
Q Consensus 741 ~L~~irsq~~q~~l~~~~ek~~~L~Dlqe~~~md~d~~~qlle~lr~~p~~~k~~~~p~~~~~~~~~l~~~kIG~G~fG~ 820 (1181)
|+.|+-+.+..+-+....+++-.|.|.... ++++...+.++.--.. +.......|. .+.||.|++|.
T Consensus 66 KlGQ~lS~r~dllp~~~~~~L~~Lqd~v~p--~~~~~~~~~l~~elg~---------~~~~~F~~fd--~~plasaSigQ 132 (437)
T TIGR01982 66 KFGQTLSTRADLLPADIAEELSLLQDRVPP--FDFKVARKVIEAALGG---------PLEELFAEFE--EKPLAAASIAQ 132 (437)
T ss_pred HHhHHHHhCcccCCHHHHHHHHHHhcCCCC--CCHHHHHHHHHHHhCc---------CHHHHHhhCC--Ccceeeeehhh
Confidence 344555555555566777888888777664 5677777666542111 2222222222 34699999999
Q ss_pred EEEEEEcCCCeEEEEEEecCCCCCCh----------------------------------------hHHHHHHHHHHhcC
Q psy14556 821 VYAARELDRQVKLAIKEIPEKNLGDV----------------------------------------QPLHEEIKLHSQLR 860 (1181)
Q Consensus 821 VYka~d~~tg~~VAIKii~~~~~~~~----------------------------------------e~f~rEi~IL~~L~ 860 (1181)
||+|+. .+|+.||||+.++...... -.+.+|+..+.++.
T Consensus 133 Vh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~Ea~n~~~~~ 211 (437)
T TIGR01982 133 VHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRREAANASELG 211 (437)
T ss_pred eEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHHHHHHHHHH
Confidence 999986 4789999999865421100 02445555555552
Q ss_pred -----CCCeeeEcccc-ccCCcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHh-hhhhccccceecccCCC
Q psy14556 861 -----HRNIVQYLGSV-SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILE-GLKYLHGQKIVHRDIKG 933 (1181)
Q Consensus 861 -----HPNIVkl~g~~-~d~~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~-AL~yLHs~gIVHrDLKP 933 (1181)
+++| .+-.++ ......++||||++|++|.++...... .. ....++.+++. .+..+|..|++|+|+||
T Consensus 212 ~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~g~~H~D~hP 285 (437)
T TIGR01982 212 ENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRDGFFHADLHP 285 (437)
T ss_pred HhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhCCceeCCCCc
Confidence 3332 222222 223457899999999999988753211 11 12345556665 47889999999999999
Q ss_pred CCcccccCCCeeeeecCCccccccc
Q psy14556 934 DNVLVNTYSGVVKISDFGTSKRLAG 958 (1181)
Q Consensus 934 ~NILLd~~~g~vKLiDFGlAk~l~~ 958 (1181)
.||+++. +++++|+|||++..+..
T Consensus 286 gNilv~~-~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 286 GNIFVLK-DGKIIALDFGIVGRLSE 309 (437)
T ss_pred ccEEECC-CCcEEEEeCCCeeECCH
Confidence 9999987 78999999999977653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.4e-12 Score=157.18 Aligned_cols=237 Identities=23% Similarity=0.272 Sum_probs=172.8
Q ss_pred eecccCceEEEEEEEc-CCCeEEEEEEecCCC--CCChhHHHHHHHHHHhcC-CCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAAREL-DRQVKLAIKEIPEKN--LGDVQPLHEEIKLHSQLR-HRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~-~tg~~VAIKii~~~~--~~~~e~f~rEi~IL~~L~-HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.||+|+|+.|-..... .....+|.|.+.... ....+....|..+-..+. |+|++++++...+.+..++.++|..|+
T Consensus 27 ~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~ 106 (601)
T KOG0590|consen 27 SIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGG 106 (601)
T ss_pred cccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCccccc
Confidence 4899999999888763 344567777775443 222445566888888887 999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhcc-ccceecccCCCCCcccccCCC-eeeeecCCccccccc-CCC--C
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLH-GQKIVHRDIKGDNVLVNTYSG-VVKISDFGTSKRLAG-LCP--S 962 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLH-s~gIVHrDLKP~NILLd~~~g-~vKLiDFGlAk~l~~-~~~--~ 962 (1181)
++...+... .....+......++.|+..++.|+| ..++.|+||||+|.+++. .+ .+++.|||+|..+.. ... .
T Consensus 107 ~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~-s~~~l~~~df~~At~~~~~~g~~~~ 184 (601)
T KOG0590|consen 107 SLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDE-SGSALKIADFGLATAYRNKNGAERS 184 (601)
T ss_pred ccccccccC-CccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhcc-CCCcccCCCchhhccccccCCccee
Confidence 999888311 1224455566779999999999999 999999999999999998 67 999999999987655 221 2
Q ss_pred CccccC-CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC--
Q psy14556 963 AETFTG-TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-- 1039 (1181)
Q Consensus 963 ~~t~~G-T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-- 1039 (1181)
....+| ++.|+|||...+. ...+..+|+ ||.|+++..+++|..||.......-.....
T Consensus 185 ~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~------------------~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~ 245 (601)
T KOG0590|consen 185 LKDRCGSSPPYGAPEHLSGK-AYRGPSVDV------------------WSLGIVLSAMLTGELPWDFPSRKDGRYSSWKS 245 (601)
T ss_pred eecccCCCCCCCCcccccch-hhcCCCccc------------------ccccccccccccCCCCccccccccccceeecc
Confidence 233568 9999999999753 233444544 999999999999999998776544211111
Q ss_pred C----CCCCCCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1040 I----SRSVSVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1040 i----p~~l~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
. ..............++.+.+..+|..|..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s 279 (601)
T KOG0590|consen 246 NKGRFTQLPWNSISDQAHDLLHKILKENPSNRLS 279 (601)
T ss_pred cccccccCccccCChhhhhcccccccCCchhccc
Confidence 1 11112233344444666666677777764
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.6e-11 Score=149.06 Aligned_cols=194 Identities=19% Similarity=0.182 Sum_probs=119.7
Q ss_pred chhhhhcccchhhHHHHHhhhcccccccccChHHHHHHHHhhccCCCCcccccchHHHHhhhcccCceeecccCceEEEE
Q psy14556 744 TIRTQQLQFPLANLLEKLLLLIDLQDYDAMDYDAMVQLVEDLRTIPTKKKYMQTPMLRFLYLFALNRIELGKGSYGVVYA 823 (1181)
Q Consensus 744 ~irsq~~q~~l~~~~ek~~~L~Dlqe~~~md~d~~~qlle~lr~~p~~~k~~~~p~~~~~~~~~l~~~kIG~G~fG~VYk 823 (1181)
|+-+.+..+-+....+++..|.|... .++++...+.++.--. .++......|.. +.||+|++|.||+
T Consensus 71 Q~LStR~DllP~~~~~eL~~Lqd~vp--p~~~~~~~~~ie~elG---------~~~~~~F~~fd~--~PlasaSiaQVh~ 137 (537)
T PRK04750 71 QMLSTRRDLFPPDIADELALLQDRVP--PFDGALARAIIEKALG---------GPVEEWFDDFDI--KPLASASIAQVHF 137 (537)
T ss_pred HHHHcCcccCCHHHHHHHHHHHcCCC--CCCHHHHHHHHHHHhC---------CCHHHHHHhcCh--hhhcCCCccEEEE
Confidence 33334444445567778888877766 3556666665543211 123333334443 4699999999999
Q ss_pred EEEcCCCeEEEEEEecCCCCCC----------------------------------hhH------HHHHHHHHHhcC---
Q psy14556 824 ARELDRQVKLAIKEIPEKNLGD----------------------------------VQP------LHEEIKLHSQLR--- 860 (1181)
Q Consensus 824 a~d~~tg~~VAIKii~~~~~~~----------------------------------~e~------f~rEi~IL~~L~--- 860 (1181)
|+.+.+|+.||||+.++.-... .+. +.+|+..+.++.
T Consensus 138 A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f 217 (537)
T PRK04750 138 ARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMREAANASQLRRNF 217 (537)
T ss_pred EEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHHHHHHHHHHHHc
Confidence 9998889999999997552100 111 334444444442
Q ss_pred -CCCeeeEcccccc-CCcEEEEEeecCCCCcccchhcccCC---CCCChHHHHHHHHHHHhhhhhccccceecccCCCCC
Q psy14556 861 -HRNIVQYLGSVSE-EGYFKIFMEQVPGGSLSTLLRVKWGP---LKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDN 935 (1181)
Q Consensus 861 -HPNIVkl~g~~~d-~~~l~LVmEy~~gGSL~dlL~~~~~~---~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~N 935 (1181)
+.+.+.+-.++.+ ....++||||++|+.+.++-...... ..+.+..+..++.|++ ..|++|+|+||.|
T Consensus 218 ~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~GffHaDpHPGN 290 (537)
T PRK04750 218 EDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDGFFHADMHPGN 290 (537)
T ss_pred cCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCCeeeCCCChHH
Confidence 3322332222221 34567999999999998753211111 1233334444555554 5899999999999
Q ss_pred cccccCCC----eeeeecCCccccccc
Q psy14556 936 VLVNTYSG----VVKISDFGTSKRLAG 958 (1181)
Q Consensus 936 ILLd~~~g----~vKLiDFGlAk~l~~ 958 (1181)
|+++. ++ +++++|||++..+..
T Consensus 291 Ilv~~-~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 291 IFVSY-DPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred eEEec-CCCCCCeEEEEecceEEECCH
Confidence 99987 56 999999999977654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.4e-10 Score=116.95 Aligned_cols=126 Identities=17% Similarity=0.087 Sum_probs=94.9
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCe-eeEccccccCCcEEEEEeecCCCCcc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNI-VQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNI-Vkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
.|+.|.++.||++.. .+..|++|....... ....+.+|+.+++.+.+.++ .+++.... ...++||||++|.++.
T Consensus 5 ~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 5 PLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELL 79 (170)
T ss_pred ecCCcccCceEEEEE--CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccc
Confidence 588999999999986 477899999865432 12346789999999865443 34554433 2357999999998886
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccce-----ecccCCCCCcccccCCCeeeeecCCcccc
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKI-----VHRDIKGDNVLVNTYSGVVKISDFGTSKR 955 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gI-----VHrDLKP~NILLd~~~g~vKLiDFGlAk~ 955 (1181)
... . ....++.+++.+|+.||+.++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~--~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD--DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE--CCeEEEEecccccC
Confidence 531 0 012356799999999999985 9999999999998 46899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.2e-09 Score=131.83 Aligned_cols=178 Identities=23% Similarity=0.292 Sum_probs=134.6
Q ss_pred ecccCceEEE-EEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCccc
Q psy14556 813 LGKGSYGVVY-AARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLST 891 (1181)
Q Consensus 813 IG~G~fG~VY-ka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~d 891 (1181)
..-++.+ +| .|..+.++.+|.+..++.......+...+-++.|+.++||||+++++.++.++..|||+|.+ ..|..
T Consensus 20 ~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~ 96 (690)
T KOG1243|consen 20 TAFSSEA-LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLET 96 (690)
T ss_pred ccCCCcc-cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHH
Confidence 3334444 34 46677788899999997776655566888899999999999999999999999999999987 35666
Q ss_pred chhcccCCCCCChHHHHHHHHHHHhhhhhcc-ccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCc
Q psy14556 892 LLRVKWGPLKENESTMSFYTKQILEGLKYLH-GQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL 970 (1181)
Q Consensus 892 lL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLH-s~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~ 970 (1181)
+++.. ....+..-+.||+.||.||| +.+++|++|.-+.|+++. .|.+||++|..+..............--.
T Consensus 97 ~lk~l------~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~-~GeWkLggle~v~~~~~~~~~~~~~~~~~ 169 (690)
T KOG1243|consen 97 VLKEL------GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNE-SGEWKLGGLELVSKASGFNAPAKSLYLIE 169 (690)
T ss_pred HHHHh------HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcC-CCcEEEeeeEEEeccccCCcccccchhhh
Confidence 77643 25556667899999999997 678999999999999998 99999999998866544322111112233
Q ss_pred cccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhC
Q psy14556 971 QYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVL 1022 (1181)
Q Consensus 971 ~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTG 1022 (1181)
.|..|+.+.... -.+|. |-|||++++++.|
T Consensus 170 s~~~P~~~~~s~----~s~D~------------------~~Lg~li~el~ng 199 (690)
T KOG1243|consen 170 SFDDPEEIDPSE----WSIDS------------------WGLGCLIEELFNG 199 (690)
T ss_pred cccChhhcCccc----cchhh------------------hhHHHHHHHHhCc
Confidence 567777664221 23343 8899999999999
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.01 E-value=6.1e-10 Score=133.11 Aligned_cols=237 Identities=20% Similarity=0.207 Sum_probs=175.0
Q ss_pred eecc--cCceEEEEEEE--cCCCeEEEEEEecCCC--CCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEeec
Q psy14556 812 ELGK--GSYGVVYAARE--LDRQVKLAIKEIPEKN--LGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQV 884 (1181)
Q Consensus 812 kIG~--G~fG~VYka~d--~~tg~~VAIKii~~~~--~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy~ 884 (1181)
.+|. |.+|.||.+.. ..++..+|+|.-+... .....+=.+|+...+.+ .|++.++.+..+...+..++-+|++
T Consensus 121 ~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~ 200 (524)
T KOG0601|consen 121 RTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC 200 (524)
T ss_pred ccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeeccc
Confidence 5899 99999999988 8888999999843332 23333445666666666 4999999999999999999999999
Q ss_pred CCCCcccchhcccCCCCCChHHHHHHHHHHHh----hhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC
Q psy14556 885 PGGSLSTLLRVKWGPLKENESTMSFYTKQILE----GLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC 960 (1181)
Q Consensus 885 ~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~----AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~ 960 (1181)
+.+|..+.... ...++...++.++.+... ||.++|+.+++|-|+||+||++..+....+++|||+...+....
T Consensus 201 -~~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~ 277 (524)
T KOG0601|consen 201 -GESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGN 277 (524)
T ss_pred -cchhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEccCCc
Confidence 67887777643 223567788888888888 99999999999999999999998832789999999998877543
Q ss_pred CCCcc-----ccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc--
Q psy14556 961 PSAET-----FTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA-- 1033 (1181)
Q Consensus 961 ~~~~t-----~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~-- 1033 (1181)
-.... ..|...|++||...+ .++...|+ +++|.++.+..++-.++.......
T Consensus 278 ~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di--------------------~sl~ev~l~~~l~~~~~~~g~~~~W~ 336 (524)
T KOG0601|consen 278 FSSVFKVSKRPEGDCIYAAKELLNG-LATFASDI--------------------FSLGEVILEAILGSHLPSVGKNSSWS 336 (524)
T ss_pred cccceeeeecCCCCceEeChhhhcc-ccchHhhh--------------------cchhhhhHhhHhhcccccCCCCCCcc
Confidence 22221 247788999999964 33444444 999999999999876665542211
Q ss_pred ccCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1034 LVAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1034 l~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
-.....++..........+...+...+..+|-.|.....
T Consensus 337 ~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~ 375 (524)
T KOG0601|consen 337 QLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQI 375 (524)
T ss_pred ccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHH
Confidence 122222454445455566666788888888888876433
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.00 E-value=2e-09 Score=115.44 Aligned_cols=136 Identities=19% Similarity=0.150 Sum_probs=98.4
Q ss_pred eecccCceEEEEEEEcC------CCeEEEEEEecCCCC----------------------CChhHHH----HHHHHHHhc
Q psy14556 812 ELGKGSYGVVYAARELD------RQVKLAIKEIPEKNL----------------------GDVQPLH----EEIKLHSQL 859 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~------tg~~VAIKii~~~~~----------------------~~~e~f~----rEi~IL~~L 859 (1181)
.||.|--+.||.|.... .+..+|+|+++.... ...+.+. +|+..|+++
T Consensus 4 ~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl 83 (197)
T cd05146 4 CISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRM 83 (197)
T ss_pred ccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 69999999999997643 357899999854311 0012233 799999998
Q ss_pred CC--CCeeeEccccccCCcEEEEEeecCCCCccc-chhcccCCCCCChHHHHHHHHHHHhhhhhc-cccceecccCCCCC
Q psy14556 860 RH--RNIVQYLGSVSEEGYFKIFMEQVPGGSLST-LLRVKWGPLKENESTMSFYTKQILEGLKYL-HGQKIVHRDIKGDN 935 (1181)
Q Consensus 860 ~H--PNIVkl~g~~~d~~~l~LVmEy~~gGSL~d-lL~~~~~~~~l~e~~i~~Ia~QIa~AL~yL-Hs~gIVHrDLKP~N 935 (1181)
.. -++.+++++ ..-++||||+.+..+.. .++. ..+++.....+..+++.+|..| |+.|+||+||++.|
T Consensus 84 ~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 84 QKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 43 456666654 45679999996654422 2221 1234455667789999999998 89999999999999
Q ss_pred cccccCCCeeeeecCCcccccc
Q psy14556 936 VLVNTYSGVVKISDFGTSKRLA 957 (1181)
Q Consensus 936 ILLd~~~g~vKLiDFGlAk~l~ 957 (1181)
|+++. +.++|+|||.+....
T Consensus 156 IL~~~--~~v~iIDF~qav~~~ 175 (197)
T cd05146 156 MLWHD--GKVWFIDVSQSVEPT 175 (197)
T ss_pred EEEEC--CcEEEEECCCceeCC
Confidence 99964 789999999886654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF13281 DUF4071: Domain of unknown function (DUF4071) | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.1e-11 Score=140.89 Aligned_cols=72 Identities=51% Similarity=0.773 Sum_probs=69.6
Q ss_pred chhhHHHHHhhhcccCCCccccccceeeEEEEEEEeecccchhhhhhhhccccCCCcccccccCCcceEEee
Q psy14556 11 SRTLAMVLNNLIGKKGSLSSVTDYWDVATFFEISVLAEDYGKAIQAAECMFKLKPPDCLYKRDERSLFLYVH 82 (1181)
Q Consensus 11 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~va~~~~~~~~~~~~~~l~~~ 82 (1181)
-|+|+++||+++|+||+++++++|||||||||+.|+++|+.+|+++++.+++++||.|+.++-.+++.||.+
T Consensus 282 l~~i~~~l~~llg~kg~~~~~~dYWd~ATl~Ea~vL~~d~~ka~~a~e~~~~l~~~~W~l~St~~ni~Li~~ 353 (374)
T PF13281_consen 282 LRKIGVKLSSLLGRKGSLEKMQDYWDVATLLEASVLAGDYEKAIQAAEKAFKLKPPAWELESTLENIKLIRH 353 (374)
T ss_pred HHHHHHHHHHHHHhhccccccccHHHHHHHHHHHHHcCCHHHHHHHHHHHhhcCCcchhHHHHHHHHHHHHH
Confidence 489999999999999999999999999999999999999999999999999999999999999999999955
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.7e-08 Score=107.11 Aligned_cols=140 Identities=20% Similarity=0.237 Sum_probs=102.9
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCC--CCeeeEccccccC---CcEEEEEeec
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRH--RNIVQYLGSVSEE---GYFKIFMEQV 884 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~H--PNIVkl~g~~~d~---~~l~LVmEy~ 884 (1181)
+.||.|..+.||++.... ++.+++|....... .....+.+|..+++.+.+ .++.+++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 368999999999998643 57899999865432 234578999999999975 3456677766553 3678999999
Q ss_pred CCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccc-----------------------------------------
Q psy14556 885 PGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHG----------------------------------------- 923 (1181)
Q Consensus 885 ~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs----------------------------------------- 923 (1181)
+|.++.+.+.. ..+++.....++.+++++|..||+
T Consensus 83 ~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 83 DGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99988876531 134455555666677777777763
Q ss_pred ---------------cceecccCCCCCcccccC-CCeeeeecCCcccc
Q psy14556 924 ---------------QKIVHRDIKGDNVLVNTY-SGVVKISDFGTSKR 955 (1181)
Q Consensus 924 ---------------~gIVHrDLKP~NILLd~~-~g~vKLiDFGlAk~ 955 (1181)
..++|+|++|.||+++.. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 346999999999999873 35689999997753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=98.83 E-value=9.9e-09 Score=107.85 Aligned_cols=142 Identities=20% Similarity=0.194 Sum_probs=104.8
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--------ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEe
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--------DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--------~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmE 882 (1181)
..|-+|+-+.|+++.+ .|+.++||.-..+... ..++..+|+++|.++.--.|.-..=++.+...-.|+||
T Consensus 13 ~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred eeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 3688999999999987 6778788865333221 14668889999998864444333334556666779999
Q ss_pred ecCC-CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCee--eeecCCcccc
Q psy14556 883 QVPG-GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVV--KISDFGTSKR 955 (1181)
Q Consensus 883 y~~g-GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~v--KLiDFGlAk~ 955 (1181)
|++| .++.+++.........+ .....++.+|-+.+.-||..+|+|+||..+||++.+.++++ .++|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9977 48888887653333333 33367889999999999999999999999999997755544 8999999854
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=9.8e-09 Score=108.24 Aligned_cols=131 Identities=18% Similarity=0.213 Sum_probs=97.9
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCC--------hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEee
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD--------VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQ 883 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~--------~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy 883 (1181)
.+++|+-+.+|.+.+ -+.++++|.=.++.-.. .++..+|+.++.+++--.|...+=+..+.+...|+|||
T Consensus 3 ~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 3 LIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred hhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 478999999999976 34456677643332211 35577899999988644443333344466667899999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccccc
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l 956 (1181)
++|..|.+.+... ...++..+-.-+.-||..||+|+||.++||++.. +.+.++|||++..-
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~--~~i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSG--GRIYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeC--CcEEEEECCccccc
Confidence 9999999888743 1346778888888999999999999999999975 56999999998643
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=98.65 E-value=5.6e-08 Score=121.78 Aligned_cols=234 Identities=18% Similarity=0.191 Sum_probs=164.7
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCC---CCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEK---NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~---~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
-+-+|.++.++.+.-..++...++|..... ...+.+....+-.++-...||.++.....+......+++++|+.+++
T Consensus 811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~ 890 (1205)
T KOG0606|consen 811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD 890 (1205)
T ss_pred cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence 578899999999887777755555554322 22234445555555555677888877777777778999999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccccccc------C---
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG------L--- 959 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~------~--- 959 (1181)
|...++.. ...+..-....+..+..++++||...+.|+|++|.|++... ++..++.|||......- .
T Consensus 891 ~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~-~gh~~l~~~~t~~~vg~~~p~~~~sg~ 966 (1205)
T KOG0606|consen 891 LPSKLHNS---GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAY-DGHRPLTDFGTLSKVGLIPPTTDLSGP 966 (1205)
T ss_pred chhhhhcC---CCcccccccchhHHHHhhhhccccchhhcccccccchhhcc-cCCcccCccccccccccccCcCCcccc
Confidence 99998854 23445556667889999999999999999999999999987 89999999984322110 0
Q ss_pred ------------C----------CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHH
Q psy14556 960 ------------C----------PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIIS 1017 (1181)
Q Consensus 960 ------------~----------~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILy 1017 (1181)
. .......||+.|.+||...+....+..+ + |++|++++
T Consensus 967 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad--~------------------~~~g~~l~ 1026 (1205)
T KOG0606|consen 967 SSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAAD--W------------------WSSGVCLF 1026 (1205)
T ss_pred cccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcch--h------------------hhhhhhhh
Confidence 0 0011245899999999998765444333 3 88999999
Q ss_pred HHHhCCCCCCCCCcccccCCCCCCCCC-----CCCCCcchHHhhccCCCCCCCCCchh
Q psy14556 1018 QLLVLTAALKKKTSRALVAPPQISRSV-----SVPGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1018 ELLTGk~PF~~~~~~~l~~~~~ip~~l-----~~~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
|.++|.+||.......+...+. +... +.........++.+.+..+|.+|-..
T Consensus 1027 e~l~g~pp~na~tpq~~f~ni~-~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a 1083 (1205)
T KOG0606|consen 1027 EVLTGIPPFNAETPQQIFENIL-NRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGA 1083 (1205)
T ss_pred hhhcCCCCCCCcchhhhhhccc-cCCCCCCCCccccChhhhhhhhhhhccCchhccCc
Confidence 9999999999998877653222 1111 22334445556666667777776653
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.59 E-value=2.9e-07 Score=103.55 Aligned_cols=146 Identities=12% Similarity=0.008 Sum_probs=99.7
Q ss_pred ccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC-----------ChhHHHHHHHHHHhcCCCC--eeeEcccccc
Q psy14556 807 ALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG-----------DVQPLHEEIKLHSQLRHRN--IVQYLGSVSE 873 (1181)
Q Consensus 807 ~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~-----------~~e~f~rEi~IL~~L~HPN--IVkl~g~~~d 873 (1181)
....+.+-.-....|.+... .|+.|.||........ ....+.+|...+.+|..-+ ..+.++++..
T Consensus 24 ~~~~e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~ 101 (268)
T PRK15123 24 TLQGEVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGER 101 (268)
T ss_pred hcCCcEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEe
Confidence 33344455444445666654 5678999977433211 1124778999888884322 2333444432
Q ss_pred -----CCcEEEEEeecCCC-CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccccc------C
Q psy14556 874 -----EGYFKIFMEQVPGG-SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNT------Y 941 (1181)
Q Consensus 874 -----~~~l~LVmEy~~gG-SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~------~ 941 (1181)
....++|||++++. +|.+++... .....+......++.+++..+.-||+.||+|+|+++.|||++. .
T Consensus 102 ~~~~~~~~s~LVte~l~~~~sL~~~~~~~-~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 102 GSNPATRTSFIITEDLAPTISLEDYCADW-ATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred cCCCccceeEEEEeeCCCCccHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCC
Confidence 23578999999876 888887532 1223445667789999999999999999999999999999974 2
Q ss_pred CCeeeeecCCcccc
Q psy14556 942 SGVVKISDFGTSKR 955 (1181)
Q Consensus 942 ~g~vKLiDFGlAk~ 955 (1181)
+..+.|+||+.+..
T Consensus 181 ~~~~~LIDl~r~~~ 194 (268)
T PRK15123 181 DLKLSVIDLHRAQI 194 (268)
T ss_pred CceEEEEECCcccc
Confidence 46899999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.56 E-value=3.1e-07 Score=98.15 Aligned_cols=126 Identities=25% Similarity=0.234 Sum_probs=82.0
Q ss_pred EEEEEEEcCCCeEEEEEEecCCCC-------------C---------C----hhHHHHHHHHHHhcCCC--CeeeEcccc
Q psy14556 820 VVYAARELDRQVKLAIKEIPEKNL-------------G---------D----VQPLHEEIKLHSQLRHR--NIVQYLGSV 871 (1181)
Q Consensus 820 ~VYka~d~~tg~~VAIKii~~~~~-------------~---------~----~e~f~rEi~IL~~L~HP--NIVkl~g~~ 871 (1181)
.||.|.. ..+..+|+|+.+.... . . .....+|...|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888875 4567999999865311 0 0 23467899999999755 566666542
Q ss_pred ccCCcEEEEEeecC--CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhh-ccccceecccCCCCCcccccCCCeeeee
Q psy14556 872 SEEGYFKIFMEQVP--GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKY-LHGQKIVHRDIKGDNVLVNTYSGVVKIS 948 (1181)
Q Consensus 872 ~d~~~l~LVmEy~~--gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~y-LHs~gIVHrDLKP~NILLd~~~g~vKLi 948 (1181)
.-.|||||++ |..+..+.... ++......++.+++..+.. +|..||+|+||.+.||+++. +.+.|+
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~--~~~~iI 148 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDD--GKVYII 148 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEET--TCEEE-
T ss_pred ----CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeec--ceEEEE
Confidence 3469999998 55565544322 1134455677888885555 57999999999999999986 489999
Q ss_pred cCCcccccc
Q psy14556 949 DFGTSKRLA 957 (1181)
Q Consensus 949 DFGlAk~l~ 957 (1181)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=98.53 E-value=9.2e-08 Score=114.76 Aligned_cols=240 Identities=20% Similarity=0.143 Sum_probs=158.6
Q ss_pred hcccCceeecccCceEEEEEEEc-CCCeEEEEEEecCCCCCChhH--HHHHHHHHHhc-CCCCeeeEccccccCCcEEEE
Q psy14556 805 LFALNRIELGKGSYGVVYAAREL-DRQVKLAIKEIPEKNLGDVQP--LHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIF 880 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~-~tg~~VAIKii~~~~~~~~e~--f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LV 880 (1181)
+|.... +||.|.|+.|+.+... .++..|++|...+.......+ -..|+.+...+ .|.+++.++..|......|+=
T Consensus 266 df~~v~-~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip 344 (524)
T KOG0601|consen 266 DFGLVS-KISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP 344 (524)
T ss_pred CcceeE-EccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence 344333 6999999999988755 677889999886664433222 23455555555 588999988888777778899
Q ss_pred EeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC
Q psy14556 881 MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC 960 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~ 960 (1181)
.|||.++++..... -...+++...+.+..|++.++.++|++.++|+|+||+||++...++..++.|||....+.-
T Consensus 345 ~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~-- 419 (524)
T KOG0601|consen 345 LEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF-- 419 (524)
T ss_pred hhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce--
Confidence 99999998776653 2345677788889999999999999999999999999999987347889999998864321
Q ss_pred CCCccccCCcccc-CchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCC-CCCCCcccccCCC
Q psy14556 961 PSAETFTGTLQYM-APEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAA-LKKKTSRALVAPP 1038 (1181)
Q Consensus 961 ~~~~t~~GT~~Y~-APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~P-F~~~~~~~l~~~~ 1038 (1181)
........-+++ .+|.+.. .+.+.+..|+ ++||.-+.+.++|... ..+.....+. ..
T Consensus 420 -~~~~~~~~~r~~p~~~~~~e-~~~~~~~~~~------------------~sl~~~~~e~~~~~~ls~~~~~~~~i~-~~ 478 (524)
T KOG0601|consen 420 -SSGVFHHIDRLYPIAEILLE-DYPHLSKADI------------------FSLGLSVDEAITGSPLSESGVQSLTIR-SG 478 (524)
T ss_pred -ecccccccccccccchhhcc-cccccccccc------------------ccccccccccccCcccCcccccceeee-cc
Confidence 111122333444 2555532 3344445544 8999999999998743 3333322221 11
Q ss_pred CCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1039 QISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1039 ~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
..+.. +.....+..+......+++..|+..+..
T Consensus 479 ~~p~~--~~~~~~~q~~~kv~~~~~~~~~~l~~~l 511 (524)
T KOG0601|consen 479 DTPNL--PGLKLQLQVLLKVMINPDRKRRPSAVEL 511 (524)
T ss_pred cccCC--CchHHhhhhhhhhhcCCccccchhhhhh
Confidence 11111 1111334445556666777777764433
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.1e-07 Score=104.64 Aligned_cols=226 Identities=17% Similarity=0.212 Sum_probs=139.5
Q ss_pred EEEEEEEcCCCeEEEEEEec----CCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCC-----cEEEEEeecCCCCcc
Q psy14556 820 VVYAARELDRQVKLAIKEIP----EKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEG-----YFKIFMEQVPGGSLS 890 (1181)
Q Consensus 820 ~VYka~d~~tg~~VAIKii~----~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~-----~l~LVmEy~~gGSL~ 890 (1181)
.||++.+...|.+|+--.+. ++.....+....-..-+-++.|.||++++.|+.+.. ...+++|||..|+|.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 35555555555554433221 111111122333345566678999999999986643 578999999999999
Q ss_pred cchhcc-cCCCCCChHHHHHHHHHHHhhhhhcccc--ceecccCCCCCcccccCCCeeeeecCCcccccc----cCCCCC
Q psy14556 891 TLLRVK-WGPLKENESTMSFYTKQILEGLKYLHGQ--KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA----GLCPSA 963 (1181)
Q Consensus 891 dlL~~~-~~~~~l~e~~i~~Ia~QIa~AL~yLHs~--gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~----~~~~~~ 963 (1181)
.+|++. +....+......+|+.||+.||.|||+. -|+|+++..+-|++.. +|-+|+.--.-..... ......
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~-ngLIkig~~ap~s~h~s~~~~~~~Ek 239 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQH-NGLIKIGSVAPDSTHPSVNSTREAEK 239 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecC-CceEEecccCccccchhhhhhhHhhh
Confidence 999863 2445677888889999999999999987 5999999999999986 8877764221110000 000111
Q ss_pred ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCC-CCCCCcccccCCCCCCC
Q psy14556 964 ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAA-LKKKTSRALVAPPQISR 1042 (1181)
Q Consensus 964 ~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~P-F~~~~~~~l~~~~~ip~ 1042 (1181)
..-.+-++|.+||.=.. ......+|+ |++|+...+|..|..- -.+.+....... +..
T Consensus 240 ~~~~~~~g~~a~~sg~~--tn~~~a~dI------------------y~fgmcAlemailEiq~tnseS~~~~ee~--ia~ 297 (458)
T KOG1266|consen 240 SVNTSLPGFSAPESGTT--TNTTGASDI------------------YKFGMCALEMAILEIQSTNSESKVEVEEN--IAN 297 (458)
T ss_pred hccccCCccccCCcCcc--cccccchhh------------------hhhhHHHHHHHHheeccCCCcceeehhhh--hhh
Confidence 11236788999985432 223334444 9999999999998743 333333222111 111
Q ss_pred CCCCCCCcchHH-hhccCCCCCCCCCch
Q psy14556 1043 SVSVPGPGGINS-SSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1043 ~l~~~~p~~L~~-li~r~la~dPs~Rp~ 1069 (1181)
. .....+.+++ .+.+|+...|..||.
T Consensus 298 ~-i~~len~lqr~~i~kcl~~eP~~rp~ 324 (458)
T KOG1266|consen 298 V-IIGLENGLQRGSITKCLEGEPNGRPD 324 (458)
T ss_pred h-eeeccCccccCcCcccccCCCCCCcc
Confidence 1 1122233333 667788888887775
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.3e-06 Score=103.43 Aligned_cols=140 Identities=16% Similarity=0.170 Sum_probs=112.6
Q ss_pred CceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEcccccc----CCcEEEEEeecCCC-Cccc
Q psy14556 817 SYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSE----EGYFKIFMEQVPGG-SLST 891 (1181)
Q Consensus 817 ~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d----~~~l~LVmEy~~gG-SL~d 891 (1181)
.-.+.|++....+|..|++|.++............-+++++++.|+|||++.++|.. +..+++|++|+++. +|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 446889999999999999999965544444445567889999999999999998863 35689999999864 6766
Q ss_pred chhcc------------cCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccc
Q psy14556 892 LLRVK------------WGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 957 (1181)
Q Consensus 892 lL~~~------------~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~ 957 (1181)
+.-.. ..+...++..+|.++.|+..||.++|+.|+..+-|.|.+|+++. +.+++|...|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G-~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTG-KMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeC-cceEEEecccceeeec
Confidence 54211 12345678999999999999999999999999999999999987 6689998888776554
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.35 E-value=2e-05 Score=91.54 Aligned_cols=246 Identities=13% Similarity=0.066 Sum_probs=150.0
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccc------cccC-CcEEEEEeec
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGS------VSEE-GYFKIFMEQV 884 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~------~~d~-~~l~LVmEy~ 884 (1181)
.||+|+-+.+|-.-.- ...+.|++.........+...|+ .+.-.||-+-.-+.| ..+. ...-++|+.+
T Consensus 18 ~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~aqk~a~l--a~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v 92 (637)
T COG4248 18 PLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQAQKVAEL--AATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKV 92 (637)
T ss_pred cccCCccceeeecchh---hchhheeecCCCchHHHHHHHHh--ccCCCCcchhhhhcccHHHhhCCCccceeEEecccC
Confidence 5999999999965432 23467888766554433222222 122256543331221 1222 2367888888
Q ss_pred CCC-Ccccchhc---ccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC
Q psy14556 885 PGG-SLSTLLRV---KWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC 960 (1181)
Q Consensus 885 ~gG-SL~dlL~~---~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~ 960 (1181)
+|. ....+++- +..-...+|....+.++.++.+.+.||+.|.+-+|+.++|+|++. ++.+.|.|-..-... ...
T Consensus 93 ~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd-~~~V~LVdsDsfqi~-~ng 170 (637)
T COG4248 93 SGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSD-DSKVVLVDSDSFQIN-ANG 170 (637)
T ss_pred CCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeec-CceEEEEcccceeec-cCC
Confidence 665 22333321 112345678889999999999999999999999999999999987 889999886543222 222
Q ss_pred CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhC-CCCCCCCCccc------
Q psy14556 961 PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVL-TAALKKKTSRA------ 1033 (1181)
Q Consensus 961 ~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTG-k~PF~~~~~~~------ 1033 (1181)
......+|...|.+||.-.-+.. .+.+ -+...+.+-||+++++++.| ++||.+.....
T Consensus 171 ~~~~cpVg~~eftPPElQ~~~sf-~g~~--------------r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~ 235 (637)
T COG4248 171 TLHLCPVGVSEFTPPELQTLPSF-VGFE--------------RTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPL 235 (637)
T ss_pred ceEecccCccccCCHHHhccccc-cccC--------------CCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcc
Confidence 33344578999999998752211 1111 12233448899999999887 89999875421
Q ss_pred ---c------c----CCCCCCCCCCC---CCCcchHHhhccCCCCC--CCCCchhHHHHHHhccc
Q psy14556 1034 ---L------V----APPQISRSVSV---PGPGGINSSSSAPVTPT--PHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1034 ---l------~----~~~~ip~~l~~---~~p~~L~~li~r~la~d--Ps~Rp~s~~~~~~al~~ 1080 (1181)
| . .....+.+..+ .+|+.+..+..+|.+.. +.-||+ .+.++.++..
T Consensus 236 E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~-a~aW~aAl~a 299 (637)
T COG4248 236 ETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPT-AKAWVAALDA 299 (637)
T ss_pred hhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCC-HHHHHHHHHH
Confidence 1 0 01112222222 24677888888887643 445664 5555444444
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.26 E-value=6.5e-06 Score=100.17 Aligned_cols=198 Identities=18% Similarity=0.181 Sum_probs=124.9
Q ss_pred cccchhhhhcccchhhHHHHHhhhcccccccccChHHHHHHHHhhccCCCCcccccchHHHHhhhcccCceeecccCceE
Q psy14556 741 YLGTIRTQQLQFPLANLLEKLLLLIDLQDYDAMDYDAMVQLVEDLRTIPTKKKYMQTPMLRFLYLFALNRIELGKGSYGV 820 (1181)
Q Consensus 741 ~L~~irsq~~q~~l~~~~ek~~~L~Dlqe~~~md~d~~~qlle~lr~~p~~~k~~~~p~~~~~~~~~l~~~kIG~G~fG~ 820 (1181)
|+.|+-+.+...-+.+..+++..|+|.... ++++...+.++.--. .++.+...+|. .+.|+.++-|.
T Consensus 74 K~GQ~LStR~Dl~p~e~~~eL~~LQD~vpp--~~~~~~~~iie~eLG---------~~iee~F~eF~--~~PiAsASIaQ 140 (517)
T COG0661 74 KLGQILSTRPDLVPPEYAEELAKLQDRVPP--FPFEEAERIIEEELG---------RPIEELFSEFE--PEPIASASIAQ 140 (517)
T ss_pred hhhhHHhcCccccCHHHHHHHHHhhcCCCC--CCHHHHHHHHHHHhC---------CCHHHHHHHcC--CCchhhhhHhh
Confidence 344666666666677788888888877664 456666666554211 13334444443 34699999999
Q ss_pred EEEEEEcCCCeEEEEEEecCCCCCC------------------------------h----h------HHHHHHHHHHhcC
Q psy14556 821 VYAARELDRQVKLAIKEIPEKNLGD------------------------------V----Q------PLHEEIKLHSQLR 860 (1181)
Q Consensus 821 VYka~d~~tg~~VAIKii~~~~~~~------------------------------~----e------~f~rEi~IL~~L~ 860 (1181)
||+|+.. +|+.||||+.++.-... . + .+.+|+..+.++.
T Consensus 141 VH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~ 219 (517)
T COG0661 141 VHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERFR 219 (517)
T ss_pred heeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHHHH
Confidence 9999865 49999999987652110 0 0 1334555555542
Q ss_pred -----CCCeeeEccccccCCcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhh-hhhccccceecccCCCC
Q psy14556 861 -----HRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEG-LKYLHGQKIVHRDIKGD 934 (1181)
Q Consensus 861 -----HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~A-L~yLHs~gIVHrDLKP~ 934 (1181)
.|++.=.-=+++-.+.-.++|||++|-.+.+....+. ...+... ++..++.+ +..+-..|+.|.|.+|.
T Consensus 220 ~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~---ia~~~~~~f~~q~~~dgffHaDpHpG 294 (517)
T COG0661 220 ENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKE---LAELLVRAFLRQLLRDGFFHADPHPG 294 (517)
T ss_pred HHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHH---HHHHHHHHHHHHHHhcCccccCCCcc
Confidence 2332211112233455679999999999998854321 1233222 22233222 33333479999999999
Q ss_pred CcccccCCCeeeeecCCccccccc
Q psy14556 935 NVLVNTYSGVVKISDFGTSKRLAG 958 (1181)
Q Consensus 935 NILLd~~~g~vKLiDFGlAk~l~~ 958 (1181)
||+++. +|++.+.|||+...+..
T Consensus 295 Ni~v~~-~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 295 NILVRS-DGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ceEEec-CCcEEEEcCcceecCCH
Confidence 999998 89999999999877654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.21 E-value=4.8e-06 Score=92.77 Aligned_cols=133 Identities=20% Similarity=0.230 Sum_probs=98.1
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC----------------------ChhHHHHHHHHHHhcCCC--Ceee
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG----------------------DVQPLHEEIKLHSQLRHR--NIVQ 866 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~----------------------~~e~f~rEi~IL~~L~HP--NIVk 866 (1181)
.+||-|--+.||.|.+. .+.++|+|.-+..... .+...++|.++|.+|... .+.+
T Consensus 97 ~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~ 175 (304)
T COG0478 97 TKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPK 175 (304)
T ss_pred cccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCC
Confidence 47999999999999864 6789999986433110 123467899999999654 6666
Q ss_pred EccccccCCcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeee
Q psy14556 867 YLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVK 946 (1181)
Q Consensus 867 l~g~~~d~~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vK 946 (1181)
.+++ +...+|||+++|-.|...- ++......++..|+.-+..+-..||||+|+++-||++++ +|.+.
T Consensus 176 P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~-dg~~~ 242 (304)
T COG0478 176 PIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTE-DGDIV 242 (304)
T ss_pred cccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEec-CCCEE
Confidence 6664 5567999999886665432 123334445666666666666899999999999999998 89999
Q ss_pred eecCCcccccc
Q psy14556 947 ISDFGTSKRLA 957 (1181)
Q Consensus 947 LiDFGlAk~l~ 957 (1181)
++||--+....
T Consensus 243 vIDwPQ~v~~~ 253 (304)
T COG0478 243 VIDWPQAVPIS 253 (304)
T ss_pred EEeCcccccCC
Confidence 99998765443
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.21 E-value=4.3e-06 Score=90.28 Aligned_cols=106 Identities=18% Similarity=0.172 Sum_probs=80.8
Q ss_pred hhHHHHHHHHHHhcCC--CCeeeEccccccC----CcEEEEEeecCCC-CcccchhcccCCCCCChHHHHHHHHHHHhhh
Q psy14556 846 VQPLHEEIKLHSQLRH--RNIVQYLGSVSEE----GYFKIFMEQVPGG-SLSTLLRVKWGPLKENESTMSFYTKQILEGL 918 (1181)
Q Consensus 846 ~e~f~rEi~IL~~L~H--PNIVkl~g~~~d~----~~l~LVmEy~~gG-SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL 918 (1181)
..+..+|...+..|.. -.+.+.+++.... ...++|+|++++. +|.+++.... ..+......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHH
Confidence 3467888888888743 2334455544332 2468999999874 8999887531 144566777999999999
Q ss_pred hhccccceecccCCCCCcccccCCC---eeeeecCCcccc
Q psy14556 919 KYLHGQKIVHRDIKGDNVLVNTYSG---VVKISDFGTSKR 955 (1181)
Q Consensus 919 ~yLHs~gIVHrDLKP~NILLd~~~g---~vKLiDFGlAk~ 955 (1181)
.-||++||+|+|+++.|||++. ++ .+.|+||+.++.
T Consensus 132 ~~lH~~gi~H~Dl~~~NILv~~-~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAGIYHGDLNPSNILVDP-DDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCcCCCCCCCcccEEEeC-CCCceeEEEEcchhcee
Confidence 9999999999999999999987 44 799999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.8e-05 Score=86.04 Aligned_cols=139 Identities=14% Similarity=0.104 Sum_probs=99.5
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEecCCC------CCChhHHHHHHHHHHhcCC--CCeeeEccccc--c--CCcEEEE
Q psy14556 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKN------LGDVQPLHEEIKLHSQLRH--RNIVQYLGSVS--E--EGYFKIF 880 (1181)
Q Consensus 813 IG~G~fG~VYka~d~~tg~~VAIKii~~~~------~~~~e~f~rEi~IL~~L~H--PNIVkl~g~~~--d--~~~l~LV 880 (1181)
-|+||.+-|+.... .|..+-+|.-.... +.-...|.+|+..+.+|.. -.+.++..... . .-..+||
T Consensus 26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 46789999998765 33367888764221 2234679999999999853 22444442211 1 1246899
Q ss_pred EeecCC-CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCe--eeeecCCcccc
Q psy14556 881 MEQVPG-GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGV--VKISDFGTSKR 955 (1181)
Q Consensus 881 mEy~~g-GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~--vKLiDFGlAk~ 955 (1181)
+|-+.| .+|.+++... ...+.+......++.+++..+.-||+.|+.|+|+-+.||+++. ++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~-~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKT-EGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecC-CCCeeEEEEEhhccch
Confidence 998854 4888887643 2234566767789999999999999999999999999999985 445 99999987754
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.89 E-value=5e-05 Score=83.43 Aligned_cols=72 Identities=17% Similarity=0.236 Sum_probs=53.9
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCC--CeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHR--NIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HP--NIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
+.||+|..+.||+. .+..+++|..+... ....+.+|.++++.+..- .+.+.+++..+.+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 36999999999984 24467889886533 335678999999988543 34667777777777889999998863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=97.77 E-value=7.4e-06 Score=100.10 Aligned_cols=141 Identities=18% Similarity=0.215 Sum_probs=100.6
Q ss_pred HHHHhhhhhcccc-ceecccCCCCCcccccCCCeeeeecCCcccccccCCCC---------CccccCCccccCchhhccC
Q psy14556 912 KQILEGLKYLHGQ-KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS---------AETFTGTLQYMAPEVIDKG 981 (1181)
Q Consensus 912 ~QIa~AL~yLHs~-gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~---------~~t~~GT~~Y~APEvl~gg 981 (1181)
.+++.||.|+|.. ++||++|.|++|.++. ++.+||+.|+.+....+...- .........|.|||++.+.
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na-~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNA-NGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeecc-CcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 4556999999965 8999999999999998 899999999988655442110 0011245689999999764
Q ss_pred CCCCCCccccccCCCccccccccccchhHHHHHHHHHHH-hCCCCCCCCCcccccCC-----CCCCCCCCCCCCcchHHh
Q psy14556 982 QRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLL-VLTAALKKKTSRALVAP-----PQISRSVSVPGPGGINSS 1055 (1181)
Q Consensus 982 ~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELL-TGk~PF~~~~~~~l~~~-----~~ip~~l~~~~p~~L~~l 1055 (1181)
..+..+|+ +|+|+++|.+. .|+..+........... ..-....+..+|..+..+
T Consensus 185 ~~~~~sd~--------------------fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~ 244 (700)
T KOG2137|consen 185 TNTPASDV--------------------FSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRES 244 (700)
T ss_pred cccccccc--------------------eeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHH
Confidence 44333433 99999999999 56666666544332111 112223346788999999
Q ss_pred hccCCCCCCCCCchhHHHH
Q psy14556 1056 SSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1056 i~r~la~dPs~Rp~s~~~~ 1074 (1181)
+.+.+..++..|| .+++.
T Consensus 245 l~k~l~~~~~~rp-~~~~l 262 (700)
T KOG2137|consen 245 LKKLLNGDSAVRP-TLDLL 262 (700)
T ss_pred HHHHhcCCcccCc-chhhh
Confidence 9999999999999 55553
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00012 Score=77.90 Aligned_cols=140 Identities=21% Similarity=0.243 Sum_probs=81.4
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCC--CeeeEcccc---ccCCcEEEEEeecCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHR--NIVQYLGSV---SEEGYFKIFMEQVPG 886 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HP--NIVkl~g~~---~d~~~l~LVmEy~~g 886 (1181)
.|+.|..+.||++.... ..+++|..... .....+.+|..+++.+... .+.+++... ......+++|++++|
T Consensus 4 ~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 4 PLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred cCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 68999999999998754 48999997544 3346788899998888432 345566533 233457999999999
Q ss_pred CCccc----------------chh---ccc-CCCCCChHH---------HHHH------------HHHHHh-hhhhc---
Q psy14556 887 GSLST----------------LLR---VKW-GPLKENEST---------MSFY------------TKQILE-GLKYL--- 921 (1181)
Q Consensus 887 GSL~d----------------lL~---~~~-~~~~l~e~~---------i~~I------------a~QIa~-AL~yL--- 921 (1181)
..+.. .+. ... ......... .... ...+.. .+..+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 88777 111 000 000111000 0000 011111 22222
Q ss_pred ----cccceecccCCCCCcccccCCCeeeeecCCcccc
Q psy14556 922 ----HGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 955 (1181)
Q Consensus 922 ----Hs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~ 955 (1181)
....++|+|+.|.||+++..++.+-|+||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2457999999999999994367778999997743
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00018 Score=79.76 Aligned_cols=136 Identities=15% Similarity=0.111 Sum_probs=92.5
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCC-------------------h-----hHHHHHHHHHHhcC--CCCee
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD-------------------V-----QPLHEEIKLHSQLR--HRNIV 865 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~-------------------~-----e~f~rEi~IL~~L~--HPNIV 865 (1181)
.|+.|--+.||+|.. .++..+|+|++....... . ....+|...|+++. +-.+.
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 588888999999974 567899999996542211 0 11345777777763 33444
Q ss_pred eEccccccCCcEEEEEeecCCCC-cccchhcccCCCCCChHHHHHHHHHHHhhhhhccc-cceecccCCCCCcccccCCC
Q psy14556 866 QYLGSVSEEGYFKIFMEQVPGGS-LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHG-QKIVHRDIKGDNVLVNTYSG 943 (1181)
Q Consensus 866 kl~g~~~d~~~l~LVmEy~~gGS-L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs-~gIVHrDLKP~NILLd~~~g 943 (1181)
+.+.+.. -.|||||+.... -.-.|+. .++.......+..++++.+.-|-. .++||+||+.-|||+. ++
T Consensus 134 ~Pi~~~~----nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~--~~ 203 (268)
T COG1718 134 EPIAFRN----NVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH--DG 203 (268)
T ss_pred CceeecC----CeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE--CC
Confidence 4444432 459999994431 1112221 122233566678889999988887 8999999999999998 58
Q ss_pred eeeeecCCccccccc
Q psy14556 944 VVKISDFGTSKRLAG 958 (1181)
Q Consensus 944 ~vKLiDFGlAk~l~~ 958 (1181)
.+.|+|||-|.....
T Consensus 204 ~p~iID~~QaV~~~h 218 (268)
T COG1718 204 EPYIIDVSQAVTIDH 218 (268)
T ss_pred eEEEEECccccccCC
Confidence 999999998876553
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00016 Score=79.43 Aligned_cols=75 Identities=20% Similarity=0.231 Sum_probs=53.6
Q ss_pred ecccCc-eEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcC-CCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 813 LGKGSY-GVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR-HRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 813 IG~G~f-G~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~-HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
|-.|.. ..||+.... +..+.+|+..... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|.+|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 444445 789998653 3678889875443 345778999988883 344667777777667789999999998776
Q ss_pred cc
Q psy14556 891 TL 892 (1181)
Q Consensus 891 dl 892 (1181)
..
T Consensus 81 ~~ 82 (244)
T cd05150 81 AL 82 (244)
T ss_pred Hh
Confidence 44
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=97.70 E-value=4.8e-05 Score=92.25 Aligned_cols=181 Identities=23% Similarity=0.230 Sum_probs=129.0
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCC-eeeEccccccCCcEEEEEeecCCC-Ccc
Q psy14556 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRN-IVQYLGSVSEEGYFKIFMEQVPGG-SLS 890 (1181)
Q Consensus 813 IG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPN-IVkl~g~~~d~~~l~LVmEy~~gG-SL~ 890 (1181)
+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++-++.+.+.+++++++.++ +-.
T Consensus 250 fvK~altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 250 FVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 688999999998865554333 4544322 44567889999999999 777777788888999999999777 222
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCc
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL 970 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~ 970 (1181)
..... ....+.+.....+.+.-.+++++||+..-+|+| ||+..+ +..+..||+....+.... ...+..+++
T Consensus 324 ~~~~~--se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~--~~~~~~~~~v~~~L~~~~-~~~t~~~~~ 394 (829)
T KOG0576|consen 324 LEMTV--SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE--EEVKLLDFAVPPQLTRTM-KPRTAIGTP 394 (829)
T ss_pred ccCCh--hhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc--cccccccccCCcccCccc-ccccCCCCC
Confidence 22211 222344555666778889999999999888999 888865 789999999988776543 455677999
Q ss_pred cccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCC
Q psy14556 971 QYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKK 1028 (1181)
Q Consensus 971 ~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~ 1028 (1181)
.|+|||+..++......++ |++++--.++.-|-+|-..
T Consensus 395 ~~~~pev~~~~~~~~~p~~--------------------~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 395 EPLAPEVIQENTIDGCPDS--------------------GSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred CCCCchhhcccccccCCCc--------------------cCCCcchhhcCCCCCCCCC
Confidence 9999999876543333333 6766655566666655443
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00013 Score=79.88 Aligned_cols=128 Identities=20% Similarity=0.201 Sum_probs=80.0
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhH---------HHHHHHHHHhcCC---CCeeeEccc-----cccCC
Q psy14556 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQP---------LHEEIKLHSQLRH---RNIVQYLGS-----VSEEG 875 (1181)
Q Consensus 813 IG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~---------f~rEi~IL~~L~H---PNIVkl~g~-----~~d~~ 875 (1181)
+-......|.+.. -.+..+++|..........+. ..+++..+.++.. -....++.+ +.-..
T Consensus 39 ~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~ 116 (229)
T PF06176_consen 39 FKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTS 116 (229)
T ss_pred ecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeecccee
Confidence 3334444455443 366788999876554322222 2233333333322 222222222 22234
Q ss_pred cEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccc
Q psy14556 876 YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 955 (1181)
Q Consensus 876 ~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~ 955 (1181)
..+++|||++|..|.++.. +++ .+...+.+++.-||+.|+.|+|.+|.|++++. +.++++||+..+.
T Consensus 117 ~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~--~~i~iID~~~k~~ 183 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSN--NGIRIIDTQGKRM 183 (229)
T ss_pred EEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEEC--CcEEEEECccccc
Confidence 5679999999998877654 122 24456778899999999999999999999975 6699999986653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00048 Score=89.06 Aligned_cols=80 Identities=14% Similarity=0.244 Sum_probs=58.4
Q ss_pred eeecccCceEEEEEEEcCCC--eEEEEEEecCCCC-CChhHHHHHHHHHHhcC-CCCe--eeEccccccC---CcEEEEE
Q psy14556 811 IELGKGSYGVVYAARELDRQ--VKLAIKEIPEKNL-GDVQPLHEEIKLHSQLR-HRNI--VQYLGSVSEE---GYFKIFM 881 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg--~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~-HPNI--Vkl~g~~~d~---~~l~LVm 881 (1181)
.+|+.|.+..+|+......+ ..+++|+.+.... .....+.+|+.+++.+. |+++ .+++.++.+. +..|+||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 36899999999998764432 4678887654332 23456889999999995 6654 7778877664 5689999
Q ss_pred eecCCCCcc
Q psy14556 882 EQVPGGSLS 890 (1181)
Q Consensus 882 Ey~~gGSL~ 890 (1181)
||++|..+.
T Consensus 124 E~v~G~~~~ 132 (822)
T PLN02876 124 EYLEGRIFV 132 (822)
T ss_pred EecCCcccC
Confidence 999887643
|
|
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00086 Score=82.02 Aligned_cols=197 Identities=15% Similarity=0.130 Sum_probs=118.1
Q ss_pred cccchhhhhcccchhhHHHHHhhhcccccccccChHHHHHHHHhhccCCCCcccccchHHHHhhhcccCceeecccCceE
Q psy14556 741 YLGTIRTQQLQFPLANLLEKLLLLIDLQDYDAMDYDAMVQLVEDLRTIPTKKKYMQTPMLRFLYLFALNRIELGKGSYGV 820 (1181)
Q Consensus 741 ~L~~irsq~~q~~l~~~~ek~~~L~Dlqe~~~md~d~~~qlle~lr~~p~~~k~~~~p~~~~~~~~~l~~~kIG~G~fG~ 820 (1181)
|+.|..+.+.-+-|.+..+.+-.|.|....- .+++..+.++.- ...+...+..+|. .+.||.-+.|.
T Consensus 110 KlGQ~lst~~dllP~Eyv~~L~~LqD~~Pp~--~~ee~~~i~e~E---------lG~~ie~if~~f~--~~piaaASlaQ 176 (538)
T KOG1235|consen 110 KLGQHLSTRPDLLPKEYVKTLSELQDQAPPF--PWEEAFKIFEEE---------LGAPIEDIFSEFD--EEPIAAASLAQ 176 (538)
T ss_pred EechhhccccccCcHHHHHHHHHHhccCCCC--CHHHHHHHHHHH---------hCCCHHHHHHhcC--cchhhhcchhh
Confidence 4445555555566667777777776654432 233344443321 1123333444443 23699999999
Q ss_pred EEEEEEcCCCeEEEEEEecCCCCCC-------------------------------hh------HHHHHHHHHHhc----
Q psy14556 821 VYAARELDRQVKLAIKEIPEKNLGD-------------------------------VQ------PLHEEIKLHSQL---- 859 (1181)
Q Consensus 821 VYka~d~~tg~~VAIKii~~~~~~~-------------------------------~e------~f~rEi~IL~~L---- 859 (1181)
||+|+.+. |+.||||+-++.-... .+ .|.+|++...++
T Consensus 177 VhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f 255 (538)
T KOG1235|consen 177 VHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENF 255 (538)
T ss_pred eEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHH
Confidence 99998765 9999999986652110 01 134454444333
Q ss_pred CCCC------eeeEccccccCCcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhh-hhccccceecccCC
Q psy14556 860 RHRN------IVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGL-KYLHGQKIVHRDIK 932 (1181)
Q Consensus 860 ~HPN------IVkl~g~~~d~~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL-~yLHs~gIVHrDLK 932 (1181)
.|-+ |.+++-.+. ..-.|+||||+|..+.++-.-.. ..++...+.. .+.++. .-+=..|++|+|=+
T Consensus 256 ~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~i~~---~l~~~~~~qIf~~GffHaDPH 328 (538)
T KOG1235|consen 256 KDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDK--RGISPHDILN---KLVEAYLEQIFKTGFFHADPH 328 (538)
T ss_pred HhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHH--cCCCHHHHHH---HHHHHHHHHHHhcCCccCCCC
Confidence 3444 444444333 34689999999998887754321 2333443333 333332 12224589999999
Q ss_pred CCCccccc---CCCeeeeecCCccccccc
Q psy14556 933 GDNVLVNT---YSGVVKISDFGTSKRLAG 958 (1181)
Q Consensus 933 P~NILLd~---~~g~vKLiDFGlAk~l~~ 958 (1181)
|.||++.. .++.+.+-|||+...+..
T Consensus 329 PGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 329 PGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CCcEEEecCCCCCccEEEEcccccccccH
Confidence 99999983 356999999999877654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0013 Score=72.21 Aligned_cols=74 Identities=9% Similarity=0.131 Sum_probs=47.5
Q ss_pred eecccCce-EEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCC---CeeeEccccccC---CcEEEEEeec
Q psy14556 812 ELGKGSYG-VVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHR---NIVQYLGSVSEE---GYFKIFMEQV 884 (1181)
Q Consensus 812 kIG~G~fG-~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HP---NIVkl~g~~~d~---~~l~LVmEy~ 884 (1181)
.|+.|+.. .||+.. ..+++|..+.. .....+.+|..++..+... .+.++++..... +..+++|+++
T Consensus 4 ~~~~gG~~n~vy~~~-----~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 4 PVDSGGTDNATFRLG-----DDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eccCCCcccceEEcC-----CceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 47777776 588752 25677875442 2345788999999887532 344455444332 2458999999
Q ss_pred CCCCcccc
Q psy14556 885 PGGSLSTL 892 (1181)
Q Consensus 885 ~gGSL~dl 892 (1181)
+|.++.+.
T Consensus 77 ~G~~l~~~ 84 (235)
T cd05155 77 EGETATAA 84 (235)
T ss_pred cCCCCCcc
Confidence 99887543
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0021 Score=69.63 Aligned_cols=131 Identities=20% Similarity=0.262 Sum_probs=92.4
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCC----------------CCChhHHHHHHHHHHhcC------CCCeeeEc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKN----------------LGDVQPLHEEIKLHSQLR------HRNIVQYL 868 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~----------------~~~~e~f~rEi~IL~~L~------HPNIVkl~ 868 (1181)
..||+|+.-.||.-- ......||+..... .....+..+|+.....+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 369999999999632 33456889987665 122456777877777666 78999999
Q ss_pred cccccCCcEEEEEeecCC------CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCC
Q psy14556 869 GSVSEEGYFKIFMEQVPG------GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYS 942 (1181)
Q Consensus 869 g~~~d~~~l~LVmEy~~g------GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~ 942 (1181)
|+.+++...-+|+|.+.+ .+|.+++... .+++ . +...+-+-..||-+.+|+.+||+|.||++...+
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG----GLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRD 155 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC----CccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecC
Confidence 999999888999998632 3667777533 2333 2 333444555678889999999999999996532
Q ss_pred --C-eeeeec-CCc
Q psy14556 943 --G-VVKISD-FGT 952 (1181)
Q Consensus 943 --g-~vKLiD-FGl 952 (1181)
. .+.|+| ||.
T Consensus 156 ~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 156 SGEFRLVLIDGLGE 169 (199)
T ss_pred CCceEEEEEeCCCC
Confidence 2 577777 343
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0014 Score=69.64 Aligned_cols=127 Identities=23% Similarity=0.201 Sum_probs=89.8
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCee-eEccccccCCcEEEEEeecCCCCcc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIV-QYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIV-kl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
.||+|.+|.||++.+ .+..+|+|+-..++ .+..+..|+++|..++..++. +++.+..+ ++.|||+.|..|.
T Consensus 29 ~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L~ 100 (201)
T COG2112 29 ELAKGTTSVVYLGEW--RGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPLG 100 (201)
T ss_pred hhhcccccEEEEeec--cCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcchh
Confidence 599999999999998 55689999875443 356799999999999876654 35554333 3569999988887
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCC-CCCcccccCCCeeeeecCCcccccc
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIK-GDNVLVNTYSGVVKISDFGTSKRLA 957 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLK-P~NILLd~~~g~vKLiDFGlAk~l~ 957 (1181)
++.... +..+ +..+++.---|-..||-|+.|. |..+++.+ ++.+.|+||..|+...
T Consensus 101 ~~~~~~------~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~-~~~~~iIDFd~At~k~ 157 (201)
T COG2112 101 KLEIGG------DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVN-DRDVYIIDFDSATFKK 157 (201)
T ss_pred hhhhcc------cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEec-CCcEEEEEccchhhcc
Confidence 765421 1222 3355555555667799999986 44444444 4699999999987443
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0048 Score=67.14 Aligned_cols=74 Identities=14% Similarity=0.210 Sum_probs=48.3
Q ss_pred eecccCceEEEEEEEcC-CCeEEEEEEecCCCCCChhHHHHHHHHHHhcCC-CCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 812 ELGKGSYGVVYAARELD-RQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRH-RNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~-tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~H-PNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
.|..|-...+|++.... .+..|++|+....... .-...+|+.+++.+.. .-..++++.+.. .++|||++|.++
T Consensus 5 ~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~G~~l 79 (235)
T cd05157 5 RFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIPGRTL 79 (235)
T ss_pred EcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeCCCcC
Confidence 57778888999987543 3568889987544222 2234578888888843 333445444331 379999998776
Q ss_pred c
Q psy14556 890 S 890 (1181)
Q Consensus 890 ~ 890 (1181)
.
T Consensus 80 ~ 80 (235)
T cd05157 80 E 80 (235)
T ss_pred C
Confidence 4
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0037 Score=69.41 Aligned_cols=135 Identities=12% Similarity=0.103 Sum_probs=76.8
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCe-eeEccccccCCcEEEEEeecCCCCccc
Q psy14556 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNI-VQYLGSVSEEGYFKIFMEQVPGGSLST 891 (1181)
Q Consensus 813 IG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNI-Vkl~g~~~d~~~l~LVmEy~~gGSL~d 891 (1181)
+..|-...+|+.. .++..+++|..........-...+|..+++.+....+ .+++.... -++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 5567788999886 3566888998654432221235789999988853322 33343322 368999999877653
Q ss_pred c-------h----------hccc-CCCCCCh-HHHHHHHHH------------HHhhhhhcc-----ccceecccCCCCC
Q psy14556 892 L-------L----------RVKW-GPLKENE-STMSFYTKQ------------ILEGLKYLH-----GQKIVHRDIKGDN 935 (1181)
Q Consensus 892 l-------L----------~~~~-~~~~l~e-~~i~~Ia~Q------------Ia~AL~yLH-----s~gIVHrDLKP~N 935 (1181)
. + +... ...+.+. ..+..+..+ +...+.... ...++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 2 1 1000 0111111 111111111 111111110 1258999999999
Q ss_pred cccccCCCeeeeecCCcccc
Q psy14556 936 VLVNTYSGVVKISDFGTSKR 955 (1181)
Q Consensus 936 ILLd~~~g~vKLiDFGlAk~ 955 (1181)
|+++. ++ +.|+||+.+..
T Consensus 158 il~~~-~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTP-QG-LKLIDWEYASD 175 (256)
T ss_pred EEEeC-CC-CEEEeccccCc
Confidence 99987 44 88999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0049 Score=69.60 Aligned_cols=137 Identities=14% Similarity=0.123 Sum_probs=80.9
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCC--CeeeEcccc------ccCCcEEEEEee
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHR--NIVQYLGSV------SEEGYFKIFMEQ 883 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HP--NIVkl~g~~------~d~~~l~LVmEy 883 (1181)
.|..|....+|+... .+..+++|+... ...+.+..|+.++..+.+. .+.+++... ...+..++|+++
T Consensus 21 ~i~~G~~n~~y~v~~--~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 21 GISAGIENTNYFVTT--DSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred cccCccccceEEEEe--CCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 477787789998864 334788998764 2345677888888887432 244544421 234567899999
Q ss_pred cCCCCcccc----h----------hcccCCCC--------CChHHH----------HHHHHHHHhhhhhccc-------c
Q psy14556 884 VPGGSLSTL----L----------RVKWGPLK--------ENESTM----------SFYTKQILEGLKYLHG-------Q 924 (1181)
Q Consensus 884 ~~gGSL~dl----L----------~~~~~~~~--------l~e~~i----------~~Ia~QIa~AL~yLHs-------~ 924 (1181)
++|..+... . +....... ..+... ......+..++.++.+ .
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 998876431 0 00000000 000000 0001112223333332 4
Q ss_pred ceecccCCCCCcccccCCCeeeeecCCccc
Q psy14556 925 KIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954 (1181)
Q Consensus 925 gIVHrDLKP~NILLd~~~g~vKLiDFGlAk 954 (1181)
+++|+|+.|.||+++. ++.+.|+||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~-~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDG-DELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeC-CceEEEeehhhhc
Confidence 7999999999999987 5667899999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1181 | ||||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-78 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-78 | ||
| 3r49_A | 166 | Human Cyclophilin D Complexed With Quinolin-8-Amine | 2e-65 | ||
| 2z6w_A | 165 | Crystal Structure Of Human Cyclophilin D In Complex | 2e-65 | ||
| 3qyu_A | 164 | Crystal Structure Of Human Cyclophilin D At 1.54 A | 3e-65 | ||
| 2bit_X | 165 | Crystal Structure Of Human Cyclophilin D At 1.7 A R | 3e-65 | ||
| 2alf_A | 164 | Crystal Structure Of Human Cypa Mutant K131a Length | 3e-62 | ||
| 1m9e_A | 164 | X-Ray Crystal Structure Of Cyclophilin AHIV-1 Ca N- | 4e-62 | ||
| 1bck_A | 165 | Human Cyclophilin A Complexed With 2-Thr Cyclospori | 4e-62 | ||
| 2rma_A | 165 | Crystal Structures Of Cyclophilin A Complexed With | 4e-62 | ||
| 3rdd_A | 184 | Human Cyclophilin A Complexed With An Inhibitor Len | 4e-62 | ||
| 2xgy_B | 173 | Complex Of Rabbit Endogenous Lentivirus (Relik)caps | 4e-62 | ||
| 5cyh_A | 164 | Cyclophilin A Complexed With Dipeptide Gly-Pro Leng | 4e-62 | ||
| 3k0o_A | 165 | Room Temperature Structure Of Cypa Mutant Ser99thr | 8e-62 | ||
| 2x25_B | 169 | Free Acetyl-Cypa Orthorhombic Form Length = 169 | 1e-61 | ||
| 2x83_B | 163 | Evolutionary Basis Of Hiv Restriction By The Antire | 1e-61 | ||
| 2x2a_A | 165 | Free Acetyl-Cypa Trigonal Form Length = 165 | 1e-61 | ||
| 2x2c_K | 165 | Acetyl-Cypa:cyclosporine Complex Length = 165 | 1e-61 | ||
| 3k0r_A | 165 | Cryogenic Structure Of Cypa Mutant Arg55lys Length | 1e-61 | ||
| 2wlw_A | 165 | Structure Of The N-Terminal Capsid Domain Of Hiv-2 | 1e-61 | ||
| 3uch_A | 174 | Crystal Structure Of A Hypotherical Peptidyl-Prolyl | 5e-61 | ||
| 4dgd_A | 165 | Trimcyp Cyclophilin Domain From Macaca Mulatta: H70 | 2e-60 | ||
| 2r99_A | 173 | Crystal Structure Of Cyclophilin Abh-Like Domain Of | 7e-60 | ||
| 1zmf_A | 165 | C Domain Of Human Cyclophilin-33(Hcyp33) Length = 1 | 8e-60 | ||
| 1aws_A | 164 | Secypa Complexed With Hagpia (Pseudo-Symmetric Mono | 1e-59 | ||
| 1dyw_A | 173 | Biochemical And Structural Characterization Of A Di | 4e-57 | ||
| 2ck1_A | 172 | The Structure Of Oxidised Cyclophilin A From S. Man | 4e-57 | ||
| 3pmp_A | 164 | Crystal Structure Of Cyclophilin A From Moniliophth | 4e-57 | ||
| 3o7t_A | 164 | Crystal Structure Of Cyclophilin A From Moniliophth | 4e-57 | ||
| 2cfe_A | 162 | The 1.5 A Crystal Structure Of The Malassezia Sympo | 1e-56 | ||
| 1ist_A | 162 | Crystal Structure Of Yeast Cyclophilin A, Cpr1 Leng | 6e-56 | ||
| 2hqj_A | 183 | Cyclophilin From Leishmania Major Length = 183 | 2e-53 | ||
| 4i9y_A | 167 | Structure Of The C-terminal Domain Of Nup358 Length | 4e-53 | ||
| 1cyn_A | 178 | Cyclophilin B Complexed With [d-(Cholinylester)ser8 | 1e-49 | ||
| 3ich_A | 188 | Crystal Structure Of Cyclophilin B At 1.2 A Resolut | 1e-49 | ||
| 3k2c_A | 193 | Crystal Structure Of Peptidyl-Prolyl Cis-Trans Isom | 1e-49 | ||
| 4frv_A | 185 | Crystal Structure Of Mutated Cyclophilin B That Cau | 1e-49 | ||
| 4fru_A | 185 | Crystal Structure Of Horse Wild-Type Cyclophilin B | 1e-49 | ||
| 2plu_A | 186 | Crystal Structure Of Cryptosporidium Parvum Cycloph | 2e-47 | ||
| 1qng_A | 170 | Plasmodium Falciparum Cyclophilin Complexed With Cy | 4e-47 | ||
| 1xo7_A | 166 | Crystal Structure Of Cyclophilin From Trypanosoma C | 1e-46 | ||
| 1qnh_A | 170 | Plasmodium Falciparum Cyclophilin (Double Mutant) C | 2e-46 | ||
| 1ihg_A | 370 | Bovine Cyclophilin 40, Monoclinic Form Length = 370 | 9e-46 | ||
| 2c3b_A | 172 | The Crystal Structure Of Aspergillus Fumigatus Cycl | 9e-45 | ||
| 2haq_A | 172 | Crystal Structure Of Cyclophilin A From Leishmania | 1e-44 | ||
| 1h0p_A | 182 | Cyclophilin_5 From C. Elegans Length = 182 | 5e-44 | ||
| 3bt8_A | 172 | Crystal Structure Of Mutant Cyclophilin (R147a) Fro | 7e-44 | ||
| 2rmc_A | 182 | Crystal Structure Of Murine Cyclophilin C Complexed | 1e-43 | ||
| 2esl_A | 190 | Human Cyclophilin C In Complex With Cyclosporin A L | 1e-42 | ||
| 1qoi_A | 177 | U4U6 SNRNP-Specific Cyclophilin Snucyp-20 Length = | 5e-40 | ||
| 1z81_A | 229 | Crystal Structure Of Cyclophilin From Plasmodium Yo | 1e-37 | ||
| 1c5f_A | 177 | Crystal Structure Of The Cyclophilin-Like Domain Fr | 5e-37 | ||
| 2gw2_A | 198 | Crystal Structure Of The Peptidyl-Prolyl Isomerase | 4e-36 | ||
| 2wfi_A | 179 | Atomic Resolution Crystal Structure Of The Ppiase D | 7e-36 | ||
| 2wfj_A | 179 | Atomic Resolution Crystal Structure Of The Ppiase D | 7e-36 | ||
| 2he9_A | 192 | Structure Of The Peptidylprolyl Isomerase Domain Of | 2e-35 | ||
| 2a2n_A | 176 | Crystal Structure Of The Peptidylprolyl Isomerase D | 2e-29 | ||
| 2b71_A | 196 | Plasmodium Yoelii Cyclophilin-Like Protein Length = | 5e-28 | ||
| 2k7n_A | 203 | Solution Structure Of The Ppil1 Bound To A Fragment | 1e-27 | ||
| 2x7k_A | 166 | The Crystal Structure Of Ppil1 In Complex With Cycl | 1e-27 | ||
| 1xwn_A | 174 | Solution Structure Of Cyclophilin Like 1(Ppil1) And | 1e-26 | ||
| 2fu0_A | 160 | Plasmodium Falciparum Cyclophilin Pfe0505w Putative | 2e-26 | ||
| 2oju_A | 167 | X-Ray Structure Of Complex Of Human Cyclophilin J W | 2e-24 | ||
| 1xyh_A | 161 | Crystal Structure Of Recombinant Human Cyclophilin | 9e-24 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-21 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-21 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-21 | ||
| 1zkc_A | 197 | Crystal Structure Of The Cyclophiln_ring Domain Of | 1e-20 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-20 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-20 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-20 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-20 | ||
| 2poe_A | 185 | Crystal Structure Of Cryptosporidium Parvum Cycloph | 1e-19 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-19 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-19 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-18 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-18 | ||
| 2hq6_A | 185 | Structure Of The Cyclophilin_cecyp16-like Domain Of | 6e-18 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-17 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-17 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-17 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-17 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-17 | ||
| 3bo7_A | 201 | Crystal Structure Of Toxoplasma Gondii Peptidyl-Pro | 1e-17 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-17 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-17 | ||
| 1w74_A | 191 | X-Ray Structure Of Peptidyl-Prolyl Cis-Trans Isomer | 3e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-17 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-16 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-16 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-16 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-16 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-16 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-16 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-15 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-15 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-15 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-15 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-15 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-15 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-15 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-15 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-15 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-15 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-15 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-15 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-14 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-14 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-14 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-14 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-14 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-14 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-14 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-13 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-13 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-13 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-13 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-13 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-13 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-13 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-13 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-13 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-13 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-13 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-13 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-13 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-13 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-13 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-13 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-13 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-13 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-13 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-13 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 9e-13 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 9e-13 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-12 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-12 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-12 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-12 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-12 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-12 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-12 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-12 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-12 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-12 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-12 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-12 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-12 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-11 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-11 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-11 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-11 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-11 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-11 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-11 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 8e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-11 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-10 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-10 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-10 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-10 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-10 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-10 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-10 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-10 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-10 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-10 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-10 | ||
| 3t1u_A | 163 | Crystal Structure Of The Complex Of Cyclophilin-a E | 2e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-10 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-10 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-10 | ||
| 2nul_A | 164 | Peptidylprolyl Isomerase From E. Coli Length = 164 | 8e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-09 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-09 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-09 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-09 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-09 | ||
| 1clh_A | 166 | Three-Dimensional Solution Structure Of Escherichia | 5e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-09 | ||
| 1lop_A | 164 | Cyclophilin A Complexed With Succinyl-Ala-Pro-Ala-P | 5e-09 | ||
| 1j2a_A | 166 | Structure Of E. Coli Cyclophilin B K163t Mutant Len | 5e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-09 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-09 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 9e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-07 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-07 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-07 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-07 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-07 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-07 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-07 | ||
| 3s6m_A | 167 | The Structure Of A Peptidyl-Prolyl Cis-Trans Isomer | 2e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-07 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-07 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-07 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-07 | ||
| 3bkp_A | 232 | Crystal Structure Of The Toxoplasma Gondii Cyclophi | 7e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-06 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-06 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-06 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-06 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-06 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-06 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-06 |
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3R49|A Chain A, Human Cyclophilin D Complexed With Quinolin-8-Amine Length = 166 | Back alignment and structure |
|
| >pdb|2Z6W|A Chain A, Crystal Structure Of Human Cyclophilin D In Complex With Cyclosporin A Length = 165 | Back alignment and structure |
|
| >pdb|3QYU|A Chain A, Crystal Structure Of Human Cyclophilin D At 1.54 A Resolution At Room Temperature Length = 164 | Back alignment and structure |
|
| >pdb|2BIT|X Chain X, Crystal Structure Of Human Cyclophilin D At 1.7 A Resolution Length = 165 | Back alignment and structure |
|
| >pdb|2ALF|A Chain A, Crystal Structure Of Human Cypa Mutant K131a Length = 164 | Back alignment and structure |
|
| >pdb|1M9E|A Chain A, X-Ray Crystal Structure Of Cyclophilin AHIV-1 Ca N- Terminal Domain (1-146) M-Type H87a Complex. Length = 164 | Back alignment and structure |
|
| >pdb|1BCK|A Chain A, Human Cyclophilin A Complexed With 2-Thr Cyclosporin Length = 165 | Back alignment and structure |
|
| >pdb|2RMA|A Chain A, Crystal Structures Of Cyclophilin A Complexed With Cyclosporin A And N-Methyl-4-[(E)-2-Butenyl]-4,4-Dimethylthreonine Cyclosporin A Length = 165 | Back alignment and structure |
|
| >pdb|3RDD|A Chain A, Human Cyclophilin A Complexed With An Inhibitor Length = 184 | Back alignment and structure |
|
| >pdb|2XGY|B Chain B, Complex Of Rabbit Endogenous Lentivirus (Relik)capsid With Cyclophilin A Length = 173 | Back alignment and structure |
|
| >pdb|5CYH|A Chain A, Cyclophilin A Complexed With Dipeptide Gly-Pro Length = 164 | Back alignment and structure |
|
| >pdb|3K0O|A Chain A, Room Temperature Structure Of Cypa Mutant Ser99thr Length = 165 | Back alignment and structure |
|
| >pdb|2X25|B Chain B, Free Acetyl-Cypa Orthorhombic Form Length = 169 | Back alignment and structure |
|
| >pdb|2X83|B Chain B, Evolutionary Basis Of Hiv Restriction By The Antiretroviral Trimcyp Length = 163 | Back alignment and structure |
|
| >pdb|2X2A|A Chain A, Free Acetyl-Cypa Trigonal Form Length = 165 | Back alignment and structure |
|
| >pdb|2X2C|K Chain K, Acetyl-Cypa:cyclosporine Complex Length = 165 | Back alignment and structure |
|
| >pdb|3K0R|A Chain A, Cryogenic Structure Of Cypa Mutant Arg55lys Length = 165 | Back alignment and structure |
|
| >pdb|2WLW|A Chain A, Structure Of The N-Terminal Capsid Domain Of Hiv-2 Length = 165 | Back alignment and structure |
|
| >pdb|3UCH|A Chain A, Crystal Structure Of A Hypotherical Peptidyl-Prolyl Cis-Trans Isomerase E (Ppie) From Homo Sapiens At 2.50 A Resolution Length = 174 | Back alignment and structure |
|
| >pdb|4DGD|A Chain A, Trimcyp Cyclophilin Domain From Macaca Mulatta: H70c Mutant Length = 165 | Back alignment and structure |
|
| >pdb|2R99|A Chain A, Crystal Structure Of Cyclophilin Abh-Like Domain Of Human Peptidylprolyl Isomerase E Isoform 1 Length = 173 | Back alignment and structure |
|
| >pdb|1ZMF|A Chain A, C Domain Of Human Cyclophilin-33(Hcyp33) Length = 165 | Back alignment and structure |
|
| >pdb|1AWS|A Chain A, Secypa Complexed With Hagpia (Pseudo-Symmetric Monomer) Length = 164 | Back alignment and structure |
|
| >pdb|1DYW|A Chain A, Biochemical And Structural Characterization Of A Divergent Loop Cyclophilin From Caenorhabditis Elegans Length = 173 | Back alignment and structure |
|
| >pdb|2CK1|A Chain A, The Structure Of Oxidised Cyclophilin A From S. Mansoni Length = 172 | Back alignment and structure |
|
| >pdb|3PMP|A Chain A, Crystal Structure Of Cyclophilin A From Moniliophthora Perniciosa In Complex With Cyclosporin A Length = 164 | Back alignment and structure |
|
| >pdb|3O7T|A Chain A, Crystal Structure Of Cyclophilin A From Moniliophthora Perniciosa Length = 164 | Back alignment and structure |
|
| >pdb|2CFE|A Chain A, The 1.5 A Crystal Structure Of The Malassezia Sympodialis Mala S 6 Allergen, A Member Of The Cyclophilin Pan- Allergen Family Length = 162 | Back alignment and structure |
|
| >pdb|1IST|A Chain A, Crystal Structure Of Yeast Cyclophilin A, Cpr1 Length = 162 | Back alignment and structure |
|
| >pdb|2HQJ|A Chain A, Cyclophilin From Leishmania Major Length = 183 | Back alignment and structure |
|
| >pdb|4I9Y|A Chain A, Structure Of The C-terminal Domain Of Nup358 Length = 167 | Back alignment and structure |
|
| >pdb|1CYN|A Chain A, Cyclophilin B Complexed With [d-(Cholinylester)ser8]-Cyclosporin Length = 178 | Back alignment and structure |
|
| >pdb|3ICH|A Chain A, Crystal Structure Of Cyclophilin B At 1.2 A Resolution Length = 188 | Back alignment and structure |
|
| >pdb|3K2C|A Chain A, Crystal Structure Of Peptidyl-Prolyl Cis-Trans Isomerase From Encephalitozoon Cuniculi At 1.9 A Resolution Length = 193 | Back alignment and structure |
|
| >pdb|4FRV|A Chain A, Crystal Structure Of Mutated Cyclophilin B That Causes Hyperelastosis Cutis In The American Quarter Horse Length = 185 | Back alignment and structure |
|
| >pdb|4FRU|A Chain A, Crystal Structure Of Horse Wild-Type Cyclophilin B Length = 185 | Back alignment and structure |
|
| >pdb|2PLU|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cyclophilin Type Peptidyl-Prolyl Cis-Trans Isomerase Cgd2_4120 Length = 186 | Back alignment and structure |
|
| >pdb|1QNG|A Chain A, Plasmodium Falciparum Cyclophilin Complexed With Cyclosporin A Length = 170 | Back alignment and structure |
|
| >pdb|1XO7|A Chain A, Crystal Structure Of Cyclophilin From Trypanosoma Cruzi Length = 166 | Back alignment and structure |
|
| >pdb|1QNH|A Chain A, Plasmodium Falciparum Cyclophilin (Double Mutant) Complexed With Cyclosporin A Length = 170 | Back alignment and structure |
|
| >pdb|1IHG|A Chain A, Bovine Cyclophilin 40, Monoclinic Form Length = 370 | Back alignment and structure |
|
| >pdb|2C3B|A Chain A, The Crystal Structure Of Aspergillus Fumigatus Cyclophilin Reveals 3d Domain Swapping Of A Central Element Length = 172 | Back alignment and structure |
|
| >pdb|2HAQ|A Chain A, Crystal Structure Of Cyclophilin A From Leishmania Donovani Length = 172 | Back alignment and structure |
|
| >pdb|1H0P|A Chain A, Cyclophilin_5 From C. Elegans Length = 182 | Back alignment and structure |
|
| >pdb|3BT8|A Chain A, Crystal Structure Of Mutant Cyclophilin (R147a) From Leishmania Donovani Length = 172 | Back alignment and structure |
|
| >pdb|2RMC|A Chain A, Crystal Structure Of Murine Cyclophilin C Complexed With Immunosuppressive Drug Cyclosporin A Length = 182 | Back alignment and structure |
|
| >pdb|2ESL|A Chain A, Human Cyclophilin C In Complex With Cyclosporin A Length = 190 | Back alignment and structure |
|
| >pdb|1QOI|A Chain A, U4U6 SNRNP-Specific Cyclophilin Snucyp-20 Length = 177 | Back alignment and structure |
|
| >pdb|1Z81|A Chain A, Crystal Structure Of Cyclophilin From Plasmodium Yoelii Length = 229 | Back alignment and structure |
|
| >pdb|1C5F|A Chain A, Crystal Structure Of The Cyclophilin-Like Domain From Brugia Malayi Complexed With Cyclosporin A Length = 177 | Back alignment and structure |
|
| >pdb|2GW2|A Chain A, Crystal Structure Of The Peptidyl-Prolyl Isomerase Domain Of Human Cyclophilin G Length = 198 | Back alignment and structure |
|
| >pdb|2WFI|A Chain A, Atomic Resolution Crystal Structure Of The Ppiase Domain Of Human Cyclophilin G Length = 179 | Back alignment and structure |
|
| >pdb|2WFJ|A Chain A, Atomic Resolution Crystal Structure Of The Ppiase Domain Of Human Cyclophilin G In Complex With Cyclosporin A Length = 179 | Back alignment and structure |
|
| >pdb|2HE9|A Chain A, Structure Of The Peptidylprolyl Isomerase Domain Of The Human Nk-Tumour Recognition Protein Length = 192 | Back alignment and structure |
|
| >pdb|2A2N|A Chain A, Crystal Structure Of The Peptidylprolyl Isomerase Domain Of Human Ppwd1 Length = 176 | Back alignment and structure |
|
| >pdb|2B71|A Chain A, Plasmodium Yoelii Cyclophilin-Like Protein Length = 196 | Back alignment and structure |
|
| >pdb|2K7N|A Chain A, Solution Structure Of The Ppil1 Bound To A Fragment Of Skip Length = 203 | Back alignment and structure |
|
| >pdb|2X7K|A Chain A, The Crystal Structure Of Ppil1 In Complex With Cyclosporine A Suggests A Binding Mode For Skip Length = 166 | Back alignment and structure |
|
| >pdb|1XWN|A Chain A, Solution Structure Of Cyclophilin Like 1(Ppil1) And Insights Into Its Interaction With Skip Length = 174 | Back alignment and structure |
|
| >pdb|2FU0|A Chain A, Plasmodium Falciparum Cyclophilin Pfe0505w Putative Cyclosporin- Binding Domain Length = 160 | Back alignment and structure |
|
| >pdb|2OJU|A Chain A, X-Ray Structure Of Complex Of Human Cyclophilin J With Cyclosporin A Length = 167 | Back alignment and structure |
|
| >pdb|1XYH|A Chain A, Crystal Structure Of Recombinant Human Cyclophilin J Length = 161 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1ZKC|A Chain A, Crystal Structure Of The Cyclophiln_ring Domain Of Human Peptidylprolyl Isomerase (Cyclophilin)-Like 2 Isoform B Length = 197 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2POE|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cyclophilin Type Peptidyl-Prolyl Cis-Trans Isomerase Cgd2_1660 Length = 185 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2HQ6|A Chain A, Structure Of The Cyclophilin_cecyp16-like Domain Of The Serologically Defined Colon Cancer Antigen 10 From Homo Sapiens Length = 185 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3BO7|A Chain A, Crystal Structure Of Toxoplasma Gondii Peptidyl-Prolyl Cis-Trans Isomerase, 541.M00136 Length = 201 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1W74|A Chain A, X-Ray Structure Of Peptidyl-Prolyl Cis-Trans Isomerase A, Ppia, Rv0009, From Mycobacterium Tuberculosis. Length = 191 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3T1U|A Chain A, Crystal Structure Of The Complex Of Cyclophilin-a Enzyme From Azotobacter Vinelandii With Sucafpfpna Peptide Length = 163 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2NUL|A Chain A, Peptidylprolyl Isomerase From E. Coli Length = 164 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1CLH|A Chain A, Three-Dimensional Solution Structure Of Escherichia Coli Periplasmic Cyclophilin Length = 166 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1LOP|A Chain A, Cyclophilin A Complexed With Succinyl-Ala-Pro-Ala-P-Nitroanilide Length = 164 | Back alignment and structure |
|
| >pdb|1J2A|A Chain A, Structure Of E. Coli Cyclophilin B K163t Mutant Length = 166 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3S6M|A Chain A, The Structure Of A Peptidyl-Prolyl Cis-Trans Isomerase From Burkholderia Pseudomallei Length = 167 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3BKP|A Chain A, Crystal Structure Of The Toxoplasma Gondii Cyclophilin, 49.m03261 Length = 232 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2r99_A Peptidyl-prolyl CIS-trans isomerase E; CIS-trans isomerization, structural genomics consortium, SGC, alternative splicing, mRNA processing; 1.61A {Homo sapiens} SCOP: b.62.1.1 PDB: 3uch_A 1zmf_A Length = 173 | Back alignment and structure |
|---|
Score = 339 bits (873), Expect = e-110
Identities = 102/140 (72%), Positives = 121/140 (86%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGN 187
+ LRSDVVP TAENFR LCT EKGFGFK S+FHR+IP FMCQGGDFTNHNGTGGKSIYG
Sbjct: 30 MLLRSDVVPMTAENFRCLCTHEKGFGFKGSSFHRIIPQFMCQGGDFTNHNGTGGKSIYGK 89
Query: 188 KFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKK 247
KF+DENF LKHTGPG+LSMAN+GPNTNGSQFF+T KT WLD +HVVFG V EGLDV+++
Sbjct: 90 KFDDENFILKHTGPGLLSMANSGPNTNGSQFFLTCDKTDWLDGKHVVFGEVTEGLDVLRQ 149
Query: 248 LESMGSQSGKTSKKIVVANS 267
+E+ GS+ GK +K+++A+
Sbjct: 150 IEAQGSKDGKPKQKVIIADC 169
|
| >2cmt_A Peptidyl-prolyl CIS-trans isomerase E; rotamase activity, rotamase, RNA-binding, cyclosporin, cyclophilin, beta-barrel; 1.50A {Schistosoma mansoni} PDB: 2ck1_A Length = 172 | Back alignment and structure |
|---|
Score = 339 bits (873), Expect = e-110
Identities = 94/140 (67%), Positives = 117/140 (83%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGN 187
++LRSD+VP+TAENFRALCTGE+GFG+ + FHRVIP FMCQGGDF +GTGGKSIYG
Sbjct: 29 MELRSDIVPRTAENFRALCTGERGFGYHNCCFHRVIPQFMCQGGDFVKGDGTGGKSIYGR 88
Query: 188 KFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKK 247
KF+DENF L+H G G+LSMAN+GPNTNGSQFFI T K WLD +HVVFG VV+G +VVKK
Sbjct: 89 KFDDENFQLRHEGFGVLSMANSGPNTNGSQFFICTTKCDWLDGKHVVFGRVVDGQNVVKK 148
Query: 248 LESMGSQSGKTSKKIVVANS 267
+ES+GS+SGK + ++++
Sbjct: 149 MESVGSKSGKVKEPVIISRC 168
|
| >2z6w_A Peptidyl-prolyl CIS-trans isomerase; isomerase-immunosuppressant complex, immunosuppressant, cyclophilin D; HET: BMT MLE CIT; 0.96A {Homo sapiens} SCOP: b.62.1.1 PDB: 3rcg_A* 3r49_A* 3r54_A 3r56_A* 3r57_A* 3r59_A* 3rcf_A* 3r4g_A* 3rci_X* 3rck_X* 3rcl_A* 3rd9_X* 3rda_X* 3rdb_A* 3rdc_A* 2bit_X 2biu_X 3qyu_A 3k0m_A 1ak4_A* ... Length = 165 | Back alignment and structure |
|---|
Score = 339 bits (871), Expect = e-109
Identities = 111/140 (79%), Positives = 129/140 (92%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGN 187
++L++DVVPKTAENFRALCTGEKGFG+K STFHRVIP+FMCQ GDFTNHNGTGGKSIYG+
Sbjct: 22 LELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGS 81
Query: 188 KFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKK 247
+F DENFTLKH GPG+LSMANAGPNTNGSQFFI T+KT WLD +HVVFG V+EG+DVVKK
Sbjct: 82 RFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKK 141
Query: 248 LESMGSQSGKTSKKIVVANS 267
+ES GS+SG+TSKKIV+ +
Sbjct: 142 IESFGSKSGRTSKKIVITDC 161
|
| >3pmp_A Cyclophilin A; peptidyl prolyl isomerase, isomerase-immunosuppressant compl; HET: BMT; 1.47A {Moniliophthora perniciosa} PDB: 3o7t_A Length = 164 | Back alignment and structure |
|---|
Score = 338 bits (869), Expect = e-109
Identities = 98/140 (70%), Positives = 113/140 (80%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGN 187
KL + VPKTA+NFR L TG+ GFG+KDS FHRVIP FM QGGDFT HNGTGGKSIYG
Sbjct: 21 FKLYDEAVPKTAKNFRELATGQHGFGYKDSIFHRVIPQFMLQGGDFTRHNGTGGKSIYGE 80
Query: 188 KFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKK 247
KF DENF +KHT PG+LSMANAG NTNGSQFFITTV T+WLD +HVVFG V+EGLD+V+K
Sbjct: 81 KFADENFQVKHTKPGLLSMANAGANTNGSQFFITTVPTSWLDGKHVVFGEVIEGLDIVRK 140
Query: 248 LESMGSQSGKTSKKIVVANS 267
+E GS SGKT+ I + +
Sbjct: 141 VEGKGSASGKTNATIKITDC 160
|
| >3rdd_A Peptidyl-prolyl CIS-trans isomerase A; beta barrel, cytosolic, inhibito isomerase-isomerase inhibitor complex; HET: EA4; 2.14A {Homo sapiens} Length = 184 | Back alignment and structure |
|---|
Score = 338 bits (869), Expect = e-109
Identities = 105/140 (75%), Positives = 119/140 (85%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGN 187
+L +D VPKTAENFRAL TGEKGFG+K S FHR+IP FMCQGGDFT HNGTGGKSIYG
Sbjct: 41 FELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGE 100
Query: 188 KFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKK 247
KFEDENF LKHTGPGILSMANAGPNTNGSQFFI T KT WLD +HVVFG V EG+++V+
Sbjct: 101 KFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEA 160
Query: 248 LESMGSQSGKTSKKIVVANS 267
+E GS++GKTSKKI +A+
Sbjct: 161 MERFGSRNGKTSKKITIADC 180
|
| >1qng_A Peptidyl-prolyl CIS-trans isomerase; isomerase-immunosuppressant complex, cyclophilin-cyclosporin complex, immunosuppressant, cyclophilin; HET: BMT; 2.1A {Plasmodium falciparum} SCOP: b.62.1.1 PDB: 1qnh_A* Length = 170 | Back alignment and structure |
|---|
Score = 334 bits (860), Expect = e-108
Identities = 85/146 (58%), Positives = 108/146 (73%), Gaps = 6/146 (4%)
Query: 128 IKLRSDVVPKTAENFRALCTGEK------GFGFKDSTFHRVIPNFMCQGGDFTNHNGTGG 181
+L SD+ P+T ENFRALCTGEK +K+S FHR+IP FMCQGGD TN NG+GG
Sbjct: 22 FELFSDITPRTCENFRALCTGEKIGSRGKNLHYKNSIFHRIIPQFMCQGGDITNGNGSGG 81
Query: 182 KSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEG 241
+SIYG F DENF +KH PG+LSMANAGPNTN SQFFIT V WLD +HVVFG V+EG
Sbjct: 82 ESIYGRSFTDENFNMKHDQPGLLSMANAGPNTNSSQFFITLVPCPWLDGKHVVFGKVIEG 141
Query: 242 LDVVKKLESMGSQSGKTSKKIVVANS 267
++VV+++E G++SG + +V+ +
Sbjct: 142 MNVVREMEKEGAKSGYVKRSVVITDC 167
|
| >2poy_A Peptidyl-prolyl CIS-trans isomerase; isomerase-immunosuppressant complex, immunosuppressant, cyclophilin, isomerase, S genomics, structural genomics consortium; HET: BMT; 1.80A {Cryptosporidium parvum iowa II} PDB: 2plu_A* Length = 186 | Back alignment and structure |
|---|
Score = 335 bits (861), Expect = e-108
Identities = 91/147 (61%), Positives = 109/147 (74%), Gaps = 7/147 (4%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFG-------FKDSTFHRVIPNFMCQGGDFTNHNGTG 180
++L +D VP TAENFRALCTGEKG G + S FHR+IP FM QGGDFT +GTG
Sbjct: 38 MELFADKVPITAENFRALCTGEKGMGQSGKPLCYTGSFFHRIIPQFMIQGGDFTRGDGTG 97
Query: 181 GKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVE 240
G+SIYG+KF DENF H P +LSMANAGPNTNGSQFFITTV WLD +HVVFG V+E
Sbjct: 98 GESIYGSKFRDENFVYTHDAPFLLSMANAGPNTNGSQFFITTVPCPWLDGKHVVFGKVLE 157
Query: 241 GLDVVKKLESMGSQSGKTSKKIVVANS 267
G++VVK +E GSQ+GK +K + + S
Sbjct: 158 GMEVVKSIEKCGSQNGKPTKSVCITAS 184
|
| >2igv_A Peptidyl-prolyl CIS-trans isomerase 3; rotamase; 1.67A {Caenorhabditis elegans} SCOP: b.62.1.1 PDB: 1e3b_A 1e8k_A 1dyw_A 2igw_A 2hqj_A Length = 173 | Back alignment and structure |
|---|
Score = 334 bits (858), Expect = e-108
Identities = 104/147 (70%), Positives = 115/147 (78%), Gaps = 7/147 (4%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFG-------FKDSTFHRVIPNFMCQGGDFTNHNGTG 180
++L DVVPKTA NFRALCTGE G G FK S FHR+IPNFM QGGDFT NGTG
Sbjct: 22 MELYDDVVPKTAGNFRALCTGENGIGKSGKPLHFKGSKFHRIIPNFMIQGGDFTRGNGTG 81
Query: 181 GKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVE 240
G+SIYG KF DENF KHTGPG+LSMANAGPNTNGSQFF+ TVKT WLD +HVVFG VVE
Sbjct: 82 GESIYGEKFPDENFKEKHTGPGVLSMANAGPNTNGSQFFLCTVKTEWLDGKHVVFGRVVE 141
Query: 241 GLDVVKKLESMGSQSGKTSKKIVVANS 267
GLDVVK +ES GSQSGK K ++A+
Sbjct: 142 GLDVVKAVESNGSQSGKPVKDCMIADC 168
|
| >3ich_A Peptidyl-prolyl CIS-trans isomerase B; beta sandwich, cyclosporin, endoplasmic reticulum, glycoprot isomerase, rotamase; 1.20A {Homo sapiens} PDB: 3ici_A* 1cyn_A* 2esl_A* 2rmc_A* 1h0p_A 1xo7_A 1xq7_A* Length = 188 | Back alignment and structure |
|---|
Score = 334 bits (859), Expect = e-108
Identities = 91/141 (64%), Positives = 110/141 (78%), Gaps = 1/141 (0%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGN 187
L VPKT +NF AL TGEKGFG+K+S FHRVI +FM QGGDFT +GTGGKSIYG
Sbjct: 34 FGLFGKTVPKTVDNFVALATGEKGFGYKNSKFHRVIKDFMIQGGDFTRGDGTGGKSIYGE 93
Query: 188 KFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKK 247
+F DENF LKH GPG +SMANAG +TNGSQFFITTVKTAWLD +HVVFG V+EG++VV+K
Sbjct: 94 RFPDENFKLKHYGPGWVSMANAGKDTNGSQFFITTVKTAWLDGKHVVFGKVLEGMEVVRK 153
Query: 248 LESMGSQS-GKTSKKIVVANS 267
+ES + S K K +++A+
Sbjct: 154 VESTKTDSRDKPLKDVIIADC 174
|
| >3k2c_A Peptidyl-prolyl CIS-trans isomerase; ssgcid, NIH, niaid, SBRI, UW, decode, cytoplasm, rotamase, structural genomics; HET: PG5; 1.95A {Encephalitozoon cuniculi} Length = 193 | Back alignment and structure |
|---|
Score = 333 bits (855), Expect = e-107
Identities = 92/142 (64%), Positives = 108/142 (76%), Gaps = 2/142 (1%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGN 187
+KL D+VPKTA+NFR LC KG G+K STFHR+IP FM QGGD+T HNGTGG+SIYG
Sbjct: 46 MKLEDDIVPKTAKNFRTLCERPKGEGYKGSTFHRIIPGFMVQGGDYTAHNGTGGRSIYGE 105
Query: 188 KFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKK 247
KF DENF LKHT GILSMAN G +TNGSQFFIT KT WLD +HVVFG VVEG+DVV K
Sbjct: 106 KFPDENFELKHTKEGILSMANCGAHTNGSQFFITLGKTQWLDEKHVVFGEVVEGMDVVHK 165
Query: 248 LESMGSQSGKTSK--KIVVANS 267
+ GS+SG+ K +I + +
Sbjct: 166 IAKYGSESGQVKKGYRIEIRDC 187
|
| >2c3b_A Ppiase, cyclophilin; isomerase, 3D domain swapping, misfolding, Asp F 11, allergen, rotamase; 1.85A {Aspergillus fumigatus} SCOP: b.62.1.1 Length = 172 | Back alignment and structure |
|---|
Score = 328 bits (843), Expect = e-105
Identities = 86/144 (59%), Positives = 106/144 (73%), Gaps = 4/144 (2%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGN 187
L VPKTA+NFR LC G G+++STFHR+IPNFM QGGDFT NGTGG+SIYG+
Sbjct: 26 FNLFDKDVPKTAKNFRELCKRPAGEGYRESTFHRIIPNFMIQGGDFTRGNGTGGRSIYGD 85
Query: 188 KFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVE--GLDVV 245
KF DENF+ KH GILSMANAGPNTNGSQFFITT T+WLD +HVVFG V + VV
Sbjct: 86 KFADENFSRKHDKKGILSMANAGPNTNGSQFFITTAVTSWLDGKHVVFGEVADEKSYSVV 145
Query: 246 KKLESMGSQSG--KTSKKIVVANS 267
K++E++GS SG +++ + + N
Sbjct: 146 KEIEALGSSSGSVRSNTRPKIVNC 169
|
| >2haq_A Cyclophilin; rotamase, proline, isomerase, CIS-trans, protozoa, KAla-AZAR.; 1.97A {Leishmania donovani} PDB: 3eov_A* 3bt8_A Length = 172 | Back alignment and structure |
|---|
Score = 326 bits (838), Expect = e-105
Identities = 89/141 (63%), Positives = 101/141 (71%), Gaps = 2/141 (1%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGN 187
I L P T ENFR LCTGE GFG+KDS FHRVI NFM QGGDFTN +GTGGKSIYG
Sbjct: 30 IGLFGKDAPLTTENFRQLCTGEHGFGYKDSIFHRVIQNFMIQGGDFTNFDGTGGKSIYGE 89
Query: 188 KFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKK 247
KF DEN +KH G LSMANAGPNTNGSQFFITT T WLD RHVVFG V++G+DVV +
Sbjct: 90 KFADENLNVKHF-VGALSMANAGPNTNGSQFFITTAPTPWLDGRHVVFGKVLDGMDVVLR 148
Query: 248 LESMGSQS-GKTSKKIVVANS 267
+E + S + K + + S
Sbjct: 149 IEKTKTNSHDRPVKPVKIVAS 169
|
| >1mzw_A Cyclophilin H, U-snRNP-ASSOCIATED cyclophilin; cyclophilin, peptidyl-prolyl-CIS/trans isomerase, spliceosome, U4/U6-60K protein, WD protein; 2.00A {Homo sapiens} SCOP: b.62.1.1 PDB: 1qoi_A Length = 177 | Back alignment and structure |
|---|
Score = 325 bits (835), Expect = e-104
Identities = 80/146 (54%), Positives = 104/146 (71%), Gaps = 6/146 (4%)
Query: 128 IKLRSDVVPKTAENFRALCTGE-----KGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGK 182
I+L +DVVPKTAENFR CTGE G+K STFHRVI +FM QGGDF N +GTG
Sbjct: 29 IELFADVVPKTAENFRQFCTGEFRKDGVPIGYKGSTFHRVIKDFMIQGGDFVNGDGTGVA 88
Query: 183 SIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGL 242
SIY F DENF L+H+ PG+LSMAN+GP+TNG QFFIT K WLD +HVVFG +++GL
Sbjct: 89 SIYRGPFADENFKLRHSAPGLLSMANSGPSTNGCQFFITCSKCDWLDGKHVVFGKIIDGL 148
Query: 243 DVVKKLESMGS-QSGKTSKKIVVANS 267
V++K+E++ + + K +V++
Sbjct: 149 LVMRKIENVPTGPNNKPKLPVVISQC 174
|
| >2wfi_A Peptidyl-prolyl CIS-trans isomerase G; phosphoprotein, PRE-mRNA splicing, alternative splicing, nucleus, rotamase, cyclosporin; HET: OCS; 0.75A {Homo sapiens} PDB: 2wfj_A* 2gw2_A Length = 179 | Back alignment and structure |
|---|
Score = 320 bits (823), Expect = e-102
Identities = 76/149 (51%), Positives = 98/149 (65%), Gaps = 9/149 (6%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFG--------FKDSTFHRVIPNFMCQGGDFTNHNGT 179
+L SDV PKT ENFR LCTGEKG G +K FHRV+ +FM QGGDF+ NG
Sbjct: 28 FELFSDVCPKTCENFRCLCTGEKGTGKSTQKPLHYKSCLFHRVVKDFMVQGGDFSEGNGR 87
Query: 180 GGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVV 239
GG+SIYG FEDE+F +KH +LSMAN G +TNGSQFFITT T LD HVVFG V+
Sbjct: 88 GGESIYGGFFEDESFAVKHNKEFLLSMANRGKDTNGSQFFITTKPTPHLDGHHVVFGQVI 147
Query: 240 EGLDVVKKLESMGSQSG-KTSKKIVVANS 267
G +VV+++E+ + + K ++ + +
Sbjct: 148 SGQEVVREIENQKTDAASKPFAEVRILSC 176
|
| >1a58_A Cyclophilin; isomerase, ppiase; 1.95A {Brugia malayi} SCOP: b.62.1.1 PDB: 1a33_A 1c5f_A* Length = 177 | Back alignment and structure |
|---|
Score = 319 bits (821), Expect = e-102
Identities = 78/149 (52%), Positives = 98/149 (65%), Gaps = 9/149 (6%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFG--------FKDSTFHRVIPNFMCQGGDFTNHNGT 179
++L +D+ P+T NF LCTG G G +K STFHRVI NFM QGGDFT +GT
Sbjct: 25 MELYNDIAPRTCNNFLMLCTGMAGTGKISGKPLHYKGSTFHRVIKNFMIQGGDFTKGDGT 84
Query: 180 GGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVV 239
GG+SIYG F+DE F +KH P ++SMAN GPNTNGSQFFITT L+N HVVFG VV
Sbjct: 85 GGESIYGGMFDDEEFVMKHDEPFVVSMANKGPNTNGSQFFITTTPAPHLNNIHVVFGKVV 144
Query: 240 EGLDVVKKLESMGSQS-GKTSKKIVVANS 267
G +VV K+E + + S + +V+ N
Sbjct: 145 SGQEVVTKIEYLKTNSKNRPLADVVILNC 173
|
| >2he9_A NK-tumor recognition protein; cyclosporin, isomerase, membrane, repeat, rotamase, peptidylprolyl isomerase, structural genomics; 2.00A {Homo sapiens} Length = 192 | Back alignment and structure |
|---|
Score = 320 bits (822), Expect = e-102
Identities = 74/149 (49%), Positives = 98/149 (65%), Gaps = 9/149 (6%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFG--------FKDSTFHRVIPNFMCQGGDFTNHNGT 179
+L SD+ PKT +NF LC+GEKG G +K STFHRV+ NFM QGGDF+ NG
Sbjct: 38 FQLFSDICPKTCKNFLCLCSGEKGLGKTTGKKLCYKGSTFHRVVKNFMIQGGDFSEGNGK 97
Query: 180 GGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVV 239
GG+SIYG F+DENF LKH +LSMAN G +TNGSQFFITT LD HVVFG V+
Sbjct: 98 GGESIYGGYFKDENFILKHDRAFLLSMANRGKHTNGSQFFITTKPAPHLDGVHVVFGLVI 157
Query: 240 EGLDVVKKLESMGSQSG-KTSKKIVVANS 267
G +V++++E++ + + + + V +
Sbjct: 158 SGFEVIEQIENLKTDAASRPYADVRVIDC 186
|
| >1z81_A Cyclophilin; structural genomics, structural genomics consortium, SGC, isomerase; 2.80A {Plasmodium yoelii yoelii} SCOP: b.62.1.1 Length = 229 | Back alignment and structure |
|---|
Score = 318 bits (818), Expect = e-101
Identities = 77/149 (51%), Positives = 99/149 (66%), Gaps = 9/149 (6%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGF-----GFKDSTFHRVIPNFMCQGGDFTNHNGTGGK 182
+L ++VPKT+ENFR CTGE G+K++ FHRVI FM QGGDF NHNG+G
Sbjct: 78 FELFQNIVPKTSENFRQFCTGEYKVNNLPVGYKNTIFHRVIKEFMIQGGDFINHNGSGSL 137
Query: 183 SIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVV--E 240
SIYG KF+DENF +KH G+LSMAN+GPNTNG QFFITT K WLD ++VVFG ++ +
Sbjct: 138 SIYGEKFDDENFDIKHDKEGLLSMANSGPNTNGCQFFITTKKCEWLDGKNVVFGRIIDND 197
Query: 241 GLDVVKKLESMGSQS--GKTSKKIVVANS 267
L ++KK+E++ K I V
Sbjct: 198 SLLLLKKIENVSVTPYIYKPKIPINVVEC 226
|
| >1ihg_A Cyclophilin 40; ppiase immunophilin tetratricopeptide, isomerase; 1.80A {Bos taurus} SCOP: a.118.8.1 b.62.1.1 PDB: 1iip_A Length = 370 | Back alignment and structure |
|---|
Score = 307 bits (788), Expect = 6e-95
Identities = 90/148 (60%), Positives = 107/148 (72%), Gaps = 8/148 (5%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFG--------FKDSTFHRVIPNFMCQGGDFTNHNGT 179
++L +D+VPKTAENFRALCTGEKG G FK FHR+I FM QGGDF+N NGT
Sbjct: 34 LELFADIVPKTAENFRALCTGEKGIGPTTGKPLHFKGCPFHRIIKKFMIQGGDFSNQNGT 93
Query: 180 GGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVV 239
GG+SIYG KFEDENF KH G+LSMANAG NTNGSQFFITTV T LD +HVVFG V+
Sbjct: 94 GGESIYGEKFEDENFHYKHDKEGLLSMANAGSNTNGSQFFITTVPTPHLDGKHVVFGQVI 153
Query: 240 EGLDVVKKLESMGSQSGKTSKKIVVANS 267
+G+ V K LE++ + K +K V+A
Sbjct: 154 KGMGVAKILENVEVKGEKPAKLCVIAEC 181
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 296 bits (760), Expect = 5e-92
Identities = 134/177 (75%), Positives = 151/177 (85%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVS 872
LGKG+YG+VYA R+L QV++AIKEIPE++ QPLHEEI LH L+H+NIVQYLGS S
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 873 EEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIK 932
E G+ KIFMEQVPGGSLS LLR KWGPLK+NE T+ FYTKQILEGLKYLH +IVHRDIK
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149
Query: 933 GDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPV 989
GDNVL+NTYSGV+KISDFGTSKRLAG+ P ETFTGTLQYMAPE+IDKG RGYG
Sbjct: 150 GDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAA 206
|
| >2ose_A Probable peptidyl-prolyl CIS-trans isomerase; cyclophilin; 2.04A {Mimivirus} Length = 234 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 2e-90
Identities = 43/171 (25%), Positives = 63/171 (36%), Gaps = 31/171 (18%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKG-----------------FGFKDSTFHRVIPNFMCQG 170
IKL D P ENF L G+ ++ FH V+ N
Sbjct: 33 IKLFRDAFPAGVENFVQLTNGKTYRVNSNGTGKYKYNRHINRTYEGCKFHNVLHNNYIVS 92
Query: 171 GDFTNHNGTGGKSIYGNKFED---ENFTLKHTGPGILSMA----NAGPNTNGSQFFIT-- 221
GD N NG+ ++Y ++ ++ H G+LS+ +G S F IT
Sbjct: 93 GDIYNSNGSSAGTVYCDEPIPPVFGDYFYPHESKGLLSLVPYTDESGNRYYDSTFMITLD 152
Query: 222 ----TVKTAWLDNRHVVFGSVVEGLDVVKKLESM-GSQSGKTSKKIVVANS 267
+ LD VV G V GLDV+ K+ SM +G+ +
Sbjct: 153 DIRPSNVLDELDRDQVVIGQVYGGLDVLDKINSMIKPYAGRKYPTFSIGKC 203
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 3e-68
Identities = 57/183 (31%), Positives = 91/183 (49%), Gaps = 15/183 (8%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
+G+GS+G V+ ++ + A+K++ + EE+ + L IV G+V
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAV 119
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
E + IFME + GGSL L++ + G L E +Y Q LEGL+YLH ++I+H D+
Sbjct: 120 REGPWVNIFMELLEGGSLGQLIK-QMGCLPE--DRALYYLGQALEGLEYLHTRRILHGDV 176
Query: 932 KGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA-----ETFTGTLQYMAPEVIDKGQRGYG 986
K DNVL+++ + DFG + L + GT +MAPEV+ +
Sbjct: 177 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM--GKPCD 234
Query: 987 APV 989
A V
Sbjct: 235 AKV 237
|
| >2fu0_A Cyclophilin, putative; PFE0505W, cyclosporin-binding domain, structura genomics, structural genomics consortium, SGC, unknown FUNC; 1.80A {Plasmodium falciparum} SCOP: b.62.1.1 Length = 160 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 4e-68
Identities = 63/125 (50%), Positives = 80/125 (64%), Gaps = 5/125 (4%)
Query: 127 HIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYG 186
HI L KT +NF G+ + + FHRVI +FM Q GD + +GTGG+SI+G
Sbjct: 18 HISLFYKECKKTVQNFSVHSI--NGY-YNNCIFHRVIKHFMVQTGDPSG-DGTGGESIWG 73
Query: 187 NKFEDENF-TLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVV 245
N+FEDE F L H+ P ++SMAN GPNTNGSQFFITTV WLD +H VFG V +G +V
Sbjct: 74 NEFEDEFFDHLNHSKPFMVSMANCGPNTNGSQFFITTVPCPWLDFKHTVFGKVTQGSKIV 133
Query: 246 KKLES 250
+E
Sbjct: 134 LDIEK 138
|
| >2a2n_A Peptidylprolyl isomerase domain and WD repeat CON; CIS-trans isomerization, protein-folding, peptidylprolyl ISO structural genomics; 1.65A {Homo sapiens} SCOP: b.62.1.1 Length = 176 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 2e-67
Identities = 74/185 (40%), Positives = 104/185 (56%), Gaps = 19/185 (10%)
Query: 85 SDDFQMFFPSSQMRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRA 144
S + M ++ +R D + + T++ D H KL PKT ENF
Sbjct: 4 SKEEVMAATQAEGPKRVSDSAI--------IHTSMGD----IHTKLFPVECPKTVENFCV 51
Query: 145 LCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFEDE-NFTLKHTGPGI 203
G+ + TFHR+I FM Q GD T G GG+SI+G +FEDE + TL+H P
Sbjct: 52 HS--RNGY-YNGHTFHRIIKGFMIQTGDPTG-TGMGGESIWGGEFEDEFHSTLRHDRPYT 107
Query: 204 LSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESM--GSQSGKTSKK 261
LSMANAG NTNGSQFFIT V T WLDN+H VFG V +G++VV+++ ++ ++ K +
Sbjct: 108 LSMANAGSNTNGSQFFITVVPTPWLDNKHTVFGRVTKGMEVVQRISNVKVNPKTDKPYED 167
Query: 262 IVVAN 266
+ + N
Sbjct: 168 VSIIN 172
|
| >2k7n_A Peptidyl-prolyl CIS-trans isomerase-like 1; beta barrel, disorder-order transition, HOOK-like, mRNA processing, mRNA splicing, rotamase; NMR {Homo sapiens} Length = 203 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 4e-67
Identities = 61/126 (48%), Positives = 83/126 (65%), Gaps = 5/126 (3%)
Query: 127 HIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYG 186
++L PKT +NF L +G+ + + FHR+I +FM QGGD T G GG SIYG
Sbjct: 24 VLELYWKHAPKTCKNFAELA--RRGY-YNGTKFHRIIKDFMIQGGDPTG-TGRGGASIYG 79
Query: 187 NKFEDE-NFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVV 245
+FEDE + LK TG GIL+MANAGP+TNGSQFF+T T WLD +H +FG V +G+ +V
Sbjct: 80 KQFEDELHPDLKFTGAGILAMANAGPDTNGSQFFVTLAPTQWLDGKHTIFGRVCQGIGMV 139
Query: 246 KKLESM 251
++ +
Sbjct: 140 NRVGMV 145
|
| >2x7k_A Peptidyl-prolyl CIS-trans isomerase-like 1; isomerase-immunosuppressant complex, immunosuppressant; HET: MLE MVA BMT ABA SAR; 1.15A {Homo sapiens} PDB: 1xwn_A Length = 166 | Back alignment and structure |
|---|
Score = 220 bits (564), Expect = 1e-66
Identities = 61/126 (48%), Positives = 83/126 (65%), Gaps = 5/126 (3%)
Query: 127 HIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYG 186
++L PKT +NF L +G+ + + FHR+I +FM QGGD T G GG SIYG
Sbjct: 24 VLELYWKHAPKTCKNFAELA--RRGY-YNGTKFHRIIKDFMIQGGDPTG-TGRGGASIYG 79
Query: 187 NKFEDE-NFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVV 245
+FEDE + LK TG GIL+MANAGP+TNGSQFF+T T WLD +H +FG V +G+ +V
Sbjct: 80 KQFEDELHPDLKFTGAGILAMANAGPDTNGSQFFVTLAPTQWLDGKHTIFGRVCQGIGMV 139
Query: 246 KKLESM 251
++ +
Sbjct: 140 NRVGMV 145
|
| >2b71_A Cyclophilin-like protein; structural genomics, structural genomics consortium, SGC, isomerase; 2.50A {Plasmodium yoelii} SCOP: b.62.1.1 Length = 196 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 2e-64
Identities = 65/126 (51%), Positives = 80/126 (63%), Gaps = 5/126 (3%)
Query: 127 HIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYG 186
++L PKT NF LC E GF + ++ FHRVIPNF+ QGGD T G GGKSIYG
Sbjct: 51 EVELYWYHSPKTCLNFYTLC--EMGF-YDNTIFHRVIPNFVIQGGDPTG-TGKGGKSIYG 106
Query: 187 NKFEDE-NFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVV 245
FEDE N LKHTG GILSM+N GPNTN SQFFIT LD +H +F V + + +
Sbjct: 107 EYFEDEINKELKHTGAGILSMSNNGPNTNSSQFFITLAPLPHLDGKHTIFARVSKNMTCI 166
Query: 246 KKLESM 251
+ + S+
Sbjct: 167 ENIASV 172
|
| >2ok3_A Peptidyl-prolyl CIS-trans isomerase-like 3; beta-barrel, helix, disulfide bridge; 2.00A {Homo sapiens} SCOP: b.62.1.1 PDB: 1xyh_A 2oju_A* Length = 161 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 5e-60
Identities = 62/126 (49%), Positives = 79/126 (62%), Gaps = 5/126 (3%)
Query: 127 HIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYG 186
I++ + PKT ENF ALC + + FHR I FM Q GD T G GG SI+G
Sbjct: 13 KIEVFCERTPKTCENFLALC--ASNY-YNGCIFHRNIKGFMVQTGDPTG-TGRGGNSIWG 68
Query: 187 NKFEDE-NFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVV 245
KFEDE + LKH G++SMAN GPNTNGSQFFIT K LD ++ VFG V++GL+ +
Sbjct: 69 KKFEDEYSEYLKHNVRGVVSMANNGPNTNGSQFFITYGKQPHLDMKYTVFGKVIDGLETL 128
Query: 246 KKLESM 251
+LE +
Sbjct: 129 DELEKL 134
|
| >2poe_A Cyclophilin-like protein, putative; cryptosporidium parvum cyclophilin isomerase, structural genomics; 2.01A {Cryptosporidium parvum iowa II} PDB: 2qer_A Length = 185 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 2e-59
Identities = 55/130 (42%), Positives = 77/130 (59%), Gaps = 9/130 (6%)
Query: 127 HIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYG 186
+L PK +NF AL G+ +K++ FH+ I F+ QGGD T G GG+SIYG
Sbjct: 29 KFELFCSQCPKACKNFLALS--ASGY-YKNTIFHKNIKGFIIQGGDPTG-TGKGGESIYG 84
Query: 187 NKFEDENF-TLKHTGPGILSMANAG----PNTNGSQFFITTVKTAWLDNRHVVFGSVVEG 241
F+DE + LK+ GILSMA+ G PNTNGSQFFIT L+ +V+FG +++G
Sbjct: 85 RYFDDEIYPELKYDRRGILSMASKGASKKPNTNGSQFFITYSSLPQLNGEYVIFGKLIDG 144
Query: 242 LDVVKKLESM 251
+ + LE+
Sbjct: 145 FETLNTLENC 154
|
| >3bo7_A Peptidyl-prolyl CIS-trans isomerase cyclophilin-T; isomerase-immunosuppressant complex, immunosuppressant, cyclophilin, structural G structural genomics consortium, SGC; HET: BMT; 2.35A {Toxoplasma gondii} Length = 201 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 2e-59
Identities = 53/137 (38%), Positives = 75/137 (54%), Gaps = 15/137 (10%)
Query: 127 HIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNH----NGTGGK 182
+I+L +D+ P+ ++F LC + F D+ FHR I NFM QGG +
Sbjct: 19 NIELHADMAPRACDSFLRLC--AVKY-FDDTIFHRCIRNFMIQGGRAELRQPSKKKEVQQ 75
Query: 183 SIY-------GNKFEDE-NFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVV 234
S G FEDE + L H G G+LSMAN G ++N S+FFIT L+N+H +
Sbjct: 76 SPRSISGFPGGAPFEDEFDNRLVHQGIGVLSMANDGKHSNLSEFFITFKSCEHLNNKHTI 135
Query: 235 FGSVVEGLDVVKKLESM 251
FG VV GLDV+++ E +
Sbjct: 136 FGRVVGGLDVLRQWEKL 152
|
| >1zkc_A Peptidyl-prolyl CIS-trans isomerase like 2; CIS-trans isomerization, peptidylprolyl isomerase, protein- folding, structural genomics consortium; 1.65A {Homo sapiens} SCOP: b.62.1.1 Length = 197 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 9e-59
Identities = 64/126 (50%), Positives = 85/126 (67%), Gaps = 5/126 (3%)
Query: 127 HIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYG 186
+++L D+ PKT ENF LC +K + + + FHR I NF+ QGGD T GTGG+S +G
Sbjct: 32 NLELHCDLTPKTCENFIRLC--KKHY-YDGTIFHRSIRNFVIQGGDPTG-TGTGGESYWG 87
Query: 187 NKFEDE-NFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVV 245
F+DE L HTG GILSMAN+GPN+N SQFFIT A+LD +H +FG VV G DV+
Sbjct: 88 KPFKDEFRPNLSHTGRGILSMANSGPNSNRSQFFITFRSCAYLDKKHTIFGRVVGGFDVL 147
Query: 246 KKLESM 251
+E++
Sbjct: 148 TAMENV 153
|
| >2hq6_A Serologically defined colon cancer antigen 10; protein folding, peptidyl-prolyl CIS-trans isomerase, struct genomics; 1.75A {Homo sapiens} Length = 185 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 3e-57
Identities = 51/125 (40%), Positives = 76/125 (60%), Gaps = 6/125 (4%)
Query: 127 HIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYG 186
I+L S PK NF LC + + + ++ FHRV+P F+ QGGD T G+GG+SIYG
Sbjct: 37 DIELWSKEAPKACRNFIQLC--LEAY-YDNTIFHRVVPGFIVQGGDPTG-TGSGGESIYG 92
Query: 187 NKFEDE-NFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVV-EGLDV 244
F+DE + L+ G+++MANAG + NGSQFF T + L+N+H +FG V + +
Sbjct: 93 APFKDEFHSRLRFNRRGLVAMANAGSHDNGSQFFFTLGRADELNNKHTIFGKVTGDTVYN 152
Query: 245 VKKLE 249
+ +L
Sbjct: 153 MLRLS 157
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 2e-55
Identities = 55/188 (29%), Positives = 97/188 (51%), Gaps = 16/188 (8%)
Query: 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQY 867
IE+G+GS+ VY + + V++A E+ ++ L + Q EE ++ L+H NIV++
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 868 LGS----VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHG 923
S V + + E + G+L T L+ ++ + + + +QIL+GL++LH
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVM--KIKVLRSWCRQILKGLQFLHT 147
Query: 924 QK--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKG 981
+ I+HRD+K DN+ + +G VKI D G + A+ GT ++MAPE+
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMY--- 202
Query: 982 QRGYGAPV 989
+ Y V
Sbjct: 203 EEKYDESV 210
|
| >1w74_A Peptidyl-prolyl CIS-trans isomerase A; cyclophilin, ppiase, RV0009, rotamase, structural proteomics in europe, spine; 2.6A {Mycobacterium tuberculosis} SCOP: b.62.1.1 Length = 191 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 8e-53
Identities = 59/139 (42%), Positives = 73/139 (52%), Gaps = 19/139 (13%)
Query: 127 HIKLRSDVVPKTAENFRALCTGEKGFGFKDS------------TFHRVIPNFMCQGGDFT 174
I L + PKT NF L G K + +++ FHRVI FM QGGD T
Sbjct: 36 KIALFGNHAPKTVANFVGLAQGTKDYSTQNASGGPSGPFYDGAVFHRVIQGFMIQGGDPT 95
Query: 175 NHNGTGGKSIYGNKFEDE-NFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHV 233
G GG G KF DE + L+ P +L+MANAGP TNGSQFFIT KT L+ RH
Sbjct: 96 G-TGRGGP---GYKFADEFHPELQFDKPYLLAMANAGPGTNGSQFFITVGKTPHLNRRHT 151
Query: 234 VFGSVV--EGLDVVKKLES 250
+FG V+ E VV+ +
Sbjct: 152 IFGEVIDAESQRVVEAISK 170
|
| >3bkp_A Cyclophilin; malaria, isomerase, structural GENO structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 232 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 9e-50
Identities = 44/143 (30%), Positives = 69/143 (48%), Gaps = 22/143 (15%)
Query: 127 HIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGK--SI 184
++L + P NF LC +G+ + ++ FHRV+ +F+ QGGD T G GG +
Sbjct: 34 DVELWARECPLACRNFVQLC--LEGY-YVNTIFHRVVKDFIVQGGDPTG-TGRGGADTTF 89
Query: 185 YGNKFEDE-NFTLKHTGPGILSMANAGPN--------------TNGSQFFITTVKTAWLD 229
G F+ E + LK G++ +AN G + TNG+QFFIT + L+
Sbjct: 90 DGKPFDVETHPRLKFRYRGLVGVANLGRSSKDAENDERGRSLGTNGNQFFITLARADVLN 149
Query: 230 NRHVVFGSVV-EGLDVVKKLESM 251
N + +FG V L + K +
Sbjct: 150 NAYTLFGKVTGHTLYNLMKFNDL 172
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 6e-49
Identities = 56/181 (30%), Positives = 94/181 (51%), Gaps = 11/181 (6%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD---VQPLHEEIKLHSQLRHRNIVQYL 868
++G+G + VY A L V +A+K++ +L D +EI L QL H N+++Y
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLL---RVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
S E+ I +E G LS ++ + + + E T+ Y Q+ L+++H ++
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPER--TVWKYFVQLCSALEHMHSRR 156
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGY 985
++HRDIK NV + T +GVVK+ D G + + +A + GT YM+PE I + GY
Sbjct: 157 VMHRDIKPANVFI-TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH--ENGY 213
Query: 986 G 986
Sbjct: 214 N 214
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 3e-47
Identities = 45/197 (22%), Positives = 85/197 (43%), Gaps = 27/197 (13%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQL-RHRNIVQYL 868
++G G +G V+ + AIK + G D Q E+ H+ L +H ++V+Y
Sbjct: 18 KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKE-NESTMSFYTKQILEGLKYLHGQKIV 927
+ +E+ + I E GGSL+ + + + E+ + Q+ GL+Y+H +V
Sbjct: 78 SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLV 137
Query: 928 HRDIKGDNVLVN------------------TYSGVVKISDFGTSKRLAGLCPSAETFTGT 969
H DIK N+ ++ + + KI D G R++ S + G
Sbjct: 138 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS----SPQVEEGD 193
Query: 970 LQYMAPEVIDKGQRGYG 986
+++A EV+ + +
Sbjct: 194 SRFLANEVL-QENYTHL 209
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 7e-47
Identities = 52/178 (29%), Positives = 89/178 (50%), Gaps = 8/178 (4%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLG 869
++G+GS+G + + + IKEI + + + E+ + + ++H NIVQY
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLL-RVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
S E G I M+ GG L + K +E++ + + QI LK++H +KI+H
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQ--ILDWFVQICLALKHVHDRKILH 148
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYG 986
RDIK N+ + T G V++ DFG ++ L A GT Y++PE+ + + Y
Sbjct: 149 RDIKSQNIFL-TKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICE--NKPYN 203
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-46
Identities = 56/179 (31%), Positives = 94/179 (52%), Gaps = 6/179 (3%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
ELG G++G VY A+ + A K I K+ +++ EI++ + H IV+ LG+
Sbjct: 26 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
+G I +E PGG++ ++ L E + + +Q+LE L +LH ++I+HRD+
Sbjct: 86 YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ--IQVVCRQMLEALNFLHSKRIIHRDL 143
Query: 932 KGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI---DKGQRGYGA 987
K NVL+ T G ++++DFG S + ++F GT +MAPEV+ Y
Sbjct: 144 KAGNVLM-TLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDY 201
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-46
Identities = 51/181 (28%), Positives = 74/181 (40%), Gaps = 11/181 (6%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQL-RHRNIVQYL 868
LG GSYG V+ R + A+K G D E+ H ++ +H V+
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
+ E G + E G SL L E + + Y + L L +LH Q +VH
Sbjct: 124 QAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQ--VWGYLRDTLLALAHLHSQGLVH 180
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAP 988
D+K N+ + G K+ DFG L + E G +YMAPE++ Q YG
Sbjct: 181 LDVKPANIFL-GPRGRCKLGDFGLLVELGT-AGAGEVQEGDPRYMAPELL---QGSYGTA 235
Query: 989 V 989
Sbjct: 236 A 236
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-46
Identities = 65/177 (36%), Positives = 101/177 (57%), Gaps = 8/177 (4%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIP-EKNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
++GKGS+G V+ + Q +AIK I E+ +++ + +EI + SQ + +Y GS
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 871 VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRD 930
++ I ME + GGS LL + GPL E + ++ ++IL+GL YLH +K +HRD
Sbjct: 89 YLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQ--IATILREILKGLDYLHSEKKIHRD 144
Query: 931 IKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGA 987
IK NVL++ G VK++DFG + +L TF GT +MAPEVI + Y +
Sbjct: 145 IKAANVLLSE-HGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS--AYDS 198
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-45
Identities = 53/178 (29%), Positives = 97/178 (54%), Gaps = 7/178 (3%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
++G+G+ G VY A ++ ++AI+++ + + + EI + + ++ NIV YL S
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
+ ME + GGSL+ + V + E + ++ ++ L+ L++LH +++HRDI
Sbjct: 87 LVGDELWVVMEYLAGGSLTDV--VTETCMDEGQ--IAAVCRECLQALEFLHSNQVIHRDI 142
Query: 932 KGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPV 989
K DN+L+ G VK++DFG ++ T GT +MAPEV+ ++ YG V
Sbjct: 143 KSDNILLGM-DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT--RKAYGPKV 197
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 5e-45
Identities = 64/178 (35%), Positives = 101/178 (56%), Gaps = 7/178 (3%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
+LG+GSYG VY A + +AIK++P ++ D+Q + +EI + Q ++V+Y GS
Sbjct: 36 KLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSY 93
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
+ I ME GS+S ++R++ L E+E ++ + L+GL+YLH + +HRDI
Sbjct: 94 FKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE--IATILQSTLKGLEYLHFMRKIHRDI 151
Query: 932 KGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPV 989
K N+L+NT G K++DFG + +L T GT +MAPEVI + GY
Sbjct: 152 KAGNILLNT-EGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQ--EIGYNCVA 206
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 6e-45
Identities = 47/193 (24%), Positives = 83/193 (43%), Gaps = 14/193 (7%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRN--IVQYL 868
+G G V+ +Q+ AIK + + + EI ++L+ + I++
Sbjct: 36 IGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
+ Y + ME L++ L+ K + E Y K +LE + +H IVH
Sbjct: 95 DYEITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWER--KSYWKNMLEAVHTIHQHGIVH 150
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS--AETFTGTLQYMAPEVIDKGQRGYG 986
D+K N L+ G++K+ DFG + ++ S ++ GT+ YM PE I K
Sbjct: 151 SDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI-KDMSSSR 207
Query: 987 APVRQRDKINPCC 999
+ + KI+P
Sbjct: 208 ENGKSKSKISPKS 220
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-44
Identities = 55/178 (30%), Positives = 94/178 (52%), Gaps = 7/178 (3%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
++G+GS G+V ARE ++A+K + + + L E+ + +H N+V+ S
Sbjct: 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
+ ME + GG+L+ + V L E + ++ + +L+ L YLH Q ++HRDI
Sbjct: 112 LVGEELWVLMEFLQGGALTDI--VSQVRLNEEQ--IATVCEAVLQALAYLHAQGVIHRDI 167
Query: 932 KGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPV 989
K D++L+ G VK+SDFG +++ P ++ GT +MAPEVI + Y V
Sbjct: 168 KSDSILLTL-DGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS--RSLYATEV 222
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-44
Identities = 66/182 (36%), Positives = 100/182 (54%), Gaps = 12/182 (6%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIP---EKNLGDVQPLHEEIKLHSQLRHRNIVQYL 868
E+G GS+G VY AR++ +AIK++ +++ Q + +E++ +LRH N +QY
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
G E + ME GS S LL V PL+E E ++ T L+GL YLH ++H
Sbjct: 121 GCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVE--IAAVTHGALQGLAYLHSHNMIH 177
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQR-GYGA 987
RD+K N+L++ G+VK+ DFG++ +A A +F GT +MAPEVI Y
Sbjct: 178 RDVKAGNILLSE-PGLVKLGDFGSASIMA----PANSFVGTPYWMAPEVILAMDEGQYDG 232
Query: 988 PV 989
V
Sbjct: 233 KV 234
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-44
Identities = 47/193 (24%), Positives = 82/193 (42%), Gaps = 14/193 (7%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRH--RNIVQYL 868
+G G V+ +Q+ AIK + + + EI ++L+ I++
Sbjct: 17 IGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
+ Y + ME L++ L+ K + E Y K +LE + +H IVH
Sbjct: 76 DYEITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWER--KSYWKNMLEAVHTIHQHGIVH 131
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS--AETFTGTLQYMAPEVIDKGQRGYG 986
D+K N L+ G++K+ DFG + ++ S ++ GT+ YM PE I K
Sbjct: 132 SDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI-KDMSSSR 188
Query: 987 APVRQRDKINPCC 999
+ + KI+P
Sbjct: 189 ENGKSKSKISPKS 201
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-44
Identities = 46/193 (23%), Positives = 81/193 (41%), Gaps = 14/193 (7%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRH--RNIVQYL 868
+G G V+ +Q+ AIK + + + EI ++L+ I++
Sbjct: 64 IGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
+ Y + ME L++ L+ K + E Y K +LE + +H IVH
Sbjct: 123 DYEITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWER--KSYWKNMLEAVHTIHQHGIVH 178
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS--AETFTGTLQYMAPEVIDKGQRGYG 986
D+K N L+ G++K+ DFG + ++ S ++ G + YM PE I K
Sbjct: 179 SDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI-KDMSSSR 235
Query: 987 APVRQRDKINPCC 999
+ + KI+P
Sbjct: 236 ENGKSKSKISPKS 248
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 6e-44
Identities = 65/186 (34%), Positives = 99/186 (53%), Gaps = 13/186 (6%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIP-EKNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
+G G+ VV AA ++ K+AIK I EK + L +EI+ SQ H NIV Y S
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 871 VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKE-----NESTMSFYTKQILEGLKYLHGQK 925
+ + M+ + GGS+ +++ + +EST++ +++LEGL+YLH
Sbjct: 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG 141
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAE-----TFTGTLQYMAPEVIDK 980
+HRD+K N+L+ G V+I+DFG S LA TF GT +MAPEV+++
Sbjct: 142 QIHRDVKAGNILLGE-DGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ 200
Query: 981 GQRGYG 986
RGY
Sbjct: 201 V-RGYD 205
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-43
Identities = 52/192 (27%), Positives = 80/192 (41%), Gaps = 27/192 (14%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
+G G +G V+ A+ IK + N + E+K ++L H NIV Y G
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCW 73
Query: 872 SEEGYFK----------------IFMEQVPGGSLSTLLRVKWG-PLKENESTMSFYTKQI 914
Y I ME G+L + + G L + +QI
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL--ALELFEQI 131
Query: 915 LEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMA 974
+G+ Y+H +K+++RD+K N+ + + VKI DFG L GTL+YM+
Sbjct: 132 TKGVDYIHSKKLINRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDG-KRTRSKGTLRYMS 189
Query: 975 PEVIDKGQRGYG 986
PE I + YG
Sbjct: 190 PEQISS--QDYG 199
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 5e-43
Identities = 59/217 (27%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 800 LRFLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL 859
LR+ F + LG+G++G V AR AIK+I + + E+ L + L
Sbjct: 2 LRYASDFEEIAV-LGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASL 59
Query: 860 RHRNIVQYLGSVSEEGYFK-------------IFMEQVPGGSLSTLLRVKWGPLKENEST 906
H+ +V+Y + E F I ME G+L L+ + + +E
Sbjct: 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY- 118
Query: 907 MSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAE-- 964
+QILE L Y+H Q I+HRD+K N+ + S VKI DFG +K + +
Sbjct: 119 -WRLFRQILEALSYIHSQGIIHRDLKPMNIFI-DESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 965 ------------TFTGTLQYMAPEVIDKGQRGYGAPV 989
+ GT Y+A EV+ G Y +
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVL-DGTGHYNEKI 212
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 8e-42
Identities = 63/192 (32%), Positives = 94/192 (48%), Gaps = 25/192 (13%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQYLGS 870
+G G+YG VY R + AIK + + + + +EI + + HRNI Y G+
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 871 VSEEGYFK-----------IFMEQVPGGSLSTLLRV-KWGPLKENESTMSFYTKQILEGL 918
+ K + ME GS++ L++ K LKE +++ ++IL GL
Sbjct: 90 -----FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW--IAYICREILRGL 142
Query: 919 KYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
+LH K++HRDIKG NVL+ T + VK+ DFG S +L TF GT +MAPEVI
Sbjct: 143 SHLHQHKVIHRDIKGQNVLL-TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201
Query: 979 ---DKGQRGYGA 987
+ Y
Sbjct: 202 ACDENPDATYDF 213
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 2e-41
Identities = 40/188 (21%), Positives = 75/188 (39%), Gaps = 15/188 (7%)
Query: 812 ELGKG--SYGVVYAARELDRQVKLAIKEIP--EKNLGDVQPLHEEIKLHSQLRHRNIVQY 867
+GKG V AR + ++ I + V L E+ + H NIV Y
Sbjct: 32 VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRV-KWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
+ + + + GS L+ + NE +++ + +L+ L Y+H
Sbjct: 92 RATFIADNELWVVTSFMAYGSAKDLICTHFMDGM--NELAIAYILQGVLKALDYIHHMGY 149
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFG-------TSKRLAGLCPSAETFTGTLQYMAPEVID 979
VHR +K ++L++ G V +S +R + + L +++PEV+
Sbjct: 150 VHRSVKASHILISV-DGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQ 208
Query: 980 KGQRGYGA 987
+ +GY A
Sbjct: 209 QNLQGYDA 216
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-41
Identities = 56/180 (31%), Positives = 95/180 (52%), Gaps = 8/180 (4%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLG 869
LGKGS+ VY A + +++AIK I +K + G VQ + E+K+H QL+H +I++
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
+ Y + +E G ++ L+ + P ENE+ + QI+ G+ YLH I+HR
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEA--RHFMHQIITGMLYLHSHGILHR 136
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPV 989
D+ N+L+ + +KI+DFG + +L T GT Y++PE+ + +G
Sbjct: 137 DLTLSNLLLTR-NMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR--SAHGLES 193
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-41
Identities = 50/199 (25%), Positives = 79/199 (39%), Gaps = 28/199 (14%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSV 871
LG+G +GVV+ A+ AIK I N + + E+K ++L H IV+Y +
Sbjct: 13 LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 872 SEEGYFK------------IFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLK 919
E+ + I M+ +L + + + S QI E ++
Sbjct: 73 LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 920 YLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT------------ 967
+LH + ++HRD+K N+ T VVK+ DFG + T
Sbjct: 133 FLHSKGLMHRDLKPSNIFF-TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQV 191
Query: 968 GTLQYMAPEVIDKGQRGYG 986
GT YM+PE I Y
Sbjct: 192 GTKLYMSPEQIHG--NSYS 208
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 7e-40
Identities = 52/179 (29%), Positives = 81/179 (45%), Gaps = 15/179 (8%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLG 869
+G GSYG R L KE+ ++ + Q L E+ L +L+H NIV+Y
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 870 SVSEE--GYFKIFMEQVPGGSLSTLL---RVKWGPLKENESTMSFYTKQILEGLKYLHGQ 924
+ + I ME GG L++++ + L E + Q+ LK H +
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF--VLRVMTQLTLALKECHRR 130
Query: 925 K-----IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
++HRD+K NV + VK+ DFG ++ L A+TF GT YM+PE +
Sbjct: 131 SDGGHTVLHRDLKPANVFL-DGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQM 188
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 8e-40
Identities = 55/171 (32%), Positives = 90/171 (52%), Gaps = 7/171 (4%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD--VQPLHEEIKLHSQLRHRNIVQYLG 869
++G GS+G V+ A V A+K + E++ V E+ + +LRH NIV ++G
Sbjct: 44 KIGAGSFGTVHRAEWHGSDV--AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK--IV 927
+V++ I E + GSL LL + +E + +G+ YLH + IV
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIV 161
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
HR++K N+LV+ VK+ DFG S+ A S+++ GT ++MAPEV+
Sbjct: 162 HRNLKSPNLLVDK-KYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVL 211
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 9e-40
Identities = 52/180 (28%), Positives = 90/180 (50%), Gaps = 9/180 (5%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLG 869
LGKG + + + D + A K +P+ L + + EI +H L H+++V + G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
+ + + +E SL L + + L E E+ +Y +QI+ G +YLH +++HR
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEA--RYYLRQIVLGCQYLHRNRVIHR 139
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPV 989
D+K N+ +N VKI DFG + ++ + GT Y+APEV+ K +G+ V
Sbjct: 140 DLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK--KGHSFEV 196
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 9e-40
Identities = 52/180 (28%), Positives = 90/180 (50%), Gaps = 9/180 (5%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLG 869
LGKG + + + D + A K +P+ L + + EI +H L H+++V + G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
+ + + +E SL L + + L E E+ +Y +QI+ G +YLH +++HR
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEA--RYYLRQIVLGCQYLHRNRVIHR 165
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPV 989
D+K N+ +N VKI DFG + ++ + GT Y+APEV+ K +G+ V
Sbjct: 166 DLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK--KGHSFEV 222
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 9e-40
Identities = 41/183 (22%), Positives = 65/183 (35%), Gaps = 19/183 (10%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVS 872
LG+G + V L A+K I D + E +H H NI++ +
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 873 EEGYFK----IFMEQVPGGSLSTLL---RVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
E K + + G+L + + K L E++ I GL+ +H +
Sbjct: 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL--GICRGLEAIHAKG 154
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFG---------TSKRLAGLCPSAETFTGTLQYMAPE 976
HRD+K N+L+ G + D G R A T+ Y APE
Sbjct: 155 YAHRDLKPTNILLGD-EGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213
Query: 977 VID 979
+
Sbjct: 214 LFS 216
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-39
Identities = 56/177 (31%), Positives = 88/177 (49%), Gaps = 10/177 (5%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIP-EKNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
ELG G+ GVV+ + +A K I E + E+++ + IV + G+
Sbjct: 40 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99
Query: 871 VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ-KIVHR 929
+G I ME + GGSL +L+ G + E + + +++GL YL + KI+HR
Sbjct: 100 FYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQI--LGKVSIAVIKGLTYLREKHKIMHR 156
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYG 986
D+K N+LVN+ G +K+ DFG S +L A +F GT YM+PE + Y
Sbjct: 157 DVKPSNILVNS-RGEIKLCDFGVSGQLID--SMANSFVGTRSYMSPERLQ--GTHYS 208
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-39
Identities = 57/180 (31%), Positives = 91/180 (50%), Gaps = 11/180 (6%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLG 869
LGKG +G VY ARE + LA+K + + L G L E+++ S LRH NI++ G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
+ + +E P G++ L+ K E + + Y ++ L Y H ++++HR
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRT--ATYITELANALSYCHSKRVIHR 133
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPV 989
DIK +N+L+ + G +KI+DFG S GTL Y+ PE+I+ R + V
Sbjct: 134 DIKPENLLLGSA-GELKIADFGWSVHAPSS--RRTDLCGTLDYLPPEMIEG--RMHDEKV 188
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 7e-39
Identities = 51/192 (26%), Positives = 82/192 (42%), Gaps = 17/192 (8%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGS 870
LG+G+ V+ R AIK + V E ++ +L H+NIV+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 871 VSEEGYFKIF--MEQVPGGSLSTLL--RVKWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
E ME P GSL T+L L E+E + ++ G+ +L I
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF--LIVLRDVVGGMNHLRENGI 133
Query: 927 VHRDIKGDNVLVNTYS---GVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDK--- 980
VHR+IK N++ V K++DFG ++ L + GT +Y+ P++ ++
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVSLYGTEEYLHPDMYERAVL 192
Query: 981 ---GQRGYGAPV 989
Q+ YGA V
Sbjct: 193 RKDHQKKYGATV 204
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-38
Identities = 53/181 (29%), Positives = 84/181 (46%), Gaps = 11/181 (6%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIP-EKNLGDVQPLHEEIK-LHSQLRHRNIVQYLG 869
ELG+G+YGVV R + +A+K I N + + L ++ + V + G
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRV---KWGPLKENESTMSFYTKQILEGLKYLHGQ-K 925
++ EG I ME + SL + K + E+ + I++ L++LH +
Sbjct: 74 ALFREGDVWICME-LMDTSLDKFYKQVIDKGQTIPEDI--LGKIAVSIVKALEHLHSKLS 130
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGY 985
++HRD+K NVL+N G VK+ DFG S L + + G YMAPE I+
Sbjct: 131 VIHRDVKPSNVLINA-LGQVKMCDFGISGYLVDDV-AKDIDAGCKPYMAPERINPELNQK 188
Query: 986 G 986
G
Sbjct: 189 G 189
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-38
Identities = 53/181 (29%), Positives = 83/181 (45%), Gaps = 10/181 (5%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIP-EKNLGDVQPLHEEIK-LHSQLRHRNIVQYLG 869
E+G+G+YG V +A+K I + + + L ++ + IVQ+ G
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKE--NESTMSFYTKQILEGLKYLHGQ-KI 926
++ EG I ME + S + + L + E + T ++ L +L KI
Sbjct: 89 ALFREGDCWICME-LMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKI 147
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT-GTLQYMAPEVIDKGQRGY 985
+HRDIK N+L++ SG +K+ DFG S +L A+T G YMAPE ID
Sbjct: 148 IHRDIKPSNILLDR-SGNIKLCDFGISGQLVD--SIAKTRDAGCRPYMAPERIDPSASRQ 204
Query: 986 G 986
G
Sbjct: 205 G 205
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 49/181 (27%), Positives = 81/181 (44%), Gaps = 11/181 (6%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIP-EKNLGDVQPLHEEIK-LHSQLRHRNIVQYLG 869
E+G G+ G V+ R +A+K++ N + + + ++ + IVQ G
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ-KIVH 928
+ I ME + G L + GP+ E + T I++ L YL + ++H
Sbjct: 92 TFITNTDVFIAME-LMGTCAEKLKKRMQGPIPERI--LGKMTVAIVKALYYLKEKHGVIH 148
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVID---KGQRGY 985
RD+K N+L++ G +K+ DFG S RL + + G YMAPE ID + Y
Sbjct: 149 RDVKPSNILLDE-RGQIKLCDFGISGRLVDDK-AKDRSAGCAAYMAPERIDPPDPTKPDY 206
Query: 986 G 986
Sbjct: 207 D 207
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-38
Identities = 62/182 (34%), Positives = 95/182 (52%), Gaps = 15/182 (8%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLG 869
LGKG +G VY ARE + +A+K + + L G L EI++ S LRH NI++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
+ + +E P G L L+ K G E S + + +++ + L Y H +K++HR
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQ-KHGRFDEQRS--ATFMEELADALHYCHERKVIHR 138
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT--GTLQYMAPEVIDKGQRGYGA 987
DIK +N+L+ Y G +KI+DFG S PS T GTL Y+ PE+I+ + +
Sbjct: 139 DIKPENLLM-GYKGELKIADFGWSV----HAPSLRRRTMCGTLDYLPPEMIEG--KTHDE 191
Query: 988 PV 989
V
Sbjct: 192 KV 193
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-37
Identities = 51/191 (26%), Positives = 82/191 (42%), Gaps = 17/191 (8%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
LG+G+ V+ R AIK + V E ++ +L H+NIV+
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 872 SEEGYFKIF--MEQVPGGSLSTLL--RVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
E ME P GSL T+L L E+E + ++ G+ +L IV
Sbjct: 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF--LIVLRDVVGGMNHLRENGIV 134
Query: 928 HRDIKGDNVLVNTYS---GVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDK---- 980
HR+IK N++ V K++DFG ++ L + GT +Y+ P++ ++
Sbjct: 135 HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVSLYGTEEYLHPDMYERAVLR 193
Query: 981 --GQRGYGAPV 989
Q+ YGA V
Sbjct: 194 KDHQKKYGATV 204
|
| >3s6m_A Peptidyl-prolyl CIS-trans isomerase; seattle structural genomics center for infectious disease; 1.65A {Burkholderia pseudomallei} PDB: 3t1u_A* Length = 167 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 3e-37
Identities = 42/130 (32%), Positives = 60/130 (46%), Gaps = 17/130 (13%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGN 187
++L PKT ENF +KG + + FHRVI FM QGG F +
Sbjct: 17 LELDEAKAPKTVENFLNYV--KKGH-YDGTIFHRVINGFMIQGGGFE-PGLKQKPT--DA 70
Query: 188 KFEDE-NFTLKHTGPGILSMA-NAGPNTNGSQFFITTVKTAWLDNR--------HVVFGS 237
+E N LK+ ++MA P++ +QFFI +L++ + VFG
Sbjct: 71 PIANEANNGLKND-TYTIAMARTNDPHSATAQFFINVNDNEFLNHSSPTPQGWGYAVFGK 129
Query: 238 VVEGLDVVKK 247
VVEG D+V K
Sbjct: 130 VVEGQDIVDK 139
|
| >1lop_A Cyclophilin A; rotamase, isomerase-isomerase inhibitor complex; HET: NIT; 1.80A {Escherichia coli} SCOP: b.62.1.1 PDB: 2nul_A 2rs4_A Length = 164 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 9e-37
Identities = 45/130 (34%), Positives = 64/130 (49%), Gaps = 17/130 (13%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGN 187
IK D P+T +NF C +GF + ++ FHRVI FM QGG F +
Sbjct: 13 IKTFDDKAPETVKNFLDYC--REGF-YNNTIFHRVINGFMIQGGGFE-PGMKQKAT--KE 66
Query: 188 KFEDE-NFTLKHTGPGILSMA-NAGPNTNGSQFFITTVKTAWLDNR--------HVVFGS 237
++E N LK+T G L+MA P++ +QFFI V +L+ + VF
Sbjct: 67 PIKNEANNGLKNT-RGTLAMARTQAPHSATAQFFINVVDNDFLNFSGESLQGWGYCVFAE 125
Query: 238 VVEGLDVVKK 247
VV+G+D V K
Sbjct: 126 VVDGMDEVDK 135
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-36
Identities = 49/174 (28%), Positives = 84/174 (48%), Gaps = 14/174 (8%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD--VQPLHEEIKLHSQLRHRNIVQYLG 869
+GKG +G VY R +V AI+ I + + ++ E+ + Q RH N+V ++G
Sbjct: 40 LIGKGRFGQVYHGR-WHGEV--AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
+ + I G +L +++R L N+ T ++I++G+ YLH + I+H+
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNK-TRQI-AQEIVKGMGYLHAKGILHK 154
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAET-----FTGTLQYMAPEVI 978
D+K NV + +G V I+DFG L G L ++APE+I
Sbjct: 155 DLKSKNVFYD--NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEII 206
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-36
Identities = 45/187 (24%), Positives = 76/187 (40%), Gaps = 16/187 (8%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQYLGS 870
LG G+ G + D + +A+K I + E++L + H N+++Y +
Sbjct: 31 VLGHGAEGTIVYRGMFDNR-DVAVKRILPECFSFAD---REVQLLRESDEHPNVIRYFCT 86
Query: 871 VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRD 930
+ + I +E +L V+ +Q GL +LH IVHRD
Sbjct: 87 EKDRQFQYIAIELC-AATLQE--YVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRD 143
Query: 931 IKGDNVLVNTYSGV----VKISDFGTSKRLAGLCPSAE---TFTGTLQYMAPEVID-KGQ 982
+K N+L++ + ISDFG K+LA S GT ++APE++ +
Sbjct: 144 LKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCK 203
Query: 983 RGYGAPV 989
V
Sbjct: 204 ENPTYTV 210
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-36
Identities = 62/225 (27%), Positives = 86/225 (38%), Gaps = 47/225 (20%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-----GDVQPLHEEIKLHSQLRHRNIVQ 866
+G+GSYGVV A E + AIK + + + DV+ + E++L +L H NI +
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 867 YLGSVSEEGYFKIFMEQVPGGSL-----------------------------STLLRVKW 897
+E Y + ME GG L +
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 898 GPLKENESTMSFYT--------KQILEGLKYLHGQKIVHRDIKGDNVLVNT-YSGVVKIS 948
ES +QI L YLH Q I HRDIK +N L +T S +K+
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLV 212
Query: 949 DFGTSKRLAGLCPSAE----TFTGTLQYMAPEVIDKGQRGYGAPV 989
DFG SK L T GT ++APEV++ YG
Sbjct: 213 DFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-36
Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 20/187 (10%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD-------VQPLHEEIKLHSQLRHRNI 864
++GKG +G+V+ R + + +AIK + + Q E+ + S L H NI
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 865 VQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ 924
V+ G + ++ ME VP G L L K P+K + + I G++Y+ Q
Sbjct: 86 VKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSV-KLRL-MLDIALGIEYMQNQ 141
Query: 925 K--IVHRDIKGDNVLVNTYSG----VVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
IVHRD++ N+ + + K++DFG S++ S G Q+MAPE I
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH---SVSGLLGNFQWMAPETI 198
Query: 979 DKGQRGY 985
+ Y
Sbjct: 199 GAEEESY 205
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-36
Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 795 MQTPMLRFLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIK 854
MQT +R ++F LG G++ V+ ++ A+K I + L EI
Sbjct: 2 MQTTNIRKTFIF---MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIA 58
Query: 855 LHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLR-VKWGPLKENESTMSFYTKQ 913
+ +++H NIV ++ + M+ V GG L R ++ G E ++ S +Q
Sbjct: 59 VLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL--FDRILERGVYTEKDA--SLVIQQ 114
Query: 914 ILEGLKYLHGQKIVHRDIKGDNVLVNTYSG--VVKISDFGTSKRLAGLCPSAETFTGTLQ 971
+L +KYLH IVHRD+K +N+L T + I+DFG SK T GT
Sbjct: 115 VLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GIMSTACGTPG 172
Query: 972 YMAPEVIDKGQRGYGAPV 989
Y+APEV+ + + Y V
Sbjct: 173 YVAPEVLAQ--KPYSKAV 188
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 53/181 (29%), Positives = 83/181 (45%), Gaps = 22/181 (12%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHE----EIKLHSQLRHRNIVQY 867
+G G +G VY A + +V A+K D+ E E KL + L+H NI+
Sbjct: 14 IIGIGGFGKVYRAFWIGDEV--AVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK-- 925
G +E + ME GG L+ +L K P +++ QI G+ YLH +
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDI---LVNW-AVQIARGMNYLHDEAIV 127
Query: 926 -IVHRDIKGDNVLVNTYSG-------VVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEV 977
I+HRD+K N+L+ ++KI+DFG ++ + + G +MAPEV
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--RTTKMSAAGAYAWMAPEV 185
Query: 978 I 978
I
Sbjct: 186 I 186
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-35
Identities = 53/186 (28%), Positives = 85/186 (45%), Gaps = 10/186 (5%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-----GDVQPLHEEIKLHSQLRHRNIVQ 866
+GKG + VV + + A+K + + L E + L+H +IV+
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 867 YLGSVSEEGYFKIFMEQVPGGSL-STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
L + S +G + E + G L +++ +E+ S Y +QILE L+Y H
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN 150
Query: 926 IVHRDIKGDNVLVNTYSG--VVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQR 983
I+HRD+K VL+ + VK+ FG + +L A GT +MAPEV+ +
Sbjct: 151 IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR--E 208
Query: 984 GYGAPV 989
YG PV
Sbjct: 209 PYGKPV 214
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-35
Identities = 49/170 (28%), Positives = 83/170 (48%), Gaps = 12/170 (7%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
+G+G++GVV A+ + V AIK+I ++ + + E++ S++ H NIV+ G+
Sbjct: 15 VVGRGAFGVVCKAKWRAKDV--AIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK---IVH 928
+ ME GGSL +L + + Q +G+ YLH + ++H
Sbjct: 71 LNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI 978
RD+K N+L+ V+KI DFGT+ + G+ +MAPEV
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTACDIQT---HMTNNKGSAAWMAPEVF 175
|
| >1v9t_A Cyclophilin B; beta barrel, isomerase-isomerase inhibitor complex; HET: NIT; 1.70A {Escherichia coli} SCOP: b.62.1.1 PDB: 1j2a_A* 1vai_A* 1clh_A Length = 166 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-35
Identities = 45/130 (34%), Positives = 67/130 (51%), Gaps = 14/130 (10%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGN 187
++L P + +NF GF + ++TFHRVIP FM QGG FT K
Sbjct: 18 LELDKQKAPVSVQNFVDYV--NSGF-YNNTTFHRVIPGFMIQGGGFTE-QMQQKKP--NP 71
Query: 188 KFEDE-NFTLKHTGPGILSMA-NAGPNTNGSQFFITTVKTAWLDNR-----HVVFGSVVE 240
++E + L++T G ++MA A ++ SQFFI A+LD+ + VFG VV+
Sbjct: 72 PIKNEADNGLRNT-RGTIAMARTADKDSATSQFFINVADNAFLDHGQRDFGYAVFGKVVK 130
Query: 241 GLDVVKKLES 250
G+DV K+
Sbjct: 131 GMDVADKISQ 140
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-35
Identities = 61/183 (33%), Positives = 94/183 (51%), Gaps = 11/183 (6%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLG 869
ELGKG++ VV ++ + A I K L D Q L E ++ L+H NIV+
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLR-VKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
S+SEEG+ + + V GG L V E ++ S +QILE + + H +VH
Sbjct: 78 SISEEGHHYLIFDLVTGGEL--FEDIVAREYYSEADA--SHCIQQILEAVLHCHQMGVVH 133
Query: 929 RDIKGDNVLVNTYS--GVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYG 986
R++K +N+L+ + VK++DFG + + G + F GT Y++PEV+ K YG
Sbjct: 134 RNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK--DPYG 191
Query: 987 APV 989
PV
Sbjct: 192 KPV 194
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 47/171 (27%), Positives = 78/171 (45%), Gaps = 11/171 (6%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD--VQPLHEEIKLHSQLRHRNIVQYLG 869
+G GS+G VY + V A+K + +Q E+ + + RH NI+ ++G
Sbjct: 31 RIGSGSFGTVYKGK-WHGDV--AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
+ I + G SL L + + + +Q G+ YLH + I+HR
Sbjct: 88 YSTAPQLA-IVTQWCEGSSLYHHLHASETKFEMKK-LIDI-ARQTARGMDYLHAKSIIHR 144
Query: 930 DIKGDNVLVNTYSGVVKISDFGTS--KRLAGLCPSAETFTGTLQYMAPEVI 978
D+K +N+ ++ VKI DFG + K E +G++ +MAPEVI
Sbjct: 145 DLKSNNIFLHE-DNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-35
Identities = 44/181 (24%), Positives = 81/181 (44%), Gaps = 17/181 (9%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
LGKG +G + + +KE+ + + +E+K+ L H N+++++G +
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
++ E + GG+L +++ ++ +SF K I G+ YLH I+HRD+
Sbjct: 77 YKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQ-RVSF-AKDIASGMAYLHSMNIIHRDL 134
Query: 932 KGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAE--------------TFTGTLQYMAPEV 977
N LV + V ++DFG ++ + E T G +MAPE+
Sbjct: 135 NSHNCLVRE-NKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 978 I 978
I
Sbjct: 194 I 194
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-34
Identities = 61/189 (32%), Positives = 90/189 (47%), Gaps = 16/189 (8%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--------DVQPLHEEIKLHSQLRHRN 863
LG G+ G V A E K+AI+ I ++ + EI++ +L H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 864 IVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHG 923
I++ E Y+ I +E + GG L + V LKE Y Q+L ++YLH
Sbjct: 202 IIKIKNFFDAEDYY-IVLELMEGGELFDKV-VGNKRLKEATC--KLYFYQMLLAVQYLHE 257
Query: 924 QKIVHRDIKGDNVLVNTYS--GVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI-DK 980
I+HRD+K +NVL+++ ++KI+DFG SK L T GT Y+APEV+
Sbjct: 258 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYLAPEVLVSV 316
Query: 981 GQRGYGAPV 989
G GY V
Sbjct: 317 GTAGYNRAV 325
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 50/184 (27%), Positives = 87/184 (47%), Gaps = 17/184 (9%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
+G+GS+G V A + +++ A K+IP+ + DV +EI++ L H NI++ +
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 872 SEEGYFKIFMEQVPGGSLSTLLR-VKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRD 930
+ + ME GG L R V +E+++ + K +L + Y H + HRD
Sbjct: 76 EDNTDIYLVMELCTGGEL--FERVVHKRVFRESDA--ARIMKDVLSAVAYCHKLNVAHRD 131
Query: 931 IKGDNVLVNTYSG--VVKISDFGTSKRLAGLCPSAETFT---GTLQYMAPEVIDKGQRGY 985
+K +N L T S +K+ DFG + R + GT Y++P+V+ + Y
Sbjct: 132 LKPENFLFLTDSPDSPLKLIDFGLAAR----FKPGKMMRTKVGTPYYVSPQVL---EGLY 184
Query: 986 GAPV 989
G
Sbjct: 185 GPEC 188
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-34
Identities = 51/179 (28%), Positives = 81/179 (45%), Gaps = 6/179 (3%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
ELG G++GVV+ E K I D + EI + +QL H ++ +
Sbjct: 58 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
++ + +E + GG L + + + E E Y +Q EGLK++H IVH DI
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV--INYMRQACEGLKHMHEHSIVHLDI 175
Query: 932 KGDNVLVNTYSG-VVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPV 989
K +N++ T VKI DFG + +L T T ++ APE++D+ G
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT-ATAEFAAPEIVDR--EPVGFYT 231
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 49/199 (24%), Positives = 86/199 (43%), Gaps = 13/199 (6%)
Query: 795 MQTPMLRFLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIK 854
M+ Y L LG+GS+ + A+K I ++ + Q +EI
Sbjct: 1 MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ---KEIT 57
Query: 855 LHSQLR-HRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLR-VKWGPLKENESTMSFYTK 912
H NIV+ ++ + + ME + GG L R K E E+ S+ +
Sbjct: 58 ALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL--FERIKKKKHFSETEA--SYIMR 113
Query: 913 QILEGLKYLHGQKIVHRDIKGDNVLVNTYSG--VVKISDFGTSKRLAGLCPSAETFTGTL 970
+++ + ++H +VHRD+K +N+L + +KI DFG ++ +T TL
Sbjct: 114 KLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTL 173
Query: 971 QYMAPEVIDKGQRGYGAPV 989
Y APE++++ GY
Sbjct: 174 HYAAPELLNQ--NGYDESC 190
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 4e-34
Identities = 60/186 (32%), Positives = 92/186 (49%), Gaps = 18/186 (9%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLG 869
ELGKG++ VV ++ A K I K L D Q L E ++ +L+H NIV+
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLR-VKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
S+ EE + + + V GG L V E ++ S +QILE + Y H IVH
Sbjct: 73 SIQEESFHYLVFDLVTGGEL--FEDIVAREFYSEADA--SHCIQQILESIAYCHSNGIVH 128
Query: 929 RDIKGDNVLVNTYS--GVVKISDFGTSKRLAGLCPSAETFT---GTLQYMAPEVIDKGQR 983
R++K +N+L+ + + VK++DFG + +E + GT Y++PEV+ K
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGLAIE----VNDSEAWHGFAGTPGYLSPEVLKK--D 182
Query: 984 GYGAPV 989
Y PV
Sbjct: 183 PYSKPV 188
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-34
Identities = 48/179 (26%), Positives = 84/179 (46%), Gaps = 6/179 (3%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
ELG G++GVV+ E A K + + D + + +EI+ S LRH +V +
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
++ + E + GG L + + + E+E+ Y +Q+ +GL ++H VH D+
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA--VEYMRQVCKGLCHMHENNYVHLDL 281
Query: 932 KGDNVL-VNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPV 989
K +N++ S +K+ DFG + L T GT ++ APEV + + G
Sbjct: 282 KPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-GTAEFAAPEVAEG--KPVGYYT 337
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-34
Identities = 63/190 (33%), Positives = 91/190 (47%), Gaps = 18/190 (9%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--------GDVQPLHEEIKLHSQLRHRN 863
LG G+ G V A E K+AIK I ++ + EI++ +L H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 864 IVQYLGSVSEEGYFKIFMEQVPGGSLSTLLR-VKWGPLKENESTMSFYTKQILEGLKYLH 922
I++ E Y+ I +E + GG L + V LKE Y Q+L ++YLH
Sbjct: 77 IIKIKNFFDAEDYY-IVLELMEGGEL--FDKVVGNKRLKEATC--KLYFYQMLLAVQYLH 131
Query: 923 GQKIVHRDIKGDNVLVNTYSG--VVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI-D 979
I+HRD+K +NVL+++ ++KI+DFG SK L G T GT Y+APEV+
Sbjct: 132 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLCGTPTYLAPEVLVS 190
Query: 980 KGQRGYGAPV 989
G GY V
Sbjct: 191 VGTAGYNRAV 200
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 139 bits (350), Expect = 7e-34
Identities = 57/191 (29%), Positives = 86/191 (45%), Gaps = 20/191 (10%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIP-EKNLGDVQPLHEEIKLHSQLRHRNIVQ---- 866
LG G +G V D ++AIK+ E + + + EI++ +L H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 867 --YLGSVSEEGYFKIFMEQVPGGSLSTLL--RVKWGPLKENESTMSFYTKQILEGLKYLH 922
L ++ + ME GG L L LKE I L+YLH
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI--RTLLSDISSALRYLH 138
Query: 923 GQKIVHRDIKGDNVLV--NTYSGVVKISDFGTSKRL--AGLCPSAETFTGTLQYMAPEVI 978
+I+HRD+K +N+++ + KI D G +K L LC F GTLQY+APE++
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC---TEFVGTLQYLAPELL 195
Query: 979 DKGQRGYGAPV 989
+ Q+ Y V
Sbjct: 196 E--QKKYTVTV 204
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 53/187 (28%), Positives = 84/187 (44%), Gaps = 18/187 (9%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIP-EKNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
+LG G++G V+ E ++ IK I +++ ++ + EI++ L H NI++
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 871 VSEEGYFKIFMEQVPGGSL---STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
+ I ME GG L + + L E + KQ++ L Y H Q +V
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYV--AELMKQMMNALAYFHSQHVV 146
Query: 928 HRDIKGDNVLVNTYS--GVVKISDFGTSKRLAGLCPSAETFT---GTLQYMAPEVIDKGQ 982
H+D+K +N+L S +KI DFG ++ S E T GT YMAPEV +
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAEL----FKSDEHSTNAAGTALYMAPEVF---K 199
Query: 983 RGYGAPV 989
R
Sbjct: 200 RDVTFKC 206
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 53/186 (28%), Positives = 85/186 (45%), Gaps = 19/186 (10%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLG 869
LGKGS+G V ++ Q + A+K I + + D + E++L +L H NI++
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLR-VKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
+ + F I E GG L +K E+++ + KQ+ G+ Y+H IVH
Sbjct: 89 ILEDSSSFYIVGELYTGGEL--FDEIIKRKRFSEHDA--ARIIKQVFSGITYMHKHNIVH 144
Query: 929 RDIKGDNVLVNTYSG--VVKISDFGTSKRLAGLCPSAETFT---GTLQYMAPEVIDKGQR 983
RD+K +N+L+ + +KI DFG S GT Y+APEV+ +
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTC----FQQNTKMKDRIGTAYYIAPEVL---RG 197
Query: 984 GYGAPV 989
Y
Sbjct: 198 TYDEKC 203
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 36/208 (17%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIP--------------------------EKNLGD 845
E+GKGSYGVV A + A+K + + G
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 846 VQPLHEEIKLHSQLRHRNIVQ-Y--LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKE 902
++ +++EI + +L H N+V+ L +E+ + + E V G + + PL E
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLY-MVFELVNQGPV--MEVPTLKPLSE 136
Query: 903 NESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS 962
+++ FY + +++G++YLH QKI+HRDIK N+LV G +KI+DFG S G
Sbjct: 137 DQA--RFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV-GEDGHIKIADFGVSNEFKGSDAL 193
Query: 963 AETFTGTLQYMAPEVIDKGQRGY-GAPV 989
GT +MAPE + + ++ + G +
Sbjct: 194 LSNTVGTPAFMAPESLSETRKIFSGKAL 221
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-33
Identities = 50/204 (24%), Positives = 84/204 (41%), Gaps = 31/204 (15%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQYLGS 870
LG GS G V + +A+K + EIKL ++ H N+++Y S
Sbjct: 22 ILGYGSSGTVVFQGSFQGR-PVAVKRMLIDFCDIAL---MEIKLLTESDDHPNVIRYYCS 77
Query: 871 VSEEGYFKIFMEQVPGGSLSTLL----RVKWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
+ + + I +E +L L+ + E +QI G+ +LH KI
Sbjct: 78 ETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKI 136
Query: 927 VHRDIKGDNVLVNTYSGV------------VKISDFGTSKRLAG----LCPSAETFTGTL 970
+HRD+K N+LV+T S + ISDFG K+L + +GT
Sbjct: 137 IHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTS 196
Query: 971 QYMAPEVIDK-----GQRGYGAPV 989
+ APE++++ +R +
Sbjct: 197 GWRAPELLEESNNLQTKRRLTRSI 220
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-33
Identities = 55/179 (30%), Positives = 91/179 (50%), Gaps = 6/179 (3%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
LG G +G V+ E +KLA K I + + D + + EI + +QL H N++Q +
Sbjct: 96 ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF 155
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
+ + ME V GG L + + L E ++ + KQI EG++++H I+H D+
Sbjct: 156 ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT--ILFMKQICEGIRHMHQMYILHLDL 213
Query: 932 KGDNVL-VNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPV 989
K +N+L VN + +KI DFG ++R F GT +++APEV++ P
Sbjct: 214 KPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-GTPEFLAPEVVN--YDFVSFPT 269
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-33
Identities = 60/186 (32%), Positives = 93/186 (50%), Gaps = 18/186 (9%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLG 869
ELGKG++ VV ++ A K I K L D Q L E ++ +L+H NIV+
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLR-VKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
S+ EE + + + V GG L V E ++ S +QILE + Y H IVH
Sbjct: 96 SIQEESFHYLVFDLVTGGEL--FEDIVAREFYSEADA--SHCIQQILESIAYCHSNGIVH 151
Query: 929 RDIKGDNVLVNTYS--GVVKISDFGTSKRLAGLCPSAETFT---GTLQYMAPEVIDKGQR 983
R++K +N+L+ + + VK++DFG + + +E + GT Y++PEV+ K
Sbjct: 152 RNLKPENLLLASKAKGAAVKLADFGLAIEV----NDSEAWHGFAGTPGYLSPEVLKK--D 205
Query: 984 GYGAPV 989
Y PV
Sbjct: 206 PYSKPV 211
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-33
Identities = 49/197 (24%), Positives = 85/197 (43%), Gaps = 27/197 (13%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR-HRNIVQYLGSV 871
L +G + VY A+++ + A+K + + + +E+ +L H NIVQ+ +
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 872 S--------EEGYFKIFMEQVPGGSLSTLLRVKW-GPLKENESTMSFYTKQILEGLKYLH 922
S + F + E G + L +++ GPL + FY Q ++++H
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY--QTCRAVQHMH 153
Query: 923 GQK--IVHRDIKGDNVLVNTYSGVVKISDFG------------TSKRLAGLCPSAETFTG 968
QK I+HRD+K +N+L++ G +K+ DFG S + L T
Sbjct: 154 RQKPPIIHRDLKVENLLLSN-QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 969 TLQYMAPEVIDKGQRGY 985
T Y PE+ID
Sbjct: 213 TPMYRTPEIIDLYSNFP 229
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-33
Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 18/203 (8%)
Query: 801 RFLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR 860
RF ++ L LG+G++ V L + A+K I ++ + E+++ Q +
Sbjct: 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ 68
Query: 861 -HRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLR-VKWGPLKENESTMSFYTKQILEGL 918
HRN+++ + EE F + E++ GGS+ L K E E+ S + + L
Sbjct: 69 GHRNVLELIEFFEEEDRFYLVFEKMRGGSI--LSHIHKRRHFNELEA--SVVVQDVASAL 124
Query: 919 KYLHGQKIVHRDIKGDNVLVNTYSGV--VKISDFGTSKRL-------AGLCPSAETFTGT 969
+LH + I HRD+K +N+L + V VKI DF + P T G+
Sbjct: 125 DFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 970 LQYMAPEVIDK---GQRGYGAPV 989
+YMAPEV++ Y
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRC 207
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 8e-33
Identities = 36/229 (15%), Positives = 77/229 (33%), Gaps = 30/229 (13%)
Query: 783 EDLRTIPTKKKYMQTPMLRFLYLFALNRIELGKGSYGVVYAARELDRQV-----KLAIKE 837
E +P K + + L LG+G++ VY A + D K +K
Sbjct: 46 EWQCKLPAIKPKTEFQLGSKLVYV---HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKV 102
Query: 838 IPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLL---- 893
N + + ++ +++ + + + E G+L +
Sbjct: 103 QKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYK 162
Query: 894 RVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTY----------SG 943
+ + + ++L ++ +H +I+H DIK DN ++ S
Sbjct: 163 NTPEKVMPQGLV--ISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA 220
Query: 944 VVKISDFGTSKRLAGLCPSAETFT---GTLQYMAPEVIDKGQRGYGAPV 989
+ + D G S + L P FT T + E++ + + +
Sbjct: 221 GLALIDLGQSIDM-KLFPKGTIFTAKCETSGFQCVEMLSN--KPWNYQI 266
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 9e-33
Identities = 55/183 (30%), Positives = 88/183 (48%), Gaps = 15/183 (8%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIK-LHSQLRHRNIVQYLGS 870
++G GSY V ++ A+K I +K+ D EEI+ L +H NI+
Sbjct: 29 DIGVGSYSVCKRCIHKATNMEFAVKII-DKSKRDPT---EEIEILLRYGQHPNIITLKDV 84
Query: 871 VSEEGYFKIFMEQVPGGSLSTLLR-VKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
+ Y + E + GG L L + ++ E E+ S I + ++YLH Q +VHR
Sbjct: 85 YDDGKYVYVVTELMKGGEL--LDKILRQKFFSEREA--SAVLFTITKTVEYLHAQGVVHR 140
Query: 930 DIKGDNVLVNTYSG---VVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYG 986
D+K N+L SG ++I DFG +K+L T T ++APEV+++ +GY
Sbjct: 141 DLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER--QGYD 198
Query: 987 APV 989
A
Sbjct: 199 AAC 201
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-33
Identities = 49/189 (25%), Positives = 91/189 (48%), Gaps = 19/189 (10%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG------DVQPLHEEIKLHSQLRHRNIV 865
ELG G + +V R+ + A K I ++ L + + E+ + ++RH NI+
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
+ + +E V GG L L + L E+E+ + + KQIL+G+ YLH ++
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEA--TQFLKQILDGVHYLHSKR 128
Query: 926 IVHRDIKGDNVLV---NTYSGVVKISDFGTSKRLAGLCPSAE--TFTGTLQYMAPEVIDK 980
I H D+K +N+++ N + +K+ DFG + ++ E GT +++APE+++
Sbjct: 129 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE---AGNEFKNIFGTPEFVAPEIVN- 184
Query: 981 GQRGYGAPV 989
G
Sbjct: 185 -YEPLGLEA 192
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 54/181 (29%), Positives = 91/181 (50%), Gaps = 10/181 (5%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIP-EKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
LG+G+YG V A + +A+K + ++ + + + +EI ++ L H N+V++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
E +F+E GG L + + E ++ F Q++ G+ YLHG I HRDI
Sbjct: 75 REGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFF--HQLMAGVVYLHGIGITHRDI 131
Query: 932 KGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA--ETFTGTLQYMAPEVIDKGQRGY-GAP 988
K +N+L++ +KISDFG + GTL Y+APE++ + R + P
Sbjct: 132 KPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR--REFHAEP 188
Query: 989 V 989
V
Sbjct: 189 V 189
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 45/179 (25%), Positives = 74/179 (41%), Gaps = 7/179 (3%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
+LG+G +G+V+ E + K + K D + +EI + + RHRNI+ S
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESF 70
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
+ E + G + + L E E Y Q+ E L++LH I H DI
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREI--VSYVHQVCEALQFLHSHNIGHFDI 128
Query: 932 KGDNVL-VNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPV 989
+ +N++ S +KI +FG +++L F +Y APEV
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF-TAPEYYAPEVHQ--HDVVSTAT 184
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 55/190 (28%), Positives = 87/190 (45%), Gaps = 22/190 (11%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHE------EIKLHSQLR----H 861
LGKG +G V+A L ++++AIK IP + PL + E+ L ++ H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 862 RNIVQYLGSVSEEGYFKIFME-QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKY 920
+++ L + F + +E +P L + K GPL E S F Q++ +++
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFF--GQVVAAIQH 154
Query: 921 LHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA--ETFTGTLQYMAPEVI 978
H + +VHRDIK +N+L++ G K+ DFG L F GT Y PE I
Sbjct: 155 CHSRGVVHRDIKDENILIDLRRGCAKLIDFG----SGALLHDEPYTDFDGTRVYSPPEWI 210
Query: 979 DKGQRGYGAP 988
+ Y A
Sbjct: 211 SR--HQYHAL 218
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-32
Identities = 48/187 (25%), Positives = 86/187 (45%), Gaps = 15/187 (8%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG------DVQPLHEEIKLHSQLRHRNIV 865
ELG G + +V RE ++ A K I ++ + + E+ + Q+ H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
+ +E V GG L L + L E E+ + + KQIL+G+ YLH +K
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEA--TSFIKQILDGVNYLHTKK 135
Query: 926 IVHRDIKGDNVLVNTYSG---VVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQ 982
I H D+K +N+++ + +K+ DFG + + F GT +++APE+++
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIVN--Y 192
Query: 983 RGYGAPV 989
G
Sbjct: 193 EPLGLEA 199
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 27/177 (15%), Positives = 62/177 (35%), Gaps = 15/177 (8%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD--VQPLHEEIKLHSQLRHRNIVQYLG 869
+L + G ++ R + +K + ++ + +EE H N++ LG
Sbjct: 17 KLNENHSGELWKGRWQGNDI--VVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 870 SVSE--EGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK-- 925
+ + + +P GSL +L + + + F + G+ +LH +
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKF-ALDMARGMAFLHTLEPL 133
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQ 982
I + +V+++ +IS + ++APE + K
Sbjct: 134 IPRHALNSRSVMIDE-DMTARISMADVKFSF-----QSPGRMYAPAWVAPEALQKKP 184
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-32
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 13/206 (6%)
Query: 789 PTKKKYMQTPMLRFLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG---D 845
T ++Q F + R LGKGS+G V ++ + A+K I ++ + D
Sbjct: 11 ATPGMFVQHSTAIFSDRYKGQR-VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD 69
Query: 846 VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENES 905
+ L E++L QL H NI++ ++GYF + E GG L + + E ++
Sbjct: 70 KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVDA 128
Query: 906 TMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYS--GVVKISDFGTSKRLAGLCPSA 963
+ +Q+L G+ Y+H KIVHRD+K +N+L+ + S ++I DFG S
Sbjct: 129 --ARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKM 185
Query: 964 ETFTGTLQYMAPEVIDKGQRGYGAPV 989
+ GT Y+APEV+ Y
Sbjct: 186 KDKIGTAYYIAPEVL---HGTYDEKC 208
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 7e-32
Identities = 58/184 (31%), Positives = 88/184 (47%), Gaps = 18/184 (9%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
ELG+G+ +VY ++ Q A+K + + D + + EI + +L H NI++
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 872 SEEGYFKIFMEQVPGGSLSTLLR-VKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRD 930
+ +E V GG L R V+ G E ++ + KQILE + YLH IVHRD
Sbjct: 118 ETPTEISLVLELVTGGEL--FDRIVEKGYYSERDA--ADAVKQILEAVAYLHENGIVHRD 173
Query: 931 IKGDNVLVNTYSG--VVKISDFGTSKRLAGLCPSAETFT---GTLQYMAPEVIDKGQRGY 985
+K +N+L T + +KI+DFG SK + GT Y APE++ Y
Sbjct: 174 LKPENLLYATPAPDAPLKIADFGLSKIV----EHQVLMKTVCGTPGYCAPEILRG--CAY 227
Query: 986 GAPV 989
G V
Sbjct: 228 GPEV 231
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-32
Identities = 49/189 (25%), Positives = 86/189 (45%), Gaps = 19/189 (10%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL------GDVQPLHEEIKLHSQLRHRNIV 865
ELG G + +V RE ++ A K I ++ + + E+ + Q+ H NI+
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
+ +E V GG L L + L E E+ + + KQIL+G+ YLH +K
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEA--TSFIKQILDGVNYLHTKK 135
Query: 926 IVHRDIKGDNVLVNTYSG---VVKISDFGTSKRLAGLCPSAE--TFTGTLQYMAPEVIDK 980
I H D+K +N+++ + +K+ DFG + + E GT +++APE+++
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE---DGVEFKNIFGTPEFVAPEIVN- 191
Query: 981 GQRGYGAPV 989
G
Sbjct: 192 -YEPLGLEA 199
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 9e-32
Identities = 54/181 (29%), Positives = 91/181 (50%), Gaps = 10/181 (5%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIP-EKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
LG+G+YG V A + +A+K + ++ + + + +EI ++ L H N+V++ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
E +F+E GG L + + E ++ F Q++ G+ YLHG I HRDI
Sbjct: 75 REGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFF--HQLMAGVVYLHGIGITHRDI 131
Query: 932 KGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA--ETFTGTLQYMAPEVIDKGQRGY-GAP 988
K +N+L++ +KISDFG + GTL Y+APE++ + R + P
Sbjct: 132 KPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR--REFHAEP 188
Query: 989 V 989
V
Sbjct: 189 V 189
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-31
Identities = 49/189 (25%), Positives = 87/189 (46%), Gaps = 19/189 (10%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG------DVQPLHEEIKLHSQLRHRNIV 865
ELG G + VV RE ++ A K I ++ + + E+ + +++H N++
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
+ + +E V GG L L + L E E+ + + KQIL G+ YLH +
Sbjct: 78 TLHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEA--TEFLKQILNGVYYLHSLQ 134
Query: 926 IVHRDIKGDNVLV---NTYSGVVKISDFGTSKRLAGLCPSAE--TFTGTLQYMAPEVIDK 980
I H D+K +N+++ N +KI DFG + ++ E GT +++APE+++
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID---FGNEFKNIFGTPEFVAPEIVN- 190
Query: 981 GQRGYGAPV 989
G
Sbjct: 191 -YEPLGLEA 198
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-31
Identities = 53/185 (28%), Positives = 86/185 (46%), Gaps = 17/185 (9%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLG 869
LGKGS+G V ++ Q + A+K I + + D + E++L +L H NI++
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
+ + F I E GG L + +K E+++ + KQ+ G+ Y+H IVHR
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDA--ARIIKQVFSGITYMHKHNIVHR 145
Query: 930 DIKGDNVLVNTYS--GVVKISDFGTSKRLAGLCPSAETFT---GTLQYMAPEVIDKGQRG 984
D+K +N+L+ + +KI DFG S GT Y+APEV+ +
Sbjct: 146 DLKPENILLESKEKDCDIKIIDFGLSTC----FQQNTKMKDRIGTAYYIAPEVL---RGT 198
Query: 985 YGAPV 989
Y
Sbjct: 199 YDEKC 203
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-31
Identities = 41/206 (19%), Positives = 80/206 (38%), Gaps = 40/206 (19%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHE-----------------EIKL 855
L +G + + + ++ A+K+ + L + + E+++
Sbjct: 39 LNQGKFNKIILCEKDNKFY--ALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 856 HSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKEN------ESTMSF 909
+ +++ + G ++ I E + S+ + L +N +
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD-EYFFVLDKNYTCFIPIQVIKC 155
Query: 910 YTKQILEGLKYLHGQK-IVHRDIKGDNVLVNTYSGVVKISDFGTSK-----RLAGLCPSA 963
K +L Y+H +K I HRD+K N+L++ G VK+SDFG S+ ++ G
Sbjct: 156 IIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN-GRVKLSDFGESEYMVDKKIKGSR--- 211
Query: 964 ETFTGTLQYMAPEVIDKGQRGYGAPV 989
GT ++M PE GA V
Sbjct: 212 ----GTYEFMPPEFFSNESSYNGAKV 233
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 47/184 (25%), Positives = 72/184 (39%), Gaps = 26/184 (14%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHE-EIKLHSQLRHRNIVQYLGSV 871
+GKG YG V+ V A+K ++ E E+ LRH NI+ ++ S
Sbjct: 16 VGKGRYGEVWRGSWQGENV--AVKIFSSRDEKSWF--RETELYNTVMLRHENILGFIASD 71
Query: 872 ----SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ--- 924
+ GSL L++ + + I GL +LH +
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 925 -----KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF----TGTLQYMAP 975
I HRD+K N+LV +G I+D G + + + GT +YMAP
Sbjct: 128 TQGKPAIAHRDLKSKNILVKK-NGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 976 EVID 979
EV+D
Sbjct: 187 EVLD 190
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-31
Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 12/205 (5%)
Query: 789 PTKKKYMQTPMLRFLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DV 846
T ++ + ++ + +LG G+YG V R+ V+ AIK I + ++
Sbjct: 22 ATPGMFITSKKGHLSEMYQRVK-KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSN 80
Query: 847 QPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENEST 906
L EE+ + L H NI++ ++ + + ME GG L + + E ++
Sbjct: 81 SKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI-IHRMKFNEVDA- 138
Query: 907 MSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYS--GVVKISDFGTSKRLAGLCPSAE 964
+ KQ+L G+ YLH IVHRD+K +N+L+ + ++KI DFG S +
Sbjct: 139 -AVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN-QKKMK 196
Query: 965 TFTGTLQYMAPEVIDKGQRGYGAPV 989
GT Y+APEV+ ++ Y
Sbjct: 197 ERLGTAYYIAPEVL---RKKYDEKC 218
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 6e-31
Identities = 48/186 (25%), Positives = 80/186 (43%), Gaps = 15/186 (8%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHR-NIVQYL 868
ELG+G + VV + A K + ++ G + EI + + ++
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 869 GSVSEEGYFKIFMEQVPGGSL-STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
+ +E GG + S L + EN+ KQILEG+ YLH IV
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDV--IRLIKQILEGVYYLHQNNIV 153
Query: 928 HRDIKGDNVLVNTYS--GVVKISDFGTSKRLAGLCPSAE--TFTGTLQYMAPEVIDKGQR 983
H D+K N+L+++ G +KI DFG S+++ + E GT +Y+APE+++
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG---HACELREIMGTPEYLAPEILN--YD 208
Query: 984 GYGAPV 989
Sbjct: 209 PITTAT 214
|
| >3rfy_A Peptidyl-prolyl CIS-trans isomerase CYP38, chloro; cyclophilin, peptidyl prolyl isomerase, ppiase, TLP,; 2.39A {Arabidopsis thaliana} Length = 369 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 38/173 (21%), Positives = 60/173 (34%), Gaps = 42/173 (24%)
Query: 115 MVTNLDDNLESEH----IKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQG 170
M + DN E I L P TA NF L E+ F + R F+ Q
Sbjct: 175 MKVKIKDNPNIEDCVFRIVLDGYNAPVTAGNFVDLV--ERHF-YDGMEIQRS-DGFVVQT 230
Query: 171 GD-------FTNHNGTGGKSI-------------YGNKFED-----ENFTLKHTGPGILS 205
GD F + + +++ YG+ E+ + G ++
Sbjct: 231 GDPEGPAEGFIDPSTEKTRTVPLEIMVTGEKTPFYGSTLEELGLYKAQVVIPFNAFGTMA 290
Query: 206 MANAG--PNTNGSQFFITTVK-------TAWLDNRHVVFGSVVEGLDVVKKLE 249
MA ++ SQ F + + LD R+ VFG V + D + L+
Sbjct: 291 MAREEFENDSGSSQVFWLLKESELTPSNSNILDGRYAVFGYVTDNEDFLADLK 343
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-30
Identities = 49/190 (25%), Positives = 76/190 (40%), Gaps = 19/190 (10%)
Query: 808 LNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQ 866
L++ LG G G V K A+K + D +E+ H Q +IV
Sbjct: 32 LSKQVLGLGVNGKVLECFHRRTGQKCALKLLY-----DSPKARQEVDHHWQASGGPHIVC 86
Query: 867 ----YLGSVSEEGYFKIFMEQVPGGSLSTLLR-VKWGPLKENESTMSFYTKQILEGLKYL 921
Y + I ME + GG L R + G E + + I +++L
Sbjct: 87 ILDVYENMHHGKRCLLIIMECMEGGEL--FSRIQERGDQAFTEREAAEIMRDIGTAIQFL 144
Query: 922 HGQKIVHRDIKGDNVLVNTYSG--VVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVID 979
H I HRD+K +N+L + V+K++DFG +K + +T T Y+APEV+
Sbjct: 145 HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ--NALQTPCYTPYYVAPEVLG 202
Query: 980 KGQRGYGAPV 989
Y
Sbjct: 203 P--EKYDKSC 210
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 47/188 (25%), Positives = 80/188 (42%), Gaps = 20/188 (10%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHE------EIKLHSQLRHR--N 863
LG G +G VY+ + + +AIK + + + D L E+ L ++
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 864 IVQYLGSVSEEGYFKIFMEQV-PGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLH 922
+++ L F + +E+ P L + + G L+E + F Q+LE +++ H
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFF--WQVLEAVRHCH 166
Query: 923 GQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA--ETFTGTLQYMAPEVIDK 980
++HRDIK +N+L++ G +K+ DFG L F GT Y PE I
Sbjct: 167 NCGVLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVYSPPEWIRY 222
Query: 981 GQRGYGAP 988
Y
Sbjct: 223 --HRYHGR 228
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 56/186 (30%), Positives = 89/186 (47%), Gaps = 13/186 (6%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHE----EIKLHSQLRHRNIVQYL 868
LG+GSYG V + + + A+K + +K L + EI+L +LRH+N++Q +
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 869 GSVSEEGYFKIF--MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
+ E K++ ME G L V ++ Y Q+++GL+YLH Q I
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQA--HGYFCQLIDGLEYLHSQGI 130
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA--ETFTGTLQYMAPEVIDKGQRG 984
VH+DIK N+L+ T G +KIS G ++ L T G+ + PE+ G
Sbjct: 131 VHKDIKPGNLLL-TTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIA-NGLDT 188
Query: 985 Y-GAPV 989
+ G V
Sbjct: 189 FSGFKV 194
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-30
Identities = 58/219 (26%), Positives = 90/219 (41%), Gaps = 31/219 (14%)
Query: 790 TKKKYMQTPMLRFLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL------ 843
Y++ + + R +LG G+YG V +E + + AIK I +
Sbjct: 22 NPGMYVRKKEGKIGESYFKVR-KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYS 80
Query: 844 -------GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLR-V 895
+ ++ EI L L H NI++ ++ YF + E GG L + +
Sbjct: 81 DDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL--FEQII 138
Query: 896 KWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYS--GVVKISDFGTS 953
E + + KQIL G+ YLH IVHRDIK +N+L+ + +KI DFG S
Sbjct: 139 NRHKFDECD--AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLS 196
Query: 954 KRLAGLCPSAETFT---GTLQYMAPEVIDKGQRGYGAPV 989
GT Y+APEV+ ++ Y
Sbjct: 197 SF----FSKDYKLRDRLGTAYYIAPEVL---KKKYNEKC 228
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 57/184 (30%), Positives = 94/184 (51%), Gaps = 15/184 (8%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIK-----EIPEKNLGDVQPLHEEIKLHSQLRHRNIVQY 867
LG+GS+ V AREL + AIK I ++N V + E + S+L H V+
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKEN--KVPYVTRERDVMSRLDHPFFVKL 95
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
+ ++ + G L +R K G +E+ FYT +I+ L+YLHG+ I+
Sbjct: 96 YFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSF--DETCTRFYTAEIVSALEYLHGKGII 152
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT--GTLQYMAPEVIDKGQRGY 985
HRD+K +N+L+N ++I+DFGT+K L+ A + GT QY++PE++ + +
Sbjct: 153 HRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE--KSA 209
Query: 986 GAPV 989
Sbjct: 210 CKSS 213
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-30
Identities = 53/186 (28%), Positives = 76/186 (40%), Gaps = 18/186 (9%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQ---- 866
LG G G V Q K A+K + D E++LH + + +IV+
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 123
Query: 867 YLGSVSEEGYFKIFMEQVPGGSLSTLLR-VKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
Y + I ME + GG L R G E S K I E ++YLH
Sbjct: 124 YENLYAGRKCLLIVMECLDGGEL--FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 181
Query: 926 IVHRDIKGDNVLVNTYSG--VVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQR 983
I HRD+K +N+L + ++K++DFG +K S T T Y+APEV+
Sbjct: 182 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS-HNSLTTPCYTPYYVAPEVLGP--E 238
Query: 984 GYGAPV 989
Y
Sbjct: 239 KYDKSC 244
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-30
Identities = 28/210 (13%), Positives = 58/210 (27%), Gaps = 36/210 (17%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYL 868
L G VV+ R+++R A+K +++ LHE ++L + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 869 GSVSEEGYFKI-------------------------FMEQVPGGSLSTLL----RVKWGP 899
+ L L V
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 900 LKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGL 959
E + T Q++ L + +VH DN+ + G + + D ++
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMP-DGRLMLGDVSALWKVGTR 247
Query: 960 CPSAETFTGTLQYMAPEVIDKGQRGYGAPV 989
P + + Y E ++ + +
Sbjct: 248 GP---ASSVPVTYAPREFLNASTATFTHAL 274
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-29
Identities = 47/198 (23%), Positives = 79/198 (39%), Gaps = 32/198 (16%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--------GDVQPLHEEIK-LHSQLRHR 862
+G+G VV + A+K + + E L H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 863 NIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLR-VKWGPLKENESTMSFYTKQILEGLKYL 921
+I+ + S + + + + G L + L E E+ + +LE + +L
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGEL--FDYLTEKVALSEKET--RSIMRSLLEAVSFL 216
Query: 922 HGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK------RLAGLCPSAETFTGTLQYMAP 975
H IVHRD+K +N+L++ +++SDFG S +L LC GT Y+AP
Sbjct: 217 HANNIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEKLRELC-------GTPGYLAP 268
Query: 976 EVI----DKGQRGYGAPV 989
E++ D+ GYG V
Sbjct: 269 EILKCSMDETHPGYGKEV 286
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 46/186 (24%), Positives = 76/186 (40%), Gaps = 28/186 (15%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHE-EIKLHSQLRHRNIVQYLGS 870
++GKG YG V+ + +V A+K E EI +RH NI+ ++ +
Sbjct: 44 QIGKGRYGEVWMGKWRGEKV--AVKVFFTTEEASWF--RETEIYQTVLMRHENILGFIAA 99
Query: 871 VSEEGYFK----IFMEQVPGGSLSTLLRVKWGPLKENES-TMSFYTKQILEGLKYLHGQ- 924
+ + + GSL L+ L +++ + GL +LH +
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAY---SSVSGLCHLHTEI 154
Query: 925 -------KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAE----TFTGTLQYM 973
I HRD+K N+LV +G I+D G + + + T GT +YM
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 974 APEVID 979
PEV+D
Sbjct: 214 PPEVLD 219
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 50/199 (25%), Positives = 80/199 (40%), Gaps = 33/199 (16%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---------GDVQPLHEEIK-LHSQLRH 861
LG+G VV + A+K I + +E+ L H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 862 RNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLR-VKWGPLKENESTMSFYTKQILEGLKY 920
NI+Q + +F + + + G L + L E E+ + +LE +
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGEL--FDYLTEKVTLSEKET--RKIMRALLEVICA 139
Query: 921 LHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK------RLAGLCPSAETFTGTLQYMA 974
LH IVHRD+K +N+L++ +K++DFG S +L +C GT Y+A
Sbjct: 140 LHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSCQLDPGEKLREVC-------GTPSYLA 191
Query: 975 PEVI----DKGQRGYGAPV 989
PE+I + GYG V
Sbjct: 192 PEIIECSMNDNHPGYGKEV 210
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 51/187 (27%), Positives = 97/187 (51%), Gaps = 20/187 (10%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHE--------EIKLHSQLRHRNI 864
LG G++G V+ A + ++ ++ +K I ++ + + + + EI + S++ H NI
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 865 VQYLGSVSEEGYFKIFMEQ-VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHG 923
++ L +G+F++ ME+ G L + + L E + S+ +Q++ + YL
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFI-DRHPRLDEPLA--SYIFRQLVSAVGYLRL 148
Query: 924 QKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA--ETFTGTLQYMAPEVIDKG 981
+ I+HRDIK +N+++ +K+ DFG++ A L TF GT++Y APEV+
Sbjct: 149 KDIIHRDIKDENIVIAED-FTIKLIDFGSA---AYLERGKLFYTFCGTIEYCAPEVLMG- 203
Query: 982 QRGYGAP 988
Y P
Sbjct: 204 -NPYRGP 209
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-29
Identities = 59/184 (32%), Positives = 94/184 (51%), Gaps = 21/184 (11%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGS 870
+GKG++ V AR + ++AIK I + L +Q L E+++ L H NIV+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 871 VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRD 930
+ E + ME GG + L V G +KE E+ F +QI+ ++Y H ++IVHRD
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYL-VAHGRMKEKEARSKF--RQIVSAVQYCHQKRIVHRD 139
Query: 931 IKGDNVLVNTYSGVVKISDFGTS------KRLAGLCPSAETFTGTLQYMAPEVIDKGQRG 984
+K +N+L++ +KI+DFG S +L + F G Y APE+ +G +
Sbjct: 140 LKAENLLLDA-DMNIKIADFGFSNEFTVGGKL-------DAFCGAPPYAAPELF-QG-KK 189
Query: 985 YGAP 988
Y P
Sbjct: 190 YDGP 193
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-29
Identities = 55/179 (30%), Positives = 88/179 (49%), Gaps = 12/179 (6%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVS 872
+G G++GV R+ + +A+K E+ + + EI H LRH NIV++ +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVK-YIERGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 873 EEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIK 932
+ I ME GG L + G E+E+ F +Q+L G+ Y H +I HRD+K
Sbjct: 87 TPTHLAIIMEYASGGELYERI-CNAGRFSEDEARFFF--QQLLSGVSYCHSMQICHRDLK 143
Query: 933 GDNVLV-NTYSGVVKISDFGTSK--RLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAP 988
+N L+ + + +KI DFG SK L ++ GT Y+APEV+ + + Y
Sbjct: 144 LENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLR--QEYDGK 197
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 46/185 (24%), Positives = 76/185 (41%), Gaps = 28/185 (15%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHE-EIKLHSQLRHRNIVQYLGSV 871
+GKG +G V+ + +V A+K + E EI LRH NI+ ++ +
Sbjct: 50 IGKGRFGEVWRGKWRGEEV--AVKIFSSREERSW--FREAEIYQTVMLRHENILGFIAAD 105
Query: 872 SEEGYFK----IFMEQVPGGSLSTLLRVKWGPLKENES-TMSFYTKQILEGLKYLHGQ-- 924
+++ + + GSL L + ++ GL +LH +
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLAL---STASGLAHLHMEIV 160
Query: 925 ------KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF----TGTLQYMA 974
I HRD+K N+LV +G I+D G + R + + GT +YMA
Sbjct: 161 GTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 975 PEVID 979
PEV+D
Sbjct: 220 PEVLD 224
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 54/190 (28%), Positives = 75/190 (39%), Gaps = 32/190 (16%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHE-EIKLHSQLRHRNIVQYLGSV 871
+G+G YG VY +R V A+K N + +E I + H NI +++
Sbjct: 21 IGRGRYGAVYKGSLDERPV--AVKVFSFANRQNFI--NEKNIYRVPLMEHDNIARFIVGD 76
Query: 872 SEEGYFK-----IFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ-- 924
+ ME P GSL L + + + GL YLH +
Sbjct: 77 ERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLA----HSVTRGLAYLHTELP 132
Query: 925 -------KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAE--------TFTGT 969
I HRD+ NVLV G ISDFG S RL G + GT
Sbjct: 133 RGDHYKPAISHRDLNSRNVLVKN-DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGT 191
Query: 970 LQYMAPEVID 979
++YMAPEV++
Sbjct: 192 IRYMAPEVLE 201
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 9e-28
Identities = 47/181 (25%), Positives = 79/181 (43%), Gaps = 22/181 (12%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKN-LGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
++G+G++G V++ R +A+K E +E ++ Q H NIV+ +G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 871 VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRD 930
+++ I ME V GG T LR + L+ T+ G++YL + +HRD
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARLR--VKTLLQMVGDAAAGMEYLESKCCIHRD 238
Query: 931 IKGDNVLVNTYSGVVKISDFG----------TSKRLAGLCPSAETFTGTLQYMAPEVIDK 980
+ N LV V+KISDFG + P +++ APE ++
Sbjct: 239 LAARNCLVTE-KNVLKISDFGMSREEADGVYAASGGLRQVP--------VKWTAPEALNY 289
Query: 981 G 981
G
Sbjct: 290 G 290
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 52/186 (27%), Positives = 82/186 (44%), Gaps = 26/186 (13%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHE-EIKLHSQLRHRNIVQYLGSV 871
+G +G V+ A+ L+ V A+K P ++ Q +E E+ ++H NI+Q++G+
Sbjct: 32 KARGRFGCVWKAQLLNEYV--AVKIFPIQDKQSWQ--NEYEVYSLPGMKHENILQFIGAE 87
Query: 872 SEEGYFK----IFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ--- 924
+ GSLS L+ + NE T + GL YLH
Sbjct: 88 KRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAET--MARGLAYLHEDIPG 143
Query: 925 -------KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAET--FTGTLQYMAP 975
I HRDIK NVL+ + I+DFG + + + +T GT +YMAP
Sbjct: 144 LKDGHKPAISHRDIKSKNVLLKN-NLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAP 202
Query: 976 EVIDKG 981
EV++
Sbjct: 203 EVLEGA 208
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 58/181 (32%), Positives = 85/181 (46%), Gaps = 14/181 (7%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPE---KNLGDVQPLHEEIKLHSQLRHRNIVQYLG 869
LG G++G V K+A+K + ++L V + EI+ RH +I++
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
+S F + ME V GG L + K G ++E E+ F +QIL + Y H +VHR
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYI-CKHGRVEEMEARRLF--QQILSAVDYCHRHMVVHR 135
Query: 930 DIKGDNVLVNTYSGVVKISDFGTS--KRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGA 987
D+K +NVL++ KI+DFG S T G+ Y APEVI R Y
Sbjct: 136 DLKPENVLLDA-HMNAKIADFGLSNMMSDGEFL---RTSCGSPNYAAPEVISG--RLYAG 189
Query: 988 P 988
P
Sbjct: 190 P 190
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-27
Identities = 49/182 (26%), Positives = 89/182 (48%), Gaps = 16/182 (8%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIK-----EIPEKNLGDVQPLHEEIKLHSQLRHRNIVQY 867
LG GS+G V + + A+K ++ + ++ E ++ + +V+
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK--QIEHTLNEKRILQAVNFPFLVKL 106
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
S + + ME V GG + + LR + G +E FY QI+ +YLH ++
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRF--SEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGA 987
+RD+K +N+L++ G ++++DFG +KR+ G T GT + +APE+I +GY
Sbjct: 164 YRDLKPENLLID-QQGYIQVTDFGFAKRVKG---RTWTLCGTPEALAPEIIL--SKGYNK 217
Query: 988 PV 989
V
Sbjct: 218 AV 219
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 6e-27
Identities = 51/190 (26%), Positives = 85/190 (44%), Gaps = 22/190 (11%)
Query: 810 RIE-LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHE--EIKLHSQLRHRNIVQ 866
+I +G+GSYGVV+ R D +AIK+ E V EI++ QL+H N+V
Sbjct: 7 KIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVN 66
Query: 867 YLGSVSEEGYFKI---FMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHG 923
L + + + + ++ L + E + T Q L+ + + H
Sbjct: 67 LLEVFRRKRRLHLVFEYCDH----TVLHELDRYQRGV--PEHLVKSITWQTLQAVNFCHK 120
Query: 924 QKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GLCPSAETFTG---TLQYMAPEVID 979
+HRD+K +N+L+ V+K+ DFG A L ++ + T Y +PE++
Sbjct: 121 HNCIHRDVKPENILITK-HSVIKLCDFG----FARLLTGPSDYYDDEVATRWYRSPELL- 174
Query: 980 KGQRGYGAPV 989
G YG PV
Sbjct: 175 VGDTQYGPPV 184
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 8e-27
Identities = 55/190 (28%), Positives = 92/190 (48%), Gaps = 26/190 (13%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYL---- 868
+G GS+GVVY A+ D +AIK++ + D + + E+++ +L H NIV+
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 869 --GSVSEEGYFKIFMEQVPGGSLSTLLRV-KWGPLKENESTMS---FYTKQILEGLKYLH 922
G +E Y + ++ VP T+ RV + + + Y Q+ L Y+H
Sbjct: 118 SSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 923 GQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG---TLQYMAPEVID 979
I HRDIK N+L++ + V+K+ DFG++K+L E + Y APE+I
Sbjct: 174 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV----RGEPNVSYICSRYYRAPELI- 228
Query: 980 KGQRGYGAPV 989
G Y + +
Sbjct: 229 FGATDYTSSI 238
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-26
Identities = 56/195 (28%), Positives = 90/195 (46%), Gaps = 37/195 (18%)
Query: 813 LGKGSYGVVYAARELD-RQVKLAIKEIP----EKNLGDVQPLHEEIKLHSQLRHRNIVQY 867
+G GS+GVV+ A+ ++ +V AIK++ KN E+++ ++H N+V
Sbjct: 48 IGNGSFGVVFQAKLVESDEV--AIKKVLQDKRFKN--------RELQIMRIVKHPNVVDL 97
Query: 868 L------GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKEN----ESTMSFYTKQILEG 917
G +E + + +E VP T+ R K + Y Q+L
Sbjct: 98 KAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153
Query: 918 LKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG---TLQYMA 974
L Y+H I HRDIK N+L++ SGV+K+ DFG++K L + E + Y A
Sbjct: 154 LAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI----AGEPNVSYICSRYYRA 209
Query: 975 PEVIDKGQRGYGAPV 989
PE+I G Y +
Sbjct: 210 PELI-FGATNYTTNI 223
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 59/267 (22%), Positives = 118/267 (44%), Gaps = 20/267 (7%)
Query: 733 VQLVEFLPYLGTIRTQQLQFPLANLLEKLLLLIDLQDYDAMDYDAMV-QLVEDLRTIPTK 791
++ +E G +T F + LL+ L+ L D + + + + + +E + +K
Sbjct: 6 LRQLEQFILDGPAQTNGQCFSVETLLDILICLYDECNNSPLRREKNILEYLEWAKPFTSK 65
Query: 792 KKYMQTPMLRFLYLFALNRIELGKGSYGVVYAARELDRQVKLAIK-----EIPEKNLGDV 846
K M+ F L ++ +G+G++G V + + A+K E+ ++ +
Sbjct: 66 VKQMRLHREDFEIL----KV-IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRA--ET 118
Query: 847 QPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENEST 906
EE + + I + ++ + M+ GG L TLL L E +
Sbjct: 119 ACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMAR 178
Query: 907 MSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGLCPSAET 965
FY +++ + +H VHRDIK DN+L++ +G ++++DFG+ +L +
Sbjct: 179 --FYLAEMVIAIDSVHQLHYVHRDIKPDNILMD-MNGHIRLADFGSCLKLMEDGTVQSSV 235
Query: 966 FTGTLQYMAPEVI---DKGQRGYGAPV 989
GT Y++PE++ + G+ YG
Sbjct: 236 AVGTPDYISPEILQAMEGGKGRYGPEC 262
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 60/190 (31%), Positives = 91/190 (47%), Gaps = 22/190 (11%)
Query: 810 RIE-LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPL--HEEIKLHSQLRHRNIVQ 866
+ +G+GSYG+V R D +AIK+ E + + EIKL QLRH N+V
Sbjct: 29 NLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVN 88
Query: 867 YLGSVSEEGYFKI---FMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHG 923
L ++ + + F++ ++ L + L + + Y QI+ G+ + H
Sbjct: 89 LLEVCKKKKRWYLVFEFVDH----TILDDLELFPNGL--DYQVVQKYLFQIINGIGFCHS 142
Query: 924 QKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG-LCPSAETFTG---TLQYMAPEVID 979
I+HRDIK +N+LV+ SGVVK+ DFG A L E + T Y APE++
Sbjct: 143 HNIIHRDIKPENILVSQ-SGVVKLCDFG----FARTLAAPGEVYDDEVATRWYRAPELL- 196
Query: 980 KGQRGYGAPV 989
G YG V
Sbjct: 197 VGDVKYGKAV 206
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 36/163 (22%), Positives = 57/163 (34%), Gaps = 15/163 (9%)
Query: 839 PEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWG 898
P + + +I+ +N V L S + Y I M+ +L + +
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 899 PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 958
QI E +++LH + ++HRD+K N+ VVK+ DFG +
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQ 216
Query: 959 LCPSAETFT------------GTLQYMAPEVIDKGQRGYGAPV 989
T GT YM+PE I Y V
Sbjct: 217 DEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG--NNYSHKV 257
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 20/111 (18%), Positives = 39/111 (35%), Gaps = 3/111 (2%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIP-EKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
+G+G +GVV+ A+ AIK I + + E+K ++L H IV+Y +
Sbjct: 14 MGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 73
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLH 922
E K ++ W + + ++ +
Sbjct: 74 LETPPEK--WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 23/199 (11%), Positives = 57/199 (28%), Gaps = 38/199 (19%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLR--------- 860
LG+ A + + + ++ + EE+ LR
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 861 ----------------HRNIVQYLGSVSEEGYFKIFM-EQVPGGSLSTLLR--VKWGPLK 901
+ +++ + F +L T +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 902 EN--ESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGL 959
++ T Q++ L LH +VH ++ +++++ G V ++ F R
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQ-RGGVFLTGFEHLVRDG-- 257
Query: 960 CPSAETFTGTLQYMAPEVI 978
+ + + + PE+
Sbjct: 258 --ARVVSSVSRGFEPPELE 274
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 3e-26
Identities = 51/185 (27%), Positives = 88/185 (47%), Gaps = 22/185 (11%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIK-----EIPEKNLGDVQPLHEEIKLHSQLRHRNIVQY 867
LG GS+G V+ R A+K + V+ ++E + S + H I++
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK--QVEHTNDERLMLSIVTHPFIIRM 71
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKE---NESTMSFYTKQILEGLKYLHGQ 924
G+ + + M+ + GG L +LLR K FY ++ L+YLH +
Sbjct: 72 WGTFQDAQQIFMIMDYIEGGELFSLLR------KSQRFPNPVAKFYAAEVCLALEYLHSK 125
Query: 925 KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRG 984
I++RD+K +N+L++ +G +KI+DFG +K + T GT Y+APEV+ +
Sbjct: 126 DIIYRDLKPENILLD-KNGHIKITDFGFAKYVPD---VTYTLCGTPDYIAPEVVST--KP 179
Query: 985 YGAPV 989
Y +
Sbjct: 180 YNKSI 184
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-26
Identities = 45/180 (25%), Positives = 82/180 (45%), Gaps = 20/180 (11%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
+LG G YG VY + +A+K + E + +V+ +E + +++H N+VQ LG
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
+ E F I E + G+L LR + + + + + QI ++YL + +HR++
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNL 344
Query: 932 KGDNVLVNTYSGVVKISDFGTS---------KRLAGLCPSAETFTGTLQYMAPEVIDKGQ 982
N LV + +VK++DFG S P +++ APE + +
Sbjct: 345 AARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFP--------IKWTAPESLAYNK 395
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 60/175 (34%), Positives = 89/175 (50%), Gaps = 22/175 (12%)
Query: 813 LGKGSYGVVYAARE--LDRQVKLAIKEIPEKNLGD---VQPLHEEIKLHSQLRHRNIVQY 867
LG G VY A + L+ +V AIK I ++ E+ SQL H+NIV
Sbjct: 19 LGGGGMSTVYLAEDTILNIKV--AIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
+ E+ + + ME + G +LS + GPL + + +T QIL+G+K+ H +IV
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAI--NFTNQILDGIKHAHDMRIV 133
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT------GTLQYMAPE 976
HRDIK N+L+ + +KI DFG +K L S + T GT+QY +PE
Sbjct: 134 HRDIKPQNILI-DSNKTLKIFDFGIAKAL-----SETSLTQTNHVLGTVQYFSPE 182
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 49/170 (28%), Positives = 80/170 (47%), Gaps = 10/170 (5%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
E+G G +G+V+ + K+AIK I E + EE ++ +L H +VQ G
Sbjct: 15 EIGSGQFGLVHLGY-WLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
E+ + E + G LS LR + G T+ + EG+ YL ++HRD+
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFA--AETLLGMCLDVCEGMAYLEEACVIHRDL 130
Query: 932 KGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL---QYMAPEVI 978
N LV + V+K+SDFG ++ + + TGT ++ +PEV
Sbjct: 131 AARNCLVGE-NQVIKVSDFGMTRFVLD--DQYTSSTGTKFPVKWASPEVF 177
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-25
Identities = 53/193 (27%), Positives = 88/193 (45%), Gaps = 26/193 (13%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQ---YLG 869
G+G++G V +E + +AIK++ + + + ++ + L H NIVQ Y
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKKVIQ-DPRFRNRELQIMQDLAVLHHPNIVQLQSYFY 89
Query: 870 SVSEEG----YFKIFMEQVPGGSLSTLLRV-KWGPLKENESTMS---FYTKQILEGLKYL 921
++ E Y + ME VP TL R + ++ + Q++ + L
Sbjct: 90 TLGERDRRDIYLNVVMEYVP----DTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCL 145
Query: 922 H--GQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG---TLQYMAPE 976
H + HRDIK NVLVN G +K+ DFG++K+L+ +E + Y APE
Sbjct: 146 HLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS----PSEPNVAYICSRYYRAPE 201
Query: 977 VIDKGQRGYGAPV 989
+I G + Y V
Sbjct: 202 LI-FGNQHYTTAV 213
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-25
Identities = 48/188 (25%), Positives = 82/188 (43%), Gaps = 16/188 (8%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIK-----EIPEKNLGDVQPLHEEIKLHSQLRHRNIVQY 867
+G+G++ V + A+K ++ ++ +V EE + R I Q
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRG--EVSCFREERDVLVNGDRRWITQL 126
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
+ +E Y + ME GG L TLL + + FY +I+ + +H V
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMAR--FYLAEIVMAIDSVHRLGYV 184
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGLCPSAETFTGTLQYMAPEVI-----DKG 981
HRDIK DN+L+ G ++++DFG+ +L A + GT Y++PE++ G
Sbjct: 185 HRDIKPDNILL-DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPG 243
Query: 982 QRGYGAPV 989
YG
Sbjct: 244 TGSYGPEC 251
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-25
Identities = 60/181 (33%), Positives = 85/181 (46%), Gaps = 14/181 (7%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPE---KNLGDVQPLHEEIKLHSQLRHRNIVQYLG 869
LG G++G V + K+A+K + ++L V + EI+ RH +I++
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
+S + ME V GG L + K G L E ES F +QIL G+ Y H +VHR
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLF--QQILSGVDYCHRHMVVHR 140
Query: 930 DIKGDNVLVNTYSGVVKISDFGTS--KRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGA 987
D+K +NVL++ KI+DFG S T G+ Y APEVI R Y
Sbjct: 141 DLKPENVLLDA-HMNAKIADFGLSNMMSDGEFL---RTSCGSPNYAAPEVISG--RLYAG 194
Query: 988 P 988
P
Sbjct: 195 P 195
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 48/170 (28%), Positives = 76/170 (44%), Gaps = 10/170 (5%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
ELG G +GVV + Q +A+K I E +E + +L H +V++ G
Sbjct: 15 ELGSGQFGVVKLGK-WKGQYDVAVKMIKE-GSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
S+E I E + G L LR L+ S + + EG+ +L + +HRD+
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKGLE--PSQLLEMCYDVCEGMAFLESHQFIHRDL 130
Query: 932 KGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL---QYMAPEVI 978
N LV+ VK+SDFG ++ + + GT ++ APEV
Sbjct: 131 AARNCLVDR-DLCVKVSDFGMTRYVLD--DQYVSSVGTKFPVKWSAPEVF 177
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-25
Identities = 52/194 (26%), Positives = 88/194 (45%), Gaps = 35/194 (18%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRH----RNIVQYL 868
+GKGS+G V ++ D + A+K + K ++ +++R+ I+Q L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYM-NK---------QKCVERNEVRNVFKELQIMQGL 72
Query: 869 GS---VSEEGYF----KIF--MEQVPGGSLSTLLRVKWGPLKE---NESTMSFYTKQILE 916
V+ F +F ++ + GG L L+ + E T+ + +++
Sbjct: 73 EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ------QNVHFKEETVKLFICELVM 126
Query: 917 GLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPE 976
L YL Q+I+HRD+K DN+L++ G V I+DF + L T GT YMAPE
Sbjct: 127 ALDYLQNQRIIHRDMKPDNILLD-EHGHVHITDFNIAAMLPRETQ-ITTMAGTKPYMAPE 184
Query: 977 VI-DKGQRGYGAPV 989
+ + GY V
Sbjct: 185 MFSSRKGAGYSFAV 198
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-25
Identities = 51/185 (27%), Positives = 88/185 (47%), Gaps = 15/185 (8%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIK-----EIPEKNLGDVQPLHEEIKLHSQLRHRNIVQY 867
+G+G++G V R + A+K E+ +++ D EE + + +VQ
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRS--DSAFFWEERDIMAFANSPWVVQL 134
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
+ ++ Y + ME +PGG L L+ E FYT +++ L +H +
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMGFI 190
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGLCPSAETFTGTLQYMAPEVIDK--GQRG 984
HRD+K DN+L++ SG +K++DFGT ++ +T GT Y++PEV+ G
Sbjct: 191 HRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 249
Query: 985 YGAPV 989
YG
Sbjct: 250 YGREC 254
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 55/177 (31%), Positives = 84/177 (47%), Gaps = 13/177 (7%)
Query: 812 ELGKGSYGVVYAAR----ELDRQVKLAIKEI-PEKNLGDVQPLHEEIKLHSQLRHRNIVQ 866
+LG+G +G V R + ++A+K + PE + L +EI++ L H NIV+
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 867 YLGSVSEEGY--FKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ 924
Y G +E+G K+ ME +P GSL L + N Y QI +G+ YL +
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKI--NLKQQLKYAVQICKGMDYLGSR 145
Query: 925 KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT---LQYMAPEVI 978
+ VHRD+ NVLV + VKI DFG +K + + + APE +
Sbjct: 146 QYVHRDLAARNVLVES-EHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECL 201
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 51/176 (28%), Positives = 85/176 (48%), Gaps = 12/176 (6%)
Query: 812 ELGKGSYGVVYAAR----ELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQY 867
+LGKG++G V R + + +A+K++ ++ EI++ L+H NIV+Y
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 868 LGSVSEEGY--FKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
G G K+ ME +P GSL L+ + + + YT QI +G++YL ++
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYLGTKR 134
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT---LQYMAPEVI 978
+HRD+ N+LV VKI DFG +K L + + + APE +
Sbjct: 135 YIHRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 42/143 (29%), Positives = 74/143 (51%), Gaps = 3/143 (2%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
+LG G YG VY + +A+K + E + +V+ +E + +++H N+VQ LG
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
+ E F I E + G+L LR + + + + + QI ++YL + +HRD+
Sbjct: 79 TREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 137
Query: 932 KGDNVLVNTYSGVVKISDFGTSK 954
N LV + +VK++DFG S+
Sbjct: 138 AARNCLVGE-NHLVKVADFGLSR 159
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 51/176 (28%), Positives = 85/176 (48%), Gaps = 12/176 (6%)
Query: 812 ELGKGSYGVVYAAR----ELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQY 867
+LGKG++G V R + + +A+K++ ++ EI++ L+H NIV+Y
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 868 LGSVSEEGY--FKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
G G K+ ME +P GSL L+ + + + YT QI +G++YL ++
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYLGTKR 165
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT---LQYMAPEVI 978
+HRD+ N+LV VKI DFG +K L + + + APE +
Sbjct: 166 YIHRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 220
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 51/170 (30%), Positives = 77/170 (45%), Gaps = 10/170 (5%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
ELG G +GVV + Q +AIK I E EE K+ L H +VQ G
Sbjct: 31 ELGTGQFGVVKYGK-WRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
+++ I E + G L LR + + K + E ++YL ++ +HRD+
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHRFQ--TQQLLEMCKDVCEAMEYLESKQFLHRDL 146
Query: 932 KGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL---QYMAPEVI 978
N LVN GVVK+SDFG S+ + + G+ ++ PEV+
Sbjct: 147 AARNCLVND-QGVVKVSDFGLSRYVLD--DEYTSSVGSKFPVRWSPPEVL 193
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-25
Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 29/200 (14%)
Query: 808 LNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPL--HEEIKLHSQLRHRNIV 865
L +I G+G++G V+ AR K+A+K++ +N + P+ EIK+ L+H N+V
Sbjct: 22 LAKI--GQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 79
Query: 866 QYLGSVSEEGYFKI-----------FMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQI 914
+ + F E L+ LL S + + +
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFCEH----DLAGLLSNVLVKF--TLSEIKRVMQML 133
Query: 915 LEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAET--FTG---T 969
L GL Y+H KI+HRD+K NVL+ GV+K++DFG + R L +++ +T T
Sbjct: 134 LNGLYYIHRNKILHRDMKAANVLITR-DGVLKLADFGLA-RAFSLAKNSQPNRYTNRVVT 191
Query: 970 LQYMAPEVIDKGQRGYGAPV 989
L Y PE++ G+R YG P+
Sbjct: 192 LWYRPPELL-LGERDYGPPI 210
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 6e-25
Identities = 63/199 (31%), Positives = 95/199 (47%), Gaps = 36/199 (18%)
Query: 808 LNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHE--------EIKLHSQL 859
L+ + G+G + VY AR+ + +AIK+I LG + EIKL +L
Sbjct: 15 LDFL--GEGQFATVYKARDKNTNQIVAIKKIK---LGHRSEAKDGINRTALREIKLLQEL 69
Query: 860 RHRNIVQYLGSVSEEGYFKI-----FMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQI 914
H NI+ L + + I FME L +++ L S + Y
Sbjct: 70 SHPNIIGLLDAFGHKS--NISLVFDFMET----DLEVIIKDNSLVL--TPSHIKAYMLMT 121
Query: 915 LEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS-AETFTG---TL 970
L+GL+YLH I+HRD+K +N+L++ +GV+K++DFG LA S +T T
Sbjct: 122 LQGLEYLHQHWILHRDLKPNNLLLDE-NGVLKLADFG----LAKSFGSPNRAYTHQVVTR 176
Query: 971 QYMAPEVIDKGQRGYGAPV 989
Y APE++ G R YG V
Sbjct: 177 WYRAPELL-FGARMYGVGV 194
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-25
Identities = 49/180 (27%), Positives = 76/180 (42%), Gaps = 24/180 (13%)
Query: 810 RIE--LGKGSYGVVYAAR--ELDRQVKLAIKEIPEKNLGD---VQPLHEEIKLHSQLRHR 862
R+ +G+G G VY A +R V A+K + E D + E + +L+
Sbjct: 37 RLRRLVGRGGMGDVYEAEDTVRERIV--ALKLMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 863 NIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLH 922
++V +G + M + G L+ +LR + GPL + +QI L H
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLR-RQGPLAPPRAVA--IVRQIGSALDAAH 151
Query: 923 GQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT------GTLQYMAPE 976
HRD+K +N+LV + + DFG + + E T GTL YMAPE
Sbjct: 152 AAGATHRDVKPENILV-SADDFAYLVDFGIASAT-----TDEKLTQLGNTVGTLYYMAPE 205
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 54/179 (30%), Positives = 80/179 (44%), Gaps = 10/179 (5%)
Query: 806 FALNRIELGKGSYGVVYAA--RELDRQVKLAIKEI-PEKNLGDVQPLHEEIKLHSQLRHR 862
+ IELG G++G V R +Q+ +AIK + D + + E ++ QL +
Sbjct: 11 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 70
Query: 863 NIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLH 922
IV+ +G E + ME GG L L K + S ++ Q+ G+KYL
Sbjct: 71 YIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPV--SNVAELLHQVSMGMKYLE 127
Query: 923 GQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT---LQYMAPEVI 978
+ VHRD+ NVL+ KISDFG SK L + L++ APE I
Sbjct: 128 EKNFVHRDLAARNVLLVN-RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 8e-25
Identities = 50/190 (26%), Positives = 94/190 (49%), Gaps = 21/190 (11%)
Query: 808 LNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHE--EIKLHSQLRHRNIV 865
L +I G+G+YG V+ A+ + +A+K + + + P EI L +L+H+NIV
Sbjct: 7 LEKI--GEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 866 QYLGSVSEEGYFKI---FMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLH 922
+ + + + F +Q L G L + + + Q+L+GL + H
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDL--DPEIVKSFLFQLLKGLGFCH 118
Query: 923 GQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG---TLQYMAPEVID 979
+ ++HRD+K N+L+N +G +K+++FG + R G+ P ++ TL Y P+V+
Sbjct: 119 SRNVLHRDLKPQNLLINR-NGELKLANFGLA-RAFGI-PV-RCYSAEVVTLWYRPPDVL- 173
Query: 980 KGQRGYGAPV 989
G + Y +
Sbjct: 174 FGAKLYSTSI 183
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-25
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 27/213 (12%)
Query: 786 RTIPTKKKYMQTPMLRFLYLFALNRIE-LGKGSYGVVYAARELDRQVKLAIKEIPEKNLG 844
+ + Y Q M ++ ++E +G+G+YGVVY A++ ++ +A+K I
Sbjct: 7 HSSGRENLYFQGLMEKY------QKLEKVGEGTYGVVYKAKDSQGRI-VALKRIRLDAED 59
Query: 845 DVQPLHE--EIKLHSQLRHRNIVQYLGSVSEEGYFKI---FMEQVPGGSLSTLLRVKWGP 899
+ P EI L +L H NIV + + E + FME+ L +L
Sbjct: 60 EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK----DLKKVLDENKTG 115
Query: 900 LKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGL 959
L +S + Y Q+L G+ + H +I+HRD+K N+L+N+ G +K++DFG + R G+
Sbjct: 116 L--QDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINS-DGALKLADFGLA-RAFGI 171
Query: 960 CPSAETFTG---TLQYMAPEVIDKGQRGYGAPV 989
P ++T TL Y AP+V+ G + Y V
Sbjct: 172 -PV-RSYTHEVVTLWYRAPDVL-MGSKKYSTSV 201
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 57/181 (31%), Positives = 89/181 (49%), Gaps = 15/181 (8%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLG 869
LG+GS+G V A Q K+A+K I + L + EI LRH +I++
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
++ + +E GG L + V+ + E+E F +QI+ ++Y H KIVHR
Sbjct: 77 VITTPTDIVMVIEYA-GGELFDYI-VEKKRMTEDEGRRFF--QQIICAIEYCHRHKIVHR 132
Query: 930 DIKGDNVLVNTYSGVVKISDFGTS--KRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGA 987
D+K +N+L++ + VKI+DFG S +T G+ Y APEVI+ + Y
Sbjct: 133 DLKPENLLLDD-NLNVKIADFGLSNIMTDGNFL---KTSCGSPNYAAPEVING--KLYAG 186
Query: 988 P 988
P
Sbjct: 187 P 187
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 55/171 (32%), Positives = 83/171 (48%), Gaps = 16/171 (9%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
+GKG +G V +V A+K I KN Q E + +QLRH N+VQ LG +
Sbjct: 28 TIGKGEFGDVMLGDYRGNKV--AVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 872 S-EEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRD 930
E+G I E + GSL LR + + + + F + + E ++YL G VHRD
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF-SLDVCEAMEYLEGNNFVHRD 142
Query: 931 IKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT---LQYMAPEVI 978
+ NVLV+ V K+SDFG +K ++ T +++ APE +
Sbjct: 143 LAARNVLVS-EDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEAL 186
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 46/151 (30%), Positives = 75/151 (49%), Gaps = 9/151 (5%)
Query: 812 ELGKGSYGVVYAAR----ELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQY 867
+LGKG++G V R + +A+K++ + EI++ L IV+Y
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 868 LGSVSEEGY--FKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
G G ++ ME +P G L L+ L + S + Y+ QI +G++YL ++
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL--DASRLLLYSSQICKGMEYLGSRR 147
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956
VHRD+ N+LV + VKI+DFG +K L
Sbjct: 148 CVHRDLAARNILVES-EAHVKIADFGLAKLL 177
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 43/170 (25%), Positives = 78/170 (45%), Gaps = 10/170 (5%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
LG G +G V+ + K+A+K + + ++ E L QL+H+ +V+ V
Sbjct: 20 RLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
++E + I E + GSL L+ G + QI EG+ ++ + +HRD+
Sbjct: 78 TQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDM-AAQIAEGMAFIEERNYIHRDL 135
Query: 932 KGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL---QYMAPEVI 978
+ N+LV+ + KI+DFG ++ + G ++ APE I
Sbjct: 136 RAANILVS-DTLSCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAI 182
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 53/174 (30%), Positives = 78/174 (44%), Gaps = 10/174 (5%)
Query: 812 ELGKGSYGVVYAAR---ELDRQVKLAIKEI-PEKNLGDVQPLHEEIKLHSQLRHRNIVQY 867
+G G G V R R V +AIK + + E + Q H NI++
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
G V+ I E + GSL T LR G + + + + G++YL V
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQ--LVGMLRGVGAGMRYLSDLGYV 173
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT---LQYMAPEVI 978
HRD+ NVLV++ + V K+SDFG S+ L +A T TG +++ APE I
Sbjct: 174 HRDLAARNVLVDS-NLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI 226
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 44/152 (28%), Positives = 71/152 (46%), Gaps = 12/152 (7%)
Query: 812 ELGKGSYGVVYAAR----ELDRQVKLAIKEI-PEKNLGDVQPLHEEIKLHSQLRHRNIVQ 866
+LG+G +G V +A+K + + +EI + L H +I++
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 867 YLGSVSEEGY--FKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ 924
Y G + G ++ ME VP GSL L + + + +QI EG+ YLH Q
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 925 KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956
+HRD+ NVL++ +VKI DFG +K +
Sbjct: 154 HYIHRDLAARNVLLDN-DRLVKIGDFGLAKAV 184
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-24
Identities = 55/190 (28%), Positives = 88/190 (46%), Gaps = 12/190 (6%)
Query: 806 FALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHR 862
F R+ LG+G +G V+A + A K++ +K L Q E K+ +++ R
Sbjct: 187 FLDFRV-LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSR 245
Query: 863 NIVQ--YLGSVSEEGYFKIFMEQVPGGSLST-LLRVKWGPLKENESTMSFYTKQILEGLK 919
IV Y + M + GG + + V E FYT QI+ GL+
Sbjct: 246 FIVSLAYAFETKTDLCL--VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 920 YLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVID 979
+LH + I++RD+K +NVL++ G V+ISD G + L + + GT +MAPE++
Sbjct: 304 HLHQRNIIYRDLKPENVLLD-DDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362
Query: 980 KGQRGYGAPV 989
Y V
Sbjct: 363 G--EEYDFSV 370
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 5e-24
Identities = 44/178 (24%), Positives = 71/178 (39%), Gaps = 22/178 (12%)
Query: 813 LGKGSYGVVYAAREL---DRQVKLAIKE-IPEKNLGDVQPLHEEIKLHSQLRHRNIVQYL 868
+ G G +Y A + R V +K + + E + +++ H +IVQ
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPV--VLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 869 GSVSEEGYFK-----IFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHG 923
V I ME V G SL L E ++ Y +IL L YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG---QKLPVAE-AIA-YLLEILPALSYLHS 200
Query: 924 QKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKG 981
+V+ D+K +N+++ +K+ D G R+ S GT + APE++ G
Sbjct: 201 IGLVYNDLKPENIMLT--EEQLKLIDLGAVSRIN----SFGYLYGTPGFQAPEIVRTG 252
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 47/179 (26%), Positives = 75/179 (41%), Gaps = 24/179 (13%)
Query: 813 LGKGSYGVVYAAR--ELDRQVKLAIKEIPEKNLGD---VQPLHEEIKLHSQLRHRNIVQY 867
LG G V+ AR R V A+K + D E + + L H IV
Sbjct: 20 LGFGGMSEVHLARDLRDHRDV--AVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 868 LGSVSEEGYFK----IFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHG 923
+ E I ME V G +L ++ + GP+ + + L + H
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAI--EVIADACQALNFSHQ 134
Query: 924 QKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT------GTLQYMAPE 976
I+HRD+K N+++ + + VK+ DFG ++ +A S + T GT QY++PE
Sbjct: 135 NGIIHRDVKPANIMI-SATNAVKVMDFGIARAIAD---SGNSVTQTAAVIGTAQYLSPE 189
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 9e-24
Identities = 59/191 (30%), Positives = 95/191 (49%), Gaps = 24/191 (12%)
Query: 808 LNRIELGKGSYGVVYAARE-LDRQVKLAIKEIPEKNLGDVQPLHE--EIKLHSQLRHRNI 864
L +I G+G+YGVVY A+ A+K+I + + P EI + +L+H NI
Sbjct: 7 LEKI--GEGTYGVVYKAQNNYGETF--ALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 865 VQYLGSVSEEGYFKI---FMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYL 921
V+ + + + ++Q L LL V G L T + Q+L G+ Y
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQ----DLKKLLDVCEGGL--ESVTAKSFLLQLLNGIAYC 116
Query: 922 HGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG---TLQYMAPEVI 978
H ++++HRD+K N+L+N G +KI+DFG + R G+ P +T TL Y AP+V+
Sbjct: 117 HDRRVLHRDLKPQNLLINR-EGELKIADFGLA-RAFGI-PV-RKYTHEIVTLWYRAPDVL 172
Query: 979 DKGQRGYGAPV 989
G + Y +
Sbjct: 173 -MGSKKYSTTI 182
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 50/176 (28%), Positives = 77/176 (43%), Gaps = 13/176 (7%)
Query: 812 ELGKGSYGVVYAAR---ELDRQVKLAIKEIPEKNLGDVQPLHE---EIKLHSQLRHRNIV 865
+LG GS+GVV + V +A+K + L + + + E+ L HRN++
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
+ G V + E P GSL LR G T+S Y Q+ EG+ YL ++
Sbjct: 85 RLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLL--GTLSRYAVQVAEGMGYLESKR 141
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT---LQYMAPEVI 978
+HRD+ N+L+ T +VKI DFG + L + APE +
Sbjct: 142 FIHRDLAARNLLLAT-RDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-23
Identities = 49/208 (23%), Positives = 90/208 (43%), Gaps = 20/208 (9%)
Query: 785 LRTIPTKKKYMQTPMLRFLYLFALNRI----ELGKGSYGVVYAARELDRQVKLAIKEIPE 840
L T+ K + + + + +LG+G +G V+ + ++AIK +
Sbjct: 243 LTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKP 301
Query: 841 KNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPL 900
+ + +E ++ +LRH +VQ VSEE + I E + GSL L+ + G
Sbjct: 302 GTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKY 359
Query: 901 KENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC 960
+ QI G+ Y+ VHRD++ N+LV + V K++DFG ++ +
Sbjct: 360 LRLPQLVDM-AAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIED-- 415
Query: 961 PSAETFTGT------LQYMAPEVIDKGQ 982
+T +++ APE G+
Sbjct: 416 ---NEYTARQGAKFPIKWTAPEAALYGR 440
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-23
Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 34/200 (17%)
Query: 806 FALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRH---- 861
F+++RI +G+G +G VY R+ D A+K + +K + IK+
Sbjct: 191 FSVHRI-IGRGGFGEVYGCRKADTGKMYAMKCL-DK---------KRIKMKQGETLALNE 239
Query: 862 RNIVQYLGS------VSEEGYF----KIF--MEQVPGGSLSTLLRVKWGPLKENESTMSF 909
R ++ + + V F K+ ++ + GG L L + G E + M F
Sbjct: 240 RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEAD--MRF 296
Query: 910 YTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT 969
Y +I+ GL+++H + +V+RD+K N+L++ G V+ISD G + + GT
Sbjct: 297 YAAEIILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSK--KKPHASVGT 353
Query: 970 LQYMAPEVIDKGQRGYGAPV 989
YMAPEV+ KG Y +
Sbjct: 354 HGYMAPEVLQKGV-AYDSSA 372
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 58/201 (28%), Positives = 88/201 (43%), Gaps = 39/201 (19%)
Query: 808 LNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHE---------EIKLHSQ 858
L ++ G G+Y VY V +A+KE+ L E EI L +
Sbjct: 10 LEKL--GNGTYATVYKGLNKTTGVYVALKEV---KLD-----SEEGTPSTAIREISLMKE 59
Query: 859 LRHRNIVQYLGSVSEEGYFKI---FMEQVPGGSLSTLL---RVKWGPLKENESTMSFYTK 912
L+H NIV+ + E + FM+ L + V P + + ++
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDN----DLKKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 913 QILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS-AETFTG--- 968
Q+L+GL + H KI+HRD+K N+L+N G +K+ DFG LA TF+
Sbjct: 116 QLLQGLAFCHENKILHRDLKPQNLLINK-RGQLKLGDFG----LARAFGIPVNTFSSEVV 170
Query: 969 TLQYMAPEVIDKGQRGYGAPV 989
TL Y AP+V+ G R Y +
Sbjct: 171 TLWYRAPDVL-MGSRTYSTSI 190
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 32/186 (17%), Positives = 71/186 (38%), Gaps = 20/186 (10%)
Query: 812 ELGKGSYGVVYAAR-------ELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNI 864
LG+G++ ++ + ++ +K + + + + E + S+L H+++
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 865 VQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ 924
V G + E V GSL T L+ + N KQ+ + +L
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCI--NILWKLEVAKQLAAAMHFLEEN 132
Query: 925 KIVHRDIKGDNVLVNT-------YSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEV 977
++H ++ N+L+ +K+SD G S + + + ++ PE
Sbjct: 133 TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL----PKDILQERIPWVPPEC 188
Query: 978 IDKGQR 983
I+ +
Sbjct: 189 IENPKN 194
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 53/202 (26%), Positives = 85/202 (42%), Gaps = 15/202 (7%)
Query: 789 PTKKKYMQTPMLRFLYLFALNRI----ELGKGSYGVVYAAR----ELDRQVKLAIKEIPE 840
+L+F + + +G G +G VY ++V +AIK +
Sbjct: 24 GAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA 83
Query: 841 KN-LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGP 899
E + Q H NI++ G +S+ I E + G+L LR K G
Sbjct: 84 GYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE 143
Query: 900 LKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGL 959
+ + + I G+KYL VHRD+ N+LVN+ + V K+SDFG S+ L
Sbjct: 144 FSVLQ--LVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS-NLVCKVSDFGLSRVLEDD 200
Query: 960 CPSAETFTGT---LQYMAPEVI 978
+ T +G +++ APE I
Sbjct: 201 PEATYTTSGGKIPIRWTAPEAI 222
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-23
Identities = 51/197 (25%), Positives = 88/197 (44%), Gaps = 37/197 (18%)
Query: 810 RIE-LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHE----------EIKLHSQ 858
+++ LG+G+Y VY + +A+KEI L E+ L
Sbjct: 6 KLDKLGEGTYATVYKGKSKLTDNLVALKEIR---------LEHEEGAPCTAIREVSLLKD 56
Query: 859 LRHRNIVQYLGSVSEEGYFKI---FMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQIL 915
L+H NIV + E + ++++ L L + N + + Q+L
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLDK----DLKQYLDDCGNII--NMHNVKLFLFQLL 110
Query: 916 EGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG---TLQY 972
GL Y H QK++HRD+K N+L+N G +K++DFG + R + P+ +T+ TL Y
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINE-RGELKLADFGLA-RAKSI-PT-KTYDNEVVTLWY 166
Query: 973 MAPEVIDKGQRGYGAPV 989
P+++ G Y +
Sbjct: 167 RPPDIL-LGSTDYSTQI 182
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 47/213 (22%), Positives = 87/213 (40%), Gaps = 59/213 (27%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQ----- 866
LG GS+G+V +++ + A+K++ + D + + E+ + L H NI++
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKVLQ----DPRYKNRELDIMKVLDHVNIIKLVDYF 69
Query: 867 ---------------------------------YLGSVSEEGYFKIFMEQVPGGSLSTLL 893
+ + S+ Y + ME VP TL
Sbjct: 70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP----DTLH 125
Query: 894 RVKWGPLKENESTMS-----FYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKIS 948
+V ++ ++ Y Q+ + ++H I HRDIK N+LVN+ +K+
Sbjct: 126 KVLKSFIRSGR-SIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLC 184
Query: 949 DFGTSKRLAGLCPSAETFTG---TLQYMAPEVI 978
DFG++K+L +E + Y APE++
Sbjct: 185 DFGSAKKLI----PSEPSVAYICSRFYRAPELM 213
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 47/174 (27%), Positives = 79/174 (45%), Gaps = 10/174 (5%)
Query: 812 ELGKGSYGVVYAAR---ELDRQVKLAIKEI-PEKNLGDVQPLHEEIKLHSQLRHRNIVQY 867
+G G +G V + R +++ +AIK + + E + Q H NI++
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
G V++ I E + GSL + LR + + + I G+KYL V
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGYV 169
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT---LQYMAPEVI 978
HRD+ N+L+N+ + V K+SDFG + L +A T G +++ +PE I
Sbjct: 170 HRDLAARNILINS-NLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 25/194 (12%)
Query: 808 LNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHE--EIKLHSQLRHRNIV 865
+ ++ G+G+YG VY A + +AIK I ++ + P E+ L +L+HRNI+
Sbjct: 39 ITKL--GEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNII 96
Query: 866 QYLGSVSEEGYFKI---FMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLH 922
+ + + + E L + K + + + + Q++ G+ + H
Sbjct: 97 ELKSVIHHNHRLHLIFEYAEN----DLKKYMD-KNPDV--SMRVIKSFLYQLINGVNFCH 149
Query: 923 GQKIVHRDIKGDNVLVNTYS----GVVKISDFGTSKRLAGLCPSAETFTG---TLQYMAP 975
++ +HRD+K N+L++ V+KI DFG + R G+ P FT TL Y P
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA-RAFGI-PI-RQFTHEIITLWYRPP 206
Query: 976 EVIDKGQRGYGAPV 989
E++ G R Y V
Sbjct: 207 EIL-LGSRHYSTSV 219
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-23
Identities = 50/212 (23%), Positives = 91/212 (42%), Gaps = 20/212 (9%)
Query: 781 LVEDLRTIPTKKKYMQTPMLRFLYLFALNRI----ELGKGSYGVVYAARELDRQVKLAIK 836
L L T+ K + + + + +LG+G +G V+ + ++AIK
Sbjct: 156 LCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIK 214
Query: 837 EIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVK 896
+ + + +E ++ +LRH +VQ VSEE + I E + GSL L+ +
Sbjct: 215 TLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGE 272
Query: 897 WGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956
G + QI G+ Y+ VHRD++ N+LV + V K++DFG ++ +
Sbjct: 273 TGKYLRLPQLVDM-AAQIASGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLI 330
Query: 957 AGLCPSAETFTGT------LQYMAPEVIDKGQ 982
+T +++ APE G+
Sbjct: 331 ED-----NEYTARQGAKFPIKWTAPEAALYGR 357
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-23
Identities = 48/187 (25%), Positives = 84/187 (44%), Gaps = 9/187 (4%)
Query: 806 FALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHR 862
F R+ LGKG +G V A + A K++ +K + E ++ ++ R
Sbjct: 186 FRQYRV-LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 244
Query: 863 NIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLH 922
+V + + + + + GG L + G E+ FY +I GL+ LH
Sbjct: 245 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 923 GQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQ 982
++IV+RD+K +N+L++ G ++ISD G + + + GT+ YMAPEV+
Sbjct: 304 RERIVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQT-IKGRVGTVGYMAPEVVKN-- 359
Query: 983 RGYGAPV 989
Y
Sbjct: 360 ERYTFSP 366
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 50/180 (27%), Positives = 77/180 (42%), Gaps = 12/180 (6%)
Query: 806 FALNRIELGKGSYGVVYAA--RELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRH 861
L ELG G++G V + +A+K + + L E + QL +
Sbjct: 18 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN 77
Query: 862 RNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYL 921
IV+ +G E + + ME G L+ L+ + +K+ + Q+ G+KYL
Sbjct: 78 PYIVRMIGICEAESWM-LVMEMAELGPLNKYLQ-QNRHVKDK--NIIELVHQVSMGMKYL 133
Query: 922 HGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT---LQYMAPEVI 978
VHRD+ NVL+ T KISDFG SK L + T +++ APE I
Sbjct: 134 EESNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 192
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 53/187 (28%), Positives = 83/187 (44%), Gaps = 30/187 (16%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIV------- 865
LG G G+V++A + D ++AIK+I + V+ EIK+ +L H NIV
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 866 ----QYLGSVSEEGYFKI------FMEQVPGGSLSTLLRV-KWGPLKENESTMSFYTKQI 914
Q V +ME + L V + GPL E + Q+
Sbjct: 79 PSGSQLTDDVGSLTELNSVYIVQEYME-------TDLANVLEQGPLLEEH--ARLFMYQL 129
Query: 915 LEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG---TLQ 971
L GLKY+H ++HRD+K N+ +NT V+KI DFG ++ + + T
Sbjct: 130 LRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKW 189
Query: 972 YMAPEVI 978
Y +P ++
Sbjct: 190 YRSPRLL 196
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-23
Identities = 50/203 (24%), Positives = 94/203 (46%), Gaps = 14/203 (6%)
Query: 787 TIPTKKKYMQTPMLRFLYLFALNRI----ELGKGSYGVVYAARELDRQVKLAIKEIPEKN 842
++P Q P + + + +LG G +G V+ A ++ K+A+K + +
Sbjct: 166 SVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGS 224
Query: 843 LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKE 902
+ V+ E + L+H +V+ V++E + I E + GSL L+ G +
Sbjct: 225 M-SVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQP 282
Query: 903 NESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS 962
+ F + QI EG+ ++ + +HRD++ N+LV+ S V KI+DFG ++ +
Sbjct: 283 LPKLIDF-SAQIAEGMAFIEQRNYIHRDLRAANILVS-ASLVCKIADFGLARVIED--NE 338
Query: 963 AETFTGTL---QYMAPEVIDKGQ 982
G ++ APE I+ G
Sbjct: 339 YTAREGAKFPIKWTAPEAINFGS 361
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 5e-23
Identities = 59/212 (27%), Positives = 90/212 (42%), Gaps = 16/212 (7%)
Query: 773 MDYDAMVQLVEDLRTIPTKKKYMQTPMLRFLYLFALNRIELGKGSYGVVYAA--RELDRQ 830
MD D + KK +++ L + IELG G++G V R +Q
Sbjct: 310 MDTSVFESPFSDPEELKDKKLFLKRDNLL------IADIELGCGNFGSVRQGVYRMRKKQ 363
Query: 831 VKLAIKEI-PEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889
+ +AIK + D + + E ++ QL + IV+ +G E + ME GG L
Sbjct: 364 IDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPL 422
Query: 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISD 949
L K + S ++ Q+ G+KYL + VHR++ NVL+ KISD
Sbjct: 423 HKFLVGKREEIPV--SNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVN-RHYAKISD 479
Query: 950 FGTSKRLAGLCPSAETFTGT---LQYMAPEVI 978
FG SK L + L++ APE I
Sbjct: 480 FGLSKALGADDSYYTARSAGKWPLKWYAPECI 511
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 102 bits (254), Expect = 6e-23
Identities = 27/215 (12%), Positives = 56/215 (26%), Gaps = 35/215 (16%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEI-------------------------PEKNLGDVQ 847
LG+ A + + + KN +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 848 PLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFME----QVPGGSLSTLLRVKWGPLKEN 903
I ++ + + +E + +L T V +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 904 EST----MSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-AG 958
+S T Q++ L LH +VH ++ +++++ G V ++ F R A
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQ-RGGVFLTGFEHLVRDGAS 264
Query: 959 LCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRD 993
+ A ++ GQ D
Sbjct: 265 AVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFD 299
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 8e-23
Identities = 46/186 (24%), Positives = 66/186 (35%), Gaps = 39/186 (20%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQ---- 866
LG G G V Q K A+K + D E++LH + + +IV+
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 79
Query: 867 YLGSVSEEGYFKIFMEQVPGGSLSTLLR-VKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
Y + I ME + GG L R G E S K I E ++YLH
Sbjct: 80 YENLYAGRKCLLIVMECLDGGEL--FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN 137
Query: 926 IVHRDIKGDNVLVNTYSG--VVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQR 983
I HRD+K +N+L + ++K++DFG A E
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFG---------------------FAKETT---GE 173
Query: 984 GYGAPV 989
Y
Sbjct: 174 KYDKSC 179
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 9e-23
Identities = 47/195 (24%), Positives = 81/195 (41%), Gaps = 37/195 (18%)
Query: 812 ELGKGSYGVVYAAR-----ELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQ 866
ELG+G++G V+ A ++ +A+K + + L + E +L + L+H +IV+
Sbjct: 22 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 867 YLGSVSEEGYFKIFMEQVPGGSLSTLLR--------VKWGPLKENESTMSFYT-----KQ 913
+ G + + E + G L+ LR + G ++ + + Q
Sbjct: 82 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 914 ILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFG----------TSKRLAGLCPSA 963
I G+ YL Q VHRD+ N LV + +VKI DFG + P
Sbjct: 142 IASGMVYLASQHFVHRDLATRNCLVGA-NLLVKIGDFGMSRDVYSTDYYRVGGHTMLP-- 198
Query: 964 ETFTGTLQYMAPEVI 978
+++M PE I
Sbjct: 199 ------IRWMPPESI 207
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 56/186 (30%), Positives = 85/186 (45%), Gaps = 20/186 (10%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIK-----EIPEKNLGDVQPLHEEIKLHSQLRHRNIVQY 867
LGKG++G V +E A+K I K+ +V E ++ RH +
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD--EVAHTLTENRVLQNSRHPFLTAL 213
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKE---NESTMSFYTKQILEGLKYLHGQ 924
S ME GG L L +E +E FY +I+ L YLH +
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHLS------RERVFSEDRARFYGAEIVSALDYLHSE 267
Query: 925 K-IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQR 983
K +V+RD+K +N+++ G +KI+DFG K + +TF GT +Y+APEV++
Sbjct: 268 KNVVYRDLKLENLML-DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED--N 324
Query: 984 GYGAPV 989
YG V
Sbjct: 325 DYGRAV 330
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-22
Identities = 60/201 (29%), Positives = 88/201 (43%), Gaps = 33/201 (16%)
Query: 808 LNRIELGKGSYGVVYAARELDRQVKLAIKEI---PEKNLGDVQPLHE--EIKLHSQLR-- 860
+ I G G+YG VY AR+ +A+K + G P+ E+ L +L
Sbjct: 14 VAEI--GVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAF 71
Query: 861 -HRNIVQYLG---SVSEEGYFKI-----FMEQVPGGSLSTLLRVKWGPLKENESTMSFYT 911
H N+V+ + + + K+ ++Q L T L P T+
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ----DLRTYLDKAPPPGLP-AETIKDLM 126
Query: 912 KQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG--- 968
+Q L GL +LH IVHRD+K +N+LV + G VK++DFG LA + T
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTS-GGTVKLADFG----LARIYSYQMALTPVVV 181
Query: 969 TLQYMAPEVIDKGQRGYGAPV 989
TL Y APEV+ Y PV
Sbjct: 182 TLWYRAPEVL-LQST-YATPV 200
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-22
Identities = 57/187 (30%), Positives = 86/187 (45%), Gaps = 23/187 (12%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIK-----EIPEKNLGDVQPLHEEIKLHSQLRHRNIVQY 867
LGKG++G V RE A+K I K+ +V E ++ RH +
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD--EVAHTVTESRVLQNTRHPFLTAL 70
Query: 868 LGS--VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKE---NESTMSFYTKQILEGLKYLH 922
+ + F ME GG L L +E E FY +I+ L+YLH
Sbjct: 71 KYAFQTHDRLCF--VMEYANGGELFFHLS------RERVFTEERARFYGAEIVSALEYLH 122
Query: 923 GQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQ 982
+ +V+RDIK +N+++ G +KI+DFG K + +TF GT +Y+APEV++
Sbjct: 123 SRDVVYRDIKLENLML-DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-- 179
Query: 983 RGYGAPV 989
YG V
Sbjct: 180 NDYGRAV 186
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 1e-22
Identities = 57/242 (23%), Positives = 92/242 (38%), Gaps = 48/242 (19%)
Query: 771 DAMDYDAMVQLVEDLRTIPTKKKYMQTPMLRFLYLFALNRIELGKGSYGVVYAARELDRQ 830
D MDYD V+L + + +Y ++G+G+YG VY A+ D +
Sbjct: 1 DKMDYDFKVKLSSERERVEDLFEYE--------------GCKVGRGTYGHVYKAKRKDGK 46
Query: 831 --VKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKI-----FMEQ 883
A+K+I + + EI L +L+H N++ K+ + E
Sbjct: 47 DDKDYALKQIEGTGI-SMSAC-REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 104
Query: 884 VPGGSLSTLLRVKWGPLKEN------ESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVL 937
L +++ + QIL+G+ YLH ++HRD+K N+L
Sbjct: 105 ----DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANIL 160
Query: 938 VNTYS---GVVKISDFGTSKRLA-GLCPSAETFTG------TLQYMAPEVIDKGQRGYGA 987
V G VKI+D G A + T Y APE++ G R Y
Sbjct: 161 VMGEGPERGRVKIADMG----FARLFNSPLKPLADLDPVVVTFWYRAPELL-LGARHYTK 215
Query: 988 PV 989
+
Sbjct: 216 AI 217
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-22
Identities = 51/174 (29%), Positives = 79/174 (45%), Gaps = 13/174 (7%)
Query: 812 ELGKGSYGVVYAAR---ELDRQVKLAIKEI-PEKNLGDVQPLHEEIKLHSQLRHRNIVQY 867
LG+G +G VY ++ +A+K + L + + E + L H +IV+
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
+G + EE + I ME P G L L LK T+ Y+ QI + + YL V
Sbjct: 79 IGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYLESINCV 135
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL---QYMAPEVI 978
HRDI N+LV + VK+ DFG S+ + + T ++M+PE I
Sbjct: 136 HRDIAVRNILVAS-PECVKLGDFGLSRYIED--EDYYKASVTRLPIKWMSPESI 186
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 56/175 (32%), Positives = 84/175 (48%), Gaps = 16/175 (9%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
+GKG +G V +V A+K I KN Q E + +QLRH N+VQ LG +
Sbjct: 200 TIGKGEFGDVMLGDYRGNKV--AVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 872 SEE-GYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRD 930
EE G I E + GSL LR + + + + F + + E ++YL G VHRD
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF-SLDVCEAMEYLEGNNFVHRD 314
Query: 931 IKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT---LQYMAPEVIDKGQ 982
+ NVLV+ V K+SDFG +K + T +++ APE + + +
Sbjct: 315 LAARNVLVS-EDNVAKVSDFGLTKEA------SSTQDTGKLPVKWTAPEALREKK 362
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-22
Identities = 54/193 (27%), Positives = 87/193 (45%), Gaps = 34/193 (17%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRH----RNIVQYL 868
+G+GSY V R A+K + +K E + + +++ +
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVV-KK---------ELVNDDEDIDWVQTEKHVFEQA 66
Query: 869 GS----VSEEGYF----KIF--MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGL 918
+ V F ++F +E V GG L ++ + L E + FY+ +I L
Sbjct: 67 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHAR--FYSAEISLAL 123
Query: 919 KYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT--GTLQYMAPE 976
YLH + I++RD+K DNVL+ G +K++D+G K GL P T T GT Y+APE
Sbjct: 124 NYLHERGIIYRDLKLDNVLL-DSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPE 180
Query: 977 VIDKGQRGYGAPV 989
++ YG V
Sbjct: 181 ILRG--EDYGFSV 191
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-22
Identities = 50/194 (25%), Positives = 78/194 (40%), Gaps = 36/194 (18%)
Query: 812 ELGKGSYGVVYAAR-----ELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQ 866
ELG+G++G V+ A ++ +A+K + E + Q E +L + L+H++IV+
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 867 YLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTK------------QI 914
+ G +E + E + G L+ LR K Q+
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 915 LEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTS----------KRLAGLCPSAE 964
G+ YL G VHRD+ N LV VVKI DFG S + P
Sbjct: 168 AAGMVYLAGLHFVHRDLATRNCLVGQ-GLVVKIGDFGMSRDIYSTDYYRVGGRTMLP--- 223
Query: 965 TFTGTLQYMAPEVI 978
+++M PE I
Sbjct: 224 -----IRWMPPESI 232
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 4e-22
Identities = 54/195 (27%), Positives = 95/195 (48%), Gaps = 31/195 (15%)
Query: 813 LGKGSYGVVYAARELDRQV--KL-AIKEIPEKNLGDVQPLHEEIKLHSQLRH----RNIV 865
LG G+YG V+ R++ KL A+K + + + ++ H R ++
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATI---------VQKAKTTEHTRTERQVL 112
Query: 866 QYLGS----VSEEGYF----KIF--MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQIL 915
+++ V+ F K+ ++ + GG L T L + E+E Y +I+
Sbjct: 113 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS-QRERFTEHEVQ--IYVGEIV 169
Query: 916 EGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKR-LAGLCPSAETFTGTLQYMA 974
L++LH I++RDIK +N+L+ +G V ++DFG SK +A A F GT++YMA
Sbjct: 170 LALEHLHKLGIIYRDIKLENILL-DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 228
Query: 975 PEVIDKGQRGYGAPV 989
P+++ G G+ V
Sbjct: 229 PDIVRGGDSGHDKAV 243
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 5e-22
Identities = 55/187 (29%), Positives = 95/187 (50%), Gaps = 21/187 (11%)
Query: 813 LGKGSYGVVYAAREL---DRQVKLAIK-----EIPEKNLGDVQPLHEEIKLHSQLRHRNI 864
LG+GS+G V+ +++ D + A+K + ++ V+ E L ++ H I
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD--RVRTKMERDIL-VEVNHPFI 88
Query: 865 VQYLGSVSEEG--YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLH 922
V+ + EG Y ++ + GG L T L K E + FY ++ L +LH
Sbjct: 89 VKLHYAFQTEGKLYL--ILDFLRGGDLFTRLS-KEVMFTEEDVK--FYLAELALALDHLH 143
Query: 923 GQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQ 982
I++RD+K +N+L++ G +K++DFG SK A +F GT++YMAPEV+++
Sbjct: 144 SLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR-- 200
Query: 983 RGYGAPV 989
RG+
Sbjct: 201 RGHTQSA 207
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 6e-22
Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 17/176 (9%)
Query: 812 ELGKGSYGVVYAAR---ELDRQVKLAIKEIPEKNLGDVQP-LHEEIKLHSQLRHRNIVQY 867
+G+G +G V+ + + +AIK V+ +E Q H +IV+
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
+G ++E + I ME G L + L+V+ L +++ Y Q+ L YL ++ V
Sbjct: 82 IGVITENPVW-IIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLESKRFV 138
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT-----LQYMAPEVI 978
HRDI NVLV++ + VK+ DFG S+ + + + + +++MAPE I
Sbjct: 139 HRDIAARNVLVSS-NDCVKLGDFGLSRYME----DSTYYKASKGKLPIKWMAPESI 189
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 7e-22
Identities = 56/185 (30%), Positives = 85/185 (45%), Gaps = 18/185 (9%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIK-----EIPEKNLGDVQPLHEEIK-LHSQLRHRNIVQ 866
LGKGS+G V+ A AIK + + DV+ E + L H +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD--DVECTMVEKRVLSLAWEHPFLTH 82
Query: 867 YLGS--VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ 924
+ E +F ME + GG L ++ + +T FY +I+ GL++LH +
Sbjct: 83 MFCTFQTKENLFF--VMEYLNGGDLMYHIQ-SCHKFDLSRAT--FYAAEIILGLQFLHSK 137
Query: 925 KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRG 984
IV+RD+K DN+L+ G +KI+DFG K TF GT Y+APE++ +
Sbjct: 138 GIVYRDLKLDNILL-DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG--QK 194
Query: 985 YGAPV 989
Y V
Sbjct: 195 YNHSV 199
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-21
Identities = 60/187 (32%), Positives = 88/187 (47%), Gaps = 22/187 (11%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIK-----EIPEKNLGDVQPLHEEIK-LHSQLRHRNIVQ 866
LGKGS+G V AR + A+K I + + DV+ E + L H + Q
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDD--DVECTMTEKRILSLARNHPFLTQ 88
Query: 867 YLGSVSEEG--YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ 924
+F ME V GG L ++ K E + FY +I+ L +LH +
Sbjct: 89 LFCCFQTPDRLFF--VMEFVNGGDLMFHIQ-KSRRFDEARAR--FYAAEIISALMFLHDK 143
Query: 925 KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT--GTLQYMAPEVIDKGQ 982
I++RD+K DNVL+ + G K++DFG K G+C T T GT Y+APE++ +
Sbjct: 144 GIIYRDLKLDNVLL-DHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPEILQE-- 198
Query: 983 RGYGAPV 989
YG V
Sbjct: 199 MLYGPAV 205
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-21
Identities = 53/193 (27%), Positives = 87/193 (45%), Gaps = 34/193 (17%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRH----RNIVQYL 868
+G+GSY V R A++ + +K E + + +++ +
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVV-KK---------ELVNDDEDIDWVQTEKHVFEQA 109
Query: 869 GS----VSEEGYF----KIF--MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGL 918
+ V F ++F +E V GG L ++ + L E + FY+ +I L
Sbjct: 110 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHAR--FYSAEISLAL 166
Query: 919 KYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT--GTLQYMAPE 976
YLH + I++RD+K DNVL+ G +K++D+G K GL P T T GT Y+APE
Sbjct: 167 NYLHERGIIYRDLKLDNVLL-DSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPE 223
Query: 977 VIDKGQRGYGAPV 989
++ YG V
Sbjct: 224 ILRG--EDYGFSV 234
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-21
Identities = 44/156 (28%), Positives = 71/156 (45%), Gaps = 14/156 (8%)
Query: 812 ELGKGSYGVVYAAR-----ELDRQVKLAIKEIPEK-NLGDVQPLHEEIKLHSQLRHRNIV 865
LG G++G VY + +++A+K +PE + D E + S+ H+NIV
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYT-----KQILEGLKY 920
+ +G + I ME + GG L + LR + P S+++ + I G +Y
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 921 LHGQKIVHRDIKGDNVLVNTYSG--VVKISDFGTSK 954
L +HRDI N L+ V KI DFG ++
Sbjct: 156 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 1e-21
Identities = 54/186 (29%), Positives = 92/186 (49%), Gaps = 17/186 (9%)
Query: 813 LGKGSYGVVYAARELDRQ-------VKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIV 865
LGKG YG V+ R++ +K+ K + +N D E + +++H IV
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 866 QYLGS--VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHG 923
+ + + Y +E + GG L L + G E+ + FY +I L +LH
Sbjct: 85 DLIYAFQTGGKLYL--ILEYLSGGELFMQLE-REGIFMEDTAC--FYLAEISMALGHLHQ 139
Query: 924 QKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQR 983
+ I++RD+K +N+++N + G VK++DFG K TF GT++YMAPE++ +
Sbjct: 140 KGIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR--S 196
Query: 984 GYGAPV 989
G+ V
Sbjct: 197 GHNRAV 202
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-21
Identities = 56/185 (30%), Positives = 87/185 (47%), Gaps = 18/185 (9%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIK-----EIPEKNLGDVQPLHEEIK-LHSQLRHRNIVQ 866
+GKGS+G V AR +V A+K I +K + + + E L ++H +V
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK--EEKHIMSERNVLLKNVKHPFLVG 103
Query: 867 YLGSVSEEG--YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ 924
S YF ++ + GG L L+ + E + FY +I L YLH
Sbjct: 104 LHFSFQTADKLYF--VLDYINGGELFYHLQ-RERCFLEPRAR--FYAAEIASALGYLHSL 158
Query: 925 KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRG 984
IV+RD+K +N+L+ G + ++DFG K + TF GT +Y+APEV+ K +
Sbjct: 159 NIVYRDLKPENILL-DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK--QP 215
Query: 985 YGAPV 989
Y V
Sbjct: 216 YDRTV 220
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-21
Identities = 43/156 (27%), Positives = 71/156 (45%), Gaps = 14/156 (8%)
Query: 812 ELGKGSYGVVYAAR-----ELDRQVKLAIKEIPEK-NLGDVQPLHEEIKLHSQLRHRNIV 865
LG G++G VY + +++A+K +PE + D E + S+ H+NIV
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSF-----YTKQILEGLKY 920
+ +G + I +E + GG L + LR + P S+++ + I G +Y
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 921 LHGQKIVHRDIKGDNVLVNTYSG--VVKISDFGTSK 954
L +HRDI N L+ V KI DFG ++
Sbjct: 197 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 99.7 bits (248), Expect = 2e-21
Identities = 55/183 (30%), Positives = 84/183 (45%), Gaps = 14/183 (7%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIK-----EIPEKNLGDVQPLHEEIK-LHSQLRHRNIVQ 866
LGKGS+G V + A+K + + + DV+ E + L + + Q
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD--DVECTMVEKRVLALPGKPPFLTQ 406
Query: 867 YLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
ME V GG L ++ + G KE + FY +I GL +L + I
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEPHAV--FYAAEIAIGLFFLQSKGI 463
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYG 986
++RD+K DNV++ G +KI+DFG K + +TF GT Y+APE+I + YG
Sbjct: 464 IYRDLKLDNVML-DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY--QPYG 520
Query: 987 APV 989
V
Sbjct: 521 KSV 523
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-21
Identities = 44/153 (28%), Positives = 72/153 (47%), Gaps = 14/153 (9%)
Query: 812 ELGKGSYGVVYAAR-----ELDRQVKLAIKEIPEK-NLGDVQPLHEEIKLHSQLRHRNIV 865
ELG+GS+G+VY + + + ++AIK + E ++ + E + + ++V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENE-------STMSFYTKQILEGL 918
+ LG VS+ + ME + G L + LR + N S M +I +G+
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 919 KYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFG 951
YL+ K VHRD+ N +V VKI DFG
Sbjct: 152 AYLNANKFVHRDLAARNCMVAE-DFTVKIGDFG 183
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-21
Identities = 44/175 (25%), Positives = 80/175 (45%), Gaps = 13/175 (7%)
Query: 812 ELGKGSYGVVYAAR----ELDRQVKLAIKEI-PEKNLGDVQPLHEEIKLHSQLRHRNIVQ 866
LG G++G VY ++ +AIKE+ + + + +E + + + + ++ +
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 867 YLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
LG + + +P G L +R + + + QI +G+ YL +++
Sbjct: 82 LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQIAKGMNYLEDRRL 138
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT---LQYMAPEVI 978
VHRD+ NVLV T VKI+DFG + +L G G +++MA E I
Sbjct: 139 VHRDLAARNVLVKT-PQHVKITDFGLA-KLLGAEEKEYHAEGGKVPIKWMALESI 191
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 23/146 (15%), Positives = 44/146 (30%), Gaps = 13/146 (8%)
Query: 812 ELGKGSYGVVYAARE--LDRQVKLAIKEIPEKNLGD---VQPLHEEIKLHSQLRHRNIVQ 866
G + A + LDRQV A+ + + + +Q S++ + +
Sbjct: 38 FHGGVPPLQFWQALDTALDRQV--ALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 867 YLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
L V + E + GGSL + + + + H +
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVAD---TSPSPVGAI--RAMQSLAAAADAAHRAGV 150
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFGT 952
V V+ G V ++ T
Sbjct: 151 ALSIDHPSRVRVSI-DGDVVLAYPAT 175
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 5e-21
Identities = 57/185 (30%), Positives = 87/185 (47%), Gaps = 18/185 (9%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIK-----EIPEKNLGDVQPLHEEIK-LHSQLRHRNIVQ 866
LGKGS+G V + A+K + + + DV+ E + L + + Q
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD--DVECTMVEKRVLALPGKPPFLTQ 85
Query: 867 YLGSVSEEG--YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ 924
YF ME V GG L ++ + G KE + FY +I GL +L +
Sbjct: 86 LHSCFQTMDRLYF--VMEYVNGGDLMYHIQ-QVGRFKEPHAV--FYAAEIAIGLFFLQSK 140
Query: 925 KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRG 984
I++RD+K DNV+++ G +KI+DFG K + +TF GT Y+APE+I +
Sbjct: 141 GIIYRDLKLDNVMLD-SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY--QP 197
Query: 985 YGAPV 989
YG V
Sbjct: 198 YGKSV 202
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 7e-21
Identities = 37/148 (25%), Positives = 71/148 (47%), Gaps = 8/148 (5%)
Query: 812 ELGKGSYGVVYAARELD---RQVKLAIKEIPEK-NLGDVQPLHEEIKLHSQLRHRNIVQY 867
+G+G +G VY LD +++ A+K + ++G+V E + H N++
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 868 LGSVSE-EGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
LG EG + + + G L +R + + + + Q+ +G+KYL +K
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGMKYLASKKF 149
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFGTSK 954
VHRD+ N +++ VK++DFG ++
Sbjct: 150 VHRDLAARNCMLDE-KFTVKVADFGLAR 176
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 8e-21
Identities = 39/148 (26%), Positives = 70/148 (47%), Gaps = 8/148 (5%)
Query: 812 ELGKGSYGVVYAAR---ELDRQVKLAIKEIPEK-NLGDVQPLHEEIKLHSQLRHRNIVQY 867
+GKG +GVVY + +++ AIK + + V+ E L L H N++
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 868 LGSVS-EEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
+G + EG + + + G L +R + + + Q+ G++YL QK
Sbjct: 88 IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKD--LISFGLQVARGMEYLAEQKF 145
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFGTSK 954
VHRD+ N +++ S VK++DFG ++
Sbjct: 146 VHRDLAARNCMLDE-SFTVKVADFGLAR 172
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-20
Identities = 32/157 (20%), Positives = 60/157 (38%), Gaps = 15/157 (9%)
Query: 812 ELGKGSYGVVYAAR---ELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQ 866
LGKG +G V A+ E VK+A+K + + D++ E + H ++ +
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 867 YLGSVSEEGYFK------IFMEQVPGGSLSTLLRVKWGPLKENESTMS---FYTKQILEG 917
+G + + + G L L + + I G
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 918 LKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954
++YL + +HRD+ N ++ V ++DFG S+
Sbjct: 150 MEYLSSRNFIHRDLAARNCMLAE-DMTVCVADFGLSR 185
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-20
Identities = 58/199 (29%), Positives = 90/199 (45%), Gaps = 31/199 (15%)
Query: 808 LNRIELGKGSYGVVYAARELDRQVKL-AIKEIPEKNLGDVQPLHE--EIKLHSQLR---H 861
+ I G+G+YG V+ AR+L + A+K + + + PL E+ + L H
Sbjct: 16 VAEI--GEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 73
Query: 862 RNIVQYLG---SVSEEGYFKI-----FMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQ 913
N+V+ + K+ ++Q L+T L K T+ Q
Sbjct: 74 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ----DLTTYLD-KVPEPGVPTETIKDMMFQ 128
Query: 914 ILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG---TL 970
+L GL +LH ++VHRD+K N+LV + SG +K++DFG LA + T TL
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTS-SGQIKLADFG----LARIYSFQMALTSVVVTL 183
Query: 971 QYMAPEVIDKGQRGYGAPV 989
Y APEV+ Y PV
Sbjct: 184 WYRAPEVL-LQSS-YATPV 200
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 34/156 (21%), Positives = 61/156 (39%), Gaps = 14/156 (8%)
Query: 812 ELGKGSYGVVY---AARELDRQVKLAIKEIPEKN--LGDVQPLHEEIKLHSQLRHRNIVQ 866
LG+G +G V +E +K+A+K + N +++ E H N+++
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 867 YLGSVSEEG-----YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMS---FYTKQILEGL 918
LG E + + + G L T L + + I G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 919 KYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954
+YL + +HRD+ N ++ V ++DFG SK
Sbjct: 161 EYLSNRNFLHRDLAARNCMLRD-DMTVCVADFGLSK 195
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 3e-20
Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 23/162 (14%)
Query: 812 ELGKGSYGVVYAAR-----ELDRQVKLAIKEIPEK-NLGDVQPLHEEIKLHSQL-RHRNI 864
LG G++G V A + D + +A+K + +L + + L E+K+ S L H NI
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 865 VQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTK------------ 912
V LG+ + G + E G L LR K ++++ +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 913 ---QILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFG 951
Q+ +G+ +L + +HRD+ N+L+ + KI DFG
Sbjct: 150 FSYQVAKGMAFLASKNCIHRDLAARNILLTH-GRITKICDFG 190
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 42/176 (23%), Positives = 75/176 (42%), Gaps = 15/176 (8%)
Query: 812 ELGKGSYGVVYAAR----ELDRQVKLAIKEIPEKNLGDVQP--LHEEIKLHSQLRHRNIV 865
LG G +G V+ ++ + IK I + G + + + L H +IV
Sbjct: 20 VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIED-KSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
+ LG + + +P GSL +R G L + + QI +G+ YL
Sbjct: 79 RLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQ--LLLNWGVQIAKGMYYLEEHG 135
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT---LQYMAPEVI 978
+VHR++ NVL+ + V+++DFG + L ++ +++MA E I
Sbjct: 136 MVHRNLAARNVLLKS-PSQVQVADFGVA-DLLPPDDKQLLYSEAKTPIKWMALESI 189
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 3e-20
Identities = 47/176 (26%), Positives = 84/176 (47%), Gaps = 17/176 (9%)
Query: 812 ELGKGSYGVVYAAR---ELDRQVKLAIKEI-PEKNLGDVQPLHEEIKLHSQLRHRNIVQY 867
+G+G +G V+ + + +AIK + + +E Q H +IV+
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
+G ++E + I ME G L + L+V+ L +++ Y Q+ L YL ++ V
Sbjct: 457 IGVITENPVW-IIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTALAYLESKRFV 513
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT-----LQYMAPEVI 978
HRDI NVLV++ + VK+ DFG S+ + + + + +++MAPE I
Sbjct: 514 HRDIAARNVLVSS-NDCVKLGDFGLSRYME----DSTYYKASKGKLPIKWMAPESI 564
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 4e-20
Identities = 48/196 (24%), Positives = 75/196 (38%), Gaps = 38/196 (19%)
Query: 812 ELGKGSYGVVYAAR-----ELDRQVKLAIKEIPEK-NLGDVQPLHEEIKLHSQLRHRNIV 865
ELG+ +G VY ++ +AIK + +K + E L ++L+H N+V
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTK------------- 912
LG V+++ + G L L ++ + K
Sbjct: 76 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 913 QILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTS----------KRLAGLCPS 962
QI G++YL +VH+D+ NVLV VKISD G L P
Sbjct: 136 QIAAGMEYLSSHHVVHKDLATRNVLVYD-KLNVKISDLGLFREVYAADYYKLLGNSLLP- 193
Query: 963 AETFTGTLQYMAPEVI 978
+++MAPE I
Sbjct: 194 -------IRWMAPEAI 202
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-20
Identities = 50/191 (26%), Positives = 87/191 (45%), Gaps = 31/191 (16%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPE--KNLGDVQPLHEEIKLHSQLRHRNIVQ---- 866
+G G+YG V +A + K+AIK++ ++ + + E+ L ++H N++
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 867 YLGSVSEEGYFKI-----FMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYL 921
+ + S ++ FM+ + L ++ E + + + Q+L+GLKY+
Sbjct: 92 FTPASSLRNFYDFYLVMPFMQ-------TDLQKIMGLKFSEEK--IQYLVYQMLKGLKYI 142
Query: 922 HGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG---TLQYMAPEVI 978
H +VHRD+K N+ VN +KI DFG ++ + TG T Y APEVI
Sbjct: 143 HSAGVVHRDLKPGNLAVNE-DCELKILDFGLAR------HADAEMTGYVVTRWYRAPEVI 195
Query: 979 DKGQRGYGAPV 989
Y V
Sbjct: 196 -LSWMHYNQTV 205
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-20
Identities = 40/172 (23%), Positives = 72/172 (41%), Gaps = 19/172 (11%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR-HRNIVQYLGSV 871
LG+G Y V+ A + K+ +K + + + EIK+ LR NI+ V
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNIITLADIV 100
Query: 872 SEEGYFKI--FMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
+ E V L + L + + + FY +IL+ L Y H I+HR
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYD--IRFYMYEILKALDYCHSMGIMHR 154
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG---TLQYMAPEVI 978
D+K NV+++ +++ D+G LA + + + + PE++
Sbjct: 155 DVKPHNVMIDHEHRKLRLIDWG----LAEFYHPGQEYNVRVASRYFKGPELL 202
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-20
Identities = 44/162 (27%), Positives = 79/162 (48%), Gaps = 23/162 (14%)
Query: 812 ELGKGSYGVVYAAR-------ELDRQVKLAIKEIPEK-NLGDVQPLHEEIKLHSQL-RHR 862
LG+G++G V A + V +A+K + + D+ L E+++ + +H+
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 863 NIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTK---------- 912
NI+ LG+ +++G + +E G+L LR + P E ++ +
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 913 ---QILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFG 951
Q+ G++YL QK +HRD+ NVLV + V+KI+DFG
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTE-NNVMKIADFG 202
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-20
Identities = 48/193 (24%), Positives = 85/193 (44%), Gaps = 26/193 (13%)
Query: 784 DLRTIPTKKKYMQTPMLRFLYLFALNRI----ELGKGSYGVVYAAR-----ELDRQVKLA 834
D +P + + P + F +R+ LG+G++G V A + +A
Sbjct: 2 DPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVA 61
Query: 835 IKEIPEK-NLGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGY-FKIFMEQVPGGSLST 891
+K + E + + L E+K+ + H N+V LG+ ++ G + +E G+LST
Sbjct: 62 VKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 121
Query: 892 LLRVKWGPLKENESTMSFYTK-------------QILEGLKYLHGQKIVHRDIKGDNVLV 938
LR K + K Q+ +G+++L +K +HRD+ N+L+
Sbjct: 122 YLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 181
Query: 939 NTYSGVVKISDFG 951
+ VVKI DFG
Sbjct: 182 SE-KNVVKICDFG 193
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 5e-20
Identities = 43/200 (21%), Positives = 74/200 (37%), Gaps = 35/200 (17%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEK-----------NLGDVQPLHEEIKLHSQLR 860
+ GSYG V A + + +AIK + + + + EI+L +
Sbjct: 29 FISSGSYGAVCAGVDSEGI-PVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 861 HRNIVQYL---GSVSEEGYFKI-----FMEQVPGGSLSTLLRVKWGPLKENESTMSFYTK 912
H NI+ E K+ M L+ ++ + + + ++
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRT----DLAQVIHDQRIVISPQH--IQYFMY 141
Query: 913 QILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG---T 969
IL GL LH +VHRD+ N+L+ + + I DF LA + T
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLAD-NNDITICDFN----LAREDTADANKTHYVTH 196
Query: 970 LQYMAPEVIDKGQRGYGAPV 989
Y APE++ +G+ V
Sbjct: 197 RWYRAPELV-MQFKGFTKLV 215
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 5e-20
Identities = 44/162 (27%), Positives = 78/162 (48%), Gaps = 23/162 (14%)
Query: 812 ELGKGSYGVVYAAR-------ELDRQVKLAIKEIPEK-NLGDVQPLHEEIKLHSQL-RHR 862
LG+G++G V A + +R K+A+K + D+ L E+++ + +H+
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135
Query: 863 NIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTK---------- 912
NI+ LG+ +++G + +E G+L L+ + P E S +
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 913 ---QILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFG 951
Q+ G++YL +K +HRD+ NVLV V+KI+DFG
Sbjct: 196 CAYQVARGMEYLASKKCIHRDLAARNVLVTE-DNVMKIADFG 236
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 5e-20
Identities = 50/195 (25%), Positives = 81/195 (41%), Gaps = 46/195 (23%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEI-PEKNLGDVQPLHEEIKLHSQLRHRNIVQ---- 866
LG+G+YGVV +A +AIK+I P EIK+ +H NI+
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNI 77
Query: 867 ------------YLGSVSEEGYFKIFMEQVPGGSLSTLLRV-KWGPLKENESTMSFYTKQ 913
Y+ + E M+ + L RV L ++ + ++ Q
Sbjct: 78 QRPDSFENFNEVYI--IQE------LMQ-------TDLHRVISTQMLSDDH--IQYFIYQ 120
Query: 914 ILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYM 973
L +K LHG ++HRD+K N+L+N+ + +K+ DFG ++ + TG M
Sbjct: 121 TLRAVKVLHGSNVIHRDLKPSNLLINS-NCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 974 ----------APEVI 978
APEV+
Sbjct: 180 VEFVATRWYRAPEVM 194
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 5e-20
Identities = 51/180 (28%), Positives = 84/180 (46%), Gaps = 28/180 (15%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPE--KNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
+G G+ G+V AA + + +AIK++ +N + + E+ L + H+NI+ L
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92
Query: 871 VSEEGYFKIF---------MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYL 921
+ + + F M+ + L +V L MS+ Q+L G+K+L
Sbjct: 93 FTPQKSLEEFQDVYIVMELMD-------ANLCQVIQMELDH--ERMSYLLYQMLCGIKHL 143
Query: 922 HGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG---TLQYMAPEVI 978
H I+HRD+K N++V + +KI DFG LA ++ T T Y APEVI
Sbjct: 144 HSAGIIHRDLKPSNIVVKS-DCTLKILDFG----LARTAGTSFMMTPYVVTRYYRAPEVI 198
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 5e-20
Identities = 53/215 (24%), Positives = 81/215 (37%), Gaps = 46/215 (21%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPE--KNLGDVQPLHEEIKLHSQLRHRNIVQYL- 868
+G GSYG V A + + +AIK+I ++L D + + EI + ++L H ++V+ L
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLD 119
Query: 869 --GSVSEEGYFKI-----FMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYL 921
E + ++ + L R L E + +L G+KY+
Sbjct: 120 IVIPKDVEKFDELYVVLEIADS----DFKKLFRTP-VYLTELH--IKTLLYNLLVGVKYV 172
Query: 922 HGQKIVHRDIKGDNVLVNTYSGVVKISDFG------------------------TSKRLA 957
H I+HRD+K N LVN VK+ DFG
Sbjct: 173 HSAGILHRDLKPANCLVNQ-DCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231
Query: 958 GLCPSAETFTG---TLQYMAPEVIDKGQRGYGAPV 989
TG T Y APE+I Q Y +
Sbjct: 232 HTKNLKRQLTGHVVTRWYRAPELI-LLQENYTEAI 265
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 6e-20
Identities = 49/191 (25%), Positives = 85/191 (44%), Gaps = 33/191 (17%)
Query: 812 ELGKGSYGVVYAAR--ELDRQVKLAIKEIPEK-NLGDVQPLHEEIKLHSQL-RHRNIVQY 867
+G+G++G V AR + ++ AIK + E + D + E+++ +L H NI+
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTK-------------QI 914
LG+ GY + +E P G+L LR + ++ T +
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 915 LEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTS-------KRLAGLCPSAETFT 967
G+ YL ++ +HRD+ N+LV + V KI+DFG S K+ G P
Sbjct: 152 ARGMDYLSQKQFIHRDLAARNILVGE-NYVAKIADFGLSRGQEVYVKKTMGRLP------ 204
Query: 968 GTLQYMAPEVI 978
+++MA E +
Sbjct: 205 --VRWMAIESL 213
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 7e-20
Identities = 53/179 (29%), Positives = 90/179 (50%), Gaps = 23/179 (12%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEI-PEKNLGDVQPLHEEIKLHSQLRHRNIVQYL--- 868
+G+G+YG+V +A + +V++AIK+I P ++ Q EIK+ + RH NI+
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 869 GSVSEEGYFKI-----FMEQVPGGSLSTLLRV-KWGPLKENESTMSFYTKQILEGLKYLH 922
+ + E + ME + L ++ K L + + ++ QIL GLKY+H
Sbjct: 95 RAPTIEQMKDVYIVQDLME-------TDLYKLLKTQHLSNDH--ICYFLYQILRGLKYIH 145
Query: 923 GQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG---TLQYMAPEVI 978
++HRD+K N+L+NT + +KI DFG ++ T T Y APE++
Sbjct: 146 SANVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 8e-20
Identities = 36/148 (24%), Positives = 71/148 (47%), Gaps = 8/148 (5%)
Query: 812 ELGKGSYGVVYAARELD---RQVKLAIKEIPEK-NLGDVQPLHEEIKLHSQLRHRNIVQY 867
+G+G +G VY LD +++ A+K + ++G+V E + H N++
Sbjct: 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 868 LGSVSE-EGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
LG EG + + + G L +R + + + + Q+ +G+K+L +K
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGMKFLASKKF 213
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFGTSK 954
VHRD+ N +++ VK++DFG ++
Sbjct: 214 VHRDLAARNCMLDE-KFTVKVADFGLAR 240
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 9e-20
Identities = 46/159 (28%), Positives = 75/159 (47%), Gaps = 21/159 (13%)
Query: 812 ELGKGSYGVVYAA-----RELDRQVKLAIKEIPEK-NLGDVQPLHEEIKLHSQL-RHRNI 864
LG G++G V A + D +K+A+K + + + + L E+K+ S L +H NI
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 865 VQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENEST------------MSFYTK 912
V LG+ + G + E G L LR K L+ + + + F +
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF-SS 171
Query: 913 QILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFG 951
Q+ +G+ +L + +HRD+ NVL+ T V KI DFG
Sbjct: 172 QVAQGMAFLASKNCIHRDVAARNVLL-TNGHVAKIGDFG 209
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 44/175 (25%), Positives = 80/175 (45%), Gaps = 13/175 (7%)
Query: 812 ELGKGSYGVVYAAR----ELDRQVKLAIKEI-PEKNLGDVQPLHEEIKLHSQLRHRNIVQ 866
LG G++G VY ++ +AIKE+ + + + +E + + + + ++ +
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 867 YLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
LG + + +P G L +R + + + QI +G+ YL +++
Sbjct: 82 LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQIAKGMNYLEDRRL 138
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT---LQYMAPEVI 978
VHRD+ NVLV T VKI+DFG + +L G G +++MA E I
Sbjct: 139 VHRDLAARNVLVKT-PQHVKITDFGLA-KLLGAEEKEYHAEGGKVPIKWMALESI 191
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 42/167 (25%), Positives = 73/167 (43%), Gaps = 28/167 (16%)
Query: 812 ELGKGSYGVVYAAR-----ELDRQVKLAIKEIPEK-NLGDVQPLHEEIKLHSQLRHRNIV 865
LG+G +G V A +A+K + E + +++ L E + Q+ H +++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLR----------------VKWGPLKENESTMSF 909
+ G+ S++G + +E GSL LR +E ++
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 910 -----YTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFG 951
+ QI +G++YL K+VHRD+ N+LV +KISDFG
Sbjct: 150 GDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAE-GRKMKISDFG 195
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-19
Identities = 44/162 (27%), Positives = 78/162 (48%), Gaps = 23/162 (14%)
Query: 812 ELGKGSYGVVYAAR-------ELDRQVKLAIKEIPEK-NLGDVQPLHEEIKLHSQL-RHR 862
LG+G +G V A + V +A+K + + D+ L E+++ + +H+
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 863 NIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTK---------- 912
NI+ LG+ +++G + +E G+L LR + P E ++ +
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 913 ---QILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFG 951
Q+ G++YL QK +HRD+ NVLV + V+KI+DFG
Sbjct: 208 CTYQLARGMEYLASQKCIHRDLAARNVLVTE-NNVMKIADFG 248
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 2e-19
Identities = 51/180 (28%), Positives = 83/180 (46%), Gaps = 28/180 (15%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPE--KNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
+G G+ G+V AA + +AIK++ +N + + E+ L + H+NI+ L
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 129
Query: 871 VSEEGYFKIF---------MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYL 921
+ + + F M+ + L +V L MS+ Q+L G+K+L
Sbjct: 130 FTPQKTLEEFQDVYLVMELMD-------ANLCQVIQMELDHE--RMSYLLYQMLCGIKHL 180
Query: 922 HGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG---TLQYMAPEVI 978
H I+HRD+K N++V + +KI DFG LA ++ T T Y APEVI
Sbjct: 181 HSAGIIHRDLKPSNIVVKS-DCTLKILDFG----LARTAGTSFMMTPYVVTRYYRAPEVI 235
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 41/167 (24%), Positives = 70/167 (41%), Gaps = 28/167 (16%)
Query: 812 ELGKGSYGVVYAAR-----ELDRQVKLAIKEIPEK-NLGDVQPLHEEIKLHSQLRHRNIV 865
++G+G++G V+ AR + +A+K + E+ + E L ++ + NIV
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLR----------------VKWGPLKENESTMSF 909
+ LG + + E + G L+ LR + +S
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 910 YT-----KQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFG 951
+Q+ G+ YL +K VHRD+ N LV + VVKI+DFG
Sbjct: 174 AEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGE-NMVVKIADFG 219
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-18
Identities = 48/180 (26%), Positives = 91/180 (50%), Gaps = 29/180 (16%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPE--KNLGDVQPLHEEIKLHSQLRHRNIVQ---- 866
+G G+YG V AA + +++A+K++ +++ + + E++L ++H N++
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 867 YLGSVSEEGYFKI-----FMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYL 921
+ + S E + + M L+ +++ + L ++ + F QIL GLKY+
Sbjct: 97 FTPARSLEEFNDVYLVTHLMGA----DLNNIVKCQ--KLTDDH--VQFLIYQILRGLKYI 148
Query: 922 HGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG---TLQYMAPEVI 978
H I+HRD+K N+ VN +KI DFG ++ +A+ TG T Y APE++
Sbjct: 149 HSADIIHRDLKPSNLAVNE-DCELKILDFGLAR------HTADEMTGYVATRWYRAPEIM 201
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-18
Identities = 55/190 (28%), Positives = 87/190 (45%), Gaps = 28/190 (14%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPE--KNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
+G G+YG V +A + K+AIK++ ++ + + E++L +RH N++ L
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 871 VSEEGYFKIF---------MEQVPGGSLSTLLRV-KWGPLKENESTMSFYTKQILEGLKY 920
+ + F M + L ++ K L E+ + F Q+L+GL+Y
Sbjct: 93 FTPDETLDDFTDFYLVMPFMG-------TDLGKLMKHEKLGEDR--IQFLVYQMLKGLRY 143
Query: 921 LHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAET-FTGTLQYMAPEVID 979
+H I+HRD+K N+ VN +KI DFG LA S T + T Y APEVI
Sbjct: 144 IHAAGIIHRDLKPGNLAVNE-DCELKILDFG----LARQADSEMTGYVVTRWYRAPEVI- 197
Query: 980 KGQRGYGAPV 989
Y V
Sbjct: 198 LNWMRYTQTV 207
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 48/167 (28%), Positives = 74/167 (44%), Gaps = 28/167 (16%)
Query: 812 ELGKGSYGVVYAAR-----ELDRQVKLAIKEIPEK-NLGDVQPLHEEIKLHSQL-RHRNI 864
LG G++G V A + +++A+K + EK + + + L E+K+ +QL H NI
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 865 VQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTK------------ 912
V LG+ + G + E G L LR K E+E +
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 913 --------QILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFG 951
Q+ +G+++L + VHRD+ NVLV VVKI DFG
Sbjct: 172 EDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH-GKVVKICDFG 217
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 8e-18
Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 41/207 (19%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPE--KNLGDVQPLHEEIKLHSQLR-HRNIVQYLG 869
LGKG+YG+V+ + + +A+K+I + +N D Q EI + ++L H NIV L
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 870 SVSEEGYFKI-----FMEQVPGGSLSTLLRV-KWGPLKENESTMSFYTKQILEGLKYLHG 923
+ + + +ME + L V + L+ + Q+++ +KYLH
Sbjct: 77 VLRADNDRDVYLVFDYME-------TDLHAVIRANILEPVH--KQYVVYQLIKVIKYLHS 127
Query: 924 QKIVHRDIKGDNVLVNTYSGVVKISDFG-----------TSKRLAGLCPSAETFTGTLQY 972
++HRD+K N+L+N VK++DFG T+ + + E F
Sbjct: 128 GGLLHRDMKPSNILLNA-ECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 973 M----------APEVIDKGQRGYGAPV 989
+ APE++ G Y +
Sbjct: 187 LTDYVATRWYRAPEIL-LGSTKYTKGI 212
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 1e-17
Identities = 40/158 (25%), Positives = 69/158 (43%), Gaps = 34/158 (21%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPE--KNLGDVQPLHEEIKLHSQLRHRNIVQ--- 866
+G+GSYG VY A + + + +AIK++ ++L D + + EI + ++L+ I++
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYD 92
Query: 867 -------------YLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQ 913
Y+ V E + L L + L E +
Sbjct: 93 LIIPDDLLKFDELYI--VLE------IADS----DLKKLFKTP-IFLTEEH--IKTILYN 137
Query: 914 ILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFG 951
+L G ++H I+HRD+K N L+N VK+ DFG
Sbjct: 138 LLLGENFIHESGIIHRDLKPANCLLNQ-DCSVKVCDFG 174
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 87.6 bits (216), Expect = 1e-17
Identities = 101/666 (15%), Positives = 208/666 (31%), Gaps = 195/666 (29%)
Query: 391 FQFERLDWQKTEVVELFYNADVAIVDIS-IQEQRSSLLYHLGVRESFGMKQNI----LLY 445
F+ +Q +++ +F +A V D +Q+ S+L + K + L+
Sbjct: 9 FETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLF 68
Query: 446 NDCDTETAVRVKMSCQGYTFVTYRLEDCGSCLTTHTLSVTSEQR-PSLEPRVPLTVRLKK 504
+ K FV L L + + +EQR PS+ R+ + R +
Sbjct: 69 ------WTLLSKQEEMVQKFVEEVLRINYKFLMS---PIKTEQRQPSMMTRMYIEQR-DR 118
Query: 505 ILQDVEIQSKVHIKEKFLADLRKAREMYSGEELKTALYNLRQRLDDPKVL------SGEV 558
+ D ++ +K ++ R + Y +L+ AL LR VL SG+
Sbjct: 119 LYNDNQVFAKYNVS-------RL--QPY--LKLRQALLELR---PAKNVLIDGVLGSGKT 164
Query: 559 VL--NVL---------------MSFRDIQDYDAMVQLVEDLRTIPTKKKYMQTPMLRFLY 601
+ +V ++ ++ + ++++++ L +
Sbjct: 165 WVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQ-IDPNWTSRSDHSSNI 223
Query: 602 LFALNSLYKRDERSLFLYVHENS----DDFESSEVGSLLE-FLLQC--------YSNCSS 648
++S+ R L +EN + ++++ F L C
Sbjct: 224 KLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKA---WNAFNLSCKILLTTRFKQVTDF 280
Query: 649 LGYGSNTLLEALEGCYLFSLQNTN--LSTAL-ISLRSVPTCRSGKNRVVCSGKYNLRQRL 705
L + T + + L L + +P R V +
Sbjct: 281 LSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLP-------REVLTT-------- 325
Query: 706 DDPKVLS--GEVVLNVLMSFRDIQDYDAMVQLVEFLPYLGTIRTQQLQFPLANLLEKLLL 763
+P+ LS E S RD + + ++ + L ++E L
Sbjct: 326 -NPRRLSIIAE-------SIRD------GLATWDNWKHVNCDK-------LTTIIESSLN 364
Query: 764 LIDLQDYDAMDYDAMVQLVEDLRTIPTK---------KKYMQTPMLRFLYLFALNRIELG 814
+++ +Y M +D + IPT K ++ L+ ++L
Sbjct: 365 VLEPAEYRKM-FDRLSVFPPSAH-IPTILLSLIWFDVIKSDVMVVVNKLHKYSL------ 416
Query: 815 KGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQ-----YL 868
+++Q K + IP L L E LH + H NI + L
Sbjct: 417 ------------VEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDL 464
Query: 869 GSVSEEGYF---------------------KI-----FMEQ----------VPGGSLSTL 892
+ YF + F+EQ G L+TL
Sbjct: 465 IPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTL 524
Query: 893 LRVKW--GPLKENESTMSFYTKQILEGLKYLHGQKIV---HRDI-------KGDNVLVNT 940
++K+ + +N+ IL+ L + ++ + D+ + + +
Sbjct: 525 QQLKFYKPYICDNDPKYERLVNAILDFLPK-IEENLICSKYTDLLRIALMAEDEAIFEEA 583
Query: 941 YSGVVK 946
+ V +
Sbjct: 584 HKQVQR 589
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 85.3 bits (210), Expect = 9e-17
Identities = 100/670 (14%), Positives = 201/670 (30%), Gaps = 185/670 (27%)
Query: 34 YWDVATFFEISVLA-------EDYGKAI-QAAECMFKLKPPDCLYKRDERSLFLY---VH 82
Y D+ + FE + + +D K+I E + D +L L+ +
Sbjct: 18 YKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKD----AVSGTLRLFWTLLS 73
Query: 83 ENSDDFQMFFPSSQMRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVV------- 135
+ + Q F + Y ++ + ++ + + + +L +D
Sbjct: 74 KQEEMVQKFVEEVL--RINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNV 131
Query: 136 --PKTAENFR-ALCT----------GEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGK 182
+ R AL G G G K + +C
Sbjct: 132 SRLQPYLKLRQALLELRPAKNVLIDGVLGSG-K-----TWVALDVCLSYKVQCKMDFK-- 183
Query: 183 SIY----GNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSV 238
I+ N E +L M + I T+ D+ + +
Sbjct: 184 -IFWLNLKNCNSPE---------TVLEMLQK------LLYQIDPNWTSRSDHSSNIKLRI 227
Query: 239 VEGLDVVKKLESMGSQSGKTSKKIVVANSDSHSETDSQSSLSSKALMDVVCVI-----DV 293
+++L + S+ + ++ + Q++ + A ++ C I
Sbjct: 228 HSIQAELRRL--LKSKPYENCLLVL----L-----NVQNAKAWNA-FNLSCKILLTTRFK 275
Query: 294 SVPSDLSHRRRALDEIIQACSLVNAKLNLIEFESETDSQSSLSSKALMDVVCVIDVSVPS 353
V LS SL + + L E + SL K L D P
Sbjct: 276 QVTDFLSAATT------THISLDHHSMTLTPDEVK-----SLLLKYL-------DCR-PQ 316
Query: 354 DLSHRRRALDEIIQACSLVNAKLNLIEIKRLIFCLFWFQFERLD-WQKTEVVELFYNADV 412
DL R L + S++ + + W ++ ++ + T ++E N
Sbjct: 317 DL--PREVLTTNPRRLSIIAESIR-DGLAT------WDNWKHVNCDKLTTIIESSLNV-- 365
Query: 413 AIVDISIQEQRSSLLYH-LGV-RESFGMKQNIL--LYNDCDTETAVRVKMSCQGYTFVTY 468
+ E R ++ L V S + +L ++ D V V ++ Y
Sbjct: 366 ----LEPAEYRK--MFDRLSVFPPSAHIPTILLSLIWFDVIKSD-VMVVVN----KLHKY 414
Query: 469 RLEDCGSCLTTHTLSVTSEQRPSLEPRVPLTVRLKKILQDVEIQSKVHIKEKFLADLRKA 528
L + +T ++ PS+ ++ +E + +H R
Sbjct: 415 SLVEKQPKESTISI-------PSI---------YLELKVKLENEYALH---------RSI 449
Query: 529 REMYSGEELKTALYNLRQRLDD----PKVLSGEVVLNV---LMSFRDIQDYDAMVQLVED 581
+ Y N+ + D P L ++ L + + + D
Sbjct: 450 VDHY----------NIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLD 499
Query: 582 LRTIPTKKKYMQTPMLRFLYLFALNSL-----YKRDERSLFLYVHENSDDFESSEVGSLL 636
R + K ++ T + LN+L YK Y+ +N +E V ++L
Sbjct: 500 FRFLEQKIRHDSTAWNASGSI--LNTLQQLKFYKP-------YICDNDPKYER-LVNAIL 549
Query: 637 EFLLQCYSNC 646
+FL + N
Sbjct: 550 DFLPKIEENL 559
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-17
Identities = 55/181 (30%), Positives = 81/181 (44%), Gaps = 33/181 (18%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHE---EIKLHSQLRHRNIVQYLG 869
+G G +G VY L K+A+K Q + E EI+ S RH ++V +G
Sbjct: 47 IGHGVFGKVYKGV-LRDGAKVALKRR---TPESSQGIEEFETEIETLSFCRHPHLVSLIG 102
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILE-------GLKYLH 922
E + + + G+L L P +MS+ +Q LE GL YLH
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHLYGSDLP----TMSMSW--EQRLEICIGAARGLHYLH 156
Query: 923 GQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT-------GTLQYMAP 975
+ I+HRD+K N+L++ + V KI+DFG SK + T GTL Y+ P
Sbjct: 157 TRAIIHRDVKSINILLDE-NFVPKITDFGISK----KGTELDQ-THLSTVVKGTLGYIDP 210
Query: 976 E 976
E
Sbjct: 211 E 211
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 4e-16
Identities = 50/183 (27%), Positives = 84/183 (45%), Gaps = 34/183 (18%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
LG+G +G VY R D + +A+K + E+ G E+++ S HRN+++ G
Sbjct: 38 LGRGGFGKVYKGRLADGTL-VAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96
Query: 872 SEEG-----YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYT-KQIL----EGLKYL 921
Y + GS+++ LR + E++ + + ++I GL YL
Sbjct: 97 MTPTERLLVY-----PYMANGSVASCLRER----PESQPPLDWPKRQRIALGSARGLAYL 147
Query: 922 HGQ---KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAET-----FTGTLQYM 973
H KI+HRD+K N+L++ + DFG LA L +T GT+ ++
Sbjct: 148 HDHCDPKIIHRDVKAANILLDEEF-EAVVGDFG----LAKLMDYKDTHVTTAVRGTIGHI 202
Query: 974 APE 976
APE
Sbjct: 203 APE 205
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 6e-15
Identities = 50/185 (27%), Positives = 83/185 (44%), Gaps = 39/185 (21%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEI-PEKNLGDVQPLHE---EIKLHSQLRHRNIVQYL 868
+G+G +GVVY ++ +A+K++ ++ + + EIK+ ++ +H N+V+ L
Sbjct: 39 MGEGGFGVVYKGY-VNNTT-VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 869 GSVSEEG-----YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYT-KQILE----GL 918
G S+ Y +P GSL L + +S++ +I + G+
Sbjct: 97 GFSSDGDDLCLVY-----VYMPNGSLLDRLSCL-----DGTPPLSWHMRCKIAQGAANGI 146
Query: 919 KYLHGQKIVHRDIKGDNVLV-NTYSGVVKISDFGTSKRLAGLCPSAET------FTGTLQ 971
+LH +HRDIK N+L+ + KISDFG LA GT
Sbjct: 147 NFLHENHHIHRDIKSANILLDEAF--TAKISDFG----LARASEKFAQTVMTSRIVGTTA 200
Query: 972 YMAPE 976
YMAPE
Sbjct: 201 YMAPE 205
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 7e-15
Identities = 46/185 (24%), Positives = 80/185 (43%), Gaps = 37/185 (20%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHE----EIKLHSQLRHR------ 862
+GKGS+G V A + +A+K + +N + H EI++ LR +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMV--RN---EKRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 863 NIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSF-----YTKQILEG 917
N++ L + + + + E + +L L++ K S + IL+
Sbjct: 160 NVIHMLENFTFRNHICMTFELL-SMNLYELIK------KNKFQGFSLPLVRKFAHSILQC 212
Query: 918 LKYLHGQKIVHRDIKGDNVLVNTY-SGVVKISDFGTSKRLAGLCPSAETFTGTLQ---YM 973
L LH +I+H D+K +N+L+ +K+ DFG+S C + +Q Y
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS------CYEHQRVYTYIQSRFYR 266
Query: 974 APEVI 978
APEVI
Sbjct: 267 APEVI 271
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 47/190 (24%), Positives = 84/190 (44%), Gaps = 33/190 (17%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR-----------H 861
LG G + V+ A+++ +A+K + + EIKL ++
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED-EIKLLQRVNDADNTKEDSMGA 85
Query: 862 RNIVQYLGSVSEEGYFK----IFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEG 917
+I++ L + +G + E V G +L L++ K+ + +KQ+L G
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIK-KYEHRGIPLIYVKQISKQLLLG 143
Query: 918 LKYLHGQ-KIVHRDIKGDNVLV-----NTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQ 971
L Y+H + I+H DIK +NVL+ +KI+D G + C E +T ++Q
Sbjct: 144 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA------CWYDEHYTNSIQ 197
Query: 972 ---YMAPEVI 978
Y +PEV+
Sbjct: 198 TREYRSPEVL 207
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 46/176 (26%), Positives = 73/176 (41%), Gaps = 25/176 (14%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRH-RNIVQYLGSV 871
+G GS+G +Y ++ ++AIK E LH E K++ ++ I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL--ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYT-----KQILEGLKYLHGQKI 926
+E Y + ME + G SL L S T Q++ ++Y+H +
Sbjct: 75 AEGDYNVMVMELL-GPSLEDLFN-------FCSRKFSLKTVLLLADQMISRIEYIHSKNF 126
Query: 927 VHRDIKGDNVLVNTY--SGVVKISDFGTSKRLAGLC-----PSAET--FTGTLQYM 973
+HRD+K DN L+ +V I DFG +K+ P E TGT +Y
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 39/153 (25%), Positives = 66/153 (43%), Gaps = 20/153 (13%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRH-RNIVQYLGSV 871
+G+GS+GV++ L ++AIK E D L +E + + L I
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF--EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYT-----KQILEGLKYLHGQKI 926
E + + ++ + G SL LL S T KQ+L ++ +H + +
Sbjct: 76 QEGLHNVLVIDLL-GPSLEDLL-------DLCGRKFSVKTVAMAAKQMLARVQSIHEKSL 127
Query: 927 VHRDIKGDNVLVNTYSG----VVKISDFGTSKR 955
V+RDIK DN L+ + ++ + DFG K
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-13
Identities = 47/187 (25%), Positives = 75/187 (40%), Gaps = 39/187 (20%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHE----EIKLHSQLRHR------ 862
+GKGS+G V A + Q +AIK I KN + E++L +
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIKII--KN---KKAFLNQAQIEVRLLELMNKHDTEMKY 116
Query: 863 NIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSF-----YTKQILEG 917
IV + + E + +L LLR N +S + +Q+
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEML-SYNLYDLLR------NTNFRGVSLNLTRKFAQQMCTA 169
Query: 918 LKYLHGQK--IVHRDIKGDNVL-VNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQ--- 971
L +L + I+H D+K +N+L N +KI DFG+S C + +Q
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS------CQLGQRIYQYIQSRF 223
Query: 972 YMAPEVI 978
Y +PEV+
Sbjct: 224 YRSPEVL 230
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 73.1 bits (179), Expect = 2e-13
Identities = 45/171 (26%), Positives = 72/171 (42%), Gaps = 15/171 (8%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR-HRNIVQYLGSV 871
+G GS+G +Y + ++AIK E L E K++ L+ I
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
E Y + M+ + G SL L L + T+ Q++ ++++H + +HRDI
Sbjct: 73 VEGDYNVLVMDLL-GPSLEDLFNFCSRKL--SLKTVLMLADQMINRVEFVHSKSFLHRDI 129
Query: 932 KGDNVLVNTY--SGVVKISDFGTSKRLAGLC-----PSAET--FTGTLQYM 973
K DN L+ + V I DFG +K+ P E TGT +Y
Sbjct: 130 KPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 31/196 (15%), Positives = 72/196 (36%), Gaps = 45/196 (22%)
Query: 813 LGKGSYGVVYAAREL--------DRQVKLAIKEIPEK-----------NLGDVQPLHEEI 853
+ + G++Y A ++ K ++K + +++
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 854 KLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYT-- 911
KL+S I +G + ++ + G SL + L + +S +
Sbjct: 110 KLYS-TPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALD------VSPKHVLSERSVL 162
Query: 912 ---KQILEGLKYLHGQKIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGLCPSAE--- 964
++L+ L++LH + VH ++ +N+ V+ V ++ +G + R CPS +
Sbjct: 163 QVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR---YCPSGKHVA 219
Query: 965 -------TFTGTLQYM 973
G L+++
Sbjct: 220 YVEGSRSPHEGDLEFI 235
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 38/153 (24%), Positives = 64/153 (41%), Gaps = 20/153 (13%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRH-RNIVQYLGSV 871
+G G++G + + L +AIK E LH E + + QL I Q
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYT-----KQILEGLKYLHGQKI 926
Y + +E + G SL L + T S T Q++ ++Y+H + +
Sbjct: 75 PCGKYNAMVLELL-GPSLEDLFD-------LCDRTFSLKTVLMIAIQLISRMEYVHSKNL 126
Query: 927 VHRDIKGDNVLV----NTYSGVVKISDFGTSKR 955
++RD+K +N L+ N V+ I DF +K
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 38/190 (20%), Positives = 77/190 (40%), Gaps = 36/190 (18%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL------------- 859
+G G +G++Y A ++ K A + + + PL E+K + ++
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEY-QENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 860 --RHRNIVQYLGS---VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQI 914
+ I + GS + ++ + + G L + +ST+ ++
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQN---GTFKKSTVLQLGIRM 160
Query: 915 LEGLKYLHGQKIVHRDIKGDNVLVNTYSG-VVKISDFGTSKRLAGLCPSAE--------- 964
L+ L+Y+H + VH DIK N+L+ + V ++D+G S R CP+
Sbjct: 161 LDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR---YCPNGNHKQYQENPR 217
Query: 965 -TFTGTLQYM 973
GT+++
Sbjct: 218 KGHNGTIEFT 227
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 4e-12
Identities = 39/200 (19%), Positives = 68/200 (34%), Gaps = 53/200 (26%)
Query: 813 LGKGSYGVVYAARELDRQ-----VKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQY 867
+G+G +G +Y A + +K P N PL E+K + + +Q
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN----GPLFTELKFYQRAAKPEQIQK 98
Query: 868 LGSVSEEG--------YFKIFMEQVP----------GGSLSTLLRVKWGPLKENESTMSF 909
+ + + G L + + N S
Sbjct: 99 WIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIY-------EANAKRFSR 151
Query: 910 YT-----KQILEGLKYLHGQKIVHRDIKGDNVLVNTYSG-VVKISDFGTSKRLAGLCPSA 963
T +IL+ L+Y+H + VH DIK N+L+N + V + D+G + R CP
Sbjct: 152 KTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR---YCPEG 208
Query: 964 E----------TFTGTLQYM 973
GT+++
Sbjct: 209 VHKAYAADPKRCHDGTIEFT 228
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-11
Identities = 40/207 (19%), Positives = 78/207 (37%), Gaps = 59/207 (28%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHE----EIKLHSQLRHR-----N 863
+G G++G V + +D + A+K + +N ++ E + ++++ N
Sbjct: 43 MGDGTFGRVLLCQHIDNKKYYAVKVV--RN---IKKYTRSAKIEADILKKIQNDDINNNN 97
Query: 864 IVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSF-----YTKQILEGL 918
IV+Y G + + E + G SL ++ + N + Y +IL+ L
Sbjct: 98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIIT------RNNYNGFHIEDIKLYCIEILKAL 150
Query: 919 KYLHGQKIVHRDIKGDNVLVNTYSGV------------------------VKISDFGTSK 954
YL + H D+K +N+L++ +K+ DFG +
Sbjct: 151 NYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA- 209
Query: 955 RLAGLCPSAETFTGTLQ---YMAPEVI 978
++ + Y APEVI
Sbjct: 210 -----TFKSDYHGSIINTRQYRAPEVI 231
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-11
Identities = 40/203 (19%), Positives = 75/203 (36%), Gaps = 55/203 (27%)
Query: 813 LGKGSYGVVYAARELDR-QVKLAIKEIPEKNLGDVQPLHE----EIKLHSQLRHR----- 862
LG+G++G V + R + ++A+K I +N V E EI + +++ +
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALKII--RN---VGKYREAARLEINVLKKIKEKDKENK 81
Query: 863 -NIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSF-----YTKQILE 916
V + G+ I E + G + L+ + N Q+
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLK------ENNFQPYPLPHVRHMAYQLCH 134
Query: 917 GLKYLHGQKIVHRDIKGDNVLVNTYSGV------------------VKISDFGTSKRLAG 958
L++LH ++ H D+K +N+L ++++DFG++
Sbjct: 135 ALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA----- 189
Query: 959 LCPSAETFTGTLQ---YMAPEVI 978
E T + Y PEVI
Sbjct: 190 -TFDHEHHTTIVATRHYRPPEVI 211
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 43/203 (21%), Positives = 70/203 (34%), Gaps = 55/203 (27%)
Query: 813 LGKGSYGVVYAARELDRQVKL-AIKEIPEKNLGDVQPLHE----EIKLHSQLRHR----- 862
LG+G++G V + + A+K + KN V E EI++ L
Sbjct: 22 LGEGAFGKVVECIDHKAGGRHVAVKIV--KN---VDRYCEAARSEIQVLEHLNTTDPNST 76
Query: 863 -NIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSF-----YTKQILE 916
VQ L G+ I E + G S ++ + QI +
Sbjct: 77 FRCVQMLEWFEHHGHICIVFELL-GLSTYDFIK------ENGFLPFRLDHIRKMAYQICK 129
Query: 917 GLKYLHGQKIVHRDIKGDNVLVNTYSGV------------------VKISDFGTSKRLAG 958
+ +LH K+ H D+K +N+L +K+ DFG++
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA----- 184
Query: 959 LCPSAETFTGTLQ---YMAPEVI 978
E + + Y APEVI
Sbjct: 185 -TYDDEHHSTLVSTRHYRAPEVI 206
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 6e-08
Identities = 45/239 (18%), Positives = 77/239 (32%), Gaps = 91/239 (38%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR--------HRNI 864
LG G + V+ + ++ + +A+K + + + +EI+L +R +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 865 VQYLGSVSEEGYFKIFMEQVPGG------------SLSTLLRV-KWGPLKENESTMSFYT 911
VQ L F G L + + L +
Sbjct: 104 VQLLDD---------FKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGL--PLPCVKKII 152
Query: 912 KQILEGLKYLHGQ-KIVHRDIKGDNVLV-------------------------------- 938
+Q+L+GL YLH + +I+H DIK +N+L+
Sbjct: 153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 939 ----------------NTYSGVVKISDFGTSKRLAGLCPSAETFTG---TLQYMAPEVI 978
N VKI+D G + C + FT T QY + EV+
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNA------CWVHKHFTEDIQTRQYRSLEVL 265
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 2e-07
Identities = 40/239 (16%), Positives = 69/239 (28%), Gaps = 63/239 (26%)
Query: 796 QTPMLRFLYLFALNRIE----LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQP--- 848
Q + F + +++ +G+G +G V+ V AIK I + V
Sbjct: 7 QKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPV--AIKIIAIEGPDLVNGSHQ 64
Query: 849 -----LHEEIKLHSQL---------RHRNIVQYLGSVSEEGYFK---------------- 878
+ EI + +L R + +G +
Sbjct: 65 KTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGS 124
Query: 879 --------------IFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ 924
I +E GG +R K L +S + Q+ L
Sbjct: 125 ANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSIL----HQLTASLAVAEAS 180
Query: 925 -KIVHRDIKGDNVLVNTYSGVVKISDFGTSKR----LAGLCPSAETFTGTLQYMAPEVI 978
+ HRD+ NVL+ + K+ K GL S +T + V+
Sbjct: 181 LRFEHRDLHWGNVLLKKT-SLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVV 238
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 16/44 (36%), Positives = 30/44 (68%), Gaps = 1/44 (2%)
Query: 913 QILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956
Q+ +G+++L +K +HRD+ N+L+ + VVKI DFG ++ +
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILL-SEKNVVKICDFGLARDI 243
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 30/141 (21%), Positives = 56/141 (39%), Gaps = 15/141 (10%)
Query: 812 ELGKGSYGVVYAAR-----ELDRQVKLAIKEIPEK-NLGDVQPLHEEIKLHSQL-RHRNI 864
LG+G++G V A + +A+K + E + + L E+K+ + H N+
Sbjct: 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88
Query: 865 VQYLGSVSEE-GYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHG 923
V LG+ ++ G + +E G+LST LR K + +G Y+
Sbjct: 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY----KTKGARFRQGKDYVG- 143
Query: 924 QKIVHRDIKGDNVLVNTYSGV 944
+ D+K + +
Sbjct: 144 --AIPVDLKRRLDSITSSQSS 162
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1181 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 2z6w_A | 165 | Peptidyl-prolyl CIS-trans isomerase; isomerase-imm | 100.0 | |
| 2r99_A | 173 | Peptidyl-prolyl CIS-trans isomerase E; CIS-trans i | 100.0 | |
| 2cmt_A | 172 | Peptidyl-prolyl CIS-trans isomerase E; rotamase ac | 100.0 | |
| 3pmp_A | 164 | Cyclophilin A; peptidyl prolyl isomerase, isomeras | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 2wfi_A | 179 | Peptidyl-prolyl CIS-trans isomerase G; phosphoprot | 100.0 | |
| 2haq_A | 172 | Cyclophilin; rotamase, proline, isomerase, CIS-tra | 100.0 | |
| 2igv_A | 173 | Peptidyl-prolyl CIS-trans isomerase 3; rotamase; 1 | 100.0 | |
| 1qng_A | 170 | Peptidyl-prolyl CIS-trans isomerase; isomerase-imm | 100.0 | |
| 1a58_A | 177 | Cyclophilin; isomerase, ppiase; 1.95A {Brugia mala | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ich_A | 188 | Peptidyl-prolyl CIS-trans isomerase B; beta sandwi | 100.0 | |
| 3rdd_A | 184 | Peptidyl-prolyl CIS-trans isomerase A; beta barrel | 100.0 | |
| 2poy_A | 186 | Peptidyl-prolyl CIS-trans isomerase; isomerase-imm | 100.0 | |
| 2he9_A | 192 | NK-tumor recognition protein; cyclosporin, isomera | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3k2c_A | 193 | Peptidyl-prolyl CIS-trans isomerase; ssgcid, NIH, | 100.0 | |
| 4fru_A | 185 | Cyclophilin B, peptidyl-prolyl CIS-trans isomerase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 1mzw_A | 177 | Cyclophilin H, U-snRNP-ASSOCIATED cyclophilin; cyc | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2c3b_A | 172 | Ppiase, cyclophilin; isomerase, 3D domain swapping | 100.0 | |
| 1z81_A | 229 | Cyclophilin; structural genomics, structural genom | 100.0 | |
| 2ok3_A | 161 | Peptidyl-prolyl CIS-trans isomerase-like 3; beta-b | 100.0 | |
| 2poe_A | 185 | Cyclophilin-like protein, putative; cryptosporidiu | 100.0 | |
| 2ose_A | 234 | Probable peptidyl-prolyl CIS-trans isomerase; cycl | 100.0 | |
| 1zkc_A | 197 | Peptidyl-prolyl CIS-trans isomerase like 2; CIS-tr | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2b71_A | 196 | Cyclophilin-like protein; structural genomics, str | 100.0 | |
| 2fu0_A | 160 | Cyclophilin, putative; PFE0505W, cyclosporin-bindi | 100.0 | |
| 2x7k_A | 166 | Peptidyl-prolyl CIS-trans isomerase-like 1; isomer | 100.0 | |
| 3bo7_A | 201 | Peptidyl-prolyl CIS-trans isomerase cyclophilin-T; | 100.0 | |
| 1w74_A | 191 | Peptidyl-prolyl CIS-trans isomerase A; cyclophilin | 100.0 | |
| 2a2n_A | 176 | Peptidylprolyl isomerase domain and WD repeat CON; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2k7n_A | 203 | Peptidyl-prolyl CIS-trans isomerase-like 1; beta b | 100.0 | |
| 1ihg_A | 370 | Cyclophilin 40; ppiase immunophilin tetratricopept | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2hq6_A | 185 | Serologically defined colon cancer antigen 10; pro | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3bkp_A | 232 | Cyclophilin; malaria, isomerase, structural GENO s | 100.0 | |
| 1lop_A | 164 | Cyclophilin A; rotamase, isomerase-isomerase inhib | 100.0 | |
| 1v9t_A | 166 | Cyclophilin B; beta barrel, isomerase-isomerase in | 100.0 | |
| 3s6m_A | 167 | Peptidyl-prolyl CIS-trans isomerase; seattle struc | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.98 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.98 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.98 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.98 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.98 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.98 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.98 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.98 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.98 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.98 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.98 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.98 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.98 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.98 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.98 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.98 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.98 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.98 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.98 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.98 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.98 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.97 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.97 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.97 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.97 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.97 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.97 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.97 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 3rfy_A | 369 | Peptidyl-prolyl CIS-trans isomerase CYP38, chloro; | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.96 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.8 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.69 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.52 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.04 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.94 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.79 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.49 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.19 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.11 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.97 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.87 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.86 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.85 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.85 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.63 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 96.98 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.74 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.66 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.54 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.43 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.27 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.06 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.98 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.83 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.82 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.55 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.7 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.26 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.94 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.13 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=439.76 Aligned_cols=246 Identities=25% Similarity=0.362 Sum_probs=199.2
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEe
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmE 882 (1181)
+|.+. ++||+|+||+||+|++..+++.||||++.+.... ..+.+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus 25 ~Y~~~-~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 25 KYVRL-QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CEEEE-EEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEe-EEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 34443 3799999999999999999999999999766433 35679999999999999999999999999999999999
Q ss_pred ecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC
Q psy14556 883 QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS 962 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~ 962 (1181)
||+||+|.+++... ....+++..++.|+.||+.||+|||++|||||||||+||||+. ++.+||+|||+|+.+......
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~-~g~vKl~DFGla~~~~~~~~~ 181 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTK-DGTVQLGDFGIARVLNSTVEL 181 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECT-TCCEEECSTTEESCCCHHHHH
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECC-CCCEEEcccccceeecCCccc
Confidence 99999999999754 4456789999999999999999999999999999999999988 899999999999877543333
Q ss_pred CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC--C
Q psy14556 963 AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ--I 1040 (1181)
Q Consensus 963 ~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~--i 1040 (1181)
..+.+||+.|||||++.+.. ++..+|+ ||+||+||||+||+.||.+.+..++...+. .
T Consensus 182 ~~~~~GT~~YmAPE~l~~~~--y~~~~Di------------------wSlGvilyemltG~~PF~~~~~~~~~~~i~~~~ 241 (350)
T 4b9d_A 182 ARACIGTPYYLSPEICENKP--YNNKSDI------------------WALGCVLYELCTLKHAFEAGSMKNLVLKIISGS 241 (350)
T ss_dssp HHHHHSCCTTCCHHHHTTCC--CCHHHHH------------------HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC
T ss_pred ccccCCCccccCHHHHCCCC--CCcHHHH------------------HHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC
Confidence 34567999999999998654 3444554 999999999999999999988766432211 1
Q ss_pred CCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1041 SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1041 p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
....+...+..+..++.+|+++||.+||+..+.
T Consensus 242 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~ 274 (350)
T 4b9d_A 242 FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSI 274 (350)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 112344567889999999999999999965444
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=415.81 Aligned_cols=239 Identities=23% Similarity=0.342 Sum_probs=204.8
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
.++||+|+||+||+|+++.+++.||||++........+.+.+|+.+|++++|||||++++++.+++.+|||||||+||+|
T Consensus 79 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 158 (346)
T 4fih_A 79 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 158 (346)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEH
T ss_pred eEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcH
Confidence 34799999999999999999999999999877666778899999999999999999999999999999999999999999
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT 969 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT 969 (1181)
.+++... .+++..++.|+.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+.+........+.+||
T Consensus 159 ~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~-~g~vKl~DFGla~~~~~~~~~~~~~~GT 233 (346)
T 4fih_A 159 TDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH-DGRVKLSDFGFCAQVSKEVPRRKSLVGT 233 (346)
T ss_dssp HHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TCCEEECCCTTCEECCSSSCCBCCCCSC
T ss_pred HHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECC-CCCEEEecCcCceecCCCCCcccccccC
Confidence 9999753 5789999999999999999999999999999999999998 8999999999999887665566678899
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC----CCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ----ISRSVS 1045 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~----ip~~l~ 1045 (1181)
+.|||||++.+.. |+..+|+ ||+||++|||++|+.||.+.+..++...+. ......
T Consensus 234 p~YmAPEvl~~~~--y~~~~Di------------------WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~ 293 (346)
T 4fih_A 234 PYWMAPELISRLP--YGPEVDI------------------WSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNL 293 (346)
T ss_dssp GGGCCHHHHTTCC--BCTHHHH------------------HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCG
T ss_pred cCcCCHHHHCCCC--CCcHHHH------------------HHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCcc
Confidence 9999999997654 4455555 999999999999999999887655322111 111112
Q ss_pred CCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1046 VPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1046 ~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
...+..+..++.+|+.+||.+|++..+.
T Consensus 294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~ 321 (346)
T 4fih_A 294 HKVSPSLKGFLDRLLVRDPAQRATAAEL 321 (346)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 3456778889999999999999964443
|
| >2z6w_A Peptidyl-prolyl CIS-trans isomerase; isomerase-immunosuppressant complex, immunosuppressant, cyclophilin D; HET: BMT MLE CIT; 0.96A {Homo sapiens} SCOP: b.62.1.1 PDB: 3rcg_A* 3r49_A* 3r54_A 3r56_A* 3r57_A* 3r59_A* 3rcf_A* 3r4g_A* 3rci_X* 3rck_X* 3rcl_A* 3rd9_X* 3rda_X* 3rdb_A* 3rdc_A* 2bit_X 2biu_X 3qyu_A 3k0m_A 1ak4_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=368.85 Aligned_cols=163 Identities=70% Similarity=1.147 Sum_probs=156.9
Q ss_pred cccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCC
Q psy14556 97 MRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNH 176 (1181)
Q Consensus 97 ~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~ 176 (1181)
+|++|||++ +.+|+.|+|+||||++.||+||+||++||+|++||+|+|+.||||+|+|||||||++.+
T Consensus 3 ~~~v~~di~------------i~~t~~G~i~ieL~~~~aP~t~~NF~~L~~g~~g~~Y~g~~fhRvi~~f~iQgGd~~~~ 70 (165)
T 2z6w_A 3 NPLVYLDVD------------ANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNH 70 (165)
T ss_dssp CCEEEEEEE------------ETTEEEEEEEEEECTTTCHHHHHHHHHHHHTTTSCCSTTCBEEEEETTTEEEECCTTTS
T ss_pred CCEEEEEEE------------ECCEeeeEEEEEEeCCCCcHHHHHHHHHhccCCCccCcCCEEEEEECCCEEEeCCccCC
Confidence 578999997 56899999999999999999999999999998999999999999999999999999888
Q ss_pred CCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCCCCC
Q psy14556 177 NGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGSQSG 256 (1181)
Q Consensus 177 ~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t~~g 256 (1181)
+|+|+.++||.+|++|+..++|+++|+|||||++||++|||||||++++||||++|+|||+|++|||||++|+++++.++
T Consensus 71 ~g~gg~si~g~~f~dE~~~l~h~~~G~lsmA~~gp~s~~SQFfI~~~~~~~Ldg~~~vFG~Vv~G~dvv~~I~~~~~~~~ 150 (165)
T 2z6w_A 71 NGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSG 150 (165)
T ss_dssp SSSCCCBTTBSCBCCCCCCSCCCSTTEEEECCSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHHHHTCCTTS
T ss_pred CCCCCCcccCCcccCcccccccCCCCEEEEeeCCCCCcccEEEEEcCCCcccCCCeeEEEEEEcCHHHHHHHHhCCCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999899
Q ss_pred CcccceEEeeecccc
Q psy14556 257 KTSKKIVVANSDSHS 271 (1181)
Q Consensus 257 ~P~~~V~I~~cGvl~ 271 (1181)
+|.++|+|.+||+|.
T Consensus 151 ~P~~~v~I~~~g~l~ 165 (165)
T 2z6w_A 151 RTSKKIVITDCGQLS 165 (165)
T ss_dssp CCSSCEEEEEEEECC
T ss_pred CCCCcEEEEEeEEEC
Confidence 999999999999973
|
| >2r99_A Peptidyl-prolyl CIS-trans isomerase E; CIS-trans isomerization, structural genomics consortium, SGC, alternative splicing, mRNA processing; 1.61A {Homo sapiens} SCOP: b.62.1.1 PDB: 3uch_A 1zmf_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=371.18 Aligned_cols=164 Identities=63% Similarity=1.076 Sum_probs=157.5
Q ss_pred ccccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCC
Q psy14556 96 QMRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTN 175 (1181)
Q Consensus 96 ~~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~ 175 (1181)
.+|.+|||++ +.+|+.|+|+||||++.||+||+||++||+|++||+|+|+.||||+|+|||||||++.
T Consensus 10 ~~~~v~~di~------------i~~t~~G~i~ieL~~~~aP~t~~NF~~L~~g~~g~~Y~g~~FhRvi~~f~iQgGd~~~ 77 (173)
T 2r99_A 10 SNPQVYMDIK------------IGNKPAGRIQMLLRSDVVPMTAENFRCLCTHEKGFGFKGSSFHRIIPQFMCQGGDFTN 77 (173)
T ss_dssp CCCEEEEEEE------------ETTEEEEEEEEEECTTTCHHHHHHHHHHHHTTTSCCSTTCBEEEEETTTEEEECCTTT
T ss_pred CCCEEEEEEE------------ECCccceeEEEEECCCCCcHHHHHHHHHhcccCCceecCCEEEEeeCCCEEEeCCcCC
Confidence 4689999986 5589999999999999999999999999999999889999999999999999999998
Q ss_pred CCCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCCCC
Q psy14556 176 HNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGSQS 255 (1181)
Q Consensus 176 ~~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t~~ 255 (1181)
++|+||.++||.+|++|++.++|+++|+|||||++||++|||||||++++||||++|+|||+|++|||||++|+++++.+
T Consensus 78 ~~g~gg~si~g~~f~dE~~~l~h~~~G~lsmA~~gp~t~gSQFfIt~~~~~~LDg~~tVFG~Vv~G~dvv~~I~~~~~~~ 157 (173)
T 2r99_A 78 HNGTGGKSIYGKKFDDENFILKHTGPGLLSMANSGPNTNGSQFFLTCDKTDWLDGKHVVFGEVTEGLDVLRQIEAQGSKD 157 (173)
T ss_dssp SSSSCCCBTTBSCBCCCCCCSCCCSSSEEEECCSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHHHTTCCTT
T ss_pred CCCCCCCccCCCcccCcccCcccCCCcEEEEccCCCCCcccEEEEECCCCCccCCCeeEEEEEEcCHHHHHHHHhCCCCC
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999999999988
Q ss_pred CCcccceEEeeecccc
Q psy14556 256 GKTSKKIVVANSDSHS 271 (1181)
Q Consensus 256 g~P~~~V~I~~cGvl~ 271 (1181)
++|.++|+|.+||+|.
T Consensus 158 ~~P~~~v~I~~cG~l~ 173 (173)
T 2r99_A 158 GKPKQKVIIADCGEYV 173 (173)
T ss_dssp CCCSSCEEEEEEEECC
T ss_pred CCCCCCeEEEEeeeEC
Confidence 9999999999999974
|
| >2cmt_A Peptidyl-prolyl CIS-trans isomerase E; rotamase activity, rotamase, RNA-binding, cyclosporin, cyclophilin, beta-barrel; 1.50A {Schistosoma mansoni} PDB: 2ck1_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=371.23 Aligned_cols=164 Identities=59% Similarity=1.053 Sum_probs=157.3
Q ss_pred ccccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCC
Q psy14556 96 QMRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTN 175 (1181)
Q Consensus 96 ~~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~ 175 (1181)
.+|.+|||++ +.+|+.|+|+||||++.||+||+||++||+|++||+|+|+.||||+|+|||||||+..
T Consensus 9 ~~~~v~~di~------------i~~t~~G~i~ieL~~~~aP~t~~NF~~L~~~~~g~~Y~g~~FhRvi~~f~iQgGd~~~ 76 (172)
T 2cmt_A 9 NLPRVFFDIR------------IGNGDAGRIVMELRSDIVPRTAENFRALCTGERGFGYHNCCFHRVIPQFMCQGGDFVK 76 (172)
T ss_dssp CCCEEEEEEE------------ETTEEEEEEEEEECTTTCHHHHHHHHHHHHTTTSCSSTTCBEEEEETTTEEEECCTTT
T ss_pred CCCEEEEEEE------------ECCeecceEEEEEcCCCCCHHHHHHHHHhccCCCceECCCEEEEEECCCEEEcCCccC
Confidence 4689999986 5589999999999999999999999999998889889999999999999999999998
Q ss_pred CCCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCCCC
Q psy14556 176 HNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGSQS 255 (1181)
Q Consensus 176 ~~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t~~ 255 (1181)
++|+||+++||.+|++|+..++|+++|+|||||++||++|||||||++++||||++|+|||+|++|||||++|+++++.+
T Consensus 77 ~~G~gg~si~g~~f~dE~~~l~h~~~G~lsmA~~gp~t~gSQFfIt~~~~~~LDg~~tvFG~Vv~G~dvv~~I~~~~~~~ 156 (172)
T 2cmt_A 77 GDGTGGKSIYGRKFDDENFQLRHEGFGVLSMANSGPNTNGSQFFICTTKCDWLDGKHVVFGRVVDGQNVVKKMESVGSKS 156 (172)
T ss_dssp SSSSCCCBTTBSCBCCCCCCSCCCSTTEEEECCSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHGGGGCCTT
T ss_pred CCCCCCCccCCCcccccccCcccCCceEEEEeeCCCCCcccEEEEECCCCCccCCCeeEEEEEEcCHHHHHHHHhCCCCC
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999999999988
Q ss_pred CCcccceEEeeecccc
Q psy14556 256 GKTSKKIVVANSDSHS 271 (1181)
Q Consensus 256 g~P~~~V~I~~cGvl~ 271 (1181)
++|.++|+|.+||+|.
T Consensus 157 ~~P~~~v~I~~~g~l~ 172 (172)
T 2cmt_A 157 GKVKEPVIISRCGELI 172 (172)
T ss_dssp CCCSSCEEEEEEEEEC
T ss_pred CCCCCCEEEEEeEeEC
Confidence 9999999999999974
|
| >3pmp_A Cyclophilin A; peptidyl prolyl isomerase, isomerase-immunosuppressant compl; HET: BMT; 1.47A {Moniliophthora perniciosa} SCOP: b.62.1.1 PDB: 3o7t_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=367.99 Aligned_cols=163 Identities=62% Similarity=1.018 Sum_probs=157.0
Q ss_pred cccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCC
Q psy14556 97 MRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNH 176 (1181)
Q Consensus 97 ~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~ 176 (1181)
+|++|||+. +.+|+.|+|+||||++.||+||+||++||+|++||+|+|+.||||+|+|||||||+..+
T Consensus 2 ~p~vf~di~------------i~~t~~G~i~ieL~~~~aP~t~~nF~~L~~g~~g~~Y~g~~fhRvi~~f~iQgGd~~~~ 69 (164)
T 3pmp_A 2 MANVFFNIS------------INDKPEGRIVFKLYDEAVPKTAKNFRELATGQHGFGYKDSIFHRVIPQFMLQGGDFTRH 69 (164)
T ss_dssp CCCEEEEEE------------ETTEEEEEEEEEECTTTCHHHHHHHHHHHHTTTSCSSTTCBEEEEETTTEEEECCTTTS
T ss_pred CCEEEEEEE------------ECCEEeeEEEEEEeCCCCcHHHHHHHHHhcccCCCcccCCEEEEEECCCeEEeCCCCCC
Confidence 689999997 55899999999999999999999999999998999999999999999999999998888
Q ss_pred CCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCCCCC
Q psy14556 177 NGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGSQSG 256 (1181)
Q Consensus 177 ~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t~~g 256 (1181)
+|+|++++||.+|++|+..++|+++|+|||||++++++|||||||++++||||++|+|||+|++|||||++|+++++.++
T Consensus 70 ~g~gg~si~g~~~~dE~~~l~h~~~G~lsma~~g~~t~~SQFfIt~~~~~~Ld~~~~vFG~Vv~G~~vv~~I~~~~~~~~ 149 (164)
T 3pmp_A 70 NGTGGKSIYGEKFADENFQVKHTKPGLLSMANAGANTNGSQFFITTVPTSWLDGKHVVFGEVIEGLDIVRKVEGKGSASG 149 (164)
T ss_dssp SSSCCCBTTBSCBCCCCCCSCCCSTTEEEECBSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHHHTTCCTTC
T ss_pred CCCCCcccCCccccccccccCcCCCcEEEEeeCCCCCcccEEEEECCCChhhCCCccEEEEEeCCHHHHHHHHhCCCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccceEEeeecccc
Q psy14556 257 KTSKKIVVANSDSHS 271 (1181)
Q Consensus 257 ~P~~~V~I~~cGvl~ 271 (1181)
+|.++|+|.+||+|.
T Consensus 150 ~P~~~v~I~~cg~l~ 164 (164)
T 3pmp_A 150 KTNATIKITDCGTVA 164 (164)
T ss_dssp CCSSCEEEEEEEEC-
T ss_pred CcccCEEEEeCeEEC
Confidence 999999999999973
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=417.52 Aligned_cols=239 Identities=23% Similarity=0.340 Sum_probs=205.8
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
.++||+|+||+||+|+++.+++.||||++........+.+.+|+.+|++++|||||+++++|.+++.+|||||||+||+|
T Consensus 156 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L 235 (423)
T 4fie_A 156 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 235 (423)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred eeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcH
Confidence 34799999999999999999999999999887777778899999999999999999999999999999999999999999
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT 969 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT 969 (1181)
.++++.. .+++..+..|+.||+.||+|||++|||||||||+||||+. +|.+||+|||+|+.+........+.+||
T Consensus 236 ~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~-~g~vKl~DFGla~~~~~~~~~~~~~~GT 310 (423)
T 4fie_A 236 TDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH-DGRVKLSDFGFCAQVSKEVPRRKSLVGT 310 (423)
T ss_dssp HHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECT-TCCEEECCCTTCEECCSSCCCBCCCEEC
T ss_pred HHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcC-CCCEEEecCccceECCCCCccccccccC
Confidence 9999754 4789999999999999999999999999999999999998 8999999999999887665566678899
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCC----CCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPP----QISRSVS 1045 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~----~ip~~l~ 1045 (1181)
+.|||||++.+.. |+..+|+ ||+||++|||++|+.||.+.+...+...+ .......
T Consensus 311 p~YmAPEvl~~~~--y~~~~Di------------------WSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~ 370 (423)
T 4fie_A 311 PYWMAPELISRLP--YGPEVDI------------------WSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNL 370 (423)
T ss_dssp TTTCCHHHHTTCC--BCTHHHH------------------HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCT
T ss_pred cCcCCHHHHCCCC--CCcHHHH------------------HHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCccc
Confidence 9999999997654 4555555 99999999999999999988765532211 1111122
Q ss_pred CCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1046 VPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1046 ~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
..++..+..++.+||.+||.+|++..+.
T Consensus 371 ~~~s~~~~dli~~~L~~dP~~R~ta~el 398 (423)
T 4fie_A 371 HKVSPSLKGFLDRLLVRDPAQRATAAEL 398 (423)
T ss_dssp TSSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 3567788899999999999999964443
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=408.00 Aligned_cols=243 Identities=26% Similarity=0.338 Sum_probs=203.1
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCC---CCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEK---NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFM 881 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~---~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVm 881 (1181)
+|.+.+ +||+|+||+||+|++..+++.||||++.+. .....+.+.+|+.+|++++|||||++++++.+++.+|+||
T Consensus 33 dy~i~~-~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 33 DFKFGK-ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GEEEEE-EEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEE-EEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 455544 799999999999999999999999999754 2345678999999999999999999999999999999999
Q ss_pred eecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC-
Q psy14556 882 EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC- 960 (1181)
Q Consensus 882 Ey~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~- 960 (1181)
|||+||+|.++++.. ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.+....
T Consensus 112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~-~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE-DMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-TSCEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcC-CCCEEEEEcCCceecCCCCC
Confidence 999999999999854 35789999999999999999999999999999999999988 8999999999999875432
Q ss_pred -CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC
Q psy14556 961 -PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ 1039 (1181)
Q Consensus 961 -~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~ 1039 (1181)
....+.+||+.|||||++.+..+ +..+|+ ||+||++|+|++|+.||.+.+..++...+.
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y--~~~~Di------------------WSlGvilyeml~G~~PF~~~~~~~~~~~i~ 247 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSA--CKSSDL------------------WALGCIIYQLVAGLPPFRAGNEGLIFAKII 247 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCB--CHHHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cccccCcccCcccCCHHHHcCCCC--CcHHHH------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 23456789999999999986543 444554 999999999999999999988765432111
Q ss_pred -CCCCCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1040 -ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1040 -ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
..-..+...++.+..++.+|+.+||.+|++..+
T Consensus 248 ~~~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e 281 (311)
T 4aw0_A 248 KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEE 281 (311)
T ss_dssp HTCCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGG
T ss_pred cCCCCCCcccCHHHHHHHHHHccCCHhHCcChHH
Confidence 011122345677888999999999999997443
|
| >2wfi_A Peptidyl-prolyl CIS-trans isomerase G; phosphoprotein, PRE-mRNA splicing, alternative splicing, nucleus, rotamase, cyclosporin; HET: OCS; 0.75A {Homo sapiens} PDB: 2wfj_A* 2gw2_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=370.02 Aligned_cols=166 Identities=47% Similarity=0.750 Sum_probs=154.5
Q ss_pred cCCcccccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCC---------ccccCCEEEEe
Q psy14556 92 FPSSQMRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKG---------FGFKDSTFHRV 162 (1181)
Q Consensus 92 ~~ss~~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G---------~~Y~g~~FhRV 162 (1181)
..++.+|++|||++ +.+|+.|+|+||||++.||+||+||++||+|++| + |+|+.||||
T Consensus 4 ~~~~~~~~vf~di~------------i~~t~~G~i~ieL~~~~aP~t~~NF~~L~~g~~g~~~~~~~~~~-Y~g~~FhRv 70 (179)
T 2wfi_A 4 GIKVQRPRCFFDIA------------INNQPAGRVVFELFSDVCPKTCENFRCLCTGEKGTGKSTQKPLH-YKSCLFHRV 70 (179)
T ss_dssp ----CCCEEEEEEE------------ETTEEEEEEEEEECTTTCHHHHHHHHHHHHCTTCBCTTTCSBSC-CTTCBEEEE
T ss_pred CcCCCCCeEEEEEE------------ECCccceEEEEEEcCCCCChHHHHHHHHhcCCcCcccccccCCe-ECCCEEEEE
Confidence 34456889999997 6689999999999999999999999999987654 5 999999999
Q ss_pred cCCceEeeCCCCCCCCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCH
Q psy14556 163 IPNFMCQGGDFTNHNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGL 242 (1181)
Q Consensus 163 ip~f~iQgGd~~~~~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~ 242 (1181)
+|+|||||||++.++|+|++++||..|++|++.++|+++|+|||||++||++|||||||++++||||++|+|||+|++||
T Consensus 71 i~~f~iQgGd~~~~~g~gg~si~g~~f~dE~~~~~h~~~G~lsMAn~gp~tngSQFfIt~~~~~~LDg~~tVFG~Vv~G~ 150 (179)
T 2wfi_A 71 VKDFMVQGGDFSEGNGRGGESIYGGFFEDESFAVKHNKEFLLSMANRGKDTNGSQFFITTKPTPHLDGHHVVFGQVISGQ 150 (179)
T ss_dssp ETTTEEEECCTTTSSSSCCCCTTSSCBCCCCCCSCCCSTTEEEECCSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECH
T ss_pred ECCCEEEcccccCCCCCCCCcccCCcccccccCcCcCCCeEEEEEeCCCCCcceEEEEEcCCCcccCCCeeEEEEEeCCH
Confidence 99999999999888999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhCCC-CCCCcccceEEeeeccc
Q psy14556 243 DVVKKLESMGS-QSGKTSKKIVVANSDSH 270 (1181)
Q Consensus 243 dVL~kI~~~~t-~~g~P~~~V~I~~cGvl 270 (1181)
|||++|+++++ .+++|.++|+|.+||+|
T Consensus 151 dvv~~I~~~~t~~~~~P~~~v~I~~~G~l 179 (179)
T 2wfi_A 151 EVVREIENQKTDAASKPFAEVRILSCGEL 179 (179)
T ss_dssp HHHHHHHTCCBCTTSCBSSCEEEEEEEEC
T ss_pred HHHHHHHcCCCCCCCCCCCCeEEEeCeeC
Confidence 99999999998 56899999999999986
|
| >2haq_A Cyclophilin; rotamase, proline, isomerase, CIS-trans, protozoa, KAla-AZAR.; 1.97A {Leishmania donovani} PDB: 3eov_A* 3bt8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=368.73 Aligned_cols=163 Identities=55% Similarity=0.906 Sum_probs=155.9
Q ss_pred cccccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCC
Q psy14556 95 SQMRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFT 174 (1181)
Q Consensus 95 s~~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~ 174 (1181)
..++++|||++ +.+|+.|+|+||||++.||+||+||++||+|++||+|+|+.||||+|+|||||||+.
T Consensus 9 ~~~~~v~~di~------------i~~t~~G~i~ieL~~~~aP~t~~NF~~L~~g~~g~~Y~g~~FhRvi~~f~iQgGd~~ 76 (172)
T 2haq_A 9 EVTAKVYFDVM------------IDSEPLGRITIGLFGKDAPLTTENFRQLCTGEHGFGYKDSIFHRVIQNFMIQGGDFT 76 (172)
T ss_dssp CCCEEEEEEEE------------ETTEEEEEEEEEECTTTCHHHHHHHHHHHHTTTSCCSTTCBCCEEETTTEEEECCTT
T ss_pred CCCCeEEEEEE------------ECCEecceEEEEEeCCCCcHHHHHHHHHhccCCCcccCCCEEEEEECCCEEecCCcc
Confidence 45789999997 679999999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCCC
Q psy14556 175 NHNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGSQ 254 (1181)
Q Consensus 175 ~~~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t~ 254 (1181)
.++|+||+++||.+|++|+..++|+ +|+|||||++||++|||||||++++|+||++|+|||+|++|||||++|+++++.
T Consensus 77 ~~~g~gg~si~g~~f~dE~~~l~h~-~G~lsmAn~gp~tngSQFfIt~~~~~~LDg~~~vFG~Vv~G~dvv~~I~~~~t~ 155 (172)
T 2haq_A 77 NFDGTGGKSIYGEKFADENLNVKHF-VGALSMANAGPNTNGSQFFITTAPTPWLDGRHVVFGKVLDGMDVVLRIEKTKTN 155 (172)
T ss_dssp TSSSSCCCCSSSSCBCCCCCCSCCC-TTEEEECCSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHHHTSCBC
T ss_pred CCCCCCCccccCCcccCcCCCcccC-ceEEEEccCCCCCcccEEEEECCCCCccCCCEeEEEEEeCCHHHHHHHHhCCcC
Confidence 7899999999999999999999999 999999999999999999999999999999999999999999999999999994
Q ss_pred -CCCcccceEEeeeccc
Q psy14556 255 -SGKTSKKIVVANSDSH 270 (1181)
Q Consensus 255 -~g~P~~~V~I~~cGvl 270 (1181)
+++|.++|+|.+||+|
T Consensus 156 ~~~~P~~~v~I~~~g~l 172 (172)
T 2haq_A 156 SHDRPVKPVKIVASGEL 172 (172)
T ss_dssp GGGCBSSCEEEEEEEEC
T ss_pred CCCcCCCCeEEEEeEEC
Confidence 5699999999999986
|
| >2igv_A Peptidyl-prolyl CIS-trans isomerase 3; rotamase; 1.67A {Caenorhabditis elegans} SCOP: b.62.1.1 PDB: 1e3b_A 1e8k_A 1dyw_A 2igw_A 2hqj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=368.48 Aligned_cols=163 Identities=64% Similarity=1.013 Sum_probs=155.5
Q ss_pred cccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCc-------cccCCEEEEecCCceEe
Q psy14556 97 MRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGF-------GFKDSTFHRVIPNFMCQ 169 (1181)
Q Consensus 97 ~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~-------~Y~g~~FhRVip~f~iQ 169 (1181)
+|++|||++ +.+|+.|+|+||||++.||+||+||++||++++|+ +|+|+.||||+|+||||
T Consensus 3 ~~~v~~di~------------i~~~~~G~i~ieL~~~~aP~t~~NF~~L~~~~~g~g~~~~~~~Y~g~~FhRvi~~f~iQ 70 (173)
T 2igv_A 3 RSKVFFDIT------------IGGKASGRIVMELYDDVVPKTAGNFRALCTGENGIGKSGKPLHFKGSKFHRIIPNFMIQ 70 (173)
T ss_dssp CCEEEEEEE------------ETTEEEEEEEEEECTTTCHHHHHHHHHHHHTTTCBCTTSSBSCCTTCBCCEEETTTEEE
T ss_pred CCEEEEEEE------------ECCEecceEEEEEeCCCCcHHHHHHHHHhcCCCCCCccCccceECCCEEEEEECCCEEE
Confidence 578999987 55899999999999999999999999999987774 29999999999999999
Q ss_pred eCCCCCCCCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHH
Q psy14556 170 GGDFTNHNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLE 249 (1181)
Q Consensus 170 gGd~~~~~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~ 249 (1181)
|||++.++|+|++++||.+|++|+..++|+++|+|||||++||++|||||||++++||||++|+|||+|++|||||++|+
T Consensus 71 gGd~~~~~G~gg~siyg~~f~dE~~~l~h~~~G~lsmAn~gp~tngSQFfIt~~~~~~LDg~~~vFG~Vv~G~dvv~~I~ 150 (173)
T 2igv_A 71 GGDFTRGNGTGGESIYGEKFPDENFKEKHTGPGVLSMANAGPNTNGSQFFLCTVKTEWLDGKHVVFGRVVEGLDVVKAVE 150 (173)
T ss_dssp ECCTTTSSSSCCCBTTBSCBCCCCCCSCCCSTTEEEECCSSTTCBSSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHHH
T ss_pred cCCCCCCCCCCCCccCCCcccCcccccCCCCCeEEEEeeCCCCCcceEEEEEcCCccccCCCeeEEEEEecCHHHHHHHH
Confidence 99999889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hCCCCCCCcccceEEeeecccc
Q psy14556 250 SMGSQSGKTSKKIVVANSDSHS 271 (1181)
Q Consensus 250 ~~~t~~g~P~~~V~I~~cGvl~ 271 (1181)
++++.+++|.++|+|.+||+++
T Consensus 151 ~~~t~~~~P~~~v~I~~~g~l~ 172 (173)
T 2igv_A 151 SNGSQSGKPVKDCMIADCGQLK 172 (173)
T ss_dssp TTCCTTSCCSSCEEEEEEEEEC
T ss_pred hCCCCCCCCCCCEEEEEeEEEc
Confidence 9999889999999999999985
|
| >1qng_A Peptidyl-prolyl CIS-trans isomerase; isomerase-immunosuppressant complex, cyclophilin-cyclosporin complex, immunosuppressant, cyclophilin; HET: BMT; 2.1A {Plasmodium falciparum} SCOP: b.62.1.1 PDB: 1qnh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=366.79 Aligned_cols=162 Identities=54% Similarity=0.984 Sum_probs=154.3
Q ss_pred ccccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCcc-------ccCCEEEEecCCceE
Q psy14556 96 QMRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFG-------FKDSTFHRVIPNFMC 168 (1181)
Q Consensus 96 ~~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~-------Y~g~~FhRVip~f~i 168 (1181)
.+|++|||++ +.+|+.|+|+||||++.||+||+||++||+|+ |++ |+|+.||||+|+|||
T Consensus 2 ~~~~v~~di~------------i~~~~~G~i~ieL~~~~aP~t~~NF~~L~~~~-g~g~~~~~~~Y~g~~FhRvi~~f~i 68 (170)
T 1qng_A 2 KRSKVFFDIS------------IDNSNAGRIIFELFSDITPRTCENFRALCTGE-KIGSRGKNLHYKNSIFHRIIPQFMC 68 (170)
T ss_dssp CSCEEEEEEE------------ESSSEEEEEEEEECTTTCHHHHHHHHHHHHTC-EECTTSSEECCTTCBCCEEETTTEE
T ss_pred CCCEEEEEEe------------ECCEeceeEEEEEcCCCCCHHHHHHHHHhccC-CcCccCccceECCCEEEEEECCCEE
Confidence 4679999997 56899999999999999999999999999765 664 999999999999999
Q ss_pred eeCCCCCCCCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHH
Q psy14556 169 QGGDFTNHNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKL 248 (1181)
Q Consensus 169 QgGd~~~~~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI 248 (1181)
||||++.++|+|++++||.+|++|++.++|+++|+|||||++||++|||||||++++||||++|+|||+|++|||||++|
T Consensus 69 QgGd~~~~~g~gg~si~g~~f~dE~~~l~h~~~G~lsmAn~gp~tngSQFfIt~~~~~~Ldg~~~vFG~Vv~G~dvv~~I 148 (170)
T 1qng_A 69 QGGDITNGNGSGGESIYGRSFTDENFNMKHDQPGLLSMANAGPNTNSSQFFITLVPCPWLDGKHVVFGKVIEGMNVVREM 148 (170)
T ss_dssp EECCTTTSSSSCCCBTTBSCBCCCCCCSCCCSTTEEEECCSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHH
T ss_pred EcCCccCCCCCCCccccCCcccccccccccCCCCEEEEeecCCCCcccEEEEECCCCcccCCCeeEEEEEECCHHHHHHH
Confidence 99999888999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhCCCCCCCcccceEEeeeccc
Q psy14556 249 ESMGSQSGKTSKKIVVANSDSH 270 (1181)
Q Consensus 249 ~~~~t~~g~P~~~V~I~~cGvl 270 (1181)
+++++.+++|.++|+|.+||+|
T Consensus 149 ~~~~t~~~~P~~~v~I~~cG~l 170 (170)
T 1qng_A 149 EKEGAKSGYVKRSVVITDCGEL 170 (170)
T ss_dssp HTTCCTTCCCSSCEEEEEEEEC
T ss_pred HhCCCCCCCCCCCeEEEeceeC
Confidence 9999988999999999999986
|
| >1a58_A Cyclophilin; isomerase, ppiase; 1.95A {Brugia malayi} SCOP: b.62.1.1 PDB: 1a33_A 1c5f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=367.27 Aligned_cols=162 Identities=49% Similarity=0.799 Sum_probs=153.9
Q ss_pred ccccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCC---------ccccCCEEEEecCCc
Q psy14556 96 QMRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKG---------FGFKDSTFHRVIPNF 166 (1181)
Q Consensus 96 ~~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G---------~~Y~g~~FhRVip~f 166 (1181)
.+|++|||++ +.+|+.|+|+||||++.||+||+||++||+|++| + |+|+.||||+|+|
T Consensus 5 ~~~~v~~di~------------i~~~~~G~i~ieL~~~~aP~t~~NF~~L~~~~~g~~~~~g~~~~-Y~g~~FhRvi~~f 71 (177)
T 1a58_A 5 DRRRVFLDVT------------IDGNLAGRIVMELYNDIAPRTCNNFLMLCTGMAGTGKISGKPLH-YKGSTFHRVIKNF 71 (177)
T ss_dssp GCEEEEEEEE------------ETTEEEEEEEEEECTTTCHHHHHHHHHHHHCTTCBCTTTCSBCC-CTTCBEEEEETTT
T ss_pred CCcEEEEEEE------------ECCEeceeEEEEEcCCCCchHHHHHHHHhcCCcCcccccCCcce-eCCCEEEEEECCC
Confidence 5789999997 5689999999999999999999999999987543 5 9999999999999
Q ss_pred eEeeCCCCCCCCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHH
Q psy14556 167 MCQGGDFTNHNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVK 246 (1181)
Q Consensus 167 ~iQgGd~~~~~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~ 246 (1181)
||||||++.++|+||+++||.+|++|++.++|+++|+|||||++||++|||||||++++||||++|+|||+|++|||||+
T Consensus 72 ~iQgGd~~~~~g~gg~si~g~~f~dE~~~~~h~~~G~lsmAn~gp~tngSQFfIt~~~~~~LDg~~~VFG~Vv~G~dvv~ 151 (177)
T 1a58_A 72 MIQGGDFTKGDGTGGESIYGGMFDDEEFVMKHDEPFVVSMANKGPNTNGSQFFITTTPAPHLNNIHVVFGKVVSGQEVVT 151 (177)
T ss_dssp EEEECCCSSSSSSCCCCTTSSCBCCCCCCSCCCSSSEEEECCSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECHHHHH
T ss_pred EEEeCCccCCCCCCCCcccCCcccCcccCcccCCCeEEEEeeCCCCCceeEEEEECCCCCccCCCEEEEEEEEcCHHHHH
Confidence 99999999889999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHhCCC-CCCCcccceEEeeeccc
Q psy14556 247 KLESMGS-QSGKTSKKIVVANSDSH 270 (1181)
Q Consensus 247 kI~~~~t-~~g~P~~~V~I~~cGvl 270 (1181)
+|+++++ .+++|.++|+|.+||+|
T Consensus 152 ~I~~~~~~~~~~P~~~v~I~~~G~l 176 (177)
T 1a58_A 152 KIEYLKTNSKNRPLADVVILNCGEL 176 (177)
T ss_dssp HHHTSCBCTTSCBSSCEEEEEEEEE
T ss_pred HHHhCCCCCCCcCCCCeEEEEeEEE
Confidence 9999998 46899999999999987
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=405.11 Aligned_cols=239 Identities=26% Similarity=0.346 Sum_probs=196.2
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
..+||+|+||+||+|+++.+++.||||+++.... ..+|+.++++++|||||++++++.+++.+|||||||+||+|
T Consensus 63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 137 (336)
T 4g3f_A 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred CcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence 4479999999999999999999999999976533 24799999999999999999999999999999999999999
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCC-eeeeecCCcccccccCCC-----CC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSG-VVKISDFGTSKRLAGLCP-----SA 963 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g-~vKLiDFGlAk~l~~~~~-----~~ 963 (1181)
.++++.. ..+++..+..|+.||+.||+|||++|||||||||+|||++. +| ++||+|||+|+.+..... ..
T Consensus 138 ~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~-~g~~vKl~DFGla~~~~~~~~~~~~~~~ 213 (336)
T 4g3f_A 138 GQLIKQM---GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSS-DGSRAALCDFGHALCLQPDGLGKSLLTG 213 (336)
T ss_dssp HHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECT-TSCCEEECCCTTCEEC------------
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeC-CCCEEEEeeCCCCeEccCCCcccceecC
Confidence 9999854 35789999999999999999999999999999999999987 55 799999999987654321 12
Q ss_pred ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCC----CC
Q psy14556 964 ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAP----PQ 1039 (1181)
Q Consensus 964 ~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~----~~ 1039 (1181)
...+||+.|||||++.+..+ +..+|+ ||+||+||||+||++||.+.+...+... ..
T Consensus 214 ~~~~GT~~YmAPE~~~~~~y--~~~~Di------------------wSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~ 273 (336)
T 4g3f_A 214 DYIPGTETHMAPEVVMGKPC--DAKVDI------------------WSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPP 273 (336)
T ss_dssp CCCCCCGGGCCHHHHTTCCC--CTHHHH------------------HHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCC
T ss_pred CccccCccccCHHHHCCCCC--CcHHHH------------------HHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCC
Confidence 33579999999999986543 444554 9999999999999999998776554221 11
Q ss_pred CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1040 ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1040 ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
.....+..+++.+..++.+|+++||.+||+ +.+.+..+
T Consensus 274 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s-a~el~~~l 311 (336)
T 4g3f_A 274 PIREIPPSCAPLTAQAIQEGLRKEPVHRAS-AMELRRKV 311 (336)
T ss_dssp GGGGSCTTSCHHHHHHHHHHTCSSGGGSCC-HHHHHHHH
T ss_pred CchhcCccCCHHHHHHHHHHccCCHhHCcC-HHHHHHHH
Confidence 112345567888999999999999999985 55544433
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=395.30 Aligned_cols=237 Identities=24% Similarity=0.392 Sum_probs=193.9
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEcccccc----CCcEEEEEee
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSE----EGYFKIFMEQ 883 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d----~~~l~LVmEy 883 (1181)
.++||+|+||+||+|.+..+++.||+|++..... ...+.+.+|+.+|++++|||||++++++.+ ++.+||||||
T Consensus 31 ~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy 110 (290)
T 3fpq_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred eeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeC
Confidence 3479999999999999999999999999965433 235679999999999999999999999865 3568999999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccc--eecccCCCCCcccccCCCeeeeecCCcccccccCCC
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP 961 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~g--IVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~ 961 (1181)
|+||+|.+++... ..+++..+..|+.||+.||+|||++| ||||||||+|||++..++.+||+|||+|+.... .
T Consensus 111 ~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--~ 185 (290)
T 3fpq_A 111 MTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--S 185 (290)
T ss_dssp CCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT--T
T ss_pred CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC--C
Confidence 9999999999854 35789999999999999999999998 999999999999986578999999999976443 3
Q ss_pred CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc-c---cCC
Q psy14556 962 SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA-L---VAP 1037 (1181)
Q Consensus 962 ~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~-l---~~~ 1037 (1181)
...+.+||+.|||||++.+ . ++..+|+ ||+||+||||+||+.||.+..... + ...
T Consensus 186 ~~~~~~GTp~YmAPE~~~~-~--y~~~~Di------------------wSlGvilyelltg~~Pf~~~~~~~~~~~~i~~ 244 (290)
T 3fpq_A 186 FAKAVIGTPEFMAPEMYEE-K--YDESVDV------------------YAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 244 (290)
T ss_dssp SBEESCSSCCCCCGGGGGT-C--CCTHHHH------------------HHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT
T ss_pred ccCCcccCccccCHHHcCC-C--CCcHHHH------------------HHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc
Confidence 3456789999999999864 3 4455555 999999999999999998755422 2 111
Q ss_pred CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1038 PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1038 ~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
...+...+...++.+..++.+|+++||..||+..+
T Consensus 245 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e 279 (290)
T 3fpq_A 245 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKD 279 (290)
T ss_dssp TCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 12222333445667889999999999999996433
|
| >3ich_A Peptidyl-prolyl CIS-trans isomerase B; beta sandwich, cyclosporin, endoplasmic reticulum, glycoprot isomerase, rotamase; 1.20A {Homo sapiens} PDB: 3ici_A* 1cyn_A* 2esl_A* 2rmc_A* 1h0p_A 1xo7_A 1xq7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=371.35 Aligned_cols=170 Identities=55% Similarity=0.896 Sum_probs=158.8
Q ss_pred ccccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCC
Q psy14556 96 QMRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTN 175 (1181)
Q Consensus 96 ~~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~ 175 (1181)
..+++|||++ +.+|+.|+|+||||++.||+||+||++||+|++||+|+|+.||||+|+|||||||+..
T Consensus 14 ~~~~v~~di~------------i~~t~~G~i~ieL~~~~aP~t~~NF~~L~~g~~g~~Y~g~~FhRvi~~f~iQgGd~~~ 81 (188)
T 3ich_A 14 VTVKVYFDLR------------IGDEDVGRVIFGLFGKTVPKTVDNFVALATGEKGFGYKNSKFHRVIKDFMIQGGDFTR 81 (188)
T ss_dssp EEEEEEEEEE------------ETTEEEEEEEEEECTTTCHHHHHHHHHHHHTTTSCSSTTCBCCEEETTTEEEECCTTT
T ss_pred cCCeEEEEEE------------ECCEeceeEEEEEcCCCCcHHHHHHHHHhcccCCccccCCEEEEEECCCEEEcCCccC
Confidence 3578999986 5589999999999999999999999999999999999999999999999999999877
Q ss_pred CCCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCCC-
Q psy14556 176 HNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGSQ- 254 (1181)
Q Consensus 176 ~~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t~- 254 (1181)
++|+||.++||.+|++|+..++|+++|+|||||+++|++|||||||++++||||++|+|||+|++|||||++|+++++.
T Consensus 82 ~~g~gg~si~g~~f~dE~~~l~h~~~G~lsmAn~gp~tngSQFfIt~~~~~~LDg~~tVFG~Vv~G~dvv~~I~~~~~~~ 161 (188)
T 3ich_A 82 GDGTGGKSIYGERFPDENFKLKHYGPGWVSMANAGKDTNGSQFFITTVKTAWLDGKHVVFGKVLEGMEVVRKVESTKTDS 161 (188)
T ss_dssp SSSSCCCBTTBSCBCCCCCCSCCCSTTEEEECCSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHHHTSCBCT
T ss_pred CCCCCCccccCCcccccccCcccCCCeEEEEccCCCCCcccEEEEECCCCcccCCCeeEEEEEeCCHHHHHHHHhCCcCC
Confidence 8999999999999999999999999999999999999999999999999999999999999999999999999999994
Q ss_pred CCCcccceEEeeeccccCCCCCC
Q psy14556 255 SGKTSKKIVVANSDSHSETDSQS 277 (1181)
Q Consensus 255 ~g~P~~~V~I~~cGvl~~~~~~p 277 (1181)
+++|.++|+|.+||++...+|++
T Consensus 162 ~~~P~~~v~I~~~~~l~~~~Pf~ 184 (188)
T 3ich_A 162 RDKPLKDVIIADCGKIEVEKPFA 184 (188)
T ss_dssp TSCBSSCEEEEEEEEEEEEEEEE
T ss_pred CCeECCCEEEEEeEEEecCCCCC
Confidence 56999999999999995544443
|
| >3rdd_A Peptidyl-prolyl CIS-trans isomerase A; beta barrel, cytosolic, inhibito isomerase-isomerase inhibitor complex; HET: EA4; 2.14A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=367.88 Aligned_cols=164 Identities=66% Similarity=1.078 Sum_probs=158.4
Q ss_pred ccccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCC
Q psy14556 96 QMRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTN 175 (1181)
Q Consensus 96 ~~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~ 175 (1181)
.+|++|||++ +.+|+.|+|+||||++.||+||+||++||++++|++|+|+.||||+|+|||||||+..
T Consensus 21 ~~p~v~~di~------------i~~~~~G~I~ieL~~~~aP~t~~NF~~L~~~~~g~~Y~g~~FhRvi~~f~iQgGd~~~ 88 (184)
T 3rdd_A 21 VNPTVFFDIA------------VDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTR 88 (184)
T ss_dssp CCCEEEEEEE------------ETTEEEEEEEEEECTTTSHHHHHHHHHHHHTTTSCSSTTCBCCEEETTTEEEECCTTT
T ss_pred CCCEEEEEEe------------ECCEeeeEEEEEEeCCCCcHHHHHHHHHhccCcCcccCCCEEEEccCCcEEEeCCCCC
Confidence 5789999986 6689999999999999999999999999999999999999999999999999999988
Q ss_pred CCCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCCCC
Q psy14556 176 HNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGSQS 255 (1181)
Q Consensus 176 ~~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t~~ 255 (1181)
++|+|+.++||.+|++|++.++|+++|+||||++++|++|||||||++++|+||++|+|||+|++|||||++|+++++.+
T Consensus 89 ~~g~gg~si~g~~~~de~~~l~h~~~G~lsmA~~gp~s~gSQFfIt~~~~~~LDg~~tVFG~Vv~G~dvv~~I~~~~~~~ 168 (184)
T 3rdd_A 89 HNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRN 168 (184)
T ss_dssp SSSSCCCBTTBSCBCCCCCCSCCCSTTEEEECCSSTTCBSSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHHHTTCCTT
T ss_pred CCCCCCcccCCCcccCcccccccCCCcEEEEEeCCCCCcccEEEEEeCCchhhCCCceEEEEEecCHHHHHHHHhcCCCC
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcccceEEeeecccc
Q psy14556 256 GKTSKKIVVANSDSHS 271 (1181)
Q Consensus 256 g~P~~~V~I~~cGvl~ 271 (1181)
|+|.++|+|.+||+|+
T Consensus 169 g~P~~~v~I~~cG~l~ 184 (184)
T 3rdd_A 169 GKTSKKITIADCGQLE 184 (184)
T ss_dssp SCCSSCEEEEEEEECC
T ss_pred CCCcCCeEEEeCeEEC
Confidence 9999999999999985
|
| >2poy_A Peptidyl-prolyl CIS-trans isomerase; isomerase-immunosuppressant complex, immunosuppressant, cyclophilin, isomerase, S genomics, structural genomics consortium; HET: BMT; 1.80A {Cryptosporidium parvum iowa II} PDB: 2plu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=367.94 Aligned_cols=162 Identities=57% Similarity=0.941 Sum_probs=154.8
Q ss_pred ccccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCcc-------ccCCEEEEecCCceE
Q psy14556 96 QMRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFG-------FKDSTFHRVIPNFMC 168 (1181)
Q Consensus 96 ~~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~-------Y~g~~FhRVip~f~i 168 (1181)
.+|.+|||+. +.+|+.|+|+||||++.||+||+||++||+|++|++ |+|+.||||+|+|||
T Consensus 18 ~~~~v~~di~------------i~~t~~G~I~ieL~~~~aP~t~~NF~~L~~g~~g~~~~~~~~~Y~g~~FhRVi~~f~i 85 (186)
T 2poy_A 18 GNPVVYFDIS------------IGQTPAGRITMELFADKVPITAENFRALCTGEKGMGQSGKPLCYTGSFFHRIIPQFMI 85 (186)
T ss_dssp CCCEEEEEEE------------ETTEEEEEEEEEECTTTCHHHHHHHHHHHHTTTCBCTTSSBSCCTTCBCCEEETTTEE
T ss_pred CCCEEEEEEe------------ECCEecccEEEEEeCCCCcHHHHHHHHHhcccCCccccCccceECCCEEEEEeCCCEE
Confidence 5789999987 558999999999999999999999999999988885 999999999999999
Q ss_pred eeCCCCCCCCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHH
Q psy14556 169 QGGDFTNHNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKL 248 (1181)
Q Consensus 169 QgGd~~~~~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI 248 (1181)
||||++.++|+|++++||.+|++|+..++|+++|+|||||++||++|||||||++++|+||++|+|||+|++|||||++|
T Consensus 86 QgGd~~~~~G~gg~si~g~~f~dE~~~l~h~~~G~lsMAn~gpntngSQFFIt~~~~~~LDg~~tVFG~Vv~Gmdvv~~I 165 (186)
T 2poy_A 86 QGGDFTRGDGTGGESIYGSKFRDENFVYTHDAPFLLSMANAGPNTNGSQFFITTVPCPWLDGKHVVFGKVLEGMEVVKSI 165 (186)
T ss_dssp EECCTTTSSSSCCCCTTC-CBCCCCCCSCCCSTTEEEECCSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHH
T ss_pred EeCCCCCCCCCCCCccCCCcccCcccccccCCCcEEEEeeCCCCCcccEEEEECCCCcccCCCeeEEEEEecCHHHHHHH
Confidence 99999888999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhCCCCCCCcccceEEeeecc
Q psy14556 249 ESMGSQSGKTSKKIVVANSDS 269 (1181)
Q Consensus 249 ~~~~t~~g~P~~~V~I~~cGv 269 (1181)
+++++.+++|.++|+|.+||+
T Consensus 166 ~~~~t~~~~P~~~v~I~~cG~ 186 (186)
T 2poy_A 166 EKCGSQNGKPTKSVCITASGV 186 (186)
T ss_dssp HHTCCTTSCCSSCEEEEEEEC
T ss_pred HhCCCCCCCCCCCEEEEeCCC
Confidence 999998999999999999996
|
| >2he9_A NK-tumor recognition protein; cyclosporin, isomerase, membrane, repeat, rotamase, peptidylprolyl isomerase, structural genomics; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=368.67 Aligned_cols=164 Identities=45% Similarity=0.732 Sum_probs=154.7
Q ss_pred ccccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCC---------CccccCCEEEEecCCc
Q psy14556 96 QMRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEK---------GFGFKDSTFHRVIPNF 166 (1181)
Q Consensus 96 ~~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~---------G~~Y~g~~FhRVip~f 166 (1181)
..|++|||++ +.+|+.|+|+||||++.||+||+||++||+|++ ++ |+|+.||||+|+|
T Consensus 18 ~~~~vf~di~------------i~~t~~G~I~ieL~~~~aP~t~~NF~~L~~g~~g~~~~~~k~~~-Y~g~~FhRVi~~f 84 (192)
T 2he9_A 18 GSPQCHFDIE------------INREPVGRIMFQLFSDICPKTCKNFLCLCSGEKGLGKTTGKKLC-YKGSTFHRVVKNF 84 (192)
T ss_dssp -CCEEEEEEE------------ETTEEEEEEEEEECTTTCHHHHHHHHHHHHCTTCBCTTTCSBSC-CTTCBEEEEETTT
T ss_pred CCCeEEEEEE------------ECCEecceEEEEEcCCCCchHHHHHHHHhcCCCCcccccccCCe-ECCCEEEEEECCC
Confidence 5789999997 668999999999999999999999999998765 45 9999999999999
Q ss_pred eEeeCCCCCCCCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHH
Q psy14556 167 MCQGGDFTNHNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVK 246 (1181)
Q Consensus 167 ~iQgGd~~~~~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~ 246 (1181)
||||||++.++|+|++++||..|++|++.++|+++|+|||||++||++|||||||++++||||++|+|||+|++|||||+
T Consensus 85 miQgGd~~~~~G~gg~siyg~~f~dE~~~l~h~~~G~lsMAn~gp~tngSQFFIt~~~~~~LDg~~tVFG~Vv~Gmdvv~ 164 (192)
T 2he9_A 85 MIQGGDFSEGNGKGGESIYGGYFKDENFILKHDRAFLLSMANRGKHTNGSQFFITTKPAPHLDGVHVVFGLVISGFEVIE 164 (192)
T ss_dssp EEEECCTTTSSSSCCCCTTSSCBCCCCCCSCCCSTTEEEECCSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECHHHHH
T ss_pred EEEcCcccCCCCCCCCcccCCcccCccccCCCCCCeEEEEEeCCCCCcceEEEEEcCCCcccCCCccEEEEEEeCHHHHH
Confidence 99999998889999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHhCCC-CCCCcccceEEeeeccccC
Q psy14556 247 KLESMGS-QSGKTSKKIVVANSDSHSE 272 (1181)
Q Consensus 247 kI~~~~t-~~g~P~~~V~I~~cGvl~~ 272 (1181)
+|+++++ .+++|.++|+|.+||++..
T Consensus 165 ~I~~~~t~~~~~P~~~v~I~~~g~l~~ 191 (192)
T 2he9_A 165 QIENLKTDAASRPYADVRVIDCGVLAT 191 (192)
T ss_dssp HHHTSCBCTTSCBSSCEEEEEEEECC-
T ss_pred HHHcCCcCCCCCCcCCeEEEEeEEEcc
Confidence 9999998 4689999999999999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=400.48 Aligned_cols=247 Identities=22% Similarity=0.283 Sum_probs=193.9
Q ss_pred eeecccCceEEEEEEEc-----CCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 811 IELGKGSYGVVYAAREL-----DRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~-----~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
++||+|+||+||+|++. .+++.||||+++.......+.|.+|+.+|++++|||||++++++.+.+.+|||||||+
T Consensus 47 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~ 126 (329)
T 4aoj_A 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMR 126 (329)
T ss_dssp EEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred EEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 47999999999999875 3678999999987665567789999999999999999999999999999999999999
Q ss_pred CCCcccchhccc------------CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcc
Q psy14556 886 GGSLSTLLRVKW------------GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTS 953 (1181)
Q Consensus 886 gGSL~dlL~~~~------------~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlA 953 (1181)
+|+|.++++... ...++++..+..|+.||+.||+|||+++||||||||+|||++. ++.+||+|||++
T Consensus 127 ~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~-~~~~Ki~DFGla 205 (329)
T 4aoj_A 127 HGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ-GLVVKIGDFGMS 205 (329)
T ss_dssp TCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET-TTEEEECCCC--
T ss_pred CCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC-CCcEEEcccccc
Confidence 999999997542 1246889999999999999999999999999999999999998 899999999999
Q ss_pred cccccCCC--CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCC
Q psy14556 954 KRLAGLCP--SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKT 1030 (1181)
Q Consensus 954 k~l~~~~~--~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~ 1030 (1181)
+.+..... ......||+.|||||++.+..++. .+|+ |||||+||||+| |+.||.+.+
T Consensus 206 ~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~--~sDv------------------wS~Gvvl~Ellt~G~~Pf~~~~ 265 (329)
T 4aoj_A 206 RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTT--ESDV------------------WSFGVVLWEIFTYGKQPWYQLS 265 (329)
T ss_dssp --------------CCCCGGGCCHHHHTTCCCCH--HHHH------------------HHHHHHHHHHHTTSCCTTCSSC
T ss_pred eeccCCCcceecCcccccccccChhhhcCCCCCc--cccc------------------cchHHHHHHHHcCCCCCCCCCC
Confidence 87643322 223456999999999998765443 3333 999999999999 899999887
Q ss_pred cccccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcc
Q psy14556 1031 SRALVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTG 1079 (1181)
Q Consensus 1031 ~~~l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~ 1079 (1181)
..++..... .....+..+++.+..++.+|++++|..||+ +.+.+..++
T Consensus 266 ~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs-~~ei~~~L~ 315 (329)
T 4aoj_A 266 NTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHS-IKDVHARLQ 315 (329)
T ss_dssp HHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCC-HHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcC-HHHHHHHHH
Confidence 655432111 111233457888999999999999999995 444444433
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=403.08 Aligned_cols=241 Identities=25% Similarity=0.352 Sum_probs=192.5
Q ss_pred hcccCceeecccCceEEEEEEEc---CCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEE
Q psy14556 805 LFALNRIELGKGSYGVVYAAREL---DRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKI 879 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~---~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~L 879 (1181)
+|.+.+ +||+|+||+||+|++. .+++.||+|++++... .....+.+|+.+|++++|||||++++++.+++.+|+
T Consensus 25 ~Y~i~~-~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 25 QFELLK-VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GEEEEE-EEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred ccEEEE-EEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 344444 7999999999999874 4678999999976532 234568899999999999999999999999999999
Q ss_pred EEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccC
Q psy14556 880 FMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGL 959 (1181)
Q Consensus 880 VmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~ 959 (1181)
|||||+||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.....
T Consensus 104 vmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~-~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDE-EGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECT-TSCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcC-CCCEEecccccceeccCC
Confidence 99999999999999854 35789999999999999999999999999999999999998 899999999999876655
Q ss_pred CCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC
Q psy14556 960 CPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ 1039 (1181)
Q Consensus 960 ~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~ 1039 (1181)
.....+.+||+.|||||++.+..+ +..+|+ ||+||++|||+||+.||.+.+..++...+.
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y--~~~~Di------------------wSlGvilyemltG~~PF~~~~~~~~~~~i~ 239 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGH--TQSADW------------------WSFGVLMFEMLTGTLPFQGKDRKETMTMIL 239 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCC--CTHHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CccccccccCcccCCHHHhccCCC--CCCCcc------------------cchHHHHHHHHhCCCCCCCcCHHHHHHHHH
Confidence 555567789999999999986644 344544 999999999999999999988765432111
Q ss_pred -CCCCCCCCCCcchHHhhccCCCCCCCCCchh
Q psy14556 1040 -ISRSVSVPGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1040 -ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
-....+...++.+..++.+|+++||.+|++.
T Consensus 240 ~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 240 KAKLGMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred cCCCCCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 1111233467788889999999999999985
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=398.72 Aligned_cols=242 Identities=23% Similarity=0.309 Sum_probs=197.7
Q ss_pred eeecccCceEEEEEEEc-----CCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 811 IELGKGSYGVVYAAREL-----DRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~-----~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
++||+|+||+||+|++. .++..||||+++.......+.|.+|+.+|++++|||||++++++.+++.+|||||||+
T Consensus 19 ~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~ 98 (299)
T 4asz_A 19 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMK 98 (299)
T ss_dssp EEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred eEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCC
Confidence 47999999999999875 3578999999987665557789999999999999999999999999999999999999
Q ss_pred CCCcccchhccc----------CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccc
Q psy14556 886 GGSLSTLLRVKW----------GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 955 (1181)
Q Consensus 886 gGSL~dlL~~~~----------~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~ 955 (1181)
+|+|.++++... ....+++..+..|+.||+.||+|||+++||||||||+|||++. ++.+||+|||+|+.
T Consensus 99 ~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~-~~~~Ki~DFGla~~ 177 (299)
T 4asz_A 99 HGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE-NLLVKIGDFGMSRD 177 (299)
T ss_dssp TCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG-GGCEEECCCSCHHH
T ss_pred CCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECC-CCcEEECCccccee
Confidence 999999997531 3457899999999999999999999999999999999999998 89999999999987
Q ss_pred cccCCCC--CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q psy14556 956 LAGLCPS--AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSR 1032 (1181)
Q Consensus 956 l~~~~~~--~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~ 1032 (1181)
....... .....||+.|||||++.++.++. .+|+ |||||+||||+| |+.||.+.+..
T Consensus 178 ~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~--k~DV------------------wS~Gvvl~Ellt~G~~Pf~~~~~~ 237 (299)
T 4asz_A 178 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTT--ESDV------------------WSLGVVLWEIFTYGKQPWYQLSNN 237 (299)
T ss_dssp HTGGGCEEETTTEEECGGGCCHHHHHHCCCCH--HHHH------------------HHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred cCCCCceeecCceecChhhcCHHHHcCCCCCc--hhhH------------------HHHHHHHHHHHcCCCCCCCCCCHH
Confidence 6543221 22345899999999998765443 3444 999999999999 89999998876
Q ss_pred cccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1033 ALVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1033 ~l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
++..... .....+..+|..+..++.+|++.+|..||++.+.
T Consensus 238 ~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i 280 (299)
T 4asz_A 238 EVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI 280 (299)
T ss_dssp HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 6432211 1112344678889999999999999999964443
|
| >3k2c_A Peptidyl-prolyl CIS-trans isomerase; ssgcid, NIH, niaid, SBRI, UW, decode, cytoplasm, rotamase, structural genomics; HET: PG5; 1.95A {Encephalitozoon cuniculi} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=366.32 Aligned_cols=164 Identities=57% Similarity=0.955 Sum_probs=158.4
Q ss_pred ccccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCC
Q psy14556 96 QMRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTN 175 (1181)
Q Consensus 96 ~~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~ 175 (1181)
.+|++|||+. +.+|+.|+|+||||++.||+||+||++||+|++|++|+|+.||||+|+|||||||+..
T Consensus 26 ~~p~v~~di~------------i~~t~~G~I~ieL~~~~aP~tv~NF~~L~~g~~g~~Y~g~~FhRvi~~f~iQgGd~~~ 93 (193)
T 3k2c_A 26 ASGNVYFDVY------------ANEESLGRIVMKLEDDIVPKTAKNFRTLCERPKGEGYKGSTFHRIIPGFMVQGGDYTA 93 (193)
T ss_dssp CTTCEEEEEE------------ETTEEEEEEEEEECTTTSHHHHHHHHHHHHSCTTSSSTTCBEEEEETTTEEEECCTTT
T ss_pred CCCEEEEEEe------------ECCEEeeEEEEEEcCCCChHHHHHHHHHhccccCCcccCCEEEEEeCCCEEEeCCCCC
Confidence 5689999997 5689999999999999999999999999998899999999999999999999999888
Q ss_pred CCCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCCCC
Q psy14556 176 HNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGSQS 255 (1181)
Q Consensus 176 ~~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t~~ 255 (1181)
++|+|+.++||.+|++|+..++|+++|+|||||.+++++||||||+++++|+||++|+|||+|++|||||++|+++++++
T Consensus 94 ~~g~gg~si~g~~f~dE~~~l~h~~~G~lsmAn~gp~t~gSQFFIt~~~~~~LDg~~tVFG~Vv~Gmdvv~~I~~~~t~~ 173 (193)
T 3k2c_A 94 HNGTGGRSIYGEKFPDENFELKHTKEGILSMANCGAHTNGSQFFITLGKTQWLDEKHVVFGEVVEGMDVVHKIAKYGSES 173 (193)
T ss_dssp SSSSCCCCTTSSCBCCCCCCSCCCSTTEEEECCSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHHHTTCCTT
T ss_pred CCCcCCcccCCCcccccccccccCCCcEEEEEeCCCCCCccEEEEECCCCcccCCCccEEEEEeCCHHHHHHHHhcCCCC
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcc--cceEEeeecccc
Q psy14556 256 GKTS--KKIVVANSDSHS 271 (1181)
Q Consensus 256 g~P~--~~V~I~~cGvl~ 271 (1181)
|+|. ++|+|.+||+|.
T Consensus 174 g~P~~~~~v~I~~cG~l~ 191 (193)
T 3k2c_A 174 GQVKKGYRIEIRDCGVLG 191 (193)
T ss_dssp CCCCTTCCEEEEEEEECC
T ss_pred CcCccCccEEEEEceEeC
Confidence 9999 999999999987
|
| >4fru_A Cyclophilin B, peptidyl-prolyl CIS-trans isomerase; cyclophilin-type ppiase, peptidyl-prolyl CIS-trans isomerase chaperone, foldase; HET: ME2 PEG; 1.10A {Equus caballus} PDB: 4frv_A* 3ich_A 3ici_A* 1cyn_A* 2esl_A* 2rmc_A* 1h0p_A 1xo7_A 1xq7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=367.91 Aligned_cols=170 Identities=55% Similarity=0.898 Sum_probs=160.2
Q ss_pred ccccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCC
Q psy14556 96 QMRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTN 175 (1181)
Q Consensus 96 ~~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~ 175 (1181)
..+++|||++ +.+|+.|+|+||||++.||+||+||++||+|++|++|+|+.||||+|+|||||||++.
T Consensus 11 ~~~~v~~di~------------i~~~~~G~i~ieL~~~~aP~t~~NF~~L~~~~~g~~Y~g~~FhRvi~~f~iQgGd~~~ 78 (185)
T 4fru_A 11 VTVKVYFDLR------------IGDEDIGRVVIGLFGKTVPKTVDNFVALATGEKGFGYKDSKFHRVIKDFMIQGGDFTR 78 (185)
T ss_dssp EEEEEEEEEE------------ETTEEEEEEEEEECTTTSHHHHHHHHHHHHTTTSCCSTTCBCCEEETTTEEEECCTTT
T ss_pred cCcEEEEEEE------------ECCEecceEEEEEeCCCCcHHHHHHHHHHhcCCCCeEcCCEEEEeeCCCeEEECCCCC
Confidence 4679999997 5689999999999999999999999999998888559999999999999999999998
Q ss_pred CCCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCC-C
Q psy14556 176 HNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGS-Q 254 (1181)
Q Consensus 176 ~~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t-~ 254 (1181)
++|+|+.++||.+|++|+..++|+++|+|||||++++++||||||+++++||||++|+|||+|++|||||++|+++++ .
T Consensus 79 ~~g~gg~si~g~~f~de~~~~~h~~~G~lsma~~gp~t~~SQFfI~~~~~~~Ld~~~~vFG~Vv~G~dvv~~I~~~~t~~ 158 (185)
T 4fru_A 79 GDGTGGKSIYGERFPDENFKLKHYGPGWVSMANAGKDTNGSQFFITTVKTAWLDGKHVVFGKVLEGMEVVRKVETTKTDG 158 (185)
T ss_dssp SSSSCCCBTTBSCBCCCCCCSCCCSTTEEEECCSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHHHTSCBCT
T ss_pred CCCCCCccccCCccCccccccCcCCCeEEEEeeCCCCCcceEEEEEeCCCcccCCCccEEEEEeCCHHHHHHHHhCCCCC
Confidence 899999999999999999999999999999999999999999999999999999999999999999999999999999 4
Q ss_pred CCCcccceEEeeeccccCCCCCC
Q psy14556 255 SGKTSKKIVVANSDSHSETDSQS 277 (1181)
Q Consensus 255 ~g~P~~~V~I~~cGvl~~~~~~p 277 (1181)
+++|.++|+|.+||++..+++++
T Consensus 159 ~~~P~~~v~I~~~g~l~~~~Pf~ 181 (185)
T 4fru_A 159 RDKPLKDVTIADCGKIEVEKPFA 181 (185)
T ss_dssp TSCBSSCEEEEEEEEEEEEEEEE
T ss_pred CCcCCCCEEEEEceEEecCCCCc
Confidence 68999999999999997665544
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=389.49 Aligned_cols=244 Identities=25% Similarity=0.290 Sum_probs=187.3
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEE
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIF 880 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LV 880 (1181)
.+|.+.+ +||+|+||+||+|++..+++.||+|++++... ...+.+.+|+.++++++||||+++++++.+++.+|+|
T Consensus 13 g~Y~i~~-~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 13 GNYQIVK-TLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp -CCEEEE-EEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eCeEEEE-EEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 3455543 79999999999999999999999999976533 3356799999999999999999999999999999999
Q ss_pred EeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC
Q psy14556 881 MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC 960 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~ 960 (1181)
|||+ +|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.....
T Consensus 92 mEy~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~-~~~vkl~DFGla~~~~~~- 165 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDE-HLNVKIADFGLSNIMTDG- 165 (275)
T ss_dssp EECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECT-TCCEEECCSSCC-------
T ss_pred EeCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECC-CCCEEEeecCCCeecCCC-
Confidence 9999 78999988754 36889999999999999999999999999999999999988 899999999999876543
Q ss_pred CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-
Q psy14556 961 PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ- 1039 (1181)
Q Consensus 961 ~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~- 1039 (1181)
....+.+||+.|||||++.+..+ ++..+|+ ||+||++|+|+||+.||.+.+...+...+.
T Consensus 166 ~~~~~~~GT~~Y~APE~~~~~~y-~~~~~Di------------------wSlGvily~lltg~~PF~~~~~~~~~~~i~~ 226 (275)
T 3hyh_A 166 NFLKTSCGSPNYAAPEVISGKLY-AGPEVDV------------------WSCGVILYVMLCRRLPFDDESIPVLFKNISN 226 (275)
T ss_dssp ---------CTTSCHHHHSSSSC-CCTHHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CccCCeeECcccCChhhhcCCCC-CCChhhh------------------HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc
Confidence 33445689999999999975432 3344555 999999999999999999887655422111
Q ss_pred CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1040 ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1040 ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
-....+...++.+..++.+|+++||.+||+..+.
T Consensus 227 ~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~ei 260 (275)
T 3hyh_A 227 GVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEI 260 (275)
T ss_dssp TCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 1111223467788889999999999999964443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=392.28 Aligned_cols=247 Identities=21% Similarity=0.235 Sum_probs=199.3
Q ss_pred eeecccCceEEEEEEEc-----CCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeec
Q psy14556 811 IELGKGSYGVVYAAREL-----DRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQV 884 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~-----~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~ 884 (1181)
++||+|+||+||+|++. .+++.||||+++.... ...+.|.+|+.++++++|||||+++|++.+++.++||||||
T Consensus 32 ~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~ 111 (308)
T 4gt4_A 32 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYC 111 (308)
T ss_dssp EEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcC
Confidence 36999999999999864 4678999999975543 34678999999999999999999999999999999999999
Q ss_pred CCCCcccchhcccC-------------CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCC
Q psy14556 885 PGGSLSTLLRVKWG-------------PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFG 951 (1181)
Q Consensus 885 ~gGSL~dlL~~~~~-------------~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFG 951 (1181)
++|+|.++|..... ...+++..+..|+.||+.||+|||+++||||||||+|||++. ++.+||+|||
T Consensus 112 ~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~-~~~~Ki~DFG 190 (308)
T 4gt4_A 112 SHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD-KLNVKISDLG 190 (308)
T ss_dssp SSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG-GGCEEECCSC
T ss_pred CCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC-CCCEEECCcc
Confidence 99999999964321 235789999999999999999999999999999999999998 8999999999
Q ss_pred cccccccCC--CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCC
Q psy14556 952 TSKRLAGLC--PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKK 1028 (1181)
Q Consensus 952 lAk~l~~~~--~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~ 1028 (1181)
+++.+.... .......||+.|||||++.++.++.++ |+ |||||+||||+| |..||.+
T Consensus 191 lar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ks--DV------------------wSfGvvl~El~t~g~~Pf~~ 250 (308)
T 4gt4_A 191 LFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDS--DI------------------WSYGVVLWEVFSYGLQPYCG 250 (308)
T ss_dssp CBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHH--HH------------------HHHHHHHHHHHTTTCCTTTT
T ss_pred cceeccCCCceeEecccccCCcccCHHHHhCCCCCccc--hh------------------hhHHHHHHHHHhCCCCCCCC
Confidence 998765432 223446799999999999877654443 33 999999999998 8999999
Q ss_pred CCcccccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcc
Q psy14556 1029 KTSRALVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTG 1079 (1181)
Q Consensus 1029 ~~~~~l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~ 1079 (1181)
.+..++..... .....+..+|..+..++.+|++.+|..||++. +.+..|+
T Consensus 251 ~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~-ei~~~L~ 302 (308)
T 4gt4_A 251 YSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFK-DIHSRLR 302 (308)
T ss_dssp CCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHH
T ss_pred CCHHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHH-HHHHHHH
Confidence 88766432211 11123456788899999999999999999644 4444443
|
| >1mzw_A Cyclophilin H, U-snRNP-ASSOCIATED cyclophilin; cyclophilin, peptidyl-prolyl-CIS/trans isomerase, spliceosome, U4/U6-60K protein, WD protein; 2.00A {Homo sapiens} SCOP: b.62.1.1 PDB: 1qoi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=361.17 Aligned_cols=163 Identities=50% Similarity=0.852 Sum_probs=153.8
Q ss_pred ccccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCc-----cccCCEEEEecCCceEee
Q psy14556 96 QMRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGF-----GFKDSTFHRVIPNFMCQG 170 (1181)
Q Consensus 96 ~~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~-----~Y~g~~FhRVip~f~iQg 170 (1181)
.+|.+|||++ +.+|+.|+|+||||++.||+||+||++||+++.|. +|+|+.||||+|+|||||
T Consensus 9 ~~~~v~~di~------------i~~t~~G~i~ieL~~~~aP~t~~NF~~L~~~~~g~~g~~~~Y~g~~FhRvi~~f~iQg 76 (177)
T 1mzw_A 9 VNPVVFFDVS------------IGGQEVGRMKIELFADVVPKTAENFRQFCTGEFRKDGVPIGYKGSTFHRVIKDFMIQG 76 (177)
T ss_dssp CCCEEEEEEE------------ETTEEEEEEEEEECTTTCHHHHHHHHHHHHTCCEETTEECSSTTCBCCEEETTTEEEE
T ss_pred CCCEEEEEEE------------ECCeeceeEEEEEcCCCCcHHHHHHHHHHhcccCCcCccceECCCEEEEEECCCEEEc
Confidence 5789999986 45899999999999999999999999999766532 499999999999999999
Q ss_pred CCCCCCCCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHh
Q psy14556 171 GDFTNHNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLES 250 (1181)
Q Consensus 171 Gd~~~~~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~ 250 (1181)
||++.++|+|++++||.+|++|+..++|+++|+|||||++||++|||||||++++||||++|+|||+|++|||||++|++
T Consensus 77 Gd~~~~~G~gg~si~g~~f~dE~~~l~h~~~G~lsmAn~gp~tngSQFfIt~~~~~~LDg~~~VFG~Vv~G~dvv~~I~~ 156 (177)
T 1mzw_A 77 GDFVNGDGTGVASIYRGPFADENFKLRHSAPGLLSMANSGPSTNGCQFFITCSKCDWLDGKHVVFGKIIDGLLVMRKIEN 156 (177)
T ss_dssp CCTTTSSSCCCCCTTSSCBCCCCCCSCCCSTTEEEECCSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHHHT
T ss_pred CCcccCCCCCCCccCCCcccCcccccccCCCCEEEEccCCCCCcceEEEEECCCCCccCCCeeEEEEEeCCHHHHHHHHh
Confidence 99988899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCC-CCCCcccceEEeeeccc
Q psy14556 251 MGS-QSGKTSKKIVVANSDSH 270 (1181)
Q Consensus 251 ~~t-~~g~P~~~V~I~~cGvl 270 (1181)
+++ .+++|.++|+|.+||+|
T Consensus 157 ~~t~~~~~P~~~v~I~~cG~l 177 (177)
T 1mzw_A 157 VPTGPNNKPKLPVVISQCGEM 177 (177)
T ss_dssp SCBCGGGCBSSCEEEEEEEEC
T ss_pred CCcCCCCCCCCCEEEEeceeC
Confidence 999 68999999999999986
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=385.27 Aligned_cols=238 Identities=22% Similarity=0.334 Sum_probs=186.8
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
++||+|+||+||+|++.. .||||+++.... ...+.|.+|+.++++++|||||++++++.+ +.++||||||+||+
T Consensus 42 ~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGs 117 (307)
T 3omv_A 42 TRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSS 117 (307)
T ss_dssp EECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCB
T ss_pred eEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCC
Confidence 369999999999998643 599999865432 235679999999999999999999998865 56899999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC--CCCccc
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC--PSAETF 966 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~--~~~~t~ 966 (1181)
|.+++... ...+++..+..|+.||+.||+|||+++||||||||+||||+. ++.+||+|||+|+...... ......
T Consensus 118 L~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~-~~~~Ki~DFGla~~~~~~~~~~~~~~~ 194 (307)
T 3omv_A 118 LYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHE-GLTVKIGDFGLATVKSRWSGSQQVEQP 194 (307)
T ss_dssp HHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEET-TEEEEECCCSSCBC------------C
T ss_pred HHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECC-CCcEEEeeccCceecccCCcceeeccc
Confidence 99999754 335789999999999999999999999999999999999998 8999999999998765322 233456
Q ss_pred cCCccccCchhhccCCC-CCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc-----cCCCCC
Q psy14556 967 TGTLQYMAPEVIDKGQR-GYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL-----VAPPQI 1040 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~-~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l-----~~~~~i 1040 (1181)
+||+.|||||++.+... .++..+|+ |||||+||||+||+.||.+.+.... ......
T Consensus 195 ~GT~~ymAPE~l~~~~~~~y~~ksDV------------------wS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~ 256 (307)
T 3omv_A 195 TGSVLWMAPEVIRMQDNNPFSFQSDV------------------YSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYAS 256 (307)
T ss_dssp CCCTTSCCHHHHHCCSSCCCCHHHHH------------------HHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCC
T ss_pred ccCCCccCHHHhhccCCCCCCcHHHh------------------HhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC
Confidence 79999999999974321 23444444 9999999999999999988665331 111111
Q ss_pred --CCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1041 --SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1041 --p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
....+..++..+..++.+|++++|..||++.+.
T Consensus 257 p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei 291 (307)
T 3omv_A 257 PDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQI 291 (307)
T ss_dssp CCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHH
T ss_pred CCcccccccchHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 123345678889999999999999999965443
|
| >2c3b_A Ppiase, cyclophilin; isomerase, 3D domain swapping, misfolding, Asp F 11, allergen, rotamase; 1.85A {Aspergillus fumigatus} SCOP: b.62.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=359.36 Aligned_cols=165 Identities=55% Similarity=0.919 Sum_probs=124.3
Q ss_pred cchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCC
Q psy14556 99 QRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNG 178 (1181)
Q Consensus 99 ~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g 178 (1181)
++|||++... ++ ...|+.|+|+||||++.||+||+||++||+|++|++|+|+.||||+|+|||||||+..++|
T Consensus 4 ~vf~di~i~~----~~---~~~T~~G~i~ieL~~~~aP~t~~NF~~L~~g~~g~~Y~g~~fhRvi~~f~iQgGd~~~~~g 76 (172)
T 2c3b_A 4 QVFFDVEYAP----VG---TAETKVGRIVFNLFDKDVPKTAKNFRELCKRPAGEGYRESTFHRIIPNFMIQGGDFTRGNG 76 (172)
T ss_dssp CEEEEEEECC----TT---CSCCEEEEEEEEECTTTSHHHHHHHHHHHHSCTTTSSTTCBCCEEETTTEEEECC------
T ss_pred EEEEEEEeCC----CC---ceecccccEEEEEcCCCCcHHHHHHHHHhccCCCcccCCCEEEEEeCCCEEEeCCcCCCCC
Confidence 7899997441 11 2368899999999999999999999999999899999999999999999999999777899
Q ss_pred CCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEc--CHHHHHHHHhCCCCCC
Q psy14556 179 TGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVE--GLDVVKKLESMGSQSG 256 (1181)
Q Consensus 179 ~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVie--G~dVL~kI~~~~t~~g 256 (1181)
+|++++||.+|++|+..++|+++|+|||||++||++|||||||++++||||++|+|||+|++ |||||++|+++++.++
T Consensus 77 ~gg~si~g~~f~dE~~~~~h~~~G~lsmA~~gp~t~gSQFfIt~~~~~~LDg~~tvFG~Vv~~~G~dvv~~I~~~~t~~~ 156 (172)
T 2c3b_A 77 TGGRSIYGDKFADENFSRKHDKKGILSMANAGPNTNGSQFFITTAVTSWLDGKHVVFGEVADEKSYSVVKEIEALGSSSG 156 (172)
T ss_dssp ----------------CHHHHHTCEEEEC---------CEEEECSCCTTCCSCCEEEEEECSHHHHHHHHHHHTTCCTTS
T ss_pred CCCcccCCCcccCcccccccCCCeEEEEeeCCCCCcccEEEEECCCCCccCCCeeEEEEEEecCCHHHHHHHHhCCCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999 9999999999999655
Q ss_pred --CcccceEEeeeccc
Q psy14556 257 --KTSKKIVVANSDSH 270 (1181)
Q Consensus 257 --~P~~~V~I~~cGvl 270 (1181)
+|.++|+|.+||+|
T Consensus 157 ~~~P~~~v~I~~cG~l 172 (172)
T 2c3b_A 157 SVRSNTRPKIVNCGEL 172 (172)
T ss_dssp CCCSSSCCEEEEEEEC
T ss_pred CccCCCCeEEEeCeeC
Confidence 99999999999986
|
| >1z81_A Cyclophilin; structural genomics, structural genomics consortium, SGC, isomerase; 2.80A {Plasmodium yoelii yoelii} SCOP: b.62.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=364.37 Aligned_cols=167 Identities=48% Similarity=0.806 Sum_probs=155.2
Q ss_pred cCCcccccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCc-----cccCCEEEEecCCc
Q psy14556 92 FPSSQMRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGF-----GFKDSTFHRVIPNF 166 (1181)
Q Consensus 92 ~~ss~~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~-----~Y~g~~FhRVip~f 166 (1181)
.....+|.+|||+. +.+|+.|+|+||||++.||+||+||++||++++|. +|+|+.||||+|+|
T Consensus 54 ~~~~~~~~V~~dis------------i~~t~~G~I~ieL~~d~aP~tv~NF~~L~~~~~g~~g~~~~Y~gt~FHRVi~~F 121 (229)
T 1z81_A 54 LTNPSNPVVFMDIN------------LGNNFLGKFKFELFQNIVPKTSENFRQFCTGEYKVNNLPVGYKNTIFHRVIKEF 121 (229)
T ss_dssp SSSTTCCEEEEEEE------------ETTEEEEEEEEEECTTTCHHHHHHHHHHHHTCCBSSSSBCSSTTEECCEEETTT
T ss_pred ccCCCCcEEEEEEe------------ECCeecccEEEEEcCCCCCHHHHHHHHHhhCCCCCcCCCceECCCEEEEEeCCC
Confidence 34446789999986 45789999999999999999999999999876542 39999999999999
Q ss_pred eEeeCCCCCCCCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEE--cCHHH
Q psy14556 167 MCQGGDFTNHNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVV--EGLDV 244 (1181)
Q Consensus 167 ~iQgGd~~~~~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVi--eG~dV 244 (1181)
||||||++.++|+|++++||.+|++|++.++|+++|+|||||++||++|||||||++++|+||++|+|||+|+ +||||
T Consensus 122 miQgGD~~~g~G~Gg~siyg~~f~dE~~~l~h~~~G~LsMAn~gpntngSQFFIt~~~~~~LDg~~tVFG~Vv~~eGmdV 201 (229)
T 1z81_A 122 MIQGGDFINHNGSGSLSIYGEKFDDENFDIKHDKEGLLSMANSGPNTNGCQFFITTKKCEWLDGKNVVFGRIIDNDSLLL 201 (229)
T ss_dssp EEEECCTTTSSSCCCCBTTBSCCCCCCCCSCCCSTTEEEECCSSSSCCCSCEEEESSCCGGGBTTBCEEEEECSHHHHHH
T ss_pred EEEcCCCcCCCCCCCCccCCCcccccccccccCCCcEEEeccCCCCCcccEEEEECCCCcccCCCeeEEEEEEecCcHHH
Confidence 9999999888999999999999999999999999999999999999999999999999999999999999999 99999
Q ss_pred HHHHHhCCCCC--CCcccceEEeeeccc
Q psy14556 245 VKKLESMGSQS--GKTSKKIVVANSDSH 270 (1181)
Q Consensus 245 L~kI~~~~t~~--g~P~~~V~I~~cGvl 270 (1181)
|++|+++++.. ++|.++|+|.+||+|
T Consensus 202 v~~I~~~~t~~~~~~P~~~V~I~~cG~l 229 (229)
T 1z81_A 202 LKKIENVSVTPYIYKPKIPINVVECGEL 229 (229)
T ss_dssp HHHHHHSCBCTTTCCBSSCEEEEEEEEC
T ss_pred HHHHHhCCCCCCCCCCCCCeEEEeCeeC
Confidence 99999999954 899999999999986
|
| >2ok3_A Peptidyl-prolyl CIS-trans isomerase-like 3; beta-barrel, helix, disulfide bridge; 2.00A {Homo sapiens} SCOP: b.62.1.1 PDB: 1xyh_A 2oju_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=344.81 Aligned_cols=157 Identities=41% Similarity=0.671 Sum_probs=148.5
Q ss_pred cEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCCCCCcC
Q psy14556 115 MVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFEDENF 194 (1181)
Q Consensus 115 ~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~~dE~~ 194 (1181)
|.|+++|+.|+|+||||++.||+||+||++|| +.|| |+|+.||||+|+|||||||+. ++|+||+++||.+|++|..
T Consensus 1 m~v~~~T~~G~i~ieL~~~~aP~t~~NF~~L~--~~g~-Y~g~~fhRvi~~f~iQgGd~~-~~g~gg~si~g~~~~dE~~ 76 (161)
T 2ok3_A 1 MSVTLHTDVGDIKIEVFCERTPKTCENFLALC--ASNY-YNGCIFHRNIKGFMVQTGDPT-GTGRGGNSIWGKKFEDEYS 76 (161)
T ss_dssp CEEEEEETTEEEEEEECTTTCHHHHHHHHHHH--HTTT-TTTCBCCEEETTTEEEECCTT-SSSSCCCCTTSSCBCCCCC
T ss_pred CEEEEEeCCccEEEEEcCCCCcHHHHHHHHHh--hhcc-cCCCEEEEEECCCEEecCCCC-CCCCCCCcccCCccccccC
Confidence 67889999999999999999999999999999 6788 999999999999999999998 6899999999999999975
Q ss_pred -ccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCCC-C-CCcccceEEeeecccc
Q psy14556 195 -TLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGSQ-S-GKTSKKIVVANSDSHS 271 (1181)
Q Consensus 195 -~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t~-~-g~P~~~V~I~~cGvl~ 271 (1181)
.++|+++|+||||+++++++||||||+++++|+||++|+|||+|++|||||++|+++++. + ++|.++|+|.+|+++.
T Consensus 77 ~~l~h~~~G~lsma~~gp~s~~SQFfI~~~~~~~Ldg~~tvFG~Vv~G~dvv~~I~~~~~~~~~~~P~~~v~I~~~~i~~ 156 (161)
T 2ok3_A 77 EYLKHNVRGVVSMANNGPNTNGSQFFITYGKQPHLDMKYTVFGKVIDGLETLDELEKLPVNEKTYRPLNDVHIKDITIHA 156 (161)
T ss_dssp TTCCSCSTTEEEECCSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHHHTCCBCTTTCCBSSCCBEEEEEEEC
T ss_pred cCcCcCCCeEEEEecCCCCCcceEEEEEcCCCCccCCCEeEEEEEeCCHHHHHHHHhCCccCCCCCcCCCeEEEEEEEec
Confidence 789999999999999999999999999999999999999999999999999999999984 3 8999999999999998
Q ss_pred CCCC
Q psy14556 272 ETDS 275 (1181)
Q Consensus 272 ~~~~ 275 (1181)
+|.+
T Consensus 157 ~Pf~ 160 (161)
T 2ok3_A 157 NPFA 160 (161)
T ss_dssp CSCC
T ss_pred CCCC
Confidence 7654
|
| >2poe_A Cyclophilin-like protein, putative; cryptosporidium parvum cyclophilin isomerase, structural genomics; 2.01A {Cryptosporidium parvum iowa II} PDB: 2qer_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=351.27 Aligned_cols=161 Identities=39% Similarity=0.596 Sum_probs=149.3
Q ss_pred CCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCCCCC
Q psy14556 113 EGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFEDE 192 (1181)
Q Consensus 113 ~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~~dE 192 (1181)
..+.|.++|+.|+|+||||++.||+||+||++|| +.|| |+|+.||||+|+|||||||++ ++|+||.++||.+|++|
T Consensus 15 ~~~~v~i~t~~G~i~ieL~~~~aP~t~~NF~~L~--~~g~-Y~g~~FhRvi~~f~iQgGd~~-~~g~gg~si~g~~~~dE 90 (185)
T 2poe_A 15 YFQGVRIITNYGDLKFELFCSQCPKACKNFLALS--ASGY-YKNTIFHKNIKGFIIQGGDPT-GTGKGGESIYGRYFDDE 90 (185)
T ss_dssp CCCEEEEEETTEEEEEEECTTTCHHHHHHHHHHH--HTTT-TTTEEEEEECTTSEEEEEETT-SSSSCCCBTTBSCBCCC
T ss_pred CceEEEEEecCccEEEEEeCCCCcHHHHHHHHHh--ccCC-CCCCEEEEEECCCEEEcCCCC-CCCCCCCccCCCccccc
Confidence 4567788999999999999999999999999999 7788 999999999999999999998 68999999999999999
Q ss_pred c-CccccCCCceEEeecCC----CCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCC-CCCCcccceEEee
Q psy14556 193 N-FTLKHTGPGILSMANAG----PNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGS-QSGKTSKKIVVAN 266 (1181)
Q Consensus 193 ~-~~l~h~~~G~Lsma~~g----~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t-~~g~P~~~V~I~~ 266 (1181)
. ..++|+++|+|||||++ ||++|||||||++++|+||++|+|||+|++|||||++|+++++ .+++|.++|+|.+
T Consensus 91 ~~~~l~h~~~G~lsmA~~g~~~~p~s~gSQFFIt~~~~~~LDg~~tVFG~Vv~Gmdvv~~I~~~~t~~~~~P~~~v~I~~ 170 (185)
T 2poe_A 91 IYPELKYDRRGILSMASKGASKKPNTNGSQFFITYSSLPQLNGEYVIFGKLIDGFETLNTLENCPSDKSHKPIDEIIIKD 170 (185)
T ss_dssp CCTTSCCCSTTEEEECCSCC-CCCSCBCSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHHHHSCBCTTSCBSSCCEEEE
T ss_pred ccCCCccCCCeEEEEecCCCCCCCCCccceEEEECCCCCccCCCeeEEEEEeCCHHHHHHHHhCCcCCCCCcCCCeEEEE
Confidence 7 78999999999999999 9999999999999999999999999999999999999999998 5689999999999
Q ss_pred eccccCCCCCC
Q psy14556 267 SDSHSETDSQS 277 (1181)
Q Consensus 267 cGvl~~~~~~p 277 (1181)
|+++.+|.+.|
T Consensus 171 ~~i~~dPf~d~ 181 (185)
T 2poe_A 171 IVIHSNPIADQ 181 (185)
T ss_dssp EEEECCC----
T ss_pred EEEECCCCCCc
Confidence 99998777655
|
| >2ose_A Probable peptidyl-prolyl CIS-trans isomerase; cyclophilin; 2.04A {Mimivirus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=366.64 Aligned_cols=173 Identities=27% Similarity=0.429 Sum_probs=153.6
Q ss_pred ccccCCcccccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccC-----------C----C--
Q psy14556 89 QMFFPSSQMRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGE-----------K----G-- 151 (1181)
Q Consensus 89 ~~~~~ss~~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~-----------~----G-- 151 (1181)
...+.+..+|.+|||++ +.+|+.|+|+||||++.||+||+||++||+|+ + |
T Consensus 6 ~~~p~~~~~p~v~~di~------------i~~t~~G~I~ieL~~d~aP~tv~NF~~L~~g~~~~~~p~~~~~~~~~~G~~ 73 (234)
T 2ose_A 6 EDLPNSGKNPRVYMDIV------------LNNEIIGRLQIKLFRDAFPAGVENFVQLTNGKTYRVNSNGTGKYKYNRHIN 73 (234)
T ss_dssp SSCCCCCSSCEEEEEEE------------ETTEEEEEEEEEECGGGCHHHHHHHHHHHHTCCCC---------------C
T ss_pred cccCcCCCCCEEEEEEE------------ECCcccceEEEEEcCCCCcHHHHHHHHHhcCCccccccccccccccccCCc
Confidence 45566668899999997 44799999999999999999999999999876 4 5
Q ss_pred ccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCC-----CCCCcCccccCCCceEEeec----CCCCCCcceEEEEc
Q psy14556 152 FGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNK-----FEDENFTLKHTGPGILSMAN----AGPNTNGSQFFITT 222 (1181)
Q Consensus 152 ~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~-----~~dE~~~l~h~~~G~Lsma~----~g~nt~gSQFfItl 222 (1181)
|+|+|+.||||+|+|||||||+..++|+||+++||.. |+ ++.++|+++|+||||| +|++++|||||||+
T Consensus 74 ~~Y~gt~FHRVi~~FmiQgGd~~~g~G~Gg~siyg~~~~p~~f~--~~~l~h~~~G~lsMAn~~~~~gpntngSQFFIt~ 151 (234)
T 2ose_A 74 RTYEGCKFHNVLHNNYIVSGDIYNSNGSSAGTVYCDEPIPPVFG--DYFYPHESKGLLSLVPYTDESGNRYYDSTFMITL 151 (234)
T ss_dssp CCSTTCBCCEEETTTEEEECCCC----CCCCCTTTTCCBCCCCC--SCCCCSCSTTEEEECCEECTTSCEEBCSCEEEES
T ss_pred eEECCcEEEEEECCCEEEcCCccCCCCCCCccccCCccCccccc--CcCccCCCCCEEEEecccccCCCCCccceEEEEe
Confidence 7799999999999999999998778999999999988 66 5689999999999999 89999999999999
Q ss_pred CC------CCCCCCCCeEEEEEEcCHHHHHHHHhCCCC-CCCcccceEEeeeccccCCCC
Q psy14556 223 VK------TAWLDNRHVVFGSVVEGLDVVKKLESMGSQ-SGKTSKKIVVANSDSHSETDS 275 (1181)
Q Consensus 223 ~~------~p~LDg~~vVFGrVieG~dVL~kI~~~~t~-~g~P~~~V~I~~cGvl~~~~~ 275 (1181)
++ +||||++|+|||+|++|||||++|+++++. +++|.++|+|.+||++.++.+
T Consensus 152 ~~~~~~~g~p~LDg~~tVFG~Vv~GmdVv~~I~~~~t~~~~~P~~~V~I~~~~~l~~p~~ 211 (234)
T 2ose_A 152 DDIRPSNVLDELDRDQVVIGQVYGGLDVLDKINSMIKPYAGRKYPTFSIGKCGAYLDSSQ 211 (234)
T ss_dssp SCCCTTSSGGGSCTTSEEEEEEEECHHHHHHHHHHTCCCTTCCCCCEEEEEEEECCCHHH
T ss_pred cCccccCCCcccCCCeeEEEEEeCCHHHHHHHHhCCcCCCCCccCCEEEEEEEEecCCcc
Confidence 99 999999999999999999999999999994 599999999999999977643
|
| >1zkc_A Peptidyl-prolyl CIS-trans isomerase like 2; CIS-trans isomerization, peptidylprolyl isomerase, protein- folding, structural genomics consortium; 1.65A {Homo sapiens} SCOP: b.62.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=351.09 Aligned_cols=163 Identities=42% Similarity=0.714 Sum_probs=152.4
Q ss_pred cCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCCC
Q psy14556 111 DQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFE 190 (1181)
Q Consensus 111 ~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~~ 190 (1181)
+.+...|++.|+.|+|+||||++.||+||+||++|| +.|| |+|+.||||+|+|||||||++ ++|+||.++||.+|+
T Consensus 16 ~~~~~~v~l~T~~G~I~ieL~~~~aP~tv~NF~~L~--~~g~-Ydg~~FhRVi~~f~iQgGd~~-~~g~Gg~si~g~~f~ 91 (197)
T 1zkc_A 16 PRGSGYVRLHTNKGDLNLELHCDLTPKTCENFIRLC--KKHY-YDGTIFHRSIRNFVIQGGDPT-GTGTGGESYWGKPFK 91 (197)
T ss_dssp CCSCEEEEEEETTEEEEEEECTTTSHHHHHHHHHHH--HTTT-TTTEEEEEEETTTEEEECCTT-SSSSCCCBTTBSCBC
T ss_pred CCCCcEEEEEeCCccEEEEEcCCCCcHHHHHHHHHH--hcCC-CCCCEEEEEeCCCEEEcCCCC-CCCCCCCccCCCccc
Confidence 445667899999999999999999999999999999 7888 999999999999999999998 689999999999999
Q ss_pred CC-cCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCCCC--CCcccceEEeee
Q psy14556 191 DE-NFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGSQS--GKTSKKIVVANS 267 (1181)
Q Consensus 191 dE-~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t~~--g~P~~~V~I~~c 267 (1181)
+| +..++|+.+|+|||||+++|++|||||||++++|+||++|+|||+|++|||||++|+++++.. ++|..+|+|.+|
T Consensus 92 dE~~~~l~h~~~G~lsMAn~gp~sngSQFFIt~~~~~~LDg~~tVFG~Vv~Gmdvv~~I~~~~t~~~~~~P~~~i~I~~~ 171 (197)
T 1zkc_A 92 DEFRPNLSHTGRGILSMANSGPNSNRSQFFITFRSCAYLDKKHTIFGRVVGGFDVLTAMENVESDPKTDRPKEEIRIDAT 171 (197)
T ss_dssp CCCCTTCCSCSTTEEEECCSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHHHHSCBCTTTCCBSSCCEEEEE
T ss_pred cccCcCcCCCCceEEEEecCCCCCcccEEEEEcCCCCccCCCccEEEEEEcCHHHHHHHHcCCCCCCCCCcCCCeEEEEE
Confidence 99 478999999999999999999999999999999999999999999999999999999999944 899999999999
Q ss_pred ccccCCCCCC
Q psy14556 268 DSHSETDSQS 277 (1181)
Q Consensus 268 Gvl~~~~~~p 277 (1181)
+++.++.+.+
T Consensus 172 ~v~~dPf~d~ 181 (197)
T 1zkc_A 172 TVFVDPYEEA 181 (197)
T ss_dssp EEEECTTHHH
T ss_pred EEEcCCcccH
Confidence 9998776544
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=380.24 Aligned_cols=246 Identities=25% Similarity=0.331 Sum_probs=180.5
Q ss_pred hhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCC------
Q psy14556 803 LYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEG------ 875 (1181)
Q Consensus 803 ~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~------ 875 (1181)
..+|...+ +||+|+||+||+|+++.+++.||||+++..... ..+.+.+|+.+|++++|||||++++++.+.+
T Consensus 4 l~dy~~~~-~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 4 LTDFEPIQ-CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHHEEEEE-EEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred chhCEEee-EEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 34555544 699999999999999999999999999755432 3567899999999999999999999986543
Q ss_pred ------cEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeec
Q psy14556 876 ------YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISD 949 (1181)
Q Consensus 876 ------~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiD 949 (1181)
++|+|||||+||+|.+++.........++..++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~-~~~vKl~D 161 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTM-DDVVKVGD 161 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TCCEEECC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECC-CCcEEEcc
Confidence 47999999999999999986533334456678899999999999999999999999999999988 89999999
Q ss_pred CCcccccccCCCC------------CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHH
Q psy14556 950 FGTSKRLAGLCPS------------AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIIS 1017 (1181)
Q Consensus 950 FGlAk~l~~~~~~------------~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILy 1017 (1181)
||+|+.+...... ..+.+||+.|||||++.+..+ +..+|+ ||+||++|
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y--~~~~Di------------------wSlGvily 221 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY--SHKVDI------------------FSLGLILF 221 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCC--CTHHHH------------------HHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCC--CCHHHH------------------HHHHHHHH
Confidence 9999876543211 223579999999999986543 444555 99999999
Q ss_pred HHHhCCCCCCCCCccc--c--cCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1018 QLLVLTAALKKKTSRA--L--VAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1018 ELLTGk~PF~~~~~~~--l--~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
||++ ||.+..... + ......|.. .....+....++.+|++++|..||+..+.+
T Consensus 222 ell~---Pf~~~~~~~~~~~~~~~~~~p~~-~~~~~~~~~~li~~~L~~dP~~Rps~~eil 278 (299)
T 4g31_A 222 ELLY---PFSTQMERVRTLTDVRNLKFPPL-FTQKYPCEYVMVQDMLSPSPMERPEAINII 278 (299)
T ss_dssp HHHS---CCSSHHHHHHHHHHHHTTCCCHH-HHHHCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHcc---CCCCccHHHHHHHHHhcCCCCCC-CcccCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 9996 887643221 1 111111111 011223345689999999999999755543
|
| >2b71_A Cyclophilin-like protein; structural genomics, structural genomics consortium, SGC, isomerase; 2.50A {Plasmodium yoelii} SCOP: b.62.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=349.35 Aligned_cols=170 Identities=41% Similarity=0.667 Sum_probs=152.3
Q ss_pred cccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCC
Q psy14556 97 MRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNH 176 (1181)
Q Consensus 97 ~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~ 176 (1181)
....||+..-. ...+.|+++|+.|+|+||||++.||+||+||++|| ++|| |+|+.||||+|+|||||||++ +
T Consensus 25 ~~~~~~~~~~~----~~~~~V~l~T~~G~I~ieL~~~~aP~tv~NF~~L~--~~g~-Y~g~~FhRVi~~f~iQgGd~~-~ 96 (196)
T 2b71_A 25 EKIAYYKMKGH----TERGYITIYTNLGDFEVELYWYHSPKTCLNFYTLC--EMGF-YDNTIFHRVIPNFVIQGGDPT-G 96 (196)
T ss_dssp HHHHHHHHHHH----HHSCEEEEEETTEEEEEEECTTTSHHHHHHHHHHH--HTTT-TTTEEEEEEETTTEEEEEETT-S
T ss_pred ccceeeecCCc----CCCcEEEEEeCCCCEEEEEeCCCCcHHHHHHHHHh--hcCC-cCCCEEEEEeCCcEEEcCCCC-C
Confidence 34556665422 34678999999999999999999999999999999 7788 999999999999999999998 6
Q ss_pred CCCCCcccCCCCCCCCc-CccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCC-C
Q psy14556 177 NGTGGKSIYGNKFEDEN-FTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGS-Q 254 (1181)
Q Consensus 177 ~g~gg~si~g~~~~dE~-~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t-~ 254 (1181)
+|+||+++||.+|++|. ..++|+++|+||||++|||++|||||||++++||||++|+|||+|++|||||++|+++++ .
T Consensus 97 ~g~gg~si~g~~~~dE~~~~l~h~~~G~lsMAn~gpns~gSQFFIt~~~~~~LDg~~tVFG~Vv~Gmdvv~~I~~~~t~~ 176 (196)
T 2b71_A 97 TGKGGKSIYGEYFEDEINKELKHTGAGILSMSNNGPNTNSSQFFITLAPLPHLDGKHTIFARVSKNMTCIENIASVQTTA 176 (196)
T ss_dssp SSSCCCBTTBSCBCCCCCTTCCCCSTTEEEECCSSTTCBSSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHHHTSCBCT
T ss_pred CCCCCCccCCCcccccccCCcCcCCCeEEEEccCCCCCcccEEEEECCCCCccCCCEeEEEEEecCHHHHHHHHhCCcCC
Confidence 89999999999999995 579999999999999999999999999999999999999999999999999999999998 5
Q ss_pred CCCcccceEEeeeccccCCC
Q psy14556 255 SGKTSKKIVVANSDSHSETD 274 (1181)
Q Consensus 255 ~g~P~~~V~I~~cGvl~~~~ 274 (1181)
+++|.++|+|.+|+++.+|+
T Consensus 177 ~~~P~~~i~I~~~~i~~dP~ 196 (196)
T 2b71_A 177 TNKPIFDLKILRTSTAVNAD 196 (196)
T ss_dssp TCCBSSCCEEEEEEC-----
T ss_pred CCCCCCCeEEEEEEEecCCC
Confidence 68999999999999998764
|
| >2fu0_A Cyclophilin, putative; PFE0505W, cyclosporin-binding domain, structura genomics, structural genomics consortium, SGC, unknown FUNC; 1.80A {Plasmodium falciparum} SCOP: b.62.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=339.53 Aligned_cols=153 Identities=43% Similarity=0.703 Sum_probs=145.8
Q ss_pred CcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCCCCCc
Q psy14556 114 GMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFEDEN 193 (1181)
Q Consensus 114 ~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~~dE~ 193 (1181)
.+.|+++|+.|+|+||||++.||+||+||++|| ++|| |+|+.||||+|+|||||||+. ++|+|++++||.+|++|.
T Consensus 5 ~~~v~~~T~~G~i~ieL~~~~aP~t~~NF~~L~--~~g~-Y~g~~fhRvi~~f~iQgGd~~-~~g~gg~si~g~~~~dE~ 80 (160)
T 2fu0_A 5 PKSAIIYTTMGDIHISLFYKECKKTVQNFSVHS--INGY-YNNCIFHRVIKHFMVQTGDPS-GDGTGGESIWGNEFEDEF 80 (160)
T ss_dssp CCEEEEEETTEEEEEEECTTTCHHHHHHHHHHH--HTTT-TTTCBCCEEETTTEEEECCTT-SSSSCCCCTTSSCBCCCC
T ss_pred CCEEEEEecCccEEEEEeCCCChHHHHHHHHHh--ccCc-cCCCEEEEEECCCEEEeCCcC-CCCCCCCcccCCCccccc
Confidence 467899999999999999999999999999999 7788 999999999999999999997 589999999999999998
Q ss_pred C-ccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCCC-CCCcccceEEeeeccc
Q psy14556 194 F-TLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGSQ-SGKTSKKIVVANSDSH 270 (1181)
Q Consensus 194 ~-~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t~-~g~P~~~V~I~~cGvl 270 (1181)
. .++|+++|+||||+++|+++||||||+++++|+||++|+|||+|++|||||++|+++++. +++|.++|+|.+|.++
T Consensus 81 ~~~l~h~~~G~lsmA~~gp~s~~SQFfI~~~~~~~Ldg~~tvFG~Vv~G~dvv~~I~~~~t~~~~~P~~~v~I~~~~v~ 159 (160)
T 2fu0_A 81 FDHLNHSKPFMVSMANCGPNTNGSQFFITTVPCPWLDFKHTVFGKVTQGSKIVLDIEKVRTDKRDKPLEDIKILNIKIN 159 (160)
T ss_dssp BTTBCSSSSSEEEECCSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHHHTSCBCTTSCBSSCCBEEEEEEC
T ss_pred cCCcccCCceEEEEecCCCCCcccEEEEECCCCCccCCCcEEEEEEEcCHHHHHHHHhCCcCCCCCcCCCeEEEEEEEe
Confidence 7 699999999999999999999999999999999999999999999999999999999994 7999999999999875
|
| >2x7k_A Peptidyl-prolyl CIS-trans isomerase-like 1; isomerase-immunosuppressant complex, immunosuppressant; HET: MLE MVA BMT ABA SAR; 1.15A {Homo sapiens} PDB: 1xwn_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=341.49 Aligned_cols=155 Identities=40% Similarity=0.724 Sum_probs=147.2
Q ss_pred CCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCCCC
Q psy14556 112 QEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFED 191 (1181)
Q Consensus 112 ~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~~d 191 (1181)
+..+.|.++|+.|+|+||||++.||+||+||++|| ++|| |+|+.||||+|+|||||||++ ++|+||.++||.+|++
T Consensus 9 ~~~~~v~l~t~~G~i~ieL~~~~aP~t~~NF~~L~--~~g~-Y~g~~fhRvi~~f~iQgGd~~-~~g~gg~si~g~~~~d 84 (166)
T 2x7k_A 9 WQPPNVYLETSMGIIVLELYWKHAPKTCKNFAELA--RRGY-YNGTKFHRIIKDFMIQGGDPT-GTGRGGASIYGKQFED 84 (166)
T ss_dssp CCCSEEEEEETTEEEEEEECTTTCHHHHHHHHHHH--HHTT-TTTEECCEEETTTEEEECCTT-SSSSCCCCTTSSCBCC
T ss_pred cCCCEEEEEeCCCcEEEEEccCCCCHHHHHHHHHH--hcCC-CCCCEEEEEECCCEEEcCCCC-CCCCCCCccCCCcccc
Confidence 45678999999999999999999999999999999 6788 999999999999999999998 6899999999999999
Q ss_pred Cc-CccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCC-CCCCcccceEEeeecc
Q psy14556 192 EN-FTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGS-QSGKTSKKIVVANSDS 269 (1181)
Q Consensus 192 E~-~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t-~~g~P~~~V~I~~cGv 269 (1181)
|. ..++|+++|+|||||++||++||||||+++++|+||++|+|||+|++|||||++|+++++ .+++|.++|+|.+|.+
T Consensus 85 E~~~~l~h~~~G~lsmAn~gp~s~gSQFfI~~~~~~~Ldg~~tvFG~Vv~G~dvv~~I~~~~t~~~~~P~~~i~I~~~~i 164 (166)
T 2x7k_A 85 ELHPDLKFTGAGILAMANAGPDTNGSQFFVTLAPTQWLDGKHTIFGRVCQGIGMVNRVGMVETNSQDRPVDDVKIIKAYP 164 (166)
T ss_dssp CCCTTSCCCSTTEEEECBSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHHTTSCBCTTSCBSSCCEEEEEEE
T ss_pred ccccccCCCCCeEEEEeeCCCCCccceEEEECCCCCccCCCeeEEEEEEcCHHHHHHHHcCCcCCCCCcCCCeEEEEEEE
Confidence 98 489999999999999999999999999999999999999999999999999999999998 4589999999999987
Q ss_pred c
Q psy14556 270 H 270 (1181)
Q Consensus 270 l 270 (1181)
+
T Consensus 165 ~ 165 (166)
T 2x7k_A 165 S 165 (166)
T ss_dssp C
T ss_pred e
Confidence 6
|
| >3bo7_A Peptidyl-prolyl CIS-trans isomerase cyclophilin-T; isomerase-immunosuppressant complex, immunosuppressant, cyclophilin, structural G structural genomics consortium, SGC; HET: BMT; 2.35A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=349.63 Aligned_cols=163 Identities=35% Similarity=0.536 Sum_probs=144.2
Q ss_pred cCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeC-----CCCCCCCCCCcccC
Q psy14556 111 DQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGG-----DFTNHNGTGGKSIY 185 (1181)
Q Consensus 111 ~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgG-----d~~~~~g~gg~si~ 185 (1181)
.++...|++.|+.|+|+||||++.||+||+||++|| +.|| |+|+.||||+|+|||||| |++ ++|+||.++|
T Consensus 3 ~~~~~~v~l~T~~G~i~ieL~~~~aP~t~~NF~~L~--~~g~-Ydg~~FhRvi~~f~iQgG~~~~~Dp~-~~g~gg~si~ 78 (201)
T 3bo7_A 3 LKKKGYLRIVTTQGSLNIELHADMAPRACDSFLRLC--AVKY-FDDTIFHRCIRNFMIQGGRAELRQPS-KKKEVQQSPR 78 (201)
T ss_dssp --CCEEEEEEETTEEEEEEECTTTCHHHHHHHHHHH--HTTT-TTTCBEEEEETTTEEEECCGGGCCC--------CCSS
T ss_pred CCCceEEEEEeCCCCEEEEEcCCCCcHHHHHHHHHH--hcCc-cCCCEEEEeeCCCEEEcCcccccCCC-CCCCCCcccc
Confidence 345678899999999999999999999999999999 7788 999999999999999999 987 6899999999
Q ss_pred -------CCCCCCC-cCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCC-CCC
Q psy14556 186 -------GNKFEDE-NFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGS-QSG 256 (1181)
Q Consensus 186 -------g~~~~dE-~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t-~~g 256 (1181)
|.+|++| ...++|+.+|+||||++|||++|||||||++++||||++|+|||+|++|||||++|+++++ .++
T Consensus 79 ~~~~~~~g~~f~dE~~~~l~h~~~G~lsmA~~gp~s~gSQFFIt~~~~~~LDg~~tVFG~Vv~Gmdvv~~I~~~~t~~~~ 158 (201)
T 3bo7_A 79 SISGFPGGAPFEDEFDNRLVHQGIGVLSMANDGKHSNLSEFFITFKSCEHLNNKHTIFGRVVGGLDVLRQWEKLETDKKD 158 (201)
T ss_dssp CCCSSTTCCCBCCCCCTTCCCCSTTEEEECCSSTTCBSSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHHTTCCBCTTS
T ss_pred ccccccCCCcccCcccCCCCcCCCcEEEEeeCCCCCcccEEEEECCCCcccCCCceEEEEEecCHHHHHHHHhCCcCCCC
Confidence 8999999 4789999999999999999999999999999999999999999999999999999999999 458
Q ss_pred CcccceEEeeeccccCCCCCC
Q psy14556 257 KTSKKIVVANSDSHSETDSQS 277 (1181)
Q Consensus 257 ~P~~~V~I~~cGvl~~~~~~p 277 (1181)
+|..+|+|.+|+++.++.+.+
T Consensus 159 ~P~~~i~I~~~~v~~dPf~d~ 179 (201)
T 3bo7_A 159 KPLKPPKVEEIIVFKNPFEDA 179 (201)
T ss_dssp CBSSCCBEEEEEEEECCC---
T ss_pred CcCCCeEEEEEEEEcCCccCH
Confidence 999999999999998877665
|
| >1w74_A Peptidyl-prolyl CIS-trans isomerase A; cyclophilin, ppiase, RV0009, rotamase, structural proteomics in europe, spine; 2.6A {Mycobacterium tuberculosis} SCOP: b.62.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=343.23 Aligned_cols=158 Identities=39% Similarity=0.621 Sum_probs=143.7
Q ss_pred ccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCC-------------CccccCCEEEEecCCceEeeCCCC
Q psy14556 108 MTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEK-------------GFGFKDSTFHRVIPNFMCQGGDFT 174 (1181)
Q Consensus 108 ~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~-------------G~~Y~g~~FhRVip~f~iQgGd~~ 174 (1181)
..++++.+.|+++|+.|+|+||||++.||+||+||++||+|++ +| |+|+.||||+|+|||||||+.
T Consensus 17 ~~~~~~~~~v~l~t~~G~I~ieL~~~~aP~tv~NF~~L~tG~~~~~~~~~g~~~~~~~-Y~g~~FhRVi~~fmiQgGd~~ 95 (191)
T 1w74_A 17 TNSPLATATATLHTNRGDIKIALFGNHAPKTVANFVGLAQGTKDYSTQNASGGPSGPF-YDGAVFHRVIQGFMIQGGDPT 95 (191)
T ss_dssp ----CCSEEEEEEETTEEEEEEECTTTSHHHHHHHHHHHHTCSCCSSCCTTBSSSSCS-STTEEEEEEETTTEEEECCTT
T ss_pred ccCCCCCeEEEEEecceeEEEEEcCCCChHHHHHHHHHhcCCcccccccccccccCCc-cCCCEEEEEeCCCEEecCCCC
Confidence 3456777899999999999999999999999999999998854 45 999999999999999999986
Q ss_pred CCCCCCCcccCCCCCCCC-cCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEc--CHHHHHHHHhC
Q psy14556 175 NHNGTGGKSIYGNKFEDE-NFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVE--GLDVVKKLESM 251 (1181)
Q Consensus 175 ~~~g~gg~si~g~~~~dE-~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVie--G~dVL~kI~~~ 251 (1181)
++|+|+ ||.+|++| +..++|+++|+|||||+|||++|||||||++++||||++|+|||+|++ |||||++|+++
T Consensus 96 -g~G~gg---~g~~f~dE~~~~l~h~~~G~lsMAn~gpntngSQFFIt~~~~~~LDg~~tVFG~Vv~~~Gmdvv~~I~~~ 171 (191)
T 1w74_A 96 -GTGRGG---PGYKFADEFHPELQFDKPYLLAMANAGPGTNGSQFFITVGKTPHLNRRHTIFGEVIDAESQRVVEAISKT 171 (191)
T ss_dssp -SSSSCC---SSCCBCCCCCTTCCSCSSSEEEECCSSTTCBSSCEEEESSCCGGGTTTSCEEEEECSHHHHHHHHHHHTS
T ss_pred -CCCCCC---CCCccccccccCCCcCCCcEEEEeeCCCCCccceEEEEcCCCcccCCCeeEEEEEEECCCHHHHHHHHcC
Confidence 577777 58899999 468999999999999999999999999999999999999999999999 99999999999
Q ss_pred CC-CCCCcccceEEeeeccc
Q psy14556 252 GS-QSGKTSKKIVVANSDSH 270 (1181)
Q Consensus 252 ~t-~~g~P~~~V~I~~cGvl 270 (1181)
++ .+++|.++|+|.+|+++
T Consensus 172 ~t~~~~~P~~~v~I~~~~i~ 191 (191)
T 1w74_A 172 ATDGNDRPTDPVVIESITIS 191 (191)
T ss_dssp CBCTTSCBSSCCEEEEEEEC
T ss_pred CcCCCCCcCCCeEEEEEEEC
Confidence 99 56899999999999974
|
| >2a2n_A Peptidylprolyl isomerase domain and WD repeat CON; CIS-trans isomerization, protein-folding, peptidylprolyl ISO structural genomics; 1.65A {Homo sapiens} SCOP: b.62.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=338.39 Aligned_cols=152 Identities=45% Similarity=0.731 Sum_probs=144.7
Q ss_pred CcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCCCCCc
Q psy14556 114 GMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFEDEN 193 (1181)
Q Consensus 114 ~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~~dE~ 193 (1181)
...|+++|+.|+|+||||++.||+||+||++|| +.|| |+|+.||||+|+|||||||+. ++|+|++++||.+|++|.
T Consensus 21 ~~~v~~~t~~G~i~ieL~~~~aP~t~~NF~~L~--~~g~-Y~g~~FhRvi~~f~iQgGd~~-~~g~gg~si~g~~~~dE~ 96 (176)
T 2a2n_A 21 SDSAIIHTSMGDIHTKLFPVECPKTVENFCVHS--RNGY-YNGHTFHRIIKGFMIQTGDPT-GTGMGGESIWGGEFEDEF 96 (176)
T ss_dssp CSEEEEEETTEEEEEEECTTTCHHHHHHHHHHH--HTTT-TTTCBCCEEETTTEEEECCTT-SSSSCCCCTTSSCBCCCC
T ss_pred CCEEEEEecCccEEEEEeCCCChHHHHHHHHHh--hcCc-cCCCEEEEEECCcEEEccCCC-CCCCCCCcccCCcccccc
Confidence 457899999999999999999999999999999 6788 999999999999999999997 589999999999999998
Q ss_pred C-ccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCCC--CCCcccceEEeeecc
Q psy14556 194 F-TLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGSQ--SGKTSKKIVVANSDS 269 (1181)
Q Consensus 194 ~-~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t~--~g~P~~~V~I~~cGv 269 (1181)
. .++|+++|+|||||++||++||||||+++++||||++|+|||+|++|||||++|+++++. +++|.++|+|.+|.+
T Consensus 97 ~~~l~h~~~G~lsmA~~gp~s~gSQFFIt~~~~~~LDg~~tVFG~Vv~Gmdvv~~I~~~~t~~~~~~P~~~v~I~~v~v 175 (176)
T 2a2n_A 97 HSTLRHDRPYTLSMANAGSNTNGSQFFITVVPTPWLDNKHTVFGRVTKGMEVVQRISNVKVNPKTDKPYEDVSIINITV 175 (176)
T ss_dssp CTTCCSCSSSEEEECCSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHHHTSCBCTTTCCBSSCCBEEEEEE
T ss_pred ccccccCCceEEEEEeCCCCCcccEEEEECCCCCccCCCeeEEEEEeCCHHHHHHHHcCCccCCCCccCCCeEEEEEEE
Confidence 8 699999999999999999999999999999999999999999999999999999999986 789999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=380.51 Aligned_cols=242 Identities=21% Similarity=0.267 Sum_probs=192.5
Q ss_pred eeecccCceEEEEEEEcCC-----CeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCC-CCeeeEcccccc-CCcEEEEEe
Q psy14556 811 IELGKGSYGVVYAARELDR-----QVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRH-RNIVQYLGSVSE-EGYFKIFME 882 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~t-----g~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~H-PNIVkl~g~~~d-~~~l~LVmE 882 (1181)
++||+|+||+||+|.+..+ ++.||||.+...... ..+.+.+|+.+|++++| ||||+++++|.+ ++.++||||
T Consensus 70 ~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~E 149 (353)
T 4ase_A 70 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVE 149 (353)
T ss_dssp EEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEE
T ss_pred eEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEE
Confidence 3799999999999997654 368999999765432 35679999999999965 999999999865 467899999
Q ss_pred ecCCCCcccchhcccC-------------CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeec
Q psy14556 883 QVPGGSLSTLLRVKWG-------------PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISD 949 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~-------------~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiD 949 (1181)
||++|+|.++|+.... ...+++..+..|+.||+.||+|||+++||||||||+|||++. ++.+||+|
T Consensus 150 y~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~-~~~vKi~D 228 (353)
T 4ase_A 150 FCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE-KNVVKICD 228 (353)
T ss_dssp CCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG-GGCEEECC
T ss_pred cCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC-CCCEEECc
Confidence 9999999999975321 245789999999999999999999999999999999999998 89999999
Q ss_pred CCcccccccCCC--CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCC
Q psy14556 950 FGTSKRLAGLCP--SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAAL 1026 (1181)
Q Consensus 950 FGlAk~l~~~~~--~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF 1026 (1181)
||+|+.+..... ......||+.|||||++.++.++. .+|+ |||||+||||+| |+.||
T Consensus 229 FGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~--ksDV------------------wS~Gv~l~El~t~G~~Pf 288 (353)
T 4ase_A 229 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI--QSDV------------------WSFGVLLWEIFSLGASPY 288 (353)
T ss_dssp CGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCH--HHHH------------------HHHHHHHHHHTTTSCCSS
T ss_pred chhhhhcccCCCceeeccccccccccCHHHHhcCCCCC--cccE------------------eehHHHHHHHHhCCCCCC
Confidence 999987654322 223456899999999998765443 3444 999999999998 99999
Q ss_pred CCCCccc-ccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1027 KKKTSRA-LVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1027 ~~~~~~~-l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.+.+..+ +..... .....+..+++.+..++.+|++.+|..||++.+.
T Consensus 289 ~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~ei 338 (353)
T 4ase_A 289 PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 338 (353)
T ss_dssp TTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHH
Confidence 9876433 211000 1112234567789999999999999999965444
|
| >2k7n_A Peptidyl-prolyl CIS-trans isomerase-like 1; beta barrel, disorder-order transition, HOOK-like, mRNA processing, mRNA splicing, rotamase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=343.89 Aligned_cols=162 Identities=39% Similarity=0.693 Sum_probs=151.9
Q ss_pred CCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCCCC
Q psy14556 112 QEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFED 191 (1181)
Q Consensus 112 ~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~~d 191 (1181)
+..+.|+++|+.|+|+||||++.||+||+||++|| ++|| |+|+.||||+|+|||||||+. ++++++.++||.+|++
T Consensus 9 ~~~~~V~l~T~~G~I~ieL~~d~aP~tv~NF~~L~--~~g~-Ydg~~FhRVi~~F~iQgGd~~-~~g~gg~si~g~~f~d 84 (203)
T 2k7n_A 9 WQPPNVYLETSMGIIVLELYWKHAPKTCKNFAELA--RRGY-YNGTKFHRIIKDFMIQGGDPT-GTGRGGASIYGKQFED 84 (203)
T ss_dssp CCCSEEEEEESSCEEEEEECTTTCTTHHHHHHHHH--HHTC-GGGCEEEEEETTTEEEEECSS-SSSSCCCTTSCSCBCC
T ss_pred cCCCEEEEEeCCCcEEEEEccCCCcHHHHHHHHHH--hcCc-cCCCEEEEEeCCcEEEcCCCC-CCCCCCCccCCCcccc
Confidence 45678999999999999999999999999999999 6788 999999999999999999998 5889999999999999
Q ss_pred Cc-CccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCC-CCCCcccceEEeeecc
Q psy14556 192 EN-FTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGS-QSGKTSKKIVVANSDS 269 (1181)
Q Consensus 192 E~-~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t-~~g~P~~~V~I~~cGv 269 (1181)
|. ..++|+++|+|||||.++|+++|||||+++++|+||++|+|||+|++|||||++|+++++ .+++|.++|+|.+|++
T Consensus 85 E~~~~l~h~~~G~lsMAn~gpnsngSQFFIt~~~~~~LDg~~tVFG~VveGmdvv~kI~~~~t~~~~~P~~~V~I~~~~v 164 (203)
T 2k7n_A 85 ELHPDLKFTGAGILAMANAGPDTNGSQFFVTLAPTQWLDGKHTIFGRVCQGIGMVNRVGMVETNSQDRPVDDVKIIKAYP 164 (203)
T ss_dssp CCCCSSCCCSSCEEEEEESSTTCEEEEEEEESSCCCSSTTTSCEEEEEESCHHHHHHHHSCCEEETTEECCCCBEEEEEE
T ss_pred cccccccCCCCeEEEEeeCCCCCcccEEEEEcCCCCccCCCeeEEEEEEcCHHHHHHHHcCCcCCCCCcCCCeEEEEEEE
Confidence 98 489999999999999999999999999999999999999999999999999999999998 5689999999999999
Q ss_pred ccCCCCCC
Q psy14556 270 HSETDSQS 277 (1181)
Q Consensus 270 l~~~~~~p 277 (1181)
+..+....
T Consensus 165 ~~~~~s~~ 172 (203)
T 2k7n_A 165 SGGGGSGG 172 (203)
T ss_dssp CCCCCCCC
T ss_pred EecCCCCC
Confidence 98775443
|
| >1ihg_A Cyclophilin 40; ppiase immunophilin tetratricopeptide, isomerase; 1.80A {Bos taurus} SCOP: a.118.8.1 b.62.1.1 PDB: 1iip_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=373.89 Aligned_cols=172 Identities=55% Similarity=0.866 Sum_probs=159.7
Q ss_pred cCCcc-cccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCc--------cccCCEEEEe
Q psy14556 92 FPSSQ-MRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGF--------GFKDSTFHRV 162 (1181)
Q Consensus 92 ~~ss~-~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~--------~Y~g~~FhRV 162 (1181)
+|++. +|.||||++ +.+|+.|+|+||||++.||+||+||++||+|++|+ +|+|+.||||
T Consensus 9 ~~~~~~~~~v~~~~~------------~~~~~~G~i~~~l~~~~~P~t~~nf~~l~~~~~~~~~~~g~~~~y~~~~fhrv 76 (370)
T 1ihg_A 9 KPSNPSNPRVFFDVD------------IGGERVGRIVLELFADIVPKTAENFRALCTGEKGIGPTTGKPLHFKGCPFHRI 76 (370)
T ss_dssp SSSCTTSCEEEEEEE------------ETTEEEEEEEEEECTTTCHHHHHHHHHHHHCTTCBCTTTSSBSCCTTCBEEEE
T ss_pred CCCCCCCCeEEEEEE------------ECCEecccEEEEEcCCCCchHHHHHHHHcCCCcCcCccCCCcceeCCcEeEEE
Confidence 34443 889999986 56899999999999999999999999999986643 3999999999
Q ss_pred cCCceEeeCCCCCCCCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCH
Q psy14556 163 IPNFMCQGGDFTNHNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGL 242 (1181)
Q Consensus 163 ip~f~iQgGd~~~~~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~ 242 (1181)
||||||||||++.++|+||+++||.+|++|++.++|+++|+|||||+|||++|||||||++++|||||+|+|||+|++||
T Consensus 77 ~~~f~~q~Gd~~~~~g~g~~~~~~~~~~~e~~~~~~~~~g~l~ma~~~~~~~~sqffi~~~~~~~ld~~~~vfG~v~~g~ 156 (370)
T 1ihg_A 77 IKKFMIQGGDFSNQNGTGGESIYGEKFEDENFHYKHDKEGLLSMANAGSNTNGSQFFITTVPTPHLDGKHVVFGQVIKGM 156 (370)
T ss_dssp ETTTEEEECCTTTSSSSCCCBTTBSCBCCCCCCBCCCSTTEEEECCSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECH
T ss_pred ECCcEEECCCCCCCCCCCCCCCCCCCcCCCcCCcCCCCCeEEEEeeCCCCCCCceEEEeCCCCcccCCCceEEEEEecCH
Confidence 99999999999988999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCcccceEEeeeccccCCCC
Q psy14556 243 DVVKKLESMGSQSGKTSKKIVVANSDSHSETDS 275 (1181)
Q Consensus 243 dVL~kI~~~~t~~g~P~~~V~I~~cGvl~~~~~ 275 (1181)
+||++|++.++..++|..+|+|.+||++....+
T Consensus 157 ~v~~~i~~~~~~~~~P~~~v~I~~~g~l~~~~~ 189 (370)
T 1ihg_A 157 GVAKILENVEVKGEKPAKLCVIAECGELKEGDD 189 (370)
T ss_dssp HHHHHHHTSCEETTEESSCEEEEEEEEECTTCC
T ss_pred HHHHHHHcCCCCCCccceeEEEEEEEEeccCcc
Confidence 999999999986699999999999999976543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=364.56 Aligned_cols=243 Identities=21% Similarity=0.210 Sum_probs=178.2
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHH--HHHHHHHHhcCCCCeeeEccccccCC----cEEEEEeec
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPL--HEEIKLHSQLRHRNIVQYLGSVSEEG----YFKIFMEQV 884 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f--~rEi~IL~~L~HPNIVkl~g~~~d~~----~l~LVmEy~ 884 (1181)
++||+|+||+||+|++ +|+.||||+++... .+.+ ..|+..+.+++|||||++++++.+++ .+|||||||
T Consensus 9 ~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~ 83 (303)
T 3hmm_A 9 ESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEECSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCC
Confidence 4799999999999987 68899999996442 2333 34556667889999999999997653 589999999
Q ss_pred CCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhcccc--------ceecccCCCCCcccccCCCeeeeecCCccccc
Q psy14556 885 PGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ--------KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956 (1181)
Q Consensus 885 ~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~--------gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l 956 (1181)
++|+|.++++.. .+++..+..++.|++.||+|||++ +||||||||+|||++. ++.+||+|||+|+..
T Consensus 84 ~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~-~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 84 EHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRH 158 (303)
T ss_dssp TTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECT-TSCEEECCCTTCEEE
T ss_pred CCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECC-CCCEEEEeCCCCccc
Confidence 999999999754 578899999999999999999987 9999999999999998 899999999999876
Q ss_pred ccCCC----CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc
Q psy14556 957 AGLCP----SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR 1032 (1181)
Q Consensus 957 ~~~~~----~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~ 1032 (1181)
..... .....+||+.|||||++.+...... ..++...|.|||||+||||+||..||......
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~--------------~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~ 224 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH--------------FESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTC--------------HHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCC
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccC--------------CccChhHhhhhHHHHHHHHHHCCCCCCccccc
Confidence 54322 1223579999999999975421111 11223334499999999999998877654332
Q ss_pred cccCCC--------------CCCCCCCCC---------CCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1033 ALVAPP--------------QISRSVSVP---------GPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1033 ~l~~~~--------------~ip~~l~~~---------~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
...... .......++ .+..+..++.+|++.+|..||+ +.+....+
T Consensus 225 ~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~ei~~~L 292 (303)
T 3hmm_A 225 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT-ALRIKKTL 292 (303)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCC-HHHHHHHH
T ss_pred cccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcC-HHHHHHHH
Confidence 210000 001111122 2235678999999999999995 44433333
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=376.58 Aligned_cols=243 Identities=22% Similarity=0.316 Sum_probs=192.1
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEccccc------cCCc
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVS------EEGY 876 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~------d~~~ 876 (1181)
+|.+. ++||+|+||+||+|++..+++.||||++++.... ..+.+.+|+.+|+.++|||||++++++. +.+.
T Consensus 55 ~Y~~~-~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 55 EYEII-ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SEEEE-EEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CeEEE-EEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 34444 4799999999999999999999999999765432 2467889999999999999999999865 3467
Q ss_pred EEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccccc
Q psy14556 877 FKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956 (1181)
Q Consensus 877 l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l 956 (1181)
+|||||||+ |+|.+++... ..+++..++.++.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+.+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~-~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNE-NCELKIGDFGMARGL 208 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT-TCCEEECCCTTCBCC
T ss_pred EEEEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCC-CCCEEEeecceeeec
Confidence 999999995 6798888743 46889999999999999999999999999999999999998 899999999999876
Q ss_pred ccC----CCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc
Q psy14556 957 AGL----CPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR 1032 (1181)
Q Consensus 957 ~~~----~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~ 1032 (1181)
... .....+.+||+.|||||++.+.. .++..+|+ ||+||++|||++|++||.+.+..
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~-~~~~~~Di------------------WSlG~il~ell~G~~pF~g~~~~ 269 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLH-EYTQAIDL------------------WSVGCIFGEMLARRQLFPGKNYV 269 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCS-CCCTHHHH------------------HHHHHHHHHHHHTSCSSCCSSHH
T ss_pred ccCccccccccccceeChHhcCHHHhcCCC-CCCChhhe------------------ehhHHHHHHHHHCCCCCCCCCHH
Confidence 432 12344578999999999987543 35566666 99999999999999999987754
Q ss_pred cccCC-------C------------------CCCCCC-------CCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1033 ALVAP-------P------------------QISRSV-------SVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1033 ~l~~~-------~------------------~ip~~l-------~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
+.... + .++... .+..+.....++.+|+..||.+|++..+
T Consensus 270 ~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e 341 (398)
T 4b99_A 270 HQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAA 341 (398)
T ss_dssp HHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHH
Confidence 32100 0 011110 1223455667999999999999996433
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=390.26 Aligned_cols=247 Identities=23% Similarity=0.284 Sum_probs=207.0
Q ss_pred hhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEe
Q psy14556 803 LYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 803 ~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmE 882 (1181)
.++|.+.+ +||+|+||+||+|.++.+++.||+|++........+.+.+|+.+|+.++||||++++++|.+.+.+|||||
T Consensus 156 l~~Y~i~~-~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 156 LDHYDIHE-ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GGTEEEEE-EEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccccEEEE-EEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 34555544 69999999999999999999999999987766566789999999999999999999999999999999999
Q ss_pred ecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccC-CCeeeeecCCcccccccCCC
Q psy14556 883 QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTY-SGVVKISDFGTSKRLAGLCP 961 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~-~g~vKLiDFGlAk~l~~~~~ 961 (1181)
||+||+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.. .+.+||+|||+|+.+... .
T Consensus 235 ~~~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-~ 311 (573)
T 3uto_A 235 FMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-Q 311 (573)
T ss_dssp CCCCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-S
T ss_pred ecCCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-C
Confidence 99999999988643 2357899999999999999999999999999999999999852 479999999999887543 3
Q ss_pred CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc-----C
Q psy14556 962 SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV-----A 1036 (1181)
Q Consensus 962 ~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~-----~ 1036 (1181)
.....+||+.|||||++.+.. ++..+|+ ||+||++|+|++|..||.+.+..++. .
T Consensus 312 ~~~~~~GT~~y~APEv~~~~~--y~~~~Di------------------WSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~ 371 (573)
T 3uto_A 312 SVKVTTGTAEFAAPEVAEGKP--VGYYTDM------------------WSVGVLSYILLSGLSPFGGENDDETLRNVKSC 371 (573)
T ss_dssp EEEEECSSGGGCCHHHHTTCC--BCHHHHH------------------HHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT
T ss_pred ceeeeEECccccCHHHhCCCC--CCcHHHH------------------HHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhC
Confidence 344567999999999998654 4445555 99999999999999999998875532 2
Q ss_pred CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1037 PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1037 ~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
...++......++..+..++.+||..||.+|++..+.
T Consensus 372 ~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~ 408 (573)
T 3uto_A 372 DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 408 (573)
T ss_dssp CCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 2334444445667788889999999999999964443
|
| >2hq6_A Serologically defined colon cancer antigen 10; protein folding, peptidyl-prolyl CIS-trans isomerase, struct genomics; 1.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=334.28 Aligned_cols=161 Identities=34% Similarity=0.574 Sum_probs=148.7
Q ss_pred ccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCC
Q psy14556 110 RDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKF 189 (1181)
Q Consensus 110 ~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~ 189 (1181)
.+++...|.++|+.|+|+||||++.||+||+||++|| +.|| |+|+.||||+|+|||||||+. ++|+||+++||.+|
T Consensus 20 ~~~~~~~V~l~T~~G~I~ieL~~~~aP~tv~NF~~L~--~~g~-Y~g~~FhRvi~~f~iQgGd~~-~~g~gg~si~g~~~ 95 (185)
T 2hq6_A 20 EPPTNGKVLLKTTAGDIDIELWSKEAPKACRNFIQLC--LEAY-YDNTIFHRVVPGFIVQGGDPT-GTGSGGESIYGAPF 95 (185)
T ss_dssp CCCCBCEEEEEETTEEEEEEEBTTTCHHHHHHHHHHH--HTTT-TTTEECCEEETTTEEEECCTT-SSSSCCCCTTSSCB
T ss_pred CCCCCCEEEEEeCCccEEEEEeCCCCcHHHHHHHHHh--hcCc-cCCCEEEEEECCCEEEcCCCC-CCCCCCCcccCCcc
Confidence 3455677899999999999999999999999999999 6788 999999999999999999997 68999999999999
Q ss_pred CCCcC-ccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHH--HHHHhCCC-CCCCcccceEEe
Q psy14556 190 EDENF-TLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVV--KKLESMGS-QSGKTSKKIVVA 265 (1181)
Q Consensus 190 ~dE~~-~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL--~kI~~~~t-~~g~P~~~V~I~ 265 (1181)
++|.. .++|+++|+|||||+++|++||||||+++++|+||++|+|||+|+ |++|+ ++|+++++ .+++|..+|+|.
T Consensus 96 ~dE~~~~l~h~~~G~lsMA~~g~~s~gSQFFIt~~~~~~LDg~~tVFG~V~-G~~v~~~~~i~~~~~~~~~~P~~~v~I~ 174 (185)
T 2hq6_A 96 KDEFHSRLRFNRRGLVAMANAGSHDNGSQFFFTLGRADELNNKHTIFGKVT-GDTVYNMLRLSEVDIDDDERPHNPHKIK 174 (185)
T ss_dssp CCCCBTTBCSCSSSEEEECCSSTTCBCSCEEEESSCCGGGTTTSCEEEEEC-GGGHHHHHHTTCSCBCTTSCBSSCCEEE
T ss_pred ccccccCcccCCCeEEEEccCCCCCccceEEEECCCCCccCCCceEEEEEE-eCeeehhhHHhhCCcCCCCCCCCCeEEE
Confidence 99986 689999999999999999999999999999999999999999999 88775 67888888 678999999999
Q ss_pred eeccccCCCC
Q psy14556 266 NSDSHSETDS 275 (1181)
Q Consensus 266 ~cGvl~~~~~ 275 (1181)
+|+++.+|.+
T Consensus 175 ~~~v~~~Pf~ 184 (185)
T 2hq6_A 175 SCEVLFNPFD 184 (185)
T ss_dssp EEEEEECTTC
T ss_pred EEEEeCCCCC
Confidence 9999987754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=393.29 Aligned_cols=240 Identities=24% Similarity=0.321 Sum_probs=193.8
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHH---HHHHHhcCCCCeeeEccccccCCcEE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEE---IKLHSQLRHRNIVQYLGSVSEEGYFK 878 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rE---i~IL~~L~HPNIVkl~g~~~d~~~l~ 878 (1181)
+|.+.+ +||+|+||+||+|+++.+++.||||++.+.. ......+.+| +.+++.++|||||+++++|.+.+.+|
T Consensus 190 df~i~k-~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 190 DFSVHR-IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GEEEEE-EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HeEEEE-EEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 344443 7999999999999999999999999996542 1223334444 56667789999999999999999999
Q ss_pred EEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccccccc
Q psy14556 879 IFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 958 (1181)
Q Consensus 879 LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~ 958 (1181)
+|||||+||+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+. +|++||+|||+|+.+..
T Consensus 269 lVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~-~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE-HGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECT-TSCEEECCCTTCEECSS
T ss_pred EEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeC-CCCEEecccceeeecCC
Confidence 999999999999999854 35789999999999999999999999999999999999998 89999999999987754
Q ss_pred CCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc---c
Q psy14556 959 LCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL---V 1035 (1181)
Q Consensus 959 ~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l---~ 1035 (1181)
....+.+||+.|||||++.++ ..|+..+|+ ||+||+||||++|.+||.+.+.... .
T Consensus 345 --~~~~t~~GTp~YmAPEvl~~~-~~y~~~vDi------------------WSLGvilYEmLtG~~PF~~~~~~~~~~i~ 403 (689)
T 3v5w_A 345 --KKPHASVGTHGYMAPEVLQKG-VAYDSSADW------------------FSLGCMLFKLLRGHSPFRQHKTKDKHEID 403 (689)
T ss_dssp --CCCCSCCSCGGGCCHHHHSTT-CCCCTHHHH------------------HHHHHHHHHHHHSSCTTCGGGCCCHHHHH
T ss_pred --CCCCCccCCcCccCHHHHhCC-CCCCcHHHH------------------HHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 334567899999999999643 245556665 9999999999999999987654321 1
Q ss_pred CC-CCCCCCCCCCCCcchHHhhccCCCCCCCCCchh
Q psy14556 1036 AP-PQISRSVSVPGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1036 ~~-~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
.. ...+...+...+..+..++.+++.+||.+|+..
T Consensus 404 ~~i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~ 439 (689)
T 3v5w_A 404 RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGC 439 (689)
T ss_dssp HHHHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTC
T ss_pred HhhcCCCCCCCccCCHHHHHHHHHHccCCHhHCCCC
Confidence 10 011122233466778889999999999999974
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=362.89 Aligned_cols=199 Identities=22% Similarity=0.268 Sum_probs=166.4
Q ss_pred hhcccCceeecccCceEEEEEEEc---CCCeEEEEEEecCCCCCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEE
Q psy14556 804 YLFALNRIELGKGSYGVVYAAREL---DRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKI 879 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~---~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~L 879 (1181)
+.|.+.+ +||+|+||+||+|+++ .+++.||+|.+.+. ....++.+|+.+|+.+ +||||+++++++.+.+++|+
T Consensus 21 ~~Y~i~~-~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l 97 (361)
T 4f9c_A 21 NVFKIED-KIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI 97 (361)
T ss_dssp GTCEEEE-EEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred CcEEEEE-EEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence 4455544 7999999999999875 46789999998654 3456788999999998 69999999999999999999
Q ss_pred EEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccC
Q psy14556 880 FMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGL 959 (1181)
Q Consensus 880 VmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~ 959 (1181)
|||||+||+|.++++ .+++..++.++.||+.||+|||++||+||||||+|||++.+.+.+||+|||+|+.....
T Consensus 98 vmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 98 AMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 999999999999985 47889999999999999999999999999999999999874589999999999765432
Q ss_pred C----------------------------CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHH
Q psy14556 960 C----------------------------PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVF 1011 (1181)
Q Consensus 960 ~----------------------------~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwS 1011 (1181)
. ....+.+||+.|+|||++.+. ..++..+|+ ||
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~Di------------------WS 232 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDM------------------WS 232 (361)
T ss_dssp SCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHH------------------HH
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccch------------------hh
Confidence 1 112345799999999999754 345666666 99
Q ss_pred HHHHHHHHHhCCCCCCCCC
Q psy14556 1012 LCVIISQLLVLTAALKKKT 1030 (1181)
Q Consensus 1012 LGvILyELLTGk~PF~~~~ 1030 (1181)
+||++|||++|+.||...+
T Consensus 233 lG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 233 AGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp HHHHHHHHHHTCSSSSCCS
T ss_pred hHHHHHHHHHCCCCCCCCC
Confidence 9999999999999996544
|
| >3bkp_A Cyclophilin; malaria, isomerase, structural GENO structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=343.43 Aligned_cols=163 Identities=29% Similarity=0.489 Sum_probs=148.7
Q ss_pred cCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccC--CCC
Q psy14556 111 DQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIY--GNK 188 (1181)
Q Consensus 111 ~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~--g~~ 188 (1181)
++....|++.|+.|+|+||||++.||+||+||++|| +.|| |+|+.||||+|+|||||||++ ++|+||.++| |.+
T Consensus 18 p~~~~~V~l~T~~G~I~ieL~~d~aP~tv~NF~~L~--~~g~-Ydgt~FhRVi~~FmiQgGdp~-~~G~Gg~si~~~g~~ 93 (232)
T 3bkp_A 18 GSTRGKVVLHTSLGDLDVELWARECPLACRNFVQLC--LEGY-YVNTIFHRVVKDFIVQGGDPT-GTGRGGADTTFDGKP 93 (232)
T ss_dssp CSCBCEEEEEETTEEEEEEEBTTTCHHHHHHHHHHH--HHTT-TTTCBEEEEETTTEEEECCTT-SSSSCCCCCTTTTCC
T ss_pred CCCCCEEEEEECCCcEEEEEcCCCCcHHHHHHHHHh--hcCc-cCCCEEEEEeCCCEEEcCCCC-CCCCCCCccccCCCc
Confidence 445678899999999999999999999999999999 6788 999999999999999999998 6899999999 999
Q ss_pred CCCCcC-ccccCCCceEEeecCCC--------------CCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHH--HHHHHhC
Q psy14556 189 FEDENF-TLKHTGPGILSMANAGP--------------NTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDV--VKKLESM 251 (1181)
Q Consensus 189 ~~dE~~-~l~h~~~G~Lsma~~g~--------------nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dV--L~kI~~~ 251 (1181)
|++|.. .++|+.+|+||||++++ +++|||||||++++|+||++|+|||+|+ ||+| |++|+++
T Consensus 94 f~dE~~~~l~h~~~G~lsMA~~g~~~~~~~n~e~g~~~~sngSQFFIt~~~~p~LDg~~tVFG~Vv-g~~v~~v~kI~~~ 172 (232)
T 3bkp_A 94 FDVETHPRLKFRYRGLVGVANLGRSSKDAENDERGRSLGTNGNQFFITLARADVLNNAYTLFGKVT-GHTLYNLMKFNDL 172 (232)
T ss_dssp BCCCCCTTCCCCSTTEEEECCCC----------------CBCSCEEEESSCCGGGTTTSCEEEEEC-GGGHHHHHHHTTS
T ss_pred cCCccccCcCcCCCeEEEEeccCCcccccccccccccCCCcCCEEEEECCCCcccCCCccEEEEEE-eCchHHHHHHHcC
Confidence 999976 78999999999999997 6999999999999999999999999999 7765 8999999
Q ss_pred CC-CCCCcccceEEeeeccccCCCCCCc
Q psy14556 252 GS-QSGKTSKKIVVANSDSHSETDSQSS 278 (1181)
Q Consensus 252 ~t-~~g~P~~~V~I~~cGvl~~~~~~p~ 278 (1181)
++ .+++|..+|+|.+|+++.++.+...
T Consensus 173 ~t~~~~~P~~~i~I~~~~vl~dPf~d~~ 200 (232)
T 3bkp_A 173 EVGKEDRPMTPPFIKSVDVLWNPFEDLV 200 (232)
T ss_dssp CBCGGGCBSSCCBEEEEEEEECCCTTCC
T ss_pred CcCCCCCcCCCeEEEEEEEEcCChhhhh
Confidence 98 5789999999999999998776553
|
| >1lop_A Cyclophilin A; rotamase, isomerase-isomerase inhibitor complex; HET: NIT; 1.80A {Escherichia coli} SCOP: b.62.1.1 PDB: 2nul_A 2rs4_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=322.76 Aligned_cols=148 Identities=30% Similarity=0.537 Sum_probs=135.6
Q ss_pred EEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCCCCCcCc-
Q psy14556 117 TNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFEDENFT- 195 (1181)
Q Consensus 117 vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~~dE~~~- 195 (1181)
|+++|+.|+|+||||++.||+||+||++|| ++|| |+|+.||||+|+|||||||++.+. |.+++|.+|++|...
T Consensus 2 v~l~T~~G~i~ieL~~~~aP~t~~NF~~L~--~~g~-Y~g~~FhRvi~~f~iQgGd~~~~~---g~~~~g~~~~dE~~~~ 75 (164)
T 1lop_A 2 VTFHTNHGDIVIKTFDDKAPETVKNFLDYC--REGF-YNNTIFHRVINGFMIQGGGFEPGM---KQKATKEPIKNEANNG 75 (164)
T ss_dssp EEEEETTEEEEEEECTTTSHHHHHHHHHHH--HTTT-TTTEECCEEETTTEEEESSEETTT---EECCCCCCBCCCCCSS
T ss_pred EEEEeCCCCEEEEEeCCCCcHHHHHHHHHH--hcCC-CCCCEEEEEeCCceEecCCcccCC---CcCCCCCccccccccc
Confidence 678999999999999999999999999999 7888 999999999999999999997433 566789999999865
Q ss_pred cccCCCceEEeec-CCCCCCcceEEEEcCCCCCCCCC--------CeEEEEEEcCHHHHHHHHhCCCC-----CCCcccc
Q psy14556 196 LKHTGPGILSMAN-AGPNTNGSQFFITTVKTAWLDNR--------HVVFGSVVEGLDVVKKLESMGSQ-----SGKTSKK 261 (1181)
Q Consensus 196 l~h~~~G~Lsma~-~g~nt~gSQFfItl~~~p~LDg~--------~vVFGrVieG~dVL~kI~~~~t~-----~g~P~~~ 261 (1181)
++| .+|+||||+ .+||++||||||+++++||||++ |+|||+|++|||||++|+++++. +++|.++
T Consensus 76 l~~-~~G~lsmA~~~~p~s~gSQFfI~~~~~~~Ld~~~~~~~~~~~tvFG~Vv~G~dvv~~I~~~~t~~~~~~~~~P~~~ 154 (164)
T 1lop_A 76 LKN-TRGTLAMARTQAPHSATAQFFINVVDNDFLNFSGESLQGWGYCVFAEVVDGMDEVDKIKGVATGRSGMHQDVPKED 154 (164)
T ss_dssp CCC-CTTEEEECCCSSTTCBCSCEEEESSCCGGGSCCSSSTTTSCCCEEEEEEECHHHHHHHHTSCEEEETTEEEEESSC
T ss_pred ccc-CccEEEEeecCCCCCccceEEEEcCCccccCCccccccCCceEEEEEEecCHHHHHHHHhCCcCCccccCCCcCCC
Confidence 566 599999997 47999999999999999999998 99999999999999999999884 4799999
Q ss_pred eEEeeecccc
Q psy14556 262 IVVANSDSHS 271 (1181)
Q Consensus 262 V~I~~cGvl~ 271 (1181)
|+|.+|++++
T Consensus 155 v~I~~~~v~~ 164 (164)
T 1lop_A 155 VIIESVTVSE 164 (164)
T ss_dssp CEEEEEEECC
T ss_pred eEEEEEEEeC
Confidence 9999999873
|
| >1v9t_A Cyclophilin B; beta barrel, isomerase-isomerase inhibitor complex; HET: NIT; 1.70A {Escherichia coli} SCOP: b.62.1.1 PDB: 1j2a_A* 1vai_A* 1clh_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=320.12 Aligned_cols=152 Identities=30% Similarity=0.496 Sum_probs=137.2
Q ss_pred CcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCCCCCc
Q psy14556 114 GMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFEDEN 193 (1181)
Q Consensus 114 ~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~~dE~ 193 (1181)
...|.++|+.|+|+||||++.||+||+||++|| ++|| |+|+.||||+|+|||||||++... +...++.+|++|.
T Consensus 4 ~~~v~~~t~~G~i~ieL~~~~aP~t~~NF~~L~--~~g~-Y~g~~FhRvi~~f~iQgGd~~~~~---~~~~~g~~~~dE~ 77 (166)
T 1v9t_A 4 DPHVLLTTSAGNIELELDKQKAPVSVQNFVDYV--NSGF-YNNTTFHRVIPGFMIQGGGFTEQM---QQKKPNPPIKNEA 77 (166)
T ss_dssp SCEEEEEETTEEEEEEECTTTCHHHHHHHHHHH--HTTT-TTTCBEEEEETTTEEEESSBCTTC---CBCCCCCCBCCCG
T ss_pred CeEEEEEeCCccEEEEEcCCCCcHHHHHHHHHh--ccCC-CCCCEEEEEECCcEEEcCCcCcCC---CCCCCCCcccccc
Confidence 457889999999999999999999999999999 7888 999999999999999999997543 2334688899998
Q ss_pred CccccCCCceEEeecC-CCCCCcceEEEEcCCCCCCCCC-----CeEEEEEEcCHHHHHHHHhCCCC-----CCCcccce
Q psy14556 194 FTLKHTGPGILSMANA-GPNTNGSQFFITTVKTAWLDNR-----HVVFGSVVEGLDVVKKLESMGSQ-----SGKTSKKI 262 (1181)
Q Consensus 194 ~~l~h~~~G~Lsma~~-g~nt~gSQFfItl~~~p~LDg~-----~vVFGrVieG~dVL~kI~~~~t~-----~g~P~~~V 262 (1181)
....|+.+|+|||||+ +||++|||||||++++||||++ |+|||+|++|||||++|+++++. +++|.++|
T Consensus 78 ~~~l~~~~G~lsmA~~~~p~t~gSQFfI~~~~~~~Ld~~~~~~~~tvFG~Vv~G~dvv~~I~~~~~~~~~~~~~~P~~~v 157 (166)
T 1v9t_A 78 DNGLRNTRGTIAMARTADKDSATSQFFINVADNAFLDHGQRDFGYAVFGKVVKGMDVADKISQVPTHDVGPYQNVPSKPV 157 (166)
T ss_dssp GGSCCCCTTEEEECCCSSTTCBCSCEEEESSCCGGGSCCSSCCCCCEEEEEEECHHHHHHHHTSCEEEETTEEEEESSCC
T ss_pred cccccCCceEEEEeecCCCCCccceEEEEeCCccccCCccCcCCeeEEEEEecCHHHHHHHHhCCCCCCCccCCCcCCCe
Confidence 7666677999999997 6999999999999999999998 99999999999999999999984 37899999
Q ss_pred EEeeecccc
Q psy14556 263 VVANSDSHS 271 (1181)
Q Consensus 263 ~I~~cGvl~ 271 (1181)
+|.+|++++
T Consensus 158 ~I~~~~v~~ 166 (166)
T 1v9t_A 158 VILSATVLP 166 (166)
T ss_dssp BEEEEEECC
T ss_pred EEEEEEEeC
Confidence 999999863
|
| >3s6m_A Peptidyl-prolyl CIS-trans isomerase; seattle structural genomics center for infectious disease; 1.65A {Burkholderia pseudomallei} SCOP: b.62.1.1 PDB: 3t1u_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=319.29 Aligned_cols=151 Identities=28% Similarity=0.464 Sum_probs=136.2
Q ss_pred CcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCCCCCc
Q psy14556 114 GMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFEDEN 193 (1181)
Q Consensus 114 ~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~~dE~ 193 (1181)
+|.|+++|+.|+|+||||++.||+||+||++|| ++|| |+|+.||||+|+|||||||++.+. +.+.++.++++|.
T Consensus 3 ~~~v~l~T~~G~i~ieL~~~~aP~t~~NF~~L~--~~g~-Y~g~~FhRvi~~f~iQgGd~~~~~---~~~~~~~~~~~E~ 76 (167)
T 3s6m_A 3 GSMVELHTNHGVIKLELDEAKAPKTVENFLNYV--KKGH-YDGTIFHRVINGFMIQGGGFEPGL---KQKPTDAPIANEA 76 (167)
T ss_dssp CCEEEEEETTEEEEEEECTTTCHHHHHHHHHHH--HHTT-TTTEECCEEETTTEEEESSEETTT---EECCCCCCBCCCG
T ss_pred CcEEEEEeCCceEEEEEeCCCCcHHHHHHHHHh--hhcc-cCCCEeEEecCCcEEEeccccCCC---CCCCCCCccCCcc
Confidence 578999999999999999999999999999999 6788 999999999999999999997543 3345678899986
Q ss_pred CccccCCCceEEeec-CCCCCCcceEEEEcCCCCCCCCC--------CeEEEEEEcCHHHHHHHHhCCCC-----CCCcc
Q psy14556 194 FTLKHTGPGILSMAN-AGPNTNGSQFFITTVKTAWLDNR--------HVVFGSVVEGLDVVKKLESMGSQ-----SGKTS 259 (1181)
Q Consensus 194 ~~l~h~~~G~Lsma~-~g~nt~gSQFfItl~~~p~LDg~--------~vVFGrVieG~dVL~kI~~~~t~-----~g~P~ 259 (1181)
....++.+|+||||| .+||++||||||++.+++|||++ |+|||+|++|||||++|++++++ +++|.
T Consensus 77 ~~~l~~~~G~lsmA~~~~p~t~gSQFfI~~~~~~~Ld~~~~~~~~~~~~VFG~Vv~G~dvv~~I~~~~t~~~~~~~~~P~ 156 (167)
T 3s6m_A 77 NNGLKNDTYTIAMARTNDPHSATAQFFINVNDNEFLNHSSPTPQGWGYAVFGKVVEGQDIVDKIKAVKTGSKGFHQDVPN 156 (167)
T ss_dssp GGCCCCCTTEEEECCCSSTTCBCSCEEEESSCCGGGSCCSSSTTTCCCCEEEEEEECHHHHHHHTTSCBBC---CBTCBS
T ss_pred cccccCCccEEEEecCCCCCCccceEEEEcCCchhcCCcccccCCCCceEEEEEEcCHHHHHHHHcCCcCCCcccCCCcC
Confidence 544445799999999 67999999999999999999998 99999999999999999999984 47999
Q ss_pred cceEEeeeccc
Q psy14556 260 KKIVVANSDSH 270 (1181)
Q Consensus 260 ~~V~I~~cGvl 270 (1181)
++|+|.+|.++
T Consensus 157 ~~v~I~~~~il 167 (167)
T 3s6m_A 157 DDVVIEKAVVV 167 (167)
T ss_dssp SCCEEEEEEEC
T ss_pred CCeEEEEEEEC
Confidence 99999999875
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=339.96 Aligned_cols=238 Identities=22% Similarity=0.325 Sum_probs=201.3
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
++||+|+||+||+|.+..+++.||+|++........+.+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (297)
T 3fxz_A 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105 (297)
T ss_dssp EEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHH
T ss_pred eeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHH
Confidence 47999999999999999999999999997776667788999999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCc
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL 970 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~ 970 (1181)
+++... .+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||++..............||+
T Consensus 106 ~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 180 (297)
T 3fxz_A 106 DVVTET----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQITPEQSKRSTMVGTP 180 (297)
T ss_dssp HHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TCCEEECCCTTCEECCSTTCCBCCCCSCG
T ss_pred HHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECC-CCCEEEeeCCCceecCCcccccCCccCCc
Confidence 999754 5789999999999999999999999999999999999988 89999999999987765555555667999
Q ss_pred cccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC----CCCCCCCCCC
Q psy14556 971 QYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA----PPQISRSVSV 1046 (1181)
Q Consensus 971 ~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~----~~~ip~~l~~ 1046 (1181)
.|+|||++.+..++ ...|+ ||+|+++|+|++|+.||.+.+...... ........+.
T Consensus 181 ~y~aPE~~~~~~~~--~~~Di------------------wslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (297)
T 3fxz_A 181 YWMAPEVVTRKAYG--PKVDI------------------WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE 240 (297)
T ss_dssp GGCCHHHHHCSCBC--THHHH------------------HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGG
T ss_pred CccChhhhcCCCCC--cHHHH------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCcc
Confidence 99999999866443 33444 999999999999999998876543211 0111111223
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
..+..+..++.+|++.||..||+..+.
T Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~el 267 (297)
T 3fxz_A 241 KLSAIFRDFLNRCLEMDVEKRGSAKEL 267 (297)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHH
Confidence 467778899999999999999975544
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=338.34 Aligned_cols=247 Identities=25% Similarity=0.357 Sum_probs=202.7
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC---hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD---VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~---~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
++||+|+||.||+|++..+++.||+|.+....... .+.+.+|+.++++++||||+++++++.+.+..++||||++|+
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~ 96 (294)
T 4eqm_A 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGP 96 (294)
T ss_dssp EEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred EEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCC
Confidence 47999999999999999999999999986554333 467889999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC-CCCccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC-PSAETF 966 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~-~~~~t~ 966 (1181)
+|.+++... ..+++..++.++.|++.||+|||++||+||||||+||+++. ++.+||+|||+++...... ......
T Consensus 97 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~ 172 (294)
T 4eqm_A 97 TLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDS-NKTLKIFDFGIAKALSETSLTQTNHV 172 (294)
T ss_dssp BHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TSCEEECCCSSSTTC-----------
T ss_pred CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC-CCCEEEEeCCCccccccccccccCcc
Confidence 999999754 35789999999999999999999999999999999999988 8999999999998765432 122345
Q ss_pred cCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc------CCCCC
Q psy14556 967 TGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV------APPQI 1040 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~------~~~~i 1040 (1181)
.||+.|+|||++.+...+..+ |+ ||+|+++|+|++|+.||.+.+..... ..+..
T Consensus 173 ~gt~~y~aPE~~~~~~~~~~~--Di------------------~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 232 (294)
T 4eqm_A 173 LGTVQYFSPEQAKGEATDECT--DI------------------YSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNV 232 (294)
T ss_dssp --CCSSCCHHHHHTCCCCTTH--HH------------------HHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCH
T ss_pred ccCccccCHhHhcCCCCCchH--hH------------------HHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCc
Confidence 699999999999866544333 33 99999999999999999987764421 11222
Q ss_pred CCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcccC
Q psy14556 1041 SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGNN 1081 (1181)
Q Consensus 1041 p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~~ 1081 (1181)
+.......+..+..++.+|++++|..||++++++...+...
T Consensus 233 ~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 233 TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 23345667889999999999999999999999988888774
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=345.94 Aligned_cols=240 Identities=24% Similarity=0.309 Sum_probs=198.8
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCC---CCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEK---NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~---~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.+||+|+||+||+|++..+++.||+|++++. .....+.+.+|+.+++.++||||+++++++.+.+.+|+||||++||
T Consensus 11 ~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg 90 (337)
T 1o6l_A 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 90 (337)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 3699999999999999999999999999654 2345677899999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++............+
T Consensus 91 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-~g~vkL~DFG~a~~~~~~~~~~~~~~ 166 (337)
T 1o6l_A 91 ELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDGATMKTFC 166 (337)
T ss_dssp BHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT-TSCEEECCCTTCBCSCCTTCCBCCCE
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECC-CCCEEEeeccchhhcccCCCcccccc
Confidence 999998754 35789999999999999999999999999999999999988 89999999999986544444455678
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-CCCCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-ISRSVSV 1046 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-ip~~l~~ 1046 (1181)
||+.|+|||++.+..+ +..+|+ ||+||++|||++|+.||.+.+...+...+. -....+.
T Consensus 167 gt~~y~aPE~~~~~~~--~~~~Di------------------wslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~ 226 (337)
T 1o6l_A 167 GTPEYLAPEVLEDNDY--GRAVDW------------------WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR 226 (337)
T ss_dssp ECGGGCCGGGGSSSCB--CTTHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT
T ss_pred cChhhCChhhhcCCCC--Cchhhc------------------ccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 9999999999976543 344444 999999999999999999877654322111 0111223
Q ss_pred CCCcchHHhhccCCCCCCCCCc----hhHHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRH----ISVNTN 1074 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp----~s~~~~ 1074 (1181)
..+..+..++.+|+..+|.+|+ .++.+.
T Consensus 227 ~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei 258 (337)
T 1o6l_A 227 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV 258 (337)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHH
T ss_pred CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHH
Confidence 4677888899999999999998 355553
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=332.10 Aligned_cols=241 Identities=21% Similarity=0.317 Sum_probs=198.4
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
.++||+|+||+||+|.+..+++.||+|.+........+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 15 ~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 94 (310)
T 3s95_A 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL 94 (310)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred cceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcH
Confidence 34799999999999999999999999999766555677899999999999999999999999999999999999999999
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCC------
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA------ 963 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~------ 963 (1181)
.+++... ...+++..++.++.|++.||+|||++||+||||||+||+++. ++.+||+|||+++.........
T Consensus 95 ~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 171 (310)
T 3s95_A 95 RGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRE-NKNVVVADFGLARLMVDEKTQPEGLRSL 171 (310)
T ss_dssp HHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECT-TSCEEECCCTTCEECC------------
T ss_pred HHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECC-CCCEEEeecccceecccccccccccccc
Confidence 9999853 345789999999999999999999999999999999999988 8999999999998764332211
Q ss_pred --------ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc
Q psy14556 964 --------ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV 1035 (1181)
Q Consensus 964 --------~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~ 1035 (1181)
....||+.|+|||++.+..++.. .|+ ||+|+++|+|++|..||.........
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~Di------------------~slG~~l~el~~g~~~~~~~~~~~~~ 231 (310)
T 3s95_A 172 KKPDRKKRYTVVGNPYWMAPEMINGRSYDEK--VDV------------------FSFGIVLCEIIGRVNADPDYLPRTMD 231 (310)
T ss_dssp --------CCCCSCGGGCCHHHHTTCCCCTH--HHH------------------HHHHHHHHHHHHTCCSSTTTSCBCTT
T ss_pred cccccccccccCCCcceeCHHHhcCCCCCcH--HHH------------------HHHHHHHHHHhcCCCCCcchhhhHHH
Confidence 14569999999999976544333 333 99999999999999999876554332
Q ss_pred CCCC----CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1036 APPQ----ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1036 ~~~~----ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.... .....+...+..+..++.+|++.+|..||+..+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l 273 (310)
T 3s95_A 232 FGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKL 273 (310)
T ss_dssp SSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 2111 2223345678889999999999999999975443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=337.20 Aligned_cols=246 Identities=23% Similarity=0.318 Sum_probs=194.3
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEe
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmE 882 (1181)
..|.+.+ +||+|+||+||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 7 ~~y~i~~-~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 7 EDWDLVQ-TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TCEEEEE-EEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhceeee-EEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 3444444 69999999999999999999999999965533 234678999999999999999999999999999999999
Q ss_pred ecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC--
Q psy14556 883 QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC-- 960 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~-- 960 (1181)
|+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 86 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-TCCEEECCCTTCEECEETTEE
T ss_pred cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeC-CCCEEEEEeeccceeccCCcc
Confidence 99999999999743 45889999999999999999999999999999999999988 8999999999998654321
Q ss_pred CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC----
Q psy14556 961 PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA---- 1036 (1181)
Q Consensus 961 ~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~---- 1036 (1181)
.......||+.|+|||++.+... .+...|+ ||+|+++|+|++|+.||.+........
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~~Di------------------wslG~il~~ll~g~~pf~~~~~~~~~~~~~~ 222 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREF-HAEPVDV------------------WSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 222 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSB-CHHHHHH------------------HHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH
T ss_pred cccCCCccCcCccCcHHhccCCC-CCCcccH------------------HHHHHHHHHHHhCCCCCCCCchHHHHHHHHh
Confidence 22335679999999999975432 1223333 999999999999999998766532110
Q ss_pred CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1037 PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1037 ~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
............+..+..++.+|+..+|..||+..+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ei 259 (323)
T 3tki_A 223 EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDI 259 (323)
T ss_dssp TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred cccccCCccccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 0111111123456778889999999999999974444
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=329.14 Aligned_cols=245 Identities=26% Similarity=0.392 Sum_probs=193.2
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--------------------------ChhHHHHHHHHHHh
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--------------------------DVQPLHEEIKLHSQ 858 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--------------------------~~e~f~rEi~IL~~ 858 (1181)
.|.+. ++||+|+||.||+|++..+++.||+|++...... ..+.+.+|+.++++
T Consensus 14 ~y~~~-~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 14 QYTLK-DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TEEEE-EEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred ceEEE-eEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 34443 3799999999999999999999999999655321 23668999999999
Q ss_pred cCCCCeeeEcccccc--CCcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCc
Q psy14556 859 LRHRNIVQYLGSVSE--EGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNV 936 (1181)
Q Consensus 859 L~HPNIVkl~g~~~d--~~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 936 (1181)
++||||+++++++.+ .+..++||||+++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 999999999999876 5689999999999999987653 3678999999999999999999999999999999999
Q ss_pred ccccCCCeeeeecCCcccccccCCCCCccccCCccccCchhhccCCCC-CCCccccccCCCccccccccccchhHHHHHH
Q psy14556 937 LVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRG-YGAPVRQRDKINPCCRIEYKKMKINVFLCVI 1015 (1181)
Q Consensus 937 LLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~-~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvI 1015 (1181)
|++. ++.+||+|||+++.............||+.|+|||++.+.... .+...|+ ||+|++
T Consensus 169 l~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di------------------~slG~~ 229 (298)
T 2zv2_A 169 LVGE-DGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDV------------------WAMGVT 229 (298)
T ss_dssp EECT-TSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHH------------------HHHHHH
T ss_pred EECC-CCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhh------------------HhHHHH
Confidence 9988 8999999999998776543334456799999999999754321 1222333 999999
Q ss_pred HHHHHhCCCCCCCCCcccccCC---CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1016 ISQLLVLTAALKKKTSRALVAP---PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1016 LyELLTGk~PF~~~~~~~l~~~---~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
+|+|++|+.||.+.....+... ...........+..+..++.+|++.+|..||+..+.
T Consensus 230 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~ 290 (298)
T 2zv2_A 230 LYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEI 290 (298)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred HHHHHHCCCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHH
Confidence 9999999999988765433211 111112234567889999999999999999975443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=346.84 Aligned_cols=236 Identities=26% Similarity=0.320 Sum_probs=192.7
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCC---CCCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEeecCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEK---NLGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~---~~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
.+||+|+||+||+|++..+++.||+|++++. .....+.+.+|..+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 29 ~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~g 108 (353)
T 3txo_A 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNG 108 (353)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCC
Confidence 3799999999999999999999999999754 234466788999999988 799999999999999999999999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccc
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF 966 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~ 966 (1181)
|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++............
T Consensus 109 g~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~-~g~ikL~DFG~a~~~~~~~~~~~~~ 184 (353)
T 3txo_A 109 GDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDH-EGHCKLADFGMCKEGICNGVTTATF 184 (353)
T ss_dssp CBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT-TSCEEECCCTTCBCSCC--------
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECC-CCCEEEccccceeecccCCcccccc
Confidence 9999999754 35789999999999999999999999999999999999988 8999999999998655444445567
Q ss_pred cCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCCC-CCCCC
Q psy14556 967 TGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQI-SRSVS 1045 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~i-p~~l~ 1045 (1181)
+||+.|+|||++.+..+ +..+|+ ||+||++|+|++|+.||.+.+..++...+.. ....+
T Consensus 185 ~gt~~y~aPE~~~~~~~--~~~~Di------------------wslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p 244 (353)
T 3txo_A 185 CGTPDYIAPEILQEMLY--GPAVDW------------------WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP 244 (353)
T ss_dssp -CCGGGCCHHHHHHHHC--TTHHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred CCCcCeEChhhcCCCCc--CCccCC------------------CcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 89999999999976543 334444 9999999999999999998887654322111 11122
Q ss_pred CCCCcchHHhhccCCCCCCCCCchh
Q psy14556 1046 VPGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1046 ~~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
...+..+..++.+|+.++|.+|+..
T Consensus 245 ~~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 245 TWLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred CCCCHHHHHHHHHHhhhCHHHccCC
Confidence 3466778889999999999999986
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=333.11 Aligned_cols=238 Identities=24% Similarity=0.365 Sum_probs=199.6
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
.+||+|+||.||+|++..+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus 51 ~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 130 (321)
T 2c30_A 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT 130 (321)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHH
T ss_pred EEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHH
Confidence 37999999999999999999999999998777667788999999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCc
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL 970 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~ 970 (1181)
+++... .+++..+..++.|++.||.|||++||+||||||+||+++. ++.+||+|||++..............||+
T Consensus 131 ~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 205 (321)
T 2c30_A 131 DIVSQV----RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTL-DGRVKLSDFGFCAQISKDVPKRKSLVGTP 205 (321)
T ss_dssp HHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TCCEEECCCTTCEECCSSSCCBCCCCSCG
T ss_pred HHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC-CCcEEEeeeeeeeecccCccccccccCCc
Confidence 998743 5789999999999999999999999999999999999987 89999999999987765444455667999
Q ss_pred cccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCC----CCCCCCCCC
Q psy14556 971 QYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAP----PQISRSVSV 1046 (1181)
Q Consensus 971 ~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~----~~ip~~l~~ 1046 (1181)
.|+|||++.+..++. ..|+ ||+|+++|+|++|+.||.+......... ....-....
T Consensus 206 ~y~aPE~~~~~~~~~--~~Dv------------------~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2c30_A 206 YWMAPEVISRSLYAT--EVDI------------------WSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSH 265 (321)
T ss_dssp GGCCHHHHTTCCBCT--HHHH------------------HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGG
T ss_pred cccCHhhhcCCCCCc--hhhH------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccc
Confidence 999999997654333 3333 9999999999999999988765442111 100011122
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
..+..+..++.+|+..+|..||+..+.
T Consensus 266 ~~~~~l~~li~~~l~~dp~~Rps~~el 292 (321)
T 2c30_A 266 KVSPVLRDFLERMLVRDPQERATAQEL 292 (321)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 456778899999999999999974444
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=340.66 Aligned_cols=244 Identities=22% Similarity=0.313 Sum_probs=201.3
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC------ChhHHHHHHHHHHhcCCCCeeeEccccccCCcE
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG------DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYF 877 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~------~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l 877 (1181)
+.|.+. ++||+|+||.||+|.+..+++.||+|++.+.... ..+.+.+|+.++++++||||+++++++.+.+.+
T Consensus 12 ~~y~~~-~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 12 DFYDIG-EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GTEEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hceEEe-eEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 344443 4799999999999999999999999999765432 346799999999999999999999999999999
Q ss_pred EEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCC----eeeeecCCcc
Q psy14556 878 KIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSG----VVKISDFGTS 953 (1181)
Q Consensus 878 ~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g----~vKLiDFGlA 953 (1181)
++||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++ .+||+|||++
T Consensus 91 ~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLD-KNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESC-TTSSSCCEEECCCSSC
T ss_pred EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeC-CCCCccCEEEEecCCc
Confidence 9999999999999999743 46889999999999999999999999999999999999987 44 7999999999
Q ss_pred cccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc
Q psy14556 954 KRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA 1033 (1181)
Q Consensus 954 k~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~ 1033 (1181)
+..... .......||+.|+|||++.+..+ +..+|+ ||+|+++|+|++|..||.+.+..+
T Consensus 167 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~--~~~~Di------------------wslGvil~~ll~g~~Pf~~~~~~~ 225 (361)
T 2yab_A 167 HEIEDG-VEFKNIFGTPEFVAPEIVNYEPL--GLEADM------------------WSIGVITYILLSGASPFLGDTKQE 225 (361)
T ss_dssp EECCTT-CCCCCCCSCGGGCCHHHHTTCCC--CTHHHH------------------HHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred eEcCCC-CccccCCCCccEECchHHcCCCC--CccccH------------------HHHHHHHHHHHhCCCCCCCCCHHH
Confidence 876543 23345679999999999976543 344444 999999999999999999887655
Q ss_pred ccC-----CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1034 LVA-----PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1034 l~~-----~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
+.. ...++.......+..+..++.+|+..+|.+||+..+.
T Consensus 226 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~ 270 (361)
T 2yab_A 226 TLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEA 270 (361)
T ss_dssp HHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 322 2222222334567788899999999999999975544
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=340.09 Aligned_cols=239 Identities=25% Similarity=0.330 Sum_probs=197.9
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.+||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..|+||||+++++
T Consensus 21 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~ 100 (328)
T 3fe3_A 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGE 100 (328)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCB
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCc
Confidence 379999999999999999999999999965532 235678899999999999999999999999999999999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++...... .......|
T Consensus 101 L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~~~~~~-~~~~~~~g 175 (328)
T 3fe3_A 101 VFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDA-DMNIKIADFGFSNEFTVG-GKLDAFCG 175 (328)
T ss_dssp HHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TSCEEECSTTCCGGGSSS-CGGGTTSS
T ss_pred HHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcC-CCCEEEeeccCceecCCC-CccccccC
Confidence 99999754 35789999999999999999999999999999999999988 899999999999766533 33445679
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-CCCCCCCC
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-ISRSVSVP 1047 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-ip~~l~~~ 1047 (1181)
|+.|+|||++.+..+ .+..+|+ ||+||++|+|++|+.||.+.+...+..... -....+..
T Consensus 176 t~~y~aPE~~~~~~~-~~~~~Di------------------wslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~ 236 (328)
T 3fe3_A 176 APPYAAPELFQGKKY-DGPEVDV------------------WSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY 236 (328)
T ss_dssp SGGGCCHHHHHTCCC-CSHHHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT
T ss_pred CcceeCcccccCCCc-CCchhhh------------------hhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC
Confidence 999999999975532 2233444 999999999999999999987655432111 11122334
Q ss_pred CCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1048 GPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1048 ~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.+..+..++.+|+..+|.+||+..+.
T Consensus 237 ~s~~~~~li~~~L~~dP~~R~t~~ei 262 (328)
T 3fe3_A 237 MSTDCENLLKRFLVLNPIKRGTLEQI 262 (328)
T ss_dssp SCHHHHHHHHHHCCSSTTTSCCHHHH
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 67778889999999999999974443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=338.18 Aligned_cols=252 Identities=19% Similarity=0.236 Sum_probs=196.9
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC---hhHHHHHHHHHHhcCCCCeeeEccccccCCc----
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD---VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGY---- 876 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~---~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~---- 876 (1181)
+.|.+. ++||+|+||.||+|++..+++.||+|++....... .+.+.+|+.++++++||||+++++++.....
T Consensus 12 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 12 DRYELG-EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred CcEEEE-EEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 344443 47999999999999999999999999997654433 3568899999999999999999999876543
Q ss_pred EEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccccc
Q psy14556 877 FKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956 (1181)
Q Consensus 877 l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l 956 (1181)
.|+||||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.+
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA-TNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TSCEEECCCSCC---
T ss_pred cEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcC-CCCEEEeeccCcccc
Confidence 49999999999999999754 35789999999999999999999999999999999999988 899999999999876
Q ss_pred ccCCC---CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc
Q psy14556 957 AGLCP---SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA 1033 (1181)
Q Consensus 957 ~~~~~---~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~ 1033 (1181)
..... ......||+.|+|||++.+..++ ...|+ ||+|+++|+|++|+.||.+.....
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~Di------------------~slG~~l~~ll~g~~pf~~~~~~~ 226 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVD--ARSDV------------------YSLGCVLYEVLTGEPPFTGDSPVS 226 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCC--HHHHH------------------HHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCC--chHhH------------------HHHHHHHHHHHhCCCCCCCCChHH
Confidence 54321 22235689999999999765433 33333 999999999999999999887644
Q ss_pred cc-----CCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1034 LV-----APPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1034 l~-----~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
.. .....+.......+..+..++.+|++.+|..||++++++...+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 227 VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp HHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 31 112222222345778899999999999999999999887666655
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=343.19 Aligned_cols=242 Identities=26% Similarity=0.323 Sum_probs=199.6
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIF 880 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LV 880 (1181)
+|.+. .+||+|+||.||+|++..+++.||+|++++.. ....+.+..|..++..+ +||||+++++++.+.+.+|+|
T Consensus 18 ~y~~~-~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv 96 (345)
T 1xjd_A 18 DFILH-KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 96 (345)
T ss_dssp TEEEE-EEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred HeEEE-EEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence 34443 47999999999999999999999999997542 34566788999999887 999999999999999999999
Q ss_pred EeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC
Q psy14556 881 MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC 960 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~ 960 (1181)
|||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++......
T Consensus 97 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-~g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 97 MEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK-DGHIKIADFGMCKENMLGD 172 (345)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT-TSCEEECCCTTCBCCCCTT
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECC-CCCEEEeEChhhhhcccCC
Confidence 9999999999999754 25789999999999999999999999999999999999988 8999999999998654443
Q ss_pred CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCCC
Q psy14556 961 PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQI 1040 (1181)
Q Consensus 961 ~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~i 1040 (1181)
......+||+.|+|||++.+.. ++..+|+ ||+||++|+|++|+.||.+.+...+...+..
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di------------------wslG~il~ell~g~~Pf~~~~~~~~~~~i~~ 232 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILLGQK--YNHSVDW------------------WSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 232 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCC--BCTHHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CcccCCCCCcccCChhhhcCCC--CCChhhh------------------HHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 4455678999999999997654 3344444 9999999999999999998876554321111
Q ss_pred -CCCCCCCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1041 -SRSVSVPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1041 -p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
....+...+..+..++.+|+..+|.+|+...
T Consensus 233 ~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~ 264 (345)
T 1xjd_A 233 DNPFYPRWLEKEAKDLLVKLFVREPEKRLGVR 264 (345)
T ss_dssp CCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTB
T ss_pred CCCCCCcccCHHHHHHHHHHhcCCHhHcCCCh
Confidence 1112234677888899999999999999753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=349.22 Aligned_cols=250 Identities=28% Similarity=0.349 Sum_probs=205.9
Q ss_pred HHhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEE
Q psy14556 801 RFLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFK 878 (1181)
Q Consensus 801 ~~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~ 878 (1181)
.+.+.|.+.+ +||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..|
T Consensus 8 ~~~~~Y~i~~-~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 8 RFTEEYQLFE-ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHHHHEEEEE-EEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred cccCCeEEEE-EeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 3445565544 799999999999999999999999999765432 3467899999999999999999999999999999
Q ss_pred EEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccccc--CCCeeeeecCCccccc
Q psy14556 879 IFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNT--YSGVVKISDFGTSKRL 956 (1181)
Q Consensus 879 LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~--~~g~vKLiDFGlAk~l 956 (1181)
+||||++||+|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++. .++.+||+|||++...
T Consensus 87 lv~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EEECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 999999999999988754 35789999999999999999999999999999999999985 2578999999999877
Q ss_pred ccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC
Q psy14556 957 AGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA 1036 (1181)
Q Consensus 957 ~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~ 1036 (1181)
...........||+.|+|||++.+..+ +..+|+ ||+||++|+|++|..||.+.+...+..
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~--~~~~DI------------------wSlGvilyell~G~~Pf~~~~~~~~~~ 223 (444)
T 3soa_A 164 EGEQQAWFGFAGTPGYLSPEVLRKDPY--GKPVDL------------------WACGVILYILLVGYPPFWDEDQHRLYQ 223 (444)
T ss_dssp CTTCCBCCCSCSCGGGCCHHHHTTCCB--CTHHHH------------------HHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cCCCceeecccCCcccCCHHHhcCCCC--CCcccc------------------HHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 655444456679999999999976543 334444 999999999999999999887655322
Q ss_pred -----CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1037 -----PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1037 -----~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
....+.......+..+..++.+|+..||..||+..+.+
T Consensus 224 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L 266 (444)
T 3soa_A 224 QIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEAL 266 (444)
T ss_dssp HHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 23344444456788899999999999999999866653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=336.98 Aligned_cols=250 Identities=24% Similarity=0.302 Sum_probs=199.9
Q ss_pred hhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCC-----CCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcE
Q psy14556 803 LYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEK-----NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYF 877 (1181)
Q Consensus 803 ~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~-----~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l 877 (1181)
.+.|.+. ++||+|+||+||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 23 ~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 23 EDVYELC-EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred ccceEEe-eEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3444444 4799999999999999999999999998532 122467899999999999999999999999999999
Q ss_pred EEEEeecCCCCcccchhcc-cCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccC--CCeeeeecCCccc
Q psy14556 878 KIFMEQVPGGSLSTLLRVK-WGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTY--SGVVKISDFGTSK 954 (1181)
Q Consensus 878 ~LVmEy~~gGSL~dlL~~~-~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~--~g~vKLiDFGlAk 954 (1181)
|+||||++|++|.+++... .....+++..++.++.||+.||+|||++||+||||||+|||++.. .+.+||+|||++.
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999999998877643 234457899999999999999999999999999999999999762 2359999999998
Q ss_pred ccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc
Q psy14556 955 RLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL 1034 (1181)
Q Consensus 955 ~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l 1034 (1181)
.............||+.|+|||++.+..+ +...|+ ||+||++|+|++|..||.+......
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~Di------------------wslG~il~~ll~g~~pf~~~~~~~~ 241 (351)
T 3c0i_A 182 QLGESGLVAGGRVGTPHFMAPEVVKREPY--GKPVDV------------------WGCGVILFILLSGCLPFYGTKERLF 241 (351)
T ss_dssp ECCTTSCBCCCCCSCGGGCCHHHHTTCCB--CTHHHH------------------HHHHHHHHHHHHSSCSSCSSHHHHH
T ss_pred EecCCCeeecCCcCCcCccCHHHHcCCCC--CchHhh------------------HHHHHHHHHHHHCCCCCCCcHHHHH
Confidence 77654444445679999999999976543 333444 9999999999999999988653221
Q ss_pred ----cCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1035 ----VAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1035 ----~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
......+.......+..+..++.+|+..+|..||+..+.
T Consensus 242 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~ 284 (351)
T 3c0i_A 242 EGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEA 284 (351)
T ss_dssp HHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 111112211223567788999999999999999986655
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-36 Score=332.97 Aligned_cols=246 Identities=26% Similarity=0.337 Sum_probs=189.3
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.++||+|+||+||+|++ ++..||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 42 ~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 119 (309)
T 3p86_A 42 KEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119 (309)
T ss_dssp EEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTC
T ss_pred eeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCC
Confidence 34799999999999987 6789999999765433 2457889999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccc--eecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAET 965 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~g--IVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t 965 (1181)
+|.+++........+++..++.++.||+.||+|||++| |+||||||+||+++. ++.+||+|||+++...........
T Consensus 120 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~-~~~~kL~Dfg~a~~~~~~~~~~~~ 198 (309)
T 3p86_A 120 SLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDK-KYTVKVCDFGLSRLKASTFLSSKS 198 (309)
T ss_dssp BHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECT-TCCEEECCCC--------------
T ss_pred cHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeC-CCcEEECCCCCCcccccccccccc
Confidence 99999985422234789999999999999999999999 999999999999988 889999999999866544333445
Q ss_pred ccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCC---CCCC
Q psy14556 966 FTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPP---QISR 1042 (1181)
Q Consensus 966 ~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~---~ip~ 1042 (1181)
..||+.|+|||++.+...+..+ |+ ||+|+++|+|++|+.||.+.+........ ....
T Consensus 199 ~~gt~~y~aPE~~~~~~~~~~~--Di------------------wslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~ 258 (309)
T 3p86_A 199 AAGTPEWMAPEVLRDEPSNEKS--DV------------------YSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL 258 (309)
T ss_dssp ---CCTTSCHHHHTTCCCCTTH--HH------------------HHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCC
T ss_pred CCCCccccChhhhcCCCCCchh--hH------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 6799999999999866544433 33 99999999999999999988765532211 1122
Q ss_pred CCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcc
Q psy14556 1043 SVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTG 1079 (1181)
Q Consensus 1043 ~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~ 1079 (1181)
..+...+..+..++.+|++.+|..||+. .+.+..+.
T Consensus 259 ~~~~~~~~~l~~li~~~l~~dP~~Rps~-~~ll~~L~ 294 (309)
T 3p86_A 259 EIPRNLNPQVAAIIEGCWTNEPWKRPSF-ATIMDLLR 294 (309)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCH-HHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHccCChhhCcCH-HHHHHHHH
Confidence 2344567889999999999999999964 44333333
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=337.31 Aligned_cols=247 Identities=28% Similarity=0.384 Sum_probs=202.1
Q ss_pred HhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEE
Q psy14556 802 FLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKI 879 (1181)
Q Consensus 802 ~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~L 879 (1181)
+.+.|.+.+ +||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..|+
T Consensus 27 ~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 27 FSDNYDVKE-ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHEEEEE-EEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccCeEEee-EEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 445555544 799999999999999999999999999765432 34678899999999999999999999999999999
Q ss_pred EEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccC--CCeeeeecCCcccccc
Q psy14556 880 FMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTY--SGVVKISDFGTSKRLA 957 (1181)
Q Consensus 880 VmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~--~g~vKLiDFGlAk~l~ 957 (1181)
||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.. ++.+||+|||++....
T Consensus 106 v~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp EECCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred EEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 99999999999888743 357899999999999999999999999999999999999762 3469999999998765
Q ss_pred cCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC-
Q psy14556 958 GLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA- 1036 (1181)
Q Consensus 958 ~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~- 1036 (1181)
.. .......||+.|+|||++.+..++ ...|+ ||+||++|+|++|..||.+.+...+..
T Consensus 183 ~~-~~~~~~~gt~~y~aPE~~~~~~~~--~~~Di------------------wslG~il~~ll~g~~Pf~~~~~~~~~~~ 241 (362)
T 2bdw_A 183 DS-EAWHGFAGTPGYLSPEVLKKDPYS--KPVDI------------------WACGVILYILLVGYPPFWDEDQHRLYAQ 241 (362)
T ss_dssp TC-CSCCCSCSCTTTCCHHHHTTCCCC--THHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred CC-cccccCCCCccccCHHHHccCCCC--chhhH------------------HHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 43 233446799999999999765433 33444 999999999999999999877654321
Q ss_pred ----CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1037 ----PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1037 ----~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
....+.......+..+..++.+|+..+|..||+..+.
T Consensus 242 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 282 (362)
T 2bdw_A 242 IKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQA 282 (362)
T ss_dssp HHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 2223333333567788999999999999999986655
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=331.39 Aligned_cols=245 Identities=22% Similarity=0.302 Sum_probs=200.4
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC------ChhHHHHHHHHHHhcCCCCeeeEccccccCCcE
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG------DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYF 877 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~------~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l 877 (1181)
+.|.. .++||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~y~~-~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 11 DYYDT-GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHEEE-EEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cceEe-ceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 33444 34799999999999999999999999999765332 357799999999999999999999999999999
Q ss_pred EEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCC----eeeeecCCcc
Q psy14556 878 KIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSG----VVKISDFGTS 953 (1181)
Q Consensus 878 ~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g----~vKLiDFGlA 953 (1181)
++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++ .+||+|||++
T Consensus 90 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~-~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD-RNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESC-SSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEec-CCCCCCCEEEEECCCC
Confidence 9999999999999999743 46789999999999999999999999999999999999987 45 8999999999
Q ss_pred cccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc
Q psy14556 954 KRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA 1033 (1181)
Q Consensus 954 k~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~ 1033 (1181)
+..... .......||+.|+|||++.+..++ ...|+ ||+|+++|+|++|..||.+.....
T Consensus 166 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~--~~~Di------------------wslG~il~~ll~g~~pf~~~~~~~ 224 (326)
T 2y0a_A 166 HKIDFG-NEFKNIFGTPEFVAPEIVNYEPLG--LEADM------------------WSIGVITYILLSGASPFLGDTKQE 224 (326)
T ss_dssp EECCTT-SCCCCCCSCTTTCCHHHHTTCCCC--THHHH------------------HHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred eECCCC-CccccccCCcCcCCceeecCCCCC--cHHHH------------------HHHHHHHHHHHHCcCCCCCCCHHH
Confidence 876543 223445799999999999765433 33443 999999999999999998877644
Q ss_pred ccC-----CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1034 LVA-----PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1034 l~~-----~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
... ....+.......+..+..++.+|+..+|..||+..+.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 270 (326)
T 2y0a_A 225 TLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270 (326)
T ss_dssp HHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 321 12222222345677888999999999999999755543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=342.29 Aligned_cols=236 Identities=25% Similarity=0.302 Sum_probs=197.0
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCC---CCCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEeecCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEK---NLGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~---~~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
.+||+|+||.||+|++..+++.||+|++.+. .....+.+.+|..++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 26 ~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~g 105 (353)
T 2i0e_A 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG 105 (353)
T ss_dssp EEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999999999999999999654 234567788999999988 899999999999999999999999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccc
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF 966 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~ 966 (1181)
|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++............
T Consensus 106 g~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~-~g~vkL~DFG~a~~~~~~~~~~~~~ 181 (353)
T 2i0e_A 106 GDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDS-EGHIKIADFGMCKENIWDGVTTKTF 181 (353)
T ss_dssp CBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT-TSCEEECCCTTCBCCCCTTCCBCCC
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcC-CCcEEEEeCCcccccccCCcccccc
Confidence 9999999854 25789999999999999999999999999999999999988 8999999999998654444445567
Q ss_pred cCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-CCCCCC
Q psy14556 967 TGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-ISRSVS 1045 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-ip~~l~ 1045 (1181)
+||+.|+|||++.+..+ +..+|+ ||+||++|||++|+.||.+.+...+...+. .....+
T Consensus 182 ~gt~~y~aPE~~~~~~~--~~~~Di------------------wslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p 241 (353)
T 2i0e_A 182 CGTPDYIAPEIIAYQPY--GKSVDW------------------WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP 241 (353)
T ss_dssp CSCGGGCCHHHHTTCCB--STHHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred cCCccccChhhhcCCCc--CCcccc------------------cchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 89999999999976543 344444 999999999999999999887655422111 111123
Q ss_pred CCCCcchHHhhccCCCCCCCCCchh
Q psy14556 1046 VPGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1046 ~~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
...+..+..++.+|+.++|.+|+..
T Consensus 242 ~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 242 KSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp TTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 3567788889999999999999964
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=322.99 Aligned_cols=250 Identities=56% Similarity=0.864 Sum_probs=201.9
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
..||+|+||.||+|.+..+++.||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 47999999999999999999999999998776666788999999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCc
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL 970 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~ 970 (1181)
+++........+++..++.++.|++.||.|||++||+||||||+||+++..++.+||+|||++..............|++
T Consensus 108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 187 (295)
T 2clq_A 108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTL 187 (295)
T ss_dssp HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCG
T ss_pred HHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCc
Confidence 99987655667788999999999999999999999999999999999987578999999999987665434444567999
Q ss_pred cccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc----CCCCCCCCCCC
Q psy14556 971 QYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV----APPQISRSVSV 1046 (1181)
Q Consensus 971 ~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~----~~~~ip~~l~~ 1046 (1181)
.|+|||++.++...++...|+ ||+|+++|+|++|+.||......... .........+.
T Consensus 188 ~y~aPE~~~~~~~~~~~~~Di------------------~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (295)
T 2clq_A 188 QYMAPEIIDKGPRGYGKAADI------------------WSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPE 249 (295)
T ss_dssp GGCCHHHHHHGGGGCSHHHHH------------------HHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCT
T ss_pred cccChhhhcCCCCCCCcHHHH------------------HHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccc
Confidence 999999997654333344444 99999999999999999865432210 00112223344
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
..+..+..++.+|+..+|..||+..+.+...+
T Consensus 250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~ 281 (295)
T 2clq_A 250 SMSAEAKAFILKCFEPDPDKRACANDLLVDEF 281 (295)
T ss_dssp TSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGG
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 56788899999999999999998665544333
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=333.63 Aligned_cols=232 Identities=24% Similarity=0.341 Sum_probs=193.7
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCC---CCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEK---NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~---~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.+||+|+||.||+|++..+++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+.+.+|+||||++||
T Consensus 12 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg 91 (318)
T 1fot_A 12 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGG 91 (318)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCC
Confidence 3699999999999999999999999999654 2245677889999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.... ......
T Consensus 92 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-~g~~kL~Dfg~a~~~~~---~~~~~~ 164 (318)
T 1fot_A 92 ELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDK-NGHIKITDFGFAKYVPD---VTYTLC 164 (318)
T ss_dssp BHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT-TSCEEECCCSSCEECSS---CBCCCC
T ss_pred CHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcC-CCCEEEeecCcceecCC---cccccc
Confidence 999999753 35789999999999999999999999999999999999988 89999999999987643 234567
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-CCCCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-ISRSVSV 1046 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-ip~~l~~ 1046 (1181)
||+.|+|||++.+..+ +..+|+ ||+||++|+|++|+.||.+.+...+...+. .....+.
T Consensus 165 gt~~y~aPE~~~~~~~--~~~~Di------------------wslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~ 224 (318)
T 1fot_A 165 GTPDYIAPEVVSTKPY--NKSIDW------------------WSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP 224 (318)
T ss_dssp SCTTTCCHHHHTTCCB--CTTHHH------------------HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT
T ss_pred CCccccCHhHhcCCCC--Ccccch------------------hhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 9999999999976543 334444 999999999999999999877644321111 0111223
Q ss_pred CCCcchHHhhccCCCCCCCCCch
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
..+..+..++.+++..+|.+|+.
T Consensus 225 ~~~~~~~~li~~lL~~dp~~R~~ 247 (318)
T 1fot_A 225 FFNEDVKDLLSRLITRDLSQRLG 247 (318)
T ss_dssp TSCHHHHHHHHHHTCSCTTTCTT
T ss_pred CCCHHHHHHHHHHhccCHHHcCC
Confidence 45677888999999999999994
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=342.42 Aligned_cols=241 Identities=25% Similarity=0.333 Sum_probs=194.4
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIF 880 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LV 880 (1181)
+|.+.+ +||+|+||+||+|++..+++.||+|++++.. ....+.+.+|..++.++ +||||+++++++.+.+.+|+|
T Consensus 53 ~y~~~~-~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 53 DFDLLR-VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GEEEEE-EEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred HcEEEE-EEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 344433 7999999999999999999999999997653 23356688999999887 899999999999999999999
Q ss_pred EeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC
Q psy14556 881 MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC 960 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~ 960 (1181)
|||++||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++......
T Consensus 132 ~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~-~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS-EGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT-TSCEEECCCTTCBCCCCTT
T ss_pred EEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECC-CCCEEEeecceeeecccCC
Confidence 9999999999998754 35789999999999999999999999999999999999998 8999999999998654444
Q ss_pred CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc-------
Q psy14556 961 PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA------- 1033 (1181)
Q Consensus 961 ~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~------- 1033 (1181)
....+.+||+.|+|||++.+.. ++..+|+ ||+||++|||++|+.||.......
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~~~--~~~~~Di------------------wslGvllyell~G~~Pf~~~~~~~~~~~~~~ 267 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRGED--YGFSVDW------------------WALGVLMFEMMAGRSPFDIVGSSDNPDQNTE 267 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTTCC--BCTHHHH------------------HHHHHHHHHHHHSSCSSTTTTC------CCH
T ss_pred CccccccCCcccCCchhhcCCC--CChHHHH------------------HHHHHHHHHHHhCCCCCcccccccccchhhH
Confidence 4556678999999999997654 3444444 999999999999999997543211
Q ss_pred --ccCCC-CCCCCCCCCCCcchHHhhccCCCCCCCCCchh
Q psy14556 1034 --LVAPP-QISRSVSVPGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1034 --l~~~~-~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
+...+ ......+...+..+..++.+|+..+|.+|+..
T Consensus 268 ~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 268 DYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred HHHHHHHhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 10000 01112233466778889999999999999974
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=333.02 Aligned_cols=235 Identities=24% Similarity=0.329 Sum_probs=182.8
Q ss_pred eeecccCceEEEEEEEc---CCCeEEEEEEecCCCC----CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEee
Q psy14556 811 IELGKGSYGVVYAAREL---DRQVKLAIKEIPEKNL----GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQ 883 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~---~tg~~VAIKii~~~~~----~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy 883 (1181)
++||+|+||.||+|++. .+++.||+|++.+... .....+.+|+.+++.++||||+++++++.+.+.+|+||||
T Consensus 23 ~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 102 (327)
T 3a62_A 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEY 102 (327)
T ss_dssp EEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred EEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeC
Confidence 47999999999999985 6889999999976532 2345688999999999999999999999999999999999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCC
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA 963 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~ 963 (1181)
+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.........
T Consensus 103 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~ 178 (327)
T 3a62_A 103 LSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNH-QGHVKLTDFGLCKESIHDGTVT 178 (327)
T ss_dssp CTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECT-TSCEEECCCSCC----------
T ss_pred CCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECC-CCcEEEEeCCcccccccCCccc
Confidence 9999999999754 25778899999999999999999999999999999999987 8999999999997654433444
Q ss_pred ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-CCC
Q psy14556 964 ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-ISR 1042 (1181)
Q Consensus 964 ~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-ip~ 1042 (1181)
....||+.|+|||++.+..+ +...|+ ||+|+++|+|++|+.||.+.+...+..... ...
T Consensus 179 ~~~~gt~~y~aPE~~~~~~~--~~~~Di------------------wslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 238 (327)
T 3a62_A 179 HTFCGTIEYMAPEILMRSGH--NRAVDW------------------WSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL 238 (327)
T ss_dssp CTTSSCCTTSCHHHHTTSCC--CTHHHH------------------HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC
T ss_pred cccCCCcCccCHhhCcCCCC--CCcccc------------------hhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence 55679999999999976543 333443 999999999999999999877654321111 111
Q ss_pred CCCCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1043 SVSVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1043 ~l~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
..+...+..+..++.+|+..+|..||.
T Consensus 239 ~~p~~~~~~~~~li~~~L~~dp~~R~~ 265 (327)
T 3a62_A 239 NLPPYLTQEARDLLKKLLKRNAASRLG 265 (327)
T ss_dssp CCCTTSCHHHHHHHHHHSCSCGGGSTT
T ss_pred CCCCCCCHHHHHHHHHHHhcCHhhccC
Confidence 223456778888999999999999984
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=336.85 Aligned_cols=236 Identities=25% Similarity=0.320 Sum_probs=192.8
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC---hhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEeecCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD---VQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~---~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
.+||+|+||.||+|++..+++.||+|++.+..... .+.+.+|..+++++ +||||+++++++.+.+.+|+||||++|
T Consensus 15 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~g 94 (345)
T 3a8x_A 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 94 (345)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999999999999999997654332 45688999999988 899999999999999999999999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccc
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF 966 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~ 966 (1181)
|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++............
T Consensus 95 g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-~g~~kL~DFG~a~~~~~~~~~~~~~ 170 (345)
T 3a8x_A 95 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS-EGHIKLTDYGMCKEGLRPGDTTSTF 170 (345)
T ss_dssp CBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT-TSCEEECCGGGCBCSCCTTCCBCCC
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECC-CCCEEEEeccccccccCCCCccccc
Confidence 9999999754 35789999999999999999999999999999999999988 8999999999998654444445567
Q ss_pred cCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc---------cccCC
Q psy14556 967 TGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR---------ALVAP 1037 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~---------~l~~~ 1037 (1181)
+||+.|+|||++.+..+ +..+|+ ||+||++|||++|+.||...... .+...
T Consensus 171 ~gt~~y~aPE~~~~~~~--~~~~Di------------------wslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (345)
T 3a8x_A 171 CGTPNYIAPEILRGEDY--GFSVDW------------------WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 230 (345)
T ss_dssp CSCGGGCCHHHHTTCCB--CTHHHH------------------HHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHH
T ss_pred CCCccccCccccCCCCC--ChHHhH------------------HHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHH
Confidence 89999999999976543 344444 99999999999999999763211 11000
Q ss_pred C-CCCCCCCCCCCcchHHhhccCCCCCCCCCchh
Q psy14556 1038 P-QISRSVSVPGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1038 ~-~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
+ ......+...+..+..++.+|+..+|.+|+..
T Consensus 231 i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 231 ILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred HHcCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 0 01111233466778889999999999999974
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=328.64 Aligned_cols=252 Identities=23% Similarity=0.261 Sum_probs=195.0
Q ss_pred HhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEE
Q psy14556 802 FLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIF 880 (1181)
Q Consensus 802 ~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LV 880 (1181)
+.+.|.+..++||+|+||.||+|.+..+++.||+|++........+.+.+|+.++.++ +||||+++++++.+.+.+++|
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 3445666556799999999999999999999999999877666678899999999985 799999999999999999999
Q ss_pred EeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCe---eeeecCCcccccc
Q psy14556 881 MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGV---VKISDFGTSKRLA 957 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~---vKLiDFGlAk~l~ 957 (1181)
|||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++. +||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~-~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEH-PNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESC-SSSSCSEEECCTTCCC---
T ss_pred EEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEcc-CCCcCceEEEEccCccccc
Confidence 9999999999999754 35789999999999999999999999999999999999987 443 9999999987654
Q ss_pred cCC-------CCCccccCCccccCchhhccCC---CCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCC
Q psy14556 958 GLC-------PSAETFTGTLQYMAPEVIDKGQ---RGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALK 1027 (1181)
Q Consensus 958 ~~~-------~~~~t~~GT~~Y~APEvl~gg~---~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~ 1027 (1181)
... .......||+.|+|||++.+.. ..++...|+ ||+||++|+|++|+.||.
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Di------------------wslG~il~~l~~g~~pf~ 227 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDL------------------WSLGVILYILLSGYPPFV 227 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHH------------------HHHHHHHHHHHHSSCSCC
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCccccc------------------HhHHHHHHHHHHCCCCCc
Confidence 211 1122345999999999996411 112223333 999999999999999998
Q ss_pred CCCcccc--------------------cCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHH
Q psy14556 1028 KKTSRAL--------------------VAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNL 1075 (1181)
Q Consensus 1028 ~~~~~~l--------------------~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~ 1075 (1181)
+....+. .....++.......+..+..++.+|+..||.+||+..+.+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 228 GRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp CCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 8654221 01111222112346778889999999999999997554433
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=341.15 Aligned_cols=242 Identities=25% Similarity=0.375 Sum_probs=198.8
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.+||+|+||.||+|.+..+++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+.+.+|+||||+.||
T Consensus 21 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg 100 (384)
T 4fr4_A 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGG 100 (384)
T ss_dssp EEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTE
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCC
Confidence 37999999999999999999999999996542 344678899999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.+... .......
T Consensus 101 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~-~g~vkL~DFG~a~~~~~~-~~~~~~~ 175 (384)
T 4fr4_A 101 DLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDE-HGHVHITDFNIAAMLPRE-TQITTMA 175 (384)
T ss_dssp EHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TSCEEECCCTTCEECCTT-CCBCCCC
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECC-CCCEEEeccceeeeccCC-CceeccC
Confidence 999999743 45789999999999999999999999999999999999988 899999999999876543 3345567
Q ss_pred CCccccCchhhccCC-CCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc---cCC-CCCCC
Q psy14556 968 GTLQYMAPEVIDKGQ-RGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL---VAP-PQISR 1042 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~-~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l---~~~-~~ip~ 1042 (1181)
||+.|+|||++.+.. ..++..+|+ ||+||++|+|++|+.||........ ... .....
T Consensus 176 gt~~Y~aPE~~~~~~~~~~~~~~Di------------------wSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 237 (384)
T 4fr4_A 176 GTKPYMAPEMFSSRKGAGYSFAVDW------------------WSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV 237 (384)
T ss_dssp SCGGGCCGGGTCCCSSCCBCTTHHH------------------HHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC
T ss_pred CCccccCCeeeccCCCCCCCcccee------------------echHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc
Confidence 999999999996431 234444444 9999999999999999986544221 110 00112
Q ss_pred CCCCCCCcchHHhhccCCCCCCCCCchhHHHHH
Q psy14556 1043 SVSVPGPGGINSSSSAPVTPTPHSRHISVNTNL 1075 (1181)
Q Consensus 1043 ~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~ 1075 (1181)
..+...+..+..++.+|+..+|..||..+++..
T Consensus 238 ~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 238 TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 223456778899999999999999998766643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=332.94 Aligned_cols=245 Identities=20% Similarity=0.270 Sum_probs=200.2
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeec
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQV 884 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~ 884 (1181)
.|.+. ++||+|+||.||+|.+..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+.+++||||+
T Consensus 6 ~y~~~-~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 6 KYMIA-EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ceEee-eEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 34443 37999999999999999999999999996543 23456889999999999999999999999999999999999
Q ss_pred CCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccC-CCeeeeecCCcccccccCCCCC
Q psy14556 885 PGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTY-SGVVKISDFGTSKRLAGLCPSA 963 (1181)
Q Consensus 885 ~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~-~g~vKLiDFGlAk~l~~~~~~~ 963 (1181)
+|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.. ++.+||+|||+++..... ...
T Consensus 84 ~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-~~~ 160 (321)
T 1tki_A 84 SGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNF 160 (321)
T ss_dssp CCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-CEE
T ss_pred CCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-Ccc
Confidence 999999999743 3457899999999999999999999999999999999999853 579999999999876542 223
Q ss_pred ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC-----CC
Q psy14556 964 ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA-----PP 1038 (1181)
Q Consensus 964 ~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~-----~~ 1038 (1181)
....||+.|+|||++.+..+ +...|+ ||+|+++|+|++|..||.+.+...+.. ..
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~--~~~~Di------------------wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 220 (321)
T 1tki_A 161 RLLFTAPEYYAPEVHQHDVV--STATDM------------------WSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY 220 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEE--CHHHHH------------------HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC
T ss_pred ccccCChhhcCcHHhcCCCC--CchhhH------------------HHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCC
Confidence 34569999999999975533 233333 999999999999999999887654321 22
Q ss_pred CCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1039 QISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1039 ~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
..+.......+..+..++.+|+..+|..||+..+.+
T Consensus 221 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l 256 (321)
T 1tki_A 221 TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEAL 256 (321)
T ss_dssp CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 222222345678889999999999999999866653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=331.71 Aligned_cols=250 Identities=23% Similarity=0.308 Sum_probs=190.2
Q ss_pred HhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCC-----
Q psy14556 802 FLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEG----- 875 (1181)
Q Consensus 802 ~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~----- 875 (1181)
+..+|...+ +||+|+||.||+|++..+++.||||++...... ..+.+.+|+.++++++||||+++++++.+.+
T Consensus 4 ~~~~y~~~~-~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 4 YLTDFEPIQ-CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHEEEEE-EEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhcCceee-EecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 445555544 699999999999999999999999999755433 3577999999999999999999999875432
Q ss_pred ----------------------------------------------------cEEEEEeecCCCCcccchhcccCCCCCC
Q psy14556 876 ----------------------------------------------------YFKIFMEQVPGGSLSTLLRVKWGPLKEN 903 (1181)
Q Consensus 876 ----------------------------------------------------~l~LVmEy~~gGSL~dlL~~~~~~~~l~ 903 (1181)
..++||||+++++|.+++..........
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 3899999999999999998654444556
Q ss_pred hHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC------------CCCccccCCcc
Q psy14556 904 ESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC------------PSAETFTGTLQ 971 (1181)
Q Consensus 904 e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~------------~~~~t~~GT~~ 971 (1181)
+..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++...... .......||+.
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTM-DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT-TCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeC-CCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 6678999999999999999999999999999999987 8999999999998765432 12233569999
Q ss_pred ccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc-cCCCCCCCCCCCCCCc
Q psy14556 972 YMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL-VAPPQISRSVSVPGPG 1050 (1181)
Q Consensus 972 Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l-~~~~~ip~~l~~~~p~ 1050 (1181)
|+|||++.+..++ ...|+ ||+|+++|+|++|..|+........ ......+. .....+.
T Consensus 242 y~aPE~~~~~~~~--~~~Di------------------~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 300 (332)
T 3qd2_B 242 YMSPEQIHGNNYS--HKVDI------------------FSLGLILFELLYSFSTQMERVRIITDVRNLKFPL-LFTQKYP 300 (332)
T ss_dssp GSCHHHHHCCCCC--THHHH------------------HHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCH-HHHHHCH
T ss_pred ccChHHhcCCCCc--chhhH------------------HHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCc-ccccCCh
Confidence 9999999865433 33333 9999999999999887654322111 00111111 1112344
Q ss_pred chHHhhccCCCCCCCCCchhHHHH
Q psy14556 1051 GINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1051 ~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
.+..++.+|++.+|..||+..+..
T Consensus 301 ~~~~li~~~l~~~p~~Rps~~~~l 324 (332)
T 3qd2_B 301 QEHMMVQDMLSPSPTERPEATDII 324 (332)
T ss_dssp HHHHHHHHHHCSSGGGSCCHHHHH
T ss_pred hHHHHHHHHccCCCCcCCCHHHHh
Confidence 567799999999999999755443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-36 Score=340.05 Aligned_cols=238 Identities=22% Similarity=0.290 Sum_probs=197.9
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFM 881 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVm 881 (1181)
.|... ..||+|+||.||+|++..+++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 42 ~y~~~-~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 42 QFDRI-KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GEEEE-EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HCEEE-EEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 34443 36999999999999999999999999996542 245677899999999999999999999999999999999
Q ss_pred eecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC
Q psy14556 882 EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP 961 (1181)
Q Consensus 882 Ey~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~ 961 (1181)
||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-~g~~kL~DFg~a~~~~~~-- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TSCEEECCCTTCEECSSC--
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECC-CCCEEEcccccceeccCC--
Confidence 999999999999854 25789999999999999999999999999999999999988 899999999999876532
Q ss_pred CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-C
Q psy14556 962 SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-I 1040 (1181)
Q Consensus 962 ~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-i 1040 (1181)
.....||+.|+|||++.+..+ +..+|+ ||+||++|+|++|..||.+.+...+...+. -
T Consensus 195 -~~~~~gt~~y~aPE~~~~~~~--~~~~Di------------------wslG~il~ell~g~~Pf~~~~~~~~~~~i~~~ 253 (350)
T 1rdq_E 195 -TWTLCGTPEALAPEIILSKGY--NKAVDW------------------WALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253 (350)
T ss_dssp -BCCCEECGGGCCHHHHTTCCB--CTHHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred -cccccCCccccCHHHhcCCCC--CCcCCE------------------ecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC
Confidence 345679999999999976543 334444 999999999999999999887655322111 0
Q ss_pred CCCCCCCCCcchHHhhccCCCCCCCCCchh
Q psy14556 1041 SRSVSVPGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1041 p~~l~~~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
....+...+..+..++.+|+..+|.+|+.+
T Consensus 254 ~~~~p~~~~~~~~~li~~lL~~dp~~R~~~ 283 (350)
T 1rdq_E 254 KVRFPSHFSSDLKDLLRNLLQVDLTKRFGN 283 (350)
T ss_dssp CCCCCTTCCHHHHHHHHHHSCSCTTTCTTS
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHHhccCC
Confidence 111233567888999999999999999984
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=318.73 Aligned_cols=245 Identities=24% Similarity=0.339 Sum_probs=203.2
Q ss_pred HhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEE
Q psy14556 802 FLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFM 881 (1181)
Q Consensus 802 ~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVm 881 (1181)
+.+.|.+.+ +||+|+||.||+|.+..++..||+|.+........+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 7 ~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 7 INQYYTLEN-TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHHHEEEEE-EEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhEEeee-EEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 344555544 7999999999999999999999999998776677788999999999999999999999999999999999
Q ss_pred eecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccc---ccCCCeeeeecCCccccccc
Q psy14556 882 EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLV---NTYSGVVKISDFGTSKRLAG 958 (1181)
Q Consensus 882 Ey~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL---d~~~g~vKLiDFGlAk~l~~ 958 (1181)
||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||++ +. ++.+||+|||++.....
T Consensus 86 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 86 ELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSP-DSPLKLIDFGLAARFKP 161 (277)
T ss_dssp ECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSST-TCCEEECCCTTCEECCT
T ss_pred eccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCC-CCcEEEEecccceeccC
Confidence 999999999988754 357899999999999999999999999999999999999 54 78999999999987654
Q ss_pred CCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC--
Q psy14556 959 LCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA-- 1036 (1181)
Q Consensus 959 ~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~-- 1036 (1181)
. .......||+.|+|||++.+. ++...|+ ||+|+++|+|++|+.||.+....++..
T Consensus 162 ~-~~~~~~~~t~~y~aPE~~~~~---~~~~~Di------------------~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 219 (277)
T 3f3z_A 162 G-KMMRTKVGTPYYVSPQVLEGL---YGPECDE------------------WSAGVMMYVLLCGYPPFSAPTDSEVMLKI 219 (277)
T ss_dssp T-SCBCCCCSCTTTCCHHHHTTC---BCTTHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred c-cchhccCCCCCccChHHhccc---CCchhhe------------------hhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 3 233445699999999998643 3333444 999999999999999999877654322
Q ss_pred ---CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1037 ---PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1037 ---~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
....+.......+..+..++.+|++.+|.+||+..+.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~ 259 (277)
T 3f3z_A 220 REGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259 (277)
T ss_dssp HHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 1222222223567889999999999999999986665
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=329.26 Aligned_cols=258 Identities=28% Similarity=0.349 Sum_probs=202.7
Q ss_pred chHHHHhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCC-----CCCChhHHHHHHHHHHhcCCCCeeeEcccc
Q psy14556 797 TPMLRFLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEK-----NLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871 (1181)
Q Consensus 797 ~p~~~~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~-----~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~ 871 (1181)
.....+.+.|.+.+ +||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.++++++||||+++++++
T Consensus 19 ~~~~~~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 97 (345)
T 3hko_A 19 GSLLELQKKYHLKG-AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY 97 (345)
T ss_dssp BCHHHHHHHEEEEE-EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred chhhhhhhheeecc-eeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh
Confidence 34566777777655 699999999999999999999999998643 234467899999999999999999999999
Q ss_pred ccCCcEEEEEeecCCCCcccchhccc-------------------------------------CCCCCChHHHHHHHHHH
Q psy14556 872 SEEGYFKIFMEQVPGGSLSTLLRVKW-------------------------------------GPLKENESTMSFYTKQI 914 (1181)
Q Consensus 872 ~d~~~l~LVmEy~~gGSL~dlL~~~~-------------------------------------~~~~l~e~~i~~Ia~QI 914 (1181)
.+.+..++||||+++|+|.+++.... ....+++..++.++.||
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 99999999999999999999885210 01223577788899999
Q ss_pred HhhhhhccccceecccCCCCCcccccCCC--eeeeecCCcccccccCCC----CCccccCCccccCchhhccCCCCCCCc
Q psy14556 915 LEGLKYLHGQKIVHRDIKGDNVLVNTYSG--VVKISDFGTSKRLAGLCP----SAETFTGTLQYMAPEVIDKGQRGYGAP 988 (1181)
Q Consensus 915 a~AL~yLHs~gIVHrDLKP~NILLd~~~g--~vKLiDFGlAk~l~~~~~----~~~t~~GT~~Y~APEvl~gg~~~~ssD 988 (1181)
+.||+|||++||+||||||+||+++. ++ .+||+|||+++.+..... ......||+.|+|||++.+....++..
T Consensus 178 ~~~l~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 178 FSALHYLHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHHHTTEECCCCCGGGEEESC-SSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHHHCCccccCCChhhEEEec-CCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999999999999999999999986 44 899999999986643221 123456999999999997543344445
Q ss_pred cccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc-----CCCCCCCCCCCCCCcchHHhhccCCCCC
Q psy14556 989 VRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV-----APPQISRSVSVPGPGGINSSSSAPVTPT 1063 (1181)
Q Consensus 989 VDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~-----~~~~ip~~l~~~~p~~L~~li~r~la~d 1063 (1181)
.|+ ||+|+++|+|++|+.||.+.+..+.. .....+.......+..+..++.+|++.+
T Consensus 257 ~Di------------------wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 318 (345)
T 3hko_A 257 CDA------------------WSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRN 318 (345)
T ss_dssp HHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSC
T ss_pred HHH------------------HHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCC
Confidence 554 99999999999999999987765432 1222222223346778899999999999
Q ss_pred CCCCchhHHHH
Q psy14556 1064 PHSRHISVNTN 1074 (1181)
Q Consensus 1064 Ps~Rp~s~~~~ 1074 (1181)
|..||+..+.+
T Consensus 319 p~~Rps~~~~l 329 (345)
T 3hko_A 319 VDERFDAMRAL 329 (345)
T ss_dssp TTTSCCHHHHH
T ss_pred hhHCCCHHHHh
Confidence 99999866653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=341.93 Aligned_cols=242 Identities=23% Similarity=0.316 Sum_probs=191.3
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHH-HHhcCCCCeeeEccccccCCcEEEE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKL-HSQLRHRNIVQYLGSVSEEGYFKIF 880 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~I-L~~L~HPNIVkl~g~~~d~~~l~LV 880 (1181)
+|.+. .+||+|+||.||+|++..+++.||+|++.+... ...+.+.+|..+ ++.++||||+++++++.+.+.+|+|
T Consensus 39 ~y~~~-~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 39 DFHFL-KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GEEEE-EEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred heEEE-EEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 34443 379999999999999999999999999976532 234456677776 5678999999999999999999999
Q ss_pred EeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC
Q psy14556 881 MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC 960 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~ 960 (1181)
|||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++......
T Consensus 118 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~-~g~ikL~DFG~a~~~~~~~ 193 (373)
T 2r5t_A 118 LDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS-QGHIVLTDFGLCKENIEHN 193 (373)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TSCEEECCCCBCGGGBCCC
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECC-CCCEEEeeCccccccccCC
Confidence 9999999999999754 35778899999999999999999999999999999999998 8999999999998755444
Q ss_pred CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-
Q psy14556 961 PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ- 1039 (1181)
Q Consensus 961 ~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~- 1039 (1181)
......+||+.|+|||++.+.. ++..+|+ ||+||++|||++|..||.+.+..++...+.
T Consensus 194 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di------------------wslG~il~ell~G~~Pf~~~~~~~~~~~i~~ 253 (373)
T 2r5t_A 194 STTSTFCGTPEYLAPEVLHKQP--YDRTVDW------------------WCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 253 (373)
T ss_dssp CCCCSBSCCCCCCCHHHHTTCC--CCTHHHH------------------HHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH
T ss_pred CccccccCCccccCHHHhCCCC--CCchhhh------------------HHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Confidence 4556678999999999997654 3344444 999999999999999999887655422111
Q ss_pred CCCCCCCCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1040 ISRSVSVPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1040 ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
.+...+...+..+..++.+|+.++|.+|+...
T Consensus 254 ~~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 254 KPLQLKPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp SCCCCCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred cccCCCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 11122345677888999999999999999863
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-35 Score=331.72 Aligned_cols=238 Identities=26% Similarity=0.305 Sum_probs=197.5
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCC---CCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEK---NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~---~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||||+ +|
T Consensus 15 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g 93 (336)
T 3h4j_B 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GG 93 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CE
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CC
Confidence 4799999999999999999999999998643 2233567999999999999999999999999999999999999 78
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...... .......
T Consensus 94 ~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~-~~~~kl~DFG~s~~~~~~-~~~~~~~ 168 (336)
T 3h4j_B 94 ELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDD-NLNVKIADFGLSNIMTDG-NFLKTSC 168 (336)
T ss_dssp EHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECT-TCCEEECCSSCTBTTTTS-BTTCCCT
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcC-CCCEEEEEeccceeccCC-ccccccc
Confidence 888888654 35789999999999999999999999999999999999998 889999999999876543 2334567
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCCCC-CCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQIS-RSVSV 1046 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~ip-~~l~~ 1046 (1181)
||+.|+|||++.+..+ .+..+|+ ||+|+++|+|++|+.||.+.....+....... ...+.
T Consensus 169 gt~~y~aPE~~~~~~~-~~~~~Di------------------wslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~ 229 (336)
T 3h4j_B 169 GSPNYAAPEVINGKLY-AGPEVDV------------------WSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPD 229 (336)
T ss_dssp TSTTTSCGGGSCCSGG-GCHHHHH------------------HHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCT
T ss_pred CCcCcCCHHHHcCCCC-CCCccch------------------hHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcc
Confidence 9999999999975432 1333444 99999999999999999988776654443322 22334
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
..+..+..++.+|+..||.+||+..+.
T Consensus 230 ~~s~~~~~li~~~L~~dP~~Rpt~~ei 256 (336)
T 3h4j_B 230 FLSPGAQSLIRRMIVADPMQRITIQEI 256 (336)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 467788899999999999999975554
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=324.36 Aligned_cols=245 Identities=23% Similarity=0.275 Sum_probs=191.9
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCC-CCChhHHHHHHHHHHhcCCCCeeeEccccccCC--cEEEEEeecCC
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKN-LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEG--YFKIFMEQVPG 886 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~-~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~--~l~LVmEy~~g 886 (1181)
.++||+|+||+||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++...+ ..++||||+++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 93 (319)
T 4euu_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (319)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTT
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCC
Confidence 347999999999999999999999999997543 344677889999999999999999999987654 78999999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccc----ccCCCeeeeecCCcccccccCCCC
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLV----NTYSGVVKISDFGTSKRLAGLCPS 962 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL----d~~~g~vKLiDFGlAk~l~~~~~~ 962 (1181)
++|.+++........+++..++.++.||+.||+|||++||+||||||+|||+ +. ++.+||+|||+++...... .
T Consensus 94 ~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~-~~~~kL~Dfg~a~~~~~~~-~ 171 (319)
T 4euu_A 94 GSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDG-QSVYKLTDFGAARELEDDE-Q 171 (319)
T ss_dssp CBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTS-CEEEEECCCTTCEECCTTC-C
T ss_pred CCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCC-CceEEEccCCCceecCCCC-c
Confidence 9999999876445558899999999999999999999999999999999998 55 6789999999998765432 3
Q ss_pred CccccCCccccCchhhccC------CCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc---
Q psy14556 963 AETFTGTLQYMAPEVIDKG------QRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA--- 1033 (1181)
Q Consensus 963 ~~t~~GT~~Y~APEvl~gg------~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~--- 1033 (1181)
.....||+.|+|||++... ...++...|+ ||+||++|+|++|+.||.......
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Di------------------wslG~il~el~~g~~pf~~~~~~~~~~ 233 (319)
T 4euu_A 172 FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDL------------------WSIGVTFYHAATGSLPFRPFEGPRRNK 233 (319)
T ss_dssp BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHH------------------HHHHHHHHHHHHSSCSEECTTCGGGCH
T ss_pred eeecccCCCccCHHHhhhccccccccCCCCcHHHH------------------HHHHHHHHHHHhCCCCCCCCCccchhH
Confidence 3345699999999998632 1122333333 999999999999999997543311
Q ss_pred -c-----cCCC-------------------C--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1034 -L-----VAPP-------------------Q--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1034 -l-----~~~~-------------------~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
+ ...+ . .+...+...+..+..++.+|++.||.+||+..+.+
T Consensus 234 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell 301 (319)
T 4euu_A 234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301 (319)
T ss_dssp HHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHH
T ss_pred HHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhh
Confidence 0 0000 0 11111222344677789999999999999755443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=335.56 Aligned_cols=247 Identities=23% Similarity=0.279 Sum_probs=202.4
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEee
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQ 883 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy 883 (1181)
+.|.+. ++||+|+||.||+|.+..+++.||+|++..........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 51 ~~y~i~-~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 51 DYYDIL-EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GTEEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEE-EEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 344444 4799999999999999999999999999766554556789999999999999999999999999999999999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccccc-CCCeeeeecCCcccccccCCCC
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGLCPS 962 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~-~~g~vKLiDFGlAk~l~~~~~~ 962 (1181)
+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++. .++.+||+|||+++..... ..
T Consensus 130 ~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~-~~ 206 (387)
T 1kob_A 130 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EI 206 (387)
T ss_dssp CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-SC
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC-cc
Confidence 9999999998743 345789999999999999999999999999999999999974 2468999999999876543 22
Q ss_pred CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc-----CC
Q psy14556 963 AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV-----AP 1037 (1181)
Q Consensus 963 ~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~-----~~ 1037 (1181)
.....||+.|+|||++.+..++ ..+|+ ||+||++|+|++|..||.+.+..... ..
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~--~~~Di------------------wSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~ 266 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDREPVG--FYTDM------------------WAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD 266 (387)
T ss_dssp EEEECSSGGGCCHHHHTTCCBC--HHHHH------------------HHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC
T ss_pred eeeeccCCCccCchhccCCCCC--CcccE------------------eeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 3345699999999999765433 33333 99999999999999999987754421 12
Q ss_pred CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1038 PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1038 ~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
...+.......+..+..++.+|+..+|..||+..+.+
T Consensus 267 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 303 (387)
T 1kob_A 267 WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDAL 303 (387)
T ss_dssp CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 2233334446778899999999999999999754443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=324.55 Aligned_cols=255 Identities=22% Similarity=0.281 Sum_probs=204.5
Q ss_pred hHHHHhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhc-CCCCeeeEccccccC
Q psy14556 798 PMLRFLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEE 874 (1181)
Q Consensus 798 p~~~~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~ 874 (1181)
....+.+.|.+..++||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 4455666777766789999999999999999999999999975432 3357899999999999 569999999999999
Q ss_pred CcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccccc--CCCeeeeecCCc
Q psy14556 875 GYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNT--YSGVVKISDFGT 952 (1181)
Q Consensus 875 ~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~--~~g~vKLiDFGl 952 (1181)
+..++||||+++++|.+++... ....+++..++.++.||+.||+|||++||+||||||+||+++. .++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~ 180 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM 180 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred CeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence 9999999999999999998643 3356889999999999999999999999999999999999975 257899999999
Q ss_pred ccccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc
Q psy14556 953 SKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR 1032 (1181)
Q Consensus 953 Ak~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~ 1032 (1181)
++...... ......||+.|+|||++.+..++. ..|+ ||+|+++|+|++|+.||.+.+..
T Consensus 181 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~--~~Di------------------wslG~il~~ll~g~~pf~~~~~~ 239 (327)
T 3lm5_A 181 SRKIGHAC-ELREIMGTPEYLAPEILNYDPITT--ATDM------------------WNIGIIAYMLLTHTSPFVGEDNQ 239 (327)
T ss_dssp CEEC----------CCCGGGCCHHHHTTCCCCT--HHHH------------------HHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ccccCCcc-ccccccCCcCccCCeeecCCCCCc--hhhH------------------HHHHHHHHHHHhCCCCCCCCCch
Confidence 98765432 233457999999999997654433 3333 99999999999999999987765
Q ss_pred ccc-----CCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1033 ALV-----APPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1033 ~l~-----~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
... .....+.......+..+..++.+|+..+|..||+..+.+
T Consensus 240 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll 286 (327)
T 3lm5_A 240 ETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICL 286 (327)
T ss_dssp HHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred HHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 431 223344444456788899999999999999999855543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=323.00 Aligned_cols=246 Identities=22% Similarity=0.312 Sum_probs=201.0
Q ss_pred hhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC------ChhHHHHHHHHHHhcCCCCeeeEccccccCCc
Q psy14556 803 LYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG------DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGY 876 (1181)
Q Consensus 803 ~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~------~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~ 876 (1181)
.+.|.+. ++||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 11 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 11 EDFYDIG-EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hccEEEe-eEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3444444 4799999999999999999999999999765332 35679999999999999999999999999999
Q ss_pred EEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCC----eeeeecCCc
Q psy14556 877 FKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSG----VVKISDFGT 952 (1181)
Q Consensus 877 l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g----~vKLiDFGl 952 (1181)
.++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++. ++ .+||+|||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~-~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLD-KNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESC-TTSSSCCEEECCCTT
T ss_pred EEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEec-CCCCcCCEEEccCcc
Confidence 99999999999999999743 45789999999999999999999999999999999999987 55 799999999
Q ss_pred ccccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc
Q psy14556 953 SKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR 1032 (1181)
Q Consensus 953 Ak~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~ 1032 (1181)
+....... ......||+.|+|||++.+..++. ..|+ ||+|+++|+|++|..||.+.+..
T Consensus 166 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~--~~Di------------------~slG~il~~l~~g~~pf~~~~~~ 224 (321)
T 2a2a_A 166 AHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGL--EADM------------------WSIGVITYILLSGASPFLGDTKQ 224 (321)
T ss_dssp CEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCT--HHHH------------------HHHHHHHHHHHHSCCSSCCSSHH
T ss_pred ceecCccc-cccccCCCCCccCcccccCCCCCC--cccc------------------HHHHHHHHHHHHCCCCCCCCCHH
Confidence 98765432 234456999999999997654433 3333 99999999999999999987765
Q ss_pred cccC-----CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1033 ALVA-----PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1033 ~l~~-----~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
+... ....+.......+..+..++.+|+..+|..||+..+.+
T Consensus 225 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l 271 (321)
T 2a2a_A 225 ETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEAL 271 (321)
T ss_dssp HHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHH
T ss_pred HHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 4321 11222222345677889999999999999999755544
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=347.61 Aligned_cols=239 Identities=25% Similarity=0.306 Sum_probs=186.6
Q ss_pred cccCceeecccCceEEEEEEEcCCCeEEEEEEecCC---CCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEe
Q psy14556 806 FALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEK---NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 806 ~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~---~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmE 882 (1181)
|.+. .+||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus 150 y~~~-~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 228 (446)
T 4ejn_A 150 FEYL-KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME 228 (446)
T ss_dssp EEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEEC
T ss_pred cEEe-EEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEe
Confidence 4443 4799999999999999999999999999653 23345667899999999999999999999999999999999
Q ss_pred ecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccc-cceecccCCCCCcccccCCCeeeeecCCcccccccCCC
Q psy14556 883 QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHG-QKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP 961 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs-~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~ 961 (1181)
|+++|+|.+++... ..+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++.......
T Consensus 229 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~-~~~~kl~DFG~a~~~~~~~~ 304 (446)
T 4ejn_A 229 YANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK-DGHIKITDFGLCKEGIKDGA 304 (446)
T ss_dssp CCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECS-SSCEEECCCCCCCTTCC---
T ss_pred eCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECC-CCCEEEccCCCceeccCCCc
Confidence 99999999998754 357899999999999999999998 99999999999999998 89999999999986554444
Q ss_pred CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-C
Q psy14556 962 SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-I 1040 (1181)
Q Consensus 962 ~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-i 1040 (1181)
......||+.|+|||++.+..+ +..+|+ ||+||++|+|++|+.||.+.+...+..... .
T Consensus 305 ~~~~~~gt~~y~aPE~~~~~~~--~~~~Di------------------wslG~il~ell~g~~Pf~~~~~~~~~~~i~~~ 364 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVLEDNDY--GRAVDW------------------WGLGVVMYEMMCGRLPFYNQDHEKLFELILME 364 (446)
T ss_dssp --CCSSSCGGGCCHHHHHTSCC--CTHHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred ccccccCCccccCHhhcCCCCC--CCccch------------------hhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC
Confidence 4556789999999999976544 334444 999999999999999999877654322111 1
Q ss_pred CCCCCCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1041 SRSVSVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1041 p~~l~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
....+...+..+..++.+|+..+|..||.
T Consensus 365 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~ 393 (446)
T 4ejn_A 365 EIRFPRTLGPEAKSLLSGLLKKDPKQRLG 393 (446)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSTTTSTT
T ss_pred CCCCCccCCHHHHHHHHHHcccCHHHhCC
Confidence 11123346778889999999999999993
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=335.51 Aligned_cols=240 Identities=24% Similarity=0.296 Sum_probs=194.2
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.
T Consensus 95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~ 174 (373)
T 2x4f_A 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174 (373)
T ss_dssp EECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEH
T ss_pred eEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHH
Confidence 46999999999999999999999999998766556678999999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccccc-CCCeeeeecCCcccccccCCCCCccccCC
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGLCPSAETFTGT 969 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~-~~g~vKLiDFGlAk~l~~~~~~~~t~~GT 969 (1181)
+++... ...+++..++.++.||+.||+|||++||+||||||+|||+.. .++.+||+|||+++..... .......||
T Consensus 175 ~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt 251 (373)
T 2x4f_A 175 DRIIDE--SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-EKLKVNFGT 251 (373)
T ss_dssp HHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT-CBCCCCCSS
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc-cccccccCC
Confidence 888643 235778999999999999999999999999999999999942 2679999999999876543 223345699
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc-----CCCCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV-----APPQISRSV 1044 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~-----~~~~ip~~l 1044 (1181)
+.|+|||++.+..++. ..|+ ||+||++|+|++|..||.+.+..+.. ....++...
T Consensus 252 ~~y~aPE~~~~~~~~~--~~Di------------------wslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 311 (373)
T 2x4f_A 252 PEFLAPEVVNYDFVSF--PTDM------------------WSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEE 311 (373)
T ss_dssp CTTCCHHHHTTCBCCH--HHHH------------------HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGG
T ss_pred CcEeChhhccCCCCCc--HHhH------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhh
Confidence 9999999997554333 3333 99999999999999999988764421 222233333
Q ss_pred CCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1045 SVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1045 ~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
....+..+..++.+|+..+|..||+..+.
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~ 340 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEA 340 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 34677889999999999999999975555
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=331.02 Aligned_cols=239 Identities=21% Similarity=0.265 Sum_probs=174.3
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcC-CCCeeeEccccccCCcEEEEEe
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR-HRNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~-HPNIVkl~g~~~d~~~l~LVmE 882 (1181)
+++....++||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++.+. ||||+++++++.+.+..|+|||
T Consensus 10 y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e 86 (325)
T 3kn6_A 10 YDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVME 86 (325)
T ss_dssp EEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred cccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEE
Confidence 33444456799999999999999999999999999643 3466889999999997 9999999999999999999999
Q ss_pred ecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCC---eeeeecCCcccccccC
Q psy14556 883 QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSG---VVKISDFGTSKRLAGL 959 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g---~vKLiDFGlAk~l~~~ 959 (1181)
|+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++ .+||+|||+++.....
T Consensus 87 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~-~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 87 LLNGGELFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTD-ENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp CCCSCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC-----CEEEECCCTTCEECCC-
T ss_pred ccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEec-CCCcccEEEeccccceecCCC
Confidence 99999999999854 46789999999999999999999999999999999999976 33 8999999999876554
Q ss_pred CCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc------
Q psy14556 960 CPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA------ 1033 (1181)
Q Consensus 960 ~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~------ 1033 (1181)
........||+.|+|||++.+..+ +...|+ ||+|+++|+|++|+.||.+.....
T Consensus 163 ~~~~~~~~~t~~y~aPE~~~~~~~--~~~~Di------------------wslG~il~~ll~g~~pf~~~~~~~~~~~~~ 222 (325)
T 3kn6_A 163 NQPLKTPCFTLHYAAPELLNQNGY--DESCDL------------------WSLGVILYTMLSGQVPFQSHDRSLTCTSAV 222 (325)
T ss_dssp ---------------------CCC--CHHHHH------------------HHHHHHHHHHHHSSCTTC-------CCCHH
T ss_pred CCcccccCCCcCccCHHHhcCCCC--CCccch------------------HHHHHHHHHHHhCCCCCCCCccccccccHH
Confidence 444455678999999999976543 333333 999999999999999998765421
Q ss_pred -cc-----CCCCCCCCCCCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1034 -LV-----APPQISRSVSVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1034 -l~-----~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
+. ....++.......+..+..++.+|+..+|..||+
T Consensus 223 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt 264 (325)
T 3kn6_A 223 EIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLK 264 (325)
T ss_dssp HHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCC
T ss_pred HHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCC
Confidence 11 0111111111246778888999999999999997
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=334.94 Aligned_cols=247 Identities=21% Similarity=0.301 Sum_probs=196.9
Q ss_pred ceeecccCceEEEEEEEc-------CCCeEEEEEEecCCCC-CChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEE
Q psy14556 810 RIELGKGSYGVVYAAREL-------DRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIF 880 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~-------~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LV 880 (1181)
.++||+|+||.||+|++. .++..||+|+++.... ...+.+.+|+.+++++ +||||+++++++.+.+.+|+|
T Consensus 86 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv 165 (370)
T 2psq_A 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 165 (370)
T ss_dssp EEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEE
Confidence 347999999999999875 3556899999976533 2356789999999999 899999999999999999999
Q ss_pred EeecCCCCcccchhcccC-------------CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeee
Q psy14556 881 MEQVPGGSLSTLLRVKWG-------------PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKI 947 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~~-------------~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKL 947 (1181)
|||+++|+|.+++..... ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||
T Consensus 166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-~~~~kl 244 (370)
T 2psq_A 166 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE-NNVMKI 244 (370)
T ss_dssp EECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT-TCCEEE
T ss_pred EEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECC-CCCEEE
Confidence 999999999999986421 234788899999999999999999999999999999999987 899999
Q ss_pred ecCCcccccccCCC--CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCC
Q psy14556 948 SDFGTSKRLAGLCP--SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTA 1024 (1181)
Q Consensus 948 iDFGlAk~l~~~~~--~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~ 1024 (1181)
+|||+++....... ......+|+.|+|||++.+..++ ...|+ |||||++|||++ |+.
T Consensus 245 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~--~~~Dv------------------wslG~il~ellt~g~~ 304 (370)
T 2psq_A 245 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT--HQSDV------------------WSFGVLMWEIFTLGGS 304 (370)
T ss_dssp CCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCC--HHHHH------------------HHHHHHHHHHHTTSCC
T ss_pred ccccCCcccCcccceecccCCCcccceECHhHhcCCCCC--cHHHH------------------HHHHHHHHHHHcCCCC
Confidence 99999986654322 22334578899999999765433 33333 999999999999 999
Q ss_pred CCCCCCcccccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1025 ALKKKTSRALVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1025 PF~~~~~~~l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
||.+....++..... .....+...+..+..++.+|+..+|..||+ +.+.+..+
T Consensus 305 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-~~ell~~L 359 (370)
T 2psq_A 305 PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPT-FKQLVEDL 359 (370)
T ss_dssp SSTTCCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC-HHHHHHHH
T ss_pred CCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcC-HHHHHHHH
Confidence 999887655432111 112234456778999999999999999985 55544443
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=329.87 Aligned_cols=245 Identities=23% Similarity=0.281 Sum_probs=198.1
Q ss_pred HHhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEE
Q psy14556 801 RFLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKI 879 (1181)
Q Consensus 801 ~~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~L 879 (1181)
.+.+.|.+.+ +||+|+||.||+|.+..+++.||+|++.+.... ..+|+.++.++ +||||+++++++.+.+..|+
T Consensus 19 ~~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 19 QFTDGYEVKE-DIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp CHHHHEEEEE-EEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEE-EEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 3455566554 799999999999999999999999999765432 45788888888 79999999999999999999
Q ss_pred EEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCC---eeeeecCCccccc
Q psy14556 880 FMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSG---VVKISDFGTSKRL 956 (1181)
Q Consensus 880 VmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g---~vKLiDFGlAk~l 956 (1181)
||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+...++ .+||+|||+++..
T Consensus 94 v~E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp EECCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99999999999998743 35789999999999999999999999999999999999854333 5999999999877
Q ss_pred ccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCc---cc
Q psy14556 957 AGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTS---RA 1033 (1181)
Q Consensus 957 ~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~---~~ 1033 (1181)
...........||+.|+|||++.+..++ ..+ +.||+||++|+|++|..||.+... .+
T Consensus 171 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~------------------DiwslG~il~ell~g~~Pf~~~~~~~~~~ 230 (342)
T 2qr7_A 171 RAENGLLMTPCYTANFVAPEVLERQGYD--AAC------------------DIWSLGVLLYTMLTGYTPFANGPDDTPEE 230 (342)
T ss_dssp BCTTCCBCCSSCCSSCCCHHHHHHHHHH--HHH------------------HHHHHHHHHHHHHHSSCSSCSSTTSCHHH
T ss_pred cCCCCceeccCCCccccCHHHhcCCCCC--Ccc------------------CeeeHhHHHHHHhcCCCCCCCCCcCCHHH
Confidence 6554455567799999999999754322 223 339999999999999999986432 22
Q ss_pred c-----cCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1034 L-----VAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1034 l-----~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
+ .....++.......+..+..++.+|+..||.+||+..+.
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~i 275 (342)
T 2qr7_A 231 ILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALV 275 (342)
T ss_dssp HHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 2 112233344445678889999999999999999986555
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=338.08 Aligned_cols=241 Identities=23% Similarity=0.319 Sum_probs=194.9
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCC---CCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEK---NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~---~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.+||+|+||+||+|++..+++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+.+.+|+||||++||
T Consensus 75 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg 154 (410)
T 3v8s_A 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG 154 (410)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTE
T ss_pred EEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 3799999999999999999999999999653 2233456889999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC-CCccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP-SAETF 966 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~-~~~t~ 966 (1181)
+|.++++.. .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++....... ...+.
T Consensus 155 ~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~-~g~ikL~DFG~a~~~~~~~~~~~~~~ 229 (410)
T 3v8s_A 155 DLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK-SGHLKLADFGTCMKMNKEGMVRCDTA 229 (410)
T ss_dssp EHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TSCEEECCCTTCEECCTTSEEECCSC
T ss_pred cHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECC-CCCEEEeccceeEeeccCCcccccCC
Confidence 999998753 4789999999999999999999999999999999999988 89999999999987654321 23356
Q ss_pred cCCccccCchhhccCCCC--CCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCC-----C
Q psy14556 967 TGTLQYMAPEVIDKGQRG--YGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPP-----Q 1039 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~~--~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~-----~ 1039 (1181)
+||+.|+|||++.+.... ++..+|+ ||+||++|||++|+.||.+.+...+...+ .
T Consensus 230 ~gt~~Y~APE~l~~~~~~~~~~~~~Di------------------wSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~ 291 (410)
T 3v8s_A 230 VGTPDYISPEVLKSQGGDGYYGRECDW------------------WSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS 291 (410)
T ss_dssp CSCGGGCCHHHHHTTTTTCEEETHHHH------------------HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred cCCccccCHHHhhccCCCcCCCCcceE------------------ecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc
Confidence 799999999999754311 2333443 99999999999999999988765432211 1
Q ss_pred CCCCCCCCCCcchHHhhccCCCCCCCC--CchhHHHH
Q psy14556 1040 ISRSVSVPGPGGINSSSSAPVTPTPHS--RHISVNTN 1074 (1181)
Q Consensus 1040 ip~~l~~~~p~~L~~li~r~la~dPs~--Rp~s~~~~ 1074 (1181)
+.-+.....+..+..++.+++..+|.+ |+...+..
T Consensus 292 ~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~ 328 (410)
T 3v8s_A 292 LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIK 328 (410)
T ss_dssp CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHH
T ss_pred ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHh
Confidence 122222356788888999999977776 76543333
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=315.68 Aligned_cols=245 Identities=25% Similarity=0.387 Sum_probs=179.6
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFM 881 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVm 881 (1181)
.|.+. .+||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 12 ~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 12 DFKVG-NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceee-eeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 34443 47999999999999999999999999996442 233577999999999999999999999999999999999
Q ss_pred eecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC
Q psy14556 882 EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP 961 (1181)
Q Consensus 882 Ey~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~ 961 (1181)
||+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||++........
T Consensus 91 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~-~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 91 EMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTR-NMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp ECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECT-TCCEEECCCTTCEECC----
T ss_pred ecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC-CCCEEEEeecceeeccCCCC
Confidence 999999999998753 245789999999999999999999999999999999999987 88999999999987654333
Q ss_pred CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCCCC
Q psy14556 962 SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQIS 1041 (1181)
Q Consensus 962 ~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~ip 1041 (1181)
......||+.|+|||++.+...+..+|+ ||+|+++|+|++|+.||...............
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di--------------------~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 227 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHGLESDV--------------------WSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA 227 (278)
T ss_dssp ------------------------CTHH--------------------HHHHHHHHHHHHSSCSSCCCSCC-----CCSS
T ss_pred cceeccCCCCcCCcchhcCCCCCchhhH--------------------HHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc
Confidence 3445668999999999976554444333 99999999999999999987655433322211
Q ss_pred C-CCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1042 R-SVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1042 ~-~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
. ..+...+..+..++.+|+..+|..||+..+.
T Consensus 228 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~ 260 (278)
T 3cok_A 228 DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSV 260 (278)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred ccCCccccCHHHHHHHHHHcccCHhhCCCHHHH
Confidence 1 2233467788899999999999999974443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=330.13 Aligned_cols=245 Identities=22% Similarity=0.228 Sum_probs=193.9
Q ss_pred eeecccCceEEEEEEEcCCC---eEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCC
Q psy14556 811 IELGKGSYGVVYAARELDRQ---VKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg---~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
.+||+|+||.||+|.+..++ ..||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 55 ~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 134 (325)
T 3kul_A 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMEN 134 (325)
T ss_dssp EEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTT
T ss_pred eEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCC
Confidence 47999999999999997554 4599999975532 2356789999999999999999999999999999999999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCC---
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA--- 963 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~--- 963 (1181)
++|.++++.. ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.........
T Consensus 135 ~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~ 211 (325)
T 3kul_A 135 GSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDS-NLVCKVSDFGLSRVLEDDPDAAYTT 211 (325)
T ss_dssp CBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-TCCEEECCCSSCEECC----CCEEC
T ss_pred CcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECC-CCCEEECCCCcccccccCccceeec
Confidence 9999999743 235789999999999999999999999999999999999988 8999999999998765432221
Q ss_pred ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--C
Q psy14556 964 ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--I 1040 (1181)
Q Consensus 964 ~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--i 1040 (1181)
....+|+.|+|||++.+..++. ..|+ ||+|+++|+|++ |..||.+.....+..... .
T Consensus 212 ~~~~~t~~y~aPE~~~~~~~~~--~~Di------------------~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~ 271 (325)
T 3kul_A 212 TGGKIPIRWTAPEAIAFRTFSS--ASDV------------------WSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY 271 (325)
T ss_dssp C---CCGGGSCHHHHHHCEECH--HHHH------------------HHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC
T ss_pred cCCCCcccccCHhHhcCCCCCc--HHHH------------------HHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC
Confidence 1233577899999997654333 3333 999999999999 999998877655422111 1
Q ss_pred CCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcc
Q psy14556 1041 SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTG 1079 (1181)
Q Consensus 1041 p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~ 1079 (1181)
....+...+..+..++.+|+..+|..||+ +.+.+..+.
T Consensus 272 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~eil~~L~ 309 (325)
T 3kul_A 272 RLPAPMGCPHALHQLMLDCWHKDRAQRPR-FSQIVSVLD 309 (325)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCC-HHHHHHHHH
T ss_pred CCCCCCCcCHHHHHHHHHHccCChhhCcC-HHHHHHHHH
Confidence 22234467888999999999999999995 444444333
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=334.74 Aligned_cols=245 Identities=23% Similarity=0.274 Sum_probs=190.4
Q ss_pred HhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHh-cCCCCeeeEcccccc----CCc
Q psy14556 802 FLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQ-LRHRNIVQYLGSVSE----EGY 876 (1181)
Q Consensus 802 ~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~-L~HPNIVkl~g~~~d----~~~ 876 (1181)
+...|.....+||+|+||+||+|.+..+++.||||++.. ...+.+|+.++.+ .+||||+++++++.. .+.
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 445566655679999999999999999999999999963 2567889998754 589999999998865 567
Q ss_pred EEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccC--CCeeeeecCCccc
Q psy14556 877 FKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTY--SGVVKISDFGTSK 954 (1181)
Q Consensus 877 l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~--~g~vKLiDFGlAk 954 (1181)
+|+||||++||+|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.. ++.+||+|||+++
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 99999999999999999854 34468899999999999999999999999999999999999863 5789999999998
Q ss_pred ccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc
Q psy14556 955 RLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL 1034 (1181)
Q Consensus 955 ~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l 1034 (1181)
..... .......||+.|+|||++.+..+ +..+|+ ||+||++|+|++|+.||.+.....+
T Consensus 213 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~--~~~~Di------------------wslG~il~ell~g~~pf~~~~~~~~ 271 (400)
T 1nxk_A 213 ETTSH-NSLTTPCYTPYYVAPEVLGPEKY--DKSCDM------------------WSLGVIMYILLCGYPPFYSNHGLAI 271 (400)
T ss_dssp ECC------------CTTCCGGGSCCCCS--SSHHHH------------------HHHHHHHHHHHHSSCSCCCCTTCSS
T ss_pred ccCCC-CccccCCCCCCccCHhhcCCCCC--CCcccH------------------HHHHHHHHHHHhCCCCCCCCccccc
Confidence 66532 22345678999999999976543 334444 9999999999999999987664332
Q ss_pred c---------CCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1035 V---------APPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1035 ~---------~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
. ....++.......+..+..++.+|+..+|.+||+..+.
T Consensus 272 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ei 319 (400)
T 1nxk_A 272 SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 319 (400)
T ss_dssp CCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred cHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 1 12223333334577889999999999999999975554
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=315.22 Aligned_cols=245 Identities=28% Similarity=0.373 Sum_probs=200.1
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEE
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFM 881 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVm 881 (1181)
+.|.+.+ +||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 6 DNYDVKE-ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTEEEEE-EEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhh-hhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4444444 79999999999999999999999999965533 23467889999999999999999999999999999999
Q ss_pred eecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccC--CCeeeeecCCcccccccC
Q psy14556 882 EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTY--SGVVKISDFGTSKRLAGL 959 (1181)
Q Consensus 882 Ey~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~--~g~vKLiDFGlAk~l~~~ 959 (1181)
||+++++|.+.+... ..+++..++.++.|++.||.|||++||+||||||+||+++.. ++.+||+|||++......
T Consensus 85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 999999998888754 357899999999999999999999999999999999999762 235999999999776543
Q ss_pred CCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc----
Q psy14556 960 CPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV---- 1035 (1181)
Q Consensus 960 ~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~---- 1035 (1181)
.......||+.|+|||++.+..++. ..|+ ||+|+++|+|++|+.||.+.....+.
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~~~~~~--~~Di------------------~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 220 (284)
T 3kk8_A 162 -EAWHGFAGTPGYLSPEVLKKDPYSK--PVDI------------------WACGVILYILLVGYPPFWDEDQHRLYAQIK 220 (284)
T ss_dssp -CBCCCSCSCGGGCCHHHHTTCCBCT--HHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred -ccccCCCCCcCCcCchhhcCCCCCc--ccch------------------HHHHHHHHHHHHCCCCCCCCchhHHHHHHH
Confidence 2233456999999999997654433 3333 99999999999999999887765432
Q ss_pred -CCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1036 -APPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1036 -~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.....+.......+..+..++.+|++.+|..||+..+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~ 259 (284)
T 3kk8_A 221 AGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQA 259 (284)
T ss_dssp HTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred hccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHH
Confidence 12223333344677889999999999999999986665
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=321.75 Aligned_cols=247 Identities=20% Similarity=0.225 Sum_probs=196.5
Q ss_pred ceeecccCceEEEEEEEc-----CCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEee
Q psy14556 810 RIELGKGSYGVVYAAREL-----DRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQ 883 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~-----~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy 883 (1181)
.++||+|+||.||+|.+. .++..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 107 (314)
T 2ivs_A 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEY 107 (314)
T ss_dssp EEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEee
Confidence 457999999999999984 4558999999975432 2356789999999999999999999999999999999999
Q ss_pred cCCCCcccchhcccC---------------------CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCC
Q psy14556 884 VPGGSLSTLLRVKWG---------------------PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYS 942 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~---------------------~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~ 942 (1181)
+++++|.+++..... ...+++..++.++.||+.||.|||++||+||||||+||+++. +
T Consensus 108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~-~ 186 (314)
T 2ivs_A 108 AKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAE-G 186 (314)
T ss_dssp CTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-T
T ss_pred cCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcC-C
Confidence 999999999986422 134788999999999999999999999999999999999997 8
Q ss_pred CeeeeecCCcccccccCCC--CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHH
Q psy14556 943 GVVKISDFGTSKRLAGLCP--SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLL 1020 (1181)
Q Consensus 943 g~vKLiDFGlAk~l~~~~~--~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELL 1020 (1181)
+.+||+|||+++....... ......+++.|+|||++.+..++.. .|+ ||+|+++|+|+
T Consensus 187 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~--~Di------------------~slG~il~el~ 246 (314)
T 2ivs_A 187 RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ--SDV------------------WSFGVLLWEIV 246 (314)
T ss_dssp TEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHH--HHH------------------HHHHHHHHHHH
T ss_pred CCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCch--hhH------------------HHHHHHHHHHH
Confidence 9999999999986654322 1223457889999999976543332 333 99999999999
Q ss_pred h-CCCCCCCCCcccccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1021 V-LTAALKKKTSRALVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1021 T-Gk~PF~~~~~~~l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
+ |..||.+.....+..... .....+...+..+..++.+|++.+|..||+ +.+.+..+
T Consensus 247 t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~~l~~~l 306 (314)
T 2ivs_A 247 TLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPV-FADISKDL 306 (314)
T ss_dssp TTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-HHHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcC-HHHHHHHH
Confidence 9 999999887655422111 112233467788999999999999999996 44443333
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=315.49 Aligned_cols=240 Identities=19% Similarity=0.268 Sum_probs=189.0
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC--hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD--VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~--~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
++||+|+||+||+|.+..+++.||+|++....... .+.+.+|+.++++++||||+++++++.+.+..++||||+++ +
T Consensus 8 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 86 (292)
T 3o0g_A 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-D 86 (292)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-E
T ss_pred eEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-C
Confidence 37999999999999999999999999997654433 46788999999999999999999999999999999999965 5
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|.+.+... ...+++..++.++.||+.||+|||++||+||||||+||+++. ++.+||+|||+++.............|
T Consensus 87 l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 163 (292)
T 3o0g_A 87 LKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR-NGELKLANFGLARAFGIPVRCYSAEVV 163 (292)
T ss_dssp HHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TSCEEECCCTTCEECCSCCSCCCSCCS
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC-CCCEEEeecccceecCCccccccCCcc
Confidence 55555432 345789999999999999999999999999999999999998 899999999999877654444455678
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCC-CCCccccc-------CC---
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALK-KKTSRALV-------AP--- 1037 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~-~~~~~~l~-------~~--- 1037 (1181)
|+.|+|||++.+.. .++..+|+ ||+||++|+|++|..||. +.+..... ..
T Consensus 164 t~~y~aPE~~~~~~-~~~~~~Di------------------wslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~ 224 (292)
T 3o0g_A 164 TLWYRPPDVLFGAK-LYSTSIDM------------------WSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224 (292)
T ss_dssp CGGGCCHHHHTTCS-CCCTHHHH------------------HHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred ccCCcChHHHcCCC-CcCchHHH------------------HHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence 99999999997543 23444444 999999999999888854 33322110 00
Q ss_pred C--------------------CCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1038 P--------------------QISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1038 ~--------------------~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
. ..........+..+..++.+|++.||.+||+..+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 280 (292)
T 3o0g_A 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280 (292)
T ss_dssp TTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred hhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHH
Confidence 0 00001122356677889999999999999974443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=322.19 Aligned_cols=251 Identities=23% Similarity=0.294 Sum_probs=197.6
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEee
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQ 883 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy 883 (1181)
..|...+ .||+|+||.||+|.+ .+++.||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 39 ~~y~~~~-~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 116 (321)
T 2qkw_B 39 NNFDHKF-LIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKY 116 (321)
T ss_dssp CCCSCCC-CSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEEC
T ss_pred hccCccc-eeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEc
Confidence 3444433 699999999999985 46889999999877666678899999999999999999999999999999999999
Q ss_pred cCCCCcccchhccc-CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC-
Q psy14556 884 VPGGSLSTLLRVKW-GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP- 961 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~-~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~- 961 (1181)
+++++|.+++.... ....+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||+++.......
T Consensus 117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~ 195 (321)
T 2qkw_B 117 MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDE-NFVPKITDFGISKKGTELDQT 195 (321)
T ss_dssp CTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECT-TCCEEECCCTTCEECSSSSCC
T ss_pred CCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECC-CCCEEEeeccccccccccccc
Confidence 99999999997542 2235889999999999999999999999999999999999987 89999999999976543221
Q ss_pred -CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC----
Q psy14556 962 -SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA---- 1036 (1181)
Q Consensus 962 -~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~---- 1036 (1181)
......||+.|+|||++.++.++.. .|+ ||+|+++|+|++|+.||.+........
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~--~Di------------------~slG~il~ell~g~~p~~~~~~~~~~~~~~~ 255 (321)
T 2qkw_B 196 HLSTVVKGTLGYIDPEYFIKGRLTEK--SDV------------------YSFGVVLFEVLCARSAIVQSLPREMVNLAEW 255 (321)
T ss_dssp CCBCCCEEETTTCCHHHHHHCBCCTH--HHH------------------HHHHHHHHHHHHCCTTCSCSSSSSCCCHHHH
T ss_pred ccccccCCCccccCHHHhcCCCCCcc--cch------------------HhHHHHHHHHHhCCCcccccCcHHHHHHHHH
Confidence 2233458999999999976654333 333 999999999999999998766543211
Q ss_pred ------C--------CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1037 ------P--------PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1037 ------~--------~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
. +..........+..+..++.+|++.+|..||+. .+.+..+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~-~ell~~L 310 (321)
T 2qkw_B 256 AVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSM-GDVLWKL 310 (321)
T ss_dssp THHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCH-HHHHHHH
T ss_pred hhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCH-HHHHHHH
Confidence 0 111112222334557778999999999999964 4433333
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=321.05 Aligned_cols=245 Identities=16% Similarity=0.190 Sum_probs=195.5
Q ss_pred ceeecccCceEEEEEEEcCCC-------eEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEe
Q psy14556 810 RIELGKGSYGVVYAARELDRQ-------VKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg-------~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmE 882 (1181)
.++||+|+||.||+|.+..++ ..||+|++........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 92 (289)
T 4fvq_A 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQE 92 (289)
T ss_dssp EEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEE
T ss_pred eeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEE
Confidence 347999999999999988766 5799999977666667889999999999999999999999999999999999
Q ss_pred ecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCe--------eeeecCCccc
Q psy14556 883 QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGV--------VKISDFGTSK 954 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~--------vKLiDFGlAk 954 (1181)
|+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++. +||+|||++.
T Consensus 93 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~-~~~~~~~~~~~~kl~Dfg~~~ 169 (289)
T 4fvq_A 93 FVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIR-EEDRKTGNPPFIKLSDPGISI 169 (289)
T ss_dssp CCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEE-CCBGGGTBCCEEEECCCCSCT
T ss_pred CCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEec-CCcccccccceeeeccCcccc
Confidence 99999999999854 234788899999999999999999999999999999999987 555 9999999986
Q ss_pred ccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCC-CCCCCCCccc
Q psy14556 955 RLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLT-AALKKKTSRA 1033 (1181)
Q Consensus 955 ~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk-~PF~~~~~~~ 1033 (1181)
.... .....||+.|+|||++.+. ..++...|+ ||+|+++|+|++|. +||.......
T Consensus 170 ~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di------------------wslG~il~el~~g~~~~~~~~~~~~ 226 (289)
T 4fvq_A 170 TVLP----KDILQERIPWVPPECIENP-KNLNLATDK------------------WSFGTTLWEICSGGDKPLSALDSQR 226 (289)
T ss_dssp TTSC----HHHHHHTTTTSCHHHHHCG-GGCCHHHHH------------------HHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred cccC----ccccCCcCcccCHHHhCCC-CCCCchhHH------------------HHHHHHHHHHHcCCCCCccccchHH
Confidence 5532 1234588999999999752 123333333 99999999999955 5555544433
Q ss_pred ccCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcccC
Q psy14556 1034 LVAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGNN 1081 (1181)
Q Consensus 1034 l~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~~ 1081 (1181)
...........+...+..+..++.+|++.+|..|| ++.+.+..+..-
T Consensus 227 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~~ll~~l~~l 273 (289)
T 4fvq_A 227 KLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRP-SFRAIIRDLNSL 273 (289)
T ss_dssp HHHHHHTTCCCCCCSSCTTHHHHHHHSCSSGGGSC-CHHHHHHHHHTC
T ss_pred HHHHhhccCCCCCCCCHHHHHHHHHHcCCChhHCc-CHHHHHHHHHHh
Confidence 22111122333445677899999999999999997 577777777664
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=322.54 Aligned_cols=253 Identities=21% Similarity=0.271 Sum_probs=200.7
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC---hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEE
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD---VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIF 880 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~---~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LV 880 (1181)
..|.+.+ +||+|+||.||+|.+..+++.||+|++....... .+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 34 ~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 34 GPYRLRR-LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp CCEEEEE-EEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccEEEEE-EEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 3444443 7999999999999999999999999997653332 46789999999999999999999999999999999
Q ss_pred EeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC
Q psy14556 881 MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC 960 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~ 960 (1181)
|||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||++.......
T Consensus 113 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~-~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSA-DDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TSCEEECSCCC--------
T ss_pred EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcC-CCCEEEecCccCccccccc
Confidence 9999999999999854 35789999999999999999999999999999999999987 8899999999997665432
Q ss_pred -CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc----c
Q psy14556 961 -PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL----V 1035 (1181)
Q Consensus 961 -~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l----~ 1035 (1181)
.......|++.|+|||++.+..++..+|+ ||+|+++|+|++|+.||.+.....+ .
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di--------------------~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 248 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADI--------------------YALTCVLYECLTGSPPYQGDQLSVMGAHIN 248 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHH--------------------HHHHHHHHHHHHSSCSSCSCHHHHHHHHHH
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhH--------------------HHHHHHHHHHHHCCCCCCCchHHHHHHHhc
Confidence 12234568999999999976654444433 9999999999999999998765432 1
Q ss_pred CCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcccC
Q psy14556 1036 APPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGNN 1081 (1181)
Q Consensus 1036 ~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~~ 1081 (1181)
.....+.......+..+..++.+|+..+|..||++++++..++...
T Consensus 249 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~ 294 (309)
T 2h34_A 249 QAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAA 294 (309)
T ss_dssp SCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred cCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence 2222333445667889999999999999999999999988888775
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=327.73 Aligned_cols=245 Identities=25% Similarity=0.289 Sum_probs=184.1
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEee
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQ 883 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy 883 (1181)
+.|.+ ..+||+|+||.||+|++..+++.||+|++.... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 53 ~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 53 DFFEV-ESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GTEEE-EEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CcEEE-eeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 33444 347999999999999999999999999997553 345688999999999999999999999999999999999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccccc--CCCeeeeecCCcccccccCCC
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNT--YSGVVKISDFGTSKRLAGLCP 961 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~--~~g~vKLiDFGlAk~l~~~~~ 961 (1181)
+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. .++.+||+|||+++..... .
T Consensus 130 ~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~ 205 (349)
T 2w4o_A 130 VTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-V 205 (349)
T ss_dssp CCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-c
Confidence 9999999998743 35789999999999999999999999999999999999963 3679999999999866532 2
Q ss_pred CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc-c-----c
Q psy14556 962 SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA-L-----V 1035 (1181)
Q Consensus 962 ~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~-l-----~ 1035 (1181)
......||+.|+|||++.+..++ ...|+ ||+||++|+|++|..||....... + .
T Consensus 206 ~~~~~~gt~~y~aPE~~~~~~~~--~~~Di------------------wslG~il~ell~g~~pf~~~~~~~~~~~~i~~ 265 (349)
T 2w4o_A 206 LMKTVCGTPGYCAPEILRGCAYG--PEVDM------------------WSVGIITYILLCGFEPFYDERGDQFMFRRILN 265 (349)
T ss_dssp -------CGGGSCHHHHTTCCCC--THHHH------------------HHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHT
T ss_pred ccccccCCCCccCHHHhcCCCCC--cccch------------------HHHHHHHHHHHhCCCCCCCCcccHHHHHHHHh
Confidence 23345699999999999765433 33433 999999999999999998766533 1 1
Q ss_pred CCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHH
Q psy14556 1036 APPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNL 1075 (1181)
Q Consensus 1036 ~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~ 1075 (1181)
.....+.......+..+..++.+|+..+|.+||+..+.+.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 266 CEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1222333334456788999999999999999998665544
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=330.81 Aligned_cols=248 Identities=18% Similarity=0.240 Sum_probs=196.1
Q ss_pred hcccCceeeccc--CceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEE
Q psy14556 805 LFALNRIELGKG--SYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIF 880 (1181)
Q Consensus 805 ~~~l~~~kIG~G--~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LV 880 (1181)
.|.+.+ +||+| +||.||+|++..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 26 ~y~~~~-~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 26 CYELLT-VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GEEEEE-EEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cEEEEe-cccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 444443 79999 9999999999999999999999755332 246788899999999999999999999999999999
Q ss_pred EeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC
Q psy14556 881 MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC 960 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~ 960 (1181)
|||+++++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||.+.......
T Consensus 105 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~-~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 105 TSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISV-DGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp EECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TCCEEECCGGGCEECEETT
T ss_pred EEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC-CCCEEEcccccceeecccc
Confidence 9999999999999764 3345889999999999999999999999999999999999987 8999999999886543211
Q ss_pred -------CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc
Q psy14556 961 -------PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA 1033 (1181)
Q Consensus 961 -------~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~ 1033 (1181)
.......||+.|+|||++.+....++..+|+ ||+||++|+|++|+.||.+.+...
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di------------------wslG~il~el~~g~~pf~~~~~~~ 244 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDI------------------YSVGITACELANGHVPFKDMPATQ 244 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHH------------------HHHHHHHHHHHHSSCTTTTCCSTT
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHH------------------HHHHHHHHHHHHCCCCCCCCCHHH
Confidence 1122346899999999997643344555555 999999999999999998765533
Q ss_pred ccCCCC---C--------------------------------------------CCCCCCCCCcchHHhhccCCCCCCCC
Q psy14556 1034 LVAPPQ---I--------------------------------------------SRSVSVPGPGGINSSSSAPVTPTPHS 1066 (1181)
Q Consensus 1034 l~~~~~---i--------------------------------------------p~~l~~~~p~~L~~li~r~la~dPs~ 1066 (1181)
...... . ........+..+..++.+|+..||.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 324 (389)
T 3gni_B 245 MLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDA 324 (389)
T ss_dssp HHHHC--------------------------------------------------------CCHHHHHHHHHHTCSCTTT
T ss_pred HHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCccc
Confidence 210000 0 00122335666888999999999999
Q ss_pred CchhHHH
Q psy14556 1067 RHISVNT 1073 (1181)
Q Consensus 1067 Rp~s~~~ 1073 (1181)
||+..+.
T Consensus 325 Rpta~el 331 (389)
T 3gni_B 325 RPSASTL 331 (389)
T ss_dssp SCCHHHH
T ss_pred CCCHHHH
Confidence 9985554
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=322.47 Aligned_cols=241 Identities=24% Similarity=0.390 Sum_probs=187.4
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
+||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..++||||++ ++|.
T Consensus 12 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~ 90 (317)
T 2pmi_A 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLK 90 (317)
T ss_dssp -------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHH
T ss_pred EECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHH
Confidence 69999999999999999999999999975543 345778999999999999999999999999999999999997 6999
Q ss_pred cchhccc---CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 891 TLLRVKW---GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 891 dlL~~~~---~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+++.... ....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.............
T Consensus 91 ~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~ 169 (317)
T 2pmi_A 91 KYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINK-RGQLKLGDFGLARAFGIPVNTFSSEV 169 (317)
T ss_dssp HHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT-TCCEEECCCSSCEETTSCCCCCCCCC
T ss_pred HHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcC-CCCEEECcCccceecCCCcccCCCCc
Confidence 8886432 2245788999999999999999999999999999999999988 89999999999987754434444567
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC--------C--
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA--------P-- 1037 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~--------~-- 1037 (1181)
||+.|+|||++.+.. .++..+|+ ||+||++|+|++|+.||.+.+..+... +
T Consensus 170 ~t~~y~aPE~~~~~~-~~~~~~Di------------------wslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 230 (317)
T 2pmi_A 170 VTLWYRAPDVLMGSR-TYSTSIDI------------------WSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNE 230 (317)
T ss_dssp SCCTTCCHHHHTTCC-CCCTHHHH------------------HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCT
T ss_pred ccccccCchHhhCCC-CCCcHHHH------------------HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 899999999996432 23444444 999999999999999998876532110 0
Q ss_pred ---------CC----C------------CCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1038 ---------PQ----I------------SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1038 ---------~~----i------------p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
+. + ........+..+..++.+|+..+|.+||+..+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~ 291 (317)
T 2pmi_A 231 SLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQA 291 (317)
T ss_dssp TTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred hHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHH
Confidence 00 0 001112456678889999999999999975444
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.93 Aligned_cols=241 Identities=22% Similarity=0.262 Sum_probs=194.3
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
.+||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.
T Consensus 16 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (269)
T 4hcu_A 16 QEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS 93 (269)
T ss_dssp EEEEECSSCEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred heecCCCccEEEEEEec-CCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHH
Confidence 37999999999999986 467899999975543 3477999999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC-CCCccccCC
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC-PSAETFTGT 969 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~-~~~~t~~GT 969 (1181)
+++... ...+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||+++...... .......+|
T Consensus 94 ~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 170 (269)
T 4hcu_A 94 DYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE-NQVIKVSDFGMTRFVLDDQYTSSTGTKFP 170 (269)
T ss_dssp HHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG-GGCEEECCTTGGGGBCCHHHHSTTSTTCC
T ss_pred HHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcC-CCCEEeccccccccccccccccccCcccc
Confidence 999754 335789999999999999999999999999999999999987 7899999999997654321 122234567
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--CCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--ISRSVSV 1046 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--ip~~l~~ 1046 (1181)
+.|+|||++.+..++. ..|+ ||+|+++|+|++ |+.||.+.....+..... .....+.
T Consensus 171 ~~y~aPE~~~~~~~~~--~~Di------------------~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (269)
T 4hcu_A 171 VKWASPEVFSFSRYSS--KSDV------------------WSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR 230 (269)
T ss_dssp GGGCCHHHHHHCCCCH--HHHH------------------HHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT
T ss_pred cccCCHHHhcCCCCCc--hhhh------------------HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCC
Confidence 8899999997654433 3333 999999999999 999999877655422111 1222334
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHHHHHh
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNTNLVC 1077 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~~~~a 1077 (1181)
..+..+..++.+|++.+|..||+. .+.+..
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rps~-~~ll~~ 260 (269)
T 4hcu_A 231 LASTHVYQIMNHCWRERPEDRPAF-SRLLRQ 260 (269)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCH-HHHHHH
T ss_pred cCCHHHHHHHHHHccCCcccCcCH-HHHHHH
Confidence 467788999999999999999964 444333
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=313.19 Aligned_cols=241 Identities=23% Similarity=0.347 Sum_probs=193.4
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC-------hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEee
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD-------VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQ 883 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~-------~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy 883 (1181)
++||+|+||.||+|++..+++.||+|++....... .+.+.+|+.++++++||||+++++++.+.. ++||||
T Consensus 25 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~ 102 (287)
T 4f0f_A 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEF 102 (287)
T ss_dssp EECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEEC
T ss_pred hccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEe
Confidence 47999999999999999999999999996554322 267899999999999999999999987765 699999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccc--eecccCCCCCcccccCCCe-----eeeecCCccccc
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK--IVHRDIKGDNVLVNTYSGV-----VKISDFGTSKRL 956 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~g--IVHrDLKP~NILLd~~~g~-----vKLiDFGlAk~l 956 (1181)
+++++|.+++... ...+++..++.++.|++.||+|||++| |+||||||+||+++. ++. +||+|||+++..
T Consensus 103 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~-~~~~~~~~~kl~Dfg~~~~~ 179 (287)
T 4f0f_A 103 VPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQS-LDENAPVCAKVADFGLSQQS 179 (287)
T ss_dssp CTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESC-CCTTCSCCEEECCCTTCBCC
T ss_pred cCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEec-cCCCCceeEEeCCCCccccc
Confidence 9999998888653 346789999999999999999999999 999999999999976 454 999999999754
Q ss_pred ccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc--
Q psy14556 957 AGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL-- 1034 (1181)
Q Consensus 957 ~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l-- 1034 (1181)
.. ......||+.|+|||++.+....++...|+ ||+|+++|+|++|+.||........
T Consensus 180 ~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di------------------~slG~~l~~l~~g~~pf~~~~~~~~~~ 238 (287)
T 4f0f_A 180 VH---SVSGLLGNFQWMAPETIGAEEESYTEKADT------------------YSFAMILYTILTGEGPFDEYSYGKIKF 238 (287)
T ss_dssp SS---CEECCCCCCTTSCGGGSSCSSCEECHHHHH------------------HHHHHHHHHHHHSSCTTTTCCCCHHHH
T ss_pred cc---cccccCCCccccCchhhccCCCCcCchhhH------------------HHHHHHHHHHHcCCCCCccccccHHHH
Confidence 43 234456999999999985433333334444 9999999999999999987665432
Q ss_pred ---cCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1035 ---VAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1035 ---~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
..........+...+..+..++.+|++.+|..||+ +.+.+..+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~~ll~~L 284 (287)
T 4f0f_A 239 INMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPH-FSYIVKEL 284 (287)
T ss_dssp HHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC-HHHHHHHH
T ss_pred HHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcC-HHHHHHHH
Confidence 11122233344567888999999999999999995 44544443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=312.64 Aligned_cols=244 Identities=22% Similarity=0.341 Sum_probs=196.5
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC------ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG------DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFK 878 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~------~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~ 878 (1181)
.|.+. ++||+|+||.||+|++..+++.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 6 ~y~~~-~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 6 HYEMG-EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhH-HhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 34443 3799999999999999999999999999755322 3577999999999999999999999999999999
Q ss_pred EEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCC----eeeeecCCccc
Q psy14556 879 IFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSG----VVKISDFGTSK 954 (1181)
Q Consensus 879 LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g----~vKLiDFGlAk 954 (1181)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++ .+||+|||.+.
T Consensus 85 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~-~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLD-KNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESC-SSSSSCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEec-CCCCCCceEEEecccce
Confidence 999999999999999753 35789999999999999999999999999999999999987 44 89999999998
Q ss_pred ccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc
Q psy14556 955 RLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL 1034 (1181)
Q Consensus 955 ~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l 1034 (1181)
...... ......|++.|+|||++.+..++. ..|+ ||+|+++|+|++|..||.+.+....
T Consensus 161 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~--~~Di------------------~slG~il~~l~~g~~p~~~~~~~~~ 219 (283)
T 3bhy_A 161 KIEAGN-EFKNIFGTPEFVAPEIVNYEPLGL--EADM------------------WSIGVITYILLSGASPFLGETKQET 219 (283)
T ss_dssp ECC---------CCCGGGCCHHHHTTCCCCT--HHHH------------------HHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred eccCCC-cccccCCCcCccCcceecCCCCCc--chhh------------------hhHHHHHHHHHHCCCCCCCcchHHH
Confidence 765432 223456899999999997654333 3333 9999999999999999998776443
Q ss_pred cC-----CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1035 VA-----PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1035 ~~-----~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
.. ....+.......+..+..++.+|+..+|..||+..+..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l 264 (283)
T 3bhy_A 220 LTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSL 264 (283)
T ss_dssp HHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred HHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHH
Confidence 21 11222222345677899999999999999999866653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=331.01 Aligned_cols=246 Identities=24% Similarity=0.291 Sum_probs=186.2
Q ss_pred hhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEe
Q psy14556 803 LYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 803 ~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmE 882 (1181)
.+.|.+.+ +||+|+||+||+|++..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 19 ~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 19 SDRYDFVK-DIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp TTTEEEEE-EESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCcEEEEE-EeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 34454444 79999999999999999999999999976543 34678999999999999999999999999999999999
Q ss_pred ecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCC--eeeeecCCcccccccCC
Q psy14556 883 QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSG--VVKISDFGTSKRLAGLC 960 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g--~vKLiDFGlAk~l~~~~ 960 (1181)
|+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++ .+||+|||+++.....
T Consensus 97 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~-~~~~~~kl~Dfg~a~~~~~~- 171 (361)
T 3uc3_A 97 YASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLH- 171 (361)
T ss_dssp CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECS-SSSCCEEECCCCCC-------
T ss_pred eCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC-CCCceEEEeecCcccccccc-
Confidence 99999999998754 25789999999999999999999999999999999999986 44 5999999999754322
Q ss_pred CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc-----
Q psy14556 961 PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV----- 1035 (1181)
Q Consensus 961 ~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~----- 1035 (1181)
.......||+.|+|||++.+..+. ....|+ ||+||++|+|++|+.||.+.......
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~~Di------------------wslG~il~ell~g~~Pf~~~~~~~~~~~~~~ 232 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYD-GKIADV------------------WSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ 232 (361)
T ss_dssp ---------CTTSCHHHHHCSSCC-HHHHHH------------------HHHHHHHHHHHHSSCSCC----CCCHHHHHH
T ss_pred CCCCCCcCCCCcCChhhhcCCCCC-CCeeee------------------ehhHHHHHHHHhCCCCCCCCccHHHHHHHHH
Confidence 223345699999999999754322 111333 99999999999999999876542210
Q ss_pred --CCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1036 --APPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1036 --~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
.............+..+..++.+|+..+|..||+..+..
T Consensus 233 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell 273 (361)
T 3uc3_A 233 RILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIK 273 (361)
T ss_dssp HHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred HHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 011111122234677888999999999999999765553
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=336.51 Aligned_cols=241 Identities=20% Similarity=0.277 Sum_probs=194.2
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCC---CCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEK---NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~---~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.+||+|+||+||+|++..+++.||+|++.+. .....+.+.+|..++..++||||+++++++.+.+.+|+||||++||
T Consensus 80 ~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg 159 (437)
T 4aw2_A 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGG 159 (437)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCC
Confidence 4799999999999999999999999999653 1223455889999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC-Cccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS-AETF 966 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~-~~t~ 966 (1181)
+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++........ ....
T Consensus 160 ~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~-~g~vkL~DFGla~~~~~~~~~~~~~~ 236 (437)
T 4aw2_A 160 DLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM-NGHIRLADFGSCLKLMEDGTVQSSVA 236 (437)
T ss_dssp BHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TSCEEECCCTTCEECCTTSCEECCSC
T ss_pred cHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcC-CCCEEEcchhhhhhcccCCCcccccc
Confidence 999999753 345789999999999999999999999999999999999998 899999999999776543222 2345
Q ss_pred cCCccccCchhhcc---CCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCC------
Q psy14556 967 TGTLQYMAPEVIDK---GQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAP------ 1037 (1181)
Q Consensus 967 ~GT~~Y~APEvl~g---g~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~------ 1037 (1181)
+||+.|+|||++.. +...++..+|+ ||+||++|||++|+.||.+.+..++...
T Consensus 237 ~GT~~Y~APE~l~~~~~~~~~~~~~~Dv------------------wSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~ 298 (437)
T 4aw2_A 237 VGTPDYISPEILQAMEGGKGRYGPECDW------------------WSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE 298 (437)
T ss_dssp CSCGGGCCHHHHHHHHTSCCEECTHHHH------------------HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred cCCcCeeChHHHhhcccCCCCCCCcCee------------------HHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc
Confidence 79999999999962 12233444444 9999999999999999998876543211
Q ss_pred -CCCCCCCCCCCCcchHHhhccCCCCCCCC--CchhHHH
Q psy14556 1038 -PQISRSVSVPGPGGINSSSSAPVTPTPHS--RHISVNT 1073 (1181)
Q Consensus 1038 -~~ip~~l~~~~p~~L~~li~r~la~dPs~--Rp~s~~~ 1073 (1181)
..+|.. ....+..+..++.+++..+|.+ |+...+.
T Consensus 299 ~~~~p~~-~~~~s~~~~dLi~~lL~~~~~r~~r~~~~ei 336 (437)
T 4aw2_A 299 RFQFPTQ-VTDVSENAKDLIRRLICSREHRLGQNGIEDF 336 (437)
T ss_dssp HCCCCSS-CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHH
T ss_pred cccCCcc-cccCCHHHHHHHHHHhcccccccCCCCHHHH
Confidence 122221 1346777888999999887777 6654343
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-35 Score=325.35 Aligned_cols=248 Identities=20% Similarity=0.234 Sum_probs=197.2
Q ss_pred eeecccCceEEEEEEEc-----CCCeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeec
Q psy14556 811 IELGKGSYGVVYAAREL-----DRQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQV 884 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~-----~tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~ 884 (1181)
++||+|+||.||+|++. .+++.||+|+++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 53 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 132 (343)
T 1luf_A 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYM 132 (343)
T ss_dssp EEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecC
Confidence 47999999999999987 45589999999765332 3567899999999999999999999999999999999999
Q ss_pred CCCCcccchhcccC---------------------CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCC
Q psy14556 885 PGGSLSTLLRVKWG---------------------PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSG 943 (1181)
Q Consensus 885 ~gGSL~dlL~~~~~---------------------~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g 943 (1181)
++++|.+++..... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++
T Consensus 133 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~-~~ 211 (343)
T 1luf_A 133 AYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGE-NM 211 (343)
T ss_dssp TTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG-GG
T ss_pred CCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECC-CC
Confidence 99999999975321 246889999999999999999999999999999999999987 88
Q ss_pred eeeeecCCcccccccCC--CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh
Q psy14556 944 VVKISDFGTSKRLAGLC--PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV 1021 (1181)
Q Consensus 944 ~vKLiDFGlAk~l~~~~--~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT 1021 (1181)
.+||+|||+++...... .......+|+.|+|||++.+..++. ..|+ ||+|+++|+|++
T Consensus 212 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~--~~Di------------------~slG~il~el~t 271 (343)
T 1luf_A 212 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT--ESDV------------------WAYGVVLWEIFS 271 (343)
T ss_dssp CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCH--HHHH------------------HHHHHHHHHHHT
T ss_pred eEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCc--cccc------------------HHHHHHHHHHHh
Confidence 99999999997664322 1223345789999999998665333 3333 999999999999
Q ss_pred -CCCCCCCCCcccccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1022 -LTAALKKKTSRALVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1022 -Gk~PF~~~~~~~l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
|..||.+.+..++..... .....+...+..+..++.+|++.+|..||+ +.+....+..
T Consensus 272 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~~~~~~L~~ 332 (343)
T 1luf_A 272 YGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPS-FCSIHRILQR 332 (343)
T ss_dssp TTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-HHHHHHHHHH
T ss_pred cCCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCC-HHHHHHHHHH
Confidence 999999877655322111 111233456788999999999999999996 4454444444
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=329.81 Aligned_cols=251 Identities=21% Similarity=0.259 Sum_probs=194.3
Q ss_pred hcccCceeecccCceEEEEEE-----EcCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhc-CCCCeeeEccccccCC-c
Q psy14556 805 LFALNRIELGKGSYGVVYAAR-----ELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEG-Y 876 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~-----d~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~-~ 876 (1181)
+|.+ ..+||+|+||.||+|+ +..+++.||+|++..... ...+.+.+|+.+++++ +||||+++++++.+.+ .
T Consensus 23 ~y~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 101 (359)
T 3vhe_A 23 RLKL-GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 101 (359)
T ss_dssp GEEE-EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred ceee-ceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence 3444 4479999999999998 455678999999975433 2346799999999999 7999999999987754 5
Q ss_pred EEEEEeecCCCCcccchhcccC----------------------------------------------------------
Q psy14556 877 FKIFMEQVPGGSLSTLLRVKWG---------------------------------------------------------- 898 (1181)
Q Consensus 877 l~LVmEy~~gGSL~dlL~~~~~---------------------------------------------------------- 898 (1181)
.++||||+++|+|.+++.....
T Consensus 102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (359)
T 3vhe_A 102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181 (359)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence 9999999999999999975422
Q ss_pred -----CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC--CCccccCCcc
Q psy14556 899 -----PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP--SAETFTGTLQ 971 (1181)
Q Consensus 899 -----~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~--~~~t~~GT~~ 971 (1181)
...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++....... ......||+.
T Consensus 182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~ 260 (359)
T 3vhe_A 182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE-KNVVKICDFGLARDIYKDPDYVRKGDARLPLK 260 (359)
T ss_dssp --CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG-GGCEEECCCGGGSCTTSCTTCEEC--CEECGG
T ss_pred ccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcC-CCcEEEEeccceeeecccccchhccccCCCce
Confidence 112788999999999999999999999999999999999987 78999999999986643222 2233458899
Q ss_pred ccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccC---CCCCCCCCCCC
Q psy14556 972 YMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVA---PPQISRSVSVP 1047 (1181)
Q Consensus 972 Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~---~~~ip~~l~~~ 1047 (1181)
|+|||++.+..++ ...|+ ||+|+++|+|++ |..||.+........ ........+..
T Consensus 261 y~aPE~~~~~~~~--~~~Di------------------~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (359)
T 3vhe_A 261 WMAPETIFDRVYT--IQSDV------------------WSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY 320 (359)
T ss_dssp GCCHHHHHHCCCC--HHHHH------------------HHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTT
T ss_pred eEChhhhcCCCCC--chhhh------------------hhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCC
Confidence 9999999865433 33333 999999999998 999998876433210 00111222345
Q ss_pred CCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1048 GPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1048 ~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
.+..+..++.+|++.+|..||+ +.+.+..+
T Consensus 321 ~~~~l~~li~~~l~~dP~~Rps-~~ell~~L 350 (359)
T 3vhe_A 321 TTPEMYQTMLDCWHGEPSQRPT-FSELVEHL 350 (359)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCC-HHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCCC-HHHHHHHH
Confidence 6778999999999999999995 55544444
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=316.75 Aligned_cols=239 Identities=27% Similarity=0.360 Sum_probs=199.3
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.++||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+++++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 106 (303)
T 3a7i_A 27 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 106 (303)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred hhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCc
Confidence 4479999999999999999999999999976543 446789999999999999999999999999999999999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||++..............|
T Consensus 107 L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 181 (303)
T 3a7i_A 107 ALDLLEPG----PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE-HGEVKLADFGVAGQLTDTQIKRNTFVG 181 (303)
T ss_dssp HHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TSCEEECCCTTCEECBTTBCCBCCCCS
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECC-CCCEEEeecccceecCccccccCccCC
Confidence 99998643 5789999999999999999999999999999999999987 889999999999877654444455679
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCC--CCCCCCCCC
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAP--PQISRSVSV 1046 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~--~~ip~~l~~ 1046 (1181)
++.|+|||++.+..++. ..|+ ||+|+++|+|++|+.||........... ...+.....
T Consensus 182 ~~~y~aPE~~~~~~~~~--~~Di------------------~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T 3a7i_A 182 TPFWMAPEVIKQSAYDS--KADI------------------WSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG 241 (303)
T ss_dssp CGGGCCHHHHTTCCBCT--HHHH------------------HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCS
T ss_pred CcCccCHHHHhcCCCCc--hhhh------------------HHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCcc
Confidence 99999999997654333 3333 9999999999999999988765442111 011223344
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
..+..+..++.+|+..+|..||+..+.
T Consensus 242 ~~~~~l~~li~~~l~~dp~~Rps~~~l 268 (303)
T 3a7i_A 242 NYSKPLKEFVEACLNKEPSFRPTAKEL 268 (303)
T ss_dssp SCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 567789999999999999999975544
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=319.53 Aligned_cols=248 Identities=20% Similarity=0.262 Sum_probs=196.8
Q ss_pred ceeecccCceEEEEEEE-----cCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEe
Q psy14556 810 RIELGKGSYGVVYAARE-----LDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d-----~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmE 882 (1181)
...||+|+||.||+|.+ ..+++.||+|++..... ...+.+.+|+.+++++ +||||+++++++.+.+..++|||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 107 (313)
T 1t46_A 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE 107 (313)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEe
Confidence 34799999999999985 45778999999975533 2356799999999999 99999999999999999999999
Q ss_pred ecCCCCcccchhcccC---------------CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeee
Q psy14556 883 QVPGGSLSTLLRVKWG---------------PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKI 947 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~---------------~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKL 947 (1181)
|+++|+|.+++..... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~-~~~~kl 186 (313)
T 1t46_A 108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH-GRITKI 186 (313)
T ss_dssp CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET-TTEEEE
T ss_pred cCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcC-CCCEEE
Confidence 9999999999986532 124789999999999999999999999999999999999987 899999
Q ss_pred ecCCcccccccCCCC--CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCC
Q psy14556 948 SDFGTSKRLAGLCPS--AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTA 1024 (1181)
Q Consensus 948 iDFGlAk~l~~~~~~--~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~ 1024 (1181)
+|||++......... .....+|+.|+|||++.+..++. ..|+ ||+|+++|+|++ |..
T Consensus 187 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--~~Di------------------~slG~il~ellt~g~~ 246 (313)
T 1t46_A 187 CDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF--ESDV------------------WSYGIFLWELFSLGSS 246 (313)
T ss_dssp CCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCH--HHHH------------------HHHHHHHHHHHTTTCC
T ss_pred ccccccccccccccceeccCCCCcceeeChHHhcCCCCCh--HHHH------------------HHHHHHHHHHHhCCCC
Confidence 999999876543221 22344778999999997654333 3333 999999999999 999
Q ss_pred CCCCCCcccccC---CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcc
Q psy14556 1025 ALKKKTSRALVA---PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTG 1079 (1181)
Q Consensus 1025 PF~~~~~~~l~~---~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~ 1079 (1181)
||.+........ ........+...+..+..++.+|++.+|..||+ +.+.+..+.
T Consensus 247 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~ell~~L~ 303 (313)
T 1t46_A 247 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPT-FKQIVQLIE 303 (313)
T ss_dssp SSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC-HHHHHHHHH
T ss_pred CCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcC-HHHHHHHHH
Confidence 998876433110 011122223456788999999999999999995 555444443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=321.08 Aligned_cols=257 Identities=20% Similarity=0.248 Sum_probs=196.8
Q ss_pred hhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEE
Q psy14556 803 LYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFM 881 (1181)
Q Consensus 803 ~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVm 881 (1181)
.+.|... .+||+|+||.||+|++ .+++.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 29 ~~~y~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 106 (326)
T 3uim_A 29 SDNFSNK-NILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY 106 (326)
T ss_dssp TTSSCST-TEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEE
T ss_pred hhccccc-eeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEE
Confidence 3444443 4799999999999974 46889999999765432 3447899999999999999999999999999999999
Q ss_pred eecCCCCcccchhccc-CCCCCChHHHHHHHHHHHhhhhhcccc---ceecccCCCCCcccccCCCeeeeecCCcccccc
Q psy14556 882 EQVPGGSLSTLLRVKW-GPLKENESTMSFYTKQILEGLKYLHGQ---KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 957 (1181)
Q Consensus 882 Ey~~gGSL~dlL~~~~-~~~~l~e~~i~~Ia~QIa~AL~yLHs~---gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~ 957 (1181)
||+++++|.+++.... ....+++..++.++.|++.||+|||++ ||+||||||+|||++. ++.+||+|||+++...
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg~~~~~~ 185 (326)
T 3uim_A 107 PYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDE-EFEAVVGDFGLAKLMD 185 (326)
T ss_dssp ECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECT-TCCEEECCCSSCEECC
T ss_pred EeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECC-CCCEEeccCccccccC
Confidence 9999999999998643 234588999999999999999999999 9999999999999988 8899999999998765
Q ss_pred cCCCC-CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc---
Q psy14556 958 GLCPS-AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA--- 1033 (1181)
Q Consensus 958 ~~~~~-~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~--- 1033 (1181)
..... .....||+.|+|||++.++.++. ..|+ ||+|+++|+|++|+.||.......
T Consensus 186 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~Di------------------~slG~il~~l~~g~~pf~~~~~~~~~~ 245 (326)
T 3uim_A 186 YKDTHVTTAVRGTIGHIAPEYLSTGKSSE--KTDV------------------FGYGVMLLELITGQRAFDLARLANDDD 245 (326)
T ss_dssp SSSSCEECCCCSCGGGCCHHHHHHSEECH--HHHH------------------HHHHHHHHHHHHCCCSBCHHHHTTTSC
T ss_pred cccccccccccCCcCccCHHHhccCCCCc--cccc------------------hhHHHHHHHHHhCCCcccccccccccc
Confidence 43222 23345999999999997654333 3333 999999999999999996321100
Q ss_pred ---------ccCC--------CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcccCCC
Q psy14556 1034 ---------LVAP--------PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGNNGG 1083 (1181)
Q Consensus 1034 ---------l~~~--------~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~~~~ 1083 (1181)
.... ...........+..+..++.+|++.+|..|| ++.+.+..+.....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp-s~~ell~~L~~~~~ 311 (326)
T 3uim_A 246 VMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERP-KMSEVVRMLEGDGL 311 (326)
T ss_dssp SBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSC-CHHHHHHHHHTSSC
T ss_pred hhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCC-CHHHHHHHhcCcch
Confidence 0000 0111111122235677799999999999999 57777777776433
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-34 Score=317.78 Aligned_cols=245 Identities=24% Similarity=0.268 Sum_probs=197.7
Q ss_pred hhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEe
Q psy14556 803 LYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 803 ~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmE 882 (1181)
...|.+. ++||+|+||.||+|++..+++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 8 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 8 RKTFIFM-EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hccceee-eeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3444443 479999999999999999999999999986655555778999999999999999999999999999999999
Q ss_pred ecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccc---ccCCCeeeeecCCcccccccC
Q psy14556 883 QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLV---NTYSGVVKISDFGTSKRLAGL 959 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL---d~~~g~vKLiDFGlAk~l~~~ 959 (1181)
|+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||++ +. ++.+||+|||++......
T Consensus 87 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~-~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 87 LVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEE-NSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSST-TCCEEBCSCSTTCCCCCB
T ss_pred cCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCC-CCCEEEccCCcceecCCC
Confidence 99999999998754 257899999999999999999999999999999999999 44 789999999998764432
Q ss_pred CCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc----
Q psy14556 960 CPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV---- 1035 (1181)
Q Consensus 960 ~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~---- 1035 (1181)
......||+.|+|||++.+..++ ...|+ ||+|+++|+|++|..||.+.....+.
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~--~~~Di------------------~slG~il~~l~~g~~pf~~~~~~~~~~~i~ 220 (304)
T 2jam_A 163 --IMSTACGTPGYVAPEVLAQKPYS--KAVDC------------------WSIGVITYILLCGYPPFYEETESKLFEKIK 220 (304)
T ss_dssp --TTHHHHSCCCBCCTTTBSSCSCC--HHHHH------------------HHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred --ccccccCCCCccChHHhccCCCC--chhhH------------------HHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 22334689999999999755433 33333 99999999999999999987764432
Q ss_pred -CCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1036 -APPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1036 -~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
.....+.......+..+..++.+|+..+|..||+..+..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l 260 (304)
T 2jam_A 221 EGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKAL 260 (304)
T ss_dssp HCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred cCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 122233344456778899999999999999999866653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=324.42 Aligned_cols=240 Identities=24% Similarity=0.341 Sum_probs=197.9
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCC
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
.+.||+|+||.||++.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 46 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 125 (335)
T 2owb_A 46 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 125 (335)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCC
Confidence 3479999999999999999999999999965532 2356788999999999999999999999999999999999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccc
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF 966 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~ 966 (1181)
++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++.............
T Consensus 126 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~ 201 (335)
T 2owb_A 126 RSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKVL 201 (335)
T ss_dssp CBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT-TCCEEECCCTTCEECCSTTCCBCCC
T ss_pred CCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcC-CCCEEEeeccCceecccCccccccc
Confidence 9999988754 35789999999999999999999999999999999999988 8899999999998775444444556
Q ss_pred cCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-CCCCCC
Q psy14556 967 TGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-ISRSVS 1045 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-ip~~l~ 1045 (1181)
.||+.|+|||++.+...+. ..|+ ||+|+++|+|++|+.||......+...... .....+
T Consensus 202 ~gt~~y~aPE~~~~~~~~~--~~Di------------------~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 261 (335)
T 2owb_A 202 CGTPNYIAPEVLSKKGHSF--EVDV------------------WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP 261 (335)
T ss_dssp CSCCSSCCHHHHHTSCBCT--HHHH------------------HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC
T ss_pred CCCccccCHHHhccCCCCc--hhhH------------------HHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCC
Confidence 7999999999997654333 3333 999999999999999999876544321111 111223
Q ss_pred CCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1046 VPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1046 ~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
...+..+..++.+|+..+|.+||+..+.
T Consensus 262 ~~~~~~~~~li~~~l~~dp~~Rps~~el 289 (335)
T 2owb_A 262 KHINPVAASLIQKMLQTDPTARPTINEL 289 (335)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCGGGG
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 3566788899999999999999975544
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=328.54 Aligned_cols=245 Identities=14% Similarity=0.107 Sum_probs=193.8
Q ss_pred ceeecccCceEEEEE-----EEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcC---CCCeeeEccccccCCcEEEEE
Q psy14556 810 RIELGKGSYGVVYAA-----RELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR---HRNIVQYLGSVSEEGYFKIFM 881 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka-----~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~---HPNIVkl~g~~~d~~~l~LVm 881 (1181)
..+||+|+||+||+| .+..+++.||+|++... ....+.+|+.+++.++ |+||+++++++...+..++||
T Consensus 70 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~ 146 (365)
T 3e7e_A 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVG 146 (365)
T ss_dssp EEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEE
T ss_pred EEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEE
Confidence 347999999999999 46778899999999654 3467888898888887 999999999999999999999
Q ss_pred eecCCCCcccchhccc--CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccC----------CCeeeeec
Q psy14556 882 EQVPGGSLSTLLRVKW--GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTY----------SGVVKISD 949 (1181)
Q Consensus 882 Ey~~gGSL~dlL~~~~--~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~----------~g~vKLiD 949 (1181)
||+++|+|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||++.. ++.+||+|
T Consensus 147 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~D 226 (365)
T 3e7e_A 147 ELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALID 226 (365)
T ss_dssp CCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECC
T ss_pred eccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEee
Confidence 9999999999997432 24568899999999999999999999999999999999999752 57999999
Q ss_pred CCcccccccC--CCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCC
Q psy14556 950 FGTSKRLAGL--CPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALK 1027 (1181)
Q Consensus 950 FGlAk~l~~~--~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~ 1027 (1181)
||+++.+... ........||+.|+|||++.+..++ ..+|+ ||+||++|||+||+.||.
T Consensus 227 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~Di------------------wslG~il~elltg~~pf~ 286 (365)
T 3e7e_A 227 LGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN--YQIDY------------------FGVAATVYCMLFGTYMKV 286 (365)
T ss_dssp CTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBS--THHHH------------------HHHHHHHHHHHHSSCCCE
T ss_pred CchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCC--ccccH------------------HHHHHHHHHHHhCCCccc
Confidence 9999765422 1223445799999999999866543 34444 999999999999999997
Q ss_pred CCCcccccCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1028 KKTSRALVAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1028 ~~~~~~l~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
............+.. .+.+..+..++.+++..+|..|++.+++....+..
T Consensus 287 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 287 KNEGGECKPEGLFRR---LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp EEETTEEEECSCCTT---CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred cCCCCceeechhccc---cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 655433222111221 24466788899999999999999988876555544
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=320.88 Aligned_cols=249 Identities=22% Similarity=0.267 Sum_probs=177.5
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcC-CCCeeeEcccc--------ccCCcEEEE
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR-HRNIVQYLGSV--------SEEGYFKIF 880 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~-HPNIVkl~g~~--------~d~~~l~LV 880 (1181)
.++||+|+||.||+|++..+++.||+|++........+.+.+|+.+++++. ||||+++++++ .....+++|
T Consensus 33 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv 112 (337)
T 3ll6_A 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLL 112 (337)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEE
T ss_pred EEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEE
Confidence 347999999999999999999999999986665555677899999999996 99999999988 344568999
Q ss_pred EeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccc--eecccCCCCCcccccCCCeeeeecCCccccccc
Q psy14556 881 MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 958 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~g--IVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~ 958 (1181)
|||+ +|+|.+++........+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||+++....
T Consensus 113 ~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~~~~~~~ 190 (337)
T 3ll6_A 113 TELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSN-QGTIKLCDFGSATTISH 190 (337)
T ss_dssp EECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECT-TSCEEBCCCTTCBCCSS
T ss_pred EEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECC-CCCEEEecCccceeccc
Confidence 9999 4789888875434556889999999999999999999999 999999999999998 88999999999987654
Q ss_pred CCCC------------CccccCCccccCchhhcc-CCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCC
Q psy14556 959 LCPS------------AETFTGTLQYMAPEVIDK-GQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAA 1025 (1181)
Q Consensus 959 ~~~~------------~~t~~GT~~Y~APEvl~g-g~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~P 1025 (1181)
.... .....||+.|+|||++.. ....++...|+ ||+|+++|+|++|+.|
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv------------------~slG~il~el~~g~~p 252 (337)
T 3ll6_A 191 YPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDI------------------WALGCILYLLCFRQHP 252 (337)
T ss_dssp CC-------------------------------CCTTSCSSHHHHH------------------HHHHHHHHHHHHSSCC
T ss_pred cCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhH------------------HHHHHHHHHHHhCCCC
Confidence 2211 113458999999999832 11122333333 9999999999999999
Q ss_pred CCCCCcccccCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1026 LKKKTSRALVAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1026 F~~~~~~~l~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
|.......+.... .........+..+..++.+|++.+|..|| ++.+.+..+..
T Consensus 253 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~e~l~~l~~ 305 (337)
T 3ll6_A 253 FEDGAKLRIVNGK-YSIPPHDTQYTVFHSLIRAMLQVNPEERL-SIAEVVHQLQE 305 (337)
T ss_dssp C-------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSC-CHHHHHHHHHH
T ss_pred CcchhHHHhhcCc-ccCCcccccchHHHHHHHHHccCChhhCc-CHHHHHHHHHH
Confidence 9876654432221 22222345667789999999999999999 56665555544
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=316.57 Aligned_cols=243 Identities=21% Similarity=0.272 Sum_probs=198.5
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
.+||+|+||.||+|.+..++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 97 (288)
T 3kfa_A 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 97 (288)
T ss_dssp EESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHH
T ss_pred eecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHH
Confidence 47999999999999999999999999996543 34577999999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC-CccccCC
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS-AETFTGT 969 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~-~~t~~GT 969 (1181)
+++... ....+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||++......... .....++
T Consensus 98 ~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 175 (288)
T 3kfa_A 98 DYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE-NHLVKVADFGLSRLMTGDTYTAHAGAKFP 175 (288)
T ss_dssp HHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECG-GGCEEECCCCGGGTSCSSSSEEETTEEEC
T ss_pred HHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcC-CCCEEEccCccceeccCCccccccCCccc
Confidence 999764 4456889999999999999999999999999999999999987 789999999999876543221 2223467
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCC--CCCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPP--QISRSVSV 1046 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~--~ip~~l~~ 1046 (1181)
+.|+|||++.+..++.. .|+ ||+|+++|+|++ |..||.+.+...+.... ......+.
T Consensus 176 ~~y~aPE~~~~~~~~~~--~Di------------------~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 3kfa_A 176 IKWTAPESLAYNKFSIK--SDV------------------WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE 235 (288)
T ss_dssp GGGCCHHHHHHCCCCHH--HHH------------------HHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCT
T ss_pred cCcCChhhhccCCCCch--hhH------------------HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCC
Confidence 89999999976644333 333 999999999999 99999987765532211 11222334
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHHHHHh
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNTNLVC 1077 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~~~~a 1077 (1181)
..+..+..++.+|+..+|..||+ +.+.+..
T Consensus 236 ~~~~~l~~li~~~l~~dp~~Rps-~~~~~~~ 265 (288)
T 3kfa_A 236 GCPEKVYELMRACWQWNPSDRPS-FAEIHQA 265 (288)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCC-HHHHHHH
T ss_pred CCCHHHHHHHHHHhCCChhhCcC-HHHHHHH
Confidence 67788999999999999999985 4444333
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=315.56 Aligned_cols=243 Identities=26% Similarity=0.390 Sum_probs=195.8
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFM 881 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVm 881 (1181)
+|.+. .+||+|+||.||+|.+..++..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 10 ~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (279)
T 3fdn_A 10 DFEIG-RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 88 (279)
T ss_dssp GEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cEEEe-eEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence 34443 37999999999999999999999999985432 233567899999999999999999999999999999999
Q ss_pred eecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC
Q psy14556 882 EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP 961 (1181)
Q Consensus 882 Ey~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~ 961 (1181)
||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++......
T Consensus 89 e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~-~~~~~l~Dfg~~~~~~~~-- 162 (279)
T 3fdn_A 89 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSS-- 162 (279)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECT-TSCEEECSCCEESCC-----
T ss_pred ecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcC-CCCEEEEeccccccCCcc--
Confidence 999999999998754 35788999999999999999999999999999999999987 899999999998655432
Q ss_pred CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-C
Q psy14556 962 SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-I 1040 (1181)
Q Consensus 962 ~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-i 1040 (1181)
......|++.|+|||++.+...+..+| + ||+|+++|+|++|..||...+......... .
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~D--i------------------~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 222 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEGRMHDEKVD--L------------------WSLGVLCYEFLVGKPPFEANTYQETYKRISRV 222 (279)
T ss_dssp -----CCCCTTCCHHHHTTCCCCTTHH--H------------------HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT
T ss_pred cccccCCCCCccCHhHhccCCCCccch--h------------------HhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC
Confidence 233456899999999997654443333 3 999999999999999999877654322111 1
Q ss_pred CCCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1041 SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1041 p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
....+...+..+..++.+|+..+|..||+..+..
T Consensus 223 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l 256 (279)
T 3fdn_A 223 EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 256 (279)
T ss_dssp CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHh
Confidence 2223345677889999999999999999865553
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=315.76 Aligned_cols=240 Identities=24% Similarity=0.336 Sum_probs=197.4
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC---ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCC
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG---DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~---~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
.+.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 99 (294)
T 2rku_A 20 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 99 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCC
Confidence 34799999999999999999999999999655322 356788999999999999999999999999999999999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccc
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF 966 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~ 966 (1181)
++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||++.............
T Consensus 100 ~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~ 175 (294)
T 2rku_A 100 RSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE-DLEVKIGDFGLATKVEYDGERKKVL 175 (294)
T ss_dssp CBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT-TCCEEECCCTTCEECCSTTCCBCCC
T ss_pred CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcC-CCCEEEEeccCceecccCccccccc
Confidence 9999988754 35789999999999999999999999999999999999987 8899999999998765444444456
Q ss_pred cCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-CCCCCC
Q psy14556 967 TGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-ISRSVS 1045 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-ip~~l~ 1045 (1181)
.||+.|+|||++.+...+. ..|+ ||+|+++|+|++|+.||......+...... .....+
T Consensus 176 ~~~~~y~aPE~~~~~~~~~--~~Di------------------~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T 2rku_A 176 CGTPNYIAPEVLSKKGHSF--EVDV------------------WSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP 235 (294)
T ss_dssp CSCCSSCCHHHHTTSCBCT--HHHH------------------HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC
T ss_pred cCCCCcCCcchhccCCCCc--hhhH------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCc
Confidence 7999999999997654333 3333 999999999999999999876544211111 111223
Q ss_pred CCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1046 VPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1046 ~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
...+..+..++.+|+..+|..||+..+.
T Consensus 236 ~~~~~~~~~li~~~l~~~p~~Rps~~~l 263 (294)
T 2rku_A 236 KHINPVAASLIQKMLQTDPTARPTINEL 263 (294)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCGGGG
T ss_pred cccCHHHHHHHHHHcccChhhCcCHHHH
Confidence 3567788899999999999999975444
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=323.83 Aligned_cols=245 Identities=18% Similarity=0.171 Sum_probs=191.1
Q ss_pred eeecccCceEEEEEEEcCCCeE----EEEEEecCCC-CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 811 IELGKGSYGVVYAARELDRQVK----LAIKEIPEKN-LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~----VAIKii~~~~-~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
.+||+|+||+||+|.+..+++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++||||++
T Consensus 19 ~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 97 (325)
T 3kex_A 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLP 97 (325)
T ss_dssp EEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCT
T ss_pred eeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCC
Confidence 4799999999999999887765 7888875443 334566889999999999999999999886 456899999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC--CC
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP--SA 963 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~--~~ 963 (1181)
+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++....... ..
T Consensus 98 ~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~-~~~~kl~Dfg~a~~~~~~~~~~~~ 174 (325)
T 3kex_A 98 LGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKS-PSQVQVADFGVADLLPPDDKQLLY 174 (325)
T ss_dssp TCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESS-SSCEEECSCSGGGGSCCCTTCCC-
T ss_pred CCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECC-CCeEEECCCCcccccCcccccccc
Confidence 99999999753 235778889999999999999999999999999999999987 89999999999987654322 22
Q ss_pred ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--C
Q psy14556 964 ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--I 1040 (1181)
Q Consensus 964 ~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--i 1040 (1181)
....++..|+|||++.++.++. ..|+ ||+|+++|+|++ |..||.+.....+..... .
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~--~~Di------------------~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~ 234 (325)
T 3kex_A 175 SEAKTPIKWMALESIHFGKYTH--QSDV------------------WSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE 234 (325)
T ss_dssp ----CCTTTSCHHHHHHCCCCH--HHHH------------------HHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC
T ss_pred cCCCCcccccChHHhccCCCCh--hhHh------------------HHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC
Confidence 3345788999999998665433 3333 999999999999 999999877654322111 1
Q ss_pred CCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1041 SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1041 p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
....+...+..+..++.+|+..+|..||+ +.+.+..+..
T Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~el~~~l~~ 273 (325)
T 3kex_A 235 RLAQPQICTIDVYMVMVKCWMIDENIRPT-FKELANEFTR 273 (325)
T ss_dssp BCCCCTTBCTTTTHHHHHHTCSCTTTSCC-HHHHHHHHHH
T ss_pred CCCCCCcCcHHHHHHHHHHcCCChhhCcC-HHHHHHHHHH
Confidence 11223345667888999999999999985 5555555544
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=313.89 Aligned_cols=249 Identities=23% Similarity=0.293 Sum_probs=195.3
Q ss_pred HhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCC-CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEE
Q psy14556 802 FLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKN-LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIF 880 (1181)
Q Consensus 802 ~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~-~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LV 880 (1181)
+.+.|...+ +||+|+||.||+|.+..++..||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 20 i~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 20 IDDLFIFKR-KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHHHEEEEE-EEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhheeecc-eeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 445555544 7999999999999999999999999996553 33467899999999999999999999999999999999
Q ss_pred EeecCCCCcccchhcc-cCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccC--CCeeeeecCCcccccc
Q psy14556 881 MEQVPGGSLSTLLRVK-WGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTY--SGVVKISDFGTSKRLA 957 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~-~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~--~g~vKLiDFGlAk~l~ 957 (1181)
|||+++++|.+++... .....+++..++.++.||+.||+|||++||+||||||+||+++.. ++.+||+|||++....
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999999988642 123468899999999999999999999999999999999999532 5789999999997765
Q ss_pred cCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCC
Q psy14556 958 GLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAP 1037 (1181)
Q Consensus 958 ~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~ 1037 (1181)
.. .......||+.|+|||++.+ . ++...|+ ||+|+++|+|++|+.||.+.+...+...
T Consensus 179 ~~-~~~~~~~~t~~y~aPE~~~~-~--~~~~~Di------------------~slG~il~~ll~g~~pf~~~~~~~~~~~ 236 (285)
T 3is5_A 179 SD-EHSTNAAGTALYMAPEVFKR-D--VTFKCDI------------------WSAGVVMYFLLTGCLPFTGTSLEEVQQK 236 (285)
T ss_dssp ---------CTTGGGCCHHHHTT-C--CCHHHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred Cc-ccCcCcccccCcCChHHhcc-C--CCcccCe------------------ehHHHHHHHHHhCCCCCCCCCHHHHHhh
Confidence 43 22344568999999999853 2 2333333 9999999999999999998876553221
Q ss_pred C----CCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1038 P----QISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1038 ~----~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
. ........+.+..+..++.+|++.+|..||+..+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 276 (285)
T 3is5_A 237 ATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQV 276 (285)
T ss_dssp HHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred hccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 1 11111223467788899999999999999985554
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=313.35 Aligned_cols=240 Identities=24% Similarity=0.337 Sum_probs=186.7
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
++||+|+||+||+|++ .+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++ +
T Consensus 8 ~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 85 (288)
T 1ob3_A 8 EKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-D 85 (288)
T ss_dssp EEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-E
T ss_pred hhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-C
Confidence 3799999999999998 6788999999965532 2356789999999999999999999999999999999999964 8
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|.+++... ...+++..++.++.||+.||+|||++||+||||||+||+++. ++.+||+|||+++.............|
T Consensus 86 l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 162 (288)
T 1ob3_A 86 LKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR-EGELKIADFGLARAFGIPVRKYTHEIV 162 (288)
T ss_dssp HHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TSCEEECCTTHHHHHCC---------C
T ss_pred HHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC-CCCEEEeECccccccCccccccccccc
Confidence 88888753 235778899999999999999999999999999999999988 899999999999876543333344568
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC-------C----
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA-------P---- 1037 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~-------~---- 1037 (1181)
|+.|+|||++.+.. .++..+|+ ||+||++|+|++|+.||.+.+..+... .
T Consensus 163 t~~y~aPE~~~~~~-~~~~~~Di------------------wslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 223 (288)
T 1ob3_A 163 TLWYRAPDVLMGSK-KYSTTIDI------------------WSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK 223 (288)
T ss_dssp CCTTCCHHHHTTCC-SCCTHHHH------------------HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cccccCchheeCCC-CCCcHHHH------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChh
Confidence 99999999996432 23444444 999999999999999998766432100 0
Q ss_pred --------CC----CC-------CCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1038 --------PQ----IS-------RSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1038 --------~~----ip-------~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
+. .. .......+..+..++.+|+..||.+||+..+.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 279 (288)
T 1ob3_A 224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (288)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 00 00 011123566677899999999999999755443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=309.96 Aligned_cols=244 Identities=22% Similarity=0.248 Sum_probs=195.6
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
.+||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.
T Consensus 14 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (268)
T 3sxs_A 14 KELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLL 91 (268)
T ss_dssp EEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHH
T ss_pred eeeccCCCceEEEEEec-CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHH
Confidence 47999999999999875 567899999975543 3467999999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC-CCccccCC
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP-SAETFTGT 969 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~-~~~t~~GT 969 (1181)
+++... ...+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||++........ ......+|
T Consensus 92 ~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 168 (268)
T 3sxs_A 92 NYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDR-DLCVKVSDFGMTRYVLDDQYVSSVGTKFP 168 (268)
T ss_dssp HHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECT-TCCEEECCTTCEEECCTTCEEECCSCCCC
T ss_pred HHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECC-CCCEEEccCccceecchhhhhcccCCCcC
Confidence 999754 235789999999999999999999999999999999999988 89999999999986643321 12223467
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--CCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--ISRSVSV 1046 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--ip~~l~~ 1046 (1181)
+.|+|||++.+..++..+|+ ||+|+++|+|++ |+.||............. .....+.
T Consensus 169 ~~y~aPE~~~~~~~~~~~Di--------------------~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 228 (268)
T 3sxs_A 169 VKWSAPEVFHYFKYSSKSDV--------------------WAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPH 228 (268)
T ss_dssp GGGCCHHHHHHSEEETTHHH--------------------HHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCT
T ss_pred cccCCHHHHhccCCchhhhh--------------------HHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCC
Confidence 78999999976554443333 999999999999 999999877655322111 1122233
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
..+..+..++.+|++.+|..||+ +.+.+..+..
T Consensus 229 ~~~~~l~~li~~~l~~~p~~Rps-~~~ll~~L~~ 261 (268)
T 3sxs_A 229 LASDTIYQIMYSCWHELPEKRPT-FQQLLSSIEP 261 (268)
T ss_dssp TSCHHHHHHHHHTTCSSGGGSCC-HHHHHHHHGG
T ss_pred cChHHHHHHHHHHcCCChhhCcC-HHHHHHHHHH
Confidence 45778999999999999999985 5555554443
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=317.45 Aligned_cols=244 Identities=25% Similarity=0.325 Sum_probs=191.8
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCC-----CChhHHHHHHHHHHhcC---CCCeeeEccccccCC-
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-----GDVQPLHEEIKLHSQLR---HRNIVQYLGSVSEEG- 875 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-----~~~e~f~rEi~IL~~L~---HPNIVkl~g~~~d~~- 875 (1181)
.|.+. .+||+|+||+||+|++..+++.||+|++..... .....+.+|+.+++.++ ||||+++++++....
T Consensus 10 ~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~ 88 (308)
T 3g33_A 10 RYEPV-AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT 88 (308)
T ss_dssp CCEEE-EEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred ceEEE-EEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence 34443 479999999999999999999999999964321 22456788888887775 999999999987654
Q ss_pred ----cEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCC
Q psy14556 876 ----YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFG 951 (1181)
Q Consensus 876 ----~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFG 951 (1181)
..++||||+. ++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg 165 (308)
T 3g33_A 89 DREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS-GGTVKLADFG 165 (308)
T ss_dssp SSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECT-TSCEEECSCS
T ss_pred CCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC-CCCEEEeeCc
Confidence 5899999995 6999998865 3344889999999999999999999999999999999999987 8999999999
Q ss_pred cccccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCc
Q psy14556 952 TSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTS 1031 (1181)
Q Consensus 952 lAk~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~ 1031 (1181)
+++..... .......||+.|+|||++.+..++.. +|+ ||+||++|+|++|+.||.+.+.
T Consensus 166 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~--~Di------------------wslG~il~~l~~g~~pf~~~~~ 224 (308)
T 3g33_A 166 LARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATP--VDM------------------WSVGCIFAEMFRRKPLFCGNSE 224 (308)
T ss_dssp CTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCST--HHH------------------HHHHHHHHHTTTSSCSCCCSSH
T ss_pred cccccCCC-cccCCccccccccCchHHcCCCCCch--HHH------------------HHHHHHHHHHHhCCCCCCCCCH
Confidence 99876533 23345679999999999987654443 443 9999999999999999988776
Q ss_pred ccccC----------CCCCCCC------------------CCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1032 RALVA----------PPQISRS------------------VSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1032 ~~l~~----------~~~ip~~------------------l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
..... ....+.. .....+..+..++.+|++.||.+||+..+.
T Consensus 225 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 294 (308)
T 3g33_A 225 ADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRA 294 (308)
T ss_dssp HHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHH
Confidence 43210 0001110 112456677889999999999999975544
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=318.93 Aligned_cols=243 Identities=23% Similarity=0.316 Sum_probs=189.0
Q ss_pred eeecccCceEEEEEE----EcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEcccccc--CCcEEEEEeec
Q psy14556 811 IELGKGSYGVVYAAR----ELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSE--EGYFKIFMEQV 884 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~----d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d--~~~l~LVmEy~ 884 (1181)
++||+|+||+||+|+ +..+++.||+|++........+.+.+|+.++++++||||+++++++.. ...+++||||+
T Consensus 16 ~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 95 (295)
T 3ugc_A 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 95 (295)
T ss_dssp EEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECC
T ss_pred heeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeC
Confidence 479999999999998 567889999999986655556789999999999999999999998854 35689999999
Q ss_pred CCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC---
Q psy14556 885 PGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP--- 961 (1181)
Q Consensus 885 ~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~--- 961 (1181)
++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+||+++. ++.+||+|||+++.......
T Consensus 96 ~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~ 172 (295)
T 3ugc_A 96 PYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEFFK 172 (295)
T ss_dssp TTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE-TTEEEECCCCSCC----------
T ss_pred CCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcC-CCeEEEccCcccccccCCcceee
Confidence 999999999754 234788999999999999999999999999999999999998 89999999999987654321
Q ss_pred CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc---cC--
Q psy14556 962 SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL---VA-- 1036 (1181)
Q Consensus 962 ~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l---~~-- 1036 (1181)
......++..|+|||++.+..++. ..|+ ||+|+++|+|++|..||........ ..
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~--~~Di------------------~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~ 232 (295)
T 3ugc_A 173 VKEPGESPIFWYAPESLTESKFSV--ASDV------------------WSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 232 (295)
T ss_dssp ---CTTCGGGGCCHHHHHHCCCCH--HHHH------------------HHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTC
T ss_pred eccCCCCccceeCcHHhcCCCCCh--HHHH------------------HHHHHHHHHHHhcccccCCChHHHHhhhcCcc
Confidence 122334778899999998665433 3333 9999999999999999876432110 00
Q ss_pred -------------CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHh
Q psy14556 1037 -------------PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVC 1077 (1181)
Q Consensus 1037 -------------~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~a 1077 (1181)
........+...+..+..++.+|++.+|..||+ +.+.+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~el~~~ 285 (295)
T 3ugc_A 233 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPS-FRDLALR 285 (295)
T ss_dssp CTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCC-HHHHHHH
T ss_pred ccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCC-HHHHHHH
Confidence 001112234467788999999999999999996 4444333
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=315.69 Aligned_cols=250 Identities=23% Similarity=0.286 Sum_probs=194.5
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCC----CCChhHHHHHHHHHHhcCCCCeeeEcccc--ccCCcE
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKN----LGDVQPLHEEIKLHSQLRHRNIVQYLGSV--SEEGYF 877 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~----~~~~e~f~rEi~IL~~L~HPNIVkl~g~~--~d~~~l 877 (1181)
..|.+.+ +||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++ .+.+..
T Consensus 5 ~~y~i~~-~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 5 GKYLMGD-LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp CCBCCCC-EEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred cceeEee-EEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 3444444 7999999999999999999999999996542 23356799999999999999999999998 455689
Q ss_pred EEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccc
Q psy14556 878 KIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 957 (1181)
Q Consensus 878 ~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~ 957 (1181)
++||||++++ |.+++... ....+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++....
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~-~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTT-GGTLKISALGVAEALH 160 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-TCCEEECCCTTCEECC
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcC-CCcEEeeccccccccC
Confidence 9999999766 66776643 3456889999999999999999999999999999999999987 8999999999998764
Q ss_pred cCC--CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc
Q psy14556 958 GLC--PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV 1035 (1181)
Q Consensus 958 ~~~--~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~ 1035 (1181)
... .......||+.|+|||++.+.....+...|+ ||+|+++|+|++|+.||.+.+...+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di------------------~slG~il~~l~~g~~p~~~~~~~~~~ 222 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDI------------------WSAGVTLYNITTGLYPFEGDNIYKLF 222 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHH------------------HHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhH------------------HHHHHHHHHHHhCCCCCCCchHHHHH
Confidence 321 1223456899999999997543322333443 99999999999999999987764432
Q ss_pred CCCC-CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHH
Q psy14556 1036 APPQ-ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNL 1075 (1181)
Q Consensus 1036 ~~~~-ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~ 1075 (1181)
.... .....+...+..+..++.+|+..+|..||+..+...
T Consensus 223 ~~i~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 223 ENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp HHHHHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHhcCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2111 111223456778899999999999999997655543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=323.87 Aligned_cols=240 Identities=19% Similarity=0.203 Sum_probs=191.3
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEee
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQ 883 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy 883 (1181)
.|.+. ++||+|+||.||+|++..+++.||||++..... .+.+.+|+.+++++ +||||+++++++...+..++||||
T Consensus 10 ~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 10 NFRVG-KKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TEEEE-EECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CeEEE-EEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 34443 379999999999999999999999999975533 34688999999999 999999999999999999999999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCe-----eeeecCCccccccc
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGV-----VKISDFGTSKRLAG 958 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~-----vKLiDFGlAk~l~~ 958 (1181)
+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++. ++. +||+|||+++.+..
T Consensus 87 ~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~-~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 87 L-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGR-PGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp C-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECC-GGGTCTTSEEECCCTTCEESBC
T ss_pred C-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecc-CCCCCCceEEEEEcccceeeec
Confidence 9 99999999854 346789999999999999999999999999999999999987 555 99999999987654
Q ss_pred CCCC-------CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCc
Q psy14556 959 LCPS-------AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTS 1031 (1181)
Q Consensus 959 ~~~~-------~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~ 1031 (1181)
.... .....||+.|+|||++.+..++ ...|+ ||||+++|+|++|+.||.+.+.
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~Di------------------~slG~il~ell~g~~Pf~~~~~ 222 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQS--RRDDL------------------EALGHMFMYFLRGSLPWQGLKA 222 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC--HHHHH------------------HHHHHHHHHHHHSSCTTTTCCC
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCC--chhHH------------------HHHHHHHHHHhcCCCCcccccc
Confidence 3221 2356799999999999865433 33333 9999999999999999998654
Q ss_pred ccccC---C-----CCCC-CCCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1032 RALVA---P-----PQIS-RSVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1032 ~~l~~---~-----~~ip-~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
..+.. . ...+ .......| .+..++.+|++.+|..||...+
T Consensus 223 ~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~ 271 (330)
T 2izr_A 223 DTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDY 271 (330)
T ss_dssp SSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHH
T ss_pred ccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHH
Confidence 33210 0 0011 11122344 7888999999999999997433
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=324.06 Aligned_cols=246 Identities=23% Similarity=0.361 Sum_probs=198.7
Q ss_pred HHhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--------ChhHHHHHHHHHHhcCCCCeeeEccccc
Q psy14556 801 RFLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--------DVQPLHEEIKLHSQLRHRNIVQYLGSVS 872 (1181)
Q Consensus 801 ~~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--------~~e~f~rEi~IL~~L~HPNIVkl~g~~~ 872 (1181)
.+.+.|...+ +||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.++++++||||+++++++.
T Consensus 21 ~~~~~y~~~~-~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 21 EYSQKYSTMS-PLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE 99 (335)
T ss_dssp HHHHHEEEEE-ECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ccccceEEEe-EEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3445555544 799999999999999999999999999765321 3456788999999999999999999999
Q ss_pred cCCcEEEEEeecCCC-CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCC
Q psy14556 873 EEGYFKIFMEQVPGG-SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFG 951 (1181)
Q Consensus 873 d~~~l~LVmEy~~gG-SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFG 951 (1181)
+.+..++||||+.+| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~-~~~~kL~Dfg 175 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAE-DFTIKLIDFG 175 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-TSCEEECCCT
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcC-CCcEEEeecc
Confidence 999999999999776 999998743 35889999999999999999999999999999999999988 8999999999
Q ss_pred cccccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCc
Q psy14556 952 TSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTS 1031 (1181)
Q Consensus 952 lAk~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~ 1031 (1181)
+++..... .......||+.|+|||++.+..+ .+...|+ ||+|+++|+|++|+.||.....
T Consensus 176 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~~Di------------------wslG~il~el~~g~~pf~~~~~ 235 (335)
T 3dls_A 176 SAAYLERG-KLFYTFCGTIEYCAPEVLMGNPY-RGPELEM------------------WSLGVTLYTLVFEENPFCELEE 235 (335)
T ss_dssp TCEECCTT-CCBCEECSCGGGCCHHHHTTCCB-CSHHHHH------------------HHHHHHHHHHHHSSCSCSSGGG
T ss_pred cceECCCC-CceeccCCCccccChhhhcCCCC-CCCcccc------------------hhHHHHHHHHHhCCCchhhHHH
Confidence 99876543 23344579999999999975432 1333343 9999999999999999986433
Q ss_pred ccccCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHH
Q psy14556 1032 RALVAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLV 1076 (1181)
Q Consensus 1032 ~~l~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~ 1076 (1181)
.. .. ....+...+..+..++.+|+..+|..||+..+....
T Consensus 236 ~~-~~----~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 TV-EA----AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp GT-TT----CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred HH-hh----ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 11 111233467789999999999999999985555443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=315.21 Aligned_cols=241 Identities=24% Similarity=0.299 Sum_probs=187.8
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC--hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD--VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~--~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
++||+|+||+||+|.+..+++.||+|++....... .+.+.+|+.++++++||||+++++++.+.+..++||||+++++
T Consensus 9 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (311)
T 4agu_A 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTV 88 (311)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEH
T ss_pred eEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCch
Confidence 37999999999999999999999999986554322 4568899999999999999999999999999999999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|.+++... ..+++..++.++.|++.||+|||++||+||||||+||+++. ++.+||+|||++..............|
T Consensus 89 l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 164 (311)
T 4agu_A 89 LHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITK-HSVIKLCDFGFARLLTGPSDYYDDEVA 164 (311)
T ss_dssp HHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TSCEEECCCTTCEECC-----------
T ss_pred HHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcC-CCCEEEeeCCCchhccCcccccCCCcC
Confidence 99887643 35789999999999999999999999999999999999988 899999999999877654444445678
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc-------------
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV------------- 1035 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~------------- 1035 (1181)
|+.|+|||++.+.. .++...|+ ||+|+++|+|++|+.||.+....+..
T Consensus 165 ~~~y~aPE~~~~~~-~~~~~~Di------------------~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
T 4agu_A 165 TRWYRSPELLVGDT-QYGPPVDV------------------WAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPR 225 (311)
T ss_dssp -GGGCCHHHHHTCS-CCCTHHHH------------------HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred CccccChHHHhcCC-CCCcchhh------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccc
Confidence 99999999996422 23334444 99999999999999999887653310
Q ss_pred -----------CCCCCCCCC--------CCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1036 -----------APPQISRSV--------SVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1036 -----------~~~~ip~~l--------~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
....++... ....+..+..++.+|++.+|..||+..+..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 283 (311)
T 4agu_A 226 HQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283 (311)
T ss_dssp HHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHH
T ss_pred cccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHh
Confidence 000111110 124566688899999999999999755443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=320.61 Aligned_cols=245 Identities=24% Similarity=0.330 Sum_probs=188.7
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC--hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEe
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD--VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~--~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmE 882 (1181)
.|.+. ++||+|+||+||+|++. +++.||+|++....... .+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 22 ~y~~~-~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 22 KYQKL-EKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp EEEEE-EEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred hhHhh-hhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 34443 47999999999999985 58899999997553322 4678899999999999999999999999999999999
Q ss_pred ecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC
Q psy14556 883 QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS 962 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~ 962 (1181)
|++ ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++........
T Consensus 100 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~a~~~~~~~~~ 175 (311)
T 3niz_A 100 FME-KDLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINS-DGALKLADFGLARAFGIPVRS 175 (311)
T ss_dssp CCS-EEHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT-TCCEEECCCTTCEETTSCCC-
T ss_pred CCC-CCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECC-CCCEEEccCcCceecCCCccc
Confidence 996 5777777643 345789999999999999999999999999999999999988 899999999999877654444
Q ss_pred CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCC-----
Q psy14556 963 AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAP----- 1037 (1181)
Q Consensus 963 ~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~----- 1037 (1181)
.....||+.|+|||++.+.. .++..+|+ ||+||++|+|++|+.||.+....+....
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~-~~~~~~Di------------------wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 236 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSK-KYSTSVDI------------------WSIGCIFAEMITGKPLFPGVTDDDQLPKIFSIL 236 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCC-SCCTHHHH------------------HHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHH
T ss_pred ccCCcccCCcCCHHHhcCCC-CCCchHHh------------------HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHH
Confidence 45567899999999996532 23444444 9999999999999999988765432100
Q ss_pred --C---CCCC---------------------CCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1038 --P---QISR---------------------SVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1038 --~---~ip~---------------------~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
+ ..+. ......+..+..++.+|+..||.+||+..+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 299 (311)
T 3niz_A 237 GTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAM 299 (311)
T ss_dssp CCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred CCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 0 0000 01122445667899999999999999754443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=308.96 Aligned_cols=239 Identities=26% Similarity=0.360 Sum_probs=183.2
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC----CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL----GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~----~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
++||+|+||.||+|.+ ++..||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 13 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (271)
T 3dtc_A 13 EIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARG 90 (271)
T ss_dssp EEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTT
T ss_pred eeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCC
Confidence 4799999999999997 478999999865433 2357789999999999999999999999999999999999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccc---eecccCCCCCccccc-------CCCeeeeecCCccccc
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK---IVHRDIKGDNVLVNT-------YSGVVKISDFGTSKRL 956 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~g---IVHrDLKP~NILLd~-------~~g~vKLiDFGlAk~l 956 (1181)
++|.+++... .+++..++.++.|++.||.|||++| |+||||||+||+++. .++.+||+|||++...
T Consensus 91 ~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~ 166 (271)
T 3dtc_A 91 GPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW 166 (271)
T ss_dssp EEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC----
T ss_pred CCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccc
Confidence 9999998633 6789999999999999999999999 899999999999975 2578999999999866
Q ss_pred ccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC
Q psy14556 957 AGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA 1036 (1181)
Q Consensus 957 ~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~ 1036 (1181)
.... .....||+.|+|||++.+..++.. .|+ ||+|+++|+|++|+.||.+.+......
T Consensus 167 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~--~Di------------------~slG~~l~~l~~g~~p~~~~~~~~~~~ 224 (271)
T 3dtc_A 167 HRTT--KMSAAGAYAWMAPEVIRASMFSKG--SDV------------------WSYGVLLWELLTGEVPFRGIDGLAVAY 224 (271)
T ss_dssp -----------CCGGGSCHHHHHHCCCSHH--HHH------------------HHHHHHHHHHHHCCCTTTTSCHHHHHH
T ss_pred cccc--ccCCCCccceeCHHHhccCCCCch--hhH------------------HHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 5432 224568999999999976543333 333 999999999999999999877544211
Q ss_pred ---CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1037 ---PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1037 ---~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
........+...+..+..++.+|++.+|..||+ +.+.+..+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~~e~l~~L 268 (271)
T 3dtc_A 225 GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPS-FTNILDQL 268 (271)
T ss_dssp HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-HHHHHHHH
T ss_pred hhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcC-HHHHHHHH
Confidence 122223344567788999999999999999986 55554444
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=321.62 Aligned_cols=248 Identities=22% Similarity=0.257 Sum_probs=194.1
Q ss_pred ceeecccCceEEEEEEEc-----CCCeEEEEEEecCCC-CCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEe
Q psy14556 810 RIELGKGSYGVVYAAREL-----DRQVKLAIKEIPEKN-LGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~-----~tg~~VAIKii~~~~-~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmE 882 (1181)
...||+|+||.||+|.+. .++..||+|++.... ....+.+.+|+.+++++ +||||+++++++...+..++|||
T Consensus 50 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 129 (344)
T 1rjb_A 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE 129 (344)
T ss_dssp EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEe
Confidence 347999999999999973 466789999997543 33467899999999999 89999999999999999999999
Q ss_pred ecCCCCcccchhcccCC--------------------CCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCC
Q psy14556 883 QVPGGSLSTLLRVKWGP--------------------LKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYS 942 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~~--------------------~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~ 942 (1181)
|+++|+|.+++...... ..+++..++.++.||+.||.|||++||+||||||+||+++. +
T Consensus 130 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~-~ 208 (344)
T 1rjb_A 130 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH-G 208 (344)
T ss_dssp CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEET-T
T ss_pred cCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcC-C
Confidence 99999999999864321 23688999999999999999999999999999999999987 8
Q ss_pred CeeeeecCCcccccccCCCC--CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHH
Q psy14556 943 GVVKISDFGTSKRLAGLCPS--AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLL 1020 (1181)
Q Consensus 943 g~vKLiDFGlAk~l~~~~~~--~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELL 1020 (1181)
+.+||+|||++......... .....+|+.|+|||++.++.++. ..|+ ||+|+++|+|+
T Consensus 209 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~--~~Di------------------~slG~il~el~ 268 (344)
T 1rjb_A 209 KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI--KSDV------------------WSYGILLWEIF 268 (344)
T ss_dssp TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCH--HHHH------------------HHHHHHHHHHT
T ss_pred CcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCCh--hHhH------------------HHHHHHHHHHH
Confidence 99999999999876543221 22344788999999997654333 3333 99999999999
Q ss_pred h-CCCCCCCCCcccccC---CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcc
Q psy14556 1021 V-LTAALKKKTSRALVA---PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTG 1079 (1181)
Q Consensus 1021 T-Gk~PF~~~~~~~l~~---~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~ 1079 (1181)
| |..||.+........ ........+...+..+..++.+|+..+|..||+ +.+.+..+.
T Consensus 269 t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~~l~~~l~ 330 (344)
T 1rjb_A 269 SLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS-FPNLTSFLG 330 (344)
T ss_dssp TTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-HHHHHHHHH
T ss_pred cCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcC-HHHHHHHHH
Confidence 8 999998876533110 011122233456888999999999999999996 444443333
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=321.30 Aligned_cols=248 Identities=15% Similarity=0.174 Sum_probs=182.1
Q ss_pred eeecccCceEEEEEEEcCCCe---EEEEEEecCCC--CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcE------EE
Q psy14556 811 IELGKGSYGVVYAARELDRQV---KLAIKEIPEKN--LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYF------KI 879 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~---~VAIKii~~~~--~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l------~L 879 (1181)
+.||+|+||.||+|.+..++. .||+|++.... ....+.+.+|+.++++++||||+++++++...... ++
T Consensus 29 ~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 108 (323)
T 3qup_A 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMV 108 (323)
T ss_dssp EEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEE
T ss_pred ceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEE
Confidence 479999999999999877665 89999997653 23357799999999999999999999998776554 99
Q ss_pred EEeecCCCCcccchhccc---CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccccc
Q psy14556 880 FMEQVPGGSLSTLLRVKW---GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956 (1181)
Q Consensus 880 VmEy~~gGSL~dlL~~~~---~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l 956 (1181)
||||+++++|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 109 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~-~~~~kl~Dfg~a~~~ 187 (323)
T 3qup_A 109 ILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAE-DMTVCVADFGLSRKI 187 (323)
T ss_dssp EEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT-TSCEEECCCCC----
T ss_pred EEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcC-CCCEEEeeccccccc
Confidence 999999999999986432 2235889999999999999999999999999999999999988 899999999999876
Q ss_pred ccCCC--CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q psy14556 957 AGLCP--SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRA 1033 (1181)
Q Consensus 957 ~~~~~--~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~ 1033 (1181)
..... ......+++.|+|||++.+..++. ..|+ ||+|+++|+|++ |..||.+.....
T Consensus 188 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--~~Di------------------~slG~il~ell~~g~~p~~~~~~~~ 247 (323)
T 3qup_A 188 YSGDYYRQGCASKLPVKWLALESLADNLYTV--HSDV------------------WAFGVTMWEIMTRGQTPYAGIENAE 247 (323)
T ss_dssp -------------CCGGGCCHHHHHHCCCCH--HHHH------------------HHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred cccccccccccccCcccccCchhhcCCCCCC--ccch------------------hhHHHHHHHHHhCCCCCccccChHH
Confidence 44321 122334678999999997664333 3333 999999999999 999999877655
Q ss_pred ccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1034 LVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1034 l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
+..... .....+...+..+..++.+|++.+|..||+ +.+....+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~~l~~~l~~ 295 (323)
T 3qup_A 248 IYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPS-FTCLRMELEN 295 (323)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCC-HHHHHHHHHH
T ss_pred HHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcC-HHHHHHHHHH
Confidence 422111 112234467788999999999999999985 4444444443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=319.41 Aligned_cols=243 Identities=23% Similarity=0.267 Sum_probs=189.2
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC--hhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEE
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD--VQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIF 880 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~--~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LV 880 (1181)
+.|... .+||+|+||+||+|++..+++.||||++....... ......|+..+.++ +||||+++++++.+.+..++|
T Consensus 57 ~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRL-SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEE-EEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeee-heeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 445444 47999999999999999999999999986543322 33455566555555 999999999999999999999
Q ss_pred EeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC
Q psy14556 881 MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC 960 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~ 960 (1181)
|||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 136 ~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~-~~~~kl~DFG~a~~~~~~- 210 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGP-RGRCKLGDFGLLVELGTA- 210 (311)
T ss_dssp EECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECG-GGCEEECCCTTCEECC---
T ss_pred Eecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECC-CCCEEEccceeeeecccC-
Confidence 9999 77998888754 235789999999999999999999999999999999999988 889999999999776543
Q ss_pred CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCCC
Q psy14556 961 PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQI 1040 (1181)
Q Consensus 961 ~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~i 1040 (1181)
.......||+.|+|||++.+ . ++...|+ ||+|+++|+|++|..||.+............
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~-~--~~~~~Di------------------wslG~il~el~~g~~~~~~~~~~~~~~~~~~ 269 (311)
T 3p1a_A 211 GAGEVQEGDPRYMAPELLQG-S--YGTAADV------------------FSLGLTILEVACNMELPHGGEGWQQLRQGYL 269 (311)
T ss_dssp ----CCCCCGGGCCGGGGGT-C--CSTHHHH------------------HHHHHHHHHHHHTCCCCSSHHHHHHHTTTCC
T ss_pred CCCcccCCCccccCHhHhcC-C--CCchhhH------------------HHHHHHHHHHHhCCCCCCCccHHHHHhccCC
Confidence 22334569999999999864 3 3344444 9999999999999766665443332222223
Q ss_pred CCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1041 SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1041 p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
+.......+..+..++.+|++.+|..||+..+.
T Consensus 270 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el 302 (311)
T 3p1a_A 270 PPEFTAGLSSELRSVLVMMLEPDPKLRATAEAL 302 (311)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CcccccCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 333445678889999999999999999975444
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-34 Score=314.43 Aligned_cols=239 Identities=27% Similarity=0.368 Sum_probs=193.1
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
..+||+|+||.||+|.+..+++.||+|.+.... ..+.+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 34 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 111 (314)
T 3com_A 34 LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSV 111 (314)
T ss_dssp EEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred heeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCH
Confidence 347999999999999999999999999997543 457799999999999999999999999999999999999999999
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT 969 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT 969 (1181)
.+++... ...+++..++.++.||+.||.|||++|++|+||||+||+++. ++.+||+|||++..............|+
T Consensus 112 ~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 188 (314)
T 3com_A 112 SDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNT-EGHAKLADFGVAGQLTDTMAKRNTVIGT 188 (314)
T ss_dssp HHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TCCEEECCCTTCEECBTTBSCBCCCCSC
T ss_pred HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECC-CCCEEEeecccchhhhhhccccCccCCC
Confidence 9998743 235789999999999999999999999999999999999988 8899999999998766544444456799
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC----CCCCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA----PPQISRSVS 1045 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~----~~~ip~~l~ 1045 (1181)
+.|+|||++.+..++.. .|+ ||+|+++|+|++|+.||.......... ........+
T Consensus 189 ~~y~aPE~~~~~~~~~~--~Di------------------~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 248 (314)
T 3com_A 189 PFWMAPEVIQEIGYNCV--ADI------------------WSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKP 248 (314)
T ss_dssp GGGCCHHHHSSSCBCTT--HHH------------------HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSG
T ss_pred CCccChhhcCCCCCCcc--ccH------------------HHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCc
Confidence 99999999976544333 333 999999999999999998766533211 111111112
Q ss_pred CCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1046 VPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1046 ~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
...+..+..++.+|+..+|..||+..+.
T Consensus 249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~l 276 (314)
T 3com_A 249 ELWSDNFTDFVKQCLVKSPEQRATATQL 276 (314)
T ss_dssp GGSCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 3356788899999999999999976555
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=334.09 Aligned_cols=242 Identities=21% Similarity=0.269 Sum_probs=192.8
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
++||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 120 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 199 (377)
T 3cbl_A 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 199 (377)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred eEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCH
Confidence 479999999999999999999999999875432 2245688999999999999999999999999999999999999999
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC--Ccccc
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS--AETFT 967 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~--~~t~~ 967 (1181)
.++++.. ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++........ .....
T Consensus 200 ~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~-~~~~kl~DfG~s~~~~~~~~~~~~~~~~ 276 (377)
T 3cbl_A 200 LTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTE-KNVLKISDFGMSREEADGVYAASGGLRQ 276 (377)
T ss_dssp HHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-TCCEEECCGGGCEECTTSEEECCSSCCE
T ss_pred HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcC-CCcEEECcCCCceecCCCceeecCCCCC
Confidence 9999754 234678899999999999999999999999999999999987 899999999999765432111 11123
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--CCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--ISRSV 1044 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--ip~~l 1044 (1181)
+++.|+|||++.++.++.+ .| .||+|+++|||++ |..||.+.....+..... .....
T Consensus 277 ~~~~y~aPE~~~~~~~~~~--~D------------------vwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~ 336 (377)
T 3cbl_A 277 VPVKWTAPEALNYGRYSSE--SD------------------VWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC 336 (377)
T ss_dssp EEGGGSCHHHHHHCEEEHH--HH------------------HHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCC
T ss_pred CCcCcCCHhHhccCCCCch--hh------------------HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 5678999999976543332 23 3999999999998 999999877644321111 11122
Q ss_pred CCCCCcchHHhhccCCCCCCCCCchhHHHHHH
Q psy14556 1045 SVPGPGGINSSSSAPVTPTPHSRHISVNTNLV 1076 (1181)
Q Consensus 1045 ~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~ 1076 (1181)
+..++..+..++.+|++.+|..||+ +.+...
T Consensus 337 ~~~~~~~l~~li~~cl~~dP~~Rps-~~~i~~ 367 (377)
T 3cbl_A 337 PELCPDAVFRLMEQCWAYEPGQRPS-FSTIYQ 367 (377)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCC-HHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcC-HHHHHH
Confidence 3456788999999999999999996 444333
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=336.86 Aligned_cols=240 Identities=22% Similarity=0.303 Sum_probs=193.4
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.+||+|+||+||+|+++.+++.||+|++.+.. ....+.+.+|..++..++||||+++++++.+.+.+|+||||++||
T Consensus 67 ~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg 146 (412)
T 2vd5_A 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGG 146 (412)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCC
Confidence 37999999999999999999999999996532 123456889999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC-CCccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP-SAETF 966 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~-~~~t~ 966 (1181)
+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++....... .....
T Consensus 147 ~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~-~g~vkL~DFGla~~~~~~~~~~~~~~ 223 (412)
T 2vd5_A 147 DLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDR-CGHIRLADFGSCLKLRADGTVRSLVA 223 (412)
T ss_dssp BHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TSCEEECCCTTCEECCTTSCEECSSC
T ss_pred cHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecC-CCCEEEeechhheeccCCCcccccee
Confidence 999999754 235789999999999999999999999999999999999998 89999999999987654322 22345
Q ss_pred cCCccccCchhhccC-----CCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCC----
Q psy14556 967 TGTLQYMAPEVIDKG-----QRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAP---- 1037 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg-----~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~---- 1037 (1181)
+||+.|+|||++.+. ...++..+|+ ||+||++|||++|+.||.+.+..++...
T Consensus 224 ~Gt~~Y~APE~l~~~~~~~~~~~~~~~~Di------------------wSlGvilyelltG~~Pf~~~~~~~~~~~i~~~ 285 (412)
T 2vd5_A 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDW------------------WALGVFAYEMFYGQTPFYADSTAETYGKIVHY 285 (412)
T ss_dssp CSCGGGCCHHHHHHHHTCTTCSEECTHHHH------------------HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred ccccCcCCHHHHhhcccCcCCCCCChHHhh------------------hHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 799999999999731 1123333443 9999999999999999998876543211
Q ss_pred ---CCCCCCCCCCCCcchHHhhccCCCCCCCCCc--hhHHH
Q psy14556 1038 ---PQISRSVSVPGPGGINSSSSAPVTPTPHSRH--ISVNT 1073 (1181)
Q Consensus 1038 ---~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp--~s~~~ 1073 (1181)
..++. .....+..+..++.+|+. +|..|. .++++
T Consensus 286 ~~~~~~p~-~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~e 324 (412)
T 2vd5_A 286 KEHLSLPL-VDEGVPEEARDFIQRLLC-PPETRLGRGGAGD 324 (412)
T ss_dssp HHHCCCC-----CCCHHHHHHHHTTSS-CGGGCTTTTTHHH
T ss_pred ccCcCCCc-cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHH
Confidence 11111 123567888999999998 999985 34555
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=346.28 Aligned_cols=239 Identities=23% Similarity=0.300 Sum_probs=197.4
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.+||+|+||.||+|++..+++.||+|++.+.. ....+.+.+|+.++++++||||+++++++.+.+.+|+||||++||
T Consensus 191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg 270 (543)
T 3c4z_A 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGG 270 (543)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCC
Confidence 46999999999999999999999999996542 234567899999999999999999999999999999999999999
Q ss_pred Ccccchhccc-CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccc
Q psy14556 888 SLSTLLRVKW-GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF 966 (1181)
Q Consensus 888 SL~dlL~~~~-~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~ 966 (1181)
+|.+++.... ....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.+..........
T Consensus 271 ~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~-~g~vkL~DFGla~~~~~~~~~~~~~ 349 (543)
T 3c4z_A 271 DIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDD-DGNVRISDLGLAVELKAGQTKTKGY 349 (543)
T ss_dssp BHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT-TSCEEECCCTTCEECCTTCCCBCCC
T ss_pred CHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeC-CCCEEEeecceeeeccCCCcccccc
Confidence 9999987542 2346889999999999999999999999999999999999998 8999999999998776544444556
Q ss_pred cCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc----cccCCC-CCC
Q psy14556 967 TGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR----ALVAPP-QIS 1041 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~----~l~~~~-~ip 1041 (1181)
.||+.|+|||++.+.. ++..+|+ ||+||++|||++|+.||.+.... .+...+ ...
T Consensus 350 ~GT~~Y~APE~l~~~~--~~~~~Di------------------wSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~ 409 (543)
T 3c4z_A 350 AGTPGFMAPELLLGEE--YDFSVDY------------------FALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA 409 (543)
T ss_dssp CSCTTTSCHHHHTTCC--BCTHHHH------------------HHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC
T ss_pred cCCccccChhhhcCCC--CChHHhc------------------CcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc
Confidence 8999999999997654 3344444 99999999999999999886432 111100 011
Q ss_pred CCCCCCCCcchHHhhccCCCCCCCCCchh
Q psy14556 1042 RSVSVPGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1042 ~~l~~~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
...+...+..+..++.+|+..+|.+||..
T Consensus 410 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 410 VTYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred cCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 12234567888899999999999999964
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=337.07 Aligned_cols=246 Identities=25% Similarity=0.342 Sum_probs=201.5
Q ss_pred HhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEE
Q psy14556 802 FLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFK 878 (1181)
Q Consensus 802 ~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~ 878 (1181)
+.+.|... ++||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 24 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 24 FSDRYKGQ-RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp HHHHEEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCceEEe-eEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34455553 47999999999999999999999999996553 234678999999999999999999999999999999
Q ss_pred EEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccccc--CCCeeeeecCCccccc
Q psy14556 879 IFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNT--YSGVVKISDFGTSKRL 956 (1181)
Q Consensus 879 LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~--~~g~vKLiDFGlAk~l 956 (1181)
+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. .++.+||+|||+++..
T Consensus 103 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 999999999999988743 35789999999999999999999999999999999999952 2679999999999876
Q ss_pred ccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC
Q psy14556 957 AGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA 1036 (1181)
Q Consensus 957 ~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~ 1036 (1181)
... .......||+.|+|||++.+ . ++..+|+ ||+||++|+|++|.+||.+.+..++..
T Consensus 180 ~~~-~~~~~~~gt~~y~aPE~~~~-~--~~~~~Di------------------wslG~il~~ll~g~~pf~~~~~~~~~~ 237 (484)
T 3nyv_A 180 EAS-KKMKDKIGTAYYIAPEVLHG-T--YDEKCDV------------------WSTGVILYILLSGCPPFNGANEYDILK 237 (484)
T ss_dssp CCC-CSHHHHTTGGGTCCHHHHHT-C--CCTHHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ccc-cccccCCCCccccCceeecC-C--CCCccee------------------HHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 543 22334569999999999964 2 3444444 999999999999999999887655322
Q ss_pred -----CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1037 -----PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1037 -----~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
....+.......+..+..++.+|+..+|..||+..+.
T Consensus 238 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~ 279 (484)
T 3nyv_A 238 KVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDA 279 (484)
T ss_dssp HHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 1122222223467788899999999999999986655
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=308.69 Aligned_cols=247 Identities=20% Similarity=0.271 Sum_probs=195.3
Q ss_pred HhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEE
Q psy14556 802 FLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFK 878 (1181)
Q Consensus 802 ~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~ 878 (1181)
+..+|.+.+ +||+|+||.||+|.+..+++.||+|++...... ....+.+|+..+..+ +||||+++++++.+.+..+
T Consensus 9 ~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 9 YTTEFHELE-KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHEEEEE-EEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred ccchhhhhh-hhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 344555544 799999999999999999999999999765333 346788999999999 9999999999999999999
Q ss_pred EEEeecCCCCcccchhccc-CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccccc-----------------
Q psy14556 879 IFMEQVPGGSLSTLLRVKW-GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNT----------------- 940 (1181)
Q Consensus 879 LVmEy~~gGSL~dlL~~~~-~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~----------------- 940 (1181)
+||||+++++|.+++.... ....+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 9999999999999997532 1245789999999999999999999999999999999999974
Q ss_pred -CCCeeeeecCCcccccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHH
Q psy14556 941 -YSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQL 1019 (1181)
Q Consensus 941 -~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyEL 1019 (1181)
....+||+|||.+...... ....||+.|+|||++.+. ..++...|+ ||+|+++|+|
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~~Di------------------~slG~il~~l 224 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQEN-YTHLPKADI------------------FALALTVVCA 224 (289)
T ss_dssp --CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTC-CTTHHHHHH------------------HHHHHHHHHH
T ss_pred CCceEEEEcccccccccCCc----cccCCCccccChhHhcCC-CCCCchhhH------------------HHHHHHHHHH
Confidence 1347999999999876542 233589999999999643 222233333 9999999999
Q ss_pred HhCCCCCCCCCcccccCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1020 LVLTAALKKKTSRALVAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1020 LTGk~PF~~~~~~~l~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
++|.+|+.............. ...+...+..+..++.+|++.+|..||+..+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l 277 (289)
T 1x8b_A 225 AGAEPLPRNGDQWHEIRQGRL-PRIPQVLSQEFTELLKVMIHPDPERRPSAMAL 277 (289)
T ss_dssp TTCCCCCSSSHHHHHHHTTCC-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hcCCCCCcchhHHHHHHcCCC-CCCCcccCHHHHHHHHHHhCCCcccCCCHHHH
Confidence 999988765543222111111 22334577889999999999999999975554
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=313.75 Aligned_cols=237 Identities=26% Similarity=0.373 Sum_probs=195.7
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
++||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 20 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 99 (284)
T 2vgo_A 20 RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRG 99 (284)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTE
T ss_pred heecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCC
Confidence 47999999999999999999999999995432 233567899999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||++...... ......
T Consensus 100 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~-~~~~kl~Dfg~~~~~~~~--~~~~~~ 173 (284)
T 2vgo_A 100 ELYKELQKH---GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGY-KGELKIADFGWSVHAPSL--RRRTMC 173 (284)
T ss_dssp EHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECT-TCCEEECCCTTCEECSSS--CBCCCC
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcC-CCCEEEecccccccCccc--cccccc
Confidence 999999754 25789999999999999999999999999999999999987 889999999998765432 233456
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-CCCCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-ISRSVSV 1046 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-ip~~l~~ 1046 (1181)
|++.|+|||++.+...+..+ |+ ||+|+++|+|++|..||............. .....+.
T Consensus 174 ~~~~y~aPE~~~~~~~~~~~--Di------------------~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T 2vgo_A 174 GTLDYLPPEMIEGKTHDEKV--DL------------------WCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP 233 (284)
T ss_dssp SCGGGCCHHHHTTCCBCTTH--HH------------------HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT
T ss_pred CCCCcCCHHHhccCCCCccc--ch------------------hhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCC
Confidence 89999999999865444333 33 999999999999999998876544321110 1112234
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
..+..+..++.+|+..+|..||+..+.
T Consensus 234 ~~~~~~~~li~~~l~~~p~~Rps~~~l 260 (284)
T 2vgo_A 234 FLSDGSKDLISKLLRYHPPQRLPLKGV 260 (284)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred cCCHHHHHHHHHHhhcCHhhCCCHHHH
Confidence 567788999999999999999986555
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-34 Score=337.43 Aligned_cols=246 Identities=26% Similarity=0.360 Sum_probs=197.8
Q ss_pred HhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCC--CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEE
Q psy14556 802 FLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKN--LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKI 879 (1181)
Q Consensus 802 ~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~--~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~L 879 (1181)
+...|...+ +||+|+||+||+|++..++..||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus 35 ~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 35 LSEMYQRVK-KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp HHHHEEEEE-EEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhcCeEEee-EEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 444555544 7999999999999999999999999997653 3346789999999999999999999999999999999
Q ss_pred EEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccC--CCeeeeecCCcccccc
Q psy14556 880 FMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTY--SGVVKISDFGTSKRLA 957 (1181)
Q Consensus 880 VmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~--~g~vKLiDFGlAk~l~ 957 (1181)
||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.. ++.+||+|||++....
T Consensus 114 v~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 114 VMECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred EEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 99999999999888754 357899999999999999999999999999999999999752 3469999999998765
Q ss_pred cCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC-
Q psy14556 958 GLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA- 1036 (1181)
Q Consensus 958 ~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~- 1036 (1181)
... ......||+.|+|||++.+ . ++..+|+ ||+||++|+|++|..||.+.+..++..
T Consensus 191 ~~~-~~~~~~gt~~y~aPE~l~~-~--~~~~~Di------------------wslG~il~~ll~g~~pf~~~~~~~~~~~ 248 (494)
T 3lij_A 191 NQK-KMKERLGTAYYIAPEVLRK-K--YDEKCDV------------------WSIGVILFILLAGYPPFGGQTDQEILRK 248 (494)
T ss_dssp TTB-CBCCCCSCTTTCCHHHHTT-C--BCTHHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred CCc-cccccCCCcCeeCHHHHcc-c--CCCchhH------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 432 3344579999999999853 2 3444444 999999999999999999888755422
Q ss_pred ----CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1037 ----PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1037 ----~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
....+.......+..+..++.+|+..+|.+||+..+.
T Consensus 249 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~ 289 (494)
T 3lij_A 249 VEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQA 289 (494)
T ss_dssp HHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHH
Confidence 2223333334567888999999999999999976554
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=306.57 Aligned_cols=245 Identities=23% Similarity=0.322 Sum_probs=196.1
Q ss_pred hhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEE
Q psy14556 803 LYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFM 881 (1181)
Q Consensus 803 ~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVm 881 (1181)
...|.+.+ +||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 6 VEDWDLVQ-TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHEEEEE-EEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ecceEEEE-EeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 34555544 79999999999999999999999999965433 33577899999999999999999999999999999999
Q ss_pred eecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC-
Q psy14556 882 EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC- 960 (1181)
Q Consensus 882 Ey~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~- 960 (1181)
||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||.+.......
T Consensus 85 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~-~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 85 EYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp ECCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-TCCEEECCCTTCEECEETTE
T ss_pred EecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEcc-CCCEEEeeCCCccccCCCcc
Confidence 99999999999874 346789999999999999999999999999999999999987 8999999999997654321
Q ss_pred -CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc-----
Q psy14556 961 -PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL----- 1034 (1181)
Q Consensus 961 -~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l----- 1034 (1181)
.......|++.|+|||++.+... .+...|+ ||+|+++|+|++|+.||.+......
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~Di------------------~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 221 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREF-HAEPVDV------------------WSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSB-CHHHHHH------------------HHHHHHHHHHHHSSCCCSCSCTTSHHHHHH
T ss_pred hhcccCCccccCccChHHHhcCCC-CCCcchH------------------HHHHHHHHHHHhCCCCCCCCchHHHHHHHh
Confidence 22334568999999999975432 1222333 9999999999999999987664321
Q ss_pred cCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1035 VAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1035 ~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
..... ........+..+..++.+|+..+|..||+..+
T Consensus 222 ~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 258 (276)
T 2yex_A 222 KEKKT-YLNPWKKIDSAPLALLHKILVENPSARITIPD 258 (276)
T ss_dssp HTTCT-TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred hhccc-ccCchhhcCHHHHHHHHHHCCCCchhCCCHHH
Confidence 11111 11112246778889999999999999997443
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=307.40 Aligned_cols=240 Identities=13% Similarity=0.179 Sum_probs=192.3
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEccccccC--CcEEEEEeecCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSEE--GYFKIFMEQVPG 886 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~--~~l~LVmEy~~g 886 (1181)
.+||+|+||.||+|++ ++..||+|++...... ..+.+.+|+.++++++||||+++++++.+. +..++||||+++
T Consensus 16 ~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 93 (271)
T 3kmu_A 16 TKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPY 93 (271)
T ss_dssp EEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTT
T ss_pred HHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCC
Confidence 4799999999999998 4889999999765432 346789999999999999999999999877 789999999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccc--eecccCCCCCcccccCCCeeeeecCCcccccccCCCCCc
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAE 964 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~g--IVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~ 964 (1181)
++|.+++... ....+++..++.++.||+.||+|||++| |+||||||+||+++. ++.++|+|||++..... .
T Consensus 94 ~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~-~~~~~l~~~~~~~~~~~-----~ 166 (271)
T 3kmu_A 94 GSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDE-DMTARISMADVKFSFQS-----P 166 (271)
T ss_dssp CBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECT-TSCEEEEGGGSCCTTSC-----T
T ss_pred CcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcC-CcceeEEeccceeeecc-----c
Confidence 9999999864 3346889999999999999999999999 999999999999987 78899988887654322 2
Q ss_pred cccCCccccCchhhccCCCCC-CCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC---CCCC
Q psy14556 965 TFTGTLQYMAPEVIDKGQRGY-GAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA---PPQI 1040 (1181)
Q Consensus 965 t~~GT~~Y~APEvl~gg~~~~-ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~---~~~i 1040 (1181)
...||+.|+|||++.+..... +...|+ ||+|+++|+|++|+.||.+.+...... ....
T Consensus 167 ~~~~t~~y~aPE~~~~~~~~~~~~~~Di------------------~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 228 (271)
T 3kmu_A 167 GRMYAPAWVAPEALQKKPEDTNRRSADM------------------WSFAVLLWELVTREVPFADLSNMEIGMKVALEGL 228 (271)
T ss_dssp TCBSCGGGSCHHHHHSCGGGSCHHHHHH------------------HHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCC
T ss_pred CccCCccccChhhhccCCCCCCCchhhH------------------HHHHHHHHHHHhCCCCccccChHHHHHHHHhcCC
Confidence 346899999999997543222 112333 999999999999999999877654311 1112
Q ss_pred CCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1041 SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1041 p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
....+...+..+..++.+|++.+|..||+ +.+.+..+
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~~~il~~L 265 (271)
T 3kmu_A 229 RPTIPPGISPHVSKLMKICMNEDPAKRPK-FDMIVPIL 265 (271)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCC-HHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcC-HHHHHHHH
Confidence 22334567888999999999999999995 55544444
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=310.55 Aligned_cols=237 Identities=23% Similarity=0.258 Sum_probs=189.3
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
++||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.
T Consensus 30 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (283)
T 3gen_A 30 KELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL 107 (283)
T ss_dssp EECC---CEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHH
T ss_pred hhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHH
Confidence 47999999999999875 677899999975543 3467999999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC-CCCccccCC
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC-PSAETFTGT 969 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~-~~~~t~~GT 969 (1181)
+++... ...+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||+++...... .......+|
T Consensus 108 ~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 184 (283)
T 3gen_A 108 NYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND-QGVVKVSDFGLSRYVLDDEYTSSVGSKFP 184 (283)
T ss_dssp HHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECT-TSCEEECSTTGGGGBCCHHHHSTTSTTSC
T ss_pred HHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcC-CCCEEEccccccccccccccccccCCccC
Confidence 999753 235789999999999999999999999999999999999987 8899999999997654321 112233467
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--CCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--ISRSVSV 1046 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--ip~~l~~ 1046 (1181)
+.|+|||++.+..++. ..|+ ||+|+++|+|++ |+.||...+......... .....+.
T Consensus 185 ~~y~aPE~~~~~~~~~--~~Dv------------------~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (283)
T 3gen_A 185 VRWSPPEVLMYSKFSS--KSDI------------------WAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH 244 (283)
T ss_dssp GGGCCHHHHHHCCCSH--HHHH------------------HHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCT
T ss_pred cccCCHHHhccCCCCc--hhhH------------------HHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCC
Confidence 8899999998664333 3333 999999999998 999999877654322111 1222234
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
..+..+..++.+|++.+|..||+..+
T Consensus 245 ~~~~~l~~li~~~l~~~p~~Rps~~~ 270 (283)
T 3gen_A 245 LASEKVYTIMYSCWHEKADERPTFKI 270 (283)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHH
Confidence 55778999999999999999986433
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-34 Score=314.05 Aligned_cols=247 Identities=24% Similarity=0.346 Sum_probs=183.9
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC---ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEE
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG---DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIF 880 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~---~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LV 880 (1181)
..|.+. ++||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 32 ~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 32 ANFRIE-KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGEEEE-EEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceEEE-EeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 344444 4799999999999999999999999999764332 346788999999999999999999999999999999
Q ss_pred EeecCCCCcccchhcc-cCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccC
Q psy14556 881 MEQVPGGSLSTLLRVK-WGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGL 959 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~-~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~ 959 (1181)
|||+++++|.+++... .....+++..++.++.||+.||.|||++|++||||||+||+++. ++.+||+|||++......
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~-~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TSCEEECCC---------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcC-CCCEEEEeccceeeecCC
Confidence 9999999999998742 13456789999999999999999999999999999999999987 899999999999876554
Q ss_pred CCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc--c---
Q psy14556 960 CPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA--L--- 1034 (1181)
Q Consensus 960 ~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~--l--- 1034 (1181)
........|++.|+|||++.+..++. ..|+ ||+|+++|+|++|+.||.+..... +
T Consensus 190 ~~~~~~~~~~~~y~aPE~~~~~~~~~--~~Dv------------------~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 249 (310)
T 2wqm_A 190 TTAAHSLVGTPYYMSPERIHENGYNF--KSDI------------------WSLGCLLYEMAALQSPFYGDKMNLYSLCKK 249 (310)
T ss_dssp ---------CCSSCCHHHHTTCCCCH--HHHH------------------HHHHHHHHHHHHSSCTTC---CCHHHHHHH
T ss_pred CccccccCCCeeEeChHHhCCCCCCc--hhhH------------------HHHHHHHHHHHhCCCCCcccchhHHHHHHH
Confidence 33344556899999999997654333 3333 999999999999999998754321 1
Q ss_pred cCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1035 VAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1035 ~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
......+.......+..+..++.+|+..+|..||+..+
T Consensus 250 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 287 (310)
T 2wqm_A 250 IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTY 287 (310)
T ss_dssp HHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred hhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHH
Confidence 11112222223456788999999999999999996443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=346.24 Aligned_cols=236 Identities=22% Similarity=0.286 Sum_probs=195.3
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCC---CCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEK---NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~---~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.+||+|+||.||+|++..+++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+.+.+|+||||++||
T Consensus 190 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg 269 (576)
T 2acx_A 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG 269 (576)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCC
Confidence 3799999999999999999999999999654 2234567889999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|.+++... +...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..... .......
T Consensus 270 ~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~-~g~vKL~DFGla~~~~~~-~~~~~~~ 346 (576)
T 2acx_A 270 DLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDD-HGHIRISDLGLAVHVPEG-QTIKGRV 346 (576)
T ss_dssp BHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT-TSCEEECCCTTCEECCTT-CCEECCC
T ss_pred cHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeC-CCCeEEEecccceecccC-ccccccC
Confidence 999998754 3445889999999999999999999999999999999999998 899999999999876543 2234457
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc----ccCC-CCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA----LVAP-PQISR 1042 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~----l~~~-~~ip~ 1042 (1181)
||+.|+|||++.+..+ +..+|+ ||+||++|+|++|+.||.+..... +... ...+.
T Consensus 347 GT~~Y~APEvl~~~~~--~~~~Di------------------wSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~ 406 (576)
T 2acx_A 347 GTVGYMAPEVVKNERY--TFSPDW------------------WALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE 406 (576)
T ss_dssp SCGGGCCHHHHTTCEE--SSHHHH------------------HHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC
T ss_pred CCccccCHHHHcCCCC--CccchH------------------HHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc
Confidence 9999999999976543 333444 999999999999999999865321 1110 11222
Q ss_pred CCCCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1043 SVSVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1043 ~l~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
..+...+..+..++.+|+..+|.+|+.
T Consensus 407 ~~p~~~s~~~~dLI~~lL~~dP~~R~g 433 (576)
T 2acx_A 407 EYSERFSPQARSLCSQLLCKDPAERLG 433 (576)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTT
T ss_pred cCCccCCHHHHHHHHHhccCCHHHcCC
Confidence 334456788899999999999999994
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=337.46 Aligned_cols=248 Identities=25% Similarity=0.314 Sum_probs=201.2
Q ss_pred HHhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCC--CCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEE
Q psy14556 801 RFLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEK--NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFK 878 (1181)
Q Consensus 801 ~~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~--~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~ 878 (1181)
.+...|.+.+ +||+|+||+||+|.+..+++.||+|++.+. .....+.+.+|+.++++++||||+++++++.+.+.+|
T Consensus 19 ~~~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 97 (486)
T 3mwu_A 19 TFAERYNIVC-MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (486)
T ss_dssp HHHHHEEEEE-EEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ChhcceEEeE-EEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEE
Confidence 4556666654 799999999999999999999999998643 2334678999999999999999999999999999999
Q ss_pred EEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccccc--CCCeeeeecCCccccc
Q psy14556 879 IFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNT--YSGVVKISDFGTSKRL 956 (1181)
Q Consensus 879 LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~--~~g~vKLiDFGlAk~l 956 (1181)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. .++.+||+|||+++..
T Consensus 98 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp EEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 999999999999988754 35789999999999999999999999999999999999964 2458999999999876
Q ss_pred ccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC
Q psy14556 957 AGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA 1036 (1181)
Q Consensus 957 ~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~ 1036 (1181)
... .......||+.|+|||++.+. ++..+|+ ||+||++|+|++|..||.+.+..++..
T Consensus 175 ~~~-~~~~~~~gt~~y~aPE~~~~~---~~~~~Di------------------wslG~il~~ll~g~~pf~~~~~~~~~~ 232 (486)
T 3mwu_A 175 QQN-TKMKDRIGTAYYIAPEVLRGT---YDEKCDV------------------WSAGVILYILLSGTPPFYGKNEYDILK 232 (486)
T ss_dssp CCC-----CCTTGGGGCCGGGGGSC---CCHHHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred CCC-CccCCCcCCCCCCCHHHhCCC---CCchhhH------------------HHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 543 233445799999999999642 3444444 999999999999999999887655322
Q ss_pred -----CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1037 -----PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1037 -----~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
....+.......+..+..++.+|+..+|..||+..+.+
T Consensus 233 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l 275 (486)
T 3mwu_A 233 RVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCL 275 (486)
T ss_dssp HHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 11222222334677788999999999999999866553
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=313.66 Aligned_cols=242 Identities=22% Similarity=0.284 Sum_probs=182.0
Q ss_pred ceeecccCceEEEEEEEcCC---CeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 810 RIELGKGSYGVVYAARELDR---QVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~t---g~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
.++||+|+||.||+|.+..+ +..||+|.+..... ...+.+.+|+.++++++||||+++++++. ++..++||||++
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~ 98 (281)
T 1mp8_A 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCT 98 (281)
T ss_dssp EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred EeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCC
Confidence 34799999999999998653 46799999865432 23567899999999999999999999985 457899999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC-CCc
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP-SAE 964 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~-~~~ 964 (1181)
+++|.+++... ...+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||+++....... ...
T Consensus 99 ~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~ 175 (281)
T 1mp8_A 99 LGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDSTYYKAS 175 (281)
T ss_dssp TEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE-TTEEEECC----------------
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECC-CCCEEECccccccccCcccccccc
Confidence 99999999754 345789999999999999999999999999999999999998 89999999999987654321 122
Q ss_pred cccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--CC
Q psy14556 965 TFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--IS 1041 (1181)
Q Consensus 965 t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--ip 1041 (1181)
...+++.|+|||++.+..++. ..|+ ||+|+++|+|++ |..||.+....++..... ..
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~--~~Di------------------~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~ 235 (281)
T 1mp8_A 176 KGKLPIKWMAPESINFRRFTS--ASDV------------------WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER 235 (281)
T ss_dssp ---CCGGGCCHHHHHHCCCSH--HHHH------------------HHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred cCCCcccccChhhcccCCCCC--ccCc------------------hHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC
Confidence 334678999999997654333 3333 999999999997 999999877655322111 11
Q ss_pred CCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHH
Q psy14556 1042 RSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLV 1076 (1181)
Q Consensus 1042 ~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~ 1076 (1181)
...+...+..+..++.+|++.+|..||+ +.+.+.
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~~l~~ 269 (281)
T 1mp8_A 236 LPMPPNCPPTLYSLMTKCWAYDPSRRPR-FTELKA 269 (281)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCC-HHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcC-HHHHHH
Confidence 2234567888999999999999999996 444333
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-34 Score=326.48 Aligned_cols=248 Identities=20% Similarity=0.292 Sum_probs=197.3
Q ss_pred ceeecccCceEEEEEEEcC-------CCeEEEEEEecCCCC-CChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEE
Q psy14556 810 RIELGKGSYGVVYAARELD-------RQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIF 880 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~-------tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LV 880 (1181)
.++||+|+||.||+|++.. .+..||+|++..... ...+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 74 ~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv 153 (382)
T 3tt0_A 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI 153 (382)
T ss_dssp EEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEE
Confidence 3479999999999999754 336899999975533 2346789999999999 999999999999999999999
Q ss_pred EeecCCCCcccchhcccC-------------CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeee
Q psy14556 881 MEQVPGGSLSTLLRVKWG-------------PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKI 947 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~~-------------~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKL 947 (1181)
|||+++|+|.+++..... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||
T Consensus 154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~kL 232 (382)
T 3tt0_A 154 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE-DNVMKI 232 (382)
T ss_dssp EECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TCCEEE
T ss_pred EEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcC-CCcEEE
Confidence 999999999999986421 235889999999999999999999999999999999999988 899999
Q ss_pred ecCCcccccccCCC--CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCC
Q psy14556 948 SDFGTSKRLAGLCP--SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTA 1024 (1181)
Q Consensus 948 iDFGlAk~l~~~~~--~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~ 1024 (1181)
+|||+++....... ......+|+.|+|||++.+..++. ..|+ ||+|+++|+|++ |..
T Consensus 233 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~--~~Di------------------wslG~il~ellt~g~~ 292 (382)
T 3tt0_A 233 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH--QSDV------------------WSFGVLLWEIFTLGGS 292 (382)
T ss_dssp CSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCH--HHHH------------------HHHHHHHHHHHTTSCC
T ss_pred cccCcccccccccccccccCCCCCcceeCHHHhcCCCCCc--hhHH------------------HHHHHHHHHHHhCCCC
Confidence 99999987654322 223345788999999997654333 3333 999999999999 999
Q ss_pred CCCCCCcccccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcc
Q psy14556 1025 ALKKKTSRALVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTG 1079 (1181)
Q Consensus 1025 PF~~~~~~~l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~ 1079 (1181)
||.+.+..++..... .....+...+..+..++.+|++.+|..||+ +.+.+..+.
T Consensus 293 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~ell~~L~ 348 (382)
T 3tt0_A 293 PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPT-FKQLVEDLD 348 (382)
T ss_dssp SSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCC-HHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcC-HHHHHHHHH
Confidence 999887655422111 112233467788999999999999999986 444433333
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=324.45 Aligned_cols=250 Identities=20% Similarity=0.268 Sum_probs=186.7
Q ss_pred HHhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEE
Q psy14556 801 RFLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFK 878 (1181)
Q Consensus 801 ~~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~ 878 (1181)
...+.|.+.+ +||+|+||+||+|.+..+++.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 31 ~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 31 TSIDRYRRIT-KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp -CGGGEEEEE-EEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhEEEEE-EEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 3445555544 799999999999999999999999999755432 2456789999999999999999999999999999
Q ss_pred EEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccccc----CCCeeeeecCCccc
Q psy14556 879 IFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNT----YSGVVKISDFGTSK 954 (1181)
Q Consensus 879 LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~----~~g~vKLiDFGlAk 954 (1181)
+||||++ ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ..+.+||+|||+++
T Consensus 110 lv~e~~~-~~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EEEECCS-EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EEEecCC-CCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 9999996 5999988754 35789999999999999999999999999999999999953 24579999999998
Q ss_pred ccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc
Q psy14556 955 RLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL 1034 (1181)
Q Consensus 955 ~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l 1034 (1181)
.............||+.|+|||++.+.. .++..+|+ ||+||++|+|++|+.||.+....+.
T Consensus 186 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~Di------------------wslG~il~ell~g~~pf~~~~~~~~ 246 (329)
T 3gbz_A 186 AFGIPIRQFTHEIITLWYRPPEILLGSR-HYSTSVDI------------------WSIACIWAEMLMKTPLFPGDSEIDQ 246 (329)
T ss_dssp HHC-----------CCTTCCHHHHTTCC-CCCTHHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ccCCcccccCCCcCCccccCHHHhcCCC-CCCcHHHH------------------HHHHHHHHHHHHCCCCcCCCCHHHH
Confidence 7764444444556899999999997532 23444444 9999999999999999988765331
Q ss_pred cCC----------CCCC---------CCC------------CCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1035 VAP----------PQIS---------RSV------------SVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1035 ~~~----------~~ip---------~~l------------~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
... ...+ ... ....+..+..++.+|++.||.+||+..+.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 317 (329)
T 3gbz_A 247 LFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNAL 317 (329)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 100 0000 000 001445677899999999999999754443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=354.09 Aligned_cols=235 Identities=25% Similarity=0.300 Sum_probs=198.3
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCC---CCCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEK---NLGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~---~~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
+||+|+||.||+|++..+++.||||++++. .....+.+..|..++..+ +||+|+++++++.+.+.+|+||||++||
T Consensus 348 ~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg 427 (674)
T 3pfq_A 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG 427 (674)
T ss_dssp ESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSC
T ss_pred EEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCC
Confidence 699999999999999999999999999753 234467788999999988 7999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+++..........+..
T Consensus 428 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~-~g~ikL~DFGla~~~~~~~~~~~~~~ 503 (674)
T 3pfq_A 428 DLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDS-EGHIKIADFGMCKENIWDGVTTKTFC 503 (674)
T ss_dssp BHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECS-SSCEEECCCTTCEECCCTTCCBCCCC
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcC-CCcEEEeecceeeccccCCccccccc
Confidence 999999854 25789999999999999999999999999999999999998 89999999999986554444556678
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-CCCCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-ISRSVSV 1046 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-ip~~l~~ 1046 (1181)
||+.|+|||++.+..+ +..+|+ ||||++||||++|+.||.+.+..++...+. .....+.
T Consensus 504 GT~~Y~APE~l~~~~~--~~~~Dv------------------wSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~ 563 (674)
T 3pfq_A 504 GTPDYIAPEIIAYQPY--GKSVDW------------------WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK 563 (674)
T ss_dssp SCSSSCCHHHHTCCCB--STHHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT
T ss_pred CCCcccCHhhhcCCCC--CccceE------------------echHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence 9999999999976543 444444 999999999999999999987755432211 1112233
Q ss_pred CCCcchHHhhccCCCCCCCCCchh
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
..+..+..++.+++.++|.+|+..
T Consensus 564 ~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 564 SMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp TSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred cCCHHHHHHHHHHccCCHHHCCCC
Confidence 567788889999999999999976
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=329.24 Aligned_cols=247 Identities=21% Similarity=0.283 Sum_probs=193.8
Q ss_pred eeecccCceEEEEEE-----EcCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeec
Q psy14556 811 IELGKGSYGVVYAAR-----ELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQV 884 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~-----d~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~ 884 (1181)
++||+|+||.||+|. +..+++.||+|+++.... .....+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 77 ~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 156 (367)
T 3l9p_A 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELM 156 (367)
T ss_dssp EECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred eEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeC
Confidence 479999999999999 445778999999965432 23456889999999999999999999999999999999999
Q ss_pred CCCCcccchhccc----CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccC--CCeeeeecCCccccccc
Q psy14556 885 PGGSLSTLLRVKW----GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTY--SGVVKISDFGTSKRLAG 958 (1181)
Q Consensus 885 ~gGSL~dlL~~~~----~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~--~g~vKLiDFGlAk~l~~ 958 (1181)
++|+|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||++.. +..+||+|||+++.+..
T Consensus 157 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~ 236 (367)
T 3l9p_A 157 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 236 (367)
T ss_dssp TTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHH
T ss_pred CCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCcccccccc
Confidence 9999999998642 22457889999999999999999999999999999999999851 33699999999976543
Q ss_pred CC--CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCccccc
Q psy14556 959 LC--PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALV 1035 (1181)
Q Consensus 959 ~~--~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~ 1035 (1181)
.. .......||+.|+|||++.++.++ ..+|+ |||||++|+|++ |..||.+.....+.
T Consensus 237 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~--~~~Dv------------------wslG~il~ellt~g~~pf~~~~~~~~~ 296 (367)
T 3l9p_A 237 AGYYRKGGCAMLPVKWMPPEAFMEGIFT--SKTDT------------------WSFGVLLWEIFSLGYMPYPSKSNQEVL 296 (367)
T ss_dssp HSSCTTCCGGGSCGGGCCHHHHHHCCCC--HHHHH------------------HHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred ccccccCCCcCCcccEECHHHhcCCCCC--cHHHH------------------HHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 22 223345689999999999766433 33333 999999999998 99999988765542
Q ss_pred CCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1036 APPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1036 ~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
.... .....+...+..+..++.+|++.+|..||+ +.+.+..+
T Consensus 297 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~eil~~l 340 (367)
T 3l9p_A 297 EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPN-FAIILERI 340 (367)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-HHHHHHHH
T ss_pred HHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcC-HHHHHHHH
Confidence 2111 112223456778999999999999999996 44444433
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=320.96 Aligned_cols=249 Identities=20% Similarity=0.298 Sum_probs=195.2
Q ss_pred ceeecccCceEEEEEEEc-------CCCeEEEEEEecCCCC-CChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEE
Q psy14556 810 RIELGKGSYGVVYAAREL-------DRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIF 880 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~-------~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LV 880 (1181)
.+.||+|+||.||+|.+. .++..||+|++..... ...+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 119 (334)
T 2pvf_A 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI 119 (334)
T ss_dssp EEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEE
T ss_pred eeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEE
Confidence 447999999999999976 4567899999975532 2356789999999999 899999999999999999999
Q ss_pred EeecCCCCcccchhcccC-------------CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeee
Q psy14556 881 MEQVPGGSLSTLLRVKWG-------------PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKI 947 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~~-------------~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKL 947 (1181)
|||+++++|.+++..... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||
T Consensus 120 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~kL 198 (334)
T 2pvf_A 120 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE-NNVMKI 198 (334)
T ss_dssp EECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-TCCEEE
T ss_pred EECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcC-CCCEEE
Confidence 999999999999985421 124788999999999999999999999999999999999987 899999
Q ss_pred ecCCcccccccCCC--CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCC
Q psy14556 948 SDFGTSKRLAGLCP--SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTA 1024 (1181)
Q Consensus 948 iDFGlAk~l~~~~~--~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~ 1024 (1181)
+|||+++....... ......+++.|+|||++.+..++.. .|+ ||+|+++|+|++ |..
T Consensus 199 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~--~Di------------------~slG~il~ellt~g~~ 258 (334)
T 2pvf_A 199 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ--SDV------------------WSFGVLMWEIFTLGGS 258 (334)
T ss_dssp CCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHH--HHH------------------HHHHHHHHHHHTTSCC
T ss_pred ccccccccccccccccccCCCCcccceeChHHhcCCCcChH--HHH------------------HHHHHHHHHHHhCCCC
Confidence 99999987654321 1223457889999999976543332 333 999999999999 999
Q ss_pred CCCCCCcccccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1025 ALKKKTSRALVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1025 PF~~~~~~~l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
||.+....++..... .....+...+..+..++.+|+..+|..||+ +.+.+..+..
T Consensus 259 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~ell~~L~~ 315 (334)
T 2pvf_A 259 PYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPT-FKQLVEDLDR 315 (334)
T ss_dssp SSTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-HHHHHHHHHH
T ss_pred CcCcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcC-HHHHHHHHHH
Confidence 999877655322111 112233456788999999999999999985 5554444443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=314.78 Aligned_cols=248 Identities=23% Similarity=0.367 Sum_probs=192.2
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEee
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQ 883 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy 883 (1181)
..|.+.+ +||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 19 ~~y~i~~-~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 19 EVWEIVG-ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GTEEEEE-EEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred cceeecc-eeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 3444433 699999999999999999999999999877767788899999999999999999999999999999999999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCC
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA 963 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~ 963 (1181)
+++++|.+++... ...+++..++.++.||+.||.|||++|++||||||+||+++. ++.+||+|||++..........
T Consensus 98 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~ 174 (302)
T 2j7t_A 98 CPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTL-EGDIRLADFGVSAKNLKTLQKR 174 (302)
T ss_dssp CTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT-TSCEEECCCHHHHHHHHHHHC-
T ss_pred CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECC-CCCEEEEECCCCcccccccccc
Confidence 9999999988753 235789999999999999999999999999999999999987 8899999999876443222223
Q ss_pred ccccCCccccCchhhccC---CCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCC---
Q psy14556 964 ETFTGTLQYMAPEVIDKG---QRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAP--- 1037 (1181)
Q Consensus 964 ~t~~GT~~Y~APEvl~gg---~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~--- 1037 (1181)
....||+.|+|||++... ...++...|+ ||+|+++|+|++|+.||...+.......
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di------------------~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 236 (302)
T 2j7t_A 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADI------------------WSLGITLIEMAQIEPPHHELNPMRVLLKIAK 236 (302)
T ss_dssp ----CCGGGCCHHHHHHHHTTSTTTTTHHHH------------------HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred ccccCChhhcCCeeeccccCCCCCCchhhhH------------------HHHHHHHHHHhcCCCCCccCCHHHHHHHHhc
Confidence 345689999999998421 1122333333 9999999999999999998765432111
Q ss_pred -CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1038 -PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1038 -~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.......+...+..+..++.+|+..+|..||+..+.
T Consensus 237 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 273 (302)
T 2j7t_A 237 SDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQL 273 (302)
T ss_dssp SCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred cCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHH
Confidence 111111223456778899999999999999975443
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=331.14 Aligned_cols=245 Identities=19% Similarity=0.245 Sum_probs=184.0
Q ss_pred ceeecccCceEEEEEEEc---CCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 810 RIELGKGSYGVVYAAREL---DRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~---~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
.++||+|+||.||+|++. .++..||||.++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 50 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 129 (373)
T 2qol_A 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYME 129 (373)
T ss_dssp CEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCC
Confidence 347999999999999876 4677899999975532 235679999999999999999999999999999999999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCC--
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA-- 963 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~-- 963 (1181)
+++|.++++.. ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.........
T Consensus 130 ~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~ 206 (373)
T 2qol_A 130 NGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS-NLVCKVSDFGLGRVLEDDPEAAYT 206 (373)
T ss_dssp TCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TCCEEECCC---------------
T ss_pred CCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcC-CCCEEECcCccccccccCCcccee
Confidence 99999999753 345788999999999999999999999999999999999988 8999999999998765432211
Q ss_pred -ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--
Q psy14556 964 -ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ-- 1039 (1181)
Q Consensus 964 -~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~-- 1039 (1181)
....+++.|+|||++.+..++. ..|+ ||+|+++|||++ |+.||.+.+...+.....
T Consensus 207 ~~~~~~~~~y~aPE~~~~~~~~~--~~Dv------------------~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~ 266 (373)
T 2qol_A 207 TRGGKIPIRWTSPEAIAYRKFTS--ASDV------------------WSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266 (373)
T ss_dssp -------CTTSCHHHHHHCCCCH--HHHH------------------HHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTT
T ss_pred ccCCCcCCCccChhhhccCCcCc--hhcH------------------HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 1123567899999998664433 3333 999999999998 999998877654322111
Q ss_pred CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1040 ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1040 ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
.....+...+..+..++.+|++.+|..||. +.+.+..+
T Consensus 267 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~~i~~~L 304 (373)
T 2qol_A 267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPK-FEQIVSIL 304 (373)
T ss_dssp EECCCCTTCBHHHHHHHHHHTCSSGGGSCC-HHHHHHHH
T ss_pred CCCCCCccccHHHHHHHHHHhCcChhhCcC-HHHHHHHH
Confidence 111223457788999999999999999996 44433333
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-34 Score=310.80 Aligned_cols=250 Identities=24% Similarity=0.240 Sum_probs=195.9
Q ss_pred hcccCceeecccCceEEEEEEEc--CCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEE
Q psy14556 805 LFALNRIELGKGSYGVVYAAREL--DRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFM 881 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~--~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVm 881 (1181)
.+.+...+||+|+||.||+|.+. .++..||+|++..... ...+.+.+|+.++++++||||+++++++ ..+..++||
T Consensus 10 ~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~ 88 (287)
T 1u59_A 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVM 88 (287)
T ss_dssp GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred HhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEE
Confidence 34454557999999999999854 4678899999976532 2356789999999999999999999999 456799999
Q ss_pred eecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC
Q psy14556 882 EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP 961 (1181)
Q Consensus 882 Ey~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~ 961 (1181)
||+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||++........
T Consensus 89 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~-~~~~kl~Dfg~~~~~~~~~~ 165 (287)
T 1u59_A 89 EMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN-RHYAKISDFGLSKALGADDS 165 (287)
T ss_dssp ECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEE-TTEEEECCCTTCEECTTCSC
T ss_pred EeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcC-CCCEEECcccceeeeccCcc
Confidence 999999999998743 345789999999999999999999999999999999999997 89999999999987653322
Q ss_pred ---CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCC
Q psy14556 962 ---SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAP 1037 (1181)
Q Consensus 962 ---~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~ 1037 (1181)
......+|+.|+|||++.+..++.. .|+ ||+|+++|+|++ |+.||.+.....+...
T Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~--~Di------------------~slG~il~ellt~g~~p~~~~~~~~~~~~ 225 (287)
T 1u59_A 166 YYTARSAGKWPLKWYAPECINFRKFSSR--SDV------------------WSYGVTMWEALSYGQKPYKKMKGPEVMAF 225 (287)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEECHH--HHH------------------HHHHHHHHHHHTTSCCTTTTCCTHHHHHH
T ss_pred eeeccccccccccccCHHHhccCCCCch--hhH------------------HHHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence 1223346889999999975543332 333 999999999998 9999988776543211
Q ss_pred CC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcc
Q psy14556 1038 PQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTG 1079 (1181)
Q Consensus 1038 ~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~ 1079 (1181)
.. .....+...+..+..++.+|+..+|..||+ +.+.+..+.
T Consensus 226 i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~~l~~~l~ 268 (287)
T 1u59_A 226 IEQGKRMECPPECPPELYALMSDCWIYKWEDRPD-FLTVEQRMR 268 (287)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCC-HHHHHHHHH
T ss_pred HhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcC-HHHHHHHHH
Confidence 11 112234567888999999999999999995 444433333
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=313.48 Aligned_cols=244 Identities=25% Similarity=0.309 Sum_probs=193.8
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEcccc--ccCCcEEEEEeecCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSV--SEEGYFKIFMEQVPG 886 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~--~d~~~l~LVmEy~~g 886 (1181)
.+||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.++++++||||+++++++ ...+..++||||+++
T Consensus 12 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 91 (279)
T 2w5a_A 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG 91 (279)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTT
T ss_pred hhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCC
Confidence 3799999999999999999999999999765432 356789999999999999999999987 446789999999999
Q ss_pred CCcccchhccc-CCCCCChHHHHHHHHHHHhhhhhccccc-----eecccCCCCCcccccCCCeeeeecCCcccccccCC
Q psy14556 887 GSLSTLLRVKW-GPLKENESTMSFYTKQILEGLKYLHGQK-----IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC 960 (1181)
Q Consensus 887 GSL~dlL~~~~-~~~~l~e~~i~~Ia~QIa~AL~yLHs~g-----IVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~ 960 (1181)
++|.+++.... ....+++..++.++.|++.||.|||++| |+||||||+||+++. ++.+||+|||+++......
T Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~-~~~~kl~dfg~~~~~~~~~ 170 (279)
T 2w5a_A 92 GDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDT 170 (279)
T ss_dssp EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECS-SSCEEECCCCHHHHC---C
T ss_pred CCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcC-CCCEEEecCchheeecccc
Confidence 99999997532 2345889999999999999999999999 999999999999987 8899999999998765432
Q ss_pred CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-
Q psy14556 961 PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ- 1039 (1181)
Q Consensus 961 ~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~- 1039 (1181)
.......|++.|+|||++.+..++ ...|+ ||+|+++|+|++|+.||...+...+.....
T Consensus 171 ~~~~~~~~~~~y~aPE~~~~~~~~--~~~Di------------------~slG~il~~l~~g~~p~~~~~~~~~~~~i~~ 230 (279)
T 2w5a_A 171 SFAKTFVGTPYYMSPEQMNRMSYN--EKSDI------------------WSLGCLLYELCALMPPFTAFSQKELAGKIRE 230 (279)
T ss_dssp HHHHHHHSCCTTCCHHHHHCC-CC--HHHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccccccCCCccccChHHhccCCCC--chhhH------------------HHHHHHHHHHHHCCCCCcccCHHHHHHHHhh
Confidence 222334689999999999765433 23333 999999999999999999877654322111
Q ss_pred -CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHH
Q psy14556 1040 -ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLV 1076 (1181)
Q Consensus 1040 -ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~ 1076 (1181)
.....+...+..+..++.+|+..+|..||+ +.+.+.
T Consensus 231 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~~ll~ 267 (279)
T 2w5a_A 231 GKFRRIPYRYSDELNEIITRMLNLKDYHRPS-VEEILE 267 (279)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC-HHHHHT
T ss_pred cccccCCcccCHHHHHHHHHHcCCCcccCCC-HHHHHh
Confidence 111233456788999999999999999996 444333
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-34 Score=339.77 Aligned_cols=246 Identities=20% Similarity=0.261 Sum_probs=200.4
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
.+||+|+||.||+|.+..++..||||.+.... ...+.+.+|+.+|++++||||+++++++.+.+.+++||||+++|+|.
T Consensus 226 ~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~ 304 (495)
T 1opk_A 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 304 (495)
T ss_dssp EESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred eEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHH
Confidence 47999999999999999999999999997543 34678999999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC-CCccccCC
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP-SAETFTGT 969 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~-~~~t~~GT 969 (1181)
++++.. ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++....... ......++
T Consensus 305 ~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~~ 382 (495)
T 1opk_A 305 DYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGE-NHLVKVADFGLSRLMTGDTYTAHAGAKFP 382 (495)
T ss_dssp HHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG-GGCEEECCTTCEECCTTCCEECCTTCCCC
T ss_pred HHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECC-CCcEEEeecccceeccCCceeecCCCcCC
Confidence 999864 3456789999999999999999999999999999999999987 88999999999987653221 12223467
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCC--CCCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPP--QISRSVSV 1046 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~--~ip~~l~~ 1046 (1181)
+.|+|||++.++.++.+ .|+ ||||+++|||++ |..||.+.+...+.... ......+.
T Consensus 383 ~~y~aPE~~~~~~~~~~--sDv------------------wSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 442 (495)
T 1opk_A 383 IKWTAPESLAYNKFSIK--SDV------------------WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE 442 (495)
T ss_dssp GGGCCHHHHHHCEECHH--HHH------------------HHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCT
T ss_pred cceeCHhHHhcCCCCcH--HhH------------------HhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 89999999976543333 333 999999999999 99999987765532211 11122334
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
.++..+..++.+|+..+|..||+ +.+.+..+..
T Consensus 443 ~~~~~l~~li~~cl~~dP~~RPs-~~el~~~L~~ 475 (495)
T 1opk_A 443 GCPEKVYELMRACWQWNPSDRPS-FAEIHQAFET 475 (495)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCC-HHHHHHHHHT
T ss_pred CCCHHHHHHHHHHcCcChhHCcC-HHHHHHHHHH
Confidence 57788999999999999999995 5555555544
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-34 Score=319.44 Aligned_cols=244 Identities=21% Similarity=0.215 Sum_probs=187.0
Q ss_pred eeecccCceEEEEEEEcCCCeE----EEEEEecCCC-CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 811 IELGKGSYGVVYAARELDRQVK----LAIKEIPEKN-LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~----VAIKii~~~~-~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
.+||+|+||+||+|++..+++. ||+|.+.... ....+.+.+|+.++++++||||+++++++.+.. .++|+||++
T Consensus 21 ~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~ 99 (327)
T 3poz_A 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMP 99 (327)
T ss_dssp EEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCT
T ss_pred eEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecC
Confidence 4799999999999998877764 5888775443 344678999999999999999999999998754 789999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC--C
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS--A 963 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~--~ 963 (1181)
+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++........ .
T Consensus 100 ~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~ 176 (327)
T 3poz_A 100 FGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT-PQHVKITDFGLAKLLGAEEKEYHA 176 (327)
T ss_dssp TCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE-TTEEEECCTTHHHHHTTTCC----
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECC-CCCEEEccCcceeEccCCcccccc
Confidence 99999999764 345788999999999999999999999999999999999988 899999999999876543222 2
Q ss_pred ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--C
Q psy14556 964 ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--I 1040 (1181)
Q Consensus 964 ~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--i 1040 (1181)
....+|+.|+|||++.+..++.+ .|+ ||+|+++|+|++ |+.||.+.+...+..... .
T Consensus 177 ~~~~~t~~y~aPE~~~~~~~~~~--~Di------------------~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 236 (327)
T 3poz_A 177 EGGKVPIKWMALESILHRIYTHQ--SDV------------------WSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236 (327)
T ss_dssp ---CCCGGGSCHHHHHHCCCCHH--HHH------------------HHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred cCCCccccccChHHhccCCCCch--hhh------------------hhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC
Confidence 23346889999999987654433 333 999999999999 999999877655422111 1
Q ss_pred CCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcc
Q psy14556 1041 SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTG 1079 (1181)
Q Consensus 1041 p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~ 1079 (1181)
....+...+..+..++.+|+..+|..||+. .+.+..+.
T Consensus 237 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~ell~~l~ 274 (327)
T 3poz_A 237 RLPQPPICTIDVYMIMVKCWMIDADSRPKF-RELIIEFS 274 (327)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSCGGGSCCH-HHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhhCCCH-HHHHHHHH
Confidence 122334567788899999999999999864 44443333
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=314.40 Aligned_cols=247 Identities=27% Similarity=0.372 Sum_probs=190.6
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhc-CCCCeeeEcccccc------CCcE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSE------EGYF 877 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d------~~~l 877 (1181)
.|.+. ..||+|+||.||+|++..+++.||+|++.... ...+.+.+|+.+++++ +||||+++++++.. .+..
T Consensus 25 ~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 102 (326)
T 2x7f_A 25 IFELV-ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 102 (326)
T ss_dssp TEEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEE
T ss_pred cEEEE-EEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceE
Confidence 34443 37999999999999999999999999997543 3457799999999999 89999999999876 4689
Q ss_pred EEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccc
Q psy14556 878 KIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 957 (1181)
Q Consensus 878 ~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~ 957 (1181)
++||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++....
T Consensus 103 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~-~~~~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 103 WLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTE-NAEVKLVDFGVSAQLD 180 (326)
T ss_dssp EEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT-TCCEEECCCTTTC---
T ss_pred EEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcC-CCCEEEeeCcCceecC
Confidence 9999999999999999754 2346788999999999999999999999999999999999987 8999999999998765
Q ss_pred cCCCCCccccCCccccCchhhccC---CCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc
Q psy14556 958 GLCPSAETFTGTLQYMAPEVIDKG---QRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL 1034 (1181)
Q Consensus 958 ~~~~~~~t~~GT~~Y~APEvl~gg---~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l 1034 (1181)
..........||+.|+|||++... ...++...|+ ||+|+++|+|++|..||.+......
T Consensus 181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di------------------~slG~il~~l~~g~~p~~~~~~~~~ 242 (326)
T 2x7f_A 181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDL------------------WSLGITAIEMAEGAPPLCDMHPMRA 242 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHH------------------HHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred cCccccccccCCccccChhhhccccccCcCCCccchH------------------HHHHHHHHHHHhCCCCCCCCcHHHH
Confidence 443334455799999999999632 1122233333 9999999999999999987765432
Q ss_pred cC---CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1035 VA---PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1035 ~~---~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.. ....+.......+..+..++.+|+..+|..||+..+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 284 (326)
T 2x7f_A 243 LFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQL 284 (326)
T ss_dssp HHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred HHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHH
Confidence 11 1112233345567889999999999999999986555
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-34 Score=318.97 Aligned_cols=244 Identities=20% Similarity=0.248 Sum_probs=185.2
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCC----cEEEEEeecCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEG----YFKIFMEQVPG 886 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~----~l~LVmEy~~g 886 (1181)
.+||+|+||+||+|++. ++.||+|++..... ......+|+.++++++||||+++++++.+.. .+++||||+++
T Consensus 30 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~ 106 (322)
T 3soc_A 30 EVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEK 106 (322)
T ss_dssp EEEECSTTCEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred heecccCceEEEEEEEC--CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCC
Confidence 47999999999999874 78999999964422 2345667899999999999999999987754 47999999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhcccc----------ceecccCCCCCcccccCCCeeeeecCCccccc
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ----------KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~----------gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l 956 (1181)
|+|.++++.. .+++..++.++.|++.||+|||++ ||+||||||+|||++. ++.+||+|||+++..
T Consensus 107 g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~-~~~~kL~DFg~a~~~ 181 (322)
T 3soc_A 107 GSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN-NLTACIADFGLALKF 181 (322)
T ss_dssp CBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECT-TCCEEECCCTTCEEE
T ss_pred CCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECC-CCeEEEccCCccccc
Confidence 9999999754 478999999999999999999999 9999999999999988 889999999999876
Q ss_pred ccCCCC--CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc
Q psy14556 957 AGLCPS--AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL 1034 (1181)
Q Consensus 957 ~~~~~~--~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l 1034 (1181)
...... .....||+.|+|||++.+... ... .+....+.||+||++|+|+||+.||.+......
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~--------------~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 246 (322)
T 3soc_A 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAIN-FQR--------------DAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246 (322)
T ss_dssp CTTSCCCCCTTCCCCGGGCCHHHHTTCCC-CCH--------------HHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCC
T ss_pred ccccCccccccCccCccccCHhhcccccc-cCc--------------CCCccchhHHHHHHHHHHHhCCCCCCCCcchhc
Confidence 543322 233569999999999975321 111 122233449999999999999999987654221
Q ss_pred cCC-------CC--------CCCCCCCCC---------CcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1035 VAP-------PQ--------ISRSVSVPG---------PGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1035 ~~~-------~~--------ip~~l~~~~---------p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
... +. ......+.. +..+..++.+|++.+|..||+ +.+.+..+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~ell~~L 313 (322)
T 3soc_A 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS-AGCVGERI 313 (322)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCC-HHHHHHHH
T ss_pred cchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcC-HHHHHHHH
Confidence 100 00 011111111 223788999999999999995 55544443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=328.47 Aligned_cols=244 Identities=22% Similarity=0.345 Sum_probs=181.4
Q ss_pred hhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcC-CCCeeeEccccccC--CcE
Q psy14556 803 LYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLR-HRNIVQYLGSVSEE--GYF 877 (1181)
Q Consensus 803 ~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~-HPNIVkl~g~~~d~--~~l 877 (1181)
...|.+.+ +||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.+. ||||+++++++... ..+
T Consensus 8 ~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 8 LRKYELVK-KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HTTEEEEE-C-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred cCceEEEE-EeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 34454444 69999999999999999999999999965432 23567889999999997 99999999998654 479
Q ss_pred EEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccc
Q psy14556 878 KIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 957 (1181)
Q Consensus 878 ~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~ 957 (1181)
|+||||++ ++|..++... .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.+.
T Consensus 87 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNA-ECHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT-TCCEEECCCTTCEESS
T ss_pred EEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcC-CCCEEecCCccccccc
Confidence 99999996 6888888753 5788899999999999999999999999999999999988 8999999999998653
Q ss_pred cC---------------------CCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHH
Q psy14556 958 GL---------------------CPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVII 1016 (1181)
Q Consensus 958 ~~---------------------~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvIL 1016 (1181)
.. ........||+.|+|||++.+. ..++..+|+ ||+||++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di------------------wSlG~il 221 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDM------------------WSLGCIL 221 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHH------------------HHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhH------------------HHHHHHH
Confidence 21 1122345799999999999752 234445555 9999999
Q ss_pred HHHHhCCCCCCCCCcccccCCC----CCC----------------------------C----------------CCCCCC
Q psy14556 1017 SQLLVLTAALKKKTSRALVAPP----QIS----------------------------R----------------SVSVPG 1048 (1181)
Q Consensus 1017 yELLTGk~PF~~~~~~~l~~~~----~ip----------------------------~----------------~l~~~~ 1048 (1181)
|+|++|++||.+.+.......+ ..| . ......
T Consensus 222 ~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (388)
T 3oz6_A 222 GEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC 301 (388)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCC
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccC
Confidence 9999999999987653311000 000 0 001145
Q ss_pred CcchHHhhccCCCCCCCCCchhHH
Q psy14556 1049 PGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1049 p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
+..+..++.+|+..||.+|++..+
T Consensus 302 ~~~~~dll~~~L~~dP~~R~t~~e 325 (388)
T 3oz6_A 302 NEEALDLLDKLLQFNPNKRISAND 325 (388)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred CHHHHHHHHHhhccCcccCCCHHH
Confidence 667788999999999999997433
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=311.15 Aligned_cols=244 Identities=22% Similarity=0.314 Sum_probs=191.8
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCC----CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL----GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~----~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
..+||+|+||.||+|.+ +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 36 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 113 (307)
T 2nru_A 36 GNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMP 113 (307)
T ss_dssp CCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred CCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecC
Confidence 35799999999999986 678999999965422 225678999999999999999999999999999999999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC--C
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS--A 963 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~--~ 963 (1181)
+++|.+++........+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||++......... .
T Consensus 114 ~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~-~~~~kl~Dfg~~~~~~~~~~~~~~ 192 (307)
T 2nru_A 114 NGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDE-AFTAKISDFGLARASEKFAQTVMT 192 (307)
T ss_dssp TCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT-TCCEEECCCTTCEECCSCSSCEEC
T ss_pred CCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcC-CCcEEEeecccccccccccccccc
Confidence 9999999976544556889999999999999999999999999999999999987 889999999999766542221 2
Q ss_pred ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCC------
Q psy14556 964 ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAP------ 1037 (1181)
Q Consensus 964 ~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~------ 1037 (1181)
....||+.|+|||++.+. . +...|+ ||+|+++|+|++|..||...........
T Consensus 193 ~~~~g~~~y~aPE~~~~~-~--~~~~Dv------------------~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 251 (307)
T 2nru_A 193 SRIVGTTAYMAPEALRGE-I--TPKSDI------------------YSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIE 251 (307)
T ss_dssp SSCCSCGGGCCHHHHTTE-E--CTHHHH------------------HHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHH
T ss_pred cccCCCcCcCChHHhcCC-C--Cccchh------------------HHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhh
Confidence 335689999999998642 2 223333 9999999999999999987665432110
Q ss_pred ---CC----CCCC---CCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1038 ---PQ----ISRS---VSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1038 ---~~----ip~~---l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
.. +... .....+..+..++.+|+..+|..||+ +.+.+..+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps-~~~l~~~L 301 (307)
T 2nru_A 252 DEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPD-IKKVQQLL 301 (307)
T ss_dssp TTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCC-HHHHHHHH
T ss_pred hhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcC-HHHHHHHH
Confidence 00 0111 11122345777999999999999996 44544444
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=309.32 Aligned_cols=239 Identities=24% Similarity=0.376 Sum_probs=192.1
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEcccccc----CCcEEEEEee
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSE----EGYFKIFMEQ 883 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d----~~~l~LVmEy 883 (1181)
..+||+|+||.||+|.+..++..||+|.+..... ...+.+.+|+.++++++||||+++++++.. ...+++||||
T Consensus 31 ~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 110 (290)
T 1t4h_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEe
Confidence 4479999999999999999999999999965432 235678999999999999999999998764 4568999999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccc--eecccCCCCCcccccCCCeeeeecCCcccccccCCC
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP 961 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~g--IVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~ 961 (1181)
+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||+++..++.+||+|||++..... .
T Consensus 111 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~--~ 185 (290)
T 1t4h_A 111 MTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--S 185 (290)
T ss_dssp CCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT--T
T ss_pred cCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc--c
Confidence 9999999999753 35778999999999999999999999 999999999999984488999999999975443 2
Q ss_pred CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc----cCC
Q psy14556 962 SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL----VAP 1037 (1181)
Q Consensus 962 ~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l----~~~ 1037 (1181)
......||+.|+|||++.+ . ++...|+ ||+|+++|+|++|+.||........ ...
T Consensus 186 ~~~~~~~t~~y~aPE~~~~-~--~~~~~Di------------------~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 244 (290)
T 1t4h_A 186 FAKAVIGTPEFMAPEMYEE-K--YDESVDV------------------YAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 244 (290)
T ss_dssp SBEESCSSCCCCCGGGGGT-C--CCTHHHH------------------HHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT
T ss_pred ccccccCCcCcCCHHHHhc-c--CCCcchH------------------HHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc
Confidence 3334569999999998863 2 3333443 9999999999999999987554221 111
Q ss_pred CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1038 PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1038 ~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
...+.......+..+..++.+|++.+|..||+..+..
T Consensus 245 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 281 (290)
T 1t4h_A 245 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281 (290)
T ss_dssp TCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 1222333345567789999999999999999755443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=311.26 Aligned_cols=248 Identities=25% Similarity=0.300 Sum_probs=191.8
Q ss_pred ccCceeecccCceEEEEEE----EcCCCeEEEEEEecCCC-CCChhHHHHHHHHHHhcCCCCeeeEccccccC--CcEEE
Q psy14556 807 ALNRIELGKGSYGVVYAAR----ELDRQVKLAIKEIPEKN-LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEE--GYFKI 879 (1181)
Q Consensus 807 ~l~~~kIG~G~fG~VYka~----d~~tg~~VAIKii~~~~-~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~--~~l~L 879 (1181)
+...++||+|+||.||+|+ +..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+. +.+++
T Consensus 23 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 102 (302)
T 4e5w_A 23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 102 (302)
T ss_dssp EEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEE
T ss_pred hhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEE
Confidence 3334579999999999998 56789999999997553 33467899999999999999999999999776 67899
Q ss_pred EEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccC
Q psy14556 880 FMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGL 959 (1181)
Q Consensus 880 VmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~ 959 (1181)
||||+++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+||+++. ++.+||+|||++......
T Consensus 103 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~-~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 103 IMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES-EHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp EEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE-TTEEEECCCTTCEECCTT
T ss_pred EEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcC-CCCEEECcccccccccCC
Confidence 99999999999999654 235789999999999999999999999999999999999988 899999999999876543
Q ss_pred CC---CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc----
Q psy14556 960 CP---SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR---- 1032 (1181)
Q Consensus 960 ~~---~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~---- 1032 (1181)
.. ......||..|+|||++.+..++.. . +.||+|+++|+|++|..|+......
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~--~------------------Di~slG~il~~l~~g~~p~~~~~~~~~~~ 239 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIA--S------------------DVWSFGVTLHELLTYCDSDSSPMALFLKM 239 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHHHCEEEHH--H------------------HHHHHHHHHHHHHTTTCGGGSHHHHHHHH
T ss_pred CcceeccCCCCCCccccCCeeecCCCCCcc--h------------------hHHHHHHHHHHHHHccCCCcchhhHHhhc
Confidence 22 2233458888999999976543322 2 2399999999999999986543210
Q ss_pred -----------cccC--CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1033 -----------ALVA--PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1033 -----------~l~~--~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
.+.. ........+...+..+..++.+|++.+|..||+ +.+.+..+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~~ll~~L 297 (302)
T 4e5w_A 240 IGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTS-FQNLIEGF 297 (302)
T ss_dssp HCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCC-HHHHHHHH
T ss_pred cCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCC-HHHHHHHH
Confidence 0000 011122234467788999999999999999985 44444433
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=309.51 Aligned_cols=247 Identities=24% Similarity=0.286 Sum_probs=195.3
Q ss_pred HhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEcccccc--------
Q psy14556 802 FLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSE-------- 873 (1181)
Q Consensus 802 ~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d-------- 873 (1181)
+...|...+ .||+|+||.||+|.+..+++.||+|.+.... +.+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 9 FGMDFKEIE-LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHEEEEE-EEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hccccceee-eeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 334455444 6999999999999999999999999997543 467899999999999999999998754
Q ss_pred --------CCcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCee
Q psy14556 874 --------EGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVV 945 (1181)
Q Consensus 874 --------~~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~v 945 (1181)
...+++||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+||+++. ++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~-~~~~ 161 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVD-TKQV 161 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE-TTEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcC-CCCE
Confidence 45689999999999999999754 2346789999999999999999999999999999999999998 8999
Q ss_pred eeecCCcccccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCC
Q psy14556 946 KISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAA 1025 (1181)
Q Consensus 946 KLiDFGlAk~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~P 1025 (1181)
||+|||++....... ......|++.|+|||++.+..++. ..|+ ||+|+++|+|++|..|
T Consensus 162 kl~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~--~~Di------------------~slG~il~~l~~~~~~ 220 (284)
T 2a19_B 162 KIGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGK--EVDL------------------YALGLILAELLHVCDT 220 (284)
T ss_dssp EECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCT--HHHH------------------HHHHHHHHHHHSCCSS
T ss_pred EECcchhheeccccc-cccccCCcccccChhhhccCCCcc--hhhh------------------HHHHHHHHHHHhcCCc
Confidence 999999998765432 233456999999999997654333 3333 9999999999999999
Q ss_pred CCCCCcccccCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1026 LKKKTSRALVAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1026 F~~~~~~~l~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
|.......... .....+...+..+..++.+|+..+|..||+ +.+.+..+..
T Consensus 221 ~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps-~~e~l~~l~~ 271 (284)
T 2a19_B 221 AFETSKFFTDL---RDGIISDIFDKKEKTLLQKLLSKKPEDRPN-TSEILRTLTV 271 (284)
T ss_dssp HHHHHHHHHHH---HTTCCCTTSCHHHHHHHHHHTCSSGGGSCC-HHHHHHHHHH
T ss_pred chhHHHHHHHh---hcccccccCCHHHHHHHHHHccCChhhCcC-HHHHHHHHHH
Confidence 86543211000 011123456778889999999999999995 5554444443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-34 Score=337.98 Aligned_cols=240 Identities=26% Similarity=0.274 Sum_probs=197.8
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCC---CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCC
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
...||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..|+||||+++
T Consensus 21 ~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~g 100 (476)
T 2y94_A 21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSG 100 (476)
T ss_dssp EEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 347999999999999999999999999996542 23456799999999999999999999999999999999999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccc
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF 966 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~ 966 (1181)
|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++...... ....+.
T Consensus 101 g~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~-~~~vkL~DFG~a~~~~~~-~~~~~~ 175 (476)
T 2y94_A 101 GELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDA-HMNAKIADFGLSNMMSDG-EFLRTS 175 (476)
T ss_dssp EEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECT-TCCEEECCCSSCEECCTT-CCBCCC
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEec-CCCeEEEeccchhhcccc-cccccc
Confidence 9999999743 35789999999999999999999999999999999999988 899999999999876543 233456
Q ss_pred cCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCCC-CCCCC
Q psy14556 967 TGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQI-SRSVS 1045 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~i-p~~l~ 1045 (1181)
+||+.|+|||++.+..+ .+..+|+ ||+||++|+|++|+.||.+.+...+...+.- ....+
T Consensus 176 ~gt~~y~aPE~~~~~~~-~~~~~Di------------------wSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p 236 (476)
T 2y94_A 176 CGSPNYAAPEVISGRLY-AGPEVDI------------------WSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP 236 (476)
T ss_dssp CSCSTTCCHHHHTTCCB-CSHHHHH------------------HHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC
T ss_pred CCCcCeEChhhccCCCC-CCCccee------------------hhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC
Confidence 79999999999975432 2333444 9999999999999999998776543221110 01122
Q ss_pred CCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1046 VPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1046 ~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
...+..+..++.+|+..+|.+||+..+.
T Consensus 237 ~~~s~~~~~Li~~~L~~dP~~Rpt~~ei 264 (476)
T 2y94_A 237 QYLNPSVISLLKHMLQVDPMKRATIKDI 264 (476)
T ss_dssp TTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred ccCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 3456778889999999999999976555
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=331.04 Aligned_cols=234 Identities=24% Similarity=0.337 Sum_probs=189.5
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccC-CcEEEEEeecCCCCc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEE-GYFKIFMEQVPGGSL 889 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~-~~l~LVmEy~~gGSL 889 (1181)
++||+|+||.||+|.+. ++.||||+++... ..+.+.+|+.++++++||||+++++++.+. +..++||||+++|+|
T Consensus 199 ~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L 274 (450)
T 1k9a_A 199 QTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 274 (450)
T ss_dssp EEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBH
T ss_pred eeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcH
Confidence 37999999999999874 7799999997553 567899999999999999999999997665 479999999999999
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT 969 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT 969 (1181)
.++++.. +...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++..... .....++
T Consensus 275 ~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~~~~---~~~~~~~ 349 (450)
T 1k9a_A 275 VDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASST---QDTGKLP 349 (450)
T ss_dssp HHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT-TSCEEECCCTTCEECC---------CCC
T ss_pred HHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECC-CCCEEEeeCCCccccccc---ccCCCCC
Confidence 9999865 3444688899999999999999999999999999999999987 899999999999855432 2223578
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--CCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--ISRSVSV 1046 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--ip~~l~~ 1046 (1181)
+.|+|||++.+..++. ..|+ ||||+++|||++ |+.||.+.+..++..... .....+.
T Consensus 350 ~~y~aPE~~~~~~~~~--~sDv------------------wslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~ 409 (450)
T 1k9a_A 350 VKWTAPEALREKKFST--KSDV------------------WSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD 409 (450)
T ss_dssp TTTSCHHHHHSSCCCH--HHHH------------------HHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCT
T ss_pred cceeCHHHhcCCCCCc--HHHH------------------HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 8999999997654333 3333 999999999998 999999877655322111 1122344
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.++..+..++.+|+..+|..||++.+.
T Consensus 410 ~~~~~l~~li~~cl~~dp~~Rpt~~~l 436 (450)
T 1k9a_A 410 GCPPAVYDVMKNCWHLDAATRPTFLQL 436 (450)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 678889999999999999999965443
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=329.67 Aligned_cols=202 Identities=26% Similarity=0.353 Sum_probs=153.0
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEcccccc-----CCc
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSE-----EGY 876 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d-----~~~ 876 (1181)
+.|.+.+ +||+|+||+||+|.+..+++.||||++...... ..+.+.+|+.+|+.++||||+++++++.. .+.
T Consensus 53 ~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 53 DRYEIRH-LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp TTEEECC-C-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCeEEee-EeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 4455544 699999999999999999999999999654332 35678999999999999999999999843 367
Q ss_pred EEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccccc
Q psy14556 877 FKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956 (1181)
Q Consensus 877 l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l 956 (1181)
+|+||||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 132 ~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~-~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQ-DCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT-TCCEEECCCTTCBCT
T ss_pred EEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECC-CCCEeecccccchhc
Confidence 99999998 6789888874 346889999999999999999999999999999999999998 899999999999876
Q ss_pred ccCCC---------------------------CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchh
Q psy14556 957 AGLCP---------------------------SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKIN 1009 (1181)
Q Consensus 957 ~~~~~---------------------------~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~D 1009 (1181)
..... .....+||+.|+|||++..+. .++..+|+
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~~Di------------------ 267 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQE-NYTEAIDV------------------ 267 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCC-CCCTHHHH------------------
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCC-CCCcHhHH------------------
Confidence 43211 123356899999999874332 34555555
Q ss_pred HHHHHHHHHHHh-----------CCCCCCCCC
Q psy14556 1010 VFLCVIISQLLV-----------LTAALKKKT 1030 (1181)
Q Consensus 1010 wSLGvILyELLT-----------Gk~PF~~~~ 1030 (1181)
||+||+||||++ |++||.+.+
T Consensus 268 wSlG~il~elltg~~~~~~~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 268 WSIGCIFAELLNMIKENVAYHADRGPLFPGSS 299 (458)
T ss_dssp HHHHHHHHHHHTTSTTTCSSGGGCCCSCC---
T ss_pred HHHHHHHHHHHHhccccccccccccccCCCCc
Confidence 999999999999 777777654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=310.91 Aligned_cols=240 Identities=23% Similarity=0.312 Sum_probs=182.3
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
++||+|+||.||+|++ .++.||+|.+... ...+.+.+|+.++++++||||+++++++.+ ..++||||+++++|.
T Consensus 14 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~ 87 (307)
T 2eva_A 14 EVVGRGAFGVVCKAKW--RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLY 87 (307)
T ss_dssp EEEECCSSSEEEEEEE--TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHH
T ss_pred eEeecCCCceEEEEEE--CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHH
Confidence 4799999999999987 4788999998643 345679999999999999999999999874 479999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccc---cceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHG---QKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs---~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+++........+++..++.++.|++.||.|||+ +||+||||||+||+++.....+||+|||++...... .....
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---~~~~~ 164 (307)
T 2eva_A 88 NVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNK 164 (307)
T ss_dssp HHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------------
T ss_pred HHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---cccCC
Confidence 999865333346788899999999999999999 899999999999999873335899999999765432 23346
Q ss_pred CCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc--c--CCCCCCCC
Q psy14556 968 GTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL--V--APPQISRS 1043 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l--~--~~~~ip~~ 1043 (1181)
||+.|+|||++.+..++.+ .|+ ||+|+++|+|++|+.||........ . ........
T Consensus 165 gt~~y~aPE~~~~~~~~~~--~Di------------------~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 224 (307)
T 2eva_A 165 GSAAWMAPEVFEGSNYSEK--CDV------------------FSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP 224 (307)
T ss_dssp CCTTSSCHHHHTCCCCCTH--HHH------------------HHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCC
T ss_pred CCCceEChhhhCCCCCCcH--HHH------------------HHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCC
Confidence 8999999999976543333 333 9999999999999999986543221 0 00111122
Q ss_pred CCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1044 VSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1044 l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
.....+..+..++.+|++.+|..||+ +.+.+..+..
T Consensus 225 ~~~~~~~~l~~li~~~l~~dp~~Rps-~~ell~~L~~ 260 (307)
T 2eva_A 225 LIKNLPKPIESLMTRCWSKDPSQRPS-MEEIVKIMTH 260 (307)
T ss_dssp CBTTCCHHHHHHHHHHTCSSGGGSCC-HHHHHHHHHH
T ss_pred cccccCHHHHHHHHHHhcCChhhCcC-HHHHHHHHHH
Confidence 23456788999999999999999995 5555444443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=320.51 Aligned_cols=237 Identities=30% Similarity=0.395 Sum_probs=192.2
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC---ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG---DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~---~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.+||+|+||.||+|++..+++.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..++||||+. |
T Consensus 60 ~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g 138 (348)
T 1u5q_A 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-G 138 (348)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred eEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-C
Confidence 4699999999999999999999999999765332 24568899999999999999999999999999999999996 6
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||++. ++.+||+|||++..... .....
T Consensus 139 ~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~kL~DfG~a~~~~~----~~~~~ 211 (348)
T 1u5q_A 139 SASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE-PGLVKLGDFGSASIMAP----ANSFV 211 (348)
T ss_dssp EHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET-TTEEEECCCTTCBSSSS----BCCCC
T ss_pred CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC-CCCEEEeeccCceecCC----CCccc
Confidence 787777543 235789999999999999999999999999999999999997 89999999999976643 23456
Q ss_pred CCccccCchhhccC-CCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC---CCCCCCC
Q psy14556 968 GTLQYMAPEVIDKG-QRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA---PPQISRS 1043 (1181)
Q Consensus 968 GT~~Y~APEvl~gg-~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~---~~~ip~~ 1043 (1181)
||+.|+|||++.+. ...++..+|+ ||+||++|+|++|+.||.+.+...... ....+..
T Consensus 212 gt~~y~aPE~~~~~~~~~~~~~~Di------------------wslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 273 (348)
T 1u5q_A 212 GTPYWMAPEVILAMDEGQYDGKVDV------------------WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL 273 (348)
T ss_dssp SCGGGCCHHHHHTTSSCCBCTHHHH------------------HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred CCcceeCHhhhccccCCCCCcHHHH------------------HHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC
Confidence 99999999998531 1123333444 999999999999999998876533211 1112222
Q ss_pred CCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1044 VSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1044 l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.....+..+..++.+|+..+|..||+..+.
T Consensus 274 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~l 303 (348)
T 1u5q_A 274 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 303 (348)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 234567889999999999999999986554
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=329.42 Aligned_cols=249 Identities=25% Similarity=0.320 Sum_probs=186.1
Q ss_pred hhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCC--------CChhHHHHHHHHHHhcCCCCeeeEccccccC
Q psy14556 803 LYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--------GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEE 874 (1181)
Q Consensus 803 ~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--------~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~ 874 (1181)
.+.|.+. ++||+|+||+||+|.+..+++.||+|++.+... .....+.+|+.++++++||||+++++++..
T Consensus 134 ~~~y~~~-~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 134 RDEYIMS-KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HTTEEEE-EEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hccEEEE-eEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 3445443 479999999999999999999999999965421 123458899999999999999999999854
Q ss_pred CcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccC--CCeeeeecCCc
Q psy14556 875 GYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTY--SGVVKISDFGT 952 (1181)
Q Consensus 875 ~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~--~g~vKLiDFGl 952 (1181)
+..++||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.. +..+||+|||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred CceEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccc
Confidence 4589999999999999988743 467899999999999999999999999999999999999752 34699999999
Q ss_pred ccccccCCCCCccccCCccccCchhhccC-CCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCc
Q psy14556 953 SKRLAGLCPSAETFTGTLQYMAPEVIDKG-QRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTS 1031 (1181)
Q Consensus 953 Ak~l~~~~~~~~t~~GT~~Y~APEvl~gg-~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~ 1031 (1181)
++..... .......||+.|+|||++.+. ...++..+|+ ||+||++|+|++|..||.+...
T Consensus 289 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di------------------wslG~il~~lltg~~pf~~~~~ 349 (419)
T 3i6u_A 289 SKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDC------------------WSLGVILFICLSGYPPFSEHRT 349 (419)
T ss_dssp TTSCC------------CTTCCTTTTC----CTTHHHHHH------------------HHHHHHHHHHHHSSCSSCCCSS
T ss_pred ceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhh------------------HhHHHHHHHHHHCCCCCCCCcc
Confidence 9876542 233456799999999998531 1223333443 9999999999999999987544
Q ss_pred ccc------cCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHH
Q psy14556 1032 RAL------VAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNL 1075 (1181)
Q Consensus 1032 ~~l------~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~ 1075 (1181)
... ..............+..+..++.+|++.+|..||+..+.+.
T Consensus 350 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 350 QVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp SCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 221 11111111222356778889999999999999998665543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-34 Score=318.96 Aligned_cols=245 Identities=25% Similarity=0.323 Sum_probs=189.7
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC--hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEe
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD--VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~--~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmE 882 (1181)
.|... .+||+|+||.||+|++..+++.||+|++....... .+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 26 ~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 26 KYENL-GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GEEEE-EEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hheee-eEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 34443 37999999999999999999999999986554332 4557899999999999999999999999999999999
Q ss_pred ecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC
Q psy14556 883 QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS 962 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~ 962 (1181)
|+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++........
T Consensus 105 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~ 180 (331)
T 4aaa_A 105 FVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEV 180 (331)
T ss_dssp CCSEEHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TSCEEECCCTTC---------
T ss_pred cCCcchHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcC-CCcEEEEeCCCceeecCCccc
Confidence 99999998876632 35789999999999999999999999999999999999988 889999999999876654444
Q ss_pred CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc-------
Q psy14556 963 AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV------- 1035 (1181)
Q Consensus 963 ~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~------- 1035 (1181)
.....||+.|+|||++.+. ..++...|+ ||+|+++|+|++|+.||.+.+..+..
T Consensus 181 ~~~~~~t~~y~aPE~~~~~-~~~~~~~Di------------------~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 241 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVGD-VKYGKAVDV------------------WAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCL 241 (331)
T ss_dssp ---CCCCCTTCCHHHHTTC-TTCCTHHHH------------------HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cCCCcCCccccCcccccCC-CCcchHHHH------------------HHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence 4456799999999999653 223344444 99999999999999999887643210
Q ss_pred -----------------CCCCCCC--------CCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1036 -----------------APPQISR--------SVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1036 -----------------~~~~ip~--------~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.....+. ...+..+..+..++.+|+..+|..||+..+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el 304 (331)
T 4aaa_A 242 GNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAEL 304 (331)
T ss_dssp CSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGG
T ss_pred CCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHH
Confidence 0000111 0112457778899999999999999975443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-34 Score=311.24 Aligned_cols=248 Identities=22% Similarity=0.213 Sum_probs=192.5
Q ss_pred hcccCceeecccCceEEEEEEE--cCCCeEEEEEEecCCCCCC--hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEE
Q psy14556 805 LFALNRIELGKGSYGVVYAARE--LDRQVKLAIKEIPEKNLGD--VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIF 880 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d--~~tg~~VAIKii~~~~~~~--~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LV 880 (1181)
.|.+...+||+|+||.||+|.+ ..+++.||+|++....... .+.+.+|+.+++.++||||+++++++ ..+..++|
T Consensus 17 ~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv 95 (291)
T 1xbb_A 17 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLV 95 (291)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEE
T ss_pred hhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEE
Confidence 4455555799999999999954 5667899999997654332 56799999999999999999999999 56778999
Q ss_pred EeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC
Q psy14556 881 MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC 960 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~ 960 (1181)
|||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++.......
T Consensus 96 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~-~~~~kl~Dfg~~~~~~~~~ 171 (291)
T 1xbb_A 96 MEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADE 171 (291)
T ss_dssp EECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE-TTEEEECCCTTCEECCTTC
T ss_pred EEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeC-CCcEEEccCCcceeeccCC
Confidence 9999999999999853 35789999999999999999999999999999999999998 8999999999998765432
Q ss_pred CC---CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccC
Q psy14556 961 PS---AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVA 1036 (1181)
Q Consensus 961 ~~---~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~ 1036 (1181)
.. .....+++.|+|||++.+..++.. . +.||+|+++|+|++ |+.||.+.+...+..
T Consensus 172 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~--~------------------Di~slG~il~~l~~~g~~p~~~~~~~~~~~ 231 (291)
T 1xbb_A 172 NYYKAQTHGKWPVKWYAPECINYYKFSSK--S------------------DVWSFGVLMWEAFSYGQKPYRGMKGSEVTA 231 (291)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCEEEHH--H------------------HHHHHHHHHHHHHTTTCCSSTTCCHHHHHH
T ss_pred CcccccccCCCCceeeChHHhccCCCChh--h------------------hHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 21 122346788999999975543322 2 33999999999999 999999877654322
Q ss_pred CCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1037 PPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1037 ~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
... .....+...+..+..++.+|++.+|..||+ +.+.+..+
T Consensus 232 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~~l~~~L 274 (291)
T 1xbb_A 232 MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPG-FAAVELRL 274 (291)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCC-HHHHHHHH
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcC-HHHHHHHH
Confidence 111 112233467888999999999999999996 44444333
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-34 Score=316.65 Aligned_cols=247 Identities=21% Similarity=0.287 Sum_probs=193.4
Q ss_pred eeecccCceEEEEEEEcCCCeEE--EEEEecCCC-CCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEeecCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKL--AIKEIPEKN-LGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~V--AIKii~~~~-~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
..||+|+||.||+|++..++..+ ++|.+.... ....+.+.+|+.+++++ +||||+++++++.+.+..++||||+++
T Consensus 31 ~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 110 (327)
T 1fvr_A 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 110 (327)
T ss_dssp EEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred eeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCC
Confidence 47999999999999998888765 999986542 33456799999999999 999999999999999999999999999
Q ss_pred CCcccchhccc-------------CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcc
Q psy14556 887 GSLSTLLRVKW-------------GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTS 953 (1181)
Q Consensus 887 GSL~dlL~~~~-------------~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlA 953 (1181)
++|.+++.... ....+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 111 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~~kL~Dfg~~ 189 (327)
T 1fvr_A 111 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE-NYVAKIADFGLS 189 (327)
T ss_dssp CBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG-GGCEEECCTTCE
T ss_pred CCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC-CCeEEEcccCcC
Confidence 99999997541 1246889999999999999999999999999999999999987 789999999999
Q ss_pred cccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q psy14556 954 KRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSR 1032 (1181)
Q Consensus 954 k~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~ 1032 (1181)
+..... .......+++.|+|||++.+..++. ..|+ ||+|+++|+|++ |+.||.+.+..
T Consensus 190 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~--~~Di------------------~slG~il~ellt~g~~pf~~~~~~ 248 (327)
T 1fvr_A 190 RGQEVY-VKKTMGRLPVRWMAIESLNYSVYTT--NSDV------------------WSYGVLLWEIVSLGGTPYCGMTCA 248 (327)
T ss_dssp ESSCEE-CCC----CCTTTCCHHHHHHCEECH--HHHH------------------HHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred cccccc-ccccCCCCCccccChhhhccccCCc--hhcc------------------hHHHHHHHHHHcCCCCCCCCCcHH
Confidence 754332 1222345788999999997554332 2333 999999999998 99999988765
Q ss_pred cccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1033 ALVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1033 ~l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
.+..... .....+...+..+..++.+|+..+|..||+ +.+.+..+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~ell~~L~~ 297 (327)
T 1fvr_A 249 ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPS-FAQILVSLNR 297 (327)
T ss_dssp HHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCC-HHHHHHHHHH
T ss_pred HHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcC-HHHHHHHHHH
Confidence 5322111 112233456788999999999999999995 5554444443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=309.32 Aligned_cols=235 Identities=20% Similarity=0.205 Sum_probs=190.2
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
+.||+|+||.||+|.+..+++.||+|++.... ..+.+.+|+.+++.+ +|+||+++++++.+....++||||+ +++|
T Consensus 16 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L 92 (298)
T 1csn_A 16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSL 92 (298)
T ss_dssp EEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCH
Confidence 46999999999999999999999999986543 335688999999999 8999999999999999999999999 9999
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCe-----eeeecCCcccccccCCC---
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGV-----VKISDFGTSKRLAGLCP--- 961 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~-----vKLiDFGlAk~l~~~~~--- 961 (1181)
.+++... ...+++..++.++.||+.||+|||++||+||||||+||+++. ++. +||+|||+++.......
T Consensus 93 ~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~-~~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 169 (298)
T 1csn_A 93 EDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGR-PNSKNANMIYVVDFGMVKFYRDPVTKQH 169 (298)
T ss_dssp HHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECC-SSSTTTTCEEECCCTTCEESBCTTTCCB
T ss_pred HHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecc-CCCCCCCeEEEEECcccccccccccccc
Confidence 9999854 235789999999999999999999999999999999999976 444 99999999987654322
Q ss_pred ----CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc---
Q psy14556 962 ----SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL--- 1034 (1181)
Q Consensus 962 ----~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l--- 1034 (1181)
......||+.|+|||++.+..++. ..|+ ||+|+++|+|++|+.||.+......
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~Di------------------~slG~il~el~~g~~pf~~~~~~~~~~~ 229 (298)
T 1csn_A 170 IPYREKKNLSGTARYMSINTHLGREQSR--RDDL------------------EALGHVFMYFLRGSLPWQGLKAATNKQK 229 (298)
T ss_dssp CCCCCCCCCCSCTTTCCHHHHTTCCCCH--HHHH------------------HHHHHHHHHHHHSSCTTSSCCSCCHHHH
T ss_pred ccccCccCCCCCcccCCchhhcCCCCCh--HHHH------------------HHHHHHHHHHHcCCCCcchhhccccHHH
Confidence 123456999999999997654333 3333 9999999999999999998653211
Q ss_pred cC------CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1035 VA------PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1035 ~~------~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
.. ............+..+..++.+|++.+|..||+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~ 272 (298)
T 1csn_A 230 YERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYD 272 (298)
T ss_dssp HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHH
T ss_pred HHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHH
Confidence 00 00011112235678899999999999999999643
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=328.50 Aligned_cols=240 Identities=23% Similarity=0.337 Sum_probs=185.5
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEcccccc------CCcEEEEEee
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSE------EGYFKIFMEQ 883 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d------~~~l~LVmEy 883 (1181)
.++||+|+||.||+|++..+++.||||++..... ...+|+.+++.++||||+++++++.. ..++++||||
T Consensus 59 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~ 134 (420)
T 1j1b_A 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 134 (420)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEEC
T ss_pred eeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhc
Confidence 3479999999999999999999999999965432 23479999999999999999998743 2347899999
Q ss_pred cCCCCcccchhc-ccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC
Q psy14556 884 VPGGSLSTLLRV-KWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS 962 (1181)
Q Consensus 884 ~~gGSL~dlL~~-~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~ 962 (1181)
+++ +|.+++.. ......+++..++.++.||+.||+|||++||+||||||+|||++.+.+.+||+|||+++.+.... .
T Consensus 135 ~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~-~ 212 (420)
T 1j1b_A 135 VPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-P 212 (420)
T ss_dssp CCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC-C
T ss_pred ccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCC-C
Confidence 965 56555542 12345688999999999999999999999999999999999999746789999999998765432 2
Q ss_pred CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc-------
Q psy14556 963 AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV------- 1035 (1181)
Q Consensus 963 ~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~------- 1035 (1181)
.....||+.|+|||++.+. ..++..+|+ ||+||++|||++|+.||.+.+..+..
T Consensus 213 ~~~~~~t~~y~aPE~~~~~-~~~~~~~Di------------------wSlG~il~ell~G~~pf~~~~~~~~l~~i~~~l 273 (420)
T 1j1b_A 213 NVSYICSRYYRAPELIFGA-TDYTSSIDV------------------WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 273 (420)
T ss_dssp CCSCCSCTTSCCHHHHTTC-SSCCTHHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred ceeeeeCCCcCCHHHHcCC-CCCCchhhh------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 3345789999999999643 234445555 99999999999999999987642210
Q ss_pred ---------------CCCCCCC--------CCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1036 ---------------APPQISR--------SVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1036 ---------------~~~~ip~--------~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
....++. ......+..+..++.+|+..+|.+|++..+.+
T Consensus 274 g~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l 335 (420)
T 1j1b_A 274 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335 (420)
T ss_dssp CSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHh
Confidence 0011111 11234567788899999999999999866554
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=335.53 Aligned_cols=247 Identities=26% Similarity=0.309 Sum_probs=198.2
Q ss_pred HHhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCC-------------CChhHHHHHHHHHHhcCCCCeeeE
Q psy14556 801 RFLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-------------GDVQPLHEEIKLHSQLRHRNIVQY 867 (1181)
Q Consensus 801 ~~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-------------~~~e~f~rEi~IL~~L~HPNIVkl 867 (1181)
.+...|... ++||+|+||+||+|++..+++.||+|++..... ...+.+.+|+.++++++||||+++
T Consensus 33 ~i~~~Y~~~-~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 111 (504)
T 3q5i_A 33 KIGESYFKV-RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111 (504)
T ss_dssp CGGGTEEEE-EEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CcccceEEE-eEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 344555554 479999999999999999999999999975432 235678999999999999999999
Q ss_pred ccccccCCcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCC--Cee
Q psy14556 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYS--GVV 945 (1181)
Q Consensus 868 ~g~~~d~~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~--g~v 945 (1181)
++++.+.+.+++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++..+ ..+
T Consensus 112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 112 FDVFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSE
T ss_pred EEEEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccE
Confidence 99999999999999999999999988754 3578999999999999999999999999999999999998732 269
Q ss_pred eeecCCcccccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCC
Q psy14556 946 KISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAA 1025 (1181)
Q Consensus 946 KLiDFGlAk~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~P 1025 (1181)
||+|||+++..... .......||+.|+|||++.+ . ++..+|+ ||+||++|+|++|..|
T Consensus 189 kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~--~~~~~Di------------------wslG~il~~ll~g~~p 246 (504)
T 3q5i_A 189 KIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-K--YNEKCDV------------------WSCGVIMYILLCGYPP 246 (504)
T ss_dssp EECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT-C--BCTHHHH------------------HHHHHHHHHHHHSSCS
T ss_pred EEEECCCCEEcCCC-CccccccCCcCCCCHHHhcc-C--CCchHHH------------------HHHHHHHHHHHhCCCC
Confidence 99999999876543 23345579999999999863 2 3444444 9999999999999999
Q ss_pred CCCCCcccccCCC-----CCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1026 LKKKTSRALVAPP-----QISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1026 F~~~~~~~l~~~~-----~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
|.+.+..++.... ..+.......+..+..++.+|+..+|..||+..+.
T Consensus 247 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~ 299 (504)
T 3q5i_A 247 FGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEA 299 (504)
T ss_dssp SCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 9998776543221 12222223567788999999999999999976555
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=306.91 Aligned_cols=245 Identities=19% Similarity=0.237 Sum_probs=189.7
Q ss_pred eeecccCceEEEEEEEcCCCe---EEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcE-EEEEeecC
Q psy14556 811 IELGKGSYGVVYAARELDRQV---KLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYF-KIFMEQVP 885 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~---~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l-~LVmEy~~ 885 (1181)
++||+|+||+||+|.+..++. .||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.. ++||||+.
T Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~ 106 (298)
T 3pls_A 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMC 106 (298)
T ss_dssp EEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCT
T ss_pred ceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEeccc
Confidence 479999999999999765544 799999975433 2356789999999999999999999999776554 99999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC----C
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC----P 961 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~----~ 961 (1181)
+++|.+++... ...+++..++.++.|++.||+|||++||+||||||+||+++. ++.+||+|||+++...... .
T Consensus 107 ~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~-~~~~kl~Dfg~~~~~~~~~~~~~~ 183 (298)
T 3pls_A 107 HGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDE-SFTVKVADFGLARDILDREYYSVQ 183 (298)
T ss_dssp TCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT-TCCEEECCTTSSCTTTTGGGGCSC
T ss_pred CCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC-CCcEEeCcCCCcccccCCcccccc
Confidence 99999999753 345678999999999999999999999999999999999987 8899999999997654321 2
Q ss_pred CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCC-CCCCCCCcccccCCCC-
Q psy14556 962 SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLT-AALKKKTSRALVAPPQ- 1039 (1181)
Q Consensus 962 ~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk-~PF~~~~~~~l~~~~~- 1039 (1181)
......+++.|+|||.+.+..++. ..|+ ||+|+++|+|++|. +||...+...+.....
T Consensus 184 ~~~~~~~~~~y~aPE~~~~~~~~~--~~Di------------------~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~ 243 (298)
T 3pls_A 184 QHRHARLPVKWTALESLQTYRFTT--KSDV------------------WSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243 (298)
T ss_dssp CSSCTTCGGGGSCHHHHTTCCCCH--HHHH------------------HHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT
T ss_pred cCcCCCCCccccChhhhccCCCCh--hhch------------------hhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc
Confidence 223345789999999997654333 3333 99999999999955 5555555444321111
Q ss_pred -CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcc
Q psy14556 1040 -ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTG 1079 (1181)
Q Consensus 1040 -ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~ 1079 (1181)
.....+...+..+..++.+|++.+|..||+ +.+.+..+.
T Consensus 244 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~~ll~~l~ 283 (298)
T 3pls_A 244 GRRLPQPEYCPDSLYQVMQQCWEADPAVRPT-FRVLVGEVE 283 (298)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-HHHHHHHHH
T ss_pred CCCCCCCccchHHHHHHHHHHccCChhhCcC-HHHHHHHHH
Confidence 112223456778999999999999999995 454444333
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-34 Score=317.59 Aligned_cols=254 Identities=20% Similarity=0.235 Sum_probs=199.3
Q ss_pred hhcccCceeecccCceEEEEEEEc-----CCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcE
Q psy14556 804 YLFALNRIELGKGSYGVVYAAREL-----DRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYF 877 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~-----~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l 877 (1181)
..|.+. ++||+|+||.||+|.+. .+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 25 ~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 103 (322)
T 1p4o_A 25 EKITMS-RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 103 (322)
T ss_dssp GGEEEE-EEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred hheeee-eEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence 344443 47999999999999876 4578899999975432 2345688999999999999999999999999999
Q ss_pred EEEEeecCCCCcccchhccc-------CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecC
Q psy14556 878 KIFMEQVPGGSLSTLLRVKW-------GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDF 950 (1181)
Q Consensus 878 ~LVmEy~~gGSL~dlL~~~~-------~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDF 950 (1181)
++||||+++++|.+++.... ....+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+||
T Consensus 104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~-~~~~kl~Df 182 (322)
T 1p4o_A 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE-DFTVKIGDF 182 (322)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECT-TCCEEECCT
T ss_pred EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcC-CCeEEECcC
Confidence 99999999999999997531 1235678999999999999999999999999999999999998 889999999
Q ss_pred CcccccccCCCC--CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCC
Q psy14556 951 GTSKRLAGLCPS--AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALK 1027 (1181)
Q Consensus 951 GlAk~l~~~~~~--~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~ 1027 (1181)
|+++........ .....+|+.|+|||++.+..++. ..|+ ||+|+++|+|++ |..||.
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--~~Di------------------~slG~il~el~~~g~~p~~ 242 (322)
T 1p4o_A 183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT--YSDV------------------WSFGVVLWEIATLAEQPYQ 242 (322)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCH--HHHH------------------HHHHHHHHHHHHTSCCTTT
T ss_pred ccccccccccccccccCCCCCCCccChhhhccCCCCc--hhhH------------------HHHHHHHHHHHhcCCCccc
Confidence 999866433211 22334688999999997654333 3333 999999999999 899999
Q ss_pred CCCcccccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1028 KKTSRALVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1028 ~~~~~~l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
+.+...+..... .....+...+..+..++.+|++.+|..||+ +.+.+..+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~e~l~~L~~ 296 (322)
T 1p4o_A 243 GLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPS-FLEIISSIKE 296 (322)
T ss_dssp TSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-HHHHHHHHGG
T ss_pred cCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcC-HHHHHHHHHH
Confidence 877654321110 111223467788999999999999999985 5555555555
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=318.08 Aligned_cols=246 Identities=22% Similarity=0.275 Sum_probs=193.6
Q ss_pred ceeecccCceEEEEEEEcCCCe-----EEEEEEecCCCC-CChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEe
Q psy14556 810 RIELGKGSYGVVYAARELDRQV-----KLAIKEIPEKNL-GDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~-----~VAIKii~~~~~-~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmE 882 (1181)
...||+|+||.||+|.+..++. .||+|.+..... ...+.+.+|+.+++++ +||||+++++++.+.+..++|||
T Consensus 51 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 130 (333)
T 2i1m_A 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE 130 (333)
T ss_dssp EEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEe
Confidence 3479999999999999877654 799999975532 2356789999999999 89999999999999999999999
Q ss_pred ecCCCCcccchhccc-----------CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCC
Q psy14556 883 QVPGGSLSTLLRVKW-----------GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFG 951 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~-----------~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFG 951 (1181)
|+++|+|.+++.... ....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 131 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg 209 (333)
T 2i1m_A 131 YCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN-GHVAKIGDFG 209 (333)
T ss_dssp CCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEG-GGEEEBCCCG
T ss_pred cCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECC-CCeEEECccc
Confidence 999999999997532 1235788999999999999999999999999999999999987 8899999999
Q ss_pred cccccccCCCC--CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCC
Q psy14556 952 TSKRLAGLCPS--AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKK 1028 (1181)
Q Consensus 952 lAk~l~~~~~~--~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~ 1028 (1181)
++......... .....+|+.|+|||++.+..++. ..|+ ||+|+++|+|++ |..||.+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--~~Di------------------~slG~il~el~t~g~~p~~~ 269 (333)
T 2i1m_A 210 LARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTV--QSDV------------------WSYGILLWEIFSLGLNPYPG 269 (333)
T ss_dssp GGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCH--HHHH------------------HHHHHHHHHHTTTSCCSSTT
T ss_pred cccccccccceeecCCCCCCccccCHHHhccCCCCh--HHHH------------------HHHHHHHHHHHcCCCCCCcc
Confidence 99866543221 22344688999999997654333 3333 999999999999 9999988
Q ss_pred CCcccccC---CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHh
Q psy14556 1029 KTSRALVA---PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVC 1077 (1181)
Q Consensus 1029 ~~~~~l~~---~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~a 1077 (1181)
........ ........+...+..+..++.+|++.+|..||+ +.+.+..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~~l~~~ 320 (333)
T 2i1m_A 270 ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPT-FQQICSF 320 (333)
T ss_dssp CCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-HHHHHHH
T ss_pred cchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcC-HHHHHHH
Confidence 65433111 001112223446788999999999999999996 4443333
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=304.75 Aligned_cols=242 Identities=21% Similarity=0.260 Sum_probs=194.1
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.
T Consensus 14 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (267)
T 3t9t_A 14 QEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLS 91 (267)
T ss_dssp EEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHH
T ss_pred eEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHH
Confidence 47999999999999986 567899999976543 3477999999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC-CCCccccCC
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC-PSAETFTGT 969 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~-~~~~t~~GT 969 (1181)
+++... ...+++..++.++.|++.||.|||++|++||||||+||+++. ++.+||+|||++....... .......++
T Consensus 92 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 168 (267)
T 3t9t_A 92 DYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE-NQVIKVSDFGMTRFVLDDQYTSSTGTKFP 168 (267)
T ss_dssp HHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECG-GGCEEECCTTGGGGBCCHHHHSTTSTTCC
T ss_pred HHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECC-CCCEEEccccccccccccccccccccccc
Confidence 999754 235778999999999999999999999999999999999987 7899999999997654321 112234577
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--CCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--ISRSVSV 1046 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--ip~~l~~ 1046 (1181)
+.|+|||++.+..++. ..|+ ||+|+++|+|++ |+.||.......+..... .....+.
T Consensus 169 ~~y~aPE~~~~~~~~~--~~Di------------------~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~ 228 (267)
T 3t9t_A 169 VKWASPEVFSFSRYSS--KSDV------------------WSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR 228 (267)
T ss_dssp GGGCCHHHHHHCCCCH--HHHH------------------HHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT
T ss_pred ccccChhhhcCCCccc--hhch------------------hhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCc
Confidence 8999999997654333 3333 999999999999 899999877654322111 1122234
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
..+..+..++.+|++.+|..||+ +.+.+..+
T Consensus 229 ~~~~~l~~li~~~l~~~p~~Rps-~~~ll~~L 259 (267)
T 3t9t_A 229 LASTHVYQIMNHCWRERPEDRPA-FSRLLRQL 259 (267)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCC-HHHHHHHH
T ss_pred cCcHHHHHHHHHHccCChhhCcC-HHHHHHHH
Confidence 56778999999999999999996 44444333
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-34 Score=323.83 Aligned_cols=249 Identities=23% Similarity=0.319 Sum_probs=195.7
Q ss_pred hcccCceeecccCceEEEEEEEc---CCCeEEEEEEecCCC----CCChhHHHHHHHHHHhc-CCCCeeeEccccccCCc
Q psy14556 805 LFALNRIELGKGSYGVVYAAREL---DRQVKLAIKEIPEKN----LGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGY 876 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~---~tg~~VAIKii~~~~----~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~ 876 (1181)
.|.+. ++||+|+||.||+|++. .+++.||||+++... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 55 ~y~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 55 NFELL-KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GEEEE-EEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred ceEEE-EEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 34443 36999999999999984 588999999996542 23456678899999999 69999999999999999
Q ss_pred EEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccccc
Q psy14556 877 FKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956 (1181)
Q Consensus 877 l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l 956 (1181)
.++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDS-NGHVVLTDFGLSKEF 209 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TSCEEESCSSEEEEC
T ss_pred EEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC-CCcEEEeeCCCCeec
Confidence 99999999999999999754 25789999999999999999999999999999999999988 899999999999865
Q ss_pred ccCC-CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc-
Q psy14556 957 AGLC-PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL- 1034 (1181)
Q Consensus 957 ~~~~-~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l- 1034 (1181)
.... .......||+.|+|||++.++...++...|+ |||||++|+|++|+.||........
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv------------------wslG~il~ell~g~~pf~~~~~~~~~ 271 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDW------------------WSLGVLMYELLTGASPFTVDGEKNSQ 271 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHH------------------HHHHHHHHHHHHSSCTTSCTTSCCCH
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhH------------------HHHHHHHHHHHHCCCCCccCCccchH
Confidence 4322 2233457999999999997654444444555 9999999999999999986543221
Q ss_pred ---cCC-CCCCCCCCCCCCcchHHhhccCCCCCCCCCch----hHHHHHH
Q psy14556 1035 ---VAP-PQISRSVSVPGPGGINSSSSAPVTPTPHSRHI----SVNTNLV 1076 (1181)
Q Consensus 1035 ---~~~-~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~----s~~~~~~ 1076 (1181)
... .......+...+..+..++.+|+..+|.+||. ++++.+.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 272 AEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp HHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHHHHHhccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 000 00112233456778888999999999999994 4555443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-34 Score=321.55 Aligned_cols=203 Identities=21% Similarity=0.312 Sum_probs=170.3
Q ss_pred hhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcC-----CCCeeeEccccccCCcE
Q psy14556 803 LYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR-----HRNIVQYLGSVSEEGYF 877 (1181)
Q Consensus 803 ~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~-----HPNIVkl~g~~~d~~~l 877 (1181)
.+.|.+. .+||+|+||+||+|++..+++.||+|++.... ...+.+..|+.+++.+. ||||+++++++...+..
T Consensus 34 ~~~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~ 111 (360)
T 3llt_A 34 NNAFLVI-RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM 111 (360)
T ss_dssp TTTEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred cCEEEEE-EEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence 3444444 47999999999999999999999999996432 23456788999999996 99999999999999999
Q ss_pred EEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccccc-----------------
Q psy14556 878 KIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNT----------------- 940 (1181)
Q Consensus 878 ~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~----------------- 940 (1181)
++||||+ +++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 112 ~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~ 189 (360)
T 3llt_A 112 CLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189 (360)
T ss_dssp EEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred EEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccc
Confidence 9999999 99999999865 3345789999999999999999999999999999999999973
Q ss_pred -------CCCeeeeecCCcccccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHH
Q psy14556 941 -------YSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLC 1013 (1181)
Q Consensus 941 -------~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLG 1013 (1181)
.++.+||+|||+++.... ......||+.|+|||++.+..++.. .|+ ||+|
T Consensus 190 ~~~~~~~~~~~~kl~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~--~Di------------------wslG 246 (360)
T 3llt_A 190 KIQIYRTKSTGIKLIDFGCATFKSD---YHGSIINTRQYRAPEVILNLGWDVS--SDM------------------WSFG 246 (360)
T ss_dssp EEEEEEESCCCEEECCCTTCEETTS---CCCSCCSCGGGCCHHHHTTCCCCTT--HHH------------------HHHH
T ss_pred cccccccCCCCEEEEeccCceecCC---CCcCccCcccccCcHHHcCCCCCCc--cch------------------HHHH
Confidence 267899999999986543 2334579999999999987654443 333 9999
Q ss_pred HHHHHHHhCCCCCCCCCcc
Q psy14556 1014 VIISQLLVLTAALKKKTSR 1032 (1181)
Q Consensus 1014 vILyELLTGk~PF~~~~~~ 1032 (1181)
|++|+|++|+.||.+.+..
T Consensus 247 ~il~ell~g~~pf~~~~~~ 265 (360)
T 3llt_A 247 CVLAELYTGSLLFRTHEHM 265 (360)
T ss_dssp HHHHHHHHSSCSCCCSSHH
T ss_pred HHHHHHHHCCCCCCCCcHH
Confidence 9999999999999876643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=309.84 Aligned_cols=248 Identities=23% Similarity=0.252 Sum_probs=184.5
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHh--cCCCCeeeEcccccc----CCcEE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQ--LRHRNIVQYLGSVSE----EGYFK 878 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~--L~HPNIVkl~g~~~d----~~~l~ 878 (1181)
+|.+. ++||+|+||+||+|++ +++.||+|++... ..+.+.+|.+++.. ++||||+++++++.. ....+
T Consensus 9 ~y~~~-~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 9 DITLL-ECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GCEEE-EEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cEEEE-EeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 34443 3799999999999987 6889999998543 34556777777777 799999999998543 35689
Q ss_pred EEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhcc--------ccceecccCCCCCcccccCCCeeeeecC
Q psy14556 879 IFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLH--------GQKIVHRDIKGDNVLVNTYSGVVKISDF 950 (1181)
Q Consensus 879 LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLH--------s~gIVHrDLKP~NILLd~~~g~vKLiDF 950 (1181)
+||||+++|+|.++++.. .+++..++.++.||+.||+||| ++||+||||||+|||++. ++.+||+||
T Consensus 83 lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Df 157 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKK-NGQCCIADL 157 (301)
T ss_dssp EEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECT-TSCEEECCC
T ss_pred EehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcC-CCCEEEeeC
Confidence 999999999999999643 5789999999999999999999 999999999999999997 899999999
Q ss_pred CcccccccCCCC----CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhC----
Q psy14556 951 GTSKRLAGLCPS----AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVL---- 1022 (1181)
Q Consensus 951 GlAk~l~~~~~~----~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTG---- 1022 (1181)
|+++........ .....||+.|+|||++.+...... ..+....+.||+|+++|+|++|
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--------------~~~~~~~DvwslG~il~el~tg~~~~ 223 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDC--------------FDSYKRVDIWAFGLVLWEVARRMVSN 223 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTC--------------HHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCc--------------ccCCchhhHHHHHHHHHHHHhhhcCc
Confidence 999766543221 223469999999999975421100 0122334449999999999999
Q ss_pred ------CCCCCCCCcccc--------cC----CCCCCCC-CCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1023 ------TAALKKKTSRAL--------VA----PPQISRS-VSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1023 ------k~PF~~~~~~~l--------~~----~~~ip~~-l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
..||........ .. .+.++.. .....+..+..++.+|++.+|..||+ +.+.+..+
T Consensus 224 ~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~~i~~~L 297 (301)
T 3q4u_A 224 GIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT-ALRIKKTL 297 (301)
T ss_dssp TBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCC-HHHHHHHH
T ss_pred cccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCC-HHHHHHHH
Confidence 888876543221 00 0111100 11123356888999999999999996 55544443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-34 Score=318.17 Aligned_cols=241 Identities=21% Similarity=0.253 Sum_probs=184.0
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
.+||+|+||+||+|++..+++.||+|++...... ....+.+|+.++++++||||+++++++.+.+..++||||++ ++|
T Consensus 8 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l 86 (324)
T 3mtl_A 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDL 86 (324)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEH
T ss_pred EEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCH
Confidence 4799999999999999999999999999654332 22345679999999999999999999999999999999996 588
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT 969 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT 969 (1181)
.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++.............||
T Consensus 87 ~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~t 163 (324)
T 3mtl_A 87 KQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINE-RGELKLADFGLARAKSIPTKTYDNEVVT 163 (324)
T ss_dssp HHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECT-TCCEEECSSSEEECC------------C
T ss_pred HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECC-CCCEEEccCcccccccCCccccccccCc
Confidence 8888754 335788999999999999999999999999999999999988 8899999999998765444444455789
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC----------CCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA----------PPQ 1039 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~----------~~~ 1039 (1181)
+.|+|||++.+.. .++...|+ ||+|+++|+|++|+.||.+.+..+... ...
T Consensus 164 ~~y~aPE~~~~~~-~~~~~~Di------------------wslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 224 (324)
T 3mtl_A 164 LWYRPPDILLGST-DYSTQIDM------------------WGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEET 224 (324)
T ss_dssp GGGCCHHHHTTCC-CCCTHHHH------------------HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccccChhhhcCCC-CCCcHHHH------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHh
Confidence 9999999996532 23444444 999999999999999999877543210 000
Q ss_pred CCC---------------------CCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1040 ISR---------------------SVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1040 ip~---------------------~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
.+. ......+..+..++.+|+..||.+||+..+.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 280 (324)
T 3mtl_A 225 WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAM 280 (324)
T ss_dssp STTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred chhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHh
Confidence 110 01123456677899999999999999755553
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=316.44 Aligned_cols=247 Identities=22% Similarity=0.308 Sum_probs=197.0
Q ss_pred ceeecccCceEEEEEE----EcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccc--cCCcEEEEEee
Q psy14556 810 RIELGKGSYGVVYAAR----ELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVS--EEGYFKIFMEQ 883 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~----d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~--d~~~l~LVmEy 883 (1181)
.++||+|+||.||+|+ +..+++.||+|++........+.+.+|+.++++++||||+++++++. +.+..++||||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 107 (327)
T 3lxl_A 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEY 107 (327)
T ss_dssp EEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEEC
T ss_pred hhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEee
Confidence 3479999999999998 46788999999998776555677999999999999999999999875 45679999999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC--
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP-- 961 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~-- 961 (1181)
+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||+++. ++.+||+|||++........
T Consensus 108 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~~~~~~~~~~~~ 184 (327)
T 3lxl_A 108 LPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVES-EAHVKIADFGLAKLLPLDKDYY 184 (327)
T ss_dssp CTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE-TTEEEECCGGGCEECCTTCSEE
T ss_pred cCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECC-CCCEEEcccccceecccCCccc
Confidence 99999999997532 25789999999999999999999999999999999999988 89999999999987653322
Q ss_pred -CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC----
Q psy14556 962 -SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA---- 1036 (1181)
Q Consensus 962 -~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~---- 1036 (1181)
......+|+.|+|||++.+..++.. .| .||+|+++|+|++|..||..........
T Consensus 185 ~~~~~~~~~~~y~aPE~~~~~~~~~~--~D------------------i~slG~il~~ll~g~~p~~~~~~~~~~~~~~~ 244 (327)
T 3lxl_A 185 VVREPGQSPIFWYAPESLSDNIFSRQ--SD------------------VWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE 244 (327)
T ss_dssp ECSSCCCSCGGGSCHHHHHHCEEEHH--HH------------------HHHHHHHHHHHHTTTCGGGSHHHHHHHHCC--
T ss_pred eeeccCCccccccCHHHhccCCCChH--Hh------------------HHHHHHHHHHHHhCCCCCccccchhhhhcccc
Confidence 1223457888999999976543332 22 3999999999999999997655421100
Q ss_pred -------------CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1037 -------------PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1037 -------------~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
........+...+..+..++.+|++.+|..||+ +.+.+..+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~ell~~L~~ 300 (327)
T 3lxl_A 245 RDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPS-FSALGPQLDM 300 (327)
T ss_dssp --CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-HHHHHHHHHH
T ss_pred cccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcC-HHHHHHHHHH
Confidence 011122234567888999999999999999985 5555555555
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=319.03 Aligned_cols=253 Identities=21% Similarity=0.260 Sum_probs=198.6
Q ss_pred HhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC--------hhHHHHHHHHHHhc-CCCCeeeEccccc
Q psy14556 802 FLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD--------VQPLHEEIKLHSQL-RHRNIVQYLGSVS 872 (1181)
Q Consensus 802 ~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~--------~e~f~rEi~IL~~L-~HPNIVkl~g~~~ 872 (1181)
+...|... .+||+|+||.||+|.+..+++.||||++....... .+.+.+|+.+++++ +||||+++++++.
T Consensus 92 ~~~~y~~~-~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 92 FYQKYDPK-DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhcccc-eEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 33444443 47999999999999999999999999997654221 35678999999999 8999999999999
Q ss_pred cCCcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCc
Q psy14556 873 EEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGT 952 (1181)
Q Consensus 873 d~~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGl 952 (1181)
..+..++||||++|++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++. ++.+||+|||+
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~-~~~ikl~DfG~ 246 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDD-NMQIRLSDFGF 246 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-TCCEEECCCTT
T ss_pred eCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC-CCCEEEEecCc
Confidence 999999999999999999999753 35789999999999999999999999999999999999988 89999999999
Q ss_pred ccccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc
Q psy14556 953 SKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR 1032 (1181)
Q Consensus 953 Ak~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~ 1032 (1181)
+..+... .......||+.|+|||++.+....... .+....+.||+||++|+|++|..||.+....
T Consensus 247 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~--------------~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 311 (365)
T 2y7j_A 247 SCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHP--------------GYGKEVDLWACGVILFTLLAGSPPFWHRRQI 311 (365)
T ss_dssp CEECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSC--------------CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ccccCCC-cccccCCCCCCccChhhccccccccCc--------------CCCchhhHHhHHHHHHHHHHCCCCCCCCCHH
Confidence 9876543 233456799999999999643211000 1122233399999999999999999887654
Q ss_pred cccC-----CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1033 ALVA-----PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1033 ~l~~-----~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
.... ....+.......+..+..++.+|+..+|..||+..+.+
T Consensus 312 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell 358 (365)
T 2y7j_A 312 LMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQAL 358 (365)
T ss_dssp HHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 3211 11111111234567789999999999999999755443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=322.48 Aligned_cols=202 Identities=24% Similarity=0.369 Sum_probs=162.9
Q ss_pred HHhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEccccccC----
Q psy14556 801 RFLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSEE---- 874 (1181)
Q Consensus 801 ~~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~---- 874 (1181)
.+.+.|.+.+ +||+|+||.||+|.+..+++.||||++...... ..+.+.+|+.++++++||||+++++++...
T Consensus 23 ~i~~~y~~~~-~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 23 HVPDNYIIKH-LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CCCTTEEEEE-EEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred eecCCEEEEE-EEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence 3445555544 799999999999999999999999999754332 356789999999999999999999998766
Q ss_pred -CcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcc
Q psy14556 875 -GYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTS 953 (1181)
Q Consensus 875 -~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlA 953 (1181)
+.+|+||||+. ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++
T Consensus 102 ~~~~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~-~~~~kL~DFGla 176 (432)
T 3n9x_A 102 FDELYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQ-DCSVKVCDFGLA 176 (432)
T ss_dssp CCCEEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT-TCCEEECCCTTC
T ss_pred CCeEEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECC-CCCEEEccCCCc
Confidence 57999999985 699999874 346889999999999999999999999999999999999988 899999999999
Q ss_pred cccccCCC----------------------CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHH
Q psy14556 954 KRLAGLCP----------------------SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVF 1011 (1181)
Q Consensus 954 k~l~~~~~----------------------~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwS 1011 (1181)
+....... ......||+.|+|||++.... .++..+|+ ||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~~Di------------------wS 237 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQE-NYTKSIDI------------------WS 237 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCS-CCCTHHHH------------------HH
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCC-CCCccccc------------------ch
Confidence 87654321 124567999999999975332 34455555 99
Q ss_pred HHHHHHHHHhCCCCCC
Q psy14556 1012 LCVIISQLLVLTAALK 1027 (1181)
Q Consensus 1012 LGvILyELLTGk~PF~ 1027 (1181)
+||++|||++|..||.
T Consensus 238 lG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 238 TGCIFAELLNMLQSHI 253 (432)
T ss_dssp HHHHHHHHHTTCTTTC
T ss_pred HHHHHHHHHhcccccc
Confidence 9999999998544443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=307.10 Aligned_cols=247 Identities=23% Similarity=0.280 Sum_probs=198.1
Q ss_pred hhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC---------ChhHHHHHHHHHHhcC-CCCeeeEccccc
Q psy14556 803 LYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG---------DVQPLHEEIKLHSQLR-HRNIVQYLGSVS 872 (1181)
Q Consensus 803 ~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~---------~~e~f~rEi~IL~~L~-HPNIVkl~g~~~ 872 (1181)
...|... .+||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.+++++. ||||+++++++.
T Consensus 16 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 16 YENYEPK-EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp TTTEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhcccee-eeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3444443 4799999999999999999999999999765421 1356789999999995 999999999999
Q ss_pred cCCcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCc
Q psy14556 873 EEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGT 952 (1181)
Q Consensus 873 d~~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGl 952 (1181)
+.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++. ++.+||+|||+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~-~~~~kl~dfg~ 170 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD-DMNIKLTDFGF 170 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-TCCEEECCCTT
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcC-CCcEEEecccc
Confidence 999999999999999999999754 35789999999999999999999999999999999999988 88999999999
Q ss_pred ccccccCCCCCccccCCccccCchhhccC----CCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCC
Q psy14556 953 SKRLAGLCPSAETFTGTLQYMAPEVIDKG----QRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKK 1028 (1181)
Q Consensus 953 Ak~l~~~~~~~~t~~GT~~Y~APEvl~gg----~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~ 1028 (1181)
+...... .......|++.|+|||++.+. ...++... +.||+|+++|+|++|..||..
T Consensus 171 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~------------------Di~slG~~l~~l~~g~~p~~~ 231 (298)
T 1phk_A 171 SCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEV------------------DMWSTGVIMYTLLAGSPPFWH 231 (298)
T ss_dssp CEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHH------------------HHHHHHHHHHHHHHSSCSSCC
T ss_pred hhhcCCC-cccccccCCccccCHHHhccccccccccCCccc------------------ccHhHHHHHHHHHHCCCCCcC
Confidence 9876543 233445689999999998632 11222233 339999999999999999988
Q ss_pred CCccccc-----CCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1029 KTSRALV-----APPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1029 ~~~~~l~-----~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.+..... .....+.......+..+..++.+|+..+|..||+..+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 281 (298)
T 1phk_A 232 RKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 281 (298)
T ss_dssp SSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred ccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 7654431 12222222223567789999999999999999975544
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=331.69 Aligned_cols=244 Identities=20% Similarity=0.286 Sum_probs=194.0
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
++||+|+||.||+|.+. ++..||||+++... ...+.+.+|+.++++++||||+++++++. .+..++||||+++|+|.
T Consensus 194 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~ 270 (454)
T 1qcf_A 194 KKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLL 270 (454)
T ss_dssp EEEECCSSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHH
T ss_pred EEcccCCceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHH
Confidence 47999999999999985 46789999997654 35688999999999999999999999986 56789999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC-CCCccccCC
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC-PSAETFTGT 969 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~-~~~~t~~GT 969 (1181)
++++.. ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++...... .......++
T Consensus 271 ~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~~ 348 (454)
T 1qcf_A 271 DFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSA-SLVCKIADFGLARVIEDNEYTAREGAKFP 348 (454)
T ss_dssp HHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECT-TCCEEECSTTGGGGBCCHHHHTTCSSSSC
T ss_pred HHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECC-CCcEEEeeCCCceEcCCCceeccCCCccc
Confidence 999754 2235678889999999999999999999999999999999998 8999999999998764321 112233467
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--CCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--ISRSVSV 1046 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--ip~~l~~ 1046 (1181)
+.|+|||++.++.++. ..|+ ||||+++|||+| |+.||.+.+..++..... .....+.
T Consensus 349 ~~y~aPE~~~~~~~~~--~~Dv------------------wslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~ 408 (454)
T 1qcf_A 349 IKWTAPEAINFGSFTI--KSDV------------------WSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPE 408 (454)
T ss_dssp GGGSCHHHHHHCCCCH--HHHH------------------HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCT
T ss_pred ccccCHHHhccCCCCc--HHHH------------------HhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 8999999997665433 3333 999999999999 999999877655322111 1112234
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
.++..+..++.+|+..+|..||+ +.+....+..
T Consensus 409 ~~~~~l~~li~~cl~~dp~~RPt-~~~i~~~L~~ 441 (454)
T 1qcf_A 409 NCPEELYNIMMRCWKNRPEERPT-FEYIQSVLDD 441 (454)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCC-HHHHHHHHHT
T ss_pred CCCHHHHHHHHHHccCChhHCcC-HHHHHHHHHH
Confidence 57788999999999999999996 4444444444
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=339.08 Aligned_cols=199 Identities=24% Similarity=0.317 Sum_probs=160.0
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCC--CCChhHHHHHHHHHHhcCCCCeeeEccccccC------C
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKN--LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEE------G 875 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~--~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~------~ 875 (1181)
..|... .+||+|+||+||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 62 ~~y~~~-~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 62 KRYQNL-KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp TTEEEE-EEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEE-EEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 334443 37999999999999999999999999997542 22356788999999999999999999998654 4
Q ss_pred cEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccc
Q psy14556 876 YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 955 (1181)
Q Consensus 876 ~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~ 955 (1181)
.+|+||||++++ |.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~-~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-DCTLKILDFGLART 213 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TSCEEECCCCCC--
T ss_pred eEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeC-CCCEEEEEEEeeee
Confidence 579999999654 5555542 3778999999999999999999999999999999999998 89999999999987
Q ss_pred cccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCc
Q psy14556 956 LAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTS 1031 (1181)
Q Consensus 956 l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~ 1031 (1181)
.... .......||+.|+|||++.+..+ +..+|+ ||+||++|+|++|+.||.+.+.
T Consensus 214 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~--~~~~Di------------------wSlG~il~ell~g~~pF~g~~~ 268 (464)
T 3ttj_A 214 AGTS-FMMTPYVVTRYYRAPEVILGMGY--KENVDI------------------WSVGCIMGEMVRHKILFPGRDY 268 (464)
T ss_dssp ---C-CCC----CCCTTCCHHHHTTCCC--CTTHHH------------------HHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCCC-cccCCCcccccccCHHHHcCCCC--CHHHHH------------------HHHHHHHHHHHhCCCCCCCCCH
Confidence 6542 23345679999999999986643 444554 9999999999999999998764
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-33 Score=314.13 Aligned_cols=242 Identities=24% Similarity=0.335 Sum_probs=190.6
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC-----ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG-----DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~-----~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
+.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 95 (346)
T 1ua2_A 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 95 (346)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCC
Confidence 4799999999999999999999999999654321 23568899999999999999999999999999999999996
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcc
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAET 965 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t 965 (1181)
+ +|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++. ++.+||+|||+++...........
T Consensus 96 ~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg~a~~~~~~~~~~~~ 171 (346)
T 1ua2_A 96 T-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE-NGVLKLADFGLAKSFGSPNRAYTH 171 (346)
T ss_dssp E-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TCCEEECCCGGGSTTTSCCCCCCC
T ss_pred C-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcC-CCCEEEEecccceeccCCcccCCc
Confidence 5 888887643 345778889999999999999999999999999999999988 899999999999877654444555
Q ss_pred ccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC---------
Q psy14556 966 FTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA--------- 1036 (1181)
Q Consensus 966 ~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~--------- 1036 (1181)
..||+.|+|||++.+.. .++...|+ ||+||++|+|++|.+||.+.+..+...
T Consensus 172 ~~~t~~y~aPE~~~~~~-~~~~~~Di------------------wslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~ 232 (346)
T 1ua2_A 172 QVVTRWYRAPELLFGAR-MYGVGVDM------------------WAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP 232 (346)
T ss_dssp SCCCCTTCCHHHHTTCS-CCCHHHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCchHhhCCC-CCCchhhh------------------HhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 67999999999996432 23334444 999999999999999998876532100
Q ss_pred -CCCCCC------C-------------CCCCCCcchHHhhccCCCCCCCCCchhHHHHH
Q psy14556 1037 -PPQISR------S-------------VSVPGPGGINSSSSAPVTPTPHSRHISVNTNL 1075 (1181)
Q Consensus 1037 -~~~ip~------~-------------l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~ 1075 (1181)
....+. . .....+..+..++.+|+..+|.+||+..+.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000110 0 01234567888999999999999997555443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=312.89 Aligned_cols=248 Identities=27% Similarity=0.359 Sum_probs=190.0
Q ss_pred hhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCC--------CChhHHHHHHHHHHhcCCCCeeeEccccccC
Q psy14556 803 LYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--------GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEE 874 (1181)
Q Consensus 803 ~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--------~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~ 874 (1181)
.+.|.+.+ +||+|+||.||+|.+..+++.||||++..... .....+.+|+.++++++||||+++++++..+
T Consensus 9 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 9 RDEYIMSK-TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHEEEEE-EEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhceeEee-EEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 34455544 79999999999999999999999999965432 1234588999999999999999999998765
Q ss_pred CcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccC--CCeeeeecCCc
Q psy14556 875 GYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTY--SGVVKISDFGT 952 (1181)
Q Consensus 875 ~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~--~g~vKLiDFGl 952 (1181)
+ .++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.. +..+||+|||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred c-eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 5 8999999999999998874 3467899999999999999999999999999999999999862 22599999999
Q ss_pred ccccccCCCCCccccCCccccCchhhcc-CCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCc
Q psy14556 953 SKRLAGLCPSAETFTGTLQYMAPEVIDK-GQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTS 1031 (1181)
Q Consensus 953 Ak~l~~~~~~~~t~~GT~~Y~APEvl~g-g~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~ 1031 (1181)
++..... .......||+.|+|||++.+ +...++...|+ ||+|+++|+|++|..||.....
T Consensus 164 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di------------------~slG~il~~l~~g~~pf~~~~~ 224 (322)
T 2ycf_A 164 SKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDC------------------WSLGVILFICLSGYPPFSEHRT 224 (322)
T ss_dssp CEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHH------------------HHHHHHHHHHHHSSCSSCSTTC
T ss_pred ceecccc-cccccccCCcCccCchhhccCCCCCCCchhhH------------------HHHHHHHHHHHhCCCCCcccch
Confidence 9876432 11223468999999999853 11223333444 9999999999999999987654
Q ss_pred cc-cc-----CCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1032 RA-LV-----APPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1032 ~~-l~-----~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
.. +. .............+..+..++.+|+..+|..||+..+.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l 273 (322)
T 2ycf_A 225 QVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 273 (322)
T ss_dssp SSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHh
Confidence 32 10 111111112235677888999999999999999866553
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=326.96 Aligned_cols=250 Identities=21% Similarity=0.228 Sum_probs=192.1
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCC-CCChhHHHHHHHHHHhcCCCCeeeEccccccCC--cEEEEEeecCC
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKN-LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEG--YFKIFMEQVPG 886 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~-~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~--~l~LVmEy~~g 886 (1181)
.++||+|+||+||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+ ..++||||+++
T Consensus 14 ~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~ 93 (396)
T 4eut_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTT
T ss_pred EEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCC
Confidence 347999999999999999999999999997543 334677889999999999999999999987654 78999999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccc----ccCCCeeeeecCCcccccccCCCC
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLV----NTYSGVVKISDFGTSKRLAGLCPS 962 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL----d~~~g~vKLiDFGlAk~l~~~~~~ 962 (1181)
|+|.+++........+++..++.++.||+.||+|||++||+||||||+|||+ +. ++.+||+|||+++...... .
T Consensus 94 g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~-~~~~kL~DFG~a~~~~~~~-~ 171 (396)
T 4eut_A 94 GSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDG-QSVYKLTDFGAARELEDDE-Q 171 (396)
T ss_dssp EEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTS-CEEEEECCGGGCEECCCGG-G
T ss_pred CCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCC-ceeEEEecCCCceEccCCC-c
Confidence 9999999865444558899999999999999999999999999999999998 54 6789999999998765432 2
Q ss_pred CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc----c----
Q psy14556 963 AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA----L---- 1034 (1181)
Q Consensus 963 ~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~----l---- 1034 (1181)
.....||+.|+|||++.+...... ....+....+.||+||++|+|++|+.||....... +
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~------------~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~ 239 (396)
T 4eut_A 172 FVSLYGTEEYLHPDMYERAVLRKD------------HQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239 (396)
T ss_dssp SSCSSSCCTTCCHHHHHHHCC--C------------HHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred cccccCCccccCHHHhhccccccc------------cccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence 334569999999999864211000 01123334455999999999999999997543211 0
Q ss_pred -cCCC---------------------CCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1035 -VAPP---------------------QISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1035 -~~~~---------------------~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
...+ ..+...+...+..+..++.+|++.||.+|++..+.
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~ 300 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHH
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHH
Confidence 0000 01111122234567779999999999999975443
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=309.55 Aligned_cols=244 Identities=23% Similarity=0.260 Sum_probs=185.8
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEcccc-------------
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV------------- 871 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~------------- 871 (1181)
.|... ++||+|+||.||+|.+..+++.||+|++........+.+.+|+.++++++||||+++++++
T Consensus 12 ~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 12 RYMDL-KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TEEEE-EECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred ceeEE-EEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 34443 3799999999999999999999999999766555567899999999999999999999876
Q ss_pred -ccCCcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecC
Q psy14556 872 -SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDF 950 (1181)
Q Consensus 872 -~d~~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDF 950 (1181)
.+.+..++||||++ |+|.+++... .+++..++.++.||+.||+|||++||+||||||+||+++..++.+||+||
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred ccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence 34467899999996 6999988642 57889999999999999999999999999999999999864779999999
Q ss_pred CcccccccCC---CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCC
Q psy14556 951 GTSKRLAGLC---PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALK 1027 (1181)
Q Consensus 951 GlAk~l~~~~---~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~ 1027 (1181)
|+++...... .......+++.|+|||++.+.. .++...|+ ||+|+++|+|++|+.||.
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di------------------~slG~il~el~~g~~pf~ 226 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPN-NYTKAIDM------------------WAAGCIFAEMLTGKTLFA 226 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTT-CCCHHHHH------------------HHHHHHHHHHHHSSCSSC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcc-cCCchhhh------------------HhHHHHHHHHHhCCCCCC
Confidence 9998764321 1223345799999999986422 23333333 999999999999999999
Q ss_pred CCCcccccCC-------------------------------CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1028 KKTSRALVAP-------------------------------PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1028 ~~~~~~l~~~-------------------------------~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
+.+....... ...........+..+..++.+|++.+|.+||+..+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 303 (320)
T 2i6l_A 227 GAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEA 303 (320)
T ss_dssp CSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred CCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHH
Confidence 8765331100 000001123467889999999999999999975555
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=307.47 Aligned_cols=242 Identities=22% Similarity=0.268 Sum_probs=187.8
Q ss_pred eeecccCceEEEEEEEcC---CCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCC
Q psy14556 811 IELGKGSYGVVYAARELD---RQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~---tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
+.||+|+||.||+|.+.. ++..||+|.+..... ...+.+.+|+.++++++||||+++++++.++ ..++||||+++
T Consensus 18 ~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~ 96 (281)
T 3cc6_A 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPY 96 (281)
T ss_dssp EEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEECCTT
T ss_pred EEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEecCCC
Confidence 479999999999998654 345799999976532 3356789999999999999999999998754 56899999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC-CCcc
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP-SAET 965 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~-~~~t 965 (1181)
++|.+++... ...+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||++........ ....
T Consensus 97 ~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~ 173 (281)
T 3cc6_A 97 GELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVAS-PECVKLGDFGLSRYIEDEDYYKASV 173 (281)
T ss_dssp CBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEE-TTEEEECCCCGGGCC---------C
T ss_pred CCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECC-CCcEEeCccCCCccccccccccccc
Confidence 9999999754 235778999999999999999999999999999999999988 89999999999987654322 1223
Q ss_pred ccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--CCC
Q psy14556 966 FTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--ISR 1042 (1181)
Q Consensus 966 ~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--ip~ 1042 (1181)
..+++.|+|||++.+..++. ..|+ ||+|+++|+|++ |+.||.......+..... ...
T Consensus 174 ~~~~~~y~aPE~~~~~~~~~--~~Di------------------~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~ 233 (281)
T 3cc6_A 174 TRLPIKWMSPESINFRRFTT--ASDV------------------WMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL 233 (281)
T ss_dssp CCCCGGGCCHHHHHHCCCCH--HHHH------------------HHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC
T ss_pred CCCCcceeCchhhccCCCCc--hhcc------------------HHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC
Confidence 45788999999997654333 3333 999999999998 999998766554321111 111
Q ss_pred CCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHh
Q psy14556 1043 SVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVC 1077 (1181)
Q Consensus 1043 ~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~a 1077 (1181)
..+...+..+..++.+|+..+|..||+ +.+.+..
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rps-~~ell~~ 267 (281)
T 3cc6_A 234 PKPDLCPPVLYTLMTRCWDYDPSDRPR-FTELVCS 267 (281)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCC-HHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHccCCchhCcC-HHHHHHH
Confidence 223356778999999999999999995 4443333
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=306.22 Aligned_cols=242 Identities=25% Similarity=0.273 Sum_probs=188.8
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCC---CCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCC
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEK---NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~---~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
.++||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 95 (276)
T 2h6d_A 16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG 95 (276)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCC
Confidence 34799999999999999999999999999643 233466899999999999999999999999999999999999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccc
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF 966 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~ 966 (1181)
++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++. ++.+||+|||++...... ......
T Consensus 96 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~-~~~~~l~dfg~~~~~~~~-~~~~~~ 170 (276)
T 2h6d_A 96 GELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDA-HMNAKIADFGLSNMMSDG-EFLRTS 170 (276)
T ss_dssp CBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECT-TSCEEECCCCGGGCCCC--------
T ss_pred CcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECC-CCCEEEeecccccccCCC-cceecc
Confidence 9999999754 25788999999999999999999999999999999999987 889999999999876543 222345
Q ss_pred cCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-CCCCCC
Q psy14556 967 TGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-ISRSVS 1045 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-ip~~l~ 1045 (1181)
.|++.|+|||++.+... .+...|+ ||+|+++|+|++|+.||.......+..... -....+
T Consensus 171 ~~~~~y~aPE~~~~~~~-~~~~~Di------------------~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 231 (276)
T 2h6d_A 171 CGSPNYAAPEVISGRLY-AGPEVDI------------------WSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP 231 (276)
T ss_dssp ------CCTGGGTTSCC-CHHHHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred cCCccccCHHHHcCCCC-CCccchH------------------HHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc
Confidence 68999999999975432 1222333 999999999999999998876544322111 011123
Q ss_pred CCCCcchHHhhccCCCCCCCCCchhHHHHH
Q psy14556 1046 VPGPGGINSSSSAPVTPTPHSRHISVNTNL 1075 (1181)
Q Consensus 1046 ~~~p~~L~~li~r~la~dPs~Rp~s~~~~~ 1075 (1181)
...+..+..++.+|+..+|..||+..+...
T Consensus 232 ~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 232 EYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 345778899999999999999998665533
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=306.64 Aligned_cols=242 Identities=19% Similarity=0.268 Sum_probs=191.4
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
++||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+ +..++||||+++++|.
T Consensus 19 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~ 95 (279)
T 1qpc_A 19 ERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLV 95 (279)
T ss_dssp EEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHH
T ss_pred eeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHH
Confidence 47999999999999875 56789999996543 346789999999999999999999999874 4689999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC-CCccccCC
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP-SAETFTGT 969 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~-~~~t~~GT 969 (1181)
+++... ....+++..++.++.|++.||+|||++||+||||||+||+++. ++.+||+|||++........ ......++
T Consensus 96 ~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 173 (279)
T 1qpc_A 96 DFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD-TLSCKIADFGLARLIEDNEYTAREGAKFP 173 (279)
T ss_dssp HHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-TSCEEECCCTTCEECSSSCEECCTTCCCC
T ss_pred HHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcC-CCCEEECCCcccccccCcccccccCCCCc
Confidence 999753 2235788999999999999999999999999999999999987 88999999999987654221 12234467
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCC--CCCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPP--QISRSVSV 1046 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~--~ip~~l~~ 1046 (1181)
+.|+|||++.++.++. ..|+ ||+|+++|+|++ |+.||.+.+..++.... ......+.
T Consensus 174 ~~y~aPE~~~~~~~~~--~~Di------------------~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (279)
T 1qpc_A 174 IKWTAPEAINYGTFTI--KSDV------------------WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 233 (279)
T ss_dssp TTTSCHHHHHHCEECH--HHHH------------------HHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred cCccChhhhccCCCCc--hhhh------------------HHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcc
Confidence 8999999997654332 2333 999999999999 99999987764432111 11122334
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
..+..+..++.+|++.+|..||+ +.+....+
T Consensus 234 ~~~~~l~~li~~~l~~~p~~Rps-~~~l~~~l 264 (279)
T 1qpc_A 234 NCPEELYQLMRLCWKERPEDRPT-FDYLRSVL 264 (279)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCC-HHHHHHHH
T ss_pred cccHHHHHHHHHHhccChhhCCC-HHHHHHHH
Confidence 56788999999999999999995 44443333
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=307.52 Aligned_cols=245 Identities=18% Similarity=0.253 Sum_probs=188.0
Q ss_pred eeecccCceEEEEEEEcCC---CeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEcccc-ccCCcEEEEEeecC
Q psy14556 811 IELGKGSYGVVYAARELDR---QVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSV-SEEGYFKIFMEQVP 885 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~t---g~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~-~d~~~l~LVmEy~~ 885 (1181)
++||+|+||.||+|.+..+ ...||+|.+..... ...+.+.+|+.++++++||||+++++++ ..++..++||||++
T Consensus 31 ~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~ 110 (298)
T 3f66_A 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 110 (298)
T ss_dssp EEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCT
T ss_pred ceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCC
Confidence 4799999999999986543 34689999875432 2356789999999999999999999985 55678899999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC----C
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC----P 961 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~----~ 961 (1181)
+++|.+++... ...+++..++.++.|++.||+|||++||+||||||+||+++. ++.+||+|||+++...... .
T Consensus 111 ~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~-~~~~kl~Dfg~a~~~~~~~~~~~~ 187 (298)
T 3f66_A 111 HGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEYYSVH 187 (298)
T ss_dssp TCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT-TCCEEECSCGGGCCCSCGGGCBC-
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECC-CCCEEECcccccccccccchhccc
Confidence 99999999753 345678899999999999999999999999999999999987 8899999999998664322 1
Q ss_pred CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCC--
Q psy14556 962 SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPP-- 1038 (1181)
Q Consensus 962 ~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~-- 1038 (1181)
......+|+.|+|||.+.+..++.+ .|+ ||+|+++|+|++ |.+||.+.+...+....
T Consensus 188 ~~~~~~~~~~y~aPE~~~~~~~~~~--~Di------------------~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~ 247 (298)
T 3f66_A 188 NKTGAKLPVKWMALESLQTQKFTTK--SDV------------------WSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247 (298)
T ss_dssp ----CCBCGGGSCHHHHHHCCCCHH--HHH------------------HHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHT
T ss_pred cccCCCCCccccChHHhcCCCCChH--HHH------------------HHHHHHHHHHHhCCCCCCccCCHHHHHHHHhc
Confidence 1223457889999999976544333 333 999999999999 56777766654432111
Q ss_pred CCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcc
Q psy14556 1039 QISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTG 1079 (1181)
Q Consensus 1039 ~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~ 1079 (1181)
......+...+..+..++.+|++.+|..||+ +.+.+..+.
T Consensus 248 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~ell~~L~ 287 (298)
T 3f66_A 248 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPS-FSELVSRIS 287 (298)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-HHHHHHHHH
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCChhhCcC-HHHHHHHHH
Confidence 1112223456788999999999999999985 555444443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=321.79 Aligned_cols=239 Identities=14% Similarity=0.146 Sum_probs=172.8
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC---ChhHHHHHHHHHHhc--CCCCeeeEcccc-------ccC---
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG---DVQPLHEEIKLHSQL--RHRNIVQYLGSV-------SEE--- 874 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~---~~e~f~rEi~IL~~L--~HPNIVkl~g~~-------~d~--- 874 (1181)
..+||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.+++.+ +||||++++..+ ...
T Consensus 67 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~ 146 (371)
T 3q60_A 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSC
T ss_pred eeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCC
Confidence 34799999999999999999999999999876432 245677885555544 699988865333 221
Q ss_pred --------------CcEEEEEeecCCCCcccchhcccCCCCCChHHH------HHHHHHHHhhhhhccccceecccCCCC
Q psy14556 875 --------------GYFKIFMEQVPGGSLSTLLRVKWGPLKENESTM------SFYTKQILEGLKYLHGQKIVHRDIKGD 934 (1181)
Q Consensus 875 --------------~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i------~~Ia~QIa~AL~yLHs~gIVHrDLKP~ 934 (1181)
..+|+||||++ ++|.+++..... .+.+..+ ..++.||+.||+|||++||+||||||+
T Consensus 147 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~ 223 (371)
T 3q60_A 147 PFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPD 223 (371)
T ss_dssp SSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHH
Confidence 34899999997 899999986422 2234444 567799999999999999999999999
Q ss_pred CcccccCCCeeeeecCCcccccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHH
Q psy14556 935 NVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCV 1014 (1181)
Q Consensus 935 NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGv 1014 (1181)
|||++. ++.+||+|||+++..... .....+|+.|+|||++.++...++..+|+ ||+||
T Consensus 224 NIll~~-~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~Di------------------wSlG~ 281 (371)
T 3q60_A 224 NLFIMP-DGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATFTHALNA------------------WQLGL 281 (371)
T ss_dssp GEEECT-TSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEECCHHHHH------------------HHHHH
T ss_pred HEEECC-CCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCcCccccH------------------HHHHH
Confidence 999998 899999999999876432 21345779999999997533334444444 99999
Q ss_pred HHHHHHhCCCCCCCCCcccccC----------CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1015 IISQLLVLTAALKKKTSRALVA----------PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1015 ILyELLTGk~PF~~~~~~~l~~----------~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
++|+|++|+.||.+........ ............+..+..++.+|+..+|..||+..+.
T Consensus 282 il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 350 (371)
T 3q60_A 282 SIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA 350 (371)
T ss_dssp HHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHH
T ss_pred HHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 9999999999999875432110 1111112223567889999999999999999986554
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=314.77 Aligned_cols=252 Identities=17% Similarity=0.180 Sum_probs=193.2
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccc----cCCcEEEEEeecC
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVS----EEGYFKIFMEQVP 885 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~----d~~~l~LVmEy~~ 885 (1181)
.++||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++. .....++||||++
T Consensus 34 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~ 113 (317)
T 2buj_A 34 IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFK 113 (317)
T ss_dssp EEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCT
T ss_pred EEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCC
Confidence 347999999999999999999999999997665555678999999999999999999999986 3457899999999
Q ss_pred CCCcccchhccc-CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC--
Q psy14556 886 GGSLSTLLRVKW-GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS-- 962 (1181)
Q Consensus 886 gGSL~dlL~~~~-~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~-- 962 (1181)
+++|.+++.... ....+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++.........
T Consensus 114 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~-~~~~kl~dfg~~~~~~~~~~~~~ 192 (317)
T 2buj_A 114 RGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGD-EGQPVLMDLGSMNQACIHVEGSR 192 (317)
T ss_dssp TCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT-TSCEEECCCSSCEESCEEEESHH
T ss_pred CCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC-CCCEEEEecCcchhccccccccc
Confidence 999999987521 2356789999999999999999999999999999999999987 889999999988765321111
Q ss_pred -------CccccCCccccCchhhccCCC-CCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc--
Q psy14556 963 -------AETFTGTLQYMAPEVIDKGQR-GYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR-- 1032 (1181)
Q Consensus 963 -------~~t~~GT~~Y~APEvl~gg~~-~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~-- 1032 (1181)
.....||+.|+|||++.+... .++...| .||+|+++|+|++|+.||......
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~D------------------i~slG~il~el~~g~~p~~~~~~~~~ 254 (317)
T 2buj_A 193 QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTD------------------VWSLGCVLYAMMFGEGPYDMVFQKGD 254 (317)
T ss_dssp HHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHH------------------HHHHHHHHHHHHHSSCTTHHHHHTTS
T ss_pred ccccccccccccCCcccCCHhHhccCCCcCCCchhh------------------HHHHHHHHHHHHhCCCChhhhhcccc
Confidence 012347999999999864321 1223333 399999999999999999753211
Q ss_pred cc--cCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcccC
Q psy14556 1033 AL--VAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGNN 1081 (1181)
Q Consensus 1033 ~l--~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~~ 1081 (1181)
.+ ..............+..+..++.+|++.+|..|| ++.+.+..+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~~ll~~L~~~ 304 (317)
T 2buj_A 255 SVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRP-HIPLLLSQLEAL 304 (317)
T ss_dssp CHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSC-CHHHHHHHHHHT
T ss_pred hhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCC-CHHHHHHHhhhc
Confidence 10 0001111222345678899999999999999999 466666666553
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-34 Score=321.18 Aligned_cols=237 Identities=24% Similarity=0.324 Sum_probs=191.4
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
.+||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++++|
T Consensus 39 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 118 (360)
T 3eqc_A 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL 118 (360)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred eeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCH
Confidence 379999999999999999999999999976532 2356789999999999999999999999999999999999999999
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhcccc-ceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ-KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~-gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
.+++... ..+++..+..++.|++.||.|||++ ||+||||||+||+++. ++.+||+|||++...... ......|
T Consensus 119 ~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~--~~~~~~g 192 (360)
T 3eqc_A 119 DQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDS--MANSFVG 192 (360)
T ss_dssp HHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECT-TCCEEECCCCCCHHHHHH--C----CC
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECC-CCCEEEEECCCCcccccc--cccCCCC
Confidence 9999754 2577899999999999999999996 9999999999999998 889999999999765432 2234569
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCC-----------
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAP----------- 1037 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~----------- 1037 (1181)
|+.|+|||++.+..++ ...|+ ||+|+++|+|++|+.||...+...+...
T Consensus 193 t~~y~aPE~~~~~~~~--~~~Di------------------~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 252 (360)
T 3eqc_A 193 TRSYMSPERLQGTHYS--VQSDI------------------WSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252 (360)
T ss_dssp CCTTCCHHHHTTCCCS--HHHHH------------------HHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------
T ss_pred CCCeECHHHHcCCCCC--chhhH------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCC
Confidence 9999999999765433 33333 9999999999999999987664332000
Q ss_pred ----------------------------------CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1038 ----------------------------------PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1038 ----------------------------------~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
...+.......+..+..++.+|+..+|.+||+..+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 322 (360)
T 3eqc_A 253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 322 (360)
T ss_dssp ---------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHH
T ss_pred CCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHH
Confidence 001111112346678889999999999999986555
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=328.85 Aligned_cols=245 Identities=12% Similarity=0.067 Sum_probs=178.2
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCC---CCCChhHHHHHH---HHHHhcCCCCeeeEc-------cccccCC-
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEK---NLGDVQPLHEEI---KLHSQLRHRNIVQYL-------GSVSEEG- 875 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~---~~~~~e~f~rEi---~IL~~L~HPNIVkl~-------g~~~d~~- 875 (1181)
.++||+|+||.||+|++..+++.||||++... .....+.+.+|+ .++++++||||++++ +++.+.+
T Consensus 78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 157 (377)
T 3byv_A 78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157 (377)
T ss_dssp EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence 34799999999999999899999999999744 223357789999 455556899999998 4444332
Q ss_pred ----------------cEEEEEeecCCCCcccchhcccC----CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCC
Q psy14556 876 ----------------YFKIFMEQVPGGSLSTLLRVKWG----PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDN 935 (1181)
Q Consensus 876 ----------------~l~LVmEy~~gGSL~dlL~~~~~----~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~N 935 (1181)
..|+||||+ +|+|.+++..... ...+++..++.|+.||+.||+|||++||+||||||+|
T Consensus 158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~N 236 (377)
T 3byv_A 158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVD 236 (377)
T ss_dssp CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 388999999 7899999985411 1122347788899999999999999999999999999
Q ss_pred cccccCCCeeeeecCCcccccccCCCCCccccCCccccCchhhccCCCC-CCCccccccCCCccccccccccchhHHHHH
Q psy14556 936 VLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRG-YGAPVRQRDKINPCCRIEYKKMKINVFLCV 1014 (1181)
Q Consensus 936 ILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~-~ssDVDi~~dI~~~~~i~~~~~k~DwSLGv 1014 (1181)
||++. ++.+||+|||+++.... ......| +.|+|||++.+.... ... .....++...+.|||||
T Consensus 237 Ill~~-~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~----------~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 237 IVLDQ-RGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHR----------DRRTLMTFSFDAWALGL 301 (377)
T ss_dssp EEECT-TCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHH----------CCEEECCHHHHHHHHHH
T ss_pred EEEcC-CCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccc----------cccccCChhhhHHHHHH
Confidence 99997 89999999999986432 2334567 999999999765000 000 00001222333399999
Q ss_pred HHHHHHhCCCCCCCCCcccccCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1015 IISQLLVLTAALKKKTSRALVAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1015 ILyELLTGk~PF~~~~~~~l~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
++|+|++|+.||.+........... ......+..+..++.+|+..+|..||+..+.
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~ 357 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEWIF---RSCKNIPQPVRALLEGFLRYPKEDRLLPLQA 357 (377)
T ss_dssp HHHHHHHSSCCC------CCSGGGG---SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHH
T ss_pred HHHHHHHCCCCCcccccccchhhhh---hhccCCCHHHHHHHHHHcCCCchhCCCHHHH
Confidence 9999999999998876544322211 1224677889999999999999999976554
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=317.29 Aligned_cols=245 Identities=21% Similarity=0.222 Sum_probs=187.5
Q ss_pred eeecccCceEEEEEEEcCCCeE----EEEEEecCC-CCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 811 IELGKGSYGVVYAARELDRQVK----LAIKEIPEK-NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~----VAIKii~~~-~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
.+||+|+||.||+|.+..+++. |++|.+... .....+.+.+|+.++++++||||+++++++.... .++|+||++
T Consensus 21 ~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~ 99 (327)
T 3lzb_A 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMP 99 (327)
T ss_dssp EEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCS
T ss_pred EEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecC
Confidence 3799999999999999887764 577777544 3345678999999999999999999999998765 889999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC--C
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS--A 963 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~--~ 963 (1181)
+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++........ .
T Consensus 100 ~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~-~~~~kL~DfG~a~~~~~~~~~~~~ 176 (327)
T 3lzb_A 100 FGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT-PQHVKITDFGLAKLLGAEEKEYHA 176 (327)
T ss_dssp SCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE-TTEEEECCTTC-------------
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcC-CCCEEEccCcceeEccCccccccc
Confidence 99999999754 235788999999999999999999999999999999999988 899999999999876533221 2
Q ss_pred ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--C
Q psy14556 964 ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--I 1040 (1181)
Q Consensus 964 ~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--i 1040 (1181)
....+|+.|+|||++.+..++. ..|+ ||+|+++|+|++ |..||.+.....+..... .
T Consensus 177 ~~~~~t~~y~aPE~~~~~~~~~--~~Di------------------~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~ 236 (327)
T 3lzb_A 177 EGGKVPIKWMALESILHRIYTH--QSDV------------------WSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236 (327)
T ss_dssp ---CCCGGGSCHHHHHHCCCCH--HHHH------------------HHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred cCCCccccccCHHHHcCCCCCh--HHHH------------------HHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC
Confidence 2334678999999998654433 3333 999999999999 999999887655422111 1
Q ss_pred CCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1041 SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1041 p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
....+...+..+..++.+|+..+|..||+ +.+.+..+..
T Consensus 237 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~ell~~L~~ 275 (327)
T 3lzb_A 237 RLPQPPICTIDVYMIMRKCWMIDADSRPK-FRELIIEFSK 275 (327)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCC-HHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcCCChhHCcC-HHHHHHHHHH
Confidence 12223456778899999999999999986 4444444443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=309.87 Aligned_cols=246 Identities=17% Similarity=0.187 Sum_probs=183.6
Q ss_pred ceeecccCceEEEEEEEcC---CCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEccccccCC-----cEEE
Q psy14556 810 RIELGKGSYGVVYAARELD---RQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEG-----YFKI 879 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~---tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~-----~l~L 879 (1181)
.+.||+|+||.||+|.+.. ++..||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+ ..++
T Consensus 39 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 118 (313)
T 3brb_A 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMV 118 (313)
T ss_dssp EEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEE
T ss_pred ccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEE
Confidence 3479999999999998765 5668999999755332 3467899999999999999999999987654 4599
Q ss_pred EEeecCCCCcccchhcc---cCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccccc
Q psy14556 880 FMEQVPGGSLSTLLRVK---WGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956 (1181)
Q Consensus 880 VmEy~~gGSL~dlL~~~---~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l 956 (1181)
||||+++++|.+++... .....+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++..
T Consensus 119 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~-~~~~kl~Dfg~~~~~ 197 (313)
T 3brb_A 119 ILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRD-DMTVCVADFGLSKKI 197 (313)
T ss_dssp EEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECT-TSCEEECSCSCC---
T ss_pred EEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC-CCcEEEeecCcceec
Confidence 99999999999998532 23456889999999999999999999999999999999999988 889999999999876
Q ss_pred ccCC--CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q psy14556 957 AGLC--PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRA 1033 (1181)
Q Consensus 957 ~~~~--~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~ 1033 (1181)
.... .......+++.|+|||.+.+..++. ..|+ ||+|+++|+|++ |..||.+.....
T Consensus 198 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--~~Di------------------~slG~il~el~~~g~~p~~~~~~~~ 257 (313)
T 3brb_A 198 YSGDYYRQGRIAKMPVKWIAIESLADRVYTS--KSDV------------------WAFGVTMWEIATRGMTPYPGVQNHE 257 (313)
T ss_dssp -------------CCGGGSCHHHHHSSCCCH--HHHH------------------HHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred ccccccCcccccCCCccccCchhhcCCCccc--hhhh------------------HHHHHHHHHHHhcCCCCCccCCHHH
Confidence 4332 1122345788999999997654333 3333 999999999999 899998877655
Q ss_pred ccCCC--CCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHh
Q psy14556 1034 LVAPP--QISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVC 1077 (1181)
Q Consensus 1034 l~~~~--~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~a 1077 (1181)
+.... ......+...+..+..++.+|+..+|..||+ +.+.+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~~l~~~ 302 (313)
T 3brb_A 258 MYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPT-FSVLRLQ 302 (313)
T ss_dssp HHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCC-HHHHHHH
T ss_pred HHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcC-HHHHHHH
Confidence 32111 1112233456788999999999999999995 4444333
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=306.28 Aligned_cols=239 Identities=18% Similarity=0.257 Sum_probs=188.5
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcC-CCCeeeEcccccc--CCcEEEEE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR-HRNIVQYLGSVSE--EGYFKIFM 881 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~-HPNIVkl~g~~~d--~~~l~LVm 881 (1181)
.|.+. ++||+|+||.||+|.+..+++.||+|++... ..+.+.+|+.++++++ ||||+++++++.+ ....++||
T Consensus 37 ~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 37 DYQLV-RKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred ceEEE-EEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 34443 3799999999999999999999999999643 3577999999999997 9999999999987 67899999
Q ss_pred eecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC
Q psy14556 882 EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP 961 (1181)
Q Consensus 882 Ey~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~ 961 (1181)
||+++++|.++++ .+++..++.++.||+.||+|||++||+||||||+|||++..+..+||+|||+++......
T Consensus 113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~- 185 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 185 (330)
T ss_dssp ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC-
T ss_pred eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC-
Confidence 9999999999886 367889999999999999999999999999999999998734499999999998765432
Q ss_pred CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc--c-----
Q psy14556 962 SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA--L----- 1034 (1181)
Q Consensus 962 ~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~--l----- 1034 (1181)
......|++.|+|||++.+.. .++...|+ ||+||++|+|++|+.||....... +
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di------------------wslG~il~~ll~g~~p~~~~~~~~~~l~~~~~ 246 (330)
T 3nsz_A 186 EYNVRVASRYFKGPELLVDYQ-MYDYSLDM------------------WSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 246 (330)
T ss_dssp CCCSCCSCGGGCCHHHHTTCC-CCCTHHHH------------------HHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHH
T ss_pred ccccccccccccChhhhcCCC-cCCchhhH------------------HHHHHHHHHHHhCCCCcccCCchHHHHHHHHH
Confidence 234456899999999996522 23334444 999999999999999995433210 0
Q ss_pred ----------------cCC------------CC----CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1035 ----------------VAP------------PQ----ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1035 ----------------~~~------------~~----ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
... .. .........+..+..++.+|+..||.+||+..+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~ 317 (330)
T 3nsz_A 247 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 317 (330)
T ss_dssp HHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred hcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHH
Confidence 000 00 0111112257778889999999999999975444
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=324.57 Aligned_cols=207 Identities=24% Similarity=0.390 Sum_probs=155.1
Q ss_pred HhhhcccCceeecccCceEEEEEEEc--CCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEcccc--ccCCcE
Q psy14556 802 FLYLFALNRIELGKGSYGVVYAAREL--DRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV--SEEGYF 877 (1181)
Q Consensus 802 ~~~~~~l~~~kIG~G~fG~VYka~d~--~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~--~d~~~l 877 (1181)
+.+.|.+...+||+|+||+||+|++. .+++.||+|++.... ..+.+.+|+.++++++||||+++++++ ......
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 34556666668999999999999976 568899999996543 346788999999999999999999999 456789
Q ss_pred EEEEeecCCCCcccchhccc------CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccc----ccCCCeeee
Q psy14556 878 KIFMEQVPGGSLSTLLRVKW------GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLV----NTYSGVVKI 947 (1181)
Q Consensus 878 ~LVmEy~~gGSL~dlL~~~~------~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL----d~~~g~vKL 947 (1181)
++||||+. ++|.+++.... ....+++..++.++.||+.||+|||++||+||||||+|||+ +. ++.+||
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~-~~~~kl 173 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPE-RGRVKI 173 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTT-TTCEEE
T ss_pred EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCC-CCcEEE
Confidence 99999995 57777775321 22358899999999999999999999999999999999999 44 689999
Q ss_pred ecCCcccccccCC---CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCC
Q psy14556 948 SDFGTSKRLAGLC---PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTA 1024 (1181)
Q Consensus 948 iDFGlAk~l~~~~---~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~ 1024 (1181)
+|||+++...... .......||+.|+|||++.+.. .++..+|+ ||+||++|+|++|+.
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~Di------------------wSlG~il~ell~g~~ 234 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR-HYTKAIDI------------------WAIGCIFAELLTSEP 234 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCC-SCCHHHHH------------------HHHHHHHHHHHHSSC
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCC-cccchhhh------------------HHHHHHHHHHHhCCC
Confidence 9999998765422 1223456899999999997532 24444444 999999999999999
Q ss_pred CCCCCCc
Q psy14556 1025 ALKKKTS 1031 (1181)
Q Consensus 1025 PF~~~~~ 1031 (1181)
||.+...
T Consensus 235 pf~~~~~ 241 (405)
T 3rgf_A 235 IFHCRQE 241 (405)
T ss_dssp TTCCCC-
T ss_pred CCCCccc
Confidence 9987654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=311.33 Aligned_cols=251 Identities=21% Similarity=0.252 Sum_probs=193.3
Q ss_pred hcccCceeecccCceEEEEEEE-----cCCCeEEEEEEecCCCCC-ChhHHHHHHHHHHhc-CCCCeeeEccccccC-Cc
Q psy14556 805 LFALNRIELGKGSYGVVYAARE-----LDRQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQL-RHRNIVQYLGSVSEE-GY 876 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d-----~~tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~-~~ 876 (1181)
.|.+ ..+||+|+||.||+|.+ ..+++.||+|++...... ..+.+.+|+.+++++ +||||+++++++... +.
T Consensus 28 ~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 106 (316)
T 2xir_A 28 RLKL-GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 106 (316)
T ss_dssp GEEE-EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred heee-eeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence 3444 34799999999999985 356789999999765332 345789999999999 799999999998765 45
Q ss_pred EEEEEeecCCCCcccchhcccC-------------CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCC
Q psy14556 877 FKIFMEQVPGGSLSTLLRVKWG-------------PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSG 943 (1181)
Q Consensus 877 l~LVmEy~~gGSL~dlL~~~~~-------------~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g 943 (1181)
+++||||+++++|.+++..... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~-~~ 185 (316)
T 2xir_A 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE-KN 185 (316)
T ss_dssp CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG-GG
T ss_pred eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC-CC
Confidence 9999999999999999985422 122788999999999999999999999999999999999987 78
Q ss_pred eeeeecCCcccccccCCCC--CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh
Q psy14556 944 VVKISDFGTSKRLAGLCPS--AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV 1021 (1181)
Q Consensus 944 ~vKLiDFGlAk~l~~~~~~--~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT 1021 (1181)
.+||+|||+++........ .....+|+.|+|||++.+..++. ..|+ ||+|+++|+|++
T Consensus 186 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~--~~Di------------------~slG~il~~l~t 245 (316)
T 2xir_A 186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI--QSDV------------------WSFGVLLWEIFS 245 (316)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCH--HHHH------------------HHHHHHHHHHHT
T ss_pred CEEECCCccccccccCccceeccCCCcceeecCchhhccccccc--hhHH------------------HHHHHHHHHHHh
Confidence 9999999999866443221 22345788999999997654333 3333 999999999998
Q ss_pred -CCCCCCCCCcccccC-C--CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1022 -LTAALKKKTSRALVA-P--PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1022 -Gk~PF~~~~~~~l~~-~--~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
|..||.+........ . .......+...+..+..++.+|++.+|..||+ +.+.+..+
T Consensus 246 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~ell~~L 305 (316)
T 2xir_A 246 LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT-FSELVEHL 305 (316)
T ss_dssp TSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-HHHHHHHH
T ss_pred CCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcC-HHHHHHHH
Confidence 999998866433110 0 00111223346778999999999999999995 55544433
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=329.77 Aligned_cols=244 Identities=20% Similarity=0.263 Sum_probs=189.6
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
.+||+|+||.||+|.+.. +..||||+++... ...+.+.+|+.++++++||||+++++++.+ +..++||||+++|+|.
T Consensus 190 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~ 266 (452)
T 1fmk_A 190 VKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 266 (452)
T ss_dssp EEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHH
T ss_pred eeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHH
Confidence 479999999999999865 4679999997654 345789999999999999999999999876 6789999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC-CCccccCC
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP-SAETFTGT 969 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~-~~~t~~GT 969 (1181)
+++... ....+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++....... ......++
T Consensus 267 ~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~~~ 344 (452)
T 1fmk_A 267 DFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE-NLVCKVADFGLARLIEDNEYTARQGAKFP 344 (452)
T ss_dssp HHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG-GGCEEECCCCTTC--------------CC
T ss_pred HHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECC-CCCEEECCCccceecCCCceecccCCccc
Confidence 999753 2235778899999999999999999999999999999999987 78999999999987653221 12233467
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--CCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--ISRSVSV 1046 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--ip~~l~~ 1046 (1181)
..|+|||++.++.++.+ .|+ ||||+++|||++ |+.||.+....++..... .....+.
T Consensus 345 ~~y~aPE~~~~~~~~~~--sDv------------------wslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~ 404 (452)
T 1fmk_A 345 IKWTAPEAALYGRFTIK--SDV------------------WSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP 404 (452)
T ss_dssp GGGSCHHHHHHCCCCHH--HHH------------------HHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred ccccCHhHHhcCCCCcc--ccH------------------HhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 89999999986644333 333 999999999999 999999877654322111 1112234
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
.++..+..++.+|++.+|..||+ +.+....+..
T Consensus 405 ~~~~~l~~li~~cl~~dP~~Rpt-~~~l~~~L~~ 437 (452)
T 1fmk_A 405 ECPESLHDLMCQCWRKEPEERPT-FEYLQAFLED 437 (452)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCC-HHHHHHHHHT
T ss_pred CCCHHHHHHHHHHccCChhhCcC-HHHHHHHHHH
Confidence 57788999999999999999996 4554444444
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-33 Score=317.78 Aligned_cols=244 Identities=24% Similarity=0.333 Sum_probs=187.7
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEccccccCC------
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEG------ 875 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~------ 875 (1181)
..|... .+||+|+||.||+|.+..+++.||||++...... ..+.+.+|+.+++.++||||+++++++...+
T Consensus 25 ~~y~~~-~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 25 AVYRDL-QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp SSEEEE-EEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred ceEEEe-EEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 334443 4799999999999999999999999999654332 2467889999999999999999999987653
Q ss_pred cEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccc
Q psy14556 876 YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 955 (1181)
Q Consensus 876 ~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~ 955 (1181)
.+|+||||+ +++|.++++.. .+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~-~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE-DCELKILDFGLARQ 177 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT-TCCEEECCCTTCEE
T ss_pred eEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcC-CCCEEEEeeecccc
Confidence 469999999 88999998753 5789999999999999999999999999999999999988 89999999999987
Q ss_pred cccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc
Q psy14556 956 LAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV 1035 (1181)
Q Consensus 956 l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~ 1035 (1181)
... ......+|+.|+|||++.+. ..++..+|+ ||+||++|+|++|+.||.+.+..+..
T Consensus 178 ~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~Di------------------wslG~il~ell~g~~pf~~~~~~~~l 235 (367)
T 1cm8_A 178 ADS---EMTGYVVTRWYRAPEVILNW-MRYTQTVDI------------------WSVGCIMAEMITGKTLFKGSDHLDQL 235 (367)
T ss_dssp CCS---SCCSSCSCGGGCCTHHHHTT-TCCCTTHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ccc---ccCcCcCCCCcCCHHHHhCC-CCCChhhhH------------------HHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 643 23445789999999999752 234444544 99999999999999999987643210
Q ss_pred C--------C--------------------CCC----CCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHH
Q psy14556 1036 A--------P--------------------PQI----SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLV 1076 (1181)
Q Consensus 1036 ~--------~--------------------~~i----p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~ 1076 (1181)
. + +.. -.......+..+..++.+|+..||.+|++..+.+..
T Consensus 236 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 236 KEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 0 0 000 011223456778889999999999999975555443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=306.99 Aligned_cols=236 Identities=24% Similarity=0.318 Sum_probs=182.0
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEcccccc-CCcEEEEEeecCCCCc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSE-EGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d-~~~l~LVmEy~~gGSL 889 (1181)
+.||+|+||.||+|.+ +++.||+|++.... ..+.+.+|+.++++++||||+++++++.+ .+..++||||+++++|
T Consensus 27 ~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L 102 (278)
T 1byg_A 27 QTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 102 (278)
T ss_dssp EEEEECSSCEEEEEEE--TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred eEEecCCCceEEEEEE--cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCH
Confidence 3699999999999987 47899999996543 45789999999999999999999998654 4579999999999999
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT 969 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT 969 (1181)
.+++... ....+++..++.++.|++.||.|||++|++||||||+||+++. ++.+||+|||++...... .....++
T Consensus 103 ~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~-~~~~~l~Dfg~~~~~~~~---~~~~~~~ 177 (278)
T 1byg_A 103 VDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASST---QDTGKLP 177 (278)
T ss_dssp HHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT-TSCEEECCCCC---------------CC
T ss_pred HHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeC-CCcEEEeecccccccccc---ccCCCcc
Confidence 9999754 2223678889999999999999999999999999999999987 889999999998765432 2233578
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCC--CCCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPP--QISRSVSV 1046 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~--~ip~~l~~ 1046 (1181)
+.|+|||++.+..++. ..|+ ||+|+++|+|++ |..||...+...+.... ......+.
T Consensus 178 ~~y~aPE~~~~~~~~~--~~Di------------------~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 237 (278)
T 1byg_A 178 VKWTAPEALREKKFST--KSDV------------------WSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD 237 (278)
T ss_dssp TTTSCHHHHHHCCCCH--HHHH------------------HHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCT
T ss_pred ccccCHHHhCCCCCCc--hhcH------------------HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcc
Confidence 8999999997654333 3333 999999999998 99999987765542211 11223344
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHHHHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNTNLV 1076 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~~~~ 1076 (1181)
..+..+..++.+|+..+|..||+ +.+.+.
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rps-~~~l~~ 266 (278)
T 1byg_A 238 GCPPAVYEVMKNCWHLDAAMRPS-FLQLRE 266 (278)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCC-HHHHHH
T ss_pred cCCHHHHHHHHHHhcCChhhCCC-HHHHHH
Confidence 66888999999999999999996 444333
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=304.41 Aligned_cols=246 Identities=19% Similarity=0.205 Sum_probs=188.6
Q ss_pred hhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEcccc-ccCCcEEEEE
Q psy14556 803 LYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV-SEEGYFKIFM 881 (1181)
Q Consensus 803 ~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~-~d~~~l~LVm 881 (1181)
.+.|.+.+ +||+|+||.||+|++..+++.||+|++..... .+.+.+|+.+++.++|++++..+..+ ...+..++||
T Consensus 8 ~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 8 GNRYRLGR-KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ---CEEEE-EEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCceEEee-eecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 34454444 79999999999999999999999998755432 24588999999999988877666555 6677889999
Q ss_pred eecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccc---ccCCCeeeeecCCccccccc
Q psy14556 882 EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLV---NTYSGVVKISDFGTSKRLAG 958 (1181)
Q Consensus 882 Ey~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL---d~~~g~vKLiDFGlAk~l~~ 958 (1181)
||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +. ++.+||+|||+++....
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~-~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKK-GNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGG-TTCEEECCCTTCEECBC
T ss_pred Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCC-CCeEEEecCccceeccC
Confidence 999 99999999743 2357899999999999999999999999999999999999 55 78999999999987654
Q ss_pred CCC-------CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCc
Q psy14556 959 LCP-------SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTS 1031 (1181)
Q Consensus 959 ~~~-------~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~ 1031 (1181)
... ......||+.|+|||++.+..++. ..|+ ||+|+++|+|++|+.||.+...
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~Di------------------~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSR--RDDL------------------ESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCH--HHHH------------------HHHHHHHHHHHHSSCTTSSCCC
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCc--hhHH------------------HHHHHHHHHHhcCCCCCcccch
Confidence 322 123456999999999998654333 3333 9999999999999999987654
Q ss_pred ccccCCC--------C-CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHH
Q psy14556 1032 RALVAPP--------Q-ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLV 1076 (1181)
Q Consensus 1032 ~~l~~~~--------~-ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~ 1076 (1181)
....... . .........+..+..++.+|++.+|..||+ +.+.+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt-~~~l~~ 273 (296)
T 4hgt_A 221 ATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPD-YSYLRQ 273 (296)
T ss_dssp SSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCC-HHHHHH
T ss_pred hhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCC-HHHHHH
Confidence 3321100 0 011112345788999999999999999996 444333
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-33 Score=313.12 Aligned_cols=249 Identities=24% Similarity=0.303 Sum_probs=190.1
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEcccccc--------
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSE-------- 873 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d-------- 873 (1181)
..|.+.+ +||+|+||.||+|++..+++.||+|++...... ....+.+|+.+++.++||||+++++++..
T Consensus 17 ~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 17 SKYEKLA-KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGEEEEE-ECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred cceeEEE-EEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 3444443 699999999999999999999999998655332 35678899999999999999999999876
Q ss_pred CCcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcc
Q psy14556 874 EGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTS 953 (1181)
Q Consensus 874 ~~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlA 953 (1181)
.+..++||||+++ +|.+.+... ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~a 171 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR-DGVLKLADFGLA 171 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TSCEEECCCTTC
T ss_pred CceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcC-CCCEEEccchhc
Confidence 4568999999964 676666543 235789999999999999999999999999999999999988 899999999999
Q ss_pred cccccCC----CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCC
Q psy14556 954 KRLAGLC----PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKK 1029 (1181)
Q Consensus 954 k~l~~~~----~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~ 1029 (1181)
+.+.... .......||+.|+|||++.+.. .++..+|+ ||+||++|+|++|+.||.+.
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~Di------------------wslG~il~ell~g~~pf~~~ 232 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER-DYGPPIDL------------------WGAGCIMAEMWTRSPIMQGN 232 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCC-SCCTHHHH------------------HHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccCCcccccCccCchhhcCCC-CCCcHhHH------------------HHHHHHHHHHHhCCCCCCCC
Confidence 8765221 2223456899999999996432 23444444 99999999999999999987
Q ss_pred CcccccCC-----CCCCCCCCCC----------------------------CCcchHHhhccCCCCCCCCCchhHHHHHH
Q psy14556 1030 TSRALVAP-----PQISRSVSVP----------------------------GPGGINSSSSAPVTPTPHSRHISVNTNLV 1076 (1181)
Q Consensus 1030 ~~~~l~~~-----~~ip~~l~~~----------------------------~p~~L~~li~r~la~dPs~Rp~s~~~~~~ 1076 (1181)
+....... ...+....+. .+..+..++.+|+..||.+||+..+.+..
T Consensus 233 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 233 TEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp SHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 75432100 0000000000 13446789999999999999986555433
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-33 Score=314.21 Aligned_cols=248 Identities=19% Similarity=0.252 Sum_probs=184.6
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCC--CCeeeEccccccCCcEEEEEeecC
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRH--RNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~H--PNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
..+||+|+||.||+|.+ .+++.||+|++...... ..+.+.+|+.++++++| |||+++++++.+.+..++|||+ .
T Consensus 14 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~ 91 (343)
T 3dbq_A 14 LKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-G 91 (343)
T ss_dssp EEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-C
T ss_pred EEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-C
Confidence 34799999999999987 46889999999755432 24678999999999976 9999999999999999999994 5
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC--CC
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP--SA 963 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~--~~ 963 (1181)
+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....... ..
T Consensus 92 ~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~--~~~~kl~DFG~a~~~~~~~~~~~~ 166 (343)
T 3dbq_A 92 NIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVK 166 (343)
T ss_dssp SEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE--TTEEEECCCSSSCCC---------
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE--CCcEEEeecccccccCcccccccC
Confidence 88999999854 3578899999999999999999999999999999999996 58899999999987654322 12
Q ss_pred ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc--c--cCCCC
Q psy14556 964 ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA--L--VAPPQ 1039 (1181)
Q Consensus 964 ~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~--l--~~~~~ 1039 (1181)
....||+.|+|||++.+........ .....+....+.||+||++|+|++|+.||.+..... + .....
T Consensus 167 ~~~~gt~~y~aPE~~~~~~~~~~~~---------~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 237 (343)
T 3dbq_A 167 DSQVGTVNYMPPEAIKDMSSSRENG---------KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 237 (343)
T ss_dssp ---CCCCSSCCHHHHHHCC--------------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred CCCcCCcCcCCHHHHhhcccccccc---------ccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCC
Confidence 3456999999999996521110000 000122333444999999999999999998754321 1 01111
Q ss_pred CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1040 ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1040 ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.....+...+..+..++.+|+..+|..||+..+.
T Consensus 238 ~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~ 271 (343)
T 3dbq_A 238 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271 (343)
T ss_dssp SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 2222333445678899999999999999976555
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=305.91 Aligned_cols=245 Identities=22% Similarity=0.336 Sum_probs=180.0
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.++||+|+||.||+|++.. .||+|++...... ..+.+.+|+.++++++||||++++++. ..+..++||||++++
T Consensus 29 ~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~ 104 (289)
T 3og7_A 29 GQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGS 104 (289)
T ss_dssp EEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEE
T ss_pred eeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCC
Confidence 4479999999999998533 5999999655432 356789999999999999999999965 455689999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC--CCCcc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC--PSAET 965 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~--~~~~t 965 (1181)
+|.+++... ...+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||++....... .....
T Consensus 105 ~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~ 181 (289)
T 3og7_A 105 SLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHE-DNTVKIGDFGLATEKSRWSGSHQFEQ 181 (289)
T ss_dssp EHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET-TTEEEECCCC----------------
T ss_pred cHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC-CCCEEEccceeccccccccccccccc
Confidence 999998643 345788999999999999999999999999999999999998 8999999999997654321 22234
Q ss_pred ccCCccccCchhhccCC-CCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc-------CC
Q psy14556 966 FTGTLQYMAPEVIDKGQ-RGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV-------AP 1037 (1181)
Q Consensus 966 ~~GT~~Y~APEvl~gg~-~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~-------~~ 1037 (1181)
..||+.|+|||++.... ..++...|+ ||+|+++|+|++|+.||.+....... ..
T Consensus 182 ~~gt~~y~aPE~~~~~~~~~~~~~~Di------------------~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 243 (289)
T 3og7_A 182 LSGSILWMAPEVIRMQDSNPYSFQSDV------------------YAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL 243 (289)
T ss_dssp --CCCTTCCHHHHC----CCSCHHHHH------------------HHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSC
T ss_pred cCCCccccCchhhcccCCCCCCcccch------------------HHHHHHHHHHHHCCCCccccchHHHHHHHhccccc
Confidence 56899999999996221 122223333 99999999999999999886543311 01
Q ss_pred CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1038 PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1038 ~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
...........+..+..++.+|++.+|..||+ +.+.+..+..
T Consensus 244 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~ell~~L~~ 285 (289)
T 3og7_A 244 SPDLSKVRSNCPKRMKRLMAECLKKKRDERPS-FPRILAEIEE 285 (289)
T ss_dssp CCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCC-HHHHHHHHHH
T ss_pred CcchhhccccCCHHHHHHHHHHccCChhhCCC-HHHHHHHHHH
Confidence 11122234467788999999999999999995 5555554443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=308.46 Aligned_cols=245 Identities=29% Similarity=0.383 Sum_probs=174.6
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCC-CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKN-LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~-~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++||||+++++
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 99 (303)
T 2vwi_A 20 QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS 99 (303)
T ss_dssp EEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCB
T ss_pred hheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCc
Confidence 347999999999999998899999999986543 2345678899999999999999999999999999999999999999
Q ss_pred cccchhcc-----cCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC--
Q psy14556 889 LSTLLRVK-----WGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP-- 961 (1181)
Q Consensus 889 L~dlL~~~-----~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~-- 961 (1181)
|.+++... .....+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++........
T Consensus 100 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~-~~~~kl~dfg~~~~~~~~~~~~ 178 (303)
T 2vwi_A 100 VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGE-DGSVQIADFGVSAFLATGGDIT 178 (303)
T ss_dssp HHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT-TCCEEECCCHHHHHCC------
T ss_pred hHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcC-CCCEEEEeccchheeccCCCcc
Confidence 99998741 12345789999999999999999999999999999999999987 89999999999876543211
Q ss_pred ---CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc---
Q psy14556 962 ---SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV--- 1035 (1181)
Q Consensus 962 ---~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~--- 1035 (1181)
......||+.|+|||++.+.. .++...|+ ||+|+++|+|++|+.||.........
T Consensus 179 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di------------------~slG~il~~l~~g~~pf~~~~~~~~~~~~ 239 (303)
T 2vwi_A 179 RNKVRKTFVGTPCWMAPEVMEQVR-GYDFKADI------------------WSFGITAIELATGAAPYHKYPPMKVLMLT 239 (303)
T ss_dssp ---------CCCTTCCHHHHHHHH-CCCTHHHH------------------HHHHHHHHHHHHSSCTTTTSCGGGHHHHH
T ss_pred chhhhcccCCCccccCHHHhcccc-CCCchhhH------------------HHHHHHHHHHHhCCCCCccCchhhHHHHH
Confidence 123356899999999986421 12333333 99999999999999999886654321
Q ss_pred ---CCCCC-----CCCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1036 ---APPQI-----SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1036 ---~~~~i-----p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
..... ........+..+..++.+|+..+|..||+..+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 286 (303)
T 2vwi_A 240 LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286 (303)
T ss_dssp HTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred hccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHh
Confidence 01111 1122234567788999999999999999755543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.98 E-value=6.7e-33 Score=303.46 Aligned_cols=249 Identities=19% Similarity=0.203 Sum_probs=192.2
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEcccc-ccCCcEEEEEe
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV-SEEGYFKIFME 882 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~-~d~~~l~LVmE 882 (1181)
+.|.+.+ .||+|+||.||+|++..+++.||+|++..... .+.+.+|+.+++.++|++++..+..+ ...+..++|||
T Consensus 9 ~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 9 NRYRLGR-KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTEEEEE-EEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cEEEEEE-EEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 3444433 69999999999999999999999999865543 35689999999999988866665554 56678899999
Q ss_pred ecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccc--cCCCeeeeecCCcccccccCC
Q psy14556 883 QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVN--TYSGVVKISDFGTSKRLAGLC 960 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd--~~~g~vKLiDFGlAk~l~~~~ 960 (1181)
|+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++ ..++.+||+|||++.......
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 99 99999999743 23578999999999999999999999999999999999995 237899999999998765433
Q ss_pred C-------CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc
Q psy14556 961 P-------SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA 1033 (1181)
Q Consensus 961 ~-------~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~ 1033 (1181)
. ......||+.|+|||++.+..++. ..|+ ||+|+++|+|++|+.||.+.....
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~Di------------------~slG~il~~l~~g~~pf~~~~~~~ 222 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSR--RDDL------------------ESLGYVLMYFNLGSLPWQGLKAAT 222 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCH--HHHH------------------HHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred cccccccccccccccccccCChhhhcCCCCCc--chhh------------------HHHHHHHHHHHhCCCCCCCcCchh
Confidence 2 123456999999999998654333 3333 999999999999999999754322
Q ss_pred ccC--------CCCC-CCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcc
Q psy14556 1034 LVA--------PPQI-SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTG 1079 (1181)
Q Consensus 1034 l~~--------~~~i-p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~ 1079 (1181)
... .... ........+..+..++.+|++.+|..||+ +.+....+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~~l~~~l~ 276 (296)
T 3uzp_A 223 KRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPD-YSYLRQLFR 276 (296)
T ss_dssp SSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCC-HHHHHHHHH
T ss_pred hhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCC-HHHHHHHHH
Confidence 110 0001 11122456788999999999999999995 444433333
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=9.9e-33 Score=307.62 Aligned_cols=252 Identities=20% Similarity=0.255 Sum_probs=183.8
Q ss_pred HhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhc--CCCCeeeEccccccC----C
Q psy14556 802 FLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL--RHRNIVQYLGSVSEE----G 875 (1181)
Q Consensus 802 ~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L--~HPNIVkl~g~~~d~----~ 875 (1181)
+.+.|.+.+ +||+|+||.||+|++. ++.||+|++... ......+|.+++..+ +||||+++++++... .
T Consensus 35 ~~~~y~~~~-~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 35 IAKQIQMVK-QIGKGRYGEVWMGKWR--GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp HHHHCEEEE-EEEEETTEEEEEEEET--TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccceEEEe-EeecCCCeEEEEEEEC--CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 344555544 7999999999999874 889999998543 234456666666655 899999999998776 7
Q ss_pred cEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhcccc--------ceecccCCCCCcccccCCCeeee
Q psy14556 876 YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ--------KIVHRDIKGDNVLVNTYSGVVKI 947 (1181)
Q Consensus 876 ~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~--------gIVHrDLKP~NILLd~~~g~vKL 947 (1181)
..++||||+++|+|.++++.. .+++..++.++.|++.||.|||++ ||+||||||+|||++. ++.+||
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~-~~~~kl 183 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK-NGTCCI 183 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECT-TSCEEE
T ss_pred ceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECC-CCCEEE
Confidence 899999999999999999754 578999999999999999999999 9999999999999987 889999
Q ss_pred ecCCcccccccCCCC----CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhC-
Q psy14556 948 SDFGTSKRLAGLCPS----AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVL- 1022 (1181)
Q Consensus 948 iDFGlAk~l~~~~~~----~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTG- 1022 (1181)
+|||+++........ .....||+.|+|||++.+......... ....+.||+||++|||++|
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~--------------~~~~DiwslG~il~el~tg~ 249 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQS--------------YIMADMYSFGLILWEVARRC 249 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHH--------------HHHHHHHHHHHHHHHHHTTB
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccC--------------ccccchHHHHHHHHHHHhcc
Confidence 999999766543222 124569999999999976543332110 0112339999999999999
Q ss_pred ---------CCCCCCCCccc--------ccCCCCCCCCCC-----CCCCcchHHhhccCCCCCCCCCchhHHHHHHhcc
Q psy14556 1023 ---------TAALKKKTSRA--------LVAPPQISRSVS-----VPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTG 1079 (1181)
Q Consensus 1023 ---------k~PF~~~~~~~--------l~~~~~ip~~l~-----~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~ 1079 (1181)
..||....... ...........+ ...+..+..++.+|++.+|..||+ +.+.+..+.
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~ell~~L~ 327 (337)
T 3mdy_A 250 VSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT-ALRVKKTLA 327 (337)
T ss_dssp CBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCC-HHHHHHHHH
T ss_pred CcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCC-HHHHHHHHH
Confidence 66665543211 011111111111 123445788999999999999995 455444433
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=7.2e-33 Score=338.72 Aligned_cols=243 Identities=24% Similarity=0.252 Sum_probs=191.6
Q ss_pred ccCceeecccCceEEEEEEEc--CCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEee
Q psy14556 807 ALNRIELGKGSYGVVYAAREL--DRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQ 883 (1181)
Q Consensus 807 ~l~~~kIG~G~fG~VYka~d~--~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy 883 (1181)
.+...+||+|+||.||+|.+. .++..||||+++.... ...+.+.+|+.+|++++||||+++++++.. +..++||||
T Consensus 338 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~ 416 (613)
T 2ozo_A 338 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEM 416 (613)
T ss_dssp EEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred eEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEe
Confidence 344447999999999999875 3567899999976533 356789999999999999999999999976 569999999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC-
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS- 962 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~- 962 (1181)
+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.+......
T Consensus 417 ~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~-~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 417 AGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVN-RHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp CTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE-TTEEEECCCSTTTTCC------
T ss_pred CCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcC-CCcEEEeeccCcccccCCCcee
Confidence 9999999999743 345789999999999999999999999999999999999998 899999999999876532211
Q ss_pred --CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC
Q psy14556 963 --AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ 1039 (1181)
Q Consensus 963 --~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~ 1039 (1181)
.....+++.|+|||++.++.++. .+|+ |||||+||||++ |+.||.+.+..++.....
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~~~~~--~sDv------------------wSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~ 553 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFRKFSS--RSDV------------------WSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553 (613)
T ss_dssp --------CCTTSCHHHHHHCCCCH--HHHH------------------HHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH
T ss_pred eeccCCCCccceeCHhhhcCCCCCc--HHHH------------------HHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence 11233568999999997664433 3333 999999999998 999999877655432111
Q ss_pred --CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1040 --ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1040 --ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.....+..++..+..++.+|+..+|..||.+.+.
T Consensus 554 ~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l 589 (613)
T 2ozo_A 554 QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTV 589 (613)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHH
T ss_pred cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 1112334578899999999999999999975443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=4.1e-33 Score=313.98 Aligned_cols=240 Identities=21% Similarity=0.250 Sum_probs=185.4
Q ss_pred eeecccCceEEEEEEEcCCC----eEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 811 IELGKGSYGVVYAARELDRQ----VKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg----~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
++||+|+||.||+|.+..++ ..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 50 ~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 129 (333)
T 1mqb_A 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYME 129 (333)
T ss_dssp EEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred cEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCC
Confidence 47999999999999876543 4699999975532 234568899999999999999999999999999999999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC---
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS--- 962 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~--- 962 (1181)
+++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++........
T Consensus 130 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~~~~~~~~~~~~~~ 206 (333)
T 1mqb_A 130 NGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS-NLVCKVSDFGLSRVLEDDPEATYT 206 (333)
T ss_dssp TEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TCCEEECCCCC-------------
T ss_pred CCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECC-CCcEEECCCCcchhhccccccccc
Confidence 99999999753 345789999999999999999999999999999999999987 899999999999876543221
Q ss_pred CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--
Q psy14556 963 AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ-- 1039 (1181)
Q Consensus 963 ~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~-- 1039 (1181)
.....+|+.|+|||++.+..++. ..|+ ||+|+++|+|++ |+.||.+....++.....
T Consensus 207 ~~~~~~~~~y~aPE~~~~~~~~~--~~Di------------------~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~ 266 (333)
T 1mqb_A 207 TSGGKIPIRWTAPEAISYRKFTS--ASDV------------------WSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 266 (333)
T ss_dssp ----CCCGGGSCHHHHHSCCCCH--HHHH------------------HHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred cCCCCccccccCchhcccCCCCc--hhhh------------------HHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC
Confidence 11234678899999997654333 3333 999999999999 999998876654322111
Q ss_pred CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1040 ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1040 ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.....+...+..+..++.+|++.+|..||+..+.
T Consensus 267 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 300 (333)
T 1mqb_A 267 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADI 300 (333)
T ss_dssp CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 1112234577889999999999999999974443
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.4e-33 Score=314.40 Aligned_cols=247 Identities=21% Similarity=0.206 Sum_probs=172.0
Q ss_pred HHhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEcccccc----CCc
Q psy14556 801 RFLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSE----EGY 876 (1181)
Q Consensus 801 ~~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d----~~~ 876 (1181)
.+.++|.+.++.||+|+||.||+|.+..+++.||+|++... .....+....++.++||||+++++++.. ...
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 34566777666799999999999999999999999999643 1222333344667799999999999876 456
Q ss_pred EEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccC--CCeeeeecCCccc
Q psy14556 877 FKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTY--SGVVKISDFGTSK 954 (1181)
Q Consensus 877 l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~--~g~vKLiDFGlAk 954 (1181)
+++||||+++|+|.+++... ....+++..++.++.||+.||.|||++||+||||||+||+++.. ++.+||+|||+++
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 89999999999999999865 34568899999999999999999999999999999999999752 4569999999998
Q ss_pred ccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc
Q psy14556 955 RLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL 1034 (1181)
Q Consensus 955 ~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l 1034 (1181)
..... ......||+.|+|||++.+..++. ..+.||+|+++|+|++|..||.+.....+
T Consensus 180 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~--------------------~~Di~slG~il~~l~~g~~pf~~~~~~~~ 237 (336)
T 3fhr_A 180 ETTQN--ALQTPCYTPYYVAPEVLGPEKYDK--------------------SCDMWSLGVIMYILLCGFPPFYSNTGQAI 237 (336)
T ss_dssp EC------------------------CHHHH--------------------HHHHHHHHHHHHHHHHSSCCC--------
T ss_pred ecccc--ccccCCCCcCccChhhhCCCCCCc--------------------hhhHHHHHHHHHHHHHCCCCCCCccchhh
Confidence 65532 233456899999999986543322 23339999999999999999987765443
Q ss_pred cC---------CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1035 VA---------PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1035 ~~---------~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
.. ....+.......+..+..++.+|+..+|..||+..+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 286 (336)
T 3fhr_A 238 SPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFM 286 (336)
T ss_dssp -------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred hhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 11 11123333345678899999999999999999865553
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.98 E-value=6.2e-33 Score=302.80 Aligned_cols=242 Identities=24% Similarity=0.285 Sum_probs=176.3
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC--hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD--VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~--~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.+||+|+||.||+|++..+++.||+|++....... .+.+.++...++.++||||+++++++.+.+..++||||++ ++
T Consensus 13 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 91 (290)
T 3fme_A 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TS 91 (290)
T ss_dssp EEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EE
T ss_pred HhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cc
Confidence 47999999999999999999999999996553221 2334455556888899999999999999999999999996 58
Q ss_pred cccchhcc-cCCCCCChHHHHHHHHHHHhhhhhcccc-ceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccc
Q psy14556 889 LSTLLRVK-WGPLKENESTMSFYTKQILEGLKYLHGQ-KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF 966 (1181)
Q Consensus 889 L~dlL~~~-~~~~~l~e~~i~~Ia~QIa~AL~yLHs~-gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~ 966 (1181)
|.+++... .....+++..++.++.|++.||+|||++ ||+||||||+||+++. ++.+||+|||+++...... .....
T Consensus 92 l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~-~~~~kl~Dfg~~~~~~~~~-~~~~~ 169 (290)
T 3fme_A 92 LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA-LGQVKMCDFGISGYLVDDV-AKDID 169 (290)
T ss_dssp HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECT-TCCEEBCCC----------------
T ss_pred hHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECC-CCCEEEeecCCcccccccc-ccccc
Confidence 87777541 1345688999999999999999999998 9999999999999988 8899999999998765432 22334
Q ss_pred cCCccccCchhhccC--CCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc--ccC--CCCC
Q psy14556 967 TGTLQYMAPEVIDKG--QRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA--LVA--PPQI 1040 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg--~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~--l~~--~~~i 1040 (1181)
.||+.|+|||++... ...++...| .||+|+++|+|++|+.||....... +.. ....
T Consensus 170 ~~t~~y~aPE~~~~~~~~~~~~~~~D------------------i~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 231 (290)
T 3fme_A 170 AGCKPYMAPERINPELNQKGYSVKSD------------------IWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS 231 (290)
T ss_dssp CCCCCCSCHHHHSCCTTC--CCHHHH------------------HHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC
T ss_pred CCCccccChhhcChhhcCcCCCcHHH------------------HHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC
Confidence 699999999997321 112233333 3999999999999999998643321 100 0111
Q ss_pred CCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1041 SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1041 p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
+.......+..+..++.+|++.+|..||+..+.
T Consensus 232 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~ 264 (290)
T 3fme_A 232 PQLPADKFSAEFVDFTSQCLKKNSKERPTYPEL 264 (290)
T ss_dssp CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCcccccCCHHHHHHHHHHhhcChhhCcCHHHH
Confidence 222233567788999999999999999975554
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.5e-33 Score=310.86 Aligned_cols=245 Identities=18% Similarity=0.255 Sum_probs=193.9
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC-----------------hhHHHHHHHHHHhcCCCCeee
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD-----------------VQPLHEEIKLHSQLRHRNIVQ 866 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~-----------------~e~f~rEi~IL~~L~HPNIVk 866 (1181)
..|.+.+ +||+|+||.||+|.+ +++.||+|.+....... .+.+.+|+.++++++||||++
T Consensus 31 ~~y~~~~-~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 31 NDYRIIR-TLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp TTEEEEE-EEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred CceEEEE-EEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 3444443 699999999999998 89999999996442221 178999999999999999999
Q ss_pred EccccccCCcEEEEEeecCCCCcccc------hhcccCCCCCChHHHHHHHHHHHhhhhhccc-cceecccCCCCCcccc
Q psy14556 867 YLGSVSEEGYFKIFMEQVPGGSLSTL------LRVKWGPLKENESTMSFYTKQILEGLKYLHG-QKIVHRDIKGDNVLVN 939 (1181)
Q Consensus 867 l~g~~~d~~~l~LVmEy~~gGSL~dl------L~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs-~gIVHrDLKP~NILLd 939 (1181)
+++++.+.+..++||||+++++|.++ +... ....+++..++.++.||+.||.|||+ +||+||||||+||+++
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD 186 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence 99999999999999999999999999 5532 24578899999999999999999999 9999999999999998
Q ss_pred cCCCeeeeecCCcccccccCCCCCccccCCccccCchhhccCCCCCCC-ccccccCCCccccccccccchhHHHHHHHHH
Q psy14556 940 TYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGA-PVRQRDKINPCCRIEYKKMKINVFLCVIISQ 1018 (1181)
Q Consensus 940 ~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ss-DVDi~~dI~~~~~i~~~~~k~DwSLGvILyE 1018 (1181)
. ++.+||+|||.+...... ......|++.|+|||++.+.. .+.. ..|+ ||+|+++|+
T Consensus 187 ~-~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~~~Di------------------~slG~il~~ 244 (348)
T 2pml_X 187 K-NGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNES-SYNGAKVDI------------------WSLGICLYV 244 (348)
T ss_dssp T-TSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCC-CEEHHHHHH------------------HHHHHHHHH
T ss_pred C-CCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCC-CCCcchhhH------------------HHHHHHHHH
Confidence 7 899999999999876442 334456899999999997542 1111 3333 999999999
Q ss_pred HHhCCCCCCCCCc-cccc-----CCCCCCCC---------------CCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1019 LLVLTAALKKKTS-RALV-----APPQISRS---------------VSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1019 LLTGk~PF~~~~~-~~l~-----~~~~ip~~---------------l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
|++|..||..... ..+. .....+.. .....+..+..++.+|++.+|..||+..+.+
T Consensus 245 l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l 321 (348)
T 2pml_X 245 MFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDAL 321 (348)
T ss_dssp HHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred HHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 9999999998765 2211 11111110 1145677888999999999999999755443
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.98 E-value=2.9e-32 Score=302.90 Aligned_cols=247 Identities=23% Similarity=0.300 Sum_probs=191.8
Q ss_pred hhcccCceeecccCceEEEEEEEc-CCCeEEEEEEecCCCC--CChhHHHHHHHHHHhc---CCCCeeeEccccc-----
Q psy14556 804 YLFALNRIELGKGSYGVVYAAREL-DRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQL---RHRNIVQYLGSVS----- 872 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~-~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L---~HPNIVkl~g~~~----- 872 (1181)
..|.+.+ +||+|+||.||+|++. .+++.||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 11 ~~y~~~~-~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 11 QQYECVA-EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GTEEEEE-EEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hceeeee-eecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 3444443 7999999999999995 6789999999864322 2344677888888777 8999999999986
Q ss_pred cCCcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCc
Q psy14556 873 EEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGT 952 (1181)
Q Consensus 873 d~~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGl 952 (1181)
.....++||||+. ++|.+++... ....+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~-~~~~kl~Dfg~ 166 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS-SGQIKLADFGL 166 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TCCEEECSCCS
T ss_pred CCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcC-CCCEEEecCcc
Confidence 5678999999996 6999998764 3345789999999999999999999999999999999999988 89999999999
Q ss_pred ccccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc
Q psy14556 953 SKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR 1032 (1181)
Q Consensus 953 Ak~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~ 1032 (1181)
++...... ......||+.|+|||++.+..++. ..|+ ||+|+++|+|++|+.||.+....
T Consensus 167 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~--~~Di------------------~slG~il~~l~~g~~pf~~~~~~ 225 (326)
T 1blx_A 167 ARIYSFQM-ALTSVVVTLWYRAPEVLLQSSYAT--PVDL------------------WSVGCIFAEMFRRKPLFRGSSDV 225 (326)
T ss_dssp CCCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCT--HHHH------------------HHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccCCC-CccccccccceeCHHHHhcCCCCc--chhH------------------HHHHHHHHHHHcCCCCCCCCCHH
Confidence 97665322 233456899999999997654333 3333 99999999999999999887643
Q ss_pred cccC----------------CCC------------CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHH
Q psy14556 1033 ALVA----------------PPQ------------ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNL 1075 (1181)
Q Consensus 1033 ~l~~----------------~~~------------ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~ 1075 (1181)
.... ... .........+..+..++.+|++.+|..||+..+.+.
T Consensus 226 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 226 DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 2100 000 001122346677888999999999999998655543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=315.86 Aligned_cols=238 Identities=21% Similarity=0.343 Sum_probs=186.1
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccc------------------
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVS------------------ 872 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~------------------ 872 (1181)
.+||+|+||+||+|.+..+++.||+|++...... ..+|+.+++.++||||+++++++.
T Consensus 13 ~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (383)
T 3eb0_A 13 KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNK 88 (383)
T ss_dssp EEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC----------------
T ss_pred EEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccccccccccccc
Confidence 4799999999999999999999999998654322 347999999999999999999883
Q ss_pred --------------------cCCcEEEEEeecCCCCcccchhcc-cCCCCCChHHHHHHHHHHHhhhhhccccceecccC
Q psy14556 873 --------------------EEGYFKIFMEQVPGGSLSTLLRVK-WGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931 (1181)
Q Consensus 873 --------------------d~~~l~LVmEy~~gGSL~dlL~~~-~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDL 931 (1181)
+...+++||||++ ++|.+.+... .....+++..++.++.||+.||+|||++||+||||
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Di 167 (383)
T 3eb0_A 89 LGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDI 167 (383)
T ss_dssp ---------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCC
T ss_pred ccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCcc
Confidence 3345899999997 5777776531 13456889999999999999999999999999999
Q ss_pred CCCCcccccCCCeeeeecCCcccccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHH
Q psy14556 932 KGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVF 1011 (1181)
Q Consensus 932 KP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwS 1011 (1181)
||+|||++..++.+||+|||+++...... ......+|+.|+|||++.+.. .++..+|+ ||
T Consensus 168 kp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~-~~~~~~Di------------------ws 227 (383)
T 3eb0_A 168 KPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGAT-EYTPSIDL------------------WS 227 (383)
T ss_dssp CGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCS-SCCTHHHH------------------HH
T ss_pred CHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCC-CCCcchhh------------------hh
Confidence 99999998557899999999998765432 333456899999999986532 24444554 99
Q ss_pred HHHHHHHHHhCCCCCCCCCcccccC----------------------CCCCC--------CCCCCCCCcchHHhhccCCC
Q psy14556 1012 LCVIISQLLVLTAALKKKTSRALVA----------------------PPQIS--------RSVSVPGPGGINSSSSAPVT 1061 (1181)
Q Consensus 1012 LGvILyELLTGk~PF~~~~~~~l~~----------------------~~~ip--------~~l~~~~p~~L~~li~r~la 1061 (1181)
+||++|+|++|+.||.+.+..+... ...++ ...+...+..+..++.+|+.
T Consensus 228 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 307 (383)
T 3eb0_A 228 IGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307 (383)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence 9999999999999999876533110 00011 11233466778899999999
Q ss_pred CCCCCCchhHHH
Q psy14556 1062 PTPHSRHISVNT 1073 (1181)
Q Consensus 1062 ~dPs~Rp~s~~~ 1073 (1181)
.+|.+||+..+.
T Consensus 308 ~dP~~R~t~~e~ 319 (383)
T 3eb0_A 308 YEPDLRINPYEA 319 (383)
T ss_dssp SSGGGSCCHHHH
T ss_pred CChhhCCCHHHH
Confidence 999999976555
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=301.22 Aligned_cols=246 Identities=25% Similarity=0.321 Sum_probs=198.4
Q ss_pred HhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCC--CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEE
Q psy14556 802 FLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKN--LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKI 879 (1181)
Q Consensus 802 ~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~--~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~L 879 (1181)
+...|.+.+ +||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 20 ~~~~y~i~~-~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 20 FAERYNIVC-MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHEEEEE-EEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HhhcceeeE-EEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 444555544 7999999999999999999999999996543 3456789999999999999999999999999999999
Q ss_pred EEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccC--CCeeeeecCCcccccc
Q psy14556 880 FMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTY--SGVVKISDFGTSKRLA 957 (1181)
Q Consensus 880 VmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~--~g~vKLiDFGlAk~l~ 957 (1181)
||||+++++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++.. ++.+||+|||++....
T Consensus 99 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 99999999999888754 257899999999999999999999999999999999999752 3479999999998765
Q ss_pred cCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC-
Q psy14556 958 GLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA- 1036 (1181)
Q Consensus 958 ~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~- 1036 (1181)
... ......|++.|+|||++.+. ++...|+ ||+|+++|+|++|..||.+.+...+..
T Consensus 176 ~~~-~~~~~~~~~~y~aPE~~~~~---~~~~~Di------------------~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (287)
T 2wei_A 176 QNT-KMKDRIGTAYYIAPEVLRGT---YDEKCDV------------------WSAGVILYILLSGTPPFYGKNEYDILKR 233 (287)
T ss_dssp CCS-SCSCHHHHHTTCCHHHHTTC---CCTHHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred CCC-ccccccCcccccChHHhcCC---CCCchhh------------------HhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 432 22334588999999998642 3333333 999999999999999999877654321
Q ss_pred ----CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1037 ----PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1037 ----~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
....+.......+..+..++.+|+..+|..||+..+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el 274 (287)
T 2wei_A 234 VETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274 (287)
T ss_dssp HHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHH
Confidence 1112222224567789999999999999999986555
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.98 E-value=8.1e-33 Score=302.25 Aligned_cols=246 Identities=25% Similarity=0.324 Sum_probs=187.2
Q ss_pred HhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEcccccc--------
Q psy14556 802 FLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSE-------- 873 (1181)
Q Consensus 802 ~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d-------- 873 (1181)
+...|...+ .||+|+||.||+|++..+++.||+|++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 4 YASDFEEIA-VLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHHEEEEE-EEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccccchhhh-eeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 445555554 699999999999999999999999999543 2234678899999999999999999998744
Q ss_pred -----CCcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeee
Q psy14556 874 -----EGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKIS 948 (1181)
Q Consensus 874 -----~~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLi 948 (1181)
.+..++||||+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~-~~~~kl~ 158 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE-SRNVKIG 158 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TSCEEEC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcC-CCCEEEe
Confidence 46789999999999999999753 345678889999999999999999999999999999999987 8899999
Q ss_pred cCCcccccccCC--------------CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHH
Q psy14556 949 DFGTSKRLAGLC--------------PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCV 1014 (1181)
Q Consensus 949 DFGlAk~l~~~~--------------~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGv 1014 (1181)
|||++....... .......||+.|+|||++.+.. .++...|+ ||+|+
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di------------------~slG~ 219 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTG-HYNEKIDM------------------YSLGI 219 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCS-CCCTHHHH------------------HHHHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCC-CCcchhhH------------------HHHHH
Confidence 999997654221 1223456899999999996431 23333444 99999
Q ss_pred HHHHHHhCCCCCCCCCc-cc----c-cCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1015 IISQLLVLTAALKKKTS-RA----L-VAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1015 ILyELLTGk~PF~~~~~-~~----l-~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
++|+|++ ||..... .. + .....++...+...+..+..++.+|+..+|..||+..+..
T Consensus 220 il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 282 (303)
T 1zy4_A 220 IFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282 (303)
T ss_dssp HHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHh
Confidence 9999998 5543221 11 1 1123345555556677789999999999999999755443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=317.86 Aligned_cols=248 Identities=18% Similarity=0.241 Sum_probs=185.2
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcC--CCCeeeEccccccCCcEEEEEeecC
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLR--HRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~--HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
..+||+|+||.||+|.+.. ++.||||++...... ..+.+.+|+.++++++ ||||+++++++...+.+|+||| +.
T Consensus 61 ~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~ 138 (390)
T 2zmd_A 61 LKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CG 138 (390)
T ss_dssp EEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CC
T ss_pred EEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cC
Confidence 3479999999999998765 889999999765432 3567899999999996 5999999999999999999999 56
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC--CC
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP--SA 963 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~--~~ 963 (1181)
+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+..... ..
T Consensus 139 ~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~--~~~~kl~DFG~a~~~~~~~~~~~~ 213 (390)
T 2zmd_A 139 NIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVK 213 (390)
T ss_dssp SEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES--SSCEEECCCSSSCCC---------
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE--CCeEEEEecCccccccCCCccccC
Confidence 88999999854 3677888999999999999999999999999999999995 58999999999987654322 22
Q ss_pred ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc--c--cCCCC
Q psy14556 964 ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA--L--VAPPQ 1039 (1181)
Q Consensus 964 ~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~--l--~~~~~ 1039 (1181)
....||+.|+|||++.+........ .....+....+.||+||++|+|++|+.||.+..... + .....
T Consensus 214 ~~~~gt~~y~aPE~~~~~~~~~~~~---------~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~ 284 (390)
T 2zmd_A 214 DSQVGAVNYMPPEAIKDMSSSRENG---------KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 284 (390)
T ss_dssp CCSCCCGGGCCHHHHHCC---------------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTT
T ss_pred CCCCcCCCccChHHhhhcccccccc---------ccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcc
Confidence 3457999999999996421100000 000112333344999999999999999998754321 1 00111
Q ss_pred CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1040 ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1040 ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.....+...+..+..++.+|+..+|..||+..+.
T Consensus 285 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~el 318 (390)
T 2zmd_A 285 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318 (390)
T ss_dssp SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred ccCCCCccchHHHHHHHHHHcccChhhCCCHHHH
Confidence 1112223346678889999999999999976555
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=5.3e-33 Score=319.77 Aligned_cols=245 Identities=18% Similarity=0.242 Sum_probs=181.6
Q ss_pred eeecccCceEEEEEEEcCC---CeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccc-cCCcEEEEEeecC
Q psy14556 811 IELGKGSYGVVYAARELDR---QVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVS-EEGYFKIFMEQVP 885 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~t---g~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~-d~~~l~LVmEy~~ 885 (1181)
++||+|+||.||+|.+..+ +..||+|.+..... ...+.+.+|+.++++++||||+++++++. .++..++||||++
T Consensus 95 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~ 174 (373)
T 3c1x_A 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 174 (373)
T ss_dssp EEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCT
T ss_pred cEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCC
Confidence 4799999999999987543 35689999865432 33577999999999999999999999864 4568899999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC----
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP---- 961 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~---- 961 (1181)
+|+|.++++.. ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.......
T Consensus 175 ~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-~~~~kL~DFG~a~~~~~~~~~~~~ 251 (373)
T 3c1x_A 175 HGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSVH 251 (373)
T ss_dssp TCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TCCEEECCC---------------
T ss_pred CCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECC-CCCEEEeecccccccccccccccc
Confidence 99999999753 335678889999999999999999999999999999999987 88999999999986643221
Q ss_pred CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC-
Q psy14556 962 SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ- 1039 (1181)
Q Consensus 962 ~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~- 1039 (1181)
......+|+.|+|||++.+..++. ..|+ ||+|+++|+|++ |.+||.+.+..++.....
T Consensus 252 ~~~~~~~~~~y~aPE~~~~~~~~~--~~Dv------------------wSlG~il~ellt~~~~p~~~~~~~~~~~~~~~ 311 (373)
T 3c1x_A 252 NKTGAKLPVKWMALESLQTQKFTT--KSDV------------------WSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 311 (373)
T ss_dssp ------CCGGGSCHHHHHHCCCCH--HHHH------------------HHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHT
T ss_pred ccCCCCCcccccChHHhcCCCCCc--HHHH------------------HHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHc
Confidence 112344778999999998664433 3333 999999999999 678888766544321110
Q ss_pred -CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcc
Q psy14556 1040 -ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTG 1079 (1181)
Q Consensus 1040 -ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~ 1079 (1181)
.....+...+..+..++.+|+..+|..||+ +.+.+..+.
T Consensus 312 ~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs-~~ell~~L~ 351 (373)
T 3c1x_A 312 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPS-FSELVSRIS 351 (373)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-HHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCcC-HHHHHHHHH
Confidence 111223456788999999999999999985 444444333
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.9e-33 Score=311.81 Aligned_cols=248 Identities=22% Similarity=0.280 Sum_probs=189.2
Q ss_pred eeecccCceEEEEEE-----EcCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeec
Q psy14556 811 IELGKGSYGVVYAAR-----ELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQV 884 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~-----d~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~ 884 (1181)
+.||+|+||.||+|+ +..+++.||+|.+..... .....+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 36 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 115 (327)
T 2yfx_A 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELM 115 (327)
T ss_dssp EECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred EEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecC
Confidence 479999999999998 556788999999964432 23567889999999999999999999999999999999999
Q ss_pred CCCCcccchhcccC----CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccccc--CCCeeeeecCCccccccc
Q psy14556 885 PGGSLSTLLRVKWG----PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNT--YSGVVKISDFGTSKRLAG 958 (1181)
Q Consensus 885 ~gGSL~dlL~~~~~----~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~--~~g~vKLiDFGlAk~l~~ 958 (1181)
++++|.+++..... ...+++..++.++.||+.||.|||++||+||||||+|||++. .+..+||+|||++.....
T Consensus 116 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~ 195 (327)
T 2yfx_A 116 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 195 (327)
T ss_dssp TTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC
T ss_pred CCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcccccccccc
Confidence 99999999986421 245788899999999999999999999999999999999984 144799999999976543
Q ss_pred CC--CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCccccc
Q psy14556 959 LC--PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALV 1035 (1181)
Q Consensus 959 ~~--~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~ 1035 (1181)
.. .......+++.|+|||++.+..++. ..|+ ||+|+++|+|++ |..||.+.....+.
T Consensus 196 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--~~Di------------------~slG~il~ellt~g~~p~~~~~~~~~~ 255 (327)
T 2yfx_A 196 ASYYRKGGCAMLPVKWMPPEAFMEGIFTS--KTDT------------------WSFGVLLWEIFSLGYMPYPSKSNQEVL 255 (327)
T ss_dssp ------CCGGGSCGGGCCHHHHHHCCCCH--HHHH------------------HHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred ccccccCCCcCCCcceeCHhHhcCCCCCc--hhhH------------------HHHHHHHHHHHcCCCCCCCCcCHHHHH
Confidence 22 1223345789999999997654333 3333 999999999998 99999887764432
Q ss_pred CCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcc
Q psy14556 1036 APPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTG 1079 (1181)
Q Consensus 1036 ~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~ 1079 (1181)
.... .....+...+..+..++.+|+..+|..||+ +.+.+..+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~~ll~~l~ 300 (327)
T 2yfx_A 256 EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPN-FAIILERIE 300 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-HHHHHHHHH
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcC-HHHHHHHHH
Confidence 1111 111223456788999999999999999996 444443333
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.7e-33 Score=311.62 Aligned_cols=248 Identities=22% Similarity=0.282 Sum_probs=191.6
Q ss_pred hcccCceeecccCceEEEEEEE----cCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccC--CcE
Q psy14556 805 LFALNRIELGKGSYGVVYAARE----LDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEE--GYF 877 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d----~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~--~~l 877 (1181)
++....++||+|+||+||++.+ ..+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence 3433445799999999988764 45788999999976532 2356789999999999999999999999774 678
Q ss_pred EEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccc
Q psy14556 878 KIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 957 (1181)
Q Consensus 878 ~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~ 957 (1181)
++||||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++....
T Consensus 111 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~-~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDN-DRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-TCCEEECCGGGCEECC
T ss_pred EEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcC-CCCEEECCcccccccc
Confidence 9999999999999999754 4789999999999999999999999999999999999988 8999999999998765
Q ss_pred cCCC---CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc
Q psy14556 958 GLCP---SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL 1034 (1181)
Q Consensus 958 ~~~~---~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l 1034 (1181)
.... ......+|+.|+|||++.+..++.. .| .||+|+++|+|++|..||........
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~--~D------------------i~slG~il~~ll~g~~p~~~~~~~~~ 245 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYA--SD------------------VWSFGVTLYELLTHCDSSQSPPTKFL 245 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHH--HH------------------HHHHHHHHHHHHTTTCGGGSHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcH--HH------------------HHHHHHHHHHHHhCCCcccccchhhh
Confidence 4321 1223457888999999976543322 23 39999999999999999986543210
Q ss_pred ---------------cC--CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1035 ---------------VA--PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1035 ---------------~~--~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
.. ........+...+..+..++.+|++.+|..||+ +.+.+..+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps-~~ell~~L 305 (318)
T 3lxp_A 246 ELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPT-FENLIPIL 305 (318)
T ss_dssp HHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-HHHHHHHH
T ss_pred hhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcC-HHHHHHHH
Confidence 00 011122234467788999999999999999996 44433333
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-32 Score=311.46 Aligned_cols=246 Identities=24% Similarity=0.319 Sum_probs=193.1
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccC-----CcE
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEE-----GYF 877 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~-----~~l 877 (1181)
..|...+ +||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++++++||||+++++++... ...
T Consensus 27 ~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 27 PRYTNLS-YIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTEEEEE-EEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred ccEEEEE-EeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 3444443 79999999999999999999999999975432 2246788999999999999999999988654 468
Q ss_pred EEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccc
Q psy14556 878 KIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 957 (1181)
Q Consensus 878 ~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~ 957 (1181)
++||||+. ++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 106 ~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~-~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT-TCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT-TCCEEECCCTTCEECC
T ss_pred EEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECC-CCCEEEEeCcceEecC
Confidence 99999995 6898888753 5789999999999999999999999999999999999988 8899999999998765
Q ss_pred cCCCC---CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc
Q psy14556 958 GLCPS---AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL 1034 (1181)
Q Consensus 958 ~~~~~---~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l 1034 (1181)
..... .....||+.|+|||++.++. .++..+|+ ||+||++|+|++|+.||.+.+..+.
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~Di------------------wslG~il~ell~g~~pf~~~~~~~~ 240 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSK-GYTKSIDI------------------WSVGCILAEMLSNRPIFPGKHYLDQ 240 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBC-SCSTHHHH------------------HHHHHHHHHHHHSSCSSCCSSGGGH
T ss_pred CCCCccccccccccccCCCCCHHhcCCC-CCCcchhH------------------HHHHHHHHHHHHCCCCCCCCChHHH
Confidence 43221 23457999999999876432 23444444 9999999999999999988765432
Q ss_pred cCCC-------------------------CCCC-------CCCCCCCcchHHhhccCCCCCCCCCchhHHHHH
Q psy14556 1035 VAPP-------------------------QISR-------SVSVPGPGGINSSSSAPVTPTPHSRHISVNTNL 1075 (1181)
Q Consensus 1035 ~~~~-------------------------~ip~-------~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~ 1075 (1181)
.... ..+. ......+..+..++.+|+..+|.+||+..+.+.
T Consensus 241 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 241 LNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1100 0000 011345667888999999999999997555543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.5e-33 Score=341.19 Aligned_cols=242 Identities=21% Similarity=0.216 Sum_probs=190.6
Q ss_pred ccCceeecccCceEEEEEEE--cCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEe
Q psy14556 807 ALNRIELGKGSYGVVYAARE--LDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 807 ~l~~~kIG~G~fG~VYka~d--~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmE 882 (1181)
.+...+||+|+||.||+|.+ ..+++.||||+++.... ...+.+.+|+.++++++||||+++++++.. +..++|||
T Consensus 371 ~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E 449 (635)
T 4fl3_A 371 TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVME 449 (635)
T ss_dssp EEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred cccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEE
Confidence 33445799999999999965 45678999999975433 235789999999999999999999999865 45899999
Q ss_pred ecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC-
Q psy14556 883 QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP- 961 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~- 961 (1181)
|+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.+.....
T Consensus 450 ~~~~g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~-~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 450 MAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp CCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE-TTEEEECCTTHHHHTTC----
T ss_pred ccCCCCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeC-CCCEEEEEcCCccccccCccc
Confidence 99999999999743 35789999999999999999999999999999999999998 89999999999987654321
Q ss_pred --CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCC
Q psy14556 962 --SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPP 1038 (1181)
Q Consensus 962 --~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~ 1038 (1181)
......+|+.|+|||++.+..++. .+|+ ||+|+++|||++ |+.||.+.+..++....
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~--~sDv------------------wSlGv~l~ellt~G~~Pf~~~~~~~~~~~i 585 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSS--KSDV------------------WSFGVLMWEAFSYGQKPYRGMKGSEVTAML 585 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCH--HHHH------------------HHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred cccccCCCCceeeeChhhhcCCCCCc--HHHH------------------HHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 122234678999999997654433 3333 999999999998 99999988765532211
Q ss_pred C--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1039 Q--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1039 ~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
. .....+..++..+..++.+|+..+|..||+..+.
T Consensus 586 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l 622 (635)
T 4fl3_A 586 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAV 622 (635)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 1 1122344678889999999999999999975443
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.2e-33 Score=315.04 Aligned_cols=246 Identities=17% Similarity=0.173 Sum_probs=186.5
Q ss_pred ceeecccCceEEEEEEEcC---CCeEEEEEEecCCCCC-----------ChhHHHHHHHHHHhcCCCCeeeEcccccc--
Q psy14556 810 RIELGKGSYGVVYAARELD---RQVKLAIKEIPEKNLG-----------DVQPLHEEIKLHSQLRHRNIVQYLGSVSE-- 873 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~---tg~~VAIKii~~~~~~-----------~~e~f~rEi~IL~~L~HPNIVkl~g~~~d-- 873 (1181)
.++||+|+||.||+|.+.. ++..||+|++...... ..+.+.+|+.+++.++||||+++++++..
T Consensus 42 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~ 121 (345)
T 2v62_A 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEF 121 (345)
T ss_dssp EEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEES
T ss_pred EeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccccccc
Confidence 3479999999999999987 7889999999765321 12346778889999999999999999877
Q ss_pred --CCcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCC--eeeeec
Q psy14556 874 --EGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSG--VVKISD 949 (1181)
Q Consensus 874 --~~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g--~vKLiD 949 (1181)
....++||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++. ++ .+||+|
T Consensus 122 ~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kL~D 196 (345)
T 2v62_A 122 KGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGY-KNPDQVYLAD 196 (345)
T ss_dssp SSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEES-SSTTSEEECC
T ss_pred CCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEcc-CCCCcEEEEe
Confidence 67899999999 999999998542 6889999999999999999999999999999999999987 55 999999
Q ss_pred CCcccccccCCCC-------CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhC
Q psy14556 950 FGTSKRLAGLCPS-------AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVL 1022 (1181)
Q Consensus 950 FGlAk~l~~~~~~-------~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTG 1022 (1181)
||+++.+...... .....||+.|+|||++.+..++ ...|+ ||+|+++|+|++|
T Consensus 197 fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~Di------------------~slG~il~ell~g 256 (345)
T 2v62_A 197 YGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALS--RRSDV------------------EILGYCMLRWLCG 256 (345)
T ss_dssp CTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCC--HHHHH------------------HHHHHHHHHHHHS
T ss_pred CCCceecccccccccchhccccccCCCccccCHHHhcCCCCC--chhhH------------------HHHHHHHHHHHhC
Confidence 9999876432211 1345699999999999865433 33333 9999999999999
Q ss_pred CCCCCCCCccc--ccC-----CCCCCCC-----CCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcccC
Q psy14556 1023 TAALKKKTSRA--LVA-----PPQISRS-----VSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGNN 1081 (1181)
Q Consensus 1023 k~PF~~~~~~~--l~~-----~~~ip~~-----l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~~ 1081 (1181)
+.||.+..... +.. ...++.. .....+..+..++.+|+..+|..||+ +.+.+..+...
T Consensus 257 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~~l~~~L~~~ 326 (345)
T 2v62_A 257 KLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPN-YQALKKILNPH 326 (345)
T ss_dssp SCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCC-HHHHHHHHCTT
T ss_pred CCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCC-HHHHHHHHhcc
Confidence 99997643211 100 0011110 01257788999999999999999985 66666666654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-32 Score=315.97 Aligned_cols=245 Identities=22% Similarity=0.300 Sum_probs=185.5
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCC------cEEEEEee
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEG------YFKIFMEQ 883 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~------~l~LVmEy 883 (1181)
..+||+|+||+||+|++..+++ ||+|++...... ..+|+.+++.++||||+++++++...+ .+++||||
T Consensus 45 ~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~ 119 (394)
T 4e7w_A 45 CKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119 (394)
T ss_dssp EEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEEC
T ss_pred eEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeec
Confidence 3479999999999999887776 888877544322 237999999999999999999985433 48899999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCC
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA 963 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~ 963 (1181)
++++.+..+.........+++..++.++.||+.||+|||++||+||||||+|||++..++.+||+|||+++...... ..
T Consensus 120 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~-~~ 198 (394)
T 4e7w_A 120 VPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE-PN 198 (394)
T ss_dssp CSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC-CC
T ss_pred cCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC-CC
Confidence 97654444433222345688999999999999999999999999999999999998448999999999998765432 33
Q ss_pred ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC-------
Q psy14556 964 ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA------- 1036 (1181)
Q Consensus 964 ~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~------- 1036 (1181)
....||+.|+|||++.+.. .++..+|+ ||+||++|+|++|+.||.+.+..+...
T Consensus 199 ~~~~~t~~y~aPE~~~~~~-~~~~~~Di------------------wSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 259 (394)
T 4e7w_A 199 VSYICSRYYRAPELIFGAT-NYTTNIDI------------------WSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLG 259 (394)
T ss_dssp CSSCSCGGGCCHHHHTTCS-SCCTHHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred cccccCcCccCHHHHcCCC-CCCcHHHH------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 3457899999999996432 34445555 999999999999999999876432100
Q ss_pred ---------------CCCC--------CCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcc
Q psy14556 1037 ---------------PPQI--------SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTG 1079 (1181)
Q Consensus 1037 ---------------~~~i--------p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~ 1079 (1181)
...+ ....+...+..+..++.+|+..+|..||+..+.+.....
T Consensus 260 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 325 (394)
T 4e7w_A 260 TPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325 (394)
T ss_dssp CCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred CCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhh
Confidence 0011 111223466788899999999999999986655443333
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=307.27 Aligned_cols=245 Identities=22% Similarity=0.301 Sum_probs=189.0
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccC-----CcE
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEE-----GYF 877 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~-----~~l 877 (1181)
..|.+.+ +||+|+||.||+|.+..+++.||||++..... .....+.+|+.++++++||||+++++++... ...
T Consensus 11 ~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 11 SDFQLKS-LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp TTEEEEE-EEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred cceEEee-EEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 3444443 69999999999999999999999999964432 2245688999999999999999999987654 679
Q ss_pred EEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccc
Q psy14556 878 KIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 957 (1181)
Q Consensus 878 ~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~ 957 (1181)
++||||+. ++|.+++... .+++..++.++.|++.||+|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 90 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS-NCDLKVCDFGLARIID 163 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT-TCCEEECCCTTCEECC
T ss_pred EEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcC-CCcEEEEecccccccc
Confidence 99999995 6898888753 5789999999999999999999999999999999999988 8899999999998765
Q ss_pred cCCCC----------CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCC
Q psy14556 958 GLCPS----------AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALK 1027 (1181)
Q Consensus 958 ~~~~~----------~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~ 1027 (1181)
..... .....||+.|+|||++.++. .++...|+ ||+||++|+|++|+.||.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~Di------------------~slG~il~~l~~g~~pf~ 224 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSA-KYSRAMDV------------------WSCGCILAELFLRRPIFP 224 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCC-CCCHHHHH------------------HHHHHHHHHHHHSSCSCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCC-CccchhhH------------------HHHHHHHHHHHhCCCCCC
Confidence 32111 12346899999999986422 23333444 999999999999999999
Q ss_pred CCCccccc-------CCC----------------------CCC----CCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1028 KKTSRALV-------APP----------------------QIS----RSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1028 ~~~~~~l~-------~~~----------------------~ip----~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
+.+..... ..+ ..+ .......+..+..++.+|+..||..||+..+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 304 (353)
T 2b9h_A 225 GRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEAL 304 (353)
T ss_dssp CSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 87642210 000 000 011235677788899999999999999755443
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-32 Score=314.96 Aligned_cols=245 Identities=22% Similarity=0.314 Sum_probs=176.0
Q ss_pred hhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEccccccC------
Q psy14556 803 LYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSEE------ 874 (1181)
Q Consensus 803 ~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~------ 874 (1181)
...|... .+||+|+||.||+|.+..+++.||||++...... ..+.+.+|+.+++.++||||+++++++...
T Consensus 28 ~~~y~~~-~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEE-EECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEe-eEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 3444444 3799999999999999999999999999654322 356788999999999999999999988653
Q ss_pred CcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccc
Q psy14556 875 GYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954 (1181)
Q Consensus 875 ~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk 954 (1181)
...|+|||++ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~-~~~~kL~DFG~a~ 180 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE-DCELKILDFGLAR 180 (367)
T ss_dssp CCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TCCEEECC-----
T ss_pred CeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECC-CCCEEEeeccccc
Confidence 5689999999 8899999874 25789999999999999999999999999999999999988 8999999999998
Q ss_pred ccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc
Q psy14556 955 RLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL 1034 (1181)
Q Consensus 955 ~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l 1034 (1181)
..... .....||+.|+|||++.+. ..++..+|+ ||+||++|+|++|+.||.+.+....
T Consensus 181 ~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~Di------------------wslG~il~ell~g~~pf~~~~~~~~ 238 (367)
T 2fst_X 181 HTADE---MTGYVATRWYRAPEIMLNW-MHYNQTVDI------------------WSVGCIMAELLTGRTLFPGTDHIDQ 238 (367)
T ss_dssp -------------CCCTTCCHHHHTTC-CSCCTTHHH------------------HHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccc---CCCcCcCcCccChHHHcCC-cCCCchhhH------------------HHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 75432 3345799999999999752 234444444 9999999999999999998765321
Q ss_pred cC-------C---------------------CCCCC----CCCCCCCcchHHhhccCCCCCCCCCchhHHHHHH
Q psy14556 1035 VA-------P---------------------PQISR----SVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLV 1076 (1181)
Q Consensus 1035 ~~-------~---------------------~~ip~----~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~ 1076 (1181)
.. . ...+. ......+..+..++.+|+..||.+||+..+.+..
T Consensus 239 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 239 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00 0 00000 0112345667889999999999999986555433
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=315.23 Aligned_cols=198 Identities=24% Similarity=0.321 Sum_probs=156.6
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEccccccCC------c
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEG------Y 876 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~------~ 876 (1181)
.|... .+||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++...+ .
T Consensus 26 ~y~~~-~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 26 RYQNL-KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred heeEe-eeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 44443 3699999999999999999999999999754322 2466889999999999999999999987654 7
Q ss_pred EEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccccc
Q psy14556 877 FKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956 (1181)
Q Consensus 877 l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l 956 (1181)
.++||||++ ++|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..
T Consensus 105 ~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~-~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 105 VYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-DCTLKILDFGLARTA 177 (371)
T ss_dssp EEEEEECCS-EEHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TSCEEECCCCC----
T ss_pred eEEEEEcCC-CCHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcC-CCCEEEEEeeccccc
Confidence 899999996 577777752 3778899999999999999999999999999999999998 899999999999866
Q ss_pred ccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCc
Q psy14556 957 AGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTS 1031 (1181)
Q Consensus 957 ~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~ 1031 (1181)
... .......||+.|+|||++.+..++ ..+|+ ||+||++|+|++|+.||.+.+.
T Consensus 178 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~--~~~Di------------------wslG~il~el~~g~~pf~~~~~ 231 (371)
T 2xrw_A 178 GTS-FMMTPYVVTRYYRAPEVILGMGYK--ENVDI------------------WSVGCIMGEMIKGGVLFPGTDH 231 (371)
T ss_dssp -------------CTTCCHHHHTTCCCC--TTHHH------------------HHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccc-cccCCceecCCccCHHHhcCCCCC--chHhH------------------HHHHHHHHHHHhCCCCCCCCCH
Confidence 532 223345789999999999865433 34444 9999999999999999998765
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-32 Score=308.80 Aligned_cols=245 Identities=24% Similarity=0.308 Sum_probs=191.5
Q ss_pred ceeecccCceEEEEEEE----cCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccC--CcEEEEEee
Q psy14556 810 RIELGKGSYGVVYAARE----LDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEE--GYFKIFMEQ 883 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d----~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~--~~l~LVmEy 883 (1181)
.++||+|+||.||+|++ ..+++.||+|++........+.+.+|+.++++++||||+++++++... ...++||||
T Consensus 46 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 125 (326)
T 2w1i_A 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY 125 (326)
T ss_dssp EEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECC
T ss_pred eeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEEC
Confidence 34799999999999984 568899999999876555567899999999999999999999988665 378999999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC-
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS- 962 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~- 962 (1181)
+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++.........
T Consensus 126 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~-~~~~kL~Dfg~~~~~~~~~~~~ 202 (326)
T 2w1i_A 126 LPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN-ENRVKIGDFGLTKVLPQDKEYY 202 (326)
T ss_dssp CTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE-TTEEEECCCTTCEECCSSCSEE
T ss_pred CCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcC-CCcEEEecCcchhhcccccccc
Confidence 9999999999754 235789999999999999999999999999999999999988 899999999999876543221
Q ss_pred --CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc-------
Q psy14556 963 --AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA------- 1033 (1181)
Q Consensus 963 --~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~------- 1033 (1181)
.....++..|+|||++.+..++.. . +.||+|+++|+|++|..||.......
T Consensus 203 ~~~~~~~~~~~y~aPE~~~~~~~~~~--~------------------Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~ 262 (326)
T 2w1i_A 203 KVKEPGESPIFWYAPESLTESKFSVA--S------------------DVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 262 (326)
T ss_dssp ECSSCCSCCGGGCCHHHHHHCEEEHH--H------------------HHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTT
T ss_pred ccccCCCCceeEECchhhcCCCCCch--h------------------hHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccc
Confidence 223347788999999976543322 2 33999999999999999987542110
Q ss_pred ---------ccC--CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1034 ---------LVA--PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1034 ---------l~~--~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
+.. ........+...+..+..++.+|++.+|..||+ +.+.+..+
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~el~~~L 317 (326)
T 2w1i_A 263 KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPS-FRDLALRV 317 (326)
T ss_dssp CCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCC-HHHHHHHH
T ss_pred cchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcC-HHHHHHHH
Confidence 000 000111223457788999999999999999996 44444333
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=309.25 Aligned_cols=250 Identities=24% Similarity=0.318 Sum_probs=180.7
Q ss_pred HHhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCC-----
Q psy14556 801 RFLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEG----- 875 (1181)
Q Consensus 801 ~~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~----- 875 (1181)
...+.|.+.+ +||+|+||.||+|++..+++.||||++.... ...+...+|+..++.++||||+++++++...+
T Consensus 20 ~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 20 KEMDRFQVER-MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HHHTTEEEC-----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred hhccceEEEE-EEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 3445565554 6999999999999999999999999986543 33456778889999999999999999985533
Q ss_pred --cEEEEEeecCCCCcccchh-cccCCCCCChHHHHHHHHHHHhhhhhcc--ccceecccCCCCCcccccCCCeeeeecC
Q psy14556 876 --YFKIFMEQVPGGSLSTLLR-VKWGPLKENESTMSFYTKQILEGLKYLH--GQKIVHRDIKGDNVLVNTYSGVVKISDF 950 (1181)
Q Consensus 876 --~l~LVmEy~~gGSL~dlL~-~~~~~~~l~e~~i~~Ia~QIa~AL~yLH--s~gIVHrDLKP~NILLd~~~g~vKLiDF 950 (1181)
..++||||+++ +|...+. .......+++..++.++.|++.||.||| ++||+||||||+|||++..++.+||+||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Df 176 (360)
T 3e3p_A 98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176 (360)
T ss_dssp CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCC
T ss_pred ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeC
Confidence 38899999976 4444333 2224456788999999999999999999 9999999999999999865789999999
Q ss_pred CcccccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCC
Q psy14556 951 GTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKT 1030 (1181)
Q Consensus 951 GlAk~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~ 1030 (1181)
|+++...... ......||+.|+|||++.+.. .++...|+ ||+||++|+|++|+.||.+.+
T Consensus 177 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~~Di------------------~slG~il~ell~g~~pf~~~~ 236 (360)
T 3e3p_A 177 GSAKKLSPSE-PNVAYICSRYYRAPELIFGNQ-HYTTAVDI------------------WSVGCIFAEMMLGEPIFRGDN 236 (360)
T ss_dssp TTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCS-SCCTHHHH------------------HHHHHHHHHHHHSSCSSCCSS
T ss_pred CCceecCCCC-CcccccCCcceeCHHHHcCCC-CCCcHHHH------------------HHHHHHHHHHHhCCCCcCCCC
Confidence 9998765432 233456899999999996432 23344444 999999999999999999876
Q ss_pred cccccCCC----------------------CC-----------CCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1031 SRALVAPP----------------------QI-----------SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1031 ~~~l~~~~----------------------~i-----------p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
........ .. ........+..+..++.+|+..+|.+||+..+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 312 (360)
T 3e3p_A 237 SAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEA 312 (360)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHH
Confidence 53311000 00 011112245578889999999999999975554
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=303.82 Aligned_cols=242 Identities=23% Similarity=0.313 Sum_probs=187.8
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC--hhHHHHHHHHHHhcCCCCeeeEccccccCCc------
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD--VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGY------ 876 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~--~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~------ 876 (1181)
.|.. ...||+|+||.||+|.+..+++.||||++....... .+.+.+|+.+++.++||||+++++++...+.
T Consensus 25 ~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 25 TYVS-PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred eEEE-eeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 3444 347999999999999999999999999997654322 4678899999999999999999999877654
Q ss_pred EEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccccc
Q psy14556 877 FKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956 (1181)
Q Consensus 877 l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l 956 (1181)
+++||||+. ++|.+++.. .+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++..
T Consensus 104 ~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~-~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE-DCELKILDFGLARHA 176 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECT-TCCEEECSTTCTTC-
T ss_pred EEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECC-CCcEEEeecccccCC
Confidence 599999996 688887752 3789999999999999999999999999999999999997 889999999999765
Q ss_pred ccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC
Q psy14556 957 AGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA 1036 (1181)
Q Consensus 957 ~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~ 1036 (1181)
... .....+|+.|+|||++.+. ..++...|+ ||+|+++|+|++|+.||.+.+..+...
T Consensus 177 ~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~Di------------------~slG~il~el~~g~~pf~~~~~~~~~~ 234 (353)
T 3coi_A 177 DAE---MTGYVVTRWYRAPEVILSW-MHYNQTVDI------------------WSVGCIMAEMLTGKTLFKGKDYLDQLT 234 (353)
T ss_dssp ----------CCSBCCSCHHHHSCC-SCCCTTHHH------------------HHHHHHHHHHHHSSCSSBSSCHHHHHH
T ss_pred CCC---ccccccCcCcCCHHHHhCc-CCCCchhhH------------------HHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 432 3345689999999999752 223334444 999999999999999999876422100
Q ss_pred ----------------------------CCCC----CCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHH
Q psy14556 1037 ----------------------------PPQI----SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLV 1076 (1181)
Q Consensus 1037 ----------------------------~~~i----p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~ 1076 (1181)
.+.. -.......+..+..++.+|+..+|.+||+..+.+..
T Consensus 235 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 235 QILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 011223557788899999999999999986555433
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-33 Score=316.73 Aligned_cols=200 Identities=21% Similarity=0.266 Sum_probs=163.7
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcC--------CCCeeeEccccc---
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR--------HRNIVQYLGSVS--- 872 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~--------HPNIVkl~g~~~--- 872 (1181)
..|.+. .+||+|+||+||+|++..+++.||+|++... ....+.+.+|+.+++.++ ||||+++++++.
T Consensus 37 ~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 37 GRYHVI-RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CeEEEE-EEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 344443 4799999999999999999999999999643 223467889999999985 788999999987
Q ss_pred -cCCcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhcccc-ceecccCCCCCcccccCCC-------
Q psy14556 873 -EEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ-KIVHRDIKGDNVLVNTYSG------- 943 (1181)
Q Consensus 873 -d~~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~-gIVHrDLKP~NILLd~~~g------- 943 (1181)
....+++||||+ +++|.+.+... ....+++..++.++.||+.||+|||++ ||+||||||+|||++. ++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~-~~~~~~~~~ 191 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSV-NEQYIRRLA 191 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECC-CHHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEec-cchhhhhhh
Confidence 567899999999 66666666543 234578999999999999999999998 9999999999999986 33
Q ss_pred ------------------------------------------eeeeecCCcccccccCCCCCccccCCccccCchhhccC
Q psy14556 944 ------------------------------------------VVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKG 981 (1181)
Q Consensus 944 ------------------------------------------~vKLiDFGlAk~l~~~~~~~~t~~GT~~Y~APEvl~gg 981 (1181)
.+||+|||+++..... .....||+.|+|||++.+.
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~~~ 268 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIGS 268 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHHTS
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhhcCC
Confidence 7999999999876532 3345689999999999866
Q ss_pred CCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCc
Q psy14556 982 QRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTS 1031 (1181)
Q Consensus 982 ~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~ 1031 (1181)
.++ ..+|+ |||||++|+|++|+.||.+.+.
T Consensus 269 ~~~--~~~Di------------------wslG~il~elltg~~pf~~~~~ 298 (397)
T 1wak_A 269 GYN--TPADI------------------WSTACMAFELATGDYLFEPHSG 298 (397)
T ss_dssp CCC--THHHH------------------HHHHHHHHHHHHSSCSCCCCCC
T ss_pred CCC--cHHHH------------------HHHHHHHHHHhhCCCCCCCCcc
Confidence 543 34444 9999999999999999987653
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-32 Score=320.32 Aligned_cols=201 Identities=25% Similarity=0.353 Sum_probs=167.7
Q ss_pred hhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhc------CCCCeeeEccccccCCc
Q psy14556 803 LYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL------RHRNIVQYLGSVSEEGY 876 (1181)
Q Consensus 803 ~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L------~HPNIVkl~g~~~d~~~ 876 (1181)
.+.|.+.+ +||+|+||.||+|.+..+++.||||++.... ...+.+.+|+.+++.+ +|+||+++++++...+.
T Consensus 96 ~~ry~~~~-~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 96 AYRYEVLK-VIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp TTTEEEEE-EEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred cCcEEEEE-EcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 34454444 7999999999999999999999999996542 2235677899888887 57799999999999999
Q ss_pred EEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCe--eeeecCCccc
Q psy14556 877 FKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGV--VKISDFGTSK 954 (1181)
Q Consensus 877 l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~--vKLiDFGlAk 954 (1181)
+++||||+. ++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++. ++. +||+|||+++
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~-~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ-QGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESS-TTSCCEEECCCTTCE
T ss_pred EEEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcc-CCCcceEEeecccce
Confidence 999999994 7899888764 3345789999999999999999999999999999999999987 665 9999999997
Q ss_pred ccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCc
Q psy14556 955 RLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTS 1031 (1181)
Q Consensus 955 ~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~ 1031 (1181)
.... ......||+.|+|||++.+..+ +..+|+ ||+||++|+|++|..||.+.+.
T Consensus 251 ~~~~---~~~~~~gt~~y~aPE~~~~~~~--~~~~Di------------------wSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 251 YEHQ---RVYTYIQSRFYRAPEVILGARY--GMPIDM------------------WSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp ETTC---CCCSSCSCGGGCCHHHHHTBCC--CTHHHH------------------HHHHHHHHHHHHSSCSSCCSSH
T ss_pred ecCC---cccccCCCCCccChHHHhCCCC--CchHHH------------------HhHHHHHHHHHhCCCCCCCCCH
Confidence 6543 3345679999999999986654 334444 9999999999999999988765
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-32 Score=309.40 Aligned_cols=245 Identities=18% Similarity=0.251 Sum_probs=180.7
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC-----------hhHHHHHHHHHHhcCCCCeeeEccccc-
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD-----------VQPLHEEIKLHSQLRHRNIVQYLGSVS- 872 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~-----------~e~f~rEi~IL~~L~HPNIVkl~g~~~- 872 (1181)
.|.+. .+||+|+||.||+|.+.. ++.||+|++....... .+.+.+|+.++++++||||+++++++.
T Consensus 23 ~y~~~-~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 23 PYTVQ-RFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp SCEEE-EEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred ceEEe-EEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 34443 379999999999998755 8899999996543221 267899999999999999999999983
Q ss_pred ----cCCcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeee
Q psy14556 873 ----EEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKIS 948 (1181)
Q Consensus 873 ----d~~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLi 948 (1181)
.....++||||+. |+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+
T Consensus 101 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~-~~~~kl~ 176 (362)
T 3pg1_A 101 FEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLAD-NNDITIC 176 (362)
T ss_dssp CCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TCCEEEC
T ss_pred ccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcC-CCCEEEE
Confidence 3457899999996 6787777643 346789999999999999999999999999999999999987 8899999
Q ss_pred cCCcccccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCC
Q psy14556 949 DFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKK 1028 (1181)
Q Consensus 949 DFGlAk~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~ 1028 (1181)
|||+++..... .......||+.|+|||++.+.. .++...|+ ||+||++|+|++|+.||.+
T Consensus 177 Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~-~~~~~~Di------------------wslG~il~~l~~g~~pf~~ 236 (362)
T 3pg1_A 177 DFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFK-GFTKLVDM------------------WSAGCVMAEMFNRKALFRG 236 (362)
T ss_dssp CTTC----------------CGGGCCHHHHTTCT-TCCTHHHH------------------HHHHHHHHHHHHSSCSCCC
T ss_pred ecCcccccccc-cccceecccceecCcHHhcCCC-CCCcHhHH------------------HhHHHHHHHHHhCCCCCCC
Confidence 99999755432 2233456899999999997522 23334444 9999999999999999998
Q ss_pred CCcccccC-------C----------------------CCC----CCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHH
Q psy14556 1029 KTSRALVA-------P----------------------PQI----SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNL 1075 (1181)
Q Consensus 1029 ~~~~~l~~-------~----------------------~~i----p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~ 1075 (1181)
.+...... . ... ........+..+..++.+|++.+|.+||+..+.+.
T Consensus 237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 237 STFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 76422100 0 000 01112344667888999999999999998655543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-32 Score=303.53 Aligned_cols=251 Identities=21% Similarity=0.252 Sum_probs=189.8
Q ss_pred HhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHh--cCCCCeeeEccccccCC----
Q psy14556 802 FLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQ--LRHRNIVQYLGSVSEEG---- 875 (1181)
Q Consensus 802 ~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~--L~HPNIVkl~g~~~d~~---- 875 (1181)
+...|.+. ++||+|+||.||+|++ +++.||+|++... ..+.+.+|++++.. ++||||+++++++...+
T Consensus 40 ~~~~y~~~-~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 40 IARTIVLQ-ESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHCEEE-EEEEEETTEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccEEEE-eeecCCCCcEEEEEEE--cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 44455554 4799999999999988 5889999999543 34567889999988 79999999999988775
Q ss_pred cEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhcc--------ccceecccCCCCCcccccCCCeeee
Q psy14556 876 YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLH--------GQKIVHRDIKGDNVLVNTYSGVVKI 947 (1181)
Q Consensus 876 ~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLH--------s~gIVHrDLKP~NILLd~~~g~vKL 947 (1181)
..++||||+++|+|.+++... .+++..++.++.|++.||.||| ++||+||||||+|||++. ++.+||
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~-~~~~kL 188 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCI 188 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECT-TSCEEE
T ss_pred eeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECC-CCCEEE
Confidence 899999999999999999753 5789999999999999999999 899999999999999988 889999
Q ss_pred ecCCcccccccCCC----CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhC-
Q psy14556 948 SDFGTSKRLAGLCP----SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVL- 1022 (1181)
Q Consensus 948 iDFGlAk~l~~~~~----~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTG- 1022 (1181)
+|||++........ ......||+.|+|||++.+...... ..+....+.||+|+++|+|++|
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--------------~~~~~~~Di~slG~il~el~tg~ 254 (342)
T 1b6c_B 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH--------------FESFKRADIYAMGLVFWEIARRC 254 (342)
T ss_dssp CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTC--------------HHHHHHHHHHHHHHHHHHHHTTB
T ss_pred EECCCceeccccccccccccccCCcCcccCCHhhhcccccccc--------------cccCCcccHHHHHHHHHHHHhcc
Confidence 99999987654322 1234569999999999975421110 0112234449999999999999
Q ss_pred ---------CCCCCCCCccc-----c---cCC----CCCCCC-CCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1023 ---------TAALKKKTSRA-----L---VAP----PQISRS-VSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1023 ---------k~PF~~~~~~~-----l---~~~----~~ip~~-l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
..||....... + ... +.++.. .....+..+..++.+|+..+|..||+ +.+.+..+
T Consensus 255 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps-~~~i~~~L 331 (342)
T 1b6c_B 255 SIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT-ALRIKKTL 331 (342)
T ss_dssp CBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCC-HHHHHHHH
T ss_pred CcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCC-HHHHHHHH
Confidence 78887654321 1 101 111110 01123346788999999999999995 44444433
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-32 Score=304.50 Aligned_cols=246 Identities=24% Similarity=0.294 Sum_probs=177.0
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHH--HhcCCCCeeeEcccc-----ccCCcEEEEEee
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLH--SQLRHRNIVQYLGSV-----SEEGYFKIFMEQ 883 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL--~~L~HPNIVkl~g~~-----~d~~~l~LVmEy 883 (1181)
++||+|+||.||+|++ +++.||+|++.... .+.+..|..++ ..++||||+++++.+ .....+++||||
T Consensus 19 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 93 (336)
T 3g2f_A 19 ELIGRGRYGAVYKGSL--DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEY 93 (336)
T ss_dssp EEEEECSSEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECC
T ss_pred eecccCCCeEEEEEEE--CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEec
Confidence 3799999999999976 68899999996442 34455555554 458999999999743 334568999999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhcccc---------ceecccCCCCCcccccCCCeeeeecCCccc
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ---------KIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~---------gIVHrDLKP~NILLd~~~g~vKLiDFGlAk 954 (1181)
+++|+|.+++... ..++..++.++.||+.||.|||++ ||+||||||+|||++. ++.+||+|||+++
T Consensus 94 ~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~-~~~~kL~DFG~a~ 168 (336)
T 3g2f_A 94 YPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN-DGTCVISDFGLSM 168 (336)
T ss_dssp CTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECT-TSCEEECCCTTCE
T ss_pred CCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcC-CCcEEEeecccee
Confidence 9999999999754 347888999999999999999999 9999999999999988 8999999999998
Q ss_pred ccccCC--------CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCC
Q psy14556 955 RLAGLC--------PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAAL 1026 (1181)
Q Consensus 955 ~l~~~~--------~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF 1026 (1181)
.+.... .......||+.|+|||++.+..... ....+....+.||+||++|||++|..||
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-------------~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLR-------------DXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp ECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGG-------------GHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred ecccccccCccccccccccCCCccceeCchhhcCCcccc-------------cccccccccchHHHHHHHHHHHhcCCcC
Confidence 765321 1122346999999999997531100 0112333445599999999999997766
Q ss_pred CCCCc-ccccC--------------------CCCCCCCCCCC------CCcchHHhhccCCCCCCCCCchhHHHHHHhcc
Q psy14556 1027 KKKTS-RALVA--------------------PPQISRSVSVP------GPGGINSSSSAPVTPTPHSRHISVNTNLVCTG 1079 (1181)
Q Consensus 1027 ~~~~~-~~l~~--------------------~~~ip~~l~~~------~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~ 1079 (1181)
..... ..... ........+.. .+..+..++.+|++.+|..||+ +.+.+..+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~e~l~~L~ 314 (336)
T 3g2f_A 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLT-AQXAEERMA 314 (336)
T ss_dssp STTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCC-HHHHHHHHH
T ss_pred CCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcc-hHHHHHHHH
Confidence 44332 11110 00111111111 1225888999999999999995 555444444
Q ss_pred c
Q psy14556 1080 N 1080 (1181)
Q Consensus 1080 ~ 1080 (1181)
.
T Consensus 315 ~ 315 (336)
T 3g2f_A 315 E 315 (336)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=301.02 Aligned_cols=245 Identities=23% Similarity=0.259 Sum_probs=183.0
Q ss_pred eeecccCceEEEEEEEcC-CC--eEEEEEEecCCCC---CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeec
Q psy14556 811 IELGKGSYGVVYAARELD-RQ--VKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQV 884 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~-tg--~~VAIKii~~~~~---~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~ 884 (1181)
++||+|+||.||+|.+.. ++ ..||+|+++.... ...+.+.+|+.++++++||||+++++++.+.+ .++||||+
T Consensus 24 ~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~ 102 (291)
T 1u46_A 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELA 102 (291)
T ss_dssp EECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECC
T ss_pred eeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecc
Confidence 479999999999998643 33 3689999875532 23567899999999999999999999998765 88999999
Q ss_pred CCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC--
Q psy14556 885 PGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS-- 962 (1181)
Q Consensus 885 ~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~-- 962 (1181)
++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||++.........
T Consensus 103 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~-~~~~kl~Dfg~~~~~~~~~~~~~ 179 (291)
T 1u46_A 103 PLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT-RDLVKIGDFGLMRALPQNDDHYV 179 (291)
T ss_dssp TTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE-TTEEEECCCTTCEECCC-CCEEE
T ss_pred cCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcC-CCCEEEccccccccccccccchh
Confidence 9999999997542 35778999999999999999999999999999999999987 899999999999876543221
Q ss_pred -CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCC---
Q psy14556 963 -AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAP--- 1037 (1181)
Q Consensus 963 -~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~--- 1037 (1181)
.....+|..|+|||++.+..++. .. +.||+|+++|+|++ |+.||.+.+...+...
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~--~~------------------Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~ 239 (291)
T 1u46_A 180 MQEHRKVPFAWCAPESLKTRTFSH--AS------------------DTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 239 (291)
T ss_dssp C-----CCGGGCCHHHHHHCEEEH--HH------------------HHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred hhccCCCCceeeCchhhcCCCCCc--hh------------------hHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHc
Confidence 22345788999999997554322 22 33999999999999 9999998776543211
Q ss_pred CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1038 PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1038 ~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
.......+...+..+..++.+|++.+|..||+ +.+.+..+..
T Consensus 240 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~~l~~~l~~ 281 (291)
T 1u46_A 240 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPT-FVALRDFLLE 281 (291)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-HHHHHHHHHH
T ss_pred cCCCCCCCcCcCHHHHHHHHHHccCCcccCcC-HHHHHHHHHH
Confidence 11122233467788999999999999999995 4554444444
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-33 Score=316.65 Aligned_cols=244 Identities=18% Similarity=0.250 Sum_probs=184.1
Q ss_pred hcccCceeecccCceEEEEEEEcCC-----CeEEEEEEecCCCCC-----------ChhHHHHHHHHHHhcCCCCeeeEc
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDR-----QVKLAIKEIPEKNLG-----------DVQPLHEEIKLHSQLRHRNIVQYL 868 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~t-----g~~VAIKii~~~~~~-----------~~e~f~rEi~IL~~L~HPNIVkl~ 868 (1181)
.|.+. .+||+|+||.||+|.+..+ ++.||+|++...... ....+..|+..++.++||||++++
T Consensus 36 ~y~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 36 AWKVG-LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp EEEEE-EECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred eEEEE-EEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 34443 4799999999999998765 578999998765321 112234455666777899999999
Q ss_pred cccccC----CcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccc--cCC
Q psy14556 869 GSVSEE----GYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVN--TYS 942 (1181)
Q Consensus 869 g~~~d~----~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd--~~~ 942 (1181)
+++... ...++||||+ |++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++ . +
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~-~ 190 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN-P 190 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC-T
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC-C
Confidence 998764 5689999999 99999999753 34678999999999999999999999999999999999998 5 7
Q ss_pred CeeeeecCCcccccccCCCC-------CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHH
Q psy14556 943 GVVKISDFGTSKRLAGLCPS-------AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVI 1015 (1181)
Q Consensus 943 g~vKLiDFGlAk~l~~~~~~-------~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvI 1015 (1181)
+.+||+|||+++.+...... .....||+.|+|||++.+..+ +...|+ |||||+
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~Di------------------~slG~~ 250 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP--SRRGDL------------------EILGYC 250 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC--CHHHHH------------------HHHHHH
T ss_pred CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC--CchhhH------------------HHHHHH
Confidence 89999999999776533211 123459999999999976543 333333 999999
Q ss_pred HHHHHhCCCCCCCCCcccc-cC------CCCCC-----CCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1016 ISQLLVLTAALKKKTSRAL-VA------PPQIS-----RSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1016 LyELLTGk~PF~~~~~~~l-~~------~~~ip-----~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
+|+|++|+.||.+...... .. ...++ .......+..+..++..|++.+|..||...+.
T Consensus 251 l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l 320 (364)
T 3op5_A 251 MIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENL 320 (364)
T ss_dssp HHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred HHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHH
Confidence 9999999999997533211 00 00000 00114567889999999999999999975444
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-32 Score=326.12 Aligned_cols=244 Identities=20% Similarity=0.210 Sum_probs=190.1
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCC-CCeeeEccccccCCcEEEEEe
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRH-RNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~H-PNIVkl~g~~~d~~~l~LVmE 882 (1181)
+.|.+.+ +||+|+||.||+|++..+++.||||++..... .+.+.+|+.+++.++| ++|..+..++...+..++|||
T Consensus 7 ~~y~i~~-~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 7 NKFRLGR-KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTEECCC-CCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CcEEEEE-EEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 3444444 69999999999999999999999999865543 2458899999999987 556666666677888999999
Q ss_pred ecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccc--cCCCeeeeecCCcccccccCC
Q psy14556 883 QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVN--TYSGVVKISDFGTSKRLAGLC 960 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd--~~~g~vKLiDFGlAk~l~~~~ 960 (1181)
|+ +++|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||++ ..++.+||+|||+++.+....
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 99 99999999743 23578999999999999999999999999999999999994 227899999999998765432
Q ss_pred CC-------CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc
Q psy14556 961 PS-------AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA 1033 (1181)
Q Consensus 961 ~~-------~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~ 1033 (1181)
.. .....||+.|+|||++.+..++ ...|+ |||||+||+|++|+.||.+.....
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s--~~sDv------------------wSlGvil~elltG~~Pf~~~~~~~ 220 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQS--RRDDL------------------ESLGYVLMYFLRGSLPWQGLKAGT 220 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC--HHHHH------------------HHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred cccccccccccccCCCccccCHHHhcCCCCC--hHHHH------------------HHHHHHHHHHHhCCCCCccccchh
Confidence 21 2256799999999999865433 33333 999999999999999999865422
Q ss_pred ccC-------C--CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1034 LVA-------P--PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1034 l~~-------~--~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
... . ..........++..+..++.+|+..+|..||...+.
T Consensus 221 ~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el 269 (483)
T 3sv0_A 221 KKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYL 269 (483)
T ss_dssp HHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred HHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHH
Confidence 100 0 001111223567889999999999999999964433
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-32 Score=310.00 Aligned_cols=246 Identities=22% Similarity=0.302 Sum_probs=189.1
Q ss_pred HhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC--hhHHHHHHHHHHhcCCCCeeeEccccccCCcE--
Q psy14556 802 FLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD--VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYF-- 877 (1181)
Q Consensus 802 ~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~--~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l-- 877 (1181)
+.+.|... .+||+|+||.||+|.+..+++.||+|++....... .+.+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 40 LPKTYVSP-THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp EETTEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred ccccEEEE-eEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 33444443 47999999999999999999999999997654332 46788999999999999999999999877654
Q ss_pred ----EEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcc
Q psy14556 878 ----KIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTS 953 (1181)
Q Consensus 878 ----~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlA 953 (1181)
++||||+. ++|.+++.. .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~-~~~~kL~Dfg~a 191 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE-DCELKILDFGLA 191 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TCCEEECSTTCC
T ss_pred ceeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECC-CCCEEEEecCcc
Confidence 99999995 678777642 3789999999999999999999999999999999999988 899999999999
Q ss_pred cccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc
Q psy14556 954 KRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA 1033 (1181)
Q Consensus 954 k~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~ 1033 (1181)
+.... ......||+.|+|||++.+. ..++...|+ ||+|+++|+|++|+.||.+.+..+
T Consensus 192 ~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~Di------------------wslG~il~el~~g~~pf~~~~~~~ 249 (371)
T 4exu_A 192 RHADA---EMTGYVVTRWYRAPEVILSW-MHYNQTVDI------------------WSVGCIMAEMLTGKTLFKGKDYLD 249 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCC-SCCCTTHHH------------------HHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccc---CcCCcccCccccCHHHhcCC-CCCCcHHhH------------------HHHHHHHHHHHhCCCCCCCCChHH
Confidence 86543 23345689999999999752 223334444 999999999999999999876432
Q ss_pred ccCC----------------------------CCCC----CCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHh
Q psy14556 1034 LVAP----------------------------PQIS----RSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVC 1077 (1181)
Q Consensus 1034 l~~~----------------------------~~ip----~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~a 1077 (1181)
.... +..+ .......+..+..++.+|+..+|.+||+..+.+...
T Consensus 250 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 325 (371)
T 4exu_A 250 QLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 325 (371)
T ss_dssp HHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred HHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCc
Confidence 1100 0000 011234577888899999999999999765554333
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=302.99 Aligned_cols=201 Identities=22% Similarity=0.298 Sum_probs=166.2
Q ss_pred hcccCceeecccCceEEEEEEE-cCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCC------CeeeEccccccCCcE
Q psy14556 805 LFALNRIELGKGSYGVVYAARE-LDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHR------NIVQYLGSVSEEGYF 877 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d-~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HP------NIVkl~g~~~d~~~l 877 (1181)
.|.+. .+||+|+||.||+|.+ ..+++.||+|++.... ...+.+.+|+.+++.++|+ +|+++++++.+.+..
T Consensus 15 ~y~~~-~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 15 RYEIV-DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TEEEE-EEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred ceEEE-EEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 34443 4799999999999998 5688999999996432 2346788999999998765 499999999999999
Q ss_pred EEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccC----------------
Q psy14556 878 KIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTY---------------- 941 (1181)
Q Consensus 878 ~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~---------------- 941 (1181)
++||||+ +++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++..
T Consensus 93 ~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~ 170 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170 (339)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEE
T ss_pred EEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccccc
Confidence 9999999 89999998765 44567899999999999999999999999999999999999762
Q ss_pred --CCeeeeecCCcccccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHH
Q psy14556 942 --SGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQL 1019 (1181)
Q Consensus 942 --~g~vKLiDFGlAk~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyEL 1019 (1181)
++.+||+|||+++.... ......||+.|+|||++.+..++. ..|+ ||+|+++|+|
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~--~~Di------------------~slG~il~el 227 (339)
T 1z57_A 171 LINPDIKVVDFGSATYDDE---HHSTLVSTRHYRAPEVILALGWSQ--PCDV------------------WSIGCILIEY 227 (339)
T ss_dssp ESCCCEEECCCSSCEETTS---CCCSSCSCGGGCCHHHHTTSCCCT--HHHH------------------HHHHHHHHHH
T ss_pred ccCCCceEeeCcccccCcc---ccccccCCccccChHHhhCCCCCc--chhh------------------HHHHHHHHHH
Confidence 35799999999976543 233457999999999997654333 3333 9999999999
Q ss_pred HhCCCCCCCCCcc
Q psy14556 1020 LVLTAALKKKTSR 1032 (1181)
Q Consensus 1020 LTGk~PF~~~~~~ 1032 (1181)
++|..||...+..
T Consensus 228 ~~g~~pf~~~~~~ 240 (339)
T 1z57_A 228 YLGFTVFPTHDSK 240 (339)
T ss_dssp HHSSCSCCCSCHH
T ss_pred HhCCCCCCCCChH
Confidence 9999999887653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=330.25 Aligned_cols=244 Identities=20% Similarity=0.268 Sum_probs=193.6
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
++||+|+||.||+|.+.. +..||||+++... ...+.+.+|+.+|++++||||+++++++.+ +..++||||+++|+|.
T Consensus 273 ~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~ 349 (535)
T 2h8h_A 273 VKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 349 (535)
T ss_dssp EEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHH
T ss_pred eecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHH
Confidence 479999999999999865 4679999997654 345789999999999999999999999876 6789999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC-CCCccccCC
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC-PSAETFTGT 969 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~-~~~~t~~GT 969 (1181)
++++.. ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++...... .......++
T Consensus 350 ~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~~ 427 (535)
T 2h8h_A 350 DFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE-NLVCKVADFGLARLIEDNEYTARQGAKFP 427 (535)
T ss_dssp HHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG-GGCEEECCTTSTTTCCCHHHHTTCSTTSC
T ss_pred HHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcC-CCcEEEcccccceecCCCceecccCCcCc
Confidence 999753 2235778899999999999999999999999999999999987 7899999999998664321 112223467
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--CCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--ISRSVSV 1046 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--ip~~l~~ 1046 (1181)
..|+|||++.++.++. ..|+ ||||++||||++ |+.||.+....++..... .....+.
T Consensus 428 ~~y~aPE~~~~~~~~~--~sDv------------------wSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~ 487 (535)
T 2h8h_A 428 IKWTAPEAALYGRFTI--KSDV------------------WSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP 487 (535)
T ss_dssp GGGSCHHHHHHCCCCH--HHHH------------------HHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred ccccCHHHhccCCCCc--hhhH------------------HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence 8999999998664433 3333 999999999999 999999877654322111 1112234
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
.++..+..++.+|++.+|..||+ +.+....+..
T Consensus 488 ~~~~~l~~li~~cl~~dP~~RPt-~~~l~~~L~~ 520 (535)
T 2h8h_A 488 ECPESLHDLMCQCWRKEPEERPT-FEYLQAFLED 520 (535)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCC-HHHHHHHHHT
T ss_pred CCCHHHHHHHHHHcCCChhHCcC-HHHHHHHHHH
Confidence 57788999999999999999996 4444444444
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-32 Score=303.87 Aligned_cols=253 Identities=21% Similarity=0.258 Sum_probs=192.7
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCC--CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKN--LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~--~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
.++||+|+||.||+|.+.. .+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 38 ~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~ 114 (319)
T 2y4i_B 38 GELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGR 114 (319)
T ss_dssp CCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSE
T ss_pred eeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCC
Confidence 3479999999999998754 48999986543 233566889999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccC-----CCC
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGL-----CPS 962 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~-----~~~ 962 (1181)
+|.+++... ...+++..++.++.||+.||+|||++||+||||||+||+++ ++.+||+|||+++..... ...
T Consensus 115 ~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~--~~~~~l~Dfg~~~~~~~~~~~~~~~~ 190 (319)
T 2y4i_B 115 TLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD--NGKVVITDFGLFSISGVLQAGRREDK 190 (319)
T ss_dssp EHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----CCEECCCSCCC----------CCS
T ss_pred cHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe--CCCEEEeecCCccccccccccccccc
Confidence 999999753 34577899999999999999999999999999999999997 479999999998754321 112
Q ss_pred CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC---CCC
Q psy14556 963 AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA---PPQ 1039 (1181)
Q Consensus 963 ~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~---~~~ 1039 (1181)
.....|++.|+|||++.+....... ....+....+.||+|+++|+|++|+.||.+.....+.. ...
T Consensus 191 ~~~~~g~~~y~aPE~~~~~~~~~~~-----------~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 259 (319)
T 2y4i_B 191 LRIQNGWLCHLAPEIIRQLSPDTEE-----------DKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGM 259 (319)
T ss_dssp CBCCSGGGGTSCHHHHSCBSCC--C-----------CCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTC
T ss_pred cccCCCcccccChHHhhhccccccc-----------cccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCC
Confidence 2334589999999999753211000 01123334455999999999999999999877654321 111
Q ss_pred CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcccC
Q psy14556 1040 ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGNN 1081 (1181)
Q Consensus 1040 ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~~ 1081 (1181)
.+.......+..+..++.+|++.+|..|| ++.+.+..+...
T Consensus 260 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-t~~~l~~~l~~l 300 (319)
T 2y4i_B 260 KPNLSQIGMGKEISDILLFCWAFEQEERP-TFTKLMDMLEKL 300 (319)
T ss_dssp CCCCCCSSCCTTHHHHHHHHHCSSTTTSC-CHHHHHHHHTTC
T ss_pred CCCCCcCCCCHHHHHHHHHHhcCChhhCc-CHHHHHHHHHHH
Confidence 22222335678899999999999999998 567777776664
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=311.32 Aligned_cols=245 Identities=14% Similarity=0.159 Sum_probs=187.0
Q ss_pred hcccCceeecccCceEEEEEEEcCC--------CeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeE---------
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDR--------QVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQY--------- 867 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~t--------g~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl--------- 867 (1181)
.|.+. ++||+|+||.||+|++..+ ++.||+|++... +.+.+|+.++++++||||+++
T Consensus 43 ~y~~~-~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 43 QWKLK-SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp EEEEE-EEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred eEEEE-EEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 34443 4799999999999999874 789999999754 468899999999999999984
Q ss_pred ------cccccc-CCcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccccc
Q psy14556 868 ------LGSVSE-EGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNT 940 (1181)
Q Consensus 868 ------~g~~~d-~~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~ 940 (1181)
++++.. .+..++||||+ +++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDP 194 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEET
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcC
Confidence 445444 67899999999 99999999854 2346889999999999999999999999999999999999987
Q ss_pred CCC--eeeeecCCcccccccCCC-------CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHH
Q psy14556 941 YSG--VVKISDFGTSKRLAGLCP-------SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVF 1011 (1181)
Q Consensus 941 ~~g--~vKLiDFGlAk~l~~~~~-------~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwS 1011 (1181)
++ .+||+|||+++.+..... ......||+.|+|||++.+..++ ...|+ ||
T Consensus 195 -~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~Di------------------~s 253 (352)
T 2jii_A 195 -EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPS--RRSDL------------------QS 253 (352)
T ss_dssp -TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCC--HHHHH------------------HH
T ss_pred -CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCC--chhhH------------------HH
Confidence 66 899999999987654321 11334699999999999765433 33333 99
Q ss_pred HHHHHHHHHhCCCCCCCCCcc--cc--------cCCCCCCCC--CCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcc
Q psy14556 1012 LCVIISQLLVLTAALKKKTSR--AL--------VAPPQISRS--VSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTG 1079 (1181)
Q Consensus 1012 LGvILyELLTGk~PF~~~~~~--~l--------~~~~~ip~~--l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~ 1079 (1181)
||+++|+|++|+.||.+.... .+ .....+... .....+..+..++.+|+..+|..||+ +.+.+..+.
T Consensus 254 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~~l~~~L~ 332 (352)
T 2jii_A 254 LGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPP-YAMLRNNLE 332 (352)
T ss_dssp HHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCC-HHHHHHHHH
T ss_pred HHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCC-HHHHHHHHH
Confidence 999999999999999987521 11 011111111 11245788999999999999999987 444444333
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-32 Score=303.06 Aligned_cols=244 Identities=24% Similarity=0.355 Sum_probs=188.4
Q ss_pred HhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC------ChhHHHHHHHHHHhc----CCCCeeeEcccc
Q psy14556 802 FLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG------DVQPLHEEIKLHSQL----RHRNIVQYLGSV 871 (1181)
Q Consensus 802 ~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~------~~e~f~rEi~IL~~L----~HPNIVkl~g~~ 871 (1181)
+...|.+. ++||+|+||.||+|++..+++.||+|++...... ....+.+|+.++.++ +||||+++++++
T Consensus 29 ~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 29 FEAEYRLG-PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp ----CEEE-EEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhceEEe-eEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 34455554 4799999999999999999999999999765332 234466899999998 899999999999
Q ss_pred ccCCcEEEEEee-cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecC
Q psy14556 872 SEEGYFKIFMEQ-VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDF 950 (1181)
Q Consensus 872 ~d~~~l~LVmEy-~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDF 950 (1181)
.+.+..++|||+ +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++..++.+||+||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence 999999999999 7899999999854 257899999999999999999999999999999999999844899999999
Q ss_pred CcccccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCC
Q psy14556 951 GTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKT 1030 (1181)
Q Consensus 951 GlAk~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~ 1030 (1181)
|++...... ......|++.|+|||++.+... .....|+ ||+|+++|+|++|+.||....
T Consensus 185 g~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~-~~~~~Di------------------~slG~il~~l~~g~~pf~~~~ 243 (312)
T 2iwi_A 185 GSGALLHDE--PYTDFDGTRVYSPPEWISRHQY-HALPATV------------------WSLGILLYDMVCGDIPFERDQ 243 (312)
T ss_dssp SSCEECCSS--CBCCCCSCTTTSCHHHHHHSCB-CHHHHHH------------------HHHHHHHHHHHHSSCSCCSHH
T ss_pred chhhhcccC--cccccCCcccccCceeeecCCC-CCccchH------------------HHHHHHHHHHHHCCCCCCChH
Confidence 999876542 2344568999999999975432 1112333 999999999999999998654
Q ss_pred cccccCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHH
Q psy14556 1031 SRALVAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNL 1075 (1181)
Q Consensus 1031 ~~~l~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~ 1075 (1181)
.. ...... .+...+..+..++.+|++.+|..||+..+...
T Consensus 244 ~~-~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 244 EI-LEAELH----FPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HH-HHTCCC----CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HH-hhhccC----CcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 31 111111 23456778899999999999999997555543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-32 Score=301.65 Aligned_cols=243 Identities=26% Similarity=0.290 Sum_probs=170.2
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC-ChhHHHHHHH-HHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG-DVQPLHEEIK-LHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~-~~e~f~rEi~-IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
...||+|+||.||+|.+..+++.||+|++...... ....+..|+. +++.++||||+++++++.+.+..++||||+++
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~- 105 (327)
T 3aln_A 27 LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST- 105 (327)
T ss_dssp -CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-
T ss_pred hheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-
Confidence 34699999999999999999999999999765322 2344556665 77778999999999999999999999999964
Q ss_pred Ccccchhcc--cCCCCCChHHHHHHHHHHHhhhhhcccc-ceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCc
Q psy14556 888 SLSTLLRVK--WGPLKENESTMSFYTKQILEGLKYLHGQ-KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAE 964 (1181)
Q Consensus 888 SL~dlL~~~--~~~~~l~e~~i~~Ia~QIa~AL~yLHs~-gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~ 964 (1181)
+|.+++... .....+++..++.++.|++.||.|||++ ||+||||||+||+++. ++.+||+|||+++...... ...
T Consensus 106 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~~~~~~~~~-~~~ 183 (327)
T 3aln_A 106 SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDR-SGNIKLCDFGISGQLVDSI-AKT 183 (327)
T ss_dssp EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEET-TTEEEECCCSSSCC---------
T ss_pred ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcC-CCCEEEccCCCceeccccc-ccc
Confidence 777777531 1244678999999999999999999999 9999999999999987 8999999999998765432 222
Q ss_pred cccCCccccCchhhccC--CCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc-c-ccC----
Q psy14556 965 TFTGTLQYMAPEVIDKG--QRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR-A-LVA---- 1036 (1181)
Q Consensus 965 t~~GT~~Y~APEvl~gg--~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~-~-l~~---- 1036 (1181)
...||+.|+|||++... ...++...|+ ||+|+++|+|++|+.||.+.... + +..
T Consensus 184 ~~~gt~~y~aPE~~~~~~~~~~~~~~~Di------------------~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 245 (327)
T 3aln_A 184 RDAGCRPYMAPERIDPSASRQGYDVRSDV------------------WSLGITLYELATGRFPYPKWNSVFDQLTQVVKG 245 (327)
T ss_dssp ----------------------CCSHHHH------------------HHHHHHHHHHHHSCCCSSCC-------CCCCCS
T ss_pred cCCCCccccCceeeccccCcCCCCchhhH------------------HHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcC
Confidence 34689999999998421 1112233333 99999999999999999875431 1 111
Q ss_pred -CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1037 -PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1037 -~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.+.++.......+..+..++.+|+..+|..||+..+.
T Consensus 246 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 283 (327)
T 3aln_A 246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKEL 283 (327)
T ss_dssp CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHH
Confidence 1122233334567889999999999999999986555
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-32 Score=305.15 Aligned_cols=242 Identities=18% Similarity=0.263 Sum_probs=194.2
Q ss_pred hhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC------ChhHHHHHHHHHHhcC--CCCeeeEccccccC
Q psy14556 803 LYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG------DVQPLHEEIKLHSQLR--HRNIVQYLGSVSEE 874 (1181)
Q Consensus 803 ~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~------~~e~f~rEi~IL~~L~--HPNIVkl~g~~~d~ 874 (1181)
...|.+. ++||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.++++++ ||||+++++++...
T Consensus 42 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 42 ESQYQVG-PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp TTTEEEE-EECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred cCceEEE-EEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 3344444 4799999999999999999999999999655322 2356778999999996 59999999999999
Q ss_pred CcEEEEEeecCC-CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcc
Q psy14556 875 GYFKIFMEQVPG-GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTS 953 (1181)
Q Consensus 875 ~~l~LVmEy~~g-GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlA 953 (1181)
+..++|||++.+ ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++..++.+||+|||++
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred CcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 999999999976 8999998754 357889999999999999999999999999999999999844789999999999
Q ss_pred cccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc
Q psy14556 954 KRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA 1033 (1181)
Q Consensus 954 k~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~ 1033 (1181)
+..... ......||+.|+|||++.+... .+...|+ ||+|+++|+|++|+.||.......
T Consensus 198 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~-~~~~~Di------------------~slG~il~el~~g~~pf~~~~~~~ 256 (320)
T 3a99_A 198 ALLKDT--VYTDFDGTRVYSPPEWIRYHRY-HGRSAAV------------------WSLGILLYDMVCGDIPFEHDEEII 256 (320)
T ss_dssp EECCSS--CBCCCCSCGGGSCHHHHHHSCB-CHHHHHH------------------HHHHHHHHHHHHSSCSCCSHHHHH
T ss_pred cccccc--cccCCCCCccCCChHHhccCCC-CCccchH------------------HhHHHHHHHHHHCCCCCCChhhhh
Confidence 876542 2334569999999999975432 1222333 999999999999999998654311
Q ss_pred ccCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1034 LVAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1034 l~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
.... ......+..+..++.+|++.+|..||+..+..
T Consensus 257 -~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 292 (320)
T 3a99_A 257 -RGQV----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 292 (320)
T ss_dssp -HCCC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred -cccc----cccccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 1111 12345678899999999999999999755443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-32 Score=304.23 Aligned_cols=201 Identities=19% Similarity=0.270 Sum_probs=163.9
Q ss_pred hcccCceeecccCceEEEEEEEcCCC-eEEEEEEecCCCCCChhHHHHHHHHHHhcCCCC------eeeEccccccCCcE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQ-VKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRN------IVQYLGSVSEEGYF 877 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg-~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPN------IVkl~g~~~d~~~l 877 (1181)
.|.+. .+||+|+||+||+|.+..++ +.||+|+++... ...+.+.+|+.+++.++|++ ++.+++++...+..
T Consensus 20 ~y~~~-~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 20 RYEIV-GNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TEEEE-EEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cEEEE-EEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 44443 47999999999999998776 799999996432 23467889999999997665 89999999999999
Q ss_pred EEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccccc-----------------
Q psy14556 878 KIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNT----------------- 940 (1181)
Q Consensus 878 ~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~----------------- 940 (1181)
++||||+ +++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 98 ~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred EEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccc
Confidence 9999999 66777776644 3346789999999999999999999999999999999999932
Q ss_pred -CCCeeeeecCCcccccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHH
Q psy14556 941 -YSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQL 1019 (1181)
Q Consensus 941 -~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyEL 1019 (1181)
.++.+||+|||+++.... ......||+.|+|||++.+..++. ..|+ ||+|+++|+|
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~--~~Di------------------~slG~il~el 232 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHE---HHTTIVATRHYRPPEVILELGWAQ--PCDV------------------WSIGCILFEY 232 (355)
T ss_dssp ESCCCEEECCCTTCEETTS---CCCSSCSCGGGCCHHHHTTCCCCT--HHHH------------------HHHHHHHHHH
T ss_pred cCCCcEEEeecCccccccc---cccCCcCCCcccCCeeeecCCCCC--ccch------------------HHHHHHHHHH
Confidence 267999999999976543 234457999999999997654433 3333 9999999999
Q ss_pred HhCCCCCCCCCcc
Q psy14556 1020 LVLTAALKKKTSR 1032 (1181)
Q Consensus 1020 LTGk~PF~~~~~~ 1032 (1181)
++|..||.+....
T Consensus 233 ~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 233 YRGFTLFQTHENR 245 (355)
T ss_dssp HHSSCSCCCSSHH
T ss_pred HhCCCCCCCCCHH
Confidence 9999999987653
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-32 Score=307.33 Aligned_cols=195 Identities=23% Similarity=0.316 Sum_probs=160.1
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcC-----------CCCeeeEccccccCC---
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR-----------HRNIVQYLGSVSEEG--- 875 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~-----------HPNIVkl~g~~~d~~--- 875 (1181)
.++||+|+||.||+|++..+++.||+|++.... ...+.+.+|+.++++++ ||||+++++++...+
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 102 (373)
T 1q8y_A 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG 102 (373)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTE
T ss_pred EEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCC
Confidence 347999999999999999999999999996432 23466889999999886 899999999987654
Q ss_pred -cEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhcccc-ceecccCCCCCccccc-----CCCeeeee
Q psy14556 876 -YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ-KIVHRDIKGDNVLVNT-----YSGVVKIS 948 (1181)
Q Consensus 876 -~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~-gIVHrDLKP~NILLd~-----~~g~vKLi 948 (1181)
.+++|||++ +++|.+++... ....+++..++.++.||+.||+|||++ ||+||||||+|||++. ..+.+||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~ 180 (373)
T 1q8y_A 103 VHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIA 180 (373)
T ss_dssp EEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEEC
T ss_pred ceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEc
Confidence 789999999 99999999764 334578999999999999999999998 9999999999999953 13489999
Q ss_pred cCCcccccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCC
Q psy14556 949 DFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKK 1028 (1181)
Q Consensus 949 DFGlAk~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~ 1028 (1181)
|||+++..... .....||+.|+|||++.+..++. ..|+ ||+|+++|+|++|+.||.+
T Consensus 181 Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~--~~Di------------------~slG~il~el~~g~~pf~~ 237 (373)
T 1q8y_A 181 DLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGC--GADI------------------WSTACLIFELITGDFLFEP 237 (373)
T ss_dssp CCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCT--HHHH------------------HHHHHHHHHHHHSSCCC--
T ss_pred ccccccccCCC---CCCCCCCccccCcHHHhCCCCCc--hHhH------------------HHHHHHHHHHHhCCCCCCC
Confidence 99999876542 23446899999999998665433 3333 9999999999999999987
Q ss_pred CC
Q psy14556 1029 KT 1030 (1181)
Q Consensus 1029 ~~ 1030 (1181)
..
T Consensus 238 ~~ 239 (373)
T 1q8y_A 238 DE 239 (373)
T ss_dssp --
T ss_pred Cc
Confidence 65
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=293.78 Aligned_cols=240 Identities=23% Similarity=0.246 Sum_probs=169.8
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC--hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD--VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~--~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.+||+|+||.||+|.+..+++.||+|++....... .+.+.++..+++.++||||+++++++.+.+..++||||+ ++.
T Consensus 31 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~ 109 (318)
T 2dyl_A 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTC 109 (318)
T ss_dssp EEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEE
T ss_pred ceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCc
Confidence 36999999999999999999999999997654322 233445556788889999999999999999999999999 555
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhcccc-ceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ-KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~-gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+..+.... ...+++..++.++.||+.||.|||++ ||+||||||+||+++. ++.+||+|||++....... ......
T Consensus 110 ~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~-~~~~kl~dfg~~~~~~~~~-~~~~~~ 185 (318)
T 2dyl_A 110 AEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE-RGQIKLCDFGISGRLVDDK-AKDRSA 185 (318)
T ss_dssp HHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECT-TSCEEECCCTTC--------------
T ss_pred HHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECC-CCCEEEEECCCchhccCCc-cccccC
Confidence 65555432 23578999999999999999999996 9999999999999987 8899999999997665432 223446
Q ss_pred CCccccCchhhccC---CCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc-cc----cCCCC
Q psy14556 968 GTLQYMAPEVIDKG---QRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR-AL----VAPPQ 1039 (1181)
Q Consensus 968 GT~~Y~APEvl~gg---~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~-~l----~~~~~ 1039 (1181)
||+.|+|||++.+. ...++...| .||+|+++|+|++|+.||...... .. .....
T Consensus 186 ~~~~y~aPE~~~~~~~~~~~~~~~~D------------------i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 247 (318)
T 2dyl_A 186 GCAAYMAPERIDPPDPTKPDYDIRAD------------------VWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP 247 (318)
T ss_dssp -CCTTCCHHHHC--------CCTHHH------------------HHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCC
T ss_pred CCccccChhhcccccccccCCccccc------------------hhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCC
Confidence 89999999999532 112222333 399999999999999999874321 11 11111
Q ss_pred CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1040 ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1040 ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.........+..+..++.+|+..+|..||+..+.
T Consensus 248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 281 (318)
T 2dyl_A 248 PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKL 281 (318)
T ss_dssp CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 1111123467889999999999999999986554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=294.60 Aligned_cols=221 Identities=15% Similarity=0.052 Sum_probs=179.8
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC---hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD---VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFM 881 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~---~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVm 881 (1181)
.|.+. .+||+|+||.||+|++..+++.||+|++....... .+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 32 ~y~i~-~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 32 RYRLL-IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TEEEE-EEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEE-EEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 44444 47999999999999999999999999997664433 367899999999999999999999999999999999
Q ss_pred eecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC
Q psy14556 882 EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP 961 (1181)
Q Consensus 882 Ey~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~ 961 (1181)
||++|++|.++++.. .....+..++.|++.||+|||++||+||||||+|||++. ++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~-~g~~kl~~~~---------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSI-DGDVVLAYPA---------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEET-TSCEEECSCC----------
T ss_pred EecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcC-CCCEEEEecc----------
Confidence 999999999999632 245567889999999999999999999999999999997 8899998544
Q ss_pred CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc------
Q psy14556 962 SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV------ 1035 (1181)
Q Consensus 962 ~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~------ 1035 (1181)
|++| ++...|+ ||+||++|+|+||+.||.+.+.....
T Consensus 175 ----------~~~~---------~~~~~Di------------------~slG~il~elltg~~Pf~~~~~~~~~~~~~~~ 217 (286)
T 3uqc_A 175 ----------TMPD---------ANPQDDI------------------RGIGASLYALLVNRWPLPEAGVRSGLAPAERD 217 (286)
T ss_dssp ----------CCTT---------CCHHHHH------------------HHHHHHHHHHHHSEECSCCCSBCCCSEECCBC
T ss_pred ----------ccCC---------CCchhHH------------------HHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH
Confidence 3332 2223333 99999999999999999987764321
Q ss_pred --CCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcccC
Q psy14556 1036 --APPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGNN 1081 (1181)
Q Consensus 1036 --~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~~ 1081 (1181)
.....+.......+..+..++.+|++.||..| ++.+.+..+...
T Consensus 218 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R--s~~el~~~L~~~ 263 (286)
T 3uqc_A 218 TAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR--SASTLLNLMQQA 263 (286)
T ss_dssp TTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC--CHHHHHHHHHHH
T ss_pred hccCCCChhhcccCCCHHHHHHHHHHcccCCccC--CHHHHHHHHHHH
Confidence 11111122335678889999999999999999 788877777763
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=294.04 Aligned_cols=248 Identities=19% Similarity=0.244 Sum_probs=183.1
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcC--CCCeeeEccccccCCcEEEEEeecC
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLR--HRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~--HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
..+||+|+||.||+|.+. +++.||+|++...... ..+.+.+|+.++++++ ||||+++++++.+.+..++||| +.
T Consensus 33 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~ 110 (313)
T 3cek_A 33 LKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CG 110 (313)
T ss_dssp EEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CC
T ss_pred EEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cC
Confidence 347999999999999875 5889999999755332 3567899999999997 5999999999999999999999 55
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC--CC
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP--SA 963 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~--~~ 963 (1181)
+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||+++....... ..
T Consensus 111 ~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~--~~~~kL~Dfg~~~~~~~~~~~~~~ 185 (313)
T 3cek_A 111 NIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVK 185 (313)
T ss_dssp SEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE--TTEEEECCCSSSCC----------
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE--CCeEEEeeccccccccCccccccc
Confidence 89999999854 3678889999999999999999999999999999999996 48999999999987654322 12
Q ss_pred ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc--c--cCCCC
Q psy14556 964 ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA--L--VAPPQ 1039 (1181)
Q Consensus 964 ~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~--l--~~~~~ 1039 (1181)
....||+.|+|||++.+....... . .....+....+.||+|+++|+|++|+.||....... + .....
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~~-~--------~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 256 (313)
T 3cek_A 186 DSQVGTVNYMPPEAIKDMSSSREN-G--------KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 256 (313)
T ss_dssp ----CCGGGCCHHHHTTCC-------------------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTT
T ss_pred cCCCCCCCcCCHHHHhhccccccc-c--------cccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcc
Confidence 334689999999999642110000 0 000122334444999999999999999998754321 1 00111
Q ss_pred CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1040 ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1040 ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.....+...+..+..++.+|++.+|..||+..+.
T Consensus 257 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 290 (313)
T 3cek_A 257 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290 (313)
T ss_dssp SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred cccCCcccchHHHHHHHHHHccCCcccCcCHHHH
Confidence 1122233446778999999999999999976555
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.4e-32 Score=332.01 Aligned_cols=239 Identities=19% Similarity=0.236 Sum_probs=189.1
Q ss_pred hhcccCceeecccCceEEEEEEEcC-CCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCc-----
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELD-RQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGY----- 876 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~-tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~----- 876 (1181)
..|.+.+ +||+|+||.||+|.+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++...+.
T Consensus 80 ~~y~i~~-~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 80 GQYEVKG-CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTEEEEE-EEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CceEEEE-EEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 3444443 79999999999999976 789999999865432 234578899999999999999999999987665
Q ss_pred EEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccccc
Q psy14556 877 FKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956 (1181)
Q Consensus 877 l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l 956 (1181)
.|+||||++|++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++. +.+||+|||+++..
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~--~~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE--EQLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS--SCEEECCCTTCEET
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeC--CcEEEEecccchhc
Confidence 7999999999999988753 5789999999999999999999999999999999999986 48999999999876
Q ss_pred ccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC
Q psy14556 957 AGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA 1036 (1181)
Q Consensus 957 ~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~ 1036 (1181)
... ....||+.|+|||++.++. +...|+ ||+||++|+|++|..||.+.....+..
T Consensus 232 ~~~----~~~~gt~~y~aPE~~~~~~---~~~sDi------------------~slG~~l~~l~~g~~~~~~~~~~~~~~ 286 (681)
T 2pzi_A 232 NSF----GYLYGTPGFQAPEIVRTGP---TVATDI------------------YTVGRTLAALTLDLPTRNGRYVDGLPE 286 (681)
T ss_dssp TCC----SCCCCCTTTSCTTHHHHCS---CHHHHH------------------HHHHHHHHHHHSCCCEETTEECSSCCT
T ss_pred ccC----CccCCCccccCHHHHcCCC---CCceeh------------------hhhHHHHHHHHhCCCCCcccccccccc
Confidence 542 3456999999999997542 333333 999999999999999988743322210
Q ss_pred CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1037 PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1037 ~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
.......+..+..++.+|++.+|..||++++++...+..
T Consensus 287 -----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 287 -----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp -----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 000112345688899999999999999988886655543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=306.95 Aligned_cols=203 Identities=22% Similarity=0.267 Sum_probs=166.1
Q ss_pred hhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcC-CC-----CeeeEccccccCCc
Q psy14556 803 LYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR-HR-----NIVQYLGSVSEEGY 876 (1181)
Q Consensus 803 ~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~-HP-----NIVkl~g~~~d~~~ 876 (1181)
.+.|.+.+ +||+|+||+||+|.+..+++.||||++.... ...+.+.+|+.+++.++ |+ +|+++++++...+.
T Consensus 53 ~~~y~~~~-~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 53 MDRYEIDS-LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp TTTEEEEE-EEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeEEEEE-EEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 34455443 7999999999999999999999999996432 22456778999988885 55 49999999999999
Q ss_pred EEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhcc--ccceecccCCCCCccccc-CCCeeeeecCCcc
Q psy14556 877 FKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLH--GQKIVHRDIKGDNVLVNT-YSGVVKISDFGTS 953 (1181)
Q Consensus 877 l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLH--s~gIVHrDLKP~NILLd~-~~g~vKLiDFGlA 953 (1181)
.++||||++ ++|.+++... ....+++..++.++.|++.||.||| +.||+||||||+|||++. .++.+||+|||++
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred eEEEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 999999995 6999998764 2345789999999999999999999 579999999999999953 2678999999999
Q ss_pred cccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc
Q psy14556 954 KRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR 1032 (1181)
Q Consensus 954 k~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~ 1032 (1181)
+.... ......||+.|+|||++.+..++ ..+|+ ||+||++|+|++|+.||.+.+..
T Consensus 209 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~--~~~Di------------------wSlG~il~elltg~~pf~~~~~~ 264 (382)
T 2vx3_A 209 CQLGQ---RIYQYIQSRFYRSPEVLLGMPYD--LAIDM------------------WSLGCILVEMHTGEPLFSGANEV 264 (382)
T ss_dssp EETTC---CCCSSCSCGGGCCHHHHTTCCCC--THHHH------------------HHHHHHHHHHHHSSCSSCCSSHH
T ss_pred eeccc---ccccccCCccccChHHHcCCCCC--cHHHH------------------HHHHHHHHHHHhCCCCCCCCCHH
Confidence 87653 23445799999999999866433 34444 99999999999999999987653
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=326.28 Aligned_cols=242 Identities=22% Similarity=0.291 Sum_probs=189.3
Q ss_pred ceeecccCceEEEEEEEcCC---CeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 810 RIELGKGSYGVVYAARELDR---QVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~t---g~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
.++||+|+||.||+|.+..+ +..||+|.+..... ...+.+.+|+.++++++||||+++++++.+ +..++||||++
T Consensus 395 ~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv~E~~~ 473 (656)
T 2j0j_A 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCT 473 (656)
T ss_dssp EEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred eeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEEEEcCC
Confidence 34799999999999998653 46799999865432 234678999999999999999999999854 56899999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC-CCc
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP-SAE 964 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~-~~~ 964 (1181)
+|+|.++++.. ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++....... ...
T Consensus 474 ~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~-~~~vkL~DFG~a~~~~~~~~~~~~ 550 (656)
T 2j0j_A 474 LGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDSTYYKAS 550 (656)
T ss_dssp TCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE-TTEEEECCCCCCCSCCC-------
T ss_pred CCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeC-CCCEEEEecCCCeecCCCcceecc
Confidence 99999999754 345789999999999999999999999999999999999998 89999999999987654321 122
Q ss_pred cccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--CC
Q psy14556 965 TFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--IS 1041 (1181)
Q Consensus 965 t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--ip 1041 (1181)
...+|+.|+|||++.+..+ +..+|+ ||+|+++|||++ |..||.+....++..... ..
T Consensus 551 ~~~~t~~y~aPE~~~~~~~--~~~~Di------------------wSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~ 610 (656)
T 2j0j_A 551 KGKLPIKWMAPESINFRRF--TSASDV------------------WMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER 610 (656)
T ss_dssp ---CCGGGCCHHHHHHCCC--CHHHHH------------------HHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCC
T ss_pred CCCCCcceeCHHHhcCCCC--CchhhH------------------HHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC
Confidence 3446789999999976543 333444 999999999997 999999877655322111 11
Q ss_pred CCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHH
Q psy14556 1042 RSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLV 1076 (1181)
Q Consensus 1042 ~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~ 1076 (1181)
...+...+..+..++.+|++.+|..||+ +.+.+.
T Consensus 611 ~~~~~~~~~~l~~li~~~l~~dP~~RPs-~~el~~ 644 (656)
T 2j0j_A 611 LPMPPNCPPTLYSLMTKCWAYDPSRRPR-FTELKA 644 (656)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCC-HHHHHH
T ss_pred CCCCccccHHHHHHHHHHcCCChhHCcC-HHHHHH
Confidence 2234467788999999999999999996 444333
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-31 Score=310.56 Aligned_cols=245 Identities=24% Similarity=0.248 Sum_probs=176.6
Q ss_pred cccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEeec
Q psy14556 806 FALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQV 884 (1181)
Q Consensus 806 ~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy~ 884 (1181)
++....+||+|+||+||.+. ..+++.||||.+... ..+.+.+|+.+++++ +||||+++++++.+.+..|+||||+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 44445579999999998754 567899999998643 245678999999886 8999999999999999999999999
Q ss_pred CCCCcccchhcccCCC----CCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccC------------CCeeeee
Q psy14556 885 PGGSLSTLLRVKWGPL----KENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTY------------SGVVKIS 948 (1181)
Q Consensus 885 ~gGSL~dlL~~~~~~~----~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~------------~g~vKLi 948 (1181)
. |+|.+++....... ...+..++.++.||+.||+|||++||+||||||+|||++.. ++.+||+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 5 69999997542111 11334567799999999999999999999999999999751 3489999
Q ss_pred cCCcccccccCCCC----CccccCCccccCchhhccCC-----CCCCCccccccCCCccccccccccchhHHHHHHHHHH
Q psy14556 949 DFGTSKRLAGLCPS----AETFTGTLQYMAPEVIDKGQ-----RGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQL 1019 (1181)
Q Consensus 949 DFGlAk~l~~~~~~----~~t~~GT~~Y~APEvl~gg~-----~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyEL 1019 (1181)
|||+++........ .....||+.|+|||++.+.. ..++..+| .||+||++|+|
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~D------------------iwSlG~il~el 232 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSID------------------IFSMGCVFYYI 232 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHH------------------HHHHHHHHHHH
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhh------------------hHhHHHHHHHH
Confidence 99999876543221 22356999999999997521 12333333 39999999999
Q ss_pred Hh-CCCCCCCCCcccc---cCCCCCCCCC---CCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1020 LV-LTAALKKKTSRAL---VAPPQISRSV---SVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1020 LT-Gk~PF~~~~~~~l---~~~~~ip~~l---~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
++ |..||........ ......+... ....+..+..++.+|+..+|..||+..+.
T Consensus 233 lt~g~~Pf~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ei 293 (434)
T 2rio_A 233 LSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293 (434)
T ss_dssp HTTSCCTTCSTTTHHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HhCCCCCCCCchhhHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHH
Confidence 99 9999987544321 1111111111 11223567789999999999999975544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=309.08 Aligned_cols=244 Identities=13% Similarity=0.038 Sum_probs=177.8
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHHHHHHHHhcCC-CCeeeEc------------------
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRH-RNIVQYL------------------ 868 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~rEi~IL~~L~H-PNIVkl~------------------ 868 (1181)
++||+|+||+||+|.+..+++.||||++..... ...+.+.+|+.+++.++| +|.....
T Consensus 84 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (413)
T 3dzo_A 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 163 (413)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC--
T ss_pred cccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCC
Confidence 479999999999999999999999999974332 236789999999999987 3221111
Q ss_pred ---ccccc-----CCcEEEEEeecCCCCcccchhcc----cCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCc
Q psy14556 869 ---GSVSE-----EGYFKIFMEQVPGGSLSTLLRVK----WGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNV 936 (1181)
Q Consensus 869 ---g~~~d-----~~~l~LVmEy~~gGSL~dlL~~~----~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NI 936 (1181)
.++.. ...++++|+++ +++|.++++.. .....+++..++.++.||+.||+|||++||+||||||+||
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NI 242 (413)
T 3dzo_A 164 KMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDI 242 (413)
T ss_dssp -------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred ccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceE
Confidence 11111 12467777766 78999888521 1233566788889999999999999999999999999999
Q ss_pred ccccCCCeeeeecCCcccccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHH
Q psy14556 937 LVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVII 1016 (1181)
Q Consensus 937 LLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvIL 1016 (1181)
|++. ++.+||+|||+++..... .....| +.|+|||++.+....++.. ....++...|.|||||++
T Consensus 243 Ll~~-~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~----------~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 243 VLDQ-RGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQH----------HPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp EECT-TCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGG----------CCEEECHHHHHHHHHHHH
T ss_pred EEec-CCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccc----------cCcCCCchhhHHHHHHHH
Confidence 9998 889999999999876543 344567 9999999995321111000 011233344459999999
Q ss_pred HHHHhCCCCCCCCCcccccCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1017 SQLLVLTAALKKKTSRALVAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1017 yELLTGk~PF~~~~~~~l~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
|+|++|+.||.+.+........ +. .....+..+..++.+|+..+|..||+..+.
T Consensus 308 ~elltg~~Pf~~~~~~~~~~~~-~~--~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~ 361 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGGSEWI-FR--SCKNIPQPVRALLEGFLRYPKEDRLLPLQA 361 (413)
T ss_dssp HHHHHSSCCCCTTGGGSCSGGG-GS--SCCCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHCCCCCCCcchhhhHHHH-Hh--hcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 9999999999987665432221 11 123567889999999999999999986443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-30 Score=286.00 Aligned_cols=225 Identities=23% Similarity=0.289 Sum_probs=176.4
Q ss_pred HHhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHH-HhcCCCCeeeEcccccc----CC
Q psy14556 801 RFLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLH-SQLRHRNIVQYLGSVSE----EG 875 (1181)
Q Consensus 801 ~~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL-~~L~HPNIVkl~g~~~d----~~ 875 (1181)
.+...|....+.||+|+||.||+|.+..+++.||+|++.. ...+.+|+.++ +.++||||+++++++.. .+
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 4556677666679999999999999999999999999954 35678899988 55699999999999876 67
Q ss_pred cEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccC--CCeeeeecCCcc
Q psy14556 876 YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTY--SGVVKISDFGTS 953 (1181)
Q Consensus 876 ~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~--~g~vKLiDFGlA 953 (1181)
.+++||||+++++|.+++... ....+++..++.++.|++.||+|||++||+||||||+||+++.. ++.+||+|||++
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred eEEEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 899999999999999999865 34468899999999999999999999999999999999999863 578999999998
Q ss_pred cccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc
Q psy14556 954 KRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA 1033 (1181)
Q Consensus 954 k~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~ 1033 (1181)
..... . .++...|+ ||+||++|+|++|+.||.+.....
T Consensus 168 ~~~~~----------------------~--~~~~~~Di------------------wslG~il~el~tg~~pf~~~~~~~ 205 (299)
T 3m2w_A 168 KETTG----------------------E--KYDKSCDM------------------WSLGVIMYILLCGYPPFYSNHGLA 205 (299)
T ss_dssp EECTT----------------------C--GGGGHHHH------------------HHHHHHHHHHHHSSCSCCC-----
T ss_pred ccccc----------------------c--cCCchhhH------------------HHHHHHHHHHHHCCCCCCCCcchh
Confidence 65331 1 11122333 999999999999999998766543
Q ss_pred ccC----CCC-----CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1034 LVA----PPQ-----ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1034 l~~----~~~-----ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
... ... .+.......+..+..++.+|+..+|..||+..+.
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~ 254 (299)
T 3m2w_A 206 ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 254 (299)
T ss_dssp --CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred hhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 211 111 1111113467788999999999999999975554
|
| >3rfy_A Peptidyl-prolyl CIS-trans isomerase CYP38, chloro; cyclophilin, peptidyl prolyl isomerase, ppiase, TLP,; 2.39A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=303.83 Aligned_cols=135 Identities=27% Similarity=0.406 Sum_probs=120.5
Q ss_pred cceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCC---------------------
Q psy14556 122 NLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTG--------------------- 180 (1181)
Q Consensus 122 ~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~g--------------------- 180 (1181)
+.|+|+|+||++.||+||+||++|| ++|| |+|+.|||| |+|||||||++. +|+|
T Consensus 186 ~~G~I~IeL~~d~AP~Tv~NFl~L~--~~Gf-YdGt~FHRV-~gFmIQgGDp~g-~G~G~~~~~~g~~~~iP~E~~~~G~ 260 (369)
T 3rfy_A 186 EDCVFRIVLDGYNAPVTAGNFVDLV--ERHF-YDGMEIQRS-DGFVVQTGDPEG-PAEGFIDPSTEKTRTVPLEIMVTGE 260 (369)
T ss_dssp SEEEEEEEEETTTCHHHHHHHHHHH--HTTT-TTTEECEEE-EEEEECCCCCCC-CCSCCCSCCCCCCCSSSSSSCSSSS
T ss_pred cceEEEEEEeCCCCcHHHHHHHHHh--hcCC-cCCCeeeee-CCeeEecCCCCC-CCCCccCcccCcCcccCccccccCC
Confidence 4999999999999999999999999 7899 999999999 999999999984 5555
Q ss_pred CcccCCCCCCCCcC-----ccccCCCceEEeecC--CCCCCcceEEEEc-------CCCCCCCCCCeEEEEEEcCHHHHH
Q psy14556 181 GKSIYGNKFEDENF-----TLKHTGPGILSMANA--GPNTNGSQFFITT-------VKTAWLDNRHVVFGSVVEGLDVVK 246 (1181)
Q Consensus 181 g~si~g~~~~dE~~-----~l~h~~~G~Lsma~~--g~nt~gSQFfItl-------~~~p~LDg~~vVFGrVieG~dVL~ 246 (1181)
+.++|+..|++|++ .++|+.+|+|||||+ +||++|||||||+ ++.+||||+|+|||+|++|||||+
T Consensus 261 g~piyg~~fedegf~~~~~~L~h~~~G~LsMAns~~gPnSngSQFFItl~d~~L~~~~~~~LDgkytVFG~VveGmdVVd 340 (369)
T 3rfy_A 261 KTPFYGSTLEELGLYKAQVVIPFNAFGTMAMAREEFENDSGSSQVFWLLKESELTPSNSNILDGRYAVFGYVTDNEDFLA 340 (369)
T ss_dssp CCSCCCSSTGGGTEEEEEEEECCCCCCCCCCSSCCCCCCCSSCCCCCCCEEEEECSCCCSSSCSCEEEEEEEEESTTGGG
T ss_pred CCCcCCCccccccccccccccccCCCceEEEeecCCCCCCccceEEEEecccccCCCCCcccCCCeeEEEEEecCHHHHH
Confidence 46788888888754 788999999999998 8999999999999 478999999999999999999999
Q ss_pred HHHhCCCCCCCcccceEEee
Q psy14556 247 KLESMGSQSGKTSKKIVVAN 266 (1181)
Q Consensus 247 kI~~~~t~~g~P~~~V~I~~ 266 (1181)
+|++ |.....++|.+
T Consensus 341 kI~~-----GD~I~sv~I~~ 355 (369)
T 3rfy_A 341 DLKV-----GDVIESIQVVS 355 (369)
T ss_dssp GCCT-----TCEEEEEEEEE
T ss_pred HHhC-----CCceEEEEEec
Confidence 9987 55556666654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-31 Score=325.02 Aligned_cols=245 Identities=21% Similarity=0.260 Sum_probs=189.8
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCC-CCChhHHHHHHHHHHhcCCCCeeeEcccccc------CCc
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKN-LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSE------EGY 876 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~-~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d------~~~ 876 (1181)
..|.+.+ +||+|+||.||+|.+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.. .+.
T Consensus 14 grY~i~~-~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKE-RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCC-CCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEE-EEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 4455544 7999999999999999999999999986542 2235678999999999999999999998765 678
Q ss_pred EEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCC---eeeeecCCcc
Q psy14556 877 FKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSG---VVKISDFGTS 953 (1181)
Q Consensus 877 l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g---~vKLiDFGlA 953 (1181)
.++||||++|++|.+++........+++..++.++.|++.||+|||++||+||||||+||+++. ++ .+||+|||.+
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~-~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQP-GPQRLIHKIIDLGYA 171 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEEC-CSSSCEEEECSCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeec-CCCceeEEEcccccc
Confidence 8999999999999999986544456888999999999999999999999999999999999986 34 4999999999
Q ss_pred cccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc
Q psy14556 954 KRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA 1033 (1181)
Q Consensus 954 k~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~ 1033 (1181)
...... .......||+.|+|||++.+..++..+|+ ||+|+++|+|++|..||.+.....
T Consensus 172 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDI--------------------wSLGviLyeLltG~~Pf~~~~~~~ 230 (676)
T 3qa8_A 172 KELDQG-ELCTEFVGTLQYLAPELLEQKKYTVTVDY--------------------WSFGTLAFECITGFRPFLPNWQPV 230 (676)
T ss_dssp CBTTSC-CCCCCCCSCCTTCSSCSSCCSCCSTTHHH--------------------HHHHHHHHHHHSSCSSCCSSCHHH
T ss_pred cccccc-cccccccCCcccCChHHhccCCCCchhHH--------------------HHHHHHHHHHHHCCCCCCcccchh
Confidence 876543 23344579999999999976654444333 999999999999999997642110
Q ss_pred -------------------ccCCCCC------CCCCCCCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1034 -------------------LVAPPQI------SRSVSVPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1034 -------------------l~~~~~i------p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
......+ +.......+..+..++.+|+..||..||+..
T Consensus 231 ~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~ 293 (676)
T 3qa8_A 231 QWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDP 293 (676)
T ss_dssp HSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCT
T ss_pred hhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHH
Confidence 0111111 1222223456788899999999999999753
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-30 Score=305.00 Aligned_cols=239 Identities=20% Similarity=0.207 Sum_probs=174.1
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
..+||+|+||+||.. ...+++.||||++.... .+.+.+|+.+++.+ +||||+++++++.+.+..|+||||+. |+
T Consensus 29 ~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~ 103 (432)
T 3p23_A 29 KDVLGHGAEGTIVYR-GMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-AT 103 (432)
T ss_dssp EEEEEECGGGCEEEE-EESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EE
T ss_pred CCeeecCcCEEEEEE-EEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CC
Confidence 347999999997643 45678899999996543 23467899999999 79999999999999999999999995 69
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccC----CCeeeeecCCcccccccCC---C
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTY----SGVVKISDFGTSKRLAGLC---P 961 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~----~g~vKLiDFGlAk~l~~~~---~ 961 (1181)
|.+++.... ....+..++.++.||+.||+|||++||+||||||+|||++.. ...+||+|||+++...... .
T Consensus 104 L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~ 181 (432)
T 3p23_A 104 LQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFS 181 (432)
T ss_dssp HHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--------
T ss_pred HHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCccee
Confidence 999987542 234455667899999999999999999999999999999531 2367899999998765332 1
Q ss_pred CCccccCCccccCchhhccCC-CCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccC---
Q psy14556 962 SAETFTGTLQYMAPEVIDKGQ-RGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVA--- 1036 (1181)
Q Consensus 962 ~~~t~~GT~~Y~APEvl~gg~-~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~--- 1036 (1181)
......||+.|+|||++.+.. ..++..+|+ ||+||++|+|++ |..||..........
T Consensus 182 ~~~~~~gt~~y~APE~l~~~~~~~~t~~~Di------------------wSlG~il~ellt~g~~pf~~~~~~~~~~~~~ 243 (432)
T 3p23_A 182 RRSGVPGTEGWIAPEMLSEDCKENPTYTVDI------------------FSAGCVFYYVISEGSHPFGKSLQRQANILLG 243 (432)
T ss_dssp ----CCSCTTSCCGGGTSCC---CCCTHHHH------------------HHHHHHHHHHHTTSCBTTBSTTTHHHHHHTT
T ss_pred eccccCCCcCccChhhhhcccccCCCcHHHH------------------HHHHHHHHHHHcCCCCCcchhhHHHHHHHhc
Confidence 233456999999999996421 222334444 999999999999 999997665433211
Q ss_pred CCCCCCCC-CCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1037 PPQISRSV-SVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1037 ~~~ip~~l-~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
........ ....+..+..++.+|++.+|..||+..+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ev 281 (432)
T 3p23_A 244 ACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281 (432)
T ss_dssp CCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred cCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHH
Confidence 11111110 01112336679999999999999975544
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-31 Score=297.90 Aligned_cols=225 Identities=14% Similarity=0.086 Sum_probs=168.2
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCC--------CChhHHHHHHHHHHhcC----------------
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--------GDVQPLHEEIKLHSQLR---------------- 860 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--------~~~e~f~rEi~IL~~L~---------------- 860 (1181)
.|.+. ++||+|+||+||+|++ +++.||||++..... ...+.+.+|+.+++.++
T Consensus 21 ~y~~~-~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 21 KLQRC-EKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHTC-EEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cchhe-eeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 34443 4799999999999998 789999999976532 23477999999999986
Q ss_pred ----------CCCeeeEcccccc-------------CCcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhh
Q psy14556 861 ----------HRNIVQYLGSVSE-------------EGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEG 917 (1181)
Q Consensus 861 ----------HPNIVkl~g~~~d-------------~~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~A 917 (1181)
||||+++++++.+ .+.+|+||||+++|++.+.+.. ..+++..++.++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 5666666666654 7889999999999977666643 257899999999999999
Q ss_pred hhhcc-ccceecccCCCCCcccccCCC--------------------eeeeecCCcccccccCCCCCccccCCccccCch
Q psy14556 918 LKYLH-GQKIVHRDIKGDNVLVNTYSG--------------------VVKISDFGTSKRLAGLCPSAETFTGTLQYMAPE 976 (1181)
Q Consensus 918 L~yLH-s~gIVHrDLKP~NILLd~~~g--------------------~vKLiDFGlAk~l~~~~~~~~t~~GT~~Y~APE 976 (1181)
|+||| ++||+||||||+|||++. ++ .+||+|||+++..... ...||+.|+|||
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~-~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE 247 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKK-TSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEE-CSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSG
T ss_pred HHHHHHhCCEeECCCCHHHEEEec-cCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChh
Confidence 99999 999999999999999987 55 8999999999876532 347999999999
Q ss_pred hhccCCCCCCCccccccCCCccccccccccchhHHHHHH-HHHHHhCCCCCCCCCc-----ccccCCCCCCCC----CCC
Q psy14556 977 VIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVI-ISQLLVLTAALKKKTS-----RALVAPPQISRS----VSV 1046 (1181)
Q Consensus 977 vl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvI-LyELLTGk~PF~~~~~-----~~l~~~~~ip~~----l~~ 1046 (1181)
++.+.. ...+|+ ||+|++ .+++++|..||.+... ..+......... ...
T Consensus 248 ~~~g~~---~~~~Di------------------wsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (336)
T 2vuw_A 248 LFTGDG---DYQFDI------------------YRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMK 306 (336)
T ss_dssp GGCCCS---SHHHHH------------------HHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHH
T ss_pred hhcCCC---ccceeh------------------hhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhh
Confidence 997543 233333 997666 8889999999975321 111111111111 111
Q ss_pred CCCcchHHhhccCCCCC
Q psy14556 1047 PGPGGINSSSSAPVTPT 1063 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~d 1063 (1181)
..+..+..++.+|++.+
T Consensus 307 ~~s~~~~dli~~~L~~d 323 (336)
T 2vuw_A 307 QIKRKIQEFHRTMLNFS 323 (336)
T ss_dssp HHHHHHHHHHHHGGGSS
T ss_pred hcCHHHHHHHHHHhccC
Confidence 24556677888888766
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-28 Score=299.47 Aligned_cols=186 Identities=18% Similarity=0.105 Sum_probs=134.5
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEecCCCCC----------ChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEE
Q psy14556 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLG----------DVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFM 881 (1181)
Q Consensus 813 IG~G~fG~VYka~d~~tg~~VAIKii~~~~~~----------~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVm 881 (1181)
++.|++|.+..++....|+.+++|.+.+.... ..+++.+|+++|+++ .|+||+++++++++++.+||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 67788888887777778999999999765321 245699999999999 7999999999999999999999
Q ss_pred eecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC
Q psy14556 882 EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP 961 (1181)
Q Consensus 882 Ey~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~ 961 (1181)
||++|++|.+++... .++++. .|+.||+.||+|||++|||||||||+|||++. +|.+||+|||+|+.......
T Consensus 322 Eyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~-dg~vKL~DFGlAr~~~~~~~ 394 (569)
T 4azs_A 322 EKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDA-RQHARLIDFGSIVTTPQDCS 394 (569)
T ss_dssp ECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECT-TSCEEECCCTTEESCC---C
T ss_pred ecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECC-CCCEEEeecccCeeCCCCCc
Confidence 999999999999854 234443 47899999999999999999999999999988 89999999999988776555
Q ss_pred CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCC
Q psy14556 962 SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAAL 1026 (1181)
Q Consensus 962 ~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF 1026 (1181)
...+.+||+.|+|||++.+. ..+..++ |++|+++|++.++..|+
T Consensus 395 ~~~t~vGTp~YmAPE~l~g~-~~~~~d~--------------------~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 395 WPTNLVQSFFVFVNELFAEN-KSWNGFW--------------------RSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp CSHHHHHHHHHHHHHHC--------------------------------------CCCCTTHHHH
T ss_pred cccCceechhhccHHHhCCC-CCCcccc--------------------cccccchhhhccccchh
Confidence 56667899999999999753 3333333 77888777766654443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=9e-24 Score=254.95 Aligned_cols=185 Identities=16% Similarity=0.103 Sum_probs=140.7
Q ss_pred CceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC--------hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEE
Q psy14556 809 NRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD--------VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIF 880 (1181)
Q Consensus 809 ~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~--------~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LV 880 (1181)
..++||+|+||.||+|.. .++.+++|......... .+++.+|+.++++++||||+++..++...+..|+|
T Consensus 340 ~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp --------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 345799999999999943 56788999875543322 34579999999999999999655555566778999
Q ss_pred EeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC
Q psy14556 881 MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC 960 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~ 960 (1181)
|||++|++|.+++.. +..++.|++.||+|||++||+||||||+|||++. .+||+|||+++......
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~---~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK---DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS---SEEECCCTTCEECCCHH
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC---eEEEEECccCEECCCcc
Confidence 999999999999873 4568999999999999999999999999999985 89999999998775432
Q ss_pred CC-------CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCC
Q psy14556 961 PS-------AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALK 1027 (1181)
Q Consensus 961 ~~-------~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~ 1027 (1181)
.. .....||+.|+|||++.+....|+..+|. |+..+-..+.+.++.+|.
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~------------------ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDR------------------WEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTT------------------HHHHHHHHHHHHTCSCCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhH------------------HHHHHHHHHHHHhccccC
Confidence 11 13457999999999997533334444443 988888888888877764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=3.9e-20 Score=205.31 Aligned_cols=139 Identities=19% Similarity=0.192 Sum_probs=113.6
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC------------------ChhHHHHHHHHHHhcCCCCeeeEccccc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG------------------DVQPLHEEIKLHSQLRHRNIVQYLGSVS 872 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~------------------~~e~f~rEi~IL~~L~HPNIVkl~g~~~ 872 (1181)
.+||+|+||.||+|.+ .+++.||+|+++..... ....+.+|+.++++++ | +++.+++.
T Consensus 96 ~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~ 171 (282)
T 1zar_A 96 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA 171 (282)
T ss_dssp EEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE
T ss_pred CEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe
Confidence 5799999999999999 88999999999654221 1346889999999999 4 56666543
Q ss_pred cCCcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCc
Q psy14556 873 EEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGT 952 (1181)
Q Consensus 873 d~~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGl 952 (1181)
. +..|+||||++|++|.+ +.. .....++.|++.||.|||++||+||||||+|||++ ++.+||+|||+
T Consensus 172 ~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~--~~~vkl~DFG~ 238 (282)
T 1zar_A 172 W-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS--EEGIWIIDFPQ 238 (282)
T ss_dssp E-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE--TTEEEECCCTT
T ss_pred c-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE--CCcEEEEECCC
Confidence 3 56799999999999998 431 12446899999999999999999999999999998 79999999999
Q ss_pred ccccccCCCCCccccCCccccCchhhc
Q psy14556 953 SKRLAGLCPSAETFTGTLQYMAPEVID 979 (1181)
Q Consensus 953 Ak~l~~~~~~~~t~~GT~~Y~APEvl~ 979 (1181)
++. +..|+|||.+.
T Consensus 239 a~~-------------~~~~~a~e~l~ 252 (282)
T 1zar_A 239 SVE-------------VGEEGWREILE 252 (282)
T ss_dssp CEE-------------TTSTTHHHHHH
T ss_pred CeE-------------CCCCCHHHHHH
Confidence 863 34578999985
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=2e-17 Score=180.60 Aligned_cols=133 Identities=18% Similarity=0.123 Sum_probs=102.4
Q ss_pred eeecccCceEEEEEEEcCCCeE--EEEEEecCCCCCC------------------------hhHHHHHHHHHHhcCCCCe
Q psy14556 811 IELGKGSYGVVYAARELDRQVK--LAIKEIPEKNLGD------------------------VQPLHEEIKLHSQLRHRNI 864 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~--VAIKii~~~~~~~------------------------~e~f~rEi~IL~~L~HPNI 864 (1181)
..||+|+||.||+|.+..+|+. ||||+++...... ...+.+|+.++.++.|++|
T Consensus 53 ~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 132 (258)
T 1zth_A 53 GVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGV 132 (258)
T ss_dssp EEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4799999999999998778888 9999975442110 1257899999999987754
Q ss_pred --eeEccccccCCcEEEEEeecCC-C----CcccchhcccCCCCCChHHHHHHHHHHHhhhhhcc-ccceecccCCCCCc
Q psy14556 865 --VQYLGSVSEEGYFKIFMEQVPG-G----SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLH-GQKIVHRDIKGDNV 936 (1181)
Q Consensus 865 --Vkl~g~~~d~~~l~LVmEy~~g-G----SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLH-s~gIVHrDLKP~NI 936 (1181)
..+++. +..++||||+.+ | +|.++... .++..+..++.|++.||.||| +.||+||||||+||
T Consensus 133 ~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NI 202 (258)
T 1zth_A 133 SVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNI 202 (258)
T ss_dssp CCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSE
T ss_pred CCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHE
Confidence 333332 357899999942 4 44443321 234567789999999999999 99999999999999
Q ss_pred ccccCCCeeeeecCCccccc
Q psy14556 937 LVNTYSGVVKISDFGTSKRL 956 (1181)
Q Consensus 937 LLd~~~g~vKLiDFGlAk~l 956 (1181)
|++. .++|+|||+|...
T Consensus 203 Ll~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 203 MYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp EESS---SEEECCCTTCEET
T ss_pred EEcC---cEEEEECcccccC
Confidence 9975 8999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.52 E-value=7.4e-15 Score=170.47 Aligned_cols=136 Identities=11% Similarity=0.079 Sum_probs=92.9
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--------------ChhHHHHHHHHHHhcCCCCeeeEccccccC-
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--------------DVQPLHEEIKLHSQLRHRNIVQYLGSVSEE- 874 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--------------~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~- 874 (1181)
..+||+|++|.||+|.+ .+|+.||||+++..... .......+.++.....|+|+.+++......
T Consensus 100 ~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp 178 (397)
T 4gyi_A 100 GSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVP 178 (397)
T ss_dssp EEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCC
T ss_pred cCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCC
Confidence 34799999999999987 46889999998643110 011222223332233344443333322111
Q ss_pred -----CcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCC------
Q psy14556 875 -----GYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSG------ 943 (1181)
Q Consensus 875 -----~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g------ 943 (1181)
...+|||||++|++|..+... .....++.||+.+|.+||++|||||||||.|||++. ++
T Consensus 179 ~p~~~~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~-dgd~~d~~ 248 (397)
T 4gyi_A 179 EPIAQSRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHGLIHGDFNEFNILIRE-EKDAEDPS 248 (397)
T ss_dssp CEEEEETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEE-EECSSCTT
T ss_pred eeeeccCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeC-CCCccccc
Confidence 223699999999888766531 123457899999999999999999999999999986 44
Q ss_pred ----eeeeecCCccccc
Q psy14556 944 ----VVKISDFGTSKRL 956 (1181)
Q Consensus 944 ----~vKLiDFGlAk~l 956 (1181)
.+.|+||+-+...
T Consensus 249 ~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 249 SITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SEEEEEEECCCTTCEET
T ss_pred ccccceEEEEeCCcccC
Confidence 4899999977543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.04 E-value=2.6e-10 Score=123.13 Aligned_cols=132 Identities=18% Similarity=0.198 Sum_probs=103.6
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcC-CCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR-HRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~-HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
.++.|+.+.||++.. .+..+++|+...........+.+|+.+++.+. +..+.++++++.+.+..|+|||+++|.+|.
T Consensus 21 ~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 98 (263)
T 3tm0_A 21 DTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCS 98 (263)
T ss_dssp CCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHH
T ss_pred eccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehh
Confidence 467788899999974 36789999986532233456899999999984 677888999988888999999999999987
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccc-----------------------------------------------
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHG----------------------------------------------- 923 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs----------------------------------------------- 923 (1181)
+.+.. ......++.+++.+|..||+
T Consensus 99 ~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 170 (263)
T 3tm0_A 99 EEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPREL 170 (263)
T ss_dssp HHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHH
T ss_pred hccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHH
Confidence 65321 12233577899999999998
Q ss_pred ------------cceecccCCCCCcccccCCCeeeeecCCccc
Q psy14556 924 ------------QKIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954 (1181)
Q Consensus 924 ------------~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk 954 (1181)
..++|+|++|.||+++. ++.+.|+||+.+.
T Consensus 171 ~~~l~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 171 YDFLKTEKPEEELVFSHGDLGDSNIFVKD-GKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHCCCCCCEEEECSSCCTTSEEEET-TEEEEECCCTTCE
T ss_pred HHHHHhcCCCCCceEECCCCCcCcEEEEC-CcEEEEEEchhcc
Confidence 56899999999999975 4456799999774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.94 E-value=1.8e-09 Score=115.03 Aligned_cols=128 Identities=19% Similarity=0.166 Sum_probs=93.8
Q ss_pred eec-ccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCC--eeeEccccccCCcEEEEEeecCCCC
Q psy14556 812 ELG-KGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRN--IVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 812 kIG-~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPN--IVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.++ .|..+.||++.. .++..+++|+.... ....+.+|+.+++.+.+.+ +.+++++....+..++||||++|.+
T Consensus 26 ~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~ 101 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 101 (264)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred ecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcc
Confidence 355 455699999964 55678999998654 2355889999999985444 5668888887788999999999988
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhcccc--------------------------------------------
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ-------------------------------------------- 924 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~-------------------------------------------- 924 (1181)
|. ... .+ ...++.+++..|..||+.
T Consensus 102 l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (264)
T 1nd4_A 102 LL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 170 (264)
T ss_dssp TT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred cC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence 84 221 11 123566777777777754
Q ss_pred --------------ceecccCCCCCcccccCCCeeeeecCCcccc
Q psy14556 925 --------------KIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 955 (1181)
Q Consensus 925 --------------gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~ 955 (1181)
+++|+|++|.||+++. ++.+.|+|||.+..
T Consensus 171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 171 FARLKARMPDGEDLVVTHGDACLPNIMVEN-GRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEET-TEEEEECCCTTCEE
T ss_pred HHHHHHhcCCCCCeEEECCCCCCCcEEEEC-CcEEEEEcchhccc
Confidence 3999999999999976 45566999998743
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.79 E-value=9.8e-09 Score=116.45 Aligned_cols=138 Identities=16% Similarity=0.196 Sum_probs=102.1
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEec--CCCC-CChhHHHHHHHHHHhcC--CCCeeeEccccccC---CcEEEEEe
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIP--EKNL-GDVQPLHEEIKLHSQLR--HRNIVQYLGSVSEE---GYFKIFME 882 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~--~~~~-~~~e~f~rEi~IL~~L~--HPNIVkl~g~~~d~---~~l~LVmE 882 (1181)
+.|+.|.++.||++... +..+++|+.. .... .....+.+|+.+++.+. +..+.+++.++.+. +..|+|||
T Consensus 44 ~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 36899999999998753 4578888876 3321 22456889999999996 45578888887766 55899999
Q ss_pred ecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccc---------------------------------------
Q psy14556 883 QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHG--------------------------------------- 923 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs--------------------------------------- 923 (1181)
|++|..+.+... ..++......++.+++..|..||+
T Consensus 122 ~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 122 FVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred ecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 999988854221 134567777889999999999996
Q ss_pred -------------------cceecccCCCCCcccccCCC-eeeeecCCcccc
Q psy14556 924 -------------------QKIVHRDIKGDNVLVNTYSG-VVKISDFGTSKR 955 (1181)
Q Consensus 924 -------------------~gIVHrDLKP~NILLd~~~g-~vKLiDFGlAk~ 955 (1181)
..++|+|++|.||+++.++. .+.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 46999999999999987332 368999998853
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.49 E-value=6.2e-08 Score=107.48 Aligned_cols=199 Identities=16% Similarity=0.135 Sum_probs=120.2
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcC-CCC--eeeEccccccCC---cEEEEEeecC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR-HRN--IVQYLGSVSEEG---YFKIFMEQVP 885 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~-HPN--IVkl~g~~~d~~---~l~LVmEy~~ 885 (1181)
.++.|....||++. ..+++|+.... .....+.+|+.+++.+. +.. +.+++......+ ..|+||++++
T Consensus 27 ~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 27 ISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp EEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred ecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 58999999999863 35888986432 23467899999998883 322 344554443332 4589999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccc------------------------------------------
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHG------------------------------------------ 923 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs------------------------------------------ 923 (1181)
|.+|...... .++......++.+++..|..||+
T Consensus 100 G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 100 GVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 9888753221 23455556666777777666664
Q ss_pred ----------------cceecccCCCCCcccccC-CCeeeeecCCcccccccCCCCCccccCCccc---cCchhhccCCC
Q psy14556 924 ----------------QKIVHRDIKGDNVLVNTY-SGVVKISDFGTSKRLAGLCPSAETFTGTLQY---MAPEVIDKGQR 983 (1181)
Q Consensus 924 ----------------~gIVHrDLKP~NILLd~~-~g~vKLiDFGlAk~l~~~~~~~~t~~GT~~Y---~APEvl~gg~~ 983 (1181)
..++|+|++|.||+++.+ .+.+.|+||+.+..-... ........+ ..|+....--.
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~----~Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD----NDFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT----HHHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH----HHHHHHHhhccccCHHHHHHHHH
Confidence 247999999999999863 346789999988643211 000011111 23443321000
Q ss_pred CCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc
Q psy14556 984 GYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR 1032 (1181)
Q Consensus 984 ~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~ 1032 (1181)
.|.. .+. .............|+++.++|.+.+|..+|......
T Consensus 251 ~Y~~-~~~-----~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~~g~~ 293 (304)
T 3sg8_A 251 HYKH-KDI-----PTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYEEGLN 293 (304)
T ss_dssp HHTC-SCH-----HHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHHHHHH
T ss_pred HcCC-CCc-----HHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHHHHHH
Confidence 1110 000 000111223345689999999999999988654443
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=5.5e-06 Score=89.48 Aligned_cols=133 Identities=14% Similarity=0.141 Sum_probs=92.9
Q ss_pred eecccCce-EEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcC-CCCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 812 ELGKGSYG-VVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR-HRNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 812 kIG~G~fG-~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~-HPNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
.+..|..| .||+......+..+++|+.+.. ....+.+|...|+.+. +--+.+++.++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34555554 6899877777778999987543 2456889999998884 33467788888888999999999999887
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccc----------------------------------------------
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHG---------------------------------------------- 923 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs---------------------------------------------- 923 (1181)
.+..... ......+..++...|..||+
T Consensus 108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 6654321 11122334444444444442
Q ss_pred ------------cceecccCCCCCcccccCCCeeeeecCCcccc
Q psy14556 924 ------------QKIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 955 (1181)
Q Consensus 924 ------------~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~ 955 (1181)
..++|+|+++.|||++. ++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~-~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDE-GKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEET-TEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEEC-CeEEEEEECccccc
Confidence 13799999999999986 55667999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.97 E-value=1.2e-05 Score=89.62 Aligned_cols=132 Identities=21% Similarity=0.189 Sum_probs=86.0
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCC---CeeeEccccc-cCCcEEEEEeecCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHR---NIVQYLGSVS-EEGYFKIFMEQVPGG 887 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HP---NIVkl~g~~~-d~~~l~LVmEy~~gG 887 (1181)
.++.|....||+. +..+++|+... ......+.+|..+|+.+.+. .+.+++.+.. ..+..++|||+++|.
T Consensus 26 ~l~~G~~n~v~~v-----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 26 SLGEGFRNYAILV-----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEECSSEEEEEE-----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred ecCCCcceeEEEE-----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 5788888899987 45678888532 22346789999999999652 3455665553 456788999999998
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhcc---------------------------------------------
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLH--------------------------------------------- 922 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLH--------------------------------------------- 922 (1181)
+|....-. .++......++.++...|..||
T Consensus 99 ~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 99 ILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp ECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 88652110 1122222233333333333333
Q ss_pred ---------------ccceecccCCCCCccccc--CCCe-eeeecCCcccc
Q psy14556 923 ---------------GQKIVHRDIKGDNVLVNT--YSGV-VKISDFGTSKR 955 (1181)
Q Consensus 923 ---------------s~gIVHrDLKP~NILLd~--~~g~-vKLiDFGlAk~ 955 (1181)
...++|+|++|.||+++. .++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 235799999999999975 1244 58999998754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.86 E-value=3.8e-05 Score=88.23 Aligned_cols=104 Identities=17% Similarity=0.184 Sum_probs=61.8
Q ss_pred ccccccChHHHHHHHHhhccCCCCcccccchHHHHhhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCC----
Q psy14556 768 QDYDAMDYDAMVQLVEDLRTIPTKKKYMQTPMLRFLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---- 843 (1181)
Q Consensus 768 qe~~~md~d~~~qlle~lr~~p~~~k~~~~p~~~~~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---- 843 (1181)
..|..++.+.+.+.+......+... ...-+.||.|..+.||++....+++.+++|.......
T Consensus 7 ~~~~~l~~~~v~~~l~~~~~~~~~~--------------~~~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~ 72 (397)
T 2olc_A 7 PLYETLNESSAVALAVKLGLFPSKS--------------TLTCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGE 72 (397)
T ss_dssp CCCCCCCHHHHHHHHHHTTC-------------------CCEEEECCSSSSEEEEEEEC----CEEEEEEECCC------
T ss_pred cccccCCHHHHHHHHHhcCcCCCCC--------------ceEEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCC
Confidence 4466677777776655322111100 0112369999999999997655677899998753211
Q ss_pred ---CChhHHHHHHHHHHhcCC--C-CeeeEccccccCCcEEEEEeecCCC
Q psy14556 844 ---GDVQPLHEEIKLHSQLRH--R-NIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 844 ---~~~e~f~rEi~IL~~L~H--P-NIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
...+++..|..+++.+.. | .+.+++.+ +.+..++|||++++.
T Consensus 73 ~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 73 SWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVMEDLSHL 120 (397)
T ss_dssp -CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEECCCTTS
T ss_pred CCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEEEEeCCCc
Confidence 234567889999988742 3 34455544 334568999999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.85 E-value=4.7e-05 Score=85.85 Aligned_cols=80 Identities=13% Similarity=0.044 Sum_probs=56.1
Q ss_pred ee-cccCceEEEEEEEc--C----CCeEEEEEEecCCC---CCChhHHHHHHHHHHhcC-C--CCeeeEccccccC---C
Q psy14556 812 EL-GKGSYGVVYAAREL--D----RQVKLAIKEIPEKN---LGDVQPLHEEIKLHSQLR-H--RNIVQYLGSVSEE---G 875 (1181)
Q Consensus 812 kI-G~G~fG~VYka~d~--~----tg~~VAIKii~~~~---~~~~e~f~rEi~IL~~L~-H--PNIVkl~g~~~d~---~ 875 (1181)
.| +.|....+|+.... . ++..+++|+..... ......+.+|+.+++.+. + ..+.+++.+..+. +
T Consensus 27 ~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g 106 (357)
T 3ats_A 27 GVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLG 106 (357)
T ss_dssp EECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTS
T ss_pred ECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccC
Confidence 57 88889999988653 1 15688999875432 112356788999988874 2 3566777776554 4
Q ss_pred cEEEEEeecCCCCccc
Q psy14556 876 YFKIFMEQVPGGSLST 891 (1181)
Q Consensus 876 ~l~LVmEy~~gGSL~d 891 (1181)
..++|||+++|.++.+
T Consensus 107 ~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 107 TPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SCEEEEECCCCBCCCB
T ss_pred CceEEEEecCCCChhh
Confidence 6789999999888764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00018 Score=79.78 Aligned_cols=136 Identities=12% Similarity=0.105 Sum_probs=78.0
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcC--CCCeeeEccc------cccCCcEEEEEee
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR--HRNIVQYLGS------VSEEGYFKIFMEQ 883 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~--HPNIVkl~g~------~~d~~~l~LVmEy 883 (1181)
.|+.|..+.||++... +..+++|+.... .+.+..|..+++.|. .-.+.+++.. ....+..+++|+|
T Consensus 39 ~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 39 VIQGNQMALVWKVHTD--SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp ECC----CEEEEEEET--TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eccccccCcEEEEEeC--CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4666778899998752 345899998652 244556666666553 1133444431 1245678999999
Q ss_pred cCCCCccc-----------c---hhcccCCC--C---------CChHH-------------------------------H
Q psy14556 884 VPGGSLST-----------L---LRVKWGPL--K---------ENEST-------------------------------M 907 (1181)
Q Consensus 884 ~~gGSL~d-----------l---L~~~~~~~--~---------l~e~~-------------------------------i 907 (1181)
++|.++.. . ++...... + ..+.. +
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 99876531 0 11100000 0 01110 1
Q ss_pred HHHHHHHHhhhhhcc-------------ccceecccCCCCCcccccCCCeeeeecCCccc
Q psy14556 908 SFYTKQILEGLKYLH-------------GQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954 (1181)
Q Consensus 908 ~~Ia~QIa~AL~yLH-------------s~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk 954 (1181)
..+..++..++.+|+ ...++|+|+++.||+++. ++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~-~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGE-NEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECG-GGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeC-CCcEEEEehhhcc
Confidence 111122334556665 357999999999999976 5789999999874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=96.98 E-value=0.001 Score=77.23 Aligned_cols=32 Identities=22% Similarity=0.325 Sum_probs=27.7
Q ss_pred cccceecccCCCCCcccccCCCeeeeecCCcccc
Q psy14556 922 HGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 955 (1181)
Q Consensus 922 Hs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~ 955 (1181)
+...++|+|++|.|||++. ++ ++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~-~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQ-DS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECS-SC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeC-CC-CEEEeCccccc
Confidence 5678999999999999986 44 99999998754
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0034 Score=70.70 Aligned_cols=74 Identities=12% Similarity=0.099 Sum_probs=59.3
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcC---CCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR---HRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~---HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.|+.|....+|+... ++..+++|+.... ....+.+|+..|+.|. ...+.+++.+....+..++|||+++|..
T Consensus 43 ~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 43 KLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred EeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 689999999999874 4668889987643 2466889999998883 3567888888877788999999999887
Q ss_pred cc
Q psy14556 889 LS 890 (1181)
Q Consensus 889 L~ 890 (1181)
+.
T Consensus 118 ~~ 119 (312)
T 3jr1_A 118 NK 119 (312)
T ss_dssp CC
T ss_pred CC
Confidence 63
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0059 Score=67.49 Aligned_cols=138 Identities=14% Similarity=0.126 Sum_probs=75.7
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCC--eeeEcccc------ccCCcEEEEEee
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRN--IVQYLGSV------SEEGYFKIFMEQ 883 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPN--IVkl~g~~------~d~~~l~LVmEy 883 (1181)
.|+.|....+|+.... ++ .+++|+.... ...+.+..|..+++.+.... +.+++... ...+..+++|++
T Consensus 29 ~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 29 GIAEGVENSNFLLHTT-KD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred ccCCCcccceEEEEeC-Cc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4788888999998753 33 6889998653 12345677888887773211 33343221 223567899999
Q ss_pred cCCCCcccc--------------hhcccCCCC------CChHHHHHHH---------------HHHHhhhhhcc------
Q psy14556 884 VPGGSLSTL--------------LRVKWGPLK------ENESTMSFYT---------------KQILEGLKYLH------ 922 (1181)
Q Consensus 884 ~~gGSL~dl--------------L~~~~~~~~------l~e~~i~~Ia---------------~QIa~AL~yLH------ 922 (1181)
++|..+... ++....... .........+ ..+...++.++
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 988765321 111000100 0000000000 01222233332
Q ss_pred -ccceecccCCCCCcccccCCCeeeeecCCccc
Q psy14556 923 -GQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954 (1181)
Q Consensus 923 -s~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk 954 (1181)
..+++|+|+++.|||++. ++.+.|+||+.+.
T Consensus 185 ~~~~liHgDl~~~Nil~~~-~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLG-DELSGLIDFYFAC 216 (322)
T ss_dssp SCEEEECSCCCGGGEEEET-TEEEEECCCTTCE
T ss_pred CCcccCCCCCCccCEEEeC-CceEEEecchhcc
Confidence 357999999999999986 4445799999774
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.54 E-value=0.0078 Score=65.89 Aligned_cols=74 Identities=18% Similarity=0.068 Sum_probs=54.1
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCC---CCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRH---RNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~H---PNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
.+|.|..+.||+... .+|+.|++|+.+.........+.+|+..|+.|.. -.+.+++++. ..++|||+++++.
T Consensus 22 ~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 22 ERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred ecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence 589999999999974 5678999998866555445678899999998842 2344555442 2478999998765
Q ss_pred cc
Q psy14556 889 LS 890 (1181)
Q Consensus 889 L~ 890 (1181)
..
T Consensus 97 ~~ 98 (288)
T 3f7w_A 97 PT 98 (288)
T ss_dssp CC
T ss_pred CC
Confidence 43
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.43 E-value=0.0038 Score=68.88 Aligned_cols=71 Identities=11% Similarity=0.025 Sum_probs=44.6
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCe-eeEccccccCCcEEEEEeec-CCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNI-VQYLGSVSEEGYFKIFMEQV-PGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNI-Vkl~g~~~d~~~l~LVmEy~-~gGS 888 (1181)
..|+.|....+|++ ..+++|+....... .....+|+.+++.+....+ .++++...+ .-++++||+ +|.+
T Consensus 24 ~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 24 LERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAGAQT 94 (301)
T ss_dssp EEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTTCEE
T ss_pred eEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCCCcc
Confidence 36888999999998 45889988654222 1224568888877642222 455554433 346899999 7666
Q ss_pred cc
Q psy14556 889 LS 890 (1181)
Q Consensus 889 L~ 890 (1181)
+.
T Consensus 95 l~ 96 (301)
T 3dxq_A 95 MS 96 (301)
T ss_dssp CC
T ss_pred CC
Confidence 64
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.27 E-value=0.011 Score=69.19 Aligned_cols=74 Identities=18% Similarity=0.192 Sum_probs=50.7
Q ss_pred eeecccCceEEEEEEEcC-------CCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCC-eeeEccccccCCcEEEEEe
Q psy14556 811 IELGKGSYGVVYAARELD-------RQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRN-IVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~-------tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPN-IVkl~g~~~d~~~l~LVmE 882 (1181)
..|+.|....+|++.... .+..+++|+.... ...+.+.+|..+++.+...+ ..++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 358888889999998643 2578999998432 11256678999998884333 3566665543 28999
Q ss_pred ecCCCCcc
Q psy14556 883 QVPGGSLS 890 (1181)
Q Consensus 883 y~~gGSL~ 890 (1181)
|++|.+|.
T Consensus 153 ~l~G~~l~ 160 (429)
T 1nw1_A 153 YIPSRPLS 160 (429)
T ss_dssp CCCEEECC
T ss_pred EeCCcccC
Confidence 99875654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.06 E-value=0.033 Score=61.62 Aligned_cols=138 Identities=12% Similarity=0.151 Sum_probs=80.1
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCC--CCeeeEccc-----cccCCcEEEEEeec
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRH--RNIVQYLGS-----VSEEGYFKIFMEQV 884 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~H--PNIVkl~g~-----~~d~~~l~LVmEy~ 884 (1181)
.|+ |....||++.. .+|+.+++|...... ...+.+..|..+++.+.. -.+.+++.. ....+..+++|+++
T Consensus 33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEC-CSSSEEEEECC-TTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred eec-CcccceEEEEc-CCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 466 78889998754 345678999986432 234667788888887742 224444443 12245678899999
Q ss_pred CCCCccc----c----------hhcccC--C----CCCChHH----------------------HHHHHHHHHhhhhhc-
Q psy14556 885 PGGSLST----L----------LRVKWG--P----LKENEST----------------------MSFYTKQILEGLKYL- 921 (1181)
Q Consensus 885 ~gGSL~d----l----------L~~~~~--~----~~l~e~~----------------------i~~Ia~QIa~AL~yL- 921 (1181)
+|.++.. . ++.... . ...+... ....+.+++..+..+
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8865531 0 010000 0 0111110 011122222222221
Q ss_pred ---cccceecccCCCCCcccccCCCeeeeecCCcccc
Q psy14556 922 ---HGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 955 (1181)
Q Consensus 922 ---Hs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~ 955 (1181)
+...++|+|+++.||+++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~--~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR--D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES--S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc--C-CCEEEECCCCCc
Confidence 345789999999999997 3 799999987743
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.98 E-value=0.019 Score=63.93 Aligned_cols=33 Identities=30% Similarity=0.349 Sum_probs=27.2
Q ss_pred ccceecccCCCCCcccccC---CCeeeeecCCcccc
Q psy14556 923 GQKIVHRDIKGDNVLVNTY---SGVVKISDFGTSKR 955 (1181)
Q Consensus 923 s~gIVHrDLKP~NILLd~~---~g~vKLiDFGlAk~ 955 (1181)
...++|||+.+.|||++.. .+.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 4589999999999999762 15789999998754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.83 E-value=0.019 Score=66.48 Aligned_cols=139 Identities=22% Similarity=0.198 Sum_probs=82.2
Q ss_pred eeecccCceEEEEEEEcC-------CCeEEEEEEecCCCCCChhHHHHHHHHHHhcC-CCCeeeEccccccCCcEEEEEe
Q psy14556 811 IELGKGSYGVVYAARELD-------RQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR-HRNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~-------tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~-HPNIVkl~g~~~d~~~l~LVmE 882 (1181)
+.|..|-...+|++.... .++.+++|+.... ......+.+|..+++.+. +.-..++++.+.+. +|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEE
Confidence 357778888999987632 3478999986432 234566779999998884 32235666666542 9999
Q ss_pred ecCCCCcccc-hh----------------cccC--CCCC--ChHHHHHHHHHHHhh-------------------hhhcc
Q psy14556 883 QVPGGSLSTL-LR----------------VKWG--PLKE--NESTMSFYTKQILEG-------------------LKYLH 922 (1181)
Q Consensus 883 y~~gGSL~dl-L~----------------~~~~--~~~l--~e~~i~~Ia~QIa~A-------------------L~yLH 922 (1181)
|++|.+|..- +. .... .... -+.++..+..++-.. +..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998776421 10 0000 0111 134455555544321 12221
Q ss_pred --------ccceecccCCCCCcccccC---CCeeeeecCCccc
Q psy14556 923 --------GQKIVHRDIKGDNVLVNTY---SGVVKISDFGTSK 954 (1181)
Q Consensus 923 --------s~gIVHrDLKP~NILLd~~---~g~vKLiDFGlAk 954 (1181)
...++|+|+.+.||+++.. .+.+.|+||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2369999999999999873 2689999999875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.82 E-value=0.016 Score=65.73 Aligned_cols=73 Identities=10% Similarity=0.062 Sum_probs=43.9
Q ss_pred eecccCceEEEEEEEcC--------CCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCC-eeeEccccccCCcEEEEEe
Q psy14556 812 ELGKGSYGVVYAARELD--------RQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRN-IVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~--------tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPN-IVkl~g~~~d~~~l~LVmE 882 (1181)
.|+.|....+|++.... .+..+++|+....... ......|..+++.+...+ +.++++... -++|||
T Consensus 40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~e 114 (369)
T 3c5i_A 40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIEE 114 (369)
T ss_dssp EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEecC----CcEEEE
Confidence 57888888999997643 1268889987543221 122467888888774323 345555432 268999
Q ss_pred ecCCCCc
Q psy14556 883 QVPGGSL 889 (1181)
Q Consensus 883 y~~gGSL 889 (1181)
|++|.++
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9988655
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.55 E-value=0.069 Score=63.25 Aligned_cols=74 Identities=19% Similarity=0.169 Sum_probs=49.0
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCe-eeEccccccCCcEEEEEeecCCCCcc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNI-VQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNI-Vkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
.|+.|-...+|++.....+..+++|+........ -...+|..+++.|...++ .++++.+.. .+||||++|.+|.
T Consensus 115 ~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~l~ 189 (458)
T 2qg7_A 115 IINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYALS 189 (458)
T ss_dssp EECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEECC
T ss_pred EcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCccCC
Confidence 5888888999999875445789999885432221 123689999998864444 466766632 2599999886654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.70 E-value=0.1 Score=58.93 Aligned_cols=68 Identities=12% Similarity=0.071 Sum_probs=43.4
Q ss_pred cccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcC---CCCeeeEccc------cccCCcEEEEEeec
Q psy14556 814 GKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR---HRNIVQYLGS------VSEEGYFKIFMEQV 884 (1181)
Q Consensus 814 G~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~---HPNIVkl~g~------~~d~~~l~LVmEy~ 884 (1181)
|.|....||+... .++ .+++|+...... ..|+.+++.|. -|++.+++.. ....+..+++|+|+
T Consensus 32 G~g~~N~vy~v~~-~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i 103 (339)
T 3i1a_A 32 GADTNAFAYQADS-ESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFI 103 (339)
T ss_dssp TSCSSCEEEEEEC-SSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECC
T ss_pred cCccccceEEEEe-CCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEecc
Confidence 4444678999874 344 899998865432 35666666552 2334555533 23356789999999
Q ss_pred CCCCc
Q psy14556 885 PGGSL 889 (1181)
Q Consensus 885 ~gGSL 889 (1181)
+|..+
T Consensus 104 ~G~~~ 108 (339)
T 3i1a_A 104 HAPNG 108 (339)
T ss_dssp CCCBT
T ss_pred CCCcC
Confidence 98766
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.94 E-value=0.27 Score=57.72 Aligned_cols=74 Identities=8% Similarity=0.075 Sum_probs=48.2
Q ss_pred eecccCceEEEEEEEcCC-------CeEEEEEEecCCCCCChhHHHHHHHHHHhcC-CCCeeeEccccccCCcEEEEEee
Q psy14556 812 ELGKGSYGVVYAARELDR-------QVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR-HRNIVQYLGSVSEEGYFKIFMEQ 883 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~t-------g~~VAIKii~~~~~~~~e~f~rEi~IL~~L~-HPNIVkl~g~~~d~~~l~LVmEy 883 (1181)
.|..|-...+|++..... +..+++|+...... ..-...+|..+++.+. +.-..++++.+. -++||||
T Consensus 77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ef 151 (424)
T 3mes_A 77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEEF 151 (424)
T ss_dssp EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEEC
T ss_pred EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEEE
Confidence 577788889999986421 57899999754332 2223467888888874 222345554332 2689999
Q ss_pred cCCCCcc
Q psy14556 884 VPGGSLS 890 (1181)
Q Consensus 884 ~~gGSL~ 890 (1181)
++|.+|.
T Consensus 152 I~G~~l~ 158 (424)
T 3mes_A 152 IDGEPLT 158 (424)
T ss_dssp CCSEECC
T ss_pred eCCccCC
Confidence 9987653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.13 E-value=1.2 Score=51.44 Aligned_cols=31 Identities=23% Similarity=0.273 Sum_probs=25.1
Q ss_pred ceecccCCCCCccccc-----CCCeeeeecCCcccc
Q psy14556 925 KIVHRDIKGDNVLVNT-----YSGVVKISDFGTSKR 955 (1181)
Q Consensus 925 gIVHrDLKP~NILLd~-----~~g~vKLiDFGlAk~ 955 (1181)
.++|+|+.+.|||+.. .++.++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 4689999999999932 256899999998853
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1181 | ||||
| d2cfea1 | 162 | b.62.1.1 (A:1-162) Cyclophilin-like allergen Mal s | 3e-49 | |
| d1qnga_ | 170 | b.62.1.1 (A:) Cyclophilin (eukaryotic) {Plasmodium | 3e-45 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-45 | |
| d2z6wa1 | 164 | b.62.1.1 (A:2-165) Mitochondrial peptidyl-prolyl c | 1e-43 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-43 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-43 | |
| d2igva1 | 172 | b.62.1.1 (A:1-172) Cyclophilin (eukaryotic) {Caeno | 1e-42 | |
| d2c3ba1 | 171 | b.62.1.1 (A:1-171) Cyclophilin (eukaryotic) {Asper | 2e-42 | |
| d1a33a_ | 174 | b.62.1.1 (A:) Cyclophilin (eukaryotic) {Nematode ( | 4e-42 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-42 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-42 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-41 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-41 | |
| d1ihga2 | 195 | b.62.1.1 (A:2-196) Cyclophilin 40 isomerase domain | 4e-41 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-41 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-39 | |
| d2r99a1 | 161 | b.62.1.1 (A:139-299) Mitochondrial peptidyl-prolyl | 3e-39 | |
| d1h0pa_ | 182 | b.62.1.1 (A:) Cyclophilin (eukaryotic) {Caenorhabd | 3e-39 | |
| d2rmca_ | 182 | b.62.1.1 (A:) Cyclophilin (eukaryotic) {Mouse (Mus | 6e-39 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-39 | |
| d1zkca1 | 178 | b.62.1.1 (A:280-457) Peptidyl-prolyl cis-trans iso | 1e-38 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-38 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-37 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-37 | |
| d1xwna1 | 166 | b.62.1.1 (A:1-166) Peptidyl-prolyl cis-trans isome | 2e-37 | |
| d1xo7a_ | 166 | b.62.1.1 (A:) Cyclophilin (eukaryotic) {Trypanosom | 4e-37 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-37 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-36 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-36 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-36 | |
| d1qoia_ | 173 | b.62.1.1 (A:) Cyclophilin (eukaryotic) {Human (Hom | 2e-35 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-35 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-35 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-35 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-34 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-34 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-34 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-34 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-33 | |
| d2ok3a1 | 159 | b.62.1.1 (A:1-159) Cyclophilin-like protein PPIL3B | 3e-33 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-33 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-33 | |
| d1z81a1 | 186 | b.62.1.1 (A:25-210) Cyclophilin (eukaryotic) {Plas | 9e-33 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-32 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-32 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-32 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-32 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-32 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-32 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-32 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-32 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-31 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-31 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-31 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-31 | |
| d1w74a_ | 171 | b.62.1.1 (A:) Peptidyl-prolyl cis-trans isomerase | 8e-31 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-31 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-30 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-30 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-30 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-30 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-29 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-29 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-29 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-29 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-29 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-29 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-28 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-28 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-28 | |
| d2a2na1 | 164 | b.62.1.1 (A:483-646) Peptidylprolyl isomerase doma | 1e-27 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-27 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-27 | |
| d2fu0a1 | 155 | b.62.1.1 (A:5-159) Putative cyclophilin PFE0505w { | 9e-27 | |
| d2b71a1 | 169 | b.62.1.1 (A:23-191) Cyclophilin-like protein PY006 | 6e-26 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-25 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-23 | |
| d1lopa_ | 164 | b.62.1.1 (A:) Peptidyl-prolyl cis-trans isomerase | 1e-23 | |
| d1v9ta_ | 166 | b.62.1.1 (A:) Peptidyl-prolyl cis-trans isomerase | 1e-21 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-20 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-15 |
| >d2cfea1 b.62.1.1 (A:1-162) Cyclophilin-like allergen Mal s 6 {Malassezia sympodialis [TaxId: 76777]} Length = 162 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Cyclophilin-like allergen Mal s 6 species: Malassezia sympodialis [TaxId: 76777]
Score = 169 bits (430), Expect = 3e-49
Identities = 100/140 (71%), Positives = 113/140 (80%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGN 187
KL DVVPKTA NFRALCTGEKGFG+ S FHRVIP+FM QGGDFT NGTGGKSIYG
Sbjct: 20 FKLFDDVVPKTAANFRALCTGEKGFGYAGSHFHRVIPDFMLQGGDFTAGNGTGGKSIYGA 79
Query: 188 KFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKK 247
KF DENF LKH PG+LSMANAGPNTNGSQFFITTV T+WLD +HVVFG V++G++VVK
Sbjct: 80 KFADENFQLKHNKPGLLSMANAGPNTNGSQFFITTVVTSWLDGKHVVFGEVIDGMNVVKA 139
Query: 248 LESMGSQSGKTSKKIVVANS 267
+E+ GS SGK +I +A
Sbjct: 140 IEAEGSGSGKPRSRIEIAKC 159
|
| >d1qnga_ b.62.1.1 (A:) Cyclophilin (eukaryotic) {Plasmodium falciparum [TaxId: 5833]} Length = 170 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Cyclophilin (eukaryotic) species: Plasmodium falciparum [TaxId: 5833]
Score = 158 bits (401), Expect = 3e-45
Identities = 85/147 (57%), Positives = 108/147 (73%), Gaps = 6/147 (4%)
Query: 127 HIKLRSDVVPKTAENFRALCTGE------KGFGFKDSTFHRVIPNFMCQGGDFTNHNGTG 180
+L SD+ P+T ENFRALCTGE K +K+S FHR+IP FMCQGGD TN NG+G
Sbjct: 21 IFELFSDITPRTCENFRALCTGEKIGSRGKNLHYKNSIFHRIIPQFMCQGGDITNGNGSG 80
Query: 181 GKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVE 240
G+SIYG F DENF +KH PG+LSMANAGPNTN SQFFIT V WLD +HVVFG V+E
Sbjct: 81 GESIYGRSFTDENFNMKHDQPGLLSMANAGPNTNSSQFFITLVPCPWLDGKHVVFGKVIE 140
Query: 241 GLDVVKKLESMGSQSGKTSKKIVVANS 267
G++VV+++E G++SG + +V+ +
Sbjct: 141 GMNVVREMEKEGAKSGYVKRSVVITDC 167
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 6e-45
Identities = 59/181 (32%), Positives = 91/181 (50%), Gaps = 6/181 (3%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
ELG G++G VY A+ + V A K I K+ +++ EI + + H NIV+ L +
Sbjct: 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
E I +E GG++ ++ PL E++ + KQ L+ L YLH KI+HRD+
Sbjct: 79 YYENNLWILIEFCAGGAVDAVMLELERPLTESQ--IQVVCKQTLDALNYLHDNKIIHRDL 136
Query: 932 KGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI---DKGQRGYGAP 988
K N+L G +K++DFG S + ++F GT +MAPEV+ R Y
Sbjct: 137 KAGNILFTL-DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYK 195
Query: 989 V 989
Sbjct: 196 A 196
|
| >d2z6wa1 b.62.1.1 (A:2-165) Mitochondrial peptidyl-prolyl cis-trans isomerase, cyclophilin F {Human (Homo sapiens) [TaxId: 9606]} Length = 164 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Mitochondrial peptidyl-prolyl cis-trans isomerase, cyclophilin F species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 1e-43
Identities = 111/140 (79%), Positives = 129/140 (92%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGN 187
++L++DVVPKTAENFRALCTGEKGFG+K STFHRVIP+FMCQ GDFTNHNGTGGKSIYG+
Sbjct: 21 LELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNHNGTGGKSIYGS 80
Query: 188 KFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKK 247
+F DENFTLKH GPG+LSMANAGPNTNGSQFFI T+KT WLD +HVVFG V+EG+DVVKK
Sbjct: 81 RFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKK 140
Query: 248 LESMGSQSGKTSKKIVVANS 267
+ES GS+SG+TSKKIV+ +
Sbjct: 141 IESFGSKSGRTSKKIVITDC 160
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 2e-43
Identities = 58/181 (32%), Positives = 93/181 (51%), Gaps = 11/181 (6%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYL 868
LGKG +G VY ARE + LA+K + + L G L E+++ S LRH NI++
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
G + + +E P G++ L+ K E + + Y ++ L Y H ++++H
Sbjct: 73 GYFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQRT--ATYITELANALSYCHSKRVIH 129
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAP 988
RDIK +N+L+ + +G +KI+DFG S T GTL Y+ PE+I+ R +
Sbjct: 130 RDIKPENLLLGS-AGELKIADFGWSVHAPS--SRRTTLCGTLDYLPPEMIE--GRMHDEK 184
Query: 989 V 989
V
Sbjct: 185 V 185
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 159 bits (403), Expect = 3e-43
Identities = 51/177 (28%), Positives = 86/177 (48%), Gaps = 4/177 (2%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
ELG G++GVV+ E A K + + D + + +EI+ S LRH +V +
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
++ + E + GG L + + + E+E Y +Q+ +GL ++H VH D+
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDE--AVEYMRQVCKGLCHMHENNYVHLDL 150
Query: 932 KGDNVLVNT-YSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGA 987
K +N++ T S +K+ DFG + L S + TGT ++ APEV + GY
Sbjct: 151 KPENIMFTTKRSNELKLIDFGLTAHLDP-KQSVKVTTGTAEFAAPEVAEGKPVGYYT 206
|
| >d2igva1 b.62.1.1 (A:1-172) Cyclophilin (eukaryotic) {Caenorhabditis elegans, isoform 3 [TaxId: 6239]} Length = 172 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Cyclophilin (eukaryotic) species: Caenorhabditis elegans, isoform 3 [TaxId: 6239]
Score = 151 bits (382), Expect = 1e-42
Identities = 103/147 (70%), Positives = 114/147 (77%), Gaps = 7/147 (4%)
Query: 128 IKLRSDVVPKTAENFRALCTGE-------KGFGFKDSTFHRVIPNFMCQGGDFTNHNGTG 180
++L DVVPKTA NFRALCTGE K FK S FHR+IPNFM QGGDFT NGTG
Sbjct: 22 MELYDDVVPKTAGNFRALCTGENGIGKSGKPLHFKGSKFHRIIPNFMIQGGDFTRGNGTG 81
Query: 181 GKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVE 240
G+SIYG KF DENF KHTGPG+LSMANAGPNTNGSQFF+ TVKT WLD +HVVFG VVE
Sbjct: 82 GESIYGEKFPDENFKEKHTGPGVLSMANAGPNTNGSQFFLCTVKTEWLDGKHVVFGRVVE 141
Query: 241 GLDVVKKLESMGSQSGKTSKKIVVANS 267
GLDVVK +ES GSQSGK K ++A+
Sbjct: 142 GLDVVKAVESNGSQSGKPVKDCMIADC 168
|
| >d2c3ba1 b.62.1.1 (A:1-171) Cyclophilin (eukaryotic) {Aspergillus fumigatus [TaxId: 5085]} Length = 171 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Cyclophilin (eukaryotic) species: Aspergillus fumigatus [TaxId: 5085]
Score = 150 bits (380), Expect = 2e-42
Identities = 86/145 (59%), Positives = 106/145 (73%), Gaps = 4/145 (2%)
Query: 127 HIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYG 186
L VPKTA+NFR LC G G+++STFHR+IPNFM QGGDFT NGTGG+SIYG
Sbjct: 24 VFNLFDKDVPKTAKNFRELCKRPAGEGYRESTFHRIIPNFMIQGGDFTRGNGTGGRSIYG 83
Query: 187 NKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVE--GLDV 244
+KF DENF+ KH GILSMANAGPNTNGSQFFITT T+WLD +HVVFG V + V
Sbjct: 84 DKFADENFSRKHDKKGILSMANAGPNTNGSQFFITTAVTSWLDGKHVVFGEVADEKSYSV 143
Query: 245 VKKLESMGSQSG--KTSKKIVVANS 267
VK++E++GS SG +++ + + N
Sbjct: 144 VKEIEALGSSSGSVRSNTRPKIVNC 168
|
| >d1a33a_ b.62.1.1 (A:) Cyclophilin (eukaryotic) {Nematode (Brugia malayi) [TaxId: 6279]} Length = 174 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Cyclophilin (eukaryotic) species: Nematode (Brugia malayi) [TaxId: 6279]
Score = 149 bits (378), Expect = 4e-42
Identities = 78/150 (52%), Positives = 98/150 (65%), Gaps = 9/150 (6%)
Query: 127 HIKLRSDVVPKTAENFRALCTGEKGFG--------FKDSTFHRVIPNFMCQGGDFTNHNG 178
++L +D+ P+T NF LCTG G G +K STFHRVI NFM QGGDFT +G
Sbjct: 21 VMELYNDIAPRTCNNFLMLCTGMAGTGKISGKPLHYKGSTFHRVIKNFMIQGGDFTKGDG 80
Query: 179 TGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSV 238
TGG+SIYG F+DE F +KH P ++SMAN GPNTNGSQFFITT L+N HVVFG V
Sbjct: 81 TGGESIYGGMFDDEEFVMKHDEPFVVSMANKGPNTNGSQFFITTTPAPHLNNIHVVFGKV 140
Query: 239 VEGLDVVKKLESMGSQS-GKTSKKIVVANS 267
V G +VV K+E + + S + +V+ N
Sbjct: 141 VSGQEVVTKIEYLKTNSKNRPLADVVILNC 170
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 155 bits (393), Expect = 7e-42
Identities = 50/179 (27%), Positives = 85/179 (47%), Gaps = 4/179 (2%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
ELG G++GVV+ E K I D + EI + +QL H ++ +
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
++ + +E + GG L + + + E E + Y +Q EGLK++H IVH DI
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAE--VINYMRQACEGLKHMHEHSIVHLDI 153
Query: 932 KGDNVLV-NTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPV 989
K +N++ + VKI DFG + +L + T T ++ APE++D+ G+ +
Sbjct: 154 KPENIMCETKKASSVKIIDFGLATKLNP-DEIVKVTTATAEFAAPEIVDREPVGFYTDM 211
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (388), Expect = 9e-42
Identities = 63/183 (34%), Positives = 95/183 (51%), Gaps = 12/183 (6%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD---VQPLHEEIKLHSQLRHRNIVQYL 868
E+G GS+G VY AR++ +AIK++ Q + +E++ +LRH N +QY
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
G E + ME G + L K PL+E E ++ T L+GL YLH ++H
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVE--IAAVTHGALQGLAYLHSHNMIH 138
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRG-YGA 987
RD+K N+L++ G+VK+ DFG++ + A +F GT +MAPEVI G Y
Sbjct: 139 RDVKAGNILLSE-PGLVKLGDFGSASIM----APANSFVGTPYWMAPEVILAMDEGQYDG 193
Query: 988 PVR 990
V
Sbjct: 194 KVD 196
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 1e-41
Identities = 55/210 (26%), Positives = 105/210 (50%), Gaps = 14/210 (6%)
Query: 780 QLVEDLRTIPTKKKYMQTPMLRFLYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIP 839
+++E LR+I + P ++ ++G+G+ G VY A ++ ++AI+++
Sbjct: 4 EILEKLRSIVSVGD----PKKKYTRF-----EKIGQGASGTVYTAMDVATGQEVAIRQMN 54
Query: 840 EKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGP 899
+ + + EI + + ++ NIV YL S + ME + GGSL+ ++
Sbjct: 55 LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD 114
Query: 900 LKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGL 959
E ++ ++ L+ L++LH +++HRDIK DN+L+ G VK++DFG ++
Sbjct: 115 ----EGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQITPE 169
Query: 960 CPSAETFTGTLQYMAPEVIDKGQRGYGAPV 989
T GT +MAPEV+ + G +
Sbjct: 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 3e-41
Identities = 56/187 (29%), Positives = 97/187 (51%), Gaps = 16/187 (8%)
Query: 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYL 868
IE+G+GS+ VY + + V++A E+ ++ L + Q EE ++ L+H NIV++
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 869 GS----VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLH-- 922
S V + + E + G+L T L+ ++ +K + + +QIL+GL++LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKV--LRSWCRQILKGLQFLHTR 131
Query: 923 GQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQ 982
I+HRD+K DN+ + +G VKI D G + A+ GT ++MAPE+ +
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMY---E 186
Query: 983 RGYGAPV 989
Y V
Sbjct: 187 EKYDESV 193
|
| >d1ihga2 b.62.1.1 (A:2-196) Cyclophilin 40 isomerase domain {Cow (Bos taurus) [TaxId: 9913]} Length = 195 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Cyclophilin 40 isomerase domain species: Cow (Bos taurus) [TaxId: 9913]
Score = 148 bits (373), Expect = 4e-41
Identities = 90/149 (60%), Positives = 107/149 (71%), Gaps = 8/149 (5%)
Query: 127 HIKLRSDVVPKTAENFRALCTGEKGFG--------FKDSTFHRVIPNFMCQGGDFTNHNG 178
++L +D+VPKTAENFRALCTGEKG G FK FHR+I FM QGGDF+N NG
Sbjct: 32 VLELFADIVPKTAENFRALCTGEKGIGPTTGKPLHFKGCPFHRIIKKFMIQGGDFSNQNG 91
Query: 179 TGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSV 238
TGG+SIYG KFEDENF KH G+LSMANAG NTNGSQFFITTV T LD +HVVFG V
Sbjct: 92 TGGESIYGEKFEDENFHYKHDKEGLLSMANAGSNTNGSQFFITTVPTPHLDGKHVVFGQV 151
Query: 239 VEGLDVVKKLESMGSQSGKTSKKIVVANS 267
++G+ V K LE++ + K +K V+A
Sbjct: 152 IKGMGVAKILENVEVKGEKPAKLCVIAEC 180
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 6e-41
Identities = 56/173 (32%), Positives = 87/173 (50%), Gaps = 8/173 (4%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEI-PEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
ELG G+ GVV+ + +A K I E + E+++ + IV + G+
Sbjct: 13 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 871 VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLH-GQKIVHR 929
+G I ME + GGSL +L+ K G + E + + +++GL YL KI+HR
Sbjct: 73 FYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQI--LGKVSIAVIKGLTYLREKHKIMHR 129
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQ 982
D+K N+LVN+ G +K+ DFG S +L A +F GT YM+PE +
Sbjct: 130 DVKPSNILVNS-RGEIKLCDFGVSGQLID--SMANSFVGTRSYMSPERLQGTH 179
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 7e-40
Identities = 46/176 (26%), Positives = 81/176 (46%), Gaps = 7/176 (3%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
+G GS+G VY + V + + + +Q E+ + + RH NI+ ++G
Sbjct: 15 RIGSGSFGTVYKGK-WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG-Y 72
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
S I + G SL L + + + + +Q +G+ YLH + I+HRD+
Sbjct: 73 STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIK--LIDIARQTAQGMDYLHAKSIIHRDL 130
Query: 932 KGDNVLVNTYSGVVKISDFGTSKRLAGLCPS--AETFTGTLQYMAPEVIDKGQRGY 985
K +N+ ++ VKI DFG + + S E +G++ +MAPEVI +
Sbjct: 131 KSNNIFLHE-DLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 1e-39
Identities = 55/181 (30%), Positives = 88/181 (48%), Gaps = 8/181 (4%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD-VQPLHEEIKLHSQLRHRNIVQYLGS 870
LG+G+YG V A + +A+K + K D + + +EI ++ L H N+V++ G
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 871 VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRD 930
E +F+E GG L + + E + Q++ G+ YLHG I HRD
Sbjct: 72 RREGNIQYLFLEYCSGGELFDRIE-PDIGM--PEPDAQRFFHQLMAGVVYLHGIGITHRD 128
Query: 931 IKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS--AETFTGTLQYMAPEVIDKGQRGYGAP 988
IK +N+L++ +KISDFG + GTL Y+APE++ K + + P
Sbjct: 129 IKPENLLLDE-RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL-KRREFHAEP 186
Query: 989 V 989
V
Sbjct: 187 V 187
|
| >d2r99a1 b.62.1.1 (A:139-299) Mitochondrial peptidyl-prolyl cis-trans isomerase, cyclophilin F {Human (Homo sapiens) [TaxId: 9606]} Length = 161 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Mitochondrial peptidyl-prolyl cis-trans isomerase, cyclophilin F species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 3e-39
Identities = 102/140 (72%), Positives = 121/140 (86%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGN 187
+ LRSDVVP TAENFR LCT EKGFGFK S+FHR+IP FMCQGGDFTNHNGTGGKSIYG
Sbjct: 20 MLLRSDVVPMTAENFRCLCTHEKGFGFKGSSFHRIIPQFMCQGGDFTNHNGTGGKSIYGK 79
Query: 188 KFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKK 247
KF+DENF LKHTGPG+LSMAN+GPNTNGSQFF+T KT WLD +HVVFG V EGLDV+++
Sbjct: 80 KFDDENFILKHTGPGLLSMANSGPNTNGSQFFLTCDKTDWLDGKHVVFGEVTEGLDVLRQ 139
Query: 248 LESMGSQSGKTSKKIVVANS 267
+E+ GS+ GK +K+++A+
Sbjct: 140 IEAQGSKDGKPKQKVIIADC 159
|
| >d1h0pa_ b.62.1.1 (A:) Cyclophilin (eukaryotic) {Caenorhabditis elegans, isoform 5 [TaxId: 6239]} Length = 182 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Cyclophilin (eukaryotic) species: Caenorhabditis elegans, isoform 5 [TaxId: 6239]
Score = 141 bits (357), Expect = 3e-39
Identities = 85/142 (59%), Positives = 100/142 (70%), Gaps = 1/142 (0%)
Query: 127 HIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYG 186
I L VPKTA NF L KG G+ S FHRVI +FM QGGDFT +GTGG+SIYG
Sbjct: 24 VIGLFGKTVPKTATNFIELAKKPKGEGYPGSKFHRVIADFMIQGGDFTRGDGTGGRSIYG 83
Query: 187 NKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVK 246
KF DENF LKH G G LSMANAG +TNGSQFFITTVKT WLD RHVVFG ++EG+DVV+
Sbjct: 84 EKFADENFKLKHYGAGWLSMANAGADTNGSQFFITTVKTPWLDGRHVVFGKILEGMDVVR 143
Query: 247 KLESMGSQSG-KTSKKIVVANS 267
K+E G + + +++A S
Sbjct: 144 KIEQTEKLPGDRPKQDVIIAAS 165
|
| >d2rmca_ b.62.1.1 (A:) Cyclophilin (eukaryotic) {Mouse (Mus musculus), variant C [TaxId: 10090]} Length = 182 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Cyclophilin (eukaryotic) species: Mouse (Mus musculus), variant C [TaxId: 10090]
Score = 141 bits (355), Expect = 6e-39
Identities = 83/141 (58%), Positives = 98/141 (69%), Gaps = 1/141 (0%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGN 187
I L +VVPKT ENF AL TGEKG+G+K S FHRVI +FM QGGDFT +GTGG SIYG
Sbjct: 26 IGLFGNVVPKTVENFVALATGEKGYGYKGSIFHRVIKDFMIQGGDFTARDGTGGMSIYGE 85
Query: 188 KFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKK 247
F DENF LKH G G +SMANAGP+TNGSQFFIT K WLD +HVVFG V++G+ VV
Sbjct: 86 TFPDENFKLKHYGIGWVSMANAGPDTNGSQFFITLTKPTWLDGKHVVFGKVLDGMTVVHS 145
Query: 248 LESMGSQS-GKTSKKIVVANS 267
+E + + + NS
Sbjct: 146 IELQATDGHDRPLTDCTIVNS 166
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 9e-39
Identities = 56/181 (30%), Positives = 94/181 (51%), Gaps = 9/181 (4%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHEEIKLHSQLRHRNIVQYL 868
LG+GS+ V AREL + AIK + ++++ V + E + S+L H V+
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
+ ++ + G L +R K G E FYT +I+ L+YLHG+ I+H
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETC--TRFYTAEIVSALEYLHGKGIIH 131
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLA--GLCPSAETFTGTLQYMAPEVIDKGQRGYG 986
RD+K +N+L+N ++I+DFGT+K L+ A +F GT QY++PE++ +
Sbjct: 132 RDLKPENILLNE-DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKS 190
Query: 987 A 987
+
Sbjct: 191 S 191
|
| >d1zkca1 b.62.1.1 (A:280-457) Peptidyl-prolyl cis-trans isomerase-like 2, Cyclophilin-60, PPI domain {Human (Homo sapiens) [TaxId: 9606]} Length = 178 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Peptidyl-prolyl cis-trans isomerase-like 2, Cyclophilin-60, PPI domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-38
Identities = 65/141 (46%), Positives = 90/141 (63%), Gaps = 7/141 (4%)
Query: 127 HIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYG 186
+++L D+ PKT ENF LC K + + FHR I NF+ QGGD T GTGG+S +G
Sbjct: 13 NLELHCDLTPKTCENFIRLC---KKHYYDGTIFHRSIRNFVIQGGDPT-GTGTGGESYWG 68
Query: 187 NKFEDE-NFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVV 245
F+DE L HTG GILSMAN+GPN+N SQFFIT A+LD +H +FG VV G DV+
Sbjct: 69 KPFKDEFRPNLSHTGRGILSMANSGPNSNRSQFFITFRSCAYLDKKHTIFGRVVGGFDVL 128
Query: 246 KKLESM--GSQSGKTSKKIVV 264
+E++ ++ + ++I +
Sbjct: 129 TAMENVESDPKTDRPKEEIRI 149
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-38
Identities = 51/181 (28%), Positives = 83/181 (45%), Gaps = 11/181 (6%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLG 869
+G GSYG R L KE+ ++ + Q L E+ L +L+H NIV+Y
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 870 SVSEE--GYFKIFMEQVPGGSLSTLLRVKWGPLKE-NESTMSFYTKQILEGLKYLH---- 922
+ + I ME GG L++++ + +E + Q+ LK H
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130
Query: 923 -GQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKG 981
G ++HRD+K NV ++ VK+ DFG ++ L A+ F GT YM+PE +++
Sbjct: 131 GGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRM 189
Query: 982 Q 982
Sbjct: 190 S 190
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-37
Identities = 57/179 (31%), Positives = 87/179 (48%), Gaps = 10/179 (5%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
+GKG +G V +V A+K I KN Q E + +QLRH N+VQ LG +
Sbjct: 14 TIGKGEFGDVMLGDYRGNKV--AVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 872 SEE-GYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRD 930
EE G I E + GSL LR + G + ++ + E ++YL G VHRD
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRD 128
Query: 931 IKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPV 989
+ NVLV+ V K+SDFG +K + + +T +++ APE + + + + V
Sbjct: 129 LAARNVLVSE-DNVAKVSDFGLTKEAS---STQDTGKLPVKWTAPEALREKKFSTKSDV 183
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-37
Identities = 54/183 (29%), Positives = 82/183 (44%), Gaps = 10/183 (5%)
Query: 806 FALNRIELGKGSYGVVYAA--RELDRQVKLAIKEI-PEKNLGDVQPLHEEIKLHSQLRHR 862
+ IELG G++G V R +Q+ +AIK + D + + E ++ QL +
Sbjct: 10 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 69
Query: 863 NIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLH 922
IV+ +G E + ME GG L L K + S ++ Q+ G+KYL
Sbjct: 70 YIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEI--PVSNVAELLHQVSMGMKYLE 126
Query: 923 GQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG---LCPSAETFTGTLQYMAPEVID 979
+ VHRD+ NVL+ KISDFG SK L + L++ APE I+
Sbjct: 127 EKNFVHRDLAARNVLLVN-RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 185
Query: 980 KGQ 982
+
Sbjct: 186 FRK 188
|
| >d1xwna1 b.62.1.1 (A:1-166) Peptidyl-prolyl cis-trans isomerase-like 1, PPIL1 {Human (Homo sapiens) [TaxId: 9606]} Length = 166 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Peptidyl-prolyl cis-trans isomerase-like 1, PPIL1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 2e-37
Identities = 61/140 (43%), Positives = 85/140 (60%), Gaps = 6/140 (4%)
Query: 127 HIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYG 186
++L PKT +NF L + + FHR+I +FM QGGD T G GG SIYG
Sbjct: 24 VLELYWKHAPKTCKNFAELARRGY---YNGTKFHRIIKDFMIQGGDPTG-TGRGGASIYG 79
Query: 187 NKFEDE-NFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVV 245
+FEDE + LK TG GIL+MANAGP+TNGSQFF+T T WLD +H +FG V +G+ +V
Sbjct: 80 KQFEDELHPDLKFTGAGILAMANAGPDTNGSQFFVTLAPTQWLDGKHTIFGRVCQGIGMV 139
Query: 246 KKLESMGSQS-GKTSKKIVV 264
++ + + S + + +
Sbjct: 140 NRVGMVETNSQDRPVDDVKI 159
|
| >d1xo7a_ b.62.1.1 (A:) Cyclophilin (eukaryotic) {Trypanosoma cruzi [TaxId: 5693]} Length = 166 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Cyclophilin (eukaryotic) species: Trypanosoma cruzi [TaxId: 5693]
Score = 135 bits (340), Expect = 4e-37
Identities = 86/141 (60%), Positives = 105/141 (74%), Gaps = 2/141 (1%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGN 187
I L + VPKT ENF+ L +GE GFG+K S FHRVI NFM QGGDFTN +GTGGKSIYG
Sbjct: 24 IGLFGNDVPKTVENFKQLASGENGFGYKGSIFHRVIRNFMIQGGDFTNFDGTGGKSIYGT 83
Query: 188 KFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKK 247
+F+DEN +KH G +SMANAGPN+NGSQFF+TT T WLD RHVVFG VVEG+DVVKK
Sbjct: 84 RFDDENLKIKHF-VGAVSMANAGPNSNGSQFFVTTAPTPWLDGRHVVFGKVVEGMDVVKK 142
Query: 248 LESMGS-QSGKTSKKIVVANS 267
+E+ + + K K + + +
Sbjct: 143 VENTKTGLNDKPKKAVKINDC 163
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 5e-37
Identities = 50/179 (27%), Positives = 83/179 (46%), Gaps = 6/179 (3%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
ELG G +GVV + + +AIK I E ++ + + EE K+ L H +VQ G
Sbjct: 11 ELGTGQFGVVKYGKWRGQY-DVAIKMIKEGSMSEDE-FIEEAKVMMNLSHEKLVQLYGVC 68
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
+++ I E + G L LR + K + E ++YL ++ +HRD+
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLREMRHRF--QTQQLLEMCKDVCEAMEYLESKQFLHRDL 126
Query: 932 KGDNVLVNTYSGVVKISDFGTSKRLA-GLCPSAETFTGTLQYMAPEVIDKGQRGYGAPV 989
N LVN GVVK+SDFG S+ + S+ +++ PEV+ + + +
Sbjct: 127 AARNCLVND-QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 184
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 137 bits (346), Expect = 3e-36
Identities = 60/181 (33%), Positives = 87/181 (48%), Gaps = 9/181 (4%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGS 870
LG G++ V A + Q +AIK I +K L G + EI + +++H NIV
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 871 VSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRD 930
G+ + M+ V GG L + + G E + S Q+L+ +KYLH IVHRD
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRIV-EKGFYTERD--ASRLIFQVLDAVKYLHDLGIVHRD 132
Query: 931 IKGDNVLVNTYS--GVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAP 988
+K +N+L + + ISDFG SK T GT Y+APEV+ Q+ Y
Sbjct: 133 LKPENLLYYSLDEDSKIMISDFGLSKMEDP-GSVLSTACGTPGYVAPEVL--AQKPYSKA 189
Query: 989 V 989
V
Sbjct: 190 V 190
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 4e-36
Identities = 45/179 (25%), Positives = 85/179 (47%), Gaps = 6/179 (3%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
LG G +G V+ + K+A+K + + ++ E L QL+H+ +V+ V
Sbjct: 20 RLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
++E + I E + GSL L+ +K + + QI EG+ ++ + +HRD+
Sbjct: 78 TQEPIY-IITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 135
Query: 932 KGDNVLVNTYSGVVKISDFGTSKRL-AGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPV 989
+ N+LV+ KI+DFG ++ + + E +++ APE I+ G + V
Sbjct: 136 RAANILVSDT-LSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 7e-36
Identities = 45/175 (25%), Positives = 76/175 (43%), Gaps = 5/175 (2%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
+LG+G +G+V+ E + K + K D + +EI + + RHRNI+ S
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESF 70
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
+ E + G + + L E E + Y Q+ E L++LH I H DI
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNERE--IVSYVHQVCEALQFLHSHNIGHFDI 128
Query: 932 KGDNVLVNTY-SGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGY 985
+ +N++ T S +KI +FG +++L + +Y APEV
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQL-KPGDNFRLLFTAPEYYAPEVHQHDVVST 182
|
| >d1qoia_ b.62.1.1 (A:) Cyclophilin (eukaryotic) {Human (Homo sapiens), U4/U6 snRNP-specific cyclophilin snucyp-20 [TaxId: 9606]} Length = 173 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Cyclophilin (eukaryotic) species: Human (Homo sapiens), U4/U6 snRNP-specific cyclophilin snucyp-20 [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-35
Identities = 80/147 (54%), Positives = 104/147 (70%), Gaps = 6/147 (4%)
Query: 127 HIKLRSDVVPKTAENFRALCTGE-----KGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGG 181
I+L +DVVPKTAENFR CTGE G+K STFHRVI +FM QGGDF N +GTG
Sbjct: 24 KIELFADVVPKTAENFRQFCTGEFRKDGVPIGYKGSTFHRVIKDFMIQGGDFVNGDGTGV 83
Query: 182 KSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEG 241
SIY F DENF L+H+ PG+LSMAN+GP+TNG QFFIT K WLD +HVVFG +++G
Sbjct: 84 ASIYRGPFADENFKLRHSAPGLLSMANSGPSTNGCQFFITCSKCDWLDGKHVVFGKIIDG 143
Query: 242 LDVVKKLESMGS-QSGKTSKKIVVANS 267
L V++K+E++ + + K +V++
Sbjct: 144 LLVMRKIENVPTGPNNKPKLPVVISQC 170
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 3e-35
Identities = 47/172 (27%), Positives = 83/172 (48%), Gaps = 6/172 (3%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
E+G G +G+V+ L++ K+AIK I E + + EE ++ +L H +VQ G
Sbjct: 12 EIGSGQFGLVHLGYWLNKD-KVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLYGVC 69
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
E+ + E + G LS LR + G T+ + EG+ YL ++HRD+
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEACVIHRDL 127
Query: 932 KGDNVLVNTYSGVVKISDFGTSKRLAGLCPS-AETFTGTLQYMAPEVIDKGQ 982
N LV + V+K+SDFG ++ + + + +++ +PEV +
Sbjct: 128 AARNCLVGE-NQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 5e-35
Identities = 50/182 (27%), Positives = 82/182 (45%), Gaps = 8/182 (4%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQP----LHEEIKLHSQLRHRNIVQY 867
LGKGS+G V+ A AIK + + + + E+ L H +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
+ + ME + GG L ++ + +T FY +I+ GL++LH + IV
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRAT--FYAAEIILGLQFLHSKGIV 125
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGA 987
+RD+K DN+L++ G +KI+DFG K TF GT Y+APE++ + +
Sbjct: 126 YRDLKLDNILLDK-DGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSV 184
Query: 988 PV 989
Sbjct: 185 DW 186
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 7e-35
Identities = 45/186 (24%), Positives = 81/186 (43%), Gaps = 13/186 (6%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHE------EIKLHSQLR--HRN 863
LG G +G VY+ + + +AIK + + + D L E+ L ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 864 IVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHG 923
+++ L F + +E+ + G L+E + Q+LE +++ H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL--ARSFFWQVLEAVRHCHN 128
Query: 924 QKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQR 983
++HRDIK +N+L++ G +K+ DFG+ L + F GT Y PE I + R
Sbjct: 129 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT--DFDGTRVYSPPEWI-RYHR 185
Query: 984 GYGAPV 989
+G
Sbjct: 186 YHGRSA 191
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 7e-35
Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 30/208 (14%)
Query: 812 ELGKGSYGVVYAAR-----ELDRQVKLAIKEIPEK-NLGDVQPLHEEIKLHSQL-RHRNI 864
LG G++G V A + +++A+K + EK + + + L E+K+ +QL H NI
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 865 VQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKEN--------------------E 904
V LG+ + G + E G L LR K E+
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 905 STMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA- 963
+ + Q+ +G+++L + VHRD+ NVLV VVKI DFG ++ +
Sbjct: 164 EDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH-GKVVKICDFGLARDIMSDSNYVV 222
Query: 964 -ETFTGTLQYMAPEVIDKGQRGYGAPVR 990
+++MAPE + +G + V
Sbjct: 223 RGNARLPVKWMAPESLFEGIYTIKSDVW 250
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (332), Expect = 1e-34
Identities = 47/179 (26%), Positives = 88/179 (49%), Gaps = 4/179 (2%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
+LG G YG VY + +A+K + +++ +V+ +E + +++H N+VQ LG
Sbjct: 24 KLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 82
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
+ E F I E + G+L LR + + + + QI ++YL + +HRD+
Sbjct: 83 TREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 141
Query: 932 KGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT-GTLQYMAPEVIDKGQRGYGAPV 989
N LV + +VK++DFG S+ + G +A +++ APE + + + V
Sbjct: 142 AARNCLVGE-NHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 199
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 1e-34
Identities = 50/185 (27%), Positives = 81/185 (43%), Gaps = 12/185 (6%)
Query: 812 ELGKGSYGVVYAARELDRQV--KLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQY 867
ELG G++G V ++V +A+K + + L E + QL + IV+
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
+G E + + ME G L+ L+ + +K+ + Q+ G+KYL V
Sbjct: 74 IGICEAESWM-LVMEMAELGPLNKYLQ-QNRHVKDKN--IIELVHQVSMGMKYLEESNFV 129
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAET---FTGTLQYMAPEVIDKGQRG 984
HRD+ NVL+ T KISDFG SK L + +++ APE I+ +
Sbjct: 130 HRDLAARNVLLVT-QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 985 YGAPV 989
+ V
Sbjct: 189 SKSDV 193
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 2e-34
Identities = 52/184 (28%), Positives = 80/184 (43%), Gaps = 16/184 (8%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQYLG-- 869
LG G G V Q K A+K + D E++LH + + +IV+ +
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 870 --SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
+ I ME + GG L + ++ G E S K I E ++YLH I
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHSINIA 133
Query: 928 HRDIKGDNVLVNTY--SGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGY 985
HRD+K +N+L + + ++K++DFG +K S T T Y+APEV+ G Y
Sbjct: 134 HRDVKPENLLYTSKRPNAILKLTDFGFAKETTS-HNSLTTPCYTPYYVAPEVL--GPEKY 190
Query: 986 GAPV 989
Sbjct: 191 DKSC 194
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 132 bits (333), Expect = 2e-34
Identities = 50/181 (27%), Positives = 92/181 (50%), Gaps = 12/181 (6%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD---VQPLHEEIKLHSQLRHRNIVQYL 868
LG GS+G V+ R A+K + ++ + V+ ++E + S + H I++
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
G+ + + M+ + GG L +LLR + FY ++ L+YLH + I++
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKDIIY 127
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAP 988
RD+K +N+L++ +G +KI+DFG +K + + T GT Y+APEV+ + Y
Sbjct: 128 RDLKPENILLDK-NGHIKITDFGFAKYVPDVT---YTLCGTPDYIAPEVV--STKPYNKS 181
Query: 989 V 989
+
Sbjct: 182 I 182
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 3e-33
Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 11/186 (5%)
Query: 810 RIE-LGKGSYGVVYAARELDRQVKLAIKEIP-----EKNLGDVQPLHEEIKLHSQLRHRN 863
+++ LG+G + VY AR+ + +AIK+I E G + EIKL +L H N
Sbjct: 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61
Query: 864 IVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHG 923
I+ L + + + + + + S + Y L+GL+YLH
Sbjct: 62 IIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVL---TPSHIKAYMLMTLQGLEYLHQ 118
Query: 924 QKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQR 983
I+HRD+K +N+L++ +GV+K++DFG +K + T Y APE++ G R
Sbjct: 119 HWILHRDLKPNNLLLDE-NGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELL-FGAR 176
Query: 984 GYGAPV 989
YG V
Sbjct: 177 MYGVGV 182
|
| >d2ok3a1 b.62.1.1 (A:1-159) Cyclophilin-like protein PPIL3B {Human (Homo sapiens) [TaxId: 9606]} Length = 159 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Cyclophilin-like protein PPIL3B species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 3e-33
Identities = 61/142 (42%), Positives = 83/142 (58%), Gaps = 7/142 (4%)
Query: 128 IKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGN 187
I++ + PKT ENF ALC + FHR I FM Q GD G GG SI+G
Sbjct: 14 IEVFCERTPKTCENFLALC---ASNYYNGCIFHRNIKGFMVQTGDP-TGTGRGGNSIWGK 69
Query: 188 KFEDE-NFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVK 246
KFEDE + LKH G++SMAN GPNTNGSQFFIT K LD ++ VFG V++GL+ +
Sbjct: 70 KFEDEYSEYLKHNVRGVVSMANNGPNTNGSQFFITYGKQPHLDMKYTVFGKVIDGLETLD 129
Query: 247 KLESM--GSQSGKTSKKIVVAN 266
+LE + ++ + + + +
Sbjct: 130 ELEKLPVNEKTYRPLNDVHIKD 151
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (321), Expect = 5e-33
Identities = 47/179 (26%), Positives = 76/179 (42%), Gaps = 12/179 (6%)
Query: 813 LGKGSYGVVYAARELD---RQVKLAIKEI-PEKNLGDVQPLHEEIKLHSQLRHRNIVQYL 868
+G G +G V + R++ +AIK + + E + Q H N++
Sbjct: 34 IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 93
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
G V++ I E + GSL + LR G + + I G+KYL VH
Sbjct: 94 GVVTKSTPVMIITEFMENGSLDSFLRQNDGQ--FTVIQLVGMLRGIAAGMKYLADMNYVH 151
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT-----GTLQYMAPEVIDKGQ 982
RD+ N+LVN+ + V K+SDFG S+ L + +++ APE I +
Sbjct: 152 RDLAARNILVNS-NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK 209
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 129 bits (325), Expect = 7e-33
Identities = 50/184 (27%), Positives = 83/184 (45%), Gaps = 13/184 (7%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLH------EEIKLHSQLRHRNIV 865
+G+G +G VY R+ D A+K + +K + Q + L S IV
Sbjct: 11 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
+ ++ + GG L L +E+ M FY +I+ GL+++H +
Sbjct: 71 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF 127
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGY 985
+V+RD+K N+L++ + G V+ISD G + + GT YMAPEV+ KG Y
Sbjct: 128 VVYRDLKPANILLDEH-GHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGV-AY 183
Query: 986 GAPV 989
+
Sbjct: 184 DSSA 187
|
| >d1z81a1 b.62.1.1 (A:25-210) Cyclophilin (eukaryotic) {Plasmodium yoelii [TaxId: 5861]} Length = 186 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Cyclophilin (eukaryotic) species: Plasmodium yoelii [TaxId: 5861]
Score = 123 bits (309), Expect = 9e-33
Identities = 76/150 (50%), Positives = 98/150 (65%), Gaps = 9/150 (6%)
Query: 127 HIKLRSDVVPKTAENFRALCTGEKGFG-----FKDSTFHRVIPNFMCQGGDFTNHNGTGG 181
+L ++VPKT+ENFR CTGE +K++ FHRVI FM QGGDF NHNG+G
Sbjct: 34 KFELFQNIVPKTSENFRQFCTGEYKVNNLPVGYKNTIFHRVIKEFMIQGGDFINHNGSGS 93
Query: 182 KSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEG 241
SIYG KF+DENF +KH G+LSMAN+GPNTNG QFFITT K WLD ++VVFG +++
Sbjct: 94 LSIYGEKFDDENFDIKHDKEGLLSMANSGPNTNGCQFFITTKKCEWLDGKNVVFGRIIDN 153
Query: 242 --LDVVKKLESM--GSQSGKTSKKIVVANS 267
L ++KK+E++ K I V
Sbjct: 154 DSLLLLKKIENVSVTPYIYKPKIPINVVEC 183
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 1e-32
Identities = 45/172 (26%), Positives = 82/172 (47%), Gaps = 6/172 (3%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
+LG+G +G V+ + ++AIK + + + +E ++ +LRH +VQ V
Sbjct: 24 KLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 81
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
SEE + I E + GSL L+ + G + QI G+ Y+ VHRD+
Sbjct: 82 SEEPIY-IVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVERMNYVHRDL 139
Query: 932 KGDNVLVNTYSGVVKISDFGTSKRLA-GLCPSAETFTGTLQYMAPEVIDKGQ 982
+ N+LV + V K++DFG ++ + + + +++ APE G+
Sbjct: 140 RAANILVGE-NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 2e-32
Identities = 49/184 (26%), Positives = 84/184 (45%), Gaps = 9/184 (4%)
Query: 812 ELGKGSYGVVYAARELDRQ---VKLAIKEI-PEKNLGDVQPLHEEIKLHSQLRHRNIVQY 867
+G+G +G V+ + + + +AIK + + +E Q H +IV+
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
+G ++E + I ME G L + L+V+ L + Y Q+ L YL ++ V
Sbjct: 74 IGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLAS--LILYAYQLSTALAYLESKRFV 130
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGLCPSAETFTGTLQYMAPEVIDKGQRGYG 986
HRDI NVLV++ VK+ DFG S+ + A +++MAPE I+ +
Sbjct: 131 HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 189
Query: 987 APVR 990
+ V
Sbjct: 190 SDVW 193
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 3e-32
Identities = 51/183 (27%), Positives = 87/183 (47%), Gaps = 12/183 (6%)
Query: 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVS 872
+G GS+GVVY A+ D +AIK++ + D + + E+++ +L H NIV+
Sbjct: 28 IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 873 EEG------YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
G Y + ++ VP + Y Q+ L Y+H I
Sbjct: 84 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI 143
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYG 986
HRDIK N+L++ + V+K+ DFG++K+L P+ ++ + Y APE+I G Y
Sbjct: 144 CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRYYRAPELI-FGATDYT 201
Query: 987 APV 989
+ +
Sbjct: 202 SSI 204
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 124 bits (312), Expect = 4e-32
Identities = 50/192 (26%), Positives = 80/192 (41%), Gaps = 19/192 (9%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQP---------LHEEIKLHSQLR-H 861
LG+G VV + A+K I G +E+ + ++ H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 862 RNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYL 921
NI+Q + +F + + + G L L + L E E + +LE + L
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKE--TRKIMRALLEVICAL 126
Query: 922 HGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVI--- 978
H IVHRD+K +N+L++ +K++DFG S +L GT Y+APE+I
Sbjct: 127 HKLNIVHRDLKPENILLDD-DMNIKLTDFGFSCQLDPGEKL-REVCGTPSYLAPEIIECS 184
Query: 979 -DKGQRGYGAPV 989
+ GYG V
Sbjct: 185 MNDNHPGYGKEV 196
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 4e-32
Identities = 48/203 (23%), Positives = 85/203 (41%), Gaps = 25/203 (12%)
Query: 812 ELGKGSYGVVYAAR-----ELDRQVKLAIKEI-PEKNLGDVQPLHEEIKLHSQL-RHRNI 864
LG G++G V A + D + +A+K + P +L + + L E+K+ S L H NI
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 865 VQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKE---------------NESTMSF 909
V LG+ + G + E G L LR K + +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 910 YTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAET--FT 967
++ Q+ +G+ +L + +HRD+ N+L+ + KI DFG ++ +
Sbjct: 150 FSYQVAKGMAFLASKNCIHRDLAARNILLTH-GRITKICDFGLARDIKNDSNYVVKGNAR 208
Query: 968 GTLQYMAPEVIDKGQRGYGAPVR 990
+++MAPE I + + V
Sbjct: 209 LPVKWMAPESIFNCVYTFESDVW 231
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 6e-32
Identities = 49/183 (26%), Positives = 77/183 (42%), Gaps = 13/183 (7%)
Query: 812 ELGKGSYGVVYAAR---ELDRQVKLAIKEIPEKNLGDVQPLHE---EIKLHSQLRHRNIV 865
+LG GS+GVV + V +A+K + L + + + E+ L HRN++
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
+ G V K+ E P GSL LR G +S Y Q+ EG+ YL ++
Sbjct: 75 RLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGT--LSRYAVQVAEGMGYLESKR 131
Query: 926 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT---GTLQYMAPEVIDKGQ 982
+HRD+ N+L+ +VKI DFG + L + APE +
Sbjct: 132 FIHRDLAARNLLL-ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190
Query: 983 RGY 985
+
Sbjct: 191 FSH 193
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 8e-32
Identities = 52/179 (29%), Positives = 89/179 (49%), Gaps = 13/179 (7%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEI-PEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGS 870
+G+G+YG+V +A + +V++AIK+I P ++ Q EIK+ + RH NI+
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 871 VSEEGYFK----IFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
+ + + + G L LL K L + + ++ QIL GLKY+H +
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLL--KTQHLSNDH--ICYFLYQILRGLKYIHSANV 130
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGL---CPSAETFTGTLQYMAPEVIDKGQ 982
+HRD+K N+L+NT + +KI DFG ++ + T Y APE++ +
Sbjct: 131 LHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 188
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 9e-32
Identities = 53/181 (29%), Positives = 84/181 (46%), Gaps = 9/181 (4%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD---VQPLHEEIKLHSQLRHRNIVQYL 868
LGKG++G V RE A+K + ++ + V E ++ RH +
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
+ ME GG L L + E FY +I+ L+YLH + +V+
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVF---TEERARFYGAEIVSALEYLHSRDVVY 128
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAP 988
RDIK +N++++ G +KI+DFG K + +TF GT +Y+APEV++ YG
Sbjct: 129 RDIKLENLMLDK-DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN--DYGRA 185
Query: 989 V 989
V
Sbjct: 186 V 186
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 123 bits (310), Expect = 1e-31
Identities = 40/183 (21%), Positives = 78/183 (42%), Gaps = 13/183 (7%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
++G GS+G +Y ++ ++AIK K LH E K++ ++ + +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
EG + + + ++ G SL L + T+ Q++ ++Y+H + +HRD+
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRKF--SLKTVLLLADQMISRIEYIHSKNFIHRDV 129
Query: 932 KGDNVLVNT--YSGVVKISDFGTSKRLAG-------LCPSAETFTGTLQYMAPEVIDKGQ 982
K DN L+ +V I DFG +K+ + TGT +Y + +
Sbjct: 130 KPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE 189
Query: 983 RGY 985
+
Sbjct: 190 QSR 192
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 122 bits (308), Expect = 2e-31
Identities = 42/189 (22%), Positives = 79/189 (41%), Gaps = 17/189 (8%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
+G+GS+GV++ L ++AIK P ++ D L +E + + L + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDI 931
+EG + + + G SL LL + ++ KQ+L ++ +H + +V+RDI
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKT--VAMAAKQMLARVQSIHEKSLVYRDI 127
Query: 932 KGDNVLVN----TYSGVVKISDFGTSKRLAG-------LCPSAETFTGTLQYMAPEVIDK 980
K DN L+ + ++ + DFG K + +GT +YM+
Sbjct: 128 KPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL- 186
Query: 981 GQRGYGAPV 989
R
Sbjct: 187 -GREQSRRD 194
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 3e-31
Identities = 45/183 (24%), Positives = 82/183 (44%), Gaps = 13/183 (7%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD------VQPLHEEIKLHSQLRHRNIV 865
ELG G + VV RE ++ A K I ++ + + E+ + +++H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK 925
+ + +E V GG L E + + KQIL G+ YLH +
Sbjct: 77 TLHEVYENKTDVILILELVAGG---ELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 133
Query: 926 IVHRDIKGDNVLV---NTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQ 982
I H D+K +N+++ N +KI DFG + ++ + GT +++APE+++
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNIFGTPEFVAPEIVNYEP 192
Query: 983 RGY 985
G
Sbjct: 193 LGL 195
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 121 bits (303), Expect = 7e-31
Identities = 46/188 (24%), Positives = 74/188 (39%), Gaps = 14/188 (7%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD---VQPLHEEIKLHSQLRHRNIVQYL 868
LG G V+ AR+L +A+K + D E + + L H IV
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 869 GSVSEE----GYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ 924
+ E I ME V G +L ++ GP+ + L + H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKR--AIEVIADACQALNFSHQN 130
Query: 925 KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAE---TFTGTLQYMAPEVIDKG 981
I+HRD+K N++++ + VK+ DFG ++ +A S GT QY++PE
Sbjct: 131 GIIHRDVKPANIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 189
Query: 982 QRGYGAPV 989
+ V
Sbjct: 190 SVDARSDV 197
|
| >d1w74a_ b.62.1.1 (A:) Peptidyl-prolyl cis-trans isomerase A, PpiA {Mycobacterium tuberculosis [TaxId: 1773]} Length = 171 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Peptidyl-prolyl cis-trans isomerase A, PpiA species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 117 bits (294), Expect = 8e-31
Identities = 54/153 (35%), Positives = 75/153 (49%), Gaps = 18/153 (11%)
Query: 127 HIKLRSDVVPKTAENFRALCTGEKGFG------------FKDSTFHRVIPNFMCQGGDFT 174
I L + PKT NF L G K + + + FHRVI FM QGGD
Sbjct: 16 KIALFGNHAPKTVANFVGLAQGTKDYSTQNASGGPSGPFYDGAVFHRVIQGFMIQGGDP- 74
Query: 175 NHNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVV 234
GTG ++ + L+ P +L+MANAGP TNGSQFFIT KT L+ RH +
Sbjct: 75 --TGTGRGGPGYKFADEFHPELQFDKPYLLAMANAGPGTNGSQFFITVGKTPHLNRRHTI 132
Query: 235 FGSVV--EGLDVVKKLESMGSQ-SGKTSKKIVV 264
FG V+ E VV+ + + + + + +V+
Sbjct: 133 FGEVIDAESQRVVEAISKTATDGNDRPTDPVVI 165
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 9e-31
Identities = 48/200 (24%), Positives = 76/200 (38%), Gaps = 24/200 (12%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
+GKG +G V+ + +V A+K + EI LRH NI+ ++ +
Sbjct: 10 SIGKGRFGEVWRGKWRGEEV--AVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAAD 66
Query: 872 SEEG----YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ--- 924
+++ + + GSL L M GL +LH +
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 925 -----KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG----LCPSAETFTGTLQYMAP 975
I HRD+K N+LV +G I+D G + R + + GT +YMAP
Sbjct: 123 TQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 976 EVIDKGQRGYGAPVRQRDKI 995
EV+D +R I
Sbjct: 182 EVLDDSINMKHFESFKRADI 201
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 2e-30
Identities = 51/192 (26%), Positives = 83/192 (43%), Gaps = 12/192 (6%)
Query: 806 FALNRIELGKGSYGVVYAARELD----RQVKLAIKEI-PEKNLGDVQPLHEEIKLHSQLR 860
++ +G G +G VY ++V +AIK + E + Q
Sbjct: 9 VTRQKV-IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 861 HRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKY 920
H NI++ G +S+ I E + G+L LR K G + + + I G+KY
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQ--LVGMLRGIAAGMKY 125
Query: 921 LHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT---GTLQYMAPEV 977
L VHRD+ N+LVN+ + V K+SDFG S+ L + T + +++ APE
Sbjct: 126 LANMNYVHRDLAARNILVNS-NLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 978 IDKGQRGYGAPV 989
I + + V
Sbjct: 185 ISYRKFTSASDV 196
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 3e-30
Identities = 46/195 (23%), Positives = 84/195 (43%), Gaps = 19/195 (9%)
Query: 812 ELGKGSYGVVYAARELD--RQVKLAIKEI-PEKNLGDVQPLHEEIKLHSQL-RHRNIVQY 867
+G+G++G V AR ++ AIK + + D + E+++ +L H NI+
Sbjct: 17 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 76
Query: 868 LGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKE-------------NESTMSFYTKQI 914
LG+ GY + +E P G+L LR + + + + +
Sbjct: 77 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 136
Query: 915 LEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMA 974
G+ YL ++ +HRD+ N+LV + V KI+DFG S R + +++MA
Sbjct: 137 ARGMDYLSQKQFIHRDLAARNILVGE-NYVAKIADFGLS-RGQEVYVKKTMGRLPVRWMA 194
Query: 975 PEVIDKGQRGYGAPV 989
E ++ + V
Sbjct: 195 IESLNYSVYTTNSDV 209
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 4e-30
Identities = 49/174 (28%), Positives = 83/174 (47%), Gaps = 5/174 (2%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQP--LHEEIKLHSQLRHRNIVQYLG 869
++G+G+YGVVY AR +A+K+I + P EI L +L H NIV+ L
Sbjct: 9 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
+ E + E + + + + Y Q+L+GL + H +++HR
Sbjct: 69 VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL--IKSYLFQLLQGLAFCHSHRVLHR 126
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQR 983
D+K N+L+NT G +K++DFG ++ + TL Y APE++ +
Sbjct: 127 DLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 5e-30
Identities = 54/192 (28%), Positives = 90/192 (46%), Gaps = 19/192 (9%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLH--EEIKLHSQLRHRNIVQYLG 869
++G+G++G V+ AR K+A+K++ +N + P+ EIK+ L+H N+V +
Sbjct: 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76
Query: 870 SVSE--------EGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYL 921
+G + + L V K S + + +L GL Y+
Sbjct: 77 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYI 133
Query: 922 HGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL----AGLCPSAETFTGTLQYMAPEV 977
H KI+HRD+K NVL+ T GV+K++DFG ++ TL Y PE+
Sbjct: 134 HRNKILHRDMKAANVLI-TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192
Query: 978 IDKGQRGYGAPV 989
+ G+R YG P+
Sbjct: 193 L-LGERDYGPPI 203
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 119 bits (298), Expect = 9e-30
Identities = 38/181 (20%), Positives = 72/181 (39%), Gaps = 14/181 (7%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR-HRNIVQYLGS 870
+LG+G Y V+ A + K+ +K + + + EIK+ LR NI+
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADI 98
Query: 871 VSE--EGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
V + + E V L + + + FY +IL+ L Y H I+H
Sbjct: 99 VKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMGIMH 152
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAP 988
RD+K NV+++ +++ D+G ++ + + PE+ + Y
Sbjct: 153 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPEL-LVDYQMYDYS 210
Query: 989 V 989
+
Sbjct: 211 L 211
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 118 bits (295), Expect = 1e-29
Identities = 50/196 (25%), Positives = 85/196 (43%), Gaps = 30/196 (15%)
Query: 812 ELGKGSYGVVYAAR-----ELDRQVKLAIKEIPEKNLGDVQP-LHEEIKLHSQLRHRNIV 865
++G+G++G V+ AR + +A+K + E+ D+Q E L ++ + NIV
Sbjct: 20 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 79
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLR---------------------VKWGPLKENE 904
+ LG + + E + G L+ LR GP +
Sbjct: 80 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 139
Query: 905 STMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL--AGLCPS 962
+ +Q+ G+ YL +K VHRD+ N LV + VVKI+DFG S+ + A +
Sbjct: 140 AEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGE-NMVVKIADFGLSRNIYSADYYKA 198
Query: 963 AETFTGTLQYMAPEVI 978
+++M PE I
Sbjct: 199 DGNDAIPIRWMPPESI 214
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 1e-29
Identities = 40/186 (21%), Positives = 83/186 (44%), Gaps = 12/186 (6%)
Query: 813 LGKGSYGVVYAARELD---RQVKLAIKEI-PEKNLGDVQPLHEEIKLHSQLRHRNIVQYL 868
+G+G +G VY LD +++ A+K + ++G+V E + H N++ L
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 869 GSVSE-EGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIV 927
G EG + + + G L +R + + + + Q+ +G+K+L +K V
Sbjct: 95 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKGMKFLASKKFV 152
Query: 928 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT----GTLQYMAPEVIDKGQR 983
HRD+ N +++ VK++DFG ++ + + +++MA E + +
Sbjct: 153 HRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 211
Query: 984 GYGAPV 989
+ V
Sbjct: 212 TTKSDV 217
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 3e-29
Identities = 45/178 (25%), Positives = 82/178 (46%), Gaps = 11/178 (6%)
Query: 812 ELGKGSYGVVYAARELDR----QVKLAIKEIPE-KNLGDVQPLHEEIKLHSQLRHRNIVQ 866
LG G++G VY + ++ +AIKE+ E + + + +E + + + + ++ +
Sbjct: 16 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 867 YLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
L + ++ + +P G L +R + + QI +G+ YL +++
Sbjct: 76 LL-GICLTSTVQLITQLMPFGCLLDYVREHKDN--IGSQYLLNWCVQIAKGMNYLEDRRL 132
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--LCPSAETFTGTLQYMAPEVIDKGQ 982
VHRD+ NVLV T VKI+DFG +K L AE +++MA E I
Sbjct: 133 VHRDLAARNVLVKT-PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 3e-29
Identities = 47/186 (25%), Positives = 83/186 (44%), Gaps = 16/186 (8%)
Query: 812 ELGKGSYGVVYAAR-----ELDRQVKLAIKEI-PEKNLGDVQPLHEEIKLHSQLRHRNIV 865
ELG+GS+G+VY + + + ++AIK + ++ + E + + ++V
Sbjct: 27 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 86
Query: 866 QYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKEN-------ESTMSFYTKQILEGL 918
+ LG VS+ + ME + G L + LR + N S M +I +G+
Sbjct: 87 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 146
Query: 919 KYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL--AGLCPSAETFTGTLQYMAPE 976
YL+ K VHRD+ N +V VKI DFG ++ + +++M+PE
Sbjct: 147 AYLNANKFVHRDLAARNCMVAE-DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 205
Query: 977 VIDKGQ 982
+ G
Sbjct: 206 SLKDGV 211
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 117 bits (295), Expect = 4e-29
Identities = 48/181 (26%), Positives = 89/181 (49%), Gaps = 12/181 (6%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHE---EIKLHSQLRHRNIVQYL 868
LG GS+G V + + A+K + ++ + ++ + E ++ + +V+
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 869 GSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVH 928
S + + ME V GG + + LR + G E FY QI+ +YLH +++
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPH--ARFYAAQIVLTFEYLHSLDLIY 164
Query: 929 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAP 988
RD+K +N+L++ G ++++DFG +KR + T GT + +APE+I +GY
Sbjct: 165 RDLKPENLLID-QQGYIQVTDFGFAKR---VKGRTWTLCGTPEALAPEIIL--SKGYNKA 218
Query: 989 V 989
V
Sbjct: 219 V 219
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 115 bits (289), Expect = 5e-29
Identities = 49/180 (27%), Positives = 86/180 (47%), Gaps = 8/180 (4%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQP--LHEEIKLHSQLRHRNIVQYLG 869
++G+G+YGVVY A+ + A+K+I + + P EI + +L+H NIV+
Sbjct: 9 KIGEGTYGVVYKAQNNYGE-TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
+ + + E + L + G T + Q+L G+ Y H ++++HR
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGGL---ESVTAKSFLLQLLNGIAYCHDRRVLHR 124
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPV 989
D+K N+L+N G +KI+DFG ++ TL Y AP+V+ G + Y +
Sbjct: 125 DLKPQNLLINR-EGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL-MGSKKYSTTI 182
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 1e-28
Identities = 41/180 (22%), Positives = 82/180 (45%), Gaps = 7/180 (3%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQP--LHEEIKLHSQLRHRNIVQYLG 869
++G+G+YG V+ A+ + +A+K + + + P EI L +L+H+NIV+
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 870 SVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHR 929
+ + + E + + + Q+L+GL + H + ++HR
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKY---FDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHR 125
Query: 930 DIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPV 989
D+K N+L+N G +K+++FG ++ TL Y P+V+ G + Y +
Sbjct: 126 DLKPQNLLINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL-FGAKLYSTSI 183
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 2e-28
Identities = 53/189 (28%), Positives = 90/189 (47%), Gaps = 17/189 (8%)
Query: 812 ELGKGSYGVVYAAREL-DRQVKLAIKEIPEKNLGDVQPLH-----EEIKLHSQLRHRNIV 865
E+G+G+YG V+ AR+L + +A+K + + + PL ++ H N+V
Sbjct: 14 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73
Query: 866 QYLGSVS-----EEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKY 920
+ + E + E V + L +V + T+ Q+L GL +
Sbjct: 74 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV--PTETIKDMMFQLLRGLDF 131
Query: 921 LHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDK 980
LH ++VHRD+K N+LV + SG +K++DFG + R+ + + TL Y APEV+ +
Sbjct: 132 LHSHRVVHRDLKPQNILVTS-SGQIKLADFGLA-RIYSFQMALTSVVVTLWYRAPEVLLQ 189
Query: 981 GQRGYGAPV 989
Y PV
Sbjct: 190 SS--YATPV 196
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 8e-28
Identities = 49/202 (24%), Positives = 83/202 (41%), Gaps = 24/202 (11%)
Query: 812 ELGKGSYGVVYAAR-----ELDRQVKLAIKEIPEKNLGDVQP--LHEEIKLHSQLRHRNI 864
LG+G++G V A + +A+K + E + E L H N+
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 865 VQYLGSVSEEG-YFKIFMEQVPGGSLSTLLRVKWGPLKE-------------NESTMSFY 910
V LG+ ++ G + +E G+LST LR K + Y
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 911 TKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP--SAETFTG 968
+ Q+ +G+++L +K +HRD+ N+L++ VVKI DFG ++ +
Sbjct: 140 SFQVAKGMEFLASRKCIHRDLAARNILLSE-KNVVKICDFGLARDIYKDPDYVRKGDARL 198
Query: 969 TLQYMAPEVIDKGQRGYGAPVR 990
L++MAPE I + V
Sbjct: 199 PLKWMAPETIFDRVYTIQSDVW 220
|
| >d2a2na1 b.62.1.1 (A:483-646) Peptidylprolyl isomerase domain and WD repeat-containing protein 1, PPWD1, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 164 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Peptidylprolyl isomerase domain and WD repeat-containing protein 1, PPWD1, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 1e-27
Identities = 60/142 (42%), Positives = 81/142 (57%), Gaps = 5/142 (3%)
Query: 127 HIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYG 186
H KL PKT ENF C + + TFHR+I FM Q GD T G G
Sbjct: 22 HTKLFPVECPKTVENF---CVHSRNGYYNGHTFHRIIKGFMIQTGDPTGTGMGGESIWGG 78
Query: 187 NKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVK 246
++ + TL+H P LSMANAG NTNGSQFFIT V T WLDN+H VFG V +G++VV+
Sbjct: 79 EFEDEFHSTLRHDRPYTLSMANAGSNTNGSQFFITVVPTPWLDNKHTVFGRVTKGMEVVQ 138
Query: 247 KLESM--GSQSGKTSKKIVVAN 266
++ ++ ++ K + + + N
Sbjct: 139 RISNVKVNPKTDKPYEDVSIIN 160
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 1e-27
Identities = 50/187 (26%), Positives = 91/187 (48%), Gaps = 13/187 (6%)
Query: 812 ELGKGSYGVVYAAREL---DRQVKLAIKEIPEKNLGD----VQPLHEEIKLHSQLRHR-N 863
LG G+YG V+ R++ D A+K + + + + E ++ +R
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 864 IVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHG 923
+V + E + ++ + GG L T L + + E + Y +I+ L++LH
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHK 147
Query: 924 QKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS-AETFTGTLQYMAPEVIDKGQ 982
I++RDIK +N+L+++ +G V ++DFG SK A F GT++YMAP+++ G
Sbjct: 148 LGIIYRDIKLENILLDS-NGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGD 206
Query: 983 RGYGAPV 989
G+ V
Sbjct: 207 SGHDKAV 213
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 6e-27
Identities = 48/195 (24%), Positives = 93/195 (47%), Gaps = 25/195 (12%)
Query: 812 ELGKGSYGVVYAAR-------ELDRQVKLAIKEI-PEKNLGDVQPLHEEIKLHSQL-RHR 862
LG+G++G V A + +R K+A+K + + D+ L E+++ + +H+
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 863 NIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKE-------------NESTMSF 909
NI+ LG+ +++G + +E G+L L+ + P E + +
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 910 YTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT-- 967
Q+ G++YL +K +HRD+ NVLV V+KI+DFG ++ + + +T
Sbjct: 140 CAYQVARGMEYLASKKCIHRDLAARNVLVTE-DNVMKIADFGLARDIHHIDYYKKTTNGR 198
Query: 968 GTLQYMAPEVIDKGQ 982
+++MAPE +
Sbjct: 199 LPVKWMAPEALFDRI 213
|
| >d2fu0a1 b.62.1.1 (A:5-159) Putative cyclophilin PFE0505w {Plasmodium falciparum [TaxId: 5833]} Length = 155 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Putative cyclophilin PFE0505w species: Plasmodium falciparum [TaxId: 5833]
Score = 105 bits (262), Expect = 9e-27
Identities = 55/140 (39%), Positives = 76/140 (54%), Gaps = 6/140 (4%)
Query: 127 HIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYG 186
HI L KT +NF G+ ++ + + +GTGG+SI+G
Sbjct: 14 HISLFYKECKKTVQNFSVHSI----NGYYNNCIFHRVIKHFMVQTGDPSGDGTGGESIWG 69
Query: 187 NKFEDENF-TLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVV 245
N+FEDE F L H+ P ++SMAN GPNTNGSQFFITTV WLD +H VFG V +G +V
Sbjct: 70 NEFEDEFFDHLNHSKPFMVSMANCGPNTNGSQFFITTVPCPWLDFKHTVFGKVTQGSKIV 129
Query: 246 KKLESMG-SQSGKTSKKIVV 264
+E + + K + I +
Sbjct: 130 LDIEKVRTDKRDKPLEDIKI 149
|
| >d2b71a1 b.62.1.1 (A:23-191) Cyclophilin-like protein PY00693 {Plasmodium yoelii [TaxId: 5861]} Length = 169 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Cyclophilin-like protein PY00693 species: Plasmodium yoelii [TaxId: 5861]
Score = 103 bits (257), Expect = 6e-26
Identities = 59/155 (38%), Positives = 79/155 (50%), Gaps = 7/155 (4%)
Query: 112 QEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGG 171
+ G +T + NL ++L PKT NF LC GF D+T + G
Sbjct: 15 ERGYIT-IYTNLGDFEVELYWYHSPKTCLNFYTLCEM----GFYDNTIFHRVIPNFVIQG 69
Query: 172 DFTNHNGTGGKSIYGNKFEDE-NFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDN 230
G GGKSIYG FEDE N LKHTG GILSM+N GPNTN SQFFIT LD
Sbjct: 70 GDPTGTGKGGKSIYGEYFEDEINKELKHTGAGILSMSNNGPNTNSSQFFITLAPLPHLDG 129
Query: 231 RHVVFGSVVEGLDVVKKLESMG-SQSGKTSKKIVV 264
+H +F V + + ++ + S+ + + K + +
Sbjct: 130 KHTIFARVSKNMTCIENIASVQTTATNKPIFDLKI 164
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 2e-25
Identities = 47/185 (25%), Positives = 88/185 (47%), Gaps = 16/185 (8%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEI--PEKNLGDVQPLHEEIKLHSQLRHRNIVQYLG 869
+G G+YG V AA + +++A+K++ P +++ + + E++L ++H N++ L
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 870 SVSEEGYFK-----IFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ 924
+ + + + G L+ +++ + K + + F QIL GLKY+H
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA 140
Query: 925 KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRG 984
I+HRD+K N+ VN +KI DFG ++ + T Y APE++
Sbjct: 141 DIIHRDLKPSNLAVNED-CELKILDFGLARH---TDDEMTGYVATRWYRAPEIM-LNWMH 195
Query: 985 YGAPV 989
Y V
Sbjct: 196 YNQTV 200
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 2e-25
Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 12/183 (6%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQP--LHEEIKLHSQLRHRNIVQYLG 869
+G G+YG V +A + K+AIK++ ++ + E++L +RH N++ L
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 870 SVSEEGYFKIFMEQVPGGSL---STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKI 926
+ + F + +K L E+ + F Q+L+GL+Y+H I
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR--IQFLVYQMLKGLRYIHAAGI 142
Query: 927 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYG 986
+HRD+K N+ VN +KI DFG +++ + T Y APEVI Y
Sbjct: 143 IHRDLKPGNLAVNE-DCELKILDFGLARQAD---SEMTGYVVTRWYRAPEVI-LNWMRYT 197
Query: 987 APV 989
V
Sbjct: 198 QTV 200
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 1e-23
Identities = 49/182 (26%), Positives = 83/182 (45%), Gaps = 16/182 (8%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEI--PEKNLGDVQPLHEEIKLHSQLRHRNIVQYLG 869
+G G+ G+V AA + +AIK++ P +N + + E+ L + H+NI+ L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 870 SVSEEGYFK------IFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHG 923
+ + + + ME + + + + MS+ Q+L G+K+LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS 137
Query: 924 QKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQR 983
I+HRD+K N++V + +KI DFG + R AG + T Y APEVI
Sbjct: 138 AGIIHRDLKPSNIVVKS-DCTLKILDFGLA-RTAGTSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 984 GY 985
Sbjct: 196 KE 197
|
| >d1lopa_ b.62.1.1 (A:) Peptidyl-prolyl cis-trans isomerase A, PpiA {Escherichia coli [TaxId: 562]} Length = 164 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Peptidyl-prolyl cis-trans isomerase A, PpiA species: Escherichia coli [TaxId: 562]
Score = 96.9 bits (240), Expect = 1e-23
Identities = 38/151 (25%), Positives = 62/151 (41%), Gaps = 18/151 (11%)
Query: 127 HIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYG 186
IK D P+T +NF C + + ++ FHRVI FM Q G K+
Sbjct: 12 VIKTFDDKAPETVKNFLDYC---REGFYNNTIFHRVINGFMIQ--GGGFEPGMKQKATKE 66
Query: 187 NKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWL--------DNRHVVFGSV 238
+ N LK+T + P++ +QFFI V +L + VF V
Sbjct: 67 PIKNEANNGLKNTRGTLAMARTQAPHSATAQFFINVVDNDFLNFSGESLQGWGYCVFAEV 126
Query: 239 VEGLDVVKKLESM-----GSQSGKTSKKIVV 264
V+G+D V K++ + G + +++
Sbjct: 127 VDGMDEVDKIKGVATGRSGMHQDVPKEDVII 157
|
| >d1v9ta_ b.62.1.1 (A:) Peptidyl-prolyl cis-trans isomerase A, PpiA {Escherichia coli [TaxId: 562]} Length = 166 | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Peptidyl-prolyl cis-trans isomerase A, PpiA species: Escherichia coli [TaxId: 562]
Score = 91.2 bits (225), Expect = 1e-21
Identities = 44/150 (29%), Positives = 66/150 (44%), Gaps = 15/150 (10%)
Query: 127 HIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYG 186
++L P + +NF + ++TFHRVIP FM QGG FT +
Sbjct: 17 ELELDKQKAPVSVQNFVDYVNSGF---YNNTTFHRVIPGFMIQGGGFTEQMQQKKPNPPI 73
Query: 187 NKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNR-----HVVFGSVVEG 241
D L++T I A ++ SQFFI A+LD+ + VFG VV+G
Sbjct: 74 KNEADNG--LRNTRGTIAMARTADKDSATSQFFINVADNAFLDHGQRDFGYAVFGKVVKG 131
Query: 242 LDVVKKLESM-----GSQSGKTSKKIVVAN 266
+DV K+ + G SK +V+ +
Sbjct: 132 MDVADKISQVPTHDVGPYQNVPSKPVVILS 161
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 92.8 bits (229), Expect = 1e-20
Identities = 42/198 (21%), Positives = 76/198 (38%), Gaps = 23/198 (11%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSV 871
+LG G + V+ A+++ +A+K + + + +EIKL ++ + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 872 SE-------------EGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGL 918
+ + M G L K+ + +KQ+L GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 919 KYLHGQ-KIVHRDIKGDNVLVNT-----YSGVVKISDFGTSKRLAGLCPSAETFTGTLQY 972
Y+H + I+H DIK +NVL+ +KI+D G + T +Y
Sbjct: 139 DYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW---YDEHYTNSIQTREY 195
Query: 973 MAPEVIDKGQRGYGAPVR 990
+PEV+ G GA +
Sbjct: 196 RSPEVLLGAPWGCGADIW 213
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 74.0 bits (181), Expect = 2e-15
Identities = 24/165 (14%), Positives = 46/165 (27%), Gaps = 21/165 (12%)
Query: 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQP----------LHEEIKLHSQLRH 861
+G+G V+ + +K + + ++
Sbjct: 7 LMGEGKESAVFNCYSEKFG-ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 862 RNIVQYLGSVSEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYL 921
R + + G + Y G ++ L + ILE +
Sbjct: 66 RALQKLQGLAVPKVY------AWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 922 HGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETF 966
+ + IVH D+ NVLV+ + I DF S +
Sbjct: 120 YHRGIVHGDLSQYNVLVSEEG--IWIIDFPQSVEVGE--EGWREI 160
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1181 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2r99a1 | 161 | Mitochondrial peptidyl-prolyl cis-trans isomerase, | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2igva1 | 172 | Cyclophilin (eukaryotic) {Caenorhabditis elegans, | 100.0 | |
| d2z6wa1 | 164 | Mitochondrial peptidyl-prolyl cis-trans isomerase, | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2cfea1 | 162 | Cyclophilin-like allergen Mal s 6 {Malassezia symp | 100.0 | |
| d1qnga_ | 170 | Cyclophilin (eukaryotic) {Plasmodium falciparum [T | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ihga2 | 195 | Cyclophilin 40 isomerase domain {Cow (Bos taurus) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1h0pa_ | 182 | Cyclophilin (eukaryotic) {Caenorhabditis elegans, | 100.0 | |
| d2rmca_ | 182 | Cyclophilin (eukaryotic) {Mouse (Mus musculus), va | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1qoia_ | 173 | Cyclophilin (eukaryotic) {Human (Homo sapiens), U4 | 100.0 | |
| d1xo7a_ | 166 | Cyclophilin (eukaryotic) {Trypanosoma cruzi [TaxId | 100.0 | |
| d2ok3a1 | 159 | Cyclophilin-like protein PPIL3B {Human (Homo sapie | 100.0 | |
| d1a33a_ | 174 | Cyclophilin (eukaryotic) {Nematode (Brugia malayi) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2c3ba1 | 171 | Cyclophilin (eukaryotic) {Aspergillus fumigatus [T | 100.0 | |
| d1z81a1 | 186 | Cyclophilin (eukaryotic) {Plasmodium yoelii [TaxId | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1zkca1 | 178 | Peptidyl-prolyl cis-trans isomerase-like 2, Cyclop | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2fu0a1 | 155 | Putative cyclophilin PFE0505w {Plasmodium falcipar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xwna1 | 166 | Peptidyl-prolyl cis-trans isomerase-like 1, PPIL1 | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2b71a1 | 169 | Cyclophilin-like protein PY00693 {Plasmodium yoeli | 100.0 | |
| d1v9ta_ | 166 | Peptidyl-prolyl cis-trans isomerase A, PpiA {Esche | 100.0 | |
| d2a2na1 | 164 | Peptidylprolyl isomerase domain and WD repeat-cont | 99.98 | |
| d1w74a_ | 171 | Peptidyl-prolyl cis-trans isomerase A, PpiA {Mycob | 99.97 | |
| d1lopa_ | 164 | Peptidyl-prolyl cis-trans isomerase A, PpiA {Esche | 99.97 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.77 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.92 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.57 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.31 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.55 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.35 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.22 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-43 Score=391.39 Aligned_cols=237 Identities=22% Similarity=0.327 Sum_probs=201.8
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
++||+|+||+||+|++..+++.||||++........+.+.+|+.++++++||||+++++++.+++.+|+|||||+||+|.
T Consensus 26 ~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~ 105 (293)
T d1yhwa1 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT 105 (293)
T ss_dssp EECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHH
T ss_pred EEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHH
Confidence 47999999999999999999999999998776667788999999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCc
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL 970 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~ 970 (1181)
+++... .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.+...........||+
T Consensus 106 ~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~-~~~vkl~DFG~a~~~~~~~~~~~~~~gt~ 180 (293)
T d1yhwa1 106 DVVTET----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM-DGSVKLTDFGFCAQITPEQSKRSTMVGTP 180 (293)
T ss_dssp HHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TCCEEECCCTTCEECCSTTCCBCCCCSCG
T ss_pred HHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECC-CCcEeeccchhheeeccccccccccccCC
Confidence 988653 5789999999999999999999999999999999999988 89999999999998766555556678999
Q ss_pred cccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCC----CCCCCCCCC
Q psy14556 971 QYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAP----PQISRSVSV 1046 (1181)
Q Consensus 971 ~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~----~~ip~~l~~ 1046 (1181)
.|+|||++.++.+ +..+|+ ||+||++|+|++|+.||.+.+....... ....-..+.
T Consensus 181 ~Y~aPE~~~~~~~--~~~~Di------------------wSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T d1yhwa1 181 YWMAPEVVTRKAY--GPKVDI------------------WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE 240 (293)
T ss_dssp GGCCHHHHSSSCB--CTHHHH------------------HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGG
T ss_pred CccChhhhcCCCC--Cchhce------------------ehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcc
Confidence 9999999986644 344444 9999999999999999998776442111 111112223
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
..+..+..++.+|+..+|.+||+..+
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s~~e 266 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGSAKE 266 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHH
Confidence 46778888999999999999996433
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-43 Score=384.41 Aligned_cols=241 Identities=28% Similarity=0.430 Sum_probs=201.1
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCC---CCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEK---NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFM 881 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~---~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVm 881 (1181)
+|.+.+ +||+|+||+||+|+++.+++.||+|++.+. .....+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 7 dy~i~~-~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 7 DFEIGR-PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GEEEEE-EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HeEEEE-EEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 454443 799999999999999999999999998643 2334677899999999999999999999999999999999
Q ss_pred eecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC
Q psy14556 882 EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP 961 (1181)
Q Consensus 882 Ey~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~ 961 (1181)
|||++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.... .
T Consensus 86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~-~~~~kl~DFG~a~~~~~--~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPS--S 159 (263)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TSCEEECCCCSCSCCCC--C
T ss_pred eecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecC-CCCEeecccceeeecCC--C
Confidence 999999999999754 35789999999999999999999999999999999999998 89999999999987654 2
Q ss_pred CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-C
Q psy14556 962 SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-I 1040 (1181)
Q Consensus 962 ~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-i 1040 (1181)
......||+.|+|||++.+..++ ..+|+ ||+||++|+|++|+.||.+.+..++...+. .
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~~~~~--~~~Di------------------wSlGvilyell~G~~Pf~~~~~~~~~~~i~~~ 219 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEGRMHD--EKVDL------------------WSLGVLCYEFLVGKPPFEANTYQETYKRISRV 219 (263)
T ss_dssp CCEETTEEGGGCCHHHHTTCCCC--TTHHH------------------HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT
T ss_pred cccccCCCCcccCHHHHcCCCCC--chhhh------------------hhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 33456799999999999876543 34444 999999999999999999887765432211 1
Q ss_pred CCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1041 SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1041 p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
....+...++.+..++.+|++.+|.+||+ +++
T Consensus 220 ~~~~p~~~s~~~~~li~~~L~~dp~~R~t-~~e 251 (263)
T d2j4za1 220 EFTFPDFVTEGARDLISRLLKHNPSQRPM-LRE 251 (263)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCC-HHH
T ss_pred CCCCCccCCHHHHHHHHHHccCCHhHCcC-HHH
Confidence 11223456788889999999999999995 444
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-43 Score=383.29 Aligned_cols=242 Identities=24% Similarity=0.323 Sum_probs=194.6
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEe
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmE 882 (1181)
++|.+. ++||+|+||+||+|+++.+++.||||++..... ...+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 5 ~dy~~~-~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 5 EDWDLV-QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TEEEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEE-EEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 345554 379999999999999999999999999976543 335679999999999999999999999999999999999
Q ss_pred ecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC--
Q psy14556 883 QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC-- 960 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~-- 960 (1181)
||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.+....
T Consensus 84 y~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~-~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 84 YCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE-RDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT-TCCEEECCCTTCEECEETTEE
T ss_pred ccCCCcHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECC-CCCEEEccchhheeeccCCcc
Confidence 99999999999743 46889999999999999999999999999999999999987 7899999999998765332
Q ss_pred CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc----C
Q psy14556 961 PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV----A 1036 (1181)
Q Consensus 961 ~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~----~ 1036 (1181)
......+||+.|+|||++.+..+ ++..+|+ ||+||++|+|+||+.||.+....... .
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~-~~~~~Di------------------wSlGvilyeml~G~~pf~~~~~~~~~~~~~~ 220 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREF-HAEPVDV------------------WSCGIVLTAMLAGELPWDQPSDSCQEYSDWK 220 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSB-CHHHHHH------------------HHHHHHHHHHHHSSCSCSSSSTTSHHHHHHH
T ss_pred ccccceeeCcCccCHhHhcCCCC-CCCceee------------------eHhHHHHHHHHhCCCCCCCCChHHHHHHHHh
Confidence 22345679999999999975432 2233444 99999999999999999876543311 0
Q ss_pred CCCCCCCCCCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1037 PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1037 ~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
............+..+..++.+|+..+|..||+
T Consensus 221 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t 253 (271)
T d1nvra_ 221 EKKTYLNPWKKIDSAPLALLHKILVENPSARIT 253 (271)
T ss_dssp TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCC
T ss_pred cCCCCCCccccCCHHHHHHHHHHcCCChhHCcC
Confidence 111111112345677788999999999999995
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=385.92 Aligned_cols=241 Identities=25% Similarity=0.351 Sum_probs=199.9
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
++||+|+||+||+|++..+++.||+|++........+.+.+|+.+|++++||||+++++++.+++.+|+|||||++|+|.
T Consensus 18 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~ 97 (288)
T d2jfla1 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVD 97 (288)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHH
T ss_pred EEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHH
Confidence 47999999999999999999999999998777677788999999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCCc
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGTL 970 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT~ 970 (1181)
+++... ...+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+..........+..||+
T Consensus 98 ~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~-~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~ 174 (288)
T d2jfla1 98 AVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTL-DGDIKLADFGVSAKNTRTIQRRDSFIGTP 174 (288)
T ss_dssp HHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TSCEEECCCTTCEECHHHHHHHTCCCSCC
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECC-CCCEEEEechhhhccCCCccccccccccc
Confidence 987653 235789999999999999999999999999999999999998 89999999999977654333334567999
Q ss_pred cccCchhhccCC---CCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC---C-CCC
Q psy14556 971 QYMAPEVIDKGQ---RGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ---I-SRS 1043 (1181)
Q Consensus 971 ~Y~APEvl~gg~---~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~---i-p~~ 1043 (1181)
.|+|||++.... ..++..+|+ ||+||++|+|+||+.||.+.+..++..... . .-.
T Consensus 175 ~y~APE~l~~~~~~~~~y~~k~Di------------------wSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 236 (288)
T d2jfla1 175 YWMAPEVVMCETSKDRPYDYKADV------------------WSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA 236 (288)
T ss_dssp TTCCHHHHTTCSTTTSSTTTHHHH------------------HHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCS
T ss_pred ccCCHHHHhhcccCCCCCChhhhH------------------HHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 999999995321 122333333 999999999999999999887765422111 1 111
Q ss_pred CCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1044 VSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1044 l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
.+...+..+..++.+|+..+|.+||+..+
T Consensus 237 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e 265 (288)
T d2jfla1 237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQ 265 (288)
T ss_dssp SGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 22346778888999999999999996443
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-43 Score=383.63 Aligned_cols=245 Identities=23% Similarity=0.298 Sum_probs=189.1
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEcccccc--CCcEEEE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSE--EGYFKIF 880 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d--~~~l~LV 880 (1181)
+|.+. ++||+|+||+||+|+++.+++.||+|++...... ..+.+.+|+.++++++||||+++++++.+ .+.+|+|
T Consensus 5 dy~~~-~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 5 DYEVL-YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hCEEe-EEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 34443 3799999999999999999999999999766443 35678999999999999999999998854 4678999
Q ss_pred EeecCCCCcccchhcc-cCCCCCChHHHHHHHHHHHhhhhhccccc-----eecccCCCCCcccccCCCeeeeecCCccc
Q psy14556 881 MEQVPGGSLSTLLRVK-WGPLKENESTMSFYTKQILEGLKYLHGQK-----IVHRDIKGDNVLVNTYSGVVKISDFGTSK 954 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~-~~~~~l~e~~i~~Ia~QIa~AL~yLHs~g-----IVHrDLKP~NILLd~~~g~vKLiDFGlAk 954 (1181)
||||++|+|.+++... .....+++..++.++.||+.||+|||++| |+||||||+|||++. ++.+||+|||+++
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~-~~~vkl~DFG~a~ 162 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLAR 162 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECT-TSCEEECCHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCC-CCcEEEeecccee
Confidence 9999999999998643 13456889999999999999999999976 999999999999998 8999999999998
Q ss_pred ccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc
Q psy14556 955 RLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL 1034 (1181)
Q Consensus 955 ~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l 1034 (1181)
.+...........||+.|+|||++.+..+ +..+|+ ||+||++|||+||+.||.+.+..++
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~--~~~~DI------------------wSlGvilyel~tg~~Pf~~~~~~~~ 222 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSY--NEKSDI------------------WSLGCLLYELCALMPPFTAFSQKEL 222 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCC--CHHHHH------------------HHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCCC--ChHHHH------------------HhhCHHHHHHhhCCCCCCCCCHHHH
Confidence 87655445556789999999999976543 344444 9999999999999999998877664
Q ss_pred cCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1035 VAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1035 ~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
...+. .....+...++.+..++.+|++.||..||+..
T Consensus 223 ~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ 261 (269)
T d2java1 223 AGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVE 261 (269)
T ss_dssp HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHH
Confidence 32211 11123445778899999999999999999633
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.7e-42 Score=383.79 Aligned_cols=244 Identities=27% Similarity=0.288 Sum_probs=186.8
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEe
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmE 882 (1181)
+.|.+. ++||+|+||+||+|+++.+++.||||++.+.... ..+.+.+|+.+|++++||||+++++++.+++.+|+|||
T Consensus 9 d~Y~~~-~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 9 DIYDFR-DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GTEEEE-EESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEE-EEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 344444 4799999999999999999999999999765433 34568899999999999999999999999999999999
Q ss_pred ecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccccc--CCCeeeeecCCcccccccCC
Q psy14556 883 QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNT--YSGVVKISDFGTSKRLAGLC 960 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~--~~g~vKLiDFGlAk~l~~~~ 960 (1181)
||+||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+.. .++.+||+|||+++.....
T Consensus 88 ~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~- 163 (307)
T d1a06a_ 88 LVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG- 163 (307)
T ss_dssp CCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred ccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC-
Confidence 99999999999743 46889999999999999999999999999999999999953 3679999999999876543
Q ss_pred CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc-----c
Q psy14556 961 PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL-----V 1035 (1181)
Q Consensus 961 ~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l-----~ 1035 (1181)
....+.+||+.|+|||++.+..++ ..+|+ ||+||++|+|++|+.||.+.....+ .
T Consensus 164 ~~~~~~~GT~~y~APE~~~~~~~~--~~~Di------------------wSlGvilyell~g~~Pf~~~~~~~~~~~i~~ 223 (307)
T d1a06a_ 164 SVLSTACGTPGYVAPEVLAQKPYS--KAVDC------------------WSIGVIAYILLCGYPPFYDENDAKLFEQILK 223 (307)
T ss_dssp ---------CTTSCHHHHTTCCCC--THHHH------------------HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHT
T ss_pred CeeeeeeeCccccCcHHHcCCCCC--cHHHh------------------hhhhHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence 233456799999999999866543 34444 9999999999999999998876543 2
Q ss_pred CCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1036 APPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1036 ~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
....++.......++.+..++.+|+..+|..||+..+
T Consensus 224 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e 260 (307)
T d1a06a_ 224 AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQ 260 (307)
T ss_dssp TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred cCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHH
Confidence 2333444455567888999999999999999996443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-42 Score=382.10 Aligned_cols=242 Identities=25% Similarity=0.333 Sum_probs=197.8
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCC---CCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEK---NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFM 881 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~---~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVm 881 (1181)
+|.+.+ .||+|+||+||+|++..+++.||||++.+. .....+.+.+|+.++++++||||+++++++.+++.+|+||
T Consensus 9 dy~i~~-~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 9 DFKFGK-ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GEEEEE-EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEE-EEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 455544 799999999999999999999999999653 2345678999999999999999999999999999999999
Q ss_pred eecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC-
Q psy14556 882 EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC- 960 (1181)
Q Consensus 882 Ey~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~- 960 (1181)
|||+||+|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+.+....
T Consensus 88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~-~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE-DMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-TSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCC-CceEEecccccceecccCCc
Confidence 999999999998754 36789999999999999999999999999999999999988 8999999999998775432
Q ss_pred -CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC
Q psy14556 961 -PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ 1039 (1181)
Q Consensus 961 -~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~ 1039 (1181)
.......||+.|+|||++.+..+ +..+|+ ||+||++|+|++|+.||.+.+..++...+.
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~--~~~~Di------------------wSlGvilyell~g~~Pf~~~~~~~~~~~i~ 223 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSA--CKSSDL------------------WALGCIIYQLVAGLPPFRAGNEYLIFQKII 223 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCC--CHHHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccccccccCCccccCceeeccCCC--Ccccce------------------ehhhHHHHHHhhCCCCCCCcCHHHHHHHHH
Confidence 22344679999999999986543 334444 999999999999999999887655422111
Q ss_pred -CCCCCCCCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1040 -ISRSVSVPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1040 -ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
..-..+...++.+..++.+|+..+|..||+..
T Consensus 224 ~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~ 256 (288)
T d1uu3a_ 224 KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCE 256 (288)
T ss_dssp TTCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSG
T ss_pred cCCCCCCccCCHHHHHHHHHHccCCHhHCcCHH
Confidence 11122335677888899999999999999643
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-42 Score=386.46 Aligned_cols=240 Identities=25% Similarity=0.320 Sum_probs=201.9
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCC---CCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEK---NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFM 881 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~---~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVm 881 (1181)
+|.+.+ +||+|+||.||+|+++.+++.||||++++. .....+.+.+|+.+|++++||||+++++++.+.+.+|+||
T Consensus 6 dy~~~~-~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 6 DFDYLK-LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GEEEEE-EEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcEEEE-EEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 344443 699999999999999999999999999754 2345678999999999999999999999999999999999
Q ss_pred eecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC
Q psy14556 882 EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP 961 (1181)
Q Consensus 882 Ey~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~ 961 (1181)
|||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. +|.+||+|||+|+.......
T Consensus 85 ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~-~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK-DGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT-TSCEEECCCTTCBCSCCTTC
T ss_pred eccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecC-CCCEEEeecccccccccCCc
Confidence 999999999998854 35788999999999999999999999999999999999998 89999999999987765555
Q ss_pred CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCCC-
Q psy14556 962 SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQI- 1040 (1181)
Q Consensus 962 ~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~i- 1040 (1181)
.....+||+.|+|||++.+..++ ..+|+ ||+||++|||++|++||.+.+..++...+..
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~--~~~Di------------------wSlGvilyeml~G~~pf~~~~~~~~~~~i~~~ 220 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYG--RAVDW------------------WGLGVVMYEMMCGRLPFYNQDHERLFELILME 220 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBC--TTHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred ccccceeCHHHhhhhhccCCCCC--hhhcc------------------cchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC
Confidence 55667899999999999876544 44444 9999999999999999999887664321110
Q ss_pred CCCCCCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1041 SRSVSVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1041 p~~l~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
.-..+...+..+..++.+|+.++|..|+.
T Consensus 221 ~~~~p~~~s~~~~dli~~~L~~dP~~R~~ 249 (337)
T d1o6la_ 221 EIRFPRTLSPEAKSLLAGLLKKDPKQRLG 249 (337)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSTTTSTT
T ss_pred CCCCCccCCHHHHHHHHhhccCCchhhcc
Confidence 11122345667788999999999999996
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-41 Score=373.33 Aligned_cols=236 Identities=25% Similarity=0.401 Sum_probs=192.5
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEcccccc----CCcEEEEEeec
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSE----EGYFKIFMEQV 884 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d----~~~l~LVmEy~ 884 (1181)
++||+|+||+||+|.+..+++.||+|.+..... ...+.+.+|+++|++++||||+++++++.+ ...+|+||||+
T Consensus 15 ~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~ 94 (270)
T d1t4ha_ 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 94 (270)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCC
Confidence 479999999999999999999999999865532 235678999999999999999999999854 35689999999
Q ss_pred CCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccc--eecccCCCCCcccccCCCeeeeecCCcccccccCCCC
Q psy14556 885 PGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQK--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS 962 (1181)
Q Consensus 885 ~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~g--IVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~ 962 (1181)
++|+|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++..++.+||+|||+++.... ..
T Consensus 95 ~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~--~~ 169 (270)
T d1t4ha_ 95 TSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SF 169 (270)
T ss_dssp CSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT--TS
T ss_pred CCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC--Cc
Confidence 999999999754 35788999999999999999999998 999999999999975478999999999976543 23
Q ss_pred CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc-c---cCCC
Q psy14556 963 AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA-L---VAPP 1038 (1181)
Q Consensus 963 ~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~-l---~~~~ 1038 (1181)
.....||+.|+|||++.+ . ++..+|+ ||+||++|||++|+.||.+..... + ....
T Consensus 170 ~~~~~GT~~Y~aPE~~~~-~--~~~~~DI------------------wSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~ 228 (270)
T d1t4ha_ 170 AKAVIGTPEFMAPEMYEE-K--YDESVDV------------------YAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG 228 (270)
T ss_dssp BEESCSSCCCCCGGGGGT-C--CCTHHHH------------------HHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT
T ss_pred cCCcccCccccCHHHhCC-C--CCCcCch------------------hhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcC
Confidence 445679999999999864 2 4444554 999999999999999998765432 2 1111
Q ss_pred CCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1039 QISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1039 ~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
..+...+...++.+..++.+|++++|..||+ +.+
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s-~~e 262 (270)
T d1t4ha_ 229 VKPASFDKVAIPEVKEIIEGCIRQNKDERYS-IKD 262 (270)
T ss_dssp CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCC-HHH
T ss_pred CCCcccCccCCHHHHHHHHHHccCCHhHCcC-HHH
Confidence 2222333456677899999999999999995 444
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.7e-41 Score=384.69 Aligned_cols=245 Identities=23% Similarity=0.284 Sum_probs=205.5
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEee
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQ 883 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy 883 (1181)
+.|.+. ++||+|+||+||+|++..+++.||||+++.......+.+.+|+.+|++++||||+++++++.+++.+|+||||
T Consensus 29 d~Y~i~-~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 29 DYYDIL-EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GTEEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEE-EEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 445544 4799999999999999999999999999876555567789999999999999999999999999999999999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccccc-CCCeeeeecCCcccccccCCCC
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGLCPS 962 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~-~~g~vKLiDFGlAk~l~~~~~~ 962 (1181)
|+||+|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||++. .++.+||+|||+|+.+... ..
T Consensus 108 ~~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-~~ 184 (352)
T d1koba_ 108 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EI 184 (352)
T ss_dssp CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-SC
T ss_pred CCCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC-Cc
Confidence 9999998877643 345889999999999999999999999999999999999973 3689999999999887643 23
Q ss_pred CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc-----CC
Q psy14556 963 AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV-----AP 1037 (1181)
Q Consensus 963 ~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~-----~~ 1037 (1181)
.....||+.|+|||++.+..+ +..+|+ ||+||++|+|+||+.||.+.+..++. ..
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~--~~~~Di------------------wSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~ 244 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDREPV--GFYTDM------------------WAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD 244 (352)
T ss_dssp EEEECSSGGGCCHHHHTTCCB--CHHHHH------------------HHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCC
T ss_pred eeeccCcccccCHHHHcCCCC--CCccch------------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 345679999999999976543 333444 99999999999999999988765532 23
Q ss_pred CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1038 PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1038 ~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
..++.......+..+..++.+|++.+|..||+..+
T Consensus 245 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e 279 (352)
T d1koba_ 245 WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHD 279 (352)
T ss_dssp CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 33455555667888999999999999999996433
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-42 Score=382.94 Aligned_cols=200 Identities=28% Similarity=0.409 Sum_probs=172.2
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC-hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEee
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD-VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQ 883 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~-~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy 883 (1181)
+|.+. ++||+|+||+||+|++..+++.||+|+++...... .+.+.+|+.+|++++|||||+++++|.+++.+|+||||
T Consensus 7 ~y~~~-~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy 85 (322)
T d1s9ja_ 7 DFEKI-SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 85 (322)
T ss_dssp GEEEE-EEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEEE-EEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 44444 47999999999999999999999999997654333 56789999999999999999999999999999999999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhcccc-ceecccCCCCCcccccCCCeeeeecCCcccccccCCCC
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQ-KIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS 962 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~-gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~ 962 (1181)
|+||+|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++. ++.+||+|||+|+..... .
T Consensus 86 ~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~-~~~vkl~DFGla~~~~~~--~ 159 (322)
T d1s9ja_ 86 MDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVSGQLIDS--M 159 (322)
T ss_dssp CTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECT-TCCEEECCCCCCHHHHHH--T
T ss_pred CCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECC-CCCEEEeeCCCccccCCC--c
Confidence 9999999999754 2578999999999999999999975 8999999999999988 899999999999876542 2
Q ss_pred CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCc
Q psy14556 963 AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTS 1031 (1181)
Q Consensus 963 ~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~ 1031 (1181)
..+.+||+.|+|||++.+..++ ..+|+ ||+||++|||++|+.||.+.+.
T Consensus 160 ~~~~~GT~~Y~APEvl~~~~y~--~~~Di------------------WSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQGTHYS--VQSDI------------------WSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp C---CCSSCCCCHHHHHCSCCC--TTHHH------------------HHHHHHHHHHHHSSCCSSCCCT
T ss_pred cccccCCccccCchHHcCCCCC--cHHHH------------------HHHHHHHHHHHHCCCCCCCCCH
Confidence 3456899999999999876544 44444 9999999999999999987654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2e-41 Score=385.53 Aligned_cols=247 Identities=23% Similarity=0.281 Sum_probs=205.0
Q ss_pred hhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEe
Q psy14556 803 LYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 803 ~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmE 882 (1181)
.++|.+.+ +||+|+||.||+|++..+++.||||++........+.+.+|+.+|++++||||+++++++.+++.+|+|||
T Consensus 25 l~~Y~i~~-~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 25 LDHYDIHE-ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GGTEEEEE-EEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccCeEEEE-EEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 44565544 69999999999999999999999999977665566789999999999999999999999999999999999
Q ss_pred ecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccccc-CCCeeeeecCCcccccccCCC
Q psy14556 883 QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGLCP 961 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~-~~g~vKLiDFGlAk~l~~~~~ 961 (1181)
||+||+|.+++... ...+++..++.++.||+.||+|||++|||||||||+|||++. .++.+||+|||+++.+... .
T Consensus 104 ~~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-~ 180 (350)
T d1koaa2 104 FMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-Q 180 (350)
T ss_dssp CCCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-S
T ss_pred cCCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc-c
Confidence 99999999998643 235889999999999999999999999999999999999964 2578999999999877543 2
Q ss_pred CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC-----
Q psy14556 962 SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA----- 1036 (1181)
Q Consensus 962 ~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~----- 1036 (1181)
...+..||+.|||||++.+..+ +..+|+ ||+||++|+|++|+.||.+.+..++..
T Consensus 181 ~~~~~~gT~~Y~aPEv~~~~~~--~~~~Di------------------wSlGvilyell~G~~Pf~~~~~~~~~~~i~~~ 240 (350)
T d1koaa2 181 SVKVTTGTAEFAAPEVAEGKPV--GYYTDM------------------WSVGVLSYILLSGLSPFGGENDDETLRNVKSC 240 (350)
T ss_dssp CEEEECSCTTTCCHHHHHTCCB--CHHHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred ccceecCcccccCHHHHcCCCC--ChhHhh------------------hhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 3345679999999999986543 334444 999999999999999999887655322
Q ss_pred CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1037 PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1037 ~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
...++.......+..+..++.+|+..||.+||+..+.
T Consensus 241 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~ei 277 (350)
T d1koaa2 241 DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 277 (350)
T ss_dssp CCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 2223333334567788889999999999999964433
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-41 Score=371.85 Aligned_cols=244 Identities=22% Similarity=0.306 Sum_probs=201.9
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCC------CChhHHHHHHHHHHhcCCCCeeeEccccccCCcE
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL------GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYF 877 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~------~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l 877 (1181)
+.|.+. ++||+|+||+||+|+++.+++.||||++.+... ...+.+.+|+.+|++++||||+++++++.+.+.+
T Consensus 10 d~Y~~~-~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 10 DYYDTG-EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GTEEEE-EEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCEEEe-EEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 345554 479999999999999999999999999965432 2357799999999999999999999999999999
Q ss_pred EEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCC----eeeeecCCcc
Q psy14556 878 KIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSG----VVKISDFGTS 953 (1181)
Q Consensus 878 ~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g----~vKLiDFGlA 953 (1181)
|+|||||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++ .+||+|||++
T Consensus 89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~-~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLD-RNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESC-SSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEec-CCCcccceEecchhhh
Confidence 9999999999999999754 36889999999999999999999999999999999999986 33 6999999999
Q ss_pred cccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc
Q psy14556 954 KRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA 1033 (1181)
Q Consensus 954 k~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~ 1033 (1181)
+..... ....+..||+.|+|||++.+..+ +..+|+ ||+||++|+|++|+.||.+.+..+
T Consensus 165 ~~~~~~-~~~~~~~~t~~y~APE~~~~~~~--~~~~Di------------------wSlGvilyell~g~~Pf~~~~~~~ 223 (293)
T d1jksa_ 165 HKIDFG-NEFKNIFGTPEFVAPEIVNYEPL--GLEADM------------------WSIGVITYILLSGASPFLGDTKQE 223 (293)
T ss_dssp EECTTS-CBCSCCCCCGGGCCHHHHTTCCB--CTHHHH------------------HHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred hhcCCC-ccccccCCCCcccCHHHHcCCCC--CCcccc------------------hhhhHHHHHHHcCCCCCCCCCHHH
Confidence 877543 33445679999999999986544 344444 999999999999999999887755
Q ss_pred ccC-----CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1034 LVA-----PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1034 l~~-----~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
... ....+.......+..+..++.+|++.+|.+||+..+.
T Consensus 224 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ei 268 (293)
T d1jksa_ 224 TLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268 (293)
T ss_dssp HHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred HHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 321 2223333334567788899999999999999964443
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.7e-41 Score=379.04 Aligned_cols=237 Identities=24% Similarity=0.349 Sum_probs=196.7
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCC---CCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEK---NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFM 881 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~---~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVm 881 (1181)
+|.+.+ +||+|+||+||+|+++.+++.||||++++. .....+.+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 5 dy~i~~-~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 5 DFQILR-TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GEEEEE-EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HeEEEE-EEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 344444 699999999999999999999999999653 2345678999999999999999999999999999999999
Q ss_pred eecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC
Q psy14556 882 EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP 961 (1181)
Q Consensus 882 Ey~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~ 961 (1181)
|||+||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~-~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDK-NGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT-TSCEEECCCSSCEECSSC--
T ss_pred eecCCcccccccccc---ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcC-CCCEEEecCccceEeccc--
Confidence 999999999988754 35678888899999999999999999999999999999998 899999999999876542
Q ss_pred CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-C
Q psy14556 962 SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ-I 1040 (1181)
Q Consensus 962 ~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~-i 1040 (1181)
..+.+||+.|+|||++.+..++. .+|+ ||+||++|+|++|+.||.+.+..++...+. -
T Consensus 158 -~~~~~Gt~~Y~APE~l~~~~y~~--~~Di------------------wSlGvilyemltG~~Pf~~~~~~~~~~~i~~~ 216 (316)
T d1fota_ 158 -TYTLCGTPDYIAPEVVSTKPYNK--SIDW------------------WSFGILIYEMLAGYTPFYDSNTMKTYEKILNA 216 (316)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCT--THHH------------------HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC
T ss_pred -cccccCcccccCHHHHcCCCCCc--hhhc------------------cccchhHHHHHhCCCCCCCcCHHHHHHHHHcC
Confidence 34567999999999998665443 4444 999999999999999999987755422211 1
Q ss_pred CCCCCCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1041 SRSVSVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1041 p~~l~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
....+...+..+..++.+|+.++|.+|++
T Consensus 217 ~~~~p~~~s~~~~~li~~~L~~dp~~R~~ 245 (316)
T d1fota_ 217 ELRFPPFFNEDVKDLLSRLITRDLSQRLG 245 (316)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSCTTTCTT
T ss_pred CCCCCCCCCHHHHHHHHHHhhhCHHhccc
Confidence 11223446677888888889999998874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-41 Score=378.43 Aligned_cols=237 Identities=28% Similarity=0.371 Sum_probs=196.4
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC---hhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD---VQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGG 887 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~---~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gG 887 (1181)
++||+|+||+||+|++..+++.||||+++...... .+.+.+|+.+|++++||||+++++++.+++.+|+|||||++|
T Consensus 21 ~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g 100 (309)
T d1u5ra_ 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGS 100 (309)
T ss_dssp EEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred EEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCC
Confidence 37999999999999999999999999997654432 456889999999999999999999999999999999999999
Q ss_pred CcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcccc
Q psy14556 888 SLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFT 967 (1181)
Q Consensus 888 SL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~ 967 (1181)
+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+.... .....
T Consensus 101 ~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~-~~~~Kl~DFG~a~~~~~----~~~~~ 172 (309)
T d1u5ra_ 101 ASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE-PGLVKLGDFGSASIMAP----ANSFV 172 (309)
T ss_dssp HHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET-TTEEEECCCTTCBSSSS----BCCCC
T ss_pred chHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECC-CCCEEEeecccccccCC----CCccc
Confidence 997666533 36789999999999999999999999999999999999997 89999999999986543 23457
Q ss_pred CCccccCchhhccCC-CCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC---CCCCCCC
Q psy14556 968 GTLQYMAPEVIDKGQ-RGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA---PPQISRS 1043 (1181)
Q Consensus 968 GT~~Y~APEvl~gg~-~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~---~~~ip~~ 1043 (1181)
||+.|+|||++.+.. ..++..+|+ ||+||++|||++|..||.+.+..+... ....+..
T Consensus 173 GT~~Y~APE~~~~~~~~~y~~~~Di------------------wSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~ 234 (309)
T d1u5ra_ 173 GTPYWMAPEVILAMDEGQYDGKVDV------------------WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL 234 (309)
T ss_dssp SCGGGCCHHHHTTTTSCCBCTHHHH------------------HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred cCccccCHHHHhccCCCCcCchhhh------------------hhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 999999999996432 224444555 999999999999999999877654321 1112223
Q ss_pred CCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1044 VSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1044 l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
.+...++.+..++.+|+..||..||+..+.
T Consensus 235 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~el 264 (309)
T d1u5ra_ 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264 (309)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 334567889999999999999999965443
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-41 Score=375.81 Aligned_cols=246 Identities=21% Similarity=0.267 Sum_probs=199.1
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
++||+|+||+||+|.+..+++.||||+++... ...+.+.+|+.+|++++||||+++++++.+++.+++|||||++|+|.
T Consensus 23 ~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~ 101 (287)
T d1opja_ 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 101 (287)
T ss_dssp EETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred eEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchH
Confidence 47999999999999999999999999987543 45678999999999999999999999999999999999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC-CccccCC
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS-AETFTGT 969 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~-~~t~~GT 969 (1181)
+++... ....+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+........ .....|+
T Consensus 102 ~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~-~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~ 179 (287)
T d1opja_ 102 DYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE-NHLVKVADFGLSRLMTGDTYTAHAGAKFP 179 (287)
T ss_dssp HHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG-GGCEEECCCCCTTTCCSSSSEEETTEEEC
T ss_pred HHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECC-CCcEEEccccceeecCCCCceeecccccc
Confidence 998754 4557889999999999999999999999999999999999998 899999999999876543222 2234588
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCC-CCCcccccCC--CCCCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALK-KKTSRALVAP--PQISRSVSV 1046 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~-~~~~~~l~~~--~~ip~~l~~ 1046 (1181)
+.|+|||++.++.++. .+|+ ||+||++|||++|+.||. +.+...+... .......+.
T Consensus 180 ~~y~aPE~~~~~~~~~--k~Di------------------wS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~ 239 (287)
T d1opja_ 180 IKWTAPESLAYNKFSI--KSDV------------------WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE 239 (287)
T ss_dssp GGGCCHHHHHHCCCSH--HHHH------------------HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred ccccChHHHcCCCCCc--hhhh------------------hhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCc
Confidence 9999999998765433 3444 999999999999766654 4444332111 111222334
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
..+..+..++.+|++.+|..||+ +++.+..+..
T Consensus 240 ~~~~~l~~li~~cl~~dP~~Rps-~~ei~~~L~~ 272 (287)
T d1opja_ 240 GCPEKVYELMRACWQWNPSDRPS-FAEIHQAFET 272 (287)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCC-HHHHHHHHHH
T ss_pred cchHHHHHHHHHHcCCCHhHCcC-HHHHHHHHHH
Confidence 57788999999999999999995 5554544443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.7e-41 Score=370.46 Aligned_cols=251 Identities=20% Similarity=0.237 Sum_probs=200.1
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC---hhHHHHHHHHHHhcCCCCeeeEccccccCC----c
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD---VQPLHEEIKLHSQLRHRNIVQYLGSVSEEG----Y 876 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~---~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~----~ 876 (1181)
++|.+. +.||+|+||+||+|++..+++.||||++++....+ .+.+.+|+.+++.++||||+++++++...+ .
T Consensus 7 drY~i~-~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 7 DRYELG-EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred ceeEEe-EEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 345544 47999999999999999999999999997665443 456899999999999999999999987653 4
Q ss_pred EEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccccc
Q psy14556 877 FKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956 (1181)
Q Consensus 877 l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l 956 (1181)
+|+||||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++..+|+|||.+...
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~-~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA-TNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-TSCEEECCCTTCEEC
T ss_pred EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCc-cccceeehhhhhhhh
Confidence 89999999999999988754 35789999999999999999999999999999999999988 899999999998765
Q ss_pred ccCC---CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc
Q psy14556 957 AGLC---PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA 1033 (1181)
Q Consensus 957 ~~~~---~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~ 1033 (1181)
.... .......||+.|+|||++.+..++ ..+|+ ||+||++|+|+||++||.+.+..+
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~--~~~Di------------------wSlGvilyelltG~~Pf~~~~~~~ 221 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVD--ARSDV------------------YSLGCVLYEVLTGEPPFTGDSPVS 221 (277)
T ss_dssp C----------------TTCCHHHHTTCCCC--HHHHH------------------HHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccCcccccCHHHHcCCCCC--cceec------------------ccchHHHHHHHhCCCCCCCcCHHH
Confidence 4322 223445799999999999765433 33444 999999999999999999887655
Q ss_pred c-----cCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcc
Q psy14556 1034 L-----VAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTG 1079 (1181)
Q Consensus 1034 l-----~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~ 1079 (1181)
+ ...+..+.......+..+..++.+|+++||.+||++++++...+.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 222 VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp HHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred HHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 3 223333444556778899999999999999999998888766554
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-41 Score=370.65 Aligned_cols=241 Identities=22% Similarity=0.215 Sum_probs=190.5
Q ss_pred ccCceeecccCceEEEEEEEc--CCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEe
Q psy14556 807 ALNRIELGKGSYGVVYAAREL--DRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 807 ~l~~~kIG~G~fG~VYka~d~--~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmE 882 (1181)
.++.++||+|+||+||+|.+. .+++.||||+++..... ..+.+.+|+.+|++++||||+++++++.+ +..++|||
T Consensus 9 ~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE 87 (277)
T d1xbba_ 9 TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVME 87 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred eecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEE
Confidence 344457999999999999864 35678999999654332 25679999999999999999999999865 45789999
Q ss_pred ecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC
Q psy14556 883 QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS 962 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~ 962 (1181)
|+++|+|.++++.. ..+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.+......
T Consensus 88 ~~~~g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~-~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 88 MAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT-QHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp CCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE-TTEEEECCCTTCEECCTTCSE
T ss_pred cCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccc-cCcccccchhhhhhccccccc
Confidence 99999999998753 35789999999999999999999999999999999999998 899999999999876543221
Q ss_pred ---CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCC
Q psy14556 963 ---AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPP 1038 (1181)
Q Consensus 963 ---~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~ 1038 (1181)
.....||+.|+|||++.++.++.++ |+ |||||++|||+| |+.||.+.+..++....
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~s--Di------------------wS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i 223 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKS--DV------------------WSFGVLMWEAFSYGQKPYRGMKGSEVTAML 223 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHH--HH------------------HHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred cccccccCCCceecCchhhcCCCCCchh--hh------------------ccchhhhhHHhhCCCCCCCCCCHHHHHHHH
Confidence 2234689999999999866543333 33 999999999998 89999988765542211
Q ss_pred C--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1039 Q--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1039 ~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
. .....+..+|..+..++.+|++.+|..||+..+
T Consensus 224 ~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~ 259 (277)
T d1xbba_ 224 EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAA 259 (277)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHH
Confidence 1 112233457888999999999999999996443
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=366.70 Aligned_cols=242 Identities=22% Similarity=0.344 Sum_probs=188.2
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
++||+|+||+||+|++. ..||||+++.... ...+.+.+|+.++++++||||+++++++.+ +.+++|||||++|+
T Consensus 14 ~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~ 89 (276)
T d1uwha_ 14 QRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSS 89 (276)
T ss_dssp SEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEE
T ss_pred EEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCC
Confidence 37999999999999753 3699999965532 345789999999999999999999998754 56899999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC--CCCccc
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC--PSAETF 966 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~--~~~~t~ 966 (1181)
|.+++... ...+++..+..++.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+...... ......
T Consensus 90 L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~-~~~~Kl~DFGla~~~~~~~~~~~~~~~ 166 (276)
T d1uwha_ 90 LYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHE-DLTVKIGDFGLATVKSRWSGSHQFEQL 166 (276)
T ss_dssp HHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET-TSSEEECCCCCSCC------------C
T ss_pred HHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcC-CCCEEEccccceeeccccCCccccccc
Confidence 99999754 235789999999999999999999999999999999999988 8999999999998765322 223456
Q ss_pred cCCccccCchhhccCCC-CCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc-----CC--C
Q psy14556 967 TGTLQYMAPEVIDKGQR-GYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV-----AP--P 1038 (1181)
Q Consensus 967 ~GT~~Y~APEvl~gg~~-~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~-----~~--~ 1038 (1181)
.||+.|||||++.+... .++..+|+ ||+||+||||+||+.||.+.+..... .. .
T Consensus 167 ~gt~~y~APE~l~~~~~~~~~~~sDi------------------wS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 228 (276)
T d1uwha_ 167 SGSILWMAPEVIRMQDKNPYSFQSDV------------------YAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS 228 (276)
T ss_dssp CCCGGGCCHHHHTTCSSCCCCHHHHH------------------HHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC
T ss_pred ccCcccCCHHHHhcccCCCCCchhhh------------------hhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC
Confidence 79999999999965332 23334444 99999999999999999987654311 11 1
Q ss_pred CCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1039 QISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1039 ~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
......+..+++.+..++.+|++.+|..||+ +++.+..+
T Consensus 229 p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt-~~~il~~L 267 (276)
T d1uwha_ 229 PDLSKVRSNCPKAMKRLMAECLKKKRDERPL-FPQILASI 267 (276)
T ss_dssp CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCC-HHHHHHHH
T ss_pred CcchhccccchHHHHHHHHHHcCCCHhHCcC-HHHHHHHH
Confidence 1112344567889999999999999999995 55544433
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.2e-41 Score=373.63 Aligned_cols=244 Identities=20% Similarity=0.219 Sum_probs=186.1
Q ss_pred eeecccCceEEEEEEEcCCCe---EEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCC
Q psy14556 811 IELGKGSYGVVYAARELDRQV---KLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPG 886 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~---~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~g 886 (1181)
++||+|+||+||+|++..+++ .||||.+..... ...+.+.+|+.+|++++|||||++++++.+++.+++|||||++
T Consensus 32 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~ 111 (299)
T d1jpaa_ 32 QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMEN 111 (299)
T ss_dssp EEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred eEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCC
Confidence 479999999999999876654 689998865433 3356799999999999999999999999999999999999999
Q ss_pred CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCC---
Q psy14556 887 GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSA--- 963 (1181)
Q Consensus 887 GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~--- 963 (1181)
|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.+.......
T Consensus 112 g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~-~~~~Kl~DFGla~~~~~~~~~~~~~ 188 (299)
T d1jpaa_ 112 GSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNS-NLVCKVSDFGLSRFLEDDTSDPTYT 188 (299)
T ss_dssp EEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TCCEEECCC----------------
T ss_pred Ccceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECC-CCcEEECCcccceEccCCCCcceee
Confidence 9999988754 335789999999999999999999999999999999999998 8999999999998765432211
Q ss_pred --ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC-
Q psy14556 964 --ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ- 1039 (1181)
Q Consensus 964 --~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~- 1039 (1181)
....||+.|+|||++.++.++. .+|+ |||||++|||+| |+.||.+.+..++.....
T Consensus 189 ~~~~~~~t~~y~aPE~~~~~~~~~--~sDv------------------wS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~ 248 (299)
T d1jpaa_ 189 SALGGKIPIRWTAPEAIQYRKFTS--ASDV------------------WSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ 248 (299)
T ss_dssp -------CGGGSCHHHHHSCCCCH--HHHH------------------HHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT
T ss_pred ecccccCCccccCHHHHhcCCCCc--cccc------------------ccchHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 1234789999999998665433 3343 999999999998 899999887765422111
Q ss_pred -CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1040 -ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1040 -ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
.....+...+..+..++.+|++.+|..||+ +.+.+..+
T Consensus 249 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-~~ei~~~L 287 (299)
T d1jpaa_ 249 DYRLPPPMDCPSALHQLMLDCWQKDRNHRPK-FGQIVNTL 287 (299)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCC-HHHHHHHH
T ss_pred CCCCCCCccchHHHHHHHHHHcCCCHhHCcC-HHHHHHHH
Confidence 112234567888999999999999999995 55544443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-41 Score=369.38 Aligned_cols=243 Identities=25% Similarity=0.261 Sum_probs=194.0
Q ss_pred cccCceeecccCceEEEEEEEcC--CCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEe
Q psy14556 806 FALNRIELGKGSYGVVYAARELD--RQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 806 ~~l~~~kIG~G~fG~VYka~d~~--tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmE 882 (1181)
+.+...+||+|+||+||+|.+.. ++..||||+++.... ...+.+.+|+.+|++++||||+++++++.+ +.+|+|||
T Consensus 10 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE 88 (285)
T d1u59a_ 10 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME 88 (285)
T ss_dssp EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred eEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEE
Confidence 33334369999999999998754 456899999975533 335779999999999999999999999865 46899999
Q ss_pred ecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC-
Q psy14556 883 QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP- 961 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~- 961 (1181)
||++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.+.....
T Consensus 89 ~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~-~~~~Kl~DFGla~~~~~~~~~ 165 (285)
T d1u59a_ 89 MAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN-RHYAKISDFGLSKALGADDSY 165 (285)
T ss_dssp CCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEE-TTEEEECCCTTCEECTTCSCE
T ss_pred eCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeecc-CCceeeccchhhhcccccccc
Confidence 99999999987643 346789999999999999999999999999999999999998 89999999999987754322
Q ss_pred --CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCC
Q psy14556 962 --SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPP 1038 (1181)
Q Consensus 962 --~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~ 1038 (1181)
......||+.|+|||++.++.++.++ |+ ||+||++|||+| |+.||.+.+..++...+
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~ks--DV------------------wS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i 225 (285)
T d1u59a_ 166 YTARSAGKWPLKWYAPECINFRKFSSRS--DV------------------WSYGVTMWEALSYGQKPYKKMKGPEVMAFI 225 (285)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHH--HH------------------HHHHHHHHHHHTTSCCTTTTCCTHHHHHHH
T ss_pred cccccccccCccccChHHHhCCCCCccc--hh------------------hcchHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 22334589999999999866543333 33 999999999998 89999987765542211
Q ss_pred C--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1039 Q--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1039 ~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
. .....+..+|..+..++.+|++.+|..||++.+
T Consensus 226 ~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~ 261 (285)
T d1u59a_ 226 EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLT 261 (285)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred HcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHH
Confidence 1 112234567888999999999999999996543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=362.74 Aligned_cols=242 Identities=21% Similarity=0.259 Sum_probs=185.3
Q ss_pred eecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCccc
Q psy14556 812 ELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLST 891 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~d 891 (1181)
+||+|+||+||+|++. ++..||||+++... ...+.+.+|+.++++++||||+++++++.+++..++||||+++|+|.+
T Consensus 12 ~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~ 89 (263)
T d1sm2a_ 12 EIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 89 (263)
T ss_dssp EEECCSSCCEEEEEET-TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred EEeeCCCeEEEEEEEC-CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHH
Confidence 6999999999999976 56789999997543 345789999999999999999999999999999999999999999999
Q ss_pred chhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC-CccccCCc
Q psy14556 892 LLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS-AETFTGTL 970 (1181)
Q Consensus 892 lL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~-~~t~~GT~ 970 (1181)
++... ...+++..+..++.||+.||+|||+++|+||||||+|||++. ++.+||+|||+++........ .....||+
T Consensus 90 ~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~-~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~ 166 (263)
T d1sm2a_ 90 YLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE-NQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 166 (263)
T ss_dssp HHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECG-GGCEEECSCC------------------CT
T ss_pred Hhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecC-CCCeEecccchheeccCCCceeecceecCc
Confidence 98753 345778899999999999999999999999999999999998 899999999999876543322 23356899
Q ss_pred cccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhC-CCCCCCCCcccccCCCC--CCCCCCCC
Q psy14556 971 QYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVL-TAALKKKTSRALVAPPQ--ISRSVSVP 1047 (1181)
Q Consensus 971 ~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTG-k~PF~~~~~~~l~~~~~--ip~~l~~~ 1047 (1181)
.|+|||++.++.++ ..+|+ ||+||++|||+|+ .+||...+..++..... .....+..
T Consensus 167 ~y~aPE~l~~~~~~--~k~DV------------------wS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~ 226 (263)
T d1sm2a_ 167 KWASPEVFSFSRYS--SKSDV------------------WSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRL 226 (263)
T ss_dssp TSCCHHHHTTCCCC--HHHHH------------------HHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTT
T ss_pred ccCChHHhcCCCCC--chhhh------------------cchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccc
Confidence 99999999866543 33444 9999999999995 66666665544322111 11222345
Q ss_pred CCcchHHhhccCCCCCCCCCchhHHHHHHhcc
Q psy14556 1048 GPGGINSSSSAPVTPTPHSRHISVNTNLVCTG 1079 (1181)
Q Consensus 1048 ~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~ 1079 (1181)
.+..+..++.+|++.+|.+||+ +++.+..++
T Consensus 227 ~~~~l~~li~~cl~~~p~~Rps-~~~il~~L~ 257 (263)
T d1sm2a_ 227 ASTHVYQIMNHCWKERPEDRPA-FSRLLRQLA 257 (263)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCC-HHHHHHHHH
T ss_pred cCHHHHHHHHHHccCCHhHCcC-HHHHHHHHH
Confidence 6778899999999999999995 555444443
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=373.69 Aligned_cols=241 Identities=25% Similarity=0.316 Sum_probs=200.1
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCC---CCCChhHHHHHHHHHH-hcCCCCeeeEccccccCCcEEEE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEK---NLGDVQPLHEEIKLHS-QLRHRNIVQYLGSVSEEGYFKIF 880 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~---~~~~~e~f~rEi~IL~-~L~HPNIVkl~g~~~d~~~l~LV 880 (1181)
+|.+. ++||+|+||+||+|++..+++.||||++++. .....+.+.+|..++. .++||||+++++++.+++.+|+|
T Consensus 3 dy~i~-~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 3 DFILH-KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TEEEE-EEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CeEEe-eEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 34444 4799999999999999999999999999654 2344566777877765 68999999999999999999999
Q ss_pred EeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC
Q psy14556 881 MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC 960 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~ 960 (1181)
||||++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++......
T Consensus 82 mEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~-~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK-DGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT-TSCEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecC-CCceeccccchhhhccccc
Confidence 9999999999999854 35778999999999999999999999999999999999997 8999999999998776555
Q ss_pred CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCCC
Q psy14556 961 PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQI 1040 (1181)
Q Consensus 961 ~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~i 1040 (1181)
.......||+.|+|||++.++.++ ..+|+ ||+||++|+|++|+.||.+.+..++...+..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~--~~~Di------------------wSlGvilyemltG~~PF~~~~~~~~~~~i~~ 217 (320)
T d1xjda_ 158 AKTNTFCGTPDYIAPEILLGQKYN--HSVDW------------------WSFGVLLYEMLIGQSPFHGQDEEELFHSIRM 217 (320)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBC--THHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccccccCCCCCcCCHHHHcCCCCC--chhhh------------------hhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 555567899999999999876544 34444 9999999999999999999887664322211
Q ss_pred -CCCCCCCCCcchHHhhccCCCCCCCCCchh
Q psy14556 1041 -SRSVSVPGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1041 -p~~l~~~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
....+...+..+..++.+|++.+|..||+.
T Consensus 218 ~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~ 248 (320)
T d1xjda_ 218 DNPFYPRWLEKEAKDLLVKLFVREPEKRLGV 248 (320)
T ss_dssp CCCCCCTTSCHHHHHHHHHHSCSSGGGSBTT
T ss_pred CCCCCCccCCHHHHHHHHHhcccCCCCCcCH
Confidence 112223467788889999999999999974
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-40 Score=365.02 Aligned_cols=239 Identities=24% Similarity=0.325 Sum_probs=190.3
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC-----ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG-----DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~-----~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
++||+|+||+||+|++..+++.||||+++..... ..+.+.+|+.++++++||||+++++++.+++.+|+||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 3699999999999999999999999999654332 24568999999999999999999999999999999999998
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCcc
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAET 965 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t 965 (1181)
++++..+.. ....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++...........
T Consensus 84 ~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~-~~~~KL~DFG~a~~~~~~~~~~~~ 159 (299)
T d1ua2a_ 84 TDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE-NGVLKLADFGLAKSFGSPNRAYTH 159 (299)
T ss_dssp EEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TCCEEECCCGGGSTTTSCCCCCCC
T ss_pred chHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecC-CCccccccCccccccCCCcccccc
Confidence 887776665 3346778899999999999999999999999999999999998 899999999999887665555556
Q ss_pred ccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC---------
Q psy14556 966 FTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA--------- 1036 (1181)
Q Consensus 966 ~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~--------- 1036 (1181)
..||+.|+|||++.++. .++..+|+ ||+||++|||+||.+||.+.+..+...
T Consensus 160 ~~gt~~y~aPE~~~~~~-~~~~~~Di------------------wSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~ 220 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGAR-MYGVGVDM------------------WAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP 220 (299)
T ss_dssp SCCCCTTCCHHHHTTCS-CCCHHHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred eecChhhccHHHHccCC-CCChhhhh------------------hhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCC
Confidence 67999999999996442 34555555 999999999999999998876533110
Q ss_pred -CCCCCC-------------------CCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1037 -PPQISR-------------------SVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1037 -~~~ip~-------------------~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
....+. ......++.+..++.+|+..||.+||+..+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e 276 (299)
T d1ua2a_ 221 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ 276 (299)
T ss_dssp CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred ChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 000000 001133456777899999999999996443
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-40 Score=378.34 Aligned_cols=238 Identities=22% Similarity=0.291 Sum_probs=198.4
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCC---CCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEE
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEK---NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIF 880 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~---~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LV 880 (1181)
++|.+.+ +||+|+||+||+|+++.+++.||||++.+. .....+.+.+|+.+|+.++||||+++++++.+.+..++|
T Consensus 41 d~y~i~~-~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIK-TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEE-EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCeEEEE-EeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 3455544 699999999999999999999999999643 234567899999999999999999999999999999999
Q ss_pred EeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC
Q psy14556 881 MEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC 960 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~ 960 (1181)
|||+.+|+|..++... ..+++..++.++.||+.||.|||++|||||||||+|||++. ++.+||+|||+|+.+...
T Consensus 120 ~e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~-~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ-QGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TSCEEECCCTTCEECSSC-
T ss_pred cccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCC-CCCEEeeeceeeeecccc-
Confidence 9999999999998754 25789999999999999999999999999999999999988 899999999999887542
Q ss_pred CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccCCCC-
Q psy14556 961 PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVAPPQ- 1039 (1181)
Q Consensus 961 ~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~~~~- 1039 (1181)
..+..||+.|||||++.+..+ +..+|+ ||+||++|+|+||+.||.+.+...+...+.
T Consensus 195 --~~~~~Gt~~Y~APE~~~~~~~--~~~~Di------------------wSlGvilyemltG~~Pf~~~~~~~~~~~i~~ 252 (350)
T d1rdqe_ 195 --TWTLCGTPEALAPEIILSKGY--NKAVDW------------------WALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCB--CTHHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred --cccccCccccCCHHHHcCCCC--Cccccc------------------cchhHHHHHHHhCCCCCCCcCHHHHHHHHhc
Confidence 345679999999999986544 334444 999999999999999999887655422111
Q ss_pred CCCCCCCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1040 ISRSVSVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1040 ip~~l~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
.....+...+..+..++.+|+..||.+|+.
T Consensus 253 ~~~~~p~~~s~~~~~li~~~L~~dP~kR~~ 282 (350)
T d1rdqe_ 253 GKVRFPSHFSSDLKDLLRNLLQVDLTKRFG 282 (350)
T ss_dssp CCCCCCTTCCHHHHHHHHHHSCSCTTTCTT
T ss_pred CCCCCCccCCHHHHHHHHHHhhhCHHhccc
Confidence 111223456777888999999999999973
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-40 Score=372.03 Aligned_cols=246 Identities=22% Similarity=0.249 Sum_probs=194.2
Q ss_pred eeecccCceEEEEEEEcCCC-----eEEEEEEecCCC-CCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEEee
Q psy14556 811 IELGKGSYGVVYAARELDRQ-----VKLAIKEIPEKN-LGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFMEQ 883 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg-----~~VAIKii~~~~-~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVmEy 883 (1181)
++||+|+||+||+|++..++ ..||+|.+.... ....+.+.+|+.+++++ +|||||++++++.+.+.+|+||||
T Consensus 43 ~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey 122 (325)
T d1rjba_ 43 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEY 122 (325)
T ss_dssp EEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEc
Confidence 47999999999999987654 379999986543 34467799999999998 899999999999999999999999
Q ss_pred cCCCCcccchhcccC--------------------CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCC
Q psy14556 884 VPGGSLSTLLRVKWG--------------------PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSG 943 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~--------------------~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g 943 (1181)
|++|+|.++++.+.. ...+++..++.++.||+.||+|||++|||||||||+|||++. ++
T Consensus 123 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~-~~ 201 (325)
T d1rjba_ 123 CCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH-GK 201 (325)
T ss_dssp CTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEET-TT
T ss_pred CCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcccccc-CC
Confidence 999999999975422 134788999999999999999999999999999999999988 89
Q ss_pred eeeeecCCcccccccCCCC--CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh
Q psy14556 944 VVKISDFGTSKRLAGLCPS--AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV 1021 (1181)
Q Consensus 944 ~vKLiDFGlAk~l~~~~~~--~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT 1021 (1181)
.+||+|||+|+........ ..+..||+.|||||++.++.++. .+|+ ||+||++|||+|
T Consensus 202 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~--~~Di------------------wS~Gvil~emlt 261 (325)
T d1rjba_ 202 VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI--KSDV------------------WSYGILLWEIFS 261 (325)
T ss_dssp EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCH--HHHH------------------HHHHHHHHHHTT
T ss_pred eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCc--ceec------------------cchhHHHHHHHh
Confidence 9999999999876654332 22455899999999998765443 3343 999999999998
Q ss_pred -CCCCCCCCCcccccC---CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1022 -LTAALKKKTSRALVA---PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1022 -Gk~PF~~~~~~~l~~---~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
|+.||.+.+...... ........+..++..+..++.+|++.+|..||+ +++.+..|
T Consensus 262 ~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt-~~ei~~~L 321 (325)
T d1rjba_ 262 LGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS-FPNLTSFL 321 (325)
T ss_dssp TSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-HHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcC-HHHHHHHH
Confidence 899999876543211 011122234457788999999999999999996 44444433
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.5e-40 Score=361.92 Aligned_cols=248 Identities=22% Similarity=0.253 Sum_probs=202.4
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCC---------hhHHHHHHHHHHhcC-CCCeeeEcccccc
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGD---------VQPLHEEIKLHSQLR-HRNIVQYLGSVSE 873 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~---------~e~f~rEi~IL~~L~-HPNIVkl~g~~~d 873 (1181)
++|.+ .++||+|+||+||+|++..+++.||||++++..... .+.+.+|+.++++++ ||||+++++++.+
T Consensus 3 ~~y~~-~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 3 ENYEP-KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTEEE-EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred ccCEE-ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 34444 347999999999999999999999999997664332 235889999999997 9999999999999
Q ss_pred CCcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcc
Q psy14556 874 EGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTS 953 (1181)
Q Consensus 874 ~~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlA 953 (1181)
++.+|+|||||++|+|.++++.. ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~-~~~~kl~DFG~a 157 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD-DMNIKLTDFGFS 157 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-TCCEEECCCTTC
T ss_pred CcceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcC-CCCeEEccchhe
Confidence 99999999999999999999754 35789999999999999999999999999999999999987 899999999999
Q ss_pred cccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc
Q psy14556 954 KRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA 1033 (1181)
Q Consensus 954 k~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~ 1033 (1181)
+.+... .......||+.|+|||.+.+...... ..++...|.||+||++|+|++|+.||.+.+...
T Consensus 158 ~~~~~~-~~~~~~~gt~~y~~PE~~~~~~~~~~--------------~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~ 222 (277)
T d1phka_ 158 CQLDPG-EKLREVCGTPSYLAPEIIECSMNDNH--------------PGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 222 (277)
T ss_dssp EECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTS--------------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred eEccCC-CceeeeeccCCCCCHHHhhccccccC--------------CCCCchheEcccchhhhhhccCCCCCCCCCHHH
Confidence 887653 33445679999999999975322111 112233344999999999999999999988655
Q ss_pred cc-----CCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1034 LV-----APPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1034 l~-----~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
+. .....+.......++.+..++.+|+..+|..||+..
T Consensus 223 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~ 265 (277)
T d1phka_ 223 MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAE 265 (277)
T ss_dssp HHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred HHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHH
Confidence 31 223334444446778889999999999999999643
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-40 Score=358.14 Aligned_cols=246 Identities=22% Similarity=0.263 Sum_probs=200.6
Q ss_pred cccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 806 FALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 806 ~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
|...+ +||+|+||+||+|+++ +++.||||++++... ..+.+.+|+.++++++||||+++++++.+++.+++||||++
T Consensus 6 ~~~~~-~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 6 LTFLK-ELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCC-CCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred CEEeE-EEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 34443 6999999999999974 778999999986544 45789999999999999999999999999999999999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC-Cc
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS-AE 964 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~-~~ 964 (1181)
+|+|.+++... ...+++..++.++.|+++||+|||++||+||||||+||+++. ++.+||+|||+++.+...... ..
T Consensus 83 ~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~-~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 83 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND-QGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp TEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECT-TCCEEECCCSSCCBCSSSSCCCCC
T ss_pred CCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcC-CCcEEECcchhheeccCCCceeec
Confidence 99999997654 235678899999999999999999999999999999999998 899999999999876543322 22
Q ss_pred cccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--CC
Q psy14556 965 TFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--IS 1041 (1181)
Q Consensus 965 t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--ip 1041 (1181)
...||+.|+|||++.++.++ ..+|+ ||+||++|||+| |+.||.+.+..++...+. ..
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~--~ksDi------------------wS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 219 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFS--SKSDI------------------WAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR 219 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCC--HHHHH------------------HHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred ccCCCCCcCCcHHhcCCCCC--cceee------------------cccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCC
Confidence 35689999999999866543 34444 999999999998 899999988766532211 11
Q ss_pred CCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1042 RSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1042 ~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
...+...+..+..++.+|++.+|..||+ +++.+..+
T Consensus 220 ~~~p~~~~~~l~~li~~cl~~dP~~RPt-~~eil~~L 255 (258)
T d1k2pa_ 220 LYRPHLASEKVYTIMYSCWHEKADERPT-FKILLSNI 255 (258)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCC-HHHHHHHH
T ss_pred CCCcccccHHHHHHHHHHccCCHhHCcC-HHHHHHHh
Confidence 2233456778999999999999999995 56655444
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-40 Score=363.93 Aligned_cols=243 Identities=19% Similarity=0.271 Sum_probs=191.2
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCCcc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGSLS 890 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~ 890 (1181)
++||+|+||+||+|.+. ++..||||+++... ...+.+.+|+.++++++||||+++++++.+ +..++||||+++|+|.
T Consensus 19 ~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~ 95 (272)
T d1qpca_ 19 ERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLV 95 (272)
T ss_dssp EEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHH
T ss_pred EEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHH
Confidence 36999999999999975 57889999997543 345789999999999999999999998765 5679999999999999
Q ss_pred cchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC-CCccccCC
Q psy14556 891 TLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP-SAETFTGT 969 (1181)
Q Consensus 891 dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~-~~~t~~GT 969 (1181)
+++... ....+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.+..... ......||
T Consensus 96 ~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~-~~~~Kl~DFGla~~~~~~~~~~~~~~~gt 173 (272)
T d1qpca_ 96 DFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD-TLSCKIADFGLARLIEDNEYTAREGAKFP 173 (272)
T ss_dssp HHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT-TSCEEECCCTTCEECSSSCEECCTTCCCC
T ss_pred HHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeec-ccceeeccccceEEccCCccccccccCCc
Confidence 987644 2335789999999999999999999999999999999999998 89999999999987754322 23345689
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCC-CCCCCCCcccccCCCC--CCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLT-AALKKKTSRALVAPPQ--ISRSVSV 1046 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk-~PF~~~~~~~l~~~~~--ip~~l~~ 1046 (1181)
+.|+|||++.++.++. ..|+ ||+||++|||+||+ +||...+..++..... .....+.
T Consensus 174 ~~y~APE~~~~~~~~~--~sDv------------------wS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~ 233 (272)
T d1qpca_ 174 IKWTAPEAINYGTFTI--KSDV------------------WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 233 (272)
T ss_dssp TTTSCHHHHHHCEECH--HHHH------------------HHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred ccccChHHHhCCCCCc--hhhh------------------hhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcc
Confidence 9999999998665433 3333 99999999999965 4555554433321111 1122234
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHHHHHhcc
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNTNLVCTG 1079 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~ 1079 (1181)
..+..+..++.+|++.+|..||+ +++.+..++
T Consensus 234 ~~~~~l~~li~~cl~~~P~~Rpt-~~ei~~~L~ 265 (272)
T d1qpca_ 234 NCPEELYQLMRLCWKERPEDRPT-FDYLRSVLE 265 (272)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCC-HHHHHHHHH
T ss_pred cChHHHHHHHHHHcCCCHhHCcC-HHHHHHHhh
Confidence 57788999999999999999995 555544443
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7e-40 Score=374.39 Aligned_cols=240 Identities=23% Similarity=0.323 Sum_probs=194.4
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCC---CChhHHHH---HHHHHHhcCCCCeeeEccccccCCcEE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNL---GDVQPLHE---EIKLHSQLRHRNIVQYLGSVSEEGYFK 878 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~---~~~e~f~r---Ei~IL~~L~HPNIVkl~g~~~d~~~l~ 878 (1181)
+|.+.+ +||+|+||.||+|++..+++.||||++.+... .....+.+ |+.+++.++||||+++++++.+.+.+|
T Consensus 5 dy~i~~-~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 5 DFSVHR-IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TEEEEE-EEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred hCeeee-EEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 455544 79999999999999999999999999864321 22233444 466777788999999999999999999
Q ss_pred EEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccccccc
Q psy14556 879 IFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 958 (1181)
Q Consensus 879 LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~ 958 (1181)
+|||||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.+..
T Consensus 84 ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~-~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE-HGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECS-SSCEEECCCTTCEECSS
T ss_pred EEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcC-CCcEEEeeeceeeecCC
Confidence 999999999999999754 35678999999999999999999999999999999999987 89999999999987654
Q ss_pred CCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc---
Q psy14556 959 LCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV--- 1035 (1181)
Q Consensus 959 ~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~--- 1035 (1181)
. ......||+.|+|||++.++. .++..+|+ ||+||+||+|+||+.||.+.+.....
T Consensus 160 ~--~~~~~~GT~~y~APE~~~~~~-~~~~~~Di------------------wSlGvilyemltG~~Pf~~~~~~~~~~~~ 218 (364)
T d1omwa3 160 K--KPHASVGTHGYMAPEVLQKGV-AYDSSADW------------------FSLGCMLFKLLRGHSPFRQHKTKDKHEID 218 (364)
T ss_dssp S--CCCSCCSCGGGCCHHHHSTTC-CCCTHHHH------------------HHHHHHHHHHHHSSCSSCSSCSSCHHHHH
T ss_pred C--cccccccccccchhHHhhcCC-CCCcccch------------------hHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 3 334567999999999996432 34445555 99999999999999999887654321
Q ss_pred -CCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchh
Q psy14556 1036 -APPQISRSVSVPGPGGINSSSSAPVTPTPHSRHIS 1070 (1181)
Q Consensus 1036 -~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s 1070 (1181)
.....+...+...++.+..++.+|+..||.+||++
T Consensus 219 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~ 254 (364)
T d1omwa3 219 RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGC 254 (364)
T ss_dssp HHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTT
T ss_pred HhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCC
Confidence 11122223344567788999999999999999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-40 Score=372.19 Aligned_cols=244 Identities=23% Similarity=0.274 Sum_probs=194.9
Q ss_pred hhhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhc-CCCCeeeEcccccc----CCcE
Q psy14556 803 LYLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSE----EGYF 877 (1181)
Q Consensus 803 ~~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d----~~~l 877 (1181)
.+.|.+..+.||+|+||+||+|++..+++.||||+++. .+.+.+|+.++.++ +||||++++++|.+ ...+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 45666655569999999999999999999999999864 35688999987655 89999999999865 4679
Q ss_pred EEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccC--CCeeeeecCCcccc
Q psy14556 878 KIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTY--SGVVKISDFGTSKR 955 (1181)
Q Consensus 878 ~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~--~g~vKLiDFGlAk~ 955 (1181)
|+|||||+||+|.+++..+ +...+++..++.|+.||+.||+|||++||+||||||+|||++.. .+.+||+|||+++.
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence 9999999999999999854 44578999999999999999999999999999999999999752 45799999999987
Q ss_pred cccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc
Q psy14556 956 LAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV 1035 (1181)
Q Consensus 956 l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~ 1035 (1181)
.... .......||+.|+|||++.+..+ +..+|+ ||+||+||+|+||+.||.+.+.....
T Consensus 164 ~~~~-~~~~~~~gt~~y~aPE~~~~~~y--~~~~Di------------------wSlGvily~lltg~~Pf~~~~~~~~~ 222 (335)
T d2ozaa1 164 TTSH-NSLTTPCYTPYYVAPEVLGPEKY--DKSCDM------------------WSLGVIMYILLCGYPPFYSNHGLAIS 222 (335)
T ss_dssp CCCC-CCCCCCSCCCSSCCCCCCCGGGG--SHHHHH------------------HHHHHHHHHHTTSSCSCEETTCC---
T ss_pred ccCC-CccccccCCcccCCcHHHcCCCC--CHHHHH------------------HhhchhHHHHhhCCCCCCCCCHHHHH
Confidence 6643 33455679999999999976543 334444 99999999999999999887654321
Q ss_pred ----CCCC-----CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1036 ----APPQ-----ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1036 ----~~~~-----ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
..+. ++.......+..+..++.+|+..+|..||+..+.
T Consensus 223 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ei 269 (335)
T d2ozaa1 223 PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269 (335)
T ss_dssp -----CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 1111 2221122356678889999999999999964444
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-40 Score=368.49 Aligned_cols=245 Identities=20% Similarity=0.270 Sum_probs=201.3
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEee
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQ 883 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy 883 (1181)
++|.+. ++||+|+||+||+|.+..+++.||+|+++.... +.+.+.+|+.+|++++||||+++++++.+++.+|+||||
T Consensus 5 ~rY~i~-~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 5 EKYMIA-EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cceEEE-EEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 344444 479999999999999999999999999976543 235688999999999999999999999999999999999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccC-CCeeeeecCCcccccccCCCC
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTY-SGVVKISDFGTSKRLAGLCPS 962 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~-~g~vKLiDFGlAk~l~~~~~~ 962 (1181)
|+||+|.+++... ...+++..++.|+.||+.||+|||++||+||||||+|||++.. ...+||+|||+++..... ..
T Consensus 83 ~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-~~ 159 (321)
T d1tkia_ 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DN 159 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-CE
T ss_pred CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC-Cc
Confidence 9999999999753 3457899999999999999999999999999999999999752 458999999999876532 23
Q ss_pred CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC-----C
Q psy14556 963 AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA-----P 1037 (1181)
Q Consensus 963 ~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~-----~ 1037 (1181)
.....+|+.|+|||.+.+..+ +..+|+ ||+||++|+|++|+.||.+.+..++.. .
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~--~~~~Di------------------WSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~ 219 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVV--STATDM------------------WSLGTLVYVLLSGINPFLAETNQQIIENIMNAE 219 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEE--CHHHHH------------------HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC
T ss_pred ccccccccccccchhccCCCC--Cchhhc------------------ccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 344568999999999976543 334444 999999999999999999988755422 2
Q ss_pred CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1038 PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1038 ~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
..++.......+..+..++.+|+..||..||+..+.
T Consensus 220 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~ei 255 (321)
T d1tkia_ 220 YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255 (321)
T ss_dssp CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred CCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 233333334567778899999999999999964443
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-39 Score=356.08 Aligned_cols=244 Identities=21% Similarity=0.246 Sum_probs=184.9
Q ss_pred eeecccCceEEEEEEEcCCC----eEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 811 IELGKGSYGVVYAARELDRQ----VKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg----~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
+.||+|+||+||+|.+..++ ..||||.++..... ..+.+.+|+.++++++|||||++++++.+.+..++||||+.
T Consensus 13 ~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~ 92 (283)
T d1mqba_ 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYME 92 (283)
T ss_dssp EEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred eEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecc
Confidence 36999999999999987654 57999999655332 34568999999999999999999999999999999999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC---
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS--- 962 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~--- 962 (1181)
++++.+++... ...+++..+..++.||+.||+|||+++|+||||||+|||++. ++.+||+|||+++.+......
T Consensus 93 ~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~-~~~~Kl~DFGla~~~~~~~~~~~~ 169 (283)
T d1mqba_ 93 NGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS-NLVCKVSDFGLSRVLEDDPEATYT 169 (283)
T ss_dssp TEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TCCEEECCCCC-------------
T ss_pred cCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECC-CCeEEEcccchhhcccCCCccceE
Confidence 99999887654 346788999999999999999999999999999999999998 899999999999876543221
Q ss_pred CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCC-CCCCCcccccCCC--C
Q psy14556 963 AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAA-LKKKTSRALVAPP--Q 1039 (1181)
Q Consensus 963 ~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~P-F~~~~~~~l~~~~--~ 1039 (1181)
.....||+.|+|||++.++.++.++ |+ |||||++|||++|..| |.+.+..++.... .
T Consensus 170 ~~~~~gt~~Y~APE~l~~~~~~~~s--DI------------------~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~ 229 (283)
T d1mqba_ 170 TSGGKIPIRWTAPEAISYRKFTSAS--DV------------------WSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 229 (283)
T ss_dssp ----CCCGGGSCHHHHHSCCCCHHH--HH------------------HHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred eccCCCCccccCHHHHccCCCCCcc--cc------------------cccHHHHHHHHhCCCCccccCCHHHHHHHHhcc
Confidence 2234589999999999876544433 33 9999999999996555 4444443332111 1
Q ss_pred CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1040 ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1040 ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
.....+...+..+..++.+|+..+|..||+ +.+.+..+
T Consensus 230 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~eil~~L 267 (283)
T d1mqba_ 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPK-FADIVSIL 267 (283)
T ss_dssp CCCCCCTTCBHHHHHHHHHHTCSSTTTSCC-HHHHHHHH
T ss_pred CCCCCchhhHHHHHHHHHHHCcCCHhHCcC-HHHHHHHH
Confidence 112234457788999999999999999995 44544433
|
| >d2r99a1 b.62.1.1 (A:139-299) Mitochondrial peptidyl-prolyl cis-trans isomerase, cyclophilin F {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Mitochondrial peptidyl-prolyl cis-trans isomerase, cyclophilin F species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-38 Score=324.22 Aligned_cols=161 Identities=65% Similarity=1.102 Sum_probs=152.0
Q ss_pred cccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCC
Q psy14556 97 MRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNH 176 (1181)
Q Consensus 97 ~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~ 176 (1181)
+|.||||++ +.++..|+|+||||.+.||+||+||++||+++++..|+|+.||||+|+|++|+|++...
T Consensus 1 np~vy~di~------------i~~~~~G~i~ieL~~~~aP~tv~nF~~L~~~~~~~~Y~g~~f~Rv~~~~~iq~G~~~~~ 68 (161)
T d2r99a1 1 NPQVYMDIK------------IGNKPAGRIQMLLRSDVVPMTAENFRCLCTHEKGFGFKGSSFHRIIPQFMCQGGDFTNH 68 (161)
T ss_dssp CCEEEEEEE------------ETTEEEEEEEEEECTTTCHHHHHHHHHHHHTTTSCCSTTCBEEEEETTTEEEECCTTTS
T ss_pred CCEEEEEEE------------ECCEeceEEEEEEcCCCCcHHHHHHHHhhhhccccccCCcEEEEEEEeeeEEeeeccCC
Confidence 579999997 56899999999999999999999999999886643499999999999999999999988
Q ss_pred CCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCCCCC
Q psy14556 177 NGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGSQSG 256 (1181)
Q Consensus 177 ~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t~~g 256 (1181)
++.++.+.++..+.++....+|+.+|+|+|++.++++++|||||+++++|+||++|+|||||++|||||++|+..++.+|
T Consensus 69 ~~~~~~~~~~~~~~~~~~~~~~~~~G~ls~~~~~~~s~~sqFfI~~~~~~~Ldg~~tvFG~Vv~G~dvl~~I~~~~~~~~ 148 (161)
T d2r99a1 69 NGTGGKSIYGKKFDDENFILKHTGPGLLSMANSGPNTNGSQFFLTCDKTDWLDGKHVVFGEVTEGLDVLRQIEAQGSKDG 148 (161)
T ss_dssp SSSCCCBTTBSCBCCCCCCSCCCSSSEEEECCSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHHHTTCCTTC
T ss_pred CCCCCccccCccccccccccccccceeeeecccCCCCcCcceEeccCCccccCCcceEEEEEeehHHHHHHHHccCCCCC
Confidence 88888999999999999999999999999999999999999999999999999999999999999999999999888999
Q ss_pred CcccceEEeeecc
Q psy14556 257 KTSKKIVVANSDS 269 (1181)
Q Consensus 257 ~P~~~V~I~~cGv 269 (1181)
+|.++|+|.+||+
T Consensus 149 ~P~~~i~I~~CGe 161 (161)
T d2r99a1 149 KPKQKVIIADCGE 161 (161)
T ss_dssp CCSSCEEEEEEEE
T ss_pred cCCCCEEEEeCCC
Confidence 9999999999996
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-39 Score=353.88 Aligned_cols=247 Identities=22% Similarity=0.282 Sum_probs=186.8
Q ss_pred cccCceeecccCceEEEEEEEcCC---CeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEE
Q psy14556 806 FALNRIELGKGSYGVVYAARELDR---QVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFM 881 (1181)
Q Consensus 806 ~~l~~~kIG~G~fG~VYka~d~~t---g~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVm 881 (1181)
|.+. ++||+|+||.||+|++..+ +..||||.++..... ..+.+.+|+.++++++||||+++++++.+ +.+|+||
T Consensus 9 ~~l~-~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv~ 86 (273)
T d1mp8a_ 9 IELG-RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIM 86 (273)
T ss_dssp EEEE-EEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred eEEE-EEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEEE
Confidence 4443 4799999999999998654 357899998654333 35679999999999999999999999864 6789999
Q ss_pred eecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC
Q psy14556 882 EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP 961 (1181)
Q Consensus 882 Ey~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~ 961 (1181)
||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++.......
T Consensus 87 E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~-~~~~Kl~DfG~a~~~~~~~~ 163 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS-NDCVKLGDFGLSRYMEDSTY 163 (273)
T ss_dssp ECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE-TTEEEECC------------
T ss_pred EeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecC-CCcEEEccchhheeccCCcc
Confidence 999999999987654 346789999999999999999999999999999999999998 89999999999987654322
Q ss_pred -CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC
Q psy14556 962 -SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ 1039 (1181)
Q Consensus 962 -~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~ 1039 (1181)
......||+.|+|||++.++.++. .+|+ ||+||++|||+| |.+||.+.+..++.....
T Consensus 164 ~~~~~~~gt~~y~apE~l~~~~~~~--~~Di------------------wSlGvil~e~lt~g~~P~~~~~~~~~~~~i~ 223 (273)
T d1mp8a_ 164 YKASKGKLPIKWMAPESINFRRFTS--ASDV------------------WMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 223 (273)
T ss_dssp -------CCGGGCCHHHHHHCCCSH--HHHH------------------HHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred eeccceecCcccchhhHhccCCCCC--cccc------------------ccchHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 233456899999999998765443 3444 999999999998 899999888766432111
Q ss_pred --CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1040 --ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1040 --ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
.....+..++..+..++.+|++.+|..||+ +.+.+..+
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps-~~ei~~~L 263 (273)
T d1mp8a_ 224 NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPR-FTELKAQL 263 (273)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-HHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcC-HHHHHHHH
Confidence 112334567888999999999999999995 55544433
|
| >d2igva1 b.62.1.1 (A:1-172) Cyclophilin (eukaryotic) {Caenorhabditis elegans, isoform 3 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Cyclophilin (eukaryotic) species: Caenorhabditis elegans, isoform 3 [TaxId: 6239]
Probab=100.00 E-value=1.6e-38 Score=327.59 Aligned_cols=162 Identities=64% Similarity=0.994 Sum_probs=153.9
Q ss_pred cccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccC--------CCccccCCEEEEecCCceE
Q psy14556 97 MRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGE--------KGFGFKDSTFHRVIPNFMC 168 (1181)
Q Consensus 97 ~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~--------~G~~Y~g~~FhRVip~f~i 168 (1181)
.|+||||++ +.++++|+|+||||.+.||+||+||++||+|+ .++ |+|+.||||+|++++
T Consensus 3 ~~~v~~Di~------------i~~~~~G~i~ieL~~~~aP~tv~nF~~L~~~~~~~~~~~k~~~-y~~~~f~rv~~~~~i 69 (172)
T d2igva1 3 RSKVFFDIT------------IGGKASGRIVMELYDDVVPKTAGNFRALCTGENGIGKSGKPLH-FKGSKFHRIIPNFMI 69 (172)
T ss_dssp CCEEEEEEE------------ETTEEEEEEEEEECTTTCHHHHHHHHHHHHTTTCBCTTSSBSC-CTTCBCCEEETTTEE
T ss_pred CCEEEEEEE------------ECCEeccEEEEEEcCCCCcHHHHHHHHHHhccccccccCcccc-cCCcceeEEEecceE
Confidence 468999997 56899999999999999999999999999874 356 999999999999999
Q ss_pred eeCCCCCCCCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHH
Q psy14556 169 QGGDFTNHNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKL 248 (1181)
Q Consensus 169 QgGd~~~~~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI 248 (1181)
|+|++..++++++..+++.++++|.....|+.+|+||||++++++++||||||++++|+||++|+|||+|++|||||++|
T Consensus 70 ~~G~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~G~lsma~~~~~~~~sqFfIt~~~~~~ld~~~~vFG~Vv~Gmdvl~~I 149 (172)
T d2igva1 70 QGGDFTRGNGTGGESIYGEKFPDENFKEKHTGPGVLSMANAGPNTNGSQFFLCTVKTEWLDGKHVVFGRVVEGLDVVKAV 149 (172)
T ss_dssp EECCTTTSSSSCCCBTTBSCBCCCCCCSCCCSTTEEEECCSSTTCBSSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHH
T ss_pred EcCCccCCCCCCCcccCCCccCccccccccCCCcEEEEeecCCCCcCceeEeeecCCcccCCceeEEEEEeccHHHHHHH
Confidence 99999988999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhCCCCCCCcccceEEeeecccc
Q psy14556 249 ESMGSQSGKTSKKIVVANSDSHS 271 (1181)
Q Consensus 249 ~~~~t~~g~P~~~V~I~~cGvl~ 271 (1181)
++.++.+|+|.++|+|.+||+|.
T Consensus 150 ~~~~~~~g~P~~~i~I~~cG~l~ 172 (172)
T d2igva1 150 ESNGSQSGKPVKDCMIADCGQLK 172 (172)
T ss_dssp HTTCCTTSCCSSCEEEEEEEEEC
T ss_pred HcCCCCCCCCCCCeEEEeccccC
Confidence 99999999999999999999984
|
| >d2z6wa1 b.62.1.1 (A:2-165) Mitochondrial peptidyl-prolyl cis-trans isomerase, cyclophilin F {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Mitochondrial peptidyl-prolyl cis-trans isomerase, cyclophilin F species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-38 Score=322.95 Aligned_cols=163 Identities=70% Similarity=1.147 Sum_probs=154.0
Q ss_pred cccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCC
Q psy14556 97 MRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNH 176 (1181)
Q Consensus 97 ~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~ 176 (1181)
+|++|||++ +.+++.|+|+||||++.||+||+||++||++.++..|+|+.||||++++++|+|++...
T Consensus 2 n~~v~~Di~------------i~~~~~G~i~ieL~~~~aP~tv~nF~~l~~~~~~~~Y~g~~f~rv~~~~~iq~g~~~~~ 69 (164)
T d2z6wa1 2 NPLVYLDVD------------ANGKPLGRVVLELKADVVPKTAENFRALCTGEKGFGYKGSTFHRVIPSFMCQAGDFTNH 69 (164)
T ss_dssp CCEEEEEEE------------ETTEEEEEEEEEECTTTCHHHHHHHHHHHHTTTSCCSTTCBEEEEETTTEEEECCTTTS
T ss_pred CCeEEEEEE------------ECCEeceEEEEEECCCcCcHHHHHHHHHHhcCCCcccCCcEEEEecccceEecCCccCC
Confidence 589999997 45889999999999999999999999999776664599999999999999999999988
Q ss_pred CCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCCCCC
Q psy14556 177 NGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGSQSG 256 (1181)
Q Consensus 177 ~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t~~g 256 (1181)
++.++...++..++++.....|+++|+||||++++++++|||||+++++|+||++|+|||+|++|||||++|+++++.++
T Consensus 70 ~~~~~~~~~~~~~~~~~~~~~~~~~G~lsma~~~~~s~~sqFfi~~~~~~~ldg~ytVFG~Vv~G~dvl~~I~~~~~~~~ 149 (164)
T d2z6wa1 70 NGTGGKSIYGSRFPDENFTLKHVGPGVLSMANAGPNTNGSQFFICTIKTDWLDGKHVVFGHVIEGMDVVKKIESFGSKSG 149 (164)
T ss_dssp SSSCCCBTTBSCBCCCCCCSCCCSTTEEEECCSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHHHHTCCTTS
T ss_pred CCCCCccccCCcCCccccccccCCccEEEEecCCCCCCCcceeccccCCCcccccceEEEEecccHHHHHHHHhCCCCCC
Confidence 88899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccceEEeeecccc
Q psy14556 257 KTSKKIVVANSDSHS 271 (1181)
Q Consensus 257 ~P~~~V~I~~cGvl~ 271 (1181)
+|.++|+|.+||+|.
T Consensus 150 ~P~~~i~I~~cG~l~ 164 (164)
T d2z6wa1 150 RTSKKIVITDCGQLS 164 (164)
T ss_dssp CCSSCEEEEEEEECC
T ss_pred CCCCCEEEEeCeecC
Confidence 999999999999984
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-39 Score=353.46 Aligned_cols=240 Identities=18% Similarity=0.281 Sum_probs=193.1
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC------ChhHHHHHHHHHHhcC--CCCeeeEccccccCC
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG------DVQPLHEEIKLHSQLR--HRNIVQYLGSVSEEG 875 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~------~~e~f~rEi~IL~~L~--HPNIVkl~g~~~d~~ 875 (1181)
++|.+. ++||+|+||+||+|++..+++.||||++.+.... ...++.+|+.++++++ ||||+++++++.+++
T Consensus 4 ~~Y~i~-~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 4 SQYQVG-PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTEEEE-EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CeEEEe-EEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 345554 4799999999999999999999999999654322 2345779999999996 899999999999999
Q ss_pred cEEEEEeecCC-CCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccc
Q psy14556 876 YFKIFMEQVPG-GSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954 (1181)
Q Consensus 876 ~l~LVmEy~~g-GSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk 954 (1181)
..++||||+.+ +++.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+++.+||+|||+|+
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccce
Confidence 99999999976 5777777643 3678999999999999999999999999999999999998646899999999998
Q ss_pred ccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccc
Q psy14556 955 RLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRAL 1034 (1181)
Q Consensus 955 ~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l 1034 (1181)
.... ....+..||+.|+|||++.+..+ ++..+|+ ||+||++|+|+||+.||.+.+. .+
T Consensus 160 ~~~~--~~~~~~~GT~~y~aPE~~~~~~~-~~~~~Di------------------wSlGvilyell~g~~Pf~~~~~-i~ 217 (273)
T d1xwsa_ 160 LLKD--TVYTDFDGTRVYSPPEWIRYHRY-HGRSAAV------------------WSLGILLYDMVCGDIPFEHDEE-II 217 (273)
T ss_dssp ECCS--SCBCCCCSCGGGSCHHHHHHSCB-CHHHHHH------------------HHHHHHHHHHHHSSCSCCSHHH-HH
T ss_pred eccc--ccccccccCCCcCCHHHHcCCCC-CCccccc------------------ccceeeehhHhhCCCCCCCchH-Hh
Confidence 6543 23445679999999999975532 2233444 9999999999999999987542 12
Q ss_pred cCCCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1035 VAPPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1035 ~~~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
..... .+...++.+..++.+|+..||..||+ +++.
T Consensus 218 ~~~~~----~~~~~s~~~~~li~~~L~~dp~~R~s-~~ei 252 (273)
T d1xwsa_ 218 RGQVF----FRQRVSSECQHLIRWCLALRPSDRPT-FEEI 252 (273)
T ss_dssp HCCCC----CSSCCCHHHHHHHHHHTCSSGGGSCC-HHHH
T ss_pred hcccC----CCCCCCHHHHHHHHHHccCCHhHCcC-HHHH
Confidence 22222 23356788899999999999999995 4443
|
| >d2cfea1 b.62.1.1 (A:1-162) Cyclophilin-like allergen Mal s 6 {Malassezia sympodialis [TaxId: 76777]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Cyclophilin-like allergen Mal s 6 species: Malassezia sympodialis [TaxId: 76777]
Probab=100.00 E-value=2.9e-38 Score=322.87 Aligned_cols=161 Identities=65% Similarity=1.063 Sum_probs=153.3
Q ss_pred cccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCC
Q psy14556 97 MRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNH 176 (1181)
Q Consensus 97 ~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~ 176 (1181)
|.+||||++ +.++++|+|+||||+++||+||+||++||+++.|++|+|+.||||+|++++|+|++..+
T Consensus 1 ~~~V~fDi~------------i~~~~~G~i~ieL~~~~aP~tv~nF~~L~~~~~~~~Y~g~~f~rv~~~~~iq~G~~~~~ 68 (162)
T d2cfea1 1 MSNVFFDIT------------KNGAPLGTIKFKLFDDVVPKTAANFRALCTGEKGFGYAGSHFHRVIPDFMLQGGDFTAG 68 (162)
T ss_dssp CCCEEEEEE------------ETTEEEEEEEEEECTTTCHHHHHHHHHHHHTTTSCCSTTCBCCEEETTTEEEECCTTTS
T ss_pred CCeEEEEEE------------ECCEEeeEEEEEEcCCCChHHHHHHHHHHhhccCCccCCCEEEEEEecceEecCCCCCC
Confidence 468999997 56899999999999999999999999999887776799999999999999999999988
Q ss_pred CCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCCCCC
Q psy14556 177 NGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGSQSG 256 (1181)
Q Consensus 177 ~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t~~g 256 (1181)
++.++.+.++.++.+|+..++|+.+|+|||++.++++++|||||++++.|+||++|+|||+|++|||||++|+..++.+|
T Consensus 69 ~~~~~~~~~~~~~~~e~~~~~h~~~G~vsm~~~~~~s~~sqF~I~~~~~~~ld~~~~vFG~Vi~G~dvl~~I~~~~~~~~ 148 (162)
T d2cfea1 69 NGTGGKSIYGAKFADENFQLKHNKPGLLSMANAGPNTNGSQFFITTVVTSWLDGKHVVFGEVIDGMNVVKAIEAEGSGSG 148 (162)
T ss_dssp SSSCCCBTTBSCBCCCCCCSCCCSTTEEEECCSSTTCBSSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHHHTTCCTTS
T ss_pred CCCCCcccCCCccccccCCCCCCCceEEEEeecCCCCCCcceEEeecCCccccccceEEEEEEehHHHHHHHhcCCCCCC
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999999888999
Q ss_pred CcccceEEeeecc
Q psy14556 257 KTSKKIVVANSDS 269 (1181)
Q Consensus 257 ~P~~~V~I~~cGv 269 (1181)
+|.++|+|.+||+
T Consensus 149 ~P~~~i~I~~cgv 161 (162)
T d2cfea1 149 KPRSRIEIAKCGV 161 (162)
T ss_dssp CCSSCEEEEEEEE
T ss_pred CCCCCeEEEeeEc
Confidence 9999999999997
|
| >d1qnga_ b.62.1.1 (A:) Cyclophilin (eukaryotic) {Plasmodium falciparum [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Cyclophilin (eukaryotic) species: Plasmodium falciparum [TaxId: 5833]
Probab=100.00 E-value=2.7e-38 Score=325.29 Aligned_cols=162 Identities=54% Similarity=0.963 Sum_probs=153.5
Q ss_pred ccccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccC-------CCccccCCEEEEecCCceE
Q psy14556 96 QMRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGE-------KGFGFKDSTFHRVIPNFMC 168 (1181)
Q Consensus 96 ~~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~-------~G~~Y~g~~FhRVip~f~i 168 (1181)
..++||||++ +.+|+.|+|+||||++.||+||+||++||+|+ .++ |+|+.||||++++++
T Consensus 2 ~r~~vy~Di~------------i~~t~~G~ivIeL~~~~aP~tv~nF~~l~~~~~~~~~~~~~~-y~g~~~~rv~~~~~i 68 (170)
T d1qnga_ 2 KRSKVFFDIS------------IDNSNAGRIIFELFSDITPRTCENFRALCTGEKIGSRGKNLH-YKNSIFHRIIPQFMC 68 (170)
T ss_dssp CSCEEEEEEE------------ESSSEEEEEEEEECTTTCHHHHHHHHHHHHTCEECTTSSEEC-CTTCBCCEEETTTEE
T ss_pred CCCEEEEEEE------------ECCEEccEEEEEECCCCChHHHHHHHhhhccccccccCccCc-cCcccceEEEeCceE
Confidence 4579999997 66899999999999999999999999999764 356 999999999999999
Q ss_pred eeCCCCCCCCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHH
Q psy14556 169 QGGDFTNHNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKL 248 (1181)
Q Consensus 169 QgGd~~~~~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI 248 (1181)
|+|+...++++++...++..+.++...+.|+.+|+||||+.+++++||||||+++++|+||++|+|||+|++|||||++|
T Consensus 69 q~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G~lsma~~~~~s~~sqFfIt~~~~~~Ld~~~~vFG~Vv~Gmdvl~~I 148 (170)
T d1qnga_ 69 QGGDITNGNGSGGESIYGRSFTDENFNMKHDQPGLLSMANAGPNTNSSQFFITLVPCPWLDGKHVVFGKVIEGMNVVREM 148 (170)
T ss_dssp EECCTTTSSSSCCCBTTBSCBCCCCCCSCCCSTTEEEECCSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHH
T ss_pred EecCccCCCCCCCcccCCCccccccccccCCCCeEEEEeecCCCCccccceeccCCcccccccccEEeEEeccHHHHHHH
Confidence 99999988899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhCCCCCCCcccceEEeeeccc
Q psy14556 249 ESMGSQSGKTSKKIVVANSDSH 270 (1181)
Q Consensus 249 ~~~~t~~g~P~~~V~I~~cGvl 270 (1181)
++.++.+|+|.++|+|.+||+|
T Consensus 149 ~~~~~~~g~P~~~i~I~~CG~l 170 (170)
T d1qnga_ 149 EKEGAKSGYVKRSVVITDCGEL 170 (170)
T ss_dssp HTTCCTTCCCSSCEEEEEEEEC
T ss_pred HhcCCCCcCCccCEEEEeeEcC
Confidence 9999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-38 Score=352.53 Aligned_cols=249 Identities=20% Similarity=0.257 Sum_probs=189.6
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeec
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQV 884 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~ 884 (1181)
++.+.+ +||+|+||+||+|++..+ ..||||+++... ...+.+.+|+.++++++|||||++++++.+ +..++||||+
T Consensus 18 ~~~i~~-~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 18 SLRLEV-KLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GEEEEE-EEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HEEEee-EEeeCCCeEEEEEEECCC-CEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 344433 699999999999998665 579999996543 345789999999999999999999999865 5679999999
Q ss_pred CCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCC-CCC
Q psy14556 885 PGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLC-PSA 963 (1181)
Q Consensus 885 ~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~-~~~ 963 (1181)
++|+|..++... ....+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++...... ...
T Consensus 94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE-NLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG-GGCEEECCCCTTC----------
T ss_pred CCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECC-CCcEEEcccchhhhccCCCceee
Confidence 999999888754 2335789999999999999999999999999999999999988 8999999999998765332 222
Q ss_pred ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCC-CCCCCcccccCCC--CC
Q psy14556 964 ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAA-LKKKTSRALVAPP--QI 1040 (1181)
Q Consensus 964 ~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~P-F~~~~~~~l~~~~--~i 1040 (1181)
....||+.|+|||++.++..+.+ .|+ ||+|+++|||++|+.| |.+....++.... ..
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~k--sDI------------------~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~ 231 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIK--SDV------------------WSFGILLTELTTKGRVPYPGMVNREVLDQVERGY 231 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHH--HHH------------------HHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred ccccccccccChHHHhCCCCCcH--Hhh------------------hcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC
Confidence 33568999999999987654443 333 9999999999996555 5555444332111 11
Q ss_pred CCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1041 SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1041 p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
....+..++..+..++.+|++.+|..||+ +++....++.
T Consensus 232 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps-~~~i~~~L~~ 270 (285)
T d1fmka3 232 RMPCPPECPESLHDLMCQCWRKEPEERPT-FEYLQAFLED 270 (285)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCC-HHHHHHHHHT
T ss_pred CCCCCcccCHHHHHHHHHHcccCHhHCcC-HHHHHHHHhh
Confidence 22344567888999999999999999995 5554555554
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-38 Score=350.87 Aligned_cols=241 Identities=26% Similarity=0.347 Sum_probs=190.0
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
++||+|+||+||+|++..+++.||||+++.... ...+.+.+|+.+|++++||||+++++++.+++.+|+||||+.++
T Consensus 8 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~- 86 (298)
T d1gz8a_ 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD- 86 (298)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEE-
T ss_pred cEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCc-
Confidence 479999999999999999999999999965533 33678999999999999999999999999999999999999654
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
+.+++... ....+++..++.++.||+.||+|||++|||||||||+|||++. ++.+||+|||.|+.............|
T Consensus 87 ~~~~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~-~~~~kl~DFG~a~~~~~~~~~~~~~~g 164 (298)
T d1gz8a_ 87 LKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT-EGAIKLADFGLARAFGVPVRTYTHEVV 164 (298)
T ss_dssp HHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TSCEEECSTTHHHHHCCCSBCTTCCBC
T ss_pred hhhhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecc-cCcceeccCCcceeccCCcccceeecc
Confidence 44444333 3446889999999999999999999999999999999999987 889999999999877655455556679
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC------------
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA------------ 1036 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~------------ 1036 (1181)
|+.|+|||++.... .++..+|+ ||+||++|+|++|+.||.+.+..+...
T Consensus 165 t~~y~apE~~~~~~-~~~~~~Di------------------wSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 225 (298)
T d1gz8a_ 165 TLWYRAPEILLGCK-YYSTAVDI------------------WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 225 (298)
T ss_dssp CCTTCCHHHHTTCS-SCCTHHHH------------------HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cceeeehhhhcccc-CCCccccc------------------cccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchh
Confidence 99999999986543 23445555 999999999999999998766432100
Q ss_pred -------CCC----CCCC-------CCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1037 -------PPQ----ISRS-------VSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1037 -------~~~----ip~~-------l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
... .+.. .....+..+..++.+|+..+|.+||+..+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~el 280 (298)
T d1gz8a_ 226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280 (298)
T ss_dssp TSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred hccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 000 0000 011334556778999999999999964444
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-38 Score=354.70 Aligned_cols=238 Identities=21% Similarity=0.218 Sum_probs=187.4
Q ss_pred eeecccCceEEEEEEEcCCCe----EEEEEEecCCC-CCChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 811 IELGKGSYGVVYAARELDRQV----KLAIKEIPEKN-LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~----~VAIKii~~~~-~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
++||+|+||+||+|.+..+++ +||+|.++... ....+.+.+|+.++++++||||+++++++.++ ..++++|++.
T Consensus 15 ~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~ 93 (317)
T d1xkka_ 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMP 93 (317)
T ss_dssp EEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred eEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEecc
Confidence 379999999999999987775 68888886543 34567899999999999999999999999865 5778899999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC--C
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS--A 963 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~--~ 963 (1181)
+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++........ .
T Consensus 94 ~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~ 170 (317)
T d1xkka_ 94 FGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT-PQHVKITDFGLAKLLGAEEKEYHA 170 (317)
T ss_dssp TCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE-TTEEEECCCSHHHHTTTTCC----
T ss_pred CCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCC-CCCeEeeccccceecccccccccc
Confidence 99999887754 446789999999999999999999999999999999999998 899999999999876543322 2
Q ss_pred ccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--C
Q psy14556 964 ETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--I 1040 (1181)
Q Consensus 964 ~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--i 1040 (1181)
....||+.|+|||++.++.++ ..+|+ |||||++|||+| |.+||.+.+..++..... .
T Consensus 171 ~~~~gt~~y~APE~l~~~~~~--~~sDv------------------wS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~ 230 (317)
T d1xkka_ 171 EGGKVPIKWMALESILHRIYT--HQSDV------------------WSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 230 (317)
T ss_dssp ----CCTTTSCHHHHHHCCCC--HHHHH------------------HHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC
T ss_pred cccccCccccChHHHhcCCCC--hhhhh------------------hhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC
Confidence 234589999999999876543 33444 999999999998 789999887765432111 1
Q ss_pred CCCCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1041 SRSVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1041 p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
....+..++..+..++.+|+..+|..||+..+
T Consensus 231 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~e 262 (317)
T d1xkka_ 231 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRE 262 (317)
T ss_dssp CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCcccCHHHHHHHHHhCCCChhhCcCHHH
Confidence 11223456778999999999999999996544
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-38 Score=352.07 Aligned_cols=250 Identities=21% Similarity=0.255 Sum_probs=197.1
Q ss_pred cccCceeecccCceEEEEEEEcC-----CCeEEEEEEecCCCCC-ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEE
Q psy14556 806 FALNRIELGKGSYGVVYAARELD-----RQVKLAIKEIPEKNLG-DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKI 879 (1181)
Q Consensus 806 ~~l~~~kIG~G~fG~VYka~d~~-----tg~~VAIKii~~~~~~-~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~L 879 (1181)
|.+.+ +||+|+||+||+|++.. +++.||||+++..... ..+++.+|+.++++++||||+++++++.+.+..++
T Consensus 15 ~~~~~-~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~ 93 (301)
T d1lufa_ 15 IEYVR-DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 93 (301)
T ss_dssp CEEEE-EEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred cEEeE-EEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEE
Confidence 44433 69999999999999753 5688999999755433 25679999999999999999999999999999999
Q ss_pred EEeecCCCCcccchhccc---------------------CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccc
Q psy14556 880 FMEQVPGGSLSTLLRVKW---------------------GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLV 938 (1181)
Q Consensus 880 VmEy~~gGSL~dlL~~~~---------------------~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILL 938 (1181)
+|||+++|+|.+++.... ....+++..+..++.||+.||+|||+++||||||||+|||+
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILl 173 (301)
T d1lufa_ 94 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV 173 (301)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEE
Confidence 999999999999986431 12347788999999999999999999999999999999999
Q ss_pred ccCCCeeeeecCCcccccccCCC--CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHH
Q psy14556 939 NTYSGVVKISDFGTSKRLAGLCP--SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVII 1016 (1181)
Q Consensus 939 d~~~g~vKLiDFGlAk~l~~~~~--~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvIL 1016 (1181)
+. ++.+||+|||+|+....... ...+..|++.|+|||.+.+..++ ..+|+ |||||++
T Consensus 174 d~-~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t--~ksDV------------------wS~Gvvl 232 (301)
T d1lufa_ 174 GE-NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT--TESDV------------------WAYGVVL 232 (301)
T ss_dssp CG-GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC--HHHHH------------------HHHHHHH
T ss_pred CC-CCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC--hhhhh------------------ccchhhH
Confidence 98 89999999999986644322 23345689999999999876544 33444 9999999
Q ss_pred HHHHhCC-CCCCCCCcccccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1017 SQLLVLT-AALKKKTSRALVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1017 yELLTGk-~PF~~~~~~~l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
|||++|. +||.+.+..++..... .....+...+..+..++.+|++.+|.+||+ +.+....+
T Consensus 233 ~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt-~~ev~~~L 296 (301)
T d1lufa_ 233 WEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPS-FCSIHRIL 296 (301)
T ss_dssp HHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-HHHHHHHH
T ss_pred HHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcC-HHHHHHHH
Confidence 9999996 6888887766432211 111233456788999999999999999995 44444433
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-38 Score=351.51 Aligned_cols=252 Identities=21% Similarity=0.287 Sum_probs=196.6
Q ss_pred hcccCceeecccCceEEEEEEEcCCCe--EEEEEEecCC-CCCChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQV--KLAIKEIPEK-NLGDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIF 880 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~--~VAIKii~~~-~~~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LV 880 (1181)
+|.+. ++||+|+||+||+|++..++. .||||.++.. .....+.+.+|+.+|+++ +||||+++++++.+++.+++|
T Consensus 11 ~~~~~-~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 11 DIKFQ-DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GCEEE-EEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HcEEE-EEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 44443 479999999999999988876 4778887544 333567899999999999 799999999999999999999
Q ss_pred EeecCCCCcccchhcc-------------cCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeee
Q psy14556 881 MEQVPGGSLSTLLRVK-------------WGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKI 947 (1181)
Q Consensus 881 mEy~~gGSL~dlL~~~-------------~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKL 947 (1181)
|||+++|+|.++++.. .....+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~-~~~~kl 168 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE-NYVAKI 168 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG-GGCEEE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcC-CCceEE
Confidence 9999999999999743 12356889999999999999999999999999999999999998 789999
Q ss_pred ecCCcccccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCC-CCC
Q psy14556 948 SDFGTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLT-AAL 1026 (1181)
Q Consensus 948 iDFGlAk~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk-~PF 1026 (1181)
+|||+++...... ......||..|+|||.+.++.++.+ .|+ |||||++|||++|. +||
T Consensus 169 ~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~--sDv------------------wSfGvil~ell~~~~~p~ 227 (309)
T d1fvra_ 169 ADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTN--SDV------------------WSYGVLLWEIVSLGGTPY 227 (309)
T ss_dssp CCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHH--HHH------------------HHHHHHHHHHHTTSCCTT
T ss_pred ccccccccccccc-cccceecCCcccchHHhccCCCCcc--cee------------------ehhHHHHHHHHhcCCCCC
Confidence 9999998665432 2234568999999999987654333 333 99999999999975 678
Q ss_pred CCCCcccccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1027 KKKTSRALVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1027 ~~~~~~~l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
.+.+..++..... .....+...++.+..++.+|++.+|.+||+ +.+.+..+..
T Consensus 228 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-~~eil~~L~~ 282 (309)
T d1fvra_ 228 CGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPS-FAQILVSLNR 282 (309)
T ss_dssp TTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCC-HHHHHHHHHH
T ss_pred CCCCHHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcC-HHHHHHHHHH
Confidence 8877666432211 112233456788999999999999999994 5554444433
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-38 Score=346.10 Aligned_cols=238 Identities=24% Similarity=0.311 Sum_probs=185.4
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEcccccc-CCcEEEEEeecCCCCc
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSE-EGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d-~~~l~LVmEy~~gGSL 889 (1181)
++||+|+||.||+|.+ .+..||||+++.. ...+.+.+|+.++++++||||+++++++.+ .+.+++||||+++|+|
T Consensus 13 ~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L 88 (262)
T d1byga_ 13 QTIGKGEFGDVMLGDY--RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 88 (262)
T ss_dssp EEEEECSSCEEEEEEE--TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred EEEecCCCeEEEEEEE--CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCH
Confidence 3699999999999998 4678999999654 345789999999999999999999998854 5678999999999999
Q ss_pred ccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccCC
Q psy14556 890 STLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTGT 969 (1181)
Q Consensus 890 ~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~GT 969 (1181)
.+++... ....+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+||+|||+++..... .....++
T Consensus 89 ~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~-~~~~kl~dfg~s~~~~~~---~~~~~~~ 163 (262)
T d1byga_ 89 VDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE-DNVAKVSDFGLTKEASST---QDTGKLP 163 (262)
T ss_dssp HHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT-TSCEEECCCCC---------------CC
T ss_pred HHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecC-CCCEeecccccceecCCC---Ccccccc
Confidence 9999754 2335789999999999999999999999999999999999998 899999999999865432 2334688
Q ss_pred ccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCCCC--CCCCCCC
Q psy14556 970 LQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAPPQ--ISRSVSV 1046 (1181)
Q Consensus 970 ~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~~~--ip~~l~~ 1046 (1181)
..|+|||++.++.++.+ .|+ |||||++|||+| |++||...+..++..... .....+.
T Consensus 164 ~~y~aPE~l~~~~~t~~--sDI------------------wSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~ 223 (262)
T d1byga_ 164 VKWTAPEALREKKFSTK--SDV------------------WSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD 223 (262)
T ss_dssp TTTSCHHHHHHCCCCHH--HHH------------------HHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCT
T ss_pred ccCCChHHHhCCCCChH--HHH------------------HhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 99999999987654433 333 999999999998 788998887766432211 2223345
Q ss_pred CCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1047 PGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1047 ~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
..++.+..++.+|+..+|.+||+. .+.+..+
T Consensus 224 ~~~~~~~~li~~cl~~dP~~Rps~-~~l~~~L 254 (262)
T d1byga_ 224 GCPPAVYEVMKNCWHLDAAMRPSF-LQLREQL 254 (262)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHH
T ss_pred cCCHHHHHHHHHHcccCHhHCcCH-HHHHHHH
Confidence 677889999999999999999964 4444443
|
| >d1ihga2 b.62.1.1 (A:2-196) Cyclophilin 40 isomerase domain {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Cyclophilin 40 isomerase domain species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.2e-37 Score=325.28 Aligned_cols=170 Identities=54% Similarity=0.833 Sum_probs=160.1
Q ss_pred ccccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCC---------CccccCCEEEEecCCc
Q psy14556 96 QMRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEK---------GFGFKDSTFHRVIPNF 166 (1181)
Q Consensus 96 ~~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~---------G~~Y~g~~FhRVip~f 166 (1181)
.+|++|||++ +.++.+|+|+||||.+.||+||+||++||+++. ++ |+|+.||||++++
T Consensus 13 ~np~v~~Di~------------i~~~~~G~I~IeL~~d~aP~tv~nF~~L~~~~~~~~~~~~~~~~-y~g~~f~rv~~~~ 79 (195)
T d1ihga2 13 SNPRVFFDVD------------IGGERVGRIVLELFADIVPKTAENFRALCTGEKGIGPTTGKPLH-FKGCPFHRIIKKF 79 (195)
T ss_dssp TSCEEEEEEE------------ETTEEEEEEEEEECTTTCHHHHHHHHHHHHCTTCBCTTTSSBSC-CTTCBEEEEETTT
T ss_pred CCCEEEEEEE------------ECCEeeeEEEEEECCCCChHHHHHHHHHhccccccccccCCccc-cCCceeeEEEcCc
Confidence 4789999997 568899999999999999999999999997653 34 9999999999999
Q ss_pred eEeeCCCCCCCCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHH
Q psy14556 167 MCQGGDFTNHNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVK 246 (1181)
Q Consensus 167 ~iQgGd~~~~~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~ 246 (1181)
++|+|++....+.++...++.++.+|.....|+.+|+|+|++.++++++|||||+++++|+||++|+|||+|++|||||+
T Consensus 80 ~i~~G~~~~~~~~~~~~~~~~~~~~~~~~~~h~~~G~lsm~~~~~~s~~SqFfItl~~~~~LDg~ytVFG~Vv~Gmdvl~ 159 (195)
T d1ihga2 80 MIQGGDFSNQNGTGGESIYGEKFEDENFHYKHDKEGLLSMANAGSNTNGSQFFITTVPTPHLDGKHVVFGQVIKGMGVAK 159 (195)
T ss_dssp EEEECCTTTSSSSCCCBTTBSCBCCCCCCBCCCSTTEEEECCSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECHHHHH
T ss_pred eeecCCccCCCCCCCccCCCCcccccccCcccCcceEEeeeecCCCCCCceeEeeccCCcccCCcceEEEEEecCHHHHH
Confidence 99999998888888888999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCCcccceEEeeeccccCCCCCCc
Q psy14556 247 KLESMGSQSGKTSKKIVVANSDSHSETDSQSS 278 (1181)
Q Consensus 247 kI~~~~t~~g~P~~~V~I~~cGvl~~~~~~p~ 278 (1181)
+|+++++++|+|.++|+|.+||+|.+.++.+-
T Consensus 160 ~I~~~~t~~~~P~~~i~I~~cG~l~~~~~~~~ 191 (195)
T d1ihga2 160 ILENVEVKGEKPAKLCVIAECGELKEGDDWGI 191 (195)
T ss_dssp HHHTSCEETTEESSCEEEEEEEEECTTCCCCC
T ss_pred HHHcCCCCCCCcCCCeEEEECcccCCCCcCCC
Confidence 99999999999999999999999999998774
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-38 Score=349.63 Aligned_cols=247 Identities=19% Similarity=0.287 Sum_probs=194.5
Q ss_pred eeecccCceEEEEEEEcCCC-------eEEEEEEecCCCCC-ChhHHHHHHHHHHhc-CCCCeeeEccccccCCcEEEEE
Q psy14556 811 IELGKGSYGVVYAARELDRQ-------VKLAIKEIPEKNLG-DVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYFKIFM 881 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg-------~~VAIKii~~~~~~-~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l~LVm 881 (1181)
++||+|+||.||+|++..++ ..||||+++..... ....+.+|...+.++ +||||+++++++.+++..++||
T Consensus 19 ~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~ 98 (299)
T d1fgka_ 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIV 98 (299)
T ss_dssp EECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEE
Confidence 47999999999999876554 47999999765432 356788899999888 8999999999999999999999
Q ss_pred eecCCCCcccchhcccC-------------CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeee
Q psy14556 882 EQVPGGSLSTLLRVKWG-------------PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKIS 948 (1181)
Q Consensus 882 Ey~~gGSL~dlL~~~~~-------------~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLi 948 (1181)
||+++|+|.+++..... ...+++..++.++.||+.||+|||+++||||||||+|||++. ++.+||+
T Consensus 99 e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~-~~~~kl~ 177 (299)
T d1fgka_ 99 EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE-DNVMKIA 177 (299)
T ss_dssp CCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT-TCCEEEC
T ss_pred EccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecC-CCCeEec
Confidence 99999999999975421 245789999999999999999999999999999999999998 8999999
Q ss_pred cCCcccccccCCCC--CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCC
Q psy14556 949 DFGTSKRLAGLCPS--AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAA 1025 (1181)
Q Consensus 949 DFGlAk~l~~~~~~--~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~P 1025 (1181)
|||+++........ .....||+.|+|||.+.++.++ ..+|+ ||||+++|||++ |.+|
T Consensus 178 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~--~k~Di------------------wS~Gvvl~ell~~g~~p 237 (299)
T d1fgka_ 178 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT--HQSDV------------------WSFGVLLWEIFTLGGSP 237 (299)
T ss_dssp STTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC--HHHHH------------------HHHHHHHHHHHTTSCCS
T ss_pred cchhhccccccccccccccCCCChhhhhhhHhcCCCCC--chhhh------------------HHhHHHHHHhccCCCCC
Confidence 99999877654322 2335689999999999876543 33444 999999999998 7899
Q ss_pred CCCCCcccccCCC--CCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhcc
Q psy14556 1026 LKKKTSRALVAPP--QISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTG 1079 (1181)
Q Consensus 1026 F~~~~~~~l~~~~--~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~ 1079 (1181)
|.+.+...+.... ......+...++.+..++.+|++.+|..|| ++.+.+..++
T Consensus 238 ~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rp-s~~eil~~L~ 292 (299)
T d1fgka_ 238 YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP-TFKQLVEDLD 292 (299)
T ss_dssp STTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSC-CHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCc-CHHHHHHHHH
Confidence 9888766542211 111223345678899999999999999999 5666655554
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-38 Score=345.97 Aligned_cols=242 Identities=23% Similarity=0.274 Sum_probs=182.8
Q ss_pred eecccCceEEEEEEEcCC---CeEEEEEEecCCCCC---ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecC
Q psy14556 812 ELGKGSYGVVYAARELDR---QVKLAIKEIPEKNLG---DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVP 885 (1181)
Q Consensus 812 kIG~G~fG~VYka~d~~t---g~~VAIKii~~~~~~---~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~ 885 (1181)
+||+|+||.||+|++... ...||||++.+.... ..+.+.+|+.+|++++||||+++++++.+ +..++||||++
T Consensus 15 ~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~ 93 (273)
T d1u46a_ 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAP 93 (273)
T ss_dssp ECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred EEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeec
Confidence 699999999999986533 347899998765332 25679999999999999999999999976 46789999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC---C
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP---S 962 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~---~ 962 (1181)
+|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++.+..... .
T Consensus 94 ~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~-~~~vkl~DfGl~~~~~~~~~~~~~ 170 (273)
T d1u46a_ 94 LGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT-RDLVKIGDFGLMRALPQNDDHYVM 170 (273)
T ss_dssp TCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE-TTEEEECCCTTCEECCC-CCEEEC
T ss_pred Ccchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccc-ccceeeccchhhhhcccCCCccee
Confidence 999998887542 35788999999999999999999999999999999999998 89999999999987654322 1
Q ss_pred CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh-CCCCCCCCCcccccCC---C
Q psy14556 963 AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV-LTAALKKKTSRALVAP---P 1038 (1181)
Q Consensus 963 ~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT-Gk~PF~~~~~~~l~~~---~ 1038 (1181)
.....|+..|+|||++.+..++ ..+|+ ||||+++|||+| |+.||.+.+..++... .
T Consensus 171 ~~~~~~~~~~~aPE~~~~~~~~--~~~Di------------------~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~ 230 (273)
T d1u46a_ 171 QEHRKVPFAWCAPESLKTRTFS--HASDT------------------WMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 230 (273)
T ss_dssp -----CCGGGCCHHHHHHCEEE--HHHHH------------------HHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS
T ss_pred cCccccCcccCCHHHHhCCCCC--cchhh------------------hhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhC
Confidence 2234578899999999865433 33333 999999999998 8999998887664221 1
Q ss_pred CCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1039 QISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1039 ~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
......+...+..+..++.+|+..+|.+||+ +++....+
T Consensus 231 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt-~~ei~~~L 269 (273)
T d1u46a_ 231 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPT-FVALRDFL 269 (273)
T ss_dssp CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-HHHHHHHH
T ss_pred CCCCCCcccccHHHHHHHHHHcCCChhHCcC-HHHHHHHH
Confidence 1122334567888999999999999999996 44444443
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-38 Score=346.97 Aligned_cols=251 Identities=22% Similarity=0.273 Sum_probs=183.9
Q ss_pred hcccCceeecccCceEEEEEEEcC-----CCeEEEEEEecCCCC-CChhHHHHHHHHHHhc-CCCCeeeEcccccc-CCc
Q psy14556 805 LFALNRIELGKGSYGVVYAARELD-----RQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQL-RHRNIVQYLGSVSE-EGY 876 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~-----tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d-~~~ 876 (1181)
+|.+. ++||+|+||.||+|++.. +++.||||+++.... ...+.+.+|..++.++ +||||+.+++++.+ .+.
T Consensus 14 ~y~~~-~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 14 RLKLG-KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GEEEE-EEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HEEEe-eEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 34443 479999999999999754 457899999975433 2355678888888777 68999999998755 457
Q ss_pred EEEEEeecCCCCcccchhcccC-------------CCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCC
Q psy14556 877 FKIFMEQVPGGSLSTLLRVKWG-------------PLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSG 943 (1181)
Q Consensus 877 l~LVmEy~~gGSL~dlL~~~~~-------------~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g 943 (1181)
+++|||||++|+|.++++.... ...+++..+..++.||+.||+|||++||+||||||+|||++. ++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~-~~ 171 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE-KN 171 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG-GG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC-CC
Confidence 8999999999999999975421 235788999999999999999999999999999999999988 89
Q ss_pred eeeeecCCcccccccCCC--CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHh
Q psy14556 944 VVKISDFGTSKRLAGLCP--SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLV 1021 (1181)
Q Consensus 944 ~vKLiDFGlAk~l~~~~~--~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLT 1021 (1181)
.+||+|||+|+....... ......||+.|+|||++.++.++ ..+|+ ||+||++|||+|
T Consensus 172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~--~~sDi------------------wS~Gvil~ellt 231 (299)
T d1ywna1 172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT--IQSDV------------------WSFGVLLWEIFS 231 (299)
T ss_dssp CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC--HHHHH------------------HHHHHHHHHHHT
T ss_pred cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCC--cccce------------------eehHHHHHHHHh
Confidence 999999999987654332 23345799999999999876543 33444 999999999999
Q ss_pred CC-CCCCCCCcccccC---CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1022 LT-AALKKKTSRALVA---PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1022 Gk-~PF~~~~~~~l~~---~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
|. +||.+........ ........+...++.+..++.+|++.+|.+||+ +.+.+..+
T Consensus 232 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt-~~eil~~L 291 (299)
T d1ywna1 232 LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT-FSELVEHL 291 (299)
T ss_dssp TSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-HHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcC-HHHHHHHH
Confidence 74 6887765433110 000111233456778899999999999999995 55544443
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-37 Score=341.87 Aligned_cols=245 Identities=23% Similarity=0.311 Sum_probs=186.6
Q ss_pred hhcccCceeecccCceEEEEEEEcCC-CeEEEEEEecCCC--CCChhHHHHHHHHHHhc---CCCCeeeEccccc-----
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDR-QVKLAIKEIPEKN--LGDVQPLHEEIKLHSQL---RHRNIVQYLGSVS----- 872 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~t-g~~VAIKii~~~~--~~~~e~f~rEi~IL~~L---~HPNIVkl~g~~~----- 872 (1181)
++|.+.+ +||+|+||+||+|++..+ ++.||||+++... ......+.+|+.+++.+ +||||+++++++.
T Consensus 7 ~~Y~i~~-~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 7 QQYECVA-EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GTEEEEE-EEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCEEEEE-EEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 3454444 699999999999999765 6789999986542 22345577888887766 7999999999884
Q ss_pred cCCcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCc
Q psy14556 873 EEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGT 952 (1181)
Q Consensus 873 d~~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGl 952 (1181)
....++++|||+.++.+...... ....+++..++.++.|++.||+|||++||+||||||+|||++. ++.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~-~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS-SGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcC-CCCeeecchhh
Confidence 34578999999988776544432 3446789999999999999999999999999999999999988 89999999999
Q ss_pred ccccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc
Q psy14556 953 SKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR 1032 (1181)
Q Consensus 953 Ak~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~ 1032 (1181)
++..... .......||+.|+|||++.+..+ +..+|+ ||+||++|||++|++||.+.+..
T Consensus 163 ~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y--~~~~Di------------------wSlG~il~ell~g~~pf~~~~~~ 221 (305)
T d1blxa_ 163 ARIYSFQ-MALTSVVVTLWYRAPEVLLQSSY--ATPVDL------------------WSVGCIFAEMFRRKPLFRGSSDV 221 (305)
T ss_dssp CCCCCGG-GGGCCCCCCCTTCCHHHHTTCCC--CTHHHH------------------HHHHHHHHHHHHSSCSCCCSSHH
T ss_pred hhhhccc-ccCCCcccChhhcCcchhcCCCC--Chhehh------------------hchHHHHHHHHHCCCCCCCCCHH
Confidence 8765432 23345679999999999986644 444554 99999999999999999987643
Q ss_pred cccC----------------C------------CCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1033 ALVA----------------P------------PQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1033 ~l~~----------------~------------~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
+... . ...........++.+..++.+|+..||..||+..+.
T Consensus 222 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~ 290 (305)
T d1blxa_ 222 DQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290 (305)
T ss_dssp HHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 2100 0 000111223345567779999999999999964433
|
| >d1h0pa_ b.62.1.1 (A:) Cyclophilin (eukaryotic) {Caenorhabditis elegans, isoform 5 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Cyclophilin (eukaryotic) species: Caenorhabditis elegans, isoform 5 [TaxId: 6239]
Probab=100.00 E-value=2.2e-37 Score=321.82 Aligned_cols=168 Identities=51% Similarity=0.825 Sum_probs=156.9
Q ss_pred ccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCC
Q psy14556 98 RQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHN 177 (1181)
Q Consensus 98 ~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~ 177 (1181)
.++|||++ +.++++|+|+||||.|.||+||+||++||++.++.+|+|+.||||+|+|++|||++..++
T Consensus 7 ~~vy~di~------------i~~~~~G~i~IeL~~d~aP~tv~nF~~l~~~g~~~~y~g~~f~rv~~~~~iq~G~~~~~~ 74 (182)
T d1h0pa_ 7 DRVYFDME------------IGGKPIGRIVIGLFGKTVPKTATNFIELAKKPKGEGYPGSKFHRVIADFMIQGGDFTRGD 74 (182)
T ss_dssp EEEEEEEE------------ETTEEEEEEEEEECTTTSHHHHHHHHHHHHSCTTTSSTTCBCCEEETTTEEEECCTTTSS
T ss_pred CeEEEEEE------------ECCEECeEEEEEECCCCChHHHHHHHHHHHhcccCCcCCceEEEEEecceEEcCCCCCCC
Confidence 47999996 668999999999999999999999999997755434999999999999999999999889
Q ss_pred CCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCC-CCC
Q psy14556 178 GTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGS-QSG 256 (1181)
Q Consensus 178 g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t-~~g 256 (1181)
+.++.+.++..+.++.....|+.+|+++|++.++++++|||||+++++|+|||+|+|||+|++|||||++|++..+ +++
T Consensus 75 ~~g~~~~~~~~~~~~~~~~~~~~~G~~~~a~~g~~s~~sqFfIt~~~~~~ldg~ytvFG~Vi~G~dvl~~I~~~~~~~~~ 154 (182)
T d1h0pa_ 75 GTGGRSIYGEKFADENFKLKHYGAGWLSMANAGADTNGSQFFITTVKTPWLDGRHVVFGKILEGMDVVRKIEQTEKLPGD 154 (182)
T ss_dssp SSCCCBTTBSCBCCCCCCSCCCSTTEEEECCSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHHHTSCEETTT
T ss_pred CCCCCCCCCCccCcccccccccCCceeeecccCCCCcCccccccccccccccccceeEEEEeehHHHHHHHHhcCCCCCC
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999998 677
Q ss_pred CcccceEEeeeccccCCCCCC
Q psy14556 257 KTSKKIVVANSDSHSETDSQS 277 (1181)
Q Consensus 257 ~P~~~V~I~~cGvl~~~~~~p 277 (1181)
+|.++|+|.+||++..++|++
T Consensus 155 ~P~~~v~I~~cG~l~~~~p~~ 175 (182)
T d1h0pa_ 155 RPKQDVIIAASGHIAVDTPFS 175 (182)
T ss_dssp EESSCEEEEEEEEEEEEEEEE
T ss_pred CCCCCEEEEECCeEeCCCCCc
Confidence 999999999999998777665
|
| >d2rmca_ b.62.1.1 (A:) Cyclophilin (eukaryotic) {Mouse (Mus musculus), variant C [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Cyclophilin (eukaryotic) species: Mouse (Mus musculus), variant C [TaxId: 10090]
Probab=100.00 E-value=4.4e-37 Score=319.68 Aligned_cols=167 Identities=51% Similarity=0.841 Sum_probs=156.0
Q ss_pred cccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCC
Q psy14556 97 MRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNH 176 (1181)
Q Consensus 97 ~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~ 176 (1181)
..+||||++ +.+|+.|+|+||||.|.||+||+||++||+++++.+|+|+.|||+++++++|+|++...
T Consensus 7 t~~vy~di~------------i~~~~~G~ivieL~~d~aP~tv~nF~~l~~~~k~~~Y~g~~f~rv~~~~~iq~G~~~~~ 74 (182)
T d2rmca_ 7 TDKVFFDVR------------IGDKDVGRIVIGLFGNVVPKTVENFVALATGEKGYGYKGSIFHRVIKDFMIQGGDFTAR 74 (182)
T ss_dssp EEEEEEEEE------------ETTEEEEEEEEEECTTTSHHHHHHHHHHHHTTTSCSSTTCBEEEEETTTEEEECCCSSS
T ss_pred CCeEEEEEE------------ECCEECcEEEEEEcCCCCcHHHHHHHHhhhcCCCccccCceeeeeecCceEEcCCCCCC
Confidence 357999996 56899999999999999999999999999887665599999999999999999999988
Q ss_pred CCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCC-CC
Q psy14556 177 NGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGS-QS 255 (1181)
Q Consensus 177 ~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t-~~ 255 (1181)
++.++.++++..+++++....|+.+|+|||++.++++++|||||++++.++||++|+|||+|++|||||++|++.++ .+
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~~G~lsma~~~~~s~~sqFfI~~~~~~~ld~~~~vFG~Vi~G~dvl~~I~~~~~~~~ 154 (182)
T d2rmca_ 75 DGTGGMSIYGETFPDENFKLKHYGIGWVSMANAGPDTNGSQFFITLTKPTWLDGKHVVFGKVLDGMTVVHSIELQATDGH 154 (182)
T ss_dssp SSSCCCBTTBSCBCCCCCCSCCCSTTEEEECCSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHHHTSCBCTT
T ss_pred CCCCCCCCcCCcccccccccccCCCccEehhhcCCCccCccccccccCCchhcccceEEEEEechHHHHHHHHhCCcCCC
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999999998 78
Q ss_pred CCcccceEEeeeccccCCCC
Q psy14556 256 GKTSKKIVVANSDSHSETDS 275 (1181)
Q Consensus 256 g~P~~~V~I~~cGvl~~~~~ 275 (1181)
|+|.++|+|.+||+|+.+.|
T Consensus 155 ~~P~~~v~I~~~g~l~~~~P 174 (182)
T d2rmca_ 155 DRPLTDCTIVNSGKIDVKTP 174 (182)
T ss_dssp SCBSSCEEEEEEEEEEEEEE
T ss_pred CcCCCCeEEEEeeEEeCCCC
Confidence 99999999999999975443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-37 Score=345.83 Aligned_cols=251 Identities=20% Similarity=0.277 Sum_probs=196.9
Q ss_pred hcccCceeecccCceEEEEEEEc-----CCCeEEEEEEecCCCC-CChhHHHHHHHHHHhc-CCCCeeeEccccccCCcE
Q psy14556 805 LFALNRIELGKGSYGVVYAAREL-----DRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQL-RHRNIVQYLGSVSEEGYF 877 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~-----~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L-~HPNIVkl~g~~~d~~~l 877 (1181)
++.+. ++||+|+||.||+|++. .+++.||||+++.... .....+.+|+.+++++ +||||+++++++.+.+..
T Consensus 24 ~~~l~-~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 24 RLSFG-KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GEEEE-EEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HeEEe-eEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 44443 47999999999999863 4668999999976543 2355789999999999 699999999999999999
Q ss_pred EEEEeecCCCCcccchhccc---------------CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCC
Q psy14556 878 KIFMEQVPGGSLSTLLRVKW---------------GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYS 942 (1181)
Q Consensus 878 ~LVmEy~~gGSL~dlL~~~~---------------~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~ 942 (1181)
++|||||++|+|.++++... ....+++..+..++.||+.||+|||++|++||||||+||+++. +
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~-~ 181 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH-G 181 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET-T
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccc-c
Confidence 99999999999999987542 2235788999999999999999999999999999999999988 8
Q ss_pred CeeeeecCCcccccccCCCC--CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHH
Q psy14556 943 GVVKISDFGTSKRLAGLCPS--AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLL 1020 (1181)
Q Consensus 943 g~vKLiDFGlAk~l~~~~~~--~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELL 1020 (1181)
+.+||+|||.++........ .....||+.|+|||++.++.++.++|| |||||++|||+
T Consensus 182 ~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DI--------------------wS~G~~l~ell 241 (311)
T d1t46a_ 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV--------------------WSYGIFLWELF 241 (311)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHH--------------------HHHHHHHHHHH
T ss_pred CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccc--------------------cchHHHHHHHH
Confidence 99999999999877643322 223568999999999987654444333 99999999999
Q ss_pred h-CCCCCCCCCcccccC---CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1021 V-LTAALKKKTSRALVA---PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1021 T-Gk~PF~~~~~~~l~~---~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
| |.+||.+.+..+... ........+...+..+..++.+|++.+|..||+ +.+.+..+
T Consensus 242 t~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs-~~~il~~L 302 (311)
T d1t46a_ 242 SLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPT-FKQIVQLI 302 (311)
T ss_dssp TTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC-HHHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcC-HHHHHHHH
Confidence 9 566676655533211 111222233456788999999999999999995 55544444
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.7e-37 Score=336.16 Aligned_cols=237 Identities=23% Similarity=0.293 Sum_probs=185.6
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC--CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL--GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~--~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
++||+|+||+||+|++. +++.||||++..... ...+.+.+|+.+|++++||||+++++++.+++..+++||++.++.
T Consensus 8 ~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~ 86 (286)
T d1ob3a_ 8 EKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDL 86 (286)
T ss_dssp EEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEH
T ss_pred cEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhh
Confidence 36999999999999985 778999999966532 336789999999999999999999999999999999999998777
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
+..+... ...+++..++.++.||+.||+|||++|||||||||+|||++. ++.+||+|||.+..............+
T Consensus 87 ~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~-~~~~kl~DfG~a~~~~~~~~~~~~~~~ 162 (286)
T d1ob3a_ 87 KKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR-EGELKIADFGLARAFGIPVRKYTHEIV 162 (286)
T ss_dssp HHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TSCEEECCTTHHHHHCC---------C
T ss_pred HHHHHhh---cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcC-CCCEEecccccceecccCccccceecc
Confidence 6666553 346889999999999999999999999999999999999988 899999999999877654444555679
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC------------
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA------------ 1036 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~------------ 1036 (1181)
++.|+|||.+.+.. .++..+|+ ||+||++|||++|+.||.+.+..+...
T Consensus 163 ~~~y~~pE~~~~~~-~~~~~~Di------------------wslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~ 223 (286)
T d1ob3a_ 163 TLWYRAPDVLMGSK-KYSTTIDI------------------WSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK 223 (286)
T ss_dssp CCTTCCHHHHTTCC-SCCTHHHH------------------HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cchhhhHHHHhCCC-CCCcceee------------------hhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChh
Confidence 99999999996543 34455555 999999999999999998765422100
Q ss_pred -------CCC-----------CCCCCCCCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1037 -------PPQ-----------ISRSVSVPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1037 -------~~~-----------ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
... .........++.+..++.+|+..||.+||+..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ 276 (286)
T d1ob3a_ 224 NWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK 276 (286)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred hccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHH
Confidence 000 00111223445667789999999999999643
|
| >d1qoia_ b.62.1.1 (A:) Cyclophilin (eukaryotic) {Human (Homo sapiens), U4/U6 snRNP-specific cyclophilin snucyp-20 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Cyclophilin (eukaryotic) species: Human (Homo sapiens), U4/U6 snRNP-specific cyclophilin snucyp-20 [TaxId: 9606]
Probab=100.00 E-value=6.3e-37 Score=315.65 Aligned_cols=162 Identities=50% Similarity=0.863 Sum_probs=150.5
Q ss_pred cccccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCc-------cccCCEEEEecCCce
Q psy14556 95 SQMRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGF-------GFKDSTFHRVIPNFM 167 (1181)
Q Consensus 95 s~~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~-------~Y~g~~FhRVip~f~ 167 (1181)
..+|.||||++ +.++++|+|+||||++.||+||+||++||+ .+| +|+++.|||++|+++
T Consensus 4 ~~np~v~~di~------------i~~~~~G~i~ieL~~~~aP~tv~nF~~L~~--~~~~~~~~~~~y~~~~f~rv~~~~~ 69 (173)
T d1qoia_ 4 PVNPVVFFDVS------------IGGQEVGRMKIELFADVVPKTAENFRQFCT--GEFRKDGVPIGYKGSTFHRVIKDFM 69 (173)
T ss_dssp CCCCEEEEEEE------------ETTEEEEEEEEEECTTTCHHHHHHHHHHHH--SCCEETTEECSSTTCBCCEEETTTE
T ss_pred CCCCEEEEEEE------------ECCEeCeEEEEEEcCCCCcHHHHHHHHhhc--ccccccCCCCCcCCcccceecccee
Confidence 36899999997 568999999999999999999999999995 444 599999999999999
Q ss_pred EeeCCCCCCCCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHH
Q psy14556 168 CQGGDFTNHNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKK 247 (1181)
Q Consensus 168 iQgGd~~~~~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~k 247 (1181)
+|+|++..+.+......++.++.++.....|+.+|+|+|+++++++++|||||++++.|+||++|+|||+|++|||||++
T Consensus 70 ~q~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G~l~ma~~~~~s~~sqFfI~~~~~~~ldg~~tvFG~Vi~G~dvl~~ 149 (173)
T d1qoia_ 70 IQGGDFVNGDGTGVASIYRGPFADENFKLRHSAPGLLSMANSGPSTNGCQFFITCSKCDWLDGKHVVFGKIIDGLLVMRK 149 (173)
T ss_dssp EEECCTTTSSSCCCCCTTSSCBCCCCCCSCCCSTTEEEECCSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECHHHHHH
T ss_pred eccCCcccCCcceeecccCCcccccccccccCCCcEEEeeecCCCCCCceeeeeccCCccCCcceeEEEEEechHHHHHH
Confidence 99999987777777777888888888888999999999999999999999999999999999999999999999999999
Q ss_pred HHhCCC-CCCCcccceEEeeeccc
Q psy14556 248 LESMGS-QSGKTSKKIVVANSDSH 270 (1181)
Q Consensus 248 I~~~~t-~~g~P~~~V~I~~cGvl 270 (1181)
|+++++ .+|+|.++|+|.+||+|
T Consensus 150 I~~~~t~~~~~P~~~i~I~~cGel 173 (173)
T d1qoia_ 150 IENVPTGPNNKPKLPVVISQCGEM 173 (173)
T ss_dssp HHTSCBCGGGCBSSCEEEEEEEEC
T ss_pred HHhCCcCCCCcCCCCEEEEcccCC
Confidence 999998 78999999999999986
|
| >d1xo7a_ b.62.1.1 (A:) Cyclophilin (eukaryotic) {Trypanosoma cruzi [TaxId: 5693]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Cyclophilin (eukaryotic) species: Trypanosoma cruzi [TaxId: 5693]
Probab=100.00 E-value=9.2e-37 Score=312.64 Aligned_cols=161 Identities=53% Similarity=0.889 Sum_probs=148.1
Q ss_pred cccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCC
Q psy14556 97 MRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNH 176 (1181)
Q Consensus 97 ~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~ 176 (1181)
.+++|||++ +.+++.|+|+||||.+.||+||+||++||+++.+.+|+|+.|||++|++++|+|++...
T Consensus 5 t~~V~~di~------------i~~~~~G~i~ieL~~~~aP~t~~nF~~l~~~~~~~~Y~g~~f~rv~~~~~iq~G~~~~~ 72 (166)
T d1xo7a_ 5 TDKVYFDIT------------IGDEPVGRVVIGLFGNDVPKTVENFKQLASGENGFGYKGSIFHRVIRNFMIQGGDFTNF 72 (166)
T ss_dssp CEEEEEEEE------------ETTEEEEEEEEEECTTTCHHHHHHHHHHHHTTTSCCSTTCBEEEEETTTEEEECCTTTS
T ss_pred CCeEEEEEE------------ECCEECcEEEEEECCCCChHHHHHHHHhhcccccccccCcEEEEEcCCCEEEeCCCCCC
Confidence 457999996 56899999999999999999999999999887777799999999999999999999988
Q ss_pred CCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCC-CC
Q psy14556 177 NGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGS-QS 255 (1181)
Q Consensus 177 ~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t-~~ 255 (1181)
++.++...++..++++.... |..+|+|+|+++++++++|||||+++++|+||++|+|||+|++|||||++|++.++ .+
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~-~~~~G~l~~a~~g~~s~~sqFfIt~~~~~~ld~~~~vfG~Vi~G~~vl~~I~~~~~~~~ 151 (166)
T d1xo7a_ 73 DGTGGKSIYGTRFDDENLKI-KHFVGAVSMANAGPNSNGSQFFVTTAPTPWLDGRHVVFGKVVEGMDVVKKVENTKTGLN 151 (166)
T ss_dssp SSSCCCBTTBSCBCCCCCCS-CCCTTEEEECCSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHHHTSCBCGG
T ss_pred CCCCCCCCCCcccccccccc-cccccceeecccCCCCCCCeeEEccCCccccCccceeeeEEeeHHHHHHHHHcCCCCCC
Confidence 88888888877777666554 55699999999999999999999999999999999999999999999999999988 77
Q ss_pred CCcccceEEeeeccc
Q psy14556 256 GKTSKKIVVANSDSH 270 (1181)
Q Consensus 256 g~P~~~V~I~~cGvl 270 (1181)
++|.++|+|.+||+|
T Consensus 152 ~~P~~~i~I~~cgvl 166 (166)
T d1xo7a_ 152 DKPKKAVKINDCGVL 166 (166)
T ss_dssp GCBSSCEEEEEEEEC
T ss_pred CCCCCCEEEEeeEeC
Confidence 899999999999986
|
| >d2ok3a1 b.62.1.1 (A:1-159) Cyclophilin-like protein PPIL3B {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Cyclophilin-like protein PPIL3B species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-36 Score=309.03 Aligned_cols=156 Identities=42% Similarity=0.681 Sum_probs=143.0
Q ss_pred cEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCCCCCcC
Q psy14556 115 MVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFEDENF 194 (1181)
Q Consensus 115 ~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~~dE~~ 194 (1181)
|+|.++|+.|+|+||||++.||+||+||++|| +.|+ |+|+.||||+++|+|||||+.. .+.++...++..+++|..
T Consensus 1 msV~~~T~~G~i~ieL~~~~aP~tv~nF~~L~--~~g~-Y~~~~f~rv~~~~~iq~Gd~~~-~~~~~~~~~~~~~~~e~~ 76 (159)
T d2ok3a1 1 MSVTLHTDVGDIKIEVFCERTPKTCENFLALC--ASNY-YNGCIFHRNIKGFMVQTGDPTG-TGRGGNSIWGKKFEDEYS 76 (159)
T ss_dssp CEEEEEETTEEEEEEECTTTCHHHHHHHHHHH--HTTT-TTTCBCCEEETTTEEEECCTTS-SSSCCCCTTSSCBCCCCC
T ss_pred CEEEEEeCCeEEEEEEcCCCChHHHHHHHHHH--hhhc-ccceeEecccCCeEEEeCCccc-cCCCCcccCCCccccccc
Confidence 68999999999999999999999999999999 6777 9999999999999999999875 455566677888887744
Q ss_pred -ccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCC--CCCCcccceEEeeecccc
Q psy14556 195 -TLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGS--QSGKTSKKIVVANSDSHS 271 (1181)
Q Consensus 195 -~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t--~~g~P~~~V~I~~cGvl~ 271 (1181)
.++|+++|+|||++.+++++|||||||+++.|+||++|+|||||++|||||++|+++++ ++++|..+|+|.+|+++.
T Consensus 77 ~~~~~~~~G~lsma~~~~~s~~sqFfIt~~~~p~ld~~~tvFG~V~~G~~vl~~I~~~~~~~~~~~P~~~i~I~~v~i~~ 156 (159)
T d2ok3a1 77 EYLKHNVRGVVSMANNGPNTNGSQFFITYGKQPHLDMKYTVFGKVIDGLETLDELEKLPVNEKTYRPLNDVHIKDITIHA 156 (159)
T ss_dssp TTCCSCSTTEEEECCSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHHHTCCBCTTTCCBSSCCBEEEEEEEC
T ss_pred cCCCCCCCeEEEEeeCCCCCcCcceEeeeccCcccccceEEEEecccchHHHHHHHcCcCCCCCCCcCCCcEEEEEEEEe
Confidence 68999999999999999999999999999999999999999999999999999999988 457899999999999998
Q ss_pred CCC
Q psy14556 272 ETD 274 (1181)
Q Consensus 272 ~~~ 274 (1181)
+|.
T Consensus 157 ~Pf 159 (159)
T d2ok3a1 157 NPF 159 (159)
T ss_dssp CSC
T ss_pred CCC
Confidence 763
|
| >d1a33a_ b.62.1.1 (A:) Cyclophilin (eukaryotic) {Nematode (Brugia malayi) [TaxId: 6279]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Cyclophilin (eukaryotic) species: Nematode (Brugia malayi) [TaxId: 6279]
Probab=100.00 E-value=1.7e-36 Score=312.77 Aligned_cols=161 Identities=48% Similarity=0.779 Sum_probs=151.1
Q ss_pred cccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCC---------CccccCCEEEEecCCce
Q psy14556 97 MRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEK---------GFGFKDSTFHRVIPNFM 167 (1181)
Q Consensus 97 ~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~---------G~~Y~g~~FhRVip~f~ 167 (1181)
.++||||++ +.+++.|+|+||||+|.||+||+||++||+++. ++ |+|+.||||+++++
T Consensus 3 ~~~v~~di~------------i~~~~~G~I~ieL~~d~aP~tv~nF~~l~~~~~~~~~~~~k~~~-Y~~~~f~Rv~~~~~ 69 (174)
T d1a33a_ 3 RRRVFLDVT------------IDGNLAGRIVMELYNDIAPRTCNNFLMLCTGMAGTGKISGKPLH-YKGSTFHRVIKNFM 69 (174)
T ss_dssp CEEEEEEEE------------ETTEEEEEEEEEECTTTCHHHHHHHHHHHHCTTCBCTTTCSBCC-CTTCBEEEEETTTE
T ss_pred CCEEEEEEE------------ECCEeceEEEEEECCCCChHHHHHHHHHHhcccCCCcccCccce-eCCceeeEEEeCCE
Confidence 568999997 457888999999999999999999999998743 45 99999999999999
Q ss_pred EeeCCCCCCCCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHH
Q psy14556 168 CQGGDFTNHNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKK 247 (1181)
Q Consensus 168 iQgGd~~~~~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~k 247 (1181)
+|+|+...+++.++.+.++....++....+|+.+|+++|++.++++++|||||+++++|+||++|+|||+|++|||||++
T Consensus 70 iq~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~l~~~~~~~~s~~sqFfI~~~~~p~ld~~~~vFG~VveG~dvl~~ 149 (174)
T d1a33a_ 70 IQGGDFTKGDGTGGESIYGGMFDDEEFVMKHDEPFVVSMANKGPNTNGSQFFITTTPAPHLNNIHVVFGKVVSGQEVVTK 149 (174)
T ss_dssp EEECCTTTSSSSCCCCTTSSCBCCCCSCSCCCSTTEEEECCSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECHHHHHH
T ss_pred EeeCCCCCCCCCCCCCccCccccccccccccCcceeeeeeccCCCCCCcccccccCCcccccccceeEEEEechHHHHHH
Confidence 99999998888888888888888888999999999999999999999999999999999999999999999999999999
Q ss_pred HHhCCC-CCCCcccceEEeeeccc
Q psy14556 248 LESMGS-QSGKTSKKIVVANSDSH 270 (1181)
Q Consensus 248 I~~~~t-~~g~P~~~V~I~~cGvl 270 (1181)
|+++++ .+++|.++|+|.+||+|
T Consensus 150 I~~~~t~~~~~P~~~i~I~~cGel 173 (174)
T d1a33a_ 150 IEYLKTNSKNRPLADVVILNCGEL 173 (174)
T ss_dssp HHTSCBCTTSCBSSCEEEEEEEEC
T ss_pred HHhCCcCCCCCCCCCEEEEeeEEE
Confidence 999998 78999999999999987
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-36 Score=343.98 Aligned_cols=239 Identities=23% Similarity=0.326 Sum_probs=186.3
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCeeeEcccccc------CCcEEEEEeec
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSE------EGYFKIFMEQV 884 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d------~~~l~LVmEy~ 884 (1181)
.+||+|+||+||+|++..+++.||||++...... ..+|+.+|++++||||++++++|.. ..++|+|||||
T Consensus 26 k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~ 101 (350)
T d1q5ka_ 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 101 (350)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECC
T ss_pred eEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEecc
Confidence 3699999999999999999999999999765432 3479999999999999999998843 34689999999
Q ss_pred CCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCc
Q psy14556 885 PGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAE 964 (1181)
Q Consensus 885 ~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~ 964 (1181)
+++.+..+.........+++..++.++.||+.||+|||++||+||||||+|||++.++..+||+|||+++...... ...
T Consensus 102 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~-~~~ 180 (350)
T d1q5ka_ 102 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNV 180 (350)
T ss_dssp SEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS-CCC
T ss_pred CCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCc-ccc
Confidence 7665544443333455788999999999999999999999999999999999998744589999999998765432 334
Q ss_pred cccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc---------
Q psy14556 965 TFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV--------- 1035 (1181)
Q Consensus 965 t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~--------- 1035 (1181)
+..||+.|+|||.+.+. ..++..+|+ ||+||++|||++|+.||.+.+..+..
T Consensus 181 ~~~gt~~y~aPE~~~~~-~~~~~~~DI------------------wSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~ 241 (350)
T d1q5ka_ 181 SYICSRYYRAPELIFGA-TDYTSSIDV------------------WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241 (350)
T ss_dssp SCCSCTTSCCHHHHTTC-SSCCTHHHH------------------HHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccChHHhhcc-cCCCcceee------------------cccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 46799999999998643 345556665 99999999999999999877643210
Q ss_pred -------------CCCCCC--------CCCCCCCCcchHHhhccCCCCCCCCCchhHHH
Q psy14556 1036 -------------APPQIS--------RSVSVPGPGGINSSSSAPVTPTPHSRHISVNT 1073 (1181)
Q Consensus 1036 -------------~~~~ip--------~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~ 1073 (1181)
....++ .......++.+..++.+|+..||.+||+..+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~ 300 (350)
T d1q5ka_ 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300 (350)
T ss_dssp CCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred ChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 000111 11223355667789999999999999964443
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-37 Score=341.19 Aligned_cols=244 Identities=19% Similarity=0.264 Sum_probs=187.9
Q ss_pred eeecccCceEEEEEEEcCCC---eEEEEEEecCC-CCCChhHHHHHHHHHHhcCCCCeeeEcccccc-CCcEEEEEeecC
Q psy14556 811 IELGKGSYGVVYAARELDRQ---VKLAIKEIPEK-NLGDVQPLHEEIKLHSQLRHRNIVQYLGSVSE-EGYFKIFMEQVP 885 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg---~~VAIKii~~~-~~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d-~~~l~LVmEy~~ 885 (1181)
++||+|+||+||+|++..++ ..||||.++.. .....+++.+|+++|++++||||+++++++.+ ++..++|||||+
T Consensus 33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~ 112 (311)
T d1r0pa_ 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK 112 (311)
T ss_dssp EEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCT
T ss_pred eEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEee
Confidence 47999999999999986543 46999999653 33345779999999999999999999999765 568999999999
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC---
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS--- 962 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~--- 962 (1181)
+|+|.+++... ....++..+..++.|++.||.|||+++|+||||||+|||++. ++.+||+|||+++........
T Consensus 113 ~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~-~~~~kL~DFG~~~~~~~~~~~~~~ 189 (311)
T d1r0pa_ 113 HGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE-KFTVKVADFGLARDMYDKEFDSVH 189 (311)
T ss_dssp TCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT-TCCEEECSSGGGCCTTTTTCCCTT
T ss_pred cCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECC-CCCEEEecccchhhccccccccce
Confidence 99999998754 345667888899999999999999999999999999999997 899999999999876543221
Q ss_pred -CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc-cccCC--C
Q psy14556 963 -AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR-ALVAP--P 1038 (1181)
Q Consensus 963 -~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~-~l~~~--~ 1038 (1181)
.....||+.|+|||.+.++.++.++|| ||||+++|||+||+.||...... ++... .
T Consensus 190 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI--------------------~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~ 249 (311)
T d1r0pa_ 190 NKTGAKLPVKWMALESLQTQKFTTKSDV--------------------WSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249 (311)
T ss_dssp CTTCSSCCGGGSCHHHHHHCCCCHHHHH--------------------HHHHHHHHHHHTTSCCSCC------CHHHHHT
T ss_pred ecccccccccccChHHHhcCCCCChhHh--------------------hhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc
Confidence 223468999999999987654444433 99999999999988877654432 21110 0
Q ss_pred CCCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhc
Q psy14556 1039 QISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCT 1078 (1181)
Q Consensus 1039 ~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al 1078 (1181)
......+..+++.+..++.+|+..||.+||+. .+.+..+
T Consensus 250 g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~-~ei~~~L 288 (311)
T d1r0pa_ 250 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSF-SELVSRI 288 (311)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH-HHHHHHH
T ss_pred CCCCCCcccCcHHHHHHHHHHcCCCHhHCcCH-HHHHHHH
Confidence 01112234567789999999999999999964 4433333
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-36 Score=342.23 Aligned_cols=242 Identities=24% Similarity=0.328 Sum_probs=185.4
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEccccccCC------
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEG------ 875 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~------ 875 (1181)
..|.+. ++||+|+||+||+|.+..+++.||||++++.... ..+.+.+|+.+|++++||||++++++|...+
T Consensus 18 ~~Y~~i-~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 18 AVYRDL-QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp SSEEEE-EEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CcEEEE-EEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 344443 3799999999999999999999999999765332 2567889999999999999999999987654
Q ss_pred cEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccc
Q psy14556 876 YFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 955 (1181)
Q Consensus 876 ~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~ 955 (1181)
.+|+||||+ +.+|..+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+.
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~-~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE-DCELKILDFGLARQ 170 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT-TCCEEECCCTTCEE
T ss_pred eEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccc-ccccccccccceec
Confidence 579999999 67777777543 5889999999999999999999999999999999999998 89999999999987
Q ss_pred cccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc
Q psy14556 956 LAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV 1035 (1181)
Q Consensus 956 l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~ 1035 (1181)
... ......||+.|+|||++.+.. .++..+|+ ||+||++|+|++|+.||.+.+.....
T Consensus 171 ~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~~Di------------------wSlGvil~ell~g~~pf~~~~~~~~~ 228 (346)
T d1cm8a_ 171 ADS---EMTGYVVTRWYRAPEVILNWM-RYTQTVDI------------------WSVGCIMAEMITGKTLFKGSDHLDQL 228 (346)
T ss_dssp CCS---SCCSSCSCGGGCCTHHHHTTT-CCCTTHHH------------------HHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred cCC---ccccccccccccCHHHHcCCC-CCCccchh------------------hcchHHHHHHHHCcCCCCCCChHHHH
Confidence 653 334567999999999997542 34445555 99999999999999999887643210
Q ss_pred C----------------------------CCCC----CCCCCCCCCcchHHhhccCCCCCCCCCchhHHHH
Q psy14556 1036 A----------------------------PPQI----SRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTN 1074 (1181)
Q Consensus 1036 ~----------------------------~~~i----p~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~ 1074 (1181)
. .+.. ........++.+..++.+|+..||.+||+..+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL 299 (346)
T d1cm8a_ 229 KEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 299 (346)
T ss_dssp HHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 0 0000 0111223455667799999999999999744443
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-37 Score=341.41 Aligned_cols=253 Identities=21% Similarity=0.243 Sum_probs=199.1
Q ss_pred hcccCceeecccCceEEEEEEEcC-----CCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCCcEE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELD-----RQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFK 878 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~-----tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~ 878 (1181)
++.+. ++||+|+||+||+|.+.. ++..||||+++.... ...+.+.+|+.++++++||||+++++++..++..+
T Consensus 21 ~~~l~-~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 21 KITMS-RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GEEEE-EEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HeEEe-eEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 34443 469999999999998753 357899999975432 23456899999999999999999999999999999
Q ss_pred EEEeecCCCCcccchhccc-------CCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCC
Q psy14556 879 IFMEQVPGGSLSTLLRVKW-------GPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFG 951 (1181)
Q Consensus 879 LVmEy~~gGSL~dlL~~~~-------~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFG 951 (1181)
+||||+++|+|.+++.... ....+++..+..++.|++.||.|||+++|+||||||+|||++. ++++||+|||
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~-~~~~Kl~DFG 178 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE-DFTVKIGDFG 178 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECT-TCCEEECCTT
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecC-CceEEEeecc
Confidence 9999999999999986431 2235678889999999999999999999999999999999998 8999999999
Q ss_pred cccccccCCCC--CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhC-CCCCCC
Q psy14556 952 TSKRLAGLCPS--AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVL-TAALKK 1028 (1181)
Q Consensus 952 lAk~l~~~~~~--~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTG-k~PF~~ 1028 (1181)
+++........ .....||+.|+|||.+.++.++. ..|+ ||+|+++|||+|| .+||.+
T Consensus 179 la~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~--~~Dv------------------~S~G~il~El~t~~~~p~~~ 238 (308)
T d1p4oa_ 179 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT--YSDV------------------WSFGVVLWEIATLAEQPYQG 238 (308)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCH--HHHH------------------HHHHHHHHHHHHTSCCTTTT
T ss_pred cceeccCCcceeeccceecccccCCHHHHccCCCCc--cccc------------------ccHHHHHHHHHhCCCCCCCC
Confidence 99876543322 22345899999999998765433 3333 9999999999998 588888
Q ss_pred CCcccccCCCC--CCCCCCCCCCcchHHhhccCCCCCCCCCchhHHHHHHhccc
Q psy14556 1029 KTSRALVAPPQ--ISRSVSVPGPGGINSSSSAPVTPTPHSRHISVNTNLVCTGN 1080 (1181)
Q Consensus 1029 ~~~~~l~~~~~--ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~~al~~ 1080 (1181)
.+..++..... .....+...+..+..++.+|++.+|.+||+ +.+.+..+..
T Consensus 239 ~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs-~~~il~~L~~ 291 (308)
T d1p4oa_ 239 LSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPS-FLEIISSIKE 291 (308)
T ss_dssp SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC-HHHHHHHHGG
T ss_pred CCHHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcC-HHHHHHHHHH
Confidence 77655322111 111123456788999999999999999995 5555555655
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-37 Score=344.54 Aligned_cols=248 Identities=24% Similarity=0.339 Sum_probs=198.6
Q ss_pred hcccCceeecccCceEEEEEEEc---CCCeEEEEEEecCCC----CCChhHHHHHHHHHHhcCC-CCeeeEccccccCCc
Q psy14556 805 LFALNRIELGKGSYGVVYAAREL---DRQVKLAIKEIPEKN----LGDVQPLHEEIKLHSQLRH-RNIVQYLGSVSEEGY 876 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~---~tg~~VAIKii~~~~----~~~~e~f~rEi~IL~~L~H-PNIVkl~g~~~d~~~ 876 (1181)
+|.+.+ +||+|+||+||+|++. .+++.||||++++.. ....+.+.+|+.++++++| |||+++++++.+...
T Consensus 25 ~y~~~~-~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 25 NFELLK-VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GEEEEE-EEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred ceEEEE-EEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 344444 7999999999999874 468999999986542 2345678899999999976 899999999999999
Q ss_pred EEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccccc
Q psy14556 877 FKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956 (1181)
Q Consensus 877 l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l 956 (1181)
++++|||+.+|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~-~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDS-NGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecC-CCCEEEeeccchhhh
Confidence 99999999999999999755 24568889999999999999999999999999999999998 899999999999876
Q ss_pred ccCC-CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccccc
Q psy14556 957 AGLC-PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALV 1035 (1181)
Q Consensus 957 ~~~~-~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~ 1035 (1181)
.... ....+..|++.|+|||.+.+....+...+|+ ||+||+||+|++|+.||.+.+.....
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDI------------------WSlG~iLyelltG~~PF~~~~~~~~~ 241 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDW------------------WSLGVLMYELLTGASPFTVDGEKNSQ 241 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHH------------------HHHHHHHHHHHHSSCTTSCTTSCCCH
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhh------------------HHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 4322 2234567999999999998766555555665 99999999999999999887654431
Q ss_pred CC-----CCCCCCCCCCCCcchHHhhccCCCCCCCCCch----hHHHHH
Q psy14556 1036 AP-----PQISRSVSVPGPGGINSSSSAPVTPTPHSRHI----SVNTNL 1075 (1181)
Q Consensus 1036 ~~-----~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~----s~~~~~ 1075 (1181)
.. .......+...+..+..++.+|+..+|.+|++ ++++.+
T Consensus 242 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil 290 (322)
T d1vzoa_ 242 AEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 290 (322)
T ss_dssp HHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHH
T ss_pred HHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHH
Confidence 11 01112223456778888999999999999996 456654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.3e-35 Score=332.07 Aligned_cols=196 Identities=21% Similarity=0.344 Sum_probs=166.1
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcC-CCCeeeEcccccc--CCcEEEEE
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR-HRNIVQYLGSVSE--EGYFKIFM 881 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~-HPNIVkl~g~~~d--~~~l~LVm 881 (1181)
+|.+. ++||+|+||+||+|++..+++.||||+++.. ..+++.+|+.+|+.++ ||||+++++++.. ...+++||
T Consensus 36 ~y~i~-~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 36 DYQLV-RKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GEEEE-EEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CeEEE-EEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 44444 3799999999999999999999999999643 3577899999999995 9999999999864 46799999
Q ss_pred eecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC
Q psy14556 882 EQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP 961 (1181)
Q Consensus 882 Ey~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~ 961 (1181)
|||.+++|..+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+++.+||+|||+|+..... .
T Consensus 112 e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~-~ 184 (328)
T d3bqca1 112 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-Q 184 (328)
T ss_dssp ECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-C
T ss_pred eecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC-C
Confidence 9999999987754 47899999999999999999999999999999999999875668999999999876543 2
Q ss_pred CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCC
Q psy14556 962 SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKT 1030 (1181)
Q Consensus 962 ~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~ 1030 (1181)
......+|+.|+|||.+.+.. .++..+|+ ||+||++|+|++|+.||....
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~-~~~~~~Di------------------wslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQ-MYDYSLDM------------------WSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCC-CCCTHHHH------------------HHHHHHHHHHHHTCSSSSCCS
T ss_pred cccccccCccccCcccccCCC-CCCcccch------------------hhhhhhhHHhccCCCCCCCCc
Confidence 344567999999999987543 34455555 999999999999999997654
|
| >d2c3ba1 b.62.1.1 (A:1-171) Cyclophilin (eukaryotic) {Aspergillus fumigatus [TaxId: 5085]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Cyclophilin (eukaryotic) species: Aspergillus fumigatus [TaxId: 5085]
Probab=100.00 E-value=1.3e-36 Score=313.15 Aligned_cols=167 Identities=54% Similarity=0.911 Sum_probs=123.0
Q ss_pred cccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCC
Q psy14556 97 MRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNH 176 (1181)
Q Consensus 97 ~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~ 176 (1181)
|+++|||+.... ..+.+|+.|+|+||||.+.||+||+||++||+++.+.+|+++.||||+|+|++|+||+..+
T Consensus 1 ~~~v~~di~~~~-------~~~~~T~~G~i~IeL~~~~aP~tv~nF~~l~~~~~~~~y~~~~f~ri~~~~~iq~G~~~~~ 73 (171)
T d2c3ba1 1 MSQVFFDVEYAP-------VGTAETKVGRIVFNLFDKDVPKTAKNFRELCKRPAGEGYRESTFHRIIPNFMIQGGDFTRG 73 (171)
T ss_dssp CCCEEEEEEECC-------TTCSCCEEEEEEEEECTTTSHHHHHHHHHHHHSCTTTSSTTCBCCEEETTTEEEECC----
T ss_pred CCeEEEeeeccc-------cccccceeeEEEEEEcCCCChHHHHHHHHHhhhcccccccCceeeEEEEEEeeEcCCccCC
Confidence 578999996332 2256899999999999999999999999999766555699999999999999999999988
Q ss_pred CCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEc--CHHHHHHHHhCCCC
Q psy14556 177 NGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVE--GLDVVKKLESMGSQ 254 (1181)
Q Consensus 177 ~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVie--G~dVL~kI~~~~t~ 254 (1181)
++.++...++..+.++...+.|+++|+||||+++++++||||||++++.|+||++|+|||+|++ |||||++|+++++.
T Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~~~G~lsma~~~~~s~~sqFfI~~~~~~~ldg~~tvFG~Vie~~G~dvl~~I~~~~t~ 153 (171)
T d2c3ba1 74 NGTGGRSIYGDKFADENFSRKHDKKGILSMANAGPNTNGSQFFITTAVTSWLDGKHVVFGEVADEKSYSVVKEIEALGSS 153 (171)
T ss_dssp ------------------CHHHHHTCEEEEC---------CEEEECSCCTTCCSCCEEEEEECSHHHHHHHHHHHTTCCT
T ss_pred CCCCCCcCCCCccccccccccCCCCceEEeeecCCCCCCcceeeccCCccccCCCceEEEEEEeccCHHHHHHHHcCCCC
Confidence 8888888888888889999999999999999999999999999999999999999999999994 99999999999985
Q ss_pred CC--CcccceEEeeeccc
Q psy14556 255 SG--KTSKKIVVANSDSH 270 (1181)
Q Consensus 255 ~g--~P~~~V~I~~cGvl 270 (1181)
++ +|..+|+|.+||+|
T Consensus 154 ~g~~~p~~~v~I~~cGel 171 (171)
T d2c3ba1 154 SGSVRSNTRPKIVNCGEL 171 (171)
T ss_dssp TSCCCSSSCCEEEEEEEC
T ss_pred CCCcCCCCCEEEEeCccC
Confidence 54 68899999999986
|
| >d1z81a1 b.62.1.1 (A:25-210) Cyclophilin (eukaryotic) {Plasmodium yoelii [TaxId: 5861]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Cyclophilin (eukaryotic) species: Plasmodium yoelii [TaxId: 5861]
Probab=100.00 E-value=5.5e-36 Score=312.37 Aligned_cols=165 Identities=48% Similarity=0.804 Sum_probs=152.6
Q ss_pred CcccccchhhhhhcccccCCCcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCC-----ccccCCEEEEecCCceE
Q psy14556 94 SSQMRQRFYDLVLEMTRDQEGMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKG-----FGFKDSTFHRVIPNFMC 168 (1181)
Q Consensus 94 ss~~~~~~~D~~~~~~~~~~~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G-----~~Y~g~~FhRVip~f~i 168 (1181)
...+|+||||++ +.++++|+|+||||.|.||+||+||++||+++.+ ++|+|+.|||+++++++
T Consensus 13 ~~~np~V~~di~------------i~~~~~G~I~ieL~~d~aP~tv~nF~~L~~~~~~~~~~~~~Y~g~~f~rv~~~~~i 80 (186)
T d1z81a1 13 NPSNPVVFMDIN------------LGNNFLGKFKFELFQNIVPKTSENFRQFCTGEYKVNNLPVGYKNTIFHRVIKEFMI 80 (186)
T ss_dssp STTCCEEEEEEE------------ETTEEEEEEEEEECTTTCHHHHHHHHHHHHTCCBSSSSBCSSTTEECCEEETTTEE
T ss_pred CCCCCEEEEEEE------------ECCEeceEEEEEEcCCCChHHHHHHHHHHhcccccCCcccccCCCeeeeeecceee
Confidence 346899999997 5588999999999999999999999999976542 24999999999999999
Q ss_pred eeCCCCCCCCCCCcccCCCCCCCCcCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcC--HHHHH
Q psy14556 169 QGGDFTNHNGTGGKSIYGNKFEDENFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEG--LDVVK 246 (1181)
Q Consensus 169 QgGd~~~~~g~gg~si~g~~~~dE~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG--~dVL~ 246 (1181)
|||++....+.++...++..+.++....+|+.+|+++|++.++++++|||||++++.|+||++|+|||+|++| ||||+
T Consensus 81 ~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G~~~~~~~g~~~~~sqFfIt~~~~p~Ldg~~tVFG~Vv~G~~mdvv~ 160 (186)
T d1z81a1 81 QGGDFINHNGSGSLSIYGEKFDDENFDIKHDKEGLLSMANSGPNTNGCQFFITTKKCEWLDGKNVVFGRIIDNDSLLLLK 160 (186)
T ss_dssp EECCTTTSSSCCCCBTTBSCCCCCCCCSCCCSTTEEEECCSSSSCCCSCEEEESSCCGGGBTTBCEEEEECSHHHHHHHH
T ss_pred ecCCccccCCcccccccCCcccccccccccCCCccchhhhcCCCccccceeeecccccccCCCccEEEEEEeCccHHHHH
Confidence 9999988888888888999999999999999999999999999999999999999999999999999999999 99999
Q ss_pred HHHhCCC--CCCCcccceEEeeeccc
Q psy14556 247 KLESMGS--QSGKTSKKIVVANSDSH 270 (1181)
Q Consensus 247 kI~~~~t--~~g~P~~~V~I~~cGvl 270 (1181)
+|+..++ .+++|.++|+|.+||+|
T Consensus 161 kI~~~~~~~~~~~P~~~i~I~~CGel 186 (186)
T d1z81a1 161 KIENVSVTPYIYKPKIPINVVECGEL 186 (186)
T ss_dssp HHHHSCBCTTTCCBSSCEEEEEEEEC
T ss_pred HHhccCCCCCCCccCCCEEEEeCCcC
Confidence 9999988 46899999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-35 Score=324.90 Aligned_cols=238 Identities=19% Similarity=0.245 Sum_probs=190.4
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEccccccCCcEEEEEeecCCCC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSEEGYFKIFMEQVPGGS 888 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~~l~LVmEy~~gGS 888 (1181)
++||+|+||+||+|++..+++.||||+++..... ..+.+.+|+.+|+.++||||+++++++.+....++++|++.+++
T Consensus 8 ~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~ 87 (292)
T d1unla_ 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDL 87 (292)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEH
T ss_pred eEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccc
Confidence 3799999999999999999999999999655433 35788999999999999999999999999999999999999999
Q ss_pred cccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCCCccccC
Q psy14556 889 LSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPSAETFTG 968 (1181)
Q Consensus 889 L~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~~~t~~G 968 (1181)
|..++.. ...+++..++.++.|++.||+|||++||+||||||+|||++. ++.+||+|||.++.............+
T Consensus 88 l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~ 163 (292)
T d1unla_ 88 KKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR-NGELKLANFGLARAFGIPVRCYSAEVV 163 (292)
T ss_dssp HHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT-TCCEEECCCTTCEECCSCCSCCCSCCS
T ss_pred ccccccc---ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccccc-CCceeeeecchhhcccCCCccceeecc
Confidence 8887763 346678999999999999999999999999999999999988 789999999999887655444455568
Q ss_pred CccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCC-Cccccc-------C----
Q psy14556 969 TLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKK-TSRALV-------A---- 1036 (1181)
Q Consensus 969 T~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~-~~~~l~-------~---- 1036 (1181)
++.|+|||++.+.. .++..+|+ ||+||++|||++|+.||... +..+.. .
T Consensus 164 ~~~~~~pe~~~~~~-~~~~~~Di------------------wSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (292)
T d1unla_ 164 TLWYRPPDVLFGAK-LYSTSIDM------------------WSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224 (292)
T ss_dssp CGGGCCHHHHTTCS-CCCTHHHH------------------HHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred ccchhhhhHhccCC-CCCchhhc------------------cccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCCh
Confidence 89999999987543 24445555 99999999999999986433 222100 0
Q ss_pred -------------------CCCCCCCCCCCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1037 -------------------PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1037 -------------------~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
...............+..++.+|+..||.+||+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~ 278 (292)
T d1unla_ 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAE 278 (292)
T ss_dssp TTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred hhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHH
Confidence 00001111223344566789999999999999643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-36 Score=333.01 Aligned_cols=238 Identities=21% Similarity=0.235 Sum_probs=176.7
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHH--HHHHHHhcCCCCeeeEccccccCC----cEEEEEeec
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHE--EIKLHSQLRHRNIVQYLGSVSEEG----YFKIFMEQV 884 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~r--Ei~IL~~L~HPNIVkl~g~~~d~~----~l~LVmEy~ 884 (1181)
++||+|+||.||+|++ +++.||||+++.. ..+.+.+ |+..+.+++||||+++++++.+.+ .+|+|||||
T Consensus 9 ~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~ 83 (303)
T d1vjya_ 9 ESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEECCSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecc
Confidence 4699999999999986 6889999998543 2334444 444556789999999999987653 689999999
Q ss_pred CCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccc--------cceecccCCCCCcccccCCCeeeeecCCccccc
Q psy14556 885 PGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHG--------QKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956 (1181)
Q Consensus 885 ~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs--------~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l 956 (1181)
++|+|.++++.. .+++..++.++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+++..
T Consensus 84 ~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~-~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 84 EHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK-NGTCCIADLGLAVRH 158 (303)
T ss_dssp TTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECT-TSCEEECCCTTCEEE
T ss_pred cCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcC-CCCeEEEecCccccc
Confidence 999999999854 57889999999999999999996 59999999999999988 899999999999876
Q ss_pred ccCCC----CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc
Q psy14556 957 AGLCP----SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR 1032 (1181)
Q Consensus 957 ~~~~~----~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~ 1032 (1181)
..... ......||+.|+|||++.+...... ..++...|.|||||+||||+||..||......
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--------------~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~ 224 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH--------------FESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTC--------------HHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCC
T ss_pred cCCCcceeccccceecccCcCChhhccccccccC--------------CCcCcchhhhhhHHHHHHHhhCCCCCCccccc
Confidence 54322 2234679999999999864321111 12333445599999999999999888654432
Q ss_pred cccCCCC--------------CCCCCCCC---------CCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1033 ALVAPPQ--------------ISRSVSVP---------GPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1033 ~l~~~~~--------------ip~~l~~~---------~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
....... ......++ .+..+..++.+|+..+|.+||+..+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e 287 (303)
T d1vjya_ 225 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287 (303)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHH
T ss_pred ccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHH
Confidence 2111000 00111111 1234778999999999999996443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-36 Score=338.84 Aligned_cols=240 Identities=25% Similarity=0.372 Sum_probs=184.2
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCC-CChhHHHHHHHHHHhcCCCCeeeEccccccCC----cEEEEEeecC
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNL-GDVQPLHEEIKLHSQLRHRNIVQYLGSVSEEG----YFKIFMEQVP 885 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~-~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~~----~l~LVmEy~~ 885 (1181)
.+||+|+||+||+|.+..+++.||||++.+... ...+.+.+|+.+|++++||||+++++++.... ..+++++++.
T Consensus 14 ~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~ 93 (345)
T d1pmea_ 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM 93 (345)
T ss_dssp EECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECC
T ss_pred EEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeec
Confidence 479999999999999999999999999975432 23567899999999999999999999986543 2344455667
Q ss_pred CCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCC---C
Q psy14556 886 GGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCP---S 962 (1181)
Q Consensus 886 gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~---~ 962 (1181)
+|+|.+++... .+++..++.++.||+.||+|||++|||||||||+|||++. ++.+||+|||+++....... .
T Consensus 94 ~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~-~~~~kl~DfG~a~~~~~~~~~~~~ 168 (345)
T d1pmea_ 94 GADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGF 168 (345)
T ss_dssp CEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT-TCCEEECCCTTCEECCGGGCBCCT
T ss_pred CCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECC-CCCEEEcccCceeeccCCCcccee
Confidence 99999999754 5789999999999999999999999999999999999997 89999999999976644322 2
Q ss_pred CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC------
Q psy14556 963 AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA------ 1036 (1181)
Q Consensus 963 ~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~------ 1036 (1181)
.....||+.|+|||++..+ ..++..+|+ ||+||++|+|++|+.||.+.+..+...
T Consensus 169 ~~~~~gt~~y~aPE~l~~~-~~~~~~~Di------------------wSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~ 229 (345)
T d1pmea_ 169 LTEYVATRWYRAPEIMLNS-KGYTKSIDI------------------WSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL 229 (345)
T ss_dssp TCCCCSCGGGCCGGGTTTB-CSCSTHHHH------------------HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred eccccccceechHHHhhcC-CCCCchhhh------------------hccCceehHHhhCCCCCCCCCHHHHHHHHhhhc
Confidence 3445699999999998543 234555555 999999999999999998766422100
Q ss_pred -CC------------------CCCC-------CCCCCCCcchHHhhccCCCCCCCCCchhHHHHH
Q psy14556 1037 -PP------------------QISR-------SVSVPGPGGINSSSSAPVTPTPHSRHISVNTNL 1075 (1181)
Q Consensus 1037 -~~------------------~ip~-------~l~~~~p~~L~~li~r~la~dPs~Rp~s~~~~~ 1075 (1181)
.+ ..+. .........+..++.+|+..||.+||+ +++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-a~e~L 293 (345)
T d1pmea_ 230 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE-VEQAL 293 (345)
T ss_dssp CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCC-HHHHH
T ss_pred cCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcC-HHHHh
Confidence 00 0000 112234455777999999999999995 55444
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-35 Score=328.73 Aligned_cols=204 Identities=26% Similarity=0.396 Sum_probs=163.7
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCC--CCChhHHHHHHHHHHhcCCCCeeeEcccccc--------C
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKN--LGDVQPLHEEIKLHSQLRHRNIVQYLGSVSE--------E 874 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~--~~~~e~f~rEi~IL~~L~HPNIVkl~g~~~d--------~ 874 (1181)
+|.+.+ +||+|+||+||+|++..+++.||||++.... ....+.+.+|+.+|++++||||+++++++.. .
T Consensus 11 rY~i~~-~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 11 KYEKLA-KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GEEEEE-EEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CEEEEE-EEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 344433 7999999999999999999999999986543 3346778999999999999999999998744 4
Q ss_pred CcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccc
Q psy14556 875 GYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954 (1181)
Q Consensus 875 ~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk 954 (1181)
+.+|+||||+.++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~-~~~~kl~dfg~~~ 165 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR-DGVLKLADFGLAR 165 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT-TSCEEECCCTTCE
T ss_pred ceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecC-CCcEEeeecceee
Confidence 56899999997776654443 3346778899999999999999999999999999999999998 8999999999997
Q ss_pred ccccCC----CCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCC
Q psy14556 955 RLAGLC----PSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKT 1030 (1181)
Q Consensus 955 ~l~~~~----~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~ 1030 (1181)
.+.... .......||+.|+|||++.+. ..++..+|+ ||+||++|||++|+.||.+.+
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~Di------------------wSlGvil~el~~g~~pf~~~~ 226 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDL------------------WGAGCIMAEMWTRSPIMQGNT 226 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHH------------------HHHHHHHHHHHHSSCSCCCSS
T ss_pred ecccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHc------------------ccCCceeeeHhhCCCCCCCCC
Confidence 665322 122335699999999999654 234455555 999999999999999998766
Q ss_pred cc
Q psy14556 1031 SR 1032 (1181)
Q Consensus 1031 ~~ 1032 (1181)
..
T Consensus 227 ~~ 228 (318)
T d3blha1 227 EQ 228 (318)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >d1zkca1 b.62.1.1 (A:280-457) Peptidyl-prolyl cis-trans isomerase-like 2, Cyclophilin-60, PPI domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Peptidyl-prolyl cis-trans isomerase-like 2, Cyclophilin-60, PPI domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-35 Score=305.00 Aligned_cols=158 Identities=43% Similarity=0.744 Sum_probs=146.4
Q ss_pred EEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCCCCCcC-
Q psy14556 116 VTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFEDENF- 194 (1181)
Q Consensus 116 ~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~~dE~~- 194 (1181)
.|.+.|+.|+|+||||++.||+||+||++|| +.|+ |+|+.||||+|++++||||+.. ++.++.+.++.++.+|..
T Consensus 2 ~v~l~T~~G~i~IeL~~~~aP~tv~nF~~L~--~~~~-Y~g~~f~rv~~~~~iq~Gd~~~-~~~~~~~~~~~~~~~E~~~ 77 (178)
T d1zkca1 2 YVRLHTNKGDLNLELHCDLTPKTCENFIRLC--KKHY-YDGTIFHRSIRNFVIQGGDPTG-TGTGGESYWGKPFKDEFRP 77 (178)
T ss_dssp EEEEEETTEEEEEEECTTTSHHHHHHHHHHH--HTTT-TTTEEEEEEETTTEEEECCTTS-SSSCCCBTTBSCBCCCCCT
T ss_pred EEEEEeCCEEEEEEEcCCCChHHHHHHHHHH--hcCC-cCceEeeeccceeEEecCCccC-CCCCCcccCCCCcCCcccc
Confidence 4678999999999999999999999999999 7778 9999999999999999999864 788888889999998854
Q ss_pred ccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCC--CCCCcccceEEeeeccccC
Q psy14556 195 TLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGS--QSGKTSKKIVVANSDSHSE 272 (1181)
Q Consensus 195 ~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t--~~g~P~~~V~I~~cGvl~~ 272 (1181)
.++|+.+|+|||++++++++||||||+++++|+||++|+|||+|++|||||++|++.++ .+++|.++|+|.+|.++.+
T Consensus 78 ~l~~~~~G~lsma~~~~~s~~sqF~It~~~~~~ld~~~~vFG~Vv~G~dvl~~I~~~~t~~~~~~P~~~v~I~~~~Il~~ 157 (178)
T d1zkca1 78 NLSHTGRGILSMANSGPNSNRSQFFITFRSCAYLDKKHTIFGRVVGGFDVLTAMENVESDPKTDRPKEEIRIDATTVFVD 157 (178)
T ss_dssp TCCSCSTTEEEECCSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHHHHSCBCTTTCCBSSCCEEEEEEEEEC
T ss_pred ccCCCCCeEEEEeecCCCCccceeeccccCCcccCCcceEEEEeeCcHHHHHHHHcCCCCCCCCccCCCeEEEEEEEEcC
Confidence 68999999999999999999999999999999999999999999999999999999987 5789999999999999988
Q ss_pred CCCCC
Q psy14556 273 TDSQS 277 (1181)
Q Consensus 273 ~~~~p 277 (1181)
+.+.+
T Consensus 158 pf~~~ 162 (178)
T d1zkca1 158 PYEEA 162 (178)
T ss_dssp TTHHH
T ss_pred Ccchh
Confidence 76544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-35 Score=325.77 Aligned_cols=242 Identities=19% Similarity=0.201 Sum_probs=184.9
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCCe-eeEccccccCCcEEEEEe
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRNI-VQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPNI-Vkl~g~~~d~~~l~LVmE 882 (1181)
+.|.+.+ +||+|+||+||+|++..+++.||||++..... .+.+.+|+++++.++|+|+ +.+.+++.+.+..++|||
T Consensus 7 ~rY~l~~-~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGR-KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTEEEEE-EEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CEEEEeE-EEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 3455544 79999999999999999999999999876543 3458899999999987665 555566677888999999
Q ss_pred ecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccccc--CCCeeeeecCCcccccccCC
Q psy14556 883 QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNT--YSGVVKISDFGTSKRLAGLC 960 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~--~~g~vKLiDFGlAk~l~~~~ 960 (1181)
|+ +++|...+... ...+++..+..++.|++.||+|||++||+||||||+|||++. .+..+||+|||+|+.+....
T Consensus 84 ~~-~~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 84 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred Ec-CCchhhhhhhc--cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 99 66676666543 346789999999999999999999999999999999998753 24589999999998775432
Q ss_pred C-------CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCccc
Q psy14556 961 P-------SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRA 1033 (1181)
Q Consensus 961 ~-------~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~ 1033 (1181)
. ......||+.|+|||++.+..++. ..|+ ||+||++|||+||+.||.......
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~Di------------------wSlG~~l~el~tg~~P~~~~~~~~ 220 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSR--RDDL------------------ESLGYVLMYFNLGSLPWQGLKAAT 220 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCH--HHHH------------------HHHHHHHHHHHHSSCTTCCCC---
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCC--hhhE------------------EecCHHHHHHHhCCCcccccchHH
Confidence 2 223457999999999998654433 3333 999999999999999998866544
Q ss_pred ccCCC---------CCCCCCCCCCCcchHHhhccCCCCCCCCCchhH
Q psy14556 1034 LVAPP---------QISRSVSVPGPGGINSSSSAPVTPTPHSRHISV 1071 (1181)
Q Consensus 1034 l~~~~---------~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~s~ 1071 (1181)
..... ...+......|..+..++.+|++.+|..||...
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~ 267 (299)
T d1ckia_ 221 KRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYS 267 (299)
T ss_dssp ----HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHH
T ss_pred HHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHH
Confidence 22111 011122345778889999999999999999643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2e-35 Score=326.81 Aligned_cols=239 Identities=20% Similarity=0.217 Sum_probs=189.6
Q ss_pred hcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCC-CCeeeEccccccCCcEEEEEee
Q psy14556 805 LFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRH-RNIVQYLGSVSEEGYFKIFMEQ 883 (1181)
Q Consensus 805 ~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~H-PNIVkl~g~~~d~~~l~LVmEy 883 (1181)
.|.+. ++||+|+||+||+|++..+++.||||+++... ..+.+.+|+++++.++| +||+.+++++.+....++||||
T Consensus 6 ~Y~i~-~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 6 HYKVG-RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TEEEE-EEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred ceEEE-EEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 34443 47999999999999999999999999986543 23457899999999975 8999999999999999999999
Q ss_pred cCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCccccc----CCCeeeeecCCcccccccC
Q psy14556 884 VPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNT----YSGVVKISDFGTSKRLAGL 959 (1181)
Q Consensus 884 ~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~----~~g~vKLiDFGlAk~l~~~ 959 (1181)
+ +++|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++. .++.+||+|||+|+.....
T Consensus 83 ~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 83 L-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp C-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred c-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 9 78999988754 335788999999999999999999999999999999999964 2568999999999876532
Q ss_pred CC-------CCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcc
Q psy14556 960 CP-------SAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSR 1032 (1181)
Q Consensus 960 ~~-------~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~ 1032 (1181)
.. ......||+.|||||++.+..++. ..|+ ||+|+++|||+||+.||.+....
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~--~~Di------------------wSlG~~l~elltg~~Pf~~~~~~ 219 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSR--RDDL------------------EALGHVFMYFLRGSLPWQGLKAA 219 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCH--HHHH------------------HHHHHHHHHHHHSSCTTSSCCSC
T ss_pred ccccceeecccCceEEchhhcCHHHhcCCCCCh--HHHH------------------HHhhHHHHHHHhCCCcCCCccch
Confidence 21 233457999999999998654333 3333 99999999999999999876553
Q ss_pred cccC---------CCCCCCCCCCCCCcchHHhhccCCCCCCCCCch
Q psy14556 1033 ALVA---------PPQISRSVSVPGPGGINSSSSAPVTPTPHSRHI 1069 (1181)
Q Consensus 1033 ~l~~---------~~~ip~~l~~~~p~~L~~li~r~la~dPs~Rp~ 1069 (1181)
.... ....++......|+.+..++..|+..+|..||.
T Consensus 220 ~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~ 265 (293)
T d1csna_ 220 TNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPD 265 (293)
T ss_dssp CHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCC
T ss_pred hHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcC
Confidence 2110 001112233456778888888898999999984
|
| >d2fu0a1 b.62.1.1 (A:5-159) Putative cyclophilin PFE0505w {Plasmodium falciparum [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Putative cyclophilin PFE0505w species: Plasmodium falciparum [TaxId: 5833]
Probab=100.00 E-value=1e-34 Score=294.16 Aligned_cols=150 Identities=44% Similarity=0.723 Sum_probs=140.2
Q ss_pred EEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCCCCCcC-
Q psy14556 116 VTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFEDENF- 194 (1181)
Q Consensus 116 ~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~~dE~~- 194 (1181)
.|+++|++|+|+||||.+.||+||+||++|| +.|+ |+|+.||||+++|++|+||+. +.+.++.+.++..++++..
T Consensus 3 ~~~i~T~~G~i~ieL~~~~aP~tv~nF~~l~--~~g~-Y~g~~f~rv~~~~~iq~Gd~~-~~~~~~~~~~~~~~~~~~~~ 78 (155)
T d2fu0a1 3 SAIIYTTMGDIHISLFYKECKKTVQNFSVHS--INGY-YNNCIFHRVIKHFMVQTGDPS-GDGTGGESIWGNEFEDEFFD 78 (155)
T ss_dssp EEEEEETTEEEEEEECTTTCHHHHHHHHHHH--HTTT-TTTCBCCEEETTTEEEECCTT-SSSSCCCCTTSSCBCCCCBT
T ss_pred eEEEEEcccEEEEEEcCCCChHHHHHHhhHh--hCCc-cccceeeeeeecceeeccCCC-CCCcCCcccCCCcccccccc
Confidence 5789999999999999999999999999999 6788 999999999999999999987 4667788889999988866
Q ss_pred ccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCC-CCCCcccceEEeeecc
Q psy14556 195 TLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGS-QSGKTSKKIVVANSDS 269 (1181)
Q Consensus 195 ~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t-~~g~P~~~V~I~~cGv 269 (1181)
.+.|.++|+++|++.++++++|||||++++.|+||++|+|||+|++|||||++|+++++ .+++|..+|+|.+|.+
T Consensus 79 ~~~~~~~~~~~~~~~~~~s~~sqFfI~~~~~~~ld~~~tvFG~Vi~G~~vv~~I~~~~t~~~~~P~~~i~I~~v~i 154 (155)
T d2fu0a1 79 HLNHSKPFMVSMANCGPNTNGSQFFITTVPCPWLDFKHTVFGKVTQGSKIVLDIEKVRTDKRDKPLEDIKILNIKI 154 (155)
T ss_dssp TBCSSSSSEEEECCSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHHHTSCBCTTSCBSSCCBEEEEEE
T ss_pred ccccCCccEEEecccCCCCCCccceecccCccccccceEEEEEEeccHHHHHHHHhCCCCCCCCcCCCcEEEEEEE
Confidence 58899999999999999999999999999999999999999999999999999999998 7899999999999854
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-35 Score=330.46 Aligned_cols=241 Identities=22% Similarity=0.322 Sum_probs=185.0
Q ss_pred hhcccCceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEccccccC-----Cc
Q psy14556 804 YLFALNRIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSEE-----GY 876 (1181)
Q Consensus 804 ~~~~l~~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d~-----~~ 876 (1181)
++|.+. ++||+|+||+||+|++..+++.||||++++.... ..+.+.+|+.+|++++||||+++++++... ..
T Consensus 18 ~rY~i~-~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 18 ERYQNL-SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp TTEEEE-EECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCeEEE-EEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 344443 3799999999999999999999999999765433 345788999999999999999999988532 34
Q ss_pred EEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCccccc
Q psy14556 877 FKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 956 (1181)
Q Consensus 877 l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l 956 (1181)
.+++|+|+.||+|.+++..+ .+++..++.++.||+.||+|||++||+||||||+|||++. ++.+|++|||.+...
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~-~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE-DCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT-TCCEEECCC----CC
T ss_pred eEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccc-cccccccccchhccc
Confidence 46667778899999998643 5889999999999999999999999999999999999998 899999999999765
Q ss_pred ccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCcccccC
Q psy14556 957 AGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTSRALVA 1036 (1181)
Q Consensus 957 ~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~~~l~~ 1036 (1181)
.. ...+..|++.|+|||++.+.. .++..+|+ ||+||++|+|++|+.||.+.+......
T Consensus 172 ~~---~~~~~~g~~~y~apE~~~~~~-~~~~~~Di------------------wSlGv~l~~ll~g~~pF~~~~~~~~~~ 229 (348)
T d2gfsa1 172 DD---EMTGYVATRWYRAPEIMLNWM-HYNQTVDI------------------WSVGCIMAELLTGRTLFPGTDHIDQLK 229 (348)
T ss_dssp TG---GGSSSCHHHHTSCHHHHTTCS-CCCTTHHH------------------HHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred Cc---ccccccccccccCchhhcCCc-cCCcccch------------------hhhhHHHHHHHhCCCCCCCCCHHHHHH
Confidence 43 234456899999999986543 33445555 999999999999999998876432100
Q ss_pred ----------------------------CCCCCC----CCCCCCCcchHHhhccCCCCCCCCCchhHH
Q psy14556 1037 ----------------------------PPQISR----SVSVPGPGGINSSSSAPVTPTPHSRHISVN 1072 (1181)
Q Consensus 1037 ----------------------------~~~ip~----~l~~~~p~~L~~li~r~la~dPs~Rp~s~~ 1072 (1181)
....+. ......+..+..++.+|+..||.+|++..+
T Consensus 230 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e 297 (348)
T d2gfsa1 230 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 297 (348)
T ss_dssp HHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHH
Confidence 000000 001234556677999999999999996433
|
| >d1xwna1 b.62.1.1 (A:1-166) Peptidyl-prolyl cis-trans isomerase-like 1, PPIL1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Peptidyl-prolyl cis-trans isomerase-like 1, PPIL1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-34 Score=294.63 Aligned_cols=150 Identities=41% Similarity=0.756 Sum_probs=140.1
Q ss_pred CcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCCCCCc
Q psy14556 114 GMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFEDEN 193 (1181)
Q Consensus 114 ~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~~dE~ 193 (1181)
.+.|.++|++|+|+||||.|.||+||+||++|| +.|| |+|+.|||++++|++||||+. +++.++...++..+++|.
T Consensus 11 ~p~v~~~T~~G~i~ieL~~~~aP~tv~nF~~L~--~~g~-Y~g~~f~rv~~~~~iq~Gd~~-~~~~~~~~~~~~~~~~e~ 86 (166)
T d1xwna1 11 PPNVYLETSMGIIVLELYWKHAPKTCKNFAELA--RRGY-YNGTKFHRIIKDFMIQGGDPT-GTGRGGASIYGKQFEDEL 86 (166)
T ss_dssp CCEEEEEESSCEEEEEECTTTCHHHHHHHHHHH--HHTS-STTCCEEEEETTTEEEECCST-TTTSSCCCSSCSCCCCCC
T ss_pred CCEEEEEECceeEEEEEcCCCChHHHHHHHHHH--hcCC-cCceeeeEEcccEEEEeCCCC-CCCCCCccCCCCcccccc
Confidence 457889999999999999999999999999999 7788 999999999999999999987 577788888899898885
Q ss_pred -CccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCC-CCCCcccceEEeee
Q psy14556 194 -FTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGS-QSGKTSKKIVVANS 267 (1181)
Q Consensus 194 -~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t-~~g~P~~~V~I~~c 267 (1181)
..+.|+++|+|+|+++++++++|||||++++.|+||++|+|||+|++|||||++|+++++ .+++|..+|+|.+.
T Consensus 87 ~~~~~~~~~G~lsm~~~~~~s~~sqFfI~~~~~~~ld~~~tvFG~Vi~G~dvl~~I~~~~t~~~~~P~~~I~I~~a 162 (166)
T d1xwna1 87 HPDLKFTGAGILAMANAGPDTNGSQFFVTLAPTQWLDGKHTIFGRVCQGIGMVNRVGMVETNSQDRPVDDVKIIKA 162 (166)
T ss_dssp CTTCCSCSSSEEEEEEEETTEEEEEEEEECSCCSTTTTTSEEEEECSSCHHHHHHHHHSCBCSSSCBSSCCCEEEE
T ss_pred CCCCCCCCCeEEEecccCCCCCCcceEEeecChhhccccceEEEEEechHHHHHHHHhCCCCCCCCCCCCeEEEEe
Confidence 468899999999999999999999999999999999999999999999999999999998 78999999999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-35 Score=330.41 Aligned_cols=193 Identities=24% Similarity=0.315 Sum_probs=152.2
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCCCCC--ChhHHHHHHHHHHhcCCCCeeeEcccccc------CCcEEEEEe
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG--DVQPLHEEIKLHSQLRHRNIVQYLGSVSE------EGYFKIFME 882 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~--~~e~f~rEi~IL~~L~HPNIVkl~g~~~d------~~~l~LVmE 882 (1181)
.+||+|+||+||+|++..+++.||||++...... ..+++.+|+.++++++||||++++++|.. ...+|+|||
T Consensus 23 ~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~E 102 (355)
T d2b1pa1 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 102 (355)
T ss_dssp EECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEE
T ss_pred EEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEe
Confidence 3799999999999999999999999999765433 34568899999999999999999999853 468999999
Q ss_pred ecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCCcccccccCCCC
Q psy14556 883 QVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGLCPS 962 (1181)
Q Consensus 883 y~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk~l~~~~~~ 962 (1181)
||.++.+..+ . ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+|++|||+++..... ..
T Consensus 103 y~~~~l~~~~-~-----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~-~~~~kl~df~~~~~~~~~-~~ 174 (355)
T d2b1pa1 103 LMDANLCQVI-Q-----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-DCTLKILDFGLARTAGTS-FM 174 (355)
T ss_dssp CCSEEHHHHH-T-----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT-TCCEEECCCCC----------
T ss_pred ccchHHHHhh-h-----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccccc-ccceeeechhhhhccccc-cc
Confidence 9976655433 3 24689999999999999999999999999999999999998 889999999998766543 33
Q ss_pred CccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCCc
Q psy14556 963 AETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKTS 1031 (1181)
Q Consensus 963 ~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~~ 1031 (1181)
.....+|+.|+|||++.+..+ +..+|+ ||+||++|+|++|+.||.+.+.
T Consensus 175 ~~~~~~t~~y~aPE~l~~~~~--~~~~Di------------------wSlG~~l~ell~g~~pF~~~~~ 223 (355)
T d2b1pa1 175 MTPYVVTRYYRAPEVILGMGY--KENVDI------------------WSVGCIMGEMVRHKILFPGRDY 223 (355)
T ss_dssp ------CCTTCCHHHHTTCCC--CTTHHH------------------HHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccccccccccChhhhcCCCC--CCCccc------------------ccccchHHHHhhCCCCCCCCCH
Confidence 345579999999999986544 334444 9999999999999999987764
|
| >d2b71a1 b.62.1.1 (A:23-191) Cyclophilin-like protein PY00693 {Plasmodium yoelii [TaxId: 5861]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Cyclophilin-like protein PY00693 species: Plasmodium yoelii [TaxId: 5861]
Probab=100.00 E-value=6.6e-34 Score=292.30 Aligned_cols=149 Identities=45% Similarity=0.734 Sum_probs=138.0
Q ss_pred EEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCCCCCcC-
Q psy14556 116 VTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFEDENF- 194 (1181)
Q Consensus 116 ~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~~dE~~- 194 (1181)
.|.+.|++|+|+||||++.||+||+||++|| +.|| |+|+.|||++++|++|||++.. .+.++.++++..+++|..
T Consensus 18 ~V~l~T~~G~i~IeL~~d~aP~tv~nF~~L~--~~g~-Y~~~~f~rv~~~~~iq~g~~~~-~~~~~~~~~~~~~~~e~~~ 93 (169)
T d2b71a1 18 YITIYTNLGDFEVELYWYHSPKTCLNFYTLC--EMGF-YDNTIFHRVIPNFVIQGGDPTG-TGKGGKSIYGEYFEDEINK 93 (169)
T ss_dssp EEEEEETTEEEEEEECTTTSHHHHHHHHHHH--HTTT-TTTEEEEEEETTTEEEEEETTS-SSSCCCBTTBSCBCCCCCT
T ss_pred EEEEEeCceeEEEEEeCCCCcHHHHHHHHHh--hCCc-cceeeeccccceeeEecccccc-ccCCCcccccccccccccc
Confidence 5789999999999999999999999999999 8889 9999999999999999999874 555667777777887754
Q ss_pred ccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCC-CCCCcccceEEeeec
Q psy14556 195 TLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGS-QSGKTSKKIVVANSD 268 (1181)
Q Consensus 195 ~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t-~~g~P~~~V~I~~cG 268 (1181)
.++|.++|+|+|+++++++++|||||++++.|+||++|+|||+|++|||||++|+++++ .+++|..+|+|.+++
T Consensus 94 ~l~h~~~g~ls~~~~~p~s~~sqFfIt~~~~~~ld~~~tvFG~Vv~G~dvl~~I~~~~~~~~~~P~~~i~I~~~~ 168 (169)
T d2b71a1 94 ELKHTGAGILSMSNNGPNTNSSQFFITLAPLPHLDGKHTIFARVSKNMTCIENIASVQTTATNKPIFDLKILRTS 168 (169)
T ss_dssp TCCCCSTTEEEECCSSTTCBSSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHHHTSCBCTTCCBSSCCEEEEEE
T ss_pred ccCCCCcEEEEhhhCCCCCCCCEEEEecCCcchhhhhcceeeEEeccHHHHHHHHhCCCCCCCCCCCCeEEEEcc
Confidence 68999999999999999999999999999999999999999999999999999999988 689999999999986
|
| >d1v9ta_ b.62.1.1 (A:) Peptidyl-prolyl cis-trans isomerase A, PpiA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Peptidyl-prolyl cis-trans isomerase A, PpiA species: Escherichia coli [TaxId: 562]
Probab=100.00 E-value=3.1e-33 Score=286.27 Aligned_cols=152 Identities=30% Similarity=0.494 Sum_probs=134.4
Q ss_pred CcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCCCCCc
Q psy14556 114 GMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFEDEN 193 (1181)
Q Consensus 114 ~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~~dE~ 193 (1181)
...|+++|+.|+|+||||+++||+||+||++|| +.|| |+|+.||||+++|++|+|++..+.+.+ .++.++++|.
T Consensus 4 ~~~V~l~T~~G~i~ieL~~~~aP~tv~nF~~L~--~~~~-Y~g~~fhRv~~~~~iq~G~~~~~~~~~---~~~~~~~~e~ 77 (166)
T d1v9ta_ 4 DPHVLLTTSAGNIELELDKQKAPVSVQNFVDYV--NSGF-YNNTTFHRVIPGFMIQGGGFTEQMQQK---KPNPPIKNEA 77 (166)
T ss_dssp SCEEEEEETTEEEEEEECTTTCHHHHHHHHHHH--HTTT-TTTCBEEEEETTTEEEESSBCTTCCBC---CCCCCBCCCG
T ss_pred CCEEEEEECCeeEEEEEeCCCChHHHHHHHHHh--hCCc-cccceeeEEEEEeecccCCcCCccccc---CCCCCccccc
Confidence 356899999999999999999999999999999 7788 999999999999999999987655444 3477888887
Q ss_pred CccccCCCceEEeec-CCCCCCcceEEEEcCCCCCCCCC-----CeEEEEEEcCHHHHHHHHhCCCC-----CCCcccce
Q psy14556 194 FTLKHTGPGILSMAN-AGPNTNGSQFFITTVKTAWLDNR-----HVVFGSVVEGLDVVKKLESMGSQ-----SGKTSKKI 262 (1181)
Q Consensus 194 ~~l~h~~~G~Lsma~-~g~nt~gSQFfItl~~~p~LDg~-----~vVFGrVieG~dVL~kI~~~~t~-----~g~P~~~V 262 (1181)
....|+.+|.|+|++ .++++++|||||++++.|+||+. |+|||+|++|||||++|+++++. +++|.++|
T Consensus 78 ~~~~~~~rg~v~~~~~~~~~s~~sqFfI~~~~~~~ld~~~~~~~~tvfG~VveG~dvl~~I~~~~~~~~~~~~~~P~~~v 157 (166)
T d1v9ta_ 78 DNGLRNTRGTIAMARTADKDSATSQFFINVADNAFLDHGQRDFGYAVFGKVVKGMDVADKISQVPTHDVGPYQNVPSKPV 157 (166)
T ss_dssp GGSCCCCTTEEEECCCSSTTCBCSCEEEESSCCGGGSCCSSCCCCCEEEEEEECHHHHHHHHTSCEEEETTEEEEESSCC
T ss_pred cccccccCCEEEEEeeecCCCcccccccccCCccccccccccCCEEEeeEEeccHHHHHHHHhCcccCCCCCCCccCCCe
Confidence 766666799999998 56899999999999999999864 89999999999999999998873 34899999
Q ss_pred EEeeecccc
Q psy14556 263 VVANSDSHS 271 (1181)
Q Consensus 263 ~I~~cGvl~ 271 (1181)
+|.+|++|+
T Consensus 158 ~I~~~~vlp 166 (166)
T d1v9ta_ 158 VILSATVLP 166 (166)
T ss_dssp BEEEEEECC
T ss_pred EEEEEEEcC
Confidence 999999985
|
| >d2a2na1 b.62.1.1 (A:483-646) Peptidylprolyl isomerase domain and WD repeat-containing protein 1, PPWD1, C-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Peptidylprolyl isomerase domain and WD repeat-containing protein 1, PPWD1, C-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=9.3e-33 Score=281.85 Aligned_cols=152 Identities=41% Similarity=0.651 Sum_probs=134.7
Q ss_pred CcEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCCCC-C
Q psy14556 114 GMVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFED-E 192 (1181)
Q Consensus 114 ~~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~~d-E 192 (1181)
...++++|+.|+|+||||.+.||+||+||++|| +.|+ |+|+.|||++++|++|+|++......+.... +..+.+ +
T Consensus 9 ~~~a~~~T~~G~i~ieL~~~~aP~tv~nF~~l~--~~g~-Y~g~~f~rv~~~~~iq~G~~~~~~~~~~~~~-~~~~~~~~ 84 (164)
T d2a2na1 9 SDSAIIHTSMGDIHTKLFPVECPKTVENFCVHS--RNGY-YNGHTFHRIIKGFMIQTGDPTGTGMGGESIW-GGEFEDEF 84 (164)
T ss_dssp CSEEEEEETTEEEEEEECTTTCHHHHHHHHHHH--HTTT-TTTCBCCEEETTTEEEECCTTSSSSCCCCTT-SSCBCCCC
T ss_pred cCEEEEEeceeEEEEEEcCCCChHHHHHHHHHH--hCCC-cccceeeEEeeeeeEeecccccccCCCceee-eccccccc
Confidence 346899999999999999999999999999999 7888 9999999999999999999876444333333 334444 4
Q ss_pred cCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEEcCHHHHHHHHhCCC--CCCCcccceEEeeecc
Q psy14556 193 NFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVVEGLDVVKKLESMGS--QSGKTSKKIVVANSDS 269 (1181)
Q Consensus 193 ~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVieG~dVL~kI~~~~t--~~g~P~~~V~I~~cGv 269 (1181)
...++|+++|+++|++.+++++||||||++++.|+||++|+|||+|++|||||++|+++++ .+|+|.++|+|.++.+
T Consensus 85 ~~~~~~~~~~~l~~~~~~~~s~~sqFfI~~~~~~~ld~~~tVFG~V~~G~dvv~~I~~~~~~~~~~~P~~~V~I~~v~i 163 (164)
T d2a2na1 85 HSTLRHDRPYTLSMANAGSNTNGSQFFITVVPTPWLDNKHTVFGRVTKGMEVVQRISNVKVNPKTDKPYEDVSIINITV 163 (164)
T ss_dssp CTTCCSCSSSEEEECCSSTTCBCSCEEEESSCCGGGTTTSCEEEEEEECHHHHHHHHTSCBCTTTCCBSSCCBEEEEEE
T ss_pred ccccccCccceeehhhcCCCCCcccceecccCccccccceeEEEEecChHHHHHHHHcCCcCCCCCCcCCCcEEEEEEE
Confidence 5688999999999999999999999999999999999999999999999999999999988 4689999999999864
|
| >d1w74a_ b.62.1.1 (A:) Peptidyl-prolyl cis-trans isomerase A, PpiA {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Peptidyl-prolyl cis-trans isomerase A, PpiA species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.97 E-value=3.9e-32 Score=279.15 Aligned_cols=151 Identities=41% Similarity=0.658 Sum_probs=132.0
Q ss_pred cEEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCc------------cccCCEEEEecCCceEeeCCCCCCCCCCCc
Q psy14556 115 MVTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGF------------GFKDSTFHRVIPNFMCQGGDFTNHNGTGGK 182 (1181)
Q Consensus 115 ~~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~------------~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~ 182 (1181)
..++++|+.|+|+||||+|.||+||+||++||++.+++ +|+|+.|||+++++++|||++.. .+.++.
T Consensus 4 ~~~ti~T~~G~I~ieL~~d~aP~tv~nF~~L~~~~~~~~~~~~~~~~~~~~Y~g~~~~rv~~~~~iq~g~~~~-~~~~~~ 82 (171)
T d1w74a_ 4 ATATLHTNRGDIKIALFGNHAPKTVANFVGLAQGTKDYSTQNASGGPSGPFYDGAVFHRVIQGFMIQGGDPTG-TGRGGP 82 (171)
T ss_dssp EEEEEEETTEEEEEEECTTTSHHHHHHHHHHHHTCSCCSSCCTTBSSSSCSSTTEEEEEEETTTEEEECCTTS-SSSCCS
T ss_pred EEEEEEECCEEEEEEEcCCCChHHHHHHHHHHhcCCccccccccccccCceECCeecccccCCceeEcccccC-CCCCCc
Confidence 46789999999999999999999999999999765432 29999999999999999999864 333333
Q ss_pred ccCCCCCCCC-cCccccCCCceEEeecCCCCCCcceEEEEcCCCCCCCCCCeEEEEEE--cCHHHHHHHHhCCC-CCCCc
Q psy14556 183 SIYGNKFEDE-NFTLKHTGPGILSMANAGPNTNGSQFFITTVKTAWLDNRHVVFGSVV--EGLDVVKKLESMGS-QSGKT 258 (1181)
Q Consensus 183 si~g~~~~dE-~~~l~h~~~G~Lsma~~g~nt~gSQFfItl~~~p~LDg~~vVFGrVi--eG~dVL~kI~~~~t-~~g~P 258 (1181)
...+.+| ...++|+++|+|+|++.+++++||||||++++.|+||++|+|||+|+ +|||||++|+++++ .+++|
T Consensus 83 ---~~~~~~e~~~~~~~~~~g~v~~~~~~~~s~~sqFfIt~~~~p~ld~~~tVFG~Vv~geGmdvl~~I~~~~~~~~~~P 159 (171)
T d1w74a_ 83 ---GYKFADEFHPELQFDKPYLLAMANAGPGTNGSQFFITVGKTPHLNRRHTIFGEVIDAESQRVVEAISKTATDGNDRP 159 (171)
T ss_dssp ---SCCBCCCCCTTCCSCSSSEEEECCSSTTCBSSCEEEESSCCGGGTTTSCEEEEECSHHHHHHHHHHHTSCBCTTSCB
T ss_pred ---ccccccccCCCcCCCCCEEEEEEecCCCCCCcceEeeccCCCccccccEEEEEEeccccHHHHHHHHcCCcCCCCcc
Confidence 2234444 55789999999999999999999999999999999999999999999 59999999999998 78999
Q ss_pred ccceEEeeecc
Q psy14556 259 SKKIVVANSDS 269 (1181)
Q Consensus 259 ~~~V~I~~cGv 269 (1181)
..+|+|.++.+
T Consensus 160 ~~~i~I~~v~i 170 (171)
T d1w74a_ 160 TDPVVIESITI 170 (171)
T ss_dssp SSCCEEEEEEE
T ss_pred CCCcEEEEEEE
Confidence 99999999865
|
| >d1lopa_ b.62.1.1 (A:) Peptidyl-prolyl cis-trans isomerase A, PpiA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Cyclophilin-like superfamily: Cyclophilin-like family: Cyclophilin (peptidylprolyl isomerase) domain: Peptidyl-prolyl cis-trans isomerase A, PpiA species: Escherichia coli [TaxId: 562]
Probab=99.97 E-value=4.1e-32 Score=277.37 Aligned_cols=149 Identities=28% Similarity=0.479 Sum_probs=129.0
Q ss_pred EEEecccceeEEEEEEcCCChHHHHHHHHHHccCCCccccCCEEEEecCCceEeeCCCCCCCCCCCcccCCCCCCCCcCc
Q psy14556 116 VTNLDDNLESEHIKLRSDVVPKTAENFRALCTGEKGFGFKDSTFHRVIPNFMCQGGDFTNHNGTGGKSIYGNKFEDENFT 195 (1181)
Q Consensus 116 ~vv~~T~~GrIvIeLf~d~aP~tv~NFl~LctG~~G~~Y~g~~FhRVip~f~iQgGd~~~~~g~gg~si~g~~~~dE~~~ 195 (1181)
+|.++|+.|+|+||||.+.||+||+||++|| +.|+ |+|+.||||+++|++|+||+..+.+.+ .++.++++|...
T Consensus 1 ~V~l~T~~G~i~ieL~~~~aP~t~~nF~~l~--~~g~-Y~g~~fhrv~~~~~iq~G~~~~~~~~~---~~~~~~~~e~~~ 74 (164)
T d1lopa_ 1 MVTFHTNHGDIVIKTFDDKAPETVKNFLDYC--REGF-YNNTIFHRVINGFMIQGGGFEPGMKQK---ATKEPIKNEANN 74 (164)
T ss_dssp CEEEEETTEEEEEEECTTTSHHHHHHHHHHH--HTTT-TTTEECCEEETTTEEEESSEETTTEEC---CCCCCBCCCCCS
T ss_pred CEEEEeCCeEEEEEEcCCCCHHHHHHHHHHH--HccC-cCCceeeEEcCCceeeeeccccCCcCC---ccCCCccccccc
Confidence 4789999999999999999999999999999 8888 999999999999999999986543332 347778888665
Q ss_pred cccCCCceEEeecC-CCCCCcceEEEEcCCC--------CCCCCCCeEEEEEEcCHHHHHHHHhCCCC-C----CCcccc
Q psy14556 196 LKHTGPGILSMANA-GPNTNGSQFFITTVKT--------AWLDNRHVVFGSVVEGLDVVKKLESMGSQ-S----GKTSKK 261 (1181)
Q Consensus 196 l~h~~~G~Lsma~~-g~nt~gSQFfItl~~~--------p~LDg~~vVFGrVieG~dVL~kI~~~~t~-~----g~P~~~ 261 (1181)
..++.+|.|+|++. +++++||||||++++. |++|++|+|||+|++|||||++|+++++. . ++|.++
T Consensus 75 ~~~h~~g~l~~~~~~~~~~~~sqFfi~~~~~~~~~~~~~~~~~~~ytvFG~Vv~G~dvl~~I~~~~t~~~~~~~~~P~~~ 154 (164)
T d1lopa_ 75 GLKNTRGTLAMARTQAPHSATAQFFINVVDNDFLNFSGESLQGWGYCVFAEVVDGMDEVDKIKGVATGRSGMHQDVPKED 154 (164)
T ss_dssp SCCCCTTEEEECCCSSTTCBCSCEEEESSCCGGGSCCSSSTTTSCCCEEEEEEECHHHHHHHHTSCEEEETTEEEEESSC
T ss_pred cccceeeEEEEeccCCCCCccceeeeeccccccccccCCCcCCCceeecCEEeccHHHHHHHHhCCcCCCCCcCCCcCCC
Confidence 45555899999974 6999999999999875 78999999999999999999999998882 3 489999
Q ss_pred eEEeeeccc
Q psy14556 262 IVVANSDSH 270 (1181)
Q Consensus 262 V~I~~cGvl 270 (1181)
|+|.++.+.
T Consensus 155 v~I~~v~I~ 163 (164)
T d1lopa_ 155 VIIESVTVS 163 (164)
T ss_dssp CEEEEEEEC
T ss_pred eEEEEEEEe
Confidence 999998765
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=1.5e-29 Score=284.70 Aligned_cols=197 Identities=22% Similarity=0.286 Sum_probs=154.4
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcC-----------CCCeeeEccccccC--Cc
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR-----------HRNIVQYLGSVSEE--GY 876 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~-----------HPNIVkl~g~~~d~--~~ 876 (1181)
.++||+|+||+||+|++..+++.||||++++... ..+.+.+|+.+++.++ |+||+++++++... ..
T Consensus 18 ~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~ 96 (362)
T d1q8ya_ 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG 96 (362)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTE
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccc
Confidence 3479999999999999999999999999975432 2456788999998875 57899999887543 56
Q ss_pred EEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccc-cceecccCCCCCcccccCCC-----eeeeecC
Q psy14556 877 FKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHG-QKIVHRDIKGDNVLVNTYSG-----VVKISDF 950 (1181)
Q Consensus 877 l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs-~gIVHrDLKP~NILLd~~~g-----~vKLiDF 950 (1181)
.+++|+++..+..............+++..++.++.||+.||+|||+ .||+||||||+|||++..+. .++|+||
T Consensus 97 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~df 176 (362)
T d1q8ya_ 97 VHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADL 176 (362)
T ss_dssp EEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCC
T ss_pred eeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeec
Confidence 77777777666544444434355677899999999999999999997 89999999999999976222 5999999
Q ss_pred CcccccccCCCCCccccCCccccCchhhccCCCCCCCccccccCCCccccccccccchhHHHHHHHHHHHhCCCCCCCCC
Q psy14556 951 GTSKRLAGLCPSAETFTGTLQYMAPEVIDKGQRGYGAPVRQRDKINPCCRIEYKKMKINVFLCVIISQLLVLTAALKKKT 1030 (1181)
Q Consensus 951 GlAk~l~~~~~~~~t~~GT~~Y~APEvl~gg~~~~ssDVDi~~dI~~~~~i~~~~~k~DwSLGvILyELLTGk~PF~~~~ 1030 (1181)
|.+..... ......||+.|+|||++.+..+ +..+|+ ||+||++++|++|+.||....
T Consensus 177 g~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~--~~~~Di------------------wSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 177 GNACWYDE---HYTNSIQTREYRSPEVLLGAPW--GCGADI------------------WSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp TTCEETTB---CCCSCCSCGGGCCHHHHHTCCC--CTHHHH------------------HHHHHHHHHHHHSSCCC----
T ss_pred cccccccc---ccccccccccccChhhccccCC--Cccccc------------------cchHHHHHHHHHCCCCCCCCc
Confidence 99976543 2344579999999999986543 344444 999999999999999997654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.77 E-value=4.8e-19 Score=182.36 Aligned_cols=131 Identities=18% Similarity=0.194 Sum_probs=102.3
Q ss_pred ceeecccCceEEEEEEEcCCCeEEEEEEecCCCCC-----C-------------hhHHHHHHHHHHhcCCCCeeeEcccc
Q psy14556 810 RIELGKGSYGVVYAARELDRQVKLAIKEIPEKNLG-----D-------------VQPLHEEIKLHSQLRHRNIVQYLGSV 871 (1181)
Q Consensus 810 ~~kIG~G~fG~VYka~d~~tg~~VAIKii~~~~~~-----~-------------~e~f~rEi~IL~~L~HPNIVkl~g~~ 871 (1181)
..+||+|+||+||+|.+. +++.||||+++..... . .....+|...+.++.|++++..+++.
T Consensus 5 g~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 5 GKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred CCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 347999999999999874 6889999987543110 0 12345688899999999999887653
Q ss_pred ccCCcEEEEEeecCCCCcccchhcccCCCCCChHHHHHHHHHHHhhhhhccccceecccCCCCCcccccCCCeeeeecCC
Q psy14556 872 SEEGYFKIFMEQVPGGSLSTLLRVKWGPLKENESTMSFYTKQILEGLKYLHGQKIVHRDIKGDNVLVNTYSGVVKISDFG 951 (1181)
Q Consensus 872 ~d~~~l~LVmEy~~gGSL~dlL~~~~~~~~l~e~~i~~Ia~QIa~AL~yLHs~gIVHrDLKP~NILLd~~~g~vKLiDFG 951 (1181)
. .+++|||+++..+.++ +...+..++.|++.+|.|||++||+||||||+|||+++ +.++|+|||
T Consensus 84 ~----~~lvme~~~~~~~~~l----------~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~--~~~~liDFG 147 (191)
T d1zara2 84 G----NAVLMELIDAKELYRV----------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE--EGIWIIDFP 147 (191)
T ss_dssp T----TEEEEECCCCEEGGGC----------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET--TEEEECCCT
T ss_pred C----CEEEEEeeccccccch----------hhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC--CCEEEEECC
Confidence 2 3799999987655432 23345678999999999999999999999999999985 569999999
Q ss_pred cccccc
Q psy14556 952 TSKRLA 957 (1181)
Q Consensus 952 lAk~l~ 957 (1181)
.|....
T Consensus 148 ~a~~~~ 153 (191)
T d1zara2 148 QSVEVG 153 (191)
T ss_dssp TCEETT
T ss_pred CcccCC
Confidence 987654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.92 E-value=1.1e-05 Score=84.23 Aligned_cols=75 Identities=17% Similarity=0.153 Sum_probs=55.1
Q ss_pred cCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcC-CCCeeeEccccccCCcEEEEEeecCCCCcccc
Q psy14556 816 GSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR-HRNIVQYLGSVSEEGYFKIFMEQVPGGSLSTL 892 (1181)
Q Consensus 816 G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~-HPNIVkl~g~~~d~~~l~LVmEy~~gGSL~dl 892 (1181)
++.+.||+.. ..+..+++|+...........+.+|...+..+. +--+.+++.+..+++..++||++++|.++.+.
T Consensus 25 ~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 25 MSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE 100 (263)
T ss_dssp CSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred CCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccc
Confidence 3346899875 355678889886655445556888999888774 43466777777788899999999998877543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.57 E-value=0.00012 Score=75.48 Aligned_cols=75 Identities=23% Similarity=0.228 Sum_probs=53.0
Q ss_pred ecccCc-eEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCC--CCeeeEccccccCCcEEEEEeecCCCCc
Q psy14556 813 LGKGSY-GVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRH--RNIVQYLGSVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 813 IG~G~f-G~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~H--PNIVkl~g~~~d~~~l~LVmEy~~gGSL 889 (1181)
+..|.. +.||+... ..+..+++|....... ..+..|...++.+.. -.+.+++.+..+++..++||++++|.++
T Consensus 18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEe-CCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 444543 67898874 4566788898755433 347788888887732 3356677777788889999999988776
Q ss_pred cc
Q psy14556 890 ST 891 (1181)
Q Consensus 890 ~d 891 (1181)
.+
T Consensus 94 ~~ 95 (255)
T d1nd4a_ 94 LS 95 (255)
T ss_dssp TT
T ss_pred cc
Confidence 44
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.31 E-value=0.00036 Score=78.01 Aligned_cols=77 Identities=16% Similarity=0.129 Sum_probs=50.6
Q ss_pred eeecccCceEEEEEEEcCCCeEEEEEEecCC-------CCCChhHHHHHHHHHHhcC-C--CCeeeEccccccCCcEEEE
Q psy14556 811 IELGKGSYGVVYAARELDRQVKLAIKEIPEK-------NLGDVQPLHEEIKLHSQLR-H--RNIVQYLGSVSEEGYFKIF 880 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~tg~~VAIKii~~~-------~~~~~e~f~rEi~IL~~L~-H--PNIVkl~g~~~d~~~l~LV 880 (1181)
+.||.|....||++....+++.+++|..... .....++...|...|+.+. + ..+.+++.+ +++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 3689999999999988777889999976431 1123456778888887762 2 345566654 34456789
Q ss_pred EeecCCCCc
Q psy14556 881 MEQVPGGSL 889 (1181)
Q Consensus 881 mEy~~gGSL 889 (1181)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999976543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.55 E-value=0.023 Score=62.69 Aligned_cols=74 Identities=16% Similarity=0.148 Sum_probs=51.4
Q ss_pred eeecccCceEEEEEEEcC-------CCeEEEEEEecCCCCCChhHHHHHHHHHHhcC-CCCeeeEccccccCCcEEEEEe
Q psy14556 811 IELGKGSYGVVYAARELD-------RQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLR-HRNIVQYLGSVSEEGYFKIFME 882 (1181)
Q Consensus 811 ~kIG~G~fG~VYka~d~~-------tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~-HPNIVkl~g~~~d~~~l~LVmE 882 (1181)
.+|+.|-.-.+|++.... ..+.|++++... ........+|..+++.+. +.-..++++++.. .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 358888889999998643 345688888752 223345678999998884 4334567777654 58999
Q ss_pred ecCCCCcc
Q psy14556 883 QVPGGSLS 890 (1181)
Q Consensus 883 y~~gGSL~ 890 (1181)
|++|.+|.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EeccccCC
Confidence 99876554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.35 E-value=0.016 Score=62.33 Aligned_cols=69 Identities=14% Similarity=0.299 Sum_probs=45.2
Q ss_pred eEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCC--eeeEcc-----ccccCCcEEEEEeecCCCCc
Q psy14556 819 GVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRN--IVQYLG-----SVSEEGYFKIFMEQVPGGSL 889 (1181)
Q Consensus 819 G~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPN--IVkl~g-----~~~d~~~l~LVmEy~~gGSL 889 (1181)
-.||++.. .+|..|++|+.+.... ..+.+..|...+..|.... ++..+. .+...+..+.++++++|..+
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 47999874 5678899999865532 3567888999888874222 121111 12345678899999977544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.22 E-value=0.12 Score=54.27 Aligned_cols=137 Identities=13% Similarity=0.042 Sum_probs=71.3
Q ss_pred ecccCceEEEEEEEcCCCeEEEEEEecCCCCCChhHHHHHHHHHHhcCCCC--eeeEccc------cccCCcEEEEEeec
Q psy14556 813 LGKGSYGVVYAARELDRQVKLAIKEIPEKNLGDVQPLHEEIKLHSQLRHRN--IVQYLGS------VSEEGYFKIFMEQV 884 (1181)
Q Consensus 813 IG~G~fG~VYka~d~~tg~~VAIKii~~~~~~~~e~f~rEi~IL~~L~HPN--IVkl~g~------~~d~~~l~LVmEy~ 884 (1181)
|..|---+.|+.... .+ .+++|++.... ..+.+..|+.++..|...+ +...+.. ....+....++.+.
T Consensus 26 i~~G~~N~ny~v~t~-~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~ 101 (316)
T d2ppqa1 26 IAEGVENSNFLLHTT-KD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 101 (316)
T ss_dssp ECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred CCCCcccCeEEEEEC-CC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeec
Confidence 666777888998753 33 58999986532 2345667777777774222 1111111 12234566677776
Q ss_pred CCCCcccchhcc------------------cCC--CCC------------------ChHHHHHHHHHHHhhhhhcc----
Q psy14556 885 PGGSLSTLLRVK------------------WGP--LKE------------------NESTMSFYTKQILEGLKYLH---- 922 (1181)
Q Consensus 885 ~gGSL~dlL~~~------------------~~~--~~l------------------~e~~i~~Ia~QIa~AL~yLH---- 922 (1181)
.+......-... ... ... ........+..+...+...+
T Consensus 102 ~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L 181 (316)
T d2ppqa1 102 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 181 (316)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred ccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCcccc
Confidence 664432211000 000 000 01111112222333333333
Q ss_pred ccceecccCCCCCcccccCCCeeeeecCCccc
Q psy14556 923 GQKIVHRDIKGDNVLVNTYSGVVKISDFGTSK 954 (1181)
Q Consensus 923 s~gIVHrDLKP~NILLd~~~g~vKLiDFGlAk 954 (1181)
..|+||+|+.++||+++. +...-|+||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~-~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLG-DELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEET-TEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhccc-ccceeEecccccc
Confidence 358999999999999987 5566899999875
|